PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Foley, DL; Mackinnon, A; Watts, GF; Shaw, JE; Magliano, DJ; Castle, DJ; McGrath, JJ; Waterreus, A; Morgan, VA; Galletly, CA				Foley, Debra L.; Mackinnon, Andrew; Watts, Gerald F.; Shaw, Jonathan E.; Magliano, Dianna J.; Castle, David J.; McGrath, John J.; Waterreus, Anna; Morgan, Vera A.; Galletly, Cherrie A.			Cardiometabolic Risk Indicators That Distinguish Adults with Psychosis from the General Population, by Age and Gender	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; AUSTRALIAN NATIONAL-SURVEY; DRUG-NAIVE PATIENTS; METABOLIC RISK; SCHIZOPHRENIA; 1ST-EPISODE; MORTALITY; ANTIPSYCHOTICS; OBESITY; PEOPLE	Individuals with psychosis are more likely than the general community to develop obesity and to die prematurely from heart disease. Interventions to improve cardiovascular outcomes are best targeted at the earliest indicators of risk, at the age they first emerge. We investigated which cardiometabolic risk indicators distinguished those with psychosis from the general population, by age by gender, and whether obesity explained the pattern of observed differences. Data was analyzed from an epidemiologically representative sample of 1,642 Australians with psychosis aged 18-64 years and a national comparator sample of 8,866 controls aged 25-64 years from the general population. Cubic b-splines were used to compare cross sectional age trends by gender for mean waist circumference, body mass index [BMI], blood pressure, fasting blood glucose, triglycerides, LDL, HDL, and total cholesterol in our psychosis and control samples. At age 25 individuals with psychosis had a significantly higher mean BMI, waist circumference, triglycerides, glucose [women only], and diastolic blood pressure and significantly lower HDL-cholesterol than controls. With the exception of triglycerides at age 60+ in men, and glucose in women at various ages, these differences were present at every age. Differences in BMI and waist circumference between samples, although dramatic, could not explain all differences in diastolic blood pressure, HDL-cholesterol or triglycerides but did explain differences in glucose. Psychosis has the hallmarks of insulin resistance by at least age 25. The entire syndrome, not just weight, should be a focus of intervention to reduce mortality from cardiovascular disease.	[Foley, Debra L.; Mackinnon, Andrew] Univ Melbourne, Orygen Youth Hlth Res Ctr, Melbourne, Vic 3010, Australia; [Foley, Debra L.; Mackinnon, Andrew] Univ Melbourne, Ctr Youth Mental Hlth, Melbourne, Vic 3010, Australia; [Watts, Gerald F.] Univ Western Australia, Lipid Disorders Clin, Metab Res Ctr, Nedlands, WA 6009, Australia; [Watts, Gerald F.] Univ Western Australia, Dept Internal Med, Royal Perth Hosp, Nedlands, WA 6009, Australia; [Watts, Gerald F.] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Shaw, Jonathan E.; Magliano, Dianna J.] Baker IDI Heart & Diabet Inst, Dept Clin Diabet & Epidemiol, Melbourne, Vic, Australia; [Castle, David J.] St Vincents Hosp, Melbourne, Vic, Australia; [Castle, David J.] Univ Melbourne, Dept Psychiat, Melbourne, Vic 3010, Australia; [McGrath, John J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Waterreus, Anna; Morgan, Vera A.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Nedlands, WA 6009, Australia; [Galletly, Cherrie A.] Univ Adelaide, Discipline Psychiat, Sch Med, Adelaide, SA 5005, Australia; [Galletly, Cherrie A.] Northern Adelaide Local Hlth Network, Adelaide, SA, Australia	Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia; Baker Heart and Diabetes Institute; St Vincent's Hospital Melbourne; University of Melbourne; University of Queensland; University of Western Australia; University of Adelaide	Foley, DL (corresponding author), Univ Melbourne, Orygen Youth Hlth Res Ctr, Melbourne, Vic 3010, Australia.	foley.debra@gmail.com	Shaw, Jonathan/E-7388-2010; Morgan, Vera/U-4851-2019; McGrath, John Joseph/G-5493-2010	Shaw, Jonathan/0000-0002-6187-2203; McGrath, John Joseph/0000-0002-4792-6068; Waterreus, Anna/0000-0002-1648-7701; Magliano, Dianna/0000-0002-9507-6096; Mackinnon, Andrew/0000-0003-0831-9801; Watts, Gerald/0000-0003-2276-1524	Australian Government Department of Health and Ageing; Commonwealth Dept of Health and Aged Care; Abbott Australasia Pty Ltd; Alphapharm Pty Ltd; AstraZeneca; Aventis Pharmaceutical; Bristol-Myers Squibb Pharmaceuticals; Eli Lilly [Aust] Pty Ltd; GlaxoSmithKline; Janssen-Cilag [Aust] Pty Ltd; Merck Lipha s.a.; Merck Sharp Dohme [Aust]; Novartis Pharmaceutical [Aust] Pty Ltd.; Novo Nordisk Pharmaceutical Pty Ltd; Pharmacia and Upjohn Pty Ltd; Pfizer Pty Ltd; Roche Diagnostics; Sanofi Synthelabo [Aust] Pty Ltd.; Servier Laboratories [Aust] Pty Ltd; BioRad Laboratories Pty Ltd; HITECH Pathology Pty Ltd; Australian Kidney Foundation; Diabetes Australia; Diabetes Australia [Northern Territory]; Queensland Health; South Australian Department of Human Services; Tasmanian Department of Health and Human Services; Territory Health Services; Victorian Department of Human Services; Victorian OIS program; Health Department of Western Australia; Colonial Foundation [Australia]	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Commonwealth Dept of Health and Aged Care; Abbott Australasia Pty Ltd(Abbott Laboratories); Alphapharm Pty Ltd; AstraZeneca(AstraZeneca); Aventis Pharmaceutical; Bristol-Myers Squibb Pharmaceuticals(Bristol-Myers Squibb); Eli Lilly [Aust] Pty Ltd(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Janssen-Cilag [Aust] Pty Ltd; Merck Lipha s.a.; Merck Sharp Dohme [Aust](Merck & Company); Novartis Pharmaceutical [Aust] Pty Ltd.; Novo Nordisk Pharmaceutical Pty Ltd(Novo Nordisk); Pharmacia and Upjohn Pty Ltd; Pfizer Pty Ltd(Pfizer); Roche Diagnostics; Sanofi Synthelabo [Aust] Pty Ltd.; Servier Laboratories [Aust] Pty Ltd; BioRad Laboratories Pty Ltd; HITECH Pathology Pty Ltd; Australian Kidney Foundation; Diabetes Australia; Diabetes Australia [Northern Territory]; Queensland Health; South Australian Department of Human Services(Department for Environment, Food & Rural Affairs (DEFRA)); Tasmanian Department of Health and Human Services; Territory Health Services; Victorian Department of Human Services; Victorian OIS program; Health Department of Western Australia; Colonial Foundation [Australia]	The psychosis survey [the SHIP study] was funded by the Australian Government Department of Health and Ageing under contract to The University of Western Australia. The general population survey [the AusDiab study] was funded by The Commonwealth Dept of Health and Aged Care, Abbott Australasia Pty Ltd, Alphapharm Pty Ltd, AstraZeneca, Aventis Pharmaceutical, Bristol-Myers Squibb Pharmaceuticals, Eli Lilly [Aust] Pty Ltd, GlaxoSmithKline, Janssen-Cilag [Aust] Pty Ltd, Merck Lipha s.a., Merck Sharp & Dohme [Aust], Novartis Pharmaceutical [Aust] Pty Ltd., Novo Nordisk Pharmaceutical Pty Ltd, Pharmacia and Upjohn Pty Ltd, Pfizer Pty Ltd, Roche Diagnostics, Sanofi Synthelabo [Aust] Pty Ltd., Servier Laboratories [Aust] Pty Ltd, BioRad Laboratories Pty Ltd, HITECH Pathology Pty Ltd, the Australian Kidney Foundation, Diabetes Australia, Diabetes Australia [Northern Territory], Queensland Health, South Australian Department of Human Services, Tasmanian Department of Health and Human Services, Territory Health Services, Victorian Department of Human Services, the Victorian OIS program and Health Department of Western Australia. Drs Foley and Mackinnon were supported by the Colonial Foundation [Australia]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaugh VL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022662; [Anonymous], AUSDIAB REP 2000; Bushe CJ, 2010, J PSYCHOPHARMACOL, V24, P17, DOI 10.1177/1359786810382468; Castle DJ, 2006, PSYCHOL MED, V36, P69, DOI 10.1017/S0033291705005969; Cohen D, 2011, NEUROPSYCHOPHARMACOL, V36, P2368, DOI 10.1038/npp.2011.94; Daumit GL, 2013, NEW ENGL J MED, V368, P1594, DOI 10.1056/NEJMoa1214530; De Hert M, 2011, BRIT J PSYCHIAT, V199, P99, DOI 10.1192/bjp.bp.110.084665; Hert M, 2012, NAT REV ENDOCRINOL, V8, P114, DOI 10.1038/nrendo.2011.156; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; DeFronzo RA, 2011, AM J CARDIOL, V108, p3B, DOI 10.1016/j.amjcard.2011.03.013; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Foley DL, 2011, ARCH GEN PSYCHIAT, V68, P609, DOI 10.1001/archgenpsychiatry.2011.2; Galletly CA, 2012, AUST NZ J PSYCHIAT, V46, P753, DOI 10.1177/0004867412453089; HOLM S, 1979, SCAND J STAT, V6, P65; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kahn RS, 2008, LANCET, V371, P1085, DOI 10.1016/S0140-6736(08)60486-9; Laursen TM, 2012, CURR OPIN PSYCHIATR, V25, P83, DOI 10.1097/YCO.0b013e32835035ca; Mitchell AJ, 2012, PSYCHOL MED, V42, P125, DOI 10.1017/S003329171100105X; Morgan VA, 2012, AUST NZ J PSYCHIAT, V46, P735, DOI 10.1177/0004867412449877; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Moser DJ, 2002, AM J PSYCHIAT, V159, P1201, DOI 10.1176/appi.ajp.159.7.1201; Newcomer JW, 2007, J CLIN PSYCHIAT, V68, P8; Newson R., 2000, STATA TECHNICAL B, V57, P20; Nielsen J, 2010, NEUROPSYCHOPHARMACOL, V35, P1997, DOI 10.1038/npp.2010.78; Polymeropoulos MH, 2009, SCHIZOPHR RES, V108, P134, DOI 10.1016/j.schres.2008.11.025; Remington G, 1998, BRIT J PSYCHIAT, V172, P66, DOI 10.1192/S0007125000297687; Remington G, 2011, J CLIN PSYCHIAT, V72, P1042, DOI 10.4088/JCP.09m05866yel; Remington G, 2010, SCHIZOPHRENIA BULL, V36, P900, DOI 10.1093/schbul/sbq083; Roberts LW, 2000, AM J PSYCHIAT, V157, P67, DOI 10.1176/ajp.157.1.67; Rouillon F, 2005, EUR PSYCHIAT, V20, pS345, DOI 10.1016/S0924-9338(05)80189-0; Ryan MCM, 2003, AM J PSYCHIAT, V160, P284, DOI 10.1176/appi.ajp.160.2.284; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Spelman LM, 2007, DIABETIC MED, V24, P481, DOI 10.1111/j.1464-5491.2007.02092.x; Stroup TS, 2011, AM J PSYCHIAT, V168, P947, DOI 10.1176/appi.ajp.2011.10111609; Tauscher J, 2001, CNS DRUGS, V15, P671, DOI 10.2165/00023210-200115090-00001; Thornicroft G, 2011, BRIT J PSYCHIAT, V199, P441, DOI 10.1192/bjp.bp.111.092718; World Health Organization, 2008, ICD 10 INT STAT CLAS; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	38	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82606	10.1371/journal.pone.0082606	http://dx.doi.org/10.1371/journal.pone.0082606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367528	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300044
J	Hicks, SL; Sharma, R; Khan, AN; Berna, CM; Waldecker, A; Talbot, K; Kennard, C; Turner, MR				Hicks, Stephen L.; Sharma, Rakesh; Khan, Amad N.; Berna, Claire M.; Waldecker, Andrea; Talbot, Kevin; Kennard, Chris; Turner, Martin R.			An Eye-Tracking Version of the Trail-Making Test	PLOS ONE			English	Article							EXECUTIVE DYSFUNCTION; PART-B; DISEASE; FMRI; AGE	The neurodegenerative disorder amyotrophic lateral sclerosis may render patients unable to speak or write, so that objective assessment of cognitive impairment, which is commonly of a dysexecutive nature, is challenging. There is therefore a need to develop other methods of assessment that utilize other relatively unaffected motor systems. In this proof-of-principle study a novel eye-tracking version of the trail-making test was compared with performance on the standard written version in a group of healthy volunteers. There was good correlation for speed between both versions of Part B (R-2=0.73), suggesting that this is a viable method to objectively assess cognitive impairment in disorders where patients are unable to speak or write.	[Hicks, Stephen L.; Sharma, Rakesh; Khan, Amad N.; Berna, Claire M.; Waldecker, Andrea; Talbot, Kevin; Kennard, Chris; Turner, Martin R.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England	University of Oxford	Turner, MR (corresponding author), Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England.	martin.turner@ndcn.ox.ac.uk		Turner, Martin/0000-0003-0267-3180; Talbot, Kevin/0000-0001-5490-1697	Rhodes Foundation; Wellcome Trust; Medical Research Council; Motor Neuron Disease Association Lady Edith Wolfson Clinician Fellowship; NIHR Biomedical Research Centre, Oxford; MRC [MR/K01014X/1, G0701923] Funding Source: UKRI; Medical Research Council [MR/K01014X/1, G0701923] Funding Source: researchfish; Motor Neurone Disease Association [Turner/Jan13/944-795] Funding Source: researchfish	Rhodes Foundation; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Motor Neuron Disease Association Lady Edith Wolfson Clinician Fellowship; NIHR Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Motor Neurone Disease Association	This work was supported by the Rhodes Foundation (RS), Wellcome Trust (SH, CB, CK), Medical Research Council & Motor Neuron Disease Association Lady Edith Wolfson Clinician Fellowship (MRT), and the NIHR Biomedical Research Centre, Oxford (CK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 2000, NEUROPSYCHOLOGIA, V38, P734, DOI 10.1016/S0028-3932(99)00146-3; ABRAHAMS S, 2013, AMYOTROPH LATERAL SC; Antoniades CA, 2010, J NEUROL, V257, P1890, DOI 10.1007/s00415-010-5632-2; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Army Individual Test Battery, 1994, MAN DIR SCOR; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.3.CO;2-M; D'Elia L., 1989, COLOR TRAILS 1 2; Drapeau CE, 2007, PERCEPT MOTOR SKILL, V104, P785, DOI 10.2466/PMS.104.3.785-791; Elamin M, 2011, NEUROLOGY, V76, P1263, DOI 10.1212/WNL.0b013e318214359f; GAUDINO EA, 1995, J CLIN EXP NEUROPSYC, V17, P529, DOI 10.1080/01688639508405143; HARTIKAINEN P, 1993, J NEURAL TRANSM-PARK, V6, P127, DOI 10.1007/BF02261006; Jacobson SC, 2011, BRAIN COGNITION, V77, P60, DOI 10.1016/j.bandc.2011.06.001; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kilani M, 2004, AMYOTROPH LATERAL SC, V5, P46, DOI 10.1080/14660820310017560; KOLIND S, 2013, AMYOTROPH LATERAL SC; Kuhlman A, 2006, J CLIN EXP NEUROPSYC, V28, P126, DOI 10.1080/13803390590929289; Lee TMC, 2000, J CLIN EXP NEUROPSYC, V22, P529, DOI 10.1076/1380-3395(200008)22:4;1-0;FT529; Moll J, 2002, ARQ NEURO-PSIQUIAT, V60, P900, DOI 10.1590/S0004-282X2002000600002; Mrazik M, 2010, ARCH CLIN NEUROPSYCH, V25, P236, DOI 10.1093/arclin/acq006; Phukan J, 2007, LANCET NEUROL, V6, P994, DOI 10.1016/S1474-4422(07)70265-X; Ricker, 1994, Assessment, V1, P47, DOI 10.1177/1073191194001001007; SEGALOWITZ SJ, 1992, J CLIN EXP NEUROPSYC, V14, P545, DOI 10.1080/01688639208402844; Sharma R, 2011, ARCH NEUROL-CHICAGO, V68, P857, DOI 10.1001/archneurol.2011.130; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013	25	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84061	10.1371/journal.pone.0084061	http://dx.doi.org/10.1371/journal.pone.0084061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367626	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300126
J	Selden, C; Spearman, CW; Kahn, D; Miller, M; Figaji, A; Erro, E; Bundy, J; Massie, I; Chalmers, SA; Arendse, H; Gautier, A; Sharratt, P; Fuller, B; Hodgson, H				Selden, Clare; Spearman, Catherine Wendy; Kahn, Delawir; Miller, Malcolm; Figaji, Anthony; Erro, Eloy; Bundy, James; Massie, Isobel; Chalmers, Sherri-Ann; Arendse, Hiram; Gautier, Aude; Sharratt, Peter; Fuller, Barry; Hodgson, Humphrey			Evaluation of Encapsulated Liver Cell Spheroids in a Fluidised-Bed Bioartificial Liver for Treatment of Ischaemic Acute Liver Failure in Pigs in a Translational Setting	PLOS ONE			English	Article							ACUTE HEPATIC-FAILURE; HEPG2 CELLS; ALGINATE; SUPPORT; BIOREACTOR; SYSTEM; MODEL; TRIAL; LINES; THROMBOELASTOGRAPHY	Liver failure is an increasing problem. Donor-organ shortage results in patients dying before receiving a transplant. Since the liver can regenerate, alternative therapies providing temporary liver-support are sought. A bioartificial-liver would temporarily substitute function in liver failure buying time for liver regeneration/organ-procurement. Our aim: to develop a prototype bioartificial-liver-machine (BAL) comprising a human liver-derived cell-line, cultured to phenotypic competence and deliverable in a clinical setting to sites distant from its preparation. The objective of this study was to determine whether its use would improve functional parameters of liver failure in pigs with acute liver failure, to provide proof-of-principle. HepG2cells encapsulated in alginate-beads, proliferated in a fluidised-bed-bioreactor providing a biomass of 4-6x10(10) cells, were transported from preparation-laboratory to point-of-use operating theatre (6000miles) under perfluorodecalin at ambient temperature. Irreversible ischaemic liver failure was induced in anaesthetised pigs, after portal-systemic-shunt, by hepatic-artery-ligation. Biochemical parameters, intracranial pressure, and functional-clotting were measured in animals connected in an extracorporeal bioartificial-liver circuit. Efficacy was demonstrated comparing outcomes between animals connected to a circuit containing alginate-encapsulated cells (Cell-bead BAL), and those connected to circuit containing alginate capsules without cells (Empty-bead BAL). Cells of the biomass met regulatory standards for sterility and provenance. All animals developed progressive liver-failure after ischaemia induction. Efficacy of BAL was demonstrated since animals connected to a functional biomass (+cells) had significantly smaller rises in intracranial pressure, lower ammonia levels, more bilirubin conjugation, improved acidosis and clotting restoration compared to animals connected to the circuit without cells. In the +cell group, human proteins accumulated in pigs' plasma. Delivery of biomass using a short-term cold-chain enabled transport and use without loss of function over 3days. Thus, a fluidised-bed bioreactor containing alginate-encapsulated HepG2cell-spheroids improved important parameters of acute liver failure in pigs. The system can readily be up-scaled and transported to point-of-use justifying development at clinical scale.	[Selden, Clare; Erro, Eloy; Bundy, James; Massie, Isobel; Chalmers, Sherri-Ann; Gautier, Aude; Hodgson, Humphrey] UCL, Sch Med, Inst Liver & Digest Hlth, London, England; [Spearman, Catherine Wendy] Univ Cape Town, Dept Med, Div Hepatol, Groote Schuur Hosp, ZA-7925 Cape Town, Western Cape, South Africa; [Kahn, Delawir; Arendse, Hiram] Univ Cape Town, Dept Surg, Groote Schuur Hosp, ZA-7925 Cape Town, Western Cape, South Africa; [Miller, Malcolm] Univ Cape Town, Dept Anaesthet, Groote Schuur Hosp, ZA-7925 Cape Town, Western Cape, South Africa; [Figaji, Anthony] Univ Cape Town, Dept Neurosurg, Red Cross Childrens Hosp, ZA-7925 Cape Town, Western Cape, South Africa; [Sharratt, Peter] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Fuller, Barry] UCL, Sch Med, Div Surg & Intervent Sci, London W1N 8AA, England	University of London; University College London; UCL Medical School; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of Cambridge; University of London; University College London; UCL Medical School	Selden, C (corresponding author), UCL, Sch Med, Inst Liver & Digest Hlth, Royal Free Hosp Campus, London, England.	c.selden@ucl.ac.uk	Miller, Malcolm/AAR-5783-2021; Figaji, Anthony/ADH-9410-2022; Spearman, C.Wendy/R-8173-2019	Miller, Malcolm/0000-0001-6137-7723; Figaji, Anthony/0000-0002-3357-6490; Erro Barbarin, Eloy/0000-0002-3558-4216; Spearman, Catherine Wendy/0000-0003-3199-301X; Selden, Angela/0000-0003-2648-443X	National Institute for Health Research [NEAT L002]; Liver Group Charity: BXHJ; Peter Stebbings Memorial Trust; Weston Foundation; Eranda Foundation; Wellcome Trust	National Institute for Health Research(National Institute for Health Research (NIHR)); Liver Group Charity: BXHJ; Peter Stebbings Memorial Trust; Weston Foundation; Eranda Foundation; Wellcome Trust(Wellcome TrustEuropean Commission)	National Institute for Health Research: NEAT L002 (http://www.nihr.ac.uk/Pages/default.aspx); Liver Group Charity: BXHJ.(http://www.ucl.ac.uk/livergroup/); Peter Stebbings Memorial Trust; Weston Foundation, (http://www.garfieldweston.org/); Eranda Foundation; Wellcome Trust, (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banares R, 2010, J HEPATOL, V52, pS459; BODE BP, 1994, ANN SURG, V220, P411, DOI 10.1097/00000658-199410000-00001; Bode BP, 2002, AM J PHYSIOL-GASTR L, V283, pG1062, DOI 10.1152/ajpgi.00031.2002; CAI ZH, 1988, ARTIF ORGANS, V12, P388, DOI 10.1111/j.1525-1594.1988.tb02793.x; Carpentier B, 2009, GUT, V58, P1690, DOI 10.1136/gut.2008.175380; Chang SJ, 1999, J BIOMAT SCI-POLYM E, V10, P531; Coward SM, 2009, ARTIF ORGANS, V33, P1117, DOI 10.1111/j.1525-1594.2009.00821.x; Coward SM, 2005, ARTIF ORGANS, V29, P152, DOI 10.1111/j.1525-1594.2005.29026.x; David B, 2004, INT J ARTIF ORGANS, V27, P284, DOI 10.1177/039139880402700404; Detry O, 2007, HEPATO-GASTROENTEROL, V54, P2109; DeVos P, 1997, BIOMATERIALS, V18, P273, DOI 10.1016/S0142-9612(96)00135-4; Erro E, 2011, J HEPATOL, V54, pS427; Erro E, 2010, J HEPATOL, V52, pS322, DOI 10.1016/S0168-8278(10)60827-6; Erro E, 2009, INT J ARTIF ORGANS, V32, P407; Erro E, 2013, BIORESEARCH OPEN ACC, V2, P1, DOI 10.1089/biores.2012.0286; Hillebrand DJ, 2010, J HEPATOL, V52, pS323, DOI 10.1016/S0168-8278(10)60830-6; Khalil M, 2001, J HEPATOL, V34, P68, DOI 10.1016/S0168-8278(00)00080-5; Klein SM, 2000, ANESTH ANALG, V91, P1091, DOI 10.1097/00000539-200011000-00009; Martini WZ, 2008, J TRAUMA, V65, P535, DOI 10.1097/TA.0b013e31818379a6; Massie I, 2012, TISSUE ENG C; Massie I, 2011, TISSUE ENG PART C-ME, V17, P765, DOI [10.1089/ten.tec.2010.0394, 10.1089/ten.TEC.2010.0394]; Massie I, 2011, CRYOLETTERS, V32, P158; Mavri-Damelin D, 2008, BIOTECHNOL BIOENG, V99, P644, DOI 10.1002/bit.21599; Mavri-Damelin Demetra, 2007, Int J Biochem Cell Biol, V39, P555, DOI 10.1016/j.biocel.2006.10.007; Miyashita T, 2003, SURG TODAY, V33, P743, DOI 10.1007/s00595-003-2599-y; Nibourg GAA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038778; Nibourg GAA, 2012, EXPERT OPIN BIOL TH, V12, P905, DOI 10.1517/14712598.2012.685714; Nieuwoudt M, 2006, BIOMATERIALS, V27, P3836, DOI 10.1016/j.biomaterials.2006.02.013; Nyberg SL, 2012, LIVER TRANSPLANT, V18, pS10, DOI 10.1002/lt.23506; Poyck PPC, 2007, INT J ARTIF ORGANS, V30, P183, DOI 10.1177/039139880703000302; Rahman TM, 2004, ARTIF ORGANS, V28, P476, DOI 10.1111/j.1525-1594.2004.07259.x; Rahman TM, 2000, INT J EXP PATHOL, V81, P145; Rifai Kinan, 2011, Liver Int, V31 Suppl 3, P13, DOI 10.1111/j.1478-3231.2011.02595.x; Roussel JC, 2008, AM J TRANSPLANT, V8, P1101, DOI 10.1111/j.1600-6143.2008.02210.x; Sauer IM, 2003, J HEPATOL, V39, P649, DOI 10.1016/S0168-8278(03)00348-9; Selden C, 1999, ANN NY ACAD SCI, V875, P353, DOI 10.1111/j.1749-6632.1999.tb08517.x; Selden C, 2000, INT J ARTIF ORGANS, V23, P774, DOI 10.1177/039139880002301107; Sosef MN, 2002, TRANSPLANTATION, V73, P204, DOI 10.1097/00007890-200201270-00009; SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006; Stange J, 2011, LIVER TRANSPLANT, V17, P705, DOI 10.1002/lt.22237; STARZL TE, 1975, AM J SURG, V129, P587, DOI 10.1016/0002-9610(75)90323-2; Stevens AC, 2001, HEPATOLOGY, V34, p299A; Tomori T, 2010, BLOOD COAGUL FIBRIN, V21, P20, DOI 10.1097/MBC.0b013e32833113e9; Van de Kerkhove MP, 2002, INT J ARTIF ORGANS, V25, P950, DOI 10.1177/039139880202501009; WOOD RP, 1993, TRANSPLANT P, V25, P53	45	29	30	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82312	10.1371/journal.pone.0082312	http://dx.doi.org/10.1371/journal.pone.0082312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367515	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300031
J	Shapter, FM; Cross, M; Ablett, G; Malory, S; Chivers, IH; King, GJ; Henry, RJ				Shapter, Frances M.; Cross, Michael; Ablett, Gary; Malory, Sylvia; Chivers, Ian H.; King, Graham J.; Henry, Robert J.			High-Throughput Sequencing and Mutagenesis to Accelerate the Domestication of Microlaena stipoides as a New Food Crop	PLOS ONE			English	Article							EVOLUTIONARY HISTORY; RICE DOMESTICATION; MUTATIONS; GRASSES; BARLEY; POPULATION; DISCOVERY; RELATIVES; GENETICS; GENES	Global food demand, climatic variability and reduced land availability are driving the need for domestication of new crop species. The accelerated domestication of a rice-like Australian dryland polyploid grass, Microlaena stipoides (Poaceae), was targeted using chemical mutagenesis in conjunction with high throughput sequencing of genes for key domestication traits. While M. stipoides has previously been identified as having potential as a new grain crop for human consumption, only a limited understanding of its genetic diversity and breeding system was available to aid the domestication process. Next generation sequencing of deeply-pooled target amplicons estimated allelic diversity of a selected base population at 14.3 SNP/Mb and identified novel, putatively mutation-induced polymorphisms at about 2.4 mutations/Mb. A 97% lethal dose (LD97) of ethyl methanesulfonate treatment was applied without inducing sterility in this polyploid species. Forward and reverse genetic screens identified beneficial alleles for the domestication trait, seed-shattering. Unique phenotypes observed in the M2 population suggest the potential for rapid accumulation of beneficial traits without recourse to a traditional cross-breeding strategy. This approach may be applicable to other wild species, unlocking their potential as new food, fibre and fuel crops.	[Shapter, Frances M.; Cross, Michael; Ablett, Gary; Malory, Sylvia; Chivers, Ian H.; King, Graham J.] So Cross Univ, Lismore, NSW 2480, Australia; [Chivers, Ian H.] Native Seeds Pty Ltd, Sandringham, Vic, Australia; [Henry, Robert J.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia	Southern Cross University; University of Queensland	Shapter, FM (corresponding author), So Cross Univ, Lismore, NSW 2480, Australia.	frances.shapter@scu.edu.au	Shapter, Frances M/A-3094-2014; Henry, Robert J/B-5824-2008; King, Graham J/AAW-3368-2020	Shapter, Frances M/0000-0001-8562-6034; Henry, Robert J/0000-0002-4060-0292; King, Graham J/0000-0002-5975-6051	Australian Research Council [LP0776409]	Australian Research Council(Australian Research Council)	Funding for this research was provided by the Australian Research Council Linkage program (Project number LP0776409,www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Ahloowalia BS, 2004, EUPHYTICA, V135, P187, DOI 10.1023/B:EUPH.0000014914.85465.4f; Aoki D, 2009, WEED BIOL MANAG, V9, P225, DOI 10.1111/j.1445-6664.2009.00343.x; Bouchenak-Khelladi Y, 2010, BOT J LINN SOC, V162, P543, DOI 10.1111/j.1095-8339.2010.01041.x; Bouchenak-Khelladi Y, 2009, GLOBAL CHANGE BIOL, V15, P2397, DOI 10.1111/j.1365-2486.2009.01860.x; Caldwell DG, 2004, PLANT J, V40, P143, DOI 10.1111/j.1365-313X.2004.02190.x; Cordeiro G, 2006, ANAL BIOCHEM, V355, P145, DOI 10.1016/j.ab.2006.03.026; Cronin JK, 2007, P NATL ACAD SCI USA, V104, P2773, DOI 10.1073/pnas.0611226104; DAVIS C, 2005, RURAL IND RES DEV CO, P1; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dong CM, 2009, PLANT GENOME-US, V2, P39, DOI 10.3835/plantgenome2008.10.0012; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Fitzgerald TL, 2011, P NATL ACAD SCI USA, V108, P21140, DOI 10.1073/pnas.1115203108; Greene EA, 2003, GENETICS, V164, P731; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Henikoff S, 2003, ANNU REV PLANT BIOL, V54, P375, DOI 10.1146/annurev.arplant.54.031902.135009; Henry R., 2010, PLANT RESOURCES FOOD; Huxtable CHA, 1990, THESIS U NEW ENGLAND; Izawa T, 2009, CURR OPIN PLANT BIOL, V12, P185, DOI 10.1016/j.pbi.2009.01.004; Kellogg EA, 2009, RICE, V2, P1, DOI 10.1007/s12284-009-9022-2; Kharabian-Masouleh A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00557; Kim SY, 2010, GENET EPIDEMIOL, V34, P479, DOI 10.1002/gepi.20501; King GJ, 1995, J MOL EVOL, V41, P732; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li CB, 2006, NEW PHYTOL, V170, P185, DOI 10.1111/j.1469-8137.2005.01647.x; Lin ZW, 2007, PLANTA, V226, P11, DOI 10.1007/s00425-006-0460-4; Malory S, 2011, PLANT BIOTECHNOL J, V9, P1131, DOI 10.1111/j.1467-7652.2011.00640.x; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; MESKEN M, 1968, EUPHYTICA, V17, P363, DOI 10.1007/BF00056237; MUNDY J, 1983, CARLSBERG RES COMMUN, V48, P81, DOI 10.1007/BF02906171; Murray BG, 2005, ANN BOT-LONDON, V96, P1293, DOI 10.1093/aob/mci281; Out AA, 2009, HUM MUTAT, V30, P1703, DOI 10.1002/humu.21122; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; Pienaar E, 2006, COMPUT BIOL CHEM, V30, P102, DOI 10.1016/j.compbiolchem.2005.11.002; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Sexton T, 2013, MOL MARKERS PLANTS, P35; Shapter FM, 2009, J CEREAL SCI, V49, P4, DOI 10.1016/j.jcs.2008.06.013; Shapter F. M., 2008, Plant Genetic Resources Characterization and Utilization, V6, P85, DOI 10.1017/S1479262108986512; SHENKIN PS, 1991, PROTEINS, V11, P297, DOI 10.1002/prot.340110408; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Stephenson P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-62; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Till BJ, 2003, GENOME RES, V13, P524, DOI 10.1101/gr.977903; Tindale NormanB., 1977, STONE TOOLS CULTURAL; Tsai H, 2011, PLANT PHYSIOL, V156, P1257, DOI 10.1104/pp.110.169748; Turner Fred, 1895, AUSTR GRASSES; van Harten A.M., 1998, MUTATION BREEDING TH; Vaughan DA, 2007, ANN BOT-LONDON, V100, P893, DOI 10.1093/aob/mcm224	50	34	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82641	10.1371/journal.pone.0082641	http://dx.doi.org/10.1371/journal.pone.0082641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367532	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300048
J	Shiotani, A; Murao, T; Fujita, Y; Fujimura, Y; Sakakibara, T; Nishio, K; Haruma, K				Shiotani, Akiko; Murao, Takahisa; Fujita, Yoshihiko; Fujimura, Yoshinori; Sakakibara, Takashi; Nishio, Kazuto; Haruma, Ken			Novel Single Nucleotide Polymorphism Markers for Low Dose Aspirin-Associated Small Bowel Bleeding	PLOS ONE			English	Article							PEPTIC-ULCER; INJURY; RISK; DRUGS; GENE; RATS	Background: Aspirin-induced enteropathy is now increasingly being recognized although the pathogenesis of small intestinal damage induced by aspirin is not well understood and related risk factors have not been established. Aim: To investigate pharmacogenomic profile of low dose aspirin (LDA)-induced small bowel bleeding. Methods: Genome-wide analysis of single nucleotide polymorphisms (SNPs) was performed using the Affymetrix DMET (TM) Plus Premier Pack. Genotypes of candidate genes associated with small bowel bleeding were determined using TaqMan SNP Genotyping Assay kits and direct sequencing. Results: In the validation study in overall 37 patients with small bowel bleeding and 400 controls, 4 of 27 identified SNPs: CYP4F11 (rs1060463) GG (p=0.003), CYP2D6 (rs28360521) GG (p=0.02), CYP24A1 (rs4809957) T allele (p=0.04), and GSTP1 (rs1695) G allele (p=0.04) were significantly more frequent in the small bowel bleeding group compared to the controls. After adjustment for significant factors, CYP2D6 (rs28360521) GG (OR 4.11, 95% CI. 1.62 -10.4) was associated with small bowel bleeding. Conclusions: CYP4F11 and CYP2D6 SNPs may identify patients at increased risk for aspirin-induced small bowel bleeding.	[Shiotani, Akiko; Murao, Takahisa; Haruma, Ken] Kawasaki Med Sch, Dept Internal Med, Div Gastroenterol, Kurashiki, Okayama, Japan; [Fujita, Yoshihiko; Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Sayama, Osaka, Japan; [Fujimura, Yoshinori; Sakakibara, Takashi] Sakakibara Heart Inst Okayama, Dept Gastroenterol, Okayama, Japan	Kawasaki Medical School; Kindai University (Kinki University)	Shiotani, A (corresponding author), Kawasaki Med Sch, Dept Internal Med, Div Gastroenterol, Kurashiki, Okayama, Japan.	shiotani@med.kawasaki-m.ac.jp			Kawasaki Medical School [23590930, 23B-11, 24B-80, 25B-36]	Kawasaki Medical School	This study was supported by Grant-in-Aid for Scientific Research (C) 23590930 and Research Project Grant (23B-11, 24B-80, and 25B-36) from Kawasaki Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Collaboration AT, 1994, BMJ-BRIT MED J, V308, P159, DOI [10.1136/bmj.308.6922.159, DOI 10.1136/BMJ.308.6922.159]; Cooke GE, 2006, EXPERT OPIN DRUG SAF, V5, P815, DOI 10.1517/14740338.5.6.815; Dagle JM, 2011, J PEDIATR-US, V159, P104, DOI 10.1016/j.jpeds.2011.01.002; Dai XM, 2009, REV CARDIOVASC MED, V10, P14; Delaney JA, 2007, CAN MED ASSOC J, V177, P347, DOI 10.1503/cmaj.070186; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; Endo H, 2009, J GASTROENTEROL, V44, P544, DOI 10.1007/s00535-009-0040-z; Endo H, 2009, DIGESTION, V79, P44, DOI 10.1159/000204465; Guengerich FP, 2005, BIOCHEM BIOPH RES CO, V338, P465, DOI 10.1016/j.bbrc.2005.08.079; Hirata Y, 2011, SCAND J GASTROENTERO, V46, P803, DOI 10.3109/00365521.2011.568522; Kalsotra A, 2004, TOXICOL APPL PHARM, V199, P295, DOI 10.1016/j.taap.2003.12.033; KENT TH, 1969, AM J PATHOL, V54, P237; Nadatani Y, 2013, SCAND J GASTROENTERO, V48, P320, DOI 10.3109/00365521.2012.758771; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Qin SY, 2008, GENOMICS, V92, P152, DOI 10.1016/j.ygeno.2008.05.004; Reuter BK, 1997, GASTROENTEROLOGY, V112, P109, DOI 10.1016/S0016-5085(97)70225-7; Shiotani A, 2008, J GASTROENTEROL, V43, P581, DOI 10.1007/s00535-008-2206-5; Shiotani A, 2012, DIGEST LIVER DIS, V44, P201, DOI 10.1016/j.dld.2011.10.005; Shiotani A, 2011, DIGEST DIS SCI, V56, P465, DOI 10.1007/s10620-010-1382-3; Shiotani A, 2010, J GASTROEN HEPATOL, V25, pS31, DOI 10.1111/j.1440-1746.2009.06212.x; Shiotani A, 2009, J GASTROENTEROL, V44, P126, DOI 10.1007/s00535-008-2290-6; Smecuol E, 2009, CLIN GASTROENTEROL H, V7, P524, DOI 10.1016/j.cgh.2008.12.019; Tan VP, 2009, CARDIOVASC REVASCULA, V10, P36, DOI 10.1016/j.carrev.2008.11.001; van Oijen MGH, 2006, DIGEST DIS SCI, V51, P2348, DOI 10.1007/s10620-006-9475-8; Wallace JL, 1997, GASTROENTEROLOGY, V112, P1000, DOI 10.1053/gast.1997.v112.pm9041264; Wallace JL, 2011, GASTROENTEROLOGY, V141, P1314, DOI 10.1053/j.gastro.2011.06.075; Watanabe T, 2008, CLIN GASTROENTEROL H, V6, P1279, DOI 10.1016/j.cgh.2008.06.021; WAX J, 1970, GASTROENTEROLOGY, V58, P772; WHITTLE BJR, 1995, BRIT J PHARMACOL, V116, P2286, DOI 10.1111/j.1476-5381.1995.tb15066.x; Zanger UM, 2004, N-S ARCH PHARMACOL, V369, P23, DOI 10.1007/s00210-003-0832-2	32	22	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84244	10.1371/journal.pone.0084244	http://dx.doi.org/10.1371/journal.pone.0084244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367646	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300134
J	Sommese, RF; Nag, S; Sutton, S; Miller, SM; Spudich, JA; Ruppel, KM				Sommese, Ruth F.; Nag, Suman; Sutton, Shirley; Miller, Susan M.; Spudich, James A.; Ruppel, Kathleen M.			Effects of Troponin T Cardiomyopathy Mutations on the Calcium Sensitivity of the Regulated Thin Filament and the Actomyosin Cross-Bridge Kinetics of Human beta-Cardiac Myosin	PLOS ONE			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; PYRENE-LABELED TROPOMYOSIN; DILATED CARDIOMYOPATHY; ALPHA-TROPOMYOSIN; MUSCLE-CONTRACTION; TRANSGENIC MICE; F-ACTIN; BINDING; MUTANTS; DISEASE	w Hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) lead to significant cardiovascular morbidity and mortality worldwide. Mutations in the genes encoding the sarcomere, the force-generating unit in the cardiomyocyte, cause familial forms of both HCM and DCM. This study examines two HCM-causing (I79N, E163K) and two DCM-causing (R141W, R173W) mutations in the troponin T subunit of the troponin complex using human beta-cardiac myosin. Unlike earlier reports using various myosin constructs, we found that none of these mutations affect the maximal sliding velocities or maximal Ca2+-activated ADP release rates involving the thin filament human b-cardiac myosin complex. Changes in Ca2+ sensitivity using the human myosin isoform do, however, mimic changes seen previously with non-human myosin isoforms. Transient kinetic measurements show that these mutations alter the kinetics of Ca2+ induced conformational changes in the regulatory thin filament proteins. These changes in calcium sensitivity are independent of active, cycling human b-cardiac myosin.	[Sommese, Ruth F.; Nag, Suman; Sutton, Shirley; Spudich, James A.; Ruppel, Kathleen M.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Miller, Susan M.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Ruppel, Kathleen M.] Stanford Univ, Dept Pediat Cardiol, Sch Med, Stanford, CA 94305 USA	Stanford University; University of California System; University of California San Francisco; Stanford University	Spudich, JA (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	jspudich@stanford.edu; kruppel@stanford.edu			National Institutes of Health [GM33289]; Human Frontier Science Program Research Grant Program [RGP0054/2009-C]; Stanford Interdisciplinary Graduate Fellowship; Stanford Dean's Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program Research Grant Program; Stanford Interdisciplinary Graduate Fellowship; Stanford Dean's Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grant GM33289 and Human Frontier Science Program Research Grant Program (RGP0054/2009-C) to J.A.S., Stanford Interdisciplinary Graduate Fellowship awarded to R. F. S., and Stanford Dean's Postdoctoral Fellowship to S.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JH, 2005, ADV PROTEIN CHEM, V71, P121, DOI 10.1016/S0065-3233(04)71004-9; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Deacon JC, 2012, CELL MOL LIFE SCI, V69, P4239, DOI 10.1007/s00018-012-1111-5; Dellefave L, 2010, CURR OPIN CARDIOL, V25, P198, DOI 10.1097/HCO.0b013e328337ba52; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; FRASER IDC, 1995, J BIOL CHEM, V270, P7836, DOI 10.1074/jbc.270.14.7836; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GRACEFFA P, 1980, J BIOL CHEM, V255, P1296; Harvey PA, 2011, J CELL BIOL, V194, P355, DOI 10.1083/jcb.201101100; Hernandez OM, 2005, J BIOL CHEM, V280, P37183, DOI 10.1074/jbc.M508114200; Hershberger R, 2013, FAMILIAL DILATED CAR; Hershberger RE, 2010, GENET MED, V12, P655, DOI 10.1097/GIM.0b013e3181f2481f; Hitchcock-DeGregori SE, 2008, ADV EXP MED BIOL, V644, P60; Ho CY, 2002, CIRCULATION, V105, P2992, DOI 10.1161/01.CIR.0000019070.70491.6D; HOFMANN PA, 1987, AM J PHYSIOL, V253, pC541, DOI 10.1152/ajpcell.1987.253.4.C541; Homsher E, 1996, BIOPHYS J, V70, P1881, DOI 10.1016/S0006-3495(96)79753-9; Huang J, 2009, BIOCHEMISTRY-US, V48, P11834, DOI 10.1021/bi901756n; ISHII Y, 1991, J BIOL CHEM, V266, P6894; ISHII Y, 1985, BIOCHEMISTRY-US, V24, P6631, DOI 10.1021/bi00344a050; Johnson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015801; Kobayashi M, 2013, J BIOL CHEM; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Lakdawala NK, 2012, CIRC-CARDIOVASC GENE, V5, P503, DOI 10.1161/CIRCGENETICS.112.962761; Lakdawala NK, 2012, J CARD FAIL, V18, P296, DOI 10.1016/j.cardfail.2012.01.013; Lin D, 1996, J CLIN INVEST, V97, P2842, DOI 10.1172/JCI118740; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038259; Lu QW, 2003, J MOL CELL CARDIOL, V35, P1421, DOI 10.1016/j.yjmcc.2003.09.003; Manning EP, 2011, BIOCHEMISTRY-US, V50, P7405, DOI 10.1021/bi200506k; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; McDonald KS, 2002, NEWS PHYSIOL SCI, V17, P185, DOI 10.1152/nips.01396.2002; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Miller T, 2001, J BIOL CHEM, V276, P3743, DOI 10.1074/jbc.M006746200; Mirza M, 2005, J BIOL CHEM, V280, P28498, DOI 10.1074/jbc.M412281200; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Moore JR, 2012, CIRC RES, V111, P375, DOI 10.1161/CIRCRESAHA.110.223842; Morimoto S, 1998, AM J PHYSIOL-CELL PH, V275, pC200, DOI 10.1152/ajpcell.1998.275.1.C200; Moss RL, 2004, CIRC RES, V94, P1290, DOI 10.1161/01.RES.0000127125.61647.4F; Olivotto I, 2010, AM J CARDIOL, V106, P261, DOI 10.1016/j.amjcard.2010.03.020; PAN BS, 1992, J BIOL CHEM, V267, P23052; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pinto JR, 2011, J BIOL CHEM, V286, P1005, DOI 10.1074/jbc.M110.168583; Ramaraj R, 2008, CARDIOL REV, V16, P172, DOI 10.1097/CRD.0b013e318178e525; Redwood C, 2000, CIRC RES, V86, P1146; Resnicow DI, 2010, P NATL ACAD SCI USA, V107, P1053, DOI 10.1073/pnas.0913527107; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Robinson P, 2002, J BIOL CHEM, V277, P40710, DOI 10.1074/jbc.M203446200; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; SHENG ZL, 1992, J BIOL CHEM, V267, P25407; Sich NM, 2010, J BIOL CHEM, V285, P39150, DOI 10.1074/jbc.M110.142232; Sivaramakrishnan S, 2009, J CARDIOVASC TRANSL, V2, P426, DOI 10.1007/s12265-009-9129-2; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; Solaro RJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/105648; Sommese RF, 2013, P NATL ACAD SCI USA, V110, P12607, DOI 10.1073/pnas.1309493110; Srikakulam R, 2004, J CELL SCI, V117, P641, DOI 10.1242/jcs.00899; Stehle R, 2010, J MOL CELL CARDIOL, V48, P843, DOI 10.1016/j.yjmcc.2009.12.020; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Sweeney HL, 1998, P NATL ACAD SCI USA, V95, P14406, DOI 10.1073/pnas.95.24.14406; Szczesna D, 1996, J BIOL CHEM, V271, P8381, DOI 10.1074/jbc.271.14.8381; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Tardiff JC, 2011, CIRC RES, V108, P765, DOI 10.1161/CIRCRESAHA.110.224170; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; Tobacman LS, 1999, J BIOL CHEM, V274, P28363, DOI 10.1074/jbc.274.40.28363; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Venkatraman G, 2005, J BIOL CHEM, V280, P17584, DOI 10.1074/jbc.M409337200; Venkatraman G, 2003, J BIOL CHEM, V278, P41670, DOI 10.1074/jbc.M302148200; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; WU CW, 1976, BIOCHEMISTRY-US, V15, P2863, DOI 10.1021/bi00658a025; Wynne J BE, 1992, BRAUNWALDS HEART DIS, P1394; Yanaga F, 1999, J BIOL CHEM, V274, P8806, DOI 10.1074/jbc.274.13.8806	72	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83403	10.1371/journal.pone.0083403	http://dx.doi.org/10.1371/journal.pone.0083403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367593	Green Published, gold			2022-12-27	WOS:000328740300103
J	Dillahunt-Aspillaga, C; Jorgensen-Smith, T; Ehlke, S; Sosinski, M; Monroe, D; Thor, J				Dillahunt-Aspillaga, Christina; Jorgensen-Smith, Tammy; Ehlke, Sarah; Sosinski, Melanie; Monroe, Douglas; Thor, Jennifer			Traumatic Brain Injury: Unmet Support Needs of Caregivers and Families in Florida	PLOS ONE			English	Article							INDIVIDUALS; VALIDATION; MANAGEMENT; QUALITY; CARERS; PEOPLE; ADULTS; SCALE; LIFE	Sustaining a Traumatic Brain Injury results in familial strain due to the significant impact the injury has upon the role and function of individuals and their families at home and in the community. Using the Stress Process Model of Caregiving, a caregiver needs assessment survey was developed and conducted to better understand the needs of individuals with a Traumatic Brain Injury and their caregivers. Survey results indicate that caregivers experience many challenges including unmet needs in areas of relational supports such as maintaining relationships, long-term emotional and financial support for themselves and the survivor, and the need for a patient or caregiver advocate. Implications for future practice are presented.	[Dillahunt-Aspillaga, Christina; Jorgensen-Smith, Tammy; Thor, Jennifer] Univ S Florida, Dept Rehabil & Mental Hlth Counseling, Tampa, FL 33620 USA; [Monroe, Douglas] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Ehlke, Sarah] Univ N Carolina, Dept Psychol, Wilmington, NC 28401 USA; [Sosinski, Melanie] Univ S Florida, Dept Social Work, Tampa, FL USA; [Dillahunt-Aspillaga, Christina] Brain Injury Assoc Florida Inc, Tallahassee, FL USA; [Monroe, Douglas] WellFlorida Council Inc, Gainesville, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Wilmington; State University System of Florida; University of South Florida	Dillahunt-Aspillaga, C (corresponding author), Univ S Florida, Dept Rehabil & Mental Hlth Counseling, Tampa, FL 33620 USA.	cdillahuntas@usf.edu		Dillahunt-Aspillaga, Christina/0000-0002-1231-2023; Jorgensen Smith, Tammy/0000-0001-6769-7269				Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Arciniegas DB, 2008, CRIT CARE CLIN, V24, P737, DOI 10.1016/j.ccc.2008.06.001; Boycott N, 2013, J HEAD TRAUMA REHAB, V28, P106, DOI 10.1097/HTR.0b013e31823fe07e; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Carnevale GJ, 2002, J HEAD TRAUMA REHAB, V17, P83, DOI 10.1097/00001199-200204000-00002; Centers for Disease Control and Prevention, 2010, TRAUMATIC BRAIN INJU; Chronister J, 2006, REHABIL PSYCHOL, V51, P190, DOI 10.1037/0090-5550.51.3.190; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; Degeneffe CE, 2011, REHABIL PSYCHOL, V56, P243, DOI 10.1037/a0024465; Family Caregiver Alliance, 2012, FCA FAM CAR ALL NAT; Finkelstein E., 2006, INCIDENCE EC BURDEN, DOI [10.1093/acprof:oso/9780195179484.001.0001, DOI 10.1093/ACPROF:OSO/9780195179484.001.0001]; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hassan STS, 2011, J NEPAL MED ASSOC, V50, P53; Hassan STS, 2012, HEALTHMED, V6, P2423; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer JS, 2010, J HEAD TRAUMA REHAB, V25, P113, DOI 10.1097/HTR.0b013e3181cf0712; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; Murray HM, 2006, BRAIN INJURY, V20, P575, DOI 10.1080/02699050600664590; O'Callaghan AM, 2011, INT J SPEECH-LANG PA, V13, P218, DOI 10.3109/17549507.2011.549240; Ramkumar NA, 2010, NEUROREHABILITATION, V27, P105, DOI 10.3233/NRE-2010-0585; Reinhard S, 2008, PATIENT SAFETY QUALI; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Turner BJ, 2011, DISABIL REHABIL, V33, P818, DOI 10.3109/09638288.2010.513422; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; WellFlorida Council Inc, 2012, WHAT IS TRAUM BRAIN; WellFlorida Council Inc, 2007, TRAUM BRAIN INJ STAT; WellFlorida Council Inc, 2010, TBI STAT FLOR; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005	37	34	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82896	10.1371/journal.pone.0082896	http://dx.doi.org/10.1371/journal.pone.0082896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GT	24358236	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700039
J	Choudhary, G; Jankowich, M; Wu, WC				Choudhary, Gaurav; Jankowich, Matthew; Wu, Wen-Chih			Prevalence and Clinical Characteristics Associated with Pulmonary Hypertension in African-Americans	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC FUNCTION; ARTERY SYSTOLIC PRESSURE; UNITED-STATES; RISK-FACTORS; HEART; DYSFUNCTION; SPIROMETRY; MORTALITY; OBESITY; DETERMINANTS	Background: Pulmonary hypertension (PH) is associated with increased mortality and morbidity. It is frequently associated with cardiopulmonary diseases that are prevalent in African Americans (AAs). However, the prevalence or determinants of PH in the AA population is not known. Methods: We conducted a cross-sectional study to estimate the prevalence of PH (defined as trans-tricuspid gradient >= 35 mm Hg) and associated clinical characteristics in AAs using the Jackson Heart Study cohort (n=3,282) who underwent echocardiography and had a measurable trans-tricuspid regurgitant jet. Echocardiography is frequently used for screening for PH despite its limitations in estimating accurate PA systolic pressures. Overall and age-adjusted gender-specific prevalence were estimated and modified Poisson regression was used to identify independent clinical, spirometric, and echocardiographic characteristics associated with PH. Results: The mean age of the study population was 56.1 +/- 12.6 years with 67.5% female. The prevalence of PH was 6.8%, with higher prevalence in female AAs (age-adjusted prevalence: Men 4.9%, 95% CI 3.6-6.2%; Women 7.7%, 95% CI 6.6-8.8%). Pulmonary hypertension prevalence increased with age (Prevalence Ratio: 10.0, 95% CI 4.0-25.1, >65 versus <45 years old), presence of obesity, higher pulse pressure, diabetes, obstructive or restrictive spirometry pattern, and severe left heart valvular disease. Also, PH was significantly associated with left atrial size and left ventricular ejection fraction. Conclusions: Pulmonary hypertension is prevalent in AAs, more in women than in men. The identified cardiopulmonary risk factors that increase the prevalence of PH may assist in diagnosis and management of these at-risk subjects in the AA population.	[Choudhary, Gaurav; Jankowich, Matthew; Wu, Wen-Chih] Brown Univ, Warren Alpert Med Sch, Providence VA Med Ctr, Vasc Res Lab, Providence, RI 02912 USA; [Choudhary, Gaurav; Jankowich, Matthew; Wu, Wen-Chih] Brown Univ, Warren Alpert Med Sch, Dept Med, Providence, RI 02912 USA	Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University	Choudhary, G (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence VA Med Ctr, Vasc Res Lab, Providence, RI 02912 USA.	Gaurav_choudhary@brown.edu	Choudhary, Gaurav/M-1643-2019	Choudhary, Gaurav/0000-0001-9343-5481	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development: Biomedical Laboratory Research and Development Service [IBX000711A]; Research Enhancement Award Program grant [REA 08-263]; VA Health Services Research and Development Service (W-CW); National Heart, Lung, and Blood Institute [N01-HC-95170, N01-HC-95171, N01HC-95172]; National Institute on Minority Health and Health Disparities; National Institute on Biomedical Imaging and Bioengineering; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095170, N01HC095172, N01HC095171] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development: Biomedical Laboratory Research and Development Service(US Department of Veterans Affairs); Research Enhancement Award Program grant; VA Health Services Research and Development Service (W-CW); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development: Biomedical Laboratory Research and Development Service (MERIT Review Award to GC, IBX000711A); Research Enhancement Award Program grant (REA 08-263) from the VA Health Services Research and Development Service (W-CW). The Jackson Heart Study is supported by contracts N01-HC-95170, N01-HC-95171, N01HC-95172 from the National Heart, Lung, and Blood Institute and the National Institute on Minority Health and Health Disparities, with additional support from the National Institute on Biomedical Imaging and Bioengineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON SV, 1992, ANN INTERN MED, V116, P888, DOI 10.7326/0003-4819-116-11-888; Bogaard Harm J, 2012, Pulm Circ, V2, P148, DOI 10.4103/2045-8932.97592; Burney PGJ, 2011, THORAX, V66, P49, DOI 10.1136/thx.2010.147041; Chaouat A, 2008, EUR RESPIR J, V32, P1371, DOI 10.1183/09031936.00015608; Chaouat A, 2005, AM J RESP CRIT CARE, V172, P189, DOI 10.1164/rccm.200401-006OC; Corp Stata S, 2010, MULT IMP AN US STATA; Enea I, 2010, G ITAL CARDIOL, V11, P402, DOI 10.1714/567.6728; Fimognari FL, 2007, J GERONTOL A-BIOL, V62, P760, DOI 10.1093/gerona/62.7.760; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Frost AE, 2011, CHEST, V139, P128, DOI 10.1378/chest.10-0075; Fulop T, 2012, SLEEP MED, V13, P1039, DOI 10.1016/j.sleep.2012.06.005; Fuqua SR, 2005, ETHNIC DIS, V15, pS18; Ghio S, 2001, J AM COLL CARDIOL, V37, P183, DOI 10.1016/S0735-1097(00)01102-5; Guglin M, 2012, INT J CLIN PRACT, V66, P13, DOI 10.1111/ijcp.12008; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hoeper MM, 2009, J AM COLL CARDIOL, V54, pS85, DOI 10.1016/j.jacc.2009.04.008; Hyduk Alexandra, 2005, Morbidity and Mortality Weekly Report, V54, P1; Kessler R, 1999, AM J RESP CRIT CARE, V159, P158, DOI 10.1164/ajrccm.159.1.9803117; Kjaergaard J, 2007, AM J CARDIOL, V99, P1146, DOI 10.1016/j.amjcard.2006.11.052; Lam CSP, 2009, CIRCULATION, V119, P2663, DOI 10.1161/CIRCULATIONAHA.108.838698; Leung CC, 2010, AM J CARDIOL, V106, P284, DOI 10.1016/j.amjcard.2010.02.039; Mannino DM, 2012, INT J TUBERC LUNG D, V16, P1405, DOI 10.5588/ijtld.12.0054; Mannino DM, 2005, INT J TUBERC LUNG D, V9, P613; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; McQuillan BM, 2001, CIRCULATION, V104, P2797, DOI 10.1161/hc4801.100076; Miller AC, 2012, AM J RESP CRIT CARE, V185, P1154, DOI 10.1164/rccm.201111-2082CI; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; OSWALDMAMMOSSER M, 1995, CHEST, V107, P1193, DOI 10.1378/chest.107.5.1193; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Poirier P, 2001, DIABETES CARE, V24, P5, DOI 10.2337/diacare.24.1.5; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rubin DB, 2004, MULTIPLE IMPUTATION; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Russo C, 2011, J AM COLL CARDIOL, V57, P1368, DOI 10.1016/j.jacc.2010.10.042; Samdarshi TE, 2009, AM HEART J, V158, P209, DOI 10.1016/j.ahj.2009.05.020; Scarlata S, 2008, RESP MED, V102, P1349, DOI 10.1016/j.rmed.2008.02.021; Setiawan VW, 2006, CANCER EPIDEM BIOMAR, V15, P1849, DOI 10.1158/1055-9965.EPI-06-0307; Shah SJ, 2012, JAMA-J AM MED ASSOC, V308, P1366, DOI 10.1001/jama.2012.12347; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Strange G, 2012, HEART, V98, P1805, DOI 10.1136/heartjnl-2012-301992; Sweeney L, 2009, EUR J MED RES, V14, P433, DOI 10.1186/2047-783X-14-10-433; Taraseviciute A, 2006, EUR J MED RES, V11, P198; Taylor HA, 2005, ETHNIC DIS, V15, pS4; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	45	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84264	10.1371/journal.pone.0084264	http://dx.doi.org/10.1371/journal.pone.0084264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358351	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700159
J	Hu, FY; Vishwanath, K; Lo, J; Erkanli, A; Mulvey, C; Lee, WT; Ramanujam, N				Hu, Fangyao; Vishwanath, Karthik; Lo, Justin; Erkanli, Alaattin; Mulvey, Christine; Lee, Walter T.; Ramanujam, Nimmi			Rapid Determination of Oxygen Saturation and Vascularity for Cancer Detection	PLOS ONE			English	Article							DIFFUSE-REFLECTANCE SPECTROSCOPY; IN-VIVO DIAGNOSIS; CERVICAL-CANCER; OPTICAL SPECTROSCOPY; RADIATION-THERAPY; BREAST-CANCER; HEMOGLOBIN; MODEL; HEAD; FLUORESCENCE	A rapid heuristic ratiometric analysis for estimating tissue hemoglobin concentration and oxygen saturation from measured tissue diffuse reflectance spectra is presented. The analysis was validated in tissue-mimicking phantoms and applied to clinical measurements in head and neck, cervical and breast tissues. The analysis works in two steps. First, a linear equation that translates the ratio of the diffuse reflectance at 584 nm and 545 nm to estimate the tissue hemoglobin concentration using a Monte Carlo-based lookup table was developed. This equation is independent of tissue scattering and oxygen saturation. Second, the oxygen saturation was estimated using non-linear logistic equations that translate the ratio of the diffuse reflectance spectra at 539 nm to 545 nm into the tissue oxygen saturation. Correlations coefficients of 0.89 (0.86), 0.77 (0.71) and 0.69 (0.43) were obtained for the tissue hemoglobin concentration (oxygen saturation) values extracted using the full spectral Monte Carlo and the ratiometric analysis, for clinical measurements in head and neck, breast and cervical tissues, respectively. The ratiometric analysis was more than 4000 times faster than the inverse Monte Carlo analysis for estimating tissue hemoglobin concentration and oxygen saturation in simulated phantom experiments. In addition, the discriminatory power of the two analyses was similar. These results show the potential of such empirical tools to rapidly estimate tissue hemoglobin in real-time spectral imaging applications.	[Hu, Fangyao; Vishwanath, Karthik; Lo, Justin; Mulvey, Christine; Ramanujam, Nimmi] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Erkanli, Alaattin] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Lee, Walter T.] Duke Univ, Med Ctr, Div Otolaryngol Head & Neck Surg, Durham, NC USA; [Lee, Walter T.] Vet Adm Med Ctr, Sect Otolaryngol Head & Neck Surg, Durham, NC USA	Duke University; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Hu, FY (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	fangyao.hu@duke.edu	Ramanujam, Nimmi/AAA-7575-2021	Ramanujam, Nimmi/0000-0001-7319-8415	National Institutes of Health [1R01EB011574-01A1, 1 R21CA 108490-01A2, 1R01CA 100559-05]; NATIONAL CANCER INSTITUTE [R21CA108490, R01CA100559, R00CA140783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study is supported by National Institutes of Health grant no. 1R01EB011574-01A1,1 R21CA 108490-01A2 and 1R01CA 100559-05.(http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EK, 2007, CANCER-AM CANCER SOC, V109, P348, DOI 10.1002/cncr.22353; Amelink A, 2008, ORAL ONCOL, V44, P65, DOI 10.1016/j.oraloncology.2006.12.011; ANDERSON RR, 1981, J INVEST DERMATOL, V77, P13, DOI 10.1111/1523-1747.ep12479191; [Anonymous], 2007, ORAL CANC NEWS; Arifler D, 2005, APPL OPTICS, V44, P4291, DOI 10.1364/AO.44.004291; Arifler D, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2398932; Bender JE, 2009, IEEE T BIO-MED ENG, V56, P960, DOI 10.1109/TBME.2008.2005994; Beumer HW, 2011, OTOLARYNG HEAD NECK, V144, P390, DOI 10.1177/0194599810394290; Brizel DM, 1997, INT J RADIAT ONCOL, V38, P285, DOI 10.1016/S0360-3016(97)00101-6; Brown JQ, 2009, CANCER RES, V69, P2919, DOI 10.1158/0008-5472.CAN-08-3370; Cardenas-Turanzas M, 2007, GYNECOL ONCOL, V107, pS138, DOI 10.1016/j.ygyno.2007.08.082; CDC, 2009, OR CANC BACKGR PAP; Chang SK, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1899686; Chang VTC, 2009, NEOPLASIA, V11, P325, DOI 10.1593/neo.81386; Chang VTC, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3495730; Cuccia DJ, 2009, J BIOMED OPT, V14; de Veld DCG, 2005, LASER SURG MED, V36, P356, DOI 10.1002/lsm.20122; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dhar S, 2012, BIOMED OPT EXPRESS, V3; Dubray B, 1996, RADIOLOGY, V201, P553, DOI 10.1148/radiology.201.2.8888257; ELLSWORTH ML, 1987, AM J PHYSIOL, V252, pH1031, DOI 10.1152/ajpheart.1987.252.5.H1031; Follen Michele, 2005, Clin Adv Hematol Oncol, V3, P41; Freeberg JA, 2007, GYNECOL ONCOL, V107, pS248, DOI 10.1016/j.ygyno.2007.07.008; Gao L, 2009, OPT EXPRESS, V17, P12293, DOI 10.1364/OE.17.012293; Georgakoudi I, 2002, AM J OBSTET GYNECOL, V186, P374, DOI 10.1067/mob.2002.121075; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Hasina R, 2001, J Dent Educ, V65, P1282; Kujan O, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004150.pub2; Lane PM, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2193157; Lawson Herschel W., 2000, Morbidity and Mortality Weekly Report, V49, P37; Lee WR, 1998, INT J RADIAT ONCOL, V42, P1069, DOI 10.1016/S0360-3016(98)00348-4; Liu Q, 2006, APPL OPTICS, V45, P4776, DOI 10.1364/AO.45.004776; Marin NM, 2005, GYNECOL ONCOL, V99, pS116, DOI 10.1016/j.ygyno.2005.07.054; Mirabal YN, 2002, J BIOMED OPT, V7, P587, DOI 10.1117/1.1502675; Muller MG, 2003, CANCER-AM CANCER SOC, V97, P1681, DOI 10.1002/cncr.11255; Nordsmark M, 2005, RADIOTHER ONCOL, V77, P18, DOI 10.1016/j.radonc.2005.06.038; Palmer GM, 2006, APPL OPTICS, V45, P1062, DOI 10.1364/AO.45.001062; Pavlova I, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3065544; Phelps JE, 2010, OPT EXPRESS, V18, P18779, DOI 10.1364/OE.18.018779; PITTMAN RN, 1975, J APPL PHYSIOL, V38, P315, DOI 10.1152/jappl.1975.38.2.315; Rahman M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907455; Sankaranarayanan R, 2005, LANCET, V365, P1927, DOI 10.1016/S0140-6736(05)66658-5; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Saslow Debbie, 2003, J Low Genit Tract Dis, V7, P67, DOI 10.1097/00128360-200304000-00001; Schwarz RA, 2008, APPL OPTICS, V47, P825, DOI 10.1364/AO.47.000825; Sharwani A, 2006, ORAL ONCOL, V42, P343, DOI 10.1016/j.oraloncology.2005.08.008; Sherris J, 2001, WESTERN J MED, V175, P231, DOI 10.1136/ewjm.175.4.231; Skala MC, 2007, OPT EXPRESS, V15, P7863, DOI 10.1364/OE.15.007863; Subhash N, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2165184; VANGEMERT MJC, 1989, IEEE T BIO-MED ENG, V36, P1146, DOI 10.1109/10.42108; Vishwanath K, 2011, APPL SPECTROSC, V65, P206, DOI 10.1366/10-06052; Wagadarikar AA, 2009, OPT EXPRESS, V17, P6368, DOI 10.1364/OE.17.006368; Wang A, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2769328; Warde P, 1998, INT J RADIAT ONCOL, V41, P347, DOI 10.1016/S0360-3016(98)00062-5; Zeferino LC, 2006, BEST PRACT RES CL OB, V20, P339, DOI 10.1016/j.bpobgyn.2006.01.018; Zhu CF, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1897398	56	11	11	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82977	10.1371/journal.pone.0082977	http://dx.doi.org/10.1371/journal.pone.0082977			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358243	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700100
J	Limburg, KE; Hayden, TA; Pine, WE; Yard, MD; Kozdon, R; Valley, JW				Limburg, Karin E.; Hayden, Todd A.; Pine, William E., III; Yard, Michael D.; Kozdon, Reinhard; Valley, John W.			Of Travertine and Time: Otolith Chemistry and Microstructure Detect Provenance and Demography of Endangered Humpback Chub in Grand Canyon, USA	PLOS ONE			English	Article							COLORADO RIVER; ADAPTIVE MANAGEMENT; GILA-CYPHA; TEMPERATURE; VARIABILITY; DELTA-C-13; CARBON; WATER; MICROCHEMISTRY; POPULATION	We developed a geochemical atlas of the Colorado River in Grand Canyon and in its tributary, the Little Colorado River, and used it to identify provenance and habitat use by Federally Endangered humpback chub, Gila cypha. Carbon stable isotope ratios (delta C-13) discriminate best between the two rivers, but fine scale analysis in otoliths requires rare, expensive instrumentation. We therefore correlated other tracers (SrSr, Ba, and Se in ratio to Ca) to delta C-13 that are easier to quantify in otoliths with other microchemical techniques. Although the Little Colorado River's water chemistry varies with major storm events, at base flow or near base flow (conditions occurring 84% of the time in our study) its chemistry differs sufficiently from the mainstem to discriminate one from the other. Additionally, when fish egress from the natal Little Colorado River to the mainstem, they encounter cold water which causes the otolith daily growth increments to decrease in size markedly. Combining otolith growth increment analysis and microchemistry permitted estimation of size and age at first egress; size at first birthday was also estimated. Emigrants < 1 year old averaged 51.2 +/- 4.4 (SE) days and 35.5 +/- 3.6 mm at egress; older fish that had recruited to the population averaged 100 +/- 7.8 days old and 51.0 +/- 2.2 mm at egress, suggesting that larger, older emigrants recruit better. Back-calculated size at age 1 was unimodal and large (78.2 +/- 3.3 mm) in Little Colorado caught fish but was bimodally distributed in Colorado mainstem caught fish (49.9 +/- 3.6 and 79 +/- 4.9 mm) suggesting that humpback chub can also rear in the mainstem. The study demonstrates the coupled usage of the two rivers by this fish and highlights the need to consider both rivers when making management decisions for humpback chub recovery.	[Limburg, Karin E.] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA; [Hayden, Todd A.] Great Lakes Fishery Commiss, Ann Arbor, MI USA; [Pine, William E., III] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Yard, Michael D.] US Geol Survey, Grand Canyon Monitoring & Res Ctr, Southwest Biol Sci Ctr, Flagstaff, AZ USA; [Kozdon, Reinhard; Valley, John W.] Univ Wisconsin, Dept Geosci, Madison, WI USA	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; State University System of Florida; University of Florida; United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison	Limburg, KE (corresponding author), SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA.	klimburg@esf.edu	Valley, John W./B-3466-2011; Kozdon, Reinhard/J-9468-2014	Valley, John W./0000-0003-3530-2722; Kozdon, Reinhard/0000-0001-6347-456X; Limburg, Karin/0000-0003-3716-8555	United States Bureau of Reclamation (USBOR); National Science Foundation; National Institutes of Health/National Institute of General Medical Sciences [DMR-0936384]; WiscSIMS [NSF-EAR 1053466]	United States Bureau of Reclamation (USBOR); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); WiscSIMS	This project was funded by the United States Bureau of Reclamation (USBOR) through a cooperative agreement to the University of Florida as part of the Near Shore Ecology Project. This work is based in part upon research conducted at the Cornell High Energy Synchrotron Source (CHESS) which is supported by the National Science Foundation and the National Institutes of Health/National Institute of General Medical Sciences under NSF award DMR-0936384. WiscSIMS is partly supported by NSF-EAR 1053466. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens RNM, 2012, FISH FISH, V13, P41, DOI 10.1111/j.1467-2979.2011.00432.x; Ben-Tzvi O, 2007, LIMNOL OCEANOGR-METH, V5, P97, DOI 10.4319/lom.2007.5.97; Brandes JA, 2009, LIMNOL OCEANOGR-METH, V7, P730, DOI 10.4319/lom.2009.7.730; Brophy D, 2004, MAR BIOL, V144, P779, DOI 10.1007/s00227-003-1240-3; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/f00-177; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; Clarkson RW, 2000, COPEIA, P402; Coggins Jr L.G., 2009, 20091075 US GEOL SUR; Coggins LG, 2011, T AM FISH SOC, V140, P456, DOI 10.1080/00028487.2011.572009; Coggins LG, 2006, N AM J FISH MANAGE, V26, P233, DOI 10.1577/M05-075.1; Converse YK, 1998, REGUL RIVER, V14, P267, DOI 10.1002/(SICI)1099-1646(199805/06)14:3<267::AID-RRR501>3.0.CO;2-5; Crossey LJ, 2009, GEOL SOC AM BULL, V121, P1034, DOI 10.1130/B26394.1; Dodrill M. J., 2012, THESIS U FLORIDA GAI; Dolnick E, 2002, GREAT UNKNOWN J WESL; Du J, 2002, THESIS MACMASTER U H; Elsdon TS, 2005, MAR ECOL PROG SER, V285, P233, DOI 10.3354/meps285233; Ferreira T, 2012, IMAGEJ USERGUIDE; Ferry JM, 2010, GEOCHIM COSMOCHIM AC, V74, P6517, DOI 10.1016/j.gca.2010.08.039; Finch C, 2012, THESIS U FLORIDA GAI; Gorman OT, 1999, ENVIRON BIOL FISH, V55, P115, DOI 10.1023/A:1007450826743; HAMMAN RL, 1982, PROG FISH CULT, V44, P213, DOI 10.1577/1548-8659(1982)44[213:SACOHC]2.0.CO;2; Hayden TA, 2012, RIVER RES APPL, DOI [10.1002/rra.2627, DOI 10.1002/RRA.2627)]; Hendrickson DA, 1997, PRELIMINARY STUDY UT; HOFF GR, 1995, B MAR SCI, V56, P578; Johnson BE, 1968, GROUNDWATER ATLAS ST; KAEDING LR, 1983, T AM FISH SOC, V112, P577, DOI 10.1577/1548-8659(1983)112<577:LHAEOT>2.0.CO;2; KALISH JM, 1989, J EXP MAR BIOL ECOL, V132, P151, DOI 10.1016/0022-0981(89)90126-3; Kozdon R, 2009, CHEM GEOL, V258, P327, DOI 10.1016/j.chemgeo.2008.10.032; Limburg KE, 2007, X-RAY SPECTROM, V36, P336, DOI 10.1002/xrs.980; Limburg KE, 2011, P NATL ACAD SCI USA, V108, pE177, DOI 10.1073/pnas.1100684108; LORAH MM, 1988, WATER RESOUR RES, V24, P1541, DOI 10.1029/WR024i009p01541; Lorenzen K, 2000, CAN J FISH AQUAT SCI, V57, P2374, DOI 10.1139/cjfas-57-12-2374; Ludsin SA, 1997, ECOL APPL, V7, P1024; Melis TS, 2012, RIVER RES APPL, V28, P764, DOI 10.1002/rra.1503; Melis TS, 2005, P INT C RES OP RIV M; MILLER TJ, 1988, CAN J FISH AQUAT SCI, V45, P1657, DOI 10.1139/f88-197; Paukert CP, 2006, T AM FISH SOC, V135, P539, DOI 10.1577/T05-204.1; Pentecost A., 2005, TRAVERTINE; Pine WE, 2013, N AM J FISH MANAGE, V33, P626, DOI 10.1080/02755947.2013.788587; Pulwarty RS, 2001, J ENVIRON MANAGE, V63, P307, DOI 10.1006/jema.2001.0494; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; SCHWARTZ DW, 1965, AM ANTIQUITY, V30, P278, DOI 10.2307/278809; Shannon JP, 2001, ISOT ENVIRON HEALT S, V37, P179, DOI 10.1080/10256010108033294; Sole VA, 2007, SPECTROCHIM ACTA B, V62, P63, DOI 10.1016/j.sab.2006.12.002; Solomon CT, 2006, CAN J FISH AQUAT SCI, V63, P79, DOI 10.1139/F05-200; Stevens LE, 1999, COLORADO RIVER BENTH, V13, P129; Stone DM, 2006, AM MIDL NAT, V155, P123, DOI 10.1674/0003-0031(2006)155[0123:OOEHCG]2.0.CO;2; Taylor HE, 1996, 96614 US GEOL SURV; Tohse H, 2008, AQUAT BIOL, V1, P259, DOI 10.3354/ab00029; Topping DJ, 2000, WATER RESOUR RES, V36, P515, DOI 10.1029/1999WR900285; Trammell M., 2012, NPSGRCANRR2012586; U.S. Bureau of Reclamation (USBOR), 2012, COL RIV BAS WAT SUPP; United States Department of the Interior (USDOI), 1973, FED REGISTER, V32, P4001; United States Department of the Interior (USDOI), 1994, FED REGISTER, V59, P13376; USFWS (U.S. Fish and Wildlife Service), 2011, FIN BIOL OP OP GLEN; USGS (United States Geological Survey), 2013, MICR REF MAT ACC; Valdez RA, 1999, SOUTHWEST NAT, V44, P384; Valdez RA, 1995, TR25008 BIOWEST INC; Van Haverbeke DR, 2013, J FISH WILDL MANAG, V4, P163, DOI 10.3996/082012-JFWM-071; Voichick N, 2007, US GEOLOGICAL SURVEY, V251; Volk EC, 1999, FISH RES, V43, P205, DOI 10.1016/S0165-7836(99)00073-9; Walters C, 2000, CONSERV ECOL, V4, part. no.; Walther BD, 2012, J FISH BIOL, V81, P796, DOI 10.1111/j.1095-8649.2012.03371.x; Weidel BC, 2007, CAN J FISH AQUAT SCI, V64, P1641, DOI 10.1139/F07-157; WERNER EE, 1983, ECOLOGY, V64, P1540, DOI 10.2307/1937508; Wright SA, 2009, RIVER RES APPL, V25, P675, DOI 10.1002/rra.1179; Yard MD, 2011, T AM FISH SOC, V140, P471, DOI 10.1080/00028487.2011.572011	67	25	26	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84235	10.1371/journal.pone.0084235	http://dx.doi.org/10.1371/journal.pone.0084235			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358346	Green Submitted, gold, Green Published			2022-12-27	WOS:000328735700157
J	Manson, JH; Gervais, MM; Kline, MA				Manson, Joseph H.; Gervais, Matthew M.; Kline, Michelle A.			Defectors Cannot Be Detected during "Small Talk'' with Strangers	PLOS ONE			English	Article							SOCIAL VALUE ORIENTATION; THIN SLICES; EVOLUTION; RECIPROCITY; COOPERATION; BEHAVIOR; TRUSTWORTHINESS; SELECTION; ACCURACY; COVER	To account for the widespread human tendency to cooperate in one-shot social dilemmas, some theorists have proposed that cooperators can be reliably detected based on ethological displays that are difficult to fake. Experimental findings have supported the view that cooperators can be distinguished from defectors based on "thin slices'' of behavior, but the relevant cues have remained elusive, and the role of the judge's perspective remains unclear. In this study, we followed triadic conversations among unacquainted same-sex college students with unannounced dyadic one-shot prisoner's dilemmas, and asked participants to guess the PD decisions made toward them and among the other two participants. Two other sets of participants guessed the PD decisions after viewing videotape of the conversations, either with foreknowledge (informed), or without foreknowledge (naive), of the post-conversation PD. Only naive video viewers approached better-than-chance prediction accuracy, and they were significantly accurate at predicting the PD decisions of only opposite-sexed conversation participants. Four ethological displays recently proposed to cue defection in one-shot social dilemmas (arms crossed, lean back, hand touch, and face touch) failed to predict either actual defection or guesses of defection by any category of observer. Our results cast doubt on the role of "greenbeard'' signals in the evolution of human prosociality, although they suggest that eavesdropping may be more informative about others' cooperative propensities than direct interaction.	[Manson, Joseph H.] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Ctr Behav Evolut & Culture, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Manson, JH (corresponding author), Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA.	jmanson@anthro.ucla.edu			International Society for Human Ethology; UCLA Academic Senate Faculty Grants Program	International Society for Human Ethology; UCLA Academic Senate Faculty Grants Program	This work was supported by International Society for Human Ethology (http://www.ishe.org) and UCLA Academic Senate Faculty Grants Program (http://www.senate.ucla.edu/committees/cor/fgp/frg-guide/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBADY N, 1992, PSYCHOL BULL, V111, P256, DOI 10.1037/0033-2909.111.2.256; Ambady N, 2000, ADV EXP SOC PSYCHOL, V32, P201, DOI 10.1016/S0065-2601(00)80006-4; Bogaert S, 2008, BRIT J SOC PSYCHOL, V47, P453, DOI 10.1348/014466607X244970; Bonnefon J-F, 2012, J EXP PSYCHOL, DOI 1037/a0028930; Boone RT, 2003, J NONVERBAL BEHAV, V27, P163, DOI 10.1023/A:1025341931128; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Brosig J, 2002, J ECON BEHAV ORGAN, V47, P275, DOI 10.1016/S0167-2681(01)00211-6; Brown W.M., 2003, EVOL PSYCHOL-US, V1, P42, DOI DOI 10.1177/147470490300100104; Centorrino S, 2011, 669 IDEI; Cleckley H., 1988, MASK SANITY, V5th; DAWES RM, 1977, J PERS SOC PSYCHOL, V35, P1, DOI 10.1037/0022-3514.35.1.1; Dawkins R., 1982, pi; Dawkins Richard, 1976, SELFISH GENE; De Neys W, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0037; Delton AW, 2011, P NATL ACAD SCI USA, V108, P13335, DOI 10.1073/pnas.1102131108; DePaulo BM, 2003, PSYCHOL BULL, V129, P74, DOI 10.1037//0033-2909.129.1.74; DeSteno D, 2012, PSYCHOL SCI, V23, P1549, DOI 10.1177/0956797612448793; Efferson C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01047; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; FEHR E, 2005, ANAL KRITIK, V27, P73; Fehr E, 2003, CSEIFO WORKING PAPER, V859, DOI [10.2139/ssrn.382950, DOI 10.2139/SSRN.382950]; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Fetchenhauer D, 2010, EVOL HUM BEHAV, V31, P80, DOI 10.1016/j.evolhumbehav.2009.06.009; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Fowler KA, 2009, PSYCHOL ASSESSMENT, V21, P68, DOI 10.1037/a0014938; Frank R. H., 1988, PASSIONS REASON STRA; FRANK RH, 1987, AM ECON REV, V77, P593; FRANK RH, 1993, ETHOL SOCIOBIOL, V14, P247, DOI 10.1016/0162-3095(93)90020-I; Frank RH, 2005, ANAL KRITIK, V27, P85; Gervais MM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2773; Hall JA, 2009, J NONVERBAL BEHAV, V33, P149, DOI 10.1007/s10919-009-0070-5; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Haselton M. G., 2006, EVOLUTION SOCIAL PSY, P15, DOI [DOI 10.4324/9780203782965, 10.4324/9780203782965]; Hayashi N, 1999, RATION SOC, V11, P27, DOI 10.1177/104346399011001002; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2004, J ECON BEHAV ORGAN, V53, P3, DOI 10.1016/S0167-2681(03)00094-5; Henrich J, 2006, COGN SYST RES, V7, P220, DOI 10.1016/j.cogsys.2005.11.010; Hill K, 2009, EVOL ANTHROPOL, V18, P187, DOI 10.1002/evan.20224; Hirshleifer J., 1987, LATEST BEST ESSAYS E, P307; Kaplan HS, 2009, PHILOS T R SOC B, V364, P3289, DOI 10.1098/rstb.2009.0115; Kikuchi M., 1999, ASIAN J SOC PSYCHOL, V2, P145, DOI DOI 10.1111/1467-839X.00030; Kiyonari T, 2000, EVOL HUM BEHAV, V21, P411, DOI 10.1016/S1090-5138(00)00055-6; Krasnow MM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01747; Kraus MW, 2009, PSYCHOL SCI, V20, P99, DOI 10.1111/j.1467-9280.2008.02251.x; Kurzban R, 2005, P NATL ACAD SCI USA, V102, P1803, DOI 10.1073/pnas.0408759102; LEVENSON MR, 1995, J PERS SOC PSYCHOL, V68, P151, DOI 10.1037/0022-3514.68.1.151; Little AC, 2013, PERS INDIV DIFFER, V54, P507, DOI 10.1016/j.paid.2012.10.018; Manson JH, 2013, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.qm689, DOI 10.5061/DRYAD.QM689]; Mehu M., 2007, J EVOLUT PSYCHOL, V5, P183, DOI [DOI 10.1556/JEP.2007.1011, 10.1556/JEP.2007.1011]; Mehu M, 2007, EVOL HUM BEHAV, V28, P415, DOI 10.1016/j.evolhumbehav.2007.05.010; Oda R, 2009, HUM NATURE-INT BIOS, V20, P331, DOI 10.1007/s12110-009-9070-8; Pontari BA, 2000, J PERS SOC PSYCHOL, V78, P1092, DOI 10.1037//0022-3514.78.6.1092; Price ME, 2006, J ORGAN BEHAV, V27, P201, DOI 10.1002/job.347; Reed LI, 2012, EVOL HUM BEHAV, V33, P200, DOI 10.1016/j.evolhumbehav.2011.09.003; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Schug J, 2010, EVOL HUM BEHAV, V31, P87, DOI 10.1016/j.evolhumbehav.2009.09.006; Smeesters D, 2003, J PERS SOC PSYCHOL, V84, P972, DOI 10.1037/0022-3514.84.5.972; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Vanneste S, 2007, EVOL HUM BEHAV, V28, P272, DOI 10.1016/j.evolhumbehav.2007.02.005; Verplaetse J, 2007, EVOL HUM BEHAV, V28, P260, DOI 10.1016/j.evolhumbehav.2007.04.006; Vogt S, 2013, EVOL HUM BEHAV, DOI [10.1016/j.evolhumbehav.2013.03.003, DOI 10.1016/J.EV0LHUMBEHAV.2013.03.003]; Von Eye A., 2005, ANAL RATER AGREEMENT; WILLIAMS GC, 1957, EVOLUTION, V11, P32, DOI 10.2307/2405809; Yamagishi T, 2003, EVOL HUM BEHAV, V24, P290, DOI 10.1016/S1090-5138(03)00035-7; Zak PJ, 2005, HORM BEHAV, V48, P522, DOI 10.1016/j.yhbeh.2005.07.009	67	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82531	10.1371/journal.pone.0082531	http://dx.doi.org/10.1371/journal.pone.0082531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GD	24358201	gold, Green Submitted, Green Published			2022-12-27	WOS:000328735700080
J	Veremeyko, T; Siddiqui, S; Sotnikov, I; Yung, A; Ponomarev, ED				Veremeyko, Tatyana; Siddiqui, Shafiuddin; Sotnikov, Ilya; Yung, Amanda; Ponomarev, Eugene D.			IL-4/IL-13-Dependent and Independent Expression of miR-124 and Its Contribution to M2 Phenotype of Monocytic Cells in Normal Conditions and during Allergic Inflammation	PLOS ONE			English	Article							ALTERNATIVE ACTIVATION; AIRWAY INFLAMMATION; CD16(+) MONOCYTES; MACROPHAGES; BLOOD; DIFFERENTIATION; POLARIZATION; MICRORNAS; MICROGLIA; MIR-223	Monocytic cells exhibit a high level of heterogeneity and have two distinct modes of their activation: 1) classical M1 path associated with inflammation and tissue damage, and 2) alternative M2 path. Although it has been demonstrated that M2 macrophages play an important role in the regulation of the allergic immune responses, tissue maintenance and repair, little is known about the mechanisms that determine the M2 phenotype. We have previously shown that miR-124 is expressed in microglia that exhibit the M2 phenotype and overexpression of miR-124 in macrophages resulted in downregulation of a number of M1 markers (MHC class II, CD86) and up-regulation of several M2 markers (Fizz1, Arg1). We further investigated whether the polarization of macrophages towards the M2 phenotype induced miR-124 expression. We found that exposure of cells to IL-4 and IL-13 resulted in the upregulation of miR-124 in macrophages. We also demonstrated that IL-4 induced expression of three miR-124 precursor transcripts with predominant expression of pri-miR-124.3, suggesting regulation of miR-124 expression by IL-4 on a transcriptional level. Expression of miR-124 in microglia did not depend on IL-4 and/or IL-13, whereas expression of miR-124 in lung resident macrophages was IL-4 and IL-13-dependent and was upregulated by systemic administration of IL-4 or during allergic inflammation. Upregulation of several M2 markers (CD206, Ym1) and downregulation of the M1 markers (CD86, iNOS, TNF) in M2-polarized macrophages was abrogated by a miR-124 inhibitor, suggesting that this microRNA contributed to the M2 phenotype development and maintenance. Finally we showed that human CD14(+)CD16(+) intermediate monocytes, which are found in increased numbers in patients with allergies and bronchial asthma, expressed high levels of miR-124 and exhibited other properties of M2-like cells. Thus, our study suggests that miR-124 serves as a regulator of the M2 polarization in various subsets of monocytic cells both in vitro and in vivo.	[Veremeyko, Tatyana; Yung, Amanda; Ponomarev, Eugene D.] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Siddiqui, Shafiuddin; Sotnikov, Ilya; Ponomarev, Eugene D.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Chinese University of Hong Kong; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ponomarev, ED (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	eponomarev@cuhk.edu.hk	Ponomarev, Eugene D./K-1546-2013	Ponomarev, Eugene D./0000-0002-0871-8522; Sotnikov, ILya/0000-0001-9968-2803; Yung, Amanda WY/0000-0003-4265-9324	National Institute of Health [RO1 NS071039-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071039] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institute of Health Grant RO1 NS071039-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abeles D, 2012, CYTOM PART A, V81A, P823, DOI 10.1002/cyto.a.22104; Banerjee S, 2013, J IMMUNOL, V190, P6542, DOI 10.4049/jimmunol.1202496; Blahna MT, 2013, CURR OPIN CELL BIOL, V25, P233, DOI 10.1016/j.ceb.2012.12.005; BRUSSELLE GG, 1994, CLIN EXP ALLERGY, V24, P73, DOI 10.1111/j.1365-2222.1994.tb00920.x; Chen QY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037149, 10.1371/journal.pone.0042971]; Dasgupta P, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-60; Garbacki N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016509; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grace-Griebenow E, 2000, IMMUNOBIOLOGY, V202, P42, DOI 10.1016/S0171-2985(00)80051-0; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kowal K, 2012, SCAND J IMMUNOL, V75, P531, DOI 10.1111/j.1365-3083.2012.02685.x; KUNG TT, 1994, INT ARCH ALLERGY IMM, V105, P83, DOI 10.1159/000236807; Liu G, 2013, ARTERIOSCL THROM VAS, V33, P170, DOI 10.1161/ATVBAHA.112.300068; Lu TX, 2013, J IMMUNOL, V190, P1576, DOI 10.4049/jimmunol.1202897; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maresz K, 2008, J REPROD IMMUNOL, V78, P140, DOI 10.1016/j.jri.2008.01.001; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Moniuszko M, 2009, CLIN IMMUNOL, V130, P338, DOI 10.1016/j.clim.2008.09.011; Moore C. S., 2013, ANN NEUROL; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Ponomarev EA, 2006, J IMMUNOL, V176, P1402, DOI 10.4049/jimmunol.176.3.1402; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Ponomarev ED, 2013, GLIA, V61, P91, DOI 10.1002/glia.22363; Ponomarev Eugene D, 2011, BMC Res Notes, V4, P517, DOI 10.1186/1756-0500-4-517; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Ruegger S, 2012, TRENDS BIOCHEM SCI, V37, P436, DOI 10.1016/j.tibs.2012.07.002; Satoh T, 2013, NATURE, V495, P524, DOI 10.1038/nature11930; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Siddiqui S, 2013, CELL IMMUNOL, V281, P159, DOI 10.1016/j.cellimm.2013.03.001; Skrzeczynska J, 2002, SCAND J IMMUNOL, V55, P629, DOI 10.1046/j.1365-3083.2002.01092.x; Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x; Sotnikov I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058979; Tugal D, 2013, ARTERIOSCL THROM VAS, V33, P1135, DOI 10.1161/ATVBAHA.113.301453; Veremeyko T, 2012, JOVE-J VIS EXP, DOI 10.3791/4097; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Zhao CQ, 2009, J PROTEOME RES, V8, P4028, DOI 10.1021/pr900364p; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	45	119	130	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81774	10.1371/journal.pone.0081774	http://dx.doi.org/10.1371/journal.pone.0081774			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358127	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700023
J	Zhang, ZY; Zhang, X; Wang, SF; Xin, WW; Tang, JX; Wang, QL				Zhang, Zhiyong; Zhang, Xin; Wang, Sufang; Xin, Wanwan; Tang, Juxiang; Wang, Qinglian			Effect of Mechanical Stress on Cotton Growth and Development	PLOS ONE			English	Article							PLANT-RESPONSE; HEIGHT GROWTH; ALLOCATION; WIND; THIGMOMORPHOGENESIS; VIBRATION; PATTERNS; BIOMASS; TOUCH	Agricultural crops experience diverse mechanical stimuli, which may affect their growth and development. This study was conducted to investigate the effects of mechanical stresses caused by hanging labels from the flower petioles (HLFP) on plant shape and cotton yields in four cotton varieties: CCRI 41, DP 99B, CCRC 21, and BAI 1. HLFP significantly reduced plant height by between 7.8% and 36.5% in all four lines and also significantly reduced the number of fruiting positions per plant in the CCRI 41, DP 99B and CCRC 21 lines. However, the number of fruiting positions in BAI 1 was unaffected. HLFP also significantly reduced the boll weight for all four cultivars and the seed cotton yields for CCRI 41, DP 99B and BAI 1. Conversely, it significantly increased the seed cotton yield for CCRC 21 by 11.2%. HLFP treatment did not significantly affect the boll count in the fruiting branches of the 1st and 2nd layers in any variety, but did significantly reduce those on the 3rd and 4th fruiting branch layers for CCRI 41 and DP 99B. Similar trends were observed for the number of bolls per FP. In general, HLFP reduced plant height and boll weight. However, the lines responded differently to HLFP treatment in terms of their total numbers of fruiting positions, boll numbers, seed cotton yields, etc. Our results also suggested that HFLP responses might be delayed for some agronomy traits of some cotton genotypes, and that hanging labels from early-opening flowers might influence the properties related with those that opened later on.	[Zhang, Zhiyong; Zhang, Xin; Wang, Sufang; Xin, Wanwan; Tang, Juxiang; Wang, Qinglian] Henan Inst Sci & Technol, Sch Life Sci & Technol, Xinxiang, Henan, Peoples R China	Henan Institute of Science & Technology	Zhang, ZY (corresponding author), Henan Inst Sci & Technol, Sch Life Sci & Technol, Xinxiang, Henan, Peoples R China.	z_zy123@163.com	Zhang, Xin/ABI-7149-2020		NSFC (National Natural Science Foundation of China) [31271648]; Science and Technology Innovation Talents Project of Henan Province of China [114100510008]	NSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Talents Project of Henan Province of China	This research was supported by the NSFC (National Natural Science Foundation of China, 31271648) and Science and Technology Innovation Talents Project of Henan Province of China (114100510008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anten NPR, 2006, PHYSIOL PLANTARUM, V128, P274, DOI 10.1111/j.1399-3054.2006.00736.x; Anten NPR, 2005, AM NAT, V166, P650, DOI 10.1086/497442; BIDDINGTON NL, 1985, ANN BOT-LONDON, V55, P109, DOI 10.1093/oxfordjournals.aob.a086869; BOYER N, 1967, CR ACAD SCI D NAT, V264, P2114; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; BRAAM J, 1990, CELL, V60, P357, DOI 10.1016/0092-8674(90)90587-5; Bruce TJA, 2007, PLANT SCI, V173, P603, DOI 10.1016/j.plantsci.2007.09.002; Chehab EW, 2009, J EXP BOT, V60, P43, DOI 10.1093/jxb/ern315; DANN IR, 1990, SCI HORTIC-AMSTERDAM, V43, P37, DOI 10.1016/0304-4238(90)90034-C; Darwin C., 1906, MOVEMENTS HABITS CLI; Fiorani F, 2002, PLANT PHYSIOL, V129, P1382, DOI 10.1104/pp.001198; FRIZZELL JL, 1960, AGRON J, V52, P69, DOI 10.2134/agronj1960.00021962005200020003x; GARTNER BL, 1994, J EXP BOT, V45, P1647, DOI 10.1093/jxb/45.11.1647; Goodman AM, 1996, J EXP BOT, V47, P1499, DOI 10.1093/jxb/47.10.1499; GRACE J, 1977, J EXP BOT, V28, P268, DOI 10.1093/jxb/28.2.268; JACOBS M. R., 1954, AUSTRALIAN JOUR BOT, V2, P35, DOI 10.1071/BT9540035; JAFFE MJ, 1984, PHYSIOL PLANTARUM, V62, P73, DOI 10.1111/j.1399-3054.1984.tb05925.x; JAFFE MJ, 1973, PLANTA, V114, P143, DOI 10.1007/BF00387472; JAFFE MJ, 1980, BIOSCIENCE, V30, P239, DOI 10.2307/1307878; Kern KA, 2005, TREE PHYSIOL, V25, P1243, DOI 10.1093/treephys/25.10.1243; Latimer J. G., 1998, HortTechnology, V8, P529; [李忠光 LI Zhong-Guang], 2010, [植物生理学通讯, Plant Physiology Communications], V46, P135; Liu Y, 2007, ANN BOT-LONDON, V99, P121, DOI 10.1093/aob/mcl230; MAKELA A, 1992, J THEOR BIOL, V159, P443, DOI 10.1016/S0022-5193(05)80690-3; Meng SX, 2006, J EXP BOT, V57, P3175, DOI 10.1093/jxb/erl079; Mitchell CA, 1996, HORTSCIENCE, V31, P31, DOI 10.21273/HORTSCI.31.1.31; Niklas KJ, 1998, ANN BOT-LONDON, V82, P147, DOI 10.1006/anbo.1998.0658; Onguso JM, 2006, SCI HORTIC-AMSTERDAM, V108, P359, DOI 10.1016/j.scienta.2006.02.013; Pigliucci M, 2002, INT J PLANT SCI, V163, P399, DOI 10.1086/339158; Potters G, 2007, TRENDS PLANT SCI, V12, P98, DOI 10.1016/j.tplants.2007.01.004; Puijalon S, 2005, J EXP BOT, V56, P777, DOI 10.1093/jxb/eri063; Simons P, 1992, ACTION PLANT MOVEMEN; TURGEON R, 1971, SCIENCE, V174, P961, DOI 10.1126/science.174.4012.961; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang YH, 2008, INT J PLANT SCI, V169, P503, DOI 10.1086/528750	35	5	5	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82256	10.1371/journal.pone.0082256	http://dx.doi.org/10.1371/journal.pone.0082256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24363813	Green Submitted, gold, Green Published			2022-12-27	WOS:000328735700051
J	Zhu, LC; Ye, YL; Luo, WH; Su, M; Wei, HP; Zhang, XB; Wei, J; Zou, CL				Zhu, Lu-Cheng; Ye, Yun-Liang; Luo, Wen-Hua; Su, Meng; Wei, Hang-Ping; Zhang, Xue-Bang; Wei, Juan; Zou, Chang-Lin			A Model to Discriminate Malignant from Benign Thyroid Nodules Using Artificial Neural Network	PLOS ONE			English	Article							SONOGRAPHIC FEATURES; PREDICTIVE-VALUE; CANCER; ULTRASOUND; MANAGEMENT; DIAGNOSIS; ULTRASONOGRAPHY; NEEDLE; CARCINOMA; CIRRHOSIS	Objective: This study aimed to construct a model for using in differentiating benign and malignant nodules with the artificial neural network and to increase the objective diagnostic accuracy of US. Materials and methods: 618 consecutive patients (528 women, 161 men) with 689 thyroid nodules (425 malignant and 264 benign nodules) were enrolled in the present study. The presence and absence of each sonographic feature was assessed for each nodule - shape, margin, echogenicity, internal composition, presence of calcifications, peripheral halo and vascularity on color Doppler. The variables meet the following criteria: important sonographic features and statistically significant difference were selected as the input layer to build the ANN for predicting the malignancy of nodules. Results: Six sonographic features including shape (Taller than wide, p<0.001), margin (Not Well-circumscribed, p<0.001), echogenicity (Hypoechogenicity, p<0.001), internal composition (Solid, p<0.001), presence of calcifications (Microcalcification, p<0.001) and peripheral halo (Absent, p<0.001) were significantly associated with malignant nodules. A three-layer 6-8-1 feed-forward ANN model was built. In the training cohort, the accuracy of the ANN in predicting malignancy of thyroid nodules was 82.3% (AUROC = 0.818), the sensitivity and specificity was 84.5% and 79.1%, respectively. In the validation cohort, the accuracy, sensitivity and specificity was 83.1%, 83.8% and 81.8%, respectively. The AUROC was 0.828. Conclusion: ANN constructed by sonographic features can discriminate benign and malignant thyroid nodules with high diagnostic accuracy.	[Zhu, Lu-Cheng; Luo, Wen-Hua; Su, Meng; Wei, Hang-Ping; Zhang, Xue-Bang; Wei, Juan; Zou, Chang-Lin] Wenzhou Med Coll, Dept Radiat Oncol & Chemotherapy, Affiliated Hosp 1, Wenzhou, Peoples R China; [Ye, Yun-Liang] Wenzhou Med Coll, Dept Oncol, Affiliated Hosp 1, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Zou, CL (corresponding author), Wenzhou Med Coll, Dept Radiat Oncol & Chemotherapy, Affiliated Hosp 1, Wenzhou, Peoples R China.	zcl19670115@163.com		Zhu, Lucheng/0000-0001-7298-4166				Baloch ZW, 2008, DIAGN CYTOPATHOL, V36, P425, DOI 10.1002/dc.20830; Bo YH, 2011, J KOREAN MED SCI, V26, P237, DOI 10.3346/jkms.2011.26.2.237; BRANDER A, 1991, RADIOLOGY, V181, P683, DOI 10.1148/radiology.181.3.1947082; Cappelli C, 2007, QJM-INT J MED, V100, P29, DOI 10.1093/qjmed/hcl121; Cappelli C, 2006, EUR J ENDOCRINOL, V155, P27, DOI 10.1530/eje.1.02177; Chan BK, 2003, J ULTRAS MED, V22, P1083, DOI 10.7863/jum.2003.22.10.1083; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Desforges JF, 1993, NEW ENGL J MED, V328, P553; Frates MC, 2005, RADIOLOGY, V237, P794, DOI 10.1148/radiol.2373050220; Frates MC, 2003, J ULTRAS MED, V22, P127, DOI 10.7863/jum.2003.22.2.127; Gharib H., 2009, ENDOCRINE PRACTICE O, V16, P468, DOI 10.4158/EP.16.3.468; Gharib Hossein, 2004, Endocr Pract, V10, P31; HARACH HR, 1985, CANCER-AM CANCER SOC, V56, P531, DOI 10.1002/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO;2-3; Hong WD, 2011, HEPAT MON, V11, P544; Kim EK, 2002, AM J ROENTGENOL, V178, P687, DOI 10.2214/ajr.178.3.1780687; Kwak JY, 2013, KOREAN J RADIOL, V14, P110, DOI 10.3348/kjr.2013.14.1.110; Lai KC, 2008, HEPATO-GASTROENTEROL, V55, P1859; Levine RF, 2001, CANCER, V91, P1595, DOI 10.1002/1097-0142(20010415)91:8+<1595::AID-CNCR1172>3.3.CO;2-G; Lin JD, 2005, THYROID, V15, P708, DOI 10.1089/thy.2005.15.708; MAZZAFERRI EL, 1992, AM J MED, V93, P359, DOI 10.1016/0002-9343(92)90163-6; Moon WJ, 2008, RADIOLOGY, V247, P762, DOI 10.1148/radiol.2473070944; Nikiforov YE, 2011, NAT REV ENDOCRINOL, V7, P569, DOI 10.1038/nrendo.2011.142; Ohori NP, 2011, ACTA CYTOL, V55, P492, DOI 10.1159/000334218; Ozel A, 2012, MED ULTRASON, V14, P24; Papini E, 2002, J CLIN ENDOCR METAB, V87, P1941, DOI 10.1210/jc.87.5.1941; Paschke R, 2011, NAT REV ENDOCRINOL, V7, P354, DOI 10.1038/nrendo.2011.1; Peccin S, 2002, J ENDOCRINOL INVEST, V25, P39, DOI 10.1007/BF03343959; Popowicz B, 2009, EUR J ENDOCRINOL, V161, P103, DOI 10.1530/EJE-09-0022; Prasad NB, 2012, THYROID, V22, P275, DOI 10.1089/thy.2011.0169; ROJESKI MT, 1985, NEW ENGL J MED, V313, P428, DOI 10.1056/NEJM198508153130707; Tae HJ, 2007, THYROID, V17, P461, DOI 10.1089/thy.2006.0337; Tan GH, 1997, ANN INTERN MED, V126, P226, DOI 10.7326/0003-4819-126-3-199702010-00009; Tomei S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-396; Vahdani P, 2009, HEPAT MON, V9, P271; Wiest PW, 1998, J ULTRAS MED, V17, P487	35	27	30	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82211	10.1371/journal.pone.0082211	http://dx.doi.org/10.1371/journal.pone.0082211			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358156	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700045
J	Goltz, D; Pleger, B; Thiel, S; Villringer, A; Muller, MM				Goltz, Dominique; Pleger, Burkhard; Thiel, Sabrina; Villringer, Arno; Mueller, Matthias M.			Sustained Spatial Attention to Vibrotactile Stimulation in the Flutter Range: Relevant Brain Regions and Their Interaction	PLOS ONE			English	Article							PRIMARY SOMATOSENSORY CORTEX; SELECTIVE ATTENTION; TACTILE STIMULI; CEREBRAL LATERALIZATION; PARIETAL CORTEX; WORKING-MEMORY; NEURAL CODES; TIME-COURSE; SI; ACTIVATION	The present functional magnetic resonance imaging (fMRI) study was designed to get a better understanding of the brain regions involved in sustained spatial attention to tactile events and to ascertain to what extent their activation was correlated. We presented continuous 20 Hz vibrotactile stimuli (range of flutter) concurrently to the left and right index fingers of healthy human volunteers. An arrow cue instructed subjects in a trial-by-trial fashion to attend to the left or right index finger and to detect rare target events that were embedded in the vibrotactile stimulation streams. We found blood oxygen level-dependent (BOLD) attentional modulation in primary somatosensory cortex (SI), mainly covering Brodmann area 1, 2, and 3b, as well as in secondary somatosensory cortex (SII), contralateral to the to-beattended hand. Furthermore, attention to the right (dominant) hand resulted in additional BOLD modulation in left posterior insula. All of the effects were caused by an increased activation when attention was paid to the contralateral hand, except for the effects in left SI and insula. In left SI, the effect was related to a mixture of both a slight increase in activation when attention was paid to the contralateral hand as well as a slight decrease in activation when attention was paid to the ipsilateral hand (i. e., the tactile distraction condition). In contrast, the effect in left posterior insula was exclusively driven by a relative decrease in activation in the tactile distraction condition, which points to an active inhibition when tactile information is irrelevant. Finally, correlation analyses indicate a linear relationship between attention effects in intrahemispheric somatosensory cortices, since attentional modulation in SI and SII were interrelated within one hemisphere but not across hemispheres. All in all, our results provide a basis for future research on sustained attention to continuous vibrotactile stimulation in the range of flutter.	[Goltz, Dominique; Pleger, Burkhard; Thiel, Sabrina; Villringer, Arno] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Goltz, Dominique; Mueller, Matthias M.] Univ Leipzig, Inst Psychol, D-04109 Leipzig, Germany; [Pleger, Burkhard] Univ Hosp Leipzig, Clin Cognit Neurol, Leipzig, Germany; [Villringer, Arno] Humboldt Univ, Berlin Sch Mind & Brain, D-10099 Berlin, Germany	Max Planck Society; Leipzig University; Leipzig University; Humboldt University of Berlin	Muller, MM (corresponding author), Univ Leipzig, Inst Psychol, D-04109 Leipzig, Germany.	m.mueller@rz.uni-leipzig.de		Villringer, Arno/0000-0003-2604-2404	Deutsche Forschungsgemeinschaft [MU 972/15-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding provided by Deutsche Forschungsgemeinschaft supported the work (www.dfg.de; grant nummer MU 972/15-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2009, BIOL PSYCHOL, V81, P77, DOI 10.1016/j.biopsycho.2009.02.001; Andersen SK, 2010, P NATL ACAD SCI USA, V107, P13878, DOI 10.1073/pnas.1002436107; Andersen SK, 2011, J COGNITIVE NEUROSCI, V23, P238, DOI 10.1162/jocn.2009.21328; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Auksztulewicz R, 2011, EUR J NEUROSCI, V34, P839, DOI 10.1111/j.1460-9568.2011.07797.x; Backes WH, 2000, CLIN NEUROPHYSIOL, V111, P1738, DOI 10.1016/S1388-2457(00)00420-X; Burton H, 1999, CEREB CORTEX, V9, P662, DOI 10.1093/cercor/9.7.662; Burton H, 2000, J CLIN NEUROPHYSIOL, V17, P575, DOI 10.1097/00004691-200011000-00004; Burton H, 2008, HUM BRAIN MAPP, V29, P207, DOI 10.1002/hbm.20384; Di Russo F, 2007, HUM BRAIN MAPP, V28, P323, DOI 10.1002/hbm.20276; Eickhoff SB, 2006, CEREB CORTEX, V16, P268, DOI 10.1093/cercor/bhi106; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eimer M, 2003, CLIN NEUROPHYSIOL, V114, P1298, DOI 10.1016/S1388-2457(03)00107-X; Eimer M, 2003, EXP BRAIN RES, V151, P24, DOI 10.1007/s00221-003-1437-1; Eimer M, 2000, PSYCHOPHYSIOLOGY, V37, P697, DOI 10.1111/1469-8986.3750697; Galazky I, 2009, J NEUROL SCI, V279, P93, DOI 10.1016/j.jns.2008.12.006; Geyer S, 1999, NEUROIMAGE, V10, P63, DOI 10.1006/nimg.1999.0440; Giabbiconi CM, 2007, NEUROIMAGE, V35, P255, DOI 10.1016/j.neuroimage.2006.11.022; Giabbiconi CM, 2004, COGNITIVE BRAIN RES, V20, P58, DOI 10.1016/j.cogbrainres.2004.01.004; Grefkes C, 2001, NEUROIMAGE, V14, P617, DOI 10.1006/nimg.2001.0858; Hamalainen H, 2000, NEUROREPORT, V11, P1673; Hillyard SA, 1997, HUM BRAIN MAPP, V5, P287, DOI 10.1002/(SICI)1097-0193(1997)5:4<287::AID-HBM14>3.0.CO;2-B; Hsiao SS, 1993, CORTEX J NEUROPHYSIO, V70, P444; HYVARINEN J, 1980, J NEUROPHYSIOL, V43, P870, DOI 10.1152/jn.1980.43.4.870; HYVARINEN J, 1978, J PHYSIOL-LONDON, V283, P523, DOI 10.1113/jphysiol.1978.sp012517; Johansen-Berg H, 2000, NEUROREPORT, V11, P1237, DOI 10.1097/00001756-200004270-00019; Johansen-Berg H, 2000, FRONT BIOSCI-LANDMRK, V5, pD894, DOI 10.2741/berg; KAAS JH, 1983, PHYSIOL REV, V63, P206, DOI 10.1152/physrev.1983.63.1.206; KAAS JH, 1993, ANN ANAT, V175, P509, DOI 10.1016/S0940-9602(11)80212-8; Kandel E.R., 2012, PRINCIPLES NEURAL SC; Katus T, 2012, J COGNITIVE NEUROSCI, V24, P1596, DOI 10.1162/jocn_a_00234; Keitel C, 2011, EXP BRAIN RES, V213, P321, DOI 10.1007/s00221-011-2667-2; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Maldjian JA, 1999, BRAIN RES, V824, P291, DOI 10.1016/S0006-8993(99)01126-9; Meador KJ, 1998, NEUROLOGY, V51, P721, DOI 10.1212/WNL.51.3.721; Meador KJ, 2002, J INT NEUROPSYCH SOC, V8, P349, DOI 10.1017/S1355617702813169; MICHIE PT, 1987, PSYCHOPHYSIOLOGY, V24, P449, DOI 10.1111/j.1469-8986.1987.tb00316.x; Mima T, 1998, J NEUROPHYSIOL, V80, P2215, DOI 10.1152/jn.1998.80.4.2215; Moore CI, 2013, J COGNITIVE NEUROSCI, V25, P49, DOI 10.1162/jocn_a_00315; Morgan ST, 1996, P NATL ACAD SCI USA, V93, P4770, DOI 10.1073/pnas.93.10.4770; MOUNTCAS.VB, 1967, SCIENCE, V155, P597, DOI 10.1126/science.155.3762.597; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Muller MM, 2008, CEREB CORTEX, V18, P1892, DOI 10.1093/cercor/bhm215; Muller MM, 1998, COGNITIVE BRAIN RES, V6, P249, DOI 10.1016/S0926-6410(97)00036-0; Muller MM, 2003, NATURE, V424, P309, DOI 10.1038/nature01812; Nelson AJ, 2004, COGNITIVE BRAIN RES, V19, P174, DOI 10.1016/j.cogbrainres.2003.11.013; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pleger B, 2006, J NEUROSCI, V26, P12596, DOI 10.1523/JNEUROSCI.4275-06.2006; PONS TP, 1986, J COMP NEUROL, V248, P313, DOI 10.1002/cne.902480303; Preuschhof C, 2006, J NEUROSCI, V26, P13231, DOI 10.1523/JNEUROSCI.2767-06.2006; Ragert P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016150; Regan D, 1989, HUMAN BRAIN ELECTROP, Vxxiv; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; RUIZ S, 1995, J NEUROPHYSIOL, V73, P525, DOI 10.1152/jn.1995.73.2.525; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Saupe K, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.058.2009; Schweizer R, 2000, SOMATOSENS MOT RES, V17, P309; Spitzer B, 2013, HUM BRAIN MAPP; Spitzer B, 2010, J NEUROSCI, V30, P4496, DOI 10.1523/JNEUROSCI.6041-09.2010; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Stephani C, 2011, BRAIN STRUCT FUNCT, V216, P137, DOI 10.1007/s00429-010-0296-3; Sterr A, 2007, NEUROREPORT, V18, P607, DOI 10.1097/WNR.0b013e3280b07c34; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Tommerdahl M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-29; Tommerdahl M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-11; Tommerdahl M, 1999, J NEUROPHYSIOL, V82, P16, DOI 10.1152/jn.1999.82.1.16; Wacker E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024860; WARREN S, 1986, J NEUROPHYSIOL, V56, P598, DOI 10.1152/jn.1986.56.3.598; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Zopf R, 2004, COGNITIVE BRAIN RES, V20, P491, DOI 10.1016/j.cogbrainres.2004.02.014	73	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84196	10.1371/journal.pone.0084196	http://dx.doi.org/10.1371/journal.pone.0084196			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367642	Green Published, gold, Green Submitted			2022-12-27	WOS:000328741900037
J	Liu, J; Qu, B; Hu, BX; Jiang, N; Wang, DB				Liu, Jie; Qu, Bo; Hu, Bingxue; Jiang, Nan; Wang, Dongbo			The Quality of Life of Men Who Have Sex with Men in China: Reliability and Validity Testing of the SF-36 Questionnaire	PLOS ONE			English	Article							36 HEALTH SURVEY; MEDICAL OUTCOMES; SCALING ASSUMPTIONS; HIV PREVENTION; PREVALENCE; VALIDATION; SYPHILIS; VIRUS; AIDS; RESPONSIVENESS	Objective: The aim of the study was to assess the psychometric properties of the 36-Item Short Form Health Survey (SF-36) in the men who have sex with men (MSM) population in China. Methods: A cross-sectional survey was conducted among 373 MSM from September to December, 2012, in Zhengzhou and Huludao City, China. Internal reliability of the questionnaire was calculated by Cronbach's alpha coefficient. Validity was analyzed through construct validity, divisional validity, and collective validity testing. Results: The overall Cronbach's alpha coefficient of the SF-36 questionnaire was 0.943, while the Cronbach's alpha coefficients for each of the dimensions were all > 0.70. Results showed that the SF-36 questionnaire was reliable and valid. Conclusions: This study provided evidence that the SF-36 is an acceptable, valid and reliable instrument in evaluating the quality of life of MSM in Mainland China.	[Liu, Jie; Qu, Bo; Hu, Bingxue; Jiang, Nan; Wang, Dongbo] China Med Univ, Fac Hlth Stat, Sch Publ Hlth, Shenyang, Peoples R China	China Medical University	Qu, B (corresponding author), China Med Univ, Fac Hlth Stat, Sch Publ Hlth, Shenyang, Peoples R China.	qubo6666@163.com	JIANG, NAN/AHB-1945-2022		National Natural Science Foundation of China [81273186, 71103200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant Number 81273186 and 71103200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bing EG, 2000, QUAL LIFE RES, V9, P55, DOI 10.1023/A:1008919227665; Bostwick WB, 2010, AM J PUBLIC HEALTH, V100, P468, DOI 10.2105/AJPH.2008.152942; Bouhnik AD, 2006, JAIDS-J ACQ IMM DEF, V42, P597, DOI 10.1097/01.qai.0000221674.76327.d7; Call SA, 2000, QUAL LIFE RES, V9, P977, DOI 10.1023/A:1016668802328; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Chen GZ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-58; Chow EPF, 2011, SEX TRANSM DIS, V38, P845, DOI 10.1097/OLQ.0b013e31821a4f43; Clark TJ, 2002, EUR J OBSTET GYN R B, V104, P96, DOI 10.1016/S0301-2115(02)00076-3; Clayson DJ, 2006, PHARMACOECONOMICS, V24, P751, DOI 10.2165/00019053-200624080-00003; DeBoer JB, 1996, QUAL LIFE RES, V5, P339, DOI 10.1007/BF00433918; Drabkin AS, 2013, AIDS PATIENT CARE ST, V27, P333, DOI 10.1089/apc.2012.0313; Eriksson LE, 2007, INT J STD AIDS, V18, P207, DOI 10.1258/095646207780132442; Fang CT, 2002, QUAL LIFE RES, V11, P753, DOI 10.1023/A:1020870402019; Guo Y, 2011, AIDS BEHAV, V15, P521, DOI 10.1007/s10461-010-9808-7; Hsiung PC, 2005, QUAL LIFE RES, V14, P141, DOI 10.1007/s11136-004-6252-z; Hu J, 2010, DIABETES RES CLIN PR, V88, P273, DOI 10.1016/j.diabres.2010.03.005; Jafari H, 2008, J POSTGRAD MED, V54, P273; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Leung YY, 2010, RHEUMATOLOGY, V49, P1495, DOI 10.1093/rheumatology/keq112; Li DL, 2010, AIDS PATIENT CARE ST, V24, P595, DOI 10.1089/apc.2010.0083; Li L, 2003, J EPIDEMIOL COMMUN H, V57, P259, DOI 10.1136/jech.57.4.259; Liao MZ, 2011, AIDS PATIENT CARE ST, V25, P683, DOI 10.1089/apc.2010.0371; Lim LLY, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-52; Lubeck DP, 1997, QUAL LIFE RES, V6, P494, DOI 10.1023/A:1018404014821; Mayer KH, 2012, LANCET, V380, P378, DOI 10.1016/S0140-6736(12)60835-6; Meng YJ, 2008, PUBLIC HEALTH, V122, P404, DOI 10.1016/j.puhe.2007.06.007; Ministry of Health in People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2011, 2011 EST HIV AIDS EP; Najafi M, 2009, J CARDIOVASC MED, V10, P316, DOI 10.2459/JCM.0b013e328326291a; Nightingale VR, 2011, AIDS BEHAV, V15, P1870, DOI 10.1007/s10461-011-9980-4; Ou FR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038861; Riley ED, 2003, QUAL LIFE RES, V12, P1051, DOI 10.1023/A:1026166021386; Ruan YH, 2009, AIDS PATIENT CARE ST, V23, P315, DOI 10.1089/apc.2008.0199; Sandfort TGM, 2003, ARCH SEX BEHAV, V32, P15, DOI 10.1023/A:1021885127560; Setia MS, 2010, INT J PUBLIC HEALTH, V55, P687, DOI 10.1007/s00038-010-0173-0; Smith MY, 1996, QUAL LIFE RES, V5, P47, DOI 10.1007/BF00435968; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; SUN YM, 2012, MODERN PREVENTIVE ME, P1012; Tate D, 2003, AIDS PATIENT CARE ST, V17, P115, DOI 10.1089/108729103763807936; Valenti Marco, 2008, Int J Med Sci, V5, P24; WACHTEL T, 1992, ANN INTERN MED, V116, P129, DOI 10.7326/0003-4819-116-2-129; Wang R, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-292; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Watkins R E, 2000, Asia Pac J Public Health, V12, P118; Wu AW, 1997, QUAL LIFE RES, V6, P481, DOI 10.1023/A:1018451930750; Wu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032312; Xia JunRui, 2010, Modern Preventive Medicine, V37, P3812; Xiao Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS66, DOI 10.1097/QAI.0b013e3181c7db43; Yu LZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050762; Zhou Biao, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P1193; 2009, DAILY CHINA, P1012	51	10	13	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e83362	10.1371/journal.pone.0083362	http://dx.doi.org/10.1371/journal.pone.0083362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HY	24367592	gold, Green Published, Green Submitted			2022-12-27	WOS:000328741900017
J	Protopsaltis, I; Ploumidis, A; Sergentanis, TN; Constantoulakis, P; Tzirogiannis, K; Kyprianidou, C; Papazafiropoulou, AK; Melidonis, A; Delakas, D				Protopsaltis, Ioannis; Ploumidis, Achilles; Sergentanis, Theodoros N.; Constantoulakis, Padelis; Tzirogiannis, Kostantinos; Kyprianidou, Chrysoula; Papazafiropoulou, Athanasia K.; Melidonis, Andreas; Delakas, Dimitrios			Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?	PLOS ONE			English	Article							GROWTH-FACTOR-I; FACTOR BINDING PROTEIN-3; URINARY-TRACT SYMPTOMS; BODY-MASS INDEX; METABOLIC SYNDROME; INSULIN-RESISTANCE; WAIST CIRCUMFERENCE; GLUCOSE-TOLERANCE; IGF-I; CANCER	Benign prostatic hyperplasia (BPH) represents a pattern of non-malignant growth of prostatic fibromuscular stroma. Metabolic disturbances such us pre-diabetes and metabolic syndrome may have a role in BPH pathophysiology. A potential explanation for the above relationship involves the insulin-like growth factor (IGF) axis as well as IGF binding proteins, (IGFBPs) of which the most abundant form is IGFBP-3. Therefore, the aim of the present study was to investigate the association between intra-prostatic levels of IGF-1, IGF-2 as well as to evaluate the role of locally expressed IGFBP-3 in BPH development in pre-diabetes. A total of 49 patients admitted to the Urology department of a tertiary urban Greek hospital, for transurethral prostate resection, or prostatectomy and with pre-diabetes [impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) or both] were finally included. The majority of the sample consisted of subjects with IGT (51.0%), followed by IFG and IGT (32.7%) and isolated IFG (16.3%). For all participants a clinical examination was performed and blood samples were collected. In addition, total prostate (TP) volume or transitional zone (TZ) volume were estimated by transrectal ultrasonography. The results of the multivariate analysis regarding TP volume showed that higher PSA (p<0.001), larger waist circumference (p=0.007) and higher IGFBP-3 expression levels (p<0.001) independently predicted higher TP volume. The results regarding the volume of the TZ showed that higher PSA (p<0.001), larger waist circumference (p<0.001) and higher IGFBP-3 expression levels (p=0.024) were independently associated with higher TZ volume. Our findings show that intra-prostatic levels of IGFBP-3, PSA and waist circumference, but not overall obesity, are positively associated with prostate volume. IGFBP-3 seems to be a multifunctional protein, which can potentiate or inhibit IGF activity.	[Protopsaltis, Ioannis; Tzirogiannis, Kostantinos; Melidonis, Andreas] Tzanio Gen Hosp Piraeus, Ctr Diabet, Piraeus, Greece; [Ploumidis, Achilles; Delakas, Dimitrios] Asklipieio Gen Hosp, Dept Urol, Voula, Greece; [Sergentanis, Theodoros N.] Natl Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Athens, Greece; [Constantoulakis, Padelis; Kyprianidou, Chrysoula] Dept Mol Pathol & Genet, Locus Medicus Lab, Athens, Greece; [Papazafiropoulou, Athanasia K.] Gen Hosp Nikaia Ag Panteleimon, Dept Internal Med 3, Piraeus, Greece; [Papazafiropoulou, Athanasia K.] Gen Hosp Nikaia Ag Panteleimon, Ctr Diabet, Piraeus, Greece	Athens Medical School; National & Kapodistrian University of Athens	Papazafiropoulou, AK (corresponding author), Gen Hosp Nikaia Ag Panteleimon, Dept Internal Med 3, Piraeus, Greece.	pathan@ath.forthnet.gr	Sergentanis, Theodoros N./AAD-8303-2019	Sergentanis, Theodoros N./0000-0002-9355-5528				Bhattacharyya N, 2006, J BIOL CHEM, V281, P24588, DOI 10.1074/jbc.M509463200; Bieche I, 2001, ONCOGENE, V20, P6955, DOI 10.1038/sj.onc.1204739; Boon T A, 2001, Curr Urol Rep, V2, P297, DOI 10.1007/s11934-001-0067-z; Bruce WR, 2000, NUTR CANCER, V37, P19, DOI 10.1207/S15327914NC3701_2; Bub JD, 2006, BIOCHEM BIOPH RES CO, V340, P1158, DOI 10.1016/j.bbrc.2005.12.103; Butt AJ, 2002, ENDOCRINOLOGY, V143, P2693, DOI 10.1210/en.143.7.2693; Chokkalingam AP, 2002, PROSTATE, V52, P98, DOI 10.1002/pros.10096; Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6; COHEN P, 1994, J CLIN ENDOCR METAB, V79, P1410, DOI 10.1210/jc.79.5.1410; COHEN P, 1994, J ENDOCRINOL, V142, P407, DOI 10.1677/joe.0.1420407; Colao A, 1999, J CLIN ENDOCR METAB, V84, P1986, DOI 10.1210/jc.84.6.1986; CONOVER CA, 1992, ENDOCRINOLOGY, V130, P3191, DOI 10.1210/en.130.6.3191; CONOVER CA, 1991, ENDOCRINOLOGY, V129, P710, DOI 10.1210/endo-129-2-710; Dagogo-Jack S, 2009, J CLIN ENDOCR METAB, V94, P2031, DOI 10.1210/jc.2008-1348; Dahle SE, 2002, J UROLOGY, V168, P599, DOI 10.1016/S0022-5347(05)64687-3; de Cremoux P, 2003, ENDOCR-RELAT CANCER, V10, P409, DOI 10.1677/erc.0.0100409; DeFronzo RA, 1997, NETH J MED, V50, P191, DOI 10.1016/S0300-2977(97)00012-0; Festa A, 2004, DIABETES, V53, P1549, DOI 10.2337/diabetes.53.6.1549; Gao Y, 2012, UROLOGY, V79, P194, DOI 10.1016/j.urology.2011.07.1399; Giovannucci E, 2003, HORM METAB RES, V35, P694, DOI 10.1055/s-2004-814147; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; GIOVANNUCCI E, 1994, AM J EPIDEMIOL, V140, P989, DOI 10.1093/oxfordjournals.aje.a117206; Grant ES, 1998, J CLIN ENDOCR METAB, V83, P3252, DOI 10.1210/jc.83.9.3252; Gupta A, 2006, UROLOGY, V68, P1198, DOI 10.1016/j.urology.2006.09.034; Hammarsten J, 1999, BLOOD PRESSURE, V8, P29, DOI 10.1080/080370599438365; Hammarsten J, 1998, PROSTATE CANCER P D, V1, P157, DOI 10.1038/sj.pcan.4500221; Hautanen A, 2000, INT J OBESITY, V24, pS64, DOI 10.1038/sj.ijo.0801281; Haynes JM, 2001, CELL SIGNAL, V13, P703, DOI 10.1016/S0898-6568(01)00205-4; Hong GS, 2010, KOREAN J UROL, V51, P631, DOI 10.4111/kju.2010.51.9.631; Janssen I, 2004, AM J CLIN NUTR, V79, P379; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; KIRBY R, 1996, TXB BENIGN PROSTATIC, P85; KIRBY R, 1996, TXB BENIGN PROSTATIC, P23; Kuo CS, 2002, DIABETES NUTR METAB, V15, P101; Lamarche B, 1998, GROWTH HORM IGF RES, V8, P1, DOI 10.1016/S1096-6374(98)80018-X; Lebovitz HE, 2005, DIABETES CARE, V28, P2322, DOI 10.2337/diacare.28.9.2322; Leibowitz BJ, 2009, J CELL PHYSIOL, V220, P182, DOI 10.1002/jcp.21748; Liao L, 2006, ENDOCRINOLOGY, V147, P3877, DOI 10.1210/en.2005-1537; Mantzoros CS, 1997, BRIT J CANCER, V76, P1115, DOI 10.1038/bjc.1997.520; Meigs JB, 2003, DIABETES, V52, P1475, DOI 10.2337/diabetes.52.6.1475; Monti S, 1998, STEROIDS, V63, P362, DOI 10.1016/S0039-128X(98)00034-8; Monti S, 2001, J CLIN ENDOCR METAB, V86, P1700, DOI 10.1210/jc.86.4.1700; Nandeesha H, 2006, CLIN CHIM ACTA, V370, P89, DOI 10.1016/j.cca.2006.01.019; NEELY EK, 1991, ACTA PAEDIATR SCAND, P116; Neuhouser ML, 2008, PROSTATE, V68, P1477, DOI 10.1002/pros.20819; Ozden C, 2007, EUR UROL, V51, P199, DOI 10.1016/j.eururo.2006.05.040; Park SH, 2005, CLIN SCI, V108, P553, DOI 10.1042/CS20040331; Parsons JK, 2006, J CLIN ENDOCR METAB, V91, P2562, DOI 10.1210/jc.2005-2799; PARTIN AW, 1991, J UROLOGY, V145, P405, DOI 10.1016/S0022-5347(17)38353-2; Poirier P, 2005, HYPERTENSION, V45, P363, DOI 10.1161/01.HYP.0000155463.90018.dc; Pollak M, 2000, EUR J CANCER, V36, P1224, DOI 10.1016/S0959-8049(00)00102-7; Reaven GM, 2005, CLIN CHEM, V51, P931, DOI 10.1373/clinchem.2005.048611; Roberts RO, 2003, AM J EPIDEMIOL, V157, P784, DOI 10.1093/aje/kwf054; Rohrmann S, 2005, INT J OBESITY, V29, P310, DOI 10.1038/sj.ijo.0802881; Sarma AV, 2002, UROLOGY, V59, P362, DOI 10.1016/S0090-4295(01)01546-1; Schenk JM, 2009, PROSTATE, V69, P1303, DOI 10.1002/pros.20974; SHAPIRO E, 1992, J UROLOGY, V147, P1293, DOI 10.1016/S0022-5347(17)37546-8; Shibata Y, 2000, PROSTATE, V42, P45; Stattin P, 2001, SCAND J UROL NEPHROL, V35, P122; STEINER MS, 1993, UROLOGY, V42, P99, DOI 10.1016/0090-4295(93)90352-B; Temml C, 2009, UROLOGY, V73, P544, DOI 10.1016/j.urology.2008.10.027; Vermeulen A, 2002, Aging Male, V5, P98, DOI 10.1080/713604678; Vikram A, 2010, PROSTATE, V70, P79, DOI 10.1002/pros.21041; Wahrenberg H, 2005, BRIT MED J, V330, P1363, DOI 10.1136/bmj.38429.473310.AE; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wannamethee SG, 2005, AM J CLIN NUTR, V81, P1313; Weyer C, 1999, DIABETES, V48, P2197, DOI 10.2337/diabetes.48.11.2197; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zappala G, 2009, BIOCHEM BIOPH RES CO, V382, P785, DOI 10.1016/j.bbrc.2009.03.112; Zucchetto A, 2005, INT J OBESITY, V29, P798, DOI 10.1038/sj.ijo.0802979	70	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e81411	10.1371/journal.pone.0081411	http://dx.doi.org/10.1371/journal.pone.0081411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367483	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900003
J	Funderburg, NT; Andrade, A; Chan, ES; Rosenkranz, SL; Lu, D; Clagett, B; Pilch-Cooper, HA; Rodriguez, B; Feinberg, J; Daar, E; Mellors, J; Kuritzkes, D; Jacobson, JM; Lederman, MM				Funderburg, Nicholas T.; Andrade, Adriana; Chan, Ellen S.; Rosenkranz, Susan L.; Lu, Darlene; Clagett, Brian; Pilch-Cooper, Heather A.; Rodriguez, Benigno; Feinberg, Judith; Daar, Eric; Mellors, John; Kuritzkes, Daniel; Jacobson, Jeffrey M.; Lederman, Michael M.			Dynamics of Immune Reconstitution and Activation Markers in HIV plus Treatment-Naive Patients Treated with Raltegravir, Tenofovir Disoproxil Fumarate and Emtricitabine	PLOS ONE			English	Article							T-CELL-ACTIVATION; ACTIVE ANTIRETROVIRAL THERAPY; VIRUS TYPE-1 INFECTION; MICROBIAL TRANSLOCATION; PLASMA-LEVELS; MEMORY CD4; DISEASE; RECOVERY; COUNT; REDISTRIBUTION	Background: The dynamics of CD4+ T cell reconstitution and changes in immune activation and inflammation in HIV-1 disease following initiation of antiretroviral therapy (ART) are incompletely defined and their underlying mechanisms poorly understood. Methods: Thirty-nine treatment-naive patients were treated with raltegravir, tenofovir DF and emtricitabine. Immunologic and inflammatory indices were examined in persons with sustained virologic control during 48 weeks of therapy. Results: Initiation of ART increased CD4+ T cell numbers and decreased activation and cell cycle entry among CD4+ and CD8+ T cell subsets, and attenuated markers of coagulation (D-dimer levels) and inflammation (IL-6 and TNFr1). These indices decayed at different rates and almost all remained elevated above levels measured in HIV-seronegatives through 48 weeks of viral control. Greater first and second phase CD4+ T cell restoration was related to lower T cell activation and cell cycling at baseline, to their decay with treatment, and to baseline levels of selected inflammatory indices, but less so to their changes on therapy. Conclusions: ART initiation results in dynamic changes in viral replication, T cell restoration, and indices of immune activation, inflammation, and coagulation. These findings suggest that determinants of T cell activation/cycling and inflammation/coagulation may have distinguishable impact on immune homeostasis.	[Funderburg, Nicholas T.; Clagett, Brian; Pilch-Cooper, Heather A.; Rodriguez, Benigno; Lederman, Michael M.] Case Western Reserve Univ, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA; [Andrade, Adriana] Johns Hopkins Univ, Baltimore, MD USA; [Chan, Ellen S.; Rosenkranz, Susan L.; Lu, Darlene] Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Feinberg, Judith] Univ Cincinnati, Med Ctr, Cincinnati, OH 45267 USA; [Daar, Eric] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Mellors, John] Univ Pittsburg, Med Ctr, Pittsburg, KS USA; [Kuritzkes, Daniel] Brigham & Womens Hosp, Boston, MA 02115 USA; [Kuritzkes, Daniel] Harvard Univ, Sch Med, Boston, MA USA; [Jacobson, Jeffrey M.] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	Case Western Reserve University; Johns Hopkins University; Harvard University; Harvard T.H. Chan School of Public Health; University System of Ohio; University of Cincinnati; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Drexel University	Funderburg, NT (corresponding author), Case Western Reserve Univ, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA.	NTF1@case.edu	Funderburg, Nicholas/L-8022-2013; Rodriguez, Benigno/C-3365-2009	Rodriguez, Benigno/0000-0001-9736-7957; feinberg, judith/0000-0003-4206-7214; Funderburg, Nicholas/0000-0003-3113-1217	National Institutes of Health [AI-69501, AI-068636, AI 36219, AI069472, AI060354, UL1 TR000170]; National Institute of Allergy and Infectious Diseases [UM1 AI068634]; UCLA CTSI [UL1TR000124];  [AI069424]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000170, UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL108743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069424, P30AI036219, P30AI060354, UM1AI068634, UM1AI069494, U01AI068636, UM1AI069412, UM1AI069472, UM1AI106701, U01AI069472, UM1AI069534, UM1AI068636, UM1AI069501, U01AI069424, U01AI069501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UCLA CTSI; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants [AI-69501, AI-068636, AI 36219 (Case Western Reserve University CFAR), AI069472, AI060354 (Harvard University CFAR) and UL1 TR000170 (Harvard Clinical and Translational Science Center) from the National Institutes of Health. AI069424 and the UCLA CTSI Grant UL1TR000124 (Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center). The Statistical and Data Management Center (SDMC) UM1 AI068634 is funded by the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade A, 2013, J INFECT DI IN PRESS; Anthony KB, 2003, JAIDS-J ACQ IMM DEF, V33, P125, DOI 10.1097/00126334-200306010-00002; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Bas S, 2004, J IMMUNOL, V172, P4470, DOI 10.4049/jimmunol.172.7.4470; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Bosch RJ, 2006, JAIDS-J ACQ IMM DEF, V43, P433, DOI 10.1097/01.qai.0000243097.27029.b7; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Bucy RP, 1999, J CLIN INVEST, V103, P1391, DOI 10.1172/JCI5863; Ciccone EJ, 2010, MUCOSAL IMMUNOL, V3, P172, DOI 10.1038/mi.2009.129; Di Mascio M, 2006, J VIROL, V80, P2665, DOI 10.1128/JVI.80.6.2665-2674.2006; Estes J, 2008, J INFECT DIS, V198, P456, DOI 10.1086/590112; Funderburg N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001915; Funderburg NT, 2010, BLOOD, V115, P161, DOI 10.1182/blood-2009-03-210179; Funderburg NT., 2012, BLOOD; Gandhi RT, 2006, JAIDS-J ACQ IMM DEF, V42, P426, DOI 10.1097/01.qai.0000226789.51992.3f; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Gray CM, 1999, J IMMUNOL, V162, P1780; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Hunt PW, 2012, GUT EPITHELIAL BARRI; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kalams SA, 1999, J VIROL, V73, P6721, DOI 10.1128/JVI.73.8.6721-6728.1999; Kalayjian RC, 2010, J INFECT DIS, V201, P1796, DOI 10.1086/652750; Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lederman MM, 2011, J INFECT DIS, V204, P1217, DOI 10.1093/infdis/jir507; Lederman MM, 2000, AIDS, V14, P2635, DOI 10.1097/00002030-200012010-00002; Lederman MM, 1998, J INFECT DIS, V178, P70, DOI 10.1086/515591; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Musselwhite LW, 2011, AIDS, V25, P787, DOI 10.1097/QAD.0b013e3283453fcb; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208; Picker LJ, 2004, J EXP MED, V200, P1299, DOI 10.1084/jem.20041049; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Schacker TW, 2010, JAIDS-J ACQ IMM DEF, V54, P59, DOI 10.1097/QAI.0b013e3181c96520; Shive CL, 2013, KEYST C IMM ACT HIV; Sieg SF, 2005, J INFECT DIS, V192, P62, DOI 10.1086/430620; Srinivasula S, 2011, BLOOD, V118, P262, DOI 10.1182/blood-2011-02-335174	41	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83514	10.1371/journal.pone.0083514	http://dx.doi.org/10.1371/journal.pone.0083514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367599	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300108
J	Garcia, AF; Lopes, JLS; Costa, AJ; Wallace, BA; Araujo, APU				Garcia, Assuero F.; Lopes, Jose L. S.; Costa-Filho, Antonio J.; Wallace, Bonnie A.; Araujo, Ana P. U.			Membrane Interactions of S100A12 (Calgranulin C)	PLOS ONE			English	Article							CALCIUM-BINDING PROTEIN; SECONDARY STRUCTURE; STABILITY; DOMAIN; ZINC; TRANSLOCATION; SPECTROSCOPY; ACTIVATION; MIGRATION; MUTANTS	S100A12 (Calgranulin C) is a small acidic calcium-binding peripheral membrane protein with two EF-hand structural motifs. It is expressed in macrophages and lymphocytes and highly up-regulated in several human inflammatory diseases. In pigs, S100A12 is abundant in the cytosol of granulocytes, where it is believed to be involved in signal modulation of inflammatory process. In this study, we investigated the interaction of the porcine S100A12 with phospholipid bilayers and the effect that ions (Ca2+, Zn2+ or both together) have in modifying protein-lipid interactions. More specifically, we intended to address issues such as: (1) is the protein-membrane interaction modulated by the presence of ions? (2) is the protein overall structure affected by the presence of the ions and membrane models simultaneously? (3) what are the specific conformational changes taking place when ions and membranes are both present? (4) does the protein have any kind of molecular preferences for a specific lipid component? To provide insight into membrane interactions and answer those questions, synchrotron radiation circular dichroism spectroscopy, fluorescence spectroscopy, and surface plasmon resonance were used. The use of these combined techniques demonstrated that this protein was capable of interacting both with lipids and with ions in solution, and enabled examination of changes that occur at different levels of structure organization. The presence of both Ca2+ and Zn2+ ions modify the binding, conformation and thermal stability of the protein in the presence of lipids. Hence, these studies examining molecular interactions of porcine S100A12 in solution complement the previously determined crystal structure information on this family of proteins, enhancing our understanding of its dynamics of interaction with membranes.	[Garcia, Assuero F.; Lopes, Jose L. S.; Costa-Filho, Antonio J.; Araujo, Ana P. U.] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Garcia, Assuero F.; Costa-Filho, Antonio J.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Fis, Ribeirao Preto, SP, Brazil; [Lopes, Jose L. S.; Wallace, Bonnie A.] Univ London, Inst Struct & Mol Biol, Birkbeck Coll, London, England	Universidade de Sao Paulo; Universidade de Sao Paulo; University of London; Birkbeck University London	Araujo, APU (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil.	anapaula@ifsc.usp.br	Araujo, Ana Paula U/I-6664-2012; Costa-Filho, Antonio J/D-3153-2012; Lopes, Jose L S/D-3213-2012; Costa-Filho, Antonio José/AAZ-1808-2020; Lopes, Jose Luiz S/AAC-2917-2021; Wallace, B A/C-3753-2008	Araujo, Ana Paula U/0000-0001-5455-084X; Costa-Filho, Antonio J/0000-0001-6730-8737; Lopes, Jose L S/0000-0003-1281-0521; Wallace, B A/0000-0001-9649-5092	Brazilian INCT-INBEQMeDI; FAPESP; CNPq [573607/2008-7, 2010/17662-8, 2012/20367-3]; UK Biotechnology and Biological Sciences Research Council (BBRSC); BBSRC; EU Integrated Infrastructure Initiative (I3), European Light Sources Activities (ELISA) [226716]; BBSRC [BB/G530417/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G530417/1] Funding Source: researchfish	Brazilian INCT-INBEQMeDI; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); UK Biotechnology and Biological Sciences Research Council (BBRSC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU Integrated Infrastructure Initiative (I3), European Light Sources Activities (ELISA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by research grants from the Brazilian INCT-INBEQMeDI, FAPESP and CNPq (to APUA grant number 573607/2008-7 and AJCF - grant numbers 2010/17662-8 and 2012/20367-3), and the UK Biotechnology and Biological Sciences Research Council (BBRSC) (to BAW), CNPq Fellowships (to JLSL and AFG), and paired UK/Brazil Partnering grants from the CNPq and BBSRC. SRCD measurements at the ISA synchtroron (Aarhus, Denmark) were enabled by beamtime grants (to BAW and JLSL). Access to the CD1 beamline at ISA is acknowledged under the EU Integrated Infrastructure Initiative (I3), European Light Sources Activities (ELISA), grant agreement number 226716. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAUDIER J, 1983, BIOCHEMISTRY-US, V22, P3360, DOI 10.1021/bi00283a009; Bauer MC, 2008, PROTEIN SCI, V17, P760, DOI 10.1110/ps.073381108; Bittova L, 2001, J BIOL CHEM, V276, P4218, DOI 10.1074/jbc.M008491200; Botelho HM, 2009, FEBS J, V276, P1776, DOI 10.1111/j.1742-4658.2009.06912.x; CALISSANO P, 1974, BIOCHEMISTRY-US, V13, P4553, DOI 10.1021/bi00719a013; DELLANGELICA EC, 1994, J BIOL CHEM, V269, P28929; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; FUJII T, 1995, J BIOCHEM-TOKYO, V117, P999, DOI 10.1093/oxfordjournals.jbchem.a124833; Garcia AF, 2008, BIOPHYS CHEM, V134, P246, DOI 10.1016/j.bpc.2008.02.013; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; GOEBELER M, 1995, BIOCHEM J, V309, P419, DOI 10.1042/bj3090419; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; HEIZMANN CW, 1991, TRENDS BIOCHEM SCI, V16, P98, DOI 10.1016/0968-0004(91)90041-S; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hsieh HL, 2002, J CELL SCI, V115, P3149; Kathir KM, 2007, BBA-BIOMEMBRANES, V1768, P3080, DOI 10.1016/j.bbamem.2007.09.007; KILHOFFER MC, 1981, BIOCHEMISTRY-US, V20, P4407, DOI 10.1021/bi00518a027; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; Klose DP, 2010, BIOINFORMATICS, V26, P2624, DOI 10.1093/bioinformatics/btq480; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lopes JLS, 2009, BBA-BIOMEMBRANES, V1788, P2252, DOI 10.1016/j.bbamem.2009.06.026; Malmendal A, 2005, BIOCHEMISTRY-US, V44, P6502, DOI 10.1021/bi050088z; Markowitz J, 2005, BIOCHEMISTRY-US, V44, P7305, DOI 10.1021/bi050321t; MCCLARE CWF, 1971, ANAL BIOCHEM, V39, P527, DOI 10.1016/0003-2697(71)90443-X; Meijer B, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/907078; Moroz OV, 2009, J MOL BIOL, V391, P536, DOI 10.1016/j.jmb.2009.06.004; Moroz OV, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-11; Mozsolits H, 2002, BIOPOLYMERS, V66, P3, DOI 10.1002/bip.10200; Rezvanpour A, 2009, GEN PHYSIOL BIOPHYS, V28, pF39; RICHMAN PG, 1979, J BIOL CHEM, V254, P5372; Rouleau P, 2003, CLIN IMMUNOL, V107, P46, DOI 10.1016/S1521-6616(02)00043-8; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Sastry M, 1998, STRUCTURE, V6, P223, DOI 10.1016/S0969-2126(98)00023-9; Schafer BW, 2000, J BIOL CHEM, V275, P30623, DOI 10.1074/jbc.M002260200; Sivaraja V, 2001, BIOPHYS J, V1, P1832; VanScyoc WS, 2002, BIOPHYS J, V83, P2767, DOI 10.1016/S0006-3495(02)75286-7; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Venyaminov SY, 2004, ANAL BIOCHEM, V334, P97, DOI 10.1016/j.ab.2004.07.032; Vogl T, 1999, J BIOL CHEM, V274, P25291, DOI 10.1074/jbc.274.36.25291; Vogl T, 2006, BBA-MOL CELL RES, V1763, P1298, DOI 10.1016/j.bbamcr.2006.08.028; WENDT B, 1988, EUR J BIOCHEM, V175, P439, DOI 10.1111/j.1432-1033.1988.tb14214.x; Yang Z, 2001, J LEUKOCYTE BIOL, V69, P986; Yang Z, 2007, J ALLERGY CLIN IMMUN, V119, P106, DOI 10.1016/j.jaci.2006.08.021; Zimmer D. B., 2010, CARDIOVASC PSYCHIAT, V2010, DOI DOI 10.1155/2010/728052; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297	53	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82555	10.1371/journal.pone.0082555	http://dx.doi.org/10.1371/journal.pone.0082555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367524	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000328740300040
J	Penelo, E; Negrete, A; Portell, M; Raich, RM				Penelo, Eva; Negrete, America; Portell, Mariona; Raich, Rosa M.			Psychometric Properties of the Eating Disorder Examination Questionnaire (EDE-Q) and Norms for Rural and Urban Adolescent Males and Females in Mexico	PLOS ONE			English	Article							BODY SHAPE MODEL; CONFIRMATORY FACTOR-ANALYSIS; SOCIOCULTURAL INFLUENCES; SCOFF QUESTIONNAIRE; SPANISH VERSION; VALIDITY; RELIABILITY; WOMEN; INTERVIEW	Aims: To contribute new evidence to the controversy about the factor structure of the Eating Disorder Examination Questionnaire (EDE-Q) and to provide, for the first time, norms based on a large adolescent Mexican community sample, regarding sex and area of residence (urban/rural). Methods: A total of 2928 schoolchildren (1544 females and 1384 males) aged 11-18 were assessed with the EDE-Q and other disordered eating questionnaire measures. Results: Confirmatory factor analysis of the attitudinal items of the EDE-Q did not support the four theorized subscales, and a two-factor solution, Restraint and Eating-Shape-Weight concern, showed better fit than the other models examined (RMSEA =.054); measurement invariance for this two-factor model across sex and area of residence was found. Satisfactory internal consistency (omega =.80) and two-week test-retest reliability (ICCa =.84;. =. 56), and evidence for convergent validity with external measures was obtained. The highest attitudinal EDE-Q scores were found for urban females and the lowest scores were found for rural males, whereas the occurrence of key eating disorder behavioural features and compensatory behaviours was similar in both areas of residence. Conclusions: This study reveals satisfactory psychometric properties and provides population norms of the EDE-Q, which may help clinicians and researchers to interpret the EDE-Q scores of adolescents from urban and rural areas in Mexico.	[Penelo, Eva] Univ Autonoma Barcelona, Lab Estadist Aplicada, Dept Psicobiol & Metodol Ciencies Salut, E-08193 Barcelona, Spain; [Negrete, America] Univ Autonoma Nayarit, Acad Instrumental, Programa Acad Psicol, Tepic, Nayarit, Mexico; [Negrete, America; Portell, Mariona; Raich, Rosa M.] Univ Autonoma Barcelona, Unitat Avaluacio & Intervencio Imatge Corporal, E-08193 Barcelona, Spain; [Portell, Mariona] Univ Autonoma Barcelona, Dept Psicobiol & Metodol Ciencies Salut, E-08193 Barcelona, Spain; [Raich, Rosa M.] Univ Autonoma Barcelona, Dept Psicol Clin & Salut, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona	Raich, RM (corresponding author), Univ Autonoma Barcelona, Unitat Avaluacio & Intervencio Imatge Corporal, E-08193 Barcelona, Spain.	rosa.raich@uab.cat	Portell, Mariona/L-5295-2014	Portell, Mariona/0000-0002-5939-6842; Raich, Rosa M./0000-0001-7819-3357; Penelo, Eva/0000-0001-6796-7660	Spanish Ministry of Economy and Competitivity [PSI2010-22067]; Catalonian Government	Spanish Ministry of Economy and Competitivity(Spanish Government); Catalonian Government	This research was partly supported by grants PSI2010-22067 from the Spanish Ministry of Economy and Competitivity, and 2009-SGR-1450 from the Catalonian Government. The funders had no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	Aardoom JJ, 2012, EAT BEHAV, V13, P305, DOI 10.1016/j.eatbeh.2012.09.002; Allen KL, 2011, EAT BEHAV, V12, P143, DOI 10.1016/j.eatbeh.2011.01.005; APA, 2000, DIAGN STAT MAN MENT; APA, 1994, DIAGN STAT MAN MENT; Barnes J, 2012, EAT BEHAV, V13, P379, DOI 10.1016/j.eatbeh.2012.05.001; Becker AE, 2010, INT J EAT DISORDER, V43, P171, DOI 10.1002/eat.20675; Berg KC, 2012, INT J EAT DISORDER, V45, P428, DOI 10.1002/eat.20931; Bojorquez I, 2004, EUR EAT DISORD REV, V12, P197, DOI 10.1002/erv.571; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; Byrne BM, 2008, PSICOTHEMA, V20, P872; Carter JC, 2001, BEHAV RES THER, V39, P625, DOI 10.1016/S0005-7967(00)00033-4; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; *CONEVAL, 2010, POBR INGR MEX; Darcy AM, 2013, BODY IMAGE, V10, P399, DOI 10.1016/j.bodyim.2013.01.008; DOMENECH JM, 2008, SPSS MACROBONFE BONF; ESCOTO MC, 2008, REV MEX PSICOL, V25, P99; Espinoza P, 2010, BODY IMAGE, V7, P70, DOI 10.1016/j.bodyim.2009.09.002; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Fairburn Christopher G., 1993, P317; FINNER H, 1993, J AM STAT ASSOC, V88, P920, DOI 10.2307/2290782; Franco Paredes Karina, 2011, Rev. Mex. de trastor. aliment, V2, P148; Franco Paredes Karina, 2010, Rev. Mex. de trastor. aliment, V1, P90; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; Garner DM, 1991, EATING DISORDER INVE; Giovazolias T, 2013, EUR J PSYCHOL ASSESS, V29, P189, DOI 10.1027/1015-5759/a000138; *GOB EST NAYAR ORG, 2012, PLAN EST DES NAYAR 2; Grilo CM, 2013, OBES SURG, V23, P657, DOI 10.1007/s11695-012-0840-8; Hay PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001541; Hidalgo-Rasmussen Carlos Alejandro, 2011, Rev. Mex. de trastor. aliment, V2, P71; Hilbert A, 2007, DIAGNOSTICA, V53, P144, DOI 10.1026/0012-1924.53.3.144; Hilbert A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029125; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Holmqvist K, 2010, EUR EAT DISORD REV, V18, P133, DOI 10.1002/erv.965; Hrabosky JI, 2008, OBESITY, V16, P763, DOI 10.1038/oby.2008.3; *INEGI, 2010, POBL 3 AN MAS MUN ED; *INEGI, 2010, TOT ESC ED BAS MED S; Jackson DL, 2009, PSYCHOL METHODS, V14, P6, DOI 10.1037/a0014694; JORESKOG KG, 1975, J AM STAT ASSOC, V70, P631, DOI 10.2307/2285946; Luce KH, 1999, INT J EAT DISORDER, V25, P349, DOI 10.1002/(SICI)1098-108X(199904)25:3&lt;349::AID-EAT15&gt;3.0.CO;2-M; Luck AJ, 2002, BRIT MED J, V325, P755, DOI 10.1136/bmj.325.7367.755; MALONEY MJ, 1988, J AM ACAD CHILD PSY, V27, P541, DOI 10.1097/00004583-198809000-00004; MANCILLA JM, 2003, REV THOMSON PSICOLOG, V1, P167; Marsh HW, 2013, DEV PSYCHOL, V49, P1194, DOI 10.1037/a0026913; McDonald RP, 1999, TEST THEORY UNIFIED; Mond JM, 2004, BEHAV RES THER, V42, P551, DOI 10.1016/S0005-7967(03)00161-X; Mond JM, 2004, INT J EAT DISORDER, V36, P195, DOI 10.1002/eat.20017; Morgan JF, 1999, BRIT MED J, V319, P1467, DOI 10.1136/bmj.319.7223.1467; Muthen B., 2010, MPLUS USERS GUIDE; Nunez-Navarro A, 2012, EUR EAT DISORD REV, V20, P23, DOI 10.1002/erv.1146; Pelaez-Fernandez MA, 2013, PSICOTHEMA, V25, P107, DOI 10.7334/psicothema2012.18; Penelo E, 2012, EUR J PSYCHOL ASSESS, V28, P76, DOI 10.1027/1015-5759/a000093; Peterson CB, 2007, INT J EAT DISORDER, V40, P386, DOI 10.1002/eat.20373; Reas DL, 2006, BEHAV RES THER, V44, P43, DOI 10.1016/j.brat.2005.01.004; Ro O, 2010, NORD J PSYCHIAT, V64, P428, DOI 10.3109/08039481003797235; Sanchez-Armass O, 2012, SALUD PUBLICA MEXICO, V54, P375, DOI 10.1590/S0036-36342012000400007; *SEDESOL, 2012, DIR GEN ADJ PLAN MIC; Statistics IS, 2010, STAT PACK SOC SCI VE; Stice E, 2002, PSYCHOL BULL, V128, P825, DOI 10.1037//0033-2909.128.5.825; Toro J, 2005, EUR EAT DISORD REV, V13, P351, DOI 10.1002/erv.650; TORO J, 1994, ACTA PSYCHIAT SCAND, V89, P147, DOI 10.1111/j.1600-0447.1994.tb08084.x; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Vazquez R, 2000, SALUD MENT, V23, P18; Villarroel AM, 2011, J PSYCHOPATHOL BEHAV, V33, P121, DOI 10.1007/s10862-009-9177-6; WHITAKER WH, 1983, J RES RURAL ED, V1, P71; White HJ, 2014, INT J EAT DISORDER, V47, P99, DOI 10.1002/eat.22199; Yucel B, 2011, EUR EAT DISORD REV, V19, P509, DOI 10.1002/erv.1104	68	58	59	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83245	10.1371/journal.pone.0083245	http://dx.doi.org/10.1371/journal.pone.0083245			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367587	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300098
J	Sun, Y; Yan, JY; Mao, HY; Zhang, L; Lyu, QF; Wu, ZH; Zheng, W; Feng, C; Zhang, YJ				Sun, Yi; Yan, JuYing; Mao, HaiYan; Zhang, Lei; Lyu, QinFeng; Wu, ZhongHua; Zheng, Wei; Feng, Cen; Zhang, YanJun			Characterization of the Complete Genome of Chikungunya in Zhejiang, China, Using a Modified Virus Discovery Method Based on cDNA-AFLP	PLOS ONE			English	Article							PHYLOGENETIC ANALYSES; IDENTIFICATION; CORONAVIRUS; OUTBREAK; INDIA	Background: Chikungunya (CHIK) virus is a mosquito-borne emerging pathogen presenting great health challenges worldwide, particularly in tropical zones. Here we report a newly detected strain of CHIK, Zhejiang/chik-sy/2012, in China, a nonindigenous region for CHIK, using a modified approach based on the classic cDNA-AFLP. We then performed etiological and phylogenetic analyses to better understand its molecular characterization and phylogenetic pattern, and also to aid in further evaluating its persistence in Southeast Asia. Methods: By using this modified procedure, we determined for the first time the complete genome sequence of the chikungunya virus strain, Zhejiang/chik-sy/2012, isolated in 2012 from a patient in Zhejiang, China. Sequence analyses revealed that this positive single strand of RNA is 12,017 bp long. We found no single amino acid mutation in A226V, D284E and A316V. Phylogenetic analysis showed that our strain shared the greatest homology with a strain isolated in Taiwan, which was derived from a strain from Indonesia. Chik-sy/2012 is in a different clade from other CHIK viruses found in China previously. Conclusions: A modified cDNA-AFLP in virus discovery was used to isolate the first CHIK and the first complete genome sequence of virus strain chik-sy/2012 in 2012 from a patient with CHIK fever in Zhejiang, China. The infection displayed great phylogenetic distance from viruses detected in Guangdong, China, in 2008 and 2010, since they were derived from another evolutionary lineage. Additional molecular epidemiology data are needed to further understand, monitor and evaluate CHIK in China.	[Sun, Yi; Yan, JuYing; Mao, HaiYan; Zhang, Lei; Zhang, YanJun] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Lyu, QinFeng; Wu, ZhongHua; Zheng, Wei] Zhejiang Int Travel Healthcare Ctr, Hangzhou, Zhejiang, Peoples R China; [Feng, Cen] Zhejiang Normal Univ, Jinhua, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; Zhejiang Normal University	Zhang, YJ (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	yjzhang@cdc.zj.cn			Zhejiang Provincial Program for the Cultivation of High-level Innoative Health talents, Youth Project of Zhejiang CDC Foundation; General Administration of Quality Supervision, Inspection and Quarantine of P.R.C [20100043]	Zhejiang Provincial Program for the Cultivation of High-level Innoative Health talents, Youth Project of Zhejiang CDC Foundation; General Administration of Quality Supervision, Inspection and Quarantine of P.R.C	This work was funded by Zhejiang Provincial Program for the Cultivation of High-level Innoative Health talents, Youth Project of Zhejiang CDC Foundation and General Administration of Quality Supervision, Inspection and Quarantine of P.R.C (20100043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Hedrick PW, 2011, GENETICS POPULATION, P111; Holmes KV, 1996, FIELDS VIROLOGY, P1075; Kumar NP, 2008, J GEN VIROL, V89, P1945, DOI 10.1099/vir.0.83628-0; Li XF, 2012, J VIROL, V86, P8904, DOI 10.1128/JVI.01289-12; Lo Presti A, 2012, INFECT GENET EVOL, V12, P392, DOI 10.1016/j.meegid.2011.12.015; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pyrc Krzysztof, 2008, V454, P73, DOI 10.1007/978-1-59745-181-9_7; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09; Zhang X, 2013, VIROL J, V10, DOI [10.1186/1743-422X-10-194, 10.1186/1743-422X-10-174]; Zheng K, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-8	16	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83014	10.1371/journal.pone.0083014	http://dx.doi.org/10.1371/journal.pone.0083014			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367579	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300090
J	Weng, ZH; Ertle, J; Zheng, SP; Lauenstein, T; Mueller, S; Bockisch, A; Gerken, G; Yang, DL; Schlaak, JF				Weng, Zhihong; Ertle, Judith; Zheng, Shaoping; Lauenstein, Thomas; Mueller, Stefan; Bockisch, Andreas; Gerken, Guido; Yang, Dongliang; Schlaak, Joerg F.			A New Model to Estimate Prognosis in Patients with Hepatocellular Carcinoma after Yttrium-90 Radioembolization	PLOS ONE			English	Article							UNITED-STATES; LIVER-CANCER; SURVIVAL; CRITERIA; RECOMMENDATIONS; MANAGEMENT; SELECTION; FUTURE	Aims: The current prognostic model to estimate the survival in hepatocellular carcinoma (HCC) patients treated with transarterial hepatic selective internal radiotherapy (SIRT) is not fully characterized. The aim of this study was to establish a new scoring model including assessment of both tumor responses and therapy-induced systemic changes in HCC patients to predict survival at an early time point post-SIRT. Methods and materials: Between 2008 and 2012, 149 HCC patients treated with SIRT were included into this study. CT images and biomarkers in blood tested at one month post-SIRT were analyzed and correlated with clinical outcome. Tumor responses were assessed by RECIST 1.1, mRECIST, and Choi criteria. Kaplan-Meier methods were used to estimate survival curves. Cox regression was used in uni- and multivariable survival analyses and in the establishment of a prognostic model. Results: A multivariate proportional hazards model was created based on the tumor response, the number of tumor nodules, the score of the model for end stage liver disease (MELD), and the serum C-reactive protein levels which were independent predictors of survival in HCC patients at one month post-SIRT. This prognostic model accurately differentiated the outcome of patients with different risk scores in this cohort (P<0.001). The model also had the ability to assign a predicted survival probability for individual patients. Conclusions: A new model to predict survival of HCC patients mainly based on tumor responses and therapy-induced systemic changes provides reliable prognosis and accurately discriminates the survival at an early time point after SIRT in these patients.	[Weng, Zhihong; Ertle, Judith; Gerken, Guido; Schlaak, Joerg F.] Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany; [Weng, Zhihong; Yang, Dongliang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China; [Zheng, Shaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Ultrasonog, Wuhan 430074, Peoples R China; [Lauenstein, Thomas] Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Mueller, Stefan; Bockisch, Andreas] Univ Hosp Essen, Inst Nucl Med, Essen, Germany	University of Duisburg Essen; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Duisburg Essen; University of Duisburg Essen	Schlaak, JF (corresponding author), Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany.	joerg.schlaak@uni-due.de		Schlaak, Joerg/0000-0002-9499-1014	Deutsche Forschungsgemeinschaft [TRR60]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft (TRR60). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HJ, 2012, LIVER TRANSPLANT, V18, P1406, DOI 10.1002/lt.23512; ATTALI P, 1987, CANCER, V59, P2108, DOI 10.1002/1097-0142(19870615)59:12<2108::AID-CNCR2820591225>3.0.CO;2-3; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Coldwell D, 2011, AM J CLIN ONCOL-CANC, V34, P337, DOI 10.1097/COC.0b013e3181ec61bb; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; El-Serag H, 2003, ANN INTERN MED, V139, P817, DOI 10.7326/0003-4819-139-10-200311180-00009; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Gillmore R, 2011, J HEPATOL, V55, P1309, DOI 10.1016/j.jhep.2011.03.007; Hamami ME, 2009, J NUCL MED, V50, P688, DOI 10.2967/jnumed.108.058347; Hsu CY, 2010, CANCER-AM CANCER SOC, V116, P3006, DOI 10.1002/cncr.25044; Jelic S, 2010, ANN ONCOL, V21, pv59, DOI 10.1093/annonc/mdq166; Kennedy A, 2007, INT J RADIAT ONCOL, V68, P13, DOI 10.1016/j.ijrobp.2006.11.060; Kennedy A, 2012, AM J CLIN ONCOL-CANC, V35, P81, DOI 10.1097/COC.0b013e3181ec60b8; Kinoshita A, 2012, MED ONCOL, V29, P2800, DOI 10.1007/s12032-012-0220-1; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Pencina MJ, 2012, STAT MED, V31, P1543, DOI 10.1002/sim.4508; Piscaglia F, 2010, DIGEST LIVER DIS, V42, pS258, DOI 10.1016/S1590-8658(10)60514-2; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Rahbari NN, 2011, ANN SURG, V253, P453, DOI 10.1097/SLA.0b013e31820d944f; Sangro B, 2012, J HEPATOL, V56, P464, DOI 10.1016/j.jhep.2011.07.012; Sangro B, 2011, HEPATOLOGY, V54, P868, DOI 10.1002/hep.24451; Stuart KE, 1996, CANCER, V77, P2217, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2217::AID-CNCR6>3.0.CO;2-M; Sun YF, 2013, HEPATOLOGY, V57, P1458, DOI 10.1002/hep.26151; Tandon P, 2009, LIVER INT, V29, P502, DOI 10.1111/j.1478-3231.2008.01957.x; Toyoda H, 2012, J HEPATOL, V57, P1251, DOI 10.1016/j.jhep.2012.07.018; Vauthey JN, 2002, J CLIN ONCOL, V20, P1527, DOI 10.1200/JCO.20.6.1527; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Yang JD, 2012, HEPATOLOGY, V56, P614, DOI 10.1002/hep.25680	37	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82225	10.1371/journal.pone.0082225	http://dx.doi.org/10.1371/journal.pone.0082225			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367506	Green Submitted, Green Published, gold			2022-12-27	WOS:000328740300022
J	Kimura, K; Tomaru, Y				Kimura, Kei; Tomaru, Yuji			Isolation and Characterization of a Single-Stranded DNA Virus Infecting the Marine Diatom Chaetoceros sp Strain SS628-11 Isolated from Western JAPAN	PLOS ONE			English	Article							RNA VIRUS; BLOOM; RAPHIDOPHYCEAE; BAY	Diatoms are significant organisms for primary production in the earth's aquatic environment. Hence, their dynamics are an important focus area in current studies. Viruses are a great concern as potential factors of diatom mortality, along with other physical, chemical, and biological factors. We isolated and characterized a new diatom virus (Csp07DNAV) that lyses the marine planktonic diatom Chaetoceros sp. strain SS628-11. This paper examines the physiological, morphological, and genomic characteristics of Csp07DNAV. The virus was isolated from a surface water sample that was collected at Hiroshima Bay, Japan. It was icosahedral, had a diameter of 34 nm, and accumulated in the nuclei of host cells. Rod-shaped virus particles also coexisted in the host nuclei. The latent period and burst size were estimated to be <12 h and 29 infectious units per host cell, respectively. Csp07DNAV had a closed circular single-stranded DNA genome (5,552 nucleotides), which included a double-stranded region and 3 open reading frames. The monophyly of Csp07DNAV and other Bacilladnavirus group single-stranded DNA viruses was supported by phylogenetic analysis that was based on the amino acid sequence of each virus protein. On the basis of these results, we considered Csp07DNAV to be a new member of the genus Bacilladnavirus.	[Kimura, Kei; Tomaru, Yuji] Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, Hatsukaichi, Hiroshima, Japan; [Kimura, Kei] Japan Soc Promot Sci, Tokyo, Japan	Japan Fisheries Research & Education Agency (FRA); Japan Society for the Promotion of Science	Tomaru, Y (corresponding author), Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, Hatsukaichi, Hiroshima, Japan.	tomaruy@affrc.go.jp			Japan Society for the Promotion of Science [22688016]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Research Fellowships for Young Scientists and Grants-in-Aid for Young Scientists (A) (22688016) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; ASAYAMA T, 1975, Japanese Journal of Applied Entomology and Zoology, V19, P149, DOI 10.1303/jjaez.19.149; Bettarel Y, 2005, AQUAT MICROB ECOL, V40, P103, DOI 10.3354/ame040103; Booth BC, 2002, DEEP-SEA RES PT II, V49, P5003, DOI 10.1016/S0967-0645(02)00175-3; Eissler Y, 2009, J PHYCOL, V45, P787, DOI 10.1111/j.1529-8817.2009.00705.x; Imai I, 1996, FISHERIES SCI, V62, P834, DOI 10.2331/fishsci.62.834; Nagasaki K, 2005, APPL ENVIRON MICROB, V71, P3528, DOI 10.1128/AEM.71.7.3528-3535.2005; Nagasaki K, 2004, APPL ENVIRON MICROB, V70, P704, DOI 10.1128/AEM.70.2.704-711.2004; NISHIHARA T, 1986, EISEI KAGAKU, V32, P226, DOI 10.1248/jhs1956.32.226; Ragueneau O, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002688; Rines JBE, 1988, BIBLIOTHECA PHYCOLOG, V79, P196; Shirai Y, 2008, APPL ENVIRON MICROB, V74, P4022, DOI 10.1128/AEM.00509-08; Suttle C. A., 1993, HDB METHODS AQUATIC, P121; Takano Y, 2006, J PHYCOL, V42, P251, DOI 10.1111/j.1529-8817.2006.00177.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomaru Y, 2004, AQUAT MICROB ECOL, V34, P227, DOI 10.3354/ame034227; Tomaru Y, 2008, AQUAT MICROB ECOL, V50, P103, DOI 10.3354/ame01170; Tomaru Y, 2013, PHYCOL RES, V61, P27, DOI 10.1111/j.1440-1835.2012.00670.x; Tomaru Y, 2012, ISME J, V6, P1445, DOI 10.1038/ismej.2011.207; Tomaru Y, 2011, CELL ORIG LIFE EXTRE, V19, P211, DOI 10.1007/978-94-007-1327-7_9; Tomaru Y, 2011, AQUAT MICROB ECOL, V64, P175, DOI 10.3354/ame01517; Tomaru Y, 2011, APPL ENVIRON MICROB, V77, P5285, DOI 10.1128/AEM.00202-11; Tomaru Y, 2011, AQUAT MICROB ECOL, V63, P223, DOI 10.3354/ame01496; Tomaru Y, 2009, APPL ENVIRON MICROB, V75, P2375, DOI 10.1128/AEM.02580-08; Toyoda Kensuke, 2012, Plankton & Benthos Research, V7, P20; VanLandingham S.L., 1968, CATALOGUE FOSSIL R 2	27	15	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82013	10.1371/journal.pone.0082013	http://dx.doi.org/10.1371/journal.pone.0082013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358139	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700005
J	Maradonna, F; Gioacchini, G; Falcinelli, S; Bertotto, D; Radaelli, G; Olivotto, I; Carnevali, O				Maradonna, Francesca; Gioacchini, Giorgia; Falcinelli, Silvia; Bertotto, Daniela; Radaelli, Giuseppe; Olivotto, Ike; Carnevali, Oliana			Probiotic Supplementation Promotes Calcification in Danio rerio Larvae: A Molecular Study	PLOS ONE			English	Article							MATRIX GLA PROTEIN; LACTIC-ACID BACTERIA; BONE-RESORBING CELLS; GENE-EXPRESSION; TELEOST FISH; DICENTRARCHUS-LABRAX; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTORS; SIGNALING PATHWAYS; SPARUS-AURATA	A growing number of studies have been showing that dietary probiotics can exert beneficial health effects in both humans and animals. We previously demonstrated that dietary supplementation with Lactobacillus rhamnosus - a component of the human gut microflora - enhances reproduction, larval development, and the biomineralization process in Danio rerio (zebrafish). The aim of this study was to identify the pathways affected by L. rhamnosus during zebrafish larval development. Our morphological and histochemical findings show that L. rhamnosus accelerates bone deposition through stimulation of the expression of key genes involved in ossification, e.g. runt-related transcription factor 2 (runx2), Sp7 transcription factor (sp7), matrix Gla protein (mgp), and bone gamma-carboxyglutamate (gla) protein (bglap) as well as through inhibition of sclerostin (sost), a bone formation inhibitor. Western blot analysis of mitogen-activated protein kinase 1 and 3-(Mapk1 and Mapk3), which are involved in osteoblast and osteocyte differentiation, documented an increase in Mapk1 16 days post fertilization (dpf) and of Mapk3 23 dpf in individuals receiving L. rhamnosus supplementation. Interestingly, a reduction of sost detected in the same individuals suggests that the probiotic may help treat bone disorders.	[Maradonna, Francesca; Gioacchini, Giorgia; Falcinelli, Silvia; Olivotto, Ike; Carnevali, Oliana] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy; [Bertotto, Daniela; Radaelli, Giuseppe] Univ Padua, Dipartimento Biomed Comparata & Alimentaz, Padua, Italy; [Carnevali, Oliana] Ist Nazl Biostrutture & Biosistemi, Rome, Italy	Marche Polytechnic University; University of Padua	Carnevali, O (corresponding author), Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy.	o.carnevali@univpm.it	Gioacchini, Giorgia/AAU-3581-2021; Olivotto, Ike/K-9397-2014; Maradonna, Francesca/AAU-3017-2021; Maradonna, Francesca/AAU-5167-2021; Carnevali, Oliana/P-2751-2015	Olivotto, Ike/0000-0002-0906-4225; Maradonna, Francesca/0000-0001-6677-1017; Carnevali, Oliana/0000-0001-5994-0572; Gioacchini, Giorgia/0000-0003-1187-7302; RADAELLI, Giuseppe/0000-0003-0176-1701; BERTOTTO, Daniela/0000-0002-1370-8679	"Fondi di Ateneo'' Universita' Politecnica delle Marche	"Fondi di Ateneo'' Universita' Politecnica delle Marche	This work was supported by "Fondi di Ateneo 2012'' Universita' Politecnica delle Marche grant awarded to OC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelli L, 2009, ANN NY ACAD SCI, V1163, P340, DOI 10.1111/j.1749-6632.2008.03670.x; Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; Apschner A, 2011, METHOD CELL BIOL, V105, P239, DOI 10.1016/B978-0-12-381320-6.00010-2; Avella MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045572; Avella MA, 2010, AM J PHYSIOL-REG I, V298, pR359, DOI 10.1152/ajpregu.00300.2009; BENJAMIN M, 1988, ANAT EMBRYOL, V178, P461, DOI 10.1007/BF00306053; BENJAMIN M, 1990, J ANAT, V169, P153; Bensimon-Brito A, 2010, J APPL ICHTHYOL, V26, P235, DOI 10.1111/j.1439-0426.2010.01412.x; Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; Carnevali O, 2013, GEN COMP ENDOCR, V188, P297, DOI 10.1016/j.ygcen.2013.02.022; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Choi YH, 2011, BIOCHEM BIOPH RES CO, V415, P472, DOI 10.1016/j.bbrc.2011.10.097; DELMAS PD, 1990, J BONE MINER RES, V5, P5, DOI 10.1002/jbmr.5650050104; Dimitroglou A, 2011, FISH SHELLFISH IMMUN, V30, P1, DOI 10.1016/j.fsi.2010.08.009; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Flores MV, 2006, DEV DYNAM, V235, P3166, DOI 10.1002/dvdy.20957; Flores MV, 2004, GENE EXPR PATTERNS, V4, P573, DOI 10.1016/j.modgep.2004.01.016; Gavaia PJ, 2006, GENE EXPR PATTERNS, V6, P637, DOI 10.1016/j.modgep.2005.11.010; Geest CR, 2009, J LEUKOCYTE BIOL, V86, P237, DOI 10.1189/jlb.0209097; Gioacchini G, 2013, REPROD FERT DEVELOP, V25, P1115, DOI 10.1071/RD12187; Gioacchini G, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094243; Gioacchini G, 2010, REPRODUCTION, V140, P953, DOI 10.1530/REP-10-0145; Giorgini E, 2010, ANAL BIOANAL CHEM, V398, P3063, DOI 10.1007/s00216-010-4234-2; HALE JE, 1988, J BIOL CHEM, V263, P5820; Hall Brian K., 2007, P13; Jun JH, 2010, J BIOL CHEM, V285, P36410, DOI 10.1074/jbc.M110.142307; Karsenty G, 2000, TRENDS ENDOCRIN MET, V11, P437, DOI 10.1016/S1043-2760(00)00322-2; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Krossoy C, 2009, J ANAT, V215, P663, DOI 10.1111/j.1469-7580.2009.01153.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamari F, 2013, AQUACULTURE, V376, P137, DOI 10.1016/j.aquaculture.2012.11.016; Lauzon HL, 2010, J APPL MICROBIOL, V108, P624, DOI 10.1111/j.1365-2672.2009.04454.x; Lewiecki EM, 2011, DISCOV MED, V12, P263; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Lian J. B., 2003, Current Pharmaceutical Design, V9, P2677, DOI 10.2174/1381612033453659; Lian JB, 2003, CALCIFIED TISSUE INT, V72, P631, DOI 10.1007/s00223-002-1058-x; Liu F, 2003, J CELL SCI, V116, P1787, DOI 10.1242/jcs.00376; Lombardo F, 2011, FISH AQUACULT J FAJ, V33; Lucero CMJ, 2013, J CELL PHYSIOL, V228, P714, DOI 10.1002/jcp.24218; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Maradonna F, 2007, BIOMARKERS, V12, P240, DOI 10.1080/13547500601070859; Matsushita T, 2009, MOL CELL BIOL, V29, P5843, DOI 10.1128/MCB.01549-08; Matsushita T, 2009, HUM MOL GENET, V18, P227, DOI 10.1093/hmg/ddn339; Mccabe LR, 2013, J CELL PHYSIOL, V228, P1793, DOI 10.1002/jcp.24340; McNulty MS, 2012, GENE EXPR PATTERNS, V12, P228, DOI 10.1016/j.gep.2012.04.003; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Newman B, 2001, J CELL BIOL, V154, P659, DOI 10.1083/jcb.200106040; Nishimura R, 2012, J BIOCHEM, V151, P247, DOI 10.1093/jb/mvs004; Oliva-Teles A, 2012, J FISH DIS, V35, P83, DOI 10.1111/j.1365-2761.2011.01333.x; Palermo FA, 2011, GEN COMP ENDOCR, V171, P293, DOI 10.1016/j.ygcen.2011.02.009; Pearse AGE, 1985, HISTOCHEMISTRY THEOR, P1512; Perez-Sanchez T, 2011, FISH SHELLFISH IMMUN, V31, P196, DOI 10.1016/j.fsi.2011.05.005; Picchietti S, 2007, FISH SHELLFISH IMMUN, V22, P57, DOI 10.1016/j.fsi.2006.03.009; Picchietti S, 2009, FISH SHELLFISH IMMUN, V26, P368, DOI 10.1016/j.fsi.2008.10.008; Pinto JP, 2003, BONE, V32, P201, DOI 10.1016/S8756-3282(02)00981-X; Pinto JP, 2005, J BONE MINER RES, V20, P1440, DOI 10.1359/JBMR.050318; Price PA, 2000, ARTERIOSCL THROM VAS, V20, P317, DOI 10.1161/01.ATV.20.2.317; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Rollo A, 2006, FISH PHYSIOL BIOCHEM, V32, P167, DOI 10.1007/s10695-006-0009-2; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Standen BT, 2013, FISH SHELLFISH IMMUN, V35, P1097, DOI 10.1016/j.fsi.2013.07.018; van der Meulen T, 2005, BBA-GENE STRUCT EXPR, V1729, P105, DOI 10.1016/j.bbaexp.2005.03.008; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Witten PE, 2010, J APPL ICHTHYOL, V26, P257, DOI 10.1111/j.1439-0426.2010.01416.x; Witten PE, 2010, J APPL ICHTHYOL, V26, P225, DOI 10.1111/j.1439-0426.2010.01410.x; Witten PE, 2009, BIOL REV, V84, P315, DOI 10.1111/j.1469-185X.2009.00077.x; Witten PE, 2001, J MORPHOL, V250, P197, DOI 10.1002/jmor.1065.abs; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027324	74	43	46	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83155	10.1371/journal.pone.0083155	http://dx.doi.org/10.1371/journal.pone.0083155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358259	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700050
J	Xiao, HX; Liu, L; Zhu, QY; Tan, ZW; Yu, WB; Tang, X; Zhan, DW; Du, YH; Wang, HB; Liu, D; Li, ZX; Yuen, KY; Ho, DD; Gao, GF; Chen, ZW				Xiao, Haixia; Liu, Li; Zhu, Qingyu; Tan, Zhiwu; Yu, Wenbo; Tang, Xian; Zhan, Dawei; Du, Yanhua; Wang, Haibo; Liu, Di; Li, Zhixin; Yuen, Kwok-Yung; Ho, David D.; Gao, George F.; Chen, Zhiwei			A Replicating Modified Vaccinia Tiantan Strain Expressing an Avian-Derived Influenza H5N1 Hemagglutinin Induce Broadly Neutralizing Antibodies and Cross-Clade Protective Immunity in Mice	PLOS ONE			English	Article							A H5N1; PANDEMIC INFLUENZA; RECOMBINANT VECTOR; RHESUS-MONKEYS; HOST-RANGE; VIRUS; IMMUNOGENICITY; MVA; TRANSMISSION; ATTENUATION	To combat the possibility of a zoonotic H5N1 pandemic in a timely fashion, it is necessary to develop a vaccine that would confer protection against homologous and heterologous human H5N1 influenza viruses. Using a replicating modified vaccinia virus Tian Tan strain (MVTT) as a vaccine vector, we constructed MVTTHA-QH and MVTTHA-AH, which expresses the H5 gene of a goose-derived Qinghai strain A/Bar-headed Goose/Qinghai/1/2005 or human-derived Anhui Strain A/Anhui/1/2005. The immunogenicity profiles of both vaccine candidates were evaluated. Vaccination with MVTTHA-QH induced a significant level of neutralizing antibodies (Nabs) against a homologous strain and a wide range of H5N1 pseudoviruses (clades 1, 2.1, 2.2, 2.3.2, and 2.3.4). Neutralization tests (NT) and Haemagglutination inhibition (HI) antibodies inhibit the live autologous virus as well as a homologous A/Xingjiang/1/2006 and a heterologous A/Vietnam/1194/2004, representing two human isolates from clade 2.2 and clade 1, respectively. Importantly, mice vaccinated with intranasal MVTTHA-QH were completely protected from challenge with lethal dosages of A/Bar-headed Goose/Qinghai/1/2005 and the A/Viet Nam/1194/2004, respectively, but not control mice that received a mock MVTTS vaccine. However, MVTTHA-AH induced much lower levels of NT against its autologous strain. Our results suggest that it is feasible to use the H5 gene from A/Bar-headed Goose/Qinghai/1/2005 to construct an effective vaccine, when using MVTT as a vector, to prevent infections against homologous and genetically divergent human H5N1 influenza viruses.	[Xiao, Haixia; Gao, George F.] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Lab Prot Engn & Vaccines, Tianjin, Peoples R China; [Liu, Li; Tan, Zhiwu; Yu, Wenbo; Tang, Xian; Du, Yanhua; Wang, Haibo; Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, AIDS Inst, Hong Kong, Hong Kong, Peoples R China; [Xiao, Haixia; Liu, Di; Li, Zhixin; Gao, George F.] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Liu, Li; Yuen, Kwok-Yung; Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Liu, Li; Yuen, Kwok-Yung; Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China; [Zhu, Qingyu; Zhan, Dawei] Acad Mil Med Sci, Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China; [Ho, David D.] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Ho, David D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY USA; [Ho, David D.] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; University of Hong Kong; Chinese Academy of Sciences; Institute of Microbiology, CAS; University of Hong Kong; University of Hong Kong; Academy of Military Medical Sciences - China; Academia Sinica - Taiwan; Rockefeller University; University of Hong Kong	Gao, GF (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Lab Prot Engn & Vaccines, Tianjin, Peoples R China.	gaof@im.ac.cn; zchenai@hku.hk	Liu, Li/ABA-8315-2020; Chen, Zhiwei/B-7793-2019; Gao, George Fu/ABD-5229-2021; Liu, Di/G-6135-2014; Liu, Di/ABD-2729-2021; Xiao, Haixia/AAZ-3374-2020	Liu, Li/0000-0003-2566-7357; Chen, Zhiwei/0000-0002-4511-2888; Liu, Di/0000-0003-3693-2726; Liu, Di/0000-0003-3693-2726; Xiao, Haixia/0000-0003-0032-5430; Yuen, Kwok-yung/0000-0002-2083-1552; Yu, Wenbo/0000-0002-9237-272X	National High-Tech R&D Project (Project 863) of China [2006AA02A205]; National Basic Research Program (Project 973) of China [2005CB523001, 2006CB504208]; National Key Technologies R&D Program of China [2006BAD06A01]; National Natural Sciences Foundation of China [30599434]; Hong Kong Research Grant Council [HK-RGC762208]; NIH [3 U19 AI051915-05S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER	National High-Tech R&D Project (Project 863) of China; National Basic Research Program (Project 973) of China(National Basic Research Program of China); National Key Technologies R&D Program of China(National Key Technology R&D Program); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Research Grant Council(Hong Kong Research Grants Council); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants from the National High-Tech R&D Project (Project 863) of China (2006AA02A205), National Basic Research Program (Project 973) of China (2005CB523001 and 2006CB504208), the National Key Technologies R&D Program of China (2006BAD06A01), the National Natural Sciences Foundation of China (30599434), Hong Kong Research Grant Council (HK-RGC762208) and NIH (3 U19 AI051915-05S1). GFG is a distinguished young investigator of the National Natural Science Foundation of China (grant number 30525010). DL is supported by the China Postdoctoral Fellowship (number 20070420542). ZC is supported by the University Development Fund of the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Barouch DH, 2001, J VIROL, V75, P5151, DOI 10.1128/JVI.75.11.5151-5158.2001; Carroll MW, 1997, VACCINE, V15, P387, DOI 10.1016/S0264-410X(96)00195-8; Chen MW, 2008, P NATL ACAD SCI USA, V105, P13538, DOI 10.1073/pnas.0806901105; Chen ZW, 2005, J VIROL, V79, P2678, DOI 10.1128/JVI.79.5.2678-2688.2005; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Fang Q, 2005, VIROLOGY, V335, P242, DOI 10.1016/j.virol.2005.02.014; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Ge JY, 2007, J VIROL, V81, P150, DOI 10.1128/JVI.01514-06; Globig A, 2009, TRANSBOUND EMERG DIS, V56, P57, DOI 10.1111/j.1865-1682.2008.01061.x; Hanke T, 1998, J GEN VIROL, V79, P83, DOI 10.1099/0022-1317-79-1-83; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hessel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016247; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Huang XX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004180; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jin LHC Q, 1977, SCI CHINA, V27, P562; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Minor PD, 2010, CLIN INFECT DIS, V50, P560, DOI 10.1086/650171; Morgan DJ, 1999, P NATL ACAD SCI USA, V96, P3854, DOI 10.1073/pnas.96.7.3854; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Olson DR, 2005, P NATL ACAD SCI USA, V102, P11059, DOI 10.1073/pnas.0408290102; Reid AH, 2003, J GEN VIROL, V84, P2285, DOI 10.1099/vir.0.19302-0; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Seth A, 1998, P NATL ACAD SCI USA, V95, P10112, DOI 10.1073/pnas.95.17.10112; Shu YL, 2006, NEW ENGL J MED, V354, P1421, DOI 10.1056/NEJMc053524; Steel J, 2011, BIODRUGS, V25, P285, DOI 10.2165/11593870-000000000-00000; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Suarez DL, 1998, J VIROL, V72, P6678, DOI 10.1128/JVI.72.8.6678-6688.1998; SUTTER G, 1994, VACCINE, V12, P1032, DOI 10.1016/0264-410X(94)90341-7; Vajo Z, 2008, PEDIATR INFECT DIS J, V27, P1052, DOI 10.1097/INF.0b013e3181861dd7; Webster RG, 2005, ARCH VIROL, P117; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; WHO/GIP, 2003, CUM NUMB CONF HUM CA; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Yu HJ, 2006, LANCET, V367, P84, DOI 10.1016/S0140-6736(05)67894-4; Yu WB, 2010, VACCINE, V28, P2088, DOI 10.1016/j.vaccine.2009.12.038; Zhu JH, 1996, ARCH VIROL, V141, P1055, DOI 10.1007/BF01718609; Zhu WJ, 2007, J VIROL METHODS, V144, P17, DOI 10.1016/j.jviromet.2007.03.012	42	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83274	10.1371/journal.pone.0083274	http://dx.doi.org/10.1371/journal.pone.0083274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358269	gold, Green Published, Green Submitted			2022-12-27	WOS:000328737700055
J	Foster, CR; Daniel, LL; Daniels, CR; Dalal, S; Singh, M; Singh, K				Foster, Cerrone R.; Daniel, Laura L.; Daniels, Christopher R.; Dalal, Suman; Singh, Mahipal; Singh, Krishna			Deficiency of Ataxia Telangiectasia Mutated Kinase Modulates Cardiac Remodeling Following Myocardial Infarction: Involvement in Fibrosis and Apoptosis	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; TISSUE INHIBITORS; MYOCYTE APOPTOSIS; OXIDATIVE STRESS; INFLAMMATORY RESPONSE; ATM; DYSFUNCTION; MICE; PHOSPHORYLATION; P53	Ataxia telangiectasia mutated kinase (ATM) is a cell cycle checkpoint protein activated in response to DNA damage. We recently reported that ATM plays a protective role in myocardial remodeling following beta-adrenergic receptor stimulation. Here we investigated the role of ATM in cardiac remodeling using myocardial infarction (MI) as a model. Methods and Results: Left ventricular (LV) structure, function, apoptosis, fibrosis, and protein levels of apoptosis-and fibrosis-related proteins were examined in wild-type (WT) and ATM heterozygous knockout (hKO) mice 7 days post-MI. Infarct sizes were similar in both MI groups. However, infarct thickness was higher in hKO-MI group. Two dimensional M-mode echocardiography revealed decreased percent fractional shortening (% FS) and ejection fraction (EF) in both MI groups when compared to their respective sham groups. However, the decrease in % FS and EF was significantly greater in WT-MI vs hKO-MI. LV end systolic and diastolic diameters were greater in WT-MI vs hKO-MI. Fibrosis, apoptosis, and a-smooth muscle actin staining was significantly higher in hKO-MI vs WT-MI. MMP-2 protein levels and activity were increased to a similar extent in the infarct regions of both groups. MMP-9 protein levels were increased in the non-infarct region of WT-MI vs WT-sham. MMP-9 protein levels and activity were significantly lower in the infarct region of WT vs hKO. TIMP-2 protein levels similarly increased in both MI groups, whereas TIMP-4 protein levels were significantly lower in the infarct region of hKO group. Phosphorylation of p53 protein was higher, while protein levels of manganese superoxide dismutase were significantly lower in the infarct region of hKO vs WT. In vitro, inhibition of ATM using KU-55933 increased oxidative stress and apoptosis in cardiac myocytes.	[Foster, Cerrone R.; Daniel, Laura L.; Daniels, Christopher R.; Dalal, Suman; Singh, Mahipal; Singh, Krishna] E Tennessee State Univ, Dept Biomed Sci, James H Quillen Coll Med, James H Quillen Vet Affairs Med Ctr, Johnson City, TN 37614 USA	East Tennessee State University	Singh, K (corresponding author), E Tennessee State Univ, Dept Biomed Sci, James H Quillen Coll Med, James H Quillen Vet Affairs Med Ctr, Johnson City, TN 37614 USA.	singhk@etsu.edu	Daniel, Laura/K-2428-2015	Daniel, Laura/0000-0003-3143-5915	National Institutes of Health [R21HL-091405, R21HL-092459]; Merit Review award from the Biomedical Laboratory Research and Development Service of the VA Office of Research and Development [BX000640]; institutional Research and Improvement funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091405, R21HL092459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Review award from the Biomedical Laboratory Research and Development Service of the VA Office of Research and Development; institutional Research and Improvement funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by National Institutes of Health (Grant numbers R21HL-091405 and R21HL-092459), a Merit Review award (number BX000640) from the Biomedical Laboratory Research and Development Service of the VA Office of Research and Development, and institutional Research and Improvement funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2012, HEART FAIL CLIN, V8, P79, DOI 10.1016/j.hfc.2011.08.010; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Bialik S, 1997, J CLIN INVEST, V100, P1363, DOI 10.1172/JCI119656; Chen W, 2013, BBA-MOL CELL RES, V1833, P945, DOI 10.1016/j.bbamcr.2012.08.023; Chen W, 2010, HEART FAIL REV, V15, P415, DOI 10.1007/s10741-010-9161-y; Chen YJ, 2005, AM J PHYSIOL-HEART C, V288, pH133, DOI 10.1152/ajpheart.00851.2003; CLEUTJENS JPM, 1995, J MOL CELL CARDIOL, V27, P1281, DOI 10.1016/S0022-2828(05)82390-9; Colucci WS, 1997, AM J CARDIOL, V80, pL15, DOI 10.1016/S0002-9149(97)00845-X; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Dalal S, 2012, MOL CELL BIOCHEM, V364, P59, DOI 10.1007/s11010-011-1205-7; Daniels CR, 2012, AM J PHYSIOL-HEART C, V303, pH1459, DOI 10.1152/ajpheart.00401.2012; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Foster CR, 2012, EXP PHYSIOL, V97, P506, DOI [10.1111/j.1469-445X.2011.01034.x, 10.1113/expphysiol.2011.061812]; Foster CR, 2011, MOL CELL BIOCHEM, V353, P13, DOI 10.1007/s11010-011-0769-6; Frangogiannis NG, 2000, CARDIOVASC RES, V48, P89, DOI 10.1016/S0008-6363(00)00158-9; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292; GOLDBERG GI, 1989, P NATL ACAD SCI USA, V86, P8207, DOI 10.1073/pnas.86.21.8207; Greene J, 1996, J BIOL CHEM, V271, P30375, DOI 10.1074/jbc.271.48.30375; Hori M, 2009, CARDIOVASC RES, V81, P457, DOI 10.1093/cvr/cvn335; Kempf T, 2012, J MOL MED, V90, P361, DOI 10.1007/s00109-011-0847-y; Khanna KK, 2001, CELL DEATH DIFFER, V8, P1052, DOI 10.1038/sj.cdd.4400874; Krishnamurthy P, 2006, HEART, V92, P1309, DOI 10.1136/hrt.2005.071001; Krishnamurthy P, 2007, HYPERTENSION, V49, P865, DOI 10.1161/01.HYP.0000258703.36986.13; Krishnamurthy P, 2009, MOL CELL BIOCHEM, V322, P53, DOI 10.1007/s11010-008-9939-6; LAVIN MF, 1995, TRENDS BIOCHEM SCI, V20, P382, DOI 10.1016/S0968-0004(00)89083-0; Li YW, 2007, AM J PHYSIOL-HEART C, V292, pH946, DOI 10.1152/ajpheart.00361.2006; Li YY, 2000, CARDIOVASC RES, V46, P214, DOI 10.1016/S0008-6363(00)00003-1; Lin CS, 2012, ORAL ONCOL, V48, P1152, DOI 10.1016/j.oraloncology.2012.05.020; Long X, 2007, MOL CELL BIOCHEM, V303, P167, DOI 10.1007/s11010-007-9470-1; Lovelock JD, 2005, AM J PHYSIOL-HEART C, V288, pH461, DOI 10.1152/ajpheart.00402.2004; Meulmeester E, 2008, CURR CANCER DRUG TAR, V8, P87, DOI 10.2174/156800908783769337; Mishra PK, 2010, CELL BIOCHEM BIOPHYS, V57, P67, DOI 10.1007/s12013-010-9084-1; Mukherjee R, 2006, AM J PHYSIOL-HEART C, V291, pH2216, DOI 10.1152/ajpheart.01343.2005; Mukherjee R, 2012, J SURG RES, V172, P59, DOI 10.1016/j.jss.2010.06.015; Obal D, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0305-1; Okada H, 2005, CIRCULATION, V111, P2430, DOI 10.1161/01.CIR.0000165066.71481.8E; Siwik DA, 1999, CIRC RES, V85, P147, DOI 10.1161/01.RES.85.2.147; Spinale FG, 2002, CIRC RES, V90, P520, DOI 10.1161/01.RES.0000013290.12884.A3; Su Y, 2000, ANN INTERN MED, V133, P770, DOI 10.7326/0003-4819-133-10-200011210-00009; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tanaka T, 2006, CELL CYCLE, V5, P1940, DOI 10.4161/cc.5.17.3191; Tao ZY, 2004, LIFE SCI, V74, P1561, DOI 10.1016/j.lfs.2003.09.042; Trueblood NA, 2001, CIRC RES, V88, P1080, DOI 10.1161/hh1001.090842; Valentin-Vega YA, 2012, BLOOD, V119, P1490, DOI 10.1182/blood-2011-08-373639; WILLEMS IEMG, 1994, AM J PATHOL, V145, P868; Yan MS, 2002, CANCER RES, V62, P5153; Yang XP, 1999, AM J PHYSIOL-HEART C, V277, pH1967, DOI 10.1152/ajpheart.1999.277.5.H1967; Zakikhani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049513	51	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83513	10.1371/journal.pone.0083513	http://dx.doi.org/10.1371/journal.pone.0083513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358288	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700127
J	Kim, SM; Park, J; Kim, SH; Park, SY; Kim, JY; Sung, JJ; Park, KS; Lee, KW				Kim, Sung-Min; Park, Junwoo; Kim, Sun Hee; Park, Su-Yeon; Kim, Jee Young; Sung, Jung-Joon; Park, Kyung Seok; Lee, Kwang-Woo			Factors Associated With the Time to Next Attack in Neuromyelitis Optica: Accelerated Failure Time Models With Random Effects	PLOS ONE			English	Article							CLINICAL PREDICTORS; DIAGNOSTIC-CRITERIA; MULTIPLE-SCLEROSIS; HETEROGENEITY; MITOXANTRONE; RITUXIMAB; EFFICACY; ASSAY	Background and Objective: Neuromyelitis optica (NMO) is an inflammatory demyelinating disorder of the central nervous system with a relapsing and remitting course. We aimed to identify factors associated with the time to next attack, including the effect of the natural disease course and the diverse treatment regimens, by applying a longitudinal statistical analysis to the individual attacks of each patient. Methods: In total, 184 acute attacks among 58 patients with either NMO or NMO spectrum disorder with anti-aquaporin-4 antibody were assessed retrospectively. Patient demographics, clinical characteristics at each attack, and type of treatment during inter-attack periods were assessed. The dependent variable was defined as the time from each attack to the next attack (inter-attack interval). An exponential accelerated failure time model with shared gamma frailty was adapted for statistical analysis. Results: A multivariable analysis revealed that the time from each attack to the next attack in NMO increased independently by 1.31 times (95% confidence interval (CI), 1.02-1.67; p = 0.035) with each additional cumulative attack experienced, by 5.34 times (95% CI, 1.57-18.13; p = 0.007) with combined azathioprine treatment and continued oral prednisolone, and by 4.26 times (95% CI, 1.09-16.61; p = 0.037) with rituximab treatment. Conclusion: The time to next attack in NMO can increase naturally in the later stages of the disease as the number of cumulative attacks increases. Nevertheless, both combined azathioprine treatment with continued oral prednisolone and rituximab treatment were also associated with a longer time to next attack, independently of the natural disease course of NMO.	[Kim, Sung-Min; Park, Su-Yeon; Sung, Jung-Joon; Park, Kyung Seok; Lee, Kwang-Woo] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Park, Junwoo; Kim, Sun Hee] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul 110744, South Korea; [Kim, Jee Young; Park, Kyung Seok] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Gyeonggi, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Park, KS (corresponding author), Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea.	pks1126@chol.com; jjsaint66@gmail.com	Kim, Sun/GSN-4867-2022		Korea Health Industry Development Institute Research fund [A121118]	Korea Health Industry Development Institute Research fund	This work was supported by grant no. A121118 from the Korea Health Industry Development Institute Research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALEN OO, 1988, STAT MED, V7, P1121, DOI 10.1002/sim.4780071105; Allison P. D., 1995, SURVIVAL ANAL USING; Bichuetti DB, 2010, ARCH NEUROL-CHICAGO, V67, P1131, DOI 10.1001/archneurol.2010.203; BORGMANN A, 1995, LANCET, V346, P873, DOI 10.1016/S0140-6736(95)92710-7; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Cabre P, 2009, J NEUROL NEUROSUR PS, V80, P1162, DOI 10.1136/jnnp.2007.143529; Costanzi C, 2011, NEUROLOGY, V77, P659, DOI 10.1212/WNL.0b013e31822a2780; Cree BAC, 2005, NEUROLOGY, V64, P1270, DOI 10.1212/01.WNL.0000159399.81861.D5; Guo Z, 2008, METHOD INFORM MED, V47, P107, DOI 10.3414/ME0478; Hougaard, 2000, ANAL MULTIVARIATE SU; Jacob A, 2009, ARCH NEUROL-CHICAGO, V66, P1128, DOI 10.1001/archneurol.2009.175; Keiding N, 1997, STAT MED, V16, P215; Kim SH, 2011, ARCH NEUROL-CHICAGO, V68, P1412, DOI 10.1001/archneurol.2011.154; Kim SH, 2011, ARCH NEUROL-CHICAGO, V68, P473, DOI 10.1001/archneurol.2010.322; Kim SM, 2013, MULT SCLER J, V19, P1060, DOI 10.1177/1352458512472748; Kim SM, 2011, J NEUROL, V258, P2176, DOI 10.1007/s00415-011-6086-x; Kim W, 2011, J CLIN NEUROL, V7, P115, DOI 10.3988/jcn.2011.7.3.115; Kitley J, 2012, BRAIN, V135, P1834, DOI 10.1093/brain/aws109; Kitley JL, 2011, ARCH NEUROL-CHICAGO, V68, P1086, DOI 10.1001/archneurol.2011.170; KNAUS WA, 1993, JAMA-J AM MED ASSOC, V270, P1233, DOI 10.1001/jama.270.10.1233; Marignier R, 2013, NEUROLOGY, V80, P2194, DOI 10.1212/WNL.0b013e318296e917; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Sormani MP, 2013, MULT SCLER J, V19, P466, DOI 10.1177/1352458512457841; Twisk JWR, 2005, J EPIDEMIOL COMMUN H, V59, P706, DOI 10.1136/jech.2004.030759; Waters P, 2008, ARCH NEUROL-CHICAGO, V65, P913, DOI 10.1001/archneur.65.7.913; Wingerchuk DM, 2007, NEUROLOGY, V68, P603, DOI 10.1212/01.wnl.0000254502.87233.9a; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2003, NEUROLOGY, V60, P848, DOI 10.1212/01.WNL.0000049912.02954.2C; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107	30	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82325	10.1371/journal.pone.0082325	http://dx.doi.org/10.1371/journal.pone.0082325			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358171	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700058
J	Milinkovic, V; Bankovic, J; Rakic, M; Stankovic, T; Skender-Gazibara, M; Ruzdijic, S; Tanic, N				Milinkovic, Vedrana; Bankovic, Jasna; Rakic, Miodrag; Stankovic, Tijana; Skender-Gazibara, Milica; Ruzdijic, Sabera; Tanic, Nikola			Identification of Novel Genetic Alterations in Samples of Malignant Glioma Patients	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; INOSITOL POLYPHOSPHATE 5-PHOSPHATASE; TUMOR-SUPPRESSOR GENES; PHOSPHATE SYNTHETASE-I; CENTRAL-NERVOUS-SYSTEM; CYCLIC-AMP; GENOMIC INSTABILITY; UREA CYCLE; HIGH-GRADE; PROTEIN-S	Glioblastoma is the most frequent and malignant human brain tumor. High level of genomic instability detected in glioma cells implies that numerous genetic alterations accumulate during glioma pathogenesis. We investigated alterations in AP-PCR DNA profiles of 30 glioma patients, and detected specific changes in 11 genes not previously associated with this disease: LHFPL3, SGCG, HTR4, ITGB1, CPS1, PROS1, GP2, KCNG2, PDE4D, KIR3DL3, and INPP5A. Further correlations revealed that 8 genes might play important role in pathogenesis of glial tumors, while changes in GP2, KCNG2 and KIR3DL3 should be considered as passenger mutations, consequence of high level of genomic instability. Identified genes have a significant role in signal transduction or cell adhesion, which are important processes for cancer development and progression. According to our results, LHFPL3 might be characteristic of primary glioblastoma, SGCG, HTR4, ITGB1, CPS1, PROS1 and INPP5A were detected predominantly in anaplastic astrocytoma, suggesting their role in progression of secondary glioblastoma, while alterations of PDE4D seem to have important role in development of both glioblastoma subtypes. Some of the identified genes showed significant association with p53, p16, and EGFR, but there was no significant correlation between loss of PTEN and any of identified genes. In conclusion our study revealed genetic alterations that were not previously associated with glioma pathogenesis and could be potentially used as molecular markers of different glioblastoma subtypes.	[Milinkovic, Vedrana; Bankovic, Jasna; Stankovic, Tijana; Ruzdijic, Sabera; Tanic, Nikola] Univ Belgrade, Inst Biol Res Sinisa Stankov, Dept Neurobiol, Belgrade, Serbia; [Rakic, Miodrag] Clin Ctr Serbia, Clin Neurosurg, Belgrade, Serbia; [Skender-Gazibara, Milica] Univ Belgrade, Sch Med, Inst Pathol, Belgrade, Serbia	University of Belgrade; Clinical Centre of Serbia; University of Belgrade	Tanic, N (corresponding author), Univ Belgrade, Inst Biol Res Sinisa Stankov, Dept Neurobiol, Belgrade, Serbia.	nikolata@ibiss.bg.ac.rs	Stanković, Tijana/F-1228-2016	Stanković, Tijana/0000-0001-5623-0612; Skender-Gazibara, Milica/0000-0001-7538-2742	Ministry of Education, Science and Technological Development, Republic of Serbia [III41031]	Ministry of Education, Science and Technological Development, Republic of Serbia	This study was supported by Grant III41031 from the Ministry of Education, Science and Technological Development, Republic of Serbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achille A, 1996, CANCER RES, V56, P3808; Andjelkovic T, 2011, TRANSL RES, V157, P19, DOI 10.1016/j.trsl.2010.09.004; Arco A, 2012, CELLS TISSUES ORGANS, V195, P550, DOI 10.1159/000329508; Bankovic J, 2010, LUNG CANCER, V67, P151, DOI 10.1016/j.lungcan.2009.04.010; Cardona DM, 2009, AM J CLIN PATHOL, V132, P877, DOI 10.1309/AJCP74XGRFWTFLJU; Cartier D, 2005, EUR J ENDOCRINOL, V153, P939, DOI 10.1530/eje.1.02051; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; Dahlback B, 2007, THROMB HAEMOSTASIS, V98, P90, DOI 10.1160/TH07-04-0269; De Juan C, 1999, INT J CANCER, V84, P344, DOI 10.1002/(SICI)1097-0215(19990820)84:4<344::AID-IJC2>3.0.CO;2-D; Fevre-Montange M, 2009, INT J ONCOL, V35, P1395, DOI 10.3892/ijo_00000457; FURMAN MA, 1977, J NEUROSURG, V46, P477, DOI 10.3171/jns.1977.46.4.0477; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gladson CL, 2010, ANNU REV PATHOL-MECH, V5, P33, DOI 10.1146/annurev-pathol-121808-102109; Goldhoff P, 2008, CLIN CANCER RES, V14, P7717, DOI 10.1158/1078-0432.CCR-08-0827; Grzesiak JJ, 2011, INT J CANCER, V129, P2905, DOI 10.1002/ijc.25942; Hahn M, 1999, CLIN CANCER RES, V5, P2431; Hayashi Y, 2001, J NEURO-ONCOL, V55, P51, DOI 10.1023/A:1012946812930; Hieken TJ, 1996, ANTICANCER RES, V16, P2321; Ichimura K, 1998, GENE CHROMOSOME CANC, V22, P9, DOI 10.1002/(SICI)1098-2264(199805)22:1<9::AID-GCC2>3.0.CO;2-1; Martinez AI, 2010, MOL GENET METAB, V101, P311, DOI 10.1016/j.ymgme.2010.08.002; Janouskova H, 2012, CANCER RES, V72, P3463, DOI 10.1158/0008-5472.CAN-11-4199; Liu HY, 2011, AM J PATHOL, V178, P652, DOI 10.1016/j.ajpath.2010.10.023; LIU TH, 1989, CHINESE MED J-PEKING, V102, P630; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Luo LP, 2003, CANCER RES, V63, P6166; Majerus PW, 1996, GENE DEV, V10, P1051, DOI 10.1101/gad.10.9.1051; Markovic J, 2008, CANCER INVEST, V26, P262, DOI 10.1080/07357900701708385; MCCLELLAND M, 1994, PCR METH APPL, V4, pS59; Mead LJ, 1997, INT J CANCER, V71, P213; MENGUBAS K, 1994, LEUKEMIA, V8, P1718; MICHELI MR, 1997, FINGERPRINTING METHO; Milinkovic V, 2012, EXP MOL PATHOL, V93, P200, DOI 10.1016/j.yexmp.2012.05.010; Misra A, 2001, MUTAT RES-FUND MOL M, V484, P53, DOI 10.1016/S0027-5107(01)00240-8; Mitchell CA, 2002, IUBMB LIFE, V53, P25, DOI 10.1080/15216540210815; Mitchell S, 2009, HUM MUTAT, V30, P56, DOI 10.1002/humu.20813; Nagaishi M, 2012, AM J PATHOL, V180, P1816, DOI 10.1016/j.ajpath.2012.01.027; Navarro JM, 1999, ELECTROPHORESIS, V20, P283, DOI 10.1002/(SICI)1522-2683(19990201)20:2<283::AID-ELPS283>3.0.CO;2-N; Ng K, 2012, J NEURO-ONCOL, V107, P1, DOI 10.1007/s11060-011-0714-2; Noda M, 2004, MOL NEUROBIOL, V29, P31, DOI 10.1385/MN:29:1:31; Ohgaki H, 2012, CLIN CANC RES; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Ozawa E, 2005, MUSCLE NERVE, V32, P563, DOI 10.1002/mus.20349; Pai VP, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2448; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Perlino E, 2000, AM J PATHOL, V157, P1727, DOI 10.1016/S0002-9440(10)64809-2; Petit MMR, 1999, GENOMICS, V57, P438, DOI 10.1006/geno.1999.5778; Sambrook, 1989, MOL CLONING; Samuelsson JK, 2010, MUTAT RES-FUND MOL M, V693, P61, DOI 10.1016/j.mrfmmm.2010.08.010; Saraon P, 2012, J BIOL CHEM, V287, P34019, DOI 10.1074/jbc.M112.384438; Sekulic A, 2010, CANCER PREV RES, V3, P1277, DOI 10.1158/1940-6207.CAPR-10-0058; Siddiqui EJ, 2005, ONCOL REP, V14, P1593; Singh KP, 2001, GENE, V269, P33, DOI 10.1016/S0378-1119(01)00458-9; Speed CJ, 1996, EMBO J, V15, P4852, DOI 10.1002/j.1460-2075.1996.tb00866.x; Valk K, 2010, ONCOLOGY-BASEL, V79, P283, DOI 10.1159/000322116; ZUTTER MM, 1993, AM J PATHOL, V142, P1439	57	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82108	10.1371/journal.pone.0082108	http://dx.doi.org/10.1371/journal.pone.0082108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358143	Green Submitted, gold, Green Published			2022-12-27	WOS:000328735700033
J	Wee, BA; Woolfit, M; Beatson, SA; Petty, NK				Wee, Bryan A.; Woolfit, Megan; Beatson, Scott A.; Petty, Nicola K.			A Distinct and Divergent Lineage of Genomic Island-Associated Type IV Secretion Systems in Legionella	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE; PATHOGENICITY ISLANDS; CONJUGATIVE ELEMENTS; PNEUMOPHILA GENOME; SEQUENCE-ANALYSIS; VIRULENCE; FAMILY; DNA	Legionella encodes multiple classes of Type IV Secretion Systems (T4SSs), including the Dot/Icm protein secretion system that is essential for intracellular multiplication in amoebal and human hosts. Other T4SSs not essential for virulence are thought to facilitate the acquisition of niche-specific adaptation genes including the numerous effector genes that are a hallmark of this genus. Previously, we identified two novel gene clusters in the draft genome of Legionella pneumophila strain 130b that encode homologues of a subtype of T4SS, the genomic island-associated T4SS (GI-T4SS), usually associated with integrative and conjugative elements (ICE). In this study, we performed genomic analyses of 14 homologous GI-T4SS clusters found in eight publicly available Legionella genomes and show that this cluster is unusually well conserved in a region of high plasticity. Phylogenetic analyses show that Legionella GI-T4SSs are substantially divergent from other members of this subtype of T4SS and represent a novel clade of GI-T4SSs only found in this genus. The GI-T4SS was found to be under purifying selection, suggesting it is functional and may play an important role in the evolution and adaptation of Legionella. Like other GI-T4SSs, the Legionella clusters are also associated with ICEs, but lack the typical integration and replication modules of related ICEs. The absence of complete replication and DNA pre-processing modules, together with the presence of Legionella-specific regulatory elements, suggest the Legionella GI-T4SS-associated ICE is unique and may employ novel mechanisms of regulation, maintenance and excision. The Legionella GI-T4SS cluster was found to be associated with several cargo genes, including numerous antibiotic resistance and virulence factors, which may confer a fitness benefit to the organism. The in-silico characterisation of this new T4SS furthers our understanding of the diversity of secretion systems involved in the frequent horizontal gene transfers that allow Legionella to adapt to and exploit diverse environmental niches.	[Wee, Bryan A.; Beatson, Scott A.; Petty, Nicola K.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Wee, Bryan A.; Beatson, Scott A.; Petty, Nicola K.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Woolfit, Megan] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Petty, Nicola K.] Univ Technol Sydney, Inst I3, Ultimo, NSW, Australia	University of Queensland; University of Queensland; Monash University; University of Technology Sydney	Beatson, SA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.	s.beatson@uq.edu.au; nicola.petty@uts.edu.au	Beatson, Scott/B-6985-2013; Wee, Bryan/AAP-3461-2021	Beatson, Scott/0000-0002-1806-3283; Wee, Bryan/0000-0001-6135-5903; Petty, Nicola/0000-0001-6528-9886	Australian National Health and Medical Research Council [566883, APP1012076]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by project grants from the Australian National Health and Medical Research Council (566883 and APP1012076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Amaro F, 2012, J BACTERIOL, V194, P1613, DOI 10.1128/JB.06626-11; Anisimova M, 2003, GENETICS, V164, P1229; Auchtung JM, 2005, P NATL ACAD SCI USA, V102, P12554, DOI 10.1073/pnas.0505835102; Baker S, 2008, J BACTERIOL, V190, P4084, DOI 10.1128/JB.00065-08; Bandyopadhyay P, 2007, INFECT IMMUN, V75, P723, DOI 10.1128/IAI.00956-06; Battle SE, 2008, J BACTERIOL, V190, P7130, DOI 10.1128/JB.00785-08; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bina XR, 2008, INFECT IMMUN, V76, P3595, DOI 10.1128/IAI.01620-07; Burrus V, 2002, MOL MICROBIOL, V46, P601, DOI 10.1046/j.1365-2958.2002.03191.x; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carter MQ, 2010, J BACTERIOL, V192, P3249, DOI 10.1128/JB.00041-10; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Cazalet C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000851; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; D'Auria G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-181; Daccord A, 2010, MOL MICROBIOL, V78, P576, DOI 10.1111/j.1365-2958.2010.07364.x; de la Cruz F, 2010, FEMS MICROBIOL REV, V34, P18, DOI 10.1111/j.1574-6976.2009.00195.x; Dimopoulou ID, 2002, ANTIMICROB AGENTS CH, V46, P1602, DOI 10.1128/AAC.46.5.1602-1603.2002; Doleans-Jordheim A, 2006, MICROBIOL-SGM, V152, P3561, DOI 10.1099/mic.0.29227-0; Gaillard M, 2006, J BACTERIOL, V188, P1999, DOI 10.1128/JB.188.5.1999-2013.2006; Gimenez G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-542; Glockner G, 2008, INT J MED MICROBIOL, V298, P411, DOI 10.1016/j.ijmm.2007.07.012; Gomez-Valero L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-536; Guglielmini J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002222; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Harrison EM, 2010, INFECT IMMUN, V78, P1437, DOI 10.1128/IAI.00621-09; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Juhas M, 2008, CELL MICROBIOL, V10, P2377, DOI 10.1111/j.1462-5822.2008.01187.x; Juhas M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r237; Juhas M, 2007, J BACTERIOL, V189, P761, DOI 10.1128/JB.01327-06; Juhas M, 2013, PLASMID, V70, P277, DOI 10.1016/j.plasmid.2013.05.008; Khan MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067298; Kim EH, 2009, FEMS MICROBIOL LETT, V301, P164, DOI 10.1111/j.1574-6968.2009.01813.x; Klockgether J, 2004, J BACTERIOL, V186, P518, DOI 10.1128/JB.186.2.518-534.2004; Klockgether J, 2007, J BACTERIOL, V189, P2443, DOI 10.1128/JB.01688-06; Klockgether J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00150; Koskiniemi S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002787; Kozak NA, 2010, J BACTERIOL, V192, P1030, DOI 10.1128/JB.01272-09; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lautner M, 2013, J BACTERIOL, V195, P1583, DOI 10.1128/JB.01739-12; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; Lee CA, 2010, MOL MICROBIOL, V75, P268, DOI 10.1111/j.1365-2958.2009.06985.x; Liu HL, 2010, J ZHEJIANG UNIV-SC B, V11, P708, DOI 10.1631/jzus.B0900417; Lurie-Weinberger MN, 2010, INT J MED MICROBIOL, V300, P470, DOI 10.1016/j.ijmm.2010.04.016; MA D, 1995, MOL MICROBIOL, V16, P45, DOI 10.1111/j.1365-2958.1995.tb02390.x; Ma J, 2013, GENOME ANNOUNC, V1, DOI DOI 10.1128/GEN0MEA.00320-13; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Mohd-Zain Z, 2004, J BACTERIOL, V186, P8114, DOI 10.1128/JB.186.23.8114-8122.2004; Molofsky AB, 2003, MOL MICROBIOL, V50, P445, DOI 10.1046/j.1365-2958.2003.03706.x; Nagai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00136; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NEI M, 1986, MOL BIOL EVOL, V3, P418; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Osborn AM, 2002, PLASMID, V48, P202; Pham P, 2001, P NATL ACAD SCI USA, V98, P8350, DOI 10.1073/pnas.111007198; Pickard D, 2003, J BACTERIOL, V185, P5055, DOI 10.1128/JB.185.17.5055-5065.2003; POOLE K, 1993, J BACTERIOL, V175, P7363, DOI 10.1128/JB.175.22.7363-7372.1993; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qiu XY, 2006, P NATL ACAD SCI USA, V103, P19830, DOI 10.1073/pnas.0606810104; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schroeder GN, 2010, J BACTERIOL, V192, P6001, DOI 10.1128/JB.00778-10; Segal G, 1999, MOL MICROBIOL, V34, P799, DOI 10.1046/j.1365-2958.1999.01642.x; Seth-Smith HMB, 2012, J BACTERIOL, V194, P1494, DOI 10.1128/JB.06403-11; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003198; Trigui H, 2013, MICROBIOLOGY; Walsh JM, 2011, FRONT BIOSCI-LANDMRK, V16, P3164, DOI 10.2741/3904; WALSH JB, 1995, GENETICS, V139, P421; Weissenmayer BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017570; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	84	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82221	10.1371/journal.pone.0082221	http://dx.doi.org/10.1371/journal.pone.0082221			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358157	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700046
J	Zhang, XP; Janke, R; Kingsley, J; Luo, J; Fasching, C; Ehmsen, KT; Heyer, WD				Zhang, Xiao-Ping; Janke, Ryan; Kingsley, James; Luo, Jerry; Fasching, Clare; Ehmsen, Kirk T.; Heyer, Wolf-Dietrich			A Conserved Sequence Extending Motif III of the Motor Domain in the Snf2-Family DNA Translocase Rad54 Is Critical for ATPase Activity	PLOS ONE			English	Article							RECOMBINATIONAL REPAIR PROTEIN; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; PCNA-BINDING; POLYMERASE; GENE; MUTATIONS; HELICASES; RECONSTITUTION; IDENTIFICATION	Rad54 is a dsDNA-dependent ATPase that translocates on duplex DNA. Its ATPase function is essential for homologous recombination, a pathway critical for meiotic chromosome segregation, repair of complex DNA damage, and recovery of stalled or broken replication forks. In recombination, Rad54 cooperates with Rad51 protein and is required to dissociate Rad51 from heteroduplex DNA to allow access by DNA polymerases for recombination-associated DNA synthesis. Sequence analysis revealed that Rad54 contains a perfect match to the consensus PIP box sequence, a widely spread PCNA interaction motif. Indeed, Rad54 interacts directly with PCNA, but this interaction is not mediated by the Rad54 PIP box-like sequence. This sequence is located as an extension of motif III of the Rad54 motor domain and is essential for full Rad54 ATPase activity. Mutations in this motif render Rad54 non-functional in vivo and severely compromise its activities in vitro. Further analysis demonstrated that such mutations affect dsDNA binding, consistent with the location of this sequence motif on the surface of the cleft formed by two RecA-like domains, which likely forms the dsDNA binding site of Rad54. Our study identified a novel sequence motif critical for Rad54 function and showed that even perfect matches to the PIP box consensus may not necessarily identify PCNA interaction sites.	[Zhang, Xiao-Ping; Janke, Ryan; Kingsley, James; Luo, Jerry; Fasching, Clare; Ehmsen, Kirk T.; Heyer, Wolf-Dietrich] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA; [Heyer, Wolf-Dietrich] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Heyer, WD (corresponding author), Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA.	wdheyer@ucdavis.edu			National Institutes of Health [GM58015, GM32432]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Peter Burgers provided materials with support from NIH grant GM32432 to PB. This work was supported by grant GM58015 from the National Institutes of Health to WDH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2011, J CELL BIOL, V192, P735, DOI 10.1083/jcb.201011025; Ceballos SJ, 2011, BBA-GENE REGUL MECH, V1809, P509, DOI 10.1016/j.bbagrm.2011.06.006; Clever B, 1999, YEAST, V15, P721, DOI 10.1002/(SICI)1097-0061(19990630)15:9<721::AID-YEA414>3.0.CO;2-W; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Dua R, 2002, J BIOL CHEM, V277, P7889, DOI 10.1074/jbc.M108546200; Durr H, 2006, NUCLEIC ACIDS RES, V34, P4160, DOI 10.1093/nar/gkl540; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; FABRE F, 1991, MOL GEN GENET, V229, P353, DOI 10.1007/BF00267455; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Gallagher S, 2008, CURRENT PROTOC MOL B, DOI 10.18.11-10.18.28; Gilljam KM, 2009, J CELL BIOL, V186, P645, DOI 10.1083/jcb.200903138; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Heyer Wolf-Dietrich, 2007, Top Curr Genet, V17, P95; Hunter N, 2007, MOL GENETICS RECOMBI, P381; Kanaar R, 1996, CURR BIOL, V6, P828, DOI 10.1016/S0960-9822(02)00606-1; Kiianitsa K, 2003, ANAL BIOCHEM, V321, P266, DOI 10.1016/S0003-2697(03)00461-5; Kiianitsa K, 2002, J BIOL CHEM, V277, P46205, DOI 10.1074/jbc.M207967200; Kiianitsa K, 2006, P NATL ACAD SCI USA, V103, P9767, DOI 10.1073/pnas.0604240103; Klein HL, 1997, GENETICS, V147, P1533; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Li X, 2007, NUCLEIC ACIDS RES, V35, P4124, DOI 10.1093/nar/gkm412; Li X, 2009, MOL CELL, V36, P704, DOI 10.1016/j.molcel.2009.09.036; Li X, 2009, NUCLEIC ACIDS RES, V37, P638, DOI 10.1093/nar/gkn980; Maloisel L, 2004, GENETICS, V167, P1133, DOI 10.1534/genetics.104.026260; Maloisel L, 2008, MOL CELL BIOL, V28, P1373, DOI 10.1128/MCB.01651-07; Matsuda M, 1999, ONCOGENE, V18, P3427, DOI 10.1038/sj.onc.1202692; Mazin AV, 2010, DNA REPAIR, V9, P286, DOI 10.1016/j.dnarep.2009.12.006; Mazin AV, 2003, J BIOL CHEM, V278, P14029, DOI 10.1074/jbc.M212779200; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Paques F, 1997, MOL CELL BIOL, V17, P6765, DOI 10.1128/MCB.17.11.6765; Petukhova G, 1999, J BIOL CHEM, V274, P29453, DOI 10.1074/jbc.274.41.29453; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; RATTRAY AJ, 1995, GENETICS, V139, P45; Richmond E, 1996, NUCLEIC ACIDS RES, V24, P3685, DOI 10.1093/nar/24.19.3685; SCHILD D, 1995, GENETICS, V140, P115; Schmidt KH, 2002, J BIOL CHEM, V277, P45331, DOI 10.1074/jbc.M207263200; Sebesta M, 2011, DNA REPAIR, V10, P567, DOI 10.1016/j.dnarep.2011.03.003; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; Shinohara M, 1997, GENETICS, V147, P1545; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Smirnova M, 2004, J BIOL CHEM, V279, P24081, DOI 10.1074/jbc.M402719200; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Solinger JA, 2001, P NATL ACAD SCI USA, V98, P8447, DOI 10.1073/pnas.121009898; Swagemakers SMA, 1998, J BIOL CHEM, V273, P28292, DOI 10.1074/jbc.273.43.28292; Tan TLR, 2003, DNA REPAIR, V2, P787, DOI 10.1016/S1568-7864(03)00070-3; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang X, 2004, MOL CELL BIOL, V24, P6891, DOI 10.1128/MCB.24.16.6891-6899.2004; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wesoly J, 2006, MOL CELL BIOL, V26, P976, DOI 10.1128/MCB.26.3.976-989.2006; Wolner B, 2005, J BIOL CHEM, V280, P10855, DOI 10.1074/jbc.M414388200; Zhang XP, 2009, NUCLEIC ACIDS RES, V37, P158, DOI 10.1093/nar/gkn914; Zhang XP, 2005, J BIOL CHEM, V280, P26303, DOI 10.1074/jbc.M503244200	62	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82184	10.1371/journal.pone.0082184	http://dx.doi.org/10.1371/journal.pone.0082184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358152	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700041
J	Koyama, T; Arias, JF; Iwabu, Y; Yokoyama, M; Fujita, H; Sato, H; Tokunaga, K				Koyama, Takayoshi; Arias, Juan Fernando; Iwabu, Yukie; Yokoyama, Masaru; Fujita, Hideaki; Sato, Hironori; Tokunaga, Kenzo			APOBEC3G Oligomerization Is Associated with the Inhibition of Both Alu and LINE-1 Retrotransposition	PLOS ONE			English	Article							L1 RETROTRANSPOSITION; REVERSE TRANSCRIPTION; RIBONUCLEOPROTEIN COMPLEXES; ANTIRETROVIRAL DEFENSE; ADAPTIVE EVOLUTION; VIRUS-REPLICATION; CRYSTAL-STRUCTURE; INSERTION; PROTEIN; ELEMENT	Alu and LINE-1 (L1), which constitute similar to 11% and similar to 17% of the human genome, respectively, are transposable non-LTR retroelements. They transpose not only in germ cells but also in somatic cells, occasionally causing cancer. We have previously demonstrated that antiretroviral restriction factors, human APOBEC3 (hA3) proteins (A-H), differentially inhibit L1 retrotransposition. In this present study, we found that hA3 members also restrict Alu retrotransposition at differential levels that correlate with those observed previously for L1 inhibition. Through deletion analyses based on the best-characterized hA3 member human APOBEC3G (hA3G), its N-terminal 30 amino acids were required for its inhibitory activity against Alu retrotransposition. The inhibitory effect of hA3G on Alu retrotransposition was associated with its oligomerization that was affected by the deletion of its N-terminal 30 amino acids. Through structural modeling, the amino acids 24 to 28 of hA3G were predicted to be located at the interface of the dimer. The mutation of these residues resulted in abrogated hA3G oligomerization, and consistently abolished the inhibitory activity of hA3G against Alu retrotransposition. Importantly, the anti-L1 activity of hA3G was also associated with hA3G oligomerization. These results suggest that the inhibitory activities of hA3G against Alu and L1 retrotransposition might involve a common mechanism.	[Koyama, Takayoshi; Arias, Juan Fernando; Iwabu, Yukie; Tokunaga, Kenzo] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Yokoyama, Masaru; Sato, Hironori] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan; [Fujita, Hideaki] Nagasaki Int Univ, Fac Pharmaceut Sci, Nagasaki, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Nagasaki International University	Tokunaga, K (corresponding author), Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan.	tokunaga@nih.go.jp	Arias, Juan F/ABI-5762-2020; Tokunaga, Kenzo/Q-9914-2018	Tokunaga, Kenzo/0000-0002-2625-5322; Fujita, Hideaki/0000-0002-4105-4430	Ministry of Health, Labor and Welfare of Japan [H24-005, H24-008, H25-010]; Ministry of Education, Science, Technology, Sports and Culture of Japan [22590428]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Technology, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS project no. H24-005, H24-008 and H25-010), and from the Ministry of Education, Science, Technology, Sports and Culture of Japan (22590428). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias JF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00275; Arjan-Odedra S, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-53; Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Belancio VP, 2010, NUCLEIC ACIDS RES, V38, P3909, DOI 10.1093/nar/gkq132; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Bulliard Y, 2009, J VIROL, V83, P12611, DOI 10.1128/JVI.01491-09; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Cho KI, 2009, NUCLEIC ACIDS RES, V37, P2672, DOI 10.1093/nar/gkp132; Claverie-Martin F, 2005, J HUM GENET, V50, P370, DOI 10.1007/s10038-005-0265-5; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Delebecque F, 2006, J VIROL, V80, P605, DOI 10.1128/JVI.80.2.605-614.2006; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; ECONOMOUPACHNIS A, 1985, P NATL ACAD SCI USA, V82, P2857, DOI 10.1073/pnas.82.9.2857; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Furtak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009081; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Goodier JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002941; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; Hulme AE, 2007, GENE, V390, P199, DOI 10.1016/j.gene.2006.08.032; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Ikeda T, 2011, NUCLEIC ACIDS RES, V39, P5538, DOI 10.1093/nar/gkr124; Iwabu Y, 2010, J BIOL CHEM, V285, P35350, DOI 10.1074/jbc.M110.173286; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Khatua AK, 2010, VIROLOGY, V400, P68, DOI 10.1016/j.virol.2010.01.021; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Kobayashi M, 2004, J VIROL, V78, P8238, DOI 10.1128/JVI.78.15.8238-8244.2004; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lavens D, 2010, NUCLEIC ACIDS RES, V38, P1902, DOI 10.1093/nar/gkp1154; Li XM, 2001, HUM MUTAT, V17, P511, DOI 10.1002/humu.1134; Lu CY, 2012, J VIROL, V86, P10517, DOI 10.1128/JVI.00868-12; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; MARTIN SL, 1991, MOL CELL BIOL, V11, P4804, DOI 10.1128/MCB.11.9.4804; Meischl C, 2000, EUR J HUM GENET, V8, P697, DOI 10.1038/sj.ejhg.5200523; MIKI Y, 1992, CANCER RES, V52, P643; MORSE B, 1988, NATURE, V333, P87, DOI 10.1038/333087a0; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; Noguchi C, 2005, HEPATOLOGY, V41, P626, DOI 10.1002/hep.20580; OhAinle M, 2006, J VIROL, V80, P3853, DOI 10.1128/JVI.80.8.3853-3862.2006; Okeoma CM, 2007, NATURE, V445, P927, DOI 10.1038/nature05540; Oldridge M, 1999, AM J HUM GENET, V64, P446, DOI 10.1086/302245; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Russell RA, 2005, J VIROL, V79, P8724, DOI 10.1128/JVI.79.14.8724-8731.2005; Sasada A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-32; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Schumann GG, 2007, BIOCHEM SOC T, V35, P637, DOI 10.1042/BST0350637; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shirakawa K, 2008, NAT STRUCT MOL BIOL, V15, P1184, DOI 10.1038/nsmb.1497; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Tan LD, 2009, FASEB J, V23, P279, DOI 10.1096/fj.07-088781; Tchenio T, 2000, NUCLEIC ACIDS RES, V28, P411, DOI 10.1093/nar/28.2.411; Turelli P, 2004, J BIOL CHEM, V279, P43371, DOI 10.1074/jbc.C400334200; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; Wallace N, 2008, GENE, V419, P1, DOI 10.1016/j.gene.2008.04.007; Wang XJ, 2010, J BIOL CHEM, V285, P14346, DOI 10.1074/jbc.M110.109314; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yoshida K, 1998, HUM MOL GENET, V7, P1129, DOI 10.1093/hmg/7.7.1129; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000378; Zheng YH, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-112	83	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84228	10.1371/journal.pone.0084228	http://dx.doi.org/10.1371/journal.pone.0084228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367644	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900039
J	van Kralingen, C; Kho, DT; Costa, J; Angel, CE; Graham, ES				van Kralingen, Christa; Kho, Dan Ting; Costa, Jessica; Angel, Catherine Elizabeth; Graham, E. Scott			Exposure to Inflammatory Cytokines IL-1 beta and TNF alpha Induces Compromise and Death of Astrocytes; Implications for Chronic Neuroinflammation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HUMAN NEURONS; REAL-TIME; CEREBROSPINAL-FLUID; SPINAL-CORD; BRAIN; CELLS; EXPRESSION; DIFFERENTIATION; CHEMOKINES	Background: Astrocytes have critical roles in the human CNS in health and disease. They provide trophic support to neurons and are innate-immune cells with keys roles during states-of-inflammation. In addition, they have integral functions associated with maintaining the integrity of the blood-brain barrier. Methods: We have used cytometric bead arrays and xCELLigence technology to monitor the to monitor the inflammatory response profiles and astrocyte compromise in real-time under various inflammatory conditions. Responses were compared to a variety of inflammatory cytokines known to be released in the CNS during neuroinflammation. Astrocyte compromise measured by xCELLigence was confirmed using ATP measurements, cleaved caspase 3 expression, assessment of nuclear morphology and cell death. Results: Inflammatory activation (IL-1 beta or TNF alpha) of astrocytes results in the transient production of key inflammatory mediators including IL-6, cell surface adhesion molecules, and various leukocyte chemoattractants. Following this phase, the NT2-astrocytes progressively become compromised, which is indicated by a loss of adhesion, appearance of apoptotic nuclei and reduction in ATP levels, followed by DEATH. The earliest signs of astrocyte compromise were observed between 24-48h post cytokine treatment. However, significant cell loss was not observed until at least 72h, where there was also an increase in the expression of cleaved-caspase 3. By 96 hours approximately 50% of the astrocytes were dead, with many of the remaining showing signs of compromise too. Numerous other inflammatory factors were tested, however these effects were only observed with IL-1 beta or TNF alpha treatment. Conclusions: Here we reveal direct sensitivity to mediators of the inflammatory milieu. We highlight the power of xCELLigence technology for revealing the early progressive compromise of the astrocytes, which occurs 24-48 hours prior to substantive cell loss. Death induced by IL-1 beta or TNF alpha is relevant clinically as these two cytokines are produced by various peripheral tissues and by resident brain cells.	[van Kralingen, Christa; Kho, Dan Ting; Costa, Jessica; Graham, E. Scott] Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Ctr Brain Res, Auckland 1, New Zealand; [Angel, Catherine Elizabeth] Univ Auckland, Fac Sci, Sch Biol Sci, Auckland 1, New Zealand	University of Auckland; University of Auckland	Graham, ES (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Ctr Brain Res, Auckland 1, New Zealand.	s.graham@auckland.ac.nz		Kho, Dan/0000-0001-7193-2954; Graham, Scott/0000-0002-2925-9126; Angel, Catherine/0000-0003-1737-8539	ESG from New Zealand Lottery Health; HRC	ESG from New Zealand Lottery Health; HRC	Funding for this study was obtained by ESG from New Zealand Lottery Health and HRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; Burkert K, 2012, NEUROCHEM INT, V60, P573, DOI 10.1016/j.neuint.2011.09.002; Cartier L, 2005, BRAIN RES REV, V48, P16, DOI 10.1016/j.brainresrev.2004.07.021; Chakraborty S, 2010, J NEUROSCI RES, V88, P1615, DOI 10.1002/jnr.22343; Combes V, 2012, TRENDS PARASITOL, V28, P311, DOI 10.1016/j.pt.2012.05.008; Croitoru-Lamoury J, 2003, GLIA, V41, P354, DOI 10.1002/glia.10181; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Diemert S, 2012, J NEUROSCI METH, V203, P69, DOI 10.1016/j.jneumeth.2011.09.012; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; Farkas E, 2006, MICROVASC RES, V72, P113, DOI 10.1016/j.mvr.2006.05.007; Goodfellow CE, 2011, J NEUROSCI RES, V89, P1685, DOI 10.1002/jnr.22692; Graham ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072011; Grimsey NL, 2012, J BIOMOL SCREEN, V17, P386, DOI 10.1177/1087057111428985; Harkness KA, 2003, J NEUROIMMUNOL, V142, P1, DOI 10.1016/S0165-5728(03)00251-0; Hedtjarn M, 2004, J CEREBR BLOOD F MET, V24, P1333, DOI 10.1097/01.WCB.0000141559.17620.36; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Keene SD, 2009, PROTEOMICS, V9, P768, DOI 10.1002/pmic.200800385; Kikuchi S, 2003, J NEUROSCI RES, V71, P591, DOI 10.1002/jnr.10479; Kleine TO, 2003, BRAIN RES BULL, V61, P327, DOI 10.1016/S0361-9230(03)00096-0; Krasowska-Zoladek A, 2007, J NEUROSCI RES, V85, P205, DOI 10.1002/jnr.21088; Lambert C, 2008, J IMMUNOL, V181, P8288, DOI 10.4049/jimmunol.181.12.8288; Lim JH, 2007, BRAIN RES, V1164, P1, DOI 10.1016/j.brainres.2007.06.020; Lu W, 2005, DEV BRAIN RES, V155, P127, DOI 10.1016/j.devbrainres.2005.01.004; McAlpine FE, 2009, NEUROBIOL DIS, V34, P163, DOI 10.1016/j.nbd.2009.01.006; McCandless EE, 2008, AM J PATHOL, V172, P799, DOI 10.2353/ajpath.2008.070918; Meeuwsen S, 2003, GLIA, V43, P243, DOI 10.1002/glia.10259; Minami M, 2001, YAKUGAKU ZASSHI, V121, P875, DOI 10.1248/yakushi.121.875; Miyazono M, 1996, J COMP NEUROL, V376, P603, DOI 10.1002/(SICI)1096-9861(19961223)376:4<603::AID-CNE8>3.0.CO;2-5; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Moodley K, 2011, J NEUROSCI METH, V200, P173, DOI 10.1016/j.jneumeth.2011.07.005; Nedergaard M, 2012, GLIA, V60, P1013, DOI 10.1002/glia.22288; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Persidsky Y, 2000, J LEUKOCYTE BIOL, V68, P413; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; Pommepuy I, 2003, ONCOLOGY-BASEL, V64, P459, DOI 10.1159/000070307; QUAGLIARELLO VJ, 1991, J CLIN INVEST, V87, P1360, DOI 10.1172/JCI115140; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Ransom BR, 2012, METHODS MOL BIOL, V814, P3, DOI 10.1007/978-1-61779-452-0_1; Trojanowski JQ, 1997, EXP NEUROL, V144, P92, DOI 10.1006/exnr.1996.6393; Unsworth CF, 2010, J NEUROSCI METH, V194, P154, DOI 10.1016/j.jneumeth.2010.09.022; Unsworth CP, 2011, BIOMATERIALS, V32, P6541, DOI 10.1016/j.biomaterials.2011.05.041; Xi BA, 2011, JALA-J LAB AUTOM, V16, P415, DOI 10.1016/j.jala.2011.09.002; Xi Biao, 2008, Biotechnology Journal, V3, P484, DOI 10.1002/biot.200800020; ZELLER M, 1995, INT J DEV NEUROSCI, V13, P437, DOI 10.1016/0736-5748(95)00025-C	47	47	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84269	10.1371/journal.pone.0084269	http://dx.doi.org/10.1371/journal.pone.0084269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367648	Green Published, gold, Green Submitted			2022-12-27	WOS:000328741900041
J	Heinrichs, J; Dong, SS; Schafer-Verwimp, A; Pocs, T; Feldberg, K; Czumaj, A; Schmidt, AR; Reitner, J; Renner, MAM; Hentschel, J; Stech, M; Schneider, H				Heinrichs, Jochen; Dong, Shanshan; Schaefer-Verwimp, Alfons; Pocs, Tamas; Feldberg, Kathrin; Czumaj, Aleksandra; Schmidt, Alexander R.; Reitner, Joachim; Renner, Matt A. M.; Hentschel, Joern; Stech, Michael; Schneider, Harald			Molecular Phylogeny of the Leafy Liverwort Lejeunea (Porellales): Evidence for a Neotropical Origin, Uneven Distribution of Sexual Systems and Insufficient Taxonomy	PLOS ONE			English	Article							CHLOROPLAST DNA-SEQUENCES; LATITUDINAL DIVERSITY GRADIENT; TUMIDA SPECIES GROUP; CRYPTIC SPECIATION; MYRIOCOLEA-IRRORATA; ENDEMIC LIVERWORT; TROPICAL AMERICA; L. DUMORT.; JUNGERMANNIOPSIDA; BIOGEOGRAPHY	Background: Lejeunea is a largely epiphytic, subcosmopolitan liverwort genus with a complex taxonomic history. Species circumscriptions and their relationships are subject to controversy; biogeographic history and diversification through time are largely unknown. Methodology and Results: We employed sequences of two chloroplast regions (trnL-trnF, rbcL) and the nuclear ribosomal ITS region of 332 accessions to explore the phylogeny of the Harpalejeunea-Lejeunea-Microlejeunea complex. Lejeunea forms a well-supported clade that splits into two main lineages corresponding to L. subg. Lejeunea and L. subg. Crossotolejeunea. Neotropical accessions dominate early diverging lineages of both main clades of Lejeunea. This pattern suggests an origin in the Neotropics followed by several colonizations from the Neotropics into the Paleotropics and vice versa. Most Afro-Madagascan clades are related to Asian clades. Several temperate Lejeunea radiations were detected. Eighty two of the 91 investigated Lejeunea species could be identified to species level. Of these 82 species, 54 were represented by multiple accessions (25 para-or polyphyletic, 29 monophyletic). Twenty nine of the 36 investigated species of L. subg. Lejeunea were monoicous and 7 dioicous. Within L. subg. Crossotolejeunea, 15 of the 46 investigated species were monoicous and 31 dioicous. Some dioicous as well as some monoicous species have disjunct ranges. Conclusions/Significance: We present the first global phylogeny of Lejeunea and the first example of a Neotropical origin of a Pantropical liverwort genus. Furthermore, we provide evidence for the Neotropics as a cradle of Lejeunea lineages and detect post-colonization radiations in Asia, Australasia, Afro-Madagascar and Europe. Dioicy/monoicy shifts are likely non-randomly distributed. The presented phylogeny points to the need of integrative taxonomical studies to clarify many Lejeunea binomials. Most importantly, it provides a framework for future studies on the diversification of this lineage in space and time, especially in the context of sexual systems in Lejeuneaceae.	[Heinrichs, Jochen; Feldberg, Kathrin] Univ Munich, Fac Biol, Munich, Germany; [Heinrichs, Jochen; Dong, Shanshan; Czumaj, Aleksandra] Univ Gottingen, Dept Systemat Bot, Albrecht von Haller Inst Plant Sci, D-37073 Gottingen, Germany; [Pocs, Tamas] Eszterhazy Coll, Dept Bot, Inst Biol, Eger, Hungary; [Schmidt, Alexander R.; Reitner, Joachim] Univ Gottingen, Courant Res Ctr Geobiol, D-37073 Gottingen, Germany; [Renner, Matt A. M.] Royal Bot Gardens & Domain Trust, Sydney, NSW, Australia; [Hentschel, Joern] Univ Jena, Dept Systemat Bot, Herbarium Haussknecht, Jena, Germany; [Hentschel, Joern] Univ Jena, Bot Garden, Jena, Germany; [Stech, Michael] Naturalis Biodivers Ctr, Leiden, Netherlands; [Stech, Michael] Leiden Univ, Leiden, Netherlands; [Schneider, Harald] Nat Hist Museum, London SW7 5BD, England	University of Munich; University of Gottingen; University of Gottingen; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Naturalis Biodiversity Center; Leiden University; Leiden University - Excl LUMC; Natural History Museum London	Heinrichs, J (corresponding author), Univ Munich, Fac Biol, Munich, Germany.	jheinrichs@lmu.de	Schneider, Harald/B-6681-2008; Renner, Matt A. M./H-6322-2011; Czumaj, Aleksandra/AAP-1122-2020	Schneider, Harald/0000-0002-4548-7268; Renner, Matt A. M./0000-0003-2286-7257; Czumaj, Aleksandra/0000-0002-3072-6334	Deutsche Forschungsgemeinschaft [HE 3584/2]; China Scholarship Council [2010697001]; German Excellence Initiative [120]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); China Scholarship Council(China Scholarship Council); German Excellence Initiative	This study was supported by the Deutsche Forschungsgemeinschaft [HE 3584/2 and 4]. SD got support from the China Scholarship Council (scholarship number 2010697001). This is publication number 120 from the Courant Research Centre Geobiology that is funded by the German Excellence Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Peng Claudine, 2005, Lindbergia, V30, P43; Ahonen I., 2005, Acta Botanica Hungarica, V47, P225, DOI 10.1556/ABot.47.2005.3-4.2; [Anonymous], 2006, THESIS U TEXAS AUSTI; BONNER C. E. B., 1960, BRYOLOGIST, V63, P217; Bystriakova N, 2011, BOT J LINN SOC, V165, P1, DOI 10.1111/j.1095-8339.2010.01092.x; Cooper ED, 2012, BIOL J LINN SOC, V107, P425, DOI 10.1111/j.1095-8312.2012.01946.x; Cooper ED, 2012, MOL PHYLOGENET EVOL, V65, P10, DOI 10.1016/j.ympev.2012.05.008; Davis CC, 2002, P NATL ACAD SCI USA, V99, P6833, DOI 10.1073/pnas.102175899; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Devos N, 2011, TAXON, V60, P1623, DOI 10.1002/tax.606007; Devos N, 2011, NEW PHYTOL, V192, P225, DOI 10.1111/j.1469-8137.2011.03783.x; Dong SS, 2013, PHYTOTAXA, V85, P41, DOI 10.11646/phytotaxa.85.2.2; Dong SS, 2012, MOL PHYLOGENET EVOL, V65, P582, DOI 10.1016/j.ympev.2012.07.009; Evans A. W., 1904, B TORREY BOT CLUB, V31, P183, DOI [http://dx.doi.org/10.2307/2478687, DOI 10.2307/2478687]; Feldberg K, 2004, PLANT SYST EVOL, V249, P247, DOI 10.1007/s00606-004-0221-4; Feldberg K, 2007, J BIOGEOGR, V34, P688, DOI 10.1111/j.1365-2699.2006.01623.x; Feldberg K, 2010, MOL PHYLOGENET EVOL, V55, P293, DOI 10.1016/j.ympev.2009.11.009; Feldberg K, 2011, BRYOLOGIST, V114, P686, DOI 10.1639/0007-2745-114.4.686; Feldberg K, 2010, CRYPTOGAMIE BRYOL, V31, P141; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forrest LL, 2011, BRYOLOGIST, V114, P102, DOI 10.1639/0007-2745-114.1.102; Fuselier L, 2009, BIOL J LINN SOC, V98, P745, DOI 10.1111/j.1095-8312.2009.01319.x; Glenny D., 1998, TUHINGA, V10, P119; Gottsche CM, 1844, NEES AB ESENBECK CG; Gradstein S.R., 2009, MEMOIRS NEW YORK BOT, V76, P140; Gradstein SR, 2006, BOT J LINN SOC, V151, P293, DOI 10.1111/j.1095-8339.2006.00531.x; Gradstein SR, 2013, PHYTOTAXA, V100, P6, DOI 10.11646/phytotaxa.100.1.2; Gradstein S. Robbert, 2001, Memoirs of the New York Botanical Garden, V86, P1; GRADSTEIN SR, 1983, ACTA BOT HUNG, V29, P127; Gradstein SR, 2004, J HATTORI BOT LAB, P235; GROLLE R, 1971, T BRIT BRYOL SOC, V6, P258, DOI 10.1179/006813871804146229; GROLLE R, 1966, Journal of the Hattori Botanical Laboratory, V29, P75; Grolle R, 2000, J BRYOL, V22, P103, DOI 10.1179/jbr.2000.22.2.103; GROLLE R., 1969, MONOGRAPHIAE BIOL, V19, P562; Grolle R., 1984, STUTTGARTER BEITRA B, V108, P1; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hartmann FA, 2006, INT J PLANT SCI, V167, P1205, DOI 10.1086/508023; Heinrichs J, 2005, PLANT SYST EVOL, V250, P105, DOI 10.1007/s00606-004-0220-5; Heinrichs J, 2005, TAXON, V54, P317, DOI 10.2307/25065360; Heinrichs J., 2002, BRYOPHYTORUM BIBLIOT, V58, P1; Heinrichs J, 2007, TAXON, V56, P31, DOI 10.2307/25065733; Heinrichs J, 2014, PLANT SYST EVOL, V300, P63, DOI 10.1007/s00606-013-0860-4; Heinrichs J, 2012, PHYTOTAXA, V69, P7, DOI 10.11646/phytotaxa.69.1.3; Heinrichs J, 2012, PHYTOTAXA, V66, P55, DOI 10.11646/phytotaxa.66.1.9; Heinrichs J, 2012, CRYPTOGAMIE BRYOL, V33, P81, DOI 10.7872/cryb.v33.iss1.2012.081; Heinrichs J, 2012, MOL PHYLOGENET EVOL, V62, P973, DOI 10.1016/j.ympev.2011.11.029; Heinrichs J, 2011, AM J BOT, V98, P1252, DOI 10.3732/ajb.1100115; Heinrichs J, 2010, MOL PHYLOGENET EVOL, V56, P1105, DOI 10.1016/j.ympev.2010.05.004; Heinrichs J, 2010, CRYPTOGAMIE BRYOL, V31, P67; Heinrichs J, 2009, J SYST EVOL, V47, P497, DOI 10.1111/j.1759-6831.2009.00028.x; Heinrichs J, 2009, MOL PHYLOGENET EVOL, V53, P113, DOI 10.1016/j.ympev.2009.05.032; Hennequin S, 2010, BOT J LINN SOC, V164, P113, DOI 10.1111/j.1095-8339.2010.01076.x; Hentschel J, 2006, PLANT SYST EVOL, V258, P211, DOI 10.1007/s00606-006-0408-y; Hentschel J, 2007, MOL PHYLOGENET EVOL, V45, P693, DOI 10.1016/j.ympev.2007.05.005; Hentschel J, 2009, MOL PHYLOGENET EVOL, V52, P142, DOI 10.1016/j.ympev.2008.12.021; Hepperle D., 2004, SEQASSEM SEQUENCE AN; Herzog T., 1926, GEOGRAPHIE MOOSE; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hutsemekers V, 2012, MOL PHYLOGENET EVOL, V62, P748, DOI 10.1016/j.ympev.2011.11.014; Ilkiu-Borges AL, 2005, NOVA HEDWIGIA, V80, P45, DOI 10.1127/0029-5035/2005/0080-0045; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; JONES EW, 1968, T BRIT BRYOL SOC, V5, P548, DOI 10.1179/006813868804146863; Korpelainen H, 2011, EVOL ECOL, V25, P45, DOI 10.1007/s10682-010-9378-1; Kraichak E, 2012, AM J BOT, V99, P1436, DOI 10.3732/ajb.1200120; Kreier HP, 2010, MOL PHYLOGENET EVOL, V57, P1260, DOI 10.1016/j.ympev.2010.10.002; Laenen B, 2011, J BIOGEOGR, V38, P631, DOI 10.1111/j.1365-2699.2010.02440.x; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Lee Gaik Ee, 2013, Polish Botanical Journal, V58, P59, DOI 10.2478/pbj-2013-0007; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Libert M-A., 1820, ANN GEN SCI PHYS, V6, P372; Longton RE, 1983, NEW MANUAL BRYOLOGY, P386; Maddison DR, 2004, MESQUITE VERSION 2 7; Marshall CR, 2006, SCIENCE, V314, P66, DOI 10.1126/science.1133351; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; McKenna DD, 2006, P NATL ACAD SCI USA, V103, P10947, DOI 10.1073/pnas.0602712103; Merckx V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-178; Merckx VSFT, 2013, AM J BOT, V100, P712, DOI 10.3732/ajb.1200330; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; MIZUTANI M, 1971, Journal of the Hattori Botanical Laboratory, V34, P445; Moreau CS, 2013, EVOLUTION, DOI [10.111/evo.12105, DOI 10.111/EV0.12105]; Patino J, 2013, J BRYOL IN PRESS; Paton J. A., 1999, LIVERWORT FLORA BRIT; Perrie LR, 2012, NEW ZEAL J BOT, V50, P475; POCS T., 2011, ACTA BIOL PLANTARUM, V1, P53; Pohjamo M, 2008, BIOL CONSERV, V141, P1204, DOI 10.1016/j.biocon.2008.02.016; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramaiya M, 2010, AM J BOT, V97, P1707, DOI 10.3732/ajb.1000171; Reiner-Drehwald M.E., 2000, TROPICAL BRYOLOGY, V19, P81, DOI DOI 10.11646/BDE.19.1.14; Reiner-Drehwald M. E., 1999, BRYOPHYT BIBLIOTH, V54, P1; Reiner-Drehwald ME, 2008, NOVA HEDWIGIA, V87, P175, DOI 10.1127/0029-5035/2008/0087-0175; Reiner-Drehwald ME, 2012, CRYPTOGAMIE BRYOL, V33, P33, DOI 10.7872/cryb.v33.iss1.2012.033; Reiner-Drehwald ME, 2010, NOVA HEDWIGIA, P117; Reiner-Drehwald ME, 2008, NOVA HEDWIGIA, V87, P387, DOI 10.1127/0029-5035/2008/0087-0387; Reiner-Drehwald ME, 2010, NOVA HEDWIGIA, V91, P519, DOI 10.1127/0029-5035/2010/0091-0519; Reiner-Drehwald ME, 2005, SYST BOT, V30, P687, DOI 10.1600/036364405775097860; Reiner-Drehwald ME, 2005, CRYPTOGAMIE BRYOL, V26, P59; Reiner-Drehwald ME, 2004, J BRYOL, V26, P103, DOI 10.1179/037366804225021056; Reiner-Drehwald ME, 2000, J HATTORI BOT LAB, P1; Reiner-Drehwald ME, 2000, NOVA HEDWIGIA, V71, P447; Reiner-Drehwald ME, 1995, THESIS; Renner Matt A. M., 2013, Polish Botanical Journal, V58, P193, DOI 10.2478/pbj-2013-0018; Renner MAM, 2013, AUST SYST BOT, V26, P13, DOI 10.1071/SB12016; Renner MAM, 2011, AUST SYST BOT, V24, P10, DOI 10.1071/SB10047; Renner MAM, 2010, AUST SYST BOT, V23, P443, DOI 10.1071/SB10037; Renner MAM, 2009, NOVA HEDWIGIA, V89, P335, DOI 10.1127/0029-5035/2009/0089-0335; Ricklefs RE, 2010, P NATL ACAD SCI USA, V107, P1265, DOI 10.1073/pnas.0913626107; Romdal TS, 2013, GLOBAL ECOL BIOGEOGR, V22, P344, DOI 10.1111/j.1466-8238.2012.00786.x; Rouhan G, 2012, SYST BOT, V37, P331, DOI 10.1600/036364412X635386; Rubasinghe SCK, 2011, BRYOLOGIST, V114, P116, DOI 10.1639/0007-2745-114.1.116; Schaumann F, 2005, PLANT SYST EVOL, V252, P27, DOI 10.1007/s00606-004-0279-z; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Schiffner V., 1893, NATURL PFLANZ, V1, P97; Schneider H, 2013, J SYST EVOL, V51, P61, DOI 10.1111/j.1759-6831.2012.00234.x; Schneider H, 2010, EVOLUTION IN ACTION: CASE STUDIES IN ADAPTIVE RADIATION, SPECIATION AND THE ORIGIN OF BIODIVERSITY, P61, DOI 10.1007/978-3-642-12425-9_4; Schuster R. M, 1980, HEPATICAE ANTHOCEROT; Schuster R. M, 1994, J HATTORI BOT LAB, V75, P211; Spruce R, 1884, T P BOT SOC EDINBURG, V15, P1, DOI DOI 10.5962/BHL.TITLE.115637; Stephani F., 1898, SPECIES HEPATICARUM, V1; Sukkharak P, 2011, TAXON, V60, P1607, DOI 10.1002/tax.606006; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Szweykowski J, 2005, PLANT SYST EVOL, V253, P133, DOI 10.1007/s00606-005-0301-0; van Zanten B. O., 1988, NOVA HEDWIGIA S, V90, P41; van Zanten BO, 1981, ADV BRYOLOGY, V1, P479; Vana J, 2012, PHYTOKEYS, V10, P13, DOI 10.3897/phytokeys.10.2654; Vanderpoorten A, 2009, INTRODUCTION TO BRYOPHYTES, P1, DOI 10.1017/CBO9780511626838; Vanderpoorten A, 2006, MOL PHYLOGENET EVOL, V40, P73, DOI 10.1016/j.ympev.2006.02.013; Vanderpoorten A, 2010, BIOL REV, V85, P471, DOI 10.1111/j.1469-185X.2009.00111.x; Weeks A, 2005, MOL PHYLOGENET EVOL, V35, P85, DOI 10.1016/j.ympev.2004.12.021; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wigginton M. J., 2004, SCRIPTA BOT BELGICA, V30, P1; Wilson R, 2007, BIOLOGY LETT, V3, P566, DOI 10.1098/rsbl.2007.0287; Wilson R, 2007, MOL PHYLOGENET EVOL, V43, P270, DOI 10.1016/j.ympev.2006.10.017; Ye W, 2013, J SYST EVOL, V51, P468, DOI 10.1111/j.1759-6831.2012.00238.x; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Yu Y, 2013, SYST BOT, V38, P553, DOI 10.1600/036364413X670304; Zhu RL, 2003, ANN BOT FENN, V40, P101	138	50	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82547	10.1371/journal.pone.0082547	http://dx.doi.org/10.1371/journal.pone.0082547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367522	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300038
J	Agaku, IT; Vardavas, CI				Agaku, Israel T.; Vardavas, Constantine I.			Disparities and Trends in Indoor Exposure to Secondhand Smoke among US Adolescents: 2000-2009	PLOS ONE			English	Article							MULTIUNIT HOUSING RESIDENTS; LARGE-HUB AIRPORTS; UNITED-STATES; HOME	Introduction: Secondhand smoke (SHS) exposure causes disease and death among nonsmokers. With a plethora of smokefree legislation implemented and a steady decrease in cigarette consumption noted over the past decade in the U.S., this study assessed trends in indoor SHS exposure among U.S. adolescents in grades 6-12 during 2000-2009. Methods: Data were obtained from the 2000-2009 National Youth Tobacco Survey -a national survey of U. S. middle and high school students. SHS exposure within an indoor area within the past seven days was self-reported. Trends in indoor SHS exposure during 2000-2009 were assessed overall and by socio-demographic characteristics, using the Wald's test in a binary logistic regression. Within-group comparisons were performed using chi-squared statistics (p<0.05). Results: The proportion of U.S. middle and high school students who were exposed to indoor SHS declined from 65.5% in 2000 to 40.5% in 2009 (p<0.05 for linear trend). Significant declines were also observed across all population subgroups. Between 2000 and 2009, prevalence of indoor SHS exposure declined significantly among both middle (58.5% to 34.3%) and high school (71.5% to 45.4%) students. Prevalence of indoor SHS exposure was significantly higher among girls (44.0% in 2009) compared to boys (37.2% in 2009) during each survey year. Similarly, prevalence of indoor SHS exposure during 20002009 was highest among non-Hispanic whites (44.2% in 2009) and lowest among non-Hispanic Asians (30.2% in 2009). During each survey year, prevalence was highest among the oldest age group ($ 18 years) and lowest among the youngest (9-11 years). Also, prevalence was significantly higher among current cigarette smokers (83.8% in 2009) compared to nonsmokers (34.0% in 2009). Conclusion: Significant declines in indoor SHS exposure among U.S. middle and high school students occurred during 2000-2009. While the results are encouraging, additional efforts are needed to further reduce youth indoor SHS exposure.	[Agaku, Israel T.; Vardavas, Constantine I.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Ctr Global Tobacco Control, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Agaku, IT (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Ctr Global Tobacco Control, 665 Huntington Ave, Boston, MA 02115 USA.	iagaku@post.harvard.edu	Vardavas, Constantine/O-4961-2016; Vardavas, Constantine I/G-7598-2011	Vardavas, Constantine/0000-0003-0171-9570; 				Agaku Israel, 2012, Morbidity and Mortality Weekly Report, V61, P889; Alpert HR, 2011, TOB CONTROL, V20, P207, DOI 10.1136/tc.2010.038711; Arrazola Rene A., 2012, Morbidity and Mortality Weekly Report, V61, P581; Behm I, 2012, TOB CONTROL, V21, P6, DOI 10.1136/tc.2010.041376; Cartmell KB, 2011, PUBLIC HEALTH REP, V126, P575, DOI 10.1177/003335491112600414; Centers for Disease Control and Prevention, 2013, STAT TOB ACT TRACK E; Cordero A., 2010, Morbidity and Mortality Weekly Report, V59, P1484; Head P, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120079; Hopkins Maggie, 2012, Morbidity and Mortality Weekly Report, V61, P914; King Brian, 2012, Morbidity and Mortality Weekly Report, V61, P948; King BA, 2013, NICOTINE TOB RES, V15, P1316, DOI 10.1093/ntr/nts254; King BA, 2010, NICOTINE TOB RES, V12, P1133, DOI 10.1093/ntr/ntq162; King BA, 2010, NICOTINE TOB RES, V12, P598, DOI 10.1093/ntr/ntq053; Kline RL, 2000, TOB CONTROL, V9, P201, DOI 10.1136/tc.9.2.201; Marshall LaTisha, 2006, Morbidity and Mortality Weekly Report, V55, P1; Rodu B, 2012, J COMMUN HEALTH, V37, P468, DOI 10.1007/s10900-011-9464-5; Tynan M., 2011, Morbidity and Mortality Weekly Report, V60, P472; U.S. Census Bureau, 2011, SCH ENR CURR POP SUR; U. S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO; US Department of Housing and Urban Development, 2009, NONSM POL PUBL HOUS; Winickoff JP, 2010, NEW ENGL J MED, V362, P2319, DOI 10.1056/NEJMhle1000941	22	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83058	10.1371/journal.pone.0083058	http://dx.doi.org/10.1371/journal.pone.0083058			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GT	24358249	gold, Green Published, Green Submitted			2022-12-27	WOS:000328737700045
J	Alibekova, R; Huang, JP; Chen, YH				Alibekova, Raushan; Huang, Jian-Pei; Chen, Yi-Hua			Adequate Prenatal Care Reduces the Risk of Adverse Pregnancy Outcomes in Women with History of Infertility: A Nationwide Population-Based Study	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; ASSISTED REPRODUCTIVE TECHNOLOGY; IN-VITRO FERTILIZATION; PERINATAL OUTCOMES; ANTENATAL CARE; SINGLETON PREGNANCIES; MATERNAL FACTORS; COHORT; CHALLENGES; CONCEPTION	Objectives: To investigate the effects of various measures of prenatal care on adverse pregnancy outcomes in women with a history of infertility. Study Design: A retrospective cohort study. Methods: Data were derived by linking 2 large nationwide population-based datasets, the National Health Insurance Research Database and Taiwan Birth Certificate Registry. The study sample included 15,056 women with an infertility diagnosis and 60,224 randomly selected women without infertility matched to the study sample by maternal age. A conditional logistic regression analysis was performed for the analysis. Results: Women diagnosed with infertility respectively had 1.39 (95% CI, 1.06 similar to 1.83), 1.15 (95% CI, 1.08 similar to 1.24), 1.13 (95% CI, 1.08 similar to 1.18), and 1.08 (95% CI, 1.05 similar to 1.12) higher odds of having very low birth weight (VLBW) babies, preterm births, labor complications, and cesarean sections (CSs) compared to women without infertility. Inadequate numbers of total and major prenatal visits and late initiation of prenatal care increased the risks of adverse pregnancy outcomes in women with infertility, especially the risk of a VLBW baby. However, no significant associations were found for the risks of adverse birth outcomes in infertile women with adequate prenatal care compared to fertile women with adequate care. Conclusions: Study findings suggest that adequate prenatal care can reduce the risk of adverse pregnancy outcomes in women with infertility.	[Alibekova, Raushan; Chen, Yi-Hua] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Huang, Jian-Pei] Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan	Taipei Medical University; Mackay Memorial Hospital	Chen, YH (corresponding author), Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei, Taiwan.	yichen251@yahoo.com.tw		Chen, Yi-Hua/0000-0003-2464-2537				Alexander GR, 2001, PUBLIC HEALTH REP, V116, P306; Basso O, 2003, HUM REPROD, V18, P2478, DOI 10.1093/humrep/deg444; Beeckman K, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-213; Brown SJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-196; Chen L M, 2001, Matern Child Health J, V5, P35, DOI 10.1023/A:1011345801673; Chung K, 2006, FERTIL STERIL, V86, P1634, DOI 10.1016/j.fertnstert.2006.04.038; Cooper AR, 2011, FERTIL STERIL, V96, P1100, DOI 10.1016/j.fertnstert.2011.08.038; Cox RG, 2011, MATERN CHILD HLTH J, V15, P931, DOI 10.1007/s10995-009-0542-6; D.O.H, 2010, MAT HLTH HDB; Davies MJ, 2012, NEW ENGL J MED, V366, P1803, DOI 10.1056/NEJMoa1008095; Dhont M, 1999, AM J OBSTET GYNECOL, V181, P688, DOI 10.1016/S0002-9378(99)70514-4; Hayashi M, 2012, FERTIL STERIL, V98, P922, DOI 10.1016/j.fertnstert.2012.05.049; Heaman Maureen I, 2008, BMC Pregnancy Childbirth, V8, P15, DOI 10.1186/1471-2393-8-15; Herbert DL, 2012, FERTIL STERIL, V97, P630, DOI 10.1016/j.fertnstert.2011.12.033; Herbst MA, 2003, AM J OBSTET GYNECOL, V189, P930, DOI 10.1067/S0002-9378(03)01055-X; Kitsantas P, 2012, WOMEN HEALTH ISS, V22, pE455, DOI 10.1016/j.whi.2012.06.003; KOGAN MD, 1994, JAMA-J AM MED ASSOC, V271, P1340, DOI 10.1001/jama.271.17.1340; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1414, DOI 10.2105/AJPH.84.9.1414; Krans EE, 2012, AM J OBSTET GYNECOL, V206, P398, DOI 10.1016/j.ajog.2011.06.082; Lin HC, 2009, J CLIN PSYCHIAT, V70, P1297, DOI 10.4088/JCP.09m05087; Liu K, 2011, J OBSTET GYNAECOL CA, V33, P1165, DOI 10.1016/S1701-2163(16)35087-3; Ludwig AK, 2006, HUM REPROD, V21, P713, DOI 10.1093/humrep/dei390; McDonald SD, 2009, EUR J OBSTET GYN R B, V146, P138, DOI 10.1016/j.ejogrb.2009.05.035; Pandian Z, 2001, HUM REPROD, V16, P2593, DOI 10.1093/humrep/16.12.2593; Partridge S, 2012, AM J PERINATOL; Petrou S, 2003, EUR J OBSTET GYN R B, V106, P40, DOI 10.1016/S0301-2115(02)00215-4; Raatikainen K, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-268; Raatikainen K, 2012, HUM REPROD, V27, P1162, DOI 10.1093/humrep/des015; Reddy UM, 2007, OBSTET GYNECOL, V109, P967, DOI 10.1097/01.AOG.0000259316.04136.30; Romundstad LB, 2008, LANCET, V372, P737, DOI 10.1016/S0140-6736(08)61041-7; Schieve LA, 2007, MATERN CHILD HLTH J, V11, P517, DOI 10.1007/s10995-007-0202-7; Segev Y, 2011, J WOMENS HEALTH, V20, P853, DOI 10.1089/jwh.2010.2603; Thomson F, 2005, BJOG-INT J OBSTET GY, V112, P632, DOI 10.1111/j.1471-0528.2004.00489.x; Wehby GL, 2009, HEALTH POLICY PLANN, V24, P175, DOI 10.1093/heapol/czp005; Welmerink DB, 2010, FERTIL STERIL, V94, P2580, DOI 10.1016/j.fertnstert.2010.03.005; Wen J, 2012, FERTIL STERIL, V97, P1331, DOI 10.1016/j.fertnstert.2012.02.053; Zhu JL, 2006, BMJ-BRIT MED J, V333, P679, DOI 10.1136/bmj.38919.495718.AE	37	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84237	10.1371/journal.pone.0084237	http://dx.doi.org/10.1371/journal.pone.0084237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GT	24358347	Green Submitted, Green Published, gold			2022-12-27	WOS:000328737700088
J	Johnson, ZI; Wheeler, BJ; Blinebry, SK; Carlson, CM; Ward, CS; Hunt, DE				Johnson, Zackary I.; Wheeler, Benjamin J.; Blinebry, Sara K.; Carlson, Christina M.; Ward, Christopher S.; Hunt, Dana E.			Dramatic Variability of the Carbonate System at a Temperate Coastal Ocean Site (Beaufort, North Carolina, USA) Is Regulated by Physical and Biogeochemical Processes on Multiple Timescales	PLOS ONE			English	Article							ACIDIFICATION; IMPACTS; SEAWATER; PH; ESTUARINE; RESPONSES; DYNAMICS; PCO(2); SINKS; RIVER	Increasing atmospheric carbon dioxide (CO2) from anthropogenic sources is acidifying marine environments resulting in potentially dramatic consequences for the physical, chemical and biological functioning of these ecosystems. If current trends continue, mean ocean pH is expected to decrease by similar to 0.2 units over the next similar to 50 years. Yet, there is also substantial temporal variability in pH and other carbon system parameters in the ocean resulting in regions that already experience change that exceeds long-term projected trends in pH. This points to short-term dynamics as an important layer of complexity on top of long-term trends. Thus, in order to predict future climate change impacts, there is a critical need to characterize the natural range and dynamics of the marine carbonate system and the mechanisms responsible for observed variability. Here, we present pH and dissolved inorganic carbon (DIC) at time intervals spanning 1 hour to >1 year from a dynamic, coastal, temperate marine system (Beaufort Inlet, Beaufort NC USA) to characterize the carbonate system at multiple time scales. Daily and seasonal variation of the carbonate system is largely driven by temperature, alkalinity and the balance between primary production and respiration, but high frequency change (hours to days) is further influenced by water mass movement (e. g. tides) and stochastic events (e. g. storms). Both annual (similar to 0.3 units) and diurnal (similar to 0.1 units) variability in coastal ocean acidity are similar in magnitude to 50 year projections of ocean acidity associated with increasing atmospheric CO2. The environmental variables driving these changes highlight the importance of characterizing the complete carbonate system rather than just pH. Short-term dynamics of ocean carbon parameters may already exert significant pressure on some coastal marine ecosystems with implications for ecology, biogeochemistry and evolution and this shorter term variability layers additive effects and complexity, including extreme values, on top of long-term trends in ocean acidification.	[Johnson, Zackary I.; Wheeler, Benjamin J.; Blinebry, Sara K.; Carlson, Christina M.; Ward, Christopher S.; Hunt, Dana E.] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA	Duke University	Johnson, ZI (corresponding author), Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA.	zij@duke.edu	Johnson, Zackary I/E-4601-2011; Hunt, Dana/A-2051-2012	Johnson, Zackary I/0000-0003-0793-8512; Hunt, Dana/0000-0002-8801-9624	US-NSF [0959630, 1031064]; Repass Family; Division Of Ocean Sciences [1031064] Funding Source: National Science Foundation	US-NSF(National Science Foundation (NSF)); Repass Family; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported in part by US-NSF# 0959630 to ZIJ and DEH and 1031064 to ZIJ (http://www.nsf.gov) and by the Repass Family to the Duke University Marine Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AJ, 2012, BIOGEOSCIENCES, V9, P893, DOI 10.5194/bg-9-893-2012; Bates NR, 1998, NATURE, V395, P58, DOI 10.1038/25703; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Boyd PW, 2011, NAT GEOSCI, V4, P273, DOI 10.1038/ngeo1150; Bozec Y, 2011, MAR CHEM, V126, P13, DOI 10.1016/j.marchem.2011.03.003; Burkholder J, 2004, P NATL ACAD SCI USA, V101, P9291, DOI 10.1073/pnas.0306842101; Byrne RH, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL040999; Cai WJ, 2011, NAT GEOSCI, V4, P766, DOI [10.1038/ngeo1297, 10.1038/NGEO1297]; Cai WJ, 2011, ANNU REV MAR SCI, V3, P123, DOI 10.1146/annurev-marine-120709-142723; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Chen CTA, 2009, DEEP-SEA RES PT II, V56, P578, DOI 10.1016/j.dsr2.2009.01.001; CLAYTON TD, 1993, DEEP-SEA RES PT I, V40, P2115, DOI 10.1016/0967-0637(93)90048-8; Dai MH, 2009, LIMNOL OCEANOGR, V54, P735, DOI 10.4319/lo.2009.54.3.0735; Dickson A.G., 2007, GUIDE BEST PRACTICES; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Dore JE, 2009, P NATL ACAD SCI USA, V106, P12235, DOI 10.1073/pnas.0906044106; Duarte CM, 2013, ESTUAR COAST, V36, P221, DOI 10.1007/s12237-013-9594-3; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Frankignoulle M, 1996, MAR ECOL PROG SER, V145, P123, DOI 10.3354/meps145123; Friedrich T, 2012, NAT CLIM CHANGE, V2, P167, DOI [10.1038/NCLIMATE1372, 10.1038/nclimate1372]; Giovannoni SJ, 2012, SCIENCE, V335, P671, DOI 10.1126/science.1198078; Gruber N, 2012, SCIENCE, V337, P220, DOI 10.1126/science.1216773; Hester KC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034913; Hinga KR, 2002, MAR ECOL PROG SER, V238, P281, DOI 10.3354/meps238281; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Johnson ZI, 2010, J MAR RES, V68, P283, DOI 10.1357/002224010793721433; Kitidis V, 2012, CONT SHELF RES, V42, P30, DOI 10.1016/j.csr.2012.04.012; Knauss JA, 2005, INTRO PHYS OCEANOGRA; Kroeker KJ, 2011, P NATL ACAD SCI USA, V108, P14515, DOI 10.1073/pnas.1107789108; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Lee K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027207; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/ngeo1441, 10.1038/NGEO1441]; MALLIN MA, 1993, MAR ECOL PROG SER, V93, P199, DOI 10.3354/meps093199; Millero FJ, 2006, MAR CHEM, V100, P80, DOI 10.1016/j.marchem.2005.12.001; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Raymond PA, 1997, ESTUARIES, V20, P381, DOI 10.2307/1352351; Schaum E, 2013, NAT CLIM CHANGE, V3, P298, DOI 10.1038/NCLIMATE1774; Shi DL, 2010, SCIENCE, V327, P676, DOI 10.1126/science.1183517; Van Heuven, 2011, ORNLCDIAC105B USDA C; WAKITA M, 2013, BIOGEOSCIENCES DISCU, V10, P8283, DOI DOI 10.5194/BGD-10-8283-2013; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105	42	42	42	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e85117	10.1371/journal.pone.0085117	http://dx.doi.org/10.1371/journal.pone.0085117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358377	gold, Green Published, Green Submitted			2022-12-27	WOS:000328737700111
J	Wang, XG; Liu, XX; Ge, HL; Yang, Q; Liu, XL; Shi, DM; Zhou, YJ				Wang, Xinguo; Liu, Xuxia; Ge, Hailong; Yang, Qing; Liu, Xiaoli; Shi, Dongmei; Zhou, Yujie			Positive Association of Coronary Calcium Detected by Computed Tomography Coronary Angiography with Periprocedural Myocardial Infarction	PLOS ONE			English	Article							CARDIAC TROPONIN ELEVATION; PLAQUE COMPOSITION; INTRAVASCULAR ULTRASOUND; INTERVENTION; IMPACT; CT	Background: Periprocedural myocardial infarction (PMI) may occur in approximately 5% to 30% of patients undergoing percutaneous coronary intervention. Whether the morphology of coronary plaque calcium affects the occurrence of PMI is unknown. Materials and Methods: A total of 616 subjects with stable angina and normal baseline cardiac troponin I levels who had undergone computed tomography angiography (CTA) were referred to elective percutaneous coronary intervention. The morphology of coronary calcium was determined by CTA analysis. PMI was defined as an elevation in 24-h post-procedural cardiac troponin I levels of. 5 times the upper limit of normal with either symptoms of myocardial ischemia, new ischemic electrocardiographic changes, or documented complications during the procedure. Logistic regression was performed to identify the effect of the morphology of coronary calcium on the occurrence of PMI. Results: According to the presence or morphology of coronary calcium as shown by CTA, 210 subjects were grouped in the heavy calcification group, 258 in the mild calcification group, 40 in the spotty calcification group and 108 in the control group. The dissection rate was significantly higher in the heavy calcification group than in the control group (7.1 % vs. 1.9%, p = 0.03). The occurrence of PMI in the heavy calcification group was significantly higher than that in the control group (OR 4.38, 95% CI 1.80-10.65, p = 0.001). After multivariate adjustment, the risk of PMI still remained significantly higher in the heavy calcification group than in the control group (OR 4.04, 95% CI 1.50-10.89, p = 0.003). Conclusions: The morphology of coronary calcium determined by CTA may help to predict the subsequent occurrence of PMI. A large amount of coronary calcium may be predictive of PMI.	[Wang, Xinguo; Ge, Hailong; Yang, Qing; Liu, Xiaoli; Shi, Dongmei; Zhou, Yujie] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China; [Liu, Xuxia; Zhou, Yujie] Minist Educ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [Liu, Xuxia; Zhou, Yujie] Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing, Peoples R China	Capital Medical University	Zhou, YJ (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China.	azzyj12@163.com	Zhou, Yu/HHN-3071-2022; Liu, Xiaoli/HGE-7614-2022		Beijing Postdoctoral Scientific [2012ZZ-41]	Beijing Postdoctoral Scientific	This work was supported by the Beijing Postdoctoral Scientific grant (No. 2012ZZ-41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Babu GG, 2011, EUR HEART J, V32, P23, DOI 10.1093/eurheartj/ehq393; Bose D, 2008, BASIC RES CARDIOL, V103, P587, DOI 10.1007/s00395-008-0745-9; Ewence AE, 2008, CIRC RES, V103, pE28, DOI 10.1161/CIRCRESAHA.108.181305; Feldman DN, 2011, CATHETER CARDIO INTE, V77, P1020, DOI 10.1002/ccd.22962; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Hong YJ, 2009, JACC-CARDIOVASC IMAG, V2, P458, DOI 10.1016/j.jcmg.2008.12.020; Iakovou I, 2003, J AM COLL CARDIOL, V42, P1900, DOI 10.1016/j.jacc.2003.06.012; Kitagawa T, 2007, AM HEART J, V154, P1191, DOI 10.1016/j.ahj.2007.07.020; Kodama T, 2012, JACC-CARDIOVASC INTE, V5, P636, DOI 10.1016/j.jcin.2012.02.016; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; Mehran R, 2000, CIRCULATION, V101, P604, DOI 10.1161/01.CIR.101.6.604; Prasad A, 2011, NEW ENGL J MED, V364, P453, DOI 10.1056/NEJMra0912134; Schmermund A, 2006, CIRCULATION, V113, P427, DOI 10.1161/CIRCULATIONAHA.105.568147; Testa L, 2009, QJM-INT J MED, V102, P369, DOI 10.1093/qjmed/hcp005; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Uetani T, 2008, EUR HEART J, V29, P1714, DOI 10.1093/eurheartj/ehn248; Uetani T, 2010, JACC-CARDIOVASC IMAG, V3, P19, DOI 10.1016/j.jcmg.2009.09.016; van Gaal WJ, 2009, INT J CARDIOL, V135, P60, DOI 10.1016/j.ijcard.2008.03.033; Watabe H, 2012, J AM COLL CARDIOL, V59, P1881, DOI 10.1016/j.jacc.2012.01.051; Zemanek D, 2013, INT J CARDIOL, V2015; Zhao L, 2011, EUR J RADIOL, V77, P436, DOI 10.1016/j.ejrad.2009.09.006	22	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82835	10.1371/journal.pone.0082835	http://dx.doi.org/10.1371/journal.pone.0082835			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358229	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700033
J	Jeong, SH; Lee, DH; Kim, BY; Choi, SW; Lee, JB; Park, SY; Choi, IS; Song, CS				Jeong, Seung-Hwan; Lee, Dong-Hun; Kim, Byoung-Yoon; Choi, Soo-Won; Lee, Joong-Bok; Park, Seung-Yong; Choi, In-Soo; Song, Chang-Seon			Immunization with a Thermostable Newcastle Disease Virus K148/08 Strain Originated from Wild Mallard Duck Confers Protection against Lethal Viscerotropic Velogenic Newcastle Disease Virus Infection in Chickens	PLOS ONE			English	Article							VACCINATION; BIRDS	Newcastle disease (ND) is one of the most devastating poultry infections because of its worldwide distribution and accompanying economical threat. In the present study, we characterized the ND virus (NDV) K148/08 strain from wild mallard duck, with regard to safety, thermostability, immunogenicity, and protective efficacy against velogenic ND viral infection. The NDV K148/08 strain offered enhanced immunogenicity and safety relative to commercially available vaccine strains. The NDV K148/08 strain was safe in 1-day-old SPF chicks after vaccination using a coarse or cabinet-type fine sprayer. We demonstrated that the NDV K148/08 strain elicited high levels of antibody responses and provided protective efficacy against lethal NDV challenge. In addition, the thermostability of the NDV K148/08 strain was as high as that of the thermostable V4 strain. Therefore, the NDV K148/08 strain may be useful to ensure NDV vaccine performance and effectiveness in developing countries, especially in remote areas without cold chains.	[Jeong, Seung-Hwan; Lee, Dong-Hun; Kim, Byoung-Yoon; Choi, Soo-Won; Lee, Joong-Bok; Park, Seung-Yong; Choi, In-Soo; Song, Chang-Seon] Konkuk Univ, Coll Vet Med, Avian Dis Lab, Seoul, South Korea	Konkuk University	Song, CS (corresponding author), Konkuk Univ, Coll Vet Med, Avian Dis Lab, Seoul, South Korea.	songcs@konkuk.ac.kr	Lee, Dong-hun/H-5082-2019	Lee, Dong-Hun/0000-0002-0820-7378	Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [610001-03-1-SU000]	Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	This work was supported by grant no. 610001-03-1-SU000 from the Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D, 2001, BRIT POULTRY SCI, V42, P5, DOI 10.1080/713655022; Alexander D J, 1974, Avian Pathol, V3, P269, DOI 10.1080/03079457409353840; Alexander D.J., 2008, LAB MANUAL ISOLATION, V4th, P135; Alexander DJ, 2008, POULTRY DIS, P75; ALLAN WH, 1976, RES VET SCI, V20, P101, DOI 10.1016/S0034-5288(18)33487-8; BEARD CW, 1967, J INFECT DIS, V117, P55, DOI 10.1093/infdis/117.1.55; BEARD CW, 1993, AVIAN DIS, V37, P222, DOI 10.2307/1591478; Bermudez AJ, 2009, DIS POULTRY, P17; Burmester BR, 1947, POULTRY SCI, V26, P614, DOI [10.3382/ps.0260614, DOI 10.3382/PS.0260614]; GODDARD RD, 1988, VACCINE, V6, P530, DOI 10.1016/0264-410X(88)90106-5; GOUGH R E, 1976, Avian Pathology, V5, P81, DOI 10.1080/03079457608418174; Kim BY, 2012, INFECT GENET EVOL, V12, P478, DOI 10.1016/j.meegid.2011.12.004; Kristensen D, 2011, VACCINE, V29, P7122, DOI 10.1016/j.vaccine.2011.05.070; LOMNICZI B, 1975, ARCH VIROL, V47, P249, DOI 10.1007/BF01317812; Pharmacopoeia E, 2004, INFECT BRONCHITIS LI, V1; REED L. J., 1938, AMER JOUR HYG, V27, P493; Senne DA, 2004, DEV BIOLOGICALS, V119, P165; Shim JB, 2011, AVIAN PATHOL, V40, P565, DOI 10.1080/03079457.2011.616187; SPRADBROW PB, 1995, VET MICROBIOL, V46, P21, DOI 10.1016/0378-1135(95)00066-J; Stephan GT, 2008, LAB MAUNAL ISOLATION, P195; STEPHENS P, 1968, AUST VET J, V44, P29, DOI 10.1111/j.1751-0813.1967.tb04764.x; Takada A, 1996, VET MICROBIOL, V50, P17, DOI 10.1016/0378-1135(96)00004-1; Villegas P, 1998, POULTRY SCI, V77, P1143, DOI 10.1093/ps/77.8.1143; Zhang R, 2010, VET MICROBIOL, V141, P246, DOI 10.1016/j.vetmic.2009.09.020	24	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83161	10.1371/journal.pone.0083161	http://dx.doi.org/10.1371/journal.pone.0083161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358260	gold, Green Submitted, Green Published			2022-12-27	WOS:000328735700108
J	Jung, AS; Koo, BK; Chong, SH; Kim, K; Choi, DK; Vu, TTT; Nguyen, MT; Jeong, B; Ryu, HB; Kim, I; Jang, YJ; Robinson, RC; Choe, H				Jung, A. Song; Koo, Bon-Kyung; Chong, Seon-Ha; Kim, Kyunhoo; Choi, Dong Kyu; Thu Trang Thi Vu; Minh Tan Nguyen; Jeong, Boram; Ryu, Han-Bong; Kim, Injune; Jang, Yeon Jin; Robinson, Robert Charles; Choe, Han			Soluble Expression of Human Leukemia Inhibitory Factor with Protein Disulfide Isomerase in Escherichia coli and Its Simple Purification	PLOS ONE			English	Article							HIGH-LEVEL EXPRESSION; LOW-TEMPERATURE INCREASES; FACTOR LIF; RECOMBINANT PROTEINS; CRYSTAL-STRUCTURE; STEM-CELLS; HUMAN PDI; DIFFERENTIATION; CLONING; GENE	Human leukemia inhibitory factor (hLIF) is a multifunctional cytokine that is essential for maintaining the pluripotency of embryonic stem cells. hLIF may be also be useful in aiding fertility through its effects on increasing the implantation rate of fertilized eggs. Thus these applications in biomedical research and clinical medicine create a high demand for bioactive hLIF. However, production of active hLIF is problematic since eukaryotic cells demonstrate limited expression and prokaryotic cells produce insoluble protein. Here, we have adopted a hybrid protein disulfide isomerase design to increase the solubility of hLIF in Escherichia coli. Low temperature expression of hLIF fused to the b'a' domain of protein disulfide isomerase (PDIb'a') increased the soluble expression in comparison to controls. A simple purification protocol for bioactive hLIF was established that includes removal of the PDIb'a' domain by cleavage by TEV protease. The resulting hLIF, which contains one extra glycine residue at the N-terminus, was highly pure and demonstrated endotoxin levels below 0.05 EU/mu g. The presence of an intramolecular disulfide bond was identified using mass spectroscopy. This purified hLIF effectively maintained the pluripotency of a murine embryonic stem cell line. Thus we have developed an effective method to produce a pure bioactive version of hLIF in E. coli for use in biomedical research.	[Jung, A. Song; Koo, Bon-Kyung; Chong, Seon-Ha; Thu Trang Thi Vu; Minh Tan Nguyen; Jeong, Boram; Ryu, Han-Bong; Jang, Yeon Jin; Choe, Han] Univ Ulsan, Coll Med, Dept Physiol, Seoul, South Korea; [Jung, A. Song; Koo, Bon-Kyung; Chong, Seon-Ha; Thu Trang Thi Vu; Minh Tan Nguyen; Jeong, Boram; Ryu, Han-Bong; Jang, Yeon Jin; Choe, Han] Univ Ulsan, Coll Med, Biomed Inst Technol, Seoul, South Korea; [Kim, Kyunhoo; Choi, Dong Kyu; Kim, Injune] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Robinson, Robert Charles] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Robinson, Robert Charles] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore	University of Ulsan; University of Ulsan; Korea Advanced Institute of Science & Technology (KAIST); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Choe, H (corresponding author), Univ Ulsan, Coll Med, Dept Physiol, Seoul, South Korea.	hchoe@ulsan.ac.kr	Robinson, Robert/G-9702-2011; Nguyen, Minh Tan/AAH-7865-2019; Kim, Injune/C-1710-2011	Robinson, Robert/0000-0001-6367-6903; Kim, Injune/0000-0001-9244-815X; choe, han/0000-0003-4604-647X	National Research Foundation [2008-0062286]; Korea government	National Research Foundation; Korea government(Korean Government)	This work was supported by the MRC grant (2008-0062286) of National Research Foundation funded by the Korea government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanova L, 2004, ANN NY ACAD SCI, V1034, P176, DOI 10.1196/annals.1335.020; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Bauer S, 2009, ANN NY ACAD SCI, V1153, P48, DOI 10.1111/j.1749-6632.2009.03986.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen JR, 2000, ENDOCRINOLOGY, V141, P4365, DOI 10.1210/en.141.12.4365; Chodorowska Grazyna, 2004, Ann Univ Mariae Curie Sklodowska Med, V59, P189; Fahnert B, 2004, ADV BIOCHEM ENG BIOT, V89, P93; Ferrer M, 2004, APPL ENVIRON MICROB, V70, P4499, DOI 10.1128/AEM.70.8.4499-4504.2004; GEARING DP, 1987, EMBO J, V6, P3995, DOI 10.1002/j.1460-2075.1987.tb02742.x; GEARING DP, 1989, BIO-TECHNOL, V7, P1157; GOUGH NM, 1988, P NATL ACAD SCI USA, V85, P2623, DOI 10.1073/pnas.85.8.2623; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; HILTON DJ, 1988, ANAL BIOCHEM, V173, P359, DOI 10.1016/0003-2697(88)90200-X; HILTON DJ, 1992, TRENDS BIOCHEM SCI, V17, P72, DOI 10.1016/0968-0004(92)90505-4; Hirai H, 2011, BIOCHEM J, V438, P11, DOI 10.1042/BJ20102152; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Huyton T, 2007, P NATL ACAD SCI USA, V104, P12737, DOI 10.1073/pnas.0705577104; Imaizumi K, 2013, PROTEIN EXPRES PURIF, V90, P20, DOI 10.1016/j.pep.2013.04.006; Imsoonthornruksa S, 2011, J BIOTECHNOL, V151, P295, DOI 10.1016/j.jbiotec.2010.12.020; Joo HJ, 2012, BLOOD, V120, P2733, DOI 10.1182/blood-2012-04-421610; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kim EE, 2012, CURR MED IMAGING REV, V8, P1; Kurokawa Y, 2001, J BIOL CHEM, V276, P14393, DOI 10.1074/jbc.M100132200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li ZJ, 2001, PROTEIN EXPRES PURIF, V21, P438, DOI 10.1006/prep.2001.1395; Lin JE, 2011, PROTEIN PEPTIDE LETT, V18, P690, DOI 10.2174/092986611795446058; Liu Y, 2005, PROTEIN EXPRES PURIF, V44, P155, DOI 10.1016/j.pep.2005.03.030; METCALF D, 1990, BLOOD, V76, P50; ROBINSON RC, 1994, CELL, V77, P1101, DOI 10.1016/0092-8674(94)90449-9; SAMAL BB, 1995, BBA-GENE STRUCT EXPR, V1260, P27, DOI 10.1016/0167-4781(94)00172-Y; SCHMELZER CH, 1993, ARCH BIOCHEM BIOPHYS, V302, P484, DOI 10.1006/abbi.1993.1243; SHIRANO Y, 1990, FEBS LETT, V271, P128, DOI 10.1016/0014-5793(90)80388-Y; Sims NA, 2012, GROWTH FACTORS, V30, P76, DOI 10.3109/08977194.2012.656760; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; SMITH AG, 1992, DEV BIOL, V151, P339, DOI 10.1016/0012-1606(92)90174-F; Song JA, 2013, APPL BIOCHEM BIOTECH, V170, P67, DOI 10.1007/s12010-013-0140-3; Sorensen HP, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-1; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Thomas JG, 1996, J BIOL CHEM, V271, P11141, DOI 10.1074/jbc.271.19.11141; Tomala M, 2010, PROTEIN EXPRES PURIF, V73, P51, DOI 10.1016/j.pep.2010.04.002; Vasina JA, 1997, PROTEIN EXPRES PURIF, V9, P211, DOI 10.1006/prep.1996.0678; Vera A, 2007, BIOTECHNOL BIOENG, V96, P1101, DOI 10.1002/bit.21218; Weickert MJ, 1997, APPL ENVIRON MICROB, V63, P4313, DOI 10.1128/AEM.63.11.4313-4320.1997; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yi AR, 2009, J MICROBIOL BIOTECHN, V19, P829, DOI 10.4014/jmb.0812.683	48	6	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83781	10.1371/journal.pone.0083781	http://dx.doi.org/10.1371/journal.pone.0083781			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358310	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700138
J	Ma, JX; Xing, D; Ma, XL; Gao, F; Wei, Q; Jia, HB; Feng, R; Yu, JT; Wang, J				Ma, JianXiong; Xing, Dan; Ma, XinLong; Gao, Feng; Wei, Qiang; Jia, HaoBo; Feng, Rui; Yu, JingTao; Wang, Jie			Intramedullary Nail versus Dynamic Compression Plate Fixation in Treating Humeral Shaft Fractures: Grading the Evidence through a Meta-Analysis	PLOS ONE			English	Article							PUBLICATION BIAS; QUALITY; RECOMMENDATIONS; OSTEOSYNTHESIS; STRENGTH	There is a debate regarding the choice of operative intervention in humeral shaft fractures that require surgical intervention. The choices for operative interventions include intramedullary nailing (IMN) and dynamic compression plate (DCP). This meta-analysis was performed to compare fracture union, functional outcomes, and complication rates in patients treated with IMN or DCP for humeral shaft fractures and to develop GRADE (Grading of Recommendations, Assessment, Development, and Evaluation)-based recommendations for using the procedures to treat humeral shaft fractures. A systematic search of all the studies published through December 2012 was conducted using the Medline, Embase, Sciencedirect, OVID and Cochrane Central databases. The randomized controlled trials (RCTs) and quasi-RCTs that compared IMN with DCP in treating adult patients with humeral shaft fractures and provided data regarding the safety and clinical effects were identified. The demographic characteristics, adverse events and clinical outcomes were manually extracted from all of the selected studies. Ten studies that included a total of 448 patients met the inclusion criteria. The results of a meta-analysis indicated that both IMN and DCP can achieve similar fracture union with a similar incidence of radial nerve injury and infection. IMN was associated with an increased risk of shoulder impingement, more restriction of shoulder movement, an increased risk of intraoperative fracture comminution, a higher incidence of implant failure, and an increased risk of re-operation. The overall GRADE system evidence quality was very low, which reduces our confidence in the recommendations of this system. DCP may be superior to IMN in the treatment of humeral shaft fractures. Because of the low quality evidence currently available, high-quality RCTs are required.	[Ma, JianXiong; Gao, Feng; Wei, Qiang] Tianjin Univ, Coll Precis Instrument & Optoelect Engn, Tianjin 300072, Peoples R China; [Ma, JianXiong; Xing, Dan; Ma, XinLong; Jia, HaoBo; Feng, Rui; Yu, JingTao; Wang, Jie] Tianjin Med Univ, Gen Hosp, Dept Orthopaed, Tianjin, Peoples R China; [Ma, XinLong] Tianjin Hosp, Dept Orthopaed Inst, Tianjin, Peoples R China	Tianjin University; Tianjin Medical University	Ma, XL (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Orthopaed, Tianjin, Peoples R China.	tjmuld@gmail.com; gaofeng@tju.edu.cn	GAO, FENG/GRX-5768-2022; wei, qiang/G-6279-2013	wei, qiang/0000-0002-4620-5269	National Natural Science Foundation of China [81102607]; National Natural Science Foundation of Tianjin [043111411, 993607711]; Scientific and Technological Project of Tianjin Public Security Bureau [2013KYSGAY033]; Key Technologies & Program of Tianjin [11ZCGYSY01800, 13JCZDJC31800]; Scientific and Technological Project of Tianjin Public Health Bureau [11KG 137, 12KG 120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Tianjin; Scientific and Technological Project of Tianjin Public Security Bureau; Key Technologies & Program of Tianjin; Scientific and Technological Project of Tianjin Public Health Bureau	This study was supported by the National Natural Science Foundation of China (grant number 81102607), the National Natural Science Foundation of Tianjin (043111411, 993607711), the Scientific and Technological Project of Tianjin Public Security Bureau (number 2013KYSGAY033), the Key Technologies & Program of Tianjin (numbers 11ZCGYSY01800, 13JCZDJC31800) and the Scientific and Technological Project of Tianjin Public Health Bureau (numbers 11KG 137, 12KG 120). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apivatthakakul T, 2010, INJURY, V41, P169, DOI 10.1016/j.injury.2009.08.002; Apivatthakakul T, 2009, OPER ORTHOP TRAUMATO, V21, P602, DOI 10.1007/s00064-009-2008-9; Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Benegas Eduardo, 2007, Acta ortop. bras., V15, P87, DOI 10.1590/S1413-78522007000200006; Bhandari M, 2006, ACTA ORTHOP, V77, P279, DOI 10.1080/17453670610046037; Bolano L, 1995, OPERATIVE TREATMENT, P33; Changulani M, 2007, INT ORTHOP, V31, P391, DOI 10.1007/s00264-006-0200-1; Chapman JR, 2000, J ORTHOP TRAUMA, V14, P162, DOI 10.1097/00005131-200003000-00002; Cole PA, 2007, HAND CLIN, V23, P437, DOI 10.1016/j.hcl.2007.11.004; Dimakopoulos P, 2005, ARCH ORTHOP TRAUM SU, V125, P27, DOI 10.1007/s00402-004-0757-3; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FOSTER RJ, 1985, J BONE JOINT SURG AM, V67A, P857, DOI 10.2106/00004623-198567060-00005; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1303, DOI 10.1016/j.jclinepi.2011.04.014; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1277, DOI 10.1016/j.jclinepi.2011.01.011; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017; Kesemenli Cumhur Cevdet, 2003, Acta Orthop Traumatol Turc, V37, P120; Kurup H, 2011, COCHRANE DB SYST REV, pD5959; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; Li Y, 2011, J SHOULDER ELB SURG, V20, P947, DOI 10.1016/j.jse.2010.12.016; Martinez AA, 2004, ARCH ORTHOP TRAUM SU, V124, P92, DOI 10.1007/s00402-003-0608-7; McCormack RG, 2000, J BONE JOINT SURG BR, V82B, P336, DOI 10.1302/0301-620X.82B3.9675; Mulier T, 1997, Acta Orthop Belg, V63, P170; Ouyang H, 2012, J SHOULDER ELBOW SUR; Park JY, 2008, J ORTHOP TRAUMA, V22, P419, DOI 10.1097/BOT.0b013e318173f751; Putti Amit B, 2009, J Orthop Surg (Hong Kong), V17, P139; Raghavendra S, 2007, Indian J Orthop, V41, P214, DOI 10.4103/0019-5413.33685; ROBINSON CM, 1992, J BONE JOINT SURG BR, V74, P558, DOI 10.1302/0301-620X.74B4.1624516; Rommens PM, 2008, INJURY, V39, P1319, DOI 10.1016/j.injury.2008.01.014; ROMMENS PM, 1995, J BONE JOINT SURG BR, V77B, P84, DOI 10.1302/0301-620X.77B1.7822403; SARMIENTO A, 1977, J BONE JOINT SURG AM, V59, P596, DOI 10.2106/00004623-197759050-00004; Sarmiento A, 2000, J BONE JOINT SURG AM, V82A, P478, DOI 10.2106/00004623-200004000-00003; Sarmiento Augusto, 2002, Instr Course Lect, V51, P257; Shao YC, 2005, J BONE JOINT SURG BR, V87B, P1647, DOI 10.1302/0301-620X.87B12.16132; Singisetti K, 2010, INT ORTHOP, V34, P571, DOI 10.1007/s00264-009-0813-2; Tsai CH, 2009, INT ORTHOP, V33, P463, DOI 10.1007/s00264-008-0537-8	40	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82075	10.1371/journal.pone.0082075	http://dx.doi.org/10.1371/journal.pone.0082075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358141	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700032
J	Shtykova, EV; Baratova, LA; Fedorova, NV; Radyukhin, VA; Ksenofontov, AL; Volkov, VV; Shishkov, AV; Dolgov, AA; Shilova, LA; Batishchev, OV; Jeffries, CM; Svergun, DI				Shtykova, Eleonora V.; Baratova, Lyudmila A.; Fedorova, Natalia V.; Radyukhin, Victor A.; Ksenofontov, Alexander L.; Volkov, Vladimir V.; Shishkov, Alexander V.; Dolgov, Alexey A.; Shilova, Liudmila A.; Batishchev, Oleg V.; Jeffries, Cy M.; Svergun, Dmitri I.			Structural Analysis of Influenza A Virus Matrix Protein M1 and Its Self-Assemblies at Low pH	PLOS ONE			English	Article							ANGLE X-RAY; SOLUTION SCATTERING; BIOLOGICAL MACROMOLECULES; NEUTRON-SCATTERING; FINE-STRUCTURE; RESOLUTION; COMPLEXES	Influenza A virus matrix protein M1 is one of the most important and abundant proteins in the virus particles broadly involved in essential processes of the viral life cycle. The absence of high-resolution data on the full-length M1 makes the structural investigation of the intact protein particularly important. We employed synchrotron small-angle X-ray scattering (SAXS), analytical ultracentrifugation and atomic force microscopy (AFM) to study the structure of M1 at acidic pH. The low-resolution structural models built from the SAXS data reveal a structurally anisotropic M1 molecule consisting of a compact NM-fragment and an extended and partially flexible C-terminal domain. The M1 monomers co-exist in solution with a small fraction of large clusters that have a layered architecture similar to that observed in the authentic influenza virions. AFM analysis on a lipid-like negatively charged surface reveals that M1 forms ordered stripes correlating well with the clusters observed by SAXS. The free NM-domain is monomeric in acidic solution with the overall structure similar to that observed in previously determined crystal structures. The NM-domain does not spontaneously self assemble supporting the key role of the C-terminus of M1 in the formation of supramolecular structures. Our results suggest that the flexibility of the C-terminus is an essential feature, which may be responsible for the multi-functionality of the entire protein. In particular, this flexibility could allow M1 to structurally organise the viral membrane to maintain the integrity and the shape of the intact influenza virus.	[Shtykova, Eleonora V.; Volkov, Vladimir V.] Russian Acad Sci, Shubnikov Inst Crystallog, Moscow, Russia; [Baratova, Lyudmila A.; Fedorova, Natalia V.; Radyukhin, Victor A.; Ksenofontov, Alexander L.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Shishkov, Alexander V.; Dolgov, Alexey A.] Russian Acad Sci, Semenov Inst Chem Phys, Moscow, Russia; [Shilova, Liudmila A.; Batishchev, Oleg V.] Russian Acad Sci, Frumkin Inst Phys Chem & Electrochem, Moscow, Russia; [Shilova, Liudmila A.; Batishchev, Oleg V.] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia; [Jeffries, Cy M.; Svergun, Dmitri I.] DESY, Hamburg Outstn, EMBL, Hamburg, Germany	Russian Academy of Sciences; FSRC Crystallography & Photonics RAS; Lomonosov Moscow State University; Russian Academy of Sciences; N.N. Semenov Federal Research Centre for Chemical Physics, Russian Academy of Sciences; Russian Academy of Sciences; Frumkin Institute of Physical Chemistry & Electrochemistry; Moscow Institute of Physics & Technology; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Svergun, DI (corresponding author), DESY, Hamburg Outstn, EMBL, Notkestr 85, Hamburg, Germany.	svergun@embl-hamburg.de	Batishchev, Oleg V/L-1976-2013; Ksenofontov, Alexander L/D-6747-2012; Radyukhin, victor/AAD-5406-2019; Shtykova, Eleonora V./G-6241-2013; Ksenofontov, Alexander/AAH-1774-2021	Batishchev, Oleg V/0000-0002-9581-2233; Ksenofontov, Alexander L/0000-0003-1585-7907; Shtykova, Eleonora V./0000-0003-4347-7266; Ksenofontov, Alexander/0000-0003-1585-7907; /0000-0002-8718-7343; Svergun, Dmitri/0000-0003-0830-5696	German Ministry of Education and Science (BMBF) project BIOSCAT [05K20912]; Russian Foundation for Basic Researches [11-04-01001, 11-03-00798]; Program of Presidium of RAS "Molecular and Cell Biology"; Federal Task Program " Scientific and Scientific-Pedagogic Personnel of Innovative Russia" [8166]	German Ministry of Education and Science (BMBF) project BIOSCAT(Federal Ministry of Education & Research (BMBF)); Russian Foundation for Basic Researches(Russian Foundation for Basic Research (RFBR)); Program of Presidium of RAS "Molecular and Cell Biology"; Federal Task Program " Scientific and Scientific-Pedagogic Personnel of Innovative Russia"	This work was supported in part by German Ministry of Education and Science (BMBF) project BIOSCAT, grant 05K20912, Russian Foundation for Basic Researches (projects #11-04-01001 and #11-03-00798), Program of Presidium of RAS "Molecular and Cell Biology," and the Federal Task Program " Scientific and Scientific-Pedagogic Personnel of Innovative Russia" for 2009-2013 (state contract #8166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzt S, 2001, VIROLOGY, V279, P439, DOI 10.1006/viro.2000.0727; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Boulo S, 2007, VIRUS RES, V124, P12, DOI 10.1016/j.virusres.2006.09.013; Bui M, 1996, J VIROL, V70, P8391, DOI 10.1128/JVI.70.12.8391-8401.1996; Calder LJ, 2010, P NATL ACAD SCI USA, V107, P10685, DOI 10.1073/pnas.1002123107; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Gomez-Puertas P, 2000, J VIROL, V74, P11538, DOI 10.1128/JVI.74.24.11538-11547.2000; Harris A, 2001, VIROLOGY, V289, P34, DOI 10.1006/viro.2001.1119; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Jacques DA, 2012, ACTA CRYSTALLOGR D, V68, P620, DOI 10.1107/S0907444912012073; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kordyukova LV, 2008, PROTEIN PEPTIDE LETT, V15, P922, DOI 10.2174/092986608785849254; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamb R. A., 2001, Fundamental virology, P725; Latham T, 2001, J VIROL, V75, P6154, DOI 10.1128/JVI.75.13.6154-6165.2001; Lee KK, 2010, EMBO J, V29, P1299, DOI 10.1038/emboj.2010.13; Maslova MV, 2004, COLLOID J+, V66, P322, DOI 10.1023/B:COLL.0000030843.30563.c9; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Nayak DP, 2009, VIRUS RES, V143, P147, DOI 10.1016/j.virusres.2009.05.010; NERMUT MV, 1972, J GEN VIROL, V17, P317, DOI 10.1099/0022-1317-17-3-317; Oxford J. S., 1987, PERSPECTIVES MED VIR, P213; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Radyukhin VA, 2009, MOL BIOL+, V43, P533, DOI 10.1134/S0026893309040013; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; Round AR, 2008, J APPL CRYSTALLOGR, V41, P913, DOI 10.1107/S0021889808021018; RUIGROK RWH, 1989, VIROLOGY, V173, P311, DOI 10.1016/0042-6822(89)90248-1; Ruigrok RWH, 2000, VIROLOGY, V267, P289, DOI 10.1006/viro.1999.0134; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Serdyuk IN, 2007, METHODS IN MOLECULAR BIOPHYSICS: STRUCTURE, DYNAMICS, FUNCTION, P1; Sha BD, 1997, NAT STRUCT BIOL, V4, P239, DOI 10.1038/nsb0397-239; Shishkov A, 2011, FEBS J, V278, P4905, DOI 10.1111/j.1742-4658.2011.08392.x; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Svergun DI, 2010, BIOL CHEM, V391, P737, DOI 10.1515/BC.2010.093; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang D, 2010, J VIROL, V84, P4673, DOI 10.1128/JVI.02306-09; Zhang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037786; ZHIRNOV OP, 1992, VIROLOGY, V186, P324, DOI 10.1016/0042-6822(92)90090-C	46	50	55	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82431	10.1371/journal.pone.0082431	http://dx.doi.org/10.1371/journal.pone.0082431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358182	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700065
J	Simpson, LA; Eng, JJ; Backman, CL; Miller, WC				Simpson, Lisa A.; Eng, Janice J.; Backman, Catherine L.; Miller, William C.			Rating of Everyday Arm-Use in the Community and Home (REACH) Scale for Capturing Affected Arm-Use after Stroke: Development, Reliability, and Validity	PLOS ONE			English	Article							SUBACUTE STROKE; INTRACLASS CORRELATIONS; MOTOR; ACCELEROMETRY; IMPAIRMENT; DISABILITY	Objective: To develop a brief, valid and reliable tool [the Rating of Everyday Arm-use in the Community and Home (REACH) scale] to classify affected upper limb use after stroke outside the clinical setting. Methods: Focus groups with clinicians, patients and caregivers (n = 33) and a literature review were employed to develop the REACH scale. A sample of community-dwelling individuals with stroke was used to assess the validity (n = 96) and inter-rater reliability (n = 73) of the new scale. Results: The REACH consists of separate scales for dominant and non-dominant affected upper limbs, and takes five minutes to administer. Each scale consists of six categories that capture 'no use' to 'full use'. The intraclass correlation coefficient and weighted kappa for inter-rater reliability were 0.97 (95% confidence interval: 0.95-0.98) and 0.91 (0.89-0.93) respectively. REACH scores correlated with external measures of upper extremity use, function and impairment (rho = 0.64-0.94). Conclusions: The REACH scale is a reliable, quick-to-administer tool that has strong relationships to other measures of upper limb use, function and impairment. By providing a rich description of how the affected upper limb is used outside of the clinical setting, the REACH scale fills an important gap among current measures of upper limb use and is useful for understanding the long term effects of stroke rehabilitation.	[Simpson, Lisa A.] Univ British Columbia, Grad Program Rehabil Sci, Vancouver, BC V5Z 1M9, Canada; [Simpson, Lisa A.; Eng, Janice J.; Miller, William C.] Vancouver Coastal Hlth, GF Strong Rehab Ctr, Rehabil Res Program, Vancouver, BC, Canada; [Eng, Janice J.] Univ British Columbia, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada; [Backman, Catherine L.; Miller, William C.] Univ British Columbia, Dept Occupat Sci & Occupat Therapy, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia; University of British Columbia	Eng, JJ (corresponding author), Univ British Columbia, Grad Program Rehabil Sci, Vancouver, BC V5Z 1M9, Canada.	janice.eng@ubc.ca	Backman, Catherine L/L-3648-2016; Miller, William/S-7407-2019	Backman, Catherine L/0000-0003-4190-7947; 	CIHR [MSH-63617]; Michael Smith Foundation for Health Research	CIHR(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	Study supported by career scientist awards (JJE) from CIHR (MSH-63617) and the Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreca Susan, 2004, Top Stroke Rehabil, V11, P31; Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108; Brenner H, 1996, EPIDEMIOLOGY, V7, P199, DOI 10.1097/00001648-199603000-00016; Chen HF, 2012, ARCH PHYS MED REHAB, V93, P1039, DOI 10.1016/j.apmr.2011.11.033; Dromerick AW, 2006, J REHABIL RES DEV, V43, P401, DOI 10.1682/JRRD.2005.04.0075; Duncan PW, 1999, STROKE, V30, P2131, DOI 10.1161/01.STR.30.10.2131; Gebruers N, 2008, CEREBROVASC DIS, V26, P533, DOI 10.1159/000160210; GOWLAND C, 1993, STROKE, V24, P58, DOI 10.1161/01.STR.24.1.58; Haaland KY, 2012, ARCH PHYS MED REHAB, V93, P1957, DOI 10.1016/j.apmr.2012.05.011; Harris JE, 2007, PHYS THER, V87, P88, DOI 10.2522/ptj.20060065; Lang Catherine E, 2007, J Neurol Phys Ther, V31, P56; Michielsen ME, 2009, J REHABIL MED, V41, P327, DOI 10.2340/16501977-0351; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Rand D, 2012, NEUROREHAB NEURAL RE, V26, P76, DOI 10.1177/1545968311408918; Rand D, 2010, AM J OCCUP THER, V64, P877, DOI 10.5014/ajot.2010.09043; Rinehart JK, 2009, STROKE, V40, P545, DOI 10.1161/STROKEAHA.108.528497; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Thrane G, 2011, J REHABIL MED, V43, P299, DOI 10.2340/16501977-0676; Uswatte G, 2006, NEUROLOGY, V67, P1189, DOI 10.1212/01.wnl.0000238164.90657.c2; Uswatte G, 2005, STROKE, V36, P2493, DOI 10.1161/01.STR.0000185928.90848.2e; Uswatte G, 2006, ARCH PHYS MED REHAB, V87, P1340, DOI 10.1016/j.apmr.2006.06.006; van der Lee JH, 2004, STROKE, V35, P1410, DOI 10.1161/01.STR.0000126900.24964.7e; van der Pas SC, 2011, ARCH PHYS MED REHAB, V92, P1437, DOI 10.1016/j.apmr.2011.02.021	26	20	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83405	10.1371/journal.pone.0083405	http://dx.doi.org/10.1371/journal.pone.0083405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GD	24358282	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700124
J	Kicinski, M				Kicinski, Michal			Publication Bias in Recent Meta-Analyses	PLOS ONE			English	Article							ANTIDEPRESSANT TRIALS; SELECTION MODELS; FILL METHOD; TRIM; PERFORMANCE; DATABASE; IMPACT; TESTS; SIZE	Introduction: Positive results have a greater chance of being published and outcomes that are statistically significant have a greater chance of being fully reported. One consequence of research underreporting is that it may influence the sample of studies that is available for a meta-analysis. Smaller studies are often characterized by larger effects in published meta-analyses, which can be possibly explained by publication bias. We investigated the association between the statistical significance of the results and the probability of being included in recent meta-analyses. Methods: For meta-analyses of clinical trials, we defined the relative risk as the ratio of the probability of including statistically significant results favoring the treatment to the probability of including other results. For meta-analyses of other studies, we defined the relative risk as the ratio of the probability of including biologically plausible statistically significant results to the probability of including other results. We applied a Bayesian selection model for meta-analyses that included at least 30 studies and were published in four major general medical journals (BMJ, JAMA, Lancet, and PLOS Medicine) between 2008 and 2012. Results: We identified 49 meta-analyses. The estimate of the relative risk was greater than one in 42 meta-analyses, greater than two in 16 meta-analyses, greater than three in eight meta-analyses, and greater than five in four meta-analyses. In 10 out of 28 meta-analyses of clinical trials, there was strong evidence that statistically significant results favoring the treatment were more likely to be included. In 4 out of 19 meta-analyses of observational studies, there was strong evidence that plausible statistically significant outcomes had a higher probability of being included. Conclusions: Publication bias was present in a substantial proportion of large meta-analyses that were recently published in four major medical journals.	Hasselt Univ, Dept Sci, Hasselt, Belgium	Hasselt University	Kicinski, M (corresponding author), Hasselt Univ, Dept Sci, Hasselt, Belgium.	michal.kicinski@uhasselt.be						Ahmed I, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7762; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Brien SE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d636; CASELLA G, 1992, AM STAT, V46, P167, DOI 10.2307/2685208; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405; Chavers S, 2011, PHARMACOEPIDEM DR S, V20, P1009, DOI 10.1002/pds.2221; Copas JB, 2001, STAT METHODS MED RES, V10, P251, DOI 10.1191/096228001678227776; Dear K. B. G., 1992, STAT SCI, V7, P237, DOI 10.1214/ss/1177011363; Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gelman A., 2003, BAYESIAN DATA ANAL; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Hedges LV, 1996, J EDUC BEHAV STAT, V21, P299, DOI 10.2307/1165338; Hedges LV, 1992, STAT SCI, V7, P246, DOI DOI 10.1214/SS/1177011364; Hemingway H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000286; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Iyengar S., 1988, STAT SCI, V3, P109, DOI DOI 10.1214/SS/1177013012; Jalota L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1110; Jang J, 2009, J STAT COMPUT SIM, V79, P691, DOI 10.1080/00949650801891595; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Kromrey JD, 2006, EDUC PSYCHOL MEAS, V66, P357, DOI 10.1177/0013164405278585; Kulinskaya E, 2008, METAANALYSIS GUIDE C; Lambert PC, 2005, STAT MED, V24, P2401, DOI 10.1002/sim.2112; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; Macaskill P, 2001, STAT MED, V20, P641, DOI 10.1002/sim.698; Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2; Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; Peters JL, 2007, STAT MED, V26, P4544, DOI 10.1002/sim.2889; Peters JL, 2010, J R STAT SOC A STAT, V173, P575, DOI 10.1111/j.1467-985X.2009.00629.x; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Rucker G, 2008, STAT MED, V27, P746, DOI 10.1002/sim.2971; Rucker G, 2011, BIOSTATISTICS, V12, P122, DOI 10.1093/biostatistics/kxq046; Rufibach K, 2011, BIOMETRICAL J, V53, P689, DOI 10.1002/bimj.201000240; Silliman NP, 1997, J AM STAT ASSOC, V92, P926, DOI 10.2307/2965556; Song FJ, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-79; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Sutton AJ, 2000, STAT METHODS MED RES, V9, P421, DOI 10.1191/096228000701555244; Terrin N, 2003, STAT MED, V22, P2113, DOI 10.1002/sim.1461; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Zhang ZH, 2013, CRIT CARE, V17, DOI 10.1186/cc11919	52	58	59	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81823	10.1371/journal.pone.0081823	http://dx.doi.org/10.1371/journal.pone.0081823			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24363797	gold, Green Published			2022-12-27	WOS:000327652100101
J	Zhang, ZH; Khoo, AA; Mihalek, I				Zhang, Zong Hong; Khoo, Aik Aun; Mihalek, Ivana			Cube - An Online Tool for Comparison and Contrasting of Protein Sequences	PLOS ONE			English	Article							FUNCTIONALLY IMPORTANT RESIDUES; AMINO-ACID SUBSTITUTIONS; WEB SERVER; EVOLUTIONARY ANALYSIS; LAC REPRESSOR; SPECIFICITY; DIVERGENCE; CONSERVATION; PREDICTION; GENE	When comparing sequences of similar proteins, two kinds of questions can be asked, and the related two kinds of inference made. First, one may ask to what degree they are similar, and then, how they differ. In the first case one may tentatively conclude that the conserved elements common to all sequences are of central and common importance to the protein's function. In the latter case the regions of specialization may be discriminative of the function or binding partners across subfamilies of related proteins. Experimental efforts - mutagenesis or pharmacological intervention - can then be pointed in either direction, depending on the context of the study. Cube simplifies this process for users that already have their favorite sets of sequences, and helps them collate the information by visualization of the conservation and specialization scores on the sequence and on the structure, and by spreadsheet tabulation. All information can be visualized on the spot, or downloaded for reference and later inspection. Server homepage: http://eopsf.org/cube	[Zhang, Zong Hong; Khoo, Aik Aun; Mihalek, Ivana] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII)	Mihalek, I (corresponding author), Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore.	ivanam@bii.a-star.edu.sg			Biomedical Research Council of the Agency for Science, Technology and Research, Singapore	Biomedical Research Council of the Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR))	This work was funded by Biomedical Research Council of the Agency for Science, Technology and Research, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhiman S, 2005, NUCLEIC ACIDS RES, V33, pD197, DOI 10.1093/nar/gki067; Adikesavan AK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002244; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bharatham K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024382; Capra JA, 2008, BIOINFORMATICS, V24, P1473, DOI 10.1093/bioinformatics/btn214; Carro A, 2006, NUCLEIC ACIDS RES, V34, pW110, DOI 10.1093/nar/gkl203; Chakrabarti S, 2007, J MOL BIOL, V373, P801, DOI 10.1016/j.jmb.2007.08.036; Chakraborty A, 2012, NUCLEIC ACIDS RES, V40, pW242, DOI 10.1093/nar/gks559; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Goldenberg O, 2009, NUCLEIC ACIDS RES, V37, pD323, DOI 10.1093/nar/gkn822; Gribaldo S, 2003, MOL BIOL EVOL, V20, P1754, DOI 10.1093/molbev/msg171; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Gu X, 2013, MOL BIOL EVOL, V30, P1713, DOI 10.1093/molbev/mst069; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Innis C, 2000, PROTEIN ENG, V13; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kalinina OV, 2004, NUCLEIC ACIDS RES, V32, pW424, DOI 10.1093/nar/gkh391; Kalinina OV, 2004, PROTEIN SCI, V13, P443, DOI 10.1110/ps.03191704; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khoury GA, 2009, PROTEIN SCI, V18, P2125, DOI 10.1002/pro.227; Knudsen B, 2001, P NATL ACAD SCI USA, V98, P14512, DOI 10.1073/pnas.251526398; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lichtarge O, 1997, J MOL BIOL, V274, P325, DOI 10.1006/jmbi.1997.1395; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Lopez P, 2002, MOL BIOL EVOL, V19, P1; Mesa AD, 2003, J MOL BIOL, V326, P1289, DOI 10.1016/S0022-2836(02)01451-1; Mihalek I, 2006, PROTEINS, V63, P87, DOI 10.1002/prot.20866; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; MILLER JH, 1977, J MOL BIOL, V109, P275, DOI 10.1016/S0022-2836(77)80034-X; Morgan DH, 2006, BIOINFORMATICS, V22, P2049, DOI 10.1093/bioinformatics/btl285; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Robins WP, 2013, P NATL ACAD SCI USA, V110, pE848, DOI 10.1073/pnas.1222538110; Sankararaman S, 2008, BIOINFORMATICS, V24, P2445, DOI 10.1093/bioinformatics/btn474; Sankararaman S, 2009, NUCLEIC ACIDS RES, V37, pW390, DOI 10.1093/nar/gkp339; Suckow J, 1996, J MOL BIOL, V261, P509, DOI 10.1006/jmbi.1996.0479; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Valdar WSJ, 2001, J MOL BIOL, V313, P399, DOI 10.1006/jmbi.2001.5034; Veerassamy S, 2003, J COMPUT BIOL, V10, P997, DOI 10.1089/106652703322756195; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Ye K, 2008, BIOINFORMATICS, V24, P18, DOI 10.1093/bioinformatics/btm537; Zhang ZH, 2012, NUCLEIC ACIDS RES, V40, pD490, DOI 10.1093/nar/gkr1129	45	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79480	10.1371/journal.pone.0079480	http://dx.doi.org/10.1371/journal.pone.0079480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24363790	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100026
J	Giusti, A; Leprince, P; Mazzucchelli, G; Thome, JP; Lagadic, L; Ducrot, V; Joaquim-Justo, C				Giusti, Arnaud; Leprince, Pierre; Mazzucchelli, Gabriel; Thome, Jean-Pierre; Lagadic, Laurent; Ducrot, Virginie; Joaquim-Justo, Celia			Proteomic Analysis of the Reproductive Organs of the Hermaphroditic Gastropod Lymnaea stagnalis Exposed to Different Endocrine Disrupting Chemicals	PLOS ONE			English	Article							MUSSEL MYTILUS-EDULIS; SYDNEY ROCK OYSTER; HALIOTIS-DIVERSICOLOR-SUPERTEXTA; PROTEIN EXPRESSION SIGNATURES; PROSOBRANCH SNAILS MOLLUSCA; SACCOSTREA-GLOMERATA; PLACOPECTEN-MAGELLANICUS; TESTOSTERONE LEVELS; SEX STEROIDS; BISPHENOL-A	Many studies have reported perturbations of mollusc reproduction following exposure to low concentrations (ng/L range) of endocrine disrupting chemicals (EDCs). However, the mechanisms of action of these molecules on molluscs are still poorly understood. Investigation of the modifications of protein expression in organisms exposed to chemicals using proteomic methods can provide a broader and more comprehensive understanding of adverse impacts of pollution on organisms than conventional biochemical biomarkers (e.g., heat-shock proteins, metallothioneins, GST, EROD). In this study we have investigated the impacts of four chemicals, which exhibit different endocrine disrupting properties in vertebrates, on the proteome of the hermaphroditic freshwater pulmonate gastropod Lymnaea stagnalis after 21 days of exposure. Testosterone, tributyltin, chlordecone and cyproterone acetate were chosen as tested compounds as they can induce adverse effects on the reproduction of this snail. The 2D-DIGE method was used to identify proteins whose expression was affected by these compounds. In addition to modifying the expression of proteins involved in the structure and function of the cytoskeleton, chemicals had impacts on the expression of proteins involved in the reproduction of L. stagnalis. Exposure to 19.2 mu g/L of chlordecone increased the abundance of ovipostatin, a peptide transmitted during mating through seminal fluid, which reduces oviposition in this species. The expression of yolk ferritin, the vitellogenin equivalent in L. stagnalis, was reduced after exposure to 94.2 ng Sn/L of tributyltin. The identification of yolk ferritin and the modification of its expression in snails exposed to chemicals were refined using western blot analysis. Our results showed that the tested compounds influenced the abundance of yolk ferritin in the reproductive organs. Alteration in proteins involved in reproductive pathways (e.g., ovipostatin and yolk ferritin) could constitute relevant evidence of interaction of EDCs with reproductive pathways that are under the control of the endocrine system of L. stagnalis.	[Giusti, Arnaud; Thome, Jean-Pierre; Joaquim-Justo, Celia] Univ Liege, CART, Lab Anim Ecol & Ecotoxicol, Liege, Belgium; [Giusti, Arnaud; Lagadic, Laurent; Ducrot, Virginie] INRA, Ecol & Sante Ecosyst UMR0985, Equipe Ecotoxicol & Qualite Milieux Aquat, F-35042 Rennes, France; [Leprince, Pierre] Univ Liege, GIGA Neurosci, Liege, Belgium; [Mazzucchelli, Gabriel] Univ Liege, GIGA R, Lab Mass Spectrometry, Liege, Belgium	University of Liege; INRAE; University of Liege; University of Liege	Giusti, A (corresponding author), Univ Liege, CART, Lab Anim Ecol & Ecotoxicol, Liege, Belgium.	Arnaud.Giusti@ulg.ac.be		Mazzucchelli, Gabriel/0000-0002-8757-8133; Leprince, pierre/0000-0002-7233-6553; Lagadic, Laurent/0000-0002-2469-8541	FNRS-F.R.I.A. grant (Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture); Belgian FNRS-FRFC grant [2.4.585.10.F]; FRSM grant [3.4559.11]	FNRS-F.R.I.A. grant (Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture)(Fonds de la Recherche Scientifique - FNRS); Belgian FNRS-FRFC grant(Fonds de la Recherche Scientifique - FNRS); FRSM grant(Fonds de la Recherche Scientifique - FNRS)	This work was financially supported by a FNRS-F.R.I.A. grant (Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture), a Belgian FNRS-FRFC grant Number: 2.4.585.10.F and a FRSM grant nr 3.4559.11. http://www.frs-fnrs.be. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese M, 2013, J CELL PHYSIOL, V228, P547, DOI 10.1002/jcp.24161; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Andrew MN, 2008, AQUAT TOXICOL, V88, P39, DOI 10.1016/j.aquatox.2008.03.003; Andrew MN, 2010, ECOTOXICOLOGY, V19, P1440, DOI 10.1007/s10646-010-0529-5; Andrew-Priestley MN, 2012, AQUAT TOXICOL, V120, P99, DOI 10.1016/j.aquatox.2012.03.020; Ankley GT, 2009, AQUAT TOXICOL, V92, P168, DOI 10.1016/j.aquatox.2009.01.013; Apraiz I, 2006, MOL CELL PROTEOMICS, V5, P1274, DOI 10.1074/mcp.M500333-MCP200; Apraiz I, 2009, MAR POLLUT BULL, V58, P1815, DOI 10.1016/j.marpolbul.2009.08.004; BARTLETT MS, 1946, J ROY STAT SOC B, V8, P128; Bauer B, 1997, ENVIRON POLLUT, V96, P299, DOI 10.1016/S0269-7491(97)00049-3; Belgers JDM, 2011, CHEMOSPHERE, V85, P1017, DOI 10.1016/j.chemosphere.2011.07.025; Benachour N, 2007, TOXICOL APPL PHARM, V222, P129, DOI 10.1016/j.taap.2007.03.033; Benninghoff AD, 2007, TOXICOL SCI, V95, P1, DOI 10.1093/toxsci/kfl157; Berth M, 2007, APPL MICROBIOL BIOT, V76, P1223, DOI 10.1007/s00253-007-1128-0; Beyret E, 2011, DEV BIOL, V355, P215, DOI 10.1016/j.ydbio.2011.04.021; Bjorkblom C, 2011, ENVIRON TOXICOL, V28, P229; BOTTKE W, 1986, CELL TISSUE RES, V243, P397; Bottke W, 1979, DEV BIOL, V186, P71; Bottke W, 1988, DEV GENES EVOL, V197, P377; Bouetard A, 2012, ECOTOXICOLOGY, V21, P2222, DOI 10.1007/s10646-012-0977-1; Bradley BP, 2002, MAR ENVIRON RES, V54, P373, DOI 10.1016/S0141-1136(02)00115-0; Campos A, 2012, J PROTEOMICS, V75, P4346, DOI 10.1016/j.jprot.2012.04.027; Cao A, 2009, AQUACULTURE, V295, P149, DOI 10.1016/j.aquaculture.2009.06.044; Chora S, 2009, AQUAT TOXICOL, V94, P300, DOI 10.1016/j.aquatox.2009.07.014; Collodoro M, 2012, J PROTEOMICS, V75, P4555, DOI 10.1016/j.jprot.2012.04.032; Coutellec MA, 2006, ECOTOXICOLOGY, V15, P199, DOI 10.1007/s10646-005-0049-x; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Czech P, 2001, AQUAT TOXICOL, V53, P103, DOI 10.1016/S0166-445X(00)00169-7; DAGOSTIN.R, 1973, BIOMETRIKA, V60, P613, DOI 10.1093/biomet/60.3.613; Damodaran Senthilkumar, 2007, Genomics Proteomics & Bioinformatics, V5, P152, DOI 10.1016/S1672-0229(08)60002-9; Damstra T., 2002, GLOBAL ASSESSMENT ST; Dondero F, 2010, SCI TOTAL ENVIRON, V408, P3775, DOI 10.1016/j.scitotenv.2010.03.040; Donohoe RM, 1996, AQUAT TOXICOL, V36, P31, DOI 10.1016/S0166-445X(96)00799-0; Dowling VA, 2006, PROTEOMICS, V6, P5597, DOI 10.1002/pmic.200600274; Ducrot V, 2010, ECOTOXICOLOGY, V19, P1312, DOI 10.1007/s10646-010-0518-8; Duft M, 2003, AQUAT TOXICOL, V64, P437, DOI 10.1016/S0166-445X(03)00102-4; Fang H, 2003, CHEM RES TOXICOL, V16, P1338, DOI 10.1021/tx030011g; Francis F, 2010, J INSECT PHYSIOL, V56, P575, DOI 10.1016/j.jinsphys.2009.12.001; Gauthier-Clerc S, 2006, GEN COMP ENDOCR, V145, P133, DOI 10.1016/j.ygcen.2005.08.004; GERAERTS WPM, 1976, GEN COMP ENDOCR, V28, P350, DOI 10.1016/0016-6480(76)90187-8; Giusti A, 2013, ENVIRON TOXICOL CHEM, V32, P1740, DOI 10.1002/etc.2234; Giusti A, 2013, ENVIRON TOXICOL CHEM, V32, P1552, DOI 10.1002/etc.2200; Gomes T, 2009, ECOTOXICOLOGY, V18, P1104, DOI 10.1007/s10646-009-0359-5; Gooding MP, 2004, INVERTEBR BIOL, V123, P237; HAMMOND B, 1979, P NATL ACAD SCI USA, V76, P6641, DOI 10.1073/pnas.76.12.6641; Harries JE, 1999, ENVIRON TOXICOL CHEM, V18, P932, DOI 10.1002/etc.5620180517; Hoffer J., 2012, QUANTIFYING SEXUAL C; Horiguchi T, 2012, MAR ENVIRON RES, V76, P56, DOI 10.1016/j.marenvres.2011.09.002; ISO ISO, 2004, 147SC ISO TC, P31; Koene JM, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00167; Koene JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010117; Lavado R, 2006, AQUAT TOXICOL, V78, pS65, DOI 10.1016/j.aquatox.2006.02.018; Leroy D, 2010, ECOTOX ENVIRON SAFE, V73, P343, DOI 10.1016/j.ecoenv.2009.11.006; Leung KMY, 2007, CHEMOSPHERE, V66, P1358, DOI 10.1016/j.chemosphere.2006.06.051; Leung PTY, 2011, AQUAT TOXICOL, V105, P49, DOI 10.1016/j.aquatox.2011.05.010; Liu WG, 2008, NEW ZEAL J MAR FRESH, V42, P417, DOI 10.1080/00288330809509970; Manduzio H, 2005, PROTEOMICS, V5, P4958, DOI 10.1002/pmic.200401328; Matozzo V, 2008, ENVIRON INT, V34, P531, DOI 10.1016/j.envint.2007.09.008; Matozzo V, 2008, ENVIRON TOXICOL PHAR, V26, P38, DOI 10.1016/j.etap.2008.01.001; McDonagh B, 2005, AQUAT TOXICOL, V73, P315, DOI 10.1016/j.aquatox.2005.03.020; Miura Y, 2005, ELECTROPHORESIS, V26, P2786, DOI 10.1002/elps.200500172; OECD, 2010, DET REV PAP MOLL LIF; OECD, 2009, TEST 229 FISH SHORT; OECD, 2000, GUID DOC AQ TOX TEST; OECD (Organisation for Economic Co-operation and Development), 2012, GUID DOC STAND TEST; Oehlmann J, 2000, ECOTOXICOLOGY, V9, P383, DOI 10.1023/A:1008972518019; Oehlmann J, 1998, HYDROBIOLOGIA, V378, P199, DOI 10.1023/A:1003218411850; Oehlmann J, 2006, ENVIRON HEALTH PERSP, V114, P127, DOI 10.1289/ehp.8065; Ortiz-Zarragoitia M, 2010, ECOTOX ENVIRON SAFE, V73, P693, DOI 10.1016/j.ecoenv.2010.04.002; Pascoal S, 2012, MOL ECOL; Purdom C.E., 1994, Chemistry and Ecology, V8, P275, DOI 10.1080/02757549408038554; Raudrant D, 2003, DRUGS, V63, P463, DOI 10.2165/00003495-200363050-00003; Rittschof D, 2005, MAR POLLUT BULL, V50, P369, DOI 10.1016/j.marpolbul.2005.02.008; Rodriguez-Ortega MJ, 2003, PROTEOMICS, V3, P1535, DOI 10.1002/pmic.200300491; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Saitoh M, 2001, BIOCHEM BIOPH RES CO, V289, P198, DOI 10.1006/bbrc.2001.5952; Sanchez BC, 2011, ENVIRON TOXICOL CHEM, V30, P274, DOI 10.1002/etc.402; Shepard JL, 2000, MAR ENVIRON RES, V50, P337, DOI 10.1016/S0141-1136(00)00065-9; Sternberg RM, 2010, ECOTOXICOLOGY, V19, P4, DOI 10.1007/s10646-009-0397-z; SUMPTER JP, 1995, ENVIRON HEALTH PERSP, V103, P173, DOI 10.2307/3432529; Thompson EL, 2012, ENVIRON POLLUT, V170, P102, DOI 10.1016/j.envpol.2012.06.015; Thompson EL, 2012, AQUAT TOXICOL, V109, P202, DOI 10.1016/j.aquatox.2011.09.018; Tillmann M, 2001, ECOTOXICOLOGY, V10, P373, DOI 10.1023/A:1012279231373; US-EPA, 1997, EPA360R96012, P120; Wang C, 2004, AQUACULTURE, V238, P483, DOI 10.1016/j.aquaculture.2004.05.024; Wang CD, 2003, INVERTEBR REPROD DEV, V44, P89, DOI 10.1080/07924259.2003.9652559; Wang CD, 2006, AQUACULTURE, V256, P423, DOI 10.1016/j.aquaculture.2006.01.017; Wang G, 2008, CURR BIOL, V18, P861, DOI 10.1016/j.cub.2008.05.009; Wright PC, 2012, THERIOGENOLOGY, V77, P738, DOI 10.1016/j.theriogenology.2011.11.012; Zhang H, 2012, COMP BIOCHEM PHYS C, V156, P51, DOI 10.1016/j.cbpc.2012.03.007; Zhou J, 2010, DEV COMP IMMUNOL, V34, P1059, DOI 10.1016/j.dci.2010.05.006; Zhou J, 2010, CHEMOSPHERE, V79, P595, DOI 10.1016/j.chemosphere.2010.01.052; Zhou X, 2007, BIOCHEM BIOPH RES CO, V362, P126, DOI 10.1016/j.bbrc.2007.07.179	94	15	15	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81086	10.1371/journal.pone.0081086	http://dx.doi.org/10.1371/journal.pone.0081086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24363793	Green Published, gold, Green Submitted			2022-12-27	WOS:000327311900114
J	Hassaballah, AI; Hassan, MA; Mardi, AN; Hamdi, M				Hassaballah, Abdallah I.; Hassan, Mohsen A.; Mardi, Azizi N.; Hamdi, Mohd			An Inverse Finite Element Method for Determining the Tissue Compressibility of Human Left Ventricular Wall during the Cardiac Cycle	PLOS ONE			English	Article							RAPID FILLING PHASE; MYOCARDIAL STIFFNESS; FIBER; ARCHITECTURE; MODEL; CONTRACTION; MUSCLE; HEART	The determination of the myocardium's tissue properties is important in constructing functional finite element (FE) models of the human heart. To obtain accurate properties especially for functional modeling of a heart, tissue properties have to be determined in vivo. At present, there are only few in vivo methods that can be applied to characterize the internal myocardium tissue mechanics. This work introduced and evaluated an FE inverse method to determine the myocardial tissue compressibility. Specifically, it combined an inverse FE method with the experimentally-measured left ventricular (LV) internal cavity pressure and volume versus time curves. Results indicated that the FE inverse method showed good correlation between LV repolarization and the variations in the myocardium tissue bulk modulus K (K = 1/compressibility), as well as provided an ability to describe in vivo human myocardium material behavior. The myocardium bulk modulus can be effectively used as a diagnostic tool of the heart ejection fraction. The model developed is proved to be robust and efficient. It offers a new perspective and means to the study of living-myocardium tissue properties, as it shows the variation of the bulk modulus throughout the cardiac cycle.	[Hassaballah, Abdallah I.; Hassan, Mohsen A.; Mardi, Azizi N.; Hamdi, Mohd] Univ Malaya, Fac Engn, Dept Mech Engn, Kuala Lumpur, Malaysia; [Hassaballah, Abdallah I.; Hassan, Mohsen A.; Mardi, Azizi N.; Hamdi, Mohd] Univ Malaya, Fac Engn, Ctr Adv Mfg & Mat Proc, Kuala Lumpur, Malaysia; [Hassan, Mohsen A.] Assiut Univ, Fac Engn, Dept Mech Engn, Assiut, Egypt	Universiti Malaya; Universiti Malaya; Egyptian Knowledge Bank (EKB); Assiut University	Hassaballah, AI (corresponding author), Univ Malaya, Fac Engn, Dept Mech Engn, Kuala Lumpur, Malaysia.	abdallahhassaballah@yahoo.com	Hassan, Mohsen A./J-9534-2012; Hassaballah, Abdallah/B-8467-2014; Abd Shukor, Mohd Hamdi/B-9093-2010	Hassan, Mohsen A./0000-0001-8599-7732; Abd Shukor, Mohd Hamdi/0000-0003-2123-3041; Hasaballa, Abdallah/0000-0003-4579-9576	Ministry of Higher Education, Malaysia [HIR-MOHE-D000001-16001]	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	This work was supported by the High Impact Research (HIR) Grant (HIR-MOHE-D000001-16001) from the Ministry of Higher Education, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002369; Augenstein KF, 2006, LECT NOTES COMPUT SC, V4190, P628; Bagnoli P, 2011, INT J ARTIF ORGANS, V34, P44, DOI 10.5301/IJAO.2011.6313; Balaraman K, 2006, 010252 SAE; Bettendorff-Bakman DE, 2008, J THEOR BIOL, V250, P581, DOI 10.1016/j.jtbi.2007.10.033; Bettendorff-Bakman DE, 2006, J THEOR BIOL, V238, P303, DOI 10.1016/j.jtbi.2005.05.009; Chen JJ, 2005, AM J PHYSIOL-HEART C, V289, pH1898, DOI 10.1152/ajpheart.00041.2005; Courneya CAM, 2010, CARDIOVASCULAR PHYSL; Dent CL, 2000, ULTRASOUND MED BIOL, V26, P375, DOI 10.1016/S0301-5629(99)00144-1; Dorri F., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P319, DOI 10.1080/10255840600960546; Eriksson T, 2013, MATH MECH SOLIDS; Evangelista A, 2011, PROG BIOPHYS MOL BIO, V107, P112, DOI 10.1016/j.pbiomolbio.2011.07.008; Evans S, 2012, COMPUT METHOD BIOMEC, V15, P1, DOI 10.1080/10255842.2012.650321; Fung YC, 1994, J BIOMECH ENG-T ASME, V61, P1007, DOI [10.1115/1.2901550, DOI 10.1115/1.2901550]; Hall J. E., 2011, GUYTON HALL TXB MED; Hassaballah AIM, 2013, J APPL MATH IN PRESS; Hassan MA, 2012, J MECH BEHAV BIOMED, V5, P99, DOI 10.1016/j.jmbbm.2011.08.011; Helm P, 2005, ANN NY ACAD SCI, V1047, P296, DOI 10.1196/annals.1341.026; Kerckhoffs RCP, 2003, ANN BIOMED ENG, V31, P536, DOI 10.1114/1.1566447; Kerckhoffs RCP, 2012, MECH RES COMMUN, V42, P40, DOI 10.1016/j.mechrescom.2011.11.004; Klabunde R., 2011, CARDIOVASCULAR PHYSL; Kohl P, 2011, CARDIAC MECHANOELECT; Kolipaka A, 2010, MAGN RESON MED, V64, P862, DOI 10.1002/mrm.22467; Kroon W, 2007, LECT NOTES COMPUT SC, V4466, P340, DOI 10.1007/978-3-540-72907-5_35; Le Rolle V, 2008, ARTIF INTELL MED, V44, P201, DOI 10.1016/j.artmed.2008.06.001; Lee LC, 2013, J APPL PHYSL; LEGRICE IJ, 1995, AM J PHYSIOL-HEART C, V269, pH571, DOI 10.1152/ajpheart.1995.269.2.H571; Lombaert H, 2012, IEEE T MED IMAGING, V31, P1436, DOI 10.1109/TMI.2012.2192743; Lombaert H, 2011, LECT NOTES COMPUT SC, V6666, P171, DOI 10.1007/978-3-642-21028-0_22; Marchesseau S, 2012, J MECH BEHAV BIOMEDI; Martina JR, 2013, ARTIFICIAL ORGANS; Masugata H, 2000, CLIN CARDIOL, V23, P115, DOI 10.1002/clc.4960230209; Niederer SA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000371; Perie D, 2013, BMC CARDIOVASC DISOR, V13, P1; Rohmer D, 2006, RECONSTRUCTION VISUA; Sengupta PP, 2006, J AM COLL CARDIOL, V48, P1988, DOI 10.1016/j.jacc.2006.08.030; Shim J, 2012, J BIOMECH, V45, P832, DOI 10.1016/j.jbiomech.2011.11.024; Stevens C, 2003, J BIOMECH, V36, P737, DOI 10.1016/S0021-9290(02)00452-9; Stouffer G, 2011, CARDIOVASCULAR HEMOD; Teske Arco J, 2007, Cardiovasc Ultrasound, V5, P27; Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301; Veress AI, 2005, MEASUREMENT STRAIN L; Wang VY, 2009, MED IMAGE ANAL, V13, P773, DOI 10.1016/j.media.2009.07.006; Watanabe S, 2006, EUR HEART J, V27, P832, DOI 10.1093/eurheartj/ehi772; Xu ZH, 2010, ACTA MATER, V58, P5972, DOI 10.1016/j.actamat.2010.07.013; Yettram AL, 1998, MED ENG PHYS, V20, P103, DOI 10.1016/S1350-4533(98)00009-5; Yin FCP, 1996, AM J PHYSIOL-HEART C, V271, pH1864, DOI 10.1152/ajpheart.1996.271.5.H1864; Zenker S, 2007, PLOS COMPUT BIOL, V3, P2072, DOI 10.1371/journal.pcbi.0030204; Zhong L, 2007, J MECH MED BIOL, V7, P107, DOI 10.1142/S0219519407002182	49	21	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82703	10.1371/journal.pone.0082703	http://dx.doi.org/10.1371/journal.pone.0082703			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367544	gold, Green Submitted, Green Published			2022-12-27	WOS:000328741900011
J	Lata, S; Ronsard, L; Sood, V; Dar, SA; Ramachandran, VG; Das, S; Banerjea, AC				Lata, Sneh; Ronsard, Larance; Sood, Vikas; Dar, Sajad A.; Ramachandran, Vishnampettai G.; Das, Shukla; Banerjea, Akhil C.			Effect on HIV-1 Gene Expression, Tat-Vpr Interaction and Cell Apoptosis by Natural Variants of HIV-1 Tat Exon 1 and Vpr from Northern India	PLOS ONE			English	Article							VIRUS TYPE-1 VPR; FUNCTIONAL-CHARACTERIZATION; SUBTYPE-B; T-CELLS; PROTEIN; RECOMBINATION; RNA; STRAINS; CYCLE; TRANSACTIVATION	Background: Since HIV-1 Tat and Vpr genes are involved in promoter transactivation, apoptosis, etc, we carried out studies to find out nature and extent of natural variation in the two genes from seropositive patients from Northern India and determined their functional implications. Methods: HIV-1 tat exon 1 and vpr were amplified from the genomic DNA isolated from the blood of HIV-1 infected individuals using specific primers by Polymerase Chain reaction (PCR) and subjected to extensive genetic analysis (CLUSTAL W, Simplot etc). Their expression was monitored by generating myc fusion clones. Tat exon 1 and Vpr variants were co-transfected with the reporter gene construct (LTR-luc) and their transactivation potential was monitored by measuring luciferase activity. Apoptosis and cell cycle analysis was done by Propidium Iodide (PI) staining followed by FACS. Results: Exon 1 of tat was amplified from 21 samples and vpr was amplified from 16 samples. One of the Tat exon 1 variants showed phylogenetic relatedness to subtype B & C and turned out to be a unique recombinant. Two of the Vpr variants were B/C/D recombinants. These natural variations were found to have no impact on the stability of Tat and Vpr. These variants differed in their ability to transactivate B LTR and C LTR promoters. B/C recombinant Tat showed better cooperative interaction with Vpr. B/C/D recombination in Vpr was found to have no effect on its co-operativity with Tat. Recombinant Tat (B/C) induced more apoptosis than wild type B and C Tat. The B/C/D recombination in Vpr did not affect its G2 arrest induction potential but reduced its apoptosis induction ability. Conclusions: Extensive sequence and region-specific variations were observed in Tat and Vpr genes from HIV-1 infected individuals from Northern India. These variations have functional implications & therefore important for the pathogenicity of virus.	[Lata, Sneh; Ronsard, Larance; Sood, Vikas; Dar, Sajad A.; Ramachandran, Vishnampettai G.; Das, Shukla] Univ Coll Med Sci, Dept Microbiol, Delhi 110095, India; [Lata, Sneh; Ronsard, Larance; Sood, Vikas; Dar, Sajad A.; Ramachandran, Vishnampettai G.; Das, Shukla] Guru Teg Bahadur Hosp, Delhi 110095, India; [Ronsard, Larance; Sood, Vikas; Banerjea, Akhil C.] Natl Inst Immunol, Virol Lab, New Delhi 110067, India	University of Delhi; University College of Medical Sciences; University of Delhi; University College of Medical Sciences; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Ramachandran, VG (corresponding author), Univ Coll Med Sci, Dept Microbiol, Delhi 110095, India.	rama_88@yahoo.com; akhil@nii.res.in	Ronsard, Larance/H-2731-2019; Dar, Sajad Ahmad/L-1065-2019; Sood, Vikas/HDM-3074-2022	Ronsard, Larance/0000-0002-5307-1940; Dar, Sajad Ahmad/0000-0003-2499-8701; 	Council of Scientific and Industrial Research, New Delhi, India; Indian Council of Medical Research, Government of India [HIV/50/142/9/2011-ECD]	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	This study was supported by Council of Scientific and Industrial Research, New Delhi, India and Indian Council of Medical Research (HIV/50/142/9/2011-ECD), Government of India, to the corresponding author, National Institute of Immunology, New Delhi, India for the period of 3 years. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2002, J VIROL, V76, P4108, DOI 10.1128/JVI.76.8.4108-4112.2002; Ammosova T, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-78; Bano AS, 2009, J GEN VIROL, V90, P2768, DOI 10.1099/vir.0.011080-0; BAYER P, 1995, J MOL BIOL, V247, P529, DOI 10.1016/S0022-2836(05)80133-0; Chiu YL, 2002, MOL CELL, V10, P585, DOI 10.1016/S1097-2765(02)00630-5; COHEN EA, 1990, J VIROL, V64, P3097, DOI 10.1128/JVI.64.6.3097-3099.1990; CULLEN BR, 1986, CELL, V46, P973, DOI 10.1016/0092-8674(86)90696-3; de la Fuente C, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-14; Dey SS, 2012, J BIOL CHEM, V287, P7945, DOI 10.1074/jbc.M111.302653; DOUGHERTY JP, 1988, J VIROL, V62, P2817, DOI 10.1128/JVI.62.8.2817-2822.1988; Fang ZM, 2010, AIDS RES HUM RETROV, V26, P359, DOI 10.1089/aid.2009.0192; Fouchier RAM, 1998, J VIROL, V72, P6004, DOI 10.1128/JVI.72.7.6004-6013.1998; FRANKEL AD, 1988, SCIENCE, V240, P70, DOI 10.1126/science.2832944; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; GOLOVKINA TV, 1994, J VIROL, V68, P5019, DOI 10.1128/JVI.68.8.5019-5026.1994; HAUBER J, 1989, J VIROL, V63, P1181, DOI 10.1128/JVI.63.3.1181-1187.1989; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; HEINZINGER NK, 1994, P NATL ACAD SCI USA, V91, P7311, DOI 10.1073/pnas.91.15.7311; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Jeang K., 1996, HUMAN RETROVIRUSES A, P3; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klostermeier D, 1997, BIOPHYS CHEM, V63, P87, DOI 10.1016/S0301-4622(96)02243-0; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Kuiken C, 2000, HIV SEQUENCE COMPEND; KUPPUSWAMY M, 1989, NUCLEIC ACIDS RES, V17, P3551, DOI 10.1093/nar/17.9.3551; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; McCloskey TW, 1997, J IMMUNOL, V158, P1014; Metzger AU, 1997, BIOCHEM BIOPH RES CO, V241, P31, DOI 10.1006/bbrc.1997.7770; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Moutouh L, 1996, P NATL ACAD SCI USA, V93, P6106, DOI 10.1073/pnas.93.12.6106; Mullick R, 2010, VIRUS RES, V147, P195, DOI 10.1016/j.virusres.2009.10.024; Neogi U, 2008, ARCH VIROL, V153, P1961, DOI 10.1007/s00705-008-0210-y; Neogi U, 2012, AIDS RES HUM RETROV, V28, P952, DOI [10.1089/aid.2011.0380, 10.1089/AID.2011.0380]; Neogi Ujjwal, 2009, AIDS Res Ther, V6, P28, DOI 10.1186/1742-6405-6-28; Nie ZL, 1998, J VIROL, V72, P4104, DOI 10.1128/JVI.72.5.4104-4115.1998; Nkolola JP, 2004, GENE THER, V11, P1068, DOI 10.1038/sj.gt.3302241; Ott M, 1998, J IMMUNOL, V160, P2872; Ouyang YB, 2012, CURR HIV RES, V10, P151, DOI 10.2174/157016212799937236; Pauza CD, 2000, P NATL ACAD SCI USA, V97, P3515, DOI 10.1073/pnas.070049797; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Rana TM, 1999, ARCH BIOCHEM BIOPHYS, V365, P175, DOI 10.1006/abbi.1999.1206; Ranga U, 2004, J VIROL, V78, P2586, DOI 10.1128/JVI.78.5.2586-2590.2004; RAPPAPORT J, 1989, New Biologist, V1, P101; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; ROBERTSON DL, 1995, J MOL EVOL, V40, P249, DOI 10.1007/BF00163230; ROBERTSON DL, 1995, NATURE, V374, P124, DOI 10.1038/374124b0; Robertson DL, 1999, HUMAN RETROVIRUSES A, P492; ROY S, 1990, GENE DEV, V4, P1365, DOI 10.1101/gad.4.8.1365; RUBEN S, 1989, J VIROL, V63, P1; SADAIE MR, 1988, P NATL ACAD SCI USA, V85, P9224, DOI 10.1073/pnas.85.23.9224; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sawaya BE, 2000, J BIOL CHEM, V275, P35209, DOI 10.1074/jbc.M005197200; SEIGEL LJ, 1986, VIROLOGY, V148, P226, DOI 10.1016/0042-6822(86)90419-8; Siddappa NB, 2005, AIDS, V19, P1426, DOI 10.1097/01.aids.0000180795.49016.89; SODROSKI J, 1985, SCIENCE, V227, P171, DOI 10.1126/science.2981427; Sorgel S, 2012, VIROLOGY, V432, P444, DOI 10.1016/j.virol.2012.06.027; Stewart SA, 1997, J VIROL, V71, P5579, DOI 10.1128/JVI.71.7.5579-5592.1997; Subbramanian RA, 1998, J EXP MED, V187, P1103, DOI 10.1084/jem.187.7.1103; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripathy SP, 2005, AIDS RES HUM RETROV, V21, P152, DOI 10.1089/aid.2005.21.152; TUMAS KM, 1993, VIROLOGY, V192, P587, DOI 10.1006/viro.1993.1075; Verhoef K, 1997, VIROLOGY, V237, P228, DOI 10.1006/viro.1997.8786; Verhoef K, 1999, J VIROL, V73, P2781, DOI 10.1128/JVI.73.4.2781-2789.1999; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3	71	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82128	10.1371/journal.pone.0082128	http://dx.doi.org/10.1371/journal.pone.0082128			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367500	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900006
J	Pence, BW; Whetten, K; Shirey, KG; Yao, J; Thielman, NM; Whetten, R; Itemba, D; Maro, V				Pence, Brian W.; Whetten, Kathryn; Shirey, Kristen G.; Yao, Jia; Thielman, Nathan M.; Whetten, Rachel; Itemba, Dafrosa; Maro, Venance			Factors Associated with Change in Sexual Transmission Risk Behavior over 3 Years among HIV-Infected Patients in Tanzania	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INCONSISTENT CONDOM USE; MALE CIRCUMCISION TRIAL; TRAUMATIC LIFE EVENTS; HOUSEHOLD DYSFUNCTION; GENDER-DIFFERENCES; CHILDHOOD ABUSE; HEALTH-STATUS; DEPRESSION; WOMEN	Background: The reduction of HIV transmission risk behaviors among those infected with HIV remains a major global health priority. Psychosocial characteristics have proven to be important correlates of sexual transmission risk behaviors in high-income countries, but little attention has focused on the influence of psychosocial and psychological factors on sexual transmission risk behaviors in African cohorts. Methodology and Principal Findings: The CHAT Study enrolled a representative sample of 499 HIV-infected patients in established HIV care and 267 newly diagnosed HIV-infected individuals from the Kilimanjaro Region of Tanzania. Participants completed in-person interviews every 6 months for 3 years. Using logistic random effects models to account for repeated observations, we assessed sociodemographic, physical health, and psychosocial predictors of self-reported unprotected sexual intercourse. Among established patients, the proportion reporting any recent unprotected sex was stable, ranging between 6-13% over 3 years. Among newly diagnosed patients, the proportion reporting any unprotected sex dropped from 43% at baseline to 11-21% at 6-36 months. In multivariable models, higher odds of reported unprotected sex was associated with female gender, younger age, being married, better physical health, and greater post-traumatic stress symptoms. In addition, within-individual changes in post-traumatic stress over time coincided with increases in unprotected sex. Conclusions and Significance: Changes in post-traumatic stress symptomatology were associated with changes in sexual transmission risk behaviors in this sample of HIV-infected adults in Tanzania, suggesting the importance of investing in appropriate mental health screening and intervention services for HIV-infected patients, both to improve mental health and to support secondary prevention efforts.	[Pence, Brian W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Whetten, Kathryn; Shirey, Kristen G.; Yao, Jia; Whetten, Rachel] Duke Univ, Ctr Hlth Policy & Inequal Res, Duke Global Hlth Inst, Sanford Sch Publ Policy, Durham, NC USA; [Shirey, Kristen G.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Duke Global Hlth Inst, Durham, NC USA; [Thielman, Nathan M.] Duke Univ, Dept Med, Div Infect Dis, Duke Global Hlth Inst, Durham, NC USA; [Itemba, Dafrosa] Tanzania Women Res Fdn, Moshi, Tanzania; [Maro, Venance] Kilimanjaro Christian Med Ctr, Moshi, Tanzania	University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; Duke University; Kilimanjaro Christian Medical Centre	Pence, BW (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.	bpence@aya.yale.edu; k.whetten@duke.edu	Thielman, Nathan/R-5142-2019	Thielman, Nathan/0000-0001-8152-2879	National Institute of Mental Health [5R01MH078756]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078756] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project described was supported by grant 5R01MH078756 from the National Institute of Mental Health (www.nimh.nih.gov). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuya AO, 2006, J AFFECT DISORDERS, V96, P89, DOI 10.1016/j.jad.2006.05.021; [Anonymous], 2012, GLOB REP UNAIDS REP; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bogart LM, 2005, AIDS BEHAV, V9, P325, DOI 10.1007/s10461-005-9006-1; Boone MR, 2013, AIDS BEHAV, V17, P1883, DOI 10.1007/s10461-012-0167-4; Chuang CH, 2006, AIDS BEHAV, V10, P201, DOI 10.1007/s10461-005-9046-6; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Deribe Kebede, 2009, East Afr J Public Health, V6, P248; Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fox JE, 2012, PUBLIC HEALTH REP, V127, P5, DOI 10.1177/00333549121270S203; Galvan FH, 2004, AIDS BEHAV, V8, P441, DOI 10.1007/s10461-004-7328-z; Hamburger ME, 2004, AIDS BEHAV, V8, P333, DOI 10.1023/B:AIBE.0000044080.04397.97; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Kalichman SC, 2008, PSYCHOSOM MED, V70, P593, DOI 10.1097/PSY.0b013e3181773bce; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; KILPATRICK DG, 1993, POSTTRAUMATIC STRESS; Kong XR, 2012, AM J EPIDEMIOL, V176, P875, DOI 10.1093/aje/kws179; KOSS MP, 1985, J CONSULT CLIN PSYCH, V53, P422, DOI 10.1037/0022-006X.53.3.422; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Leserman J, 2005, PSYCHOSOM MED, V67, P500, DOI 10.1097/01.psy.0000160459.78182.d9; Leserman J, 2002, PSYCHOL MED, V32, P1059, DOI 10.1017/S0033291702005949; Leserman J, 1997, PSYCHOSOM MED, V59, P152, DOI 10.1097/00006842-199703000-00007; Leserman J, 2008, AIDS PATIENT CARE ST, V22, P403, DOI 10.1089/apc.2007.0175; Liebschutz JM, 2000, ARCH INTERN MED, V160, P1659, DOI 10.1001/archinte.160.11.1659; Lloyd S, 2012, AIDS EDUC PREV, V24, P228, DOI 10.1521/aeap.2012.24.3.228; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Matovu JKB, 2007, REPROD HEALTH MATTER, V15, P68, DOI 10.1016/S0968-8080(07)29306-1; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Mugavero M, 2006, AIDS PATIENT CARE ST, V20, P418, DOI 10.1089/apc.2006.20.418; Myers HF, 2006, AIDS BEHAV, V10, P191, DOI 10.1007/s10461-005-9054-6; Nakimuli-Mpungu E, 2011, AIDS BEHAV; Neuhaus JM, 1998, BIOMETRICS, V54, P638, DOI 10.2307/3109770; NIH, 2012, RFAMH13040 NIH; O'Cleirigh C, 2012, JAIDS-J ACQ IMM DEF, V59, P331, DOI 10.1097/QAI.0b013e31824aed80; Pence BW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036304; Pence BW, 2007, SOUTH MED J, V100, P1114, DOI 10.1097/01.smj.0000286756.54607.9f; Pence BW, 2010, PSYCHOSOM MED, V72, P720, DOI 10.1097/PSY.0b013e3181e9eef3; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Reisner SL, 2009, AIDS CARE, V21, P1481, DOI 10.1080/09540120902893258; Rujumba J, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17429; SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932; Sikkema KJ, 2008, JAIDS-J ACQ IMM DEF, V47, P506, DOI 10.1097/QAI.0b013e318160d727; Sikkema KJ, 2011, JAIDS-J ACQ IMM DEF, V57, P230, DOI 10.1097/QAI.0b013e3182167e7a; Sikkema KJ, 2010, AIDS BEHAV, V14, P252, DOI 10.1007/s10461-009-9650-y; Smit J, 2006, PUBLIC HEALTH, V120, P534, DOI 10.1016/j.puhe.2006.01.009; Walusaga HA, 2012, AIDS PATIENT CARE ST, V26, P694, DOI 10.1089/apc.2012.0208; WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE Jr, 2001, SCORE INTERPRET SING; Weathers FW, 1996, MEASUREMENT STRESS T; Weiss NH, 2013, AIDS CARE; Wong FY, 2008, AIDS EDUC PREV, V20, P56, DOI 10.1521/aeap.2008.20.1.56; Wyatt GE, 2004, AIDS BEHAV, V8, P453, DOI 10.1007/s10461-004-7329-y	57	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82974	10.1371/journal.pone.0082974	http://dx.doi.org/10.1371/journal.pone.0082974			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367575	gold, Green Published			2022-12-27	WOS:000328740300086
J	Wu, C; Huang, R; Chen, JJ; Gu, Q; Zhu, B; Wang, J; Zhang, K; Chen, QJ; Xiong, CC; Liu, Y; Li, JQ; Zhou, YH; Ding, YT				Wu, Chao; Huang, Rui; Chen, Jianjun; Gu, Qin; Zhu, Bin; Wang, Jun; Zhang, Kui; Chen, Quanjiao; Xiong, Chaochao; Liu, Yong; Li, Jiequan; Zhou, Yi-Hua; Ding, Yitao			Avian Influenza A(H7N9) Virus Screening in Patients with Fever and Flu-Like Symptoms in a Tertiary Hospital in an Area with Confirmed Cases	PLOS ONE			English	Article							A H7N9 VIRUS	Novel avian influenza A(H7N9) virus was isolated in fatal patients in Yangtze River Delta of China in March 2013. We aimed to screen the virus in febrile patients in a tertiary hospital in an area with confirmed cases. Throat-swab specimens collected from consecutive patients with fever (>= 38 degrees C) and flu-like symptoms from April 15 to April 25, 2013 were subjected to detect novel avian influenza A(H7N9) virus with real-time PCR. The clinical outcomes in the patients and close contacts were followed up. Of total 200 patients screened, one (0.5%) was positive for avian influenza A(H7N9) virus and 199 others were negative. The infected patient experienced respiratory failure and had diffuse infiltrates in the right lower lobe in chest CT images. He received symptomatic and antibacterial treatments as well as oseltamivir. His condition was substantially improved within three days after admission; avian influenza A(H7N9) virus was not detected after 5 days' antiviral therapy. The hemagglutinin inhibition test showed that the serum titers against avian influenza A(H7N9) virus increased from <1:20 at the early phase to 1:80 at the convalescent phase. Follow-up of 23 close contacts showed that none of them developed fever and other symptoms within two weeks. Our findings suggest that although the infection rate of avian influenza A(H7N9) virus in patients with fever and flu-like symptoms is rare, the screening is valuable to rapidly define the infection, which will be critical to improve the clinical outcomes.	[Wu, Chao; Zhou, Yi-Hua] Nanjing Univ, Sch Med, Dept Infect Dis, Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Huang, Rui] Nanjing Univ Chinese Med, Dept Infect Dis, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Nanjing, Jiangsu, Peoples R China; [Chen, Jianjun; Chen, Quanjiao; Xiong, Chaochao] Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, Wuhan, Hubei, Peoples R China; [Gu, Qin] Nanjing Univ, Sch Med, Dept Intens Care Units, Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Zhu, Bin] Nanjing Univ, Sch Med, Dept Radiol, Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Jun] Nanjing Univ, Sch Med, Dept Emergency Med, Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Kui; Liu, Yong; Zhou, Yi-Hua] Nanjing Univ, Sch Med, Dept Lab Med, Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Li, Jiequan] Nanjing Municipal Ctr Dis Control, Nanjing, Jiangsu, Peoples R China; [Liu, Yong; Zhou, Yi-Hua; Ding, Yitao] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University of Chinese Medicine; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Nanjing University; Nanjing University; Nanjing University; Nanjing University; Nanjing University	Ding, YT (corresponding author), Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China.	dtchaowu@126.com	liu, yong/AAD-1467-2019; Wu, Chao/H-3195-2019; Liu, Yong/GWQ-6163-2022	Xiong, Chaochao/0000-0003-3506-6117	Jiangsu Province's Outstanding Medical Academic Leader Program [LJ201154]; Jiangsu Science and Technology Department [BL2012034]	Jiangsu Province's Outstanding Medical Academic Leader Program; Jiangsu Science and Technology Department	This study was supported by Jiangsu Province's Outstanding Medical Academic Leader Program (No. LJ201154) and a Special Grant from Jiangsu Science and Technology Department (No. BL2012034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chai Cheng-liang, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P443; Chang SY, 2013, LANCET, V381, P1621, DOI 10.1016/S0140-6736(13)60943-5; Chen JJ, 2009, VIRUS RES, V146, P19, DOI 10.1016/j.virusres.2009.08.010; Chen XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073362; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Dennis KM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3693; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hsieh SM, 2013, J INFECTION, V67, P494, DOI 10.1016/j.jinf.2013.08.003; Lo YC, 2013, EUROSURVEILLANCE, V18, P2; Wang Y, 2013, AM J RESP CRIT CARE, V188, P115, DOI 10.1164/rccm.201305-0936LE; WHO, 2013, HUM INF AV INFL A H7; World Health Organization, 2013, INT WHO SURV REC HUM; Xie L, 2013, EUR J CLIN MICROBIOL; Xu CL, 2013, EMERG INFECT DIS, V19, P1289, DOI 10.3201/eid1908.130662; Zheng LY, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-17; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379	17	2	2	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82613	10.1371/journal.pone.0082613	http://dx.doi.org/10.1371/journal.pone.0082613			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367529	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300045
J	Abelson, S; Shamai, Y; Berger, L; Skorecki, K; Tzukerman, M				Abelson, Sagi; Shamai, Yeela; Berger, Liron; Skorecki, Karl; Tzukerman, Maty			Niche-Dependent Gene Expression Profile of Intratumoral Heterogeneous Ovarian Cancer Stem Cell Populations	PLOS ONE			English	Article							CLEAR-CELL; CLINICOPATHOLOGICAL ANALYSIS; TUMOR MICROENVIRONMENT; CARCINOMA; PLASTICITY; FIBROBLASTS; METHYLATION; EVOLUTION; HALLMARKS; MARKER	Intratumoral heterogeneity challenges existing paradigms for anti-cancer therapy. We have previously demonstrated that the human embryonic stem cells (hESC)-derived cellular microenvironment in immunocompromised mice, enables functional distinction of heterogeneous tumor cells, including cells which do not grow into a tumor in a conventional direct tumor xenograft platform. We have identified and characterized six cancer cell subpopulations each clonally expanded from a single cell, derived from human ovarian clear cell carcinoma of a single tumor, to demonstrate striking intratumoral phenotypic heterogeneity that is dynamically dependent on the tumor growth microenvironment. These cancer cell subpopulations, characterized as cancer stem cell subpopulations, faithfully recapitulate the full spectrum of histological phenotypic heterogeneity known for human ovarian clear cell carcinoma. Each of the six subpopulations displays a different level of morphologic and tumorigenic differentiation wherein growth in the hESC-derived microenvironment favors growth of CD44+/aldehyde dehydrogenase positive pockets of self-renewing cells that sustain tumor growth through a process of tumorigenic differentiation into CD44-/aldehyde dehydrogenase negative derivatives. Strikingly, these derivative cells display microenvironment-dependent plasticity with the capacity to restore self-renewal markers and CD44 expression. In the current study, we delineate the distinct gene expression and epigenetic profiles of two such subpopulations, representing extremes of phenotypic heterogeneity in terms of niche-dependent self-renewal and tumorigenic differentiation. By combining Gene Set Enrichment, Gene Ontology and Pathway-focused array analyses with methylation status, we propose a suite of robust differences in tumor self-renewal and differentiation pathways that underlie the striking intratumoral phenotypic heterogeneity which characterize this and other solid tumor malignancies.	[Abelson, Sagi; Shamai, Yeela; Berger, Liron; Skorecki, Karl] Technion Israel Inst Technol, Rambam Med Ctr, Rappaport Fac Med, Haifa, Israel; [Abelson, Sagi; Shamai, Yeela; Berger, Liron; Skorecki, Karl] Technion Israel Inst Technol, Rambam Med Ctr, Res Inst, Haifa, Israel; [Skorecki, Karl; Tzukerman, Maty] Rambam Med Ctr, Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology	Skorecki, K (corresponding author), Technion Israel Inst Technol, Rambam Med Ctr, Rappaport Fac Med, Haifa, Israel.	skorecki@techunix.technion.ac.il; bimaty@techunix.technion.ac.il	Abelson, Sagi/ABG-3403-2021	Abelson, Sagi/0000-0003-1747-3819	Daniel M. Soref Charitable Trust; Skirball Foundation; Israel Science Foundation [453/06, 62/10]	Daniel M. Soref Charitable Trust; Skirball Foundation; Israel Science Foundation(Israel Science Foundation)	Finnancial support for this research was provided by the Daniel M. Soref Charitable Trust, the Skirball Foundation and by a research grant from the Israel Science Foundation (grant No. 453/06MT and grant No. 62/10 MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson S, 2012, STEM CELLS, V30, P415, DOI 10.1002/stem.1029; Bergfeld SA, 2010, CANCER METAST REV, V29, P249, DOI 10.1007/s10555-010-9222-7; Berry NB, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-8; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Burgos-Ojeda D, 2013, CANCER RES, V73, P3555, DOI 10.1158/0008-5472.CAN-12-2845; Calmon MF, 2009, NEOPLASIA, V11, P1329, DOI 10.1593/neo.91110; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; CZERNOBILSKY B, 1970, CANCER-AM CANCER SOC, V25, P762, DOI 10.1002/1097-0142(197004)25:4<762::AID-CNCR2820250404>3.0.CO;2-3; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; DeLair D, 2011, AM J SURG PATHOL, V35, P36, DOI 10.1097/PAS.0b013e3181ff400e; Ebben JD, 2010, EXPERT OPIN THER TAR, V14, P621, DOI 10.1517/14712598.2010.485186; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Espada J, 2009, CLIN TRANSL ONCOL, V11, P411, DOI 10.1007/s12094-009-0380-4; Folkman J, 2004, CANCER BIOL THER, V3, P338, DOI 10.4161/cbt.3.3.708; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He YL, 2011, DIGEST DIS SCI, V56, P681, DOI 10.1007/s10620-010-1369-0; Jamil S, 2013, INT J ONCOL, V43, P831, DOI 10.3892/ijo.2013.2014; Kajihara H, 2010, ONCOL REP, V23, P1193, DOI 10.3892/or_00000750; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Katz E, 2009, CLIN CANCER RES, V15, P70, DOI 10.1158/1078-0432.CCR-08-1233; Kobel M, 2009, AM J SURG PATHOL, V33, P14, DOI 10.1097/PAS.0b013e3181788546; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Kubota T, 1999, HUM GENET, V104, P49, DOI 10.1007/s004390050909; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lucci A, 1998, ANTICANCER RES, V18, P475; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Medina V, 2009, CLIN TRANSL ONCOL, V11, P199, DOI 10.1007/s12094-009-0341-y; Mibayashi M, 2002, MICROBIOL IMMUNOL, V46, P29, DOI 10.1111/j.1348-0421.2002.tb02673.x; MONTAG AG, 1989, INT J GYNECOL PATHOL, V8, P85, DOI 10.1097/00004347-198906000-00001; Nishimura K, 2012, PATHOBIOLOGY, V79, P290, DOI 10.1159/000337296; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004599; Ringel MD, 2002, J CLIN ENDOCR METAB, V87, P2399, DOI 10.1210/jc.87.5.2399; Rodriguez-Antona C, 2006, ONCOGENE, V25, P1679, DOI 10.1038/sj.onc.1209377; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Schmid R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-349; Schwartz DR, 2002, CANCER RES, V62, P4722; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sung SY, 2007, CURR PROB CANCER, V31, P36, DOI 10.1016/j.currproblcancer.2006.12.002; Tan DSP, 2007, J CLIN PATHOL, V60, P355, DOI 10.1136/jcp.2006.040030; Tzukerman M, 2006, CANCER RES, V66, P3792, DOI 10.1158/0008-5472.CAN-05-3467; Tzukerman M, 2003, P NATL ACAD SCI USA, V100, P13507, DOI 10.1073/pnas.2235551100; van der Horst G, 2012, MOL CANCER RES, V10, P995, DOI 10.1158/1541-7786.MCR-12-0274; van Vlerken LE, 2012, J MOL MED, V90, P791, DOI 10.1007/s00109-012-0917-9; Vincent A, 2012, BBA-REV CANCER, V1826, P83, DOI 10.1016/j.bbcan.2012.03.009; Wang ZW, 2009, CANCER LETT, V279, P8, DOI 10.1016/j.canlet.2008.09.030; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854; You A, 2011, J CANCER RES CLIN, V137, P621, DOI 10.1007/s00432-010-0916-6; Young LC, 2001, CLIN CANCER RES, V7, P1798; Yu YP, 2007, CANCER RES, V67, P8043, DOI 10.1158/0008-5472.CAN-07-0648; Zorn KK, 2005, CLIN CANCER RES, V11, P6422, DOI 10.1158/1078-0432.CCR-05-0508	64	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83651	10.1371/journal.pone.0083651	http://dx.doi.org/10.1371/journal.pone.0083651			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358304	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700068
J	Li, X; Chen, W; Zhang, L; Liu, WB; Fei, Z				Li, Xia; Chen, Wei; Zhang, Lei; Liu, Wen-bo; Fei, Zhou			Inhibition of Store-Operated Calcium Entry Attenuates MPP+-Induced Oxidative Stress via Preservation of Mitochondrial Function in PC12 Cells: Involvement of Homer1a	PLOS ONE			English	Article							MODEL; PROTECTS; ACTIVATION; APOPTOSIS; DISEASE; STIM1; NADH	The process of store-operated calcium entry (SOCE), whereby the release of intracellular Ca2+ from endoplasmic reticulum (ER) activates Ca2+ influx channels in the plasma membrane, has been demonstrated to impact a diverse range of cell functions. In the present study, we investigated the potential protective effect of SOCE inhibition against 1-methyl-4-phenylpyridinium (MPP+) injury by using pharmacological antagonists or specific small interfering RNA (siRNA) in PC12 cells. The results showed that both antagonists (15 mu M MRS-1845 and 50 mu M ML-9) and stromal interacting molecule-1 (STIM1) targeted siRNA (Si-STIM1) significantly increased cell viability, decreased apoptotic cell death and reduced intracellular reactive oxygen species (ROS) production and lipid peroxidation in MPP+ injured PC12 cells. SOCE inhibition also prevented MPP+ induced mitochondrial dysfunction and activation of mitochondrial related apoptotic factors, while had no effect on mitochondrial biogenesis. Moreover, inhibition of SOCE by antagonists and siRNA increased the expression levels of Homer1a mRNA and protein, and knockdown of Homer1a expression by specific siRNA partly reversed the protective effects induced by SOCE inhibition in PC12 cells. All these results indicated that SOCE inhibition protected PC12 cells against MPP+ insult through upregulation of Homer1a expression, and SOCE might be an ideal target for investigating therapeutic strategy against neuronal injury in PD patients.	[Li, Xia; Zhang, Lei; Liu, Wen-bo; Fei, Zhou] Fourth Mil Med Univ, Xijing Hosp, Xijing Inst Clin Neurosci, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China; [Chen, Wei] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, Xian 710049, Shaanxi, Peoples R China	Air Force Military Medical University; Xi'an Jiaotong University	Fei, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Xijing Inst Clin Neurosci, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China.	fmmuzhoufei@163.com			National Natural Science Foundation of China [30930093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (No. 30930093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; Brandt SK, 2011, NEUROSCIENCE, V172, P387, DOI 10.1016/j.neuroscience.2010.10.071; Braun A, 2009, BLOOD, V113, P2056, DOI 10.1182/blood-2008-07-171611; Chen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055601; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Ding F, 2012, APOPTOSIS, V17, P579, DOI 10.1007/s10495-012-0708-3; Esteves AR, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/693761; ESTORNELL E, 1993, FEBS LETT, V332, P127, DOI 10.1016/0014-5793(93)80498-J; Fahn Stanley, 2004, NeuroRx, V1, P139, DOI 10.1007/BF03206574; GARCIAGARCIA A, 2013, TOXICOL SCI; Henke N, 2012, J BIOL CHEM, V287, P42042, DOI 10.1074/jbc.M112.417212; Ilijic E, 2011, NEUROBIOL DIS, V43, P364, DOI 10.1016/j.nbd.2011.04.007; Jellinger KA, 2001, ADV NEUROL, V86, P55; Kurosaki T, 2010, PROG BIOPHYS MOL BIO, V103, P51, DOI 10.1016/j.pbiomolbio.2010.02.004; Lee CS, 2005, NEUROCHEM INT, V46, P169, DOI 10.1016/j.neuint.2004.07.007; Li Y, 2013, BRAIN RES, V1495, P95, DOI 10.1016/j.brainres.2012.12.005; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; Luo P, 2012, FREE RADICAL RES, V46, P766, DOI 10.3109/10715762.2012.678340; Lynch D, 2008, MITOCHONDRION, V8, P109, DOI 10.1016/j.mito.2007.09.002; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pettifer KM, 2007, PURINERG SIGNAL, V3, P399, DOI 10.1007/s11302-007-9073-z; Putney JW, 2011, NEUROCHEM RES, V36, P1157, DOI 10.1007/s11064-010-0383-0; Ritz B, 2010, ANN NEUROL, V67, P600, DOI 10.1002/ana.21937; Ryazantseva M, 2013, BIOCHIMIE, V95, P1506, DOI 10.1016/j.biochi.2013.04.009; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Song XY, 2013, NEUROSCIENCE, V242, P28, DOI 10.1016/j.neuroscience.2013.02.049; Steinbeck JA, 2011, EXP NEUROL, V232, P185, DOI 10.1016/j.expneurol.2011.08.022; Surmeier DJ, 2011, NEUROSCIENCE, V198, P221, DOI 10.1016/j.neuroscience.2011.08.045; Tappe A, 2006, NAT MED, V12, P677, DOI 10.1038/nm1406; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Zeng X, 2013, NEUROSCI LETT, V543, P183, DOI 10.1016/j.neulet.2013.03.030; Zhang LL, 2012, FOOD CHEM TOXICOL, V50, P2591, DOI 10.1016/j.fct.2012.05.045	36	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83638	10.1371/journal.pone.0083638	http://dx.doi.org/10.1371/journal.pone.0083638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358303	gold, Green Published, Green Submitted			2022-12-27	WOS:000328737700067
J	Mannaerts, I; Schroyen, B; Verhulst, S; Van Lommel, L; Schuit, F; Nyssen, M; van Grunsven, LA				Mannaerts, Inge; Schroyen, Ben; Verhulst, Stefaan; Van Lommel, Leentje; Schuit, Frans; Nyssen, Marc; van Grunsven, Leo A.			Gene Expression Profiling of Early Hepatic Stellate Cell Activation Reveals a Role for Igfbp3 in Cell Migration	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-3; BREAST-CANCER CELLS; HISTONE DEACETYLASE INHIBITOR; LIVER FIBROSIS; VALPROIC ACID; EXTRACELLULAR-MATRIX; DISTINCT ROLES; IN-VITRO; GROWTH; INSULIN	Background: Scarring of the liver is the result of prolonged exposure to exogenous or endogenous stimuli. At the onset of fibrosis, quiescent hepatic stellate cells (HSCs) activate and transdifferentiate into matrix producing, myofibroblast-like cells. Aim and methods: To identify key players during early HSC activation, gene expression profiling was performed on primary mouse HSCs cultured for 4, 16 and 64 hours. Since valproic acid (VPA) can partly inhibit HSC activation, we included VPA-treated cells in the profiling experiments to facilitate this search. Results: Gene expression profiling confirmed early changes for known genes related to HSC activation such as alpha smooth muscle actin (Acta2), lysyl oxidase (Lox) and collagen, type I, alpha 1 (Col1a1). In addition we noticed that, although genes which are related to fibrosis change between 4 and 16 hours in culture, most gene expression changes occur between 16 and 64 hours. Insulin-like growth factor binding protein 3 (Igfbp3) was identified as a gene strongly affected by VPA treatment. During normal HSC activation Igfbp3 is up regulated and this can thus be prevented by VPA treatment in vitro and in vivo. siRNA-mediated silencing of Igfbp3 in primary mouse HSCs induced matrix metalloproteinase (Mmp) 9 mRNA expression and strongly reduced cell migration. The reduced cell migration after Igfbp3 knock-down could be overcome by tissue inhibitor of metalloproteinase (TIMP) 1 treatment. Conclusion: Igfbp3 is a marker for culture-activated HSCs and plays a role in HSC migration. VPA treatment prevents Igfbp3 transcription during activation of HSCs in vitro and in vivo.	[Mannaerts, Inge; Schroyen, Ben; Verhulst, Stefaan; van Grunsven, Leo A.] Vrije Univ Brussel, Liver Cell Biol Lab, Brussels, Belgium; [Van Lommel, Leentje; Schuit, Frans] Dept Cellular & Mol Med, Louvain, Belgium; [Nyssen, Marc] Vrije Univ Brussel, Fac Med & Pharmacy, Dept Biostat & Med Informat, Brussels, Belgium	Vrije Universiteit Brussel; Vrije Universiteit Brussel	van Grunsven, LA (corresponding author), Vrije Univ Brussel, Liver Cell Biol Lab, Brussels, Belgium.	leo.van.grunsven@vub.ac.be	Verhulst, Stefaan/AAH-7603-2020; van Grunsven, Leo/E-5839-2010; Mannaerts, Inge/F-2181-2015; Mannaerts, Inge/AAC-5487-2019	Verhulst, Stefaan/0000-0001-6566-6071; van Grunsven, Leo/0000-0002-0990-7034; Mannaerts, Inge/0000-0002-2235-2555; Mannaerts, Inge/0000-0002-2235-2555	Vrije Universiteit Brussel [GOA48, GOA78]; Fund for Scientific Research, Flanders (FWO-V) [G.0260.09]; Institute for the Promotion of Innovation through Science and Technology in Flanders	Vrije Universiteit Brussel; Fund for Scientific Research, Flanders (FWO-V)(FWO); Institute for the Promotion of Innovation through Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	The work was funded by the Vrije Universiteit Brussel through GOA48 and GOA78 and by the Fund for Scientific Research, Flanders (FWO-V) G.0260.09 to LAvG. SV received a Ph.D. grant from the Institute for the Promotion of Innovation through Science and Technology in Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahasic AM, 2012, EUR J ENDOCRINOL, V166, P121, DOI 10.1530/EJE-11-0778; Arnold S, 2008, EXP BIOL MED, V233, P860, DOI 10.3181/0801-RM-12; BALLARDINI G, 1983, LIVER, V3, P58; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Baumkotter F, 2012, EXP BRAIN RES, V217, P389, DOI 10.1007/s00221-011-2878-6; Boers W, 2006, J BIOL CHEM, V281, P16289, DOI 10.1074/jbc.M600711200; CENACCHI G, 1983, VIRCHOWS ARCH B, V43, P75, DOI 10.1007/BF02932946; Chang YZ, 2008, HEPATOB PANCREAT DIS, V7, P401; Chen X, 2013, FEBS J, V280, P855, DOI 10.1111/febs.12074; Collard TJ, 2003, CARCINOGENESIS, V24, P393, DOI 10.1093/carcin/24.3.393; CORTES VL, 2012, J CELLULAR PHYSL; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Fanayan S, 2002, J BIOL CHEM, V277, P7255, DOI 10.1074/jbc.M108038200; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Firth SM, 1998, J BIOL CHEM, V273, P2631, DOI 10.1074/jbc.273.5.2631; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Fudge NJ, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-15; Gentilini A, 1998, J CELL PHYSIOL, V174, P240; Grkovic S, 2013, ONCOGENE, V32, P2412, DOI 10.1038/onc.2012.264; Guo CJ, 2009, FEBS J, V276, P5163, DOI 10.1111/j.1742-4658.2009.07213.x; Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200; Himoto T, 2013, NUTR RES, V33, P27, DOI 10.1016/j.nutres.2012.11.007; Hu K, 2008, FRONT BIOSCI, V13, P5174, DOI 10.2741/3073; Iwaisako K, 2012, J GASTROEN HEPATOL, V27, P65, DOI 10.1111/j.1440-1746.2011.07002.x; Jiang F, 2006, J HEPATOL, V45, P401, DOI 10.1016/j.jhep.2006.03.016; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; Knittel T, 1999, HISTOCHEM CELL BIOL, V112, P387, DOI 10.1007/s004180050421; Korte M, 2012, EXP BRAIN RES, V217, P435, DOI 10.1007/s00221-011-2894-6; Kuemmerle JF, 2004, AM J PHYSIOL-GASTR L, V287, pG795, DOI 10.1152/ajpgi.00009.2004; Lee MH, 2008, TOXICOL APPL PHARM, V226, P271, DOI 10.1016/j.taap.2007.09.014; Lee SH, 2004, BIOCHEM PHARMACOL, V68, P2367, DOI 10.1016/j.bcp.2004.08.022; Lin WH, 2011, J BIOL CHEM, V286, P29540, DOI 10.1074/jbc.M111.263111; Liu ZN, 2011, J HEPATOL, V54, P132, DOI 10.1016/j.jhep.2010.06.020; Liu ZA, 2010, BRIT J PHARMACOL, V159, P304, DOI 10.1111/j.1476-5381.2009.00477.x; Lobmann R, 2005, DIABETES CARE, V28, P461, DOI 10.2337/diacare.28.2.461; Mannaerts I, 2010, HEPATOLOGY, V51, P603, DOI 10.1002/hep.23334; Marra F, 1999, HEPATOLOGY, V29, P140, DOI 10.1002/hep.510290107; Martin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045844; Miyamoto S, 2004, CANCER RES, V64, P665, DOI 10.1158/0008-5472.CAN-03-1916; Patsenker E, 2007, J HEPATOL, V46, P878, DOI 10.1016/j.jhep.2006.11.011; Pinzani M, 2001, SEMIN LIVER DIS, V21, P397, DOI 10.1055/s-2001-17554; Ragland M, 2009, AM J EPIDEMIOL, V170, P1344, DOI 10.1093/aje/kwp288; Raja, 2007, Front Biosci, V12, P2849; Reiss MJ, 2010, SURGERY, V147, P295, DOI 10.1016/j.surg.2009.10.016; Roeb E, 2000, FASEB J, V14, P1671; Sato M, 2003, CELL STRUCT FUNCT, V28, P105; Scharf JG, 1998, HEPATOLOGY, V27, P1275, DOI 10.1002/hep.510270513; Schroeder TM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-362; SCHROYEN B, 2012, EUR J GASTROENTEROL; Selinski S, 2012, ARCH TOXICOL, V86, P195, DOI 10.1007/s00204-011-0747-5; Svegliati-Baroni G, 1999, HEPATOLOGY, V29, P1743, DOI 10.1002/hep.510290632; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Tsubaki J, 2002, ENDOCRINOLOGY, V143, P1778, DOI 10.1210/en.143.5.1778; Van Beneden K, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-1; Van Rossen E, 2009, HISTOCHEM CELL BIOL, V131, P313, DOI 10.1007/s00418-008-0544-2; Volzke H, 2009, EUR J ENDOCRINOL, V161, P705, DOI 10.1530/EJE-09-0374; Walker GE, 2001, ENDOCRINOLOGY, V142, P3817, DOI 10.1210/en.142.9.3817; Xia QH, 2006, CANCER RES, V66, P7237, DOI 10.1158/0008-5472.CAN-05-0487; Xue SN, 2012, EXP DIABETES RES, DOI 10.1155/2012/494579; Yamada PM, 2009, AM J PHYSIOL-CELL PH, V296, pC954, DOI 10.1152/ajpcell.00598.2008; Yang C, 2009, J AM PODIAT MED ASSN, V99, P489, DOI 10.7547/0990489; Yang CQ, 2003, GASTROENTEROLOGY, V124, P147, DOI 10.1053/gast.2003.50012	62	27	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84071	10.1371/journal.pone.0084071	http://dx.doi.org/10.1371/journal.pone.0084071			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358328	Green Submitted, Green Published, gold			2022-12-27	WOS:000328737700077
J	Kemler, M; Garnas, J; Wingfield, MJ; Gryzenhout, M; Pillay, KA; Slippers, B				Kemler, Martin; Garnas, Jeff; Wingfield, Michael J.; Gryzenhout, Marieka; Pillay, Kerry-Anne; Slippers, Bernard			Ion Torrent PGM as Tool for Fungal Community Analysis: A Case Study of Endophytes in Eucalyptus grandis Reveals High Taxonomic Diversity	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; RARE BIOSPHERE; MAGNITUDE; MYCOSPHAERELLA; TERATOSPHAERIA; METAGENOMICS; ARTIFACTS; WRINKLES; SEARCH; GENES	The Kingdom Fungi adds substantially to the diversity of life, but due to their cryptic morphology and lifestyle, tremendous diversity, paucity of formally described specimens, and the difficulty in isolating environmental strains into culture, fungal communities are difficult to characterize. This is especially true for endophytic communities of fungi living in healthy plant tissue. The developments in next generation sequencing technologies are, however, starting to reveal the true extent of fungal diversity. One of the promising new technologies, namely semiconductor sequencing, has thus far not been used in fungal diversity assessments. In this study we sequenced the internal transcribed spacer 1 (ITS1) nuclear encoded ribosomal RNA of the endophytic community of the economically important tree, Eucalyptus grandis, from South Africa using the Ion Torrent Personal Genome Machine (PGM). We determined the impact of various analysis parameters on the interpretation of the results, namely different sequence quality parameter settings, different sequence similarity cutoffs for clustering and filtering of databases for removal of sequences with incomplete taxonomy. Sequence similarity cutoff values only had a marginal effect on the identified family numbers, whereas different sequence quality filters had a large effect (89 vs. 48 families between least and most stringent filters). Database filtering had a small, but statistically significant, effect on the assignment of sequences to reference sequences. The community was dominated by Ascomycota, and particularly by families in the Dothidiomycetes that harbor well-known plant pathogens. The study demonstrates that semiconductor sequencing is an ideal strategy for environmental sequencing of fungal communities. It also highlights some potential pitfalls in subsequent data analyses when using a technology with relatively short read lengths.	[Kemler, Martin; Wingfield, Michael J.; Pillay, Kerry-Anne; Slippers, Bernard] Univ Pretoria, Dept Genet, Forestry & Agr Biotechnol Inst FABI, ZA-0002 Pretoria, South Africa; [Garnas, Jeff] Univ Pretoria, Dept Zool & Entomol, Forestry & Agr Biotechnol Inst FABI, ZA-0002 Pretoria, South Africa; [Gryzenhout, Marieka] Univ Orange Free State, Dept Plant Sci, Bloemfontein, South Africa	University of Pretoria; University of Pretoria; University of the Free State	Kemler, M (corresponding author), Univ Pretoria, Dept Genet, Forestry & Agr Biotechnol Inst FABI, ZA-0002 Pretoria, South Africa.	martin.kemler@fabi.up.ac.za	Wingfield, Michael J/A-9473-2008; Slippers, Bernard/A-9351-2008; Kemler, Martin/GSD-6740-2022; Garnas, Jeff/C-4363-2008	Slippers, Bernard/0000-0003-1491-3858; Kemler, Martin/0000-0002-0738-4233; Garnas, Jeff/0000-0002-9956-9875; Gryzenhout, Marieka/0000-0002-9224-4277	University of Pretoria postdoctoral fellowship; IRT Genomics (University of Pretoria); Tree Protection Co-operative Program (TPCP); DST/NRF Centre of Excellence in Tree Health Biotechnology (CTHB)	University of Pretoria postdoctoral fellowship; IRT Genomics (University of Pretoria); Tree Protection Co-operative Program (TPCP); DST/NRF Centre of Excellence in Tree Health Biotechnology (CTHB)(Department of Science & Technology (India))	The authors would like to acknowledge the University of Pretoria postdoctoral fellowship for funding to MK. The project was funded by the IRT Genomics (University of Pretoria), the Tree Protection Co-operative Program (TPCP) and the DST/NRF Centre of Excellence in Tree Health Biotechnology (CTHB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Arnold AE, 2007, MYCOLOGIA, V99, P185, DOI 10.3852/mycologia.99.2.185; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Crous PW, 2009, PERSOONIA, V22, P38, DOI 10.3767/003158509X424333; Crous PW, 2006, STUD MYCOL, P99, DOI 10.3114/sim.55.1.99; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fisher P. J., 1993, Sydowia, V45, P338; Fonseca A, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P263, DOI 10.1007/3-540-30985-3_13; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; Hunter GC, 2011, FUNGAL DIVERS, V50, P145, DOI 10.1007/s13225-011-0131-z; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Isaeva OV, 2010, BIOL BULL+, V37, P26, DOI 10.1134/S1062359010010048; Junemann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041606; Jumpponen A, 2010, NEW PHYTOL, V186, P496, DOI 10.1111/j.1469-8137.2010.03197.x; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lindner DL, 2013, ECOL EVOL, V3, P1751, DOI 10.1002/ece3.586; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Porter TM, 2011, NEW PHYTOL, V192, P775, DOI 10.1111/j.1469-8137.2011.03838.x; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; R Core Team, 2021, R LANGUAGE ENV STAT; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Simon UK, 2008, MOL BIOL EVOL, V25, P2251, DOI 10.1093/molbev/msn188; Slippers B, 2009, SOUTH FORESTS, V71, P101, DOI 10.2989/SF.2009.71.2.3.818; Smith H, 1996, FOREST ECOL MANAG, V89, P189, DOI 10.1016/S0378-1127(96)03847-9; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; U'ren JM, 2009, MYCOL RES, V113, P432, DOI 10.1016/j.mycres.2008.11.015; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Whiteley AS, 2012, J MICROBIOL METH, V91, P80, DOI 10.1016/j.mimet.2012.07.008; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; Wooley JC, 2010, J COMPUT SCI TECH-CH, V25, P71, DOI 10.1007/s11390-010-9306-4; Zimmerman NB, 2012, P NATL ACAD SCI USA, V109, P13022, DOI 10.1073/pnas.1209872109	50	61	61	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81718	10.1371/journal.pone.0081718	http://dx.doi.org/10.1371/journal.pone.0081718			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358124	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700020
J	Kirchner, EA; Kim, SK; Straube, S; Seeland, A; Wohrle, H; Krell, MM; Tabie, M; Fahle, M				Kirchner, Elsa Andrea; Kim, Su Kyoung; Straube, Sirko; Seeland, Anett; Woehrle, Hendrik; Krell, Mario Michael; Tabie, Marc; Fahle, Manfred			On the Applicability of Brain Reading for Predictive Human-Machine Interfaces in Robotics	PLOS ONE			English	Article							COMPUTER INTERFACE; P300; COMMUNICATION; RECONSTRUCTION	The ability of today's robots to autonomously support humans in their daily activities is still limited. To improve this, predictive human-machine interfaces (HMIs) can be applied to better support future interaction between human and machine. To infer upcoming context-based behavior relevant brain states of the human have to be detected. This is achieved by brain reading (BR), a passive approach for single trial EEG analysis that makes use of supervised machine learning (ML) methods. In this work we propose that BR is able to detect concrete states of the interacting human. To support this, we show that BR detects patterns in the electroencephalogram (EEG) that can be related to event-related activity in the EEG like the P300, which are indicators of concrete states or brain processes like target recognition processes. Further, we improve the robustness and applicability of BR in application-oriented scenarios by identifying and combining most relevant training data for single trial classification and by applying classifier transfer. We show that training and testing, i.e., application of the classifier, can be carried out on different classes, if the samples of both classes miss a relevant pattern. Classifier transfer is important for the usage of BR in application scenarios, where only small amounts of training examples are available. Finally, we demonstrate a dual BR application in an experimental setup that requires similar behavior as performed during the teleoperation of a robotic arm. Here, target recognition processes and movement preparation processes are detected simultaneously. In summary, our findings contribute to the development of robust and stable predictive HMIs that enable the simultaneous support of different interaction behaviors.	[Kirchner, Elsa Andrea; Kim, Su Kyoung; Straube, Sirko; Krell, Mario Michael; Tabie, Marc] Univ Bremen, Robot Lab, D-28359 Bremen, Germany; [Kirchner, Elsa Andrea; Kim, Su Kyoung; Seeland, Anett; Woehrle, Hendrik] German Res Ctr Artificial Intelligence DFKI, Robot Innovat Ctr RIC, Bremen, Germany; [Fahle, Manfred] Univ Bremen, Brain Res Inst 4, D-28359 Bremen, Germany; [Fahle, Manfred] City Univ London, Henry Wellcome Labs Vis Sci, London EC1V 0HB, England	University of Bremen; German Research Center for Artificial Intelligence (DFKI); University of Bremen; City University London	Kirchner, EA (corresponding author), Univ Bremen, Robot Lab, D-28359 Bremen, Germany.	elsa.kirchner@dfki.de		Straube, Sirko/0000-0002-7537-8177; Krell, Mario Michael/0000-0002-7823-3336	German Ministry of Economics and Technology [50 RA 1011, 50 RA 1012]	German Ministry of Economics and Technology(Federal Ministry for Economic Affairs and Energy (BMWi))	This work was funded by the German Ministry of Economics and Technology (http://www.bmwi.de/English/Navigation/root.html) grant no. 50 RA 1011 and grant no. 50 RA 1012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allanson J, 2004, INTERACT COMPUT, V16, P857, DOI 10.1016/j.intcom.2004.08.001; Allison B., 2007, ACE WORKSH BRAIN COM, P7; Allison BZ, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/1/013001; Bai O, 2011, CLIN NEUROPHYSIOL, V122, P364, DOI 10.1016/j.clinph.2010.07.010; Birbaumer N, 2006, PSYCHOPHYSIOLOGY, V43, P517, DOI 10.1111/j.1469-8986.2006.00456.x; Blankertz B., 2006, CLIN NEUROPHYSIOL, V113, P108, DOI DOI 10.1109/MSP.2008.4408441; Blankertz B, 2006, J UNIVERS COMPUT SCI, V12, P581; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P147, DOI 10.1109/TNSRE.2006.875557; Brodersen Kay H., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3121, DOI 10.1109/ICPR.2010.764; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; COLES MGH, 1989, PSYCHOPHYSIOLOGY, V26, P251, DOI 10.1111/j.1469-8986.1989.tb01916.x; Cutrell E., 2008, P CHI, P1; DEECKE L, 1969, EXP BRAIN RES, V7, P158; Enzinger C, 2008, EXP BRAIN RES, V190, P215, DOI 10.1007/s00221-008-1465-y; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fazli S, 2009, NEURAL NETWORKS, V22, P1305, DOI 10.1016/j.neunet.2009.06.003; Folgheraiter Michele, 2008, 2008 IEEE International Conference on Robotics and Biomimetics, P560, DOI 10.1109/ROBIO.2009.4913063; Folgheraiter M, 2009, IEEE INT C ROB AUT K; Folgheraiter M, 2012, INT J SOC ROBOT, V4, P285, DOI 10.1007/s12369-012-0147-x; George L., 2010, INT C APPL BION BIOM; Ghaderi F, 2014, J NEUROSCI METH, V221, P41, DOI 10.1016/j.jneumeth.2013.08.025; Graf B, 2009, LECT NOTES COMPUT SC, V5611, P312, DOI [10.1109/ARSO.2009.5587059, 10.1007/978-3-642-02577-8_34]; Guger C, 1999, ASSIST TECHNOL RES S, V6, P590; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Haufe S, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056001; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Ibanez J, 2011, LECT NOTES COMPUT SC, V6691, P370, DOI 10.1007/978-3-642-21501-8_46; ISREAL JB, 1980, PSYCHOPHYSIOLOGY, V17, P259, DOI 10.1111/j.1469-8986.1980.tb00146.x; Iturrate I, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026024; Jansen BH, 2004, IEEE T BIO-MED ENG, V51, P975, DOI 10.1109/TBME.2004.826684; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kaufmann T, 2011, P 5 INT BRAIN COMP I, P136; Kaupp T, 2010, ROBOT AUTON SYST, V58, P444, DOI 10.1016/j.robot.2010.02.003; Kim SK, 2013, PROC INT CONF ANTI; Kirchner EA, 2013, PERCEPTION, V42, P220; Kirchner Elsa Andrea, 2013, Proceedings of the 6th International Conference on Biomedical Electronics and Devices. BIODEVICES 2013, P168; Kirchner EA, 2009, P MACH LEARN REAL TI; Kirchner EA, 2012, P 18 ANN M ORG HUM B; Kirchner EA, 2013, IND ROBOT, V40, P530, DOI 10.1108/IR-01-2013-318; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Krauledat M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002967; Krell MM, 2013, PYSPACE; Kurihara K, 2009, COMPUT IND ENG, V56, P631, DOI 10.1016/j.cie.2008.10.004; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Leeb R, 2006, PRESENCE-TELEOP VIRT, V15, P500, DOI 10.1162/pres.15.5.500; Lotte F, 2010, INT CONF ACOUST SPEE, P614, DOI 10.1109/ICASSP.2010.5495183; Metzen Jan Hendrik, 2011, Pattern Recognition. Proceedings 33rd DAGM Symposium, P366, DOI 10.1007/978-3-642-23123-0_37; Millan JD, 2009, IEEE ENG MED BIO, P3361, DOI 10.1109/IEMBS.2009.5332828; MILLER NE, 1969, SCIENCE, V163, P434, DOI 10.1126/science.163.3866.434; Miyawaki Y, 2008, NEURON, V60, P915, DOI 10.1016/j.neuron.2008.11.004; Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006; Nijholt A, 2008, BRAIN COMPUTER INTER; Nocadal J., 1999, NUMERICAL OPTIMIZATI; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Parra LC, 2003, IEEE T NEUR SYS REH, V11, P173, DOI 10.1109/TNSRE.2003.814446; Pfurtscheller G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnpro.2010.00003; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Prodanov P, 2005, SPEECH COMMUN, V45, P231, DOI 10.1016/j.specom.2004.10.015; Reuderink B, 2008, GAMES BRAIN COMPUTER, P1; Rolke B, 2001, PSYCHOPHYSIOLOGY, V38, P165, DOI 10.1017/S0048577201991504; Rossini L, 2009, INT REV NEUROBIOL, V86, P1; Salisbury DF, 2001, CLIN NEUROPHYSIOL, V112, P1676, DOI 10.1016/S1388-2457(01)00607-1; Santucci E, 2009, NEUROPSYCHOL TRENDS, P59, DOI 10.7358/neur-2009-005-sant; Seeland A, 2013, I IEEE EMBS C NEUR E, P41, DOI 10.1109/NER.2013.6695866; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Suppes P, 2009, NEURAL COMPUT, V21, P3228, DOI 10.1162/neco.2009.04-08-764; Tabie Marc, 2013, Proceedings of the 6th International Conference on Bio-inspired Systems and Signal Processing. BIOSIGNALS 2013, P242; Trieu HT, 2009, IEEE ENG MED BIO, P7118, DOI 10.1109/IEMBS.2009.5332876; VERLEGER R, 1994, COGNITIVE BRAIN RES, V2, P103, DOI 10.1016/0926-6410(94)90007-8; Wang BY, 2009, LECT NOTES COMPUT SC, V5552, P354, DOI 10.1007/978-3-642-01510-6_41; West R, 2011, NEUROPSYCHOLOGIA, V49, P2233, DOI 10.1016/j.neuropsychologia.2010.12.028; Woehrle H, 2014, P INT C PHYS COMP SY; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Woods D.D., 1996, HUM FAC TRANSP, P3; Young JE, 2009, INT J SOC ROBOT, V1, P95, DOI 10.1007/s12369-008-0006-y; Zander TO, 2011, INT J HUM-COMPUT INT, V27, P38, DOI 10.1080/10447318.2011.535752; Zander TO, 2010, HUM-COMPUT INT-SPRIN, P181, DOI 10.1007/978-1-84996-272-8_11	78	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81732	10.1371/journal.pone.0081732	http://dx.doi.org/10.1371/journal.pone.0081732			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358125	gold, Green Submitted, Green Published			2022-12-27	WOS:000328735700021
J	McNamee, L; Ledley, F				McNamee, Laura; Ledley, Fred			Translational Science by Public Biotechnology Companies in the IPO "Class of 2000": The Impact of Technological Maturity	PLOS ONE			English	Article							BUSINESS MODEL; INNOVATION	The biotechnology industry plays a central role in the translation of nascent biomedical science into both products that offer material health benefits and creating capital growth. This study examines the relationship between the maturity of technologies in a characteristic life cycle and value creation by biotechnology companies. We examined the core technology, product development pipelines, and capitalization for a cohort of biotechnology companies that completed an IPO in 2000. Each of these companies was well financed and had core technologies on the leading edge of biological science. We found that companies with the least mature technologies had significantly higher valuations at IPO, but failed to develop products based on these technologies over the ensuing decade, and created less capital growth than companies with more mature technologies at IPO. The observation that this cohort of recently public biotechnology companies was not effective in creating value from nascent science suggests the need for new, evidence-based business strategies for translational science.	[McNamee, Laura; Ledley, Fred] Bentley Univ, Ctr Integrat Sci & Ind, Waltham, MA USA	Bentley University	McNamee, L (corresponding author), Bentley Univ, Ctr Integrat Sci & Ind, Waltham, MA USA.	lmcnamee@bentley.edu			National Biomedical Research Foundation	National Biomedical Research Foundation	This work was funded in part by the National Biomedical Research Foundation. The authors note that Dr. Ledley is a Member and Director of the National Biomedical Research Foundation (a non-profit, 501(c)(3) organization), but the Foundation had no other involvement in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth B, 2004, NAT REV DRUG DISCOV, V3, P451, DOI 10.1038/nrd1384; Booth BL, 2009, NAT BIOTECHNOL, V27, P705, DOI 10.1038/nbt0809-705; Chesbrough H, 2002, IND CORP CHANGE, V11, P529, DOI 10.1093/icc/11.3.529; Christensen Clayton, 2003, INNOVATORS SOLUTION; Cockburn IM, 1998, J IND ECON, V46, P157; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; Edwards M, 2006, NAT BIOTECHNOL, V24, P509, DOI 10.1038/nbt0506-509; Foster R. N., 1986, INNOVATION ATTACKERS; Guedj I., 2004, 10933 NBER; Harper AR, 2012, NAT BIOTECHNOL, V30, P1117, DOI 10.1038/nbt.2424; Johnson MW, 2008, HARVARD BUS REV, V86, P50; Ledford H, 2013, NATURE, V500, P513, DOI 10.1038/500513a; Lehman Brothers and McKinsey & Company, 2001, FRUITS GEN; McNamee LM, 2012, NAT BIOTECHNOL, V30, P937, DOI 10.1038/nbt.2389; Morris M, 2005, J BUS RES, V58, P726, DOI 10.1016/j.jbusres.2003.11.001; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Pisano G., 2006, SCI BUSINESS PROMISE; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Sheridan C, 2011, NAT BIOTECHNOL, V29, P121, DOI 10.1038/nbt.1769	19	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82195	10.1371/journal.pone.0082195	http://dx.doi.org/10.1371/journal.pone.0082195			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GD	24358154	gold, Green Submitted, Green Published			2022-12-27	WOS:000328735700043
J	Myhrvold, NP				Myhrvold, Nathan P.			Revisiting the Estimation of Dinosaur Growth Rates	PLOS ONE			English	Article							BODY-MASS ESTIMATION; LONG-BONE HISTOLOGY; ALLIGATOR-MISSISSIPPIENSIS; ALLOMETRIC EQUATIONS; AMERICAN ALLIGATORS; PERIOSTEAL BONE; SEXUAL-MATURITY; LIFE-HISTORY; MAMMALS; EVOLUTION	Previous growth-rate studies covering 14 dinosaur taxa, as represented by 31 data sets, are critically examined and reanalyzed by using improved statistical techniques. The examination reveals that some previously reported results cannot be replicated by using the methods originally reported; results from new methods are in many cases different, in both the quantitative rates and the qualitative nature of the growth, from results in the prior literature. Asymptotic growth curves, which have been hypothesized to be ubiquitous, are shown to provide best fits for only four of the 14 taxa. Possible reasons for non-asymptotic growth patterns are discussed; they include systematic errors in the age-estimation process and, more likely, a bias toward younger ages among the specimens analyzed. Analysis of the data sets finds that only three taxa include specimens that could be considered skeletally mature (i.e., having attained 90% of maximum body size predicted by asymptotic curve fits), and eleven taxa are quite immature, with the largest specimen having attained less than 62% of predicted asymptotic size. The three taxa that include skeletally mature specimens are included in the four taxa that are best fit by asymptotic curves. The totality of results presented here suggests that previous estimates of both maximum dinosaur growth rates and maximum dinosaur sizes have little statistical support. Suggestions for future research are presented.	Intellectual Ventures, Bellevue, WA USA	Intellectual Ventures	Myhrvold, NP (corresponding author), Intellectual Ventures, Bellevue, WA USA.	nathan@nathanmyhrvold.com		Myhrvold, Nathan/0000-0003-3994-5143				Alexander R., 1983, ANIMAL MECH; Alexander R.M., 1989, DYNAMICS DINOSAURS O; ALEXANDER RM, 1979, J ZOOL, V189, P305; ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Andersson K, 2004, J ZOOL, V262, P161, DOI 10.1017/S0952836903004564; [Anonymous], 1980, COLD LOOK WARM BLOOD; Auerbach BM, 2004, AM J PHYS ANTHROPOL, V125, P331, DOI 10.1002/ajpa.20032; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; BOX GEP, 1976, J AM STAT ASSOC, V71, P791, DOI 10.2307/2286841; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Bybee PJ, 2006, J MORPHOL, V267, P347, DOI 10.1002/jmor.10406; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Carrano MT, 2001, J ZOOL, V254, P41, DOI 10.1017/S0952836901000541; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Castanet J, 1996, CR ACAD SCI III-VIE, V319, P301; Cawley GC, 2010, J ZOOL, V280, P355, DOI 10.1111/j.1469-7998.2009.00665.x; Charnov EL, 2001, P NATL ACAD SCI USA, V98, P9460, DOI 10.1073/pnas.161294498; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; Chinsamy Anusuya, 1993, Modern Geology, V18, P319; Chinsamy-Turan A, 2011, ENCY LIFE SCI, P1; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Christiansen P, 2004, ZOOL J LINN SOC-LOND, V140, P523, DOI 10.1111/j.1096-3642.2004.00113.x; Christiansen P, 1999, ANN ZOOL FENN, V36, P93; Chrtstiansen P, 1999, J VERTEBR PALEONTOL, V19, P666, DOI 10.1080/02724634.1999.10011180; Cooper LN, 2008, P ROY SOC B-BIOL SCI, V275, P2609, DOI 10.1098/rspb.2008.0912; Curry KA, 1999, J VERTEBR PALEONTOL, V19, P654, DOI 10.1080/02724634.1999.10011179; de Ricqles A, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P411; de Ricqles A., 1983, Journal of Vertebrate Paleontology, V3, P7, DOI 10.1080/02724634.1983.10011952; de Ricqles A., 2006, ANN PAL ONTOL, V92, P187; Dickison MJ., 2007, THESIS DUKE U; Duncan CS, 2002, MED SCI SPORT EXER, V34, P673, DOI 10.1097/00005768-200204000-00018; Efron B., 1994, INTRO BOOTSTRAP; Egi N, 2001, PALAEONTOLOGY, V44, P497, DOI 10.1111/1475-4983.00189; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Erickson GM, 2006, SCIENCE, V313, P213, DOI 10.1126/science.1125721; Erickson GM, 2011, HIST BIOL, V23, P327, DOI 10.1080/08912963.2010.546856; Erickson GM, 2010, CAN J EARTH SCI, V47, P1269, DOI 10.1139/E10-051; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; Erickson GM, 2009, ANAT REC, V292, P1514, DOI 10.1002/ar.20992; Gillooly JF, 2006, PLOS BIOL, V4, P1467, DOI 10.1371/journal.pbio.0040248; Gunga HC, 2008, FOSS REC, V11, P33, DOI 10.1002/mmng.200700011; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Henderson DM, 2004, P ROY SOC B-BIOL SCI, V271, pS57, DOI 10.1098/rsbl.2003.0097; Hitchcock C, 2004, BRIT J PHILOS SCI, V55, P1, DOI 10.1093/bjps/55.1.1; Hone DWE, 2010, LETHAIA, V43, P232, DOI 10.1111/j.1502-3931.2009.00187.x; Horner JR, 2009, J VERTEBR PALEONTOL, V29, P734, DOI 10.1671/039.029.0312; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; Horner JR, 2011, 1 INT S PAL SAB SPAI, P53; Horner JR, 1996, DINOSAUR EGGS BABIES, P392; Hurlburt G, 1999, J VERTEBR PALEONTOL, V19, P338, DOI 10.1080/02724634.1999.10011145; Hutchinson JR, 2007, J THEOR BIOL, V246, P660, DOI 10.1016/j.jtbi.2007.01.023; Hutchinson JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026037; Ivie Michael A., 2001, Insecta Mundi, V15, P63; JACOBSEN T, 1989, J ZOOL, V219, P309, DOI 10.1111/j.1469-7998.1989.tb02583.x; KAUFMANN KW, 1981, OECOLOGIA, V49, P293, DOI 10.1007/BF00347588; Kilbourne BM, 2010, J ANAT, V217, P135, DOI 10.1111/j.1469-7580.2010.01253.x; Klein N, 2004, BONE HISTOLOGY GROWT; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lee AH, 2007, INTERPLAY GROWTH MEC; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; Lehman TM, 2006, HORNS BEAKS CERATOPS, P259; Loewen MA, 2009, VARIATION LATE JURAS; Mazzullo S, 1971, GEOL SOC AM B; Norell MA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P49; Packard GC, 2009, J ZOOL, V279, P102, DOI 10.1111/j.1469-7998.2009.00594.x; Packard GC, 2011, BIOL REV, V86, P549, DOI 10.1111/j.1469-185X.2010.00160.x; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Ratkowsky D., 1983, NONLINEAR REGRESSION; Reid R.E.H., 1996, Brigham Young University Geology Studies, V41, P25; Reid R.E.H., 1990, Modern Geology, V15, P19; Reiss M.J., 1991, ALLOMETRY GROWTH REP; RICHMOND NEIL D., 1965, J PALEONTOL, V39, P503; Ruff C.B., 1999, PREHISTORIC LIFEWAYS, P290; Ruff CB, 2002, PORTRAIT ARTIST CHIL, P365; Ruff C, 2007, AM J PHYS ANTHROPOL, V133, P698, DOI 10.1002/ajpa.20568; Saalfeld DT, 2008, SOUTHEAST NAT, V7, P541, DOI 10.1656/1528-7092-7.3.541; Sander P.M., 2003, PALAEONTOL Z, V77, P161, DOI DOI 10.1007/BF03004566; Sander PM, 2005, SCIENCE, V310, P1800, DOI 10.1126/science.1120125; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; SCRUTTON CT, 1973, EARTH-SCI REV, V9, P259, DOI 10.1016/0012-8252(73)90094-9; SEBENS KP, 1987, ANNU REV ECOL SYST, V18, P371, DOI 10.1146/annurev.es.18.110187.002103; Seber G. A. F., 2003, NONLINEAR REGRESSION; Seebacher F, 2001, J VERTEBR PALEONTOL, V21, P51, DOI 10.1671/0272-4634(2001)021[0051:ANMTCA]2.0.CO;2; SHINE R, 1992, AM NAT, V139, P1257, DOI 10.1086/285385; Skalski J.R., 2005, WILDLIFE DEMOGRAPHY; Smith DK, 1998, J VERTEBR PALEONTOL, V18, P126, DOI 10.1080/02724634.1998.10011039; SMITH DK, 1999, UPPER JURASSIC MORRI, V99, P135; Smith RJ, 2002, J HUM EVOL, V43, P271, DOI 10.1006/jhev.2002.0573; SOKAL RR, 1994, BIOMETRY; Spiess Andrej-Nikolai, 2010, BMC Pharmacology, V10, P6, DOI 10.1186/1471-2210-10-6; Steinsaltz D, 2011, PALEOBIOLOGY, V37, P113, DOI 10.1666/08056.1; Tsuihiji T, 2011, J VERTEBR PALEONTOL, V31, P497, DOI 10.1080/02724634.2011.557116; Tumarkin-Deratzian AR, 2007, ZOOL J LINN SOC-LOND, V150, P1, DOI 10.1111/j.1096-3642.2007.00283.x; Varricchio David J., 1993, Journal of Vertebrate Paleontology, V13, P99; Vitt LJ, 2008, HERPETOLOGY; Werning S, 2005, LONG BONE HISTOLOGY; Wilkinson PM, 1997, J WILDLIFE MANAGE, V61, P397, DOI 10.2307/3802596; WILLIAMS GE, 1989, EPISODES, V12, P162, DOI 10.18814/epiiugs/1989/v12i3/003; Wings O, 2007, J VERTEBR PALEONTOL, V27, p167A; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Woodward HN, 2005, BONE HISTOLOGY SAURO; Woodward HN, 2011, J HERPETOL, V45, P339	118	51	52	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81917	10.1371/journal.pone.0081917	http://dx.doi.org/10.1371/journal.pone.0081917			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358133	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700027
J	Nicholas, KJ; Zern, EK; Barnett, L; Smith, RM; Lorey, SL; Copeland, CA; Sadagopal, S; Kalams, SA				Nicholas, Katherine J.; Zern, Emily K.; Barnett, Louise; Smith, Rita M.; Lorey, Shelly L.; Copeland, Courtney A.; Sadagopal, Shanmugalakshmi; Kalams, Spyros A.			B Cell Responses to HIV Antigen Are a Potent Correlate of Viremia in HIV-1 Infection and Improve with PD-1 Blockade	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS HIV; CD4(+) T-CELLS; ELEVATED FREQUENCIES; EXPRESSION; ACTIVATION; RESPONSIVENESS; PERTURBATIONS; PROLIFERATION; PROGRESSION; LYMPHOCYTE	Infection with Human Immunodeficiency Virus Type 1 (HIV-1) induces defects of both cellular and humoral immune responses. Impaired CD4+ T cell help and B cell dysfunction may partially explain the low frequency of broadly neutralizing antibodies in HIV-infected individuals. To understand the extent of B cell dysfunction during HIV infection, we assessed the level of B cell activation at baseline and after stimulation with a variety of antigens. Increased levels of viremia were associated with higher baseline expression of the activation marker CD86 on B cells and with decreased ability of B cells to increase expression of CD86 after in vitro stimulation with inactivated HIV-1. In a series of cell isolation experiments B cell responses to antigen were enhanced in the presence of autologous CD4+ T cells. HIV infected individuals had a higher frequency of PD-1 expression on B cells compared to HIV-subjects and PD-1 blockade improved B cell responsiveness to HIV antigen, suggesting that inhibitory molecule expression during HIV-1 infection may contribute to some of the observed B cell defects. Our findings demonstrate that during chronic HIV infection, B cells are activated and lose full capacity to respond to antigen, but suppression of inhibitory pressures as well as a robust CD4+ T cell response may help preserve B cell function.	[Nicholas, Katherine J.; Kalams, Spyros A.] Vanderbilt Univ, Sch Med, Dept Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Zern, Emily K.; Barnett, Louise; Smith, Rita M.; Lorey, Shelly L.; Sadagopal, Shanmugalakshmi; Kalams, Spyros A.] Vanderbilt Univ, Sch Med, Div Infect Dis, Nashville, TN 37212 USA; [Copeland, Courtney A.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Kalams, SA (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.	s.kalams@vanderbilt.edu			National Institutes of Health [SAK P01 AI78064, KJN T32 AI1089554]; NIH [P30 AI54999]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI010895, P30AI042851, P30AI054999, P01AI078064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (SAK P01 AI78064 and KJN T32 AI1089554). Flow cytometric cell acquisition or sorting was performed by the Vanderbilt-Meharry Center for AIDS Research Immunopathogenesis Core, an NIH funded program (P30 AI54999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsiku OT, 2011, JAIDS-J ACQ IMM DEF, V58, P132, DOI 10.1097/QAI.0b013e318224d2e9; Antonelli LRV, 2010, BLOOD, V116, P3818, DOI 10.1182/blood-2010-05-285080; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bennett F, 2003, J IMMUNOL, V170, P711, DOI 10.4049/jimmunol.170.2.711; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Bussmann BM, 2010, VIROLOGY, V397, P7, DOI 10.1016/j.virol.2009.11.003; Conrad JA, 2012, J VIROL, V86, P4213, DOI 10.1128/JVI.06000-11; Conrad JA, 2011, J IMMUNOL, V186, P6871, DOI 10.4049/jimmunol.1004234; Cubas RA, 2013, NAT MED, V19, P494, DOI 10.1038/nm.3109; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Forster R, 1997, BLOOD, V90, P520, DOI 10.1182/blood.V90.2.520.520_520_525; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Hokey DA, 2008, EUR J IMMUNOL, V38, P1435, DOI 10.1002/eji.200737857; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kalams SA, 1999, J VIROL, V73, P6715, DOI 10.1128/JVI.73.8.6715-6720.1999; Kardava L, 2011, J CLIN INVEST, V121, P2614, DOI 10.1172/JCI45685; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Khaitan Alka, 2011, Curr HIV/AIDS Rep, V8, P4, DOI 10.1007/s11904-010-0066-0; Klatt NR, 2011, BLOOD, V118, P5803, DOI 10.1182/blood-2011-07-365874; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Lange CG, 2003, AIDS, V17, P2015, DOI 10.1097/00002030-200309260-00002; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Malaspina A, 2003, J IMMUNOL, V170, P5965, DOI 10.4049/jimmunol.170.12.5965; MARTINEZMAZA O, 1987, J IMMUNOL, V138, P3720; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Moir S, 2001, P NATL ACAD SCI USA, V98, P10362, DOI 10.1073/pnas.181347898; Moir S, 2003, P NATL ACAD SCI USA, V100, P6057, DOI 10.1073/pnas.0730819100; Moir S, 2004, J EXP MED, V200, P587, DOI 10.1084/jem.20032236; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Morris L, 1998, J EXP MED, V188, P233, DOI 10.1084/jem.188.2.233; PAHWA R, 1987, P NATL ACAD SCI USA, V84, P3826, DOI 10.1073/pnas.84.11.3826; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Porichis F, 2011, BLOOD, V118, P965, DOI 10.1182/blood-2010-12-328070; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Rutebemberwa A, 2007, AIDS RES HUM RETROV, V23, P532, DOI 10.1089/aid.2006.0136; SHIRAI A, 1992, J CLIN INVEST, V89, P561, DOI 10.1172/JCI115621; STEINHOFF MC, 1991, NEW ENGL J MED, V325, P1837, DOI 10.1056/NEJM199112263252603; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Valdez H, 2000, AIDS, V14, P11, DOI 10.1097/00002030-200001070-00002; Velu V, 2007, J VIROL, V81, P5819, DOI 10.1128/JVI.00024-07; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Walker BD, 2011, NAT MED, V17, P1194, DOI 10.1038/nm.2529	44	27	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84185	10.1371/journal.pone.0084185	http://dx.doi.org/10.1371/journal.pone.0084185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358343	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700156
J	Penney, AJ; Guinotte, JM				Penney, Andrew J.; Guinotte, John M.			Evaluation of New Zealand's High-Seas Bottom Trawl Closures Using Predictive Habitat Models and Quantitative Risk Assessment	PLOS ONE			English	Article							VULNERABLE MARINE ECOSYSTEMS; FISHERIES; PROTECTION; MANAGEMENT; SEAMOUNTS; RESERVES; IMPACTS	United Nations General Assembly Resolution 61/105 on sustainable fisheries (UNGA 2007) establishes three difficult questions for participants in high-seas bottom fisheries to answer: 1) Where are vulnerable marine systems (VMEs) likely to occur?; 2) What is the likelihood of fisheries interaction with these VMEs?; and 3) What might qualify as adequate conservation and management measures to prevent significant adverse impacts? This paper develops an approach to answering these questions for bottom trawling activities in the Convention Area of the South Pacific Regional Fisheries Management Organisation (SPRFMO) within a quantitative risk assessment and cost : benefit analysis framework. The predicted distribution of deep-sea corals from habitat suitability models is used to answer the first question. Distribution of historical bottom trawl effort is used to answer the second, with estimates of seabed areas swept by bottom trawlers being used to develop discounting factors for reduced biodiversity in previously fished areas. These are used in a quantitative ecological risk assessment approach to guide spatial protection planning to address the third question. The coral VME likelihood (average, discounted, predicted coral habitat suitability) of existing spatial closures implemented by New Zealand within the SPRFMO area is evaluated. Historical catch is used as a measure of cost to industry in a cost : benefit analysis of alternative spatial closure scenarios. Results indicate that current closures within the New Zealand SPRFMO area bottom trawl footprint are suboptimal for protection of VMEs. Examples of alternative trawl closure scenarios are provided to illustrate how the approach could be used to optimise protection of VMEs under chosen management objectives, balancing protection of VMEs against economic loss to commercial fishers from closure of historically fished areas.	[Penney, Andrew J.] Minist Fisheries, Australian Bur Agr & Resource Econ & Sci, Canberra, ACT, Australia; [Guinotte, John M.] Marine Conservat Inst, Bellevue, WA USA		Penney, AJ (corresponding author), Minist Fisheries, Australian Bur Agr & Resource Econ & Sci, Canberra, ACT, Australia.	andrew.penney@daff.gov.au			Ministry of Fisheries, New Zealand; Ministry of Fisheries; Marine Conservation Institute (Davies AJ, Guinotte JM)	Ministry of Fisheries, New Zealand; Ministry of Fisheries; Marine Conservation Institute (Davies AJ, Guinotte JM)	AJP's involvement in this work was funded as an employee of the then Ministry of Fisheries, New Zealand. The Ministry of Fisheries funded this research and publication as part of ongoing work to periodically update the New Zealand bottom fishery impact assessment, which was prepared in response to the requirements of the interim measures for bottom fisheries adopted by the South Pacific Regional Fisheries Management Organisation. Global habitat prediction work by JGM was funded under a previous project conducted at the Marine Conservation Institute (Davies AJ, Guinotte JM [2011]) PLOS ONE 6(4): e18483). The Marine Conservation Institute had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airame S, 2003, ECOL APPL, V13, pS170; Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Auster PJ, 2011, ICES J MAR SCI, V68, P254, DOI 10.1093/icesjms/fsq074; Baird SJ, 2011, 73 NZ AQ ENV BIOD; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Botsford LW, 2001, ECOL LETT, V4, P144; Clark CW, 1996, ECOL APPL, V6, P369, DOI 10.2307/2269374; Clark M. R., 2010, 46 NZ AQ ENV BIOD; Clark MR, 2009, DEEP-SEA RES PT I, V56, P1540, DOI 10.1016/j.dsr.2009.04.015; Clark MR, 2008, 200866 NZ FISH ASS; Clark MR, 2008, 200812 NZ FISH ASS; Clark MR, 2010, 201019 NZ FISH ASS; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; GEBCO, 2010, GEN BTHYMETRIC CHART; Griffiths S, 2007, ECOLOGICAL RISK ASSE; Guinotte JM, 2012, NOAA NMFS DEEP SEA C; Hall-Spencer J, 2002, P ROY SOC B-BIOL SCI, V269, P507, DOI 10.1098/rspb.2001.1910; High-Level Expert Forum, 2009, FEED WORLD 2050; Hobday AJ, 2011, FISH RES, V108, P372, DOI 10.1016/j.fishres.2011.01.013; Hobday A.J., 2007, R041072 AUSTR FISH M; Koslow JA, 2000, ICES J MAR SCI, V57, P548, DOI 10.1006/jmsc.2000.0722; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; Lauck T, 1998, ECOL APPL, V8, pS72, DOI 10.1890/1051-0761(1998)8[S72:ITPPIF]2.0.CO;2; Ministry of Fisheries, 2010, 9 M SPRFMO SCI WORK; Ministry of Fisheries, 2008, BOTT FISH IMP ASS BO; NEAFC, 2010, INF PROT BIOD MIT IM; Neil H, 2011, UNDERSTANDING MANAGI; Parker SJ, 2009, MAR ECOL PROG SER, V397, P309, DOI 10.3354/meps08115; Patrick WS, USE PRODUCTIVITY SUS; Penney AJ, 2011, 10 M SPRFMO SCI WORK; Penney AJ, 2009, MAR ECOL PROG SER, V397, P341, DOI 10.3354/meps08300; Rieser A, 2013, MAR POLICY, V40, P75, DOI 10.1016/j.marpol.2012.12.028; Rogers AD, 2008, SCI GUIDELI IN PRESS; Ross R, 2012, DIVERS DISTRIB, DOI DOI 10.1111/DDI.12010/ABSTRACT.ACCESSED; Sharp BR, 2011, MARINE PROTECTED ARE; SPRFMO, 2007, 3 SPRFMO M REN CHIL; Stone RP, 2006, CORAL REEFS, V25, P229, DOI 10.1007/s00338-006-0091-z; Tracey DM, 2011, MAR ECOL PROG SER, V430, P1, DOI 10.3354/meps09164; Waller R, 2007, J MAR BIOL ASSOC UK, V87, P1075, DOI 10.1017/S0025315407057785; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; Weaver P.P.E., 2011, INT SCI WORKSH NAT O, P45; Williams A, 2011, FISH RES, V112, P154, DOI 10.1016/j.fishres.2011.01.028; Williams A, 2010, MAR ECOL-EVOL PERSP, V31, P183, DOI 10.1111/j.1439-0485.2010.00385.x; Yesson C, 2012, J BIOGEOGR, V39, P1278, DOI 10.1111/j.1365-2699.2011.02681.x	44	29	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82273	10.1371/journal.pone.0082273	http://dx.doi.org/10.1371/journal.pone.0082273			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358162	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700052
J	Rinaldi, S; Brennan, KM; Kalna, G; Walgaard, C; van Doorn, P; Jacobs, BC; Yu, RK; Mansson, JE; Goodyear, CS; Willison, HJ				Rinaldi, Simon; Brennan, Kathryn M.; Kalna, Gabriela; Walgaard, Christa; van Doorn, Pieter; Jacobs, Bart C.; Yu, Robert K.; Mansson, Jan-Eric; Goodyear, Carl S.; Willison, Hugh J.			Antibodies to Heteromeric Glycolipid Complexes in Guillain-Barre Syndrome	PLOS ONE			English	Article							ANTI-GM1 ANTIBODIES; PERIPHERAL-NERVE; GANGLIOSIDE; CLASSIFICATION; COMPLEMENT; MEMBRANE; CLUSTERS; CRITERIA; TARGETS; MODEL	Autoantibodies are infrequently detected in the sera of patients with the demyelinating form of Guillain-Barre syndrome most commonly encountered in the Western world, despite abundant circumstantial evidence suggesting their existence. We hypothesised that antibody specificities reliant on the cis interactions of neighbouring membrane glycolipids could explain this discrepancy, and would not have been detected by traditional serological assays using highly purified preparations of single gangliosides. To assess the frequency of glycolipid complex antibodies in a Western European cohort of patients GBS we used a newly developed combinatorial glycoarray methodology to screen against large range of antigens (11 gangliosides, 8 other single glycolipids and 162 heterodimeric glycolipid complexes). Serum samples of 181 patients from a geographically defined, Western European cohort of GBS cases were analysed, along with 161 control sera. Serum IgG binding to single gangliosides was observed in 80.0% of axonal GBS cases, but in only 11.8% of cases with demyelinating electrophysiology. The inclusion of glycolipid complexes increased the positivity rate in demyelinating disease to 62.4%. There were 40 antigens with statistically significantly increased binding intensities in GBS as compared to healthy control sera. Of these, 7 complex antigens and 1 single ganglioside also produced statistically significantly increased binding intensities in GBS versus neurological disease controls. The detection of antibodies against specific complexes was associated with particular clinical features including disease severity, requirement for mechanical ventilation, and axonal electrophysiology. This study demonstrates that while antibodies against single gangliosides are often found in cases with axonal-type electrophysiology, antibodies against glycolipid complexes predominate in cases with demyelinating electrophysiology, providing a more robust serum biomarker than has ever been previously available for such cases. This work confirms the activation of the humoral immune system in the dysimmune disease process in GBS, and correlates patterns of antigen recognition with different clinical features.	[Rinaldi, Simon; Brennan, Kathryn M.; Goodyear, Carl S.; Willison, Hugh J.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Kalna, Gabriela] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Walgaard, Christa; van Doorn, Pieter; Jacobs, Bart C.] Univ Med Ctr, Erasmus Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Jacobs, Bart C.] Univ Med Ctr, Erasmus Med Ctr, Dept Immunol, Rotterdam, Netherlands; [Yu, Robert K.] Georgia Hlth Sci Univ, Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA USA; [Mansson, Jan-Eric] Sahlgrens Univ Hosp, Lab Med Clin Chem, Molndal, Sweden	University of Glasgow; Beatson Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University System of Georgia; Augusta University; Sahlgrenska University Hospital	Rinaldi, S (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	simon.rinaldi@ndcn.ox.ac.uk	willison, hugh/HCI-7819-2022; Jacobs, Bart/ABE-2210-2021	Rinaldi, Simon/0000-0003-2039-3457; Goodyear, Carl/0000-0001-5926-5941	Dutch Prinses Beatrix Fonds [PBF WAR07-28]; Netherlands Organization for Health Research and Development; Erasmus MC; Prinses Beatrix Fonds; GBS-CIDP Foundation International; Wellcome Trust [085225/08, 077041/05]; National Institutes of Health (USPHS NIH) [RO1 NS26994]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026994] Funding Source: NIH RePORTER	Dutch Prinses Beatrix Fonds; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Erasmus MC; Prinses Beatrix Fonds; GBS-CIDP Foundation International; Wellcome Trust(Wellcome Trust); National Institutes of Health (USPHS NIH); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. Christa Walgaard is funded by a scientific research grant from the Dutch Prinses Beatrix Fonds (PBF WAR07-28). Dr. B. C. Jacobs receives research support from the Netherlands Organization for Health Research and Development, Erasmus MC, Prinses Beatrix Fonds, GBS-CIDP Foundation International. Professor Willison and Dr. Rinaldi receive funding support from The Wellcome Trust (grant numbers 085225/08 to SR and 077041/05 to HJW). RKY was supported by National Institutes of Health (USPHS NIH grant number RO1 NS26994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; Brennan KM, 2011, J NEUROIMMUNOL, V238, P87, DOI 10.1016/j.jneuroim.2011.08.002; Buchwald B, 2007, NEUROBIOL DIS, V28, P113, DOI 10.1016/j.nbd.2007.07.008; DeMarco ML, 2012, BIOCHEMISTRY-US, V51, P5725, DOI 10.1021/bi3003633; Goodyear CS, 1999, J CLIN INVEST, V104, P697, DOI 10.1172/JCI6837; Greenshields KN, 2009, J CLIN INVEST, V119, P595, DOI 10.1172/JCI37338; Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512; Halstead SK, 2004, BRAIN, V127, P2109, DOI 10.1093/brain/awh231; HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2; Jacobs BC, 2012, IGOS INT GSB OUTCOME; Jones CM, 2005, ANN THORAC SURG, V79, P16, DOI 10.1016/j.athoracsur.2004.09.040; Kaida K, 2007, J NEUROIMMUNOL, V182, P212, DOI 10.1016/j.jneuroim.2006.09.013; Kaida K, 2004, ANN NEUROL, V56, P567, DOI 10.1002/ana.20222; Kuijf ML, 2005, J NEUROL SCI, V239, P37, DOI 10.1016/j.jns.2005.07.009; LI YT, 1973, J BIOL CHEM, V248, P2634; McGonigal R, 2010, BRAIN, V133, P1944, DOI 10.1093/brain/awq119; Mori K, 2012, J PHYS CHEM B, V116, P5111, DOI 10.1021/jp207881k; Nores GA, 2008, BBA-GEN SUBJECTS, V1780, P538, DOI 10.1016/j.bbagen.2007.09.008; Ogawara K, 2000, ANN NEUROL, V48, P624, DOI 10.1002/1531-8249(200010)48:4<624::AID-ANA9>3.3.CO;2-F; Rinaldi S, 2010, PROG LIPID RES, V49, P87, DOI 10.1016/j.plipres.2009.09.001; Rinaldi S, 2008, CURR OPIN NEUROL, V21, P540, DOI 10.1097/WCO.0b013e32830b84b7; Rinaldi S, 2012, METHODS MOL BIOL, V808, P413, DOI 10.1007/978-1-61779-373-8_28; Rinaldi S, 2009, GLYCOBIOLOGY, V19, P789, DOI 10.1093/glycob/cwp049; Susuki K, 2007, J NEUROSCI, V27, P3956, DOI 10.1523/JNEUROSCI.4401-06.2007; SVENNERHOLM L, 1994, BBA-LIPID LIPID MET, V1214, P115, DOI 10.1016/0005-2760(94)90034-5; Uncini A, 2010, J NEUROL NEUROSUR PS, V81, P1157, DOI 10.1136/jnnp.2010.208538; Van der Meche FGA, 2001, EUR NEUROL, V45, P133, DOI 10.1159/000052111; van Koningsveld R, 2004, LANCET, V363, P192, DOI 10.1016/S0140-6736(03)15324-X; VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390; Willison HJ, 2007, J NEUROCHEM, V103, P143, DOI 10.1111/j.1471-4159.2007.04718.x; Yu Robert K., 1994, Journal of Biomedical Science, V1, P167, DOI 10.1007/BF02253346; Yuki N, 2007, MUSCLE NERVE, V35, P691, DOI 10.1002/mus.20762; Zitman FMP, 2011, CLIN EXP NEUROIMMUNO, V2, P59, DOI DOI 10.1111/J.1759-1961.2011.00022.X	33	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82337	10.1371/journal.pone.0082337	http://dx.doi.org/10.1371/journal.pone.0082337			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358172	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700059
J	Silva, IN; Tavares, AC; Ferreira, AS; Moreira, LM				Silva, Ines N.; Tavares, Andreia C.; Ferreira, Ana S.; Moreira, Leonilde M.			Stress Conditions Triggering Mucoid Morphotype Variation in Burkholderia Species and Effect on Virulence in Galleria mellonella and Biofilm Formation In Vitro	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; PSEUDOMONAS-AERUGINOSA; CEPACIA COMPLEX; EXOPOLYSACCHARIDE BIOSYNTHESIS; COLONY MORPHOLOGY; SP NOV.; ADAPTATION; INFECTION; GENES; MULTIVORANS	Burkholderia cepacia complex (Bcc) bacteria are opportunistic pathogens causing chronic respiratory infections particularly among cystic fibrosis patients. During these chronic infections, mucoid-to-nonmucoid morphotype variation occurs, with the two morphotypes exhibiting different phenotypic properties. Here we show that in vitro, the mucoid clinical isolate Burkholderia multivorans D2095 gives rise to stable nonmucoid variants in response to prolonged stationary phase, presence of antibiotics, and osmotic and oxidative stresses. Furthermore, in vitro colony morphotype variation within other members of the Burkholderia genus occurred in Bcc and non-Bcc strains, irrespectively of their clinical or environmental origin. Survival to starvation and iron limitation was comparable for the mucoid parental isolate and the respective nonmucoid variant, while susceptibility to antibiotics and to oxidative stress was increased in the nonmucoid variants. Acute infection of Galleria mellonella larvae showed that, in general, the nonmucoid variants were less virulent than the respective parental mucoid isolate, suggesting a role for the exopolysaccharide in virulence. In addition, most of the tested nonmucoid variants produced more biofilm biomass than their respective mucoid parental isolate. As biofilms are often associated with increased persistence of pathogens in the CF lungs and are an indicative of different cell-to-cell interactions, it is possible that the nonmucoid variants are better adapted to persist in this host environment.	[Moreira, Leonilde M.] Univ Lisbon, Inst Super Tecn, Dept Bioengn, P-1699 Lisbon, Portugal; [Silva, Ines N.; Tavares, Andreia C.; Ferreira, Ana S.; Moreira, Leonilde M.] Inst Super Tecn, Ctr Biol & Chem Engn, Inst Biotechnol & Bioengn, Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico	Moreira, LM (corresponding author), Univ Lisbon, Inst Super Tecn, Dept Bioengn, P-1699 Lisbon, Portugal.	lmoreira@tecnico.ulisboa.pt	Ferreira, Ana Sofia/F-7899-2014; de Fátima Morais Moreira, Leonilde/C-6744-2011; Silva, Inês/F-7876-2014	de Fátima Morais Moreira, Leonilde/0000-0002-6838-4245; Silva, Inês/0000-0002-4078-4706; Tavares, Andreia/0000-0002-8260-0776	FEDER; Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/QUI-BIQ/118260/2010, PEst-OE/EQB/LA0023/2011]	FEDER(European Commission); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by FEDER and Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/QUI-BIQ/118260/2010; PEst-OE/EQB/LA0023/2011] and Post-doc fellowships to I.N.S. and A.S.F., respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Bylund J, 2006, J BIOL CHEM, V281, P2526, DOI 10.1074/jbc.M510692200; Chantratita N, 2007, J BACTERIOL, V189, P807, DOI 10.1128/JB.01258-06; Chung JW, 2003, INFECT IMMUN, V71, P904, DOI 10.1128/IAI.71.2.904-909.2003; Ciofu O, 2008, MICROBIOL-SGM, V154, P103, DOI 10.1099/mic.0.2007/010421-0; Coenye T, 2001, INT J SYST EVOL MICR, V51, P1481, DOI 10.1099/00207713-51-4-1481; Coenye T, 2003, J CLIN MICROBIOL, V41, P2797, DOI 10.1128/JCM.41.6.2797-2798.2003; Coenye T, 1999, INT J SYST BACTERIOL, V49, P1657, DOI 10.1099/00207713-49-4-1657; Conway BAD, 2004, J INFECT DIS, V190, P957, DOI 10.1086/423141; Doring G, 2011, FEMS MICROBIOL REV, V35, P124, DOI 10.1111/j.1574-6976.2010.00237.x; Drevinek P, 2010, J CLIN MICROBIOL, V48, P34, DOI 10.1128/JCM.01433-09; Ferreira AS, 2007, APPL ENVIRON MICROB, V73, P524, DOI 10.1128/AEM.01450-06; Ferreira AS, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00016; Ferreira AS, 2010, APPL ENVIRON MICROB, V76, P441, DOI 10.1128/AEM.01828-09; GLASS S, 1986, J INFECTION, V13, P157, DOI 10.1016/S0163-4453(86)92953-1; Goris J, 2004, INT J SYST EVOL MICR, V54, P1677, DOI 10.1099/ijs.0.63101-0; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LARSEN GY, 1993, J CLIN MICROBIOL, V31, P788, DOI 10.1128/JCM.31.4.788-792.1993; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Moreira LM, 1997, ARCH MICROBIOL, V168, P92, DOI 10.1007/s002030050474; Richau JA, 2000, J CLIN MICROBIOL, V38, P1651, DOI 10.1128/JCM.38.4.1651-1655.2000; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Seed KD, 2008, INFECT IMMUN, V76, P1267, DOI 10.1128/IAI.01249-07; Silva IN, 2011, MICROBIOL-SGM, V157, P3124, DOI 10.1099/mic.0.050989-0; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sousa SA, 2007, CELL MICROBIOL, V9, P2817, DOI 10.1111/j.1462-5822.2007.00998.x; SPEERT DP, 1990, J CLIN MICROBIOL, V28, P188, DOI 10.1128/JCM.28.2.188-194.1990; STANIER RY, 1966, J GEN MICROBIOL, V43, P159, DOI 10.1099/00221287-43-2-159; Tandhavanant S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-303; Tavares IM, 1999, RES MICROBIOL, V150, P105, DOI 10.1016/S0923-2508(99)80028-X; TERRY JM, 1991, INFECT IMMUN, V59, P471, DOI 10.1128/IAI.59.2.471-477.1991; Van Acker E, 2010, J CYST FIBROS, V9, P450, DOI 10.1016/j.jcf.2010.08.015; van Laer F, 1998, INFECT CONT HOSP EP, V19, P112; Vandamme P, 1997, INT J SYST BACTERIOL, V47, P1188, DOI 10.1099/00207713-47-4-1188; Vandamme P, 2002, SYST APPL MICROBIOL, V25, P507, DOI 10.1078/07232020260517634; Vial L, 2010, ISME J, V4, P49, DOI 10.1038/ismej.2009.95; Zlosnik JEA, 2008, J CLIN MICROBIOL, V46, P1470, DOI 10.1128/JCM.02273-07; Zlosnik JEA, 2011, AM J RESP CRIT CARE, V183, P67, DOI 10.1164/rccm.201002-0203OC; Zlosnik JEA, 2010, J INFECT DIS, V202, P770, DOI 10.1086/655663	44	14	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82522	10.1371/journal.pone.0082522	http://dx.doi.org/10.1371/journal.pone.0082522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358195	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700074
J	Skogmar, S; Schon, T; Balcha, TT; Jemal, ZH; Tibesso, G; Bjork, J; Bjorkman, P				Skogmar, Sten; Schon, Thomas; Balcha, Taye Tolera; Jemal, Zelalem Habtamu; Tibesso, Gudeta; Bjork, Jonas; Bjorkman, Per			CD4 Cell Levels during Treatment for Tuberculosis (TB) in Ethiopian Adults and Clinical Markers Associated with CD4 Lymphocytopenia	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; INFECTION; COUNTS; COINFECTION; DEPLETION; DEATH; RISK	Background: The clinical correlations and significance of subnormal CD4 levels in HIV-negative patients with TB are unclear. We have determined CD4 cell levels longitudinally during anti-tuberculosis treatment (ATT) in patients, with and without HIV co-infection, and their associations with clinical variables. Method: Adults diagnosed with TB (maximum duration of ATT for 2 weeks, and with no history of antiretroviral therapy (ART) in HIV-positive subjects) were included consecutively in eight out-patient clinics in Ethiopia. Healthy individuals were recruited for comparison at one of the study health centers. Data on patient characteristics and physical findings were collected by trained nurses following a structured questionnaire at inclusion and on follow-up visits at 2 and 6 months. In parallel, peripheral blood CD4 cell levels were determined. The evolution of CD4 cell levels during ATT was assessed, and the association between clinical characteristics and low CD4 cell levels at baseline was investigated using regression analysis. Results: In total, 1116 TB patients were included (307 HIV-infected). Among 809 HIV-negative patients, 200 (25%) had subnormal CD4 cell counts (<500 cells/mm(3)), with <350 cells/mm(3) in 82 (10%) individuals. CD4 cell levels increased significantly during the course of ATT in both HIV+ and HIV-TB-patients, but did not reach the levels in healthy subjects (median 896 cells/mm(3)). Sputum smear status, signs of wasting (low mid upper arm circumference (MUAC)), and bedridden state were significantly associated with low CD4 cell counts. Conclusion: A high proportion of Ethiopian TB patients have subnormal CD4 cell counts before starting treatment. Low CD4 cell levels are associated with smear positive disease and signs of wasting. The continuous increase of CD4 cell counts during the course of ATT suggest a reversible impact of active TB on CD4 cell homeostasis, which may be considered in interpretation of CD4 cell counts in HIV/TB co-infected subjects.	[Skogmar, Sten; Balcha, Taye Tolera; Bjorkman, Per] Lund Univ, Fac Med, Dept Clin Sci, Infect Dis Res Unit, Malmo, Sweden; [Schon, Thomas] Linkoping Univ, Fac Hlth Sci, Dept Med Microbiol, Linkoping, Sweden; [Schon, Thomas] Kalmar Cty Hosp, Dept Clin Microbiol & Infect Dis, Kalmar, Sweden; [Balcha, Taye Tolera] Minist Hlth, Addis Ababa, Ethiopia; [Jemal, Zelalem Habtamu] Oromia Reg Hlth Bur, Addis Ababa, Ethiopia; [Tibesso, Gudeta] Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Care & Treatment Programs Ethiopia, Addis Ababa, Ethiopia; [Bjork, Jonas] Skane Univ Hosp, Res & Dev Unit, Lund, Sweden	Lund University; Linkoping University; Lund University; Skane University Hospital	Skogmar, S (corresponding author), Lund Univ, Fac Med, Dept Clin Sci, Infect Dis Res Unit, Malmo, Sweden.	sten.skogmar@med.lu.se		Bjork, Jonas/0000-0003-1883-2000	Swedish International Development Cooperation Agency (SIDA); Swedish Civil Contingency Agency (MSB); Swedish Medical Society; Skane Regional Council; Marcus and Marianne Wallenberg foundation	Swedish International Development Cooperation Agency (SIDA); Swedish Civil Contingency Agency (MSB); Swedish Medical Society; Skane Regional Council; Marcus and Marianne Wallenberg foundation	The Swedish International Development Cooperation Agency (SIDA), the Swedish Civil Contingency Agency (MSB), the Swedish Medical Society, Skane Regional Council and Marcus and Marianne Wallenberg foundation have provided funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuye C, 2005, J CLIN IMMUNOL, V25, P127, DOI 10.1007/s10875-005-2818-y; Andersen AB, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-66; Begtrup K, 1997, AM J EPIDEMIOL, V145, P629, DOI 10.1093/oxfordjournals.aje.a009160; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Cingolani A, 2012, CLIN INFECT DIS, V54, P853, DOI 10.1093/cid/cir900; De Groote MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061002; Dieli F, 1999, J INFECT DIS, V180, P225, DOI 10.1086/314852; DJOMAND G, 1994, AIDS, V8, P843, DOI 10.1097/00002030-199406000-00019; Federal Ministry of Health, 2008, TUB LEPR TB HIV PREV, V4th; Gustafson P, 2007, INFECTION, V35, P69, DOI 10.1007/s15010-007-6090-3; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Hood MLH, 2013, EUR J CLIN NUTR; Iwnetu R, 2009, SCAND J INFECT DIS, V41, P462, DOI 10.1080/00365540902897697; Jones BE, 1997, CLIN INFECT DIS, V24, P988, DOI 10.1093/clinids/24.5.988; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Kim DK, 2008, EUR RESPIR J, V32, P1031, DOI 10.1183/09031936.00174907; Kony SJ, 2000, J INFECTION, V41, P167, DOI 10.1053/jinf.2000.0721; Mupere E, 2012, ANN EPIDEMIOL, V22, P466, DOI 10.1016/j.annepidem.2012.04.007; Pilheu JA, 1997, INT J TUBERC LUNG D, V1, P422; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; TURETT GS, 1994, CHEST, V105, P1335, DOI 10.1378/chest.105.5.1335; Villamor E, 2006, EUR J CLIN NUTR, V60, P163, DOI 10.1038/sj.ejcn.1602281; Walker UA, 2006, CURR OPIN RHEUMATOL, V18, P389, DOI 10.1097/01.bor.0000231908.57913.2f; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2004, HIV ASS OP CHAR; Wolday D, 2002, ETHIOPIAN MED J, V40, P11; World Health Organization, 2012, WHO POL COLL TB HIV; Zachariah R, T R SOC TROP MED HYG, V96, P291	29	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83270	10.1371/journal.pone.0083270	http://dx.doi.org/10.1371/journal.pone.0083270			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358268	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700112
J	Davies, MA; Phiri, S; Wood, R; Wellington, M; Cox, V; Bolton-Moore, C; Timmerman, V; Moultrie, H; Ndirangu, J; Rabie, H; Technau, K; Giddy, J; Maxwell, N; Boulle, A; Keiser, O; Egger, M; Eley, B				Davies, Mary-Ann; Phiri, Sam; Wood, Robin; Wellington, Maureen; Cox, Vivian; Bolton-Moore, Carolyn; Timmerman, Venessa; Moultrie, Harry; Ndirangu, James; Rabie, Helena; Technau, Karl; Giddy, Janet; Maxwell, Nicola; Boulle, Andrew; Keiser, Olivia; Egger, Matthias; Eley, Brian		IeDEA Southern Africa Steering Grp	Temporal Trends in the Characteristics of Children at Antiretroviral Therapy Initiation in Southern Africa: The IeDEA-SA Collaboration	PLOS ONE			English	Article							HIV-INFECTED CHILDREN; SUB-SAHARAN AFRICA; TREATMENT PROGRAM; RETROSPECTIVE COHORT; EARLY-DIAGNOSIS; FOLLOW-UP; OUTCOMES; INFANTS; ADOLESCENTS; MORTALITY	Background: Since 2005, increasing numbers of children have started antiretroviral therapy (ART) in sub-Saharan Africa and, in recent years, WHO and country treatment guidelines have recommended ART initiation for all infants and very young children, and at higher CD4 thresholds for older children. We examined temporal changes in patient and regimen characteristics at ART start using data from 12 cohorts in 4 countries participating in the IeDEA-SA collaboration. Methodology/Principal Findings: Data from 30,300 ART-naive children aged <16 years at ART initiation who started therapy between 2005 and 2010 were analysed. We examined changes in median values for continuous variables using the Cuzick's test for trend over time. We also examined changes in the proportions of patients with particular disease severity characteristics (expressed as a binary variable e.g. WHO Stage III/V vs I/II) using logistic regression. Between 2005 and 2010 the number of children starting ART each year increased and median age declined from 63 months (2006) to 56 months (2010). Both the proportion of children <1 year and >10 years of age increased from 12 to 19% and 18 to 22% respectively. Children had less severe disease at ART initiation in later years with significant declines in the percentage with severe immunosuppression (81 to 63%), WHO Stage III/IV disease (75 to 62%), severe anemia (12 to 7%) and weight-for-age z-score<-3 (31 to 28%). Similar results were seen when restricting to infants with significant declines in the proportion with severe immunodeficiency (98 to 82%) and Stage III/IV disease (81 to 63%). First-line regimen use followed country guidelines. Conclusions/Significance: Between 2005 and 2010 increasing numbers of children have initiated ART with a decline in disease severity at start of therapy. However, even in 2010, a substantial number of infants and children started ART with advanced disease. These results highlight the importance of efforts to improve access to HIV diagnostic testing and ART in children.	[Davies, Mary-Ann; Maxwell, Nicola; Boulle, Andrew] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Phiri, Sam] Kamuzu Cent Hosp, Lighthouse Trust Clin, Lilongwe, Malawi; [Wood, Robin] Univ Cape Town, Inst Infect Dis & Mol Med, Gugulethu Community Hlth Ctr, ZA-7925 Cape Town, South Africa; [Wood, Robin] Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Wellington, Maureen] Newlands Clin, Harare, Zimbabwe; [Cox, Vivian] Medecins Sans Frontieres South Africa, Cape Town, South Africa; [Cox, Vivian] Khayelitsha ART Programme, Cape Town, South Africa; [Bolton-Moore, Carolyn] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Bolton-Moore, Carolyn] Univ N Carolina, Chapel Hill, NC USA; [Timmerman, Venessa] Univ Cape Town, Lung Inst, Knowledge Translat Unit, ZA-7925 Cape Town, South Africa; [Moultrie, Harry] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Harriet Shezi Childrens Clin, Chris Hani Baragwanath Hosp,Fac Hlth Sci, Johannesburg, South Africa; [Ndirangu, James] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa; [Rabie, Helena] Univ Stellenbosch, Tygerberg Acad Hosp, ZA-7600 Stellenbosch, South Africa; [Technau, Karl] Rahima Moosa Mother & Child Hosp, Empilweni Serv & Res Unit, Johannesburg, South Africa; [Technau, Karl] Univ Witwatersrand, Johannesburg, South Africa; [Giddy, Janet] McCord Hosp, Sinikithemba Clin, Durban, South Africa; [Keiser, Olivia; Egger, Matthias] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Eley, Brian] Univ Cape Town, Red Cross Childrens Hosp, ZA-7925 Cape Town, South Africa; [Eley, Brian] Univ Cape Town, Sch Child & Adolescent Hlth, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of North Carolina; University of North Carolina Chapel Hill; University of Cape Town; University of Witwatersrand; University of Kwazulu Natal; Stellenbosch University; University of Witwatersrand; University of Bern; University of Cape Town; University of Cape Town	Davies, MA (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa.	mary-ann.davies@uct.ac.za	Prozesky, Hans Walter/ABE-6956-2020; Moultrie, Harry/AFV-0903-2022; Boulle, Andrew/C-1413-2008; Rabie, Helena/ABH-1437-2020; Moultrie, Harry/H-1842-2014	Prozesky, Hans Walter/0000-0001-9715-3449; Moultrie, Harry/0000-0001-9722-0699; Boulle, Andrew/0000-0002-7713-8062; Rabie, Helena/0000-0001-6336-2963; Moultrie, Harry/0000-0001-9722-0699; Keiser, Olivia/0000-0001-8191-2789; Technau, Karl-Gunter/0000-0001-7367-7512; Egger, Matthias/0000-0001-7462-5132; Ndirangu, James/0000-0002-2768-5631; Bolton Moore, Carolyn/0000-0001-9103-7746	National Institutes of Health, National Institute of Allergy and Infectious Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development [2U01AI069924]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health (www.nih.gov) (National Institute of Allergy and Infectious Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development; grant number 2U01AI069924; Pls: Egger and Davies). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anaky MF, 2010, B WORLD HEALTH ORGAN, V88, P490, DOI 10.2471/BLT.09.068015; Becquet R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028510; Bourne DE, 2009, AIDS, V23, P101, DOI 10.1097/QAD.0b013e32831c54bd; Braitstein P, 2011, JAIDS-J ACQ IMM DEF, V57, pE40, DOI 10.1097/QAI.0b013e3182167f0d; Braun M, 2011, JAIDS-J ACQ IMM DEF, V56, pE122, DOI 10.1097/QAI.0b013e31820a7f2f; Calmy AL, 2011, LANCET, V377, P1546, DOI 10.1016/S0140-6736(11)60363-2; Chakanyuka-Musanhu CC, 2013, 7 INT AIDS SOC C KUA; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Cornell M, 2009, SAMJ S AFR MED J, V99, P653; Davies MA, 2009, SAMJ S AFR MED J, V99, P730; Division of AIDS, 2009, DIV AIDS TABL GRAD S; Eley B, 2006, SAMJ S AFR MED J, V96, P988; Fatti G, 2011, JAIDS-J ACQ IMM DEF, V58, pE60, DOI 10.1097/QAI.0b013e3182303c7e; Fatti G, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-46; Fenner L, 2010, JAIDS-J ACQ IMM DEF, V54, P524, DOI 10.1097/QAI.0b013e3181e0c4cf; Ferrand R, 2010, B WORLD HEALTH ORGAN, V88, P428, DOI 10.2471/BLT.09.066126; Ferrand RA, 2010, CLIN INFECT DIS, V51, P844, DOI 10.1086/656361; Ferrand RA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000178; Ferrand RA, 2009, AIDS, V23, P2039, DOI 10.1097/QAD.0b013e32833016ce; Gray GE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000227; Heidari S, 2012, JAIDS-J ACQ IMM DEF, V59, P161, DOI 10.1097/QAI.0b013e3182427029; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Iliff P, 2008, TROP MED INT HEALTH, V13, P1459, DOI 10.1111/j.1365-3156.2008.02178.x; Inwani I, 2009, JAIDS-J ACQ IMM DEF, V50, P492, DOI 10.1097/QAI.0b013e318198a8a4; Janssen N, 2010, ARCH DIS CHILD, V95, P414, DOI 10.1136/adc.2009.169367; Jaspan HB, 2008, PEDIATR INFECT DIS J, V27, P993, DOI 10.1097/INF.0b013e31817acf7b; Kankasa C, 2009, JAIDS-J ACQ IMM DEF, V51, P202, DOI 10.1097/QAI.0b013e31819c173f; Khamadi S, 2008, J TROP PEDIATRICS, V54, P370, DOI 10.1093/tropej/fmn036; Kiboneka A, 2008, AIDS, V22, P2493, DOI 10.1097/QAD.0b013e328318f148; Laughton B, 2012, AIDS, V26, P1685, DOI 10.1097/QAD.0b013e328355d0ce; Lilian RR, 2012, J CLIN MICROBIOL, V50, P2373, DOI 10.1128/JCM.00431-12; Little K, 2007, CURR HIV RES, V5, P139, DOI 10.2174/157016207780077002; Malawi Ministry of Health, 2008, GUID US ANT THER MAL; Malawi Ministry of Health, 2006, GUID US AN THER MAL; Malawi Ministry of Health, 2011, CLIN MAN HIV CHILDR; Meyers T, 2007, J INFECT DIS, V196, pS474, DOI 10.1086/521116; Mutanga JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029656; National Department of Health of South Africa, 2005, GUID MAN HIV INF CHI; National Department of Health of South Africa, 2012, CIRC MIN 2 2012 IN A; National Department of Health South Africa, 2010, GUID MAN HIV CHILDR; National Department of Health South Africa, 2004, NAT ANT TREATM GUID; Nuwagaba-Biribonwoha H, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-44; Patel SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044914; Peacock-Villada E, 2011, PEDIATRICS, V127, pE423, DOI 10.1542/peds.2009-2701; Rollins N, 2009, AIDS, V23, P1851, DOI 10.1097/QAD.0b013e32832d84fd; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; Sutcliffe CG, 2010, PEDIATR INFECT DIS J, V29, P849, DOI 10.1097/INF.0b013e3181e753a8; Sutcliffe CG, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-54; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249; Weigel R, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-80; *WHO, 2008, WHO TECHN REF GROUP; WHO, 2006, WHO CHILD GROWTH STA; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organisation, 2006, ANT THER HIV INF INF; World Health Organization, 2010, ANT THER HIV INF INF; Zanoni BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033611	57	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81037	10.1371/journal.pone.0081037	http://dx.doi.org/10.1371/journal.pone.0081037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24363808	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200015
J	Schmidt, GM; Richter, C				Schmidt, Gertraud Maria; Richter, Claudio			Coral Growth and Bioerosion of Porites lutea in Response to Large Amplitude Internal Waves	PLOS ONE			English	Article							REEF-BUILDING CORALS; GREAT-BARRIER-REEF; CLIMATE-CHANGE; ARABIAN GULF; CALCIFICATION; TEMPERATURE; RATES; PHOTOSYNTHESIS; ACIDIFICATION; COMMUNITIES	The Similan Islands (Thailand) in the Andaman Sea are exposed to large amplitude internal waves (LAIW), as evidenced by i.a. abrupt fluctuations in temperature of up to 10 degrees C at supertidal frequencies. Although LAIW have been shown to affect coral composition and framework development in shallow waters, the role of LAIW on coral growth is so far unknown. We carried out a long-term transplant experiment with live nubbins and skeleton slabs of the dominating coral Porites lutea to assess the net growth and bioerosion in LAIW-exposed and LAIW-protected waters. Depth-related, seasonal and interannual differences in LAIW-intensities on the exposed western sides of the islands allowed us to separate the effect of LAIW from other possible factors (e.g. monsoon) affecting the corals. Coral growth and bioerosion were inversely related to LAIW intensity, and positively related to coral framework development. Accretion rates of calcareous fouling organisms on the slabs were negligible compared to bioerosion, reflecting the lack of a true carbonate framework on the exposed W faces of the Similan Islands. Our findings show that LAIW may play an important, yet so far overlooked, role in controlling coral growth in tropical waters	[Schmidt, Gertraud Maria; Richter, Claudio] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Schmidt, GM (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany.	gertraud.schmidt@awi.de	Richter, Claudio/AAT-1212-2020	Richter, Claudio/0000-0002-8182-6896	German Research Foundation [RI 1074/7-1]; National Research Council of Thailand; German Federal Ministry for Education and Research [03F0608B]	German Research Foundation(German Research Foundation (DFG)); National Research Council of Thailand(National Research Council of Thailand (NRCT)); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	Funding for this study was provided by the German Research Foundation (RI 1074/7-1: Ocean-Reef Coupling in the Andaman Sea), the National Research Council of Thailand and the German Federal Ministry for Education and Research (Grant number 03F0608B, Bioacid 3.2.3, Coral calcification in marginal reefs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2005, SCI MAR, V69, P347, DOI 10.3989/scimar.2005.69n3347; Alutoin S, 2001, MAR ENVIRON RES, V52, P289, DOI 10.1016/S0141-1136(01)00105-2; Andersson AJ, 2009, BIOGEOSCIENCES, V6, P1811, DOI 10.5194/bg-6-1811-2009; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; Bates NR, 2001, LIMNOL OCEANOGR, V46, P833, DOI 10.4319/lo.2001.46.4.0833; Behera SK, 2008, GEOPHYS RES LET, V35; Birkeland C., 1997, LIFE DEATH CORAL REE; BUDDEMEIER RW, 1974, J EXP MAR BIOL ECOL, V14, P179, DOI 10.1016/0022-0981(74)90024-0; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carreiro-Silva M, 2005, CORAL REEFS, V24, P214, DOI 10.1007/s00338-004-0445-3; CHALKER BE, 1975, PROC R SOC SER B-BIO, V190, P323, DOI 10.1098/rspb.1975.0096; CHAZOTTES V, 1995, PALAEOGEOGR PALAEOCL, V113, P189, DOI 10.1016/0031-0182(95)00043-L; Chazottes V, 2002, CORAL REEFS, V21, P375, DOI 10.1007/s00338-002-0259-0; Cohen AL, 2009, OCEANOGRAPHY, V22, P118, DOI 10.5670/oceanog.2009.102; COLES SL, 1991, CORAL REEFS, V9, P231, DOI 10.1007/BF00290427; CORTES J, 1985, B MAR SCI, V36, P339; CROSSLAND CJ, 1984, MAR ECOL PROG SER, V15, P135, DOI 10.3354/meps015135; Davies P.J., 1983, Coral Reefs, V2, P27, DOI 10.1007/BF00304729; DAVIES PS, 1989, MAR BIOL, V101, P389; DENNISON WC, 1988, J EXP MAR BIOL ECOL, V115, P67, DOI 10.1016/0022-0981(88)90190-6; Edmunds PJ, 2008, MAR BIOL, V154, P153, DOI 10.1007/s00227-008-0910-6; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fabricius KE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P493, DOI 10.1007/978-94-007-0114-4_28; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Ferrier-Pages C, 2000, CORAL REEFS, V19, P103, DOI 10.1007/s003380000078; Forsman Z.H., 2003, THESIS U HOUSTON; Gattuso JP, 1999, AM ZOOL, V39, P160; Glynn Peter W., 1997, P68; GOREAU TF, 1963, ANN NY ACAD SCI, V109, P127, DOI 10.1111/j.1749-6632.1963.tb13465.x; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; HALLOCK P, 1988, PALAEOGEOGR PALAEOCL, V63, P275, DOI 10.1016/0031-0182(88)90100-9; HALLOCK P, 1986, Palaios, V1, P389, DOI 10.2307/3514476; Hassan M, 1997, THESIS U KIEL; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HUTCHINGS PA, 1986, CORAL REEFS, V4, P239, DOI 10.1007/BF00298083; Jackson C., 2004, ATLAS INTERNAL SOLIT; Jimenez C, 2010, REVMAR-REV CIENC MAR, V2, P95; Kleypas JA, 1999, AM ZOOL, V39, P146; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; LECAMPIONALSUMARD T, 1995, MAR ECOL PROG SER, V117, P149, DOI 10.3354/meps117149; Leichter JJ, 2006, MAR ECOL PROG SER, V316, P95, DOI 10.3354/meps316095; Leichter JJ, 2005, J PHYS OCEANOGR, V35, P1945, DOI 10.1175/JPO2808.1; Leichter JJ, 2003, LIMNOL OCEANOGR, V48, P1394, DOI 10.4319/lo.2003.48.4.1394; Manzello DP, 2010, LIMNOL OCEANOGR, V55, P239, DOI 10.4319/lo.2010.55.1.0239; Manzello DP, 2009, P 11 INT COR REEF S, V1, P1299; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; Marubini F, 1999, MAR ECOL PROG SER, V188, P117, DOI 10.3354/meps188117; Marubini F, 2001, MAR ECOL PROG SER, V220, P153, DOI 10.3354/meps220153; Mayfield AB, 2012, J EXP BIOL, V215, P4183, DOI 10.1242/jeb.071688; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Osorno A, 2005, CORAL REEFS, V24, P292, DOI 10.1007/s00338-005-0478-2; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pari N, 1998, MAR ECOL PROG SER, V166, P119, DOI 10.3354/meps166119; Phongsuwan N, 2008, 10 YEARS BLEACHING F; ReakaKudla ML, 1996, CORAL REEFS, V15, P101; Riegl B, 2003, CORAL REEFS, V22, P433, DOI 10.1007/s00338-003-0335-0; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Riegl B, 2001, PALAEOGEOGR PALAEOCL, V175, P79, DOI 10.1016/S0031-0182(01)00387-X; Roder C, 2011, CORAL REEFS, V30, P57, DOI 10.1007/s00338-011-0722-x; Roder C, 2010, MAR ECOL PROG SER, V412, P113, DOI 10.3354/meps08707; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; ROSE CS, 1985, PSZNI MAR ECOL, V6, P345, DOI 10.1111/j.1439-0485.1985.tb00142.x; Rotjan RD, 2008, MAR ECOL PROG SER, V367, P73, DOI 10.3354/meps07531; Saxby T, 2003, MAR ECOL PROG SER, V248, P85, DOI 10.3354/meps248085; Schmidt GM, 2012, MAR ECOL PROG SER, V456, P113, DOI 10.3354/meps09682; SCOFFIN TP, 1980, B MAR SCI, V30, P475; SCOFFIN TP, 1992, CORAL REEFS, V11, P1, DOI 10.1007/BF00291929; Scotti A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021052; Storlazzi CD, 2005, CORAL REEFS, V24, P43, DOI 10.1007/s00338-004-0430-x; Tanzil JTI, 2009, CORAL REEFS, V28, P519, DOI 10.1007/s00338-008-0457-5; Titlyanov EA, 2007, J EXP MAR BIOL ECOL, V342, P282, DOI 10.1016/j.jembe.2006.11.007; TOMASCIK T, 1987, MAR BIOL, V94, P53, DOI 10.1007/BF00392900; Tribollet A, 2005, CORAL REEFS, V24, P422, DOI 10.1007/s00338-005-0003-7; Veron J.E.N., 2000, CORALS WORLD, V1-3; Wall M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050207; Ward-Paige CA, 2005, MAR POLLUT BULL, V51, P570, DOI 10.1016/j.marpolbul.2005.04.006	80	7	7	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e73236	10.1371/journal.pone.0073236	http://dx.doi.org/10.1371/journal.pone.0073236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24363805	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200002
J	Dingle, BM; Liu, YY; Fatheree, NY; Min, J; Rhoads, JM; Tran, DQ				Dingle, Bridgette M.; Liu, Yuying; Fatheree, Nicole Y.; Min, Juleen; Rhoads, J. Marc; Tran, Dat Q.			FoxP3(+) Regulatory T Cells Attenuate Experimental Necrotizing Enterocolitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; DENDRITIC CELLS; INTESTINAL HOMEOSTASIS; AUTOIMMUNE-DISEASES; LAMINA PROPRIA; ONTOGENY; THERAPY; RAT; TRANSPLANTATION; PREVENTION	Necrotizing enterocolitis (NEC) results from severe intestinal inflammation in premature infants. FoxP3(+) regulatory T cells (Tregs) are central to gut homeostasis. While Treg proportions are significantly reduced in the ileums of premature infants with NEC, it is unknown whether they play a critical function in preventing NEC. This study investigated Treg development in newborn rat pups and their role in experimental NEC induction. Utilizing an established rat model of experimental NEC, the ontogeny of T cells and Tregs in newborn pups was characterized by flow cytometry. To investigate the functions of Tregs, newborn pups were given Tregs harvested from adult rats prior to NEC induction to assess clinical improvement and mechanisms of immune regulation. The results revealed that there were few Treg numbers in the terminal ileums of newborn rats and 8-fold reduction after NEC. Adoptive transfer of Tregs significantly improved weight loss, survival from 53% to 88%, and NEC incidence from 87% to 35%. The Tregs modulated the immune response as manifested in reduced CD80 expression on antigen presenting cells and decreased T cell activation within the mesenteric lymph nodes. These findings suggest that while Tregs are present in the intestines, their numbers might be insufficient to dampen the excessive inflammatory state in NEC. Adoptive transfer of Tregs attenuates the severity of NEC by limiting the immune response. Strategies to enhance Tregs have a therapeutic potential in controlling the development of NEC.	[Dingle, Bridgette M.; Liu, Yuying; Fatheree, Nicole Y.; Min, Juleen; Rhoads, J. Marc; Tran, Dat Q.] Univ Texas Med Sch, Dept Pediat, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston	Tran, DQ (corresponding author), Univ Texas Med Sch, Dept Pediat, Houston, TX USA.	dat.q.tran@uth.tmc.edu	Liu, Yuying/ABB-8417-2021	Liu, Yuying/0000-0003-3848-9254	National Institutes of Health [1R01HL113304-01]; Richard W. Mithoff Endowed Chair; Pediatric Department; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113304] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard W. Mithoff Endowed Chair; Pediatric Department; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Pediatric Department start-up fund and by a grant from the National Institutes of Health (1R01HL113304-01) to DQT and supplemented with funding from Richard W. Mithoff Endowed Chair (Kathleen A. Kennedy MD, MPH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Boden EK, 2008, CURR OPIN GASTROEN, V24, P733, DOI 10.1097/MOG.0b013e328311f26e; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Collins CB, 2012, GUT, V61, P1154, DOI 10.1136/gutjnl-2011-300820; Davidson TS, 2011, EUR J IMMUNOL, V41, P2862, DOI 10.1002/eji.201141503; DiPaolo RJ, 2007, J IMMUNOL, V179, P4685, DOI 10.4049/jimmunol.179.7.4685; Dvorak B, 2008, J PEDIATR GASTR NUTR, V47, P11, DOI 10.1097/MPG.0b013e3181788618; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Hardenberg G, 2011, SEMIN IMMUNOL, V23, P130, DOI 10.1016/j.smim.2011.01.012; Henry Marion C W, 2005, Semin Pediatr Surg, V14, P181, DOI 10.1053/j.sempedsurg.2005.05.007; Henry MCW, 2009, ANNU REV MED, V60, P111, DOI 10.1146/annurev.med.60.050207.092824; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lan Q, 2012, J MOL CELL BIOL, V4, P409, DOI 10.1093/jmcb/mjs040; Liedel JL, 2011, PEDIATR RES, V69, P395, DOI 10.1203/PDR.0b013e3182114ec9; Lin PW, 2008, SEMIN PERINATOL, V32, P70, DOI 10.1053/j.semperi.2008.01.004; Liu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056547; Liu YY, 2012, AM J PHYSIOL-GASTR L, V302, pG608, DOI 10.1152/ajpgi.00266.2011; Liu YY, 2009, AM J PHYSIOL-GASTR L, V297, pG442, DOI 10.1152/ajpgi.00182.2009; Luig M, 2005, J PAEDIATR CHILD H, V41, P174, DOI 10.1111/j.1440-1754.2005.00583.x; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; Michaelsson J, 2006, J IMMUNOL, V176, P5741, DOI 10.4049/jimmunol.176.10.5741; Miyara M, 2011, AUTOIMMUN REV, V10, P744, DOI 10.1016/j.autrev.2011.05.004; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Moraes-Vasconcelos D, 2008, J CLIN IMMUNOL, V28, pS11, DOI 10.1007/s10875-008-9176-5; Muller YD, 2009, XENOTRANSPLANTATION, V16, P121, DOI 10.1111/j.1399-3089.2009.00531.x; Nadler EP, 2000, J SURG RES, V92, P71, DOI 10.1006/jsre.2000.5877; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Neu Josef, 2008, Curr Gastroenterol Rep, V10, P450, DOI 10.1007/s11894-008-0084-x; NISHIZUK.Y, 1969, SCIENCE, V166, P753, DOI 10.1126/science.166.3906.753; Nolan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006600; Petrosyan M, 2009, PEDIATR SURG INT, V25, P309, DOI 10.1007/s00383-009-2344-8; Ran-Ressler RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029032; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Sakaguchi S, 2011, METHODS MOL BIOL, V707, P3, DOI 10.1007/978-1-61737-979-6_1; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; SHNEIDER BL, 1995, J CLIN INVEST, V95, P745, DOI 10.1172/JCI117722; Sodhi C, 2008, DIS MODEL MECH, V1, P94, DOI 10.1242/dmm.000315; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tang QZ, 2012, J MOL CELL BIOL, V4, P11, DOI 10.1093/jmcb/mjr047; Tayman C, 2011, PEDIATR RES, V70, P489, DOI 10.1203/PDR.0b013e31822d7ef2; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tran DQ, 2009, HUM IMMUNOL, V70, P294, DOI 10.1016/j.humimm.2009.02.007; Tran DQ, 2009, J IMMUNOL, V182, P2929, DOI 10.4049/jimmunol.0803827; Veltkamp C, 2011, GUT, V60, P1345, DOI 10.1136/gut.2010.217117; Weitkamp JH, 2013, GUT, V62, P73, DOI 10.1136/gutjnl-2011-301551; Weitkamp JH, 2009, PEDIATR DEVEL PATHOL, V12, P443, DOI 10.2350/08-09-0533.1; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zheng Y, 2004, J IMMUNOL, V172, P2778, DOI 10.4049/jimmunol.172.5.2778	53	28	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82963	10.1371/journal.pone.0082963	http://dx.doi.org/10.1371/journal.pone.0082963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367573	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300084
J	Fujiyuki, T; Yoneda, M; Yasui, F; Kuraishi, T; Hattori, S; Kwon, H; Munekata, K; Kiso, Y; Kida, H; Kohara, M; Kai, C				Fujiyuki, Tomoko; Yoneda, Misako; Yasui, Fumihiko; Kuraishi, Takeshi; Hattori, Shosaku; Kwon, Hyun-jeong; Munekata, Keisuke; Kiso, Yuri; Kida, Hiroshi; Kohara, Michinori; Kai, Chieko			Experimental Infection of Macaques with a Wild Water Bird-Derived Highly Pathogenic Avian Influenza Virus (H5N1)	PLOS ONE			English	Article							A VIRUS; MODEL; TRANSMISSION; IMMUNITY; VACCINE	Highly pathogenic avian influenza virus (HPAIV) continues to threaten human health. Non-human primate infection models of human influenza are desired. To establish an animal infection model with more natural transmission and to determine the pathogenicity of HPAIV isolated from a wild water bird in primates, we administered a Japanese isolate of HPAIV (A/whooper swan/Hokkaido/1/2008, H5N1 clade 2.3.2.1) to rhesus and cynomolgus monkeys, in droplet form, via the intratracheal route. Infection of the lower and upper respiratory tracts and viral shedding were observed in both macaques. Inoculation of rhesus monkeys with higher doses of the isolate resulted in stronger clinical symptoms of influenza. Our results demonstrate that HPAIV isolated from a water bird in Japan is pathogenic in monkeys by experimental inoculation, and provide a new method for HPAIV infection of non-human primate hosts, a good animal model for investigation of HPAIV pathogenicity.	[Fujiyuki, Tomoko; Yoneda, Misako; Kwon, Hyun-jeong; Kiso, Yuri; Kai, Chieko] Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Tokyo 108, Japan; [Yasui, Fumihiko; Munekata, Keisuke; Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Tokyo 113, Japan; [Kuraishi, Takeshi; Hattori, Shosaku] Univ Tokyo, Amami Lab Injurious Anim, Inst Med Sci, Kagoshima, Japan; [Kida, Hiroshi] Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido 060, Japan	University of Tokyo; Tokyo Metropolitan Institute of Medical Science; University of Tokyo; Hokkaido University	Kai, C (corresponding author), Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Tokyo 108, Japan.	ckai@ims.u-tokyo.ac.jp	Fujiyuki, Tomoko Kaito/GYD-6398-2022	Fujiyuki, Tomoko Kaito/0000-0001-5533-4129	Ministry of Education, Science, Culture, and Sports, Japan	Ministry of Education, Science, Culture, and Sports, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid from the Ministry of Education, Science, Culture, and Sports, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDT RF, 1974, INFECT IMMUN, V9, P101, DOI 10.1128/IAI.9.1.101-105.1974; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Chen YX, 2009, ARCH VIROL, V154, P227, DOI 10.1007/s00705-008-0277-5; Cilloniz C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000604; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Fan SF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000409; Gao P, 1999, J VIROL, V73, P3184, DOI 10.1128/JVI.73.4.3184-3189.1999; Gao RB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013315; Itoh Y, 2008, VACCINE, V26, P562, DOI 10.1016/j.vaccine.2007.11.031; Kida H, 2006, DEV BIOLOGICALS, V124, P69; Kono K, 2008, VIROLOGY, V373, P447, DOI 10.1016/j.virol.2007.12.022; Kreijtz JHCM, 2009, J INFECT DIS, V199, P405, DOI 10.1086/595984; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Okamatsu M, 2010, VIRUS GENES, V41, P351, DOI 10.1007/s11262-010-0530-3; Qureshi NR, 2006, J THORAC IMAG, V21, P259, DOI 10.1097/01.rti.0000213573.94032.53; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Sakurai A, 2011, J VIROL METHODS, V178, P75, DOI 10.1016/j.jviromet.2011.08.015; SASLAW S, 1946, J EXP MED, V84, P113, DOI 10.1084/jem.84.2.113; Sirinonthanawech N, 2011, J MED VIROL, V83, P1418, DOI 10.1002/jmv.22146; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Suzuki E, 2008, J MED VIROL, V80, P1065, DOI 10.1002/jmv.21144; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; WHEELDON EB, 1992, LAB ANIM, V26, P29, DOI 10.1258/002367792780809020; Williams PD, 1997, TOXICOL METHOD, V7, P1; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985	26	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83551	10.1371/journal.pone.0083551	http://dx.doi.org/10.1371/journal.pone.0083551			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367600	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300109
J	Horanont, T; Phithakkitnukoon, S; Leong, TW; Sekimoto, Y; Shibasaki, R				Horanont, Teerayut; Phithakkitnukoon, Santi; Leong, Tuck W.; Sekimoto, Yoshihide; Shibasaki, Ryosuke			Weather Effects on the Patterns of People's Everyday Activities: A Study Using GPS Traces of Mobile Phone Users	PLOS ONE			English	Article								This study explores the effects that the weather has on people's everyday activity patterns. Temperature, rainfall, and wind speed were used as weather parameters. People's daily activity patterns were inferred, such as place visited, the time this took place, the duration of the visit, based on the GPS location traces of their mobile phones overlaid upon Yellow Pages information. Our analysis of 31,855 mobile phone users allowed us to infer that people were more likely to stay longer at eateries or food outlets, and (to a lesser degree) at retail or shopping areas when the weather is very cold or when conditions are calm (non-windy). When compared to people's regular activity patterns, certain weather conditions affected people's movements and activities noticeably at different times of the day. On cold days, people's activities were found to be more diverse especially after 10AM, showing greatest variations between 2PM and 6PM. A similar trend is observed between 10AM and midnight on rainy days, with people's activities found to be most diverse on days with heaviest rainfalls or on days when the wind speed was stronger than 4 km/h, especially between 10AM-1AM. Finally, we observed that different geographical areas of a large metropolis were impacted differently by the weather. Using data of urban infrastructure to characterize areas, we found strong correlations between weather conditions upon people's accessibility to trains. This study sheds new light on the influence of weather conditions on human behavior, in particular the choice of daily activities and how mobile phone data can be used to investigate the influence of environmental factors on urban dynamics.	[Horanont, Teerayut; Sekimoto, Yoshihide; Shibasaki, Ryosuke] Univ Tokyo, Sch Engn, Dept Civil Engn, Tokyo, Japan; [Phithakkitnukoon, Santi] Open Univ, Comp & Commun Dept, Milton Keynes MK7 6AA, Bucks, England; [Leong, Tuck W.] Univ Technol Sydney, Fac Engn & IT, Sydney, NSW 2007, Australia	University of Tokyo; Open University - UK; University of Technology Sydney	Horanont, T (corresponding author), Univ Tokyo, Sch Engn, Dept Civil Engn, Tokyo, Japan.	teerayut@iis.u-tokyo.ac.jp	Phithakkitnukoon, Santi/E-4204-2015; Leong, Tuck W/C-7936-2017	Phithakkitnukoon, Santi/0000-0002-5716-9363; Leong, Tuck W/0000-0002-1021-9001	DIAS (Data Integration and Analysis System); GRENE (Green Net- work of Excellence) project of Ministry of Education, Culture, Sports, Science and Technology	DIAS (Data Integration and Analysis System); GRENE (Green Net- work of Excellence) project of Ministry of Education, Culture, Sports, Science and Technology	This work was supported by the DIAS (Data Integration and Analysis System) and GRENE (Green Net- work of Excellence) project of Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2005, DOTF17007 IOW STAT U; Akhtari M, 2011, MICHIGAN J BUSINESS, V4, P51; [Anonymous], DOES IT FEEL; Calabrese F., 2010, 2010 13th International IEEE Conference on Intelligent Transportation Systems (ITSC 2010), P312, DOI 10.1109/ITSC.2010.5625119; CHARRY JM, 1981, J PERS SOC PSYCHOL, V41, P185, DOI 10.1037/0022-3514.41.1.185; COHN EG, 1990, BRIT J CRIMINOL, V30, P51, DOI 10.1093/oxfordjournals.bjc.a047980; Cools M, 2010, TRANSPORT RES REC, P22, DOI 10.3141/2157-03; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Edwards C, 2010, NEW ELECTRON, V43, P19; Gonzalez MC, 2009, NATURE, V458, DOI 10.1038/nature07850; HOWARTH E, 1984, BRIT J PSYCHOL, V75, P15, DOI 10.1111/j.2044-8295.1984.tb02785.x; Isaacman S, 2011, LECT NOTES COMPUT SC, V6696, P133, DOI 10.1007/978-3-642-21726-5_9; Maze TH, 2005, TRANSPORT RES REC, P1; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Patz JA, 2000, ANNU REV PUBL HEALTH, V21, P271, DOI 10.1146/annurev.publhealth.21.1.271; Phithakkitnukoon S, 2012, PLOS ONE, V7; Phithakkitnukoon S, 2010, ACTIVITY AWARE MAP I, P14; Phithakkitnukoon S, 2012, PLOS ONE, V10; SAUNDERS EM, 1993, AM ECON REV, V83, P1337; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Statistics Bureau Ministry of Internal and Communications, 2006, 2006 EST ENT CENS; Tokyo Metropolitan Archaeological Centre, 1998, OW SIT 3; Trenberth KE, 2002, EFFECTS CHANGING CLI; Tucker P, 2007, PUBLIC HEALTH, V121, P909, DOI 10.1016/j.puhe.2007.04.009; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053; Zenrin: Maps to the Future, MAPS FUT TEL PACK	28	59	60	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81153	10.1371/journal.pone.0081153	http://dx.doi.org/10.1371/journal.pone.0081153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367481	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000328740300003
J	Kennedy, BE; LeBlanc, VG; Mailman, TM; Fice, D; Burton, I; Karakach, TK; Karten, B				Kennedy, Barry E.; LeBlanc, Veronique G.; Mailman, Tiffany M.; Fice, Debra; Burton, Ian; Karakach, Tobias K.; Karten, Barbara			Pre-Symptomatic Activation of Antioxidant Responses and Alterations in Glucose and Pyruvate Metabolism in Niemann-Pick Type C1-Deficient Murine Brain	PLOS ONE			English	Article							LIPID STORAGE DISORDER; N-TERMINAL KINASE; NCTR-BALB/C MICE; DISEASE TYPE-C; OXIDATIVE STRESS; RAT-BRAIN; CHOLESTEROL ACCUMULATION; DEHYDROGENASE ACTIVITY; NEURONAL CHOLESTEROL; HEME OXYGENASE-1	Niemann-Pick Type C (NPC) disease is an autosomal recessive neurodegenerative disorder caused in most cases by mutations in the NPC1 gene. NPC1-deficiency is characterized by late endosomal accumulation of cholesterol, impaired cholesterol homeostasis, and a broad range of other cellular abnormalities. Although neuronal abnormalities and glial activation are observed in nearly all areas of the brain, the most severe consequence of NPC1-deficiency is a near complete loss of Purkinje neurons in the cerebellum. The link between cholesterol trafficking and NPC pathogenesis is not yet clear; however, increased oxidative stress in symptomatic NPC disease, increases in mitochondrial cholesterol, and alterations in autophagy/mitophagy suggest that mitochondria play a role in NPC disease pathology. Alterations in mitochondrial function affect energy and neurotransmitter metabolism, and are particularly harmful to the central nervous system. To investigate early metabolic alterations that could affect NPC disease progression, we performed metabolomics analyses of different brain regions from age-matched wildtype and Npc1(-/-) mice at pre-symptomatic, early symptomatic and late stage disease by H-1-NMR spectroscopy. Metabolic profiling revealed markedly increased lactate and decreased acetate/acetyl-CoA levels in Npc1(-/-) cerebellum and cerebral cortex at all ages. Protein and gene expression analyses indicated a pre-symptomatic deficiency in the oxidative decarboxylation of pyruvate to acetyl-CoA, and an upregulation of glycolytic gene expression at the early symptomatic stage. We also observed a pre-symptomatic increase in several indicators of oxidative stress and antioxidant response systems in Npc1(-/-) cerebellum. Our findings suggest that energy metabolism and oxidative stress may present additional therapeutic targets in NPC disease, especially if intervention can be started at an early stage of the disease.	[Kennedy, Barry E.; LeBlanc, Veronique G.; Mailman, Tiffany M.; Fice, Debra; Karten, Barbara] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Burton, Ian; Karakach, Tobias K.] Natl Res Council Canada, Inst Marine Biosci, Halifax, NS, Canada	Dalhousie University; International Business Machines (IBM); National Research Council Canada	Karten, B (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	bkarten@dal.ca		Karakach, Tobias/0000-0003-2460-3781; Karten, Barbara/0000-0003-2395-3333	Nova Scotia Health Research Foundation (NSHRF) [MED-PROJECT-2010-6804]; Canadian Institutes of Health Research (CIHR) [MOP 110926]; NSHRF [MED-SS-2012-8683, RSH-84188]; CIHR	Nova Scotia Health Research Foundation (NSHRF); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NSHRF; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Nova Scotia Health Research Foundation (NSHRF; MED-PROJECT-2010-6804) and the Canadian Institutes of Health Research (CIHR; MOP 110926). BEK was supported by a postgraduate fellowship from the NSHRF (MED-SS-2012-8683). BK received salary support from the CIHR in regional partnership with the NSHRF (RSH-84188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Aqul A, 2011, J NEUROSCI, V31, P9404, DOI 10.1523/JNEUROSCI.1317-11.2011; Battisti C, 2003, MOVEMENT DISORD, V18, P1405, DOI 10.1002/mds.10541; Baudry M, 2003, EXP NEUROL, V184, P887, DOI 10.1016/S0014-4886(03)00345-5; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Bolton RJ, 2003, J COMPUT GRAPH STAT, V12, P121, DOI 10.1198/1061860031374; Brouns R, 2008, CLIN CHIM ACTA, V397, P27, DOI 10.1016/j.cca.2008.07.016; Butterfield DA, 2012, ANTIOXID REDOX SIGN, V17, P1610, DOI 10.1089/ars.2011.4109; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Calkins MJ, 2010, TOXICOL SCI, V115, P557, DOI 10.1093/toxsci/kfq072; Charman M, 2010, J LIPID RES, V51, P1023, DOI 10.1194/jlr.M002345; Choi JS, 2010, BIOCHEM BIOPH RES CO, V391, P147, DOI 10.1016/j.bbrc.2009.11.022; Cluzeau CVM, 2012, HUM MOL GENET, V21, P3632, DOI 10.1093/hmg/dds193; Cologna SM, 2013, J INHERIT METAB DIS; Cologna SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047845; Correia SC, 2010, J NEUROCHEM, V112, P1, DOI 10.1111/j.1471-4159.2009.06443.x; Daszykowski M, 2005, CHEMOMETR INTELL LAB, V78, P19, DOI 10.1016/j.chemolab.2004.12.002; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; de Graaf RA, 2011, NMR BIOMED, V24, P958, DOI 10.1002/nbm.1761; Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Elrick MJ, 2010, HUM MOL GENET, V19, P837, DOI 10.1093/hmg/ddp552; Barros LF, 2013, TRENDS NEUROSCI, V36, P396, DOI 10.1016/j.tins.2013.04.002; Fernandez A, 2009, J NEUROSCI, V29, P6394, DOI 10.1523/JNEUROSCI.4909-08.2009; Fu R, 2013, HUM MOL GENET; Fu R, 2010, MOL GENET METAB, V101, P214, DOI 10.1016/j.ymgme.2010.06.018; GEKAKIS N, 1994, J BIOL CHEM, V269, P3348; German DC, 2002, NEUROSCIENCE, V109, P437, DOI 10.1016/S0306-4522(01)00517-6; Gui DY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003925; Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003; Gupta V, 2010, PROTEIN SCI, V19, P2031, DOI 10.1002/pro.505; Halim ND, 2010, GLIA, V58, P1168, DOI 10.1002/glia.20996; Hassel B, 2000, MOL NEUROBIOL, V22, P21, DOI 10.1385/MN:22:1-3:021; Hawes CM, 2010, J NEUROCHEM, V114, P311, DOI 10.1111/j.1471-4159.2010.06768.x; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Huang JY, 2011, J FORMOS MED ASSOC, V110, P537, DOI 10.1016/S0929-6646(11)60080-6; Jiang XT, 2011, J LIPID RES, V52, P1435, DOI 10.1194/jlr.D015735; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Karakach TK, 2009, ANAL CHIM ACTA, V636, P163, DOI 10.1016/j.aca.2009.01.048; Karbowski M, 2012, ACTA NEUROPATHOL, V123, P157, DOI 10.1007/s00401-011-0921-0; Karten B, 2005, BIOCHEM J, V387, P779, DOI 10.1042/BJ20041694; Karten B, 2009, BBA-MOL CELL BIOL L, V1791, P659, DOI 10.1016/j.bbalip.2009.01.025; Kennedy BE, 2012, J LIPID RES, V53, P2632, DOI 10.1194/jlr.M029942; Klein A, 2011, NEUROBIOL DIS, V41, P209, DOI 10.1016/j.nbd.2010.09.008; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Kreft M, 2012, ASN NEURO, V4, DOI 10.1042/AN20120007; Kumar A, 2011, PEDIATR NEUROL, V44, P57, DOI 10.1016/j.pediatrneurol.2010.08.004; Li H, 2005, J NEUROPATH EXP NEUR, V64, P323, DOI 10.1093/jnen/64.4.323; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lopez ME, 2011, J NEUROSCI, V31, P4367, DOI 10.1523/JNEUROSCI.5981-10.2011; Lopez-Bergami P, 2010, J BIOL CHEM, V285, P903, DOI 10.1074/jbc.M109.075630; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; MacLellan DL, 2011, MOL BIOSYST, V7, P2181, DOI 10.1039/c1mb05080j; Mairet-Coello G, 2013, NEURON, V78, P94, DOI 10.1016/j.neuron.2013.02.003; Martin E, 2005, J NEUROSCI RES, V79, P240, DOI 10.1002/jnr.20293; Mochel F, 2012, J BIOL CHEM, V287, P1361, DOI 10.1074/jbc.M111.309849; MORRIS MD, 1982, AM J PATHOL, V108, P140; Mukherjee P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-37; Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004; Ordonez MP, 2012, HUM MOL GENET, V21, P2651, DOI 10.1093/hmg/dds090; Ory DS, 2004, TRENDS CARDIOVAS MED, V14, P66, DOI 10.1016/j.tcm.2003.12.003; Pacheco Chris D., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S146239940800080X; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Prasad C, 2011, BRAIN DEV-JPN, V33, P856, DOI 10.1016/j.braindev.2011.08.003; Pressey SNR, 2012, NEUROBIOL DIS, V45, P1086, DOI 10.1016/j.nbd.2011.12.027; Quistorff B, 2011, P NATL ACAD SCI USA, V108, pE21, DOI 10.1073/pnas.1017750108; Ramamurthy Santosh, 2012, Exp Neurobiol, V21, P52, DOI 10.5607/en.2012.21.2.52; Reddy JV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000019; Reid PC, 2004, J LIPID RES, V45, P582, DOI 10.1194/jlr.D300032-JLR200; Repa JJ, 2007, J NEUROSCI, V27, P14470, DOI 10.1523/JNEUROSCI.4823-07.2007; Rosenbaum AI, 2011, J NEUROCHEM, V116, P789, DOI 10.1111/j.1471-4159.2010.06976.x; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Ross JM, 2010, P NATL ACAD SCI USA, V107, P20087, DOI 10.1073/pnas.1008189107; Rothman DL, 2011, NMR BIOMED, V24, P943, DOI 10.1002/nbm.1772; Santos MS, 2001, DIABETES-METAB RES, V17, P223, DOI 10.1002/dmrr.200; Schipper HM, 2009, J NEUROCHEM, V110, P469, DOI 10.1111/j.1471-4159.2009.06160.x; Schousboe A, 2007, NEUROTOX RES, V12, P263, DOI 10.1007/BF03033909; Serres S, 2008, J CEREBR BLOOD F MET, V28, P712, DOI 10.1038/sj.jcbfm.9600568; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Shih AY, 2005, J BIOL CHEM, V280, P22925, DOI 10.1074/jbc.M414635200; SHIO H, 1982, AM J PATHOL, V108, P150; Shulman RG, 2004, TRENDS NEUROSCI, V27, P489, DOI 10.1016/j.tins.2004.06.005; Soanes KH, 2011, J PROTEOME RES, V10, P5102, DOI 10.1021/pr2005549; Song W, 2006, J CELL PHYSIOL, V206, P655, DOI 10.1002/jcp.20509; Stacpoole PW, 2012, AGING CELL, V11, P371, DOI 10.1111/j.1474-9726.2012.00805.x; Stobart JL, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00038; Suzuki H, 2003, PEDIATR INT, V45, P1, DOI 10.1046/j.1442-200X.2003.01651.x; TRAXINGER RR, 1990, BIOCHEM INT, V22, P607; Tsang TM, 2009, NEUROCHEM RES, V34, P1261, DOI 10.1007/s11064-008-9904-5; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Vance JE, 2011, CURR OPIN LIPIDOL, V22, P204, DOI 10.1097/MOL.0b013e3283453e69; Vargas MR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001094; Vazquez MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028777; Vazquez MC, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/205713; Verwaest KA, 2011, BBA-MOL BASIS DIS, V1812, P1371, DOI 10.1016/j.bbadis.2011.08.001; Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5; Voikar V, 2002, BEHAV BRAIN RES, V132, P1, DOI 10.1016/S0166-4328(01)00380-1; Walkley SU, 2004, BBA-MOL CELL BIOL L, V1685, P48, DOI 10.1016/j.bbalip.2004.08.011; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; Wu HF, 2008, ANAL BIOCHEM, V372, P204, DOI 10.1016/j.ab.2007.10.002; Wyss MT, 2011, J NEUROSCI, V31, P7477, DOI 10.1523/JNEUROSCI.0415-11.2011; Xie CL, 2003, J LIPID RES, V44, P1780, DOI 10.1194/jlr.M300164-JLR200; YANG SY, 1987, J BIOL CHEM, V262, P13027; Yu WX, 2005, J BIOL CHEM, V280, P11731, DOI 10.1074/jbc.M412898200; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zhang M, 2008, J NEUROSCI RES, V86, P2848, DOI 10.1002/jnr.21730; Zhou Q, 2008, J NEUROCHEM, V104, P325, DOI 10.1111/j.1471-4159.2007.04957.x; Zhou QQ, 2009, FEBS LETT, V583, P1132, DOI 10.1016/j.febslet.2009.02.043	115	33	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82685	10.1371/journal.pone.0082685	http://dx.doi.org/10.1371/journal.pone.0082685			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367541	Green Published, gold			2022-12-27	WOS:000328740300056
J	Lengacher, S; Nehiri-Sitayeb, T; Steiner, N; Carneiro, L; Favrod, C; Preitner, F; Thorens, B; Stehle, JC; Dix, L; Pralong, F; Magistretti, PJ; Pellerin, L				Lengacher, Sylvain; Nehiri-Sitayeb, Touria; Steiner, Nadia; Carneiro, Lionel; Favrod, Celine; Preitner, Frederic; Thorens, Bernard; Stehle, Jean-Christophe; Dix, Laure; Pralong, Francois; Magistretti, Pierre J.; Pellerin, Luc			Resistance to Diet-Induced Obesity and Associated Metabolic Perturbations in Haploinsufficient Monocarboxylate Transporter 1 Mice	PLOS ONE			English	Article							DE-NOVO LIPOGENESIS; HIGH-FAT DIET; CELLULAR EXPRESSION; LACTATE; MOUSE; RAT; DEFICIENCY; LEPTIN; EXERCISE; MCT1	The monocarboxylate transporter 1 (MCT1 or SLC16A1) is a carrier of short-chain fatty acids, ketone bodies, and lactate in several tissues. Genetically modified C57BL/6J mice were produced by targeted disruption of the mct1 gene in order to understand the role of this transporter in energy homeostasis. Null mutation was embryonically lethal, but MCT1(+/-) mice developed normally. However, when fed high fat diet (HFD), MCT1(+/-) mice displayed resistance to development of diet-induced obesity (24.8% lower body weight after 16 weeks of HFD), as well as less insulin resistance and no hepatic steatosis as compared to littermate MCT1(+/+) mice used as controls. Body composition analysis revealed that reduced weight gain in MCT1(+/-) mice was due to decreased fat accumulation (50.0% less after 9 months of HFD) notably in liver and white adipose tissue. This phenotype was associated with reduced food intake under HFD (12.3% less over 10 weeks) and decreased intestinal energy absorption (9.6% higher stool energy content). Indirect calorimetry measurements showed similar to 15% increase in O-2 consumption and CO2 production during the resting phase, without any changes in physical activity. Determination of plasma concentrations for various metabolites and hormones did not reveal significant changes in lactate and ketone bodies levels between the two genotypes, but both insulin and leptin levels, which were elevated in MCT1(+/+) mice when fed HFD, were reduced in MCT1(+/-) mice under HFD. Interestingly, the enhancement in expression of several genes involved in lipid metabolism in the liver of MCT1(+/+) mice under high fat diet was prevented in the liver of MCT1(+/-) mice under the same diet, thus likely contributing to the observed phenotype. These findings uncover the critical role of MCT1 in the regulation of energy balance when animals are exposed to an obesogenic diet.	[Lengacher, Sylvain; Nehiri-Sitayeb, Touria; Steiner, Nadia; Carneiro, Lionel; Favrod, Celine; Pellerin, Luc] Univ Lausanne, Dept Physiol, Lausanne, Switzerland; [Lengacher, Sylvain; Magistretti, Pierre J.] Ecole Polytech Fed Lausanne, Lab Neuroenerget & Cellular Dynam, Brain & Mind Inst, Lausanne, Switzerland; [Preitner, Frederic; Thorens, Bernard] Univ Lausanne, Mouse Metab Evaluat Facil, Ctr Integrat Genom, Lausanne, Switzerland; [Stehle, Jean-Christophe; Dix, Laure] CHU Vaudois, Mouse Pathol Facil, Inst Univ Pathol, CH-1011 Lausanne, Switzerland; [Pralong, Francois] CHU Vaudois, Serv Endocrinol Diabetol & Metab, CH-1011 Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Pellerin, L (corresponding author), Univ Lausanne, Dept Physiol, Lausanne, Switzerland.	Luc.Pellerin@unil.ch	Lengacher, Sylvain/C-2591-2009; Carneiro, Lionel/AAE-9251-2020; Pellerin, Luc/A-8912-2017	Lengacher, Sylvain/0000-0003-2190-9654; Carneiro, Lionel/0000-0001-8493-4879; Pellerin, Luc/0000-0002-1016-1970; Magistretti, Pierre Julius/0000-0002-6678-320X	Human Frontier Science Program [RG118/1998-B]; Swiss Fonds National de Recherche Scientifique [3100A0-100679, 31003A-112119, 31003A-125063, 31003A-140957]	Human Frontier Science Program(Human Frontier Science Program); Swiss Fonds National de Recherche Scientifique	TNS received the Bernard Beaufrere young investigator prize from the Institut Francais pour la Nutrition. This project, which was initiated in 1998, was initially supported by grant no RG118/1998-B from the Human Frontier Science Program to LP. Then, it received the continuous support from the Swiss Fonds National de Recherche Scientifique through grant nos 3100A0-100679, 31003A-112119, 31003A-125063 and 31003A-140957 to LP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainscow EK, 2002, J PHYSIOL-LONDON, V544, P429, DOI 10.1113/jphysiol.2002.022434; Alvaro A, 2008, IUBMB LIFE, V60, P757, DOI 10.1002/iub.110; BROOKS GA, 1986, MED SCI SPORT EXER, V18, P360, DOI 10.1249/00005768-198606000-00019; Cha SH, 2009, BIOCHEM BIOPH RES CO, V386, P212, DOI 10.1016/j.bbrc.2009.06.017; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; Farooqi IS, 2001, NATURE, V414, P34, DOI 10.1038/35102112; Frederico MJS, 2011, SCAND J GASTROENTERO, V46, P1381, DOI 10.3109/00365521.2011.613945; Fukao T, 2004, PROSTAG LEUKOTR ESS, V70, P243, DOI 10.1016/j.plefa.2003.11.001; GERTZ EW, 1988, J CLIN INVEST, V82, P2017, DOI 10.1172/JCI113822; Hajduch E, 2000, FEBS LETT, V479, P89, DOI 10.1016/S0014-5793(00)01889-5; Iwanaga T, 2006, BIOMED RES-TOKYO, V27, P243, DOI 10.2220/biomedres.27.243; Jang C, 2008, J CELL BIOL, V183, P11, DOI 10.1083/jcb.200807052; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; KATZ J, 1993, J BIOL CHEM, V268, P25509; Kim EJ, 2010, J MED FOOD, V13, P743, DOI 10.1089/jmf.2009.1350; Kokorovic A, 2009, J CELL MOL MED, V13, P4403, DOI 10.1111/j.1582-4934.2008.00596.x; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Krude H, 2003, J CLIN ENDOCR METAB, V88, P4633, DOI 10.1210/jc.2003-030502; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Laeger T, 2010, APPETITE, V54, P450, DOI 10.1016/j.appet.2010.04.005; Maekawa F, 2008, J NEUROCHEM, V107, P789, DOI 10.1111/j.1471-4159.2008.05650.x; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; McCullagh KJA, 1996, AM J PHYSIOL-ENDOC M, V271, pE143, DOI 10.1152/ajpendo.1996.271.1.E143; Mercader J, 2009, AM J PHYSIOL-ENDOC M, V297, pE184, DOI 10.1152/ajpendo.00163.2009; Morris AAM, 2005, J INHERIT METAB DIS, V28, P109, DOI 10.1007/s10545-005-5518-0; Morrison CD, 2009, BBA-MOL BASIS DIS, V1792, P409, DOI 10.1016/j.bbadis.2008.09.005; Nagai A, 2010, PLACENTA, V31, P126, DOI 10.1016/j.placenta.2009.11.013; Park S, 2011, BRAIN RES, V1401, P95, DOI 10.1016/j.brainres.2011.05.040; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Powell DR, 2006, OBES REV, V7, P89, DOI 10.1111/j.1467-789X.2006.00220.x; Ritzhaupt A, 1998, J PHYSIOL-LONDON, V513, P719, DOI 10.1111/j.1469-7793.1998.719ba.x; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Sunny NE, 2010, AM J PHYSIOL-ENDOC M, V298, pE1226, DOI 10.1152/ajpendo.00033.2010; Tabarin A, 2005, DIABETES, V54, P3510, DOI 10.2337/diabetes.54.12.3510; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583; TRISCARI J, 1982, METABOLISM, V31, P223, DOI 10.1016/0026-0495(82)90057-9; van Dyken R, 2010, PSYCHONEUROENDOCRINO, V35, P1287, DOI 10.1016/j.psyneuen.2010.02.016; van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; WINDER WW, 1975, CAN J PHYSIOL PHARM, V53, P86, DOI 10.1139/y75-011; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783; Zadravec D, 2010, FASEB J, V24, P4366, DOI 10.1096/fj.09-152298; Zambell KL, 2003, J NUTR, V133, P3509, DOI 10.1093/jn/133.11.3509; Ziegler A, 2002, NMR BIOMED, V15, P222, DOI 10.1002/nbm.764	49	51	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82505	10.1371/journal.pone.0082505	http://dx.doi.org/10.1371/journal.pone.0082505			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367518	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300035
J	Martinelli, P; Sperduti, M; Devauchelle, AD; Kalenzaga, S; Gallarda, T; Lion, S; Delhommeau, M; Anssens, A; Amado, I; Meder, JF; Krebs, MO; Oppenheim, C; Piolino, P				Martinelli, Penelope; Sperduti, Marco; Devauchelle, Anne-Dominique; Kalenzaga, Sandrine; Gallarda, Thierry; Lion, Stephanie; Delhommeau, Marion; Anssens, Adele; Amado, Isabelle; Meder, Jean Francois; Krebs, Marie-Odile; Oppenheim, Catherine; Piolino, Pascale			Age-Related Changes in the Functional Network Underlying Specific and General Autobiographical Memory Retrieval: A Pivotal Role for the Anterior Cingulate Cortex	PLOS ONE			English	Article							WORKING-MEMORY; PREFRONTAL CORTEX; EPISODIC MEMORY; EXECUTIVE FUNCTIONS; PERSONAL EVENTS; COUNTING STROOP; OLDER-ADULTS; SELF; NEUROANATOMY; BRAIN	Age-related changes in autobiographical memory (AM) recall are characterized by a decline in episodic details, while semantic aspects are spared. This deleterious effect is supposed to be mediated by an inefficient recruitment of executive processes during AM retrieval. To date, contrasting evidence has been reported on the neural underpinning of this decline, and none of the previous studies has directly compared the episodic and semantic aspects of AM in elderly. We asked 20 young and 17 older participants to recall specific and general autobiographical events (i.e., episodic and semantic AM) elicited by personalized cues while recording their brain activity by means of fMRI. At the behavioral level, we confirmed that the richness of episodic AM retrieval is specifically impoverished in aging and that this decline is related to the reduction of executive functions. At the neural level, in both age groups, we showed the recruitment of a large network during episodic AM retrieval encompassing prefrontal, cortical midline and posterior regions, and medial temporal structures, including the hippocampus. This network was very similar, but less extended, during semantic AM retrieval. Nevertheless, a greater activity was evidenced in the dorsal anterior cingulate cortex (dACC) during episodic, compared to semantic AM retrieval in young participants, and a reversed pattern in the elderly. Moreover, activity in dACC during episodic AM retrieval was correlated with inhibition and richness of memories in both groups. Our findings shed light on the direct link between episodic AM retrieval, executive control, and their decline in aging, proposing a possible neuronal signature. They also suggest that increased activity in dACC during semantic AM retrieval in the elderly could be seen as a compensatory mechanism underpinning successful AM performance observed in aging. These results are discussed in the framework of recently proposed models of neural reorganization in aging.	[Martinelli, Penelope; Sperduti, Marco; Kalenzaga, Sandrine; Delhommeau, Marion; Anssens, Adele; Piolino, Pascale] Univ Paris 05, Lab Memory & Cognit, Boulogne, France; [Martinelli, Penelope; Sperduti, Marco; Kalenzaga, Sandrine; Gallarda, Thierry; Delhommeau, Marion; Anssens, Adele; Amado, Isabelle; Krebs, Marie-Odile; Piolino, Pascale] Univ Paris 05, Ctr Psychiat & Neurosci, INSERM, UMR S894, Paris, France; [Devauchelle, Anne-Dominique; Lion, Stephanie; Meder, Jean Francois; Oppenheim, Catherine] Univ Paris 05, Dept Radiol, Ctr Psychiat & Neurosci, INSERM,U894, Paris, France; [Gallarda, Thierry; Amado, Isabelle; Krebs, Marie-Odile] Ctr Hosp St Anne, Lab Physiopathol Psychiat Dis, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite	Piolino, P (corresponding author), Univ Paris 05, Lab Memory & Cognit, Boulogne, France.	pascale.piolino@parisdescartes.fr	Sperduti, Marco/AFN-4311-2022; Krebs, Marie-Odile/O-2104-2017; Piolino, pascale/F-8075-2014; Oppenheim, Catherine/N-1635-2018	Krebs, Marie-Odile/0000-0002-4715-9890; Piolino, pascale/0000-0002-7787-924X; Lion, Stephanie/0000-0003-4195-1892; Meder, Jean-Francois/0000-0002-0898-0133; Oppenheim, Catherine/0000-0003-3410-0862; Sperduti, Marco/0000-0002-0974-8811	National Hospital Clinical Research Program (NEMAUVI); Institut Universitaire de France; Ministry of Higher Education and Research of France	National Hospital Clinical Research Program (NEMAUVI); Institut Universitaire de France; Ministry of Higher Education and Research of France	This work was supported by the National Hospital Clinical Research Program (NEMAUVI to TG and PP), the Institut Universitaire de France (to PP), and the Ministry of Higher Education and Research of France (thesis funding to PM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2008, PSYCHOL SCI, V19, P33, DOI 10.1111/j.1467-9280.2008.02043.x; Addis DR, 2011, NEUROPSYCHOLOGIA, V49, P3656, DOI 10.1016/j.neuropsychologia.2011.09.021; Addis DR, 2004, NEUROIMAGE, V23, P1460, DOI 10.1016/j.neuroimage.2004.08.007; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A., 1986, AUTOBIOGRAPHICAL MEM, P225; Baena E, 2010, NEUROPSYCHOLOGIA, V48, P319, DOI 10.1016/j.neuropsychologia.2009.09.021; Barsalou L.W., 1988, REMEMBERING RECONSID, P193, DOI [10.1017/CBO9780511664014.009, DOI 10.1017/CBO9780511664014.009]; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; Cappell KA, 2010, CORTEX, V46, P462, DOI 10.1016/j.cortex.2009.11.009; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; Conway MA, 2001, J MEM LANG, V45, P493, DOI 10.1006/jmla.2001.2781; Coste C, 2011, CORTEX, V47, P771, DOI 10.1016/j.cortex.2010.07.004; Deltour J. J., 1993, ECHELLE VOCABULAIRE; Denkova E, 2006, NEUROSCI LETT, V407, P32, DOI 10.1016/j.neulet.2006.07.075; Donix M, 2010, ARCH CLIN NEUROPSYCH, V25, P383, DOI 10.1093/arclin/acq037; Ford JH, 2011, NEUROPSYCHOLOGIA, V49, P2514, DOI 10.1016/j.neuropsychologia.2011.04.032; Gardini S, 2006, NEUROIMAGE, V30, P645, DOI 10.1016/j.neuroimage.2005.10.012; Gilboa A, 2004, CEREB CORTEX, V14, P1214, DOI 10.1093/cercor/bhh082; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; Gutchess AH, 2007, SOC NEUROSCI-UK, V2, P117, DOI 10.1080/17470910701399029; Hedden T, 2010, NEUROIMAGE, V51, P421, DOI 10.1016/j.neuroimage.2010.01.089; Holland AC, 2011, NEUROPSYCHOLOGIA, V49, P3164, DOI 10.1016/j.neuropsychologia.2011.07.015; HOLLAND CA, 1990, Q J EXP PSYCHOL-A, V42, P441, DOI 10.1080/14640749008401232; Jacques PLS, 2012, NEUROBIOL AGING, V33, P1298, DOI 10.1016/j.neurobiolaging.2010.11.007; Karusu T.B., 1976, GERIATRIC PSYCHIAT, P77; Klein SB, 2010, ANN NY ACAD SCI, V1191, P1, DOI 10.1111/j.1749-6632.2010.05441.x; Levine B, 2004, J COGNITIVE NEUROSCI, V16, P1633, DOI 10.1162/0898929042568587; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; Maguire EA, 2003, BRAIN, V126, P1511, DOI 10.1093/brain/awg157; Martinelli P, 2013, NEUROPSYCHOLOGY, V27, P69, DOI 10.1037/a0030453; Martinelli P, 2013, HUM BRAIN MAPP, V34, P1515, DOI 10.1002/hbm.22008; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moscovitch M, 2005, J ANAT, V207, P35, DOI 10.1111/j.1469-7580.2005.00421.x; Moscovitch M, 1997, NEUROPSYCHOLOGIA, V35, P1017, DOI 10.1016/S0028-3932(97)00028-6; Nadel L., 2007, NEURAL PLASTICITY, V90472; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park D. C., 2005, COGNITIVE NEUROSCIEN, P218; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Picard L, 2012, CHILD DEV, V83, P1037, DOI 10.1111/j.1467-8624.2012.01736.x; Piolino P, 2004, NEUROIMAGE, V22, P1371, DOI 10.1016/j.neuroimage.2004.02.025; Piolino P, 2002, MEMORY, V10, P239, DOI 10.1080/09658210143000353; Piolino P, 2008, HIPPOCAMPUS, V18, P445, DOI 10.1002/hipo.20406; Piolino P, 2006, PSYCHOL AGING, V21, P510, DOI 10.1037/0882-7974.21.3.510; Piolino P, 2010, NEUROPSYCHOLOGIA, V48, P429, DOI 10.1016/j.neuropsychologia.2009.09.035; Piolino P, 2009, NEUROPSYCHOLOGIA, V47, P2314, DOI 10.1016/j.neuropsychologia.2009.01.020; Quinette P, 2006, NEUROPSYCHOLOGIA, V44, P2508, DOI 10.1016/j.neuropsychologia.2006.03.031; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reuter-Lorenz P. A., 2005, COGNITIVE NEUROSCIEN, P186, DOI DOI 10.1093/ACPROF:OSO/9780195156744.003.0003; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Reuter-Lorenz PA, 2010, J GERONTOL B-PSYCHOL, V65, P405, DOI 10.1093/geronb/gbq035; Ros L, 2010, AGING NEUROPSYCHOL C, V17, P89, DOI 10.1080/13825580903042650; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sperduti M, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00041; St Jacques PL, 2007, MEMORY, V15, P129, DOI 10.1080/09658210601119762; St-Laurent M, 2011, J COGNITIVE NEUROSCI, V23, P4150, DOI 10.1162/jocn_a_00079; Steinvorth S, 2006, NEUROIMAGE, V30, P285, DOI 10.1016/j.neuroimage.2005.09.025; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaidya JG, 2007, NEUROIMAGE, V37, P1346, DOI 10.1016/j.neuroimage.2007.06.015; VANDENBERG SG, 1978, PERCEPT MOTOR SKILL, V47, P599, DOI 10.2466/pms.1978.47.2.599; Viard A, 2007, CEREB CORTEX, V17, P2453, DOI 10.1093/cercor/bhl153; Viard A, 2010, HIPPOCAMPUS, V20, P153, DOI 10.1002/hipo.20601; Wechsler D, 2000, ECHELLE INTELLIGENCE; Weissman DH, 2005, CEREB CORTEX, V15, P229, DOI 10.1093/cercor/bhh125; Weissman DH, 2003, NEUROIMAGE, V19, P1361, DOI 10.1016/S1053-8119(03)00167-8; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	79	37	38	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82385	10.1371/journal.pone.0082385	http://dx.doi.org/10.1371/journal.pone.0082385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367516	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300032
J	Simon, G; Lanoe, C; Poirel, N; Rossi, S; Lubin, A; Pineau, A; Houde, O				Simon, Gregory; Lanoe, Celine; Poirel, Nicolas; Rossi, Sandrine; Lubin, Amelie; Pineau, Arlette; Houde, Olivier			Dynamics of the Anatomical Changes That Occur in the Brains of Schoolchildren as They Learn to Read	PLOS ONE			English	Article							GRAY-MATTER VOLUME; WORD FORM AREA; LANGUAGE AREAS; FMRI; NETWORKS; CONNECTIVITY; CHILDREN; METAANALYSIS; ACTIVATION; MECHANISMS	Although the functional brain network involved in reading for adults and children is now well documented, a critical lack of knowledge still exists about the structural development of these brain areas. To provide a better overview of the structural dynamics of the brain that sustain reading acquisition, we acquired anatomical MRI brain images from 55 children that were divided into two groups: one prior to the formal learning of reading (n = 33, 5-6 years old) and the second a few years after formal learning (n = 22, 9-10 years old). Reading performances were collected based on the "Alouette-R" test, a standardized test for reading text in French. Voxel-based morphometry analysis of gray matter showed that only the right insula volume was different between the two groups. Moreover, the reading group showed that the volumes of the left fusiform gyrus (corresponding to the well-known visual word form area, VWFA), the anterior part of the left inferior occipital gyrus and the left thalamus were significantly modulated by reading performance. This study reinforces the crucial role of the Visual Word Form Area in reading and correlation analyses performed between ROIs volumes suggesting that the VWFA is fully connected with the traditional left-hemispheric language brain network.	[Simon, Gregory; Lanoe, Celine; Poirel, Nicolas; Rossi, Sandrine; Lubin, Amelie; Pineau, Arlette; Houde, Olivier] Univ Paris 05, Sorbonne Paris Cite, Unite CNRS 3521, Lab Pychol Dev & Educ Enfant,LaPsyDE, Paris, France; [Simon, Gregory; Lanoe, Celine; Poirel, Nicolas; Rossi, Sandrine; Lubin, Amelie; Pineau, Arlette; Houde, Olivier] Univ Caen, Unite CNRS 3521, LaPsyDE, Lab Pychol Dev & Educ Enfant, F-14032 Caen, France; [Poirel, Nicolas; Houde, Olivier] IUF, Paris, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Caen Normandie	Simon, G (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Unite CNRS 3521, Lab Pychol Dev & Educ Enfant,LaPsyDE, Paris, France.	gregory.simon@unicaen.fr	simon, gregory/B-7275-2008; Rossi, Sandrine/B-8667-2008; LUBIN, Amelie/B-8865-2008	simon, gregory/0000-0001-6506-9349; Rossi, Sandrine/0000-0001-9285-2152; LUBIN, Amelie/0000-0002-5277-6172; Garbui, Maria Cristina/0000-0003-2100-9461; Poirel, Nicolas/0000-0002-3972-2575				Brambati SM, 2004, NEUROLOGY, V63, P742, DOI 10.1212/01.WNL.0000134673.95020.EE; Carreiras M, 2009, NATURE, V461, P983, DOI 10.1038/nature08461; Church JA, 2008, CEREB CORTEX, V18, P2054, DOI 10.1093/cercor/bhm228; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140; DEJERINE J., 1892, MEMOIRES SOC BIOL, V4, P61; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Epelbaum S, 2008, CORTEX, V44, P962, DOI 10.1016/j.cortex.2008.05.003; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fan Y, 2011, NEUROIMAGE, V54, P1862, DOI 10.1016/j.neuroimage.2010.07.025; Fiebach CJ, 2002, J COGNITIVE NEUROSCI, V14, P11, DOI 10.1162/089892902317205285; Frye RE, 2010, CEREB CORTEX, V20, P2625, DOI 10.1093/cercor/bhq010; Gaillard WD, 2003, NEUROLOGY, V60, P94, DOI 10.1212/WNL.60.1.94; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hoeft F, 2007, P NATL ACAD SCI USA, V104, P4234, DOI 10.1073/pnas.0609399104; Houde O, 2010, DEVELOPMENTAL SCI, V13, P876, DOI 10.1111/j.1467-7687.2009.00938.x; Ilg R, 2008, J NEUROSCI, V28, P4210, DOI 10.1523/JNEUROSCI.5722-07.2008; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Koyama MS, 2011, J NEUROSCI, V31, P8617, DOI 10.1523/JNEUROSCI.4865-10.2011; Krafnick AJ, 2011, NEUROIMAGE, V57, P733, DOI 10.1016/j.neuroimage.2010.10.062; Kuo WJ, 2001, NEUROREPORT, V12, P3997, DOI 10.1097/00001756-200112210-00029; LeFavrais P., 2005, ALOUETTE R TEST ANAL; Levy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006675; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Raschle NM, 2011, NEUROIMAGE, V57, P742, DOI 10.1016/j.neuroimage.2010.09.055; Rosen HJ, 2000, BRAIN COGNITION, V42, P201, DOI 10.1006/brcg.1999.1100; Rutter M, 2004, JAMA-J AM MED ASSOC, V291, P2007, DOI 10.1001/jama.291.16.2007; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shaywitz BA, 2007, ANN NEUROL, V61, P363, DOI 10.1002/ana.21093; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; van der Mark S, 2011, NEUROIMAGE, V54, P2426, DOI 10.1016/j.neuroimage.2010.10.002; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Vogel A.C., 2011, CEREB CORTEX; Zielinski BA, 2010, P NATL ACAD SCI USA, V107, P18191, DOI 10.1073/pnas.1003109107	37	15	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81789	10.1371/journal.pone.0081789	http://dx.doi.org/10.1371/journal.pone.0081789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367494	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300013
J	Yazdanpanah, Y; Perelman, J; DiLorenzo, MA; Alves, J; Barros, H; Mateus, C; Pereira, J; Mansinho, K; Robine, M; Park, JE; Ross, EL; Losina, E; Walensky, RP; Noubary, F; Freedberg, KA; Paltiel, AD				Yazdanpanah, Yazdan; Perelman, Julian; DiLorenzo, Madeline A.; Alves, Joana; Barros, Henrique; Mateus, Ceu; Pereira, Joao; Mansinho, Kamal; Robine, Marion; Park, Ji-Eun; Ross, Eric L.; Losina, Elena; Walensky, Rochelle P.; Noubary, Farzad; Freedberg, Kenneth A.; Paltiel, A. David			Routine HIV Screening in Portugal: Clinical Impact and Cost-Effectiveness	PLOS ONE			English	Article							MODEL PARAMETER-ESTIMATION; ANTIRETROVIRAL THERAPY; OPPORTUNISTIC INFECTIONS; UNITED-STATES; VIRUS; TRANSMISSION; LOPINAVIR/RITONAVIR; UNCERTAINTY; POPULATIONS; PREVENTION	Objective: To compare the clinical outcomes and cost-effectiveness of routine HIV screening in Portugal to the current practice of targeted and on-demand screening. Design: We used Portuguese national clinical and economic data to conduct a model-based assessment. Methods: We compared current HIV detection practices to strategies of increasingly frequent routine HIV screening in Portuguese adults aged 18-69. We considered several subpopulations and geographic regions with varying levels of undetected HIV prevalence and incidence. Baseline inputs for the national case included undiagnosed HIV prevalence 0.16%, annual incidence 0.03%, mean population age 43 years, mean CD4 count at care initiation 292 cells/mu L, 63% HIV test acceptance, 78% linkage to care, and HIV rapid test cost (sic)6 under the proposed routine screening program. Outcomes included quality-adjusted survival, secondary HIV transmission, cost, and incremental cost-effectiveness. Results: One-time national HIV screening increased HIV-infected survival from 164.09 quality-adjusted life months (QALMs) to 166.83 QALMs compared to current practice and had an incremental cost-effectiveness ratio (ICER) of (sic)28,000 per quality-adjusted life year (QALY). Screening more frequently in higher-risk groups was cost-effective: for example screening annually in men who have sex with men or screening every three years in regions with higher incidence and prevalence produced ICERs of (sic)21,000/QALY and (sic)34,000/QALY, respectively. Conclusions: One-time HIV screening in the Portuguese national population will increase survival and is cost-effective by international standards. More frequent screening in higher-risk regions and subpopulations is also justified. Given Portugal's challenging economic priorities, we recommend prioritizing screening in higher-risk populations and geographic settings.	[Yazdanpanah, Yazdan] Univ Paris Diderot, Hop Bichat, Paris, France; [Yazdanpanah, Yazdan] Univ Paris 07, INSERM, U1137, ATIP Avenir Inserm Modelisat Aide Decis & Cout Ef, Paris, France; [Perelman, Julian; Alves, Joana; Mateus, Ceu; Pereira, Joao] Univ Nova Lisboa, Escola Nacl Saude Publ, P-1200 Lisbon, Portugal; [Barros, Henrique] Univ Porto, Inst Saude Publ, P-4100 Porto, Portugal; [Mansinho, Kamal] Ctr Hosp Lisboa Ocidental, Lisbon, Portugal; [Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Losina, Elena; Walensky, Rochelle P.; Freedberg, Kenneth A.] Harvard Univ, Sch Med, Boston, MA USA; [DiLorenzo, Madeline A.; Robine, Marion; Park, Ji-Eun; Ross, Eric L.; Losina, Elena; Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [DiLorenzo, Madeline A.; Robine, Marion; Park, Ji-Eun; Ross, Eric L.; Losina, Elena; Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Losina, Elena; Walensky, Rochelle P.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Losina, Elena; Walensky, Rochelle P.; Freedberg, Kenneth A.] Harvard Ctr AIDS Res, Boston, MA USA; [Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Noubary, Farzad] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Noubary, Farzad] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA; [Paltiel, A. David] Yale Univ, Dept Hlth Policy & Management, Sch Publ Hlth, New Haven, CT USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidade Nova de Lisboa; Universidade do Porto; Centro Hospitalar de Lisboa Ocidental, EPE; Universidade de Lisboa; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston University; Boston University; Tufts Medical Center; Tufts University; Yale University	Yazdanpanah, Y (corresponding author), Univ Paris Diderot, Hop Bichat, Paris, France.	yazdan.yazdanpanah@bch.aphp.fr	Barros, Henrique/A-5488-2008; Mateus, Ceu/AAC-8146-2021; Mateus, Ceu/J-2554-2012; Barros, Henrique/Q-8609-2019; Alves, Joana/GXF-4738-2022; Alves, Joana/AGA-9322-2022; Alves, Joana/I-3308-2017; Perelman, Julian/B-4350-2013	Mateus, Ceu/0000-0001-6219-219X; Mateus, Ceu/0000-0001-6219-219X; Barros, Henrique/0000-0003-4699-6571; Alves, Joana/0000-0002-5736-6519; Alves, Joana/0000-0002-5736-6519; Walensky, Rochelle P./0000-0002-8795-379X; Losina, ELENA/0000-0002-3424-0892; Paltiel, A. David/0000-0002-4861-3290; Perelman, Julian/0000-0001-6634-9000; Ross, Eric/0000-0002-6025-2010	Coordenacao Nacional para Infeccao VIH/SIDA; Agence Nationale de Recherches sur le SIDA et les hepatites virales (ANRS); National Institute of Allergy and Infectious Diseases [R37 AI42006]; National Institute of Mental Health [R01 MH065869]; National Institute on Drug Abuse [R01 DA015612]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	Coordenacao Nacional para Infeccao VIH/SIDA; Agence Nationale de Recherches sur le SIDA et les hepatites virales (ANRS)(ANRSFrench National Research Agency (ANR)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Sources of funding: Coordenacao Nacional para Infeccao VIH/SIDA, Agence Nationale de Recherches sur le SIDA et les hepatites virales (ANRS), National Institute of Allergy and Infectious Diseases (R37 AI42006), National Institute of Mental Health (R01 MH065869), and the National Institute on Drug Abuse (R01 DA015612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ADM CENTR SIST SA, 2007, CONT AN 2006 HOSP SN; [Anonymous], 2007, EFFICACY SAFETY MARA; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Briggs AH, 2012, MED DECIS MAKING, V32, P722, DOI 10.1177/0272989X12458348; Briggs AH, 2012, VALUE HEALTH, V15, P835, DOI 10.1016/j.jval.2012.04.014; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; Edejer T, 2003, MAKING CHOICES HLTH; *EMIS, 1 EMIS; Esteves A, 2003, AIDS RES HUM RETROV, V19, P511, DOI 10.1089/088922203766774568; Frange P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031695; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Freedberg KA, 2007, AIDS, V21, pS117, DOI 10.1097/01.aids.0000279714.60935.a2; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Garattini L, 2011, EUR J HEALTH ECON, V12, P499, DOI 10.1007/s10198-011-0348-5; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Hamers FF, 2008, HIV MED, V9, P6, DOI 10.1111/j.1468-1293.2008.00584.x; *HAS, 2009, DEP INF VIH FRANC ST; International Monetary Fund Country Report, 2013, WORLD EC OUTL DAT; Jauffret Roustide M, 2006, B EPIDEMIOLOGIQUE HE, V33, P244; Johnson M, 2006, AIDS, V20, P711, DOI 10.1097/01.aids.0000216371.76689.63; Johnson M, 2005, AIDS, V19, P685, DOI 10.1097/01.aids.0000166091.39317.99; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004; McCormick AW, 2007, CLIN INFECT DIS, V44, P1115, DOI 10.1086/512816; *MIN SAUD, 2013, CAT APR PUBL SAUDE; Nelson M, 2005, JAIDS-J ACQ IMM DEF, V40, P404, DOI 10.1097/01.qai.0000185314.56556.c3; Organisation for Economic Co-operation and Development (OECD), 2011, HLTH GLANC 2011 OECD, DOI DOI 10.1787/HEALTH_; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 1998, MED DECIS MAKING, V18, pS93, DOI 10.1177/0272989X9801800211; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; PERELMAN J, 2013, REV SAUDE P IN PRESS; *PORT NAT I STAT, 2011, PORT STAT DAT 2009 2; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; RODRIGUES J, 2011, VIH PORT LISB PORT; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Seage GR, 2001, AM J EPIDEMIOL, V153, P619, DOI 10.1093/aje/153.7.619; *VIH SIDA, 2009, REC PORT TRAT INF VI; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; Walensky RP, 2011, JAIDS-J ACQ IMM DEF, V56, P26, DOI 10.1097/QAI.0b013e3181fb8f24; Walensky RP, 2010, CLIN INFECT DIS, V51, P392, DOI 10.1086/655130; Watensky RP, 2005, AM J MED, V118, P292, DOI 10.1016/j.amjmed.2004.07.055; Weinstein MC, 2001, ANN INTERN MED, V134, P440, DOI 10.7326/0003-4819-134-6-200103200-00008; *WHO, 2010, SCAL HIV TEST COUNC; *WHO, 2009, CHOOSING INT AR COST; Yazdanpanah Y, 2003, CLIN INFECT DIS, V36, P86, DOI 10.1086/344902; Yazdanpanah Y, 2001, INT J EPIDEMIOL, V30, P864, DOI 10.1093/ije/30.4.864; Yazdanpanah Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013132; 2012, PROGR NAC INF VIH SI	52	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84173	10.1371/journal.pone.0084173	http://dx.doi.org/10.1371/journal.pone.0084173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367639	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300131
J	Budde, LE; Berger, C; Lin, YK; Wang, JJ; Lin, XB; Frayo, SE; Brouns, SA; Spencer, DM; Till, BG; Jensen, MC; Riddell, SR; Press, OW				Budde, Lihua E.; Berger, Carolina; Lin, Yukang; Wang, Jinjuan; Lin, Xubin; Frayo, Shani E.; Brouns, Shaunda A.; Spencer, David M.; Till, Brian G.; Jensen, Michael C.; Riddell, Stanley R.; Press, Oliver W.			Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma	PLOS ONE			English	Article							GENE-THERAPY; ENHANCED SURVIVAL; CLINICAL-TRIAL; ADVERSE EVENT; PHASE-I; LYMPHOCYTES; COSTIMULATION; PROLIFERATION; PERSISTENCE; DEATH	Modification of T cells with chimeric antigen receptors (CAR) has emerged as a promising treatment modality for human malignancies. Integration of co-stimulatory domains into CARs can augment the activation and function of genetically targeted T cells against tumors. However, the potential for insertional mutagenesis and toxicities due to the infused cells have made development of safe methods for removing transferred cells an important consideration. We have genetically modified human T cells with a lentiviral vector to express a CD20-CAR containing both CD28 and CD137 co-stimulatory domains, a "suicide gene'' relying on inducible activation of caspase 9 (iC9), and a truncated CD19 selectable marker. Rapid expansion (2000 fold) of the transduced T cells was achieved in 28 days after stimulation with artificial antigen presenting cells. Transduced T cells exhibited effective CD20-specific cytotoxic activity in vitro and in a mouse xenograft tumor model. Activation of the iC9 suicide switch resulted in efficient removal of transduced T cells both in vitro and in vivo. Our work demonstrates the feasibility and promise of this approach for treating CD20(+) malignancies in a safe and more efficient manner. A phase I clinical trial using this approach in patients with relapsed indolent B-NHL is planned.	[Budde, Lihua E.] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA; [Budde, Lihua E.; Berger, Carolina; Lin, Yukang; Wang, Jinjuan; Lin, Xubin; Frayo, Shani E.; Brouns, Shaunda A.; Till, Brian G.; Jensen, Michael C.; Riddell, Stanley R.; Press, Oliver W.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Budde, Lihua E.; Till, Brian G.; Riddell, Stanley R.; Press, Oliver W.] Univ Washington, Dept Med, Seattle, WA USA; [Budde, Lihua E.; Till, Brian G.; Riddell, Stanley R.; Press, Oliver W.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Spencer, David M.] Baylor Coll Med, Houston, TX 77030 USA; [Spencer, David M.] Bellicum Pharmaceut Inc, Houston, TX USA; [Jensen, Michael C.] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA USA; [Riddell, Stanley R.] Tech Univ Munich, Inst Adv Study, D-80290 Munich, Germany	City of Hope; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Baylor College of Medicine; Seattle Children's Hospital; Technical University of Munich	Press, OW (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	press@uw.edu		Press, Oliver/0000-0002-3147-8037	David and Patricia Giuliani Family Foundation; Lymphoma Research Foundation; Edson Foundation; Leukemia & Lymphoma Special Fellow Award for Clinical Research; NATIONAL CANCER INSTITUTE [K23CA154874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER	David and Patricia Giuliani Family Foundation; Lymphoma Research Foundation; Edson Foundation; Leukemia & Lymphoma Special Fellow Award for Clinical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a major gift from the David and Patricia Giuliani Family Foundation (O.W.P.), a grant from the Lymphoma Research Foundation (O.W.P.), a pilot immunotherapy award from the Edson Foundation (L. E. B.), and a Leukemia & Lymphoma Special Fellow Award for Clinical Research (L. E. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker PS, 2010, GENE THER, V17, P1244, DOI 10.1038/gt.2010.62; Berger C, 2004, BLOOD, V103, P1261, DOI 10.1182/blood-2003-08-2908; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Brentjens R, 2010, MOL THER, V18, P666, DOI 10.1038/mt.2010.31; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; Check E, 2002, NATURE, V420, P116, DOI 10.1038/420116a; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Fan LF, 1999, HUM GENE THER, V10, P2273, DOI 10.1089/10430349950016924; Friedmann-Morvinski D, 2005, BLOOD, V105, P3087, DOI 10.1182/blood-2004-09-3737; Gerull S, 2007, HUM GENE THER, V18, P451, DOI 10.1089/hum.2006.039; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hoyos V, 2010, LEUKEMIA, V24, P1160, DOI 10.1038/leu.2010.75; Iuliucci JD, 2001, J CLIN PHARMACOL, V41, P870, DOI 10.1177/00912700122010771; James SE, 2009, BLOOD, V114, P5454, DOI 10.1182/blood-2009-08-232967; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Lamers C. H. J., 2006, J CLIN ONCOL, V24, pE20, DOI [10.1200/JCO.2006.05.9964, DOI 10.1200/JCO.2006.05.9964]; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Park JR, 2007, MOL THER, V15, P825, DOI 10.1038/sj.mt.6300104; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Shan DM, 1999, J IMMUNOL, V162, P6589; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Straathof KC, 2005, BLOOD, V105, P4247, DOI 10.1182/blood-2004-11-4564; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tey SK, 2007, BIOL BLOOD MARROW TR, V13, P913, DOI 10.1016/j.bbmt.2007.04.005; Till BG, 2008, BLOOD, V112, P2261, DOI 10.1182/blood-2007-12-128843; Till BG, 2012, BLOOD, V119, P3940, DOI 10.1182/blood-2011-10-387969; Wang J, 2007, HUM GENE THER, V18, P712, DOI 10.1089/hum.2007.028; Wang XL, 2011, BLOOD, V117, P1888, DOI 10.1182/blood-2010-10-310599; Zhao YB, 2009, J IMMUNOL, V183, P5563, DOI 10.4049/jimmunol.0900447; Zhong XS, 2010, MOL THER, V18, P413, DOI 10.1038/mt.2009.210; ZHOU LJ, 1991, J IMMUNOL, V147, P1424	37	143	187	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82742	10.1371/journal.pone.0082742	http://dx.doi.org/10.1371/journal.pone.0082742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358223	gold, Green Submitted, Green Published			2022-12-27	WOS:000328737700029
J	Kaser, M; Soltesz, F; Lawrence, P; Miller, S; Dodds, C; Croft, R; Dudas, RB; Zaman, R; Fernandez-Egea, E; Muller, U; Dean, A; Bullmore, ET; Nathan, PJ				Kaser, Muzaffer; Soltesz, Fruzsina; Lawrence, Phil; Miller, Sam; Dodds, Chris; Croft, Rodney; Dudas, Robert B.; Zaman, Rashid; Fernandez-Egea, Emilio; Mueller, Ulrich; Dean, Anna; Bullmore, Edward T.; Nathan, Pradeep J.			Oscillatory Underpinnings of Mismatch Negativity and Their Relationship with Cognitive Function in Patients with Schizophrenia	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; THETA-OSCILLATION; WAVELET ANALYSIS; DEFICITS; IMPAIRMENT; GENERATION; KETAMINE; DURATION; DELTA; SCALE	Background: Impairments in mismatch negativity (MMN) generation have been consistently reported in patients with schizophrenia. However, underlying oscillatory activity of MMN deficits in schizophrenia and the relationship with cognitive impairments have not been investigated in detail. Time-frequency power and phase analyses can provide more detailed measures of brain dynamics of MMN deficits in schizophrenia. Method: 21 patients with schizophrenia and 21 healthy controls were tested with a roving frequency paradigm to generate MMN. Time-frequency domain power and phase-locking (PL) analysis was performed on all trials using short-time Fourier transforms with Hanning window tapering. A comprehensive battery (CANTAB) was used to assess neurocognitive functioning. Results: Mean MMN amplitude was significantly lower in patients with schizophrenia (95% CI 0.18 - 0.77). Patients showed significantly lower EEG power (95% CI -1.02 - -0.014) in the similar to 4-7 Hz frequency range (theta band) between 170 and 210 ms. Patients with schizophrenia showed cognitive impairment in multiple domains of CANTAB. However, MMN impairments in amplitude and power were not correlated with clinical measures, medication dose, social functioning or neurocognitive performance. Conclusion: The findings from this study suggested that while MMN may be a useful marker to probe NMDA receptor mediated mechanisms and associated impairments in gain control and perceptual changes, it may not be a useful marker in association with clinical or cognitive changes. Trial-by-trial EEG power analysis can be used as a measure of brain dynamics underlying MMN deficits which also can have implications for the use of MMN as a biomarker for drug discovery.	[Kaser, Muzaffer; Dudas, Robert B.; Zaman, Rashid; Fernandez-Egea, Emilio; Mueller, Ulrich] Univ Cambridge, Dept Psychiat, Cambridge, England; [Kaser, Muzaffer] Bahcesehir Univ, Istanbul, Turkey; [Kaser, Muzaffer; Fernandez-Egea, Emilio; Bullmore, Edward T.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Soltesz, Fruzsina; Lawrence, Phil; Miller, Sam; Dodds, Chris; Bullmore, Edward T.] GlaxoSmithKline, Clin Unit Cambridge, Cambridge, England; [Croft, Rodney] Univ Wollongong, Dept Psychol, Wollongong, NSW 2500, Australia; [Dodds, Chris; Fernandez-Egea, Emilio; Mueller, Ulrich; Bullmore, Edward T.] Cambridge & Peterborough NHS Fdn Trust, Cambridge, England; [Dean, Anna; Bullmore, Edward T.; Nathan, Pradeep J.] Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Cambridge, England; [Nathan, Pradeep J.] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Nathan, Pradeep J.] UCB Pharma, Brussels, Belgium	University of Cambridge; Bahcesehir University; University of Cambridge; GlaxoSmithKline; University of Wollongong; University of Cambridge; Monash University; UCB Pharma SA	Kaser, M (corresponding author), Univ Cambridge, Dept Psychiat, Cambridge, England.	mk708@cam.ac.uk	Dudas, Robert/Y-1497-2019; Bullmore, Ed/C-1706-2012; Kaser, Muzaffer/N-7799-2013	Dudas, Robert/0000-0001-6151-2630; Bullmore, Ed/0000-0002-8955-8283; Kaser, Muzaffer/0000-0002-1106-1613; Croft, Rodney/0000-0002-5986-9136; Fernandez-Egea, Emilio/0000-0003-4128-8955	GlaxoSmithKline (GSK) Pharmaceuticals (United Kingdom Clinical Research Network Portfolio) [7470]; National Institute for Health Research [CL-2007-14-005] Funding Source: researchfish	GlaxoSmithKline (GSK) Pharmaceuticals (United Kingdom Clinical Research Network Portfolio); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by GlaxoSmithKline (GSK) Pharmaceuticals (United Kingdom Clinical Research Network Portfolio ID: 7470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astikainen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024208; Axelrod BN, 2002, ASSESSMENT, V9, P17, DOI 10.1177/1073191102009001003; Baldeweg T, 2004, SCHIZOPHR RES, V69, P203, DOI 10.1016/j.schres.2003.09.009; Barnett JH, 2010, NEUROSCI BIOBEHAV R, V34, P1161, DOI 10.1016/j.neubiorev.2010.01.012; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; BASAREROGLU C, 1992, INT J PSYCHOPHYSIOL, V13, P161, DOI 10.1016/0167-8760(92)90055-G; Bates AT, 2009, SCHIZOPHR RES, V115, P222, DOI 10.1016/j.schres.2009.09.036; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Benjamini Y, 2001, ANN STAT, V29, P1165; Bishop DVM, 2010, PSYCHOPHYSIOLOGY, V47, P697, DOI 10.1111/j.1469-8986.2009.00970.x; Bramon E, 2004, SCHIZOPHR RES, V67, P1, DOI 10.1016/S0920-9964(03)00132-4; Bright P, 2002, J INT NEUROPSYCH SOC, V8, P847, DOI 10.1017/S1355617702860131; Brockhaus-Dumke A, 2005, SCHIZOPHR RES, V73, P297, DOI 10.1016/j.schres.2004.05.016; Buchanan RW, 2007, SCHIZOPHRENIA BULL, V33, P1120, DOI 10.1093/schbul/sbm083; Butler PD, 2012, SCHIZOPHRENIA BULL, V38, P81, DOI 10.1093/schbul/sbr106; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; *CANTABECLIPSE, 2011, TEST ADM GUID; Cooper RJ, 2013, INT J PSYCHOPHYSIOL, V88, P74, DOI 10.1016/j.ijpsycho.2013.02.003; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Demiralp T, 2001, BRAIN TOPOGR, V13, P251, DOI 10.1023/A:1011102628306; Devrim-Ucok M, 2008, EUR ARCH PSY CLIN N, V258, P179, DOI 10.1007/s00406-007-0772-9; Fioravanti M, 2005, NEUROPSYCHOL REV, V15, P73, DOI 10.1007/s11065-005-6254-9; FLEMENBAUM A, 1973, PSYCHOL REP, V32, P783, DOI 10.2466/pr0.1973.33.3.783; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Fuentemilla L, 2008, BRAIN RES, V1220, P93, DOI 10.1016/j.brainres.2007.07.079; Hsiao FJ, 2009, BIOL PSYCHOL, V81, P58, DOI 10.1016/j.biopsycho.2009.01.007; Jahshan C, 2012, PSYCHOL MED, V42, P85, DOI 10.1017/S0033291711001061; Javitt DC, 1996, P NATL ACAD SCI USA, V93, P11962, DOI 10.1073/pnas.93.21.11962; Kawakubo Y, 2006, PROG NEURO-PSYCHOPH, V30, P1367, DOI 10.1016/j.pnpbp.2006.03.003; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keefe RSE, 2007, ARCH GEN PSYCHIAT, V64, P633, DOI 10.1001/archpsyc.64.6.633; Kirino E, 2007, INT J NEUROSCI, V117, P1257, DOI 10.1080/00207450600936635; Ko D, 2012, J CLIN NEUROL, V8, P35, DOI 10.3988/jcn.2012.8.1.35; Korostenskaja M, 2005, PROG NEURO-PSYCHOPH, V29, P543, DOI 10.1016/j.pnpbp.2005.01.019; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Kurtz MM, 2011, SCHIZOPHR RES, V127, P157, DOI 10.1016/j.schres.2010.12.004; Kurtz MM, 2005, SCHIZOPHR RES, V74, P15, DOI 10.1016/j.schres.2004.07.005; Lazarewicz MT, 2010, J COGNITIVE NEUROSCI, V22, P1452, DOI 10.1162/jocn.2009.21305; Leung S, 2010, PSYCHOPHARMACOLOGY, V208, P233, DOI 10.1007/s00213-009-1723-0; Levaux MN, 2007, EUR PSYCHIAT, V22, P104, DOI 10.1016/j.eurpsy.2006.11.004; Light GA, 2005, AM J PSYCHIAT, V162, P1741, DOI 10.1176/appi.ajp.162.9.1741; Light GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039434; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Michie PT, 2002, BIOL PSYCHIAT, V52, P749, DOI 10.1016/S0006-3223(02)01379-3; Mundt JC, 2002, BRIT J PSYCHIAT, V180, P461, DOI 10.1192/bjp.180.5.461; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Rasser PE, 2011, SCHIZOPHRENIA BULL, V37, P131, DOI 10.1093/schbul/sbp060; Rissling AJ, 2012, CLIN NEUROPHYSIOL, V123, P1942, DOI 10.1016/j.clinph.2012.02.079; Robbins TW, 2005, SCHIZOPHRENIA BULL, V31, P854, DOI 10.1093/schbul/sbi044; Rodionov V., 2009, Journal of Basic and Clinical Physiology and Pharmacology, V20, P233; Schall U, 1998, INT J NEUROPSYCHOP, V1, P19, DOI 10.1017/S146114579800100X; Schmidt A, 2012, NEUROPSYCHOPHARMACOL, V37, P865, DOI 10.1038/npp.2011.261; Sevik AE, 2011, SCHIZOPHR RES, V130, P195, DOI 10.1016/j.schres.2011.04.018; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; SHELLEY AM, 1991, BIOL PSYCHIAT, V30, P1059, DOI 10.1016/0006-3223(91)90126-7; STEER RA, 1993, J PERS ASSESS, V60, P532, DOI 10.1207/s15327752jpa6003_10; TALLONBAUDRY C, 2004, J NEUROSCI, V16, P4240; Tervaniemi M, 1999, CLIN NEUROPHYSIOL, V110, P1388, DOI 10.1016/S1388-2457(99)00108-X; Tikhonravov D, 2008, BRAIN RES, V1203, P97, DOI 10.1016/j.brainres.2008.02.006; Todd J, 2012, INT J PSYCHOPHYSIOL, V83, P222, DOI 10.1016/j.ijpsycho.2011.10.003; Toyomaki A, 2008, PROG NEURO-PSYCHOPH, V32, P95, DOI 10.1016/j.pnpbp.2007.07.020; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; Umbricht D, 2003, BIOL PSYCHIAT, V53, P1120, DOI 10.1016/S0006-3223(02)01642-6; van Wingerden M, 2012, NEURON, V76, P813, DOI 10.1016/j.neuron.2012.09.039; Wynn JK, 2010, BIOL PSYCHIAT, V67, P940, DOI 10.1016/j.biopsych.2009.11.024; Yordanova J, 2004, NEUROIMAGE, V22, P590, DOI 10.1016/j.neuroimage.2004.01.040; Zhou ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052186	68	25	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83255	10.1371/journal.pone.0083255	http://dx.doi.org/10.1371/journal.pone.0083255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GT	24358266	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000328737700053
J	Lee, JW; Kim, KS; An, HK; Kim, CH; Moon, HI; Lee, YC				Lee, Ji-Won; Kim, Kyoung-Sook; An, Hyun-Kyu; Kim, Cheorl-Ho; Moon, Hyung-In; Lee, Young-Choon			Dendropanoxide Induces Autophagy through ERK1/2 Activation in MG-63 Human Osteosarcoma Cells and Autophagy Inhibition Enhances Dendropanoxide-Induced Apoptosis	PLOS ONE			English	Article							DEATH; MECHANISMS; PATHWAYS; CANCER	Anticancer effects of dendropanoxide (DP) newly isolated from leaves and stem of Dendropanax morbifera Leveille were firstly investigated in this study. DP inhibited cell proliferation and induced apoptosis in dose-and time-dependent manner in MG-63 human osteosarcoma cells, which was dependent on the release of cytochrome c to the cytosol and the activation of caspases. Moreover, the DP-treated cells exhibited autophagy, as characterized by the punctuate patterns of microtubule-associated protein 1 light chain 3 (LC3) by confocal microscopy and the appearance of autophagic vacuoles by MDC staining. The expression levels of ATG7, Beclin-1 and LC3-II were also increased by DP treatment. Inhibition of autophagy by 3-methyladenine (3-MA) and wortmannin (Wort) significantly enhanced DP-induced apoptosis. DP treatment also caused a time-dependent increase in protein levels of extracellular signal-regulated kinase 1 and 2 (ERK1/2), and inhibition of ERK1/2 phosphorylation with U0126 resulted in a decreased DP-induced autophagy that was accompanied by an increased apoptosis and a decreased cell viability. These results indicate a cytoprotective function of autophagy against DP-induced apoptosis and suggest that the combination of DP treatment with autophagy inhibition may be a promising strategy for human osteosarcoma control. Taken together, this study demonstrated for the first time that DP could induce autophagy through ERK1/2 activation in human osteosarcoma cells and autophagy inhibition enhanced DP-induced apoptosis.	[Lee, Ji-Won; Kim, Kyoung-Sook; An, Hyun-Kyu; Moon, Hyung-In; Lee, Young-Choon] Dong A Univ, Coll Nat Resources & Life Sci, Pusan, South Korea; [Kim, Cheorl-Ho] Sungkyunkwan Univ, Dept Biol Sci, Mol & Cellular Glycobiol Unit, Kyonggi Do, South Korea	Dong A University; Sungkyunkwan University (SKKU)	Moon, HI (corresponding author), Dong A Univ, Coll Nat Resources & Life Sci, Pusan, South Korea.	himun68@dau.ac.kr; yclee@dau.ac.kr	Kim, Cheorl-Ho/T-6753-2019	Kim, Cheorl-Ho/0000-0002-6323-0714	Dong-A University research fund	Dong-A University research fund	This work was supported by the Dong-A University research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aredia Francesca, 2012, Cells, V1, P520, DOI 10.3390/cells1030520; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Choe YJ, 2012, ONCOL REP, V28, P2049, DOI 10.3892/or.2012.2034; Corcelle E, 2007, AUTOPHAGY, V3, P57, DOI 10.4161/auto.3424; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Ellington AA, 2006, CARCINOGENESIS, V27, P298, DOI 10.1093/carcin/bgi214; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gorlick R, 2009, CANC TREAT, V152, P467, DOI 10.1007/978-1-4419-0284-9_27; Green DR, 2005, J CLIN INVEST, V115, P2610, DOI 10.1172/JCI26321; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028491; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim HJ, 2013, INT J ONCOL, V42, P1985, DOI 10.3892/ijo.2013.1884; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Li X, 2011, TOXICOL APPL PHARM, V251, P146, DOI 10.1016/j.taap.2010.12.007; Longhi A, 2006, CANCER TREAT REV, V32, P423, DOI 10.1016/j.ctrv.2006.05.005; Mehta RG, 2010, PHARM RES-DORDR, V27, P950, DOI 10.1007/s11095-010-0085-y; Meschini S, 2008, AUTOPHAGY, V4, P1020, DOI 10.4161/auto.6952; Moon HI, 2011, HUM EXP TOXICOL, V30, P870, DOI 10.1177/0960327110382131; Notte A, 2011, BIOCHEM PHARMACOL, V82, P427, DOI 10.1016/j.bcp.2011.06.015; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916; Sivaprasad U, 2008, J CELL MOL MED, V12, P1265, DOI 10.1111/j.1582-4934.2008.00282.x; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Wang YY, 2013, TOXICOL IN VITRO, V27, P1928, DOI 10.1016/j.tiv.2013.06.001; Yee KS, 2009, CELL DEATH DIFFER, V16, P1135, DOI 10.1038/cdd.2009.28; Yu HY, 2012, J AGR FOOD CHEM, V60, P5400, DOI 10.1021/jf3014475; Yu HY, 2012, EVID-BASED COMPL ALT, V2012, DOI [10.1155/2012/637512, DOI 10.1155/2012/637512]; Zeng YJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030312, 10.1371/journal.pone.0043478]; Zhang X, 2012, CELL PROLIFERAT, V45, P466, DOI 10.1111/j.1365-2184.2012.00833.x	32	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83611	10.1371/journal.pone.0083611	http://dx.doi.org/10.1371/journal.pone.0083611			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358301	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700065
J	Hauzy, C; Nadin, G; Canard, E; Gounand, I; Mouquet, N; Ebenman, B				Hauzy, Celine; Nadin, Gregoire; Canard, Elsa; Gounand, Isabelle; Mouquet, Nicolas; Ebenman, Bo			Confronting the Paradox of Enrichment to the Metacommunity Perspective	PLOS ONE			English	Article							PREDATOR-PREY DYNAMICS; DENSITY-DEPENDENT DISPERSAL; METAPOPULATION DYNAMICS; FOOD WEBS; SPATIAL HETEROGENEITY; POPULATION-DYNAMICS; BIOLOGICAL-CONTROL; LAKE ECOSYSTEMS; NITROGEN-CYCLE; CROP PEST	Resource enrichment can potentially destabilize predator-prey dynamics. This phenomenon historically referred as the "paradox of enrichment" has mostly been explored in spatially homogenous environments. However, many predator-prey communities exchange organisms within spatially heterogeneous networks called metacommunities. This heterogeneity can result from uneven distribution of resources among communities and thus can lead to the spreading of local enrichment within metacommunities. Here, we adapted the original Rosenzweig-MacArthur predator-prey model, built to study the paradox of enrichment, to investigate the effect of regional enrichment and of its spatial distribution on predator-prey dynamics in metacommunities. We found that the potential for destabilization was depending on the connectivity among communities and the spatial distribution of enrichment. In one hand, we found that at low dispersal regional enrichment led to the destabilization of predator-prey dynamics. This destabilizing effect was more pronounced when the enrichment was uneven among communities. In the other hand, we found that high dispersal could stabilize the predator-prey dynamics when the enrichment was spatially heterogeneous. Our results illustrate that the destabilizing effect of enrichment can be dampened when the spatial scale of resource enrichment is lower than that of organismss movements (heterogeneous enrichment). From a conservation perspective, our results illustrate that spatial heterogeneity could decrease the regional extinction risk of species involved in specialized trophic interactions. From the perspective of biological control, our results show that the heterogeneous distribution of pest resource could favor or dampen outbreaks of pests and of their natural enemies, depending on the spatial scale of heterogeneity.	[Hauzy, Celine; Ebenman, Bo] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Hauzy, Celine] Univ Paris 06, Ecol & Evolut UMR7625, Paris, France; [Hauzy, Celine] INRA, Ecol Populat & Communautes USC2031, Paris, France; [Nadin, Gregoire] CNRS, UMR7598, Lab Jacques Louis, Paris, France; [Canard, Elsa; Gounand, Isabelle; Mouquet, Nicolas] Univ Montpellier 2, Inst Sci Evolut, Montpellier, France	Linkoping University; UDICE-French Research Universities; Sorbonne Universite; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Hauzy, C (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden.	celinehauzy@gmail.com	Isabelle, Gounand/ABX-7866-2022; MOUQUET, Nicolas/AAL-1440-2021	Mouquet, Nicolas/0000-0003-1840-6984; Gounand, Isabelle/0000-0002-0675-3973	Linkoping University	Linkoping University	CH and BE were supported by a Faculty grant from Linkoping University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KC, 2011, ECOL LETT, V14, P1158, DOI 10.1111/j.1461-0248.2011.01670.x; Amarasekare P, 2007, SPATIAL DYNAMICS COM, P170; Amarasekare P, 2010, J ANIM ECOL, V79, P282, DOI 10.1111/j.1365-2656.2009.01607.x; Amarasekare P, 2008, ANNU REV ECOL EVOL S, V39, P479, DOI 10.1146/annurev.ecolsys.39.110707.173434; ARDITI R, 1989, J THEOR BIOL, V139, P311, DOI 10.1016/S0022-5193(89)80211-5; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Briggs CJ, 2004, THEOR POPUL BIOL, V65, P299, DOI 10.1016/j.tpb.2003.11.001; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Chaplin-Kramer R, 2011, ECOL LETT, V14, P922, DOI 10.1111/j.1461-0248.2011.01642.x; Cooper JK, 2012, ECOL LETT, V15, P856, DOI 10.1111/j.1461-0248.2012.01808.x; Cottingham KL, 2000, ECOL LETT, V3, P340, DOI 10.1046/j.1461-0248.2000.00158.x; de Roos AM, 1998, THEOR POPUL BIOL, V53, P108, DOI 10.1006/tpbi.1997.1345; DEANGELIS DL, 1975, ECOLOGY, V56, P881, DOI 10.2307/1936298; DEROOS AM, 1991, P ROY SOC B-BIOL SCI, V246, P117, DOI 10.1098/rspb.1991.0132; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gardiner MM, 2009, ECOL APPL, V19, P143, DOI 10.1890/07-1265.1; Genkai-Kato M, 1999, P ROY SOC B-BIOL SCI, V266, P1215, DOI 10.1098/rspb.1999.0765; Hanski I., 1999, METAPOPULATION ECOLO; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; Hauzy C, 2007, J ANIM ECOL, V76, P552, DOI 10.1111/j.1365-2656.2007.01227.x; Hauzy C, 2010, J THEOR BIOL, V266, P458, DOI 10.1016/j.jtbi.2010.07.008; Holling C. S., 1959, Canadian Entomologist, V91, P385; Holyoak M, 1996, J ANIM ECOL, V65, P640, DOI 10.2307/5743; Holyoak M, 1996, ECOLOGY, V77, P1867, DOI 10.2307/2265790; HUFFAKER C. B., 1958, HILGARDIA, V27, P343; HUFFAKER C. B., 1963, HILGARDIA, V34, P305; Jansen VAA, 1995, OIKOS, V74, P384, DOI 10.2307/3545983; Janssen A, 1997, EXP APPL ACAROL, V21, P415, DOI 10.1023/A:1018479828913; KARR JR, 1982, ECOLOGY, V63, P1975, DOI 10.2307/1940137; Kindvall O, 1996, ECOLOGY, V77, P207, DOI 10.2307/2265670; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kirk KL, 1998, ECOLOGY, V79, P2456, DOI 10.1890/0012-9658(1998)079[2456:ECSPDA]2.0.CO;2; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; LUCKINBILL LS, 1973, ECOLOGY, V54, P1320, DOI 10.2307/1934194; Maser GL, 2007, J THEOR BIOL, V247, P337, DOI 10.1016/j.jtbi.2007.03.003; Massol F, 2011, ECOL LETT, V14, P313, DOI 10.1111/j.1461-0248.2011.01588.x; Matthews DP, 2007, ECOLOGY, V88, P2848, DOI 10.1890/06-1107.1; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; MCCAULEY E, 1993, AM NAT, V142, P412, DOI 10.1086/285547; MCCAULEY E, 1990, NATURE, V343, P455, DOI 10.1038/343455a0; Mouquet N, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P237; Murdoch W.W., 2003, CONSUMER RESOURCE DY; Nisbet R.M, 1993, PATCH DYNAMICS, P125; Oliver T, 2010, ECOL LETT, V13, P473, DOI 10.1111/j.1461-0248.2010.01441.x; PERSSON L, 1993, OIKOS, V66, P193, DOI 10.2307/3544805; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; Rip JMK, 2011, ECOL LETT, V14, P733, DOI 10.1111/j.1461-0248.2011.01636.x; Rooney N, 2008, ECOL LETT, V11, P867, DOI 10.1111/j.1461-0248.2008.01193.x; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; Roy S, 2007, J BIOSCIENCES, V32, P421, DOI 10.1007/s12038-007-0040-1; Ruokolainen L, 2011, J THEOR BIOL, V291, P76, DOI 10.1016/j.jtbi.2011.09.004; SCHEFFER M, 1995, ECOLOGY, V76, P2270, DOI 10.2307/1941701; Schindler DE, 2002, OIKOS, V98, P177, DOI 10.1034/j.1600-0706.2002.980201.x; Schops K., 1998, P119; Steiner CF, 2005, ECOL LETT, V8, P819, DOI 10.1111/j.1461-0248.2005.00785.x; Thies C, 2008, AGR ECOSYST ENVIRON, V125, P266, DOI 10.1016/j.agee.2007.12.011; VEILLEUX BG, 1979, J ANIM ECOL, V48, P787, DOI 10.2307/4195; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vos M, 2004, OIKOS, V105, P471, DOI 10.1111/j.0030-1299.2004.12930.x; WALDE SJ, 1994, J ANIM ECOL, V63, P337, DOI 10.2307/5552; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537	65	6	6	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82969	10.1371/journal.pone.0082969	http://dx.doi.org/10.1371/journal.pone.0082969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358242	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700099
J	Ito, S; Gojoubori, T; Tsunoda, K; Yamaguchi, Y; Asano, M; Goke, E; Koshi, R; Sugano, N; Yoshinuma, N; Komiyama, K; Ito, K				Ito, Satoshi; Gojoubori, Takahiro; Tsunoda, Kou; Yamaguchi, Yoko; Asano, Masatake; Goke, Eiji; Koshi, Ryosuke; Sugano, Naoyuki; Yoshinuma, Naoto; Komiyama, Kazuo; Ito, Koichi			Nicotine-Induced Expression of Low-Density Lipoprotein Receptor in Oral Epithelial Cells	PLOS ONE			English	Article							MEDIATED TOBACCO TOXICITY; HUMAN GINGIVAL; TRANSCRIPTIONAL REGULATION; PROMOTER ACTIVITY; GENE-REGULATION; SP1; METABOLISM; INTERLEUKIN-8; CHOLESTEROL; PATHWAY	Background: Nicotine use is one of the most important risk factors for the development of cardiovascular and periodontal diseases. Numerous reports have suggested the possible contribution of disturbed lipid metabolism for the development of both disease groups. Despite these observations, little is known about the relationship between tobacco smoking and the development of these diseases. Our previous microarray data revealed that nicotine induced low-density lipoprotein receptor (LDLR) expression in oral epithelial cells (OECs). The aim of the present study was to confirm nicotine-mediated LDLR induction and to elucidate the signaling mechanisms leading to the augmented expression of LDLR in OECs. Methods and Results: LDLR and nicotinic acetylcholine receptor (nAChR) subunit expression was detected by real-time PCR. The production of LDLR was demonstrated by immunofluorescence staining. nAChR-mediated LDLR induction was examined by pre-incubation of the cells with its specific inhibitor, a-bungarotoxin (alpha-BTX). The functional importance of transcription factor specific protein 1 (Sp1) was examined by luciferase assay, mithramycin pre-incubation or by small interfering RNA (siRNA) transfection. The specific binding of Sp1 to R3 region of LDLR 5'untranslated region was demonstrated with electrophoretic mobility shift assay (EMSA) and streptavidin-agarose precipitation assay followed by western blotting. The results confirmed that nicotine induced LDLR expression at the transcriptional level. Nicotine was sensed by nAChR and the signal was transduced by Sp1 which bound to the R3 region of LDLR gene. Augmented production of LDLR in the gingival epithelial cells was further demonstrated by immunofluorescence staining using the gingival tissues obtained from the smoking patients. Conclusions: Taken together, the results suggested that nicotine might contribute to the development of both cardiovascular and periodontal diseases by inducing the LDLR in OECs thereby disturbing lipid metabolism.	[Ito, Satoshi; Gojoubori, Takahiro; Tsunoda, Kou] Nihon Univ, Grad Sch Dent, Div Appl Oral Sci, Tokyo, Japan; [Yamaguchi, Yoko] Nihon Univ, Sch Dent, Dept Biochem, Tokyo 101, Japan; [Yamaguchi, Yoko] Nihon Univ, Sch Dent, Div Funct Morphol, Tokyo 101, Japan; [Asano, Masatake; Komiyama, Kazuo] Nihon Univ, Sch Dent, Dept Pathol, Tokyo 101, Japan; [Asano, Masatake; Komiyama, Kazuo] Nihon Univ, Sch Dent, Div Immunol & Pathobiol, Tokyo 101, Japan; [Goke, Eiji; Koshi, Ryosuke; Sugano, Naoyuki; Yoshinuma, Naoto] Nihon Univ, Sch Dent, Dept Periodontol, Tokyo 101, Japan; [Koshi, Ryosuke; Sugano, Naoyuki; Yoshinuma, Naoto] Nihon Univ, Sch Dent, Div Adv Dent Treatment, Tokyo 101, Japan; [Ito, Koichi] Nihon Univ, Sch Dent, Tokyo 101, Japan	Nihon University; Nihon University; Nihon University; Nihon University; Nihon University; Nihon University; Nihon University; Nihon University	Asano, M (corresponding author), Nihon Univ, Sch Dent, Dept Pathol, Tokyo 101, Japan.	asano.masatake@nihon-u.ac.jp	Asano, Masatake/ABH-5102-2020		Nihon University; Ministry of Education, Culture, Sports, Science, and Technology, JAPAN (MEXT) [S1001024, 23592778]; Health and Labour Sciences Research Grants; Research on international cooperation in medical science; Promotion and Mutual Aid Corporation for Private Schools of Japan	Nihon University; Ministry of Education, Culture, Sports, Science, and Technology, JAPAN (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labour Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Research on international cooperation in medical science; Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan)	This work was supported by: Nihon University Joint Research Grant for 2010-2012 (to Dr. Okayama and Dr. Imamura); a grant of Strategic Research Base Development Program for Private Universities from Ministry of Education, Culture, Sports, Science, and Technology, JAPAN (MEXT), 2010-2014 (S1001024) and 2011-2013 (23592778); Health and Labour Sciences Research Grants and Research on international cooperation in medical science; The Promotion and Mutual Aid Corporation for Private Schools of Japan (2011); Grant-in-aid for Scientific Research (C) (2011-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredondo J, 2005, AM J PATHOL, V166, P597, DOI 10.1016/S0002-9440(10)62281-X; Arredondo J, 2001, LAB INVEST, V81, P1653, DOI 10.1038/labinvest.3780379; Arredondo J, 2007, LIFE SCI, V80, P2191, DOI 10.1016/j.lfs.2007.01.013; Arredondo J, 2006, FASEB J, V20, P2093, DOI 10.1096/fj.06-6191com; Ashakumary L, 1997, LIPIDS, V32, P311, DOI 10.1007/s11745-997-0038-8; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Bigger CB, 1996, J BIOL CHEM, V271, P32842, DOI 10.1074/jbc.271.51.32842; Bigger CB, 1997, J BIOL CHEM, V272, P25976, DOI 10.1074/jbc.272.41.25976; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; BOOYSE FM, 1981, AM J PATHOL, V102, P229; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Campbell SC, 2008, ATHEROSCLEROSIS, V201, P225, DOI 10.1016/j.atherosclerosis.2008.04.046; Campos-Caro A, 1999, J BIOL CHEM, V274, P4693, DOI 10.1074/jbc.274.8.4693; Campos-Caro A, 2001, DNA CELL BIOL, V20, P657, DOI 10.1089/104454901753340640; Chattopadhyay K, 2008, INDIAN J MED RES, V127, P571; Chu SJ, 2012, GENE, V508, P1, DOI 10.1016/j.gene.2012.07.022; DAWSON PA, 1988, J BIOL CHEM, V263, P3372; Dunckley T, 2003, J BIOL CHEM, V278, P15633, DOI 10.1074/jbc.M210389200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Ito T, 2010, BIOCHEM BIOPH RES CO, V403, P161, DOI 10.1016/j.bbrc.2010.10.036; Johnson GK, 2010, J PERIODONTAL RES, V45, P583, DOI 10.1111/j.1600-0765.2009.01262.x; Kashiwagi Y, 2012, ARCH ORAL BIOL, V57, P483, DOI 10.1016/j.archoralbio.2011.10.007; Katz J, 2002, J PERIODONTOL, V73, P494, DOI 10.1902/jop.2002.73.5.494; KITA T, 2001, ANN NY ACAD SCI, V947, P196; Koshi R SN, 2007, NIHON U DENT J, V81, P571; Kuwahara J, 2000, Nucleic Acids Symp Ser, P265; Lau PP, 2006, ARTERIOSCL THROM VAS, V26, P143, DOI 10.1161/01.ATV.0000193510.19000.10; Lax P, 2002, CELL CALCIUM, V32, P53, DOI 10.1016/S0143-4160(02)00076-3; Laxman Vandana K, 2008, J Contemp Dent Pract, V9, P97; Lee J, 2012, LIFE SCI, V91, P1058, DOI 10.1016/j.lfs.2012.06.032; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Losche W, 2000, J CLIN PERIODONTOL, V27, P537, DOI 10.1034/j.1600-051x.2000.027008537.x; Mahanonda R, 2009, J PERIODONTAL RES, V44, P557, DOI 10.1111/j.1600-0765.2008.01153.x; Melnikova IN, 2000, NEUROPHARMACOLOGY, V39, P2615, DOI 10.1016/S0028-3908(00)00125-8; Melnikova IN, 2001, J BIOL CHEM, V276, P19040, DOI 10.1074/jbc.M010735200; Nguyen VT, 2000, AM J PATHOL, V157, P1377, DOI 10.1016/S0002-9440(10)64651-2; Nguyen VT, 2000, J DENT RES, V79, P939; Noack B, 2000, J PERIODONTOL, V71, P898, DOI 10.1902/jop.2000.71.6.898; Omagari D, 2011, CLIN EXP IMMUNOL, V165, P85, DOI 10.1111/j.1365-2249.2011.04404.x; Palmer RM, 2005, J CLIN PERIODONTOL, V32, P180, DOI 10.1111/j.1600-051X.2005.00786.x; Peeters AV, 1998, J LIPID RES, V39, P1021; Sakiyama Y, 2010, J PERIODONTAL RES, V45, P216, DOI 10.1111/j.1600-0765.2009.01226.x; Santanam N, 2012, ATHEROSCLEROSIS, V225, P264, DOI 10.1016/j.atherosclerosis.2012.07.041; Scofield MD, 2010, NEUROSCIENCE, V170, P1056, DOI 10.1016/j.neuroscience.2010.08.007; Smith AJP, 2007, EUR J HUM GENET, V15, P1186, DOI 10.1038/sj.ejhg.5201897; SUDHOF TC, 1987, J BIOL CHEM, V262, P10773; Sun XJ, 2009, CANCER RES, V69, P6445, DOI 10.1158/0008-5472.CAN-09-1001; Suzuki K, 2010, J PERIODONTAL RES, V45, P488, DOI 10.1111/j.1600-0765.2009.01263.x; Valor LM, 2002, J BIOL CHEM, V277, P8866, DOI 10.1074/jbc.M110454200; van der Heide F, 2009, INFLAMM BOWEL DIS, V15, P1199, DOI 10.1002/ibd.20884; YANG XD, 1995, J BIOL CHEM, V270, P8514, DOI 10.1074/jbc.270.15.8514; Yildiz D, 2004, TOXICON, V43, P619, DOI 10.1016/j.toxicon.2004.01.017	56	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82563	10.1371/journal.pone.0082563	http://dx.doi.org/10.1371/journal.pone.0082563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358207	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700082
J	Wang, Z; Wang, YN; Sun, CL; Yang, D; Su, LD; Xie, YJ; Zhou, L; Wang, Y; Shen, Y				Wang, Zhen; Wang, Ya-Nan; Sun, Cheng-Long; Yang, Dong; Su, Li-Da; Xie, Ya-Jun; Zhou, Lin; Wang, Yin; Shen, Ying			C-Terminal Domain of ICA69 Interacts with PICK1 and Acts on Trafficking of PICK1-PKC alpha Complex and Cerebellar Plasticity	PLOS ONE			English	Article							AMPA RECEPTOR TRAFFICKING; PDZ DOMAIN; CONTAINING PROTEIN; BINDING-PROTEIN; SUBUNIT GLUR2; PKC; DEPRESSION; PHOSPHORYLATION; RETENTION; LIGAND	Background: PICK1 (protein interacting with C-kinase 1) is a PKC (protein kinase C)-binding protein, which is essential for synaptic plasticity. The trafficking of PKC alpha-PICK1 complex to plasma membrane is critical for the internalization of GluR2 and induction of long-term depression. ICA69 (islet cell autoantigen 69 kDa) is identified as a major binding partner of PICK1. While heteromeric BAR domain complex is suggested to underlie the interaction between PICK1 and ICA69, the role of C-terminal domain of ICA69 (ICAC) in PICK1-ICA69 complex is unknown. Methodology/Principal Findings: We found that ICAC interacted with PICK1 and regulated the trafficking of PICK1-PKC alpha complex. ICAC and Delta ICAC (containing BAR domain) might function distinctly in the association of ICA69 with PICK1. While Delta ICAC domain inclined to form clusters, the distribution of ICAC was diffuse. The trafficking of PICK1 to plasma membrane mediated by activated PKC alpha was inhibited by ICA69. This action might ascribe to ICAC, because overexpression of ICAC, but not Delta ICAC, interrupted PKCa-mediated PICK1 trafficking. Notably, infusion of maltose binding protein (MBP) fusion protein, MBP-ICA69 or MBP-ICAC, in cerebellar Purkinje cells significantly inhibited the induction of long-term depression at parallel fiber-and climbing fiber-Purkinje cell synapses. Conclusions: Our experiments showed that ICAC is an important domain for the ICA69-PICK1 interaction and plays essential roles in PICK1-mediated neuronal plasticity.	[Wang, Zhen; Wang, Ya-Nan; Sun, Cheng-Long; Yang, Dong; Su, Li-Da; Xie, Ya-Jun; Zhou, Lin; Shen, Ying] Zhejiang Univ, Sch Med, Dept Neurobiol,Minist Hlth, Key Lab Med Neurobiol,Zhejiang Prov Key Lab Neuro, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Yin] Ningxia Med Univ, Dept Neurobiol, Ctr Sci Technol, Cranial Cerebral Dis Lab, Yinchuan, Peoples R China	Zhejiang University; Ningxia Medical University	Shen, Y (corresponding author), Zhejiang Univ, Sch Med, Dept Neurobiol,Minist Hlth, Key Lab Med Neurobiol,Zhejiang Prov Key Lab Neuro, Hangzhou 310003, Zhejiang, Peoples R China.	yshen@zju.edu.cn	shen, ying/HHS-5635-2022; Yang, Dong/AAE-7987-2020; Xie, Yajun/ABE-8877-2020; Xie, Yajun/AFS-3223-2022; Zhen, Wang/S-7244-2019	Yang, Dong/0000-0003-0612-1439; Xie, Yajun/0000-0003-2988-2708; wang, yanan/0000-0002-7433-3567	National Basic Research Program of the Ministry of Science and Technology of China [2009CB94140, 2011CB5044000]; National Foundation of Natural Science of China [31070945, 30960108, 31060140, 31271148]; National Foundation of Natural Science of China/Hong Kong Research Grants Council JRS fund [30731160616]; New Century Talent Award of the Ministry of Education of China [NCET-07-0751]	National Basic Research Program of the Ministry of Science and Technology of China; National Foundation of Natural Science of China(National Natural Science Foundation of China (NSFC)); National Foundation of Natural Science of China/Hong Kong Research Grants Council JRS fund; New Century Talent Award of the Ministry of Education of China	This work was supported by grants from National Basic Research Program of the Ministry of Science and Technology of China (2009CB94140 and 2011CB5044000), National Foundation of Natural Science of China (31070945, 30960108, 31060140 and 31271148), National Foundation of Natural Science of China/Hong Kong Research Grants Council JRS fund (30731160616) and New Century Talent Award of the Ministry of Education of China (NCET-07-0751). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atianjoh FE, 2010, PAIN, V151, P226, DOI 10.1016/j.pain.2010.07.017; Bassan M, 2008, EUR J NEUROSCI, V27, P66, DOI 10.1111/j.1460-9568.2007.05986.x; Cao JY, 2011, J BIOL CHEM, V286, P27698, DOI 10.1074/jbc.M111.235333; Cao M, 2007, J NEUROSCI, V27, P12945, DOI 10.1523/JNEUROSCI.2040-07.2007; Carta M, 2004, J NEUROSCI, V24, P3746, DOI 10.1523/JNEUROSCI.0067-04.2004; Chung HJ, 2000, J NEUROSCI, V20, P7258; Citri A, 2010, J NEUROSCI, V30, P16437, DOI 10.1523/JNEUROSCI.4478-10.2010; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; Iwakura Y, 2001, J BIOL CHEM, V276, P40025, DOI 10.1074/jbc.M103125200; Ji YF, 2011, BIOCHEM BIOPH RES CO, V405, P691, DOI 10.1016/j.bbrc.2011.01.105; Jin WY, 2006, J NEUROSCI, V26, P2380, DOI 10.1523/JNEUROSCI.3503-05.2006; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Leitges M, 2004, NEURON, V44, P585, DOI 10.1016/j.neuron.2004.10.024; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Madsen KL, 2008, TRAFFIC, V9, P1327, DOI 10.1111/j.1600-0854.2008.00761.x; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Masukawa K, 2006, ACTA HISTOCHEM CYTOC, V39, P173, DOI 10.1267/ahc.06025; Nakamura Y, 2011, EMBO J, V30, P719, DOI 10.1038/emboj.2010.357; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Quack I, 2011, J BIOL CHEM, V286, P12959, DOI 10.1074/jbc.M110.204024; Shao X, 2010, NEUROCHEM INT, V56, P962, DOI 10.1016/j.neuint.2010.04.006; Shen Y, 2005, NEURON, V46, P715, DOI 10.1016/j.neuron.2005.04.033; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Su LD, 2010, ALCOHOL CLIN EXP RES, V34, P1140, DOI 10.1111/j.1530-0277.2010.01190.x; Su LD, 2009, NEUROREPORT, V20, P502, DOI 10.1097/WNR.0b013e328328f397; Sun CL, 2011, CEREBELLUM, V10, P88, DOI 10.1007/s12311-010-0233-2; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; Wang DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041499; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xu JY, 2006, NEUROSIGNALS, V15, P190, DOI 10.1159/000098482; Yang W, 2007, J BIOL CHEM, V282, P9269, DOI 10.1074/jbc.M700050200; Zhu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046012	42	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83862	10.1371/journal.pone.0083862	http://dx.doi.org/10.1371/journal.pone.0083862			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358315	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700141
J	Zoppini, G; Galletti, A; Targher, G; Brangani, C; Pichiri, I; Negri, C; Stoico, V; Cacciatori, V; Bonora, E				Zoppini, Giacomo; Galletti, Anna; Targher, Giovanni; Brangani, Corinna; Pichiri, Isabella; Negri, Carlo; Stoico, Vincenzo; Cacciatori, Vittorio; Bonora, Enzo			Glycated Haemoglobin Is Inversely Related to Serum Vitamin D Levels in Type 2 Diabetic Patients	PLOS ONE			English	Article							HYPOVITAMINOSIS-D; D DEFICIENCY; PREVALENCE; HEALTH	Objective: A correlation between glucose control and 25(OH) D metabolism has been suggested by previous studies. However, this correlation has not yet been evaluated considering the impact of chronic complications of type 2 diabetes, especially the presence of nephropathy. Thus, the aim of this study was to determine the correlation between A1C and 25(OH) D in a well characterized cohort of type 2 diabetic patients. Research Design and Methods: We cross-sectionally examined the association between A1C and serum 25(OH) D in 715 type 2 diabetic patients attending our clinic during the years 2011-2012. The average age was 68612 years (range 26-94 years). The relation between A1C and serum 25(OH) D levels was modelled by multiple linear regression analyses. Results: Serum 25(OH) D levels were inversely associated with A1C levels (r = -0.116, p = .003). This relation maintains its independence in the multivariate analysis after adjusting for age, sex, A1C, BMI, treatment and duration of diabetes and nephropathy. Conclusions: In type 2 diabetic patients, high A1C levels are associated with low concentrations of serum 25(OH) D independently of duration of diabetes, diabetic treatment and nephropathy. Future studies are needed to clarify the biological relation between glucose control and vitamin D metabolism in type 2 diabetes.	[Zoppini, Giacomo; Galletti, Anna; Targher, Giovanni; Brangani, Corinna; Pichiri, Isabella; Negri, Carlo; Stoico, Vincenzo; Cacciatori, Vittorio; Bonora, Enzo] Univ Verona, Dept Med, Azienda Osped Univ Integrata, Sect Endocrinol Diabet & Metab, I-37100 Verona, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Zoppini, G (corresponding author), Univ Verona, Dept Med, Azienda Osped Univ Integrata, Sect Endocrinol Diabet & Metab, I-37100 Verona, Italy.	giacomo.zoppini@univr.it	Targher, Giovanni/AAB-9008-2019; zoppini, giacomo/AAA-9000-2022; Bonora, Enzo/AAA-5300-2022; raspolli, anna/AGF-5132-2022	Targher, Giovanni/0000-0002-4325-3900; zoppini, giacomo/0000-0003-1085-554X; BONORA, Enzo/0000-0003-1074-5164				Aksu NM, 2013, MED SCI MONITOR, V19, P264, DOI 10.12659/MSM.883880; Bland R, 2004, J STEROID BIOCHEM, V89-90, P121, DOI 10.1016/j.jsbmb.2004.03.115; BOUCHER BJ, 1995, DIABETOLOGIA, V38, P1239, DOI 10.1007/BF00422375; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Cigolini M, 2006, DIABETES CARE, V29, P722, DOI 10.2337/diacare.29.03.06.dc05-2148; Holick MF, 2011, CURR DRUG TARGETS, V12, P4; Hosseinpour F, 2003, BIOCHEM BIOPH RES CO, V303, P877, DOI 10.1016/S0006-291X(03)00442-X; Hutchinson MS, 2011, SCAND J CLIN LAB INV, V71, P399, DOI 10.3109/00365513.2011.575235; Jorde R, 2009, EUR J NUTR, V48, P349, DOI 10.1007/s00394-009-0020-3; Kositsawat J, 2010, DIABETES CARE, V33, P1236, DOI 10.2337/dc09-2150; Luo C, 2009, DIABETES VASC DIS RE, V6, P194, DOI 10.1177/1479164109337974; Mathieu C, 2005, DIABETOLOGIA, V48, P1247, DOI 10.1007/s00125-005-1802-7; Maxwell CS, 2011, NUTR REV, V69, P291, DOI 10.1111/j.1753-4887.2011.00393.x; Ozfirat Z, 2010, POSTGRAD MED J, V86, P18, DOI 10.1136/pgmj.2009.078626; Palomer X, 2008, DIABETES OBES METAB, V10, P185, DOI 10.1111/j.1463-1326.2007.00710.x; Patel P, 2010, J DIABETES, V2, P36, DOI 10.1111/j.1753-0407.2009.00057.x; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; Rajakumar K, 2012, DIABETES CARE, V35, P627, DOI 10.2337/dc11-1825; Stefanov M. V., 1996, Ukrainskii Biokhimicheskii Zhurnal, V68, P66; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Tahrani AA, 2010, INT J CLIN PRACT, V64, P351, DOI 10.1111/j.1742-1241.2009.02221.x; Xuan Y, 2013, J DIABETES; Yu Jung Re, 2012, Chonnam Med J, V48, P108, DOI 10.4068/cmj.2012.48.2.108	23	35	36	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82733	10.1371/journal.pone.0082733	http://dx.doi.org/10.1371/journal.pone.0082733			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358222	Green Submitted, gold, Green Published			2022-12-27	WOS:000328735700092
J	Gorsic, LK; Stark, AL; Wheeler, HE; Wong, SS; Im, HK; Dolan, ME				Gorsic, Lidija K.; Stark, Amy L.; Wheeler, Heather E.; Wong, Shan S.; Im, Hae K.; Dolan, M. Eileen			EPS8 Inhibition Increases Cisplatin Sensitivity in Lung Cancer Cells	PLOS ONE			English	Article							COMBINATORIAL BIOSYNTHESIS; INDUCED CYTOTOXICITY; CELLULAR GROWTH; MITHRAMYCIN; EXPRESSION; APOPTOSIS; TOXICITY; BINDING; TRANSFORMATION; CHEMOTHERAPY	Cisplatin, a commonly used chemotherapeutic, is associated with ototoxicity, renal toxicity and neurotoxicity, thus identifying means to increase the therapeutic index of cisplatin may allow for improved outcomes. A SNP (rs4343077) within EPS8, discovered through a genome wide association study of cisplatin-induced cytotoxicity and apoptosis in lymphoblastoid cell lines (LCLs), provided impetus to further study this gene. The purpose of this work was to evaluate the role of EPS8 in cellular susceptibility to cisplatin in cancerous and non-cancerous cells. We used EPS8 RNA interference to determine the effect of decreased EPS8 expression on LCL and A549 lung cancer cell sensitivity to cisplatin. EPS8 knockdown in LCLs resulted in a 7.9% increase in cisplatin-induced survival (P = 1.98x10(-7)) and an 8.7% decrease in apoptosis (P = 0.004) compared to control. In contrast, reduced EPS8 expression in lung cancer cells resulted in a 20.6% decrease in cisplatin-induced survival (P = 5.08x10(-5)). We then investigated an EPS8 inhibitor, mithramycin A, as a potential agent to increase the therapeutic index of cisplatin. Mithramycin A decreased EPS8 expression in LCLs resulting in decreased cellular sensitivity to cisplatin as evidenced by lower caspase 3/7 activation following cisplatin treatment (42.7%+/- 66.8% relative to control P = 0.0002). In 5 non-small-cell lung carcinoma (NSCLC) cell lines, mithramycin A also resulted in decreased EPS8 expression. Adding mithramycin to 4 NSCLC cell lines and a bladder cancer cell line, resulted in increased sensitivity to cisplatin that was significantly more pronounced in tumor cell lines than in LCL lines (p<0.0001). An EGFR mutant NSCLC cell line (H1975) showed no significant change in sensitivity to cisplatin with the addition of mithramycin treatment. Therefore, an inhibitor of EPS8, such as mithramycin A, could improve cisplatin treatment by increasing sensitivity of tumor relative to normal cells.	[Gorsic, Lidija K.; Stark, Amy L.; Wheeler, Heather E.; Wong, Shan S.; Dolan, M. Eileen] Univ Chicago, Dept Med, Sect Hematol Oncol, Chicago, IL 60637 USA; [Im, Hae K.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Dolan, ME (corresponding author), Univ Chicago, Dept Med, Sect Hematol Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	edolan@medicine.bsd.uchicago.edu	Wheeler, Heather/I-9279-2019	Wheeler, Heather/0000-0003-1365-9667	National Institute of Health, National Institute of General Medical Sciences [UO1GM61393]; National Institute of Health Clinical and Translational Science [TL1 RR25001]; National Institute of Health [T32CA009594]; NATIONAL CANCER INSTITUTE [F32CA165823, T32CA009594] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER	National Institute of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Health Clinical and Translational Science; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to National Institute of Health, National Institute of General Medical Sciences UO1GM61393 (MED), National Institute of Health Clinical and Translational Science Award TL1 RR25001 (ALS), National Institute of Health Cancer Biology Training Grant T32CA009594 (HEW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelo F, 2007, NUCLEIC ACIDS RES, V35, P2215, DOI 10.1093/nar/gkm037; Barcelo F, 2010, BIOCHEMISTRY-US, V49, P10543, DOI 10.1021/bi101398s; BROWN JH, 1965, NEW ENGL J MED, V272, P111, DOI 10.1056/NEJM196501212720301; Chen HJ, 2010, CANCER RES, V70, P9979, DOI 10.1158/0008-5472.CAN-10-2394; Chen YJ, 2008, MOL CANCER THER, V7, P1376, DOI 10.1158/1535-7163.MCT-07-2388; Cox NJ, 2012, CLIN PHARMACOL THER, V92, P425, DOI 10.1038/clpt.2012.115; Ding XF, 2013, ONCOL REP, V29, P697, DOI 10.3892/or.2012.2160; ELIAS EG, 1972, J BONE JOINT SURG AM, VA 54, P1730, DOI 10.2106/00004623-197254080-00013; Freeman DJ, 2009, MOL CANCER THER, V8, P1536, DOI 10.1158/1535-7163.MCT-08-0978; Gaughan Elizabeth M, 2011, Ther Adv Med Oncol, V3, P113, DOI 10.1177/1758834010397569; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; Huang RS, 2011, CLIN CANCER RES, V17, P5490, DOI 10.1158/1078-0432.CCR-11-0724; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Lee TJ, 2006, MOL CANCER THER, V5, P2737, DOI 10.1158/1535-7163.MCT-06-0426; Liu PS, 2010, ONCOGENE, V29, P3977, DOI 10.1038/onc.2010.144; Maa MC, 2007, J BIOL CHEM, V282, P19399, DOI 10.1074/jbc.M610280200; Majee S, 1999, EUR J BIOCHEM, V260, P619, DOI 10.1046/j.1432-1327.1999.00159.x; MATOSKOVA B, 1995, MOL CELL BIOL, V15, P3805; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Nunez LE, 2012, J MED CHEM, V55, P5813, DOI 10.1021/jm300234t; O'Donnell PH, 2010, PHARMACOGENET GENOM, V20, P327, DOI 10.1097/FPC.0b013e3283396c4e; Petrovic V, 2010, CANCER BIOL THER, V9, P1008, DOI 10.4161/cbt.9.12.11710; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Remsing LL, 2003, J AM CHEM SOC, V125, P5745, DOI 10.1021/ja034162h; Ricci MS, 2006, ONCOLOGIST, V11, P342, DOI 10.1634/theoncologist.11-4-342; ROBINS PR, 1973, J LAB CLIN MED, V82, P576; Roos WP, 2012, CANC LETT; Ryan W G, 1969, Trans Assoc Am Physicians, V82, P353; Shiota M, 2010, CANCER SCI, V101, P1177, DOI 10.1111/j.1349-7006.2010.01503.x; Shukla SJ, 2008, PHARMACOGENET GENOM, V18, P253, DOI 10.1097/FPC.0b013e3282f5e605; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; Tan XL, 2011, CLIN CANCER RES, V17, P5801, DOI 10.1158/1078-0432.CCR-11-1133; Wang HX, 2010, CARCINOGENESIS, V31, P1132, DOI 10.1093/carcin/bgq058; Wen YJ, 2012, HUM MOL GENET, V21, P1470, DOI 10.1093/hmg/ddr583; Wen YJ, 2011, PHARMACOGENET GENOM, V21, P476, DOI 10.1097/FPC.0b013e3283481967; Wheeler HE, 2013, PHARMACOGENOMICS J, V13, P35, DOI 10.1038/tpj.2011.38; Wheeler HE, 2013, CLIN CANCER RES, V19, P491, DOI 10.1158/1078-0432.CCR-12-2618; Wierstra I, 2007, BIOCHEM BIOPH RES CO, V352, P61, DOI 10.1016/j.bbrc.2006.10.151; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang TP, 2010, CHEM-BIOL INTERACT, V183, P181, DOI 10.1016/j.cbi.2009.09.018; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x; Ziliak D, 2011, TRANSL RES, V157, P265, DOI 10.1016/j.trsl.2011.01.005	43	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82220	10.1371/journal.pone.0082220	http://dx.doi.org/10.1371/journal.pone.0082220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367505	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900008
J	Charpentier, MJE; Drea, CM				Charpentier, Marie J. E.; Drea, Christine M.			Victims of Infanticide and Conspecific Bite Wounding in a Female-Dominant Primate: A Long-Term Study	PLOS ONE			English	Article							RING-TAILED LEMURS; BEZA-MAHAFALY-RESERVE; SEX-DIFFERENCES; SOCIAL RELATIONSHIPS; RISK-TAKING; SOUTHWESTERN MADAGASCAR; REPRODUCTIVE PARAMETERS; AGGRESSIVE COMPETITION; INBREEDING DEPRESSION; RINGTAILED LEMURS	The aggression animals receive from conspecifics varies between individuals across their lifetime. As poignantly evidenced by infanticide, for example, aggression can have dramatic fitness consequences. Nevertheless, we understand little about the sources of variation in received aggression, particularly in females. Using a female-dominant species renowned for aggressivity in both sexes, we tested for potential social, demographic, and genetic patterns in the frequency with which animals were wounded by conspecifics. Our study included 243 captive, ring-tailed lemurs (Lemur catta), followed from infancy to adulthood over a 35-year time span. We extracted injury, social, and life-history information from colony records and calculated neutral heterozygosity for a subset of animals, as an estimate of genetic diversity. Focusing on victims rather than aggressors, we used General Linear Models to explain bite-wound patterns at different life stages. In infancy, maternal age best predicted wounds received, as infants born to young mothers were the most frequent infanticide victims. In adulthood, sex best predicted wounds received, as males were three times more likely than females to be seriously injured. No relation emerged between wounds received and the other variables studied. Beyond the generally expected costs of adult male intrasexual aggression, we suggest possible additive costs associated with female-dominant societies - those suffered by young mothers engaged in aggressive disputes and those suffered by adult males aggressively targeted by both sexes. We propose that infanticide in lemurs may be a costly by-product of aggressively mediated, female social dominance. Accordingly, the benefits of female behavioral 'masculinization' accrued to females through priority of access to resources, may be partially offset by early costs in reproductive success. Understanding the factors that influence lifetime patterns of conspecific wounding is critical to evaluating the fitness costs associated with social living; however, these costs may vary substantially between societies.	[Charpentier, Marie J. E.; Drea, Christine M.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27705 USA; [Charpentier, Marie J. E.; Drea, Christine M.] Duke Univ, Dept Biol, Durham, NC USA; [Charpentier, Marie J. E.] CEFE CNRS, UMR 5175, Montpellier, France	Duke University; Duke University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Charpentier, MJE (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27705 USA.	marie.charpentier@cefe.cnrs.fr	Charpentier, Marie JE/A-5108-2016	Charpentier, Marie/0000-0001-6530-5874	NSF [BCS-0409367, IOS-0719003]; Marie Curie outgoing fellowship	NSF(National Science Foundation (NSF)); Marie Curie outgoing fellowship(European Commission)	This research was supported by NSF grants (BCS-0409367 and IOS-0719003 to CMD) and a Marie Curie outgoing fellowship (to MJEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Andrews J, 1998, FOLIA PRIMATOL, V69, P14, DOI 10.1159/000052694; Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; Arlet ME, 2009, PRIMATES, V50, P65, DOI 10.1007/s10329-008-0119-9; Baker RL, 1999, J INSECT BEHAV, V12, P213, DOI 10.1023/A:1020966817008; Belsley D., 1980, REGRESSION DIAGNOSTI, P292, DOI DOI 10.1002/0471725153; BERNSTEIN IS, 1986, AM J PRIMATOL, V10, P213, DOI 10.1002/ajp.1350100302; Boydston EE, 2001, ETHOLOGY, V107, P369, DOI 10.1046/j.1439-0310.2001.00672.x; Burbank VK., 1987, BEHAV SCI RES, V21, P70, DOI [10.1177/106939718702100103, DOI 10.1177/106939718702100103]; Castro N, 2006, AGGRESSIVE BEHAV, V32, P474, DOI 10.1002/ab.20147; Charpentier MJE, 2008, CONSERV GENET, V9, P1605, DOI 10.1007/s10592-007-9499-4; Charpentier MJE, 2008, MOL ECOL, V17, P3225, DOI 10.1111/j.1365-294X.2008.03831.x; Charpentier MJE, 2008, BEHAV GENET, V38, P151, DOI 10.1007/s10519-008-9191-6; CHENEY DL, 1977, BEHAV ECOL SOCIOBIOL, V2, P303, DOI 10.1007/BF00299742; Clutton-Brock T, 2013, J ZOOL, V289, P151, DOI 10.1111/jzo.12023; CLUTTONBROCK TH, 1979, ANIM BEHAV, V27, P211, DOI 10.1016/0003-3472(79)90141-6; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; De Waal FBM, 2007, CHIMPANZEE POLITICS, P235; Drea CM, 2008, J MORPHOL, V269, P451, DOI 10.1002/jmor.10594; Drea CM, 2007, HORM BEHAV, V51, P555, DOI 10.1016/j.yhbeh.2007.02.006; Drea CM, 2011, HORM BEHAV, V59, P417, DOI 10.1016/j.yhbeh.2010.09.011; Drea CM, 2005, INTEGR COMP BIOL, V45, P915, DOI 10.1093/icb/45.5.915; Drea CM, 2002, P ROY SOC B-BIOL SCI, V269, P1981, DOI 10.1098/rspb.2002.2109; Drews C, 1996, BEHAVIOUR, V133, P443, DOI 10.1163/156853996X00530; Duckworth RA, 2006, BEHAV ECOL, V17, P1011, DOI 10.1093/beheco/arl035; Dunbar RIM, 1984, REPROD DECISIONS EC, P265; Eklund A, 1996, BEHAVIOUR, V133, P883, DOI 10.1163/156853996X00297; Erhart EM, 2008, INT J PRIMATOL, V29, P1227, DOI 10.1007/s10764-008-9287-0; FAIRBANKS LA, 1993, BEHAVIOUR, V124, P57, DOI 10.1163/156853993X00506; Fedigan LM, 1997, AM J PHYS ANTHROPOL, V102, P161, DOI 10.1002/(SICI)1096-8644(199702)102:2<161::AID-AJPA2>3.0.CO;2-1; Forster S, 2002, GUENONS DIVERSITY AD, P245; FRANK LG, 1986, ANIM BEHAV, V34, P1510, DOI 10.1016/S0003-3472(86)80221-4; FRANK LG, 1995, NATURE, V377, P584, DOI 10.1038/377584b0; Glickman Stephen E., 1993, Perspectives in Ethology, V10, P87; Gould L, 2007, AM J PRIMATOL, V69, P1325, DOI 10.1002/ajp.20438; Gould L, 2003, AM J PHYS ANTHROPOL, V120, P182, DOI 10.1002/ajpa.10151; Gould L, 1999, INT J PRIMATOL, V20, P69, DOI 10.1023/A:1020584200807; Hausfater G, 2008, INFANTICIDE COMP EVO, P598; Hood LC, 1995, INT J PRIMATOL, V16, P997, DOI 10.1007/BF02696113; HOOD LC, 1994, AM J PRIMATOL, V33, P65, DOI 10.1002/ajp.1350330107; Hooley JM, 1983, PRIMATE SOCIAL RELAT, P142; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Hrdy SB, 1984, INFANTICIDE COMP EVO; Huntingford F., 1987, ANIMAL CONFLICT, P460; Ichino S, 2005, AM J PRIMATOL, V67, P267, DOI 10.1002/ajp.20183; Isbell LA, 1991, BEHAV ECOL, V2, P143, DOI 10.1093/beheco/2.2.143; JOLLY A, 1993, LEMUR SOCIAL SYSTEMS AND THEIR ECOLOGICAL BASIS, P85; Jolly A, 2000, INT J PRIMATOL, V21, P21, DOI 10.1023/A:1005467411880; Jolly A., 1966, LEMUR BEHAV MADAGASC, P187; Kaplan J, 1987, COMP BEHAV AFRICAN M, P127; KOYAMA N, 1991, PRIMATOLOGY TODAY, P173; Koyama N, 2002, PRIMATES, V43, P291, DOI 10.1007/BF02629604; Koyama N, 2001, PRIMATES, V42, P1, DOI 10.1007/BF02640684; Lindenfors P, 2011, ADV GENET, V75, P7, DOI 10.1016/B978-0-12-380858-5.00009-5; Lorenz K, 1966, AGGRESSION, P306; MARLER P, 1976, AM PSYCHOL, V31, P239, DOI 10.1037/0003-066X.31.3.239; Meagher S, 2000, P NATL ACAD SCI USA, V97, P3324, DOI 10.1073/pnas.060284797; MOSES LE, 1992, AM J PRIMATOL, V28, P49, DOI 10.1002/ajp.1350280105; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Nakamichi M, 1997, INT J PRIMATOL, V18, P73, DOI 10.1023/A:1026393223883; PACKER C, 1995, NATURE, V373, P60, DOI 10.1038/373060a0; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Parga JA, 2005, ZOO BIOL, V24, P295, DOI 10.1002/zoo.20062; Parga JA, 2012, AM J PHYS ANTHROPOL, V147, P21, DOI 10.1002/ajpa.21603; Parmigiani S., 1994, INFANTICIDE PARENTAL, P496; Pereira ME, 1997, BEHAVIOUR, V134, P225, DOI 10.1163/156853997X00467; PEREIRA ME, 1991, BEHAV ECOL SOCIOBIOL, V28, P141; Pereira Michael E., 1993, P285; Rosvall KA, 2011, BEHAV ECOL, V22, P1131, DOI 10.1093/beheco/arr106; Rosvall KA, 2011, ETHOLOGY, V117, P332, DOI 10.1111/j.1439-0310.2011.01881.x; RUTBERG AT, 1990, ANIM BEHAV, V40, P322, DOI 10.1016/S0003-3472(05)80927-3; Sauther Michelle L., 2006, P313, DOI 10.1007/978-0-387-34126-2_18; Sauther ML, 1999, EVOL ANTHROPOL, V8, P120, DOI 10.1002/(SICI)1520-6505(1999)8:4<120::AID-EVAN3>3.0.CO;2-O; Sauther ML, 2002, AM J PHYS ANTHROPOL, V117, P122, DOI 10.1002/ajpa.10016; SAUTHER ML, 1993, LEMUR SOCIAL SYSTEMS AND THEIR ECOLOGICAL BASIS, P135; SAUTHER ML, 1991, AM J PHYS ANTHROPOL, V84, P463, DOI 10.1002/ajpa.1330840409; SHELLY TE, 1985, ANIM BEHAV, V33, P1211, DOI 10.1016/S0003-3472(85)80181-0; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Starling AP, 2010, HORM BEHAV, V57, P76, DOI 10.1016/j.yhbeh.2009.09.016; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Stockley P, 2011, BIOL REV, V86, P341, DOI 10.1111/j.1469-185X.2010.00149.x; SUSSMAN RW, 1991, AM J PHYS ANTHROPOL, V84, P43, DOI 10.1002/ajpa.1330840105; SUSSMAN RW, 1995, EVOL ANTHROPOL, V3, P149; Takahata Y, 2008, PRIMATES, V49, P135, DOI 10.1007/s10329-007-0076-8; TAYLOR L, 1985, INT J PRIMATOL, V6, P601, DOI 10.1007/BF02692291; Tiira K, 2003, MOL ECOL, V12, P2399, DOI 10.1046/j.1365-294X.2003.01925.x; VICK LG, 1989, BEHAV ECOL SOCIOBIOL, V25, P3, DOI 10.1007/BF00299705; Wang XT, 2009, EVOL HUM BEHAV, V30, P77, DOI 10.1016/j.evolhumbehav.2008.09.006; WILSON AP, 1970, ANIM BEHAV, V18, P719, DOI 10.1016/0003-3472(70)90017-5; WILSON M, 1985, ETHOL SOCIOBIOL, V6, P59, DOI 10.1016/0162-3095(85)90041-X; Wrangham R, 1997, DEMONIC MALES APES O, P350	91	17	17	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82830	10.1371/journal.pone.0082830	http://dx.doi.org/10.1371/journal.pone.0082830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367560	Green Published, gold			2022-12-27	WOS:000328740300073
J	Cuny, C; Layer, F; Kock, R; Werner, G; Witte, W				Cuny, Christiane; Layer, Franziska; Koeck, Robin; Werner, Guido; Witte, Wolfgang			Methicillin Susceptible Staphylococcus aureus (MSSA) of Clonal Complex CC398, t571 from Infections in Humans Are Still Rare in Germany	PLOS ONE			English	Article							NEW-YORK; RESISTANT; ST398; EMERGENCE; GENE; MRSA; PREVALENCE; ANIMALS; PORCINE; ERM(T)	Methicillin-susceptible Staphylococcus aureus (MSSA) attributed to clonal complex (CC) 398 and exhibiting spa-type t571 received attention in Europe and in the USA for being associated with severe infections in humans. As this spa-type is exhibited by livestock-associated (LA) Methicillin-resistant S. aureus (MRSA) as well, it is important to discriminate LA- and human-derived strains by easy to perform, PCR-based methods. MSSA t571 contain phage int3 carrying scn and chp, whereas LA-MRSA t571 lack these markers. In contrast, pathogenicity island SaPIbov5 (detected by PCR bridging vwbbov and scn) is contained by LA-MRSA t571 and absent in the human MSSA subpopulation. Furthermore, MSSA t571 contain erm(T), the particular genomic arrangement of which was assessed by a PCR bridging erm(T) and the adjacent transposase gene. MSSA t571 are rare so far in Germany among isolates from infections in humans (0.14%) as well as among isolates from nasal colonization (0.13%). LA-MRSA t571 are also infrequent among MRSA isolated from carriage at admission to hospitals (0.1%) and also among isolates from infections in humans (0.013%).	[Cuny, Christiane; Layer, Franziska; Werner, Guido] Robert Koch Inst, Natl Reference Ctr Staphylococci & Enterococci, Wernigerode Branch, Wernigerode, Germany; [Koeck, Robin] Univ Hosp Munster, Inst Hyg, Munster, Germany; [Witte, Wolfgang] Robert Koch Inst, Wernigerode Branch, Wernigerode, Germany	Robert Koch Institute; University of Munster; Robert Koch Institute	Cuny, C (corresponding author), Robert Koch Inst, Natl Reference Ctr Staphylococci & Enterococci, Wernigerode Branch, Wernigerode, Germany.	cunych@rki.de	Köck, Robin/AAC-1552-2019	Layer, Franziska/0000-0002-4613-6478	German Federal Ministry of Education and Research [01KI1014G]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Funding came from Grant 01KI1014G from the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argudin MA, 2010, APPL ENVIRON MICROB, V76, P652, DOI 10.1128/AEM.01721-09; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Bhat M, 2009, EMERG INFECT DIS, V15, P285, DOI 10.3201/eid1502.080609; Cuny C, 2013, INT J MED MICROBIO S, VS1438-4221; Cuny C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024360; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Gomez-Sanz E, 2013, ANTIMICROB AGENTS CH, V57, P3275, DOI 10.1128/AAC.00171-13; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Holtfreter S, 2012, CLONAL DISTRIBUTION; Kadlec K, 2010, ANTIMICROB AGENTS CH, V54, P915, DOI 10.1128/AAC.01091-09; Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4; Kock R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055040; Mediavilla JR, 2012, EMERG INFECT DIS, V18, P700, DOI 10.3201/eid1804.111419; Meyer M., 1967, INT J SYST BACTERIOL, V17, P387; Pantosti A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00127; Parkhill J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-230; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Sabat AJ, 2013, EUROSURVEILLANCE, V18, P17; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Uhlemann AC, 2013, CLIN INFECT DIS, V57, P700, DOI 10.1093/cid/cit375; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; Valentin-Domelier AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028369; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; van der Mee-Marquet N, 2011, CLIN INFECT DIS, V52, P152, DOI 10.1093/cid/ciq053; van Wamel WJB, 2010, EUR J CLIN MICROBIOL, V29, P119, DOI 10.1007/s10096-009-0816-3; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vandendriessche S, 2011, J ANTIMICROB CHEMOTH, V66, P2455, DOI 10.1093/jac/dkr348; Viana D, 2010, MOL MICROBIOL, V77, P1583, DOI 10.1111/j.1365-2958.2010.07312.x; Vogel U, 2012, J CLIN MICROBIOL, V50, P1889, DOI 10.1128/JCM.00038-12; Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P316, DOI 10.1111/j.1469-0691.2010.03260.x; Witte W, 2007, J ANTIMICROB CHEMOTH, V60, P1258, DOI 10.1093/jac/dkm384; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Zhao CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038577	35	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83165	10.1371/journal.pone.0083165	http://dx.doi.org/10.1371/journal.pone.0083165			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367584	Green Published, gold			2022-12-27	WOS:000328740300095
J	Farsad, N; Guo, WS; Eckford, AW				Farsad, Nariman; Guo, Weisi; Eckford, Andrew W.			Tabletop Molecular Communication: Text Messages through Chemical Signals	PLOS ONE			English	Article							PHEROMONE COMMUNICATION	In this work, we describe the first modular, and programmable platform capable of transmitting a text message using chemical signalling - a method also known as molecular communication. This form of communication is attractive for applications where conventional wireless systems perform poorly, from nanotechnology to urban health monitoring. Using examples, we demonstrate the use of our platform as a testbed for molecular communication, and illustrate the features of these communication systems using experiments. By providing a simple and inexpensive means of performing experiments, our system fills an important gap in the molecular communication literature, where much current work is done in simulation with simplified system models. A key finding in this paper is that these systems are often nonlinear in practice, whereas current simulations and analysis often assume that the system is linear. However, as we show in this work, despite the nonlinearity, reliable communication is still possible. Furthermore, this work motivates future studies on more realistic modelling, analysis, and design of theoretical models and algorithms for these systems.	[Farsad, Nariman; Eckford, Andrew W.] York Univ, Dept Elect Engn & Comp Sci, Toronto, ON M3J 2R7, Canada; [Guo, Weisi] Univ Warwick, Sch Engn, Coventry CV4 7AL, W Midlands, England	York University - Canada; University of Warwick	Farsad, N (corresponding author), York Univ, Dept Elect Engn & Comp Sci, Toronto, ON M3J 2R7, Canada.	nariman@cse.yorku.ca	Guo, Weisi/J-7266-2019	Guo, Weisi/0000-0003-3524-3953	Natural Sciences and Engineering Research Council (NSERC) in Canada	Natural Sciences and Engineering Research Council (NSERC) in Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a Discovery grant from the Natural Sciences and Engineering Research Council (NSERC) in Canada (http://www.nserc-crsng.gc.ca/professors-professeurs/ grants-subs/dgigp-psigp_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta WC., 1992, CHEM COMMUNICATION L; Akyildiz IF, 2008, COMPUT NETW, V52, P2260, DOI 10.1016/j.comnet.2008.04.001; Alberts B., 2010, MOL BIOL CELL; Atakan B, 2012, IEEE COMMUN MAG, V50, P28, DOI 10.1109/MCOM.2012.6122529; Bochenkov V. E., 2010, METAL OXIDE NANOSTRU, V3, P31; Eckford A. W., 2010, Proceedings 2010 10th IEEE International Conference on Nanotechnology and Joint Symposium with Nano Korea 2010 KINTEX (IEEE-NANO 2010), P854, DOI 10.1109/NANO.2010.5697990; Eckford AW, 2007, 2007 41ST ANNUAL CONFERENCE ON INFORMATION SCIENCES AND SYSTEMS, VOLS 1 AND 2, P160, DOI 10.1109/CISS.2007.4298292; Farsad N., 2012, P 12 IEEE C NAN IEEE, P1, DOI [DOI 10.1109/NAN0.2012.6322018, 10.1109/NANO.2012.6322018]; Farsad N., 2011, NANO COMMUN NETW, V2, P175; Farsad N, 2012, IEEE T NANOBIOSCI, V11, P304, DOI 10.1109/TNB.2012.2186460; Guney A, 2012, IEEE T MOBILE COMPUT, V11, P353, DOI 10.1109/TMC.2011.53; Hiyama S., 2005, 2005 NSTI Nanotechnology Conference and Trade Show. NSTI Nanotech 2005, P391; Hiyama S., 2010, NANO COMMUN NETW, V1, P20, DOI [10.1016/j.nancom.2010.04.003, DOI 10.1016/J.NANCOM.2010.04.003]; Kim NR, 2012, IEEE ICC, P6146, DOI 10.1109/ICC.2012.6364816; Mahfuz M. U., 2010, NANO COMMUNICATION N, V1, P289, DOI [DOI 10.1016/J.NANCOM.2011.01.001, 10.1016/j.nancom.2011.01.001]; Moore MJ, 2009, IEEE T NANOBIOSCI, V8, P169, DOI 10.1109/TNB.2009.2025039; Munoz L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047751; Nakano T, 2012, IEEE T NANOBIOSCI, V11, P135, DOI 10.1109/TNB.2012.2191570; Nakano T, 2010, IEEE T NANOBIOSCI, V9, P213, DOI 10.1109/TNB.2010.2050070; OGrady M., 2012, SMS USAGE REMAINS ST; Pedro Sousa ATdA Lino Marques, 2008, P EURON IARP INT WOR; Pierobon M, 2013, IEEE T INFORM THEORY, V59, P942, DOI 10.1109/TIT.2012.2219496; Pierobon M, 2010, IEEE J SEL AREA COMM, V28, P602, DOI 10.1109/JSAC.2010.100509; Purnamadjaja AH, 2005, ROBOTICA, V23, P731, DOI 10.1017/S0263574704001225; Purnamadjaja AH, 2010, ROBOTICA, V28, P69, DOI 10.1017/S0263574709005591; Sousa P, 2008, SEVENTH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS, PROCEEDINGS, P489, DOI 10.1109/ICMLA.2008.133; Srinivas KV, 2012, IEEE T INFORM THEORY, V58, P4678, DOI 10.1109/TIT.2012.2193554; The International Telegraph and Telephone Consultative Comittee (CCITT), 1988, INT TEL ALPH 2, P7	28	143	147	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82935	10.1371/journal.pone.0082935	http://dx.doi.org/10.1371/journal.pone.0082935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367571	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300082
J	Korol, E; Johnston, K; Waser, N; Sifakis, F; Jafri, HS; Lo, M; Kyaw, MH				Korol, Ellen; Johnston, Karissa; Waser, Nathalie; Sifakis, Frangiscos; Jafri, Hasan S.; Lo, Mathew; Kyaw, Moe H.			A Systematic Review of Risk Factors Associated with Surgical Site Infections among Surgical Patients	PLOS ONE			English	Review							RESISTANT STAPHYLOCOCCUS-AUREUS; POOR FUNCTIONAL STATUS; CARDIAC-SURGERY; MEDIASTINITIS; MICROBIOLOGY; EPIDEMIOLOGY; SURVEILLANCE; PREDICTORS	Importance: Surgical site infection (SSI) complicates 2-5% of surgeries in the United States. Severity of SSI ranges from superficial skin infection to life-threatening conditions such as severe sepsis, and SSIs are responsible for increased morbidity, mortality, and economic burden associated with surgery. Staphylococcus aureus (S. aureus) is a commonly-isolated organism for SSI, and methicillin-resistant S. aureus SSI incidence is increasing globally. Objective: The objective of this systematic review was to characterize risk factors for SSI within observational studies describing incidence of SSI in a real-world setting. Evidence Review: An initial search identified 328 titles published in 2002-2012; 57 were identified as relevant for data extraction. Extracted information included study design and methodology, reported cumulative incidence and post-surgical time until onset of SSI, and odds ratios and associated variability for all factors considered in univariate and/or multivariable analyses. Findings: Median SSI incidence was 3.7%, ranging from 0.1% to 50.4%. Incidence of overall SSI and S. aureus SSI were both highest in tumor-related and transplant surgeries. Median time until SSI onset was 17.0 days, with longer time-to-onset for orthopedic and transplant surgeries. Risk factors consistently identified as associated with SSI included co-morbidities, advanced age, risk indices, patient frailty, and surgery complexity. Thirteen studies considered diabetes as a risk factor in multivariable analysis; 85% found a significant association with SSI, with odds ratios ranging from 1.5-24.3. Longer surgeries were associated with increased SSI risk, with a median odds ratio of 2.3 across 11 studies reporting significant results. Conclusions and Relevance: In a broad review of published literature, risk factors for SSI were characterized as describing reduced fitness, patient frailty, surgery duration, and complexity. Recognition of risk factors frequently associated with SSI allows for identification of such patients with the greatest need for optimal preventive measures to be identified and pre-treatment prior to surgery.	[Korol, Ellen; Johnston, Karissa; Waser, Nathalie] Oxford Outcomes, Vancouver, BC, Canada; [Sifakis, Frangiscos; Jafri, Hasan S.; Lo, Mathew; Kyaw, Moe H.] MedImmune, Gaithersburg, MD USA	AstraZeneca; Medimmune	Kyaw, MH (corresponding author), MedImmune, Gaithersburg, MD USA.	mkyaw11@gmail.com	Jafri, Hasan S/D-4895-2018	Jafri, Hasan S/0000-0003-2179-6450	MedImmune	MedImmune(AstraZenecaMedimmune)	The authors have the following interests: this study was sponsored by MedImmune, the employer of Frangiscos Sifakis, Hasan S. Jafri, Mathew Lo, Moe H. Kyaw at the time of the study. Ellen Korol, Karissa Johnston and Nathalie Waser are employed by Oxford Outcomes, and served as consultants for MedImmune in performing this research. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ahmed D, 2011, J CARDIOVASC SURG, V52, P99; Allpress AL, 2004, PEDIATR INFECT DIS J, V23, P231, DOI 10.1097/01.inf.0000114904.21616.ba; Anderson DJ, 2008, INFECT CONT HOSP EP, V29, P832, DOI 10.1086/590124; Anderson DJ, 2009, INFECT DIS CLIN N AM, V23, P53, DOI 10.1016/j.idc.2008.10.004; Apisarnthanarak A, 2003, INFECT CONT HOSP EP, V24, P31, DOI 10.1086/502112; Asensio A, 2008, LIVER TRANSPLANT, V14, P799, DOI 10.1002/lt.21435; Centofanti P, 2007, J CARDIOVASC SURG, V48, P641; Chemaly RF, 2010, ANN SURG ONCOL, V17, P1499, DOI 10.1245/s10434-010-0923-5; Chen TY, 2010, J AM GERIATR SOC, V58, P527, DOI 10.1111/j.1532-5415.2010.02719.x; Concato J, 2012, PHARMACOEPIDEM DR S, V21, P6, DOI 10.1002/pds.3245; Diez C, 2007, J CARDIOTHORAC SURG, V2, DOI 10.1186/1749-8090-2-23; Dulon M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-138; Erman T, 2005, SURG NEUROL, V63, P107, DOI 10.1016/j.surneu.2004.04.024; Felippe WAB, 2007, WORLD J SURG, V31, P2293, DOI 10.1007/s00268-007-9248-3; Gibbons C, 2011, Health Technol Assess, V15, P1, DOI 10.3310/hta15300; Gualis Javier, 2009, Asian Cardiovasc Thorac Ann, V17, P612, DOI 10.1177/0218492309349071; Gummert JF, 2002, THORAC CARDIOV SURG, V50, P87, DOI 10.1055/s-2002-26691; Harbarth S, 2008, INFECT CONT HOSP EP, V29, P890, DOI 10.1086/590193; Kasatpibal N, 2005, AM J INFECT CONTROL, V33, P587, DOI 10.1016/j.ajic.2004.11.012; Kaya Ekrem, 2006, Surg Infect (Larchmt), V7, P519, DOI 10.1089/sur.2006.7.519; Kaye KS, 2008, CLIN INFECT DIS, V46, P1568, DOI 10.1086/587673; Kaye KS, 2006, J AM GERIATR SOC, V54, P391, DOI 10.1111/j.1532-5415.2005.00651.x; Kim ES, 2012, INFECT CONT HOSP EP, V33, P572, DOI 10.1086/665728; Koutsoumbelis S, 2011, J BONE JOINT SURG AM, V93A, P1627, DOI 10.2106/JBJS.J.00039; Leaper DJ, 2010, SURG INFECT, V11, P283, DOI 10.1089/sur.2010.022; Lee J, 2006, J BONE JOINT SURG AM, V88A, P1705, DOI 10.2106/JBJS.E.01156; Lepelletier D, 2005, INFECT CONT HOSP EP, V26, P466, DOI 10.1086/502569; Lietard C, 2008, J NEUROSURG, V109, P729, DOI 10.3171/JNS/2008/109/10/0729; Mawalla B, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-21; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Muilwijk J, 2006, J HOSP INFECT, V62, P319, DOI 10.1016/j.jhin.2005.08.006; Olsen MA, 2003, J NEUROSURG, V98, P149, DOI 10.3171/spi.2003.98.2.0149; Omeis IA, 2011, SPINE, V36, P1410, DOI 10.1097/BRS.0b013e3181f48fa9; Omran AS, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-112; Owens CD, 2008, J HOSP INFECT, V70, P3, DOI 10.1016/S0195-6701(08)60017-1; Rutala WA, 2001, SEMIN INFECT CONTROL, V1, P157; Schmidt CO, 2008, INT J PUBLIC HEALTH, V53, P165, DOI 10.1007/s00038-008-7068-3; Sharma M, 2009, AM J INFECT CONTROL, V37, P653, DOI 10.1016/j.ajic.2008.12.012; Strom BL, 2007, MED CARE, V45, pS13, DOI 10.1097/MLR.0b013e318041f752; SUISSA S, 1995, EPIDEMIOLOGY, V6, P248, DOI 10.1097/00001648-199505000-00010; Suljagic V, 2010, SURG TODAY, V40, P763, DOI 10.1007/s00595-009-4124-4; Thanni LOA, 2004, J NATL MED ASSOC, V96, P1070; Upton A, 2005, ANZ J SURG, V75, P198, DOI 10.1111/j.1445-2197.2005.03371.x; Yano K, 2009, ACTA ORTHOP, V80, P486, DOI 10.3109/17453670903110675	44	192	202	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83743	10.1371/journal.pone.0083743	http://dx.doi.org/10.1371/journal.pone.0083743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367612	gold, Green Submitted, Green Published			2022-12-27	WOS:000328740300118
J	Long, X; Stone, MD				Long, Xi; Stone, Michael D.			Kinetic Partitioning Modulates Human Telomere DNA G-Quadruplex Structural Polymorphism	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; G-QUARTET FORMATION; CRYSTAL-STRUCTURE; K+ SOLUTION; POTASSIUM SOLUTION; MOLECULE; FLUORESCENCE; REPEAT; SPECTROSCOPY; STABILITY	Telomeres are specialized chromatin structures found at the end of chromosomes and are crucial to the maintenance of eukaryotic genome stability. Human telomere DNA is comprised of the repeating sequence (T(2)AG(3))(n), which is predominantly double-stranded but terminates with a 3 ' single-stranded tail. The guanine-rich tail can fold into secondary structures known as a G-quadruplexes (GQs) that may exist as a polymorphic mixture of anti-parallel, parallel, and several hybrid topological isomers. Using single-molecule Forster resonance energy transfer (smFRET), we have reconstructed distributions of telomere DNA GQ conformations generated by an in situ refolding protocol commonly employed in single-molecule studies of GQ structure, or using a slow cooling DNA annealing protocol typically used in the preparation of GQ samples for ensemble biophysical analyses. We find the choice of GQ folding protocol has a marked impact on the observed distributions of DNA conformations under otherwise identical buffer conditions. A detailed analysis of the kinetics of GQ folding over timescales ranging from minutes to hours revealed the distribution of GQ structures generated by in situ refolding gradually equilibrates to resemble the distribution generated by the slow cooling DNA annealing protocol. Interestingly, conditions of low ionic strength, which promote transient GQ unfolding, permit the fraction of folded DNA molecules to partition into a distribution that more closely approximates the thermodynamic folding equilibrium. Our results are consistent with a model in which kinetic partitioning occurs during in situ folding at room temperature in the presence of K+ ions, producing a long-lived non-equilibrium distribution of GQ structures in which the parallel conformation predominates on the timescale of minutes. These results suggest that telomere DNA GQ folding kinetics, and not just thermodynamic stability, likely contributes to the physiological ensemble GQ structures.	[Long, Xi; Stone, Michael D.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Stone, Michael D.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Stone, MD (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.	mds@ucsc.edu			NIH [GM095850]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095850] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was financially supported by the following grants: NIH GM095850 to MDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti P, 2003, P NATL ACAD SCI USA, V100, P1569, DOI 10.1073/pnas.0335459100; Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Antonacci C, 2007, BIOCHEMISTRY-US, V46, P4654, DOI 10.1021/bi602511p; BALAGURUMOORTHY P, 1994, J BIOL CHEM, V269, P21858; Chang CC, 2007, NUCLEIC ACIDS RES, V35, P2846, DOI 10.1093/nar/gkm155; Dai JX, 2008, BIOCHIMIE, V90, P1172, DOI 10.1016/j.biochi.2008.02.026; Dapic V, 2003, NUCLEIC ACIDS RES, V31, P2097, DOI 10.1093/nar/gkg316; GIRALDO R, 1994, P NATL ACAD SCI USA, V91, P7658, DOI 10.1073/pnas.91.16.7658; Gray DM, 2008, CHIRALITY, V20, P431, DOI 10.1002/chir.20455; Gray RD, 2009, J PHYS CHEM B, V113, P2676, DOI 10.1021/jp809578f; Green JJ, 2003, J AM CHEM SOC, V125, P3763, DOI 10.1021/ja029149w; Haider S, 2002, J MOL BIOL, V320, P189, DOI 10.1016/S0022-2836(02)00428-X; Jena PV, 2009, J AM CHEM SOC, V131, P12522, DOI 10.1021/ja903408r; KANG C, 1992, NATURE, V356, P126, DOI 10.1038/356126a0; Koirala D, 2011, NAT CHEM, V3, P782, DOI [10.1038/NCHEM.1126, 10.1038/nchem.1126]; Lee JY, 2005, P NATL ACAD SCI USA, V102, P18938, DOI 10.1073/pnas.0506144102; Li W, 2013, J AM CHEM SOC, V135, P6423, DOI 10.1021/ja4019176; Lim KW, 2009, J AM CHEM SOC, V131, P4301, DOI 10.1021/ja807503g; Long X, 2013, NUCLEIC ACIDS RES, V41, P2746, DOI 10.1093/nar/gks1341; LUSTIG AJ, 1992, NUCLEIC ACIDS RES, V20, P3021, DOI 10.1093/nar/20.12.3021; Luu KN, 2006, J AM CHEM SOC, V128, P9963, DOI 10.1021/ja062791w; Mergny JL, 2001, CHEMBIOCHEM, V2, P124, DOI 10.1002/1439-7633(20010202)2:2<124::AID-CBIC124>3.0.CO;2-L; Mergny JL, 1998, FEBS LETT, V435, P74, DOI 10.1016/S0014-5793(98)01043-6; Oganesian L, 2006, EMBO J, V25, P1148, DOI 10.1038/sj.emboj.7601006; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Patel PK, 1999, NUCLEIC ACIDS RES, V27, P2457, DOI 10.1093/nar/27.12.2457; Phan AT, 2007, NUCLEIC ACIDS RES, V35, P6517, DOI 10.1093/nar/gkm706; Tran PLT, 2011, NUCLEIC ACIDS RES, V39, P3282, DOI 10.1093/nar/gkq1292; Renciuk D, 2009, NUCLEIC ACIDS RES, V37, P6625, DOI 10.1093/nar/gkp701; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sannohe Y, 2010, CURR PROTOC NUCL ACI; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHULTZE P, 1994, J MOL BIOL, V235, P1532, DOI 10.1006/jmbi.1994.1105; Viglasky V, 2011, EUR BIOPHYS J BIOPHY, V40, P29, DOI 10.1007/s00249-010-0625-8; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Ying LM, 2003, P NATL ACAD SCI USA, V100, P14629, DOI 10.1073/pnas.2433350100	36	36	36	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83420	10.1371/journal.pone.0083420	http://dx.doi.org/10.1371/journal.pone.0083420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367594	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300104
J	Richel, O; De Vries, HJC; Dijkgraaf, MGW; Van Noesel, CJM; Prins, JM				Richel, Olivier; De Vries, Henry J. C.; Dijkgraaf, Marcel G. W.; Van Noesel, Carel J. M.; Prins, Jan M.			Risk Factors for the Presence of Anal Intraepithelial Neoplasia in HIV plus Men Who Have Sex with Men	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-PAPILLOMAVIRUS INFECTION; POSITIVE MEN; CANCER PRECURSORS; HIGH PREVALENCE; HOMOSEXUAL-MEN; LESIONS; HPV; PROGRESSION; POPULATION	Objective: Anal Intraepithelial Neoplasia (AIN) is present in the majority of HIV+ men who have sex with men (MSM) and routine AIN-screening is subject of discussion. In this study we analysed a wide range of potential risk factors for AIN in order to target screening programs. Methods: We screened 311 HIV+ MSM by high resolution anoscopy, with biopsies of suspect lesions. HIV-parameters, previous sexual transmitted infections (STI's), anal pathology, sexual practices and substance use were analysed in relation to AIN by uni-and multivariable logistic regression. Results: AIN (any grade) was found in 175/311 MSM (56%), high grade (HG) AIN in 30%. In the univariable analysis, years since HIV diagnosis, years of antiretroviral therapy (cART) and anal XTC use decreased AIN risk, while a history of anogenital warts and use of GHB (gamma-hydroxybutyric acid) increased this risk. In the multivariable analysis three parameters remained significant: years of cART (OR=0.92 per year, p=0.003), anal XTC use (OR=0.10, p=0.002) and GHB use (OR=2.60, p=0.003). No parameters were significantly associated with HGAIN, but there was a trend towards increased risk with anal enema use prior to sex (>50 times ever; p=0.07) and with a history of AIN (p=0.06). CD4 count, STI's, anal pathology, smoking, number of sex partners and anal fisting were not associated with (HG) AIN. Conclusion: GHB use increases the risk for AIN, while duration of cART and anal XTC use are negatively correlated with AIN. Given the high prevalence of AIN in HIV+ MSM, these associations are not helpful to guide a screening program.	[Richel, Olivier; Prins, Jan M.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [De Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands; [Dijkgraaf, Marcel G. W.] Univ Amsterdam, Acad Med Ctr, Clin Res Unit, NL-1105 AZ Amsterdam, Netherlands; [Van Noesel, Carel J. M.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Richel, Olivier; De Vries, Henry J. C.; Prins, Jan M.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [De Vries, Henry J. C.] Publ Hlth Serv Amsterdam, STI Outpatient Clin, Cluster Infect Dis, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam	Richel, O (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands.	o.richel@amc.nl	de Vries, Henry/K-5963-2012; Prins, Jan M./AAF-4945-2020; Dijkgraaf, Marcel GW/G-6663-2011; Richel, Olivier/AAG-2314-2019	de Vries, Henry/0000-0001-9784-547X; Prins, Jan/0000-0002-5415-8933	Maurits and Anna de Cock Foundation	Maurits and Anna de Cock Foundation	This study received a grant for equipment needed for high resolution anoscopy from the Maurits and Anna de Cock Foundation, a non profit organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez J, 2010, AIDS, V24, P2355, DOI 10.1097/QAD.0b013e32833db9ea; Barker JC, 2007, J PSYCHOACTIVE DRUGS, V39, P115, DOI 10.1080/02791072.2007.10399870; Berry J Michael, 2004, Surg Oncol Clin N Am, V13, P355; Boyle NT, 2010, BRIT J PHARMACOL, V161, P17, DOI 10.1111/j.1476-5381.2010.00899.x; Chin-Hong PV, 2005, JNCI-J NATL CANCER I, V97, P896, DOI 10.1093/jnci/dji163; Ciobotaru B, 2007, DIS COLON RECTUM, V50, P1011, DOI 10.1007/s10350-006-0873-y; Conley L, 2010, J INFECT DIS, V202, P1567, DOI 10.1086/656775; de Pokomandy A, 2011, CLIN INFECT DIS, V52, P1174, DOI 10.1093/cid/cir064; De Vries HJC, 2008, SEX TRANSM DIS, V35, P203, DOI 10.1097/OLQ.0b013e31815abb08; Gustafsson L, 1997, INT J CANCER, V71, P159, DOI 10.1002/(SICI)1097-0215(19970410)71:2<159::AID-IJC6>3.0.CO;2-#; Heard I, 2002, AIDS, V16, P1799, DOI 10.1097/00002030-200209060-00013; Holly EA, 2001, J NATL CANCER I, V93, P843, DOI 10.1093/jnci/93.11.843; Jay N, 1997, DIS COLON RECTUM, V40, P919, DOI 10.1007/BF02051199; Kreuter A, 2005, J AM ACAD DERMATOL, V52, P603, DOI 10.1016/j.jaad.2004.11.026; Kreuter A, 2010, BRIT J DERMATOL, V162, P1269, DOI 10.1111/j.1365-2133.2010.09712.x; Lillo FB, 2001, J INFECT DIS, V184, P547, DOI 10.1086/322856; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Minkoff H, 2001, AIDS, V15, P2157, DOI 10.1097/00002030-200111090-00011; Ndimbie OK, 1996, GENITOURIN MED, V72, P213; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; Palefsky JM, 2005, AIDS, V19, P1407, DOI 10.1097/01.aids.0000181012.62385.4a; Palefsky JM, 2001, J ACQ IMMUN DEF SYND, V28, P422, DOI 10.1097/00042560-200112150-00003; Palefsky JM, 1998, J ACQ IMMUN DEF SYND, V17, P320, DOI 10.1097/00042560-199804010-00005; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Piketty C, 2004, SEX TRANSM DIS, V31, P96, DOI 10.1097/01.OLQ.0000109515.75864.2B; Piketty C, 2003, ANN INTERN MED, V138, P453, DOI 10.7326/0003-4819-138-6-200303180-00008; Piketty C, 2008, AIDS, V22, P1203, DOI 10.1097/QAD.0b013e3283023f78; Richel O, 2010, BRIT J DERMATOL, V163, P1301, DOI 10.1111/j.1365-2133.2010.09982.x; Salit IE, 2009, INT PAP C 2009 MALM; Salit IE, 2010, AIDS, V24, P1307, DOI 10.1097/QAD.0b013e328339e592; Salit IE, 2009, CANCER EPIDEM BIOMAR, V18, P1986, DOI 10.1158/1055-9965.EPI-08-1141; SCHREEDER MT, 1982, J INFECT DIS, V146, P7, DOI 10.1093/infdis/146.1.7; Shia J, 2010, ARCH PATHOL LAB MED, V134, P1601, DOI 10.1043/2009-0668-RAR.1; van der Snoek EM, 2012, SEX TRANSM DIS, V39, P495, DOI 10.1097/OLQ.0b013e31825aa764; Watson AJM, 2006, ANZ J SURG, V76, P715, DOI 10.1111/j.1445-2197.2006.03837.x; Wilkin TJ, 2004, J INFECT DIS, V190, P1685, DOI 10.1086/424599	36	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84030	10.1371/journal.pone.0084030	http://dx.doi.org/10.1371/journal.pone.0084030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367625	gold, Green Submitted, Green Published			2022-12-27	WOS:000328740300125
J	Alvarez, TM; Paiva, JH; Ruiz, DM; Cairo, JPLF; Pereira, IO; Paixao, DAA; de Almeida, RF; Tonoli, CCC; Ruller, R; Santos, CR; Squina, FM; Murakami, MT				Alvarez, Thabata M.; Paiva, Joice H.; Ruiz, Diego M.; Cairo, Joao Paulo L. F.; Pereira, Isabela O.; Paixao, Douglas A. A.; de Almeida, Rodrigo F.; Tonoli, Celisa C. C.; Ruller, Roberto; Santos, Camila R.; Squina, Fabio M.; Murakami, Mario T.			Structure and Function of a Novel Cellulase 5 from Sugarcane Soil Metagenome	PLOS ONE			English	Article							SECONDARY STRUCTURE ANALYSES; CRYSTAL-STRUCTURE; ERWINIA-CHRYSANTHEMI; HYDROLYSIS REACTION; ENDOGLUCANASE; FAMILIES; ADAPTATION; BACTERIA; FAMILY-5; COMPLEX	Cellulases play a key role in enzymatic routes for degradation of plant cell-wall polysaccharides into simple and economically-relevant sugars. However, their low performance on complex substrates and reduced stability under industrial conditions remain the main obstacle for the large-scale production of cellulose-derived products and biofuels. Thus, in this study a novel cellulase with unusual catalytic properties from sugarcane soil metagenome (CelE1) was isolated and characterized. The polypeptide deduced from the celE1 gene encodes a unique glycoside hydrolase domain belonging to GH5 family. The recombinant enzyme was active on both carboxymethyl cellulose and beta-glucan with an endo-acting mode according to capillary electrophoretic analysis of cleavage products. CelE1 showed optimum hydrolytic activity at pH 7.0 and 50 degrees C with remarkable activity at alkaline conditions that is attractive for industrial applications in which conventional acidic cellulases are not suitable. Moreover, its three-dimensional structure was determined at 1.8 angstrom resolution that allowed the identification of an insertion of eight residues in the beta 8-alpha 8 loop of the catalytic domain of CelE1, which is not conserved in its psychrophilic orthologs. This 8-residue-long segment is a prominent and distinguishing feature of thermotolerant cellulases 5 suggesting that it might be involved with thermal stability. Based on its unconventional characteristics, CelE1 could be potentially employed in biotechnological processes that require thermotolerant and alkaline cellulases.	[Alvarez, Thabata M.; Cairo, Joao Paulo L. F.; Pereira, Isabela O.; Paixao, Douglas A. A.; de Almeida, Rodrigo F.; Ruller, Roberto; Squina, Fabio M.] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil; [Paiva, Joice H.; Ruiz, Diego M.; Tonoli, Celisa C. C.; Santos, Camila R.; Murakami, Mario T.] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias LNBio, Campinas, SP, Brazil		Squina, FM (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil.	fabio.squina@bioethanol.org.br; mario.murakami@lnbio.cnpem.br	Murakami, Mario T/C-2087-2012; Murakami, Mario T/F-5640-2016; Cairo, João Paulo L Franco/A-3423-2013; Squina, Fabio/J-8130-2012; Alvarez, Thabata/G-4117-2014; Ruller, ROBERTO/D-1260-2014; Santos, Camila Ramos dos/F-7095-2013	Murakami, Mario T/0000-0002-0405-8010; Cairo, João Paulo L Franco/0000-0002-4744-3111; Squina, Fabio/0000-0002-8154-7459; Tonoli, Celisa/0000-0003-2580-5588; de Oliveira Pereira, Isabela/0000-0002-8902-3115; Ruller, ROBERTO/0000-0002-5087-9493; Ruller, Roberto/0000-0001-7501-5176; Santos, Camila Ramos dos/0000-0003-0652-4211	Brazilian Research Agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [09/08312-6, 13/13309-0, 2008/58037-9, 2010/11469-1, 2012/18559-5, 2011/20977-3]; Brazilian Research Agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [478059/2009-4, 486841/2012-0]; Brazilian Research Agency Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Brazilian Research Agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Research Agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Research Agency Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Brazilian Research Agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grants number: 09/08312-6 and 13/13309-0 to MTM, 2008/58037-9 to FMS, 2010/11469-1 to TMA, 2012/18559-5 to RG, 2011/20977-3 to JPLFC; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) grants number 478059/2009-4 and 486841/2012-0 awarded to MTM; and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070014; Badieyan S, 2012, PROTEIN ENG DES SEL, V25, P223, DOI 10.1093/protein/gzs010; BARRAS F, 1992, FEBS LETT, V300, P145, DOI 10.1016/0014-5793(92)80183-H; Bischoff KM, 2006, BIOTECHNOL LETT, V28, P1761, DOI 10.1007/s10529-006-9153-0; Branden CI, 1991, CURR OPIN STRUC BIOL, V1, P978, DOI 10.1016/0959-440X(91)90094-A; Chapon V, 2001, J MOL BIOL, V310, P1055, DOI 10.1006/jmbi.2001.4787; Cohen R, 2005, APPL ENVIRON MICROB, V71, P2412, DOI 10.1128/AEM.71.5.2412-2417.2005; Cota J, 2011, BIOCHEM BIOPH RES CO, V406, P590, DOI 10.1016/j.bbrc.2011.02.098; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P1926, DOI 10.1021/bi972162m; DOMINGUEZ R, 1995, NAT STRUCT BIOL, V2, P569, DOI 10.1038/nsb0795-569; DUCROS V, 1995, STRUCTURE, V3, P939, DOI 10.1016/S0969-2126(01)00228-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Festucci-Buselli Reginaldo A., 2007, Braz. J. Plant Physiol., V19, P1, DOI 10.1590/S1677-04202007000100001; Cairo JPLF, 2013, INSECT BIOCHEM MOLEC, V43, P970, DOI 10.1016/j.ibmb.2013.07.007; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liang CN, 2011, APPL MICROBIOL BIOT, V89, P315, DOI 10.1007/s00253-010-2842-6; Liu JA, 2011, APPL MICROBIOL BIOT, V89, P1083, DOI 10.1007/s00253-010-2828-4; Lorenz P, 2005, NAT REV MICROBIOL, V3, P510, DOI 10.1038/nrmicro1161; Margeot A, 2009, CURR OPIN BIOTECH, V20, P372, DOI 10.1016/j.copbio.2009.05.009; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McIlvaine TC, 1921, J BIOL CHEM, V49, P183; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nguyen NH, 2012, BIOSCI BIOTECH BIOCH, V76, P1075, DOI 10.1271/bbb.110786; Park JI, 2011, BIORESOURCE TECHNOL, V102, P5988, DOI 10.1016/j.biortech.2011.02.036; Pereira JH, 2009, ACTA CRYSTALLOGR D, V65, P744, DOI 10.1107/S0907444909012773; Sakon J, 1996, BIOCHEMISTRY-US, V35, P10648, DOI 10.1021/bi9604439; Santos CR, 2012, BIOCHEM J, V441, P95, DOI 10.1042/BJ20110869; Shaw A, 2002, J MOL BIOL, V320, P303, DOI 10.1016/S0022-2836(02)00387-X; Shirai T, 2001, J MOL BIOL, V310, P1079, DOI 10.1006/jmbi.2001.4835; Sonan GK, 2007, BIOCHEM J, V407, P293, DOI 10.1042/BJ20070640; TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Varrot A, 2000, J MOL BIOL, V297, P819, DOI 10.1006/jmbi.2000.3567; Violot S, 2005, J MOL BIOL, V348, P1211, DOI 10.1016/j.jmb.2005.03.026; Vyas NK, 1991, CURR OPIN STRUC BIOL, V1, P723; Wen F, 2009, CURR OPIN BIOTECH, V20, P412, DOI 10.1016/j.copbio.2009.07.001; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	42	36	36	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83635	10.1371/journal.pone.0083635	http://dx.doi.org/10.1371/journal.pone.0083635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358302	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700066
J	Marini, M; Sriram, N; Schnabel, K; Maliszewski, N; Devos, T; Ekehammar, B; Wiers, R; Cai, HJ; Somogyi, M; Shiomura, K; Schnall, S; Neto, F; Bar-Anan, Y; Vianello, M; Ayala, A; Dorantes, G; Park, J; Kesebir, S; Pereira, A; Tulbure, B; Ortner, T; Stepanikova, I; Greenwald, AG; Nosekl, BA				Marini, Maddalena; Sriram, Natarajan; Schnabel, Konrad; Maliszewski, Norbert; Devos, Thierry; Ekehammar, Bo; Wiers, Reinout; Cai HuaJian; Somogyi, Monika; Shiomura, Kimihiro; Schnall, Simone; Neto, Felix; Bar-Anan, Yoav; Vianello, Michelangelo; Ayala, Alfonso; Dorantes, Gabriel; Park, Jaihyun; Kesebir, Selin; Pereira, Antonio; Tulbure, Bogdan; Ortner, Tuulia; Stepanikova, Irena; Greenwald, Anthony G.; Nosekl, Brian A.			Overweight People Have Low Levels of Implicit Weight Bias, but Overweight Nations Have High Levels of Implicit Weight Bias	PLOS ONE			English	Article							ANTI-FAT BIAS; ASSOCIATION TEST; HEALTH-PROFESSIONALS; BODY-WEIGHT; OBESITY; STIGMA; ATTITUDES; DISCRIMINATION; PREJUDICE; BELIEFS	Although a greater degree of personal obesity is associated with weaker negativity toward overweight people on both explicit (i.e., self-report) and implicit (i.e., indirect behavioral) measures, overweight people still prefer thin people on average. We investigated whether the national and cultural context - particularly the national prevalence of obesity predicts attitudes toward overweight people independent of personal identity and weight status. Data were collected from a total sample of 338,121 citizens from 71 nations in 22 different languages on the Project Implicit website (https://implicit.harvard.edu/) between May 2006 and October 2010. We investigated the relationship of the explicit and implicit weight bias with the obesity both at the individual (i.e., across individuals) and national (i.e., across nations) level. Explicit weight bias was assessed with self-reported preference between overweight and thin people; implicit weight bias was measured with the Implicit Association Test (IAT). The national estimates of explicit and implicit weight bias were obtained by averaging the individual scores for each nation. Obesity at the individual level was defined as Body Mass Index (BMI) scores, whereas obesity at the national level was defined as three national weight indicators (national BMI, national percentage of overweight and underweight people) obtained from publicly available databases. Across individuals, greater degree of obesity was associated with weaker implicit negativity toward overweight people compared to thin people. Across nations, in contrast, a greater degree of national obesity was associated with stronger implicit negativity toward overweight people compared to thin people. This result indicates a different relationship between obesity and implicit weight bias at the individual and national levels.	[Marini, Maddalena; Sriram, Natarajan; Nosekl, Brian A.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA; [Marini, Maddalena] Univ Modena & Reggio Emilia, Dept Commun & Econ, Reggio Emilia, Italy; [Schnabel, Konrad] Univ Potsdam, Dept Psychol, Potsdam, Germany; [Maliszewski, Norbert] Warsaw Univ, Dept Psychol, Warsaw, Poland; [Devos, Thierry] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA; [Ekehammar, Bo] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden; [Wiers, Reinout] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Cai HuaJian] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Somogyi, Monika] Eotvos Lorand Univ, Dept Psychol, Budapest, Hungary; [Shiomura, Kimihiro] Ferris Univ, Yokohama, Kanagawa, Japan; [Schnall, Simone] Univ Cambridge, Dept Psychol, Cambridge, England; [Neto, Felix] Univ Porto, Fac Psicol & Ciencias Educ, P-4100 Porto, Portugal; [Bar-Anan, Yoav] Ben Gurion Univ Negev, Dept Psychol, IL-84105 Beer Sheva, Israel; [Vianello, Michelangelo] Univ Padua, Dept Appl Psychol, Padua, Italy; [Ayala, Alfonso] Inst Electoral Veracruzano, Xalapa, Veracruz, Mexico; [Dorantes, Gabriel] Univ Autonoma Estado Morelos, Fac Psicol, Cuernavaca, Morelos, Mexico; [Park, Jaihyun] CUNY, Baruch Coll, Dept Psychol, New York, NY 10021 USA; [Kesebir, Selin] London Business Sch, London NW1 4SA, England; [Pereira, Antonio] Univ Rio Grande Do Norte, Brain Inst Fed, Natal, RN, Brazil; [Tulbure, Bogdan] Transilvania Univ Brasov, Dept Psychol, Brasov, Romania; [Stepanikova, Irena] Salzburg Univ, Dept Psychol, Div Psychol Assessment, A-5020 Salzburg, Austria; [Stepanikova, Irena] Univ S Carolina, Sloan Coll, Columbia, SC 29208 USA; [Greenwald, Anthony G.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA	University of Virginia; Universita di Modena e Reggio Emilia; University of Potsdam; University of Warsaw; California State University System; San Diego State University; Stockholm University; University of Amsterdam; Chinese Academy of Sciences; Institute of Psychology, CAS; Eotvos Lorand University; University of Cambridge; Universidade do Porto; Ben Gurion University; University of Padua; Universidad Autonoma del Estado de Morelos; City University of New York (CUNY) System; Baruch College (CUNY); University of London; London Business School; Transylvania University of Brasov; Salzburg University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Washington; University of Washington Seattle	Marini, M (corresponding author), Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA.	maddalena.marini@unimore.it	Bar-Anan, Yoav/AAM-7229-2021; Tulbure, Bogdan Tudor/H-4226-2015; Maliszewski, Norbert/D-9047-2015; Neto, Félix/H-6575-2013; Greenwald, Anthony G./AAB-2397-2020; Wiers, Reinout/AAB-4008-2021; Tulbure, Bogdan Tudor/AAF-4896-2021; Dorantes-Argandar, Gabriel/U-7805-2019; Kesebir, Selin/C-9905-2014; Pereira, Antonio/AAY-4372-2020; Vianello, Michelangelo/G-8919-2013; Ortner, Tuulia M./AAE-5157-2020	Tulbure, Bogdan Tudor/0000-0001-8101-1753; Neto, Félix/0000-0003-0112-880X; Greenwald, Anthony G./0000-0001-6865-8552; Wiers, Reinout/0000-0002-4312-9766; Tulbure, Bogdan Tudor/0000-0001-8101-1753; Dorantes-Argandar, Gabriel/0000-0001-9853-979X; Kesebir, Selin/0000-0002-3909-9445; Pereira, Antonio/0000-0002-0808-1058; Vianello, Michelangelo/0000-0002-1530-1469; Ortner, Tuulia M./0000-0002-5703-6915; Maliszewski, Norbert/0000-0001-6901-9509; Nosek, Brian/0000-0001-6797-5476	Project Implicit, Inc; University of Warsaw, Poland [BST164635]	Project Implicit, Inc; University of Warsaw, Poland	This project was supported by Project Implicit, Inc (http://projectimplicit.net/), a non-profit organization that includes in its mission "To develop and deliver methods for investigating and applying phenomena of implicit social cognition, including especially phenomena of implicit bias based on age, race, gender or other factors." The Polish sample was financed from a grant from the University of Warsaw, Poland (BST164635). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON DB, 1991, INT J EAT DISORDER, V10, P599; Amy NK, 2006, INT J OBESITY, V30, P147, DOI 10.1038/sj.ijo.0803105; Anderson-Fye EP, 2004, CULT MED PSYCHIAT, V28, P561, DOI 10.1007/s11013-004-1068-4; Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; Ashmore Jamile A, 2008, Eat Behav, V9, P203, DOI 10.1016/j.eatbeh.2007.09.006; Becker Anne, 1995, BODY SELF SOC VIEW F; Bessenoff GR, 2000, SOC COGNITION, V18, P329, DOI 10.1521/soco.2000.18.4.329; Brewis AA, 2011, CURR ANTHROPOL, V52, P269, DOI 10.1086/659309; Carr D, 2005, J HEALTH SOC BEHAV, V46, P244, DOI 10.1177/002214650504600303; CRANDALL CS, 1994, J PERS SOC PSYCHOL, V66, P882, DOI 10.1037/0022-3514.66.5.882; De Houwer J, 2009, PSYCHOL BULL, V135, P347, DOI 10.1037/a0014211; DOLINSKI D, 1991, POLISH PSYCHOL B, V22, P43; Eknoyan G, 2008, NEPHROL DIAL TRANSPL, V23, P47, DOI 10.1093/ndt/gfm517; Fiske A.P., 1998, HDB SOCIAL PSYCHOL, P915; Fiske SusanT., 1991, SOCIAL COGNITION 2; FURNHAM A, 1993, J SOC PSYCHOL, V133, P317, DOI 10.1080/00224545.1993.9712149; FURNHAM A, 1992, PSYCHOL REP, V71, P1149, DOI 10.2466/PR0.71.8.1149-1150; Glashouwer KA, 2013, J BEHAV THER EXP PSY, V44, P105, DOI 10.1016/j.jbtep.2012.07.015; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Heine SJ, 2002, J PERS SOC PSYCHOL, V82, P903, DOI 10.1037//0022-3514.82.6.903; Heine SJ, 2008, PSYCHOL SCI, V19, P309, DOI 10.1111/j.1467-9280.2008.02085.x; Jost JT, 2004, POLIT PSYCHOL, V25, P881, DOI 10.1111/j.1467-9221.2004.00402.x; Lane K. A., 2007, IMPLICIT MEASURES AT, P59, DOI DOI 10.1016/J.BRAT.2008.02.003; LERNER MJ, 1978, PSYCHOL BULL, V85, P1030, DOI 10.1037/0033-2909.85.5.1030; Lerner MJ, 1998, CRIT IS SOC, P1; Neumark-Sztainer D, 2002, INT J OBESITY, V26, P123, DOI 10.1038/sj.ijo.0801853; Nosek B.A., 2007, AUTOMATIC PROCESSES, P265, DOI DOI 10.1037/0022-3514.89.3.277; Nosek BA, 2005, PERS SOC PSYCHOL B, V31, P166, DOI 10.1177/0146167204271418; Nosek BA, 2007, EUR REV SOC PSYCHOL, V18, P36, DOI 10.1080/10463280701489053; Nosek BA, 2011, TRENDS COGN SCI, V15, P152, DOI 10.1016/j.tics.2011.01.005; Nosek BA, 2009, P NATL ACAD SCI USA, V106, P10593, DOI 10.1073/pnas.0809921106; Peng KP, 1997, PSYCHOL METHODS, V2, P329, DOI 10.1037/1082-989X.2.4.329; Popenoe R, 2004, FEEDING DESIRE FATNE; Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108; Puhl R M, 2003, Obes Rev, V4, P213, DOI 10.1046/j.1467-789X.2003.00122.x; Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Sabin JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048448; Schwartz MB, 2006, OBESITY, V14, P440, DOI 10.1038/oby.2006.58; Schwartz MB, 2003, OBES RES, V11, P1033, DOI 10.1038/oby.2003.142; SOBO E, 1994, SWEETNESS FAT HLTH P; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Teachman BA, 2003, HEALTH PSYCHOL, V22, P68, DOI 10.1037/0278-6133.22.1.68; Teachman BA, 2001, INT J OBESITY, V25, P1525, DOI 10.1038/sj.ijo.0801745; Teige-Mocigemba S., 2010, HDB IMPLICIT SOCIAL, P117; Vartanian LR, 2008, J HEALTH PSYCHOL, V13, P131, DOI 10.1177/1359105307084318; WAGNER CH, 1982, AM STAT, V36, P46, DOI 10.2307/2684093; WANG H, 1993, INTRO CROSS CULTURE; Wee CC, 2000, ANN INTERN MED, V132, P697, DOI 10.7326/0003-4819-132-9-200005020-00003	55	56	56	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83543	10.1371/journal.pone.0083543	http://dx.doi.org/10.1371/journal.pone.0083543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GT	24358291	Green Published, gold			2022-12-27	WOS:000328737700060
J	Naik, AW; Kangas, JD; Langmead, CJ; Murphy, RF				Naik, Armaghan W.; Kangas, Joshua D.; Langmead, Christopher J.; Murphy, Robert F.			Efficient Modeling and Active Learning Discovery of Biological Responses	PLOS ONE			English	Article							SYSTEMS BIOLOGY; MISSING DATA; PREDICTION; SELECTION	High throughput and high content screening involve determination of the effect of many compounds on a given target. As currently practiced, screening for each new target typically makes little use of information from screens of prior targets. Further, choices of compounds to advance to drug development are made without significant screening against off-target effects. The overall drug development process could be made more effective, as well as less expensive and time consuming, if potential effects of all compounds on all possible targets could be considered, yet the cost of such full experimentation would be prohibitive. In this paper, we describe a potential solution: probabilistic models that can be used to predict results for unmeasured combinations, and active learning algorithms for efficiently selecting which experiments to perform in order to build those models and determining when to stop. Using simulated and experimental data, we show that our approaches can produce powerful predictive models without exhaustive experimentation and can learn them much faster than by selecting experiments at random.	[Naik, Armaghan W.; Kangas, Joshua D.; Langmead, Christopher J.; Murphy, Robert F.] Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Murphy, Robert F.] Carnegie Mellon Univ, Dept Biol Sci, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Murphy, Robert F.] Carnegie Mellon Univ, Dept Machine Learning, Pittsburgh, PA 15213 USA; [Murphy, Robert F.] Univ Freiburg, Freiburg Inst Adv Studies, D-79106 Freiburg, Germany; [Murphy, Robert F.] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; University of Freiburg; University of Freiburg	Murphy, RF (corresponding author), Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA.	murphy@cmu.edu		Langmead, Christopher/0000-0001-7521-6736	National Institutes of Health [R01 GM075205, T32 EB009403-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institutes of Health under Award Numbers R01 GM075205 and T32 EB009403-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allison PD, 2000, SOCIOL METHOD RES, V28, P301, DOI 10.1177/0049124100028003003; Angluin D, 2010, LECT NOTES ARTIF INT, V6331, P194, DOI 10.1007/978-3-642-16108-7_18; [Anonymous], 2013, CONN MAP; Candes EJ, 2009, FOUND COMPUT MATH, V9, P717, DOI 10.1007/s10208-009-9045-5; Chen P, 2004, IEEE T PATTERN ANAL, V26, P1051, DOI 10.1109/TPAMI.2004.52; Cohn DA, 1996, J ARTIF INTELL RES, V4, P129, DOI 10.1613/jair.295; Danziger SA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000498; Een N, 2004, LECT NOTES COMPUT SC, V2919, P502, DOI 10.1007/978-3-540-24605-3_37; Even-Dar E, 2002, COMPUTATIONAL LEARNI, P193; Fujiwara Y, 2008, J CHEM INF MODEL, V48, P930, DOI 10.1021/ci700085q; Heckman J, 1998, ECONOMETRICA, V66, P1017, DOI 10.2307/2999630; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Liu Y, 2004, J CHEM INF COMP SCI, V44, P1936, DOI 10.1021/ci049810a; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Merino A, 2010, DRUG DISCOV TODAY, V15, P749, DOI 10.1016/j.drudis.2010.06.006; Mohamed TP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S57; Murphy RF, 2011, NAT CHEM BIOL, V7, P327, DOI 10.1038/nchembio.576; Pan GQ, 2004, LECT NOTES COMPUT SC, V3258, P453; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Saar-Tsechansky M, 2004, MACH LEARN, V54, P153, DOI 10.1023/B:MACH.0000011806.12374.c3; Sahinidis NV, 2003, LECT NOTES COMPUT SC, V2861, P1; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Warmuth MK, 2003, J CHEM INF COMP SCI, V43, P667, DOI 10.1021/ci025620t; Westerhoff HV, 2004, NAT BIOTECHNOL, V22, P1249, DOI 10.1038/nbt1020	27	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83996	10.1371/journal.pone.0083996	http://dx.doi.org/10.1371/journal.pone.0083996			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358322	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700075
J	Wehi, PM; Raubenheimer, D; Morgan-Richards, M				Wehi, Priscilla M.; Raubenheimer, David; Morgan-Richards, Mary			Tolerance for Nutrient Imbalance in an Intermittently Feeding Herbivorous Cricket, the Wellington Tree Weta	PLOS ONE			English	Article							FOOD SELECTION; LIFE-SPAN; ORGANISMAL STOICHIOMETRY; HEMIDEINA-CRASSIDENS; NUTRITIONAL ECOLOGY; MULTIPLE NUTRIENTS; GEOMETRIC ANALYSIS; INSECT HERBIVORE; SEXUAL SELECTION; NITROGEN-CONTENT	Organisms that regulate nutrient intake have an advantage over those that do not, given that the nutrient composition of any one resource rarely matches optimal nutrient requirements. We used nutritional geometry to model protein and carbohydrate intake and identify an intake target for a sexually dimorphic species, the Wellington tree weta (Hemideina crassidens). Despite pronounced sexual dimorphism in this large generalist herbivorous insect, intake targets did not differ by sex. In a series of laboratory experiments, we then investigated whether tree weta demonstrate compensatory responses for enforced periods of imbalanced nutrient intake. Weta pre-fed high or low carbohydrate: protein diets showed large variation in compensatory nutrient intake over short (<48 h) time periods when provided with a choice. Individuals did not strongly defend nutrient targets, although there was some evidence for weak regulation. Many weta tended to select high and low protein foods in a ratio similar to their previously identified nutrient optimum. These results suggest that weta have a wide tolerance to nutritional imbalance, and that the time scale of weta nutrient balancing could lie outside of the short time span tested here. A wide tolerance to imbalance is consistent with the intermittent feeding displayed in the wild by weta and may be important in understanding weta foraging patterns in New Zealand forests.	[Wehi, Priscilla M.; Morgan-Richards, Mary] Massey Univ, Inst Agr & Environm, Ecol Grp, Palmerston North, New Zealand; [Raubenheimer, David] Massey Univ, Inst Nat Sci, Palmerston North, New Zealand; [Raubenheimer, David] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Raubenheimer, David] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Raubenheimer, David] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Raubenheimer, David] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	Massey University; Massey University; University of Sydney; University of Sydney; University of Sydney; University of Sydney	Wehi, PM (corresponding author), Univ Otago, Ctr Sustainabil CSAFE, Dunedin, New Zealand.	priscilla.wehi@otago.ac.nz	Morgan-Richards, Mary/B-4444-2011	Raubenheimer, David/0000-0001-9050-1447; Wehi, Priscilla/0000-0001-9821-8160; Morgan-Richards, Mary/0000-0002-3913-9814	FRST postdoctoral fellowship [MAUX0905]; Massey University [MURF_11/0039]	FRST postdoctoral fellowship(New Zealand Foundation for Research, Science and Technology); Massey University	PMW was supported by FRST postdoctoral fellowship MAUX0905. MMR had Massey University Research Funding MURF_11/0039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR, 2005, AM NAT, V165, P1, DOI 10.1086/426598; Bakr EM, 2005, J APPL ENTOMOL, V129, P173, DOI 10.1111/j.1439-0418.2005.00948.x; Behmer ST, 2008, P NATL ACAD SCI USA, V105, P1977, DOI 10.1073/pnas.0711870105; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; Behmer ST, 2001, ANIM BEHAV, V61, P995, DOI 10.1006/anbe.2000.1695; Belovsky GE, 1997, EVOL ECOL, V11, P641, DOI 10.1023/A:1018430201230; BJORNDAL KA, 1991, ECOLOGY, V72, P1234, DOI 10.2307/1941097; Boersma M, 2006, ECOLOGY, V87, P1325, DOI 10.1890/0012-9658(2006)87[1325:TMOAGT]2.0.CO;2; Bonduriansky R, 2008, FUNCT ECOL, V22, P443, DOI 10.1111/j.1365-2435.2008.01417.x; Clissold FJ, 2009, ECOLOGY, V90, P3393, DOI 10.1890/09-0130.1; Cruz-Rivera E, 2000, OECOLOGIA, V123, P252, DOI 10.1007/s004420051012; Daniel M.J., 1973, Proceedings of the New Zealand Ecological Society, V20, P21; Dewhurst R, 2013, THESIS MASSEY U PALM; Fanson BG, 2013, EVOL ECOL, V27, P937, DOI 10.1007/s10682-013-9638-y; Fricke C, 2010, J EVOLUTION BIOL, V23, P157, DOI 10.1111/j.1420-9101.2009.01882.x; Frost PC, 2005, OIKOS, V109, P18, DOI 10.1111/j.0030-1299.2005.14049.x; Griffin Melissa J., 2011, New Zealand Natural Sciences, V36, P11; Griffin MJ, 2011, NEW ZEAL J ECOL, V35, P302; Haw JM, 2001, NEW ZEAL J ECOL, V25, P61; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Houston AI, 2011, ECOL LETT, V14, P1101, DOI 10.1111/j.1461-0248.2011.01678.x; Innes J., 1979, New Zealand Journal of Ecology, V2, P85; Kelly CD, 2005, BEHAV ECOL, V16, P145, DOI 10.1093/beheco/arh141; Kelly CD, 2006, ANIM BEHAV, V72, P727, DOI 10.1016/j.anbehav.2006.02.007; Kelly CD, 2006, BEHAV ECOL SOCIOBIOL, V60, P175, DOI 10.1007/s00265-005-0154-0; Leisnham PT, 2003, NEW ZEAL J ECOL, V27, P191; Lemaitre JF, 2013, BEHAV ECOL, V24, P421, DOI 10.1093/beheco/ars179; Maklakov AA, 2008, CURR BIOL, V18, P1062, DOI 10.1016/j.cub.2008.06.059; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; Mody K, 2007, ECOLOGY, V88, P1012, DOI 10.1890/06-1338; Morehouse NI, 2010, OIKOS, V119, P766, DOI 10.1111/j.1600-0706.2009.18569.x; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V250, P143, DOI 10.1098/rspb.1992.0142; Quinn JM, 2000, NEW ZEAL J MAR FRESH, V34, P253, DOI 10.1080/00288330.2000.9516931; Raubenheimer D, 2004, ECOLOGY, V85, P1203, DOI 10.1890/02-0248; Raubenheimer D, 1997, NUTR RES REV, V10, P151, DOI 10.1079/NRR19970009; Raubenheimer D, 2006, ANIM BEHAV, V71, P1253, DOI 10.1016/j.anbehav.2005.07.024; Raubenheimer D, 2003, J EXP BIOL, V206, P1669, DOI 10.1242/jeb.00336; RAUBENHEIMER D, 1993, ANIM BEHAV, V45, P953, DOI 10.1006/anbe.1993.1114; Raubenheimer D, 2007, ECOLOGY, V88, P2598, DOI 10.1890/07-0012.1; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; Schmidt JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049223; Schmitz OJ, 2008, ANNU REV ECOL EVOL S, V39, P133, DOI 10.1146/annurev.ecolsys.39.110707.173418; Simpson SJ, 2006, P NATL ACAD SCI USA, V103, P4152, DOI 10.1073/pnas.0508915103; Simpson SJ, 2000, ADV STUD BEHAV, V29, P1, DOI 10.1016/S0065-3454(08)60102-3; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; Simpson SJ, 2001, ECOLOGY, V82, P422; Simpson SJ, 2012, NATURE NUTR UNIFYING; Simpson SJ, 2010, TRENDS ECOL EVOL, V25, P53, DOI 10.1016/j.tree.2009.06.012; Spencer AM, 1995, THESIS VICTORIA U WE; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Stringer Ian A.N., 2006, New Zealand Entomologist, V29, P5; Stringer Ian A.N., 2001, P399, DOI 10.1079/9780851994086.0399; Warbrick-Smith J, 2006, P NATL ACAD SCI USA, V103, P14045, DOI 10.1073/pnas.0605225103; Warbrick-Smith J, 2009, ENTOMOL EXP APPL, V132, P65, DOI 10.1111/j.1570-7458.2009.00870.x; Wehi PM, 2013, NEW ZEAL J ECOL, V37, P75; Wehi PM, 2010, J INSECT PHYSIOL, V56, P1877, DOI 10.1016/j.jinsphys.2010.08.005; Zajitschek F, 2012, ECOL EVOL, V2, P1627, DOI 10.1002/ece3.288; Zajitschek F, 2009, ECOLOGY, V90, P1698, DOI 10.1890/08-0048.1	59	13	13	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84641	10.1371/journal.pone.0084641	http://dx.doi.org/10.1371/journal.pone.0084641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358369	Green Published, gold			2022-12-27	WOS:000328737700104
J	Xin, JG; Yang, HQ; Fan, NN; Zhao, BT; Ouyang, Z; Liu, ZM; Zhao, Y; Li, XP; Song, J; Yang, Y; Zou, QJ; Yan, QM; Zeng, YZ; Lai, LX				Xin, Jige; Yang, Huaqiang; Fan, Nana; Zhao, Bentian; Ouyang, Zhen; Liu, Zhaoming; Zhao, Yu; Li, Xiaoping; Song, Jun; Yang, Yi; Zou, Qingjian; Yan, Quanmei; Zeng, Yangzhi; Lai, Liangxue			Highly Efficient Generation of GGTA1 Biallelic Knockout Inbred Mini-Pigs with TALENs	PLOS ONE			English	Article							NUCLEAR TRANSFER; EMBRYO MICROINJECTION; GENE-KNOCKOUT; PIGS; RATS; LINE	Inbred mini-pigs are ideal organ donors for future human xenotransplantations because of their clear genetic background, high homozygosity, and high inbreeding endurance. In this study, we chose fibroblast cells from a highly inbred pig line called Banna mini-pig inbred line (BMI) as donor nuclei for nuclear transfer, combining with transcription activator-like effector nucleases (TALENs) and successfully generated alpha-1,3-galactosyltransferase (GGTA1) gene biallelic knockout (KO) pigs. To validate the efficiency of TALEN vectors, in vitro-transcribed TALEN mRNAs were microinjected into one-cell stage parthenogenetically activated porcine embryos. The efficiency of indel mutations at the GGTA1-targeting loci was as high as 73.1% (19/26) among the parthenogenetic blastocysts. TALENs were co-transfected into porcine fetal fibroblasts of BMI with a plasmid containing neomycin gene. The targeting efficiency reached 89.5% (187/209) among the survived cell clones after a 10 d selection. More remarkably 27.8% (58/209) of colonies were biallelic KO. Five fibroblast cell lines with biallelic KO were chosen as nuclear donors for somatic cell nuclear transfer (SCNT). Three miniature piglets with biallelic mutations of the GGTA1 gene were achieved. Gal epitopes on the surface of cells from all the three biallelic KO piglets were completely absent. The fibroblasts from the GGTA1 null piglets were more resistant to lysis by pooled complement-preserved normal human serum than those from wild-type pigs. These results indicate that a combination of TALENs technology with SCNT can generate biallelic KO pigs directly with high efficiency. The GGTA1 null piglets with inbred features created in this study can provide a new organ source for xenotransplantation research.	[Xin, Jige; Li, Xiaoping; Yang, Yi; Lai, Liangxue] Jilin Univ, Coll Anim Sci, Jilin Prov Key Lab Anim Embryo Engn, Changchun 130023, Peoples R China; [Yang, Huaqiang; Fan, Nana; Zhao, Bentian; Ouyang, Zhen; Liu, Zhaoming; Zhao, Yu; Song, Jun; Zou, Qingjian; Yan, Quanmei; Lai, Liangxue] Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Yang, Huaqiang; Fan, Nana; Zhao, Bentian; Ouyang, Zhen; Liu, Zhaoming; Zhao, Yu; Song, Jun; Zou, Qingjian; Yan, Quanmei; Lai, Liangxue] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Guangdong Prov Key Lab Stem Cells & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Xin, Jige; Zeng, Yangzhi; Lai, Liangxue] Yunnan Agr Univ, Anim Sci & Technol Coll, Key Lab Banna Mini Pig Inbred Line Yunnan Prov, Kunming, Peoples R China	Jilin University; Chinese Academy of Sciences; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Yunnan Agricultural University	Lai, LX (corresponding author), Jilin Univ, Coll Anim Sci, Jilin Prov Key Lab Anim Embryo Engn, Changchun 130023, Peoples R China.	lai_liangxue@gibh.ac.cn	Song, Jun/A-3487-2013; Yang, Huaqiang/H-7644-2014; Yang, Huaqiang/AAU-6402-2021	Song, Jun/0000-0002-6128-6378; Yang, Huaqiang/0000-0002-4287-0026; 	National Natural Science Foundation of China [31071293, 31071172, 31272394]; Ministry of Science and Technology National Basic Research Program of China (973 program) [2011CB944203, 2009CB941001]; Science and Technology Program of Guangzhou [12S134060176]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology National Basic Research Program of China (973 program); Science and Technology Program of Guangzhou	This work is supported by grants from the National Natural Science Foundation of China (31071293, 31071172), the Ministry of Science and Technology National Basic Research Program of China (973 program) (2011CB944203, 2009CB941001), the Science and Technology Program of Guangzhou (12S134060176), the National Natural Science Foundation of China (31272394). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NAT BIOTECHNOL, V29, P681, DOI 10.1038/nbt.1935; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Chen YN, 2007, CHINESE MED J-PEKING, V120, P739, DOI 10.1097/00029330-200705010-00001; Fan NN, 2013, CELL RES, V23, P162, DOI 10.1038/cr.2012.176; Flisikowska T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021045; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Kolber-Simonds D, 2004, P NATL ACAD SCI USA, V101, P7335, DOI 10.1073/pnas.0307819101; Kuwaki K, 2005, NAT MED, V11, P29, DOI 10.1038/nm1171; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Lillico SG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02847; Phelps CJ, 2003, SCIENCE, V299, P411, DOI 10.1126/science.1078942; Song J, 2013, CELL RES, V23, P1059, DOI 10.1038/cr.2013.85; Sun X, 2004, TRANSPL P, V36, P2488, DOI 10.1016/j.transproceed.2004.07.060; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Yang DS, 2011, CELL RES, V21, P979, DOI 10.1038/cr.2011.70; Yu P, 2004, TRANSPL P, V36, P2485, DOI 10.1016/j.transproceed.2004.07.055; YU P, 2006, J RAPID METH AUT MIC, P199; Zeng R, 2005, ANIM GENET, V36, P267, DOI 10.1111/j.1365-2052.2005.01277.x; Zhang L, 2005, TRANSPLANTATION, V79, P1128, DOI 10.1097/00007890-200505150-00031; Zhang L, 2004, TRANSPL P, V36, P2490, DOI 10.1016/j.transproceed.2004.07.064	26	59	82	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84250	10.1371/journal.pone.0084250	http://dx.doi.org/10.1371/journal.pone.0084250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358349	gold, Green Published, Green Submitted			2022-12-27	WOS:000328737700090
J	Mai, M; Tonjes, A; Kovacs, P; Stumvoll, M; Fiedler, GM; Leichtle, AB				Mai, Manuel; Toenjes, Anke; Kovacs, Peter; Stumvoll, Michael; Fiedler, Georg Martin; Leichtle, Alexander Benedikt			Serum Levels of Acylcarnitines Are Altered in Prediabetic Conditions	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; SELF-CONTAINED POPULATION; INSULIN-RESISTANCE; PLASMA ACYLCARNITINES; LIPID-METABOLISM; SKELETAL-MUSCLE; OBESITY; ASSOCIATION; CARNITINE; OXIDATION	Objective: The role of mitochondrial function in the complex pathogenesis of type 2 diabetes is not yet completely understood. Therefore, the aim of this study was to investigate serum concentrations of short-, medium-and long-chain acylcarnitines as markers of mitochondrial function in volunteers with normal, impaired or diabetic glucose control. Methods: Based on a 75 g oral glucose tolerance test, 1019 studied subjects were divided into a group with normal glucose tolerance (NGT; n = 636), isolated impaired fasting glycaemia (IFG; n = 184), impaired glucose tolerance (IGT; n = 87) or type 2 diabetes (T2D; n = 112). Serum concentrations of free carnitine and 24 acylcarnitines were measured by mass spectrometry. Results: Serum levels of acetylcarnitine (C2), propionylcarnitine (C3), octanoylcarnitine (C8), malonylcarnitine/hydroxybutyrylcarnitine (C3DC+C4OH), hexanoylcarnitine (C6), octenoylcarnitine (C8: 1), decanoylcarnitine (C10), decenoylcarnitine (C10: 1), dodecanoylcarnitine (C12), tetradecenoylcarnitine (C14: 1), tetradecadienylcarnitine (C14: 2), hydroxytetradecanoylcarnitine (C14OH), hydroxyhexadecanoylcarnitine (C16OH) and octadecenoylcarnitine (C18: 1) were significantly different among the groups (all p<0.05 adjusted for age, gender and BMI). Between the prediabetic states C14: 1, C14: 2 and C18: 1 showed significantly higher serum concentrations in persons with IGT (p<0.05). Compared to T2D the IFG and the IGT subjects showed lower serum concentrations of malonylcarnitine/hydroxybutyrylcarnitine (C3DC+C4OH) (p<0.05). Conclusion: Alterations in serum concentrations of several acylcarnitines, in particular tetradecenoylcarnitine (C14: 1), tetradecadienylcarnitine (C14: 2), octadecenoylcarnitine (C18: 1) and malonylcarnitine/hydroxybutyrylcarnitine (C3DC+C4OH) are associated not only with T2D but also with prediabetic states.	[Mai, Manuel; Toenjes, Anke; Stumvoll, Michael] Univ Leipzig, Dept Internal Med Neurol & Dermatol, Div Endocrinol, D-04109 Leipzig, Germany; [Kovacs, Peter; Stumvoll, Michael] Univ Leipzig, IFB Adipos Dis, D-04109 Leipzig, Germany; [Fiedler, Georg Martin; Leichtle, Alexander Benedikt] Univ Hosp Bern, Inselspital, Univ Inst Clin Chem, Ctr Lab Med, CH-3010 Bern, Switzerland	Leipzig University; Leipzig University; University of Bern; University Hospital of Bern	Mai, M (corresponding author), Univ Leipzig, Dept Internal Med Neurol & Dermatol, Div Endocrinol, D-04109 Leipzig, Germany.	manuel.mai@medizin.uni-leipzig.de	Fiedler, Georg Martin/C-8341-2011; Leichtle, Alexander/C-7262-2011; Stumvoll, Michael/ABE-1121-2021	Fiedler, Georg Martin/0000-0001-5689-4574; Stumvoll, Michael/0000-0001-6225-8240; Kovacs, Peter/0000-0002-0290-5423	German Research Council [SFB-1052]; German Diabetes Association; DHFD (Diabetes Hilfs- und Forschungsfonds Deutschland); Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1001]; Boehringer Ingelheim Foundation	German Research Council(German Research Foundation (DFG)); German Diabetes Association; DHFD (Diabetes Hilfs- und Forschungsfonds Deutschland); Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); Boehringer Ingelheim Foundation(Boehringer Ingelheim)	This work was supported by grants from the German Research Council (SFB-1052 "Obesity mechanisms"), from the German Diabetes Association and from the DHFD (Diabetes Hilfs- und Forschungsfonds Deutschland). IFB Adiposity Diseases is supported by the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1001. This work was supported by Boehringer Ingelheim Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2002, J AM COLL CARDIOL, V40, P937, DOI 10.1016/S0735-1097(02)02051-X; Abdul-Ghani MA, 2008, ACTA DIABETOL, V45, P147, DOI 10.1007/s00592-008-0033-z; Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Costa CCG, 1999, PEDIATR RES, V46, P440, DOI 10.1203/00006450-199910000-00013; Faerch K, 2009, DIABETOLOGIA, V52, P1714, DOI 10.1007/s00125-009-1443-3; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Ha CY, 2012, CLIN ENDOCRINOL, V76, P674, DOI 10.1111/j.1365-2265.2011.04244.x; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Indiveri C, 2011, MOL ASPECTS MED, V32, P223, DOI 10.1016/j.mam.2011.10.008; Jourdan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040009; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Lehmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011519; Lum H, 2011, J GERONTOL A-BIOL, V66, P548, DOI 10.1093/gerona/glr006; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Rodriguez-Gutierrez R, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-22; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Tai ES, 2010, DIABETOLOGIA, V53, P757, DOI 10.1007/s00125-009-1637-8; Tonjes A, 2010, EUR J HUM GENET, V18, P104, DOI 10.1038/ejhg.2009.107; Tonjes A, 2009, HUM MOL GENET, V18, P4662, DOI 10.1093/hmg/ddp423; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; VANHOVE JLK, 1993, AM J HUM GENET, V52, P958; Vernez L, 2003, J CHROMATOGR A, V984, P203, DOI 10.1016/S0021-9673(02)01838-1; Vigerust NF, 2012, FERTIL STERIL, V98, P1620, DOI 10.1016/j.fertnstert.2012.08.024; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Wolf M, 2013, J CLIN ENDOCR METAB, V98, pE1137, DOI 10.1210/jc.2012-3976; Zhao XJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE384, DOI 10.1152/ajpendo.90748.2008	32	124	126	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82459	10.1371/journal.pone.0082459	http://dx.doi.org/10.1371/journal.pone.0082459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358186	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700067
J	Morgan, C; Jenkins, SA; Kynaston, HG; Doak, SH				Morgan, Claire; Jenkins, Spencer A.; Kynaston, Howard G.; Doak, Shareen H.			The Role of Adhesion Molecules as Biomarkers for the Aggressive Prostate Cancer Phenotype	PLOS ONE			English	Article							BETA-CATENIN EXPRESSION; E-CADHERIN EXPRESSION; TIGHT JUNCTIONS; BREAST-CANCER; ALPHA-CATENIN; ADHERENS JUNCTIONS; DOWN-REGULATION; POOR-PROGNOSIS; CELLS; CARCINOMA	Background: Currently available methods for diagnosis and staging of prostate cancer lack the sensitivity to distinguish between patients with indolent prostate cancer and those requiring radical treatment. Alterations in key adherens (AJ) and tight junction (TJ) components have been hailed as potential biomarkers for prostate cancer progression but the majority of research has been carried out on individual molecules. Objective: To elucidate a panel of biomarkers that may help distinguish dormant prostate cancer from aggressive metastatic disease. Methods: We analysed the expression of 7 well known AJ and TJ components in cell lines derived from normal prostate epithelial tissue (PNT2), non-invasive (CAHPV-10) and invasive prostate cancer (LNCaP, DU145, PC-3) using gene expression, western blotting and immunofluorescence techniques. Results: Claudin 7, alpha-catenin and beta-catenin protein expression were not significantly different between CAHPV-10 cells and PNT2 cells. However, in PC-3 cells, protein levels for claudin 7, alpha-catenin were significantly down regulated (21.5 fold, p=<.001) or undetectable respectively. Immunofluoresence showed beta-catenin localisation in PC-3 cells to be cytoplasmic as opposed to membraneous. Conclusion: These results suggest aberrant Claudin 7, alpha - and beta-catenin expression and/or localisation patterns may be putative markers for distinguishing localised prostate cancer from aggressive metastatic disease when used collectively.	[Morgan, Claire; Doak, Shareen H.] Swansea Univ, Coll Med, Inst Life Sci, Canc Biomarkers Grp, Swansea, W Glam, Wales; [Jenkins, Spencer A.; Kynaston, Howard G.] Univ Wales Hosp, Dept Urol, Cardiff CF4 4XW, S Glam, Wales	Swansea University; Cardiff University	Morgan, C (corresponding author), Swansea Univ, Coll Med, Inst Life Sci, Canc Biomarkers Grp, Swansea, W Glam, Wales.	C.Morgan@swansea.ac.uk		Morgan, Claire/0000-0002-3969-0710; Doak, Shareen/0000-0002-6753-1987	Prostate Action [G2009/27]; The St David's Medical Foundation, College of Medicine, Swansea University	Prostate Action; The St David's Medical Foundation, College of Medicine, Swansea University	This work was supported by Prostate Action (grant reference number G2009/27) and The St David's Medical Foundation, College of Medicine, Swansea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltomaa S, 1999, BRIT J CANCER, V80, P477, DOI 10.1038/sj.bjc.6690381; Aaltomaa S, 2005, ANTICANCER RES, V25, P4707; Busch C, 2002, HUM PATHOL, V33, P290, DOI 10.1053/hupa.2002.32218; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; De Marzo AM, 1999, UROLOGY, V53, P707, DOI 10.1016/S0090-4295(98)00577-9; Gonzalez-Mariscal L, 2007, PROG HISTOCHEM CYTO, V42, P1, DOI 10.1016/j.proghi.2007.01.001; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Haynes MD, 2005, INT J MOL MED, V16, P3; Hollande F, 2003, J CELL SCI, V116, P1187, DOI 10.1242/jcs.00321; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Ishigaki K, 2002, J CLIN ENDOCR METAB, V87, P3433, DOI 10.1210/jc.87.7.3433; Jaggi M, 2005, UROL ONCOL-SEMIN ORI, V23, P402, DOI 10.1016/j.urolonc.2005.03.024; Kim TH, 2008, HISTOPATHOLOGY, V53, P48, DOI 10.1111/j.1365-2559.2008.03052.x; Kimura Y, 1997, AM J PATHOL, V151, P45; Kominsky SL, 2003, ONCOGENE, V22, P2021, DOI 10.1038/sj.onc.1206199; Kowalczyk AP, 1996, J INVEST DERMATOL, V107, P293, DOI 10.1111/1523-1747.ep12363000; Lanigan F, 2009, INT J CANCER, V124, P2088, DOI 10.1002/ijc.24159; Lioni M, 2007, AM J PATHOL, V170, P709, DOI 10.2353/ajpath.2007.060343; Lopez-Knowles E, 2010, CANCER EPIDEM BIOMAR, V19, P301, DOI 10.1158/1055-9965.EPI-09-0741; Luque-Garcia JL, 2010, PROTEOMICS, V10, P940, DOI 10.1002/pmic.200900441; Martin TA, 2004, EUR J CANCER, V40, P2717, DOI 10.1016/j.ejca.2004.08.008; Mol AJM, 2007, J CANCER RES CLIN, V133, P687, DOI 10.1007/s00432-007-0235-8; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Polette M, 2005, CANCER RES, V65, P7691, DOI 10.1158/0008-5472.CAN-04-4230; Saha B, 2008, PROSTATE, V68, P78, DOI 10.1002/pros.20670; Shah GV, 2009, J BIOL CHEM, V284, P1018, DOI 10.1074/jbc.M807823200; Sheehan GM, 2007, HUM PATHOL, V38, P564, DOI 10.1016/j.humpath.2006.11.007; Szasz AM, 2010, BJU INT, V105, P716, DOI 10.1111/j.1464-410X.2009.08808.x; Tobioka H, 2004, HUM PATHOL, V35, P159, DOI 10.1016/j.humpath.2003.09.013; Tzelepi VN, 2008, MODERN PATHOL, V21, P22, DOI 10.1038/modpathol.3800959; Umbas R, 1997, INT J CANCER, V74, P374, DOI 10.1002/(SICI)1097-0215(19970822)74:4<374::AID-IJC2>3.0.CO;2-S; Whitaker HC, 2008, PROSTATE, V68, P1196, DOI 10.1002/pros.20780; Will C, 2008, PERITON DIALYSIS INT, V28, P577	33	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81666	10.1371/journal.pone.0081666	http://dx.doi.org/10.1371/journal.pone.0081666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358122	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700018
J	Wang, X; Xiu, L; Hu, QL; Cui, XJ; Liu, BC; Tao, L; Wang, T; Wu, JG; Chen, Y; Chen, Y				Wang, Xiao; Xiu, Lei; Hu, Qingliang; Cui, Xinjie; Liu, Bingchun; Tao, Lin; Wang, Ting; Wu, Jingging; Chen, Yuan; Chen, Yan			Deep Sequencing-Based Transcriptional Analysis of Bovine Mammary Epithelial Cells Gene Expression in Response to In Vitro Infection with Staphylococcus aureus Stains	PLOS ONE			English	Article							GROUP-B STREPTOCOCCI; POLARIZED SECRETION; ENDOTHELIAL-CELLS; ESCHERICHIA-COLI; CHEMOKINES; MASTITIS; PATHOGEN; MODULATE; RECOGNITION; ADHERENCE	Staphylococcus aureus (S. aureus) is an important etiological organism in chronic and subclinical mastitis in lactating cows. Given the fundamental role the primary bovine mammary epithelial cells (pBMECs) play as a major first line of defense against invading pathogens, their interactions with S. aureus was hypothesized to be crucial to the establishment of the latter's infection process. This hypothesis was tested by investigating the global transcriptional responses of pBMECs to three S. aureus strains (S56,S178 and S36) with different virulent factors, using a tag-based high-throughput transcriptome sequencing technique. Approximately 4.9 million total sequence tags were obtained from each of the three S. aureus-infected libraries and the control library. Referenced to the control, 1720, 219, and 427 differentially expressed unique genes were identified in the pBMECs infected with S56, S178 and S36 S. aureus strains respectively. Gene ontology (GO) and pathway analysis of the S56-infected pBMECs referenced to those of the control revealed that the differentially expressed genes in S56-infected pBMECs were significantly involved in inflammatory response, cell signalling pathways and apoptosis. In the same vein, the clustered GO terms of the differentially expressed genes of the S178-infected pBMECs were found to comprise immune responses, metabolism transformation, and apoptosis, while those of the S36-infected pBMECs were primarily involved in cell cycle progression and immune responses. Furthermore, fundamental differences were observed in the levels of expression of immune-related genes in response to treatments with the three S. aureus strains. These differences were especially noted for the expression of important pro-inflammatory molecules, including IL-1 alpha, TNF, EFNB1, IL-8, and EGR1. The transcriptional changes associated with cellular signaling and the inflammatory response in this study may reflect different immunomodulatory mechanisms that underlie the interaction between pBMECs and S. aureus strains during infection by the latter.	[Wang, Xiao; Xiu, Lei; Hu, Qingliang; Cui, Xinjie; Liu, Bingchun; Tao, Lin; Wang, Ting; Wu, Jingging; Chen, Yuan; Chen, Yan] Inner Mongolia Univ, Coll Life Sci, Hohhot, Peoples R China	Inner Mongolia University	Wang, X (corresponding author), Inner Mongolia Univ, Coll Life Sci, Hohhot, Peoples R China.	wxiao2008@gmail.com	Lei, Xiu/G-8975-2018	Lei, Xiu/0000-0002-6905-626X	National Natural Science Foundation of China [30901066]; Natural Science Foundation of Inner Mongolia Autonomous Region [2010MS0514]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Inner Mongolia Autonomous Region	This work was supported by the National Natural Science Foundation of China (30901066) and the Natural Science Foundation of Inner Mongolia Autonomous Region (2010MS0514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken SL, 2011, J MAMMARY GLAND BIOL, V16, P291, DOI 10.1007/s10911-011-9230-4; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Almeida RA, 1996, J DAIRY SCI, V79, P1021, DOI 10.3168/jds.S0022-0302(96)76454-8; Altincicek B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052004; Alva-Murillo N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/927643; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barkema HW, 2006, J DAIRY SCI, V89, P1877, DOI 10.3168/jds.S0022-0302(06)72256-1; Benjamini Y, 2001, ANN STAT, V29, P1165; Brand B, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-24; BUEHRING GC, 1990, J DAIRY SCI, V73, P956, DOI 10.3168/jds.S0022-0302(90)78752-8; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-234; Danowski K, 2012, CZECH J ANIM SCI, V57, P207, DOI 10.17221/5919-CJAS; Davie CA, 2008, BRIT MED BULL, V86, P109, DOI 10.1093/bmb/ldn013; De Vliegher S, 2012, J DAIRY SCI, V95, P1025, DOI 10.3168/jds.2010-4074; Dego OK, 2012, VET MICROBIOL, V155, P291, DOI 10.1016/j.vetmic.2011.08.016; Doeschl-Wilson AB, 2011, GENETICS, V188, P683, DOI 10.1534/genetics.110.125625; Dwinell MB, 2003, SURGERY, V133, P601, DOI 10.1067/msy.2003.143; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FINLAY BB, 1989, SCIENCE, V243, P940, DOI 10.1126/science.2919285; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Gewirtz AT, 2002, BEST PRACT RES CL GA, V16, P851, DOI 10.1053/bega.2002.0339; GIBSON RL, 1993, INFECT IMMUN, V61, P478, DOI 10.1128/IAI.61.2.478-485.1993; Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713; HAMILL RJ, 1986, INFECT IMMUN, V54, P833, DOI 10.1128/IAI.54.3.833-836.1986; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Jensen K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-36; Kim JM, 2002, MICROBIOL IMMUNOL, V46, P333, DOI 10.1111/j.1348-0421.2002.tb02704.x; Kim JM, 2001, CLIN EXP IMMUNOL, V123, P421, DOI 10.1046/j.1365-2249.2001.01462.x; Krakauer T, 2002, CLIN DIAGN LAB IMMUN, V9, P126, DOI 10.1128/CDLI.9.1.126-131.2002; Li XY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011827; Liu QH, 2012, MICROB PATHOGENESIS, V52, P267, DOI 10.1016/j.micpath.2012.02.001; Lutzow YCS, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-18; McLoughlin RM, 2008, J IMMUNOL, V181, P1323, DOI 10.4049/jimmunol.181.2.1323; Meyer-Hoffert U, 2003, INT ARCH ALLERGY IMM, V131, P264, DOI 10.1159/000072138; Moreilhon C, 2005, PHYSIOL GENOMICS, V20, P244, DOI 10.1152/physiolgenomics.00135.2004; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; Noel S, 2007, TOXICOLOGY, V239, P96, DOI 10.1016/j.tox.2007.06.098; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; Rainard P, 2006, VET RES, V37, P369, DOI 10.1051/vetres:2006007; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; TAMURA GS, 1994, INFECT IMMUN, V62, P2450, DOI 10.1128/IAI.62.6.2450-2458.1994; Viguier C, 2009, TRENDS BIOTECHNOL, V27, P486, DOI 10.1016/j.tibtech.2009.05.004; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039856; Wang FK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028485; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Yamamoto Y, 2008, FEBS J, V275, P1260, DOI 10.1111/j.1742-4658.2008.06287.x	53	18	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82117	10.1371/journal.pone.0082117	http://dx.doi.org/10.1371/journal.pone.0082117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358144	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700034
J	Abou Zeinab, R; Wu, H; Sergi, C; Leng, RP				Abou Zeinab, Rami; Wu, Hong; Sergi, Consolato; Leng, Roger P.			Residues 240-250 in the C-Terminus of the Pirh2 Protein Complement the Function of the RING Domain in Self-Ubiquitination of the Pirh2 Protein	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVITY; HUMAN CANCER; P53 PROTEIN; E3 LIGASE; DEGRADATION; PROMOTES; ENZYMES; NEDD8; MDM2; MULTIUBIQUITINATION	Pirh2 is a p53 inducible gene that encodes a RING-H2 domain and is proposed to be a main regulator of p53 protein, thus fine tuning the DNA damage response. Pirh2 interacts physically with p53 and promotes its MDM2-independent ubiquitination and subsequent degradation as well as participates in an auto-regulatory feedback loop that controls p53 function. Pirh2 also self-ubiquitinates. Interestingly, Pirh2 is overexpressed in a wide range of human tumors. In this study, we investigated the domains and residues essential for Pirh2 self-ubiquitination. Deletions were made in each of the three major domains of Pirh2: the N-terminal domain (NTD), Ring domain (RING), and C-terminal domain (CTD). The effects of these deletions on Pirh2 self-ubiquitination were then assessed using in vitro ubiquitination assays. Our results demonstrate that the RING domain is essential, but not sufficient, for Pirh2 self-ubiquitination and that residues 240-250 of the C-terminal domain are also essential. Our results demonstrate that Pirh2 mediated p53 polyubiquitination occurs mainly through the K48 residue of ubiquitin in vitro. Our data further our understanding of the mechanism of Pirh2 self-ubiquitination and may help identify valuable therapeutic targets that play roles in reducing the effects of the overexpression of Pirh2, thus maximizing p53's response to DNA damage.	[Abou Zeinab, Rami; Wu, Hong; Sergi, Consolato; Leng, Roger P.] Univ Alberta, Dept Lab Med & Pathol, Heritage Med Res Ctr, Edmonton, AB, Canada	University of Alberta	Leng, RP (corresponding author), Univ Alberta, Dept Lab Med & Pathol, Heritage Med Res Ctr, Edmonton, AB, Canada.	rleng@ualberta.ca	Sergi, Consolato/A-1126-2009	Sergi, Consolato/0000-0002-2779-7879	Alberta Heritage Foundation for Medical Research (AHFMR); Breast Cancer Foundation NWT; Women and Children Health Research Institute (WCHRI); Canadian Institutes of Health Research (CIHR); Alberta Cancer Foundation Graduate Studentship; Women and Children's Health Research Institute Graduate Studentship (WCHRI)/Hair Massacure (University of Alberta)	Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Breast Cancer Foundation NWT; Women and Children Health Research Institute (WCHRI); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation Graduate Studentship; Women and Children's Health Research Institute Graduate Studentship (WCHRI)/Hair Massacure (University of Alberta)	This work was supported by grants from the Alberta Heritage Foundation for Medical Research (AHFMR), Breast Cancer Foundation NWT, Women and Children Health Research Institute (WCHRI), and Canadian Institutes of Health Research (CIHR) to RPL. RAZ is supported by Alberta Cancer Foundation Graduate Studentship and Women and Children's Health Research Institute Graduate Studentship (WCHRI)/Hair Massacure 2011 Award (University of Alberta). RPL is an AHFMR scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal ML, 1998, J BIOL CHEM, V273, P1, DOI 10.1074/jbc.273.1.1; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Brooks CL, 2011, FEBS LETT, V585, P2803, DOI 10.1016/j.febslet.2011.05.022; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Chan WM, 2006, MOL CANCER RES, V4, P15, DOI 10.1158/1541-7786.MCR-05-0097; David Y, 2011, J BIOL CHEM, V286, P44104, DOI 10.1074/jbc.M111.234559; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Duan WR, 2006, EXP CELL RES, V312, P3370, DOI 10.1016/j.yexcr.2006.07.005; Duan WR, 2004, JNCI-J NATL CANCER I, V96, P1718, DOI 10.1093/jnci/djh292; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu DP, 2010, ONCOGENE, V29, P949, DOI 10.1038/onc.2009.376; Logan IR, 2006, MOL CELL BIOL, V26, P6502, DOI 10.1128/MCB.00147-06; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Ozeki C, 2011, J BIOL CHEM, V286, P18251, DOI 10.1074/jbc.M110.208587; Peng D, 2008, INT J CANCER, V122, P1303, DOI 10.1002/ijc.23258; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Shen LN, 2005, EMBO J, V24, P1341, DOI 10.1038/sj.emboj.7600628; Sheng Y, 2008, NAT STRUCT MOL BIOL, V15, P1334, DOI 10.1038/nsmb.1521; Shimada M, 2009, CANCER SCI, V100, P866, DOI 10.1111/j.1349-7006.2009.01122.x; Shloush J, 2011, J BIOL CHEM, V286, P4796, DOI 10.1074/jbc.M110.157669; Soussi T, 2005, BRIT J SURG, V92, P1331, DOI 10.1002/bjs.5177; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; [苏远 Su Yuan], 2007, [中国组织化学与细胞化学杂志, Chinese Journal of Histochemistry and Cytochemistry], V16, P336; Tai E, 2010, CHARACTERIZATION E3, P124; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang XM, 2009, CANCER-AM CANCER SOC, V115, P4554, DOI 10.1002/cncr.24494; Watson IR, 2006, NEOPLASIA, V8, P655, DOI 10.1593/neo.06439; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983; Windheim M, 2008, BIOCHEM J, V409, P723, DOI 10.1042/BJ20071338; Wu H, 2011, MOL CANCER RES, V9, P1780, DOI 10.1158/1541-7786.MCR-11-0157; Wu H, 2011, NAT MED, V17, P347, DOI 10.1038/nm.2283; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yang YL, 2004, ONCOGENE, V23, P2096, DOI 10.1038/sj.onc.1207411	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82803	10.1371/journal.pone.0082803	http://dx.doi.org/10.1371/journal.pone.0082803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367557	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300070
J	Chuffa, LGA; Fioruci-Fontanelli, BA; Mendes, LO; Favaro, WJ; Pinheiro, PFF; Martinez, M; Martinez, FE				Chuffa, Luiz Gustavo A.; Fioruci-Fontanelli, Beatriz A.; Mendes, Leonardo O.; Favaro, Wagner J.; Pinheiro, Patricia Fernanda F.; Martinez, Marcelo; Martinez, Francisco Eduardo			Characterization of Chemically Induced Ovarian Carcinomas in an Ethanol-Preferring Rat Model: Influence of Long-Term Melatonin Treatment	PLOS ONE			English	Article							SEX STEROID-RECEPTORS; INCESSANT OVULATION; EPITHELIAL-CELLS; PINEAL HORMONE; CANCER RISK; ADULT RATS; IN-VIVO; ALCOHOL; CARCINOGENESIS; INHIBITION	Ovarian cancer is the fourth most common cause of cancer deaths among women, and chronic alcoholism may exert co-carcinogenic effects. Because melatonin (mel) has oncostatic properties, we aimed to investigate and characterize the chemical induction of ovarian tumors in a model of ethanol-preferring rats and to verify the influence of mel treatment on the overall features of these tumors. After rats were selected to receive ethanol (EtOH), they were surgically injected with 100 mu g of 7,12-dimethyl-benz[a] anthracene (DMBA) plus sesame oil directly under the left ovarian bursa. At 260 days old, half of the animals received i.p. injections of 200 mu g mel/100 g b.w. for 60 days. Four experimental groups were established: Group C, rats bearing ovarian carcinomas (OC); Group C+EtOH, rats voluntarily consuming 10% (v/v) EtOH and bearing OC; Group C+M, rats bearing OC and receiving mel; and Group C+EtOH+M, rats with OC consuming EtOH and receiving mel. Estrous cycle and nutritional parameters were evaluated, and anatomopathological analyses of the ovarian tumors were conducted. The incidence of ovarian tumors was higher in EtOH drinking animals 120 days post-DMBA administration, and mel efficiently reduced the prevalence of some aggressive tumors. Although mel promoted high EtOH consumption, it was effective in synchronizing the estrous cycle and reducing ovarian tumor mass by 20%. While rats in the C group displayed cysts containing serous fluid, C+EtOH rats showed solid tumor masses. After mel treatment, the ovaries of these rats presented as soft and mobile tissues. EtOH consumption increased the incidence of serous papillary carcinomas and sarcomas but not clear cell carcinomas. In contrast, mel reduced the incidence of sarcomas, endometrioid carcinomas and cystic teratomas. Combination of DMBA with EtOH intake potentiated the incidence of OC with malignant histologic subtypes. We concluded that mel reduces ovarian masses and the incidence of adenocarcinomas in ethanol-deprived rats.	[Chuffa, Luiz Gustavo A.; Fioruci-Fontanelli, Beatriz A.; Mendes, Leonardo O.; Pinheiro, Patricia Fernanda F.; Martinez, Francisco Eduardo] Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Anat, Botucatu, SP, Brazil; [Fioruci-Fontanelli, Beatriz A.; Mendes, Leonardo O.] Univ Estadual Campinas, UNICAMP, Inst Biol, Programa Posgrad Biol Celular & Estrutural, Campinas, SP, Brazil; [Favaro, Wagner J.] Univ Estadual Campinas, UNICAMP, Dept Anat Biol Celular & Fisiol & Biofis, Campinas, SP, Brazil; [Martinez, Marcelo] UFSCar Univ Fed Sao Carlos, Dept Morfol & Patol, Sao Carlos, SP, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Federal de Sao Carlos	Chuffa, LGA (corresponding author), Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Anat, Botucatu, SP, Brazil.	guchuffa@yahoo.com.br	Mendes, Leonardo O Oliveira/V-4120-2018; Martinez, Francisco Eduardo/A-8090-2008; Chuffa, Luiz Gustavo/ABC-2781-2020; Chuffa, Luiz Gustavo/CAA-2741-2022; Chuffa, Luiz Gustavo A/A-4085-2010; Martinez, Francisco Eduardo/P-4804-2018; Fávaro, Wagner José/AAS-7463-2020	Mendes, Leonardo O Oliveira/0000-0001-9761-7653; Martinez, Francisco Eduardo/0000-0002-9317-344X; Chuffa, Luiz Gustavo/0000-0002-0199-3396; Chuffa, Luiz Gustavo A/0000-0002-0199-3396; Fávaro, Wagner José/0000-0001-5830-8938	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2011/19294-9, 2013/02466-7]; Primeiros Projetos (Prope/UNESP); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Primeiros Projetos (Prope/UNESP); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors would like to give special thanks to FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Proc. n. 2011/19294-9 and 2013/02466-7), Primeiros Projetos 2013 (Prope/UNESP) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) for providing financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berstad P, 2008, BREAST CANCER RES TR, V108, P113, DOI 10.1007/s10549-007-9578-8; Chada S, 2003, CURR OPIN MOL THER, V5, P463; Chien JR, 2007, J CELL BIOCHEM, V102, P1117, DOI 10.1002/jcb.21552; Chuffa LGA, 2011, BRAZ J MED BIOL RES, V44, P217, DOI 10.1590/S0100-879X2011007500018; Chuffa LGA, 2013, REPROD TOXICOL, V39, P40, DOI 10.1016/j.reprotox.2013.04.001; Chuffa LGA, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-108; Chuffa LGA, 2011, ALCOHOL CLIN EXP RES, V35, P1498, DOI 10.1111/j.1530-0277.2011.01486.x; Chuffa LGA, 2009, MATURITAS, V62, P21, DOI 10.1016/j.maturitas.2008.09.027; Conti A, 1995, J PINEAL RES, V19, P103, DOI 10.1111/j.1600-079X.1995.tb00177.x; Cos S, 2008, CURR CANCER DRUG TAR, V8, P691, DOI 10.2174/156800908786733469; Crespi F, 2012, BRAIN RES, V1452, P39, DOI 10.1016/j.brainres.2011.10.050; Crist KA, 2005, CARCINOGENESIS, V26, P951, DOI 10.1093/carcin/bgi039; Crum CP, 2007, CLIN MED RES, V5, P35, DOI 10.3121/cmr.2007.702; FATHALLA MF, 1971, LANCET, V2, P163; Fisher SP, 2010, SLEEP, V33, P833, DOI 10.1093/sleep/33.6.833; Fleming JS, 2006, MOL CELL ENDOCRINOL, V247, P4, DOI 10.1016/j.mce.2005.09.014; GODWIN AK, 1992, J NATL CANCER I, V84, P592, DOI 10.1093/jnci/84.8.592; HILL SM, 1992, CANCER LETT, V64, P249, DOI 10.1016/0304-3835(92)90050-6; Hoyer PB, 2009, GYNECOL ONCOL, V112, P610, DOI 10.1016/j.ygyno.2008.12.013; Huang YP, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-21; Jacinto-Aleman LF, 2013, MED ORAL PATOL ORAL, V18, pE325, DOI 10.4317/medoral.18068; King SM, 2011, ENDOCR-RELAT CANCER, V18, P627, DOI 10.1530/ERC-11-0107; Konishi I, 1999, ONCOLOGY-BASEL, V57, P45, DOI 10.1159/000055274; LAVECCHIA C, 1992, J CLIN EPIDEMIOL, V45, P1025, DOI 10.1016/0895-4356(92)90119-8; Lima MFP, 2004, BRAZ J MED BIOL RES, V37, P987, DOI 10.1590/S0100-879X2004000700007; Lissoni P, 2007, PATHOL BIOL, V55, P201, DOI 10.1016/j.patbio.2006.12.025; Lynch HT, 2009, MOL ONCOL, V3, P97, DOI 10.1016/j.molonc.2009.02.004; MARDONES J, 1983, NEUROBEH TOXICOL TER, V5, P171; Masana MI, 2001, SCI STKE, V107, ppe39; MELLO NK, 1983, SCIENCE, V221, P677, DOI 10.1126/science.6867739; Molpeceres V, 2007, J GERONTOL A-BIOL, V62, P687, DOI 10.1093/gerona/62.7.687; Murdoch WJ, 2008, ADV EXP MED BIOL, V622, P119, DOI 10.1007/978-0-387-68969-2_10; Nishida T, 1998, CANCER, V83, P965, DOI 10.1002/(SICI)1097-0142(19980901)83:5<965::AID-CNCR23>3.0.CO;2-S; NISHIDA T, 1986, Acta Obstetrica et Gynaecologica Japonica (Japanese Edition), V38, P570; NISHIDA T, 1982, GANN, V73, P153; OZOLS RF, 2005, PRINCIPLES PRACTICE, P903; Peres R, 2011, ADDICT BIOL, V16, P580, DOI 10.1111/j.1369-1600.2011.00342.x; Poschl G, 2004, ALCOHOL ALCOHOLISM, V39, P155, DOI 10.1093/alcalc/agh057; Reiter RJ, 2004, J PINEAL RES, V37, P213, DOI 10.1111/j.1600-079X.2004.00165.x; Rota M, 2012, GYNECOL ONCOL, V125, P758, DOI 10.1016/j.ygyno.2012.03.031; Sauer LA, 2001, BIOCHEM PHARMACOL, V61, P1455, DOI 10.1016/S0006-2952(01)00634-7; Schouten LJ, 2004, CANCER CAUSE CONTROL, V15, P201, DOI 10.1023/B:CACO.0000019512.71560.2b; Seitz Helmut K, 2013, Subcell Biochem, V67, P131, DOI 10.1007/978-94-007-5881-0_3; Srinivasan V, 2011, RECENT PATENTS ENDOC, V5, P109, DOI 10.2174/187221411799015408; Stakleff KDS, 2003, INT J GYNECOL CANCER, V13, P405, DOI 10.1046/j.1525-1438.2003.13317.x; Stewart SL, 2004, CANCER RES, V64, P8177, DOI 10.1158/0008-5472.CAN-04-1702; Treeck O, 2006, ONCOL REP, V15, P231; Tworoger SS, 2008, CANCER-AM CANCER SOC, V112, P1169, DOI 10.1002/cncr.23275; Vanderhyden Barbara C, 2003, Reprod Biol Endocrinol, V1, P67, DOI 10.1186/1477-7827-1-67; Vanderhyden BC, 2005, CELL TISSUE RES, V322, P117, DOI 10.1007/s00441-005-1100-1; Wang Y, 2009, HEPATOLOGY, V50, P453, DOI 10.1002/hep.22978; Xi SC, 2001, PROSTATE, V46, P52	52	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81676	10.1371/journal.pone.0081676	http://dx.doi.org/10.1371/journal.pone.0081676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367487	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300008
J	Marcus, JL; Glidden, DV; Mayer, KH; Liu, AY; Buchbinder, SP; Amico, KR; McMahan, V; Kallas, EG; Montoya-Herrera, O; Pilotto, J; Grant, RM				Marcus, Julia L.; Glidden, David V.; Mayer, Kenneth H.; Liu, Albert Y.; Buchbinder, Susan P.; Amico, K. Rivet; McMahan, Vanessa; Kallas, Esper Georges; Montoya-Herrera, Orlando; Pilotto, Jose; Grant, Robert M.			No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis	PLOS ONE			English	Article							MALE CIRCUMCISION; UNITED-STATES; FOLLOW-UP; BEHAVIOR; INFECTION; MEN; PREVENTION; PARTICIPANTS; IMPACT; CHEMOPROPHYLAXIS	Objective: Preexposure prophylaxis (PrEP) with emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) reduced HIV acquisition in the iPrEx trial among men who have sex with men and transgender women. Self-reported sexual risk behavior decreased overall, but may be affected by reporting bias. We evaluated potential risk compensation using biomarkers of sexual risk behavior. Design and methods: Sexual practices were assessed at baseline and quarterly thereafter; perceived treatment assignment and PrEP efficacy beliefs were assessed at 12 weeks. Among participants with >= 1 follow-up behavioral assessment, sexual behavior, syphilis, and HIV infection were compared by perceived treatment assignment, actual treatment assignment, and perceived PrEP efficacy. Results: Overall, acute HIV infection and syphilis decreased during follow-up. Compared with participants believing they were receiving placebo, participants believing they were receiving FTC/TDF reported more receptive anal intercourse partners prior to initiating drug (12.8 vs. 7.7, P = 0.04). Belief in receiving FTC/TDF was not associated with an increase in receptive anal intercourse with no condom (ncRAI) from baseline through follow-up (risk ratio [RR] 0.9, 95% confidence interval [CI]: 0.6-1.4; P = 0.75), nor with a decrease after stopping study drug (RR 0.8, 95% CI: 0.5-1.3; P = 0.46). In the placebo arm, there were trends toward lower HIV incidence among participants believing they were receiving FTC/TDF (incidence rate ratio [IRR] 0.8, 95% CI: 0.4-1.8; P = 0.26) and also believing it was highly effective (IRR 0.5, 95% CI: 0.1-1.7; P = 0.12). Conclusions: There was no evidence of sexual risk compensation in iPrEx. Participants believing they were receiving FTC/TDF had more partners prior to initiating drug, suggesting that risk behavior was not a consequence of PrEP use.	[Marcus, Julia L.; McMahan, Vanessa; Grant, Robert M.] Gladstone Inst Virol & Immunol, San Francisco, CA USA; [Marcus, Julia L.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Glidden, David V.; Liu, Albert Y.; Buchbinder, Susan P.; Grant, Robert M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA USA; [Mayer, Kenneth H.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Liu, Albert Y.; Buchbinder, Susan P.] San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA USA; [Amico, K. Rivet] Univ Connecticut, Ctr Hlth Intervent & Prevent, Storrs, CT USA; [Kallas, Esper Georges] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Montoya-Herrera, Orlando] Fdn Ecuatoriana Equidad, Guayaquil, Guayas, Ecuador; [Pilotto, Jose] Hosp Geral Nova Iguacu, Lab AIDS & Imunol Mol, Rio De Janeiro, Brazil	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; San Francisco Department of Public Health; University of Connecticut; Universidade de Sao Paulo	Grant, RM (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA USA.	robert.grant@ucsf.edu	Pilotto, Jose Henrique/AAD-9773-2019; /AAE-4700-2020; Glidden, David/AAD-4730-2020	Pilotto, Jose Henrique/0000-0003-0521-8597; Amico, K Rivet/0000-0002-4458-6934; Grant, Robert/0000-0002-0851-7085; Kallas, Esper/0000-0003-2026-6925; Glidden, David/0000-0001-5888-1419	Division of Acquired Immunodeficiency Syndrome, National Institute of Allergy and Infectious Diseases, National Institutes of Health [UO1 AI64002]; Bill and Melinda Gates Foundation; Gladstone Institutes; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, U01AI064002] Funding Source: NIH RePORTER	Division of Acquired Immunodeficiency Syndrome, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Gladstone Institutes(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Division of Acquired Immunodeficiency Syndrome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, as a cooperative agreement (UO1 AI64002, to Dr. Grant), by the Bill and Melinda Gates Foundation, and by the Gladstone Institutes. No individuals employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J., 1995, RISK, V1st ed.; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Autier P, 1998, JNCI-J NATL CANCER I, V90, P1873, DOI 10.1093/jnci/90.24.1873; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baeten JM, 2012, NEW ENGL J MED; Bartholow BN, 2005, JAIDS-J ACQ IMM DEF, V39, P90, DOI 10.1097/01.qai.0000143600.41363.78; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Chesney MA, 1997, J ACQ IMMUN DEF SYND, V16, P266, DOI 10.1097/00042560-199712010-00007; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Desai K, 2008, AIDS, V22, P1829, DOI 10.1097/QAD.0b013e32830e00f5; Eaton Lisa A, 2007, Curr HIV/AIDS Rep, V4, P165, DOI 10.1007/s11904-007-0024-7; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Guest G, 2008, SEX TRANSM DIS, V35, P1002, DOI 10.1097/OLQ.0b013e3181812939; Herbst JH, 2008, AIDS BEHAV, V12, P1, DOI 10.1007/s10461-007-9299-3; HIGGINS DL, 1991, JAMA-J AM MED ASSOC, V266, P2419, DOI 10.1001/jama.266.17.2419; Huebner DM, 2001, ANN BEHAV MED, V23, P304, DOI 10.1207/S15324796ABM2304_10; Kasparian NA, 2009, J BEHAV MED, V32, P406, DOI 10.1007/s10865-009-9219-2; Kong XR, 2012, AM J EPIDEMIOL, V176, P875, DOI 10.1093/aje/kws179; Liu AY, 2013, J ACQUIR IMMUNE DEFI; Marrazzo J.M., 2015, C RETR OPP INF ATL M, P509; Martin JN, 2004, AIDS, V18, P787, DOI 10.1097/00002030-200403260-00010; Mattson CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002443; Mustanski BS, 2011, J SEX RES, V48, P218, DOI 10.1080/00224499.2011.558645; Peterson Leigh, 2007, PLoS Clin Trials, V2, pe27, DOI 10.1371/journal.pctr.0020027; Richens J, 2000, LANCET, V355, P400, DOI 10.1016/S0140-6736(99)09109-6; Rotheram-Borus MJ, 2009, ANNU REV CLIN PSYCHO, V5, P143, DOI 10.1146/annurev.clinpsy.032408.153530; Sarkar NN, 2008, EUR J CONTRACEP REPR, V13, P114, DOI 10.1080/13625180802011302; Schechter M, 2004, JAIDS-J ACQ IMM DEF, V35, P519, DOI 10.1097/00126334-200404150-00010; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; Vissers DCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002077; Wilde GJS, 2001, TARGET RISK DEALING	39	165	167	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81997	10.1371/journal.pone.0081997	http://dx.doi.org/10.1371/journal.pone.0081997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367497	Green Submitted, Green Published, gold			2022-12-27	WOS:000328740300016
J	Rodriguez, E; Soler, MJ; Rap, O; Barrios, C; Orfila, MA; Pascual, J				Rodriguez, Eva; Soler, Maria J.; Rap, Oana; Barrios, Clara; Orfila, Maria A.; Pascual, Julio			Risk Factors for Acute Kidney Injury in Severe Rhabdomyolysis	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CRITICALLY-ILL PATIENTS; RIFLE CRITERIA; HOSPITALIZED-PATIENTS; MECHANISMS; MYOGLOBIN	Background: Acute kidney injury (AKI) is a life-threatening complication of severe rhabdomyolysis. This study was conducted to assess risk factors for AKI and to develop a risk score for early prediction. Methods: Retrospective observational cohort study with a 9-year follow-up, carried out in an acute-care teaching-affiliated hospital. A total of 126 patients with severe rhabdomyolysis defined as serum creatine kinase (CK) > 5,000 IU/L fulfilled the inclusion criteria. Univariate and logistic regression analyses were performed to determine risk factors for AKI. Based on the values obtained for each variable, a risk score and prognostic probabilities were estimated to establish the risk for developing AKI. Results: The incidence of AKI was 58%. Death during hospitalization was significantly higher among patients with AKI, compared to patients without AKI (19.2% vs 3.6%, p = 0.008). The following variables were independently associated with AKI: peak CK (odds ratio [OR] 4.9, 95%CI 1.4-16.8), hypoalbuminemia (< 33 mg/dL, [OR 5.1, 95%CI 1.4-17-7]), metabolic acidosis (OR 5.3, 95%CI 1.4-20.3), and decreased prothrombin time (OR 4.4, 95% CI 1.3-14.5). A risk score for AKI was calculated for each patient, with an OR of 1.72 (95% CI 1.45-2.04). The discrimination value of the predictive model was established by means of a ROC curve, with the area under the curve of 0.871 (p<0.001). Conclusions: The identification of independent factors associated with AKI and a risk score for early prediction of this complication in patients with severe rhabdomyolysis may be useful in clinical practice, particularly to implement early preventive measures.	[Rodriguez, Eva; Soler, Maria J.; Rap, Oana; Barrios, Clara; Orfila, Maria A.; Pascual, Julio] Hosp Mar, Dept Nephrol, Barcelona, Spain; [Rodriguez, Eva; Soler, Maria J.; Barrios, Clara; Pascual, Julio] Inst Invest Med, Nephrol Res Grp, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Rodriguez, E (corresponding author), Hosp Mar, Dept Nephrol, Barcelona, Spain.	ERodriguezG@hospitaldelmar.cat	Soler, Maria Jose/ABC-4410-2021; Soler, Maria José/AAP-4454-2020; Barrios, Clara/AAF-6865-2021	Soler, Maria José/0000-0003-3621-0766; Rodriguez, Eva/0000-0002-4397-162X				Bagley WH, 2007, INTERN EMERG MED, V2, P210, DOI 10.1007/s11739-007-0060-8; Bagshaw SM, 2008, NEPHROL DIAL TRANSPL, V23, P1203, DOI 10.1093/ndt/gfm744; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Better OS, 2011, NAT REV NEPHROL, V7, P416, DOI 10.1038/nrneph.2011.56; Bosch X, 2009, NEW ENGL J MED, V361, P62, DOI 10.1056/NEJMra0801327; CADNAPAPHORNCHAI P, 1980, AM J MED SCI, V280, P66, DOI 10.1097/00000441-198009000-00001; de Meijer AR, 2003, INTENS CARE MED, V29, P1121, DOI 10.1007/s00134-003-1800-5; Delaney KA, 2012, J EMERG MED, V42, P521, DOI 10.1016/j.jemermed.2011.03.008; GABOW PA, 1982, MEDICINE, V61, P141, DOI 10.1097/00005792-198205000-00002; Goldfarb DS, 2002, AM J MED, V113, P260, DOI 10.1016/S0002-9343(02)01188-9; Hatamizadeh P, 2006, AM J KIDNEY DIS, V47, P428, DOI 10.1053/j.ajkd.2005.11.019; Holt SG, 2001, INTENS CARE MED, V27, P803, DOI 10.1007/s001340100878; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Melli G, 2005, MEDICINE, V84, P377, DOI 10.1097/01.md.0000188565.48918.41; Mikkelsen TS, 2005, ACTA ANAESTH SCAND, V49, P859, DOI 10.1111/j.1399-6576.2005.00577.x; Ostermann M, 2007, CRIT CARE MED, V35, P1837, DOI 10.1097/01.CCM.0000277041.13090.0A; Pinol V, 2004, DIS COLON RECTUM, V47, P1192, DOI 10.1007/s10350-004-0562-7; Reeder BJ, 2005, CURR MED CHEM, V12, P2741, DOI 10.2174/092986705774463021; RON D, 1984, ARCH INTERN MED, V144, P277, DOI 10.1001/archinte.144.2.277; ROTH D, 1988, NEW ENGL J MED, V319, P673, DOI 10.1056/NEJM198809153191103; Sever MS, 2006, NEW ENGL J MED, V354, P1052, DOI 10.1056/NEJMra054329; Sharp LS, 2004, AM J SURG, V188, P801, DOI 10.1016/j.amjsurg.2004.08.050; SINGHAL PC, 1992, AM J MED, V92, P458, DOI 10.1016/0002-9343(92)90740-3; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F; Vanholder R, 2000, J AM SOC NEPHROL, V11, P1553, DOI 10.1681/ASN.V1181553; WOODROW G, 1995, RENAL FAILURE, V17, P467, DOI 10.3109/08860229509037610; ZAGER RA, 1989, LAB INVEST, V60, P619; ZAGER RA, 1989, AM J PHYSIOL, V256, pF446, DOI 10.1152/ajprenal.1989.256.3.F446	28	16	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82992	10.1371/journal.pone.0082992	http://dx.doi.org/10.1371/journal.pone.0082992			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367578	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300089
J	Sobolevsky, S; Szell, M; Campari, R; Couronne, T; Smoreda, Z; Ratti, C				Sobolevsky, Stanislav; Szell, Michael; Campari, Riccardo; Couronne, Thomas; Smoreda, Zbigniew; Ratti, Carlo			Delineating Geographical Regions with Networks of Human Interactions in an Extensive Set of Countries	PLOS ONE			English	Article							MOBILITY	Large-scale networks of human interaction, in particular country-wide telephone call networks, can be used to redraw geographical maps by applying algorithms of topological community detection. The geographic projections of the emerging areas in a few recent studies on single regions have been suggested to share two distinct properties: first, they are cohesive, and second, they tend to closely follow socio-economic boundaries and are similar to existing political regions in size and number. Here we use an extended set of countries and clustering indices to quantify overlaps, providing ample additional evidence for these observations using phone data from countries of various scales across Europe, Asia, and Africa: France, the UK, Italy, Belgium, Portugal, Saudi Arabia, and Ivory Coast. In our analysis we use the known approach of partitioning country-wide networks, and an additional iterative partitioning of each of the first level communities into sub-communities, revealing that cohesiveness and matching of official regions can also be observed on a second level if spatial resolution of the data is high enough. The method has possible policy implications on the definition of the borderlines and sizes of administrative regions.	[Sobolevsky, Stanislav; Szell, Michael; Campari, Riccardo; Ratti, Carlo] MIT, Senseable City Lab, Cambridge, MA 02139 USA; [Couronne, Thomas; Smoreda, Zbigniew] Orange Labs, Sociol Network, Paris, France; [Couronne, Thomas; Smoreda, Zbigniew] Orange Labs, Econ Network, Paris, France; [Couronne, Thomas; Smoreda, Zbigniew] Orange Labs, Dept Serv, Paris, France	Massachusetts Institute of Technology (MIT); Orange SA; Orange SA; Orange SA	Sobolevsky, S (corresponding author), MIT, Senseable City Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	stanly@mit.edu	Smoręda, Zbigniew/D-9265-2011; Sobolevsky, Stanislav/ABH-7108-2020	Smoręda, Zbigniew/0000-0002-4047-7597; Sobolevsky, Stanislav/0000-0001-6281-0656	National Science Foundation; MIT SMART program; Center for Complex Engineering Systems (CCES) at KACST; Center for Complex Engineering Systems (CCES) at MIT; AudiVolkswagen; BBVA; The Coca Cola Company; Ericsson; Expo; Ferrovial; MIT Senseable City Lab Consortium	National Science Foundation(National Science Foundation (NSF)); MIT SMART program; Center for Complex Engineering Systems (CCES) at KACST; Center for Complex Engineering Systems (CCES) at MIT; AudiVolkswagen; BBVA(BBVA Foundation); The Coca Cola Company; Ericsson(Ericsson); Expo; Ferrovial; MIT Senseable City Lab Consortium	Financial supporters of the Senseable City Laboratory are: the National Science Foundation, the MIT SMART program, the Center for Complex Engineering Systems (CCES) at KACST and MIT, AudiVolkswagen, BBVA, The Coca Cola Company, Ericsson, Expo 2015, Ferrovial and all the members of the MIT Senseable City Lab Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attanasio O, 1991, MISMATCH LABOUR MOBI, P237; Becker SO, 2010, J PUBLIC ECON, V94, P578, DOI 10.1016/j.jpubeco.2010.06.006; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; Blondel V, 2011, PARISTECH REV; Blondel VD, 2012, ARXIV12100137; Blondel V, 2010, BRUSS STUD, P1, DOI 10.4000/brussels.806; Borge-Holthoefer J, 2013, ONLINE COLL IN PRESS; Calabrese F., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P223, DOI 10.1109/PASSAT/SocialCom.2011.247; Christaller W., 1933, ZENTRALEN ORTE SUDDE; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; FOWLKES EB, 1983, J AM STAT ASSOC, V78, P553, DOI 10.2307/2288117; Gallagher T, 1999, S EUROPEAN SOC POLIT, V4, P132, DOI DOI 10.1080/13608740408539562; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Leonardi R., 1993, REGIONS EUROPEAN COM; Mata M, 1996, LISBON OPORTO RIVALR, P123; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Miritello G, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.045102; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Phithakkitnukoon S., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P515, DOI 10.1109/PASSAT/SocialCom.2011.11; Quercia Daniele, 2010, Proceedings 2010 10th IEEE International Conference on Data Mining (ICDM 2010), P971, DOI 10.1109/ICDM.2010.152; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Ratti C, 2006, ENVIRON PLANN B, V33, P727, DOI 10.1068/b32047; Ratti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014248; Rinzivillo S, 2012, KUNSTLICHE INTELLIGE, P1; Sobolevsky S, 2013, ARXIV13083508; Szell M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00457; Thiemann C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015422; Van Hecke E, 2007, MONOGRAPHIES ENQUETE; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478	34	92	95	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81707	10.1371/journal.pone.0081707	http://dx.doi.org/10.1371/journal.pone.0081707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367490	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300010
J	Adachi, K; Osada, Y; Nakamura, R; Tamada, K; Hamano, S				Adachi, Keishi; Osada, Yoshio; Nakamura, Risa; Tamada, Koji; Hamano, Shinjiro			Unique T Cells with Unconventional Cytokine Profiles Induced in the Livers of Mice during Schistosoma mansoni Infection	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; HEPATITIS-B-VIRUS; NKT CELLS; IN-VIVO; GRANULOMATOUS PATHOLOGY; TH2 POLARIZATION; DENDRITIC CELLS; GERMINAL CENTER; HELPER-CELLS; RECEPTOR	During infection with Schistosoma, serious hepatic disorders are induced in the host. The liver possesses unique immune systems composed of specialized cells that differ from those of other immune competent organs or tissues. Host immune responses change dramatically during Schistosoma mansoni infection; in the early phase, Th1-related responses are induced, whereas during the late phase Th2 reactions dominate. Here, we describe unique T cell populations induced in the liver of mice during the period between Th1- and Th2-phases, which we term the transition phase. During this phase, varieties of immune cells including T lymphocytes increase in the liver. Subsets of CD4(+) T cells exhibit unique cytokine production profiles, simultaneously producing both IFN-gamma and IL-13 or both IFN-gamma and IL-4. Furthermore, cells triply positive for IFN-gamma, IL-13 and IL-4 also expand in the S. mansoni-infected liver. The induction of these unique cell populations does not occur in the spleen, indicating it is a phenomenon specific to the liver. In single hepatic CD4(+) T cells showing the unique cytokine profiles, both T-bet and GATA-3 are expressed. Thus, our studies show that S. mansoni infection triggers the induction of hepatic T cell subsets with unique cytokine profiles.	[Adachi, Keishi; Nakamura, Risa; Hamano, Shinjiro] Nagasaki Univ, Dept Parasitol, Inst Trop Med NEKKEN, Nagasaki 852, Japan; [Adachi, Keishi; Hamano, Shinjiro] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan; [Osada, Yoshio] Univ Occupat & Environm Hlth, Dept Immunol & Parasitol, Yahatanishi Ku, Kitakyushu, Fukuoka 807, Japan; [Tamada, Koji] Yamaguchi Univ, Grad Sch Med, Dept Immunol & Cell Signaling Anal, Ube, Yamaguchi 755, Japan	Nagasaki University; Nagasaki University; University of Occupational & Environmental Health - Japan; Yamaguchi University	Hamano, S (corresponding author), Nagasaki Univ, Dept Parasitol, Inst Trop Med NEKKEN, Nagasaki 852, Japan.	shinjiro@nagasaki-u.ac.jp	Hamano, Shinjiro/A-7932-2011; adachi, keishi/AAT-7471-2020	Hamano, Shinjiro/0000-0003-3881-8337; 	JSPS KAKENHI [24790402, 25670204]; Health Labour Sciences Research Grant [H20-Shinkoh-Ippan-016, H23-Shinkoh-Ippan-014]; Nagasaki University; MEXT	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Nagasaki University; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by JSPS KAKENHI Grants-in-Aid for Scientific Research Number 24790402 (to K. A.), 25670204 (to S. H.), (http://www.jsps.go.jp/english/e-grants/index.html), a Health Labour Sciences Research Grant (H20-Shinkoh-Ippan-016, H23-Shinkoh-Ippan-014 to S. H.) (http://www.mhlw.go.jp/english/), and the Global COE Program, Nagasaki University, supported by MEXT (to S. H.) (http://www-sdc.med.nagasaki-u.ac.jp/gcoe/activities/publication/200901_e.html, http://www.jsps.go.jp/english/e-globalcoe/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo T, 2000, IMMUNOL REV, V174, P135, DOI 10.1034/j.1600-0528.2002.017415.x; Adachi K, 2004, INT IMMUNOL, V16, P787, DOI 10.1093/intimm/dxh080; Adachi K, 2001, J IMMUNOL, V167, P5928, DOI 10.4049/jimmunol.167.10.5928; Adachi K, 2011, P NATL ACAD SCI USA, V108, P1549, DOI 10.1073/pnas.1017340108; Alonzo ES, 2011, CURR OPIN IMMUNOL, V23, P220, DOI 10.1016/j.coi.2010.12.016; Amsen D, 2009, CURR OPIN IMMUNOL, V21, P153, DOI 10.1016/j.coi.2009.03.010; Andrade ZA, 2009, PARASITE IMMUNOL, V31, P656, DOI 10.1111/j.1365-3024.2009.01157.x; Azuara V, 1997, EUR J IMMUNOL, V27, P544, DOI 10.1002/eji.1830270228; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Burdin N, 1998, J IMMUNOL, V161, P3271; Charbonnier LM, 2006, J IMMUNOL, V177, P3806, DOI 10.4049/jimmunol.177.6.3806; Cheever AW, 2000, IMMUNOL TODAY, V21, P465, DOI 10.1016/S0167-5699(00)01626-1; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Crispe IN, 2011, J HEPATOL, V54, P357, DOI 10.1016/j.jhep.2010.10.005; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Fallon PG, 2000, J IMMUNOL, V164, P2585, DOI 10.4049/jimmunol.164.5.2585; Fallon PG, 2000, IMMUNOL TODAY, V21, P29, DOI 10.1016/S0167-5699(99)01551-0; FERRICK DA, 1995, NATURE, V373, P255, DOI 10.1038/373255a0; Fitzpatrick JM, 2009, INT J PARASITOL, V39, P267, DOI 10.1016/j.ijpara.2008.06.015; Gerber DJ, 1999, J IMMUNOL, V163, P3076; Grogan JL, 2002, CURR OPIN IMMUNOL, V14, P366, DOI 10.1016/S0952-7915(02)00340-0; Hayashi N, 1999, J IMMUNOL, V163, P6702; Hesse M, 2000, AM J PATHOL, V157, P945, DOI 10.1016/S0002-9440(10)64607-X; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Jankovic D, 1999, J IMMUNOL, V163, P337; Kambayashi T, 2001, EUR J IMMUNOL, V31, P1523, DOI 10.1002/1521-4141(200105)31:5<1523::AID-IMMU1523>3.0.CO;2-S; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; King CH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001321; Klugewitz K, 2004, TRENDS IMMUNOL, V25, P590, DOI 10.1016/j.it.2004.09.006; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kovalovsky D, 2010, J IMMUNOL, V184, P6746, DOI 10.4049/jimmunol.1000776; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Naka T, 2001, IMMUNITY, V14, P535, DOI 10.1016/S1074-7613(01)00132-7; Nakahira M, 2011, INT IMMUNOL, V23, P761, DOI 10.1093/intimm/dxr087; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; O'Brien RL, 2010, SEMIN IMMUNOL, V22, P193, DOI 10.1016/j.smim.2010.03.006; Osada Y, 2005, PARASITOL INT, V54, P29, DOI 10.1016/j.parint.2004.08.004; Osada Y, 2009, INT J PARASITOL, V39, P457, DOI 10.1016/j.ijpara.2008.08.007; Pearce EJ, 2004, IMMUNOL REV, V201, P117, DOI 10.1111/j.0105-2896.2004.00187.x; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Ramiscal RR, 2013, IMMUNOL REV, V252, P146, DOI 10.1111/imr.12031; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Savioli L, 2002, T ROY SOC TROP MED H, V96, P577, DOI 10.1016/S0035-9203(02)90316-0; Soulard V, 2007, INFECT IMMUN, V75, P2511, DOI 10.1128/IAI.01818-06; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Sugimoto T, 2004, J EXP MED, V199, P535, DOI 10.1084/jem.20031368; Terada M, 2006, P NATL ACAD SCI USA, V103, P8816, DOI 10.1073/pnas.0602900103; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; Tsutsui H, 2000, IMMUNOL REV, V174, P192, DOI 10.1034/j.1600-0528.2002.017418.x; Tsutsui H, 2004, IMMUNOL REV, V202, P115, DOI 10.1111/j.0105-2896.2004.00205.x; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; Wynn TA, 2004, IMMUNOL REV, V201, P156, DOI 10.1111/j.0105-2896.2004.00176.x; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505	63	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82698	10.1371/journal.pone.0082698	http://dx.doi.org/10.1371/journal.pone.0082698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358216	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700089
J	Duval, A; Marinov, I; Bousquet, G; Gapihan, G; Starikovskaia, SM; Rousseau, A; Janin, A				Duval, Arnaud; Marinov, Ilya; Bousquet, Guilhem; Gapihan, Guillaume; Starikovskaia, Svetlana M.; Rousseau, Antoine; Janin, Anne			Cell Death Induced on Cell Cultures and Nude Mouse Skin by Non-Thermal, Nanosecond-Pulsed Generated Plasma	PLOS ONE			English	Article							PROTOPORPHYRIN-IX; ELECTRIC-FIELDS; APOPTOSIS; MEDICINE; COAGULATION; DERMATOLOGY; SELECTIVITY; LYMPHOMA; STRENGTH; NECROSIS	Non-thermal plasmas are gaseous mixtures of molecules, radicals, and excited species with a small proportion of ions and energetic electrons. Non-thermal plasmas can be generated with any high electro-magnetic field. We studied here the pathological effects, and in particular cell death, induced by nanosecond-pulsed high voltage generated plasmas homogeneously applied on cell cultures and nude mouse skin. In vitro, Jurkat cells and HMEC exhibited apoptosis and necrosis, in dose-dependent manner. In vivo, on nude mouse skin, cell death occurred for doses above 113 J/cm(2) for the epidermis, 281 J/cm(2) for the dermis, and 394 J/cm(2) for the hypodermis. Using electron microscopy, we characterized apoptosis for low doses and necrosis for high doses. We demonstrated that these effects were not related to thermal, photonic or pH variations, and were due to the production of free radicals. The ability of cold plasmas to generate apoptosis on cells in suspension and, without any sensitizer, on precise skin areas, opens new fields of application in dermatology for extracorporeal blood cell treatment and the eradication of superficial skin lesions.	[Duval, Arnaud; Bousquet, Guilhem; Gapihan, Guillaume; Janin, Anne] INSERM, U728, Paris, France; [Duval, Arnaud; Bousquet, Guilhem; Gapihan, Guillaume; Janin, Anne] Univ Paris Diderot, Sorbonne Paris Cite, Lab Pathol, UMR S 728, Paris, France; [Duval, Arnaud; Bousquet, Guilhem; Gapihan, Guillaume; Janin, Anne] Hop St Louis, AP HP, Dept Pathol, Paris, France; [Marinov, Ilya; Starikovskaia, Svetlana M.; Rousseau, Antoine] Univ Paris 11, CNRS, UPMC, Lab Phys Plasmas,Ecole Polytech, Palaiseau, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay	Duval, A (corresponding author), INSERM, U728, Paris, France.	arnaudduval@sls.aphp.fr	Bousquet, Guilhem/O-2920-2015	Bousquet, Guilhem/0000-0001-5594-6694; rousseau, antoine/0000-0002-8965-5307				ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Alkawareek MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044289; Beebe SJ, 2003, FASEB J, V17, P1493, DOI 10.1096/fj.02-0859fje; Brulle L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052653; Daeschlein G, 2010, PLASMA PROCESS POLYM, V7, P224, DOI 10.1002/ppap.200900059; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Fukai F, 1998, EXP CELL RES, V242, P92, DOI 10.1006/excr.1998.4076; Heinlin J, 2011, J EUR ACAD DERMATOL, V25, P1, DOI 10.1111/j.1468-3083.2010.03702.x; Heinlin J, 2010, J DTSCH DERMATOL GES, V8, P968, DOI 10.1111/j.1610-0387.2010.07495.x; Hoffmann M, 2012, INTERACT CARDIOV TH, V14, P239, DOI 10.1093/icvts/ivr109; Hoffmann M, 2010, INTERACT CARDIOV TH, V10, P502, DOI 10.1510/icvts.2009.223768; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Kim GJ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3292206; Knobler R, 2009, J AM ACAD DERMATOL, V61, P652, DOI 10.1016/j.jaad.2009.02.039; Koritzer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064498; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Laux CO, 2003, PLASMA SOURCES SCI T, V12, P125, DOI 10.1088/0963-0252/12/2/301; MARTIN A, 1995, ARCH DERMATOL RES, V287, P665; Martino M, 2012, EXPERT OPIN BIOL TH, V12, P1017, DOI 10.1517/14712598.2012.688025; Nastuta AV, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/10/105204; Paris P, 2005, J PHYS D APPL PHYS, V38, P3894, DOI 10.1088/0022-3727/38/21/010; Raizer Y.P., 1997, GAS DISCHARGE PHYS; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Sensenig R, 2011, ANN BIOMED ENG, V39, P674, DOI 10.1007/s10439-010-0197-x; Silve A, 2012, BIOELECTROCHEMISTRY, V87, P260, DOI 10.1016/j.bioelechem.2011.10.002; Smits T, 2009, BRIT J DERMATOL, V160, P849, DOI 10.1111/j.1365-2133.2008.09012.x; Stacey M, 2003, MUTAT RES-GEN TOX EN, V542, P65, DOI 10.1016/j.mrgentox.2003.08.006; Vandamme M, 2010, PLASMA PROCESS POLYM, V7, P264, DOI 10.1002/ppap.200900080; Vernier PT, 2003, BIOCHEM BIOPH RES CO, V310, P286, DOI 10.1016/j.bbrc.2003.08.140; Weaver JC, 2012, BIOELECTROCHEMISTRY, V87, P236, DOI 10.1016/j.bioelechem.2012.02.007; Wu AS, 2013, J SURG RES, V179, pE1, DOI 10.1016/j.jss.2012.02.039; Yoo J-O, 2012, NEW INSIGHTS MECHANI	32	12	12	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83001	10.1371/journal.pone.0083001	http://dx.doi.org/10.1371/journal.pone.0083001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358244	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700101
J	Nardi, B; Marini, A; Turchi, C; Arimatea, E; Tagliabracci, A; Bellantuono, C				Nardi, Bernardo; Marini, Alessandra; Turchi, Chiara; Arimatea, Emidio; Tagliabracci, Adriano; Bellantuono, Cesario			Role of 5-HTTLPR Polymorphism in the Development of the Inward/Outward Personality Organization: A Genetic Association Study	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; STRESSFUL LIFE EVENTS; DIFFERENTIAL SUSCEPTIBILITY; ENVIRONMENTAL ADVERSITY; PROMOTER POLYMORPHISM; THREATENING STIMULI; DEPRESSION; GENOTYPE; METAANALYSIS; MODERATION	Reciprocity with primary caregivers affects subjects' adaptive abilities toward the construction of the most useful personal meaning organization (PMO) with respect to their developmental environment. Within cognitive theory the post-rationalist approach has outlined two basic categories of identity construction and of regulation of cognitive and emotional processes: the Outward and the Inward PMO. The presence of different, consistent clinical patterns in Inward and Outward subjects is paralleled by differences in cerebral activation during emotional tasks on fMRI and by different expression of some polymorphisms in serotonin pathways. Since several lines of evidence support a role for the 5-HTTLPR polymorphism in mediating individual susceptibility to environmental emotional stimuli, this study was conducted to investigate its influence in the development of the Inward/Outward PMO. PMO was assessed and the 5-HTTLPR polymorphism investigated in 124 healthy subjects who were subdivided into an Inward (n = 52) and an Outward (n = 72) group. Case-control comparisons of short allele (S) frequencies showed significant differences between Inwards and Outwards (p = 0.036, chi 2 test; p = 0.026, exact test). Genotype frequencies were not significantly different although values slightly exceeded p <= 0.05 (p = 0.056, chi 2 test; p = 0.059, exact test). Analysis of the 5-HTTLPR genotypes according to the recessive inheritance model showed that the S/S genotype increased the likelihood of developing an Outward PMO (p = 0.0178, chi 2 test; p = 0.0143, exact test; OR = 3.43, CI (95%) = 1.188-9.925). A logistic regression analysis confirmed the association between short allele and S/S genotypes with the Outward PMO also when gender and age were considered. However none of the differences remained significant after correction for multiple testing, even though using the recessive model they approach significance. Overall our data seem to suggest a putative genetic basis for interindividual differences in PMO development.	[Nardi, Bernardo; Marini, Alessandra; Arimatea, Emidio; Bellantuono, Cesario] Polytech Univ Marche, Psychiat Unit, Dept Expt & Clin Med, Ancona, Italy; [Turchi, Chiara; Tagliabracci, Adriano] Polytech Univ Marche, Sect Legal Med, Dept Biomed Sci & Publ Hlth, Ancona, Italy	Marche Polytechnic University; Marche Polytechnic University	Turchi, C (corresponding author), Polytech Univ Marche, Sect Legal Med, Dept Biomed Sci & Publ Hlth, Ancona, Italy.	c.turchi@univpm.it	Tagliabracci, A./AAI-7414-2020; Turchi, Chiara/AAO-8614-2020	Tagliabracci, Adriano/0000-0002-4434-0475; Arimatea, Emidio/0000-0003-3201-8830; Turchi, Chiara/0000-0001-9211-810X				Akkermann K, 2012, J PSYCHIATR RES, V46, P38, DOI 10.1016/j.jpsychires.2011.09.013; Alexander N, 2012, BIOL PSYCHIAT, V72, P49, DOI 10.1016/j.biopsych.2012.01.030; Arciero G, 2004, COGNITION PSYCHOTERA, P261; Arciero G., 2000, CONSTRUCTIONS DISORD, P91, DOI [10.1037/10368-005, DOI 10.1037/10368-005]; Barry RA, 2008, J CHILD PSYCHOL PSYC, V49, P1313, DOI 10.1111/j.1469-7610.2008.01935.x; Beevers CG, 2011, J ABNORM PSYCHOL, V120, P187, DOI 10.1037/a0022125; Beevers CG, 2010, BIOL PSYCHOL, V83, P260, DOI 10.1016/j.biopsycho.2009.08.007; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; Belsky J, 2009, PSYCHOL BULL, V135, P885, DOI 10.1037/a0017376; Benjet C, 2010, J CHILD PSYCHOL PSYC, V51, P173, DOI 10.1111/j.1469-7610.2009.02149.x; Bertolino A, 2005, BIOL PSYCHIAT, V57, P1517, DOI 10.1016/j.biopsych.2005.02.031; Bevilacqua L, 2011, TRENDS COGN SCI, V15, P401, DOI 10.1016/j.tics.2011.07.009; Bowlby J, 1982, ATTACHMENT LOSS ATTA, V1; Brummett BH, 2008, BEHAV GENET, V38, P476, DOI 10.1007/s10519-008-9219-y; Carli V, 2011, EUR PSYCHIAT, V26, P471, DOI 10.1016/j.eurpsy.2011.04.008; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Chen MC, 2009, PSYCHONEUROENDOCRINO, V34, P681, DOI 10.1016/j.psyneuen.2008.11.006; Collier DA, 1996, MOL PSYCHIATR, V1, P453; CRITTENDEN PM, 1992, DEV PSYCHOPATHOL, V4, P209, DOI 10.1017/S0954579400000110; Dougherty LR, 2010, BIOL PSYCHOL, V83, P93, DOI 10.1016/j.biopsycho.2009.10.009; Ebstein RP, 2006, MOL PSYCHIATR, V11, P427, DOI 10.1038/sj.mp.4001814; Edelman S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048597; Ellis BJ, 2011, DEV PSYCHOPATHOL, V23, P7, DOI 10.1017/S0954579410000611; Fergusson DM, 2011, BRIT J PSYCHIAT, V198, P129, DOI 10.1192/bjp.bp.110.085993; Fonagy P, 1977, DEV PSYCHOPATHOL, V9, P679; Fox E, 2011, BIOL PSYCHIAT, V70, P1049, DOI 10.1016/j.biopsych.2011.07.004; Frigerio A, 2009, J CHILD PSYCHOL PSYC, V50, P1513, DOI 10.1111/j.1469-7610.2009.02126.x; Frodl T, 2010, NEUROPSYCHOPHARMACOL, V35, P1383, DOI 10.1038/npp.2010.8; Frokjaer VG, 2012, EUR NEUROPSYCHOPHARM; Gibb BE, 2009, J ABNORM PSYCHOL, V118, P734, DOI 10.1037/a0016765; Gotlib IH, 2008, BIOL PSYCHIAT, V63, P847, DOI 10.1016/j.biopsych.2007.10.008; Guidano V. F., 1987, COMPLEXITY SELF; Guidano V.F., 1991, SELF PROCESS POSTRAT; Guidano VF, 1984, COGNITIVE PROCESSES; Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146; Heils A, 1996, J NEUROCHEM, V66, P2621; Hermann A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044352; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Josephs RA, 2012, PSYCHONEUROENDOCRINO, V37, P752, DOI 10.1016/j.psyneuen.2011.09.006; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Kaufman J, 2004, P NATL ACAD SCI USA, V101, P17316, DOI 10.1073/pnas.0404376101; Klein AM, 2012, PSYCHOTHER PSYCH MED, V62, P95, DOI 10.1055/s-0032-1306320; Kobiella A, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.29; Koenen KC, 2009, J TRAUMA STRESS, V22, P416, DOI 10.1002/jts.20435; Kuepper Y, 2012, GENES BRAIN BEHAV, V11, P643, DOI 10.1111/j.1601-183X.2012.00783.x; Kuhnen CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054632; Lasky-Su JA, 2005, AM J MED GENET B, V133B, P110, DOI 10.1016/j.ajmg.b.30104; LeDoux J.E., 2002, SYNAPTIC SELF OUR BR; LESCH KP, 1994, J NEURAL TRANSM-GEN, V95, P157, DOI 10.1007/BF01276434; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Marcus G, 2004, BIRD MIND; Marsh AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025148; Mazzola V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015268; McGuffin P, 2011, BRIT J PSYCHIAT, V198, P424, DOI 10.1192/bjp.bp.110.085225; Minelli A, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-50; Mueller A, 2012, INT J PSYCHOPHYSIOL, V83, P302, DOI 10.1016/j.ijpsycho.2011.11.007; Mueller A, 2010, PSYCHONEUROENDOCRINO, V35, P289, DOI 10.1016/j.psyneuen.2009.07.002; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Munafo MR, 2009, AM J MED GENET B, V150B, P271, DOI 10.1002/ajmg.b.30808; Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009; Nakamura M, 2000, MOL PSYCHIATR, V5, P32, DOI 10.1038/sj.mp.4000698; Nardi B., 2010, EUROPEAN PSYCHOTHERA, V9, P57; Nardi B, 2012, INT J PSYCHOL STUDIE, V4, P174, DOI DOI 10.5539/IJPS.V4N2P174; Nardi B., 2008, EUR PSYCHOTHER, V8, P5; Nardi B, 2012, ACTA NEUROPSYCHIATR, V24, P336, DOI 10.1111/j.1601-5215.2011.00644.x; Nardi B, 2012, CLIN PSYCHOL PSYCHOT, V19, P78, DOI 10.1002/cpp.740; Nardi B, 2011, PSYCHIAT GENET, V21, P269, DOI 10.1097/YPG.0b013e32834371bc; Nederhof E, 2010, GENES BRAIN BEHAV, V9, P968, DOI 10.1111/j.1601-183X.2010.00637.x; Nishikawa S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047608; O'Hara R, 2012, AM J GERIAT PSYCHIAT, V20, P452, DOI 10.1097/JGP.0b013e31823e2d03; Owens M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048482; Petersen IT, 2012, DEV PSYCHOL, V48, P1463, DOI 10.1037/a0027471; Piva F, 2011, HUM PSYCHOPHARM CLIN, V26, P365, DOI 10.1002/hup.1214; Piva F, 2010, HUM PSYCHOPHARM CLIN, V25, P153, DOI 10.1002/hup.1100; Pluess M, 2013, PSYCHOL BULL, V139, P901, DOI 10.1037/a0030196; Pluess M, 2010, PROG NEURO-PSYCHOPH, V34, P1070, DOI 10.1016/j.pnpbp.2010.05.028; Priess-Groben HA, 2013, J ABNORM CHILD PSYCH, V41, P281, DOI 10.1007/s10802-012-9672-1; Risch, 2009, JAMA-J AM MED ASSOC, V302, P492; Rubino V, 2007, BRAIN RES BULL, V74, P250, DOI 10.1016/j.brainresbull.2007.06.019; Sjoberg RL, 2006, INT J NEUROPSYCHOPH, V9, P443, DOI 10.1017/S1461145705005936; Smeraldi E, 2006, PSYCHIAT GENET, V16, P153, DOI 10.1097/01.ypg.0000218611.53064.a0; Starr LR, 2012, J ABNORM CHILD PSYCH; Stoltenberg SF, 2012, INT J EAT DISORDER, V45, P492, DOI 10.1002/eat.20976; Uher R, 2008, MOL PSYCHIATR, V13, P131, DOI 10.1038/sj.mp.4002067; Uher R, 2011, J AFFECT DISORDERS, V135, P56, DOI 10.1016/j.jad.2011.03.010; Verschoor E, 2012, EUR NEUROPSYCHOPHARM, V22, P546, DOI 10.1016/j.euroneuro.2011.12.003; Wang ZW, 2011, DEPRESS ANXIETY, V28, P1067, DOI 10.1002/da.20872; Way BM, 2011, PSYCHOSOM MED, V73, P310, DOI 10.1097/PSY.0b013e31821195ed; Wermter AK, 2010, EUR CHILD ADOLES PSY, V19, P199, DOI 10.1007/s00787-009-0082-z; Wust S, 2009, PSYCHONEUROENDOCRINO, V34, P972, DOI 10.1016/j.psyneuen.2009.01.011; Zannas AS, 2012, STRESS, V15, P425, DOI 10.3109/10253890.2011.634263	93	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82192	10.1371/journal.pone.0082192	http://dx.doi.org/10.1371/journal.pone.0082192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358153	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700042
J	Tsutajima, J; Kunitake, T; Wakazono, Y; Takamiya, K				Tsutajima, Jyoji; Kunitake, Takato; Wakazono, Yoshihiko; Takamiya, Kogo			Selective Injection System into Hippocampus CA1 via Monitored Theta Oscillation	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; AMPA RECEPTOR; VIRAL VECTORS; GENE-THERAPY; FEAR MEMORY; EXPRESSION; MICE; SYNCHRONIZATION; TRAFFICKING	Methods of cell biology and electrophysiology using dissociated primary cultured neurons allow in vitro study of molecular functions; however, analysis of intact neuronal circuitry is often preferable. To investigate exogenous genes, viral vectors are most commonly injected using a pipette that is inserted from the top of the cortex. Although there are few reports that describe the success rate of injection in detail, it is sometimes difficult to locate the pipette tip accurately within the CA1 pyramidal cell layer because the pyramidal layer is only 0.1 mm thick. In the present study, we have developed a system to inject viral vectors accurately into the mouse hippocampal CA1 pyramidal cell layer using a stereotaxic injection system with simultaneous electrophysiological monitoring of theta oscillation. The pipette tip was positioned reliably based on integrated values of the theta oscillation in the hippocampal CA1 pyramidal cell layer. This approach allows accurate injection of solutions and provides an efficient method of gene transfer using viral vectors into the hippocampus, which can be a useful tool for studies involving the molecular mechanisms of neuronal functions.	[Tsutajima, Jyoji; Kunitake, Takato; Wakazono, Yoshihiko; Takamiya, Kogo] Miyazaki Univ, Fac Med, Dept Neurosci, Miyazaki, Japan	University of Miyazaki	Takamiya, K (corresponding author), Miyazaki Univ, Fac Med, Dept Neurosci, Miyazaki, Japan.	takamiya@med.miyazaki-u.ac.jp		Takamiya, Kogo/0000-0001-7240-6307	MEXT [10003308, 24650209]; Naito Foundation; Uehara Memorial Foundation; Suzuki Memorial Foundation; Takeda Science Foundation	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Suzuki Memorial Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by MEXT Grants-in-Aid for Scientific Research Grant Number 10003308 and Research on Innovative Areas (Deciphering sugar chain-based signals regulating integrative neuronal functions) (to KT) and Number 24650209, Naito Foundation (https://www.naitof.or.jp/en/), Uehara Memorial Foundation (http://www.ueharazaidan.or.jp/), Suzuki Memorial Foundation (http://www.suzukenzaidan.or.jp/), and Takeda Science Foundation (http://www.takeda-sci.or.jp/) (to KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRAGIN A, 1995, J NEUROSCI, V15, P47; Burger C, 2005, MOL THER, V11, P327, DOI 10.1016/j.ymthe.2004.08.031; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki-ki Gr, 2002, NEURON, V33, P325, DOI [10.1016/S0896-6273(02)00586-X, DOI 10.1016/S0896-6273(02)00586-X.PUBMED:11832222]; D'Apuzzo M, 2001, J NEUROPHYSIOL, V86, P1037, DOI 10.1152/jn.2001.86.2.1037; DeVito LM, 2010, HIPPOCAMPUS, V20, P208, DOI 10.1002/hipo.20610; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Franklin K. B. J., 1996, MOUSE BRAIN STEREOTA; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; KBJ F, 1996, MOUSE BRAIN STEREOTA; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kim CH, 2005, NAT NEUROSCI, V8, P985, DOI 10.1038/nn1432; Lesting J, 2011, EPILEPSIA, V52, P337, DOI 10.1111/j.1528-1167.2010.02758.x; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lindroos MM, 2005, INT J DEV NEUROSCI, V23, P65, DOI 10.1016/j.ijdevneu.2004.08.003; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lundstrom K, 2003, TRENDS BIOTECHNOL, V21, P117, DOI 10.1016/S0167-7799(02)00042-2; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mack V, 2001, SCIENCE, V292, P2501, DOI 10.1126/science.1059365; Makino Y, 2011, P NATL ACAD SCI USA, V108, P8450, DOI 10.1073/pnas.1105261108; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mastakov MY, 2001, MOL THER, V3, P225, DOI 10.1006/mthe.2001.0246; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meldrum B S, 1994, Neurology, V44, pS14; Narayanan RT, 2007, EUR J NEUROSCI, V25, P1823, DOI 10.1111/j.1460-9568.2007.05437.x; Neve RL, 1997, NEUROSCIENCE, V79, P435, DOI 10.1016/S0306-4522(96)00645-8; Pelletier JG, 2004, BIOL PSYCHIAT, V55, P559, DOI 10.1016/j.biopsych.2003.08.019; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Washbourne P, 2002, CURR OPIN NEUROBIOL, V12, P566, DOI 10.1016/S0959-4388(02)00365-3; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	38	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83129	10.1371/journal.pone.0083129	http://dx.doi.org/10.1371/journal.pone.0083129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358255	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700104
J	Agmon, N; Bloch, Y				Agmon, Noam; Bloch, Yigal			Statistics of Language Morphology Change: From Biconsonantal Hunters to Triconsonantal Farmers	PLOS ONE			English	Article							SOUTHERN LEVANT; ISRAELI COAST; JORDAN VALLEY; NEAR-EAST; ATLIT-YAM; DOMESTICATION; ORIGINS; COMPLEXITY; EMERGENCE; EVOLUTION	Linguistic evolution mirrors cultural evolution, of which one of the most decisive steps was the "agricultural revolution" that occurred 11,000 years ago in W. Asia. Traditional comparative historical linguistics becomes inaccurate for time depths greater than, say, 10 kyr. Therefore it is difficult to determine whether decisive events in human prehistory have had an observable impact on human language. Here we supplement the traditional methodology with independent statistical measures showing that following the transition to agriculture, languages of W. Asia underwent a transition from biconsonantal (2c) to triconsonantal (3c) morphology. Two independent proofs for this are provided. Firstly the reconstructed Proto-Semitic fire and hunting lexicons are predominantly 2c, whereas the farming lexicon is almost exclusively 3c in structure. Secondly, while Biblical verbs show the usual Zipf exponent of about 1, their 2c subset exhibits a larger exponent. After the 2c > 3c transition, this could arise from a faster decay in the frequency of use of the less common 2c verbs. Using an established frequency-dependent word replacement rate, we calculate that the observed increase in the Zipf exponent has occurred over the 7,500 years predating Biblical Hebrew namely, starting with the transition to agriculture.	[Agmon, Noam] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; [Bloch, Yigal] Hebrew Univ Jerusalem, Dept Jewish Hist, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Agmon, N (corresponding author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.	agmon@fh.huji.ac.il	Agmon, Noam/B-2611-2009	Agmon, Noam/0000-0003-4339-8664	Israel Science Foundation [122/08]	Israel Science Foundation(Israel Science Foundation)	The Israel Science Foundation (Grant No. 122/08) http://www.isf.org.il/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon N, 2010, BRILLS ANN AFROSIAT, V2, P23, DOI 10.1163/187666310X12688137960669; Baayen R. Harald, 2001, WORD FREQUENCY DISTR; Barnard H, 2011, J ARCHAEOL SCI, V38, P977, DOI 10.1016/j.jas.2010.11.012; Biggs RD, 1956, ASSYRIAN DICT ORIENT; Blazek V, 1993, ARCH ORIENTALNI, V60, P16; Bocquentin A, 2004, J HUM EVOL, V47, P19, DOI [10.1016/j.jhevol.2004.05.003, DOI 10.1016/J.JHEV0L.2004.05.003]; Bomhard AR., 2008, RECONSTRUCTING PROTO; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; del Olmo Lete G, 2008, QUESTIONS SEMITIC LI, P53; Diakonoff I, 1998, J SEMITIC STUD, V43, P209, DOI 10.1093/jss/43.2.209; Dietrich O, 2012, ANTIQUITY, V86, P674, DOI 10.1017/S0003598X00047840; DOLGOPOLSKY Aharon, 2008, NOSTRATIC DICT; Dolgopolsky Aron, 1998, NOSTRATIC MACROFAMIL; Ehret C, 2004, SCIENCE, V306, P1680; Ehret C, 2010, HIST TESTIMONY LANGU, P148; Evershed RP, 2008, NATURE, V455, P528, DOI 10.1038/nature07180; Ferrer Cancho R, 2010, J QUANT LINGUIST, V8, P165; GALILI E, 1993, J FIELD ARCHAEOL, V20, P133, DOI 10.1179/jfa.1993.20.2.133; Garfinkel Y, 2006, ANTIQUITY, V80, P686, DOI 10.1017/S0003598X00094138; Goldberg P, 2012, QUATERN INT, V247, P325, DOI 10.1016/j.quaint.2010.11.015; Goren-Inbar N, 2004, SCIENCE, V304, P725, DOI 10.1126/science.1095443; Henry D. O., 1975, PROBLEMS PREHISTORY, P379; JAMES SR, 1989, CURR ANTHROPOL, V30, P1, DOI 10.1086/203705; Kislev ME, 2004, J ARCHAEOL SCI, V31, P1301, DOI 10.1016/j.jas.2004.02.010; Kitchen A, 2009, P ROY SOC B-BIOL SCI, V276, P2703, DOI 10.1098/rspb.2009.0408; Koehler Ludwig, 1994, HEBREW ARAMAIC LEXIC; Kogan L, 2002, J SEMITIC STUD, V47, P183, DOI 10.1093/jss/47.2.183; Kogan L, 2011, SEMITIC LANGUAGES IN; Kuijt I, 2002, J WORLD PREHIST, V16, P361, DOI 10.1023/A:1022973114090; Kuijt I, 2009, P NATL ACAD SCI USA, V106, P10966, DOI 10.1073/pnas.0812764106; Kwapien J, 2010, ACTA PHYS POL A, V117, P716, DOI 10.12693/APhysPolA.117.716; Lawler A, 2009, SCIENCE, V325, P940, DOI [10.1126/science.325_940, 10.1126/science.325_942]; Legge A.J., 1987, Scientific American, V257, P76; Lester GB, 2011, FREQUENCY LIST BIBLI; LEVY TE, 1983, WORLD ARCHAEOL, V15, P15, DOI 10.1080/00438243.1983.9979882; Lieberman E, 2007, NATURE, V449, P713, DOI 10.1038/nature06137; Lipinski E., 2001, ORIENTALIA LOVANIENS; Lowenstamm J, 2010, BRILLS ANN AFROSIAT, V2, P1, DOI 10.1163/187666310X12688137960902; Lu HY, 2009, P NATL ACAD SCI USA, V106, P7367, DOI 10.1073/pnas.0900158106; McGovern PE, 2003, ANCIENT WINE SEARCH; MICHEL RH, 1992, NATURE, V360, P24, DOI 10.1038/360024b0; Militarev A, DATABASE AFROASIATIC; Militarev A, 2000, TIME DEPTH HIST LING, P267; Militarev Alexander, 2002, EXAMINING FARMING LA, P135; Nieuwenhuyse OP, 2006, LEIDEN J POTTERY STU, V22, P111; Oates D., 1976, PROBLEMS EC SOCIAL A, P109; Oats D, 1990, WORLD ARCH, V21, P390; Orel V., 1995, HAMITO SEMITIC ETYMO; Pagel M, 2007, NATURE, V449, P717, DOI 10.1038/nature06176; Pagel M, 2013, P NATL ACAD SCI USA, V110, P8471, DOI 10.1073/pnas.1218726110; Peltenburg E, 2000, ANTIQUITY, V74, P844, DOI 10.1017/S0003598X0006049X; Petersen AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00943; Peterson J, 1998, INT J OSTEOARCHAEOL, V8, P378, DOI 10.1002/(SICI)1099-1212(1998090)8:5<378::AID-OA436>3.0.CO;2-I; Shea JJ, 2006, J ARCHAEOL SCI, V33, P823, DOI 10.1016/j.jas.2005.10.015; SHERRATT A, 1983, WORLD ARCHAEOL, V15, P90, DOI 10.1080/00438243.1983.9979887; Smith B. D., 1998, EMERGENCE AGR; Takacs G, 1997, J CUNEIFORM STUD, V49, P108, DOI [10.2307/1359895, DOI 10.2307/1359895]; Takacs G, 1998, LINGUA POSNANIENSIS, V40, P141; Vernet i Pons E, 2008, THESIS U BARCELONA; ZEDER MA, 1994, AM ANTHROPOL, V96, P97, DOI 10.1525/aa.1994.96.1.02a00050; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	62	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e83780	10.1371/journal.pone.0083780	http://dx.doi.org/10.1371/journal.pone.0083780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	276HY	24367613	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900022
J	Zhao, CQ; Su, EM; Yang, X; Gao, ZW; Li, L; Wu, HY; Jiang, YY; Su, X				Zhao, Caiqi; Su, Emily M.; Yang, Xi; Gao, Zhaowei; Li, Ling; Wu, Haiya; Jiang, Yiyi; Su, Xiao			Important Role of Platelets in Modulating Endotoxin-Induced Lung Inflammation in CFTR-Deficient Mice	PLOS ONE			English	Article							HIGH-DOSE IBUPROFEN; LIGAND 1 PSGL-1; CYSTIC-FIBROSIS; ACTIVATING-FACTOR; P-SELECTIN; IN-VIVO; INJURY; THROMBOSIS	Mutation of CFTR (cystic fibrosis transmembrane conductance regulator) leads to cystic fibrosis (CF). Patients with CF develop abnormalities of blood platelets and recurrent lung inflammation. However, whether CFTR-mutated platelets play a role in the development of lung inflammation is elusive. Therefore, we intratracheally challenged wildtype and F508del (a common type of CFTR mutation) mice with LPS to observe changes of F508del platelets in the peripheral blood and indexes of lung inflammation (BAL neutrophils and protein levels). Furthermore, we investigated whether or not and how F508del platelets modulate the LPS-induced acute lung inflammation by targeting anti-platelet aggregation, depletion of neutrophils, reconstitution of bone marrow or neutrophils, blockade of P-selectin glycoprotein ligand-1 (PSGL-1), platelet activating factor (PAF), and correction of mutated CFTR trafficking. We found that LPS-challenged F508del mice developed severe thrombocytopenia and had higher levels of plasma TXB2 coincided with neutrophilic lung inflammation relative to wildtype control. Inhibition of F508del platelet aggregation or depletion of F508del neutrophils diminished the LPS-induced lung inflammation in the F508del mice. Moreover, wildtype mice reconstituted with either F508del bone marrow or neutrophils developed worse thrombocytopenia. Blocking PSGL-1, platelet activating factor (PAF), or rectifying trafficking of mutated CFTR in F508del mice diminished and alveolar neutrophil transmigration in the LPS-challenged F508del mice. These findings suggest that F508del platelets and their interaction with neutrophils are requisite for the development of LPS-induced lung inflammation and injury. As such, targeting platelets might be an emerging strategy for dampening recurrent lung inflammation in cystic fibrosis patients.	[Zhao, Caiqi; Yang, Xi; Gao, Zhaowei; Li, Ling; Wu, Haiya; Jiang, Yiyi; Su, Xiao] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Su, Emily M.; Su, Xiao] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); University of California System; University of California San Francisco	Su, X (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.	xsu@ips.ac.cn	Su, Xiao/CAG-9884-2022; Su, Xiao/G-4298-2010	Su, Xiao/0000-0002-8692-8365; Su, Xiao/0000-0002-8692-8365	Parker B. Francis Award; National Natural Science Foundation of China [81270139]; Key Project of Science and Technology of Shanghai [12JC1408900]; One Hundred Person Project of the Chinese Academy of Sciences [Y316P21209]; Knowledge Innovation Program of the Chinese Academy of Sciences [Y114P11209]	Parker B. Francis Award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Science and Technology of Shanghai; One Hundred Person Project of the Chinese Academy of Sciences; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	Parker B. Francis Award (X. S.); The National Natural Science Foundation of China (Grant No. 81270139, X. S.); The Key Project of Science and Technology of Shanghai (Grant No. 12JC1408900, X. S.); One Hundred Person Project of the Chinese Academy of Sciences (Grant No. Y316P21209, X. S.); The Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. Y114P11209, X. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEIJER L, 1987, BRIT J PHARMACOL, V92, P803, DOI 10.1111/j.1476-5381.1987.tb11384.x; CHANG SW, 1987, J CLIN INVEST, V79, P1498, DOI 10.1172/JCI112980; Ciabattoni G, 2000, AM J RESP CRIT CARE, V162, P1195, DOI 10.1164/ajrccm.162.4.9911071; Frenette PS, 2000, J EXP MED, V191, P1413, DOI 10.1084/jem.191.8.1413; Furie B, 2004, TRENDS MOL MED, V10, P171, DOI 10.1016/j.molmed.2004.02.008; Jacquot J, 2008, EXPERT REV MOL DIAGN, V8, P359, DOI 10.1586/14737159.8.4.359; KONSTAN MW, 1995, NEW ENGL J MED, V332, P848, DOI 10.1056/NEJM199503303321303; KUSTER LJ, 1986, THROMB RES, V43, P425, DOI 10.1016/0049-3848(86)90087-3; Lands LC, 2007, J PEDIATR-US, V151, P249, DOI 10.1016/j.jpeds.2007.04.009; Makam M, 2009, P NATL ACAD SCI USA, V106, P5779, DOI 10.1073/pnas.0813410106; Mattoscio D, 2010, FASEB J, V24, P3970, DOI 10.1096/fj.10-159921; O'Sullivan BP, 2006, AM J RESP CRIT CARE, V173, P483, DOI 10.1164/rccm.200508-1243PP; O'Sullivan BP, 2005, BLOOD, V105, P4635, DOI 10.1182/blood-2004-06-2098; Qian F, 2009, EMBO J, V28, P2896, DOI 10.1038/emboj.2009.234; RABINOVICI R, 1991, CIRC RES, V69, P12, DOI 10.1161/01.RES.69.1.12; Robert R, 2008, MOL PHARMACOL, V73, P478, DOI 10.1124/mol.107.040725; Song YL, 2004, J BIOL CHEM, V279, P40629, DOI 10.1074/jbc.M407308200; STEAD RJ, 1987, PROSTAG LEUKOTR ESS, V26, P91, DOI 10.1016/0262-1746(87)90104-1; Su X, 2004, EXP LUNG RES, V30, P479, DOI 10.1080/01902140490476382; Su X, 2011, INFLAMM RES, V60, P619, DOI 10.1007/s00011-011-0313-x; Vandendries ER, 2004, THROMB HAEMOSTASIS, V92, P459, DOI 10.1160/TH04-05-0306; Yang J, 1999, J EXP MED, V190, P1769, DOI 10.1084/jem.190.12.1769; Zimmerman GA, 2002, CRIT CARE MED, V30, pS294, DOI 10.1097/00003246-200205001-00020	23	13	14	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82683	10.1371/journal.pone.0082683	http://dx.doi.org/10.1371/journal.pone.0082683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367540	Green Submitted, Green Published, gold			2022-12-27	WOS:000328741900010
J	Bolderdijk, JW; Gorsira, M; Keizer, K; Steg, L				Bolderdijk, Jan Willem; Gorsira, Madelijne; Keizer, Kees; Steg, Linda			Values Determine the (In) Effectiveness of Informational Interventions in Promoting Pro-Environmental Behavior	PLOS ONE			English	Article							AWARENESS; NORM; TESTS	Informational interventions (e.g., awareness campaigns, carbon footprint calculators) are built on the assumption that informing the public about the environmental consequences of their actions should result in increased pro-environmental intentions and behavior. However, empirical support for this reasoning is mixed. In this paper, we argue that informational interventions may succeed in improving people's knowledge about the negative environmental consequences of one's actions, but this knowledge will not gain motivational force if people do not consider protecting the environment an important personal value. In an experiment, we measured individual differences in value priorities, and either presented participants a movie clip that portrayed the negative environmental consequences of using bottled water, or a control movie. As predicted, we found that the environmental movie improved recipients' knowledge of the negative environmental impact of bottled water, but this knowledge only resulted in concomitant changes in intentions and acceptability of related policies among participants who strongly endorsed biospheric (i.e. environmental) values, while having no effect on those who care less about the environment. Interestingly, the results suggest that although informational interventions are perhaps not always successful in directly affecting less environmentally-conscious recipients, they could still have beneficial effects, because they make those who strongly care about the environment more inclined to act on their values.	[Bolderdijk, Jan Willem] Univ Groningen, Dept Mkt, Groningen, Netherlands; [Gorsira, Madelijne; Keizer, Kees; Steg, Linda] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands	University of Groningen; University of Groningen	Bolderdijk, JW (corresponding author), Univ Groningen, Dept Mkt, Groningen, Netherlands.	j.w.bolderdijk@rug.nl	Steg, Linda/H-6878-2014	Steg, Linda/0000-0002-8375-9607; Bolderdijk, Jan Willem/0000-0003-2358-6932	NWO	NWO(Netherlands Organization for Scientific Research (NWO))	This work was conducted in the context of the Sustainable Accessibility of the Randstad programme, which is funded by the NWO. NWO funds scientific research at Dutch universities and research institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse W, 2005, J ENVIRON PSYCHOL, V25, P273, DOI 10.1016/j.jenvp.2005.08.002; Aronson E, 1992, PSYCHOL INQ, V3, P303, DOI [10.1207/s15327965pli0304_1, DOI 10.1207/S15327965PLI0304_1]; Attari SZ, 2010, P NATL ACAD SCI USA, V107, P16054, DOI 10.1073/pnas.1001509107; Bain PG, 2012, NAT CLIM CHANGE, V2, P600, DOI 10.1038/NCLIMATE1532; BAIRD JC, 1981, J APPL PSYCHOL, V66, P90; De Groot JIM, 2009, J SOC PSYCHOL, V149, P425, DOI 10.3200/SOCP.149.4.425-449; Dietz T, 2013, P NATL ACAD SCI USA, V110, P9191, DOI 10.1073/pnas.1307484110; Franz J, 2011, SUSTAIN DEV, V19, P391, DOI 10.1002/sd.446; Frick J, 2004, PERS INDIV DIFFER, V37, P1597, DOI 10.1016/j.paid.2004.02.015; GELLER ES, 1992, AM PSYCHOL, V47, P814, DOI 10.1037/0003-066X.47.6.814; Gromet DM, 2013, P NATL ACAD SCI USA, V110, P9314, DOI 10.1073/pnas.1218453110; GUAGNANO GA, 1995, ENVIRON BEHAV, V27, P699, DOI 10.1177/0013916595275005; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Kahan D, 2010, NATURE, V463, P296, DOI 10.1038/463296a; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Kaiser FG, 2003, APPL PSYCHOL-INT REV, V52, P598, DOI 10.1111/1464-0597.00153; Katzev R. D., 1987, PROMOTING ENERGY CON; Kuhlemeier H., 1999, J ENVIRON EDUC, V30, P4, DOI [10.1080/00958969909601864, DOI 10.1080/00958969909601864]; LUYBEN PD, 1982, ENVIRON BEHAV, V14, P113, DOI 10.1177/0013916582141007; Nordlund AM, 2003, J ENVIRON PSYCHOL, V23, P339, DOI 10.1016/S0272-4944(03)00037-9; Schultz P. W, 2010, PEOPLE CTR INITIATIV, P251; Schultz P. W., 2003, RES HUMAN ECOLOGY, V10, P126; Schultz P. W., 2002, NEW TOOLS ENV PROTEC, P67; Schultz PW, 1999, BASIC APPL SOC PSYCH, V21, P25, DOI 10.1207/s15324834basp2101_3; Schwartz S. H., 1977, ADV EXP SOC PSYCHOL, V10, P221, DOI [10.1016/s0065-2601(08)60358-5, 10.1016/S0065-2601(08) 60358-5, DOI 10.1016/S0065-2601(08)60358-5]; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; Spiller SA, 2013, J MARKETING RES, V50, P277, DOI 10.1509/jmr.12.0420; Staats HJ, 1996, J ENVIRON MANAGE, V46, P189, DOI 10.1006/jema.1996.0015; Steg L, 2013, ENVIRON BEHAV, V45, P526, DOI [10.1177/0013916512454730, DOI 10.1177/0013916512454730.PUBMED:23853386]; Steg L, 2010, BRIT J SOC PSYCHOL, V49, P725, DOI 10.1348/014466609X477745; Stern P., 1999, J CONSUM POLICY, V22, P461, DOI [DOI 10.1023/A:1006211709570, 10.1023/A:1006211709570]; Stern P.C, 1999, HUM ECOL REV, V6, P81; Stern PC, 2000, J SOC ISSUES, V56, P407, DOI 10.1111/0022-4537.00175; STERN PC, 1993, ENVIRON BEHAV, V25, P322, DOI 10.1177/0013916593255002; STERN PC, 1995, J APPL SOC PSYCHOL, V25, P1611, DOI 10.1111/j.1559-1816.1995.tb02636.x; STERN PC, 1994, J SOC ISSUES, V50, P65, DOI 10.1111/j.1540-4560.1994.tb02420.x; STERN PC, 1987, HDB ENV PSYCHOL; Thogersen J, 2009, J CONSUM POLICY, V32, P141, DOI 10.1007/s10603-009-9101-1; Van der Helm C, 2007, THESIS DELFT; Vandenbergh MP, 2011, NAT CLIM CHANGE, V1, P4, DOI 10.1038/nclimate1071; Werner CM, 1998, ENVIRON BEHAV, V30, P709, DOI 10.1177/001391659803000506; West SG, 1996, J PERS, V64, P1, DOI 10.1111/j.1467-6494.1996.tb00813.x	42	86	86	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83911	10.1371/journal.pone.0083911	http://dx.doi.org/10.1371/journal.pone.0083911			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367619	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300121
J	Goyal, R; Van Wickle, J; Goyal, D; Matei, N; Longo, LD				Goyal, Ravi; Van Wickle, Jonathan; Goyal, Dipali; Matei, Nathanael; Longo, Lawrence D.			Antenatal Maternal Long-Term Hypoxia: Acclimatization Responses with Altered Gene Expression in Ovine Fetal Carotid Arteries	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; INTRAUTERINE GROWTH RESTRICTION; TRANSCRIPTION FACTORS; MODULATES EXPRESSION; ALTITUDE; CELLS; SHEEP; PRETERM; PROTEIN; FAMILY	In humans and other species, long-term hypoxia (LTH) during pregnancy can lead to intrauterine growth restriction with reduced body/brain weight, dysregulation of cerebral blood flow (CBF), and other problems. To identify the signal transduction pathways and critical molecules, which may be involved in acclimatization to high altitude LTH, we conducted microarray with advanced bioinformatic analysis on carotid arteries (CA) from the normoxic near-term ovine fetus at sea-level and those acclimatized to high altitude for 110+ days during gestation. In response to LTH acclimatization, in fetal CA we identified mRNA from 38 genes upregulated >2 fold (P<0.05) and 9 genes downregulated >2-fold (P<0.05). The major genes with upregulated mRNA were SLC1A3, Insulin-like growth factor (IGF) binding protein 3, IGF type 2 receptor, transforming growth factor (TGF) Beta-3, and genes involved in the AKT and BCL2 signal transduction networks. Most genes with upregulated mRNA have a common motif for Pbx/Knotted homeobox in the promoter region, and Sox family binding sites in the 3' un translated region (UTR). Genes with downregulated mRNA included those involved in the P53 pathway and 5-lipoxygenase activating proteins. The promoter region of all genes with downregulated mRNA, had a common 49 bp region with a binding site for DOT6 and TOD6, components of the RPD3 histone deacetylase complex RPD3C(L). We also identified miRNA complementary to a number of the altered genes. Thus, the present study identified molecules in the ovine fetus, which may play a role in the acclimatization response to high-altitude associated LTH.	[Goyal, Ravi; Van Wickle, Jonathan; Goyal, Dipali; Matei, Nathanael; Longo, Lawrence D.] Loma Linda Univ, Sch Med, Ctr Perinatal Biol, Loma Linda, CA 92350 USA; [Goyal, Ravi; Longo, Lawrence D.] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA USA	Loma Linda University; Loma Linda University	Goyal, R (corresponding author), Loma Linda Univ, Sch Med, Ctr Perinatal Biol, Loma Linda, CA 92350 USA.	rgoyal@llu.edu			United States Public Health Service Grant [PO1 HD031226]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD003807, P01HD031226] Funding Source: NIH RePORTER	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was supported by United States Public Health Service Grant PO1 HD031226 to LDL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiano R, 2010, NUCLEIC ACIDS RES, V38, P5177, DOI 10.1093/nar/gkq260; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Box AH, 2010, BBA-MOL CELL RES, V1803, P951, DOI 10.1016/j.bbamcr.2010.03.011; Brown ST, 2011, BIOCHEM BIOPH RES CO, V412, P466, DOI 10.1016/j.bbrc.2011.07.122; Cabrol S, 2011, HORM RES PAEDIAT, V76, P419, DOI 10.1159/000334651; Campos B, 2012, INT J CANCER, V131, P1963, DOI 10.1002/ijc.27446; Charboneau A., 2005, Angiogenesis, V8, P289; Dasgupta C, 2012, HYPERTENSION, V60, P697, DOI 10.1161/HYPERTENSIONAHA.112.198242; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; DIECKHOFF D, 1969, PFLUG ARCH EUR J PHY, V310, P75, DOI 10.1007/BF00586876; Ducsay CA, 2007, AM J PHYSIOL-REG I, V293, pR1997, DOI 10.1152/ajpregu.00313.2007; Dukhande VV, 2011, MOL CELL BIOCHEM, V357, P189, DOI 10.1007/s11010-011-0889-z; Geiger K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026465; Gentili S, 2009, BIOL REPROD, V80, P1121, DOI 10.1095/biolreprod.108.073569; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; GIUDICE LC, 1995, J CLIN ENDOCR METAB, V80, P1548, DOI 10.1210/jc.80.5.1548; Gonsalves CS, 2010, J IMMUNOL, V184, P3878, DOI 10.4049/jimmunol.0902594; Goyal R, 2012, PEDIATR RES, V72, P137, DOI 10.1038/pr.2012.57; Goyal R, 2012, AM J PHYSIOL-REG I, V302, pR433, DOI 10.1152/ajpregu.00519.2011; Goyal R, 2010, AM J PHYSIOL-REG I, V299, pR1377, DOI 10.1152/ajpregu.00344.2010; Goyal R, 2010, AM J PHYSIOL-HEART C, V298, pH1797, DOI 10.1152/ajpheart.00112.2010; Guadall A, 2011, J BIOL CHEM, V286, P7093, DOI 10.1074/jbc.M110.162917; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; HEISTAD DD, 1978, J CLIN INVEST, V62, P761, DOI 10.1172/JCI109187; Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; KAMITOMO M, 1992, AM J PHYSIOL, V262, pH399, DOI 10.1152/ajpheart.1992.262.2.H399; Kehrer M, 2005, PEDIATR RES, V58, P927, DOI 10.1203/01.PDR.0000182579.52820.C3; Kim MS, 2006, J INVEST DERMATOL, V126, P2697, DOI 10.1038/sj.jid.5700463; KITANAKA T, 1989, AM J PHYSIOL, V256, pR1348, DOI 10.1152/ajpregu.1989.256.6.R1348; KITANAKA T, 1989, AM J PHYSIOL, V256, pR1340, DOI 10.1152/ajpregu.1989.256.6.R1340; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; Kourembanas S, 1997, KIDNEY INT, V51, P438, DOI 10.1038/ki.1997.58; LaFramboise WA, 2009, AM J PHYSIOL-CELL PH, V297, pC556, DOI 10.1152/ajpcell.00046.2009; Lee SD, 2006, INT J CARDIOL, V108, P376, DOI 10.1016/j.ijcard.2005.05.046; Lee SJ, 2009, J PHYSIOL-LONDON, V587, P2033, DOI 10.1113/jphysiol.2009.166983; LIN YS, 1988, P NATL ACAD SCI USA, V85, P3396, DOI 10.1073/pnas.85.10.3396; Lubec B, 2002, BIOL NEONATE, V81, P266, DOI 10.1159/000056758; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maves L, 2009, DEV BIOL, V333, P409, DOI 10.1016/j.ydbio.2009.07.004; McCullough R E, 1977, Obstet Gynecol Surv, V32, P596, DOI 10.1097/00006254-197709000-00012; METCALFE J, 1962, Q J EXP PHYSIOL CMS, V47, P305, DOI 10.1113/expphysiol.1962.sp001614; Monau TR, 2009, REPROD SCI, V16, P865, DOI 10.1177/1933719109336678; Moore LG, 2003, HIGH ALT MED BIOL, V4, P141, DOI 10.1089/152702903322022767; Myers DA, 2008, AM J PHYSIOL-REG I, V294, pR1312, DOI 10.1152/ajpregu.00004.2008; Ninomiya M, 2010, NEUROSCI LETT, V476, P104, DOI 10.1016/j.neulet.2010.03.082; Ord JJ, 2005, BRIT J CANCER, V93, P346, DOI 10.1038/sj.bjc.6602666; Pena JP, 2007, J PHYSIOL-LONDON, V578, P359, DOI 10.1113/jphysiol.2006.119925; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reece EA, 2008, CLIN OBSTETRICS; Rueda-Clausen CF, 2009, CARDIOVASC RES, V81, P713, DOI 10.1093/cvr/cvn341; SZYMONOWICZ W, 1990, PEDIATR RES, V28, P361, DOI 10.1203/00006450-199010000-00012; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; UNGER C, 1988, JAMA-J AM MED ASSOC, V259, P3427, DOI 10.1001/jama.259.23.3427; van Malensteina H, 2012, CANCER LETT, V315, P178, DOI 10.1016/j.canlet.2011.09.039; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Voelkel NF, 1996, J CLIN INVEST, V97, P2491, DOI 10.1172/JCI118696; Wilson SM, 2010, FASEB J, V24; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Yinon Y, 2008, AM J PATHOL, V172, P77, DOI 10.2353/ajpath.2008.070640; Zhang X, 2009, CANCER GENET CYTOGEN, V194, P23, DOI 10.1016/j.cancergencyto.2009.04.027	64	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82200	10.1371/journal.pone.0082200	http://dx.doi.org/10.1371/journal.pone.0082200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367503	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300021
J	Moelans, CB; Holst, F; Hellwinkel, O; Simon, R; van Diest, PJ				Moelans, Cathy B.; Holst, Frederik; Hellwinkel, Olaf; Simon, Ronald; van Diest, Paul J.			ESR1 Amplification in Breast Cancer by Optimized RNase FISH: Frequent but Low-Level and Heterogeneous	PLOS ONE			English	Article							GENE COPY NUMBER; CELL LUNG-CANCER; DEPENDENT PROBE AMPLIFICATION; IN-SITU HYBRIDIZATION; GEFITINIB THERAPY; SC-35 DOMAINS; GAIN; DNA; ABNORMALITIES; TRANSCRIPTION	Prevalence of ESR1 amplification in breast cancer is highly disputed and discrepancies have been related to different technical protocols and different scoring approaches. In addition, pre-mRNA artifacts have been proposed to influence outcome of ESR1 FISH analysis. We analyzed ESR1 gene copy number status combining an improved RNase FISH protocol with multiplex ligation-dependent probe amplification (MLPA) after laser microdissection. FISH showed a high prevalence of ESR1 gains and amplifications despite RNase treatment but MLPA did not confirm ESR1 copy number increases detected by FISH in more than half of cases. We suggest that the combination of the ESR1-specific intra-tumor heterogeneity and low-level copy number increase accounts for these discrepancies.	[Moelans, Cathy B.; van Diest, Paul J.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Holst, Frederik] Haukeland Hosp, Dept Clin Sci, Sect Gynecol & Obstet, N-5021 Bergen, Norway; [Hellwinkel, Olaf] Univ Med Ctr Hamburg Eppendorf, Dept Legal Med, Hamburg, Germany; [Holst, Frederik; Simon, Ronald] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany	Utrecht University; Utrecht University Medical Center; University of Bergen; Haukeland University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Moelans, CB (corresponding author), Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands.	C.B.Moelans@umcutrecht.nl; Frederik.Holst@ikm.uib.no	Holst, Frederik/H-3149-2019	Holst, Frederik/0000-0002-5928-2175; Moelans, Cathy/0000-0001-9992-8703	Deutsche Forschungsgemeinschaft [DGF SI 1347/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DGF SI 1347/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algars A, 2011, BRIT J CANCER, V105, P255, DOI 10.1038/bjc.2011.223; Bernasconi B, 2012, BREAST CANCER RES TR, V133, P161, DOI 10.1007/s10549-011-1744-3; Braude I, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-138; Bunyan DJ, 2004, BRIT J CANCER, V91, P1155, DOI 10.1038/sj.bjc.6602121; Cappuzzo F, 2005, BRIT J CANCER, V93, P1334, DOI 10.1038/sj.bjc.6602865; Cappuzzo F, 2005, J CLIN ONCOL, V23, P5007, DOI 10.1200/JCO.2005.09.111; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Coffa J, 2008, CELL ONCOL, V30, P323, DOI 10.3233/CLO-2008-0428; Dahabreh IJ, 2011, ANN ONCOL, V22, P545, DOI 10.1093/annonc/mdq432; Dahabreh IJ, 2010, CLIN CANCER RES, V16, P291, DOI 10.1158/1078-0432.CCR-09-1660; Ejlertsen B, 2012, ANN ONCOL, V23, P1138, DOI 10.1093/annonc/mdr438; EPSTEIN L, 1995, CYTOMETRY, V21, P378, DOI 10.1002/cyto.990210410; FELSENFELD G, 1963, P NATL ACAD SCI USA, V50, P644, DOI 10.1073/pnas.50.4.644; Fidler MJ, 2011, BRIT J CANCER, V105, P1920, DOI 10.1038/bjc.2011.494; Holst F, 2007, NAT GENET, V39, P655, DOI 10.1038/ng2006; Holst F, 2012, NAT REV CANCER, V12, P149, DOI 10.1038/nrc3093-c3; JENSEN DE, 1976, J BIOL CHEM, V251, P7198; Jensen KC, 2008, BREAST CANCER RES TR, V112, P453, DOI 10.1007/s10549-007-9887-y; Johnson C, 2000, J CELL BIOL, V150, P417, DOI 10.1083/jcb.150.3.417; Laenkholm AV, 2012, MOL ONCOL, V6, P428, DOI 10.1016/j.molonc.2012.04.003; Lin CH, 2013, J CLIN PATHOL, V66, P140, DOI [10.1136/jdinpath-2012-200929, 10.1136/jclinpath-2012-200929]; Martin V, 2009, J CLIN PATHOL, V62, P314, DOI 10.1136/jcp.2008.059592; Moelans CB, 2010, CELL ONCOL, V32, P311, DOI 10.3233/CLO-2009-0502; Muhlemann O, 2001, MOL CELL, V8, P33, DOI 10.1016/S1097-2765(01)00288-X; Ooi A, 2012, J PATHOL, V227, P8, DOI 10.1002/path.3974; Pentheroudakis G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070634; REMMELE W, 1987, PATHOLOGE, V8, P138; Ribeiro FR, 2007, EUR UROL, V52, P116, DOI 10.1016/j.eururo.2006.09.018; Smith KP, 1999, J CELL BIOL, V144, P617, DOI 10.1083/jcb.144.4.617; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; SZOLLOSI J, 1995, CANCER RES, V55, P5400; Teo SM, 2012, BIOINFORMATICS, V28, P2711, DOI 10.1093/bioinformatics/bts535; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Tomita S, 2009, CANCER SCI, V100, P1012, DOI 10.1111/j.1349-7006.2009.01145.x; Trask BJ, 2002, NAT REV GENET, V3, P769, DOI 10.1038/nrg905; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Vorstman JAS, 2006, HUM MUTAT, V27, P814, DOI 10.1002/humu.20330; Woelber L, 2012, J CLIN PATHOL, V65, P133, DOI 10.1136/jcp-2010-079806; Xing YG, 1995, J CELL BIOL, V131, P1635, DOI 10.1083/jcb.131.6.1635	39	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84189	10.1371/journal.pone.0084189	http://dx.doi.org/10.1371/journal.pone.0084189			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367641	Green Submitted, Green Published, gold			2022-12-27	WOS:000328740300132
J	Mowat, G; Heard, DC; Schwarz, CJ				Mowat, Garth; Heard, Douglas C.; Schwarz, Carl J.			Predicting Grizzly Bear Density in Western North America	PLOS ONE			English	Article							FLATHEAD RIVER DRAINAGE; HABITAT SELECTION; BRITISH-COLUMBIA; URSUS-ARCTOS; BLACK BEAR; RELATING POPULATIONS; INTERIOR MOUNTAINS; BODY-SIZE; BROWN; ABUNDANCE	Conservation of grizzly bears (Ursus arctos) is often controversial and the disagreement often is focused on the estimates of density used to calculate allowable kill. Many recent estimates of grizzly bear density are now available but field-based estimates will never be available for more than a small portion of hunted populations. Current methods of predicting density in areas of management interest are subjective and untested. Objective methods have been proposed, but these statistical models are so dependent on results from individual study areas that the models do not generalize well. We built regression models to relate grizzly bear density to ultimate measures of ecosystem productivity and mortality for interior and coastal ecosystems in North America. We used 90 measures of grizzly bear density in interior ecosystems, of which 14 were currently known to be unoccupied by grizzly bears. In coastal areas, we used 17 measures of density including 2 unoccupied areas. Our best model for coastal areas included a negative relationship with tree cover and positive relationships with the proportion of salmon in the diet and topographic ruggedness, which was correlated with precipitation. Our best interior model included 3 variables that indexed terrestrial productivity, 1 describing vegetation cover, 2 indices of human use of the landscape and, an index of topographic ruggedness. We used our models to predict current population sizes across Canada and present these as alternatives to current population estimates. Our models predict fewer grizzly bears in British Columbia but more bears in Canada than in the latest status review. These predictions can be used to assess population status, set limits for total human-caused mortality, and for conservation planning, but because our predictions are static, they cannot be used to assess population trend.	[Mowat, Garth] Minist Forests Lands & Nat Resource Operat, Nat Resource Sci Sect, Nelson, BC, Canada; [Heard, Douglas C.] Minist Forests Lands & Nat Resource Operat, Fish & Wildlife Sect, Prince George, BC, Canada; [Schwarz, Carl J.] Simon Fraser Univ, Dept Stat & Actuarial Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Mowat, G (corresponding author), Minist Forests Lands & Nat Resource Operat, Nat Resource Sci Sect, Nelson, BC, Canada.	garth.mowat@gov.bc.ca			BC Ministry of Environment; British Columbia Grizzly Bear Trust Fund	BC Ministry of Environment; British Columbia Grizzly Bear Trust Fund	This work was funded by BC Ministry of Environment and the British Columbia Grizzly Bear Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps C, 2009, GRIZZLY BEAR POPULAT; Apps CD, 2004, J WILDLIFE MANAGE, V68, P138, DOI 10.2193/0022-541X(2004)068[0138:EGBDAA]2.0.CO;2; Apps CD, 2006, ECOGRAPHY, V29, P561, DOI 10.1111/j.0906-7590.2006.04564.x; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Austin MA, 2004, URSUS, V15, P123, DOI 10.2192/1537-6176(2004)015<0123:GBRPIT>2.0.CO;2; Bannari A., 1995, REMOTE SENS REV, V13, P95, DOI [10.1080/02757259509532298, DOI 10.1080/02757259509532298]; Beck J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010416; Belant JL, 2006, ECOL APPL, V16, P2333, DOI 10.1890/1051-0761(2006)016[2333:IRPISU]2.0.CO;2; Ben-David M, 2004, OECOLOGIA, V138, P465, DOI 10.1007/s00442-003-1442-x; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Boulanger J, 2004, CAN J ZOOL, V82, P1267, DOI 10.1139/Z04-100; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Boyce MS, 2003, WILDLIFE SOC B, V31, P670; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Carbone C, 2009, INT J ECOLOGY, V2009; Caughley GJ, 1994, WILDLIFE ECOLOGY MAN; Ciarniello LM, 2007, ECOL APPL, V17, P1424, DOI 10.1890/06-1100.1; Ciarniello LM, 2007, J WILDLIFE MANAGE, V71, P1446, DOI 10.2193/2006-229; Cook RD, 1982, RESIDUALS INFLUENCE; Cote SD, 2005, CONSERV BIOL, V19, P1668, DOI 10.1111/j.1523-1739.2005.00252.x; Crete M, 1999, ECOL LETT, V2, P223; Festa- Bianchet M., 2010, STATUS GRIZZLY BEAR; Freckleton RP, 2005, J ANIM ECOL, V74, P353, DOI 10.1111/j.1365-2656.2005.00931.x; Fuhr B, 1990, METHODOLOGY GRIZZLY; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Gunther K, 2002, URSUS, V13, P372; Guthery FS, 2008, J WILDLIFE MANAGE, V72, P1872, DOI 10.2193/2008-179; Hamilton A, 2008, GRIZZLY BEAR POPULAT; HAMILTON AN, 2004, BRIT COLUMBIA GRIZZL; Hansen MC, 2003, EARTH INTERACT, V7; HERRERO S, 1978, CARNIVORE, V1, P7; HERRERO S., 1972, INT C BEAR RES MANAG, V2, P221; Hilderbrand GV, 1999, CAN J ZOOL, V77, P132, DOI 10.1139/cjz-77-1-132; Hovey FW, 1996, CAN J ZOOL, V74, P1409, DOI 10.1139/z96-156; Jacoby ME, 1999, J WILDLIFE MANAGE, V63, P921, DOI 10.2307/3802806; Johnson CJ, 2004, J APPL ECOL, V41, P238, DOI 10.1111/j.0021-8901.2004.00899.x; Kays RW, 2008, ECOL APPL, V18, P1014, DOI 10.1890/07-0298.1; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Kindberg J, 2011, WILDLIFE BIOL, V17, P114, DOI 10.2981/10-100; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; LEWONTIN RC, 1989, AM NAT, V134, P513, DOI 10.1086/284994; Manly B., 2010, RESOURCE SELECTION A; Mattson DJ, 2005, URSUS, V16, P11, DOI 10.2192/1537-6176(2005)016[0011:ABBAFI]2.0.CO;2; Mattson DJ, 2004, URSUS, V15, P76, DOI 10.2192/1537-6176(2004)015<0076:AMAOHC>2.0.CO;2; MATTSON DJ, 1991, CAN J ZOOL, V69, P1619, DOI 10.1139/z91-226; Mattson DJ, 2002, CONSERV BIOL, V16, P1123, DOI 10.1046/j.1523-1739.2002.00414.x; Mayor SJ, 2005, OECOLOGIA, V145, P276, DOI 10.1007/s00442-005-0114-4; McLellan BN, 2011, CAN J ZOOL, V89, P546, DOI 10.1139/Z11-026; MCLELLAN BN, 1995, CAN J ZOOL, V73, P704, DOI 10.1139/z95-082; McLellan BN, 2005, URSUS, V16, P141, DOI 10.2192/1537-6176(2005)016[0141:SSIIGB]2.0.CO;2; McLellan BN, 1999, J WILDLIFE MANAGE, V63, P911, DOI 10.2307/3802805; McLoughlin PD, 2002, OECOLOGIA, V132, P102, DOI 10.1007/s00442-002-0941-5; McLoughlin PD, COSEWIC STA IN PRESS; Miller S. D., 1997, WILDLIFE MONOGRAPHS, V133; Miller Sterling D., 2003, Ursus (Knoxville), V14, P130; Mowat G, 2006, CAN J ZOOL, V84, P473, DOI 10.1139/z06-016; Mowat G, 2005, WILDLIFE BIOL, V11, P31, DOI 10.2981/0909-6396(2005)11[31:GUAABB]2.0.CO;2; Mowat G, 2004, PREDICTING GRIZZLY B; Mysterud A, 1999, TRENDS ECOL EVOL, V14, P489, DOI 10.1016/S0169-5347(99)01713-9; Nagy JA, 1990, MANAGEMENT PLAN GRIZ; Nams VO, 2006, BIOL CONSERV, V128, P109, DOI 10.1016/j.biocon.2005.09.020; Nellemann C, 2007, BIOL CONSERV, V138, P157, DOI 10.1016/j.biocon.2007.04.011; Nielsen SE, 2004, FOREST ECOL MANAG, V199, P51, DOI 10.1016/j.foreco.2004.04.014; Nielsen SE, 2005, ECOGRAPHY, V28, P197, DOI 10.1111/j.0906-7590.2005.04002.x; Pease CM, 1999, ECOLOGY, V80, P957, DOI 10.1890/0012-9658(1999)080[0957:DOTYGB]2.0.CO;2; Popplewell C, 2003, URSUS-SERIES, V14, P27; Prather JW, 2006, J WILDLIFE MANAGE, V70, P723, DOI 10.2193/0022-541X(2006)70[723:LMTPTI]2.0.CO;2; PRITCHARD GT, 1990, CAN J ZOOL, V68, P1645, DOI 10.1139/z90-244; Proctor M., 2007, ABUNDANCE DENSITY CE; Proctor M, 2010, URSUS, V21, P169, DOI 10.2192/1537-6176-21.2.169; Reynolds-Hogland MJ, 2007, J APPL ECOL, V44, P1166, DOI 10.1111/j.1365-2664.2007.01317.x; Riley S.J., 1999, INTERMOUNTAIN J SCI, V5, P23, DOI DOI 10.1016/j.geomorph.2010.11.003; Ritchie EG, 2008, ECOL MONOGR, V78, P105, DOI 10.1890/06-2117.1; Robbins CT, 2004, URSUS, V15, P161, DOI 10.2192/1537-6176(2004)015<0161:NEOUAR>2.0.CO;2; Rode KD, 2001, OECOLOGIA, V128, P62, DOI 10.1007/s004420100637; Rode KD, 2000, CAN J ZOOL, V78, P1640, DOI 10.1139/cjz-78-9-1640; Romain-Bondi KA, 2004, BIOL CONSERV, V117, P417, DOI 10.1016/j.biocon.2003.07.005; Sarewitz D, 2004, ENVIRON SCI POLICY, V7, P385, DOI 10.1016/j.envsci.2004.06.001; Schwartz C. C., 2006, Wildlife Monographs; Schwartz C.C. S.D., 2003, WILD MAMMALS N AM BI, P556; Servheen C., 1990, MONOGRAPH SERIES, V2; Steyaert SM, 2013, J ANIM ECOL, DOI DOI 10.1111/1365-2656.12055/FULL.ACCESSED; Swenson JE, 1998, J ANIM ECOL, V67, P819, DOI 10.1046/j.1365-2656.1998.00248.x; Swenson JE, 1997, NATURE, V386, P450, DOI 10.1038/386450a0; Tabachnick B.G., 2013, USING MULTIVARIATE S, V6th ed; Taylor MK, 1994, MONOGRAPH SERIES, V3; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Wakkinen WL, 2004, URSUS, V15, P65, DOI 10.2192/1537-6176(2004)015<0065:DAPTOG>2.0.CO;2; Welch CA, 1997, ECOLOGY, V78, P1105, DOI 10.2307/2265862; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Woods JG, 1999, WILDLIFE SOC B, V27, P616; Zedrosser A, 2006, J MAMMAL, V87, P510, DOI 10.1644/05-MAMM-A-218R1.1; Zedrosser A, 2011, BIOL CONSERV, V144, P2163, DOI 10.1016/j.biocon.2011.05.005	94	29	30	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82757	10.1371/journal.pone.0082757	http://dx.doi.org/10.1371/journal.pone.0082757			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367552	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300065
J	Islam, ZU; Bishop, SC; Savill, NJ; Rowland, RRR; Lunney, JK; Trible, B; Doeschl-Wilson, AB				Islam, Zeenath U.; Bishop, Stephen C.; Savill, Nicholas J.; Rowland, Raymond R. R.; Lunney, Joan K.; Trible, Benjamin; Doeschl-Wilson, Andrea B.			Quantitative Analysis of Porcine Reproductive and Respiratory Syndrome (PRRS) Viremia Profiles from Experimental Infection: A Statistical Modelling Approach	PLOS ONE			English	Article							SYNDROME-VIRUS-INFECTION; PIGS; RESPONSES; SWINE; EVOLUTION; IMMUNITY; SUSCEPTIBILITY; REPLICATION; ARTERIVIRUS; POPULATIONS	Porcine reproductive and respiratory syndrome (PRRS) is one of the most economically significant viral diseases facing the global swine industry. Viremia profiles of PRRS virus challenged pigs reflect the severity and progression of infection within the host and provide crucial information for subsequent control measures. In this study we analyse the largest longitudinal PRRS viremia dataset from an in-vivo experiment. The primary objective was to provide a suitable mathematical description of all viremia profiles with biologically meaningful parameters for quantitative analysis of profile characteristics. The Wood's function, a gamma-type function, and a biphasic extended Wood's function were fit to the individual profiles using Bayesian inference with a likelihood framework. Using maximum likelihood inference and numerous fit criteria, we established that the broad spectrum of viremia trends could be adequately represented by either uni-or biphasic Wood's functions. Three viremic categories emerged: cleared (uni-modal and below detection within 42 days post infection(dpi)), persistent (transient experimental persistence over 42 dpi) and rebound (biphasic within 42 dpi). The convenient biological interpretation of the model parameters estimates, allowed us not only to quantify inter-host variation, but also to establish common viremia curve characteristics and their predictability. Statistical analysis of the profile characteristics revealed that persistent profiles were distinguishable already within the first 21 dpi, whereas it is not possible to predict the onset of viremia rebound. Analysis of the neutralizing antibody(nAb) data indicated that there was a ubiquitous strong response to the homologous PRRSV challenge, but high variability in the range of cross-protection of the nAbs. Persistent pigs were found to have a significantly higher nAb cross-protectivity than pigs that either cleared viremia or experienced rebound within 42 dpi. Our study provides novel insights into the nature and degree of variation of hosts' responses to infection as well as new informative traits for subsequent genomic and modelling studies.	[Islam, Zeenath U.; Bishop, Stephen C.; Doeschl-Wilson, Andrea B.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Islam, Zeenath U.; Bishop, Stephen C.; Doeschl-Wilson, Andrea B.] Univ Edinburgh, R D SVS, Edinburgh, Midlothian, Scotland; [Savill, Nicholas J.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Rowland, Raymond R. R.; Trible, Benjamin] Kansas State Univ, Coll Vet Med, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA; [Lunney, Joan K.] USDA, Beltsville Agr Res Ctr, Beltsville, MD 20705 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh; Kansas State University; United States Department of Agriculture (USDA)	Islam, ZU (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland.	zeenath.islam@roslin.ed.ac.uk		Savill, Nicholas/0000-0002-9769-6168; Wilson, Andrea/0000-0002-2658-6973; Islam, Zeenath/0000-0002-6657-9671	Wellcome Trust [091078/Z/09/Z]; NPB [12-120]; BBSRC [BBS/E/D/20211554, BBS/E/D/20241864] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20211554, BBS/E/D/20241864] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); NPB; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The development of the model fitting code was supported by a Wellcome Trust Project grant to NJS (Grant No. 091078/Z/09/Z, http://www.wellcome.ac.uk/). The characterization of neutralizing antibody responses to PRRSV and association with host factors was supported by the NPB (Grant No. 12-120, http://www.pork.org/filelibrary/ResearchGrants/Funded2012.pdf). Funding for the project also came from "Genome Canada: Application of Genomics to Improve Swine Health and Welfare" (http://www.swineimprovement.com/) and "CSHB: Development of genetic selection tools to enhance sow health using a novel acclimation challenge model in Canadian commercial herds" (http://www.swinehealth.ca/program-research-proj-11.php). This work was supported by the Roslin Institute Strategic Grant funding from the BBSRC (ISPG 1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEEVER DE, 1991, LIVEST PROD SCI, V29, P115, DOI 10.1016/0301-6226(91)90061-T; Boddicker N, 2012, J ANIM SCI, V90, P1733, DOI 10.2527/jas.2011-4464; Boddicker N, 2012, J ANIMAL SCI; Brown, 2006, APPL MIXED MODELS ME; Chand RJ, 2012, CURR OPIN VIROL, V2, P256, DOI 10.1016/j.coviro.2012.02.002; Chang CC, 2002, J VIROL, V76, P4750, DOI 10.1128/JVI.76.10.4750-4763.2002; Charpin C, 2012, I PORC, P67; Doeschl-Wilson AB, 2009, J ANIM SCI, V87, P1638, DOI 10.2527/jas.2008-1447; Duan X, 1997, ARCH VIROL, V142, P2483, DOI 10.1007/s007050050256; English S, 2012, OECOLOGIA, V169, P143, DOI 10.1007/s00442-011-2192-9; Fang Y, 2007, ARCH VIROL, V152, P1009, DOI 10.1007/s00705-007-0936-y; Friel N, 2008, J R STAT SOC B, V70, P589, DOI 10.1111/j.1467-9868.2007.00650.x; FRIESEN WO, 1993, ANNU REV PHYSIOL, V55, P661, DOI 10.1146/annurev.ph.55.030193.003305; Girolami M, 2008, THEOR COMPUT SCI, V408, P4, DOI 10.1016/j.tcs.2008.07.005; Goldberg TL, 2003, VIROLOGY, V317, P197, DOI 10.1016/j.virol.2003.07.009; Grossman M, 2003, J DAIRY SCI, V86, P988, DOI 10.3168/jds.S0022-0302(03)73682-0; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; Kumar R, 2004, J THEOR BIOL, V230, P145, DOI 10.1016/j.jtbi.2004.04.044; Lager KM, 1997, VET MICROBIOL, V58, P127, DOI 10.1016/S0378-1135(97)00159-4; Lawson SR, 1997, VIRUS RES, V51, P105, DOI 10.1016/S0168-1702(97)00086-5; Lewis CRG, 2007, VIRAL IMMUNOL, V20, P343, DOI 10.1089/vim.2007.0024; Lindley D.V., 1995, NEW CAMBRIDGE STAT T; Lopez OJ, 2004, VET IMMUNOL IMMUNOP, V102, P155, DOI 10.1016/j.vetimm.2004.09.005; Loving CL, 2007, IMMUNOLOGY, V120, P217, DOI 10.1111/j.1365-2567.2006.02493.x; Lunney JK, 2011, PROBING GENETIC CONT, pS30; Lunney JK, 2010, VIRUS RES, V154, P161, DOI 10.1016/j.virusres.2010.08.004; Mengeling WL, 2003, VET MICROBIOL, V93, P25, DOI 10.1016/S0378-1135(02)00426-1; Mulupuri P, 2008, J VIROL, V82, P358, DOI 10.1128/JVI.01023-07; Murtaugh MP, 2002, VIRAL IMMUNOL, V15, P533, DOI 10.1089/088282402320914485; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Nowak MA., 2000, VIRUS DYNAMICS MATH; Pawelek KA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002588; Petry DB, 2007, J ANIM SCI, V85, P2075, DOI 10.2527/jas.2006-721; Petry DB, 2005, J ANIM SCI, V83, P1494; Prieto C, 2009, VET J, V180, P363, DOI 10.1016/j.tvjl.2008.01.005; Reiner G, 2010, J ANIM BREED GENET, V127, P100, DOI 10.1111/j.1439-0388.2009.00818.x; Reiner G, 2009, J ANIMAL BREEDING GE, V127, P100; Rowland Raymond R. R., 2012, Frontiers in Genetics, V3, P260, DOI 10.3389/fgene.2012.00260; Rowland RRR, 2003, VET MICROBIOL, V96, P219, DOI 10.1016/j.vetmic.2003.07.006; Rowland RRR, 1999, VIROLOGY, V259, P262, DOI 10.1006/viro.1999.9789; Savill NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000416; Steri R, 2012, ANIMAL, V6, P1572, DOI 10.1017/S1751731112000766; Thanawongnuwech Roongroje, 2000, Animal Health Research Reviews, V1, P95, DOI 10.1017/S1466252300000086; Trefan L, 2011, MEAT SCI, V87, P305, DOI 10.1016/j.meatsci.2010.11.002; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Wills RW, 2003, J CLIN MICROBIOL, V41, P58, DOI 10.1128/JCM.41.1.58-62.2003; Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1; WOOD PDP, 1967, NATURE, V216, P164, DOI 10.1038/216164a0; Yoo D, 2010, VIRUS RES, V154, P48, DOI 10.1016/j.virusres.2010.07.019	50	30	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83567	10.1371/journal.pone.0083567	http://dx.doi.org/10.1371/journal.pone.0083567			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358295	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700061
J	Kabir, ZD; Katzman, AC; Kosofsky, BE				Kabir, Zeeba D.; Katzman, Aaron C.; Kosofsky, Barry E.			Molecular Mechanisms Mediating a Deficit in Recall of Fear Extinction in Adult Mice Exposed to Cocaine In Utero	PLOS ONE			English	Article							BDNF MESSENGER-RNA; PREFRONTAL CORTEX; NEUROTROPHIC FACTOR; NEUROBEHAVIORAL DISINHIBITION; HISTONE MODIFICATIONS; PRENATAL EXPOSURE; PRELIMBIC CORTEX; TRANSCRIPTION; RAT; PROTEIN	Prenatal cocaine exposure has been shown to alter cognitive processes of exposed individuals, presumed to be a result of long-lasting molecular alterations in the brain. In adult prenatal cocaine exposed (PCOC) mice we have identified a deficit in recall of fear extinction, a behavior that is dependent on the medial prefrontal cortex (mPFC) and the hippocampus. While we observed no change in the constitutive expression of brain derived neurotrophic factor (BDNF) protein and mRNA in the mPFC and hippocampus of adult PCOC mice, we observed blunted BDNF signaling in the mPFC of adult PCOC mice after fear extinction compared to the control animals. Specifically, during the consolidation phase of the extinction memory, we observed a decrease in BDNF protein and it's phospho-TrkB receptor expression. Interestingly, at this same time point there was a significant increase in total Bdnf mRNA levels in the mPFC of PCOC mice as compared with controls. In the Bdnf gene, we identified decreased constitutive binding of the transcription factors, MeCP2 and P-CREB at the promoters of Bdnf exons I and IV in the mPFC of PCOC mice, that unlike control mice remained unchanged when measured during the behavior. Finally, bilateral infusion of recombinant BDNF protein into the infralimbic subdivision of the mPFC during the consolidation phase of the extinction memory rescued the behavioral deficit in PCOC mice. In conclusion, these findings extend our knowledge of the neurobiologic impact of prenatal cocaine exposure on the mPFC of mice, which may lead to improved clinical recognition and treatment of exposed individuals.	[Kabir, Zeeba D.; Kosofsky, Barry E.] Weill Cornell Med Coll, Div Pediat Neurol, Dept Pediat, New York, NY USA; [Kabir, Zeeba D.; Kosofsky, Barry E.] Weill Cornell Med Coll, Brain & Mind Inst, New York, NY USA; [Katzman, Aaron C.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA	Cornell University; Cornell University; University of Iowa	Kosofsky, BE (corresponding author), Weill Cornell Med Coll, Div Pediat Neurol, Dept Pediat, New York, NY USA.	bar2009@med.cornell.edu			NIH-NIDA [K02 DA00354, RO1 DA08648]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008648, K02DA000354] Funding Source: NIH RePORTER	NIH-NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	NIH-NIDA Grants K02 DA00354 and RO1 DA08648 to BK The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Andero R, 2012, GENES BRAIN BEHAV, V11, P503, DOI 10.1111/j.1601-183X.2012.00801.x; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chen WG, 2003, J NEUROSCI, V23, P2572; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; Crandall JE, 2004, CEREB CORTEX, V14, P665, DOI 10.1093/cercor/bhh027; Delaney-Black V, 2011, NEUROTOXICOL TERATOL, V33, P110, DOI 10.1016/j.ntt.2010.06.011; Eiden RD, 2007, ADDICT BEHAV, V32, P465, DOI 10.1016/j.addbeh.2006.05.013; Fisher PA, 2011, DEV PSYCHOPATHOL, V23, P777, DOI 10.1017/S0954579411000290; Frank DA, 2011, NEUROTOXICOL TERATOL, V33, P100, DOI 10.1016/j.ntt.2010.06.002; Fumagalli F, 2007, EUR J NEUROSCI, V26, P2756, DOI 10.1111/j.1460-9568.2007.05918.x; Garavan H, 2000, BEHAV NEUROSCI, V114, P725, DOI 10.1037//0735-7044.114.4.725; Giordano TP, 2006, J NEUROCHEM, V99, P1197, DOI 10.1111/j.1471-4159.2006.04186.x; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; GRESSENS P, 1992, NEUROSCI LETT, V140, P113, DOI 10.1016/0304-3940(92)90694-3; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; HOLSON RR, 1992, NEUROTOXICOL TERATOL, V14, P221, DOI 10.1016/0892-0362(92)90020-B; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Kabir ZD, 2012, DEV NEUROSCI-BASEL, V34, P184, DOI 10.1159/000337712; Lester BM, 2012, DRUG ALCOHOL DEPEN, V126, P80, DOI 10.1016/j.drugalcdep.2012.04.014; Lester BM, 2010, J ADDICT DIS, V29, P259, DOI 10.1080/10550881003684921; Li TS, 2002, BIOPOLYMERS, V67, P10, DOI 10.1002/bip.10038; Lidow MS, 2001, J COMP NEUROL, V435, P263, DOI 10.1002/cne.1028; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; Lu Y, 2011, J NEUROSCI, V31, P11762, DOI 10.1523/JNEUROSCI.2707-11.2011; Morrow BA, 2005, SYNAPSE, V56, P1, DOI 10.1002/syn.20121; Paz R, 2007, NEUROPSYCHOPHARMACOL, V32, P693, DOI 10.1038/sj.npp.1301066; Peters J, 2010, SCIENCE, V328, P1288, DOI 10.1126/science.1186909; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Romano AG, 1996, PHARMACOL BIOCHEM BE, V53, P617, DOI 10.1016/0091-3057(95)02061-6; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Singer LT, 2005, INFANT BEHAV DEV, V28, P431, DOI 10.1016/j.infbeh.2005.03.002; Sobreviela T, 1996, J COMP NEUROL, V375, P417; Sotres-Bayon F, 2012, NEURON, V76, P804, DOI 10.1016/j.neuron.2012.09.028; Sotres-Bayon F, 2006, BIOL PSYCHIAT, V60, P329, DOI 10.1016/j.biopsych.2005.10.012; Sotres-Bayon F, 2010, CURR OPIN NEUROBIOL, V20, P231, DOI 10.1016/j.conb.2010.02.005; Tabuchi A, 2002, J BIOL CHEM, V277, P35920, DOI 10.1074/jbc.M204784200; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tian F, 2010, AMINO ACIDS, V38, P1067, DOI 10.1007/s00726-009-0315-y; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Warner TD, 2006, PEDIATRICS, V118, P2014, DOI 10.1542/peds.2006-0003; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wilkins AS, 1998, NEUROTOXICOL TERATOL, V20, P215, DOI 10.1016/S0892-0362(97)00125-6; Wilkins AS, 1998, NEUROTOXICOL TERATOL, V20, P227, DOI 10.1016/S0892-0362(97)00127-X	48	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84165	10.1371/journal.pone.0084165	http://dx.doi.org/10.1371/journal.pone.0084165			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358339	gold, Green Published, Green Submitted			2022-12-27	WOS:000328737700083
J	Zhao, HY; Lomash, S; Glasser, C; Mayer, ML; Schuckl, P				Zhao, Huaying; Lomash, Suvendu; Glasser, Carla; Mayer, Mark L.; Schuckl, Peter			Analysis of High Affinity Self-Association by Fluorescence Optical Sedimentation Velocity Analytical Ultracentrifugation of Labeled Proteins: Opportunities and Limitations	PLOS ONE			English	Article							N-TERMINAL DOMAIN; DETECTED SEDIMENTATION; BINDING; MACROMOLECULES; ACCURACY	Sedimentation velocity analytical ultracentrifugation (SV) is a powerful first-principle technique for the study of protein interactions, and allows a rigorous characterization of binding stoichiometry and affinities. A recently introduced commercial fluorescence optical detection system (FDS) permits analysis of high-affinity interactions by SV. However, for most proteins the attachment of an extrinsic fluorophore is an essential prerequisite for analysis by FDS-SV. Using the glutamate receptor GluA2 amino terminal domain as a model system for high-affinity homo-dimerization, we demonstrate how the experimental design and choice of fluorescent label can impact both the observed binding constants as well as the derived hydrodynamic parameter estimates for the monomer and dimer species. Specifically, FAM (5,6-carboxyfluorescein) was found to create different populations of artificially high-affinity and low-affinity dimers, as indicated by both FDS-SV and the kinetics of dimer dissociation studied using a bench-top fluorescence spectrometer and Forster Resonance Energy Transfer. By contrast, Dylight488 labeled GluA2, as well as GluA2 expressed as an EGFP fusion protein, yielded results consistent with estimates for unlabeled GluA2. Our study suggests considerations for the choice of labeling strategies, and highlights experimental designs that exploit specific opportunities of FDS-SV for improving the reliability of the binding isotherm analysis of interacting systems.	[Zhao, Huaying; Schuckl, Peter] Natl Inst Biomed Imaging & Bioengn, NIH, Lab Cellular Imaging & Macromol Biophys, Dynam Macromol Assembly Sect, Bethesda, MD USA; [Lomash, Suvendu; Glasser, Carla; Mayer, Mark L.] NICHHD, Lab Cellular & Mol Neurophysiol, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Mayer, ML (corresponding author), NICHHD, Lab Cellular & Mol Neurophysiol, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA.	mayerm@mail.nih.gov; schuckp@mail.nih.gov	Schuck, Peter/AAA-6888-2020; Mayer, Mark/AAE-7356-2019	Schuck, Peter/0000-0002-8859-6966; Mayer, Mark/0000-0003-4378-8451	Intramural Research Programs of the National Institute of Biomedical Imaging and Bioengineering; National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000051] Funding Source: NIH RePORTER	Intramural Research Programs of the National Institute of Biomedical Imaging and Bioengineering; National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Intramural Research Programs of the National Institute of Biomedical Imaging and Bioengineering and the National Institute of Child Health and Human Development, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisaka F, 1999, Tanpakushitsu Kakusan Koso, V44, P82; Balbo Andrea, 2009, J Vis Exp, DOI 10.3791/1530; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Fasano M, 2005, IUBMB LIFE, V57, P787, DOI 10.1080/15216540500404093; Ghai R, 2012, J MOL RECOGNIT, V25, P32, DOI 10.1002/jmr.1167; Ghirlando R, 2013, ANAL BIOCHEM, V440, P81, DOI 10.1016/j.ab.2013.05.011; Harding SE, 2010, BIOCHEM SOC T, V38, P901, DOI 10.1042/BST0380901; Howlett GJ, 2006, CURR OPIN CHEM BIOL, V10, P430, DOI 10.1016/j.cbpa.2006.08.017; Husain B, 2012, BIOCHEMISTRY-US, V51, P8764, DOI 10.1021/bi301226h; Jensen MH, 2011, J MOL BIOL, V414, P96, DOI 10.1016/j.jmb.2011.09.037; Johnson M.L., 1994, MODERN ANAL ULTRACEN, P37; Kingsbury JS, 2008, J BIOL CHEM, V283, P11887, DOI 10.1074/jbc.M709638200; Kingsbury JS, 2011, METHOD ENZYMOL, V492, P283, DOI 10.1016/B978-0-12-381268-1.00021-5; Kroe RR, 2009, ANAL BIOCHEM, V390, P1, DOI 10.1016/j.ab.2008.11.033; Kumar J, 2011, NEURON, V71, P319, DOI 10.1016/j.neuron.2011.05.038; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lyons DF, 2013, ANAL BIOCHEM, V437, P133, DOI 10.1016/j.ab.2013.02.019; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; Melikishvili M, 2011, DNA REPAIR, V10, P1193, DOI 10.1016/j.dnarep.2011.09.007; Rossmann M, 2011, EMBO J, V30, P959, DOI 10.1038/emboj.2011.16; SCHMIDT B, 1992, ANAL ULTRACENTRIFUGA, P176; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 1997, ANNU REV BIOPH BIOM, V26, P541, DOI 10.1146/annurev.biophys.26.1.541; Schuck Peter, 2013, Biophys Rev, V5, P159, DOI 10.1007/s12551-013-0106-2; Schuck P, 2010, BIOPHYS J, V98, P2741, DOI 10.1016/j.bpj.2010.03.004; Schuck P, 2010, BIOPHYS J, V98, P2005, DOI 10.1016/j.bpj.2009.12.4336; Zhao H., 2013, CURR PROTOC PROTEIN, V7; Zhao HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077245; Zhao HY, 2013, J GEN PHYSIOL, V141, P747, DOI 10.1085/jgp.20121077004292013c; Zhao HY, 2013, ANAL BIOCHEM, V437, P104, DOI 10.1016/j.ab.2013.02.011; Zhao HY, 2012, J GEN PHYSIOL, V139, P371, DOI 10.1085/jgp.201210770	32	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83439	10.1371/journal.pone.0083439	http://dx.doi.org/10.1371/journal.pone.0083439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358283	Green Submitted, gold, Green Published			2022-12-27	WOS:000328737700057
J	Carlsten, C; Oron, AP; Curtiss, H; Jarvis, S; Daniell, W; Kaufman, JD				Carlsten, Chris; Oron, Assaf P.; Curtiss, Heidi; Jarvis, Sara; Daniell, William; Kaufman, Joel D.			Symptoms in Response to Controlled Diesel Exhaust More Closely Reflect Exposure Perception Than True Exposure	PLOS ONE			English	Article							THRESHOLD LEVELS; SENSITIVITY; HUMANS	Background: Diesel exhaust (DE) exposures are very common, yet exposure-related symptoms haven't been rigorously examined. Objective: Describe symptomatic responses to freshly generated and diluted DE and filtered air (FA) in a controlled human exposure setting; assess whether such responses are altered by perception of exposure. Methods: 43 subjects participated within three double-blind crossover experiments to order-randomized DE exposure levels (FA and DE calibrated at 100 and/or 200 micrograms/m(3) particulate matter of diameter less than 2.5 microns), and completed questionnaires regarding symptoms and dose perception. Results: For a given symptom cluster, the majority of those exposed to moderate concentrations of diesel exhaust do not report such symptoms. The most commonly reported symptom cluster was of the nose (29%). Blinding to exposure is generally effective. Perceived exposure, rather than true exposure, is the dominant modifier of symptom reporting. Conclusion: Controlled human exposure to moderate-dose diesel exhaust is associated with a range of mild symptoms, though the majority of individuals will not experience any given symptom. Blinding to DE exposure is generally effective. Perceived DE exposure, rather than true DE exposure, is the dominant modifier of symptom reporting.	[Carlsten, Chris] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Oron, Assaf P.] Seattle Childrens Res Inst, Childrens Core Biomed Stat, Seattle, WA USA; [Curtiss, Heidi; Jarvis, Sara; Daniell, William; Kaufman, Joel D.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Daniell, William; Kaufman, Joel D.] Univ Washington, Dept Med, Seattle, WA USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Carlsten, C (corresponding author), Univ British Columbia, Dept Med, Inst Heart & Lung Hlth, Vancouver, BC, Canada.	carlsten@mail.ubc.ca	Kaufman, Joel D/B-5761-2008	Kaufman, Joel D/0000-0003-4174-9037	Environmental Protection Agency [R830954, R827355]; National Institutes of Health [M01RR-00037, ES013195, ES011139, P30ES07033]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K24ES013195, P50ES015915, P30ES007033, K23ES011139] Funding Source: NIH RePORTER	Environmental Protection Agency(United States Environmental Protection Agency); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by R830954 and R827355 (Environmental Protection Agency), M01RR-00037, ES013195, ES011139, and P30ES07033 (National Institutes of Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P665; Arts JHE, 2006, CRIT REV TOXICOL, V36, P219, DOI 10.1080/10408440500534149; Baldwin CM, 1997, EUR J EPIDEMIOL, V13, P547, DOI 10.1023/A:1007341813396; Carlsten C, 2007, THROMB RES, V120, P849, DOI 10.1016/j.thromres.2007.01.005; Davis ME, 2007, ENVIRON SCI TECHNOL, V41, P7152, DOI 10.1021/es071041z; Fiedler N, 2004, PSYCHOSOM MED, V66, P588, DOI 10.1097/01.psy.0000127872.53932.75; Fiedler N, 2000, J PSYCHOSOM RES, V48, P525, DOI 10.1016/S0022-3999(00)00088-X; Gould T, 2008, INHAL TOXICOL, V20, P49, DOI [10.1080/08958370701758478, 10.1080/08958370701758478 ]; Lang I, 2008, REGUL TOXICOL PHARM, V50, P23, DOI 10.1016/j.yrtph.2007.08.012; Reid S, 2002, OCCUP ENVIRON MED, V59, P196, DOI 10.1136/oem.59.3.196; Rosner B., 2000, FUNDAMENTALS BIOSTAT; Rudell B, 1996, OCCUP ENVIRON MED, V53, P658, DOI 10.1136/oem.53.10.658; Rudell B, 1999, OCCUP ENVIRON MED, V56, P222, DOI 10.1136/oem.56.4.222; RUMSEY DW, 1970, AM IND HYG ASSOC J, V31, P339, DOI 10.1080/0002889708506253; Shusterman D, 2003, INT ARCH OCC ENV HEA, V76, P577, DOI 10.1007/s00420-003-0459-0; Sydbom A, 2001, EUR RESPIR J, V17, P733, DOI 10.1183/09031936.01.17407330; Ternesten-Hasseus E, 2002, ALLERGY, V57, P501, DOI 10.1034/j.1398-9995.2002.23380.x; USEPA USEPA, 2002, HLTH ASS DOC DIES EN; Zhao ZH, 2008, ENVIRON HEALTH PERSP, V116, P90, DOI 10.1289/ehp.10576	19	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83573	10.1371/journal.pone.0083573	http://dx.doi.org/10.1371/journal.pone.0083573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358296	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700133
J	Chi, CW; Ye, JZ; Ding, HL; He, D; Huang, WH; Zhang, GJ; Tian, J				Chi, Chongwei; Ye, Jinzuo; Ding, Haolong; He, De; Huang, Wenhe; Zhang, Guo-Jun; Tian, Jie			Use of Indocyanine Green for Detecting the Sentinel Lymph Node in Breast Cancer Patients: From Preclinical Evaluation to Clinical Validation	PLOS ONE			English	Article							FLUORESCENCE; BIOPSY; SURGERY; DYE; IDENTIFICATION; DISSECTION; TRIAL; BLUE	Assessment of the sentinel lymph node (SLN) in patients with early stage breast cancer is vital in selecting the appropriate surgical approach. However, the existing methods, including methylene blue and nuclides, possess low efficiency and effectiveness in mapping SLNs, and to a certain extent exert side effects during application. Indocyanine green (ICG), as a fluorescent dye, has been proved reliable usage in SLN detection by several other groups. In this paper, we introduce a novel surgical navigation system to detect SLN with ICG. This system contains two charge-coupled devices (CCD) to simultaneously capture real-time color and fluorescent video images through two different bands. During surgery, surgeons only need to follow the fluorescence display. In addition, the system saves data automatically during surgery enabling surgeons to find the registration point easily according to image recognition algorithms. To test our system, 5 mice and 10 rabbits were used for the preclinical setting and 22 breast cancer patients were utilized for the clinical evaluation in our experiments. The detection rate was 100% and an average of 2.7 SLNs was found in 22 patients. Our results show that the usage of our surgical navigation system with ICG to detect SLNs in breast cancer patients is technically feasible.	[Chi, Chongwei; Ye, Jinzuo; Tian, Jie] Chinese Acad Sci, Inst Automat, Intelligent Med Res Ctr, Beijing, Peoples R China; [Ding, Haolong; He, De; Huang, Wenhe; Zhang, Guo-Jun] Shantou Univ, Coll Med, Canc Hosp, Breast Ctr, Shantou, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; Shantou University	Zhang, GJ (corresponding author), Shantou Univ, Coll Med, Canc Hosp, Breast Ctr, Shantou, Peoples R China.	guoj_zhang@yahoo.com; tian@ieee.org	Zhang, Guo-Jun/H-3890-2015; Tian, Jie/H-1190-2011	Zhang, Guo-Jun/0000-0001-5182-5887; Tian, Jie/0000-0003-0498-0432	National Basic Research Program of China (973 Program) [2011CB707700]; National Natural Science Foundation of China [81027002]; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists [2012T1G0036]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Visiting Professorship for Senior International Scientists	This paper is supported by the National Basic Research Program of China (973 Program) under Grant No. 2011CB707700, the National Natural Science Foundation of China under Grant No. 81027002, and the Chinese Academy of Sciences Visiting Professorship for Senior International Scientists under Grant No. 2012T1G0036. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford R, 2009, MOL IMAGING, V8, P341, DOI 10.2310/7290.2009.00031; Crane LMA, 2011, GYNECOL ONCOL, V120, P291, DOI 10.1016/j.ygyno.2010.10.009; Crane LMA, 2011, MOL IMAGING BIOL, V13, P1043, DOI 10.1007/s11307-010-0425-7; Denninghoff Valeria C, 2004, Mol Diagn, V8, P253, DOI 10.2165/00066982-200408040-00007; Gibbs-Strauss SL, 2009, IEEE ENG MED BIO, P2001, DOI 10.1109/IEMBS.2009.5333429; Gilmore DM, 2013, ANN SURG ONCOL, V20, P2357, DOI 10.1245/s10434-013-2905-x; Gioux S, 2010, MOL IMAGING, V9, P237, DOI 10.2310/7290.2010.00034; Giuliano AE, 2011, ARCH SURG-CHICAGO, V146, P980; Goyal A, 2006, BREAST CANCER RES TR, V99, P203, DOI 10.1007/s10549-006-9192-1; Hirche C, 2010, BREAST CANCER RES TR, V121, P373, DOI 10.1007/s10549-010-0760-z; Hutteman M, 2011, BREAST CANCER RES TR, V127, P163, DOI 10.1007/s10549-011-1419-0; Hutteman M, 2011, ANN SURG ONCOL, V18, P1006, DOI 10.1245/s10434-010-1426-0; Imai K, 2013, SURG TODAY, V43, P249, DOI 10.1007/s00595-012-0237-2; Kitai Toshiyuki, 2005, Breast Cancer, V12, P211, DOI 10.2325/jbcs.12.211; Kootstra J, 2008, ANN SURG ONCOL, V15, P2533, DOI 10.1245/s10434-008-9996-9; Krag DN, 2010, LANCET ONCOL, V11, P927, DOI 10.1016/S1470-2045(10)70207-2; Lee BT, 2010, PLAST RECONSTR SURG, V126, P1472, DOI 10.1097/PRS.0b013e3181f059c7; Liu Y, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.101303; Matsui A, 2011, BRIT J SURG, V98, P1725, DOI 10.1002/bjs.7698; Mieog JSD, 2011, ANN SURG ONCOL, V18, P2483, DOI 10.1245/s10434-011-1566-x; Motomura K, 1999, JPN J CLIN ONCOL, V29, P604, DOI 10.1093/jjco/29.12.604; Motomura K, 2001, J SURG ONCOL, V76, P95, DOI 10.1002/1096-9098(200102)76:2<95::AID-JSO1018>3.3.CO;2-4; Nguyen QT, 2010, P NATL ACAD SCI USA, V107, P4317, DOI 10.1073/pnas.0910261107; Ogawa Y, 2013, SURG TODAY; Pleijhuis RG, 2011, EJSO-EUR J SURG ONC, V37, P32, DOI 10.1016/j.ejso.2010.10.006; Savariar EN, 2013, CANCER RES, V73, P855, DOI 10.1158/0008-5472.CAN-12-2969; Schaafsma BE, 2013, BRIT J SURG, V100, P1037, DOI 10.1002/bjs.9159; Sevick-Muraca EM, 2012, ANNU REV MED, V63, P217, DOI 10.1146/annurev-med-070910-083323; Straver ME, 2010, ANN SURG ONCOL, V17, P1854, DOI 10.1245/s10434-010-0945-z; Su ZA, 2012, J OCUL PHARMACOL TH, V28, P410, DOI 10.1089/jop.2011.0221; Sugie T, 2013, ANN SURG ONCOL, V20, P2213, DOI 10.1245/s10434-013-2890-0; Sugie Tomoharu, 2010, Cancers (Basel), V2, P713, DOI 10.3390/cancers2020713; Tagaya N, 2008, AM J SURG, V195, P850, DOI 10.1016/j.amjsurg.2007.02.032; Themelis G, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3259362; Vahrmeijer AL, 2013, NAT REV CLIN ONCOL, V10, P507, DOI 10.1038/nrclinonc.2013.123; Valsecchi ME, 2011, J CLIN ONCOL, V29, P1479, DOI 10.1200/JCO.2010.33.1884; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; van der Vorst JR, 2012, ANN SURG ONCOL, V19, P4104, DOI 10.1245/s10434-012-2466-4; Yamamoto S, 2013, BREAST, V22, P933, DOI 10.1016/j.breast.2013.05.001; Zavagno G, 2008, ANN SURG, V247, P207, DOI 10.1097/SLA.0b013e31812e6a73	40	54	60	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83927	10.1371/journal.pone.0083927	http://dx.doi.org/10.1371/journal.pone.0083927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358319	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700144
J	Fujiwara, H; Takei, Y; Ishikawa, Y; Saga, Y; Machida, S; Taneichi, A; Suzuki, M				Fujiwara, Hiroyuki; Takei, Yuji; Ishikawa, Yoshiki; Saga, Yasushi; Machida, Shizuo; Taneichi, Akiyo; Suzuki, Mitsuaki			Community-Based Interventions to Improve HPV Vaccination Coverage among 13-to 15-Year-Old Females: Measures Implemented by Local Governments in Japan	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; EFFICACY; VACCINES; IMMUNITY	The purpose of this study was to examine the effect of various community-based interventions in support of HPV vaccination implemented by cities and towns within Tochigi prefecture, Japan with a view to identifying useful indicators which might guide future interventions to improve HPV vaccination coverage in the prefecture. A postal questionnaire survey of all 27 local governments in Tochigi Prefecture was conducted in December 2010. All 27 responded, and 22 provided the exact numbers of the targeted and vaccinated populations of 13- to 15-year-old girls from April to December 2010. The local governments also answered questions on the type of interventions implemented including public subsidies, school-based programs, direct mail, free tickets and recalls. Local governments that conducted a school-based vaccination program reported 96.8% coverage for the 1st dose, 96.2% for the 2nd dose, and 91.2% for the 3rd dose. Those that provided subsidies without school-based programs reported a wide range of vaccination rates: 45.7%-95.0% for the 1st dose, 41.1%-93.7% for the 2nd dose and 3.1%-90.1% for the 3rd dose. Among this group, the combination of a free ticket, direct mail and recall was most effective, with 95.0% coverage for the 1st dose, 93.7% for the 2nd dose, and 90.1% for the 3rd dose. The governments that did not offer a subsidy had the lowest vaccination coverage, with 0.8%-1.4% for the 1st dose, 0.0%-0.8% for the 2nd dose, and 0.1%-0.1% for the 3rd dose. The results of this survey indicate that school-based vaccinations and public subsidies are the most effective method to improve HPV vaccination coverage; however, the combination of a free ticket, direct mail, and recalls with public subsidies are also important measures in increasing the vaccination rate. These data may afford important indicators for the successful implementation of future HPV vaccination programs.	[Fujiwara, Hiroyuki; Takei, Yuji; Saga, Yasushi; Machida, Shizuo; Taneichi, Akiyo; Suzuki, Mitsuaki] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan; [Ishikawa, Yoshiki] Univ Tokyo, Sch Publ Hlth, Dept Hlth & Social Behav, Bunkyo Ku, Tokyo, Japan	Jichi Medical University; University of Tokyo	Suzuki, M (corresponding author), Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan.	msuzuki@jichi.ac.jp	Takei, Yuji/ABD-2485-2020		MEXT KAKENHI [25460775]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by MEXT KAKENHI Grant Number 25460775. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2010, GYNECOL OBSTET INVES, V70, P224, DOI 10.1159/000314010; Australian Government Department of Health and Ageing, 2013, INF NAT HUM PAP HPV; Bonanni P, 2009, VACCINE, V27, pA46, DOI 10.1016/j.vaccine.2008.10.085; Briss PA, 2000, AM J PREV MED, V18, P97, DOI 10.1016/S0749-3797(99)00118-X; Chadenier GMC, 2011, VACCINE, V29, P4405, DOI 10.1016/j.vaccine.2011.04.007; Committee on Immunization Finance Policies and Practices Division of Health Care Services and Division of Health Promotion and Disease Prevention, 2000, CALL SHOTS IMM FIN P; Daley MF, 2009, J ADOLESCENT HEALTH, V45, P445, DOI 10.1016/j.jadohealth.2009.04.002; Fujiwara H, 2011, VACCINE, V29, P6441, DOI 10.1016/j.vaccine.2011.06.031; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Garland SM, 2010, DRUGS, V70, P1079, DOI 10.2165/10898580-000000000-00000; Garnett GP, 2005, J INFECT DIS, V191, pS97, DOI 10.1086/425271; Gorin SNS, 2011, ADV THER, V28, P615, DOI 10.1007/s12325-011-0045-x; Hall AJ, 2010, VACCINE, V28, pA54, DOI 10.1016/j.vaccine.2010.02.034; Hinman AR, 2004, CLIN INFECT DIS, V38, P1445, DOI 10.1086/420748; Hughes JP, 2002, EPIDEMIOLOGY, V13, P631, DOI 10.1097/00001648-200211000-00006; Kessels SJM, 2012, VACCINE, V30, P3546, DOI 10.1016/j.vaccine.2012.03.063; Lindley MC, 2008, PEDIATRICS, V121, pS46, DOI 10.1542/peds.2007-1115F; Pomfret TC, 2011, J CLIN PHARM THER, V36, P1, DOI 10.1111/j.1365-2710.2009.01150.x; Taira AV, 2004, EMERG INFECT DIS, V10, P1915, DOI 10.3201/eid1011.040222	19	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84126	10.1371/journal.pone.0084126	http://dx.doi.org/10.1371/journal.pone.0084126			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358333	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700151
J	Gonzalez, Y; Doens, D; Santamaria, R; Ramos, M; Restrepo, CM; de Arruda, LB; Lleonart, R; Gutierrez, M; Fernandez, PL				Gonzalez, Yisett; Doens, Deborah; Santamaria, Ricardo; Ramos, Marla; Restrepo, Carlos M.; de Arruda, Luciana Barros; Lleonart, Ricardo; Gutierrez, Marcelino; Fernandez, Patricia L.			A Pseudopterane Diterpene Isolated From the Octocoral Pseudopterogorgia acerosa Inhibits the Inflammatory Response Mediated by TLR-Ligands and TNF-Alpha in Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTORS; BIOLOGICAL-ACTIVITY; NATURAL-PRODUCTS; ACTIVATION; EXPRESSION; TRIPTOLIDE; (+)-TOTAROL; MODULATORS; MOLECULE	Several diterpenoids isolated from terrestrial and marine environments have been identified as important anti-inflammatory agents. Although considerable progress has been made in the area of anti-inflammatory treatment, the search for more effective and safer compounds is a very active field of research. In this study we investigated the anti-inflammatory effects of a known pseudopterane diterpene (referred here as compound 1) isolated from the octocoral Pseudopterogorgia acerosa on the tumor necrosis factor-alpha (TNF-alpha) and TLRs- induced response in macrophages. Compound 1 inhibited the expression and secretion of the inflammatory mediators TNF-alpha, interleukin (IL)-6, IL-1 beta, nitric oxide (NO), interferon gamma-induced protein 10 (IP-10), ciclooxygenase (COX)-2, inducible nitric oxide synthase (iNOS) and monocyte chemoattractant protein-1 (MCP-1) induced by LPS in primary murine macrophages. This effect was associated with the inhibition of I.Ba degradation and subsequent activation of NF kappa B. Compound 1 also inhibited the expression of the co-stimulatory molecules CD80 and CD86, which is a hallmark of macrophage activation and consequent initiation of an adaptive immune response. The anti-inflammatory effect was not exclusive to LPS because compound 1 also inhibited the response of macrophages to TNF-alpha and TLR2 and TLR3 ligands. Taken together, these results indicate that compound 1 is an anti-inflammatory molecule, which modulates a variety of processes occurring in macrophage activation.	[Gonzalez, Yisett; Doens, Deborah; Ramos, Marla; Restrepo, Carlos M.; Lleonart, Ricardo; Fernandez, Patricia L.] Inst Invest Cient & Serv Alta Tecno, Ctr Biol Celular & Mol Enfermedades, Ciudad De Panama, Panama; [Gonzalez, Yisett; Doens, Deborah; Restrepo, Carlos M.] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur, India; [Santamaria, Ricardo; Gutierrez, Marcelino] Inst Invest Cient & Serv Alta Tecno, Ctr Descubrimiento Drogas & Biodiversidad, Ciudad De Panama, Panama; [de Arruda, Luciana Barros] Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol, Lab Genet & Imunol Infeccoes Virais, Rio De Janeiro, Brazil	Acharya Nagarjuna University; Universidade Federal do Rio de Janeiro	Fernandez, PL (corresponding author), Inst Invest Cient & Serv Alta Tecno, Ctr Biol Celular & Mol Enfermedades, Ciudad De Panama, Panama.	pllanes@indicasat.org.pa	Gutiérrez, Marcelino/V-8134-2019; Lleonart, Ricardo/Q-5372-2019; Arruda, Luciana B/N-9086-2013; Arruda, Luciana/B-5806-2014	Gutiérrez, Marcelino/0000-0003-1423-3772; Lleonart, Ricardo/0000-0002-5830-6315; Gonzalez, Yisett/0000-0002-1623-9484; Llanes Fernandez, Patricia/0000-0002-0762-0566	Secretar a Nacional de Ciencia Tecnolog a e Innovacion (SENACYT), Republic of Panama [FID11-082, COL08-064]; Fogarty International Center's International Cooperative Biodiversity Groups program [TW006634]; FOGARTY INTERNATIONAL CENTER [U01TW006634] Funding Source: NIH RePORTER	Secretar a Nacional de Ciencia Tecnolog a e Innovacion (SENACYT), Republic of Panama; Fogarty International Center's International Cooperative Biodiversity Groups program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Secretar a Nacional de Ciencia Tecnolog a e Innovacion (SENACYT), Republic of Panama [Grants FID11-082, COL08-064]; and [in part] by the Fogarty International Center's International Cooperative Biodiversity Groups program [Grant TW006634]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amigo M, 2008, LIFE SCI, V82, P256, DOI 10.1016/j.lfs.2007.11.017; BANDURRAGA MM, 1982, J AM CHEM SOC, V104, P6463, DOI 10.1021/ja00387a059; Berrue F, 2009, NAT PROD REP, V26, P681, DOI 10.1039/b821918b; Blunt JW, 2013, NAT PROD REP, V30, P237, DOI [10.1039/c2np20112g, 10.1039/d0np00089b]; Chung JY, 2002, J CELL SCI, V115, P679; Crow MK, 2006, SPRINGER SEMIN IMMUN, V27, P409, DOI 10.1007/s00281-006-0018-3; de las Heras B., 2009, Inflammation & Allergy Drug Targets, V8, P28; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; FENICAL W, 1987, J NAT PROD, V50, P1001, DOI 10.1021/np50054a001; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; Folmer F, 2008, BIOCHEM PHARMACOL, V75, P603, DOI 10.1016/j.bcp.2007.07.044; Giron N, 2008, TOXICOL APPL PHARM, V228, P179, DOI 10.1016/j.taap.2007.12.006; Gupta SC, 2011, MOL PHARMACOL, V80, P769, DOI 10.1124/mol.111.073122; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hughes CC, 2009, ANGEW CHEM INT EDIT, V48, P725, DOI 10.1002/anie.200804890; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Kondratyuk TP, 2012, MAR DRUGS, V10, P451, DOI 10.3390/md10020451; Lee JH, 2002, J BIOL CHEM, V277, P18411, DOI 10.1074/jbc.M201368200; Liu J, 2005, ACTA PHARMACOL SIN, V26, P223, DOI 10.1111/j.1745-7254.2005.00035.x; Lu L, 2011, ANTICANCER RES, V31, P1; Lucas R, 2003, LIFE SCI, V72, P2543, DOI 10.1016/S0024-3205(03)00167-X; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mateo CR, 2000, BBA-BIOMEMBRANES, V1509, P167, DOI 10.1016/S0005-2736(00)00291-1; Medina RA, 2008, J AM CHEM SOC, V130, P6324, DOI 10.1021/ja801383f; Micol V, 2001, BBA-BIOMEMBRANES, V1511, P281, DOI 10.1016/S0005-2736(01)00284-X; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; ODA T, 2011, INT J APP RES NAT PR, V4, P16; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Premkumar Vummidigiridhar, 2010, BMC Chemical Biology, V10, P3, DOI 10.1186/1472-6769-10-3; Roethle PA, 2008, NAT PROD REP, V25, P298, DOI 10.1039/b705660p; Singh M, 1999, PLANTA MED, V65, P2, DOI 10.1055/s-1999-13952; TINTO WF, 1991, TETRAHEDRON, V47, P8679, DOI 10.1016/S0040-4020(01)96190-3; Quang TH, 2011, BIOORGAN MED CHEM, V19, P2625, DOI 10.1016/j.bmc.2011.03.009; Urzua A, 2008, MOLECULES, V13, P882, DOI 10.3390/molecules13040822; VanGool SW, 1996, IMMUNOL REV, V153, P47; Wang W, 2010, ACTA PHARMACOL SIN, V31, P191, DOI 10.1038/aps.2009.205; Wei W, 2011, PARIS REV, P13; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529	43	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84107	10.1371/journal.pone.0084107	http://dx.doi.org/10.1371/journal.pone.0084107			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358331	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700150
J	Kimmerly, DS; Morris, BL; Floras, JS				Kimmerly, Derek S.; Morris, Beverley L.; Floras, John S.			Apnea-Induced Cortical BOLD-fMRI and Peripheral Sympathoneural Firing Response Patterns of Awake Healthy Humans	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; SYMPATHETIC-NERVE ACTIVITY; CONGESTIVE-HEART-FAILURE; HUMAN INSULAR CORTEX; HUMAN MUSCLE NERVES; CARDIOVASCULAR FUNCTION; INTRATHORACIC PRESSURE; HEMODYNAMIC-RESPONSES; MUELLER MANEUVERS; SYSTEM ACTIVATION	End-expiratory breath-holds (BH) and Mueller manoeuvres (MM) elicit large increases in muscle sympathetic nerve activity (MSNA). In 16 healthy humans (9 female, 35 +/- 4 years) we used functional magnetic resonance imaging with blood oxygen level-dependent (BOLD) contrast to determine the cortical network associated with such sympathoexcitation. We hypothesized that increases in MSNA evoked by these simulated apneas are accompanied by BOLD contrast changes in the insular cortex, thalamus and limbic cortex. A series of 150 whole-brain images were collected during 3 randomly performed 16-second end-expiratory BHs and MMs (-30 mmHg). The identical protocol was repeated separately with MSNA recorded from the fibular nerve. The time course of the sympathoexcitatory response to both breathing tasks were correlated with whole-brain BOLD signal changes. Brain sites demonstrating both positive (activation) and negative (deactivation) correlations with the MSNA time course were identified. Sympathetic burst incidence increased (p<0.001) from 29 +/- 6 (rest) to 49 +/- 6 (BH) and 47 +/- 6 bursts/100 heartbeats (MM). Increased neural activity (Z-scores) was identified in the right posterior and anterior insular cortices (3.74, 3.64), dorsal anterior cingulate (3.42), fastigial and dentate cerebellar nuclei (3.02, 3.34). Signal intensity decreased in the left posterior insula (3.28) and ventral anterior cingulate (3.01). Apnea both activates and inhibits elements of a cortical network involved in the generation of sympathetic outflow. These findings identify a neuroanatomical substrate to guide future investigations into central mechanisms contributing to disorders characterized by elevated basal MSNA and exaggerated sympathetic responses to simulated apneas such as sleep apnea and heart failure.	[Kimmerly, Derek S.; Morris, Beverley L.; Floras, John S.] Univ Toronto, Clin Cardiovasc Physiol Lab, Univ Hlth Network, Toronto, ON, Canada; [Kimmerly, Derek S.; Morris, Beverley L.; Floras, John S.] Univ Toronto, Mt Sinai Hosp, Div Cardiol, Dept Med, Toronto, ON M5G 1X5, Canada; [Kimmerly, Derek S.] Dalhousie Univ, Fac Hlth Profess, Sch Hlth & Human Performance, Halifax, NS, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Dalhousie University	Kimmerly, DS (corresponding author), Univ Toronto, Clin Cardiovasc Physiol Lab, Univ Hlth Network, Toronto, ON, Canada.	dskimmerly@dal.ca	Floras, John S./D-4042-2015; Kimmerly, Derek S/F-6536-2011	Kimmerly, Derek/0000-0002-3462-8037	Heart and Stroke Foundation of Ontario (HSFO) [NA 6407]; Canadian Institutes of Health; HSFO; Canada Research Chair in Integrative Cardiovascular Biology	Heart and Stroke Foundation of Ontario (HSFO)(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); HSFO; Canada Research Chair in Integrative Cardiovascular Biology(Canada Research Chairs)	This work was supported by the Heart and Stroke Foundation of Ontario (HSFO, Grant #NA 6407). Derek Kimmerly was a recipient of a Canadian Institutes of Health Research Postdoctoral Fellowship. Dr. J. Floras was supported by an HSFO Career Investigator Award and Canada Research Chair in Integrative Cardiovascular Biology.	Ando S, 1997, CIRCULATION, V95, P316; Barretto ACP, 2009, INT J CARDIOL, V135, P302, DOI 10.1016/j.ijcard.2008.03.056; BRADLEY DJ, 1987, J PHYSIOL-LONDON, V393, P107, DOI 10.1113/jphysiol.1987.sp016813; BRADLEY DJ, 1991, NEUROSCI RES, V12, P45, DOI 10.1016/0168-0102(91)90099-K; Bradley TD, 2003, CLIN SCI, V104, P231, DOI 10.1042/CS20020157; Cechetto DF, 2009, NEUROIMAGE, V47, P795, DOI 10.1016/j.neuroimage.2009.05.024; CECHETTO DF, 1990, CENTRAL REGULATION A, P208; Ciarka A, 2010, AM J RESP CRIT CARE, V181, P1269, DOI 10.1164/rccm.200912-1856OC; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; DAMPNEY RAL, 1994, PHYSIOL REV, V74, P323, DOI 10.1152/physrev.1994.74.2.323; Dampney RAL, 2003, ACTA PHYSIOL SCAND, V177, P209, DOI 10.1046/j.1365-201X.2003.01070.x; DELIUS W, 1972, ACTA PHYSIOL SCAND, V84, P65, DOI 10.1111/j.1748-1716.1972.tb05157.x; Eckert S, 2002, BLOOD PRESS MONIT, V7, P179, DOI 10.1097/00126097-200206000-00006; Evans KC, 1999, J PHYSIOL-LONDON, V520, P383, DOI 10.1111/j.1469-7793.1999.00383.x; FAGIUS J, 1989, HYPERTENSION, V14, P511, DOI 10.1161/01.HYP.14.5.511; FINDLEY LJ, 1983, J APPL PHYSIOL, V55, P1777, DOI 10.1152/jappl.1983.55.6.1777; FITZGERALD RS, 1981, AM J PHYSIOL, V240, pH721, DOI 10.1152/ajpheart.1981.240.5.H721; Floras JS, 2009, J AM COLL CARDIOL, V54, P375, DOI 10.1016/j.jacc.2009.03.061; Freire L, 2002, IEEE T MED IMAGING, V21, P470, DOI 10.1109/TMI.2002.1009383; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; HAGBARTH KE, 1968, ACTA PHYSIOL SCAND, V74, P96, DOI 10.1111/j.1748-1716.1968.tb04218.x; Hall MJ, 1998, J APPL PHYSIOL, V85, P1476, DOI 10.1152/jappl.1998.85.4.1476; Harper RM, 2000, J COMP NEUROL, V417, P195, DOI 10.1002/(SICI)1096-9861(20000207)417:2<195::AID-CNE5>3.0.CO;2-V; Henderson LA, 2003, J APPL PHYSIOL, V94, P1063, DOI 10.1152/japplphysiol.00702.2002; Kimmerly DS, 2007, AM J PHYSIOL-HEART C, V293, pH299, DOI 10.1152/ajpheart.00044.2007; Kimmerly DS, 2007, AM J PHYSIOL-REG I, V292, pR715, DOI 10.1152/ajpregu.00366.2006; Kimmerly DS, 2005, J PHYSIOL-LONDON, V569, P331, DOI 10.1113/jphysiol.2005.091637; Kimmerly DS, 2004, AUTON NEUROSCI-BASIC, V114, P61, DOI 10.1016/j.autneu.2004.06.005; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Macefield VG, 2010, HUM BRAIN MAPP, V31, P539, DOI 10.1002/hbm.20885; Macefield VG, 2006, J APPL PHYSIOL, V100, P266, DOI 10.1152/japplphysiol.00588.2005; Macefield VG, 1998, J AUTONOM NERV SYST, V68, P135, DOI 10.1016/S0165-1838(97)00129-X; Macey KE, 2006, RESP PHYSIOL NEUROBI, V151, P44, DOI 10.1016/j.resp.2005.05.024; Macey PM, 2008, SLEEP, V31, P967; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Macey PM, 2003, RESP PHYSIOL NEUROBI, V138, P275, DOI 10.1016/j.resp.2003.09.002; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Malpas SC, 2010, PHYSIOL REV, V90, P513, DOI 10.1152/physrev.00007.2009; MORGAN BJ, 1993, J APPL PHYSIOL, V74, P2969, DOI 10.1152/jappl.1993.74.6.2969; Moruzzi G, 1940, J NEUROPHYSIOL, V3, P20, DOI 10.1152/jn.1940.3.1.20; Narkiewicz K, 1998, CIRCULATION, V98, P772, DOI 10.1161/01.CIR.98.8.772; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Oppenheimer SM, 1996, CLIN AUTON RES, V6, P131, DOI 10.1007/BF02281899; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Peiffer C, 2008, AM J RESP CRIT CARE, V177, P440, DOI 10.1164/rccm.200612-1774OC; Sander M, 2010, J APPL PHYSIOL, V108, P1691, DOI 10.1152/japplphysiol.91539.2008; SCHOBEL HP, 1995, CLIN AUTON RES, V5, P71, DOI 10.1007/BF01827466; Shimizu T, 1997, PSYCHIAT CLIN NEUROS, V51, P397, DOI 10.1111/j.1440-1819.1997.tb02607.x; SOMERS VK, 1993, J AUTONOM NERV SYST, V44, P253, DOI 10.1016/0165-1838(93)90038-V; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Spaak J, 2005, HYPERTENSION, V46, P1327, DOI 10.1161/01.HYP.0000193497.45200.66; van de Borne P, 1998, AM J CARDIOL, V81, P432, DOI 10.1016/S0002-9149(97)00936-3; Verberne AJM, 1996, AM J PHYSIOL-REG I, V270, pR713, DOI 10.1152/ajpregu.1996.270.4.R713; von Leupoldt A, 2008, AM J RESP CRIT CARE, V177, P1026, DOI 10.1164/rccm.200712-1821OC; Weisz J, 2001, NEUROREPORT, V12, P3233, DOI 10.1097/00001756-200110290-00018; Williamson JW, 2003, J APPL PHYSIOL, V94, P1726, DOI 10.1152/japplphysiol.01152.2002; Wong SW, 2007, J APPL PHYSIOL, V103, P1402, DOI 10.1152/japplphysiol.00171.2007; Young T, 2008, SLEEP, V31, P1071	62	37	37	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82525	10.1371/journal.pone.0082525	http://dx.doi.org/10.1371/journal.pone.0082525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358198	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700077
J	Ryan, JP; Sheu, LK; Verstynen, TD; Onyewuenyi, IC; Gianaros, PJ				Ryan, John P.; Sheu, Lei K.; Verstynen, Timothy D.; Onyewuenyi, Ikechukwu C.; Gianaros, Peter J.			Cerebral Blood Flow Links Insulin Resistance and Baroreflex Sensitivity	PLOS ONE			English	Article							GLUT4 MESSENGER-RNA; FUNCTIONAL-ORGANIZATION; AUTONOMIC NEUROPATHY; HUMAN BRAIN; FOOD-INTAKE; ACTIVATION; GLUCOSE; CORTEX; MECHANISMS; PRESSURE	Insulin resistance confers risk for diabetes mellitus and associates with a reduced capacity of the arterial baroreflex to regulate blood pressure. Importantly, several brain regions that comprise the central autonomic network, which controls the baroreflex, are also sensitive to the neuromodulatory effects of insulin. However, it is unknown whether peripheral insulin resistance relates to activity within central autonomic network regions, which may in turn relate to reduced baroreflex regulation. Accordingly, we tested whether resting cerebral blood flow within central autonomic regions statistically mediated the relationship between insulin resistance and an indirect indicator of baroreflex regulation; namely, baroreflex sensitivity. Subjects were 92 community-dwelling adults free of confounding medical illnesses (48 men, 30-50 years old) who completed protocols to assess fasting insulin and glucose levels, resting baroreflex sensitivity, and resting cerebral blood flow. Baroreflex sensitivity was quantified by measuring the magnitude of spontaneous and sequential associations between beat-by-beat systolic blood pressure and heart rate changes. Individuals with greater insulin resistance, as measured by the homeostatic model assessment, exhibited reduced baroreflex sensitivity (b = -0.16, p < .05). Moreover, the relationship between insulin resistance and baroreflex sensitivity was statistically mediated by cerebral blood flow in central autonomic regions, including the insula and cingulate cortex (mediation coefficients < -0.06, p-values < .01). Activity within the central autonomic network may link insulin resistance to reduced baroreflex sensitivity. Our observations may help to characterize the neural pathways by which insulin resistance, and possibly diabetes mellitus, relates to adverse cardiovascular outcomes.	[Ryan, John P.; Gianaros, Peter J.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; [Sheu, Lei K.; Onyewuenyi, Ikechukwu C.; Gianaros, Peter J.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Verstynen, Timothy D.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Ryan, JP (corresponding author), Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA.	ryanjp@upmc.edu		Ryan, John/0000-0003-4466-4418; Verstynen, Timothy/0000-0003-4720-0336	National Institutes of Health [R01-HL089850, F32-DK-091962, K01-DK-095759]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK091962, K01DK095759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health R01-HL089850 (PG), F32-DK-091962, and K01-DK-095759 (JR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alquier T, 2001, NEUROSCI LETT, V308, P75, DOI 10.1016/S0304-3940(01)01936-X; ANDERSON EA, 1991, J CLIN INVEST, V87, P2246, DOI 10.1172/JCI115260; Banks WA, 2004, EUR J PHARMACOL, V490, P5, DOI 10.1016/j.ejphar.2004.02.040; Beissner F, 2013, J NEUROSCI, V33, P10503, DOI 10.1523/JNEUROSCI.1103-13.2013; Benarroch EE., 1997, CENTRAL AUTONOMIC NE; Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003; Berntson GG, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P433, DOI 10.1017/CBO9780511546396.019; Bonora E, 1998, DIABETES, V47, P1643, DOI 10.2337/diabetes.47.10.1643; Cechetto DF, 2009, NEUROIMAGE, V47, P795, DOI 10.1016/j.neuroimage.2009.05.024; Clarke JA, 1999, BRAZ J MED BIOL RES, V32, P85, DOI 10.1590/S0100-879X1999000100013; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Dampney RAL, 2011, J PHYSIOL-LONDON, V589, P2109, DOI 10.1113/jphysiol.2011.208579; Dampney RAL, 2003, PROG NEUROBIOL, V71, P359, DOI 10.1016/j.pneurobio.2003.11.001; DAMPNEY RAL, 1994, PHYSIOL REV, V74, P323, DOI 10.1152/physrev.1994.74.2.323; Deen B, 2011, CEREB CORTEX, V21, P1498, DOI 10.1093/cercor/bhq186; DUCHEN LW, 1980, ANN INTERN MED, V92, P301, DOI 10.7326/0003-4819-92-2-301; Eckberg D, 1992, HUMAN BAROREFLEXES H; El Messari S, 2002, J CHEM NEUROANAT, V24, P225, DOI 10.1016/S0891-0618(02)00058-3; GIANAROS PJ, 2011, HUM BRAIN MAPP, P13934; Gizdulich P, 1996, J HYPERTENS, V14, P243, DOI 10.1097/00004872-199602000-00014; GOSWAMI R, 2010, NEUROIMAGE, P13934; GOSWAMI R, 2012, J NEUROPHYSIOLOGY, P13934; Gray MA, 2009, NEUROIMAGE, V47, P1105, DOI 10.1016/j.neuroimage.2009.05.033; Harper RM, 2000, J COMP NEUROL, V417, P195, DOI 10.1002/(SICI)1096-9861(20000207)417:2<195::AID-CNE5>3.0.CO;2-V; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Henderson LA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00569; Hopkins DFC, 1997, DIABETIC MED, V14, P1044, DOI 10.1002/(SICI)1096-9136(199712)14:12<1044::AID-DIA508>3.0.CO;2-F; Jastreboff AM, 2013, DIABETES CARE, V36, P394, DOI 10.2337/dc12-1112; KIM SG, 1995, MAGNET RESON MED, V34, P293, DOI 10.1002/mrm.1910340303; KULLMANN S, 2012, NEUROENDOCRINOLOGY, P13934; La Rovere MT, 2008, ANN NONINVAS ELECTRO, V13, P191, DOI 10.1111/j.1542-474X.2008.00219.x; La Rovere MT, 1998, LANCET, V351, P478; Landsberg L, 2001, J HYPERTENS, V19, P523, DOI 10.1097/00004872-200103001-00001; Lowe B, 2004, PSYCHOTHER PSYCHOSOM, V73, P386, DOI 10.1159/000080393; Manly BFJ, 1997, RANDOMIZATION BOOTST; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2007, DIABETES CARE, V30, P1219, DOI 10.2337/dc06-2484; Meyer C, 2004, DIABETIC MED, V21, P746, DOI 10.1111/j.1464-5491.2004.01241.x; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; MUNTZEL MS, 1994, AM J PHYSIOL-REG I, V267, pR1350, DOI 10.1152/ajpregu.1994.267.5.R1350; MUNTZEL MS, 1995, CLIN EXP HYPERTENS, V17, P39, DOI 10.3109/10641969509087053; NEAFSEY EJ, 1990, PROG BRAIN RES, V85, P147; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Reims HM, 2004, J HYPERTENS, V22, P2007, DOI 10.1097/00004872-200410000-00025; Rolls ET, 2012, P NUTR SOC, V71, P488, DOI 10.1017/S0029665112000821; ROWE JW, 1981, DIABETES, V30, P219, DOI 10.2337/diab.30.3.219; RYAN JP, 2012, PSYCHOSOM MED, P13934; Saleh TM, 1998, AM J PHYSIOL-REG I, V274, pR1417, DOI 10.1152/ajpregu.1998.274.5.R1417; Sequeira H, 2000, BRAIN RES BULL, V53, P87, DOI 10.1016/S0361-9230(00)00312-9; Skrapari I, 2007, OBESITY, V15, P1685, DOI 10.1038/oby.2007.201; SPYER KM, 1989, TRENDS NEUROSCI, V12, P506, DOI 10.1016/0166-2236(89)90111-2; Stockhorst U, 2004, PHYSIOL BEHAV, V83, P47, DOI 10.1016/j.physbeh.2004.07.022; WALLACE DM, 1992, BRAIN RES BULL, V28, P447, DOI 10.1016/0361-9230(92)90046-Z; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang JJ, 2003, MAGN RESON MED, V49, P796, DOI 10.1002/mrm.10437; Watkins LL, 2000, DIABETES CARE, V23, P826, DOI 10.2337/diacare.23.6.826; Westerhof BE, 2004, J HYPERTENS, V22, P1371, DOI 10.1097/01.hjh.0000125439.28861.ed; Williamson JW, 2003, J APPL PHYSIOL, V94, P1726, DOI 10.1152/japplphysiol.01152.2002; Wong SW, 2007, NEUROIMAGE, V35, P698, DOI 10.1016/j.neuroimage.2006.12.027; Woods SC, 2003, CURR PHARM DESIGN, V9, P795, DOI 10.2174/1381612033455323; Yates KF, 2012, ARTERIOSCL THROM VAS, V32, P2060, DOI 10.1161/ATVBAHA.112.252759; Young CN, 2010, J PHYSIOL-LONDON, V588, P3593, DOI 10.1113/jphysiol.2010.191866; Yu CS, 2011, NEUROIMAGE, V54, P2571, DOI 10.1016/j.neuroimage.2010.11.018	63	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83288	10.1371/journal.pone.0083288	http://dx.doi.org/10.1371/journal.pone.0083288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358272	Green Published, gold, Green Accepted			2022-12-27	WOS:000328735700115
J	Tucker, JD; Divine, GW; Grever, WE; Thomas, RA; Joiner, MC; Smolinski, JM; Auner, GW				Tucker, James D.; Divine, George W.; Grever, William E.; Thomas, Robert A.; Joiner, Michael C.; Smolinski, Joseph M.; Auner, Gregory W.			Gene Expression-Based Dosimetry by Dose and Time in Mice Following Acute Radiation Exposure	PLOS ONE			English	Article							IN-VIVO EPR; CHROMOSOME TRANSLOCATIONS; SOMATIC MUTATION; BIOMARKERS; IRRADIATION; TERM	Rapid and reliable methods for performing biological dosimetry are of paramount importance in the event of a large-scale nuclear event. Traditional dosimetry approaches lack the requisite rapid assessment capability, ease of use, portability and low cost, which are factors needed for triaging a large number of victims. Here we describe the results of experiments in which mice were acutely exposed to Co-60 gamma rays at doses of 0 (control) to 10 Gy. Blood was obtained from irradiated mice 0.5, 1, 2, 3, 5, and 7 days after exposure. mRNA expression levels of 106 selected genes were obtained by reverse-transcription real time PCR. Stepwise regression of dose received against individual gene transcript expression levels provided optimal dosimetry at each time point. The results indicate that only 4-7 different gene transcripts are needed to explain >= 0.69 of the variance (R-2), and that receiver-operator characteristics, a measure of sensitivity and specificity, of >= 0.93 for these statistical models were achieved at each time point. These models provide an excellent description of the relationship between the actual and predicted doses up to 6 Gy. At doses of 8 and 10 Gy there appears to be saturation of the radiation-response signals with a corresponding diminution of accuracy. These results suggest that similar analyses in humans may be advantageous for use in a field-portable device designed to assess exposures in mass casualty situations.	[Tucker, James D.; Grever, William E.; Thomas, Robert A.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Divine, George W.] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Joiner, Michael C.] Wayne State Univ, Dept Radiat Oncol, Detroit, MI 48202 USA; [Smolinski, Joseph M.; Auner, Gregory W.] Wayne State Univ, Dept Elect & Comp Engn, Detroit, MI 48202 USA	Wayne State University; Henry Ford Health System; Henry Ford Hospital; Wayne State University; Wayne State University	Tucker, JD (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	jtucker@biology.biosci.wayne.edu		Auner, Gregory/0000-0002-2300-3947	Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services [HHSO100201000004C]	Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services	This project has been funded in whole or in part with Federal funds from the Biomedical Advanced Research and Development Authority (www.phe.gov/about/barda/Pages/default.aspx), Office of the Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services, under Contract No. HHSO100201000004C. The initial RFP for this funding did set the range of doses and the post-irradiation times of interest. The gender and the exact strain and age of mice were later specified by the funding agency for consistency across all funded groups. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. The funders did stipulate the choice of mouse strain, and they indicated that the highest dose evaluated should be 10 Gy.	Albertini RJ, 2001, MUTAT RES-REV MUTAT, V489, P1, DOI 10.1016/S1383-5742(01)00064-3; Amundson SA, 2000, RADIAT RES, V154, P342, DOI 10.1667/0033-7587(2000)154[0342:IOPMBI]2.0.CO;2; Bhatti P, 2010, RADIAT ENVIRON BIOPH, V49, P685, DOI 10.1007/s00411-010-0307-z; Christodouleas JP, 2011, NEW ENGL J MED, V364, P2334, DOI 10.1056/NEJMra1103676; Coleman MA, 2005, RADIAT RES, V164, P369, DOI 10.1667/RR3356.1; GRAHN D, 1957, GENETICS, V42, P189; GRANT SG, 1993, MUTAT RES, V288, P163, DOI 10.1016/0027-5107(93)90217-4; Jones IM, 2002, RADIAT RES, V158, P424, DOI 10.1667/0033-7587(2002)158[0424:TSGBAC]2.0.CO;2; Kleinerman RA, 2006, RADIAT RES, V166, P287, DOI 10.1667/RR3273.1; Maess MB, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-90; Meadows SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011535; Meadows SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001912; MOLE RH, 1984, BRIT J RADIOL, V57, P355, DOI 10.1259/0007-1285-57-677-355; Olsen LS, 1996, PHARMACOL TOXICOL, V78, P364, DOI 10.1111/j.1600-0773.1996.tb00220.x; Pabinger S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-268; Paul S, 2011, RADIAT RES, V175, P257, DOI 10.1667/RR2420.1; Saenko V, 2011, CLIN ONCOL-UK, V23, P234, DOI 10.1016/j.clon.2011.01.502; Tucker JD, 2008, MUTAT RES-REV MUTAT, V659, P211, DOI 10.1016/j.mrrev.2008.04.001; Tucker JD, 2010, ENVIRON MOL MUTAGEN, V51, P815, DOI 10.1002/em.20561; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Williams BB, 2011, RADIAT MEAS, V46, P772, DOI 10.1016/j.radmeas.2011.03.009; Williams BB, 2011, INT J RADIAT BIOL, V87, P766, DOI 10.3109/09553002.2011.583316; Yong LC, 2009, OCCUP ENVIRON MED, V66, P56, DOI 10.1136/oem.2008.038901; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	24	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83390	10.1371/journal.pone.0083390	http://dx.doi.org/10.1371/journal.pone.0083390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358280	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700123
J	Marei, HES; Althani, A; Afifi, N; Abd-Elmaksoud, A; Bernardini, C; Michetti, F; Barba, M; Pescatori, M; Maira, G; Paldino, E; Manni, L; Casalbore, P; Cenciarelli, C				Marei, Hany E. S.; Althani, Asmaa; Afifi, Nahla; Abd-Elmaksoud, Ahmed; Bernardini, Camilla; Michetti, Fabrizio; Barba, Marta; Pescatori, Mario; Maira, Giulio; Paldino, Emanuela; Manni, Luigi; Casalbore, Patrizia; Cenciarelli, Carlo			Over-Expression of hNGF in Adult Human Olfactory Bulb Neural Stem Cells Promotes Cell Growth and Oligodendrocytic Differentiation	PLOS ONE			English	Article							O2A PROGENITOR CELLS; C-FOS TRANSCRIPTION; PDGF ALPHA-RECEPTOR; NEURONAL DIFFERENTIATION; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; BASAL FOREBRAIN; GENE-THERAPY; IN-VITRO; BRAIN TRANSPLANTATION	The adult human olfactory bulb neural stem/progenitor cells (OBNC/PC) are promising candidate for cell-based therapy for traumatic and neurodegenerative insults. Exogenous application of NGF was suggested as a promising therapeutic strategy for traumatic and neurodegenerative diseases, however effective delivery of NGF into the CNS parenchyma is still challenging due mainly to its limited ability to cross the blood-brain barrier, and intolerable side effects if administered into the brain ventricular system. An effective method to ensure delivery of NGF into the parenchyma of CNS is the genetic modification of NSC to overexpress NGF gene. Overexpression of NGF in adult human OBNSC is expected to alter their proliferation and differentiation nature, and thus might enhance their therapeutic potential. In this study, we genetically modified adult human OBNS/PC to overexpress human NGF (hNGF) and green fluorescent protein (GFP) genes to provide insight about the effects of hNGF and GFP genes overexpression in adult human OBNS/PC on their in vitro multipotentiality using DNA microarray, immunophenotyping, and Western blot (WB) protocols. Our analysis revealed that OBNS/PC-GFP and OBNS/PC-GFP-hNGF differentiation is a multifaceted process involving changes in major biological processes as reflected in alteration of the gene expression levels of crucial markers such as cell cycle and survival markers, stemness markers, and differentiation markers. The differentiation of both cell classes was also associated with modulations of key signaling pathways such MAPK signaling pathway, ErbB signaling pathway, and neuroactive ligand-receptor interaction pathway for OBNS/PC-GFP, and axon guidance, calcium channel, voltage-dependent, gamma subunit 7 for OBNS/PC-GFP-hNGF as revealed by GO and KEGG. Differentiated OBNS/PC-GFP-hNGF displayed extensively branched cytoplasmic processes, a significant faster growth rate and up modulated the expression of oligodendroglia precursor cells markers (PDGFR alpha, NG2 and CNPase) respect to OBNS/PC-GFP counterparts. These findings suggest an enhanced proliferation and oligodendrocytic differentiation potential for OBNS/PC-GFP-hNGF as compared to OBNS/PC-GFP.	[Marei, Hany E. S.; Abd-Elmaksoud, Ahmed] Mansoura Univ, Fac Vet Med, Dept Cytol & Histol, Mansoura, Egypt; [Althani, Asmaa] Qatar Univ, Coll Arts & Sci, Dept Hlth Sci, Doha, Qatar; [Afifi, Nahla] Ain Shams Univ, Dept Anat, Fac Med, Cairo, Egypt; [Bernardini, Camilla; Michetti, Fabrizio; Barba, Marta] Univ Cattolica S Cuore, Inst Anat & Cell Biol, Rome, Italy; [Pescatori, Mario] Erasmus MC, Dept Surg, Rotterdam, Netherlands; [Maira, Giulio] Univ Cattolica Sacro Cuore, Inst Neurosurg, Rome, Italy; [Paldino, Emanuela; Casalbore, Patrizia] Natl Res Council Italy, Inst Cell Biol & Neurobiol, Rome, Italy; [Manni, Luigi; Cenciarelli, Carlo] Natl Res Council Italy, Inst Translat Pharmacol, Rome, Italy	Egyptian Knowledge Bank (EKB); Mansoura University; Qatar University; Egyptian Knowledge Bank (EKB); Ain Shams University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Erasmus University Rotterdam; Erasmus MC; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Marei, HES (corresponding author), Mansoura Univ, Fac Vet Med, Dept Cytol & Histol, Mansoura, Egypt.	hany800@yahoo.com	Manni, Luigi/J-5637-2018; Paldino, Emanuela/AAC-2594-2022; Marei, Hany E/AAC-7076-2019; Barba, Marta/K-5966-2016; CENCIARELLI, CARLO/AAC-1603-2019	Paldino, Emanuela/0000-0002-8483-543X; Marei, Hany E/0000-0002-0069-4212; CENCIARELLI, CARLO/0000-0001-7480-4608; Abd-Elmaksoud, Ahmed/0000-0001-5638-9578; Barba, Marta/0000-0001-6084-7666	Science and Technology Development Fund, Egypt; Associazione per le Terapie Neurochirurgiche Avanzate,Onlus	Science and Technology Development Fund, Egypt(Science and Technology Development Fund (STDF)); Associazione per le Terapie Neurochirurgiche Avanzate,Onlus	The authors thank (Egypt (Science and Technology Development Fund, http://www.stdf.org.eg/), Onlus (Associazione per le Terapie Neurochirurgiche Avanzate) for funding this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker H, 2001, J NEUROSCI, V21, P8505, DOI 10.1523/JNEUROSCI.21-21-08505.2001; Barlow A, 2003, NEURON, V40, P905, DOI 10.1016/S0896-6273(03)00730-X; Begley DJ, 2004, PHARMACOL THERAPEUT, V104, P29, DOI 10.1016/j.pharmthera.2004.08.001; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bishop KM, 2008, EXP NEUROL, V211, P574, DOI 10.1016/j.expneurol.2008.03.004; Bradbury J, 2005, LANCET NEUROL, V4, P335, DOI 10.1016/S1474-4422(05)70086-7; Butt AM, 1999, GLIA, V26, P84, DOI 10.1002/(SICI)1098-1136(199903)26:1<84::AID-GLIA9>3.3.CO;2-C; Calza L, 2003, P NATL ACAD SCI USA, V100, P7325, DOI 10.1073/pnas.1132092100; Casalbore P, 2010, J CELL PHYSIOL, V224, P710, DOI 10.1002/jcp.22170; Cattaneo A, 2008, J ALZHEIMERS DIS, V15, P255; Cenciarelli C, 2006, NEUROL RES, V28, P505, DOI 10.1179/016164106X115161; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Dechant G, 2002, ADV EXP MED BIOL, V513, P303; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Fan XYS, 2013, STEM CELLS DEV, V22, P359, DOI 10.1089/scd.2012.0131; FISCHER W, 1987, NATURE, V329, P65, DOI 10.1038/329065a0; Gage F. H., 1996, ANN NEUROL, V40, P128, DOI DOI 10.1002/ANA.410400123; Gascon E, 2005, EUR J NEUROSCI, V21, P69, DOI 10.1111/j.1460-9568.2004.03849.x; Genini D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046009; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; HEFTI F, 1986, J NEUROSCI, V6, P2155; Holmes JK, 1996, J BIOL CHEM, V271, P25240, DOI 10.1074/jbc.271.41.25240; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huang YB, 2013, CAN J NEUROL SCI, V40, P403, DOI 10.1017/S0317167100014372; Hwang DH, 2011, CELL TRANSPLANT, V20, P1361, DOI 10.3727/096368910X557155; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Ip NY, 1998, ANN NY ACAD SCI, V840, P97, DOI 10.1111/j.1749-6632.1998.tb09553.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacquet BV, 2009, DEVELOPMENT, V136, P4021, DOI 10.1242/dev.041129; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kang EC, 2011, NEURON, V72, P559, DOI 10.1016/j.neuron.2011.09.032; Kawahara H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199166; Kawasoe T, 2000, CANCER RES, V60, P3354; Khodosevich K, 2011, J CELL SCI, V124, P1268, DOI 10.1242/jcs.076059; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim SU, 2006, NEUROPATHOLOGY, V26, P129, DOI 10.1111/j.1440-1789.2006.00688.x; KOLIATSOS VE, 1991, ANN NEUROL, V30, P831, DOI 10.1002/ana.410300613; KORDOWER JH, 1994, P NATL ACAD SCI USA, V91, P10898, DOI 10.1073/pnas.91.23.10898; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; Lee HJ, 2009, GENE THER, V16, P1066, DOI 10.1038/gt.2009.51; Lee HJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000156; Lee HJ, 2007, STEM CELLS, V25, P1204, DOI 10.1634/stemcells.2006-0409; Lee HJ, 2010, J NEUROSCI RES, V88, P3282, DOI 10.1002/jnr.22474; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; LENG SL, 2009, BRAIN RES, P1170; Lin CW, 2006, J COMP NEUROL, V494, P606, DOI 10.1002/cne.20825; Liu HJ, 2013, STEM CELLS DEV, V22, P913, DOI 10.1089/scd.2012.0370; Lomoio S, 2012, EUR J HISTOCHEM, V56, P170, DOI 10.4081/ejh.2012.e27; Louhivuori V, 2011, NEUROBIOL DIS, V41, P469, DOI 10.1016/j.nbd.2010.10.018; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Majumder A, 2012, STEM CELLS, V30, P2387, DOI 10.1002/stem.1201; Manuel MN, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-9; Marei HES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033542; Marei HES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028420; Marks WJ, 2010, LANCET NEUROL, V9, P1164, DOI 10.1016/S1474-4422(10)70254-4; Martin I, 2009, BRAIN RES, V1284, P22, DOI 10.1016/j.brainres.2009.05.070; MARTINEZSERRANO A, 1995, NEURON, V15, P473, DOI 10.1016/0896-6273(95)90051-9; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nagahara AH, 2009, EXP NEUROL, V215, P153, DOI 10.1016/j.expneurol.2008.10.004; Nieto-Estevez V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053594; Nishiyama A, 1996, J NEUROSCI RES, V43, P315, DOI 10.1002/(SICI)1097-4547(19960201)43:3<315::AID-JNR6>3.3.CO;2-3; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Nomura T, 2010, CELL STEM CELL, V7, P730, DOI 10.1016/j.stem.2010.11.009; Ohishi K, 2003, SEMIN CELL DEV BIOL, V14, P143, DOI 10.1016/S1084-9521(02)00183-0; Ohishi K, 2002, INT J HEMATOL, V75, P449, DOI 10.1007/BF02982106; Oumesmar BN, 1997, J NEUROSCI, V17, P125, DOI 10.1523/JNEUROSCI.17-01-00125.1997; Pagani L, 2008, NEUROL RES, V30, P244, DOI 10.1179/016164107X230667; Park D, 2012, EXP NEUROL, V234, P521, DOI 10.1016/j.expneurol.2011.12.040; Pavlidis P, 2004, NEUROCHEM RES, V29, P1213, DOI 10.1023/B:NERE.0000023608.29741.45; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Redmond L, 1996, J NEUROSCI, V16, P2972; ROSENBERG MB, 1988, SCIENCE, V242, P1575, DOI 10.1126/science.3201248; Ryu JK, 2004, NEUROBIOL DIS, V16, P68, DOI 10.1016/j.nbd.2004.01.016; Sanchez-Sanchez R, 2012, DEV DYNAM, V241, P953, DOI 10.1002/dvdy.23779; Schecterson LC, 2012, J NEUROSCI, V32, P14000, DOI 10.1523/JNEUROSCI.2274-12.2012; SCHUMACHER JM, 1991, NEUROSCIENCE, V45, P561, DOI 10.1016/0306-4522(91)90271-O; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SIMON R, BRB ARRAY TOOLS USER, P1012; Sun P, 2006, GENES CELLS, V11, P1097, DOI 10.1111/j.1365-2443.2006.01002.x; Tago K, 2000, GENE DEV, V14, P1741; Takarada T, 2009, J NEUROCHEM, V110, P1457, DOI 10.1111/j.1471-4159.2009.06225.x; Tannemaat MR, 2008, EUR J NEUROSCI, V28, P1467, DOI 10.1111/j.1460-9568.2008.06452.x; Tuszynski MH, 1996, GENE THER, V3, P305; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; TUSZYNSKI MH, 1990, J NEUROSCI, V10, P3604; van de Wetering M, 2002, CELL, V109, pS13, DOI 10.1016/S0092-8674(02)00709-2; Vergano-Vera E, 2009, NEUROSCIENCE, V162, P39, DOI 10.1016/j.neuroscience.2009.03.033; VIGNAIS L, 1995, NEUROREPORT, V6, P1993, DOI 10.1097/00001756-199510010-00010; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Zeng LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059685; Zhang XD, 2004, EXP NEUROL, V186, P112, DOI 10.1016/j.expneurol.2003.10.022; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	101	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82206	10.1371/journal.pone.0082206	http://dx.doi.org/10.1371/journal.pone.0082206			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367504	Green Submitted, Green Published, gold			2022-12-27	WOS:000328741900007
J	Wroblewski, D; Jiang, CC; Croft, A; Farrelly, ML; Zhang, XD; Hersey, P				Wroblewski, David; Jiang, Chen Chen; Croft, Amanda; Farrelly, Margaret L.; Zhang, Xu Dong; Hersey, Peter			OBATOCLAX and ABT-737 Induce ER Stress Responses in Human Melanoma Cells that Limit Induction of Apoptosis	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; ENDOPLASMIC-RETICULUM STRESS; UP-REGULATION; BCL-2 FAMILY; MCL-1; ACTIVATION; GX15-070; RESISTANCE; INHIBITOR; MECHANISMS	Anti-apoptotic Bcl-2 family proteins, in particular, Mcl-1, are known to play a critical role in resistance of human melanoma cells to induction of apoptosis by endoplasmic reticulum stress and other agents. The present study examined whether the BH3 mimetics, Obatoclax and ABT-737, which inhibit multiple anti-apoptotic Bcl-2 family proteins, would overcome resistance to apoptosis. We report that both agents induced a strong unfolded protein response (UPR) and that RNAi knockdown of UPR signalling proteins ATF6, IRE1 alpha and XBP-1 inhibited Mcl-1 upregulation and increased sensitivity to the agents. These results demonstrate that inhibition of anti-apoptotic Bcl-2 proteins by Obatoclax and ABT-737 appears to elicit a protective feedback response in melanoma cells, by upregulation of Mcl-1 via induction of the UPR. We also report that Obatoclax, but not ABT-737, strongly induces autophagy, which appears to play a role in determining melanoma sensitivity to the agents.	[Wroblewski, David; Jiang, Chen Chen; Croft, Amanda; Farrelly, Margaret L.; Zhang, Xu Dong] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia; [Hersey, Peter] Univ Sydney, Royal N Shore Hosp, Kolling Inst, Sydney, NSW 2006, Australia	University of Newcastle; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Hersey, P (corresponding author), Univ Sydney, Royal N Shore Hosp, Kolling Inst, Sydney, NSW 2006, Australia.	Peter.Hersey@sydney.edu.au	zhang, xu/GYE-3558-2022; Zhang, xiaoyu/GXA-3206-2022; zhang, xu/GRX-9733-2022; zhang, xian/GYA-0290-2022; Jiang, Chenchen/C-2902-2014	Zhang, Xu Dong/0000-0001-9457-8003	National Health & Medical Research Council; Hunter Melanoma Foundation	National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Hunter Melanoma Foundation	This work was supported by grants from the National Health & Medical Research Council (www.nhmrc.gov.au) and the Hunter Melanoma Foundation (http://hmf.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; BASIT F, 2013, CELL DEATH DIFFER, V7, P45; Bosman MCJ, 2013, EXP HEMATOL, V41, P530, DOI 10.1016/j.exphem.2013.02.002; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Dong L, 2011, ONCOGENE, V30, P3716, DOI 10.1038/onc.2011.87; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Goard CA, 2013, CORE EVID, V8, P15, DOI 10.2147/CE.S42568; Hersey P, 2006, INT REV CYTOL, V251, P131, DOI 10.1016/S0074-7696(06)51004-6; Hetz CA, 2007, ANTIOXID REDOX SIGN, V9, P2345, DOI 10.1089/ars.2007.1793; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Huang SB, 2009, CLIN CANCER RES, V15, P150, DOI 10.1158/1078-0432.CCR-08-1575; Jiang CC, 2008, CANCER RES, V68, P6708, DOI 10.1158/0008-5472.CAN-08-0349; Jiang CC, 2007, CANCER RES, V67, P9750, DOI 10.1158/0008-5472.CAN-07-2047; Jiang CC, 2009, NEOPLASIA, V11, P945, DOI 10.1593/neo.09692; Konopleva M, 2008, CANCER RES, V68, P3413, DOI 10.1158/0008-5472.CAN-07-1919; Labi V, 2008, CELL DEATH DIFFER, V15, P977, DOI 10.1038/cdd.2008.37; Leonard JH, 2003, PIGM CELL RES, V16, P198, DOI 10.1034/j.1600-0749.2003.00033.x; Li J, 2008, CANCER CHEMOTH PHARM, V61, P525, DOI 10.1007/s00280-007-0499-3; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Liu H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-122; Mohammad RM, 2007, CLIN CANCER RES, V13, P2226, DOI 10.1158/1078-0432.CCR-06-1574; Mott JL, 2008, MOL CANCER THER, V7, P2339, DOI 10.1158/1535-7163.MCT-08-0285; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Nguyen T, 2001, CLIN CANCER RES, V7, p966S; Perez-Galan P, 2007, BLOOD, V109, P4441, DOI 10.1182/blood-2006-07-034173; Schwartz-Roberts JL, 2013, MOL CANCER THER, V12, P448, DOI 10.1158/1535-7163.MCT-12-0617; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Szegezdi E, 2009, AM J PHYSIOL-CELL PH, V296, pC941, DOI 10.1152/ajpcell.00612.2008; Tang Y, 2012, MOL PHARMACOL, V81, P527, DOI 10.1124/mol.111.076851; Tawbi HA, 2007, SEMIN ONCOL, V34, P532, DOI 10.1053/j.seminoncol.2007.09.008; Trudel S, 2007, BLOOD, V109, P5430, DOI 10.1182/blood-2006-10-047951; Urtishak KA, 2013, BLOOD, V121, P2689, DOI 10.1182/blood-2012-04-425033; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Verhaegen M, 2006, CANCER RES, V66, P11348, DOI 10.1158/0008-5472.CAN-06-1748; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Wolter KG, 2007, CELL DEATH DIFFER, V14, P1605, DOI 10.1038/sj.cdd.4402163; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937; Zhang XD, 2003, ONCOGENE, V22, P2869, DOI 10.1038/sj.onc.1206427; Zhang XD, 2006, CLIN CANCER RES, V12, P1355, DOI 10.1158/1078-0432.CCR-05-2084; Zhang XD, 1999, CANCER RES, V59, P2747; Zhu BK, 2008, ANTI-CANCER DRUG, V19, P189, DOI 10.1097/CAD.0b013e3282f3138a; Zhuang LQ, 2007, MODERN PATHOL, V20, P416, DOI 10.1038/modpathol.3800750	42	25	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84073	10.1371/journal.pone.0084073	http://dx.doi.org/10.1371/journal.pone.0084073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367627	Green Submitted, gold, Green Published			2022-12-27	WOS:000328741900028
J	Cristescu, B; Stenhouse, GB; Boyce, MS				Cristescu, Bogdan; Stenhouse, Gordon B.; Boyce, Mark S.			Perception of Human-Derived Risk Influences Choice at Top of the Food Chain	PLOS ONE			English	Article							DEER CAPREOLUS-CAPREOLUS; BEAR HABITAT SELECTION; GRIZZLY BEARS; LOGISTIC-REGRESSION; WILDLIFE RESPONSES; LARGE CARNIVORES; BED-SITES; CONSERVATION; PREDATION; ROADS	On human-used landscapes, animal behavior is a trade-off between maximizing fitness and minimizing human-derived risk. Understanding risk perception in wildlife can allow mitigation of anthropogenic risk, with benefits to long-term animal fitness. Areas where animals choose to rest should minimize risk from predators, which for large carnivores typically equate to humans. We hypothesize that high human activity leads to selection for habitat security, whereas low activity enables trading security for forage. We investigated selection of resting (bedding) sites by GPS radiocollared adult grizzly bears (n = 10) in a low density population on a multiple-use landscape in Canada. We compared security and foods at resting and random locations while accounting for land use, season, and time of day. On reclaimed mines with low human access, bears selected high horizontal cover far from trails, but did not avoid open (herbaceous) areas, resting primarily at night. In protected areas bears also bedded at night, in areas with berry shrubs and Hedysarum spp., with horizontal cover selected in the summer, during high human access. On public lands with substantial human recreation, bears bedded at day, selected resting sites with high horizontal cover in the summer and habitat edges, with bedding associated with herbaceous foods. These spatial and temporal patterns of selection suggest that bears perceive human-related risk differentially in relation to human activity level, season and time of day, and employ a security-food trade-off strategy. Although grizzly bears are presently not hunted in Alberta, their perceived risks associated with humans influence resting-site selection.	[Cristescu, Bogdan; Boyce, Mark S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Stenhouse, Gordon B.] Foothills Res Inst, Grizzly Bear Program, Hinton, AB, Canada	University of Alberta	Cristescu, B (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	cristesc@ualberta.ca	Boyce, Mark S/A-2620-2014	Boyce, Mark S/0000-0001-5811-325X; Cristescu, Bogdan/0000-0003-2964-5040	Alberta Conservation Association	Alberta Conservation Association	This study was supported financially by: 1. Alberta Conservation Association (Grant Eligible Conservation Fund): http://www. ab- conservation. com/go/ default/index. cfm/grants/grant- eligible- conservation- fund/overview/; 2. Alberta's Conservation Collaboration (Minister's Special License Program): http:// www. huntingfortomorrow. com; 3. Alberta Ingenuity Fund (Ph. D. Scholarship to primary author): http://www. albertatechfutures. ca/GSS. aspx; 4. Alberta Society of Professional Biologists (Graduate Student Scholarship to primary author): http://www. aspb. ab. ca/awards; 5. Alberta Sport, Recreation, Parks & Wildlife Foundation (Development Initiatives Program): http://www. asrpwf. ca/grant- funding- programs/development- initiatives- program. aspx; 6. American Society of Mammalogists (Grant- in- Aid of Research to primary author): http://www. mammalsociety. org/committees/grants- aid/; 7. Canadian Wildlife Federation: http://cwffcf. org/en/explore- our- work/funding- awards/; 8. Wild Sheep Foundation Alberta: http://www. wsfab. org/projects. html; 9. International Association for Bear Research and Management (Research & Conservation Grant): http://www. bearbiology. com/index. php? id = 30; 10. Mountain Equipment Co- op: http:// www. mec. ca/AST/ContentPrimary/Sustainability/CommunityContributions/ApplyForSupport. jsp 11. Safari Club International - Northern Alberta Chapter: http:// sci- northern. ab. ca/giving- back/; 12. TD Friends of the Environment Foundation: http://fef. td. com/funding/; 13. Teck Resources Limited: http://www. teck. com/ Generic. aspx? PAGE = 2008+ Sustainability+ Report+ Pages/2008+ Report& portalName = tc; 14. University of Alberta (FS Chia Ph. D. Scholarship to the primary author). All sources of funding are acknowledged and no financial benefit can result from publication. One of the funding sources for this research was a commercial source (Teck Resources Limited). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Anthony LL, 2000, BIOL CONSERV, V95, P303, DOI 10.1016/S0006-3207(00)00037-9; Atwood TC, 2009, J WILDLIFE MANAGE, V73, P876, DOI 10.2193/2008-325; BEERS TW, 1966, J FOREST, V64, P691; Benn B, 2002, URSUS, V13, P213; Blumstein DT, 2004, CONSERV BIOL, V18, P1175, DOI 10.1111/j.1523-1739.2004.00587.x; BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Burnham KP, 1998, MODEL SELECTION INFE, P514; Caro T, 2007, TRENDS ECOL EVOL, V22, P394, DOI 10.1016/j.tree.2007.06.003; Cattet M, 2008, J MAMMAL, V89, P973, DOI 10.1644/08-MAMM-A-095.1; Chatterjee S., 2006, REGRESSION ANAL EXAM, DOI DOI 10.1002/0470055464; Ciarniello LM, 2007, J WILDLIFE MANAGE, V71, P1446, DOI 10.2193/2006-229; Comiskey EJ, 2002, ECOL SOC, V6; Conover M. R., 2007, PREDATOR PREY DYNAMI; Cooper AB, 1999, ECOLOGY, V80, P566, DOI 10.1890/0012-9658(1999)080[0566:TAODCM]2.0.CO;2; Cranston J., 2005, 2004 POPULATION INVE; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; DeWitt TJ, 1999, ANIM BEHAV, V58, P397, DOI 10.1006/anbe.1999.1158; Durant SM, 2000, ANIM BEHAV, V60, P121, DOI 10.1006/anbe.2000.1433; Frair JL, 2005, LANDSCAPE ECOL, V20, P273, DOI 10.1007/s10980-005-2075-8; Frid A, 2002, CONSERV ECOL, V6; Gibeau ML, 2002, BIOL CONSERV, V103, P227, DOI 10.1016/S0006-3207(01)00131-8; Gorini L, 2012, MAMMAL REV, V42, P55, DOI 10.1111/j.1365-2907.2011.00189.x; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; JOPE KL, 1985, WILDLIFE SOC B, V13, P32; Keating KA, 2004, J WILDLIFE MANAGE, V68, P774, DOI 10.2193/0022-541X(2004)068[0774:UAIOLR]2.0.CO;2; Knopff KH, 2009, J WILDLIFE MANAGE, V73, P586, DOI 10.2193/2008-294; Kolowski JM, 2006, BIOL CONSERV, V128, P529, DOI 10.1016/j.biocon.2005.10.021; Kortello AD, 2007, ECOSCIENCE, V14, P214, DOI 10.2980/1195-6860(2007)14[214:IBCPCA]2.0.CO;2; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; Laporte I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011954; LEMMON PAUL E., 1956, FOREST SCI, V2, P314; Lima SL, 2005, ANIM BEHAV, V70, P723, DOI 10.1016/j.anbehav.2005.01.008; Linnell JDC, 1999, WILDLIFE BIOL, V5, P225, DOI 10.2981/wlb.1999.027; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Mace RD, 1996, J APPL ECOL, V33, P1395, DOI 10.2307/2404779; MCLELLAN BN, 1988, J APPL ECOL, V25, P451, DOI 10.2307/2403836; MERRILL EH, 1991, APPL ANIM BEHAV SCI, V29, P251, DOI 10.1016/0168-1591(91)90252-S; Miller SG, 2001, WILDLIFE SOC B, V29, P124; Moen GK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031699; Mollohan CM., 1987, INT C BEAR RES MANAG, V1, P145, DOI DOI 10.2307/3872620; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; MYSTERUD A, 1995, CAN J ZOOL, V73, P924, DOI 10.1139/z95-108; Mysterud A, 1999, WILDLIFE SOC B, V27, P385; Mysterud I, 1983, INT C BEAR RES MANAG, V5, P208, DOI DOI 10.2307/3872540; Nielsen Scott E., 1998, Transactions of the Wisconsin Academy of Sciences Arts and Letters, V86, P149; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; Nielsen SE, 2006, BIOL CONSERV, V130, P217, DOI 10.1016/j.biocon.2005.12.016; Nielsen SE, 2004, BIOL CONSERV, V120, P101, DOI 10.1016/j.biocon.2004.02.020; Nielsen SE, 2004, FOREST ECOL MANAG, V199, P51, DOI 10.1016/j.foreco.2004.04.014; Nielsen SE, 2003, ECOSCIENCE, V10, P1; NUDDS T D, 1977, Wildlife Society Bulletin, V5, P113; Ordiz A, 2012, BIOL CONSERV, V152, P21, DOI 10.1016/j.biocon.2012.04.006; Ordiz A, 2011, OECOLOGIA, V166, P59, DOI 10.1007/s00442-011-1920-5; PECKARSKY BL, 1988, OIKOS, V53, P185, DOI 10.2307/3566061; Podgorski T, 2008, ACTA THERIOL, V53, P97, DOI 10.1007/BF03194243; PREGIBON D, 1981, ANN STAT, V9, P705, DOI 10.1214/aos/1176345513; Purcell KL, 2009, FOREST ECOL MANAG, V258, P2696, DOI 10.1016/j.foreco.2009.09.041; Roever CL, 2008, FOREST ECOL MANAG, V256, P1262, DOI 10.1016/j.foreco.2008.06.006; Roever CL, 2010, ECOGRAPHY, V33, P1113, DOI 10.1111/j.1600-0587.2010.06077.x; Schwab C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027905; Smith DW, 2010, J WILDLIFE MANAGE, V74, P620, DOI 10.2193/2008-584; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; STIRLING I, 1990, INT C BEAR, V8, P189; Thaker M, 2011, ECOLOGY, V92, P398, DOI 10.1890/10-0126.1; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Van Moorter B, 2009, OECOLOGIA, V159, P669, DOI 10.1007/s00442-008-1245-1; Weaver JL, 1996, CONSERV BIOL, V10, P964, DOI 10.1046/j.1523-1739.1996.10040964.x; Whittaker D, 1998, WILDLIFE SOC B, V26, P312; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Zedrosser A, 2011, BIOL CONSERV, V144, P2163, DOI 10.1016/j.biocon.2011.05.005; Zielinski WJ, 2004, J WILDLIFE MANAGE, V68, P475, DOI 10.2193/0022-541X(2004)068[0475:RHSBFI]2.0.CO;2	75	20	20	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82738	10.1371/journal.pone.0082738	http://dx.doi.org/10.1371/journal.pone.0082738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367549	Green Submitted, Green Published, gold			2022-12-27	WOS:000328740300062
J	Hwang, IS; Huang, CT; Yang, JF; Guo, MC				Hwang, Ing-Shiou; Huang, Chien-Ting; Yang, Jeng-Feng; Guo, Mei-Chun			Characterization of Information-Based Learning Benefits with Submovement Dynamics and Muscular Rhythmicity	PLOS ONE			English	Article							MANUAL TRACKING; CORTICOMUSCULAR COHERENCE; FORCE OUTPUT; TASK; VARIABILITY; MOVEMENT; INTERMITTENCY; SYNCHRONIZATION; RECTIFICATION; TRAJECTORIES	For skill advancement, motor variability must be optimized based on target information during practice sessions. This study investigated structural changes in kinematic variability by characterizing submovement dynamics and muscular oscillations after practice with visuomotor tracking under different target conditions. Thirty-six participants were randomly assigned to one of three groups (simple, complex, and random). Each group practiced tracking visual targets with trajectories of varying complexity. The velocity trajectory of tracking was decomposed into 1) a primary contraction spectrally identical to the target rate and 2) an intermittent submovement profile. The learning benefits and submovement dynamics were conditional upon experimental manipulation of the target information. Only the simple and complex groups improved their skills with practice. The size of the submovements was most greatly reduced by practice with the least target information (simple > complex > random). Submovement complexity changed in parallel with learning benefits, with the most remarkable increase in practice under a moderate amount of target information (complex > simple > random). In the simple and complex protocols, skill improvements were associated with a significant decline in alpha (8-12 Hz) muscular oscillation but a potentiation of gamma (35-50 Hz) muscular oscillation. However, the random group showed no significant change in tracking skill or submovement dynamics, except that alpha muscular oscillation was reduced. In conclusion, submovement and gamma muscular oscillation are biological markers of learning benefits. Effective learning with an appropriate amount of target information reduces the size of submovements. In accordance with the challenge point hypothesis, changes in submovement complexity in response to target information had an inverted-U function, pertaining to an abundant trajectory-tuning strategy with target exactness.	[Hwang, Ing-Shiou; Huang, Chien-Ting; Yang, Jeng-Feng; Guo, Mei-Chun] Natl Cheng Kung Univ, Coll Med, Dept Phys Therapy, Tainan 70101, Taiwan; [Hwang, Ing-Shiou; Huang, Chien-Ting; Guo, Mei-Chun] Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University	Hwang, IS (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Phys Therapy, Tainan 70101, Taiwan.	ishwang@mail.ncku.edu.tw			National Science Council, R.O.C. [NSC 96-2314-B-006-028-MY2]	National Science Council, R.O.C.(Ministry of Science and Technology, Taiwan)	This research was supported by a grant from the National Science Council, R.O.C., under Grant No. NSC 96-2314-B-006-028-MY2. (http://web1.nsc.gov.tw/mp.aspx?mp=7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrykiewicz A, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-101; Bolbecker AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019824; Boonstra TW, 2012, J NEUROPHYSIOL, V107, P796, DOI 10.1152/jn.00066.2011; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; DARLING WG, 1987, J MOTOR BEHAV, V19, P291; Farmer SF, 2007, J PHYSIOL-LONDON, V579, P389, DOI 10.1113/jphysiol.2006.123174; Gao JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024446; GEORGOPOULOS AP, 1981, J NEUROPHYSIOL, V46, P725, DOI 10.1152/jn.1981.46.4.725; Grafton ST, 2008, NEUROIMAGE, V39, P1383, DOI 10.1016/j.neuroimage.2007.09.062; Guadagnoli MA, 2004, J MOTOR BEHAV, V36, P212, DOI 10.3200/JMBR.36.2.212-224; Gwin JT, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00258; Huang CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051417; Huisinga JM, 2012, NEUROSCI LETT, V524, P124, DOI 10.1016/j.neulet.2012.07.020; Hwang IS, 2009, J APPL PHYSIOL, V106, P966, DOI 10.1152/japplphysiol.90851.2008; Jordan K, 2004, EXP BRAIN RES, V156, P451, DOI 10.1007/s00221-003-1806-9; Kilner JM, 2000, J NEUROSCI, V20, P8838; Kristeva-Feige R, 2002, CLIN NEUROPHYSIOL, V113, P124, DOI 10.1016/S1388-2457(01)00722-2; Kuznetsov NA, 2010, NEUROSCI LETT, V470, P121, DOI 10.1016/j.neulet.2009.12.068; Manor B, 2010, J APPL PHYSIOL, V109, P1786, DOI 10.1152/japplphysiol.00390.2010; Marsden JF, 2000, J NEUROSCI, V20, P2307; Mendez-Balbuena I, 2012, CEREB CORTEX, V22, P628, DOI 10.1093/cercor/bhr147; MIALL RC, 1986, BEHAV BRAIN RES, V20, P185, DOI 10.1016/0166-4328(86)90003-3; MIALL RC, 1993, J MOTOR BEHAV, V25, P53, DOI 10.1080/00222895.1993.9941639; Muller H, 2009, ADV EXP MED BIOL, V629, P439, DOI 10.1007/978-0-387-77064-2_23; Muthukumaraswamy SD, 2010, J NEUROPHYSIOL, V104, P2873, DOI 10.1152/jn.00607.2010; Myers LJ, 2003, J NEUROSCI METH, V124, P157, DOI 10.1016/S0165-0270(03)00004-9; Naranjo JR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-157; NAVAS F, 1968, BIOPHYS J, V8, P252, DOI 10.1016/S0006-3495(68)86488-4; Newell KM, 2003, J EXP PSYCHOL HUMAN, V29, P379, DOI 10.1037/0096-1523.29.2.379; Newell KM, 2001, HUM MOVEMENT SCI, V20, P695, DOI 10.1016/S0167-9457(01)00073-2; Newell KM, 1997, J MOTOR BEHAV, V29, P366, DOI 10.1080/00222899709600022; Omlor W, 2007, NEUROIMAGE, V34, P1191, DOI 10.1016/j.neuroimage.2006.10.018; Pasalar S, 2005, EXP BRAIN RES, V163, P214, DOI 10.1007/s00221-004-2169-6; Pew R. W., 1974, HUMAN INFORMATION PR, P1; Ranganathan R, 2010, NEUROSCI LETT, V469, P416, DOI 10.1016/j.neulet.2009.12.041; Roitman AV, 2004, J NEUROPHYSIOL, V91, P901, DOI 10.1152/jn.00261.2003; Selen LPJ, 2006, J NEUROPHYSIOL, V96, P2750, DOI 10.1152/jn.00552.2006; Semmler JG, 2007, J APPL PHYSIOL, V103, P979, DOI 10.1152/japplphysiol.01310.2006; Shmuelof L, 2012, J NEUROPHYSIOL, V108, P578, DOI 10.1152/jn.00856.2011; Sosnoff JJ, 2005, J MOTOR BEHAV, V37, P325, DOI 10.3200/JMBR.37.4.325-336; Stegeman DF, 2010, CLIN NEUROPHYSIOL, V121, P1633, DOI 10.1016/j.clinph.2010.03.052; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390	44	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82920	10.1371/journal.pone.0082920	http://dx.doi.org/10.1371/journal.pone.0082920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367568	gold, Green Submitted, Green Published			2022-12-27	WOS:000328740300079
J	Qu, JX; Yu, XM; Liu, YM; Yin, YD; Gu, L; Cao, B; Wang, C				Qu, Jiuxin; Yu, Xiaomin; Liu, Yingmei; Yin, Yudong; Gu, Li; Cao, Bin; Wang, Chen			Specific Multilocus Variable-Number Tandem-Repeat Analysis Genotypes of Mycoplasma pneumoniae Are Associated with Diseases Severity and Macrolide Susceptibility	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CLINICAL STRAINS; RESISTANCE; INFECTION; CULTURE; FRANCE; ADULTS; CHINA; GENE	Clinical relevance of multilocus variable-number tandem-repeat (VNTR) analysis (MLVA) in patients with community-acquired pneumonia (CAP) by Mycoplasma pneumoniae (M. pneumoniae) is unknown. A multi-center, prospective study was conducted from November 2010 to April 2012. Nine hundred and fifty-four CAP patients were consecutively enrolled. M. pneumoniae clinical isolates were obtained from throat swabs. MLVA typing was applied to all isolates. Comparison of pneumonia severity index (PSI) and clinical features among patients infected with different MLVA types of M. pneumoniae were conducted. One hundred and thirty-six patients were positive with M. pneumoniae culture. The clinical isolates were clustered into 18 MLVA types. One hundred and fourteen (88.3%) isolates were resistant to macrolide, covering major MLVA types. The macrolide non-resistant rate of M. pneumoniae isolates with Mpn13-14-15-16 profile of 3-5-6-2 was significantly higher than that of other types (p <= 0.001). Patients infected with types U (5-4-5-7-2) and J (3-4-5-7-2) had significantly higher PSI scores (p<0.001) and longer total duration of cough (p = 0.011). Therefore it seems that there is a correlation between certain MLVA types and clinical severity of disease and the presence of macrolide resistance.	[Qu, Jiuxin; Yu, Xiaomin; Liu, Yingmei; Yin, Yudong; Gu, Li; Cao, Bin] Capital Med Univ, Beijing Inst Resp Med, Beijing Chaoyang Hosp, Dept Infect Dis & Clin Microbiol, Beijing, Peoples R China; [Wang, Chen] Beijing Hosp, China Minist Hlth, Beijing Key Lab Resp & Pulm Circulat Disorders, Beijing Inst Resp Med, Beijing, Peoples R China	Capital Medical University; Beijing Hospital	Cao, B (corresponding author), Capital Med Univ, Beijing Inst Resp Med, Beijing Chaoyang Hosp, Dept Infect Dis & Clin Microbiol, Beijing, Peoples R China.	caobin1999@gmail.com	Yin, Yudong/AAU-6546-2021	Yin, Yudong/0000-0001-6321-8208	New Century Excellent Talents in University [NCET-10-0006]; Chinese Respiratory Tract Infection Optimal Treatment Committee [CROTC-2009040]; Beijing Science and Technology Project [D101100049810002]; Beijing Municipal Health Bureau [2011-1004-02]	New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Chinese Respiratory Tract Infection Optimal Treatment Committee; Beijing Science and Technology Project; Beijing Municipal Health Bureau	This work was supported by a program for New Century Excellent Talents in University (NCET-10-0006), a grant from Chinese Respiratory Tract Infection Optimal Treatment Committee (CROTC-2009040), a grant from the Beijing Science and Technology Project (D101100049810002) and a grant from Beijing Municipal Health Bureau (2011-1004-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbuch D, 2011, EMERG INFECT DIS, V17, P1079, DOI [10.3201/eid1706.101558, 10.3201/eid/1706.101558]; Bebear C, 2011, FUTURE MICROBIOL, V6, P423, DOI [10.2217/fmb.11.18, 10.2217/FMB.11.18]; Benitez AJ, 2012, J CLIN MICROBIOL, V50, P3620, DOI 10.1128/JCM.01755-12; Cao B, 2010, CLIN INFECT DIS, V51, P189, DOI 10.1086/653535; Chalker V, 2011, EURO SURVEILL, V16; Chalker VJ, 2012, EURO SURVEILL, V17; Degrange S, 2009, J CLIN MICROBIOL, V47, P914, DOI 10.1128/JCM.01935-08; Dumke R, 2003, INT J MED MICROBIOL, V292, P513, DOI 10.1078/1438-4221-00231; Dumke R, 2011, J MICROBIOL METH, V86, P393, DOI 10.1016/j.mimet.2011.06.008; Eibach D, 2012, EURO SURVEILL, V17; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Kenri T, 2008, J MED MICROBIOL, V57, P469, DOI 10.1099/jmm.0.47634-0; Liu Y, 2012, J CLIN MICROBIOL, V50, P2793, DOI 10.1128/JCM.00678-12; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Morozumi M, 2005, ANTIMICROB AGENTS CH, V49, P2302, DOI 10.1128/AAC.49.6.2302-2306.2005; Pereyre S, 2007, J CLIN MICROBIOL, V45, P3534, DOI 10.1128/JCM.01345-07; Pereyre S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038585; Pereyre S, 2012, EMERG INFECT DIS, V18, P343, DOI 10.3201/eid1802.111379; Qu JX, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-172; Sun HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064607; von Baum H, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-62; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Waites KB, 2001, CUMITECH 34 LAB DIAG, P1; Zhao F, 2013, J CLIN MICROBIOL, V51, P636, DOI 10.1128/JCM.02567-12	24	30	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82174	10.1371/journal.pone.0082174	http://dx.doi.org/10.1371/journal.pone.0082174			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367502	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300020
J	Wang, QZ; Ma, AG; Han, XX; Zhao, SL; Cai, J; Ma, YB; Zhao, J; Wang, YW; Dong, HF; Zhao, ZL; Wei, L; Yu, T; Chen, PX; Schouten, EG; Kok, FJ; Kapur, A				Wang, Qiuzhen; Ma, Aiguo; Han, Xiuxia; Zhao, Shanliang; Cai, Jing; Ma, Yunbo; Zhao, Jie; Wang, Yuwen; Dong, Huaifeng; Zhao, Zhenlei; Wei, Lai; Yu, Tao; Chen, Peixue; Schouten, Evert G.; Kok, Frans J.; Kapur, Anil			Prevalence of Type 2 Diabetes among Newly Detected Pulmonary Tuberculosis Patients in China: A Community Based Cohort Study	PLOS ONE			English	Article							DOUBLE BURDEN; MELLITUS; RISK	Background: Patients with type 2 diabetes (DM) have a higher risk of developing pulmonary tuberculosis (PTB); moreover, DM co-morbidity in PTB is associated with poor PTB treatment outcomes. Community based prevalence data on DM and prediabetes (pre-DM) among TB patients is lacking, particularly from the developing world. Therefore we conducted a prospective study to investigate the prevalence of DM and pre-DM and evaluated the risk factors for the presence of DM among newly detected PTB patients in rural areas of China. Methods and Findings: In a prospective community based study carried out from 2010 to 2012, a representative sample of 6382 newly detected PTB patients from 7 TB clinics in Linyi were tested for DM. A population of 6674 non-TB controls from the same community was similarly tested as well. The prevalence of DM in TB patients (6.3%) was higher than that in non-TB controls (4.7%, p < 0.05). PTB patients had a higher odds of DM than non-TB controls (adjusted OR 3.17, 95% CI 1.14-8.84). The prevalence of DM increased with age and was significantly higher in TB patients in the age categories above 30 years (p < 0.05). Among TB patients, those with normal weight (BMI 18.5-23.9) had the lowest prevalence of DM (5.8%). Increasing age, family history of DM, positive sputum smear, cavity on chest X-ray and higher yearly income (>= 10000 RMB yuan) were positively associated and frequent outdoor activity was negatively associated with DM in PTB patients. Conclusions: The prevalence of DM in PTB patients was higher than in non-TB controls with a 3 fold higher adjusted odds ratio of having DM. Given the increasing DM prevalence and still high burden of TB in China, this association may represent a new public health challenge concerning the prevention and treatment of both diseases.	[Wang, Qiuzhen; Ma, Aiguo; Han, Xiuxia; Cai, Jing] Qingdao Univ, Inst Nutr, Qingdao 266071, Peoples R China; [Zhao, Shanliang; Ma, Yunbo] Linyi Chest Hosp, Linyi, Peoples R China; [Zhao, Jie] Yishui TB Clin, Linyi, Peoples R China; [Wang, Yuwen] Tancheng TB Clin, Linyi, Peoples R China; [Dong, Huaifeng] Yinan TB Clin, Linyi, Peoples R China; [Zhao, Zhenlei] Lanshan TB Clin, Linyi, Peoples R China; [Wei, Lai] Feixian TB Clin, Linyi, Peoples R China; [Yu, Tao] Pingyi TB Clin, Linyi, Peoples R China; [Chen, Peixue] Cangshan TB Clin, Linyi, Peoples R China; [Schouten, Evert G.; Kok, Frans J.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Kapur, Anil] World Diabet Fdn, Gentofte, Denmark	Qingdao University; Wageningen University & Research	Ma, AG (corresponding author), Qingdao Univ, Inst Nutr, Qingdao 266071, Peoples R China.	aiguoma123@gmail.com			World Diabetes Foundation [WDF08-380]; Natural Science Foundation of China, NSFC [81172662]; Specialized Research Fund for the Doctoral Program of Higher Education of China, SRFDP [20123706110004]	World Diabetes Foundation; Natural Science Foundation of China, NSFC(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China, SRFDP(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the World Diabetes Foundation, WDF08-380, http://www.worlddiabetesfoundation.org/; Natural Science Foundation of China, NSFC No. 81172662 and Specialized Research Fund for the Doctoral Program of Higher Education of China, SRFDP No. 20123706110004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bygbjerg IC, 2012, SCIENCE, V337, P1499, DOI 10.1126/science.1223466; Cheng MH, 2010, LANCET, V375, P2207, DOI 10.1016/S0140-6736(10)61014-8; Faurholt-Jepsen D, 2012, INT J TUBERC LUNG D, V16, P1680, DOI 10.5588/ijtld.12.0360; Hernandez-Pando R, 2009, ARCH IMMUNOL THER EX, V57, P355, DOI 10.1007/s00005-009-0042-9; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Jia WP, 2007, DIABETOLOGIA, V50, P286, DOI 10.1007/s00125-006-0503-1; Jick SS, 2006, ARTHRIT RHEUM-ARTHR, V55, P19, DOI 10.1002/art.21705; Kapur A, 2013, DIABETES RES CLIN PR, V101, P10, DOI 10.1016/j.diabres.2012.12.001; Kim SJ, 1995, TUBERCLE LUNG DIS, V76, P529, DOI 10.1016/0962-8479(95)90529-4; Leung CC, 2007, ARCH INTERN MED, V167, P1297, DOI 10.1001/archinte.167.12.1297; Li L, 2012, TROP MED INT HEALTH, V17, P1294, DOI 10.1111/j.1365-3156.2012.03068.x; Lin Songbai, 1998, Zhonghua Jiehe He Huxi Zazhi, V21, P504; Ministry of Health and Chinese Centre on TB Control and Prevention (CDC), 2008, NAT TUB CONTR PROGR; MUGUSI F, 1990, TUBERCLE, V71, P271, DOI 10.1016/0041-3879(90)90040-F; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; PablosMendez A, 1997, AM J PUBLIC HEALTH, V87, P574, DOI 10.2105/AJPH.87.4.574; Restrepo BI, 2011, B WORLD HEALTH ORGAN, V89, P352, DOI 10.2471/BLT.10.085738; Root HF, 1934, NEW ENGL J MED, V210, P1, DOI 10.1056/NEJM193401042100101; Shetty N, 2006, INT J TUBERC LUNG D, V10, P80; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Sullivan T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001269; Technical Guidance Group of the Fifth National TB Epidemiological Survey, 2012, CHINESE J ANTITUBERC, V34, P485; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wang QZ, 2012, DIABETES RES CLIN PR, V96, P385, DOI 10.1016/j.diabres.2011.11.012; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang Q, 2009, JPN J INFECT DIS, V62, P390; Zhou B., 2002, ZHONGHUA LIU XING BI, V1, P5	28	49	51	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82660	10.1371/journal.pone.0082660	http://dx.doi.org/10.1371/journal.pone.0082660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367535	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300051
J	Abdullah, NR; Barber, BE; William, T; Norahmad, NA; Satsu, UR; Muniandy, PK; Ismail, Z; Grigg, MJ; Jelip, J; Piera, K; von Seidlein, L; Yeo, TW; Anstey, NM; Price, RN; Auburn, S				Abdullah, Noor Rain; Barber, Bridget E.; William, Timothy; Norahmad, Nor Azrina; Satsu, Umi Rubiah; Muniandy, Prem Kumar; Ismail, Zakiah; Grigg, Matthew J.; Jelip, Jenarun; Piera, Kim; von Seidlein, Lorenz; Yeo, Tsin W.; Anstey, Nicholas M.; Price, Ric N.; Auburn, Sarah			Plasmodium vivax Population Structure and Transmission Dynamics in Sabah Malaysia	PLOS ONE			English	Article							SEVERE DISEASE; MALARIA; FALCIPARUM; MARKERS; DIVERSITY; KNOWLESI	Despite significant progress in the control of malaria in Malaysia, the complex transmission dynamics of P. vivax continue to challenge national efforts to achieve elimination. To assess the impact of ongoing interventions on P. vivax transmission dynamics in Sabah, we genotyped 9 short tandem repeat markers in a total of 97 isolates (8 recurrences) from across Sabah, with a focus on two districts, Kota Marudu (KM, n = 24) and Kota Kinabalu (KK, n = 21), over a 2 year period. STRUCTURE analysis on the Sabah-wide dataset demonstrated multiple sub-populations. Significant differentiation (F-ST = 0.243) was observed between KM and KK, located just 130 Km apart. Consistent with low endemic transmission, infection complexity was modest in both KM (mean MOI = 1.38) and KK (mean MOI = 1.19). However, population diversity remained moderate (H-E = 0.583 in KM and H-E = 0.667 in KK). Temporal trends revealed clonal expansions reflecting epidemic transmission dynamics. The haplotypes of these isolates declined in frequency over time, but persisted at low frequency throughout the study duration. A diverse array of low frequency isolates were detected in both KM and KK, some likely reflecting remnants of previous expansions. In accordance with clonal expansions, high levels of Linkage Disequilibrium (I-A(S) >.0.5 [P<0.0001] in KK and KM) declined sharply when identical haplotypes were represented once (I-A(S) = 0.07 [P = 0.0076] in KM, and I-A(S) = 0.003 [P = 0.606] in KK). All 8 recurrences, likely to be relapses, were homologous to the prior infection. These recurrences may promote the persistence of parasite lineages, sustaining local diversity. In summary, Sabah's shrinking P. vivax population appears to have rendered this low endemic setting vulnerable to epidemic expansions. Migration may play an important role in the introduction of new parasite strains leading to epidemic expansions, with important implications for malaria elimination.	[Abdullah, Noor Rain; Norahmad, Nor Azrina; Satsu, Umi Rubiah; Muniandy, Prem Kumar; Ismail, Zakiah] Inst Med Res, Herbal Med Res Ctr, Kuala Lumpur, Malaysia; [Barber, Bridget E.; William, Timothy; Grigg, Matthew J.] Queen Elizabeth Hosp, Infect Dis Unit, Kota Kinabalu, Sabah, Malaysia; [Barber, Bridget E.; Grigg, Matthew J.; Piera, Kim; von Seidlein, Lorenz; Yeo, Tsin W.; Anstey, Nicholas M.; Price, Ric N.; Auburn, Sarah] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Barber, Bridget E.; Grigg, Matthew J.; Piera, Kim; von Seidlein, Lorenz; Yeo, Tsin W.; Anstey, Nicholas M.; Price, Ric N.; Auburn, Sarah] Charles Darwin Univ, Darwin, NT 0909, Australia; [William, Timothy; Jelip, Jenarun] Sabah Dept Hlth, Kota Kinabalu, Sabah, Malaysia; [Anstey, Nicholas M.; Price, Ric N.] Royal Darwin Hosp, Div Med, Darwin, NT, Australia; [Price, Ric N.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	Kementerian Kesihatan Malaysia; Charles Darwin University; Menzies School of Health Research; Charles Darwin University; University of Oxford	Auburn, S (corresponding author), Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.	sarah.auburn@menzies.edu.au	Barber, Bridget/AAV-2681-2020; Yeo, Tsin Wen/F-9505-2015; Grigg, Matthew/AAB-2629-2021; Barber, Bridget/W-2965-2019; Auburn, Sarah/N-2266-2013	Barber, Bridget/0000-0003-1066-7960; Price, Richard/0000-0003-2000-2874; Auburn, Sarah/0000-0002-4638-536X; Grigg, Matthew Joseph/0000-0001-9914-8352	Asia Pacific Malaria Elimination Network; National Institute of Health, Ministry of Health Malaysia; Australian National Health and Medical Research Council; Wellcome Trust; APMEN; National Health and Medical Research Council, Australia	Asia Pacific Malaria Elimination Network; National Institute of Health, Ministry of Health Malaysia(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission); APMEN; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	The study was supported by the Asia Pacific Malaria Elimination Network (APMEN research grant awarded to NRA), National Institute of Health, Ministry of Health Malaysia, Australian National Health and Medical Research Council and the Wellcome Trust. SA, LVS and RNP were funded by APMEN. BW, AP, KP, BEB, TWY, and NMA were funded by the National Health and Medical Research Council, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Auburn S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053160; Barber BE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-8; Barber BE, 2013, CLIN INFECT DIS, V56, P383, DOI 10.1093/cid/cis902; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Carlton JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001160; Chan ER, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001811; Department of Statistics, 2011, POP DISTR BAS DEM CH; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Gunawardena S, 2010, AM J TROP MED HYG, V82, P235, DOI 10.4269/ajtmh.2010.09-0588; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Imwong M, 2007, INT J PARASITOL, V37, P1013, DOI 10.1016/j.ijpara.2007.02.010; Imwong M, 2009, J CLIN MICROBIOL, V47, P4173, DOI 10.1128/JCM.00811-09; Joveen-Neoh Wan Fen, 2011, J Parasitol Res, V2011, P104284, DOI 10.1155/2011/104284; Karunaweera ND, 2007, MOL ECOL NOTES, V7, P172, DOI 10.1111/j.1471-8286.2006.01534.x; Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022; Koepfli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066041; Koepfli C, 2009, J INFECT DIS, V199, P1074, DOI 10.1086/597303; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Mueller I, 2013, ADV PARASIT, V81, P77, DOI 10.1016/B978-0-12-407826-0.00003-5; Padley D, 2003, ANN TROP MED PARASIT, V97, P131, DOI 10.1179/000349803125002977; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rundi C, 2011, 3 ANN APMEN TECHN BU; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; TRAVIS J, 1990, PHILOS T R SOC B, V330, P253, DOI 10.1098/rstb.1990.0196; Van den Eede P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-151; Van den Eede P, 2010, AM J TROP MED HYG, V82, P223, DOI 10.4269/ajtmh.2010.09-0458; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; WHO, 2010, WORLD MALARIA REPORT 2010, P1; William T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002026	39	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82553	10.1371/journal.pone.0082553	http://dx.doi.org/10.1371/journal.pone.0082553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358203	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700021
J	Bennett, AE; Daniell, TJ; Opik, M; Davison, J; Moora, M; Zobel, M; Selosse, MA; Evans, D				Bennett, Alison Elizabeth; Daniell, Tim John; Oepik, Maarja; Davison, John; Moora, Mari; Zobel, Martin; Selosse, Marc-Andre; Evans, Darren			Arbuscular Mycorrhizal Fungal Networks Vary throughout the Growing Season and between Successional Stages	PLOS ONE			English	Article							BOREONEMORAL FOREST; PLANT; DYNAMICS; DIVERSITY; CHRONOSEQUENCE; DETERMINANTS; ARCHITECTURE; COMMUNITIES; RICHNESS; GLACIER	To date, few analyses of mutualistic networks have investigated successional or seasonal dynamics. Combining interaction data from multiple time points likely creates an inaccurate picture of the structure of networks (because these networks are aggregated across time), which may negatively influence their application in ecosystem assessments and conservation. Using a replicated bipartite mutualistic network of arbuscular mycorrhizal (AM) fungal-plant associations, detected using large sample numbers of plants and AM fungi identified through molecular techniques, we test whether the properties of the network are temporally dynamic either between different successional stages or within the growing season. These questions have never been directly tested in the AM fungal-plant mutualism or the vast majority of other mutualisms. We demonstrate the following results: First, our examination of two different successional stages (young and old forest) demonstrated that succession increases the proportion of specialists within the community and decreases the number of interactions. Second, AM fungal-plant mutualism structure changed throughout the growing season as the number of links between partners increased. Third, we observed shifts in associations between AM fungal and plant species throughout the growing season, potentially reflecting changes in biotic and abiotic conditions. Thus, this analysis opens up two entirely new areas of research: 1) identifying what influences changes in plant-AM fungal associations in these networks, and 2) what aspects of temporal variation and succession are of general importance in structuring bipartite networks and plant-AM fungal communities.	[Bennett, Alison Elizabeth; Daniell, Tim John] James Hutton Inst, Dundee, Scotland; [Oepik, Maarja; Davison, John; Moora, Mari; Zobel, Martin] Univ Tartu, Inst Ecol & Earth Sci, Dept Bot, EE-50090 Tartu, Estonia; [Selosse, Marc-Andre] Museum Natl Hist Nat, Dept Systemat & Evolut, F-75231 Paris, France; [Evans, Darren] Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull, Yorks, England	James Hutton Institute; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Museum National d'Histoire Naturelle (MNHN); University of Hull	Bennett, AE (corresponding author), James Hutton Inst, Dundee, Scotland.	alibenne@bio.indiana.edu	Öpik, Maarja/A-1765-2008; Zobel, Martin/H-1336-2015; Evans, Darren Mark/J-9782-2012; Moora, Mari/D-1961-2009; Daniell, Tim J/E-8482-2011	Öpik, Maarja/0000-0001-8025-7460; Zobel, Martin/0000-0001-7957-6704; Moora, Mari/0000-0002-4819-7506; Daniell, Tim J/0000-0003-0435-4343; Evans, Darren/0000-0003-4061-6726	Scottish Government Rural and Environment Research and Analysis Directorate (RESAS) Workpackage Themes one and three; Estonian Science Foundation [SF0180098s08]; Centre National de la Recherche Scientifique; European Regional Development Fund (Center of Excellence FIBIR)	Scottish Government Rural and Environment Research and Analysis Directorate (RESAS) Workpackage Themes one and three; Estonian Science Foundation; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Regional Development Fund (Center of Excellence FIBIR)(European Commission)	This research was funded by the Scottish Government Rural and Environment Research and Analysis Directorate (RESAS) Workpackage Themes one and three, by grants from Estonian Science Foundation (9050, 9157), targeted financing SF0180098s08), Centre National de la Recherche Scientifique and the European Regional Development Fund (Center of Excellence FIBIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aavik T, 2009, ANN BOT FENN, V46, P326, DOI 10.5735/085.046.0408; Albrecht M, 2010, OIKOS, V119, P1610, DOI 10.1111/j.1600-0706.2010.18376.x; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Basilio AM, 2006, AUSTRAL ECOL, V31, P975, DOI 10.1111/j.1442-9993.2006.01666.x; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bluthgen N, 2010, BASIC APPL ECOL, V11, P185, DOI 10.1016/j.baae.2010.01.001; Borowicz VA, 2001, ECOLOGY, V82, P3057; Chagnon PL, 2012, NEW PHYTOL, V194, P307, DOI 10.1111/j.1469-8137.2011.04044.x; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chaudhary VB., 2008, MYCORRHIZA STATE ART, P529, DOI DOI 10.1007/978-3-540-78826-3_26; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Covacevich F, 2011, AFR J MICROBIOL RES, V5, P2697; Daniell TJ, 2001, FEMS MICROBIOL ECOL, V36, P203, DOI 10.1111/j.1574-6941.2001.tb00841.x; Davison J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041938; Davison J, 2011, FEMS MICROBIOL ECOL, V78, P103, DOI 10.1111/j.1574-6941.2011.01103.x; Diaz-Castelazo C, 2010, ECOLOGY, V91, P793, DOI 10.1890/08-1883.1; Donatti CI, 2011, ECOL LETT, V14, P773, DOI 10.1111/j.1461-0248.2011.01639.x; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Eiler A, 2012, ISME J, V6, P330, DOI 10.1038/ismej.2011.113; Gehring C, 2009, ENVIRON ENTOMOL, V38, P93, DOI 10.1603/022.038.0111; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; Heinemeyer A, 2004, J EXP BOT, V55, P525, DOI 10.1093/jxb/erh049; JOHNSON NC, 1992, AGRON J, V84, P387, DOI 10.2134/agronj1992.00021962008400030007x; Koorem K, 2012, BASIC APPL ECOL, V13, P663, DOI 10.1016/j.baae.2012.09.008; Koorem K, 2010, FOREST ECOL MANAG, V260, P1407, DOI 10.1016/j.foreco.2010.07.043; Kuuluvainen T, 2009, AMBIO, V38, P309, DOI 10.1579/08-A-490.1; Lekberg Y, 2010, FEMS MICROBIOL ECOL, V74, P336, DOI 10.1111/j.1574-6941.2010.00956.x; Liu Y, 2009, FEMS MICROBIOL ECOL, V67, P81, DOI 10.1111/j.1574-6941.2008.00597.x; Medan D, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P245; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; Montesinos-Navarro A, 2012, NEW PHYTOL, V194, P536, DOI 10.1111/j.1469-8137.2011.04045.x; Moora M, 2009, OECOLOGIA, V159, P355, DOI 10.1007/s00442-008-1209-5; Moora M, 2007, FOREST ECOL MANAG, V250, P64, DOI 10.1016/j.foreco.2007.03.010; Moora M, 2011, J BIOGEOGR, V38, P1305, DOI 10.1111/j.1365-2699.2011.02478.x; Oehl F, 2003, APPL ENVIRON MICROB, V69, P2816, DOI 10.1128/AEM.69.5.2816-2824.2003; Oehl F, 2011, PEDOBIOLOGIA, V54, P321, DOI 10.1016/j.pedobi.2011.07.006; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Olesen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026455; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; Opik M, 2008, NEW PHYTOL, V179, P867, DOI 10.1111/j.1469-8137.2008.02515.x; Raymond B, 2009, ECOL MODEL, V220, P673, DOI 10.1016/j.ecolmodel.2008.12.011; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Sanders IR, 2010, ISME J, V4, P1081, DOI 10.1038/ismej.2010.109; Sanders IR, 2004, NEW PHYTOL, V164, P415, DOI 10.1111/j.1469-8137.2004.01208.x; Selosse MA, 1998, TRENDS ECOL EVOL, V13, P15, DOI 10.1016/S0169-5347(97)01230-5; Selosse MA, 2006, TRENDS ECOL EVOL, V21, P621, DOI 10.1016/j.tree.2006.07.003; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; Ugland KI, 2003, J ANIM ECOL, V72, P888, DOI 10.1046/j.1365-2656.2003.00748.x; Uibopuu A, 2009, SOIL BIOL BIOCHEM, V41, P2141, DOI 10.1016/j.soilbio.2009.07.026; Vacher C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001740; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1	59	47	50	2	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83241	10.1371/journal.pone.0083241	http://dx.doi.org/10.1371/journal.pone.0083241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358265	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700052
J	Chen, SS; Luetje, CW				Chen, Sisi; Luetje, Charles W.			Phenylthiophenecarboxamide Antagonists of the Olfactory Receptor Co-Receptor Subunit from a Mosquito	PLOS ONE			English	Article							DROSOPHILA ODORANT RECEPTORS; MOLECULAR-BASIS; BEHAVIOR; SYSTEM	Insects detect environmental chemicals using chemosensory receptors, such as the ORs, a family of odorant-gated ion channels. Insect ORs are multimeric complexes of unknown stoichiometry, formed by a common subunit (the odorant receptor co-receptor subunit, Orco) and one of many variable subunits that confer odorant specificity. The recent discovery of Orco directed ligands, including both agonists and antagonists, suggests Orco as a promising target for chemical control of insects. In addition to competitively inhibiting OR activation by Orco agonists, several Orco antagonists have been shown to act through a non-competitive mechanism to inhibit OR activation by odorants. We previously identified a series of Orco antagonists, including N-(4-ethylphenyl)-2-thiophenecarboxamide (OX1a, previously referred to as OLC20). Here, we explore the chemical space around the OX1a structure to identify more potent Orco antagonists. Cqui\Orco+Cqui\Or21, an OR from Culex quinquefasciatus (the Southern House Mosquito) that responds to 3-methylindole (skatole) and is thought to mediate oviposition behavior, was expressed in Xenopus oocytes and receptor function assayed by two-electrode voltage clamp electrophysiology. 22 structural analogs of OX1a were screened for antagonism of OR activation by an Orco agonist. By varying the moieties decorating the phenyl and thiophene rings, and altering the distance between the rings, we were able to identify antagonists with improved potency. Detailed examination of three of these compounds (N-mesityl-2-thiophenecarboxamide, N-(4-methylbenzyl)-2-thiophenecarboxamide and N-(2-ethylphenyl)-3-(2-thienyl)-2-propenamide)demonstrated competitive inhibition of receptor activation by an Orco agonist and non-competitive inhibition of receptor activation by an odorant. The ability to inhibit OR activation by odorants may be a general property of this class of Orco antagonist, suggesting that odorant mediated behaviors can be manipulated through Orco antagonism. The high conservation of Orco across insect species and previous demonstrations that various Orco ligands are active at ORs derived from several different insect orders suggests that Orco antagonists may have broad applicability.	[Chen, Sisi; Luetje, Charles W.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Coral Gables, FL 33124 USA	University of Miami	Luetje, CW (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Coral Gables, FL 33124 USA.	cluetje@med.miami.edu	CHEN, SI/GZL-4800-2022		NIH [RO1 DC011091]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011091] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by RO1 DC011091 from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bohbot JD, 2012, NEUROPHARMACOLOGY, V62, P2086, DOI 10.1016/j.neuropharm.2012.01.004; Carey AF, 2011, P NATL ACAD SCI USA, V108, P12987, DOI 10.1073/pnas.1103472108; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hughes DT, 2010, J CHEM ECOL, V36, P797, DOI 10.1007/s10886-010-9828-9; Jones PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030304; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Nichols AS, 2010, J BIOL CHEM, V285, P11854, DOI 10.1074/jbc.M109.058321; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Ramdya P, 2010, TRENDS GENET, V26, P307, DOI 10.1016/j.tig.2010.04.004; Rinker DC, 2012, PHYSIOL ENTOMOL, V37, P33, DOI 10.1111/j.1365-3032.2011.00821.x; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Taylor RW, 2012, ACS CHEM BIOL, V7, P1647, DOI 10.1021/cb300331z; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wicher D, 2009, ANN NY ACAD SCI, V1170, P164, DOI 10.1111/j.1749-6632.2009.04101.x; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105; Xu PX, 2013, J INSECT PHYSIOL, V59, P961, DOI 10.1016/j.jinsphys.2013.07.004	34	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84575	10.1371/journal.pone.0084575	http://dx.doi.org/10.1371/journal.pone.0084575			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358366	Green Submitted, Green Published, gold			2022-12-27	WOS:000328737700101
J	Kiggundu, VL; O'Meara, WP; Musoke, R; Nalugoda, FK; Kigozi, G; Baghendaghe, E; Lutalo, T; Achienge, MK; Reynolds, SJ; Makumbi, F; Serwadda, D; Gray, RH; Wools-Kaloustian, KK				Kiggundu, Valerian L.; O'Meara, Wendy P.; Musoke, Richard; Nalugoda, Fred K.; Kigozi, Godfrey; Baghendaghe, Enos; Lutalo, Tom; Achienge, Marion K.; Reynolds, Steven J.; Makumbi, Fred; Serwadda, David; Gray, Ronald H.; Wools-Kaloustian, Kara K.			High Prevalence of Malaria Parasitemia and Anemia among Hospitalized Children in Rakai, Uganda	PLOS ONE			English	Article							TRANSMISSION INTENSITY; MORTALITY; MORBIDITY; MISDIAGNOSIS; SITES	Background: There is a paucity of data on malaria among hospitalized children in malaria endemic areas. We determined the prevalence, presentation and treatment outcomes of malaria and anemia among children in two hospitals in Rakai, Uganda. Methods: Children under five years hospitalized in Kalisizo hospital or Bikira health center in Rakai district, Uganda between May 2011 and May 2012 were enrolled and followed-up until discharge, death or referral. Data were collected on social-demographic characteristics, current and past illnesses and clinical signs and symptoms. Blood smears, hemoglobin (Hgb) levels and HIV testing were performed from finger/heel prick blood. The associations between malaria infection and other factors were estimated using log-binomial regression to estimate adjusted prevalence risk ratios (aPRR) and 95% confidence intervals (CIs), controlling for clustering at health facilities. Results: 2471 children were enrolled. The most common medical presentations were fever (96.2%), cough (61.7%), vomiting (44.2%), diarrhea (20.8%), and seizures (16.0%). The prevalence of malaria parasitemia was 54.6%. Children with malaria were more likely to present with a history of fever (aPRR 2.23; CI 1.18-4.24) and seizures (aPRR 1.12; CI 1.09-1.16). Confirmed malaria was significantly lower among girls than boys (aPRR 0.92; CI 0.91-0.93), HIV infected children (aPRR 0.60 CI 0.52-0.71), and children with diarrhea (aPRR 0.76; CI 0.65-0.90). The overall prevalence of anemia (Hgb, 10 g/dl) was 56.3% and severe anemia (Hgb, 6 g/dL) was 17.8%. Among children with severe anemia 76.8% had malaria parasitemia, of whom 93.1% received blood transfusion. Malaria associated mortality was 0.6%. Conclusion: There was a high prevalence of malaria parasitemia and anemia among inpatient children under five years. Malaria prevention is a priority in this population.	[Kiggundu, Valerian L.; Musoke, Richard; Nalugoda, Fred K.; Kigozi, Godfrey; Baghendaghe, Enos; Lutalo, Tom; Reynolds, Steven J.; Makumbi, Fred; Serwadda, David] Kalisizo Stn, Rakai Hlth Sci Program, Kalisizo, Rakai, Uganda; [O'Meara, Wendy P.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [O'Meara, Wendy P.] Duke Global Hlth Inst, Durham, NC USA; [Achienge, Marion K.] Makerere Univ, Coll Hlth Sci, East African IeDEA Int Epidemiol Data Bases Evalu, Kampala, Uganda; [Achienge, Marion K.] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Reynolds, Steven J.] NIAID, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Makumbi, Fred; Serwadda, David] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Gray, Ronald H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Wools-Kaloustian, Kara K.] Indiana Univ Sch Med, Dept Med, Div Infect Dis, Indianapolis, IN 46202 USA	Rakai Health Sciences Program; Duke University; Duke University; Makerere University; Makerere University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Makerere University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Indiana University System; Indiana University Bloomington	Kiggundu, VL (corresponding author), Kalisizo Stn, Rakai Hlth Sci Program, Kalisizo, Rakai, Uganda.	valerian@rhsp.org		Musoke, Richard/0000-0002-2566-4191; Reynolds, Steven/0000-0002-5403-2759	National Institute of Allergy and Infectious Diseases (NIAID) [U01 A1069911]; National Institute of Child Health and Human Development (NICHD); National Cancer Institute (NCI) and National Institute of Health (NIH) through Indiana University and East Africa IeDEA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001040, U01AI069911] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute (NCI) and National Institute of Health (NIH) through Indiana University and East Africa IeDEA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by grant No. U01 A1069911 from the National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Child Health and Human Development (NICHD); National Cancer Institute (NCI) and National Institute of Health (NIH) through Indiana University and East Africa IeDEA (international epidemiological data bases to evaluate AIDs). The contents of this project are solely the responsibility of the authors and do not necessarily represent the official view of the National Institute of Allergy and Infectious Disease (NIAID); National Institute of Child Health and Human Development (NICHD); National Cancer Institute (NCI) or National Institute of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; De Beaudrap P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-132; Genton B, 2008, EXPERT REV VACCINES, V7, P597, DOI 10.1586/14760584.7.5.597; Greenwood B, 2005, CLIN INFECT DIS, V40, P1519, DOI 10.1086/429833; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hobbs CV, 2012, J INFECT DIS, V206, P1706, DOI 10.1093/infdis/jis602; Hopkins H, 2008, J INFECT DIS, V197, P510, DOI 10.1086/526502; Ministry of health U, 2010, UG CLIN GUID 2010; Ministry of health U, 2011, UG MAL PROGR REV REP; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; O'Meara WP, 2009, PARASITE IMMUNOL, V31, P574, DOI 10.1111/j.1365-3024.2009.01144.x; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Obonyo CO, 2007, AM J TROP MED HYG, V77, P23; Ohrt C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-79; Okello PE, 2006, AM J TROP MED HYG, V75, P219, DOI 10.4269/ajtmh.2006.75.219; Opoka RO, 2008, PEDIATR INFECT DIS J, V27, P319, DOI 10.1097/INF.0b013e31815d74dd; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; Reyburn H, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-4; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Talisuna AO, 2007, AM J TROP MED HYG, V77, P170; van Hensbroek MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012589; WHO, 2011, WORLD MALARIA REPORT 2011, P1	28	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82455	10.1371/journal.pone.0082455	http://dx.doi.org/10.1371/journal.pone.0082455			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358185	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700017
J	Morken, TS; Nyman, AKG; Sandvig, I; Torp, SH; Skranes, J; Goa, PE; Brubakk, AM; Wideroe, M				Morken, Tora Sund; Nyman, Axel Karl Gotffrid; Sandvig, Ioanna; Torp, Sverre Helge; Skranes, Jon; Goa, Pal Erik; Brubakk, Ann-Mari; Wideroe, Marius			Brain Development after Neonatal Intermittent Hyperoxia-Hypoxia in the Rat Studied by Longitudinal MRI and Immunohistochemistry	PLOS ONE			English	Article							WHITE-MATTER INJURY; DIFFUSION TENSOR; POSTNATAL-DEVELOPMENT; GERMINAL MATRIX; PRETERM INFANTS; CEREBRAL-CORTEX; RETINOPATHY; PREMATURITY; GROWTH; BLOOD	Background: Neonatal intermittent hyperoxia-hypoxia (IHH) is involved in the pathogenesis of retinopathy of prematurity. Whether similar oxygen fluctuations will create pathological changes in the grey and white matter of the brain is unknown. Methods: From birth until postnatal day 14 (P14), two litters (total n = 22) were reared in IHH: hyperoxia (50% O-2) interrupted by three consecutive two-minute episodes of hypoxia (12% O-2) every sixth hour. Controls (n = 8) were reared in room-air (20.9% O-2). Longitudinal MRI (Diffusion Tensor Imaging and T2-mapping) was performed on P14 and P28 and retinal and brain tissue were examined for histopathological changes. Long-term neurodevelopment was assessed on P20 and P27. Results: Mean, radial and axial diffusivity were higher in white matter of IHH versus controls at P14 (p < 0.04), while fractional anisotropy (FA) was lower in the hippocampal fimbria and tended to be lower in corpus callosum (p = 0.08) and external capsule (p = 0.05). White matter diffusivity in IHH was similar to controls at P28. Higher cortical vessel density (p = 0.005) was observed at P14. Cortical and thalamic T-2-relaxation time and mean diffusivity were higher in the IHH group at P14 (p <= 0.03), and albumin leakage was present at P28. Rats in the IHH group ran for a longer time on a Rotarod than the control group (p <= 0.005). Pups with lower bodyweight had more severe MRI alterations and albumin leakage. Conclusion: IHH led to subtle reversible changes in brain white matter diffusivity, grey matter water content and vascular density. However, alterations in blood-brain barrier permeability may point to long-term effects. The changes seen after IHH exposure were more severe in animals with lower bodyweight and future studies should aim at exploring possible interactions between IHH and growth restriction.	[Morken, Tora Sund; Torp, Sverre Helge; Skranes, Jon; Brubakk, Ann-Mari] Norwegian Univ Sci & Technol NTNU, Dept Lab Med Childrens & Womens Hlth, Trondheim, Norway; [Nyman, Axel Karl Gotffrid; Sandvig, Ioanna; Wideroe, Marius] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Skranes, Jon; Brubakk, Ann-Mari] St Olavs Univ Hosp, Cent Norway Reg Hlth Author, Dept Pediat, Trondheim, Norway; [Goa, Pal Erik] St Olavs Univ Hosp, Cent Norway Reg Hlth Author, Dept Radiol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Morken, TS (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Lab Med Childrens & Womens Hlth, Trondheim, Norway.	tora.s.morken@ntnu.no	Torp, Sverre Helge/AAN-4229-2020	Torp, Sverre Helge/0000-0001-8345-6852; Sandvig, Ioanna/0000-0002-2109-1357	Liaison Committee between the Central Norway Region Health Authority; Norwegian University of Science and Technology	Liaison Committee between the Central Norway Region Health Authority; Norwegian University of Science and Technology	This work was supported by a grant from the Liaison Committee between the Central Norway Region Health Authority and the Norwegian University of Science and Technology (to T.S.M.). URL: http://www.ntnu.no/dmf/rad/samorg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baburamani AA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00424; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Bockhorst KH, 2008, J NEUROSCI RES, V86, P1520, DOI 10.1002/jnr.21607; Braun A, 2007, J NEUROSCI, V27, P12012, DOI 10.1523/JNEUROSCI.3281-07.2007; Brehmer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049023; Buser JR, 2012, ANN NEUROL, V71, P93, DOI 10.1002/ana.22627; BUTT AM, 1990, J PHYSIOL-LONDON, V429, P47, DOI 10.1113/jphysiol.1990.sp018243; Cai J, 2012, J PATHOL, V226, P495, DOI 10.1002/path.2980; Chahboune H, 2009, CEREB CORTEX, V19, P2891, DOI 10.1093/cercor/bhp068; Chahoud I, 2009, ENVIRON RES, V109, P1021, DOI 10.1016/j.envres.2009.07.015; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Coleman RJ, 2008, PEDIATR RES, V64, P50, DOI 10.1203/PDR.0b013e31817307ac; Cunningham S, 2000, INVEST OPHTH VIS SCI, V41, P4275; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Di Fiore JM, 2012, PEDIATR RES, V72, P606, DOI 10.1038/pr.2012.132; DZIEGIELEWSKA KM, 1991, J PHYSIOL-LONDON, V439, P215, DOI 10.1113/jphysiol.1991.sp018664; El-Khoury N, 2006, PEDIATR RES, V59, P673, DOI 10.1203/01.pdr.0000214975.85311.9c; Gerstner B, 2008, J NEUROSCI, V28, P1236, DOI 10.1523/JNEUROSCI.3213-07.2008; Gonul E, 2002, MICROVASC RES, V64, P116, DOI 10.1006/mvre.2002.2413; Hartnett ME, 2012, NEW ENGL J MED, V367, P2515, DOI 10.1056/NEJMra1208129; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Kanaan A, 2006, AM J PHYSIOL-REG I, V290, pR1105, DOI 10.1152/ajpregu.00535.2005; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; LEHMENKUHLER A, 1993, NEUROSCIENCE, V55, P339, DOI 10.1016/0306-4522(93)90503-8; Lepomaki V, 2013, PEDIATR RADIOL, V43, P80, DOI 10.1007/s00247-012-2509-9; Leviton A, 2013, PEDIATR RES, V73, P362, DOI 10.1038/pr.2012.188; Lofqvist C, 2006, PEDIATRICS, V117, P1930, DOI 10.1542/peds.2005-1926; Martin RJ, 2011, NEONATOLOGY, V100, P303, DOI 10.1159/000329922; Martinussen M, 2005, BRAIN, V128, P2588, DOI 10.1093/brain/awh610; Ment LR, 1998, DEV BRAIN RES, V111, P197, DOI 10.1016/S0165-3806(98)00139-4; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Morken TS, 2013, PEDIATR RES, V73, P171, DOI 10.1038/pr.2012.170; Msall ME, 2000, PEDIATRICS, V106, P998, DOI 10.1542/peds.106.5.998; Msall ME, 2006, PEDIATRICS, V117, P2287, DOI 10.1542/peds.2006-0385; Ogunshola OO, 2000, DEV BRAIN RES, V119, P139, DOI 10.1016/S0165-3806(99)00125-X; Palmer AK, 1997, FUND APPL TOXICOL, V38, P7, DOI 10.1006/faat.1997.2319; Paxinos G, 2008, RAT BRAIN STEREOTAXI; PENN JS, 1995, INVEST OPHTH VIS SCI, V36, P2063; Pichiule P, 2002, J APPL PHYSIOL, V93, P1131, DOI 10.1152/japplphysiol.00318.2002; Ramani M, 2013, NEUROBIOL DIS, V50, P69, DOI 10.1016/j.nbd.2012.10.005; ROTH AM, 1977, AM J OPHTHALMOL, V84, P636, DOI 10.1016/0002-9394(77)90377-4; Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046; Schmitz T, 2012, EXP NEUROL, V235, P374, DOI 10.1016/j.expneurol.2012.03.002; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Schwartz ML, 2004, SEMIN PERINATOL, V28, P379, DOI 10.1053/j.semperi.2004.10.009; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Sirinyan M, 2006, STROKE, V37, P2807, DOI 10.1161/01.STR.0000245082.19294.ff; Thornton JS, 1999, MAGN RESON IMAGING, V17, P1289, DOI 10.1016/S0730-725X(99)00063-6; Vangberg TR, 2006, NEUROIMAGE, V32, P1538, DOI 10.1016/j.neuroimage.2006.04.230; Vottier G, 2011, DEV NEUROSCI-BASEL, V33, P261, DOI 10.1159/000327245; Walhovd KB, 2012, P NATL ACAD SCI USA, V109, P20089, DOI 10.1073/pnas.1208180109; WIGGLESWORTH JS, 1978, EARLY HUM DEV, V2, P179, DOI 10.1016/0378-3782(78)90010-5; Yager JY, 2009, PEDIATR NEUROL, V40, P156, DOI 10.1016/j.pediatrneurol.2008.10.025	53	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84109	10.1371/journal.pone.0084109	http://dx.doi.org/10.1371/journal.pone.0084109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358332	Green Submitted, Green Published, gold			2022-12-27	WOS:000328737700080
J	Schwingshackl, L; Dias, S; Strasser, B; Hoffmann, G				Schwingshackl, Lukas; Dias, Sofia; Strasser, Barbara; Hoffmann, Georg			Impact of Different Training Modalities on Anthropometric and Metabolic Characteristics in Overweight/Obese Subjects: A Systematic Review and Network Meta-Analysis	PLOS ONE			English	Review							C-REACTIVE PROTEIN; ALL-CAUSE MORTALITY; RESISTANCE EXERCISE; AEROBIC EXERCISE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; RISK-FACTORS; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR EVENTS; WAIST CIRCUMFERENCE	Background: The aim of this systematic review of randomized controlled trials was to compare the effects of aerobic training (AET), resistance training (RT), and combined aerobic and resistance training (CT) on anthropometric parameters, blood lipids, and cardiorespiratory fitness in overweight and obese subjects. Methods: Electronic searches for randomized controlled trials were performed in MEDLINE, EMBASE and the Cochrane Trial Register. Inclusion criteria were: Body Mass Index: >= 25 kg/m 2, 19+ years of age, supervised exercise training, and a minimum intervention period of 8 weeks. Anthropometric outcomes, blood lipids, and cardiorespiratory fitness parameters were included. Pooled effects were calculated by inverse-variance random effect pairwise meta-analyses and Bayesian random effects network meta-analyses. Findings: 15 trials enrolling 741 participants were included in the meta-analysis. Compared to RT, AET resulted in a significantly more pronounced reduction of body weight [mean differences (MD): -1.15 kg, p = 0.04], waist circumference [MD: -1.10 cm, p = 0.004], and fat mass [MD: -1.15 kg, p = 0.001] respectively. RT was more effective than AET in improving lean body mass [MD: 1.26 kg, p<0.00001]. When comparing CT with RT, MD in change of body weight [MD: -2.03 kg, p<0.0001], waist circumference [MD: -1.57 cm, p = 0.0002], and fat mass [MD: -1.88 kg, p<0.00001] were all in favor of CT. Results from the network meta-analyses confirmed these findings. Conclusion: Evidence from both pairwise and network meta-analyses suggests that CT is the most efficacious means to reduce anthropometric outcomes and should be recommended in the prevention and treatment of overweight, and obesity whenever possible.	[Schwingshackl, Lukas; Hoffmann, Georg] Univ Vienna, Fac Life Sci, Dept Nutr Sci, Vienna, Austria; [Dias, Sofia] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Strasser, Barbara] Univ Hlth Sci Med Informat & Technol, Inst Nutr Sci & Physiol, Hall In Tirol, Austria	University of Vienna; University of Bristol	Schwingshackl, L (corresponding author), Univ Vienna, Fac Life Sci, Dept Nutr Sci, Vienna, Austria.	lukas.schwingshackl@univie.ac.at	Schwingshackl, Lukas/AAC-4119-2019; Strasser, Barbara/ABG-3013-2020; Dias, Sofia/F-1922-2010; Hoffmann, Georg/B-9201-2013	Schwingshackl, Lukas/0000-0003-3407-7594; Dias, Sofia/0000-0002-2172-0221; Strasser, Barbara/0000-0002-4318-5629				Ahmadizad S, 2007, EUR J ENDOCRINOL, V157, P625, DOI 10.1530/EJE-07-0223; Ballor DL, 1996, METABOLISM, V45, P179, DOI 10.1016/S0026-0495(96)90050-5; Banz WJ, 2003, EXP BIOL MED, V228, P434, DOI 10.1177/153537020322800414; Bateman LA, 2011, AM J CARDIOL, V108, P838, DOI 10.1016/j.amjcard.2011.04.037; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Davidson LE, 2009, ARCH INTERN MED, V169, P122, DOI 10.1001/archinternmed.2008.558; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S, 2011, NICE DSU TECHNICAL S; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Donges CE, 2010, MED SCI SPORT EXER, V42, P304, DOI 10.1249/MSS.0b013e3181b117ca; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fisher G, 2011, OBESITY, V19, P1131, DOI 10.1038/oby.2010.310; Galani C, 2007, INT J PUBLIC HEALTH, V52, P348, DOI 10.1007/s00038-007-7015-8; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Ismail I, 2012, OBES REV, V13, P68, DOI 10.1111/j.1467-789X.2011.00931.x; Janssen I, 2002, DIABETES CARE, V25, P431, DOI 10.2337/diacare.25.3.431; Kelley GA, 2000, HYPERTENSION, V35, P838, DOI 10.1161/01.HYP.35.3.838; Kelley GA, 2006, METABOLISM, V55, P1500, DOI 10.1016/j.metabol.2006.06.021; Kelley George A, 2008, Prev Cardiol, V11, P71; Kodama S, 2007, ARCH INTERN MED, V167, P999, DOI 10.1001/archinte.167.10.999; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Kraemer WJ, 1999, MED SCI SPORT EXER, V31, P1320, DOI 10.1097/00005768-199909000-00014; Lee DC, 2011, CIRCULATION, V124, P2483, DOI 10.1161/CIRCULATIONAHA.111.038422; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Martins RA, 2010, EUR J APPL PHYSIOL, V110, P161, DOI 10.1007/s00421-010-1488-5; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mourier A, 1997, DIABETES CARE, V20, P385, DOI 10.2337/diacare.20.3.385; NELSON ME, 1994, JAMA-J AM MED ASSOC, V272, P1909, DOI 10.1001/jama.272.24.1909; Park Sang-Kab, 2003, Journal of Physiological Anthropology and Applied Human Science, V22, P129, DOI 10.2114/jpa.22.129; Potteiger JA, 2012, EUR J APPL PHYSIOL, V112, P2035, DOI 10.1007/s00421-011-2174-y; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; PRATLEY R, 1994, J APPL PHYSIOL, V76, P133, DOI 10.1063/1.357118; Rice B, 1999, DIABETES CARE, V22, P684, DOI 10.2337/diacare.22.5.684; ROSS R, 1994, AM J CLIN NUTR, V60, P695, DOI 10.1093/ajcn/60.5.695; Sarsan A, 2006, CLIN REHABIL, V20, P773, DOI 10.1177/0269215506070795; SMUTOK MA, 1993, METABOLISM, V42, P177, DOI 10.1016/0026-0495(93)90032-J; Stensvold D, 2010, J APPL PHYSIOL, V108, P804, DOI 10.1152/japplphysiol.00996.2009; Strasser B, 2012, OBES REV, V13, P578, DOI 10.1111/j.1467-789X.2012.00988.x; Strasser B, 2010, SPORTS MED, V40, P397, DOI 10.2165/11531380-000000000-00000; Thorogood A, 2011, AM J MED, V124, P747, DOI 10.1016/j.amjmed.2011.02.037; Wallace MB, 1997, MED SCI SPORT EXER, V29, P1170, DOI 10.1097/00005768-199709000-00008; Willis LH, 2012, J APPL PHYSIOL, V113, P1831, DOI 10.1152/japplphysiol.01370.2011; World Health Organization, 2011, OB OV FACT SHEET 311	49	91	94	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82853	10.1371/journal.pone.0082853	http://dx.doi.org/10.1371/journal.pone.0082853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358230	gold, Green Published, Green Submitted			2022-12-27	WOS:000328737700034
J	Amaral, C; Pimentel, C; Matos, RG; Arraiano, CM; Matzapetakis, M; Rodrigues-Pousada, C				Amaral, Catarina; Pimentel, Catarina; Matos, Rute G.; Arraiano, Cecilia M.; Matzapetakis, Manolis; Rodrigues-Pousada, Claudina			Two Residues in the Basic Region of the Yeast Transcription Factor Yap8 Are Crucial for Its DNA-Binding Specificity	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; ACTIVATION; COMPLEX; RECOGNITION; PROTEINS; GENE; GCN4; ACR3	In Saccharomyces cerevisiae, the transcription factor Yap8 is a key determinant in arsenic stress response. Contrary to Yap1, another basic region-leucine zipper (bZIP) yeast regulator, Yap8 has a very restricted DNA-binding specificity and only orchestrates the expression of ACR2 and ACR3 genes. In the DNA-binding basic region, Yap8 has three distinct amino acids residues, Leu26, Ser29 and Asn31, at sites of highly conserved positions in the other Yap family of transcriptional regulators and Pap1 of Schizosaccharomyces pombe. To evaluate whether these residues are relevant to Yap8 specificity, we first built a homology model of the complex Yap8bZIP-DNA based on Pap1-DNA crystal structure. Several Yap8 mutants were then generated in order to confirm the contribution of the residues predicted to interact with DNA. Using bioinformatics analysis together with in vivo and in vitro approaches, we have identified several conserved residues critical for Yap8-DNA binding. Moreover, our data suggest that Leu26 is required for Yap8 binding to DNA and that this residue together with Asn31, hinder Yap1 response element recognition by Yap8, thus narrowing its DNA-binding specificity. Furthermore our results point to a role of these two amino acids in the stability of the Yap8-DNA complex.	[Amaral, Catarina; Pimentel, Catarina; Rodrigues-Pousada, Claudina] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Genom & Stress Lab, P-2780156 Oeiras, Portugal; [Matos, Rute G.; Arraiano, Cecilia M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Control Gene Express Lab, P-2780156 Oeiras, Portugal; [Matzapetakis, Manolis] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Biomol NMR Lab, P-2780156 Oeiras, Portugal	Universidade Nova de Lisboa; Universidade Nova de Lisboa; Universidade Nova de Lisboa	Rodrigues-Pousada, C (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Genom & Stress Lab, P-2780156 Oeiras, Portugal.	claudina@itqb.unl.pt	Pimentel, Catarina/G-2821-2014; Matzapetakis, Manolis/AAH-2609-2019; Matos, Rute/J-4983-2013	Matzapetakis, Manolis/0000-0001-9730-0621; Pimentel, Catarina/0000-0002-5158-6414; Matos Luis, Rute/0000-0002-9788-7562; Amaral, Catarina/0000-0002-9442-2225; Rodrigues-Pousada, Claudina/0000-0002-5075-3639; Arraiano, Cecilia/0000-0003-1934-9301	Fundacao para a Ciencia e a Tecnologia (FCT) [PEst-OE/EQB/LA0004/2011]; European Commission [PTDCBIA-MIC/108747/2008, FP7-KBBE-2011-1-289326]; FCT [SFRH/BPD/74294/2010, SFRH/BPD/35052/2007, SFRH/BPD/75887/2011]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT-http://www.fct.pt) through grant PEst-OE/EQB/LA0004/2011, PTDCBIA-MIC/108747/2008 to CRP and FP7-KBBE-2011-1-289326 from European Commission to CMA. Authors are grateful for financial support of FCT: C. A. SFRH/BPD/74294/2010, C. P. SFRH/BPD/35052/2007 and R. M. SFRH/BPD/75887/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo D, 2003, FREE RADICAL BIO MED, V35, P889, DOI 10.1016/S0891-5849(03)00434-9; Bobrowicz P, 1997, YEAST, V13, P819, DOI 10.1002/(SICI)1097-0061(199707)13:9<819::AID-YEA142>3.0.CO;2-Y; Bouganim N, 2001, BIOCHEM CELL BIOL, V79, P441, DOI 10.1139/bcb-79-4-441; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Di YJ, 2007, J CELL SCI, V120, P256, DOI 10.1242/jcs.03346; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Fujii Y, 2000, NAT STRUCT BIOL, V7, P889; Ghosh M, 1999, P NATL ACAD SCI USA, V96, P5001, DOI 10.1073/pnas.96.9.5001; Goudot C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020924; Gulshan K, 2005, J BIOL CHEM, V280, P40524, DOI 10.1074/jbc.M504716200; HARSHMAN KD, 1988, CELL, V53, P321, DOI 10.1016/0092-8674(88)90393-5; He XJ, 2005, MOL MICROBIOL, V58, P1454, DOI 10.1111/j.1365-2958.2005.04917.x; Ilina Y, 2008, BIOCHEM J, V415, P467, DOI 10.1042/BJ20080713; KELLER W, 1995, J MOL BIOL, V254, P657, DOI 10.1006/jmbi.1995.0645; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Menezes RA, 2004, FEBS LETT, V566, P141, DOI 10.1016/j.febslet.2004.04.019; Menezes RA, 2008, BIOCHEM J, V414, P301, DOI 10.1042/BJ20071537; Nguyen DT, 2001, J BIOL CHEM, V276, P1138, DOI 10.1074/jbc.M008377200; Rodrigues-Pousada CA, 2004, FEBS LETT, V567, P80, DOI 10.1016/j.febslet.2004.03.119; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; TZAMARIAS D, 1994, NATURE, V369, P758, DOI 10.1038/369758a0; Watkins D, 2008, BIOCHEMISTRY-US, V47, P2325, DOI 10.1021/bi701826f; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; WEMMIE JA, 1994, J BIOL CHEM, V269, P32592; Wysocki R, 2004, MOL BIOL CELL, V15, P2049, DOI 10.1091/mbc.E03-04-0236; Wysocki R, 1997, J BIOL CHEM, V272, P30061, DOI 10.1074/jbc.272.48.30061	28	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83328	10.1371/journal.pone.0083328	http://dx.doi.org/10.1371/journal.pone.0083328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358276	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700119
J	Barbonetti, A; Vassallo, MRC; Cinque, B; Filipponi, S; Mastromarino, P; Cifone, MG; Francavilla, S; Francavilla, F				Barbonetti, Arcangelo; Vassallo, Maria Rosaria Caterina; Cinque, Benedetta; Filipponi, Silvia; Mastromarino, Paola; Cifone, Maria Grazia; Francavilla, Sandro; Francavilla, Felice			Soluble Products of Escherichia coli Induce Mitochondrial Dysfunction-Related Sperm Membrane Lipid Peroxidation Which Is Prevented by Lactobacilli	PLOS ONE			English	Article							HUMAN SPERMATOZOA; IN-VITRO; MOTILITY PARAMETERS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; INFERTILITY; MECHANISMS; GENERATION; APOPTOSIS; BACTERIA	Unidentified soluble factors secreted by E. coli, a frequently isolated microorganism in genitourinary infections, have been reported to inhibit mitochondrial membrane potential (Delta psi m), motility and vitality of human spermatozoa. Here we explore the mechanisms involved in the adverse impact of E. coli on sperm motility, focusing mainly on sperm mitochondrial function and possible membrane damage induced by mitochondrial-generated reactive oxygen species (ROS). Furthermore, as lactobacilli, which dominate the vaginal ecosystem of healthy women, have been shown to exert anti-oxidant protective effects on spermatozoa, we also evaluated whether soluble products from these microorganisms could protect spermatozoa against the effects of E. coli. We assessed motility (by computer-aided semen analysis), Delta psi m (with JC-1 dye by flow cytometry), mitochondrial ROS generation (with MitoSOX red dye by flow cytometry) and membrane lipid-peroxidation (with the fluorophore BODIPY C-11 by flow cytometry) of sperm suspensions exposed to E. coli in the presence and in the absence of a combination of 3 selected strains of lactobacilli (L. brevis, L. salivarius, L. plantarum). A Transwell system was used to avoid direct contact between spermatozoa and microorganisms. Soluble products of E. coli induced Delta psi m loss, mitochondrial generation of ROS and membrane lipid-peroxidation, resulting in motility loss. Soluble factors of lactobacilli prevented membrane lipid-peroxidation of E. coli-exposed spermatozoa, thus preserving their motility. In conclusion, sperm motility loss by soluble products of E. coli reflects a mitochondrial dysfunction-related membrane lipid-peroxidation. Lactobacilli could protect spermatozoa in the presence of vaginal disorders, by preventing ROS-induced membrane damage.	[Barbonetti, Arcangelo; Vassallo, Maria Rosaria Caterina; Filipponi, Silvia; Francavilla, Sandro; Francavilla, Felice] Univ Aquila, Dept Life Hlth & Environm Sci, Androl Unit, I-67100 Laquila, Italy; [Cinque, Benedetta; Cifone, Maria Grazia] Univ Aquila, Dept Life Hlth & Environm Sci, Immunopathol Lab, I-67100 Laquila, Italy; [Barbonetti, Arcangelo] San Raffaele Sulmona Inst, Sulmona, Italy; [Mastromarino, Paola] Univ Roma La Sapienza, Inst Microbiol, I-00185 Rome, Italy	University of L'Aquila; University of L'Aquila; Sapienza University Rome	Francavilla, F (corresponding author), Univ Aquila, Dept Life Hlth & Environm Sci, Androl Unit, I-67100 Laquila, Italy.	francavi@cc.univaq.it	Cifone, Maria Grazia/ABH-1984-2021; Cifone, Maria Grazia/I-3750-2019	Cifone, Maria Grazia/0000-0002-9923-5445; FRANCAVILLA, Sandro/0000-0003-0221-8524; FRANCAVILLA, Felice/0000-0003-1255-4062; Cinque, Benedetta/0000-0003-4510-9416; MASTROMARINO, Paola/0000-0002-8529-0216	Ministero dell'Universita e Ricerca, PRIN	Ministero dell'Universita e Ricerca, PRIN(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant from the Ministero dell'Universita e Ricerca, PRIN 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2007, MOL HUM REPROD, V13, P203, DOI 10.1093/molehr/gal119; Aitken RJ, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102020; AITKEN RJ, 1993, MOL REPROD DEV, V35, P302, DOI 10.1002/mrd.1080350313; Amaral S, 2013, ANDROLOGY-US, V1, P707, DOI 10.1111/j.2047-2927.2013.00098.x; Barbonetti A, 2013, ANDROLOGY-US, V1, P456, DOI 10.1111/j.2047-2927.2013.00077.x; Barbonetti A, 2010, ENDOCRINOLOGY, V151, P5882, DOI 10.1210/en.2010-0484; Barbonetti A, 2011, FERTIL STERIL, V95, P2485, DOI 10.1016/j.fertnstert.2011.03.066; BURTON GW, 1989, J NUTR, V119, P109, DOI 10.1093/jn/119.1.109; Ching JCY, 2002, INFECT IMMUN, V70, P4669, DOI 10.1128/IAI.70.8.4669-4677.2002; del Porto G B, 1975, Urology, V5, P638; DELAMIRANDE E, 1993, FREE RADICAL BIO MED, V14, P157, DOI 10.1016/0891-5849(93)90006-G; Diemer T, 2000, Curr Opin Urol, V10, P39, DOI 10.1097/00042307-200001000-00010; Diemer T, 2000, INT J ANDROL, V23, P178; Diemer T, 2003, ANDROLOGIA, V35, P100, DOI 10.1046/j.1439-0272.2003.00523.x; Diemer T, 1996, INT J ANDROL, V19, P271, DOI 10.1111/j.1365-2605.1996.tb00475.x; Eley A, 2005, HUM REPROD, V20, P2601, DOI 10.1093/humrep/dei082; Falagas ME, 2007, CLIN MICROBIOL INFEC, V13, P657, DOI 10.1111/j.1469-0691.2007.01688.x; Fraczek M, 2012, ANDROLOGIA, V44, P315, DOI 10.1111/j.1439-0272.2012.01283.x; Fraczek M, 2007, FERTIL STERIL, V88, P1076, DOI 10.1016/j.fertnstert.2006.12.025; Fujita Y, 2011, HUM REPROD, V26, P2799, DOI 10.1093/humrep/der234; Garrido-Fernandez J, 2010, INT J FOOD MICROBIOL, V140, P34, DOI 10.1016/j.ijfoodmicro.2010.02.015; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Kaushik JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008099; Koppers AJ, 2008, J CLIN ENDOCR METAB, V93, P3199, DOI 10.1210/jc.2007-2616; Koppers AJ, 2010, FREE RADICAL BIO MED, V48, P112, DOI 10.1016/j.freeradbiomed.2009.10.033; Liu JH, 2002, ASIAN J ANDROL, V4, P179; Mastromarino P, 2009, CLIN MICROBIOL INFEC, V15, P67, DOI 10.1111/j.1469-0691.2008.02112.x; Mikelsaar Marika, 2009, Microbial Ecology in Health and Disease, V21, P1, DOI 10.1080/08910600902815561; Miki Kiyoshi, 2007, Soc Reprod Fertil Suppl, V65, P309; MONGA M, 1994, J ANDROL, V15, P151; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Perdichizzi A, 2007, J CLIN IMMUNOL, V27, P152, DOI 10.1007/s10875-007-9071-5; Schulz M, 2010, FERTIL STERIL, V94, P619, DOI 10.1016/j.fertnstert.2009.01.140; Seaver LC, 2004, J BIOL CHEM, V279, P48742, DOI 10.1074/jbc.M408754200; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Spandorfer SD, 2001, J REPROD MED, V46, P806; TEAGUE NS, 1971, FERTIL STERIL, V22, P281; Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004; WOLFF H, 1993, FERTIL STERIL, V60, P154; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_	41	34	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83136	10.1371/journal.pone.0083136	http://dx.doi.org/10.1371/journal.pone.0083136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358256	gold, Green Submitted, Green Published			2022-12-27	WOS:000328735700105
J	Bhat, PG; Kumar, AMV; Naik, B; Satyanarayana, S; Deepak, KG; Nair, SA; Suryakanth, MD; Heldal, E; Enarson, DA; Reid, AJ				Bhat, Prashant G.; Kumar, Ajay M. V.; Naik, Balaji; Satyanarayana, Srinath; Deepak, K. G.; Nair, Sreenivas A.; Suryakanth, M. D.; Heldal, Einar; Enarson, Donald A.; Reid, Anthony J.			Intensified Tuberculosis Case Finding among Malnourished Children in Nutritional Rehabilitation Centres of Karnataka, India: Missed Opportunities	PLOS ONE			English	Article							MALNUTRITION	Background: Severe acute malnutrition (SAM) is the most serious form of malnutrition affecting children under-five and is associated with many infectious diseases including Tuberculosis (TB). In India, nutritional rehabilitation centres (NRCs) have been recently established for the management of SAM including TB. The National TB Programme (NTP) in India has introduced a revised algorithm for diagnosing paediatric TB. We aimed to examine whether NRCs adhered to these guidelines in diagnosing TB among SAM children. Methods: A cross-sectional study involving review of records of all SAM children identified by health workers during 2012 in six tehsils (sub-districts) with NRCs (population: 1.8 million) of Karnataka, India. Results: Of 1927 identified SAM children, 1632 (85%) reached NRCs. Of them, 1173 (72%) were evaluated for TB and 19(2%) were diagnosed as TB. Of 1173, diagnostic algorithm was followed in 460 (37%). Among remaining 763 not evaluated as per algorithm, tuberculin skin test alone was conducted in 307 (41%), chest radiography alone in 99 (13%) and no investigations in 337 (45%). The yield of TB was higher among children evaluated as per algorithm (4%) as compared to those who were not (0.3%) (OR: 15.3 [95% CI: 3.5-66.3]). Several operational challenges including non-availability of a full-time paediatrician, non-functioning X-ray machine due to frequent power cuts, use of tuberculin with suboptimal strength and difficulties in adhering to a complex diagnostic algorithm were observed. Conclusion: This study showed that TB screening in NRCs was sub-optimal in Karnataka. Some children did not reach the NRC, while many of those who did were either not or sub-optimally evaluated for TB. This study pointed to a number of operational issues that need to be addressed if this collaborative strategy is to identify more TB cases amongst malnourished children in India.	[Bhat, Prashant G.; Naik, Balaji; Deepak, K. G.; Nair, Sreenivas A.] WHO, Country Off India, TB Control Unit, New Delhi, India; [Kumar, Ajay M. V.; Satyanarayana, Srinath] Int Union TB & Lung Dis, South East Asia Reg Off, Operat Res Unit, New Delhi, India; [Suryakanth, M. D.] State TB Off, TB Control Unit, Bangalore, Karnataka, India; [Heldal, Einar; Enarson, Donald A.] Int Union TB & Lung Dis, Operat Res Unit, Paris, France; [Reid, Anthony J.] Med Sans Frontieres, Operat Res Unit LUXOR, Brussels, Luxembourg	World Health Organization; Doctors Without Borders	Bhat, PG (corresponding author), WHO, Country Off India, TB Control Unit, New Delhi, India.	bhatp74@gmail.com	Bhat, Prashant G/H-6696-2012	Bhat, Prashant G/0000-0002-2130-210X; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Nair, Sreenivas/0000-0002-2586-6797; Satyanarayana, Srinath/0000-0002-5420-2551	Department for International Development, UK	Department for International Development, UK	Funding for the course was from an anonymous donor and the Department for International Development, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan L, 2004, ECON HUM BIOL, V2, P139, DOI 10.1016/j.ehb.2003.09.003; Bruno Sunguya, 2006, DMSJ S1, V14; Cervantes-Rios E, 2012, MUTAT RES-FUND MOL M, V731, P68, DOI 10.1016/j.mrfmmm.2011.11.006; CTD, 2013, TB IND 2013; De Maayer T, 2011, ARCH DIS CHILD, V96, P560, DOI 10.1136/adc.2010.205039; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P1603, DOI 10.1017/S136898001200105X; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Jaganath D, 2012, J INFECT DIS, V206, P1809, DOI 10.1093/infdis/jis608; Joseph B, 2002, J HEALTH POPUL NUTR, V20, P239; Kanjilal B, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-19; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Kumar A, 2013, INDIAN PEDIATR, V50, P301, DOI 10.1007/s13312-013-0085-1; LaCourse S, 2013, IUATLD NAR 17 ANN C; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Lonnroth K, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P219; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Macallan Derek, 2009, MEDICINE, V37, P525, DOI DOI 10.1016/J.MPMED.2009.07.005; MoH, 2009, NFHS 3, VI; Patil NK, 2012, HINDU DAILY; UNICEF, 2009, NUTRITION; VIJAYAKUMAR M, 1990, J TROP PEDIATRICS, V36, P294, DOI 10.1093/tropej/36.6.294	23	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84255	10.1371/journal.pone.0084255	http://dx.doi.org/10.1371/journal.pone.0084255			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358350	Green Submitted, gold, Green Published			2022-12-27	WOS:000328735700158
J	Chen, WQ; Zhou, HY; Liu, SY; Fhaner, CJ; Gross, BC; Lydic, TA; Reid, GE				Chen, Weiqin; Zhou, Hongyi; Liu, Siyang; Fhaner, Cassie J.; Gross, Bethany C.; Lydic, Todd A.; Reid, Gavin E.			Altered Lipid Metabolism in Residual White Adipose Tissues of Bscl2 Deficient Mice	PLOS ONE			English	Article							SEIP CONGENITAL LIPODYSTROPHY; BROWN ADIPOCYTES; IDENTIFICATION; OXIDATION; BIOLOGY; ELOVL3	Mutations in BSCL2 underlie human congenital generalized lipodystrophy type 2 disease. We previously reported that Bscl2(-/-) mice develop lipodystrophy of white adipose tissue (WAT) due to unbridled lipolysis. The residual epididymal WAT (EWAT) displays a browning phenotype with much smaller lipid droplets (LD) and higher expression of brown adipose tissue marker proteins. Here we used targeted lipidomics and gene expression profiling to analyze lipid profiles as well as genes involved in lipid metabolism in WAT of wild-type and Bscl2(-/-) mice. Analysis of total saponified fatty acids revealed that the residual EWAT of Bscl2(-/-) mice contained a much higher proportion of oleic(18:1n9) acid concomitant with a lower proportion of palmitic(16:0) acid, as well as increased n3- polyunsaturated fatty acids (PUFA) remodeling. The acyl chains in major species of triacylglyceride (TG) and diacylglyceride (DG) in the residual EWAT of Bscl2(-/-) mice were also enriched with dietary fatty acids. These changes could be reflected by upregulation of several fatty acid elongases and desaturases. Meanwhile, Bscl2(-/-) adipocytes from EWAT had increased gene expression in lipid uptake and TG synthesis but not de novo lipogenesis. Both mitochondria and peroxisomal beta-oxidation genes were also markedly increased in Bscl2(-/-) adipocytes, highlighting that these machineries were accelerated to shunt the lipolysis liberated fatty acids through uncoupling to dissipate energy. The residual subcutaneous white adipose tissue (ScWAT) was not browning but displays similar changes in lipid metabolism. Overall, our data emphasize that, other than being essential for adipocyte differentiation, Bscl2 is also important in fatty acid remodeling and energy homeostasis.	[Chen, Weiqin; Zhou, Hongyi; Liu, Siyang] Georgia Regents Univ, Med Coll Georgia, Dept Physiol, Augusta, GA 30904 USA; [Fhaner, Cassie J.; Gross, Bethany C.; Lydic, Todd A.; Reid, Gavin E.] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Reid, Gavin E.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	University System of Georgia; Augusta University; Michigan State University; Michigan State University	Chen, WQ (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Physiol, Augusta, GA 30904 USA.	wechen@gru.edu	Chen, Weiqin/I-9782-2019; Lydic, Todd A./ADB-0177-2022	Chen, Weiqin/0000-0002-3894-5953; Reid, Gavin/0000-0002-9675-1444; Zhou, Hongyi/0000-0001-5074-5180	American Heart Association [SDG 12SDG9080000]; GRU; National Institutes of Health [GM103508]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103508] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); GRU; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank support from the American Heart Association SDG 12SDG9080000 and GRU start-up funds to WC, and funding from the National Institutes of Health GM103508 to GER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2003, TRENDS ENDOCRIN MET, V14, P214, DOI 10.1016/S1043-2760(03)00078-X; Aotani D, 2012, J CLIN ENDOCR METAB, V97, P3663, DOI 10.1210/jc.2012-1872; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; BERARDINELLI W, 1954, J CLIN ENDOCR METAB, V14, P193, DOI 10.1210/jcem-14-2-193; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boutet E, 2009, BIOCHIMIE, V91, P796, DOI 10.1016/j.biochi.2009.01.011; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chen W, 2009, ENDOCRINOLOGY; Chen WQ, 2012, MOL CELL BIOL, V32, P1099, DOI 10.1128/MCB.06465-11; Cui X, 2011, HUM MOL GENET, V20, P3022, DOI 10.1093/hmg/ddr205; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Fei WH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002201; Fernandez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021603; Flachs P, 2009, CLIN SCI, V116, P1, DOI 10.1042/CS20070456; Fu M, 2004, J CLIN ENDOCR METAB, V89, P2916, DOI 10.1210/jc.2003-030485; Green CD, 2010, J LIPID RES, V51, P1871, DOI 10.1194/jlr.M004747; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Haimi P, 2006, ANAL CHEM, V78, P8324, DOI 10.1021/ac061390w; Han XL, 2006, J AM SOC MASS SPECTR, V17, P264, DOI 10.1016/j.jasms.2005.11.003; Harris CA, 2011, J LIPID RES, V52, P657, DOI 10.1194/jlr.M013003; Hegele RA, 2007, J LIPID RES, V48, P1433, DOI 10.1194/jlr.R700004-JLR200; Herrero L, 2010, P NATL ACAD SCI USA, V107, P240, DOI 10.1073/pnas.0905310107; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Jakobsson A, 2005, AM J PHYSIOL-ENDOC M, V289, pE517, DOI 10.1152/ajpendo.00045.2005; Kienesberger PC, 2012, MOL CELL BIOL, V32, P740, DOI 10.1128/MCB.06470-11; Koivusalo M, 2001, J LIPID RES, V42, P663; Kopecky J, 2009, P NUTR SOC, V68, P361, DOI 10.1017/S0029665109990231; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; McAnoy AM, 2005, J AM SOC MASS SPECTR, V16, P1498, DOI 10.1016/j.jasms.2005.04.017; Murphy RC, 2007, ANAL BIOCHEM, V366, P59, DOI 10.1016/j.ab.2007.03.012; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Payne VA, 2008, DIABETES, V57, P2055, DOI 10.2337/db08-0184; Prieur X, 2013, DIABETOLOGIA; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Seip M, 1996, ACTA PAEDIATR, V85, P2, DOI 10.1111/j.1651-2227.1996.tb14262.x; Sim MFM, 2013, MOL METAB, V2, P38, DOI 10.1016/j.molmet.2012.11.002; Sprecher H, 1999, PROSTAG LEUKOTR ESS, V60, P317, DOI 10.1016/S0952-3278(99)80006-4; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Tian Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001364; Tikhonenko M, 2010, DIABETES, V59, P219, DOI 10.2337/db09-0728; Westerberg R, 2006, J BIOL CHEM, V281, P4958, DOI 10.1074/jbc.M511588200	42	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82526	10.1371/journal.pone.0082526	http://dx.doi.org/10.1371/journal.pone.0082526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358199	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700078
J	Ermund, A; Gustafsson, JK; Hansson, GC; Keita, AV				Ermund, Anna; Gustafsson, Jenny K.; Hansson, Gunnar C.; Keita, Asa V.			Mucus Properties and Goblet Cell Quantification in Mouse, Rat and Human Ileal Peyer's Patches	PLOS ONE			English	Article							FOLLICLE-ASSOCIATED EPITHELIUM; DENDRITIC CELLS; ANTIGEN; TRANSPORT; BACTERIA; PEPTIDOGLYCAN; EXPRESSION; INDUCTION; THICKNESS; LAYERS	Peyer's patches (PPs) are collections of lymphoid follicles in the small intestine, responsible for scanning the intestinal content for foreign antigens such as soluble molecules, particulate matter as well as intact bacteria and viruses. The immune cells of the patch are separated from the intestinal lumen by a single layer of epithelial cells, the follicle-associated epithelium (FAE). This epithelium covers the dome of the follicle and contains enterocyte-like cells and M cells, which are particularly specialized in taking up antigens from the gut. However, the presence and number of goblet cells as well as the presence of mucus on top of the FAE is controversial. When mouse ileal PPs were mounted in a horizontal Ussing-type chamber, we could observe a continuous mucus layer at mounting and new, easily removable mucus was released from the villi on the patch upon stimulation. Confocal imaging using fluorescent beads revealed a penetrable mucus layer covering the domes. Furthermore, immunostaining of FAE from mice, rats and humans with a specific antibody against the main component of intestinal mucus, the MUC2 mucin, clearly identify mucin-containing goblet cells. Transmission electron micrographs further support the identification of mucus releasing goblet cells on the domes of PPs in these species.	[Ermund, Anna; Gustafsson, Jenny K.; Hansson, Gunnar C.] Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden; [Keita, Asa V.] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden; [Keita, Asa V.] Cty Council Ostergotland, Linkoping, Sweden	University of Gothenburg; Linkoping University; City Council Ostergotland	Ermund, A (corresponding author), Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden.	anna.ermund@gu.se	Hansson, Gunnar C/A-1236-2009; Ermund, Anna/AAG-3160-2020; Hansson, Gunnar C./AAF-7324-2019	Hansson, Gunnar C/0000-0002-1900-1869; Hansson, Gunnar C./0000-0002-1900-1869; Ermund, Anna/0000-0002-3233-043X; Keita, Asa/0000-0002-6820-0215	Swedish Research Council [7461, 21027, 342-2004-4434, K2012-55X-12618-16-3]; Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation; IngaBritt and Arne Lundberg Foundation; Sahlgrenska University Hospital (LUA-ALF); Wilhelm and Martina Lundgren's Foundation; Torsten och Ragnar Soderbergs Stiftelser; Sahlgrenska Academy; National Institute of Allergy and Infectious Diseases [U01AI095473]; Swedish Foundation for Strategic Research -The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program; Riksforbundet Cystisk Fibros (RfCF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); IngaBritt and Arne Lundberg Foundation; Sahlgrenska University Hospital (LUA-ALF); Wilhelm and Martina Lundgren's Foundation; Torsten och Ragnar Soderbergs Stiftelser; Sahlgrenska Academy; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swedish Foundation for Strategic Research -The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program; Riksforbundet Cystisk Fibros (RfCF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swedish Research Council (no. 7461, 21027, 342-2004-4434 to Gunnar C. Hansson and VR-m nr: K2012-55X-12618-16-3 to Asa V. Keita); The Swedish Cancer Foundation, The Knut and Alice Wallenberg Foundation, IngaBritt and Arne Lundberg Foundation, The Sahlgrenska University Hospital (LUA-ALF), Wilhelm and Martina Lundgren's Foundation (to Anna Ermund, Jenny K. Gustafsson and Gunnar C. Hansson), Torsten och Ragnar Soderbergs Stiftelser, The Sahlgrenska Academy, National Institute of Allergy and Infectious Diseases (U01AI095473) (The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH); and The Swedish Foundation for Strategic Research -The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program (all to Gunnar C. Hansson) and Riksforbundet Cystisk Fibros (RfCF; The National association for Cystic Fibrosis; to Anna Ermund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Beyaz F, 2010, CELL TISSUE RES, V341, P417, DOI 10.1007/s00441-010-1005-5; Castro-Sanchez P, 2013, BRIT J NUTR, V109, pS3, DOI 10.1017/S0007114512005223; Donaldson DS, 2012, MUCOSAL IMMUNOL, V5, P216, DOI 10.1038/mi.2011.68; Ermund A, 2013, AM J PHYSIOL-GASTR L, V305, pG341, DOI 10.1152/ajpgi.00046.2013; Gebert A, 1997, HISTOCHEM CELL BIOL, V108, P455, DOI 10.1007/s004180050186; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011, 10.1152/ajpgi.00405.2011.]; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Henriksnas J, 2005, ACTA PHYSIOL SCAND, V184, P151, DOI 10.1111/j.1365-201X.2005.01434.x; Inamoto T, 2008, J VET MED SCI, V70, P235, DOI 10.1292/jvms.70.235; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Johansson MEV, 2011, SCIENCE, V334, P182, DOI 10.1126/science.1213909; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Jung C, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/823710; Keita AV, 2006, LAB INVEST, V86, P504, DOI 10.1038/labinvest.3700397; Kelsall BL, 1996, J EXP MED, V183, P237, DOI 10.1084/jem.183.1.237; Khan J, 1999, JPEN-PARENTER ENTER, V23, P19, DOI 10.1177/014860719902300119; Kujala P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002449; Lelouard H, 1999, INFECT IMMUN, V67, P357, DOI 10.1128/IAI.67.1.357-367.1999; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Lo D, 2003, CELL IMMUNOL, V224, P8, DOI 10.1016/S0008-8749(03)00155-2; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Meyer T, 2012, EXP MOL PATHOL, V93, P449, DOI 10.1016/j.yexmp.2012.10.002; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Neutra MR, 1996, ANNU REV IMMUNOL, V14, P275, DOI 10.1146/annurev.immunol.14.1.275; Nochi T, 2007, J EXP MED, V204, P2789, DOI 10.1084/jem.20070607; Onori P, 2001, DIGEST DIS SCI, V46, P1095, DOI 10.1023/A:1010778532240; Owen RL, 1999, SEMIN IMMUNOL, V11, P157, DOI 10.1006/smim.1999.0171; Sansonetti PJ, 1999, SEMIN IMMUNOL, V11, P193, DOI 10.1006/smim.1999.0175; Schulz O, 2012, TRENDS IMMUNOL; Terahara K, 2008, J IMMUNOL, V180, P7840, DOI 10.4049/jimmunol.180.12.7840; Tyrer PC, 2007, VACCINE, V25, P3204, DOI 10.1016/j.vaccine.2007.01.028; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Wang J, 2011, J IMMUNOL, V187, P5277, DOI 10.4049/jimmunol.1102077	36	38	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83688	10.1371/journal.pone.0083688	http://dx.doi.org/10.1371/journal.pone.0083688			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358305	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700135
J	Korkmaz, G; Tekirdag, KA; Ozturk, DG; Kosar, A; Sezerman, OU; Gozuacik, D				Korkmaz, Gozde; Tekirdag, Kumsal Ayse; Ozturk, Deniz Gulfem; Kosar, Ali; Sezerman, Osman Ugur; Gozuacik, Devrim			MIR376A Is a Regulator of Starvation-Induced Autophagy	PLOS ONE			English	Article							MICRORNA REGULATION; EXPRESSION; DIFFERENTIATION; TRANSCRIPTOME; BIOGENESIS; SIGNATURE; PROTEINS; MIR-376A; HOMOLOG; CLUSTER	Background: Autophagy is a vesicular trafficking process responsible for the degradation of long-lived, misfolded or abnormal proteins, as well as damaged or surplus organelles. Abnormalities of the autophagic activity may result in the accumulation of protein aggregates, organelle dysfunction, and autophagy disorders were associated with various diseases. Hence, mechanisms of autophagy regulation are under exploration. Methods: Over-expression of hsa-miR-376a1 (shortly MIR376A) was performed to evaluate its effects on autophagy. Autophagy-related targets of the miRNA were predicted using Microcosm Targets and MIRanda bioinformatics tools and experimentally validated. Endogenous miRNA was blocked using antagomirs and the effects on target expression and autophagy were analyzed. Luciferase tests were performed to confirm that 3' UTR sequences in target genes were functional. Differential expression of MIR376A and the related MIR376B was compared using TaqMan quantitative PCR. Results: Here, we demonstrated that, a microRNA (miRNA) from the DLK1/GTL2 gene cluster, MIR376A, played an important role in autophagy regulation. We showed that, amino acid and serum starvation-induced autophagy was blocked by MIR376A overexpression in MCF-7 and Huh7 cells. MIR376A shared the same seed sequence and had overlapping targets with MIR376B, and similarly blocked the expression of key autophagy proteins ATG4C and BECN1 (Beclin 1). Indeed, 39 UTR sequences in the mRNA of these autophagy proteins were responsive to MIR376A in luciferase assays. Antagomir tests showed that, endogenous MIR376A was participating to the control of ATG4C and BECN1 transcript and protein levels. Moreover, blockage of endogenous MIR376A accelerated starvation-induced autophagic activity. Interestingly, MIR376A and MIR376B levels were increased with different kinetics in response to starvation stress and tissue-specific level differences were also observed, pointing out to an overlapping but miRNA-specific biological role. Conclusions: Our findings underline the importance of miRNAs encoded by the DLK1/GTL2 gene cluster in stress-response control mechanisms, and introduce MIR376A as a new regulator of autophagy.	[Korkmaz, Gozde; Tekirdag, Kumsal Ayse; Ozturk, Deniz Gulfem; Kosar, Ali; Sezerman, Osman Ugur; Gozuacik, Devrim] Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey	Sabanci University	Gozuacik, D (corresponding author), Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey.	dgozuacik@sabanciuniv.edu	Devrim, Gozuacik/C-3330-2008; SEZERMAN, OSMAN U/X-6441-2018; Korkmaz, Gozde/A-1456-2015; Öztürk, Deniz Gülfem/AAH-5404-2019; Kosar, Ali/F-5827-2014	Devrim, Gozuacik/0000-0001-7739-2346; Korkmaz, Gozde/0000-0002-3574-1015; Öztürk, Deniz Gülfem/0000-0002-2514-126X; Kosar, Ali/0000-0001-6283-6717; Tekirdag-Kosar, A.Kumsal/0000-0001-7986-0035; Sezerman, Osman Ugur/0000-0003-0905-6783	Scientific and Technological Research Council of Turkey (TUBITAK) [1001]; Sabanci University; Turkish Academy of Sciences (TUBA); EMBO Strategical Development and Installation Grant (EMBO-SDIG); TUBITAK; Yousef Jameel and TUBITAK-BIDEB PhD Scholarships	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Sabanci University(Sabanci University); Turkish Academy of Sciences (TUBA)(Turkish Academy of Sciences); EMBO Strategical Development and Installation Grant (EMBO-SDIG); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Yousef Jameel and TUBITAK-BIDEB PhD Scholarships(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by The Scientific and Technological Research Council of Turkey (TUBITAK) 1001 Grant and Sabanci University. D. G. and A. K are recipients the Turkish Academy of Sciences (TUBA) GEBIP Award. D. G. is a recipient of the EMBO Strategical Development and Installation Grant (EMBO-SDIG) and A. K. is a recipient of the TUBITAK Incentive Award. G. K. and K. A. T. are recipients of Yousef Jameel and TUBITAK-BIDEB PhD Scholarships, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Breving K, 2010, INT J BIOCHEM CELL B, V42, P1316, DOI 10.1016/j.biocel.2009.09.016; Chan E, 2011, TRENDS MOL MED, V17, P235, DOI 10.1016/j.molmed.2011.01.008; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Duskova K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-250; Faraonio R, 2012, CELL DEATH DIFFER, V19, P713, DOI 10.1038/cdd.2011.143; Foley CJ, 2008, MOL CELL BIOL, V28, P4520, DOI 10.1128/MCB.02011-07; Frankel LB, 2012, CARCINOGENESIS, V33, P2018, DOI 10.1093/carcin/bgs266; Frankel LB, 2011, EMBO J, V30, P4628, DOI 10.1038/emboj.2011.331; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Hildebrand J, 2011, J INVEST DERMATOL, V131, P20, DOI 10.1038/jid.2010.268; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kircher M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-346; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Korkmaz G, 2012, AUTOPHAGY, V8, P165, DOI 10.4161/auto.8.2.18351; le Sage C, 2006, CELL CYCLE, V5, P1415, DOI 10.4161/cc.5.13.2890; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Macedo C, 2013, IMMUNOBIOLOGY, V218, P554, DOI 10.1016/j.imbio.2012.06.013; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Mestdagh P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr646; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Nachmani D, 2010, NAT IMMUNOL, V11, P806, DOI 10.1038/ni.1916; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Oral O, 2012, APOPTOSIS, V17, P810, DOI 10.1007/s10495-012-0735-0; Platta HW, 2012, BIOCHEM J, V441, P399, DOI 10.1042/BJ20111424; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Romao S, 2013, SEMIN CANCER BIOL, V23, P391, DOI 10.1016/j.semcancer.2013.03.001; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Russo G, 2009, METHODS MOL BIOL, V563, P303, DOI 10.1007/978-1-60761-175-2_17; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Silva LM, 2013, SEMIN CANCER BIOL, V23, P323, DOI 10.1016/j.semcancer.2013.05.005; Sinha S, 2008, AUTOPHAGY, V4, P989, DOI 10.4161/auto.6803; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Teferedegne B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014416; Tekirdag KA, 2013, AUTOPHAGY, V9, P374, DOI 10.4161/auto.23117; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang F, 2011, CELL RES, V21, P1196, DOI 10.1038/cr.2011.79; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wang TS, 2007, GENE CHROMOSOME CANC, V46, P336, DOI 10.1002/gcc.20415; Winter J, 2011, RNA BIOL, V8, P1149, DOI 10.4161/rna.8.6.17665; Zehavi L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-44; Zhang XY, 2009, INT J CANCER, V124, P2855, DOI 10.1002/ijc.24298; Zhao BS, 2013, ASIAN PAC J CANCER P, V14, P139, DOI 10.7314/APJCP.2013.14.1.139	54	44	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82556	10.1371/journal.pone.0082556	http://dx.doi.org/10.1371/journal.pone.0082556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358205	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700081
J	Marshall, AG; Watson, JA; Hallengren, JJ; Walters, BJ; Dobrunz, LE; Francillon, L; Wilson, JA; Phillips, SE; Wilson, SM				Marshall, Andrea G.; Watson, Jennifer A.; Hallengren, Jada J.; Walters, Brandon J.; Dobrunz, Lynn E.; Francillon, Ludwig; Wilson, Julie A.; Phillips, Scott E.; Wilson, Scott M.			Genetic Background Alters the Severity and Onset of Neuromuscular Disease Caused by the Loss of Ubiquitin-Specific Protease 14 (Usp14)	PLOS ONE			English	Article							TERMINAL HYDROLASE L1; ALZHEIMERS-DISEASE; ATAXIA MICE; PROTEINS; IDENTIFICATION; EXPRESSION; RELEASE; PATHWAY; UCH-L1; SYSTEM	In this study, we identified and characterized an N-ethyl-N-nitrosourea (ENU) induced mutation in Usp14 (nmf375) that leads to adult-onset neurological disease. The nmf375 mutation causes aberrant splicing of Usp14 mRNA, resulting in a 95% reduction in USP14. We previously showed that loss of USP14 in ataxia (ax(J)) mice results in reduced ubiquitin levels, motor endplate disease, Purkinje cell axonal dystrophy and decreased hippocampal paired pulse facilitation (PPF) during the first 4-6 weeks of life, and early postnatal lethality by two months of age. Although the loss of USP14 is comparable between the nmf375 and axJ mice, the nmf375 mice did not exhibit these axJ developmental abnormalities. However, by 12 weeks of age the nmf375 mutants present with ubiquitin depletion and motor endplate disease, indicating a continual role for USP14-mediated regulation of ubiquitin pools and neuromuscular junction (NMJ) structure in adult mice. The observation that motor endplate disease was only seen after ubiquitin depletion suggests that the preservation of NMJ structure requires the stable maintenance of synaptic ubiquitin pools. Differences in genetic background were shown to affect ubiquitin expression and dramatically alter the phenotypes caused by USP14 deficiency.	[Marshall, Andrea G.; Watson, Jennifer A.; Hallengren, Jada J.; Walters, Brandon J.; Dobrunz, Lynn E.; Francillon, Ludwig; Wilson, Julie A.; Phillips, Scott E.; Wilson, Scott M.] Univ Alabama Birmingham, Dept Neurobiol, Evelyn F McKnight Brain Inst, Civitan Int Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Wilson, SM (corresponding author), Univ Alabama Birmingham, Dept Neurobiol, Evelyn F McKnight Brain Inst, Civitan Int Res Ctr, Birmingham, AL 35294 USA.	Wilson@nrc.uab.edu		Dobrunz, Lynn E./0000-0002-3317-554X; Marshall, Andrea/0000-0001-9997-4478; Wilson, Scott/0000-0001-9376-9430; PHILLIPS, SCOTT/0000-0002-5451-0984; Walters, Brandon/0000-0002-8073-6573	NIH/NINDS [NS047533, NS074456]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047533, R21NS074456] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH/NINDS Grants NS047533 and NS074456 to SMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljakna A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043139; Anderson C, 2005, J NEUROCHEM, V95, P724, DOI 10.1111/j.1471-4159.2005.03409.x; Bhattacharyya BJ, 2012, AM J PHYSIOL-CELL PH, V302, pC698, DOI 10.1152/ajpcell.00326.2010; Butterfield DA, 2006, J ALZHEIMERS DIS, V10, P391; Camu W, 1999, J NEUROL SCI, V165, pS21, DOI 10.1016/S0022-510X(99)00022-2; Castegna A, 2002, J NEUROCHEM, V82, P1524, DOI 10.1046/j.1471-4159.2002.01103.x; Chen B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025176; Chen FJ, 2010, P NATL ACAD SCI USA, V107, P1636, DOI 10.1073/pnas.0911516107; Chen PC, 2011, J NEUROSCI, V31, P17505, DOI 10.1523/JNEUROSCI.2922-11.2011; Chen PC, 2009, J NEUROSCI, V29, P10909, DOI 10.1523/JNEUROSCI.2635-09.2009; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Crimmins S, 2006, J NEUROSCI, V26, P11423, DOI 10.1523/JNEUROSCI.3600-06.2006; Crimmins S, 2009, DEV BIOL, V325, P33, DOI 10.1016/j.ydbio.2008.09.021; DAMATO CJ, 1965, ARCH PATHOL, V80, P604; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; DUCLERT A, 1995, PHYSIOL REV, V75, P339, DOI 10.1152/physrev.1995.75.2.339; GILLINGWATER TH, 2013, NEUROPATHOLOGY APPL, P13934; Gupta VA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043794; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Helmken C, 2003, HUM GENET, V114, P11, DOI 10.1007/s00439-003-1025-2; Huang QA, 2010, APOPTOSIS, V15, P1292, DOI 10.1007/s10495-010-0466-z; JAWEED MM, 1975, J HISTOCHEM CYTOCHEM, V23, P808, DOI 10.1177/23.11.127809; JIN YN, 2012, PLOS ONE, V7, P29; Kearney JA, 2011, CURR OPIN GENET DEV, V21, P349, DOI 10.1016/j.gde.2010.12.007; Lappe-Siefke C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000631; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Paul S, 2008, BIOESSAYS, V30, P1172, DOI 10.1002/bies.20852; Plomp JJ, 1996, J PHYSIOL-LONDON, V493, P175, DOI 10.1113/jphysiol.1996.sp021373; Ramser J, 2008, AM J HUM GENET, V82, P188, DOI 10.1016/j.ajhg.2007.09.009; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Ryu KY, 2007, EMBO J, V26, P2693, DOI 10.1038/sj.emboj.7601722; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; TAI HC, 2010, PROTEINS FRONTIERS N, V3, P1; Walters BJ, 2008, MOL CELL NEUROSCI, V39, P539, DOI 10.1016/j.mcn.2008.07.028; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Wu JY, 2004, J CLIN INVEST, V113, P434, DOI 10.1172/JCI200419574; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4	41	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84042	10.1371/journal.pone.0084042	http://dx.doi.org/10.1371/journal.pone.0084042			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358326	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700148
J	Hatch, SK; Connelly, EE; Divoll, TJ; Stenhouse, IJ; Williams, KA				Hatch, Shaylyn K.; Connelly, Emily E.; Divoll, Timothy J.; Stenhouse, Iain J.; Williams, Kathryn A.			Offshore Observations of Eastern Red Bats (Lasiurus borealis) in the Mid-Atlantic United States Using Multiple Survey Methods	PLOS ONE			English	Article							WIND; FATALITIES; MIGRATION	Little is known about the migration and movements of migratory tree-roosting bat species in North America, though anecdotal observations of migrating bats over the Atlantic Ocean have been reported since at least the 1890s. Aerial surveys and boat-based surveys of wildlife off the Atlantic Seaboard detected a possible diurnal migration event of eastern red bats (Lasiurus borealis) in September 2012. One bat was sighted approximately 44 km east of Rehoboth Beach, Delaware during a boat-based survey. Eleven additional bats were observed between 16.9 and 41.8 km east of New Jersey, Delaware, and Virginia in high definition video footage collected during digital aerial surveys. Observations were collected incidentally as part of a large baseline study of seabird, marine mammal, and sea turtle distributions and movements in the offshore environment. Digital survey methods also allowed for altitude estimation for several of these bats at >100 m above sea level. These observations provide new evidence of bat movements offshore,	[Hatch, Shaylyn K.; Connelly, Emily E.; Divoll, Timothy J.; Stenhouse, Iain J.; Williams, Kathryn A.] Biodivers Res Inst, Gorham, ME USA		Hatch, SK (corresponding author), Biodivers Res Inst, Gorham, ME USA.	shay.hatch@briloon.org	Divoll, Timothy J/L-4963-2017	Stenhouse, Iain/0000-0003-3614-9862; Divoll, Timothy/0000-0002-2586-6842	Department of Energy [DE-EE0005362]; agency of the United States Government	Department of Energy(United States Department of Energy (DOE)); agency of the United States Government	This material is based upon work supported by the Department of Energy under Award Number DE-EE0005362. This manuscript was prepared as an account of work sponsored by an agency of the United States Government. Neither the United States Government nor any agency thereof, nor any of their employees, makes any warranty, expressed or implied, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. Reference herein to any specific commercial product, process, or service by trade name, trademark, manufacturer, or otherwise does not necessarily constitute or imply its endorsement, recommendation, or favoring by the United States Government or any agency thereof. The views and opinions of authors expressed herein do not necessarily state or reflect those of the United States Government or any agency thereof. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlen I, 2009, J MAMMAL, V90, P1318, DOI 10.1644/09-MAMM-S-223R.1; Allen G. M., 1923, Journal of Mammalogy, V4, P61; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Arroyo-Cabrales J, 2008, IUCN 2013 IUCN RED L; Boshamer Jan P. C., 2008, Lutra, V51, P17; Breton SP, 2009, RENEW ENERG, V34, P646, DOI 10.1016/j.renene.2008.05.040; Cryan PM, 2007, BIOL CONSERV, V139, P1, DOI 10.1016/j.biocon.2007.05.019; Cryan Paul M., 2009, P476; Cryan PM, 2003, J MAMMAL, V84, P579, DOI 10.1644/1545-1542(2003)084<0579:SDOMTB>2.0.CO;2; Czenze Zenon, 2011, Bat Research News, V52, P28; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Grady FV, 2006, J MAMMAL, V87, P148, DOI 10.1644/05-MAMM-A-179R1.1; Griffin D. R., 1970, P233; Griffin D.R., 1940, B MUS COMP ZOOL HARV, V86, P217; Hall ER, 1946, MAMMALS NEVADA; Holland RA, 2007, BEHAV ECOL SOCIOBIOL, V61, P653, DOI 10.1007/s00265-006-0297-7; Holland RA, 2010, P NATL ACAD SCI USA, V107, P6941, DOI 10.1073/pnas.0912477107; Howell Arthur H., 1908, Proceedings of the Biological Society of Washington, V21; Krueger Thorsten, 2001, Atlantic Seabirds, V3, P203; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; Mearns E.A., 1898, B AM MUS NAT HIST, V10, P303; Nichols J.T., 1920, J MAMMAL, V1, P87, DOI [10.2307/1373749, DOI 10.2307/1373749]; Norton AH, 1929, J MAMMAL, V11, P225; Pelletier SK, 2013, INFORM SYNTHESIS POT, P1; Peurach Suzanne C., 2009, Human-Wildlife Conflicts, V3, P199; Rollins KE, 2012, VET PATHOL, V49, P362, DOI 10.1177/0300985812436745; Shump K.A. Jr, 1982, Mammalian Species, P1; Smallwood KS, 2013, WILDLIFE SOC B, V37, P19, DOI 10.1002/wsb.260; Van Gelder R. G., 1961, American Museum Novitates, VNo. 2029, P1	29	14	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e83803	10.1371/journal.pone.0083803	http://dx.doi.org/10.1371/journal.pone.0083803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367614	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900023
J	Keilty, D; Buchanan, M; Ntapolias, K; Aleynikova, O; Tu, DS; Li, X; Shepherd, L; Bramwell, V; Basik, M				Keilty, Dana; Buchanan, Marguerite; Ntapolias, Katerina; Aleynikova, Olga; Tu, Dongsheng; Li, Xiao; Shepherd, Lois; Bramwell, Vivien; Basik, Mark			RSF1 and Not Cyclin D1 Gene Amplification May Predict Lack of Benefit from Adjuvant Tamoxifen in High-Risk Pre-Menopausal Women in the MA.12 Randomized Clinical Trial	PLOS ONE			English	Article							BREAST-CANCER; CHROMATIN; RECURRENCE; OVEREXPRESSION; EXPRESSION; GENOTYPE; OVARIAN; CYP2D6; 11Q13; CCND1	Most women with estrogen receptor expressing breast cancers receiving anti-estrogens such as tamoxifen may not need or benefit from them. Besides the estrogen receptor, there are no predictive biomarkers to help select breast cancer patients for tamoxifen treatment. CCND1 (cyclin D1) gene amplification is a putative candidate tamoxifen predictive biomarker. The RSF1 (remodeling and spacing factor 1) gene is frequently co-amplified with CCND1 on chromosome 11q. We validated the predictive value of these biomarkers in the MA. 12 randomized study of adjuvant tamoxifen vs. placebo in high-risk premenopausal early breast cancer. Premenopausal women with node-positive/ high-risk node-negative early breast cancer received standard adjuvant chemotherapy and then were randomized to tamoxifen (20 mg/day) or placebo for 5 yrs. Overall survival (OS) and relapse-free survival (RFS) were evaluated. Fluorescent in-situ hybridization was performed on a tissue microarray of 495 breast tumors (74% of patients) to measure CCND1 and RSF1 copy number. A multivariate Cox model to obtain hazard ratios (HR) adjusting for clinicopathologic factors was used to assess the effect of these biomarkers on Os and RFS. 672 women were followed for a median of 8.4 years. We were able to measure the DNA copy number of CCND1 in 442 patients and RSF1 in 413 patients. CCND1 gene amplification was observed in 8.7% and RSF1 in 6.8% of these patients, preferentially in estrogen receptor-positive breast cancers. No statistically significant interaction with treatment was observed for either CCND1 or RSF1 amplification, although patients with high RSF1 copy number did not show benefit from adjuvant tamoxifen (HR = 1.11, interaction p = 0.09). Unlike CCND1 amplification, RSF1 amplification may predict for outcome in high-risk premenopausal breast cancer patients treated with adjuvant tamoxifen.	[Keilty, Dana; Buchanan, Marguerite; Basik, Mark] Jewish Gen Hosp, Lady Davis Inst, Dept Oncol & Surg, Montreal, PQ, Canada; [Ntapolias, Katerina; Aleynikova, Olga] Jewish Gen Hosp, Dept Pathol, Montreal, PQ, Canada; [Tu, Dongsheng; Li, Xiao; Shepherd, Lois] Queens Univ, Canc Res Inst, NCIC Clin Trials Grp, Kingston, ON K7L 3N6, Canada; [Bramwell, Vivien] Tom Baker Canc Clin, Dept Med Oncol, Calgary, AB, Canada	Lady Davis Institute; McGill University; McGill University; Queens University - Canada; Canadian Cancer Trials Group; Tom Baker Cancer Clinic; University of Calgary	Basik, M (corresponding author), Jewish Gen Hosp, Lady Davis Inst, Dept Oncol & Surg, Montreal, PQ, Canada.	markbasik@gmail.com		Keilty, Dana/0000-0001-6374-2755	Terry Fox Research Institute; Canadian Institutes of Health Research Graduate Studentship	Terry Fox Research Institute; Canadian Institutes of Health Research Graduate Studentship(Canadian Institutes of Health Research (CIHR))	The work was funded by the Terry Fox Research Institute (to MB) and the Canadian Institutes of Health Research Graduate Studentship (to DK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bostner J, 2007, ONCOGENE, V26, P6997, DOI 10.1038/sj.onc.1210506; Bramwell VHC, 2010, ANN ONCOL, V21, P283, DOI 10.1093/annonc/mdp326; Brown LA, 2008, GENE CHROMOSOME CANC, V47, P481, DOI 10.1002/gcc.20549; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Fisher B, 2004, LANCET, V364, P858, DOI 10.1016/S0140-6736(04)16981-X; Goetz MP, 2005, J CLIN ONCOL, V23, P9312, DOI 10.1200/JCO.2005.03.3266; Hosein AN, 2010, CANCER RES, V70, P5770, DOI 10.1158/0008-5472.CAN-10-0673; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; Loyola A, 2003, MOL CELL BIOL, V23, P6759, DOI 10.1128/MCB.23.19.6759-6768.2003; Lundgren K, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3161; Mao TL, 2006, HUM PATHOL, V37, P1169, DOI 10.1016/j.humpath.2006.04.008; Ormandy CJ, 2003, BREAST CANCER RES TR, V78, P323, DOI 10.1023/A:1023033708204; Rae JM, 2012, JNCI-J NATL CANCER I, V104, P452, DOI 10.1093/jnci/djs126; Regan MM, 2012, JNCI-J NATL CANCER I, V104, P441, DOI 10.1093/jnci/djs125; Reis JS, 2006, MODERN PATHOL, V19, P999, DOI 10.1038/modpathol.3800621; Shih LM, 2005, P NATL ACAD SCI USA, V102, P14004, DOI 10.1073/pnas.0504195102; Stendahl M, 2004, BRIT J CANCER, V90, P1942, DOI 10.1038/sj.bjc.6601831; Vicent GP, 2010, MOL ENDOCRINOL, V24, P2088, DOI 10.1210/me.2010-0027; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775	19	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e81740	10.1371/journal.pone.0081740	http://dx.doi.org/10.1371/journal.pone.0081740			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367492	gold, Green Published			2022-12-27	WOS:000328741900005
J	Reno, PL; McLean, CY; Hines, JE; Capellini, TD; Bejerano, G; Kingsley, DM				Reno, Philip L.; McLean, Cory Y.; Hines, Jasmine E.; Capellini, Terence D.; Bejerano, Gill; Kingsley, David M.			A Penile Spine/Vibrissa Enhancer Sequence Is Missing in Modern and Extinct Humans but Is Retained in Multiple Primates with Penile Spines and Sensory Vibrissae	PLOS ONE			English	Article							EVOLUTION; PAPULES; CHIMPANZEE; ALIGNMENT; GENOMICS; GLANDS	Previous studies show that humans have a large genomic deletion downstream of the Androgen Receptor gene that eliminates an ancestral mammalian regulatory enhancer that drives expression in developing penile spines and sensory vibrissae. Here we use a combination of large-scale sequence analysis and PCR amplification to demonstrate that the penile spine/vibrissa enhancer is missing in all humans surveyed and in the Neandertal and Denisovan genomes, but is present in DNA samples of chimpanzees and bonobos, as well as in multiple other great apes and primates that maintain some form of penile integumentary appendage and facial vibrissae. These results further strengthen the association between the presence of the penile spine/vibrissa enhancer and the presence of penile spines and macro-or micro-vibrissae in non-human primates as well as show that loss of the enhancer is both a distinctive and characteristic feature of the human lineage.	[Reno, Philip L.; Hines, Jasmine E.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [McLean, Cory Y.; Bejerano, Gill] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Capellini, Terence D.; Bejerano, Gill; Kingsley, David M.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Kingsley, David M.] Howard Hughes Med Inst, Stanford, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Stanford University; Stanford University; Howard Hughes Medical Institute	Reno, PL (corresponding author), Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA.	philreno@psu.edu; cmclean@stanfordalumni.org	Capellini, Terence/B-8316-2016	McLean, Cory/0000-0001-9928-8216; Reno, Philip/0000-0002-7053-0344	Center for Excellence in Genomic Sciences from the National Institutes of Health [5P50HG2568]; Microsoft Research Fellow; Howard Hughes Medical Institute; NIH NCRR [RR015087, RR014491, RR016483]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016483, U42RR015087, C06RR014491] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568] Funding Source: NIH RePORTER	Center for Excellence in Genomic Sciences from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Microsoft Research Fellow(Microsoft); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded in part by a Center for Excellence in Genomic Sciences grant (5P50HG2568) from the National Institutes of Health (nih.gov). G.B. is a Packard Fellow (packard.org) and Microsoft Research Fellow (research.microsoft.com) and D. M. K. is an investigator of the Howard Hughes Medical Institute (hhmi.org). The University of Louisiana at Lafayette New Iberia Research Center is funded by NIH NCRR (RR015087, RR014491, RR016483). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN AB, 1973, ARCH DERMATOL, V108, P673, DOI 10.1001/archderm.108.5.673; Agrawal SK, 2004, INT J DERMATOL, V43, P199, DOI 10.1111/j.1365-4632.2004.02057.x; Alfoldi J, 2013, GENOME RES, V23, P1063, DOI 10.1101/gr.157503.113; BEACH FA, 1950, J EXP ZOOL, V114, P159, DOI 10.1002/jez.1401140108; DAHL JF, 1994, J MAMMAL, V75, P1, DOI 10.2307/1382229; Dixson A.F., 1998, PRIMATE SEXUALITY CO; DIXSON AF, 1976, FOLIA PRIMATOL, V26, P207, DOI 10.1159/000155751; GLICKSMA.JM, 1966, ARCH DERMATOL, V93, P56, DOI 10.1001/archderm.93.1.56; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Harris RS, 2007, IMPROVED PAIRWISE AL, DOI DOI 10.1093/molbev/msx116; Hershkovitz Philip, 1993, Fieldiana Zoology, V73, P1; HILL WCO, 1949, P ZOOL SOC LOND, V119, P363; HILL WCO, 1946, P ZOOL SOC LOND, V116, P129; HILL WCO, 1950, P ZOOL SOC LOND, V120, P311; Hiller M, 2012, CELL REP, V2, P817, DOI 10.1016/j.celrep.2012.08.032; HYMAN AB, 1969, ARCH DERMATOL, V99, P31, DOI 10.1001/archderm.99.1.31; IZOR RJ, 1981, FOLIA PRIMATOL, V35, P218, DOI 10.1159/000155973; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MATTHEWS LH, 1946, P ZOOL SOC LOND, V116, P339; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Muchlinski MN, 2010, J HUM EVOL, V58, P447, DOI 10.1016/j.jhevol.2010.01.012; MURAKAMI R, 1987, J ANAT, V153, P223; Oates JK, 1997, GENITOURIN MED, V73, P137; Perry GH, 2008, GENOME RES, V18, P1698, DOI 10.1101/gr.082016.108; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Vowles EJ, 2006, MOL BIOL EVOL, V23, P598, DOI 10.1093/molbev/msj065	28	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84258	10.1371/journal.pone.0084258	http://dx.doi.org/10.1371/journal.pone.0084258			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367647	Green Submitted, Green Published, gold			2022-12-27	WOS:000328741900040
J	Bongiorno, R; Bain, PG; Haslam, N				Bongiorno, Renata; Bain, Paul G.; Haslam, Nick			When Sex Doesn't Sell: Using Sexualized Images of Women Reduces Support for Ethical Campaigns	PLOS ONE			English	Article							ANIMAL RIGHTS; OBJECTIFICATION; OBJECTS; DEHUMANIZATION; INFORMATION; MAGAZINE; GENDER; MIND; MEN	Images of scantily clad women are used by advertisers to make products more attractive to men. This "sex sells'' approach is increasingly employed to promote ethical causes, most prominently by the animal-rights organization PETA. Yet sexualized images can dehumanize women, leaving an unresolved paradox - is it effective to advertise an ethical cause using unethical means? In Study 1, a sample of Australian male undergraduates (N = 82) viewed PETA advertisements containing either sexualized or non-sexualized images of women. Intentions to support the ethical organization were reduced for those exposed to the sexualized advertising, and this was explained by their dehumanization of the sexualized women, and not by increased arousal. Study 2 used a mixed-gender community sample from the United States (N = 280), replicating this finding and extending it by showing that behaviors helpful to the ethical cause diminished after viewing the sexualized advertisements, which was again mediated by the dehumanization of the women depicted. Alternative explanations relating to the reduced credibility of the sexualized women and their objectification were not supported. When promoting ethical causes, organizations may benefit from using advertising strategies that do not dehumanize women.	[Bongiorno, Renata; Bain, Paul G.] Univ Queensland, Brisbane, Qld, Australia; [Haslam, Nick] Univ Melbourne, Melbourne, Vic, Australia	University of Queensland; University of Melbourne	Bongiorno, R (corresponding author), Univ Queensland, Brisbane, Qld, Australia.	r.bongiorno@uq.edu.au	Haslam, Nick/D-9026-2011	Haslam, Nick/0000-0002-1913-2340; Bain, Paul/0000-0001-5521-2738; Bongiorno, Renata/0000-0003-4194-8087	Australian Research Council Discovery Project Grant [DP0771200]	Australian Research Council Discovery Project Grant(Australian Research Council)	The authors acknowledge support from the Australian Research Council Discovery Project Grant DP0771200. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Carol J, 2010, SEXUAL POLITICS MEAT; [Anonymous], 2011, BROCK REV, DOI [DOI 10.26522/BR.V12I1.333, DOI 10.26522/br.v12i1.333]; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cikara M, 2011, CURR DIR PSYCHOL SCI, V20, P149, DOI 10.1177/0963721411408713; Dudley Sid C, 1999, J MARKETING THEORY P, V7, P89, DOI DOI 10.1080/10696679.1999.11501854; Fredrickson BL, 1997, PSYCHOL WOMEN QUART, V21, P173, DOI 10.1111/j.1471-6402.1997.tb00108.x; Gray K, 2011, J PERS SOC PSYCHOL, V101, P1207, DOI 10.1037/a0025883; Grazer W. F., 1995, J APPL BUSINESS RES, V11, P47, DOI DOI 10.19030/jabr.v11i3.5859; Gruenfeld DH, 2008, J PERS SOC PSYCHOL, V95, P111, DOI 10.1037/0022-3514.95.1.111; Gurung RAR, 2007, SEX ROLES, V57, P91, DOI 10.1007/s11199-007-9219-z; Haslam N, 2006, PERS SOC PSYCHOL REV, V10, P252, DOI 10.1207/s15327957pspr1003_4; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664; Heflick NA, 2011, J EXP SOC PSYCHOL, V47, P572, DOI 10.1016/j.jesp.2010.12.020; Heflick NA, 2009, J EXP SOC PSYCHOL, V45, P598, DOI 10.1016/j.jesp.2009.02.008; Kilbourne J., 2005, INT, V24, P119; Kruse CR, 1999, SOC ANIM, V7, P179, DOI 10.1163/156853099X00077; LATOUR MS, 1990, J ADVERTISING, V19, P51, DOI 10.1080/00913367.1990.10673200; Leyens JP, 2007, SOC ISS POLICY REV, V1, P139, DOI 10.1111/j.1751-2409.2007.00006.x; Loughnan S, 2010, EUR J SOC PSYCHOL, V40, P709, DOI 10.1002/ejsp.755; Nelson MR, 2005, SEX ROLES, V53, P371, DOI 10.1007/s11199-005-6760-5; Peek CW, 1996, GENDER SOC, V10, P464, DOI 10.1177/089124396010004007; Reichert T, 2004, J MASS COMMUN Q, V81, P823, DOI 10.1177/107769900408100407; Reichert T, 2002, ANN REV SEX RES, V13, P241; Reichert T., 2007, ADVERTISING SOC REV, V8; Rudman LA, 1995, J EXP SOC PSYCHOL, V31, P493, DOI 10.1006/jesp.1995.1022; Rudman LA, 2012, PERS SOC PSYCHOL B, V38, P734, DOI 10.1177/0146167212436401; SEVERN J, 1990, J ADVERTISING, V19, P14, DOI 10.1080/00913367.1990.10673176; Stankiewicz JM, 2008, SEX ROLES, V58, P579, DOI 10.1007/s11199-007-9359-1; Vaes J, 2011, EUR J SOC PSYCHOL, V41, P774, DOI 10.1002/ejsp.824	30	20	20	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83311	10.1371/journal.pone.0083311	http://dx.doi.org/10.1371/journal.pone.0083311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367591	Green Published, gold			2022-12-27	WOS:000328740300102
J	Chen, J; Li, CS; Gao, XF; Li, CH; Liang, ZX; Yu, L; Li, YQ; Xiao, XY; Chen, LA				Chen, Jie; Li, Chunsun; Gao, Xiaofang; Li, Chonghui; Liang, Zhixin; Yu, Ling; Li, Yanqin; Xiao, Xiaoyi; Chen, Liangan			Keratinocyte Growth Factor Gene Delivery via Mesenchymal Stem Cells Protects against Lipopolysaccharide-Induced Acute Lung Injury in Mice	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; RESPIRATORY-DISTRESS-SYNDROME; MYOCARDIAL-INFARCTION; EPITHELIAL-CELLS; BONE; BLEOMYCIN; THERAPY; RATS; FIBROSIS; ANGIOPOIETIN-1	Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are associated with high morbidity and mortality, and have no specific therapy. Keratinocyte growth factor (KGF) is a critical factor for pulmonary epithelial repair and acts via the stimulation of epithelial cell proliferation. Mesenchymal stem cells (MSCs) have been proved as good therapeutic vectors. Thus, we hypothesized that MSC-based KGF gene therapy would have beneficial effects on lipopolysaccharide (LPS) induced lung injury. After two hours of intratracheal LPS administration to induce lung injury, mice received saline, MSCs alone, empty vector-engineered MSCs (MSCs-vec) or KGF-engineered MSCs (MSCs-kgf) via the tail vein. The MSCs-kgf could be detected in the recipient lungs and the level of KGF expression significantly increased in the MSCs-kgf mice. The MSC-mediated administration of KGF not only improved pulmonary microvascular permeability but also mediated a down-regulation of proinflammatory responses (reducing IL-1 beta and TNF-alpha) and an up-regulation of anti-inflammatory responses (increasing cytokine IL-10). Furthermore, the total severity scores of lung injury were significantly reduced in the MSCs-kgf group compared with the other three groups. The underlying mechanism of the protective effect of KGF on ALI may be attributed to the promotion of type II lung epithelial cell proliferation and the enhancement of surfactant synthesis. These findings suggest that MSCs-based KGF gene therapy may be a promising strategy for ALI treatment.	[Chen, Jie; Li, Chunsun; Gao, Xiaofang; Li, Chonghui; Liang, Zhixin; Yu, Ling; Li, Yanqin; Xiao, Xiaoyi; Chen, Liangan] Chinese Peoples Liberat Army Gen Hosp, Dept Resp Med, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Chen, LA (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Resp Med, Beijing, Peoples R China.	chenliangan301@163.com		jie, Chen/0000-0002-2852-3618; Chen, Liang-an/0000-0002-1829-3134; Liang, Zhixin/0000-0001-5208-7505; Liang, Zhixin/0000-0003-3520-2297	Military Hospital of Clinic High and New Technology Fund of China [2010gxjs090]	Military Hospital of Clinic High and New Technology Fund of China	Military Hospital of Clinic High and New Technology Fund of China (2010gxjs090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008013; Baba Y, 2007, HUM GENE THER, V18, P130, DOI 10.1089/hum.2006.137; Bao SY, 2005, AM J PHYSIOL-LUNG C, V288, pL36, DOI 10.1152/ajplung.00309.2003; Deterding RR, 1997, P ASSOC AM PHYSICIAN, V109, P254; Devaney J, 2011, CRIT CARE, V15, DOI 10.1186/cc10216; Frutos-Vivar F, 2006, SEM RESP CRIT CARE M, V27, P327, DOI 10.1055/s-2006-948287; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Kugathasan L, 2005, CHEST, V128, p633S, DOI 10.1378/chest.128.6_suppl.633S; Lamontagne F, 2010, CRIT CARE MED, V38, P2401, DOI 10.1097/CCM.0b013e3181fa0468; Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106; Lee JW, 2009, EXPERT OPIN BIOL TH, V9, P1259, DOI 10.1517/14712590903213651; Lefort J, 1998, J IMMUNOL, V161, P474; Lesur I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011485; Lin X, 2011, CRIT CARE CLIN, V27, P705, DOI 10.1016/j.ccc.2011.04.002; Liu KD, 2008, CLIN J AM SOC NEPHRO, V3, P578, DOI 10.2215/CJN.01630407; Loebinger MR, 2010, THORAX, V65, P362, DOI 10.1136/thx.2009.128025; Manning E, 2010, HUM GENE THER, V21, P713, DOI 10.1089/hum.2009.147; Matthay MA, 2010, CHEST, V138, P965, DOI 10.1378/chest.10-0518; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Modelska K, 1999, AM J RESP CRIT CARE, V160, P1450, DOI 10.1164/ajrccm.160.5.9901096; Nagaya N, 2004, AM J PHYSIOL-HEART C, V287, pH2670, DOI 10.1152/ajpheart.01071.2003; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Provenano M, 2007, ADV EXP MED BIOL, V593, P66; Raghavendran K, 2008, CURR MED CHEM, V15, P1911, DOI 10.2174/092986708785132942; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8; Sakamoto S, 2011, AM J RESP CELL MOL, V45, P489, DOI 10.1165/rcmb.2010-0092OC; Sugahara K, 1998, J PATHOL, V186, P90; Takao Y, 2005, ANESTH ANALG, V100, P810, DOI 10.1213/01.ANE.0000144775.19385.8C; Trono D, 2000, GENE THER, V7, P20, DOI 10.1038/sj.gt.3301105; Ulrich K, 2005, AM J PHYSIOL-LUNG C, V288, pL1179, DOI 10.1152/ajplung.00450.2004; Xie YS, 2008, COMP BIOCHEM PHYS B, V151, P225, DOI 10.1016/j.cbpb.2008.07.006; Xu J, 2008, J PATHOL, V214, P472, DOI 10.1002/path.2302; Xu JG, 2007, AM J PHYSIOL-LUNG C, V293, pL131, DOI 10.1152/ajplung.00431.2006; Xu XS, 1998, AM J RESP CELL MOL, V18, P168, DOI 10.1165/ajrcmb.18.2.2824; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Yang ZJ, 2010, CARDIOVASC THER, V28, P380, DOI 10.1111/j.1755-5922.2009.00116.x; Yano T, 1996, AM J RESP CELL MOL, V15, P433, DOI 10.1165/ajrcmb.15.4.8879176; Yao HW, 2006, CLIN EXP PHARMACOL P, V33, P793, DOI 10.1111/j.1440-1681.2006.04440.x; Yi ES, 1996, AM J PATHOL, V149, P1963; Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157672.70560.7b; Zhu YG, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/560194	47	36	42	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83303	10.1371/journal.pone.0083303	http://dx.doi.org/10.1371/journal.pone.0083303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367590	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300101
J	Huiart, L; Bouhnik, AD; Rey, D; Rousseau, F; Retornaz, F; Meresse, M; Bendiane, MK; Viens, P; Giorgi, R				Huiart, Laetitia; Bouhnik, Anne-Deborah; Rey, Dominique; Rousseau, Frederique; Retornaz, Frederique; Meresse, Megane; Bendiane, Marc Karim; Viens, Patrice; Giorgi, Roch			Complementary or Alternative Medicine as Possible Determinant of Decreased Persistence to Aromatase Inhibitor Therapy among Older Women with Non-Metastatic Breast Cancer	PLOS ONE			English	Article							ADJUVANT HORMONAL-THERAPY; POSTMENOPAUSAL WOMEN; EARLY DISCONTINUATION; MEDICATION ADHERENCE; TAMOXIFEN THERAPY; ENDOCRINE THERAPY; CLINICAL-PRACTICE; RANDOMIZED-TRIAL; COHORT; LETROZOLE	Purpose: Aromatase inhibitor therapy (AI) significantly improves survival in breast cancer patients. Little is known about adherence and persistence to aromatase inhibitors and about the causes of treatment discontinuation among older women. Methods: We constituted a cohort of women over 65 receiving a first AI therapy for breast cancer between 2006 and 2008, and followed them until June 2011. Women were selected in the population-based French National Health Insurance databases, and data was collected on the basis of pharmacy refills, medical records and face-to-face interviews. Non-persistence to treatment was defined as the first treatment discontinuation lasting more than 3 consecutive months. Time to treatment discontinuation was studied using survival analysis techniques. Results: Overall among the 382 selected women, non-persistence to treatment went from 8.7% (95% CI: 6.2-12.1) at 1 year, to 15.6% (95% CI: 12.2-19.8) at 2 years, 20.8% (95% CI: 16.7-25.6) at 3 years, and 24.7% (95% CI: 19.5-31.0) at 4 years. In the multivariate analysis on a sub-sample of 233 women with available data, women using complementary or alternative medicine (CAM) (HR = 3.2; 95% CI: 1.5-6.9) or suffering from comorbidities (HR = 2.2; 95% CI: 1.0-4.8) were more likely to discontinue their treatment, whereas women with polypharmacy (HR = 0.4; 95% CI: 0.2-0.91) were less likely to discontinue. In addition, 13% of the women with positive hormonal receptor status did not fill any prescription for anti-hormonal therapy. Conclusion: AI therapy is discontinued prematurely in a substantial portion of older patients. Some patients may use CAM not as a complementary treatment, but as an alternative to conventional medicine. Improving patient-physician communication on the use of CAM may improve hormonal therapy adherence.	[Huiart, Laetitia] CHU La Reunion, Unite Soutien Methodol, St Denis, France; [Huiart, Laetitia; Bouhnik, Anne-Deborah; Rey, Dominique; Meresse, Megane; Bendiane, Marc Karim; Giorgi, Roch] INSERM, SESSTIM U912, F-13258 Marseille, France; [Huiart, Laetitia; Bouhnik, Anne-Deborah; Rey, Dominique; Meresse, Megane; Bendiane, Marc Karim; Giorgi, Roch] Univ Aix Marseille, IRD, UMR S912, Marseille, France; [Rey, Dominique; Bendiane, Marc Karim] ORS PACA, Marseille, France; [Rousseau, Frederique; Viens, Patrice] Inst J Paoli I Calmettes, Dept Med Oncol, F-13009 Marseille, France; [Retornaz, Frederique] Ctr Gerontol Dept, Marseille, France; [Viens, Patrice] Univ Aix Marseille, Ctr Rech Cancerol Marseille, INSERM U891, Marseille, France; [Giorgi, Roch] Hop Enfants La Timone, Assistance Publ Hop Marseille, Serv Biostat & Technol Informat & Commun, Marseille, France	CHU Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Huiart, L (corresponding author), CHU La Reunion, Unite Soutien Methodol, St Denis, France.	laetitia.huiart@mail.mcgill.ca	Bouhnik, Anne-Déborah/Q-9650-2017; Huiart, Laetitia/GQB-4064-2022; Bendiane, Marc-Karim K/F-5414-2010; Bouhnik, Anne-Deborah/M-2829-2019; Viens, Patrice/Q-8499-2018; Bendiane, Marc-Karim/M-7060-2019; GIORGI, Roch/A-6438-2009	Bouhnik, Anne-Déborah/0000-0002-5418-4592; Bendiane, Marc-Karim K/0000-0003-4329-8807; Bouhnik, Anne-Deborah/0000-0002-5418-4592; Viens, Patrice/0000-0003-1511-1048; GIORGI, Roch/0000-0001-6135-3078	French Ministry of Research; French National Institute of Cancer (INCa); cancer foundations (Fondation de France and Association pour la Recherche sur le Cancer); National Institute for Health Research [UMR912 INSERM]	French Ministry of Research(Ministry of Research, FranceEuropean Commission); French National Institute of Cancer (INCa)(Institut National du Cancer (INCA) France); cancer foundations (Fondation de France and Association pour la Recherche sur le Cancer); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the French Ministry of Research, the French National Institute of Cancer (INCa), regional authorities (Conseil Regional Provence-Alpes Cote-d'Azur), cancer foundations (Fondation de France and Association pour la Recherche sur le Cancer), and the National Institute for Health Research (UMR912 INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Almeida OP, 1999, INT J GERIATR PSYCH, V14, P858, DOI 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; Balkrishnan R, 1998, CLIN THER, V20, P764, DOI 10.1016/S0149-2918(98)80139-2; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JOP.000082; Choo PW, 1999, MED CARE, V37, P846, DOI 10.1097/00005650-199909000-00002; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; Crivellari D, 2008, J CLIN ONCOL, V26, P1972, DOI 10.1200/JCO.2007.14.0459; Dezentje V, 2009, J CLIN ONCOL, V27; Eisenberg DM, 2001, ANN INTERN MED, V135, P344, DOI 10.7326/0003-4819-135-5-200109040-00011; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; FISHER B, 1989, NEW ENGL J MED, V320, P479, DOI 10.1056/NEJM198902233200802; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Hershman DL, 2011, BREAST CANCER RES TR, V126, P529, DOI 10.1007/s10549-010-1132-4; Hershman DL, 2010, J CLIN ONCOL, V28, P4120, DOI 10.1200/JCO.2009.25.9655; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Huiart L, 2011, BRIT J CANCER, V104, P1558, DOI 10.1038/bjc.2011.140; Huiart L, 2013, BREAST CANCER RES TR, V138, P325, DOI 10.1007/s10549-013-2422-4; Huiart L, 2012, EUR J CANCER, V48, P1939, DOI 10.1016/j.ejca.2012.03.004; Jernewall N, 2005, AIDS CARE, V17, P601, DOI 10.1080/09540120512331314295; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; Knippels HMA, 2000, AIDS CARE, V12, P435, DOI 10.1080/09540120050123837; Lash TL, 2006, BREAST CANCER RES TR, V99, P215, DOI 10.1007/s10549-006-9193-0; LOVE RR, 1990, J NATL CANCER I, V82, P18, DOI 10.1093/jnci/82.1.18; Maggiore RJ, 2012, CANCER-AM CANCER SOC, V118, P4815, DOI 10.1002/cncr.27427; Martin-Latry K, 2010, PHARMACOEPIDEM DR S, V19, P256, DOI 10.1002/pds.1912; McCowan C, 2008, BRIT J CANCER, V99, P1763, DOI 10.1038/sj.bjc.6604758; Murphy CC, 2012, BREAST CANCER RES TR, V134, P459, DOI 10.1007/s10549-012-2114-5; Nekhlyudov L, 2011, BREAST CANCER RES TR, V130, P681, DOI 10.1007/s10549-011-1703-z; Neugut AI, 2011, J CLIN ONCOL, V29, P2534, DOI 10.1200/JCO.2010.33.3179; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Owen-Smith A, 2007, AIDS CARE, V19, P589, DOI 10.1080/09540120701203279; Partridge AH, 2002, JNCI-J NATL CANCER I, V94, P652; Partridge AH, 2008, J CLIN ONCOL, V26, P556, DOI 10.1200/JCO.2007.11.5451; Richardson MA, 2000, J CLIN ONCOL, V18, P2505, DOI 10.1200/JCO.2000.18.13.2505; Ruddy K, 2009, CA-CANCER J CLIN, V59, P56, DOI 10.3322/caac.20004; Thomas-Schoemann A, 2011, B CANCER, V98, P645, DOI 10.1684/bdc.2011.1375; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6; Ziller V, 2009, ANN ONCOL, V20, P431, DOI 10.1093/annonc/mdn646	42	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81677	10.1371/journal.pone.0081677	http://dx.doi.org/10.1371/journal.pone.0081677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367488	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300009
J	Libby, E; Rainey, PB				Libby, Eric; Rainey, Paul B.			Eco-Evolutionary Feedback and the Tuning of Proto-Developmental Life Cycles	PLOS ONE			English	Article							PHENOTYPIC DIVERSITY; NICHE CONSTRUCTION; POPULATION-GROWTH; PLASTICITY; INDIVIDUALITY; COOPERATION; CONFLICT; CONSEQUENCES; ENVIRONMENT; EXCLUSION	Multicellular organisms depend on developmental programs to coordinate growth and differentiation from single cells, but the origins of development are unclear. A possible starting point is stochastic phenotypic variation generated by molecular noise. Given appropriate environmental conditions, noise-driven differentiation could conceivably evolve so as to come under regulatory control; however, abiotic conditions are likely to be restrictive. Drawing from an experimental system, we present a model in which environmental fluctuations are coupled to population growth. We show that this coupling generates stable selection for a single optimal strategy that is largely insensitive to environmental conditions, including the number of competitors, carrying capacity of the environment, difference in growth rates among phenotypic variants, and population density. We argue that this optimal strategy establishes stabilizing conditions likely to improve the quality and reliability of information experienced by evolving organisms, thus increasing opportunity for the evolutionary emergence of developmental programs.	[Libby, Eric; Rainey, Paul B.] Massey Univ, New Zealand Inst Adv Study, Auckland, New Zealand; [Libby, Eric] Santa Fe Inst, Santa Fe, NM 87501 USA; [Rainey, Paul B.] Max Planck Inst Evolutionary Biol, Plon, Germany	Massey University; The Santa Fe Institute; Max Planck Society	Libby, E (corresponding author), Massey Univ, New Zealand Inst Adv Study, Auckland, New Zealand.	elibby@santafe.edu	Rainey, Paul/A-3207-2008	Rainey, Paul/0000-0003-0879-5795	Foundational Questions in Evolutionary Biology Fund [RFP-12-20]; Marsden Research Council	Foundational Questions in Evolutionary Biology Fund; Marsden Research Council	This research was supported in part by grant RFP-12-20 from the Foundational Questions in Evolutionary Biology Fund as well as the Marsden Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Ancel LW, 2000, THEOR POPUL BIOL, V58, P307, DOI 10.1006/tpbi.2000.1484; Arthur W, 2002, NATURE, V415, P757, DOI 10.1038/415757a; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; BULL JJ, 1987, EVOLUTION, V41, P303, DOI 10.1111/j.1558-5646.1987.tb05799.x; Buss L., 1987, EVOLUTION INDIVIDUAL; Donaldson-Matasci MC, 2008, EVOL ECOL RES, V10, P493; Donohue K, 2005, NEW PHYTOL, V166, P83, DOI 10.1111/j.1469-8137.2005.01357.x; Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; LEVINS R, 1962, AM NAT, V96, P361, DOI 10.1086/282245; LEWONTIN RC, 1969, P NATL ACAD SCI USA, V62, P1056, DOI 10.1073/pnas.62.4.1056; Libby E, 2011, P ROY SOC B-BIOL SCI, V278, P3574, DOI 10.1098/rspb.2011.0146; LOREAU M, 1994, THEOR POPUL BIOL, V46, P58, DOI 10.1006/tpbi.1994.1019; Michod RE, 1997, AM NAT, V149, P607, DOI 10.1086/286012; Michod RE, 1996, P ROY SOC B-BIOL SCI, V263, P813, DOI 10.1098/rspb.1996.0121; Minelli A, 2010, PHILOS T R SOC B, V365, P631, DOI 10.1098/rstb.2009.0268; Moczek AP, 2011, P ROY SOC B-BIOL SCI, V278, P2705, DOI 10.1098/rspb.2011.0971; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Newman SA, 2000, J EXP ZOOL, V288, P304, DOI 10.1002/1097-010X(20001215)288:4&lt;304::AID-JEZ3&gt;3.0.CO;2-G; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; Okasha S, 2009, EVOLUTION LEVELS SEL; Rainey PB, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S14; Rainey PB, 2010, BIOESSAYS, V32, P872, DOI 10.1002/bies.201000039; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Schlichting CD, 2003, EVOL DEV, V5, P98, DOI 10.1046/j.1525-142X.2003.03015.x; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Smith J. M., 1997, MAJOR TRANSITIONS EV; Snell-Rood EC, 2010, BIOESSAYS, V32, P71, DOI 10.1002/bies.200900132; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; West-Eberhard Mary Jane, 2003, pi; WOLPERT L, 1994, DEVELOPMENT, P79; WOLPERT L, 1990, BIOL J LINN SOC, V39, P109, DOI 10.1111/j.1095-8312.1990.tb00506.x; Wolpert L, 2002, NATURE, V420, P745, DOI 10.1038/420745a	39	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82274	10.1371/journal.pone.0082274	http://dx.doi.org/10.1371/journal.pone.0082274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367511	gold, Green Submitted, Green Published			2022-12-27	WOS:000328740300027
J	Querec, TD; Gurbaxani, BM; Unger, ER				Querec, Troy David; Gurbaxani, Brian Mohan; Unger, Elizabeth Robinson			Randomization Modeling to Ascertain Clustering Patterns of Human Papillomavirus Types Detected in Cervicovaginal Samples in the United States	PLOS ONE			English	Article							GENITAL HUMAN-PAPILLOMAVIRUS; CERVICAL COINFECTION; HIGH-RISK; HPV TYPES; PREVALENCE; INFECTION; WOMEN; ACQUISITION; CONCURRENT; NEOPLASIA	Detection of multiple human papillomavirus (HPV) types in the genital tract is common. Associations among HPV types may impact HPV vaccination modeling and type replacement. The objectives were to determine the distribution of concurrent HPV type infections in cervicovaginal samples and examine type-specific associations. We analyzed HPV genotyping results from 32,245 cervicovaginal specimens collected from women aged 11 to 83 years in the United States from 2001 through 2011. Statistical power was enhanced by combining 6 separate studies. Expected concurrent infection frequencies from a series of permutation models, each with increasing fidelity to the real data, were compared with the observed data. Statistics were computed based on the distributional properties of the randomized data. Concurrent detection occurred more than expected with 0 or >= 3 HPV types and less than expected with 1 and 2 types. Some women bear a disproportionate burden of the HPV type prevalence. Type associations were observed that exceeded multiple hypothesis corrected significance. Multiple HPV types were detected more frequently than expected by chance and associations among particular HPV types were detected. However vaccine-targeted types were not specifically affected, supporting the expectation that current bivalent/quadrivalent HPV vaccination will not result in type replacement with other high-risk types.	[Querec, Troy David; Gurbaxani, Brian Mohan; Unger, Elizabeth Robinson] Ctr Dis Control & Prevent, Chron Viral Dis Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Querec, TD (corresponding author), Ctr Dis Control & Prevent, Chron Viral Dis Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30329 USA.	tquerec@cdc.gov	Querec, Troy/AAH-3564-2021	Querec, Troy/0000-0002-3787-6271; Unger, Elizabeth/0000-0002-2925-5635	American Society for Microbiology/Centers for Disease Control and Prevention Postdoctoral Research Fellowship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007610] Funding Source: NIH RePORTER	American Society for Microbiology/Centers for Disease Control and Prevention Postdoctoral Research Fellowship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The stipend for Dr. Querec was provided by the American Society for Microbiology/Centers for Disease Control and Prevention Postdoctoral Research Fellowship Program. All data were previously collected for other purposes by the Centers for Disease Control and Prevention. The funders had no role in study design, aggregating previously collected data and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Carozzi F, 2011, EUR J CANC; Chaturvedi AK, 2005, J MED VIROL, V75, P105, DOI 10.1002/jmv.20244; Chaturvedi AK, 2005, CANCER EPIDEM BIOMAR, V14, P2439, DOI 10.1158/1055-9965.EPI-05-0465; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; Cuschieri KS, 2004, J CLIN PATHOL, V57, P68, DOI 10.1136/jcp.57.1.68; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Elbasha EH, 2005, MATH BIOSCI, V197, P88, DOI 10.1016/j.mbs.2005.05.004; Gargiulo F, 2007, VIRUS RES, V125, P176, DOI 10.1016/j.virusres.2006.12.017; Hariri S, 2011, J INFECT DIS, V204, P566, DOI 10.1093/infdis/jir341; Herrero R, 2000, JNCI-J NATL CANCER I, V92, P464, DOI 10.1093/jnci/92.6.464; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Lacey CJN, 2006, VACCINE, V24, P35, DOI 10.1016/j.vaccine.2006.06.015; Mejlhede N, 2010, APMIS, V118, P346, DOI 10.1111/j.1600-0463.2010.02602.x; Mendez F, 2005, J INFECT DIS, V192, P1158, DOI 10.1086/444391; Miklos I, 2004, ECOLOGY, V85, P86, DOI 10.1890/03-0101; Molano M, 2002, BRIT J CANCER, V87, P324, DOI 10.1038/sj.bjc.6600442; Oksanen J., 2016, R PACKAG; Onyekwuluje JM, 2012, CLIN LAB, V58, P61; Palefsky JM, 1999, JNCI-J NATL CANCER I, V91, P226, DOI 10.1093/jnci/91.3.226; R Core Team, 2011, R LANG ENV STAT COMP; Rositch AF, 2011, J INFECT DIS; Rousseau MC, 2003, CANCER EPIDEM BIOMAR, V12, P1029; Rousseau MC, 2003, SEX TRANSM DIS, V30, P581, DOI 10.1097/00007435-200307000-00010; Rousseau MC, 2001, J INFECT DIS, V184, P1508, DOI 10.1086/324579; Sasagawa T, 2001, CANCER EPIDEM BIOMAR, V10, P45; Schwab A, 2011, ORGAN SCI, V22, P1105, DOI 10.1287/orsc.1100.0557; Spinillo A, 2009, VIRUS RES, V142, P154, DOI 10.1016/j.virusres.2009.02.004; Sutton AJ, 2008, STAT MED, V27, P625, DOI 10.1002/sim.2934; Thomas KK, 2000, J INFECT DIS, V182, P1097, DOI 10.1086/315805; Trottier H, 2006, CANCER EPIDEM BIOMAR, V15, P1274, DOI 10.1158/1055-9965.EPI-06-0129; Vaccarella S, 2011, J INFECT DIS, V204, P1500, DOI 10.1093/infdis/jir595; Vaccarella S, 2010, CANCER EPIDEM BIOMAR, V19, P503, DOI 10.1158/1055-9965.EPI-09-0983; van der Graaf Y, 2002, AM J EPIDEMIOL, V156, P158, DOI 10.1093/aje/kwf013; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Watson M, 2009, J WOMENS HEALTH, V18, P1731, DOI 10.1089/jwh.2009.1570	39	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82761	10.1371/journal.pone.0082761	http://dx.doi.org/10.1371/journal.pone.0082761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367553	gold, Green Submitted, Green Published			2022-12-27	WOS:000328740300066
J	Saadatian-Elahi, M; Tristan, A; Laurent, F; Rasigade, JP; Bouchiat, C; Ranc, AG; Lina, G; Dauwalder, O; Etienne, J; Bes, M; Vanderesch, F				Saadatian-Elahi, Mitra; Tristan, Anne; Laurent, Frederic; Rasigade, Jean-Philippe; Bouchiat, Coralie; Ranc, Anne-Gaelle; Lina, Gerard; Dauwalder, Olivier; Etienne, Jerome; Bes, Michele; Vanderesch, Francois			Basic Rules of Hygiene Protect Health Care and Lab Workers from Nasal Colonization by Staphylococcus aureus: An International Cross-Sectional Study	PLOS ONE			English	Article							CARRIAGE; PREVALENCE; PERSISTENT; INFECTION; CARRIERS; RISK; MICROBIOLOGY; EPIDEMIOLOGY; POPULATION; BACTEREMIA	Acquisition of nasal Staphylococcus aureus (S. aureus) colonization by contaminated hands is likely an important determinant of its nasal carriage rate in health care and lab setting. The objective of our cross-sectional study was to assess the prevalence of nasal methicillin-sensitive (MSSA) or -resistant Staphylococcus aureus (MRSA) carriage among health care professionals (HCPs) attending an international symposium and to study the association between compliance with hygiene rules, individual-related parameters, and medical conditions with nasal S. aureus carriage in this population. After obtaining consent, two nasal swabs were collected. Nasal MSSA and MRSA carriage was measured by the: i) molecular approach targeting spa, mecA and mecA-orfX junction sequences, and ii) culture on selective S. aureus media combined with mecA molecular detection of isolated strains. Information on compliance with hygiene rules, demographic variables, sector of activity and long-term medication was collected by anonymous questionnaire. The participation rate was 32.3%. In total, 176 subjects from 34 countries were included in the analysis. S. aureus was isolated from the nasal swabs of 57 (32.4%) subjects, of whom 3 (5.3%) harbored MRSA strains. Overall, 123 subjects reported working in microbiology laboratories with direct manipulation of S. aureus, and 29 acknowledged regular contacts with patients. In this exposed population, hydro-alcoholic solutions appeared to have a significant protective effect against nasal S. aureus carriage (OR = 0.36; 95% CI: 0.15-0.85). Hospital work was associated with increased risk of nasal S. aureus carriage (OR = 2.38; 95% CI: 1.07-5.29). The results of this study showed that compliance with basic rules of hygiene, such as the use of hydro-alcoholic solutions, could reduce the risk of nasal S. aureus colonization. Hydro-alcoholic solution could interrupt auto-transmission of the pathogen, consequently decreasing the overall nasal carriage rate, specifically in transient carriers.	[Saadatian-Elahi, Mitra; Tristan, Anne; Laurent, Frederic; Rasigade, Jean-Philippe; Bouchiat, Coralie; Ranc, Anne-Gaelle; Lina, Gerard; Dauwalder, Olivier; Etienne, Jerome; Bes, Michele; Vanderesch, Francois] Hosp Civils Lyon, Ctr Natl References Staphylocoques, Lyon, France; [Tristan, Anne; Laurent, Frederic; Rasigade, Jean-Philippe; Bouchiat, Coralie; Lina, Gerard; Etienne, Jerome; Bes, Michele; Vanderesch, Francois] Univ Lyon, INSERM, U1111, Lyon, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Vanderesch, F (corresponding author), Hosp Civils Lyon, Ctr Natl References Staphylocoques, Lyon, France.	francois.vandenesch@univ-lyon1.fr	bouchiat, coralie/AAG-3339-2020; Vandenesch, Francois/C-7209-2014; Rasigade, Jean-Philippe/L-9320-2014; TRISTAN, Anne/GSN-8306-2022; ETIENNE, Jerome/C-5471-2014; Tristan, Anne/L-9464-2014; LAURENT, Frederic/AGM-0706-2022; Rasigade, Jean-Philippe/AAE-1667-2021; Lina, Gerard J/L-9352-2014; DAUWALDER, Olivier/L-9619-2014	Vandenesch, Francois/0000-0001-9412-7106; Rasigade, Jean-Philippe/0000-0002-8264-0452; TRISTAN, Anne/0000-0001-9471-2655; ETIENNE, Jerome/0000-0002-3348-3315; Lina, Gerard/0000-0002-9236-7998; laurent, frederic/0000-0003-0609-9091; DAUWALDER, Olivier/0000-0003-1722-1582				Acton DS, 2009, EUR J CLIN MICROBIOL, V28, P115, DOI 10.1007/s10096-008-0602-7; Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; Amorim ML, 2009, MICROB DRUG RESIST, V15, P19, DOI 10.1089/mdr.2009.0881; Argudin MA, 2013, MICROB PATHOGENESIS, V54, P26, DOI 10.1016/j.micpath.2012.09.001; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Boisseau D, 2012, MED MALADIES INFECT, V42, P435, DOI 10.1016/j.medmal.2012.07.014; da Silva ECBF, 2008, BRAZ J INFECT DIS, V12, P504, DOI 10.1590/S1413-86702008000600012; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Elie-Turenne MC, 2010, INFECT CONT HOSP EP, V31, P574, DOI 10.1086/652525; Farzana K, 2008, PAK J PHARM SCI, V21, P290; Herwaldt LA, 1998, J HOSP INFECT, V40, pS13, DOI 10.1016/S0195-6701(98)90200-6; Herwaldt LA, 2004, INFECT CONT HOSP EP, V25, P481, DOI 10.1086/502426; Ibarra M, 2008, PEDIATR INFECT DIS J, V27, P1109, DOI 10.1097/INF.0b013e31817eeefa; Jager MM, 2010, J HOSP INFECT, V74, P292, DOI 10.1016/j.jhin.2009.11.003; Johannessen M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00056; Krebes J, 2011, J CLIN MICROBIOL, V49, P430, DOI 10.1128/JCM.02039-10; Lozano C, 2011, INT J MED MICROBIOL, V301, P500, DOI 10.1016/j.ijmm.2011.02.004; LUZAR MA, 1990, NEW ENGL J MED, V322, P505, DOI 10.1056/NEJM199002223220804; Mainous AG, 2006, ANN FAM MED, V4, P132, DOI 10.1370/afm.526; Mody L, 2008, CLIN INFECT DIS, V46, P1368, DOI 10.1086/586751; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1159, DOI 10.1007/s10096-009-0752-2; Munckhof WJ, 2009, CLIN MICROBIOL INFEC, V15, P149, DOI 10.1111/j.1469-0691.2008.02652.x; Ng LSY, 2011, J HOSP INFECT, V78, P231, DOI 10.1016/j.jhin.2011.01.025; Nulens E, 2005, EUR J CLIN MICROBIOL, V24, P145, DOI 10.1007/s10096-004-1258-6; Olsen K, 2013, EPIDEMIOL INFECT, V141, P143, DOI 10.1017/S0950268812000465; Padoveze MC, 2008, AM J INFECT CONTROL, V36, P187, DOI 10.1016/j.ajic.2007.05.012; Rashid Z, 2012, ACTA POL PHARM, V69, P985; Rijnders MIA, 2010, BRIT J GEN PRACT, V60, P902, DOI 10.3399/bjgp10X544078; Rodriguez-Avial C, 2013, ENFERM INFEC MICR CL, V31, P516, DOI 10.1016/j.eimc.2012.09.017; Ruimy R, 2010, J INFECT DIS, V202, P924, DOI 10.1086/655901; Skramm I, 2011, APMIS, V119, P522, DOI 10.1111/j.1600-0463.2011.02758.x; Stiefel U, 2011, INFECT CONT HOSP EP, V32, P185, DOI 10.1086/657944; Stone SP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3005; Tristan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051172; van Belkum A, 2007, MICROBES INFECT, V9, P1471, DOI 10.1016/j.micinf.2007.08.003; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wertheim HFL, 2006, INFECT CONT HOSP EP, V27, P863, DOI 10.1086/506401; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; Zanger P, 2012, CLIN INFECT DIS, V55, P1625, DOI 10.1093/cid/cis778; Zhang M, 2011, J HOSP INFECT, V78, P113, DOI 10.1016/j.jhin.2011.02.018	41	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82851	10.1371/journal.pone.0082851	http://dx.doi.org/10.1371/journal.pone.0082851			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367562	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300075
J	Sattin, G; Artese, A; Nadai, M; Costa, G; Parrotta, L; Alcaro, S; Palumbo, M; Richter, SN				Sattin, Giovanna; Artese, Anna; Nadai, Matteo; Costa, Giosue; Parrotta, Lucia; Alcaro, Stefano; Palumbo, Manlio; Richter, Sara N.			Conformation and Stability of Intramolecular Telomeric G-Quadruplexes: Sequence Effects in the Loops	PLOS ONE			English	Article							K+ SOLUTION; CIRCULAR-DICHROISM; MOLECULAR MECHANICS; DNA-SEQUENCE; FORCE-FIELD; IN-VITRO; CLEROCIDIN; CONTAIN; ADENINE; REPLICATION	Telomeres are guanine-rich sequences that protect the ends of chromosomes. These regions can fold into G-quadruplex structures and their stabilization by G-quadruplex ligands has been employed as an anticancer strategy. Genetic analysis in human telomeres revealed extensive allelic variation restricted to loop bases, indicating that the variant telomeric sequences maintain the ability to fold into G-quadruplex. To assess the effect of mutations in loop bases on G-quadruplex folding and stability, we performed a comprehensive analysis of mutant telomeric sequences by spectroscopic techniques, molecular dynamics simulations and gel electrophoresis. We found that when the first position in the loop was mutated from T to C or A the resulting structure adopted a less stable antiparallel topology; when the second position was mutated to C or A, lower thermal stability and no evident conformational change were observed; in contrast, substitution of the third position from A to C induced a more stable and original hybrid conformation, while mutation to T did not significantly affect G-quadruplex topology and stability. Our results indicate that allelic variations generate G-quadruplex telomeric structures with variable conformation and stability. This aspect needs to be taken into account when designing new potential anticancer molecules.	[Sattin, Giovanna; Nadai, Matteo; Richter, Sara N.] Univ Padua, Dept Mol Med, Padua, Italy; [Artese, Anna; Costa, Giosue; Parrotta, Lucia; Alcaro, Stefano] Magna Graecia Univ Catanzaro, Dipartimento Sci Salute, Catanzaro, Italy; [Palumbo, Manlio] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy	University of Padua; Magna Graecia University of Catanzaro; University of Padua	Richter, SN (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.	sara.richter@unipd.it	Costa, Giosuè/K-8461-2016; Richter, Sara/A-5578-2012	Costa, Giosuè/0000-0003-0947-9479; Richter, Sara/0000-0002-5446-9029; Palumbo, Manlio/0000-0002-3163-1564; ALCARO, Stefano/0000-0002-0437-358X	Italian Ministry of Education FIRB_IDEAS [RBID082ATK]; PRIN [2009MFRKZ8]	Italian Ministry of Education FIRB_IDEAS; PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This research work was supported by the Italian Ministry of Education FIRB_IDEAS (code RBID082ATK) and PRIN 2009 (code 2009MFRKZ8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaro S, 2013, J MED CHEM, V56, P843, DOI 10.1021/jm3013486; Alcaro S, 2010, CHEMMEDCHEM, V5, P575, DOI 10.1002/cmdc.200900541; ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; BAIRD DM, 1995, EMBO J, V14, P5433, DOI 10.1002/j.1460-2075.1995.tb00227.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bowers K.J., 2006, P ACM IEEE C SUP SC0, DOI 10.1109/SC.2006.54; Burger AM, 2005, CANCER RES, V65, P1489, DOI 10.1158/0008-5472.CAN-04-2910; Coleman J, 1999, HUM MOL GENET, V8, P1637, DOI 10.1093/hmg/8.9.1637; Cookson JC, 2005, MOL PHARMACOL, V68, P1551, DOI 10.1124/mol.105.013300; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P4927, DOI 10.1093/nar/gkm522; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P2440, DOI 10.1093/nar/gkm009; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Folini M, 2011, EXPERT OPIN THER TAR, V15, P579, DOI 10.1517/14728222.2011.556621; Gray RD, 2010, BIOCHEMISTRY-US, V49, P179, DOI 10.1021/bi901357r; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; Guedin A, 2009, NUCLEIC ACIDS RES, V37, P5559, DOI 10.1093/nar/gkp563; Hazel P, 2004, J AM CHEM SOC, V126, P16405, DOI 10.1021/ja045154j; He YJ, 2004, NUCLEIC ACIDS RES, V32, P5359, DOI 10.1093/nar/gkh875; Islam B, 2013, NUCLEIC ACIDS RES, V41, P2723, DOI 10.1093/nar/gks1331; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Karsisiotis AI, 2011, ANGEW CHEM INT EDIT, V50, P10645, DOI 10.1002/anie.201105193; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Li J, 2005, NUCLEIC ACIDS RES, V33, P4649, DOI 10.1093/nar/gki782; Lim KW, 2009, NUCLEIC ACIDS RES, V37, P6239, DOI 10.1093/nar/gkp630; Luu KN, 2006, J AM CHEM SOC, V128, P9963, DOI 10.1021/ja062791w; MCDONALD DQ, 1992, TETRAHEDRON LETT, V33, P7743, DOI 10.1016/0040-4039(93)88034-G; Mendez-Bermudez A, 2009, NUCLEIC ACIDS RES, V37, P6225, DOI 10.1093/nar/gkp629; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Nadai M, 2013, BBA-GEN SUBJECTS, V1830, P4660, DOI 10.1016/j.bbagen.2013.05.039; Nadai M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052994; Neidle S, 2010, FEBS J, V277, P1118, DOI 10.1111/j.1742-4658.2009.07463.x; Nicoludis JM, 2012, J AM CHEM SOC, V134, P20446, DOI 10.1021/ja3088746; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Phan AT, 2007, NUCLEIC ACIDS RES, V35, P6517, DOI 10.1093/nar/gkm706; Phan AT, 2006, NUCLEIC ACIDS RES, V34, P5715, DOI 10.1093/nar/gkl726; Randazzo A, 2012, TOP CURR CHEM; Redon S, 2003, NUCLEIC ACIDS RES, V31, P1605, DOI 10.1093/nar/gkg259; Richter S, 2003, NUCLEIC ACIDS RES, V31, P5149, DOI 10.1093/nar/gkg696; Richter SN, 2009, ORG BIOMOL CHEM, V7, P976, DOI 10.1039/b819049f; Richter SN, 2004, NUCLEIC ACIDS RES, V32, P5658, DOI 10.1093/nar/gkh898; Sagi J, 2010, BIOPOLYMERS, V93, P880, DOI 10.1002/bip.21481; Schrodinger I, 2006, DESMOND V3 1; Schrodinger I, 2001, MAESTRO 4 1; Skolakova P, 2010, BIOCHEM BIOPH RES CO, V399, P203, DOI 10.1016/j.bbrc.2010.07.055; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Tauchi T, 2006, ONCOGENE, V25, P5719, DOI 10.1038/sj.onc.1209577; Tomasko M, 2009, BIOCHIMIE, V91, P171, DOI 10.1016/j.biochi.2008.07.012; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Vorlickova M, 2012, METHODS, V57, P64, DOI 10.1016/j.ymeth.2012.03.011; Vorlickova M, 2012, FEBS J, V279, P29, DOI 10.1111/j.1742-4658.2011.08396.x; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Wong WC, 2010, BIOORG MED CHEM LETT, V20, P4689, DOI 10.1016/j.bmcl.2010.05.005; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0; Zhang ZJ, 2010, NUCLEIC ACIDS RES, V38, P1009, DOI 10.1093/nar/gkp1029	56	29	29	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84113	10.1371/journal.pone.0084113	http://dx.doi.org/10.1371/journal.pone.0084113			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367632	Green Submitted, Green Published, gold			2022-12-27	WOS:000328740300127
J	van Eersel, MEA; Joosten, H; Gansevoort, RT; Dullaart, RPF; Slaets, JPJ; Izaks, GJ				van Eersel, Marlise E. A.; Joosten, Hanneke; Gansevoort, Ron T.; Dullaart, Robin P. F.; Slaets, Joris P. J.; Izaks, Gerbrand J.			The Interaction of Age and Type 2 Diabetes on Executive Function and Memory in Persons Aged 35 Years or Older	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; COGNITIVE FUNCTION; ALZHEIMERS-DISEASE; BLOOD-PRESSURE; DECLINE; ATHEROSCLEROSIS; ASSOCIATION; INSULIN; MICROALBUMINURIA; ALBUMINURIA	It is generally assumed that type 2 diabetes increases the risk of cognitive dysfunction in old age. As type 2 diabetes is frequently diagnosed before the age of 50, diabetes-related cognitive dysfunction may also occur before the age of 50. Therefore, we investigated the association of type 2 diabetes with cognitive function in people aged 35-82 years. In a cross-sectional study comprising 4,135 participants of the Prevention of Renal and Vascular ENd-stage Disease study (52% men; mean age (SD), 55 (12) years) diabetes was defined according to the criteria of the American Diabetes Association. Executive function was measured with the Ruff Figural Fluency Test (RFFT; worst score, 0 points; best score, 175 points), and memory was measured with the Visual Association Test (VAT; worst score, 0 points; best score, 12 points). The association of diabetes with cognitive function was investigated with multiple linear or, if appropriate, logistic regression analysis adjusting for other cardiovascular risk factors and APOE epsilon 4 carriership. Type 2 diabetes was ascertained in 264 individuals (6%). Persons with diabetes had lower RFFT scores than persons without diabetes: mean (SD), 51 (19) vs. 70 (26) points (p<0.001). The difference in RFFT score was largest at age 35-44 years (mean difference 32 points; 95% CI, 15 to 49; p<0.001) and gradually decreased with increasing age. The association of diabetes with RFFT score was not modified by APOE epsilon 4 carriership. Similar results were found for VAT score as outcome measure although these results were only borderline statistically significant (p <= 0.10). In conclusion, type 2 diabetes was associated with cognitive dysfunction, especially in young adults. This was independent of other cardiovascular risk factors and APOE epsilon 4 carriership.	[van Eersel, Marlise E. A.; Joosten, Hanneke; Slaets, Joris P. J.; Izaks, Gerbrand J.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, Groningen, Netherlands; [Joosten, Hanneke; Gansevoort, Ron T.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands; [Dullaart, Robin P. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Slaets, Joris P. J.; Izaks, Gerbrand J.] Univ Groningen, Univ Med Ctr Groningen, Alzheimer Ctr Groningen, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	van Eersel, MEA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, Groningen, Netherlands.	mea.eersel@umcg.nl	Izaks, Gerbrand/F-5089-2014	Izaks, Gerbrand/0000-0003-3213-7637	Dutch Alzheimer Foundation; Dutch Kidney Foundation [E.033]	Dutch Alzheimer Foundation; Dutch Kidney Foundation	This study was supported by the Dutch Alzheimer Foundation (www.alzheimer-nederland.nl). The PREVEND study in general was supported by the Dutch Kidney Foundation (www.nierstichting.nl; grant E.033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvanitakis Z, 2006, NEUROLOGY, V67, P1960, DOI 10.1212/01.wnl.0000247053.45483.4e; Baan CA, 1999, EPIDEMIOLOGY, V10, P184, DOI 10.1097/00001648-199903000-00018; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Bild DE, 2005, CIRCULATION, V111, P1313, DOI 10.1161/01.CIR.0000157730.94423.4B; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Caselli RJ, 2011, NEUROLOGY, V76, P1078, DOI 10.1212/WNL.0b013e318211c3ae; Centers for Disease Control and Prevention (CDC) National Center for Health Statistics Division of Health Interview Statistics data from the National Health Interview Survey, 2010, DISTR AG DIAGN DIAB; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; Cummings JL, 2002, JAMA-J AM MED ASSOC, V287, P2335, DOI 10.1001/jama.287.18.2335; de Jong PE, 2003, NEPHROL DIAL TRANSPL, V18, P10, DOI 10.1093/ndt/18.1.10; Folsom AR, 1999, DIABETES CARE, V22, P1077, DOI 10.2337/diacare.22.7.1077; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gispen WH, 2000, TRENDS NEUROSCI, V23, P542, DOI 10.1016/S0166-2236(00)01656-8; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Izaks GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027415; Izaks GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017045; Joosten H, 2011, CLIN J AM SOC NEPHRO, V6, P1400, DOI 10.2215/CJN.05530610; KLEIN R, 1995, DIABETES CARE, V18, P258, DOI 10.2337/diacare.18.2.258; Knopman D, 2001, NEUROLOGY, V56, P42, DOI 10.1212/WNL.56.1.42; Lambers Heerspink HJ, 2008, AM J EPIDEMIOL, V168, P897, DOI 10.1093/aje/kwn209; LAUNER LJ, 1995, JAMA-J AM MED ASSOC, V274, P1846, DOI 10.1001/jama.274.23.1846; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lindeboom J., 2003, VISUAL ASS TEST MANU; Mahmoodi BK, 2009, JAMA-J AM MED ASSOC, V301, P1790, DOI 10.1001/jama.2009.565; Manolio TA, 2003, CURR HYPERTENS REP, V5, P255, DOI 10.1007/s11906-003-0029-6; Matthews FE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-185; Monster TBM, 2002, PHARMACOEPIDEM DR S, V11, P379, DOI 10.1002/pds.722; Moreira PI, 2009, J ALZHEIMERS DIS, V16, P741, DOI 10.3233/JAD-2009-0972; Nooyens ACJ, 2010, DIABETES CARE, V33, P1964, DOI 10.2337/dc09-2038; Ott A, 2004, NEUROLOGY, V62, P920, DOI 10.1212/01.WNL.0000115110.35610.80; Pavlik VN, 2005, NEUROEPIDEMIOLOGY, V24, P42, DOI 10.1159/000081049; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Ruff R, 1996, RUFF FIG FLUENC TEST; RUFF RM, 1987, DEV NEUROPSYCHOL, V3, P37, DOI 10.1080/87565648709540362; Sabayan B, 2013, STROKE, V44, P1866, DOI 10.1161/STROKEAHA.113.001460; Sacco RL, 1997, STROKE, V28, P929, DOI 10.1161/01.STR.28.5.929; Spauwen PJ, 2012, DIABETES CARE; United Nations Educational Scientific and Cultural Organization, 2006, INT STAND CLASS ED I; Vagelatos NT, 2013, EPIDEMIOL REV, V35, P152, DOI 10.1093/epirev/mxs012; van Boxtel MPJ, 1998, J GERONTOL A-BIOL, V53, pM147; van Harten B, 2006, DIABETES CARE, V29, P2539, DOI 10.2337/dc06-1637; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	46	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82991	10.1371/journal.pone.0082991	http://dx.doi.org/10.1371/journal.pone.0082991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367577	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300088
J	Hu, YX; Xu, Q; Li, K; Zhu, H; Qi, RF; Zhang, ZG; Lu, GM				Hu, Yuxiao; Xu, Qiang; Li, Kai; Zhu, Hong; Qi, Rongfeng; Zhang, Zhigiang; Lu, Guangming			Gender Differences of Brain Glucose Metabolic Networks Revealed by FDG-PET: Evidence from a Large Cohort of 400 Young Adults	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; WHITE-MATTER MICROSTRUCTURE; VOXEL-BASED MORPHOMETRY; REGIONAL GRAY-MATTER; SEX-DIFFERENCES; CORTICAL THICKNESS; HEALTHY-INDIVIDUALS; CORPUS-CALLOSUM; DIMORPHISM; SCHIZOPHRENIA	Background: Gender differences of the human brain are an important issue in neuroscience research. In recent years, an increasing amount of evidence has been gathered from noninvasive neuroimaging studies supporting a sexual dimorphism of the human brain. However, there is a lack of imaging studies on gender differences of brain metabolic networks based on a large population sample. Materials and Methods: FDG PET data of 400 right-handed, healthy subjects, including 200 females (age: 25 similar to 45 years, mean age +/- SD: 40.9 +/- 3.9 years) and 200 age-matched males were obtained and analyzed in the present study. We first investigated the regional differences of brain glucose metabolism between genders using a voxel-based two-sample t-test analysis. Subsequently, we investigated the gender differences of the metabolic networks. Sixteen metabolic covariance networks using seed-based correlation were analyzed. Seven regions showing significant regional metabolic differences between genders, and nine regions conventionally used in the resting-state network studies were selected as regions-of-interest. Permutation tests were used for comparing within-and between-network connectivity between genders. Results: Compared with the males, females showed higher metabolism in the posterior part and lower metabolism in the anterior part of the brain. Moreover, there were widely distributed patterns of the metabolic networks in the human brain. In addition, significant gender differences within and between brain glucose metabolic networks were revealed in the present study. Conclusion: This study provides solid data that reveal gender differences in regional brain glucose metabolism and brain glucose metabolic networks. These observations might contribute to the better understanding of the gender differences in human brain functions, and suggest that gender should be included as a covariate when designing experiments and explaining results of brain glucose metabolic networks in the control and experimental individuals or patients.	[Hu, Yuxiao; Zhu, Hong] Nanjing Univ, Jinling Hosp, Coll Med, Sch Clin,Dept Nucl Med, Nanjing 210008, Jiangsu, Peoples R China; [Xu, Qiang; Qi, Rongfeng; Zhang, Zhigiang; Lu, Guangming] Nanjing Univ, Jinling Hosp, Coll Med, Sch Clin,Dept Med Imaging, Nanjing 210008, Jiangsu, Peoples R China; [Li, Kai] Soochow Univ, Dept Pharmacol, Suzhou, Peoples R China	Nanjing University; Nanjing University; Soochow University - China	Zhang, ZG (corresponding author), Nanjing Univ, Jinling Hosp, Coll Med, Sch Clin,Dept Med Imaging, Nanjing 210008, Jiangsu, Peoples R China.	zhangzq2001@126.com; cjr.luguangming@vip.163.com		Xu, Qiang/0000-0002-7739-7515	Natural Scientific Foundation of China [81271553]; Jinling Hospital [2013018]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Jinling Hospital	This work was supported by grants from the Natural Scientific Foundation of China [Grant Nos. 81271553] and the Youth Grant supported by Jinling Hospital [Grant Nos. 2013018]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham A., 2013, BRAIN IMAGING BEHAV, P1; Allen JS, 2003, NEUROIMAGE, V18, P880, DOI 10.1016/S1053-8119(03)00034-X; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Brun CC, 2009, NEUROREPORT, V20, P930, DOI 10.1097/WNR.0b013e32832c5e65; Chen XH, 2007, NEUROIMAGE, V36, P691, DOI 10.1016/j.neuroimage.2007.03.063; Choi CH, 2010, NEUROREPORT, V21, P73, DOI 10.1097/WNR.0b013e3283345eb0; Chou KH, 2011, NEUROIMAGE, V54, P725, DOI 10.1016/j.neuroimage.2010.07.010; Dai XJ, 2012, SLEEP MED, V13, P720, DOI 10.1016/j.sleep.2011.09.019; Di X, 2012, BRAIN CONNECT, V2, P275, DOI 10.1089/brain.2012.0086; FILIPEK PA, 1994, CEREB CORTEX, V4, P344, DOI 10.1093/cercor/4.4.344; Filippi M, 2012, HUMAN BRAIN MAPPING; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Fujimoto T, 2008, PSYCHIAT RES-NEUROIM, V164, P58, DOI 10.1016/j.pscychresns.2006.12.014; Gilmore JH, 2007, J NEUROSCI, V27, P1255, DOI 10.1523/JNEUROSCI.3339-06.2007; Gong GL, 2011, NEUROSCIENTIST, V17, P575, DOI 10.1177/1073858410386492; Gur RC, 1999, J NEUROSCI, V19, P4065; Im K, 2006, NEUROIMAGE, V31, P31, DOI 10.1016/j.neuroimage.2005.11.042; ITO M, 1984, JPN J PHYSIOL, V34, P781, DOI 10.2170/jjphysiol.34.781; Jezzini A, 2012, P NATL ACAD SCI USA, V109, P10077, DOI 10.1073/pnas.1200143109; Junger J, 2013, NEUROIMAGE; Kawachi T, 2002, J NEUROL SCI, V199, P79, DOI 10.1016/S0022-510X(02)00112-0; Keller K, 2009, NEUROIMAGE, V47, P342, DOI 10.1016/j.neuroimage.2009.04.042; Kheradmand A, 2011, FRONTIERS NEUROLOGY, V2; Kilpatrick LA, 2006, NEUROIMAGE, V30, P452, DOI 10.1016/j.neuroimage.2005.09.065; Kong J, 2010, BEHAV BRAIN RES, V211, P215, DOI 10.1016/j.bbr.2010.03.042; Lee DS, 2008, EUR J NUCL MED MOL I, V35, P1681, DOI 10.1007/s00259-008-0808-z; Leonard CM, 2008, CEREB CORTEX, V18, P2920, DOI 10.1093/cercor/bhn052; Liu F, 2010, BRAIN RES, V1343, P37, DOI 10.1016/j.brainres.2010.04.064; Loven J., 2013, SOCIAL COGNITIVE AFF; Luders E, 2006, HUM BRAIN MAPP, V27, P314, DOI 10.1002/hbm.20187; Luders E, 2005, NEUROIMAGE, V26, P493, DOI 10.1016/j.neuroimage.2005.02.010; Lui S, 2009, AM J PSYCHIAT, V166, P196, DOI 10.1176/appi.ajp.2008.08020183; Lv B, 2010, NEUROIMAGE, V53, P373, DOI 10.1016/j.neuroimage.2010.05.020; Melonakos ED, 2011, PSYCHIAT RES-NEUROIM, V193, P65, DOI 10.1016/j.pscychresns.2011.01.009; MESULAM MM, 1982, J COMP NEUROL, V212, P1, DOI 10.1002/cne.902120102; Murdoch BE, 2010, CORTEX, V46, P858, DOI 10.1016/j.cortex.2009.07.018; Mure H, 2011, NEUROIMAGE, V54, P1244, DOI 10.1016/j.neuroimage.2010.09.028; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Rametti G, 2011, J PSYCHIATR RES, V45, P199, DOI 10.1016/j.jpsychires.2010.05.006; Sacher J, 2013, MAGN RESON IMAGING, V31, P366, DOI 10.1016/j.mri.2012.06.007; Seo EH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053922, 10.1371/journal.pone.0076875]; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; van Amelsvoort T, 2001, TRENDS ENDOCRIN MET, V12, P273, DOI 10.1016/S1043-2760(01)00422-2; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Witte AV, 2010, NEUROIMAGE, V49, P1205, DOI 10.1016/j.neuroimage.2009.09.046; Zhang ZQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028817	47	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83821	10.1371/journal.pone.0083821	http://dx.doi.org/10.1371/journal.pone.0083821			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358312	gold, Green Published, Green Submitted			2022-12-27	WOS:000328737700072
J	Kapadia, B; Viswakarma, N; Parsa, KVL; Kain, V; Behera, S; Suraj, SK; Babu, PP; Kar, A; Panda, S; Zhu, YJ; Jia, YZ; Thimmapaya, B; Reddy, JK; Misrar, P				Kapadia, Bandish; Viswakarma, Navin; Parsa, Kishore V. L.; Kain, Vasundhara; Behera, Soma; Suraj, Sashidhara Kaimal; Babu, Phanithi Prakash; Kar, Anand; Panda, Sunanda; Zhu, Yi-Jun; Jia, Yuzhi; Thimmapaya, Bayar; Reddy, Janardan K.; Misrar, Parimal			ERK2-Mediated Phosphorylation of Transcriptional Coactivator Binding Protein PIMT/NCoA6IP at Ser(298) Augments Hepatic Gluconeogenesis	PLOS ONE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; RECEPTOR (PPAR)-BINDING PROTEIN; THYROID-HORMONE; NONGENOMIC ACTIONS; TELOMERASE RNA; KINASE-C; EXPRESSION; NUCLEAR; METHYLTRANSFERASE; ACTIVATION	PRIP-Interacting protein with methyl transferase domain (PIMT) serves as a molecular bridge between CREB-binding protein (CBP)/ E1A binding protein p300 (Ep300) -anchored histone acetyl transferase and the Mediator complex sub-unit1 (Med1) and modulates nuclear receptor transcription. Here, we report that ERK2 phosphorylates PIMT at Ser(298) and enhances its ability to activate PEPCK promoter. We observed that PIMT is recruited to PEPCK promoter and adenoviral-mediated over-expression of PIMT in rat primary hepatocytes up-regulated expression of gluconeogenic genes including PEPCK. Reporter experiments with phosphomimetic PIMT mutant (PIMTS298D) suggested that conformational change may play an important role in PIMT-dependent PEPCK promoter activity. Overexpression of PIMT and Med1 together augmented hepatic glucose output in an additive manner. Importantly, expression of gluconeogenic genes and hepatic glucose output were suppressed in isolated liver specific PIMT knockout mouse hepatocytes. Furthermore, consistent with reporter experiments, PIMTS298D but not PIMTS298A augmented hepatic glucose output via up-regulating the expression of gluconeogenic genes. Pharmacological blockade of MAPK/ERK pathway using U0126, abolished PIMT/Med1-dependent gluconeogenic program leading to reduced hepatic glucose output. Further, systemic administration of T-4 hormone to rats activated ERK1/2 resulting in enhanced PIMT ser(298) phosphorylation. Phosphorylation of PIMT led to its increased binding to the PEPCK promoter, increased PEPCK expression and induction of gluconeogenesis in liver. Thus, ERK2-mediated phosphorylation of PIMT at Ser(298) is essential in hepatic gluconeogenesis, demonstrating an important role of PIMT in the pathogenesis of hyperglycemia.	[Kapadia, Bandish; Viswakarma, Navin; Parsa, Kishore V. L.; Kain, Vasundhara; Behera, Soma; Misrar, Parimal] Univ Hyderabad, Dr Reddys Inst Life Sci, Dept Biol, Hyderabad 500134, Andhra Pradesh, India; [Suraj, Sashidhara Kaimal; Babu, Phanithi Prakash] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India; [Kar, Anand; Panda, Sunanda] Devi Ahilya Univ, Dept Life Sci, Indore, Madhya Pradesh, India; [Zhu, Yi-Jun; Jia, Yuzhi; Reddy, Janardan K.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Thimmapaya, Bayar] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA	University of Hyderabad; University of Hyderabad; Devi Ahilya University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Reddy, JK (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA.	jkreddy@northwestern.edu; parimalm@drils.org	Kapadia, Bandish/I-7965-2019; Kain, Vasundhara/AAL-7371-2021; Kar, Anand/AAP-9603-2021	Kapadia, Bandish/0000-0001-6021-0008; Parsa, Kishore/0000-0001-7883-2534; Panda, Sunanda/0000-0003-4679-0223	DBT (Department of Biotechnology, India) [BT/PR13527/BRB/0/765/2010]; National Institutes of Health [DK083163, DK097249, R21A1094296]; CSIR; DBT, India; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK083163, R01DK083163, R01DK097249] Funding Source: NIH RePORTER	DBT (Department of Biotechnology, India)(Department of Biotechnology (DBT) India); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSIR(Council of Scientific & Industrial Research (CSIR) - India); DBT, India(Department of Biotechnology (DBT) India); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by DBT (Department of Biotechnology, India) funded Grant (No. BT/PR13527/BRB/0/765/2010) awarded to PM and KVLP, and the National Institutes of Health Grant DK083163 and DK097249 to J.K.R. and R21A1094296 to B. T. BK and VK are financially supported by Senior Research Fellowship from CSIR and post-doctoral fellowship from DBT, India respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati JM, 1998, J BIOL CHEM, V273, P18751, DOI 10.1074/jbc.273.30.18751; Belakavadi M, 2008, MOL CELL BIOL, V28, P3932, DOI 10.1128/MCB.02191-07; Cassuto H, 2005, J BIOL CHEM, V280, P33873, DOI 10.1074/jbc.M504119200; Chen Z, 2011, EMBO J, V30, P2405, DOI 10.1038/emboj.2011.154; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Croniger CM, 2002, BIOCHEM MOL BIOL EDU, V30, P353, DOI 10.1002/bmb.2002.494030060151; Davis PJ, 2008, FRONT NEUROENDOCRIN, V29, P211, DOI 10.1016/j.yfrne.2007.09.003; Davis PJ, 2002, J ENDOCRINOL INVEST, V25, P377, DOI 10.1007/BF03344022; Delaye J, 1975, Nouv Presse Med, V4, P3239; Duplus E, 2002, J CELL BIOCHEM, V85, P651, DOI 10.1002/jcb.10175; Franke J, 2008, J CELL SCI, V121, P3553, DOI 10.1242/jcs.033308; Gabbay RA, 1996, J BIOL CHEM, V271, P1890, DOI 10.1074/jbc.271.4.1890; Galanis A, 2001, J BIOL CHEM, V276, P965, DOI 10.1074/jbc.M007697200; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Gusterson R, 2002, J BIOL CHEM, V277, P2517, DOI 10.1074/jbc.M104626200; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; He L, 2012, J BIOL CHEM, V287, P32069, DOI 10.1074/jbc.M112.385864; Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Janknecht R, 1996, BIOCHEM BIOPH RES CO, V228, P831, DOI 10.1006/bbrc.1996.1740; JAUREGUI HO, 1981, IN VITRO CELL DEV B, V17, P1100; Jia YZ, 2012, MECH DEVELOP, V129, P193, DOI 10.1016/j.mod.2012.08.002; Jia YZ, 2004, J BIOL CHEM, V279, P24427, DOI 10.1074/jbc.M402391200; Kim GH, 2012, BIOCHEM J, V447, P437, DOI 10.1042/BJ20120861; Komonyi O, 2005, J BIOL CHEM, V280, P12397, DOI 10.1074/jbc.M409251200; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Kushiyama A, 2005, J BIOL CHEM, V280, P42016, DOI 10.1074/jbc.M503065200; Lee S, 2011, BIOCHEMISTRY-US, V50, P9500, DOI 10.1021/bi201103b; Lee SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018594; Liu YZ, 1998, J BIOL CHEM, V273, P32400, DOI 10.1074/jbc.273.49.32400; Louet JF, 2010, CELL METAB, V12, P606, DOI 10.1016/j.cmet.2010.11.009; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Misra P, 2002, J BIOL CHEM, V277, P48745, DOI 10.1074/jbc.M208829200; Misra P, 2002, J BIOL CHEM, V277, P20011, DOI 10.1074/jbc.M201739200; Monecke T, 2009, NUCLEIC ACIDS RES, V37, P3865, DOI 10.1093/nar/gkp249; Mouaikel J, 2002, MOL CELL, V9, P891, DOI 10.1016/S1097-2765(02)00484-7; Nichols A, 2000, J BIOL CHEM, V275, P24613, DOI 10.1074/jbc.M001515200; Oate SA, 1995, SCIENCE, V270, P1354, DOI DOI 10.1126/SCIENCE.270.5240.1354.PUBMED:7481822; Pandey PK, 2005, MOL CELL BIOL, V25, P10695, DOI 10.1128/MCB.25.24.10695-10710.2005; PARK EA, 1995, BIOCHEM J, V309, P913, DOI 10.1042/bj3090913; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rowan BG, 2000, J BIOL CHEM, V275, P4475, DOI 10.1074/jbc.275.6.4475; See RH, 2001, J BIOL CHEM, V276, P16310, DOI 10.1074/jbc.M008113200; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sikes ML, 2009, J IMMUNOL METHODS, V344, P58, DOI 10.1016/j.jim.2009.03.007; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Spoel SH, 2010, NEW PHYTOL, V186, P333, DOI 10.1111/j.1469-8137.2009.03125.x; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; Vomastek T, 2008, MOL CELL BIOL, V28, P6954, DOI 10.1128/MCB.00925-08; Wu RC, 2005, ENDOCR REV, V26, P393, DOI 10.1210/er.2004-0018; Xu HY, 2005, J BIOL CHEM, V280, P36013, DOI 10.1074/jbc.M508027200; Yabaluri N, 2010, J BIOSCIENCES, V35, P473, DOI 10.1007/s12038-010-0052-0; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535; Yedavalli VSRK, 2010, P NATL ACAD SCI USA, V107, P14787, DOI 10.1073/pnas.1009490107; Yuan LW, 2000, J BIOL CHEM, V275, P40946, DOI 10.1074/jbc.M007832200; Zhu YJ, 2001, P NATL ACAD SCI USA, V98, P10380, DOI 10.1073/pnas.181347498	57	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83787	10.1371/journal.pone.0083787	http://dx.doi.org/10.1371/journal.pone.0083787			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358311	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700071
J	Lewinska, M; Zelenko, U; Merzel, F; Grdadolnik, SG; Murray, JC; Rozman, D				Lewinska, Monika; Zelenko, Urska; Merzel, Franci; Grdadolnik, Simona Golic; Murray, Jeffrey C.; Rozman, Damjana			Polymorphisms of CYP51A1 from Cholesterol Synthesis: Associations with Birth Weight and Maternal Lipid Levels and Impact on CYP51 Protein Structure	PLOS ONE			English	Article							LANOSTEROL 14-ALPHA-DEMETHYLASE CYP51; SPONTANEOUS PRETERM BIRTH; GENES; MOUSE; PREGNANCY; DEMETHYLASE; METABOLISM; DYNAMICS; DISEASE; BINDING	We investigated the housekeeping cytochrome P450 CYP51A1 encoding lanosterol 14 alpha-demethylase from cholesterol synthesis that was so far not directly linked to human disorders. By direct sequencing of CYP51A1 in 188 women with spontaneous preterm delivery and 188 unrelated preterm infants (gestational age <37 weeks) we identified 22 variants where 10 are novel and rare. In infants there were two novel CYP51A1 variants where damaging effects of p.Tyr145Asp from the substrate recognition region, but not p. Asn193Asp, were predicted by PolyPhen2 and SIFT. This was confirmed by molecular modeling showing that Tyr145Asp substitution results in changed electrostatic potential of the CYP51 protein surface and lengthened distance to the heme which prevents hydrogen bonding. The CYP51 Tyr145Asp mutation is rare and thus very interesting for further structure/function relationship studies. From the 12 identified known variants rs6465348 was chosen for family based association studies due to its high minor allele frequency. Interestingly, this CYP51A1 common variant associates with small for gestational age weight in newborns (p = 0.028) and lower blood total cholesterol and low density lipoprotein cholesterol levels in mothers in 2nd trimester of pregnancy (p = 0.042 and p = 0.046 respectively). Our results indicate a new link between a cholesterol synthesis gene CYP51A1 and pregnancy pathologies.	[Lewinska, Monika; Rozman, Damjana] Univ Ljubljana, Fac Med, Ctr Funct Genom & Biochips, Ljubljana, Slovenia; [Zelenko, Urska; Merzel, Franci; Grdadolnik, Simona Golic] Natl Inst Chem Slovenia, Lab Biomol Struct, Ljubljana, Slovenia; [Grdadolnik, Simona Golic] EN FIST Ctr Excellence, Ljubljana, Slovenia; [Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA	University of Ljubljana; National Institute of Chemistry - Slovenia; University of Iowa	Rozman, D (corresponding author), Univ Ljubljana, Fac Med, Ctr Funct Genom & Biochips, Ljubljana, Slovenia.	damjana.rozman@mf.uni-lj.si	Lewinska, Monika/N-9919-2017	Lewinska, Monika/0000-0002-5275-992X; Merzel, Franci/0000-0002-2748-4901; Golic Grdadolnik, Simona/0000-0002-0873-9593; Rozman, Damjana/0000-0002-6501-2163	FP7 FightingDrugFailure ITN Marie Curie [238132]; Slovenian Research Agency [P1-0104, P1-0010, J7-4053]; NIH [HD52953]; Bill and Melinda Gates Foundation; Slovenian Research Agency; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	FP7 FightingDrugFailure ITN Marie Curie; Slovenian Research Agency(Slovenian Research Agency - Slovenia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Slovenian Research Agency(Slovenian Research Agency - Slovenia); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the FP7 FightingDrugFailure ITN Marie Curie grant #238132 to support M. Lewinska Ph.D. thesis, and by the Slovenian Research Agency program grant P1-0104, grant P1-0010 and project J7-4053, by the NIH grant HD52953, and from the Bill and Melinda Gates Foundation to JCM. U. Zelenko was funded as young researcher by the Slovenian Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Kristina M, 2004, Semin Fetal Neonatal Med, V9, P445, DOI 10.1016/j.siny.2004.04.001; Aldahmesh MA, 2012, GENET MED, V14, P955, DOI 10.1038/gim.2012.86; Amundsen AL, 2006, ATHEROSCLEROSIS, V189, P451, DOI 10.1016/j.atherosclerosis.2006.01.002; Ardlie KG, 2002, AM J HUM GENET, V71, P304, DOI 10.1086/341719; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baron IS, 2012, NEUROPSYCHOLOGY REV; Bellamine A, 2004, J LIPID RES, V45, P2000, DOI 10.1194/jlr.M400239-JLR200; Bick D, 2012, MIDWIFERY, V28, P401, DOI 10.1016/j.midw.2012.06.010; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Bream ENA, 2013, PEDIATR RES, V73, P135, DOI 10.1038/pr.2012.166; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Catov JM, 2008, OBSTET GYNECOL, V112, P1116, DOI 10.1097/AOG.0b013e31818aa5b5; Catov JM, 2007, AM J EPIDEMIOL, V166, P1312, DOI 10.1093/aje/kwm273; Catov JM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.024; Chernick MR, 2002, AM STAT, V56, P149, DOI 10.1198/000313002317572835; Costantine MM, 2013, AM J PERINAT, V30, P335, DOI 10.1055/s-0032-1324708; Cournia Z, 2005, J COMPUT CHEM, V26, P1383, DOI 10.1002/jcc.20277; Debeljak N, 2000, ARCH BIOCHEM BIOPHYS, V379, P37, DOI 10.1006/abbi.2000.1859; Edison RJ, 2007, PEDIATRICS, V120, P723, DOI 10.1542/peds.2006-1939; FISCHER RT, 1991, J BIOL CHEM, V266, P6124; FREEMAN GH, 1951, BIOMETRIKA, V38, P141, DOI 10.2307/2332323; Haataja R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001293; Herrera E, 2006, HORM RES, V65, P59, DOI 10.1159/000091507; Horvat S, 2011, DRUG METAB REV, V43, P69, DOI 10.3109/03602532.2010.540580; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikonen E, 2006, PHYSIOL REV, V86, P1237, DOI 10.1152/physrev.00022.2005; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Keber R, 2013, J LIPID RES, V54, P20, DOI 10.1194/jlr.R032326; Keber R, 2011, J BIOL CHEM, V286, P29086, DOI 10.1074/jbc.M111.253245; Kelley R I, 2000, Adv Pediatr, V47, P1; Lee SM, 2013, YONSEI MED J, V54, P839, DOI 10.3349/ymj.2013.54.4.839; Lepesheva GI, 2011, BBA-PROTEINS PROTEOM, V1814, P88, DOI 10.1016/j.bbapap.2010.06.006; Lewinska M, 2013, ACTA CHIMIC IN PRESS; Lorbek G, 2012, FEBS J, V279, P1516, DOI 10.1111/j.1742-4658.2011.08432.x; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mudd LM, 2012, ACTA OBSTET GYN SCAN, V91, P726, DOI 10.1111/j.1600-0412.2012.01391.x; Muscarella LA, 2010, J BIOMEDICINE BIOTEC, V2010; Nour Nawal M, 2012, Rev Obstet Gynecol, V5, P100; Peacock JL, 2013, PEDIATR RES, V73, P457, DOI 10.1038/pr.2012.201; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Rezen T, 2004, J MOL EVOL, V59, P51, DOI 10.1007/s00239-004-2603-1; Rogers LK, 2011, LIFE SCI, V89, P417, DOI 10.1016/j.lfs.2011.07.017; Rozman D, 1996, GENOMICS, V38, P371, DOI 10.1006/geno.1996.0640; Rozman D, 1996, ARCH BIOCHEM BIOPHYS, V333, P466, DOI 10.1006/abbi.1996.0416; Scheer N, 2012, MOL PHARMACOL, V81, P63, DOI 10.1124/mol.111.075192; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STAYTON PS, 1989, BIOCHEMISTRY-US, V28, P8201, DOI 10.1021/bi00446a035; Steffen KM, 2007, J PERINATOL, V27, P672, DOI 10.1038/sj.jp.7211806; Strushkevich N, 2010, J MOL BIOL, V397, P1067, DOI 10.1016/j.jmb.2010.01.075; Vrijkotte TGM, 2012, J CLIN ENDOCR METAB, V97, P3917, DOI 10.1210/jc.2012-1295; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Waterham HR, 2012, AM J MED GENET C, V160C, P263, DOI 10.1002/ajmg.c.31346; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Woollett LA, 2011, PLACENTA, V32, pS218, DOI 10.1016/j.placenta.2011.01.011; Zawaira A, 2010, COMPUT BIOL CHEM, V34, P42, DOI 10.1016/j.compbiolchem.2009.10.006	57	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82554	10.1371/journal.pone.0082554	http://dx.doi.org/10.1371/journal.pone.0082554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358204	Green Submitted, gold, Green Published			2022-12-27	WOS:000328737700022
J	Peng, AP; Liu, J; Gao, YZ; Chen, ZY				Peng, Anping; Liu, Juan; Gao, Yanzheng; Chen, Zeyou			Distribution of Endophytic Bacteria in Alopecurus aequalis Sobol and Oxalis corniculata L. from Soils Contaminated by Polycyclic Aromatic Hydrocarbons	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; PLANT UPTAKE; ORGANIC POLLUTANTS; DIVERSITY; PHYTOREMEDIATION; ROOTS; BIOREMEDIATION; PHENANTHRENE; PARTITION; PYRENE	The distributions of endophytic bacteria in Alopecurus aequalis Sobol and Oxalis corniculata L. grown in soils contaminated with different levels of polycyclic aromatic hydrocarbons (PAHs) were investigated with polymerase chain reaction followed by denaturing gradient gel electrophoresis technology (PCR-DGGE) and cultivation methods. Twelve types of PAHs, at concentrations varying from 0.16 to 180 mg? kg 21, were observed in the roots and shoots of the two plants. The total PAH concentrations in Alopecurus aequalis Sobol obtained from three different PAH-contaminated stations were 184, 197, and 304 mg? kg 21, and the total PAH concentrations in Oxalis corniculata L. were 251, 346, and 600 mg? kg 21, respectively. The PCR-DGGE results showed that the endophytic bacterial communities in the roots and shoots of the two plants were quite different, although most bacteria belonged to Firmicutes, Proteobacteria, Actinobacteria and Bacteroidetes. A total of 68 endophytic bacterial strains were isolated from different tissues of the two plants and classified into three phyla: Firmicutes, Proteobacteria and Bacteroidetes. In both plants, Bacillus spp. and Pseudomonas spp. were the dominant cultivable populations. With an increase in the PAH pollution level, the diversity and distribution of endophytic bacteria in the two plants changed correspondingly, and the number of cultivable endophytic bacterial strains decreased rapidly. Testing of the isolated endophytic bacteria for tolerance to each type of PAH showed that most isolates could grow well on Luria-Bertani media in the presence of different PAHs, and some isolates were able to grow rapidly on a mineral salt medium with a single PAH as the sole carbon and energy source, indicating that these strains may have the potential to degrade PAHs in plants. This research provides the first insight into the characteristics of endophytic bacterial populations under different PAH pollution levels and provides a species resource for the isolation of PAH-degrading endophytic bacteria.	[Peng, Anping; Liu, Juan; Gao, Yanzheng; Chen, Zeyou] Nanjing Agr Univ, Inst Organ Contaminant Control & Soil Remediat, Coll Resource & Environm Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Liu, J (corresponding author), Nanjing Agr Univ, Inst Organ Contaminant Control & Soil Remediat, Coll Resource & Environm Sci, Nanjing, Jiangsu, Peoples R China.	liujuan@njau.edu.cn; gaoyanzheng@njau.edu.cn	Gao, Yanzheng/G-6391-2010	Gao, Yanzheng/0000-0002-3814-3555	National Science Foundation of China [41171380, 41201501, 41071212, 21077056, 41171193]; Science Foundation of Jiangsu Province [BK2012370, BE2011780]; China Postdoctoral Science Foundation [2011M501246]; Doctoral Fund of Ministry of Education of China [20120097120012]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Jiangsu Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This work was financially supported by the National Science Foundation of China (41171380, 41201501, 41071212, 21077056, 41171193), the Science Foundation of Jiangsu Province (BK2012370, BE2011780), the China Postdoctoral Science Foundation (2011M501246) and the Doctoral Fund of Ministry of Education of China (20120097120012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Araujo WL, 2002, APPL ENVIRON MICROB, V68, P4906, DOI 10.1128/AEM.68.10.4906-4914.2002; Brecht V, 2011, PLOS ONE, V6, DOI [10.1371/journal.Pone.0019265, DOI 10.1371/J0URNAL.P0NE.0019265]; BRIGGS GG, 1983, PESTIC SCI, V14, P492, DOI 10.1002/ps.2780140506; BROOKS DS, 1994, BIOL CONTROL, V4, P373, DOI 10.1006/bcon.1994.1047; Byers HK, 1998, FEMS MICROBIOL ECOL, V25, P391, DOI 10.1111/j.1574-6941.1998.tb00491.x; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Chen WM, 2012, AQUAT BIOL, V15, P99, DOI 10.3354/ab00422; Chiou CT, 2001, ENVIRON SCI TECHNOL, V35, P1437, DOI 10.1021/es0017561; Collins C, 2006, ENVIRON SCI TECHNOL, V40, P45, DOI 10.1021/es0508166; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Dai CC, 2010, BIODEGRADATION, V21, P245, DOI 10.1007/s10532-009-9297-4; DAVISON J, 1988, BIO-TECHNOL, V6, P282, DOI 10.1038/nbt0388-282; Editorial Committee of Flora of China, 1999, FLORA CHINA, V43; Editorial Committee of Flora of China, 1987, FLORA CHINA, V9; Franzaring J, 2000, BASIC APPL ECOL, V1, P25, DOI 10.1078/1439-1791-00003; Gao YZ, 2008, CHEMOSPHERE, V72, P636, DOI 10.1016/j.chemosphere.2008.02.032; Gao YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050467; Gao YZ, 2011, J ENVIRON QUAL, V40, P653, DOI 10.2134/jeq2010.0320; Gao YZ, 2004, CHEMOSPHERE, V55, P1169, DOI 10.1016/j.chemosphere.2004.01.037; Garbeva P, 2001, MICROBIAL ECOL, V41, P369, DOI 10.1007/s002480000096; Germaine KJ, 2006, FEMS MICROBIOL ECOL, V57, P302, DOI 10.1111/j.1574-6941.2006.00121.x; Harish S, 2008, APPL SOIL ECOL, V39, P187, DOI 10.1016/j.apsoil.2007.12.006; Ho YN, 2009, J BIOSCI BIOENG, V108, pS94, DOI 10.1016/j.jbiosc.2009.08.276; Hung PQ., 2004, OMORNICE, V12, P92, DOI DOI 10.1177/1933719113488838; Juhasz AL, 2000, INT BIODETER BIODEGR, V45, P57, DOI 10.1016/S0964-8305(00)00052-4; Kaplan CW, 2004, APPL ENVIRON MICROB, V70, P1777, DOI 10.1128/AEM.70.3.1777-1786.2004; Kapley A, 2007, WORLD J MICROB BIOT, V23, P923, DOI 10.1007/s11274-006-9315-1; Khan Z., 2011, Current Topics in Plant Biology, Volume 12, P97; Kuklinsky-Sobral HL, 2005, PLANT SOIL, V273, P91, DOI 10.1007/s11104-004-6894-1; Ling WT, 2004, ENVIRON GEOL, V46, P553, DOI 10.1007/s00254-004-1028-x; Lodewyckx C, 2002, CRIT REV PLANT SCI, V21, P583, DOI 10.1080/0735-260291044377; Long HH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002702; McCully ME, 2001, AUST J PLANT PHYSIOL, V28, P983, DOI 10.1071/PP01101; Mckone TE, 2007, ENVIRON TOXICOL CHEM, V26, P2494, DOI 10.1897/06-269.1; Mendes R, 2007, APPL ENVIRON MICROB, V73, P7259, DOI 10.1128/AEM.01222-07; Miliute I., 2011, Biologija, V57, P98; Moore FP, 2006, SYST APPL MICROBIOL, V29, P539, DOI 10.1016/j.syapm.2005.11.012; MORTELMANS K, 1986, ENVIRON MOL MUTAGEN, V8, P1, DOI 10.1002/em.2860080802; Newman LA, 2005, TRENDS BIOTECHNOL, V23, P6, DOI 10.1016/j.tibtech.2004.11.010; Nogales B, 2001, APPL ENVIRON MICROB, V67, P1874, DOI 10.1128/AEM.67.4.1874-1884.2001; PAHLMAN R, 1987, CARCINOGENESIS, V8, P773, DOI 10.1093/carcin/8.6.773; Phillips LA, 2008, SOIL BIOL BIOCHEM, V40, P3054, DOI 10.1016/j.soilbio.2008.09.006; Pulford ID, 2003, ENVIRON INT, V29, P529, DOI 10.1016/S0160-4120(02)00152-6; Rajkumar M, 2009, CHEMOSPHERE, V77, P153, DOI 10.1016/j.chemosphere.2009.06.047; Robson Andreazza SP, 2010, 19 WORLD C SOIL SCI; Sessitsch A, 2002, FEMS MICROBIOL ECOL, V39, P23, DOI 10.1111/j.1574-6941.2002.tb00903.x; Sheng XF, 2008, INT BIODETER BIODEGR, V62, P88, DOI 10.1016/j.ibiod.2007.12.003; Shin DS, 2007, J MICROBIOL BIOTECHN, V17, P1361; Siciliano SD, 2001, APPL ENVIRON MICROB, V67, P2469, DOI 10.1128/AEM.67.6.2469-2475.2001; Sun L, 2008, MICROB ECOL, V55, P415, DOI 10.1007/s00248-007-9287-1; Taghavi S, 2005, APPL ENVIRON MICROB, V71, P8500, DOI 10.1128/AEM.71.12.8500-8505.2005; Tang JC, 2010, SOIL TILL RES, V110, P87, DOI 10.1016/j.still.2010.06.010; Tao S, 2004, SCI TOTAL ENVIRON, V320, P11, DOI 10.1016/S0048-9697(03)00453-4; Vendan RT, 2010, J MICROBIOL, V48, P559, DOI 10.1007/s12275-010-0082-1; Vinas M, 2005, APPL ENVIRON MICROB, V71, P7008, DOI 10.1128/AEM.71.11.7008-7018.2005; Wang YX, 2004, CURR MICROBIOL, V49, P288, DOI 10.1007/s00284-004-4348-x; West ER, 2010, CAN J MICROBIOL, V56, P209, DOI [10.1139/w10-004, 10.1139/W10-004]; Wu Q, 2006, BIOMED ENVIRON SCI, V19, P371; Yao ZL, 2008, Improved solid double-layer flat plate method for quick high-flux sifting motion of polycyclic aromatic hydrocarbon degradation bacterium, Patent No. [CN 101245366, 101245366]; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zhu LZ, 2004, ENVIRON POLLUT, V131, P505, DOI 10.1016/j.envpol.2004.02.003	63	31	33	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83054	10.1371/journal.pone.0083054	http://dx.doi.org/10.1371/journal.pone.0083054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358247	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700043
J	Thameem, F; Igo, RP; Freedman, BI; Langefeld, C; Hanson, RL; Schelling, JR; Elston, RC; Duggirala, R; Nicholas, SB; Goddard, KAB; Divers, J; Guo, XQ; Ipp, E; Kimmel, PL; Meoni, LA; Shah, VO; Smith, MW; Winkler, CA; Zager, PG; Knowler, WC; Nelson, RG; Pahl, MV; Parekh, RS; Kao, WHL; Rasooly, RS; Adler, SG; Abboud, HE; Iyengar, SK; Sedor, JR				Thameem, Farook; Igo, Robert P., Jr.; Freedman, Barry I.; Langefeld, Carl; Hanson, Robert L.; Schelling, Jeffrey R.; Elston, Robert C.; Duggirala, Ravindranath; Nicholas, Susanne B.; Goddard, Katrina A. B.; Divers, Jasmin; Guo, Xiuqing; Ipp, Eli; Kimmel, Paul L.; Meoni, Lucy A.; Shah, Vallabh O.; Smith, Michael W.; Winkler, Cheryl A.; Zager, Philip G.; Knowler, William C.; Nelson, Robert G.; Pahl, Madeline V.; Parekh, Rulan S.; Kao, W. H. Linda; Rasooly, Rebekah S.; Adler, Sharon G.; Abboud, Hanna E.; Iyengar, Sudha K.; Sedor, John R.		Family Invest Nephropathy & Diabet	A Genome-Wide Search for Linkage of Estimated Glomerular Filtration Rate (eGFR) in the Family Investigation of Nephropathy and Diabetes (FIND)	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RENAL-FUNCTION; GENETIC-VARIANTS; SERUM CREATININE; IDENTIFIES 6; ASSOCIATION; LOCI; ALBUMINURIA; TRAITS; SCAN	Objective: Estimated glomerular filtration rate (eGFR), a measure of kidney function, is heritable, suggesting that genes influence renal function. Genes that influence eGFR have been identified through genome-wide association studies. However, family-based linkage approaches may identify loci that explain a larger proportion of the heritability. This study used genome-wide linkage and association scans to identify quantitative trait loci (QTL) that influence eGFR. Methods: Genome-wide linkage and sparse association scans of eGFR were performed in families ascertained by probands with advanced diabetic nephropathy (DN) from the multi-ethnic Family Investigation of Nephropathy and Diabetes (FIND) study. This study included 954 African Americans (AA), 781 American Indians (AI), 614 European Americans (EA) and 1,611 Mexican Americans (MA). A total of 3,960 FIND participants were genotyped for 6,000 single nucleotide polymorphisms (SNPs) using the Illumina Linkage IVb panel. GFR was estimated by the Modification of Diet in Renal Disease (MDRD) formula. Results: The non-parametric linkage analysis, accounting for the effects of diabetes duration and BMI, identified the strongest evidence for linkage of eGFR on chromosome 20q11 (log of the odds [LOD] = 3.34; P = 4.4x10(-5)) in MA and chromosome 15q12 (LOD = 2.84; P = 1.5x10(-4)) in EA. In all subjects, the strongest linkage signal for eGFR was detected on chromosome 10p12 (P = 5.5x10(-4)) at 44 cM near marker rs1339048. A subsequent association scan in both ancestry-specific groups and the entire population identified several SNPs significantly associated with eGFR across the genome. Conclusion: The present study describes the localization of QTL influencing eGFR on 20q11 in MA, 15q21 in EA and 10p12 in the combined ethnic groups participating in the FIND study. Identification of causal genes/variants influencing eGFR, within these linkage and association loci, will open new avenues for functional analyses and development of novel diagnostic markers for DN.	[Thameem, Farook; Abboud, Hanna E.] Univ Texas San Antonio, Hlth Sci Ctr, Dept Med, San Antonio, TX 78284 USA; [Igo, Robert P., Jr.; Elston, Robert C.; Iyengar, Sudha K.; Sedor, John R.] Case Western Reserve Univ, Dept Biostat & Epidemiol, Cleveland, OH 44106 USA; [Freedman, Barry I.; Langefeld, Carl; Divers, Jasmin] Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC USA; [Hanson, Robert L.; Knowler, William C.; Nelson, Robert G.] Natl Inst Diabet & Digest & Kidney Dis, Phoenix Epidemiol & Clin Res Branch, NIH, Phoenix, AZ USA; [Schelling, Jeffrey R.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Duggirala, Ravindranath] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA; [Nicholas, Susanne B.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Goddard, Katrina A. B.] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA; [Guo, Xiuqing] Harbor Univ Calif Los Angeles, Med Ctr, Dept Pediat, Torrance, CA USA; [Ipp, Eli; Adler, Sharon G.] Harbor Univ Calif Los Angeles, Med Ctr, Dept Med, Torrance, CA USA; [Kimmel, Paul L.; Rasooly, Rebekah S.] Natl Inst Diabet Digest & Kidney Dis, NIH, Bethesda, MD USA; [Meoni, Lucy A.; Parekh, Rulan S.; Kao, W. H. Linda] Johns Hopkins Univ, Dept Epidemiol & Med, Baltimore, MD USA; [Shah, Vallabh O.; Zager, Philip G.] Univ New Mexico, Albuquerque, NM 87131 USA; [Smith, Michael W.] NHGRI, NIH, Bethesda, MD 20892 USA; [Winkler, Cheryl A.] NCI, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Pahl, Madeline V.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Parekh, Rulan S.] Univ Toronto, Dept Pediat, Toronto, ON, Canada	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio; Case Western Reserve University; Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Case Western Reserve University; Texas Biomedical Research Institute; University of California System; University of California Los Angeles; Kaiser Permanente; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Johns Hopkins University; University of New Mexico; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Irvine; University of Toronto	Iyengar, SK (corresponding author), Case Western Reserve Univ, Dept Biostat & Epidemiol, Cleveland, OH 44106 USA.	ski@case.edu	Igo, Rob/P-3438-2019; Parekh, Rulan/AAQ-4411-2020; Hanson, Robert L/O-3238-2015; /S-1190-2019	Igo, Rob/0000-0002-0024-1993; Hanson, Robert L/0000-0002-4252-7068; /0000-0001-7488-250X; Parekh, Rulan/0000-0001-6313-5752; Rasooly, Rebekah/0000-0002-6357-5528	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U01DK57292-05]; Intramural Research Program of the NIDDK; National Cancer Institute, National Institutes of Health [HHSN26120080001E]; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010022] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041, UL1TR000124, UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK057292, ZIADK069094, P30DK063491, ZIADK069062] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural Research Program of the NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank all the FIND participants. This study was supported by the research grant U01DK57292-05 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The study was also supported in part by the Intramural Research Program of the NIDDK. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN26120080001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This Research was supported [in part] by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Arar NH, 2008, NEPHROL DIAL TRANSPL, V23, P3184, DOI 10.1093/ndt/gfn215; Bhandari K, 2001, DIABETES, V50, pA240; Boger CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002292; Chasman DI, 2012, HUM MOL GENET, V21, P5329, DOI 10.1093/hmg/dds369; Chen GJ, 2007, AM J KIDNEY DIS, V49, P394, DOI 10.1053/j.ajkd.2006.12.011; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; ELSTON RC, 1991, BIOMETRICAL J, V33, P339, DOI 10.1002/bimj.4710330314; Fox CS, 2004, J AM SOC NEPHROL, V15, P2457, DOI 10.1097/01.ASN.0000135972.13396.6F; Franceschini N, 2012, KIDNEY INT, V82, P220, DOI 10.1038/ki.2012.107; Freedman BI, 2008, DIABETIC MED, V25, P268, DOI 10.1111/j.1464-5491.2007.02361.x; Huang YC, 2011, OPHTHALMOLOGY, V118, P642, DOI 10.1016/j.ophtha.2010.07.020; Hunt SC, 2004, AM J HYPERTENS, V17, P511, DOI 10.1016/j.amjhyper.2004.02.019; Hwang SJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S10; Igo RP, 2011, AM J NEPHROL, V33, P381, DOI 10.1159/000326763; Kiryluk K, 2008, KIDNEY INT, V74, P1109, DOI 10.1038/ki.2008.479; Knowler WC, 2005, J DIABETES COMPLICAT, V19, P1, DOI 10.1016/j.jdiacomp.2003.12.007; Kottgen A, 2010, AM J KIDNEY DIS, V56, P743, DOI 10.1053/j.ajkd.2010.05.018; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037; Li HX, 2013, DIABETES, V62, P291, DOI 10.2337/db12-0454; Liu CT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002264; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Morton NE, 1998, AM J HUM GENET, V62, P690, DOI 10.1086/301741; Mottl AK, 2008, KIDNEY INT, V74, P1185, DOI 10.1038/ki.2008.410; NELSON RG, 1988, DIABETES, V37, P1499, DOI 10.2337/diabetes.37.11.1499; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Pattaro C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002584; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pavkov ME, 2012, CLIN J AM SOC NEPHRO, V7, P78, DOI 10.2215/CJN.07610711; Perkins RM, 2012, KIDNEY INT, V82, P1332, DOI 10.1038/ki.2012.281; Placha G, 2006, DIABETES, V55, P3358, DOI 10.2337/db06-0781; Puppala S, 2007, DIABETES, V56, P2818, DOI 10.2337/db06-0984; Rossing P, 2011, KIDNEY INT, V79, pS28, DOI 10.1038/ki.2010.513; Schelling JR, 2008, DIABETES, V57, P235, DOI 10.2337/db07-0313; Thameem F, 2012, DIABETES, V61, P2385, DOI 10.2337/db11-1078; Turner ST, 2006, J AM SOC NEPHROL, V17, P2048, DOI 10.1681/ASN.2005121254; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Wouters V, 2010, EUR J HUM GENET, V18, P414, DOI 10.1038/ejhg.2009.193	40	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e81888	10.1371/journal.pone.0081888	http://dx.doi.org/10.1371/journal.pone.0081888			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358131	gold, Green Published			2022-12-27	WOS:000328737700002
J	Wylie, KP; Tanabe, J; Martin, LF; Wongngamnit, N; Tregellas, JR				Wylie, Korey P.; Tanabe, Jody; Martin, Laura F.; Wongngamnit, Narin; Tregellas, Jason R.			Nicotine Increases Cerebellar Activity during Finger Tapping	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR; SCHIZOPHRENIC-PATIENTS; NONSMOKERS; ATTENTION; BRAIN; ACTIVATION; FMRI; METAANALYSIS; MOVEMENTS; SLICES	Nicotine improves performance on several cognitive and sensorimotor tasks. The neuronal mechanisms associated with these changes in performance are, however, largely unknown. Functional magnetic resonance imaging (fMRI) was used to examine the effect of nicotine on neuronal response in nineteen healthy subjects while they performed an auditory-paced finger tapping task. Subjects performed the task, after receiving either a nicotine patch or placebo treatment, in a single blind, crossover design. Compared to placebo, nicotine treatment increased response in the cerebellar vermis. Increased vermal activity, in the absence of changes in other task-related regions suggests specificity in nicotine's effects.	[Wylie, Korey P.; Tanabe, Jody; Martin, Laura F.; Wongngamnit, Narin; Tregellas, Jason R.] Univ Colorado, Dept Psychiat, Aurora, CO 80309 USA; [Tanabe, Jody] Univ Colorado, Dept Radiol, Aurora, CO 80309 USA; [Tregellas, Jason R.] Denver Vet Affairs Med Ctr, Eastern Colorado Hlth Syst, Res Serv, Res Serv 151, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Tregellas, JR (corresponding author), Univ Colorado, Dept Psychiat, Anschutz Med Campus, Aurora, CO 80309 USA.	Jason.Tregellas@UCDenver.edu	Tregellas, Jason/J-3637-2015		Veterans Administration Biomedical Laboratory and Clinical Science Research and Development Service; National Institutes of Mental Health [MH-086383]; Brain and Behavior Research Foundation; Blowitz-Ridgeway Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086383, T32MH015442] Funding Source: NIH RePORTER	Veterans Administration Biomedical Laboratory and Clinical Science Research and Development Service; National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brain and Behavior Research Foundation; Blowitz-Ridgeway Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Veterans Administration Biomedical Laboratory and Clinical Science Research and Development Service, the National Institutes of Mental Health grant MH-086383, the Brain and Behavior Research Foundation, and the Blowitz-Ridgeway Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER LE, 1993, AM J PSYCHIAT, V150, P1856; Agulhon C, 1998, MOL BRAIN RES, V58, P123, DOI 10.1016/S0169-328X(98)00113-2; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bengtsson SL, 2005, EUR J NEUROSCI, V22, P3255, DOI 10.1111/j.1460-9568.2005.04517.x; Chan RCK, 2009, BRAIN RES REV, V59, P316, DOI 10.1016/j.brainresrev.2008.09.003; De Filippi G, 2001, PHARMACOL BIOCHEM BE, V70, P447, DOI 10.1016/S0091-3057(01)00653-0; Fant RV, 2000, PHARMACOL BIOCHEM BE, V67, P479, DOI 10.1016/S0091-3057(00)00399-3; Ghatan PH, 1998, PSYCHOPHARMACOLOGY, V136, P179, DOI 10.1007/s002130050554; Graham A, 2002, NEUROSCIENCE, V113, P493, DOI 10.1016/S0306-4522(02)00223-3; Heishman SJ, 2010, PSYCHOPHARMACOLOGY, V210, P453, DOI 10.1007/s00213-010-1848-1; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P51, DOI 10.1016/S0926-6410(00)00022-7; Jantzen KJ, 2004, P NATL ACAD SCI USA, V101, P6815, DOI 10.1073/pnas.0401300101; JONES GMM, 1992, PSYCHOPHARMACOLOGY, V108, P485, DOI 10.1007/BF02247426; Kumari V, 2003, NEUROIMAGE, V19, P1002, DOI 10.1016/S1053-8119(03)00110-1; Lawrence NS, 2002, NEURON, V36, P539, DOI 10.1016/S0896-6273(02)01004-8; Levin ED, 1998, PSYCHOPHARMACOLOGY, V140, P135, DOI 10.1007/s002130050750; OJIMA H, 1989, J COMP NEUROL, V290, P41, DOI 10.1002/cne.902900104; Penhune VB, 1998, J COGNITIVE NEUROSCI, V10, P752, DOI 10.1162/089892998563149; Rao SM, 1997, J NEUROSCI, V17, P5528; Reno LAC, 2004, NEUROSCIENCE, V124, P647, DOI 10.1016/j.neuroscience.2003.12.023; Riecker A, 2003, NEUROIMAGE, V18, P731, DOI 10.1016/S1053-8119(03)00003-X; Rivkin MJ, 2003, PEDIATR NEUROL, V28, P89, DOI 10.1016/S0887-8994(02)00492-7; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Silver H, 2002, EUR NEUROPSYCHOPHARM, V12, P141, DOI 10.1016/S0924-977X(01)00149-3; Spencer RMC, 2007, NEUROIMAGE, V36, P378, DOI 10.1016/j.neuroimage.2007.03.009; Tregellas JR, 2006, NEUROIMAGE, V32, P307, DOI 10.1016/j.neuroimage.2006.02.036; Turner JR, 2005, NICOTINIC CHOLINERGI; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; WEST RJ, 1986, PHARMACOL BIOCHEM BE, V25, P727, DOI 10.1016/0091-3057(86)90377-1; Wignall ND, 2011, EXP CLIN PSYCHOPHARM, V19, P183, DOI 10.1037/a0023292; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025	31	6	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84581	10.1371/journal.pone.0084581	http://dx.doi.org/10.1371/journal.pone.0084581			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358367	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700102
J	Enomoto, T; Ohashi, K; Shibata, R; Kambara, T; Uemura, Y; Yuasa, D; Kataoka, Y; Miyabe, M; Matsuo, K; Joki, Y; Hayakawa, S; Hiramatsu-Ito, M; Ito, M; Murohara, T; Ouchi, N				Enomoto, Takashi; Ohashi, Koji; Shibata, Rei; Kambara, Takahiro; Uemura, Yusuke; Yuasa, Daisuke; Kataoka, Yoshiyuki; Miyabe, Megumi; Matsuo, Kazuhiro; Joki, Yusuke; Hayakawa, Satoko; Hiramatsu-Ito, Mizuho; Ito, Masanori; Murohara, Toyoaki; Ouchi, Noriyuki			Transcriptional Regulation of an Insulin-Sensitizing Adipokine Adipolin/CTRP12 in Adipocytes by Kruppel-Like Factor 15	PLOS ONE			English	Article							MACROPHAGE POLARIZATION; INFLAMMATORY DISEASE; METABOLIC SYNDROME; OBESITY; ADIPONECTIN; RESISTANCE; PROTEIN; ADIPOSE; EXPRESSION; TISSUE	Obese states characterized by chronic inflammation are closely linked to the development of metabolic dysfunction. We identified adipolin/CTRP12 as an insulin-sensitizing and anti-inflammatory adipokine. Although obese conditions down-regulate adipolin expression, its molecular mechanism is largely unknown. Here we show that the transcriptional regulator Kruppel-like factor (KLF) 15 is involved in the regulation of adipolin expression in adipocytes. White adipose tissue from diet-induced obese (DIO) mice showed decreased expression of KLF9 and KLF15 among several KLFs, which was accompanied by reduced expression of adipolin. In cultured 3T3L1 adipocytes, treatment with TNF alpha significantly reduced the mRNA levels of KLF9, KLF15 and adipolin. Adenovirus-mediated overexpression of KLF15 but not KLF9 reversed TNF alpha-induced reduction of adipolin expression in adipocytes. Conversely, gene targeting ablation of KLF15 attenuated adipolin expression in adipocytes. Expression of KLF15 but not KLF9 enhanced the promoter activity of adipolin in HEK293 cells. Pretreatment of 3T3L1 adipocytes with the JNK inhibitor SP600125, but not p38 MAPK inhibitor SB203580 blocked the inhibitory effects of TNF alpha on adipolin and KLF15 expression. These data suggest that adipose inflammation under conditions of obesity suppresses adipolin expression via JNK-dependent down-regulation of KLF15 in adipocytes.	[Enomoto, Takashi; Shibata, Rei; Kambara, Takahiro; Uemura, Yusuke; Yuasa, Daisuke; Kataoka, Yoshiyuki; Miyabe, Megumi; Matsuo, Kazuhiro; Joki, Yusuke; Hayakawa, Satoko; Hiramatsu-Ito, Mizuho; Ito, Masanori; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Ohashi, Koji; Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Ouchi, N (corresponding author), Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Nagoya, Aichi 4648601, Japan.	nouchi@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014; OUCHI, Noriyuki/I-7306-2014; OHASHI, Koji/I-7307-2014	Enomoto, Takashi/0000-0002-7370-8013; Hiramatsu-Ito, Mizuho/0000-0003-1740-1794	Takeda Science Foundation; Uehara Memorial Foundation; Daiichi-Sankyo Foundation of Life Science; SENSHIN Medical Research Foundation; Cardiovascular Research Fund, Tokyo, Japan	Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Daiichi-Sankyo Foundation of Life Science; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Cardiovascular Research Fund, Tokyo, Japan	This work was supported by Grant-in-Aid for Scientific Research, Grant-in-Aid for Challenging Exploratory Research and grants from Takeda Science Foundation, the Uehara Memorial Foundation, Daiichi-Sankyo Foundation of Life Science, and SENSHIN Medical Research Foundation to N. Ouchi. R. Shibata was supported with the Grant-in-Aid for Young Scientists B and the Uehara Memorial Foundation. K. Ohashi was supported with the Grant-in-Aid for Scientific Research and The Cardiovascular Research Fund, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell-Anderson KS, 2013, DIABETES, V62, P2728, DOI 10.2337/db12-1745; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Enomoto T, 2012, BIOCHEM BIOPH RES CO, V428, P155, DOI 10.1016/j.bbrc.2012.10.031; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Kawamata Y, 2007, J BIOL CHEM, V282, P28549, DOI 10.1074/jbc.M705869200; Kilroy G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006940; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Nagare T, 2011, J BIOL CHEM, V286, P37458, DOI 10.1074/jbc.M111.242651; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Ohashi K, 2006, HYPERTENSION, V47, P1108, DOI 10.1161/01.HYP.0000222368.43759.a1; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Pei H, 2011, CELL DEATH DIFFER, V18, P315, DOI 10.1038/cdd.2010.100; Pereira RI, 2008, LIFE SCI, V83, P638, DOI 10.1016/j.lfs.2008.09.002; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Wei ZK, 2012, J BIOL CHEM, V287, P35804, DOI 10.1074/jbc.M112.365965; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamamoto J, 2004, J BIOL CHEM, V279, P16954, DOI 10.1074/jbc.M312079200	43	25	32	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83183	10.1371/journal.pone.0083183	http://dx.doi.org/10.1371/journal.pone.0083183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358263	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700110
J	Gao, T; Yang, XC; Jin, YX; Ma, HL; Li, JY; Yu, HD; Yu, QY; Zheng, X; Xu, B				Gao, Tian; Yang, Xiuchun; Jin, Yunxiang; Ma, Hailong; Li, Jinya; Yu, Haida; Yu, Qiangyi; Zheng, Xiao; Xu, Bin			Spatio-Temporal Variation in Vegetation Biomass and Its Relationships with Climate Factors in the Xilingol Grasslands, Northern China	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; RAIN-USE EFFICIENCY; GREEN-UP DATE; PRECIPITATION GRADIENT; CARBON STORAGE; DYNAMICS; METAANALYSIS; ECOSYSTEMS; PATTERNS; GROWTH	Knowledge about grassland biomass and its dynamics is critical for studying regional carbon cycles and for the sustainable use of grassland resources. In this study, we investigated the spatio-temporal variation of biomass in the Xilingol grasslands of northern China. Field-based biomass samples and MODIS time series data sets were used to establish two empirical models based on the relationship of the normalized difference vegetation index (NDVI) with above-ground biomass (AGB) as well as that of AGB with below-ground biomass (BGB). We further explored the climatic controls of these variations. Our results showed that the biomass averaged 99.01 Tg (1 Tg= 1012 g) over a total area of 19.6x10(4) km(2) and fluctuated with no significant trend from 2001 to 2012. The mean biomass density was 505.4 g/m(2), with 62.6 g/m(2) in AGB and 442.8 g/m(2) in BGB, which generally decreased from northeast to southwest and exhibited a large spatial heterogeneity. The year-to-year AGB pattern was generally consistent with the inter-annual variation in the growing season precipitation (GSP), showing a robust positive correlation (R-2=0.82, P<0.001), but an opposite coupled pattern was observed with the growing season temperature (GST) (R-2=0.61, P=0.003). Climatic factors also affected the spatial distribution of AGB, which increased progressively with the GSP gradient (R-2=0.76, P<0.0001) but decreased with an increasing GST (R-2=0.70, P<0.0001). An improved moisture index that combined the effects of GST and GSP explained more variation in AGB than did precipitation alone (R-2=0.81, P<0.0001). The relationship between AGB and GSP could be fit by a power function. This increasing slope of the GSP-AGB relationships along the GSP gradient may be partly explained by the GST-GSP spatial pattern in Xilingol. Our findings suggest that the relationships between climatic factors and AGB may be scale-dependent and that multi-scale studies and sufficient long-term field data are needed to examine the relationships between AGB and climatic factors.	[Gao, Tian; Zheng, Xiao] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Gao, Tian; Yang, Xiuchun; Jin, Yunxiang; Ma, Hailong; Li, Jinya; Yu, Haida; Yu, Qiangyi; Xu, Bin] Chinese Acad Agr Sci, Key Lab Agr, Minist Agr, Inst Agr Resources & Reg Planning, Beijing 100193, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs	Xu, B (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	xubin@caas.cn	Yu, Qiangyi/AFR-0194-2022; Li, Jinya/N-2990-2014; Yu, Qiangyi/J-9360-2014	Li, Jinya/0000-0001-8596-6194; Yu, Qiangyi/0000-0002-6457-3583	National High Technology Project (863) [2006AA10Z242, 2008AA121805]; National Natural Science Foundation of China (NSFC) [40701055]	National High Technology Project (863)(National High Technology Research and Development Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by the National High Technology Project (863, No. 2006AA10Z242, 2008AA121805) and the National Natural Science Foundation of China (NSFC, 40701055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Beedlow PA, 2013, AGR FOREST METEOROL, V169, P174, DOI 10.1016/j.agrformet.2012.10.010; Cong N, 2013, GLOBAL CHANGE BIOL, V19, P881, DOI 10.1111/gcb.12077; Department of Animal Husbandry and Veterinary General Station of Animal Husbandry and Veterinary of Ministry of Agriculture of China, 1996, RANG RES CHIN; Fan JW, 2009, J ARID ENVIRON, V73, P521, DOI 10.1016/j.jaridenv.2008.12.004; Fan JW, 2008, CLIMATIC CHANGE, V86, P375, DOI 10.1007/s10584-007-9316-6; Fang J. Y, 1996, CARBON POOLS TERREST; Fang JY, 2010, SCI CHINA LIFE SCI, V53, P757, DOI 10.1007/s11427-010-4029-x; Fang JY, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024231; Fang JY, 2001, SCIENCE, V293, P1723, DOI 10.1126/science.293.5536.1723a; Feng XM, 2011, ECOL INDIC, V11, P175, DOI 10.1016/j.ecolind.2009.07.002; Gao T, 2012, AGR 2012 1 INT C SHA, P1; [高添 Gao Tian], 2012, [地理科学进展, Progress in Geography], V31, P1724; Guo Q, 2012, GLOBAL CHANGE BIOL, V18, P3624, DOI 10.1111/gcb.12010; Hsu JS, 2012, GLOBAL CHANGE BIOL, V18, P2246, DOI 10.1111/j.1365-2486.2012.02687.x; Hu ZM, 2008, GLOBAL CHANGE BIOL, V14, P1609, DOI 10.1111/j.1365-2486.2008.01582.x; Hu ZM, 2007, SCI CHINA SER D, V50, P754, DOI 10.1007/s11430-007-0010-3; Hu ZM, 2010, GLOBAL ECOL BIOGEOGR, V19, P842, DOI 10.1111/j.1466-8238.2010.00564.x; Hutchinson M.F., 2004, ANUSPLIN VERSION 4 3; [金云翔 Jin Yunxiang], 2011, [中国科学. 生命科学, Scientia Sinica Vitae], V41, P1185; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Ma WH, 2010, SCI CHINA LIFE SCI, V53, P841, DOI 10.1007/s11427-010-4020-6; Ni J, 2002, J ARID ENVIRON, V50, P205, DOI 10.1006/jare.2001.0902; Ni J, 2011, REG ENVIRON CHANGE, V11, pS49, DOI 10.1007/s10113-010-0170-0; Ouyang W, 2012, ECOL INDIC, V18, P163, DOI 10.1016/j.ecolind.2011.11.013; Paruelo JM, 1997, ECOLOGY, V78, P953, DOI 10.1890/0012-9658(1997)078[0953:AEFNFT]2.0.CO;2; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, pB2002; Ren J, 1965, J GANSU AGR U, V2, P33; Ruppert JC, 2012, J VEG SCI, V23, P1035, DOI 10.1111/j.1654-1103.2012.01420.x; Scurlock JMO, 2002, GLOBAL CHANGE BIOL, V8, P736, DOI 10.1046/j.1365-2486.2002.00512.x; Siefert A, 2012, J VEG SCI, V23, P942, DOI 10.1111/j.1654-1103.2012.01401.x; Titlyanova AA, 1999, J VEG SCI, V10, P307, DOI 10.2307/3237060; Wu XC, 2013, GLOBAL CHANGE BIOL, V19, P870, DOI 10.1111/gcb.12086; Xu B, 2008, INT J REMOTE SENS, V29, P5313, DOI 10.1080/01431160802036276; Yang YH, 2009, J ARID ENVIRON, V73, P91, DOI 10.1016/j.jaridenv.2008.09.027; Yang YH, 2010, GLOBAL ECOL BIOGEOGR, V19, P268, DOI 10.1111/j.1466-8238.2009.00502.x; Zhang GL, 2011, J GEOGR SCI, V21, P634, DOI 10.1007/s11442-011-0869-y; 马文红, 2008, [中国科学. C辑, 生命科学, Science in China. Series C, Life Sciences], V38, P84	42	39	44	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83824	10.1371/journal.pone.0083824	http://dx.doi.org/10.1371/journal.pone.0083824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358313	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700139
J	Maestripieri, D; Klimczuk, ACE; Seneczko, M; Traficonte, DM; Wilson, MC				Maestripieri, Dario; Klimczuk, Amanda C. E.; Seneczko, Marianne; Traficonte, Daniel M.; Wilson, M. Claire			Relationship Status and Relationship Instability, but Not Dominance, Predict Individual Differences in Baseline Cortisol Levels	PLOS ONE			English	Article							ADULT ATTACHMENT; STRESS HORMONES; RESPONSES; HUMANS; POWER	We investigated variation in baseline cortisol levels in relation to relationship status (single or in a relationship), relationship characteristics (length, stability, presence or absence of clear dominance), or individual attributes (dominant or subordinate status, relative physical attractiveness, relationship worries). Study participants were 77 men and 75 women aged between 18 and 38 years. Individuals in romantic relationships had lower cortisol levels than singles. Individuals of African ethnicity, however, showed the opposite pattern. Individuals who perceived their relationship to be highly unstable had higher cortisol levels. Aside from African-Americans, married individuals reported the lowest relationship instability and the lowest cortisol levels, followed by individuals in long-term relationships, and by individuals in short-term relationships. The presence or absence of clear dominance in the relationship, dominance status, or relationship worries did not affect cortisol levels. Therefore relationship status and relationship instability were better predictors of variation in cortisol (presumably through stress-related mechanisms) than individual attributes.	[Maestripieri, Dario; Klimczuk, Amanda C. E.; Seneczko, Marianne; Traficonte, Daniel M.; Wilson, M. Claire] Univ Chicago, Inst Mind & Biol, Chicago, IL 60637 USA	University of Chicago	Maestripieri, D (corresponding author), Univ Chicago, Inst Mind & Biol, Chicago, IL 60637 USA.	dario@uchicago.edu		Wilson, M. Claire/0000-0002-9301-246X	University of Chicago	University of Chicago(University of Chicago)	This study was funded by intramural funds from the University of Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; Adam EK, 2001, PSYCHONEUROENDOCRINO, V26, P189, DOI 10.1016/S0306-4530(00)00045-7; Adkins-Regan E., 2005, HORMONES ANIMAL SOCI; Almasi B, 2013, HORM BEHAV, V64, P161, DOI 10.1016/j.yhbeh.2013.03.001; Brooks KP, 2011, PERS RELATIONSHIP, V18, P302, DOI 10.1111/j.1475-6811.2011.01357.x; Cate RM, 2002, J SOC PERS RELAT, V19, P261, DOI 10.1177/0265407502192005; Cohen S, 2006, PSYCHOSOM MED, V68, P414, DOI 10.1097/01.psy.0000221236.37158.b9; Del Giudice M, 2011, NEUROSCI BIOBEHAV R, V35, P1562, DOI 10.1016/j.neubiorev.2010.11.007; Doane LD, 2010, PSYCHONEUROENDOCRINO, V35, P430, DOI 10.1016/j.psyneuen.2009.08.005; Ellison P. T., 2009, ENDOCRINOLOGY SOCIAL; FELMLEE DH, 1994, SEX ROLES, V31, P275, DOI 10.1007/BF01544589; Flinn MV, 2011, NEUROSCI BIOBEHAV R, V35, P1611, DOI 10.1016/j.neubiorev.2011.01.005; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Higham JP, 2013, BEHAV ECOL SOCIOBIOL, V67, P19, DOI 10.1007/s00265-012-1420-6; Hruschka DJ, 2005, PSYCHONEUROENDOCRINO, V30, P698, DOI 10.1016/j.psyneuen.2005.03.002; Kidd T, 2011, PSYCHONEUROENDOCRINO, V36, P771, DOI 10.1016/j.psyneuen.2010.10.014; Maestripieri D, 2010, STRESS, V13, P413, DOI 10.3109/10253891003681137; Masi CM, 2004, J APPL PHYSIOL, V97, P941, DOI 10.1152/japplphysiol.00256.2004; Nepomnaschy PA, 2012, AM J HUM BIOL, V24, P515, DOI 10.1002/ajhb.22259; SAPOLSKY RM, 1992, PSYCHONEUROENDOCRINO, V17, P701, DOI 10.1016/0306-4530(92)90029-7; Wirth MM, 2006, HORM BEHAV, V49, P346, DOI 10.1016/j.yhbeh.2005.08.013	21	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84003	10.1371/journal.pone.0084003	http://dx.doi.org/10.1371/journal.pone.0084003			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358324	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700146
J	Tillmar, AO; Dell'Amico, B; Welander, J; Holmlund, G				Tillmar, Andreas O.; Dell'Amico, Barbara; Welander, Jenny; Holmlund, Gunilla			A Universal Method for Species Identification of Mammals Utilizing Next Generation Sequencing for the Analysis of DNA Mixtures	PLOS ONE			English	Article							MITOCHONDRIAL; MARKERS	Species identification can be interesting in a wide range of areas, for example, in forensic applications, food monitoring and in archeology. The vast majority of existing DNA typing methods developed for species determination, mainly focuses on a single species source. There are, however, many instances where all species from mixed sources need to be determined, even when the species in minority constitutes less than 1 % of the sample. The introduction of next generation sequencing opens new possibilities for such challenging samples. In this study we present a universal deep sequencing method using 454 GS Junior sequencing of a target on the mitochondrial gene 16S rRNA. The method was designed through phylogenetic analyses of DNA reference sequences from more than 300 mammal species. Experiments were performed on artificial species-species mixture samples in order to verify the method's robustness and its ability to detect all species within a mixture. The method was also tested on samples from authentic forensic casework. The results showed to be promising, discriminating over 99.9 % of mammal species and the ability to detect multiple donors within a mixture and also to detect minor components as low as 1 % of a mixed sample.	[Tillmar, Andreas O.; Dell'Amico, Barbara; Holmlund, Gunilla] Natl Board Forens Med, Dept Forens Genet & Forens Toxicol, Linkoping, Sweden; [Welander, Jenny; Holmlund, Gunilla] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden	Swedish National Board of Forensic Medicine; Linkoping University	Tillmar, AO (corresponding author), Natl Board Forens Med, Dept Forens Genet & Forens Toxicol, Linkoping, Sweden.	andreas.tillmar@rmv.se			Swedish National Board of Forensic Medicine [RMVFoU 05:25, RMVFoU 11:03]	Swedish National Board of Forensic Medicine	This work was supported by grants from the Swedish National Board of Forensic Medicine (RMVFoU 05:25 and RMVFoU 11:03). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alacs EA, 2010, FORENSIC SCI MED PAT, V6, P180, DOI 10.1007/s12024-009-9131-7; Ali ME, 2012, GENET MOL RES, V11, P1762, DOI 10.4238/2012.June.29.9; An J, 2007, FORENSIC SCI INT, V167, P59, DOI 10.1016/j.forsciint.2005.12.031; Brenig B, 2010, FORENSIC SCI INT-GEN, V4, P228, DOI 10.1016/j.fsigen.2009.10.001; Cawthorn DM, 2012, GENE, V491, P40, DOI 10.1016/j.gene.2011.09.009; Coghlan ML, 2012, PLOS GENET, V8, P436, DOI 10.1371/journal.pgen.1002657; Eurlings MCM, 2013, J FORENSIC SCI, V58, P822, DOI 10.1111/1556-4029.12072; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Gupta SK, 2006, J FORENSIC SCI, V51, P805, DOI 10.1111/j.1556-4029.2006.00154.x; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hancock-Hanser BL, 2013, MOL ECOL RESOUR, V13, P254, DOI 10.1111/1755-0998.12059; Karlsson AO, 2007, FORENSIC SCI INT, V173, P16, DOI 10.1016/j.forsciint.2007.01.019; Kitano T, 2007, INT J LEGAL MED, V121, P423, DOI 10.1007/s00414-006-0113-y; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LINDBLOM B, 1988, GENE ANAL TECH, V5, P97, DOI 10.1016/0735-0651(88)90003-9; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Naue J, 2012, INT J LEGAL MED, V126, P483, DOI 10.1007/s00414-012-0674-x; Ortea I, 2012, ELECTROPHORESIS, V33, P2201, DOI 10.1002/elps.201100576; Sakaridis I, 2013, MEAT SCI, V94, P84, DOI 10.1016/j.meatsci.2012.12.017; Tobe SS, 2008, ELECTROPHORESIS, V29, P340, DOI 10.1002/elps.200700706; Tobe SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014156; Tobe SS, 2010, FORENSIC SCI MED PAT, V6, P195, DOI 10.1007/s12024-010-9168-7; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wasser SK, 2004, P NATL ACAD SCI USA, V101, P14847, DOI 10.1073/pnas.0403170101	27	58	63	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83761	10.1371/journal.pone.0083761	http://dx.doi.org/10.1371/journal.pone.0083761			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358309	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700137
J	Low, HZ; Reuter, S; Topperwien, M; Dankenbrink, N; Peest, D; Kabalak, G; Stripecke, R; Schmidt, RE; Matthias, T; Witte, T				Low, Hui Zhi; Reuter, Sandra; Topperwien, Michael; Dankenbrink, Nadine; Peest, Dietrich; Kabalak, Gamze; Stripecke, Renata; Schmidt, Reinhold E.; Matthias, Torsten; Witte, Torsten			Association of the LILRA3 Deletion with B-NHL and Functional Characterization of the Immunostimulatory Molecule	PLOS ONE			English	Article							CLASS-I MOLECULES; LEUKOCYTE RECEPTOR CLUSTER; NON-HODGKIN-LYMPHOMA; INHIBITORY RECEPTOR; CYTOKINE PRODUCTION; MYELOID CELLS; IMMUNOGLOBULIN; COMPLEX; FAMILY; TRANSCRIPT-2	LILRA3 is the sole soluble member of the LILR family. Previous studies from our group had shown that a 6.7 kb genetic deletion of LILRA3 is associated with MS and Sjogrens syndrome. An impairment of the immune response leads to a predisposition for B-NHL, so we wanted to study whether the deletion of LILRA3 is also a risk factor for B-NHL, as well as the function of LILRA3. We discovered that the frequency of the homozygous LILRA3 deletion was significantly higher in B-NHL (6%) than in blood donors (3%) (P = 0.03). We detected binding of fluorochrome-conjugated recombinant LILRA3 to monocytes and B-cells. Incubation of PBMCs with recombinant LILRA3 induced proliferation of CD8(+) T-cells and NK cells, as determined by CFSE staining. Using a transwell system, we demonstrated that LILRA3-stimulated lymphocyte proliferation was mediated by monocytes and required both cell contact and soluble factors. Secretion of IL-6, IL-8, IL-1 beta and IL-10 in the cell supernatant was stimulated by LILRA3. We conclude that LILRA3 is an immunostimulatory molecule, whose deficiency is associated with higher frequency of B-NHL.	[Low, Hui Zhi; Topperwien, Michael; Dankenbrink, Nadine; Kabalak, Gamze; Schmidt, Reinhold E.; Witte, Torsten] Hannover Med Sch, Clin Immunol & Rheumatol, Hannover, Germany; [Peest, Dietrich; Stripecke, Renata] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Reuter, Sandra] AESKU KIPP Inst, Wendelsheim, Germany; [Matthias, Torsten] AESKU Diagnost, Wendelsheim, Germany	Hannover Medical School; Hannover Medical School	Low, HZ (corresponding author), Hannover Med Sch, Clin Immunol & Rheumatol, Hannover, Germany.	low.huizhi@mh-hannover.de	Witte, Torsten/B-5783-2016; Stripecke, Renata/G-3252-2013; Low, Hui Zhi/ABH-3088-2020	Low, Hui Zhi/0000-0002-3657-9371	DFG Klinische Forschergruppe [250, TP3, WI 1031/6-1]	DFG Klinische Forschergruppe(German Research Foundation (DFG))	This work was supported by the DFG Klinische Forschergruppe 250, TP3, WI 1031/6-1 to Torsten Witte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, MMWR RECOMM REP, V41, P1; Arm JP, 1997, J IMMUNOL, V159, P2342; Borges L, 1997, J IMMUNOL, V159, P5192; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Cho M, 2008, INT IMMUNOL, V20, P155, DOI 10.1093/intimm/dxm127; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Dietrich J, 2000, MICROBES INFECT, V2, P323, DOI 10.1016/S1286-4579(00)00294-X; Dietrich J, 2001, J IMMUNOL, V166, P2514, DOI 10.4049/jimmunol.166.4.2514; Fanger NA, 1998, EUR J IMMUNOL, V28, P3423, DOI 10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO;2-2; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Jones DC, 2011, J IMMUNOL, V186, P2990, DOI 10.4049/jimmunol.1003078; Jones D, 2009, AGENDA, V44, P39; Kabalak G, 2009, ARTHRITIS RHEUM-US, V60, P2923, DOI 10.1002/art.24804; Koch S, 2005, GENES IMMUN, V6, P445, DOI 10.1038/sj.gene.6364187; Mellemkjaer L, 2008, ARTHRITIS RHEUM, V58, P657, DOI 10.1002/art.23267; Merlo A, 2005, CLIN DIAGN LAB IMMUN, V12, P705, DOI 10.1128/CDLI.12.6.705-712.2005; Nakajima H, 1999, J IMMUNOL, V162, P5; Pfistershammer K, 2009, BLOOD, V114, P2323, DOI 10.1182/blood-2008-10-183814; Raine T, 2006, RHEUMATOLOGY, V45, P1338, DOI 10.1093/rheumatology/kel305; Rothman N, 2006, LANCET ONCOL, V7, P27, DOI 10.1016/S1470-2045(05)70434-4; Ryu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019245; Samaridis J, 1997, EUR J IMMUNOL, V27, P660, DOI 10.1002/eji.1830270313; Saverino D, 2000, J IMMUNOL, V165, P3742, DOI 10.4049/jimmunol.165.7.3742; Saverino D, 2002, J IMMUNOL, V168, P207, DOI 10.4049/jimmunol.168.1.207; Torkar M, 1998, EUR J IMMUNOL, V28, P3959, DOI 10.1002/(SICI)1521-4141(199812)28:12<3959::AID-IMMU3959>3.0.CO;2-2; Torkar M, 2000, EUR J IMMUNOL, V30, P3655, DOI 10.1002/1521-4141(200012)30:12<3655::AID-IMMU3655>3.0.CO;2-Y; Vitale M, 1999, INT IMMUNOL, V11, P29, DOI 10.1093/intimm/11.1.29; Wagtmann N, 1997, CURR BIOL, V7, P615, DOI 10.1016/S0960-9822(06)00263-6; Wang SS, 2006, CANCER RES, V66, P9771, DOI 10.1158/0008-5472.CAN-06-0324; Wende H, 2000, IMMUNOGENETICS, V51, P703, DOI 10.1007/s002510000187; Wende H, 1999, MAMM GENOME, V10, P154, DOI 10.1007/s003359900961; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81360	10.1371/journal.pone.0081360	http://dx.doi.org/10.1371/journal.pone.0081360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24363809	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200024
J	Haida, A; Dor, F; Guillaume, M; Quinquis, L; Marc, A; Marquet, LA; Antero-Jacquemin, J; Tourny-Chollet, C; Desgorces, F; Berthelot, G; Toussaint, JF				Haida, Amal; Dor, Frederic; Guillaume, Marion; Quinquis, Laurent; Marc, Andy; Marquet, Laurie-Anne; Antero-Jacquemin, Juliana; Tourny-Chollet, Claire; Desgorces, Francois; Berthelot, Geoffroy; Toussaint, Jean-Francois			Environment and Scheduling Effects on Sprint and Middle Distance Running Performances	PLOS ONE			English	Article							AMBIENT-TEMPERATURE; WINTER MORTALITY; HEART-DISEASE; MARATHON; PROGRESSION; RESPONSES; EXERCISE; EUROPE; CYCLE; MOOD	Purpose: Achievement of athletes' performances is related to several factors including physiological, environmental and institutional cycles where physical characteristics are involved. The objective of this study is to analyse the performance achieved in professional sprint and middle-distance running events (100 m to 1500 m) depending on the organization of the annual calendar of track events and their environmental conditions. Methods: From 2002 to 2008, all performances of the Top 50 international athletes in the 100 m to 1500 m races (men and women) are collected. The historical series of world records and the 10 best annual performances in these events, amounted to a total of 26,544 performances, are also included in the study. Results: Two periods with a higher frequency of peak performances are observed. The first peak occurs around the 27.15th +/- 0.21 week (first week of July) and the second peak around 34.75th +/- 0.14 week (fourth week of August). The second peak tends to be the time of major international competitions (Olympic Games, World Championships, and European Championships) and could be characterized as an institutional moment. The first one, however, corresponds to an environmental optimum as measured by the narrowing of the temperature range at the highest performance around 23.25 +/- 3.26 degrees C. Conclusions: This is the first study to demonstrate that there are two performance peaks at a specific time of year (27th and 34th weeks) in sprint and middle distance. Both institutional and ecophysiological aspects contribute to performance in the 100 m to 1500 m best performances and define the contours of human possibilities. Sport institutions may take this into account in order to provide ideal conditions to improve the next records.	[Haida, Amal; Dor, Frederic; Guillaume, Marion; Quinquis, Laurent; Marc, Andy; Marquet, Laurie-Anne; Antero-Jacquemin, Juliana; Desgorces, Francois; Berthelot, Geoffroy; Toussaint, Jean-Francois] INSEP, IRMES Biomed Res Inst Sports Epidemiol Paris Fran, Paris, France; [Haida, Amal; Tourny-Chollet, Claire] Univ Rouen, Fac Sci Sport & Educ Phys, CETAPS, Mont St Aignan, France; [Desgorces, Francois; Berthelot, Geoffroy; Toussaint, Jean-Francois] Paris Descartes Univ, Paris, France; [Toussaint, Jean-Francois] Hop Hotel Dieu, AP HP, CIMS, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Universite de Rouen Normandie; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Haida, A (corresponding author), INSEP, IRMES Biomed Res Inst Sports Epidemiol Paris Fran, Paris, France.	amal.haida@insep.fr		Antero, Juliana/0000-0001-6894-6693	Centre National de Developpement du sport; Ministry of Health, Youth and Sports	Centre National de Developpement du sport; Ministry of Health, Youth and Sports	The authors thank the Centre National de Developpement du sport and the Ministry of Health, Youth and Sports for financial assistance. The funders had no role in study design, data gathering, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author had full access to all data in the study and had final responsibility for the decision to submit for publication.	Atkinson G, 1996, SPORTS MED, V21, P292, DOI 10.2165/00007256-199621040-00005; Atkinson Greg, 2005, Clin Sports Med, V24, pe25, DOI 10.1016/j.csm.2004.11.001; Ballester F, 1997, INT J EPIDEMIOL, V26, P551, DOI 10.1093/ije/26.3.551; Barnett AG, 2007, BLOOD PRESS MONIT, V12, P195, DOI 10.1097/MBP.0b013e3280b083f4; BENNETT AF, 1985, J EXP BIOL, V115, P333; Berthelot G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001552; Boivin DB, 1997, ARCH GEN PSYCHIAT, V54, P145; Chan CB, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-21; Cheuvront SN, 2001, SPORTS MED, V31, P743, DOI 10.2165/00007256-200131100-00004; COSTILL DL, 1991, MED SCI SPORT EXER, V23, P371; Desgorces FD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003653; Eccles R, 2002, ACTA OTO-LARYNGOL, V122, P183, DOI 10.1080/00016480252814207; El Helou N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037407; Ely MR, 2008, MED SCI SPORT EXER, V40, P1675, DOI 10.1249/MSS.0b013e3181788da9; Ely MR, 2007, MED SCI SPORT EXER, V39, P487, DOI 10.1249/mss.0b013e31802d3aba; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Foster RG, 2008, CURR BIOL, V18, pR784, DOI 10.1016/j.cub.2008.07.003; Galloway SDR, 1997, MED SCI SPORT EXER, V29, P1240, DOI 10.1097/00005768-199709000-00018; Ghebre MA, 2012, J THROMB HAEMOST, V10, P352, DOI 10.1111/j.1538-7836.2012.04617.x; Hamilton SL, 2008, ANN HUM BIOL, V35, P154, DOI 10.1080/03014460801908058; Healy JD, 2003, J EPIDEMIOL COMMUN H, V57, P784, DOI 10.1136/jech.57.10.784; Hsiang SM, 2011, NATURE, V476, P438, DOI 10.1038/nature10311; Josephson KR, 1984, J EXP BIOL, V108, P77; Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2; Kenefick RW, 2007, SPORTS MED, V37, P312, DOI 10.2165/00007256-200737040-00010; Koehler K, 2012, EUR J APPL PHYSIOL, V112, P513, DOI 10.1007/s00421-011-2002-4; Lincoln GA, 2005, ENDOCRINOLOGY, V146, P3782, DOI 10.1210/en.2005-0132; Magnanou E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005904; Magnusson A, 2000, ACTA PSYCHIAT SCAND, V101, P176, DOI 10.1046/j.0902-4441.2000..x; Marino FE, 2004, J APPL PHYSIOL, V96, P124, DOI 10.1152/japplphysiol.00582.2003; McCormack GR, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2009.092841; Montain SJ, 2007, SPORTS MED, V37, P320, DOI 10.2165/00007256-200737040-00012; Mujika I, 2010, SCAND J MED SCI SPOR, V20, P24, DOI 10.1111/j.1600-0838.2010.01189.x; Regnier-Loilier A, 2011, POPULATION SOC, P1; Rocklov J, 2008, SCAND J PUBLIC HEALT, V36, P516, DOI 10.1177/1403494807088458; Somero GN, 2002, INTEGR COMP BIOL, V42, P780, DOI 10.1093/icb/42.4.780; Spengler CM, 2000, AM J RESP CRIT CARE, V162, P1038, DOI 10.1164/ajrccm.162.3.9911107; Steinacker JM, 2000, J SPORT MED PHYS FIT, V40, P327; THERMINARIAS A, 1987, Science and Sports, V2, P1, DOI 10.1016/S0765-1597(87)80039-4	39	7	10	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79548	10.1371/journal.pone.0079548	http://dx.doi.org/10.1371/journal.pone.0079548			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24363791	Green Submitted, Green Published, gold			2022-12-27	WOS:000327313100031
J	Yang, L; Huang, K; Li, XR; Du, M; Kang, X; Luo, X; Gao, L; Wang, C; Zhang, YQ; Zhang, C; Tong, QS; Huang, K; Zhang, FX; Huang, D				Yang, Liu; Huang, Kun; Li, Xiangrao; Du, Meng; Kang, Xiang; Luo, Xi; Gao, Lu; Wang, Cheng; Zhang, Yanqing; Zhang, Chun; Tong, Qiangsong; Huang, Kai; Zhang, Fengxiao; Huang, Dan			Identification of Poly(ADP-Ribose) Polymerase-1 as a Cell Cycle Regulator through Modulating Sp1 Mediated Transcription in Human Hepatoma Cells	PLOS ONE			English	Article							CANCER-CELLS; GENE-EXPRESSION; CARDIAC FIBROBLASTS; WAF1/CIP1 GENE; DNA-SYNTHESIS; PROTEIN; PARP-1; GROWTH; PHOSPHORYLATION; OVEREXPRESSION	The transcription factor Sp1 is implicated in the activation of G0/G1 phase genes. Modulation of Sp1 transcription activities may affect G1-S checkpoint, resulting in changes in cell proliferation. In this study, our results demonstrated that activated poly(ADP-ribose) polymerase 1 (PARP-1) promoted cell proliferation by inhibiting Sp1 signaling pathway. Cell proliferation and cell cycle assays demonstrated that PARP inhibitors or PARP-1 siRNA treatment significantly inhibited proliferation of hepatoma cells and induced G0/G1 cell cycle arrest in hepatoma cells, while overexpression of PARP-1 or PARP-1 activator treatment promoted cell cycle progression. Simultaneously, inhibition of PARP-1 enhanced the expression of Sp1-mediated checkpoint proteins, such as p21 and p27. In this study, we also showed that Sp1 was poly(ADP-ribosyl)ated by PARP-1 in hepatoma cells. Poly(ADP-ribosyl)ation suppressed Sp1 mediated transcription through preventing Sp1 binding to the Sp1 response element present in the promoters of target genes. Taken together, these data indicated that PARP-1 inhibition attenuated the poly(ADP-ribosyl)ation of Sp1 and significantly increased the expression of Sp1 target genes, resulting in G0/G1 cell cycle arrest and the decreased proliferative ability of the hepatoma cells.	[Yang, Liu; Huang, Kun; Li, Xiangrao; Du, Meng; Luo, Xi; Gao, Lu; Wang, Cheng; Zhang, Yanqing; Huang, Kai; Zhang, Fengxiao; Huang, Dan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiovasc Dis, Wuhan 430074, Peoples R China; [Huang, Kun; Zhang, Chun; Tong, Qiangsong; Huang, Kai; Zhang, Fengxiao; Huang, Dan] Huazhong Univ Sci & Technol, Union Hosp, Clin Ctr Human Genom Res, Wuhan 430074, Peoples R China; [Kang, Xiang] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Huang, K (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiovasc Dis, Wuhan 430074, Peoples R China.	huangkai1@mail.hust.edu.cn; xiaoyou_321@gmail.com; joy_huangdan@163.com	Kang, Xiang/H-5651-2019; Tong, Qiangsong/B-4500-2014	Kang, Xiang/0000-0002-1914-1941; Tong, Qiangsong/0000-0002-2615-6404; Zhang, Fengxiao/0000-0002-5109-4196; Yang, Liu/0000-0002-0972-8511	National Natural Science Foundation of China [81270937, 81170239, 81000112]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81270937 and 81170239 to Kai Huang and 81000112 to Dan Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2004, CANCER RES, V64, P6740, DOI 10.1158/0008-5472.CAN-04-0713; Anderson MG, 2000, J VIROL, V74, P2169, DOI 10.1128/JVI.74.5.2169-2177.2000; Augustin A, 2003, J CELL SCI, V116, P1551, DOI 10.1242/jcs.00341; Biggs JR, 1996, J BIOL CHEM, V271, P901, DOI 10.1074/jbc.271.2.901; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Carbone M, 2008, ONCOGENE, V27, P6083, DOI 10.1038/onc.2008.221; Chen F, 2005, CELL SIGNAL, V17, P1572, DOI 10.1016/j.cellsig.2005.03.012; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Chuang JY, 2009, INT J CANCER, V125, P2066, DOI 10.1002/ijc.24563; Curtin Nicola J., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S146239940500904X; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Deniaud E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007035; DYNAN WS, 1985, P NATL ACAD SCI USA, V82, P4915, DOI 10.1073/pnas.82.15.4915; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Gartel AL, 2000, ONCOGENE, V19, P5182, DOI 10.1038/sj.onc.1203900; Grinstein E, 2002, ONCOGENE, V21, P1485, DOI 10.1038/sj.onc.1205211; Hosoi Y, 2004, INT J ONCOL, V25, P461; Huang D, 2009, J MOL CELL CARDIOL, V46, P25, DOI 10.1016/j.yjmcc.2008.10.019; Huang D, 2009, CARDIOVASC RES, V81, P98, DOI 10.1093/cvr/cvn264; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kirby CA, 2012, ACTA CRYSTALLOGR F, V68, P115, DOI 10.1107/S1744309111051219; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Milutinovic S, 2004, J BIOL CHEM, V279, P27915, DOI 10.1074/jbc.M312823200; Oei SL, 1998, J BIOL CHEM, V273, P31644, DOI 10.1074/jbc.273.48.31644; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Prasad R, 2001, J BIOL CHEM, V276, P32411, DOI 10.1074/jbc.C100292200; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shieh WM, 1998, J BIOL CHEM, V273, P30069, DOI 10.1074/jbc.273.46.30069; Shimo T, 2012, BREAST CANC; Simbulan-Rosenthal CM, 2003, ONCOGENE, V22, P8460, DOI 10.1038/sj.onc.1206897; SIMONIN F, 1990, J BIOL CHEM, V265, P19249; Song J, 2001, J BIOL CHEM, V276, P30429, DOI 10.1074/jbc.M103968200; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Tapias A, 2008, CELL CYCLE, V7, P2856, DOI 10.4161/cc.7.18.6671; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Wang YT, 2008, J MOL BIOL, V380, P869, DOI 10.1016/j.jmb.2008.05.043; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Wilson AJ, 2008, MOL BIOL CELL, V19, P4062, DOI 10.1091/mbc.E08-02-0139; Wu JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000164; Xu W, 2003, METHOD ENZYMOL, V364, P205; Zaniolo K, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-96; Zeng CY, 2003, HYPERTENSION, V42, P787, DOI 10.1161/01.HYP.0000085334.34963.4E	46	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82872	10.1371/journal.pone.0082872	http://dx.doi.org/10.1371/journal.pone.0082872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367566	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900015
J	Labudda, K; Kreisel, S; Beblo, T; Mertens, M; Kurlandchikov, O; Bien, CG; Driessen, M; Woermann, FG				Labudda, Kirsten; Kreisel, Stefan; Beblo, Thomas; Mertens, Markus; Kurlandchikov, Oleg; Bien, Christian G.; Driessen, Martin; Woermann, Friedrich G.			Mesiotemporal Volume Loss Associated with Disorder Severity: A VBM Study in Borderline Personality Disorder	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; STRUCTURAL BRAIN ABNORMALITIES; POSTTRAUMATIC-STRESS-DISORDER; CHILDHOOD MALTREATMENT; HIPPOCAMPAL VOLUME; WOMEN; AMYGDALA; MRI; METAANALYSIS; TRAUMA	Results of MRI volumetry in Borderline Personality Disorder (BPD) are inconsistent. Some, but not all, studies reported decreased hippocampus, amygdala, and/or prefrontal volumes. In the current study, we used rater-independent voxel-based morphometry (VBM) in 33 female BPD patients and 33 healthy women. We measured gray matter (GM) volumes of the whole brain and of three volumes of interest (VOI), i.e., the hippocampus/parahippocampal gyrus, the amygdala and the anterior cingulate gyrus (ACC). Analyses were conducted using lifetime diagnoses of posttraumatic stress disorder (PTSD) and major depression (MD) as covariates. We used adversive childhood experiences and the numbers of BPD criteria (as an indicator of disorder severity) to investigate associations with GM volumes. We did not find volume differences between BPD patients and healthy subject, neither of the whole brain nor of the three VOIs, independent of presence or absence of comorbid PTSD and MD. We also did not find a relationship between childhood maltreatment and the patients' brain volumes. However, within the patient group, the number of BPD criteria fulfilled was inversely correlated with left hippocampal/parahippocampal volume (x=-32, y=-23, z=-18, k=496, t=5.08, p=.007). Consequently, mesiotemporal GM volumes do not seem to differentiate patients from healthy subjects, but might be associated with symptom severity within the BPD group.	[Labudda, Kirsten; Mertens, Markus; Bien, Christian G.; Woermann, Friedrich G.] Mara Hosp, Bethel Epilepsy Ctr, MRI Unit, Bielefeld, Germany; [Labudda, Kirsten; Kreisel, Stefan; Beblo, Thomas; Kurlandchikov, Oleg; Driessen, Martin] Evangel Krankenhaus Bielefeld, Dept Psychiat & Psychotherapy Bethel, Bielefeld, Germany	Evangelical Hospital Bethel (EvKB) - House Gilead I	Woermann, FG (corresponding author), Mara Hosp, Bethel Epilepsy Ctr, MRI Unit, Bielefeld, Germany.	friedrich.woermann@mara.de	Driessen, Martin/ABB-8229-2020	Driessen, Martin/0000-0003-3496-816X; Bien, Christian G./0000-0003-2225-8654	German Research Foundation [DR 358/5-1]	German Research Foundation(German Research Foundation (DFG))	Parts of this study were funded by the German Research Foundation (DR 358/5-1). The authors declare that the German Research Foundation only funded parts of the MRI costs, but none of the authors received financial funding for his/her work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Ashburner J, 2009, MAGN RESON IMAGING, V27, P1163, DOI 10.1016/j.mri.2009.01.006; Bernstein D.P., 1999, CHILDHOOD TRAUMA QUE; Bohus M, 2007, PSYCHOPATHOLOGY, V40, P126, DOI 10.1159/000098493; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Brambilla P, 2004, PSYCHIAT RES-NEUROIM, V131, P125, DOI 10.1016/j.pscychresns.2004.04.003; Brunner R, 2010, NEUROIMAGE, V49, P114, DOI 10.1016/j.neuroimage.2009.07.070; Chanen AM, 2008, PSYCHIAT RES-NEUROIM, V163, P116, DOI 10.1016/j.pscychresns.2007.08.007; Chee MWL, 2011, J COGNITIVE NEUROSCI, V23, P1065, DOI 10.1162/jocn.2010.21513; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; Driessen M, 2000, ARCH GEN PSYCHIAT, V57, P1115, DOI 10.1001/archpsyc.57.12.1115; Fernand SC, 2012, PSYCHONEUROENDOCRINO, V37, P1659, DOI 10.1016/j.psyneuen.2012.02.012; Goodman M, 2011, J PSYCHIATR RES, V45, P803, DOI 10.1016/j.jpsychires.2010.11.011; Hyde KL, 2010, HUM BRAIN MAPP, V31, P556, DOI 10.1002/hbm.20887; Irle E, 2005, BIOL PSYCHIAT, V57, P173, DOI 10.1016/j.biopsych.2004.10.004; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Keller SS, 2002, NEUROIMAGE, V16, P23, DOI 10.1006/nimg.2001.1072; Kreisel S, VOLUME HIPP IN PRESS; Kubicki M, 2002, NEUROIMAGE, V17, P1711, DOI 10.1006/nimg.2002.1296; Kuhlmann A, 2013, J PSYCHIATR NEUROSCI, V38, P129, DOI 10.1503/jpn.120039; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Minzenberg MJ, 2008, J PSYCHIATR RES, V42, P727, DOI 10.1016/j.jpsychires.2007.07.015; Nunes PM, 2009, J PERS DISORD, V23, P333, DOI 10.1521/pedi.2009.23.4.333; Pagura J, 2010, J PSYCHIATR RES, V44, P1190, DOI 10.1016/j.jpsychires.2010.04.016; Rodrigues E, 2011, EUR PSYCHIAT, V26, P452, DOI 10.1016/j.eurpsy.2010.07.005; Rusch N, 2003, NEUROIMAGE, V20, P385, DOI 10.1016/S1053-8119(03)00297-0; Schmahl CG, 2003, PSYCHIAT RES-NEUROIM, V122, P193, DOI 10.1016/S0925-4927(03)00023-4; Schmahl Christian, 2009, J Psychiatry Neurosci, V34, P289; Soloff P, 2008, PSYCHIAT RES-NEUROIM, V164, P223, DOI 10.1016/j.pscychresns.2008.02.003; Teicher MH, 2012, P NATL ACAD SCI USA, V109, pE563, DOI 10.1073/pnas.1115396109; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Elst LT, 2003, BIOL PSYCHIAT, V54, P163, DOI 10.1016/S0006-3223(03)01743-2; Vollm Birgit, 2004, Crim Behav Ment Health, V14, P39, DOI 10.1002/cbm.559; Vollm BA, 2009, CRIM BEHAV MENT HEAL, V19, P64, DOI 10.1002/cbm.716; Walker EA, 1999, AM J MED, V107, P332, DOI 10.1016/S0002-9343(99)00235-1; Weniger G, 2009, J PSYCHIATR NEUROSCI, V34, P383; Zetzsche T, 2007, PSYCHIAT RES-NEUROIM, V154, P157, DOI 10.1016/j.pscychresns.2006.05.010	38	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83677	10.1371/journal.pone.0083677	http://dx.doi.org/10.1371/journal.pone.0083677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367606	Green Submitted, Green Published, gold			2022-12-27	WOS:000328740300113
J	Zheng, CF; Nie, LW; Wang, J; Zhou, HX; Hou, HZ; Wang, H; Liu, JJ				Zheng, Chenfei; Nie, Liuwang; Wang, Jue; Zhou, Huaxing; Hou, Huazhen; Wang, Hao; Liu, Juanjuan			Recombination and Evolution of Duplicate Control Regions in the Mitochondrial Genome of the Asian Big-Headed Turtle, Platysternon megacephalum	PLOS ONE			English	Article							CONCERTED EVOLUTION; GENE REARRANGEMENTS; DNA-SEQUENCE; ORGANIZATION; HETEROPLASMY; TESTUDINES; PHYLOGENY; REPTILIA	Complete mitochondrial (mt) genome sequences with duplicate control regions (CRs) have been detected in various animal species. In Testudines, duplicate mtCRs have been reported in the mtDNA of the Asian big-headed turtle, Platysternon megacephalum, which has three living subspecies. However, the evolutionary pattern of these CRs remains unclear. In this study, we report the completed sequences of duplicate CRs from 20 individuals belonging to three subspecies of this turtle and discuss the micro-evolutionary analysis of the evolution of duplicate CRs. Genetic distances calculated with MEGA 4.1 using the complete duplicate CR sequences revealed that within turtle subspecies, genetic distances between orthologous copies from different individuals were 0.63% for CR1 and 1.2% for CR2app:addword:respectively, and the average distance between paralogous copies of CR1 and CR2 was 4.8%. Phylogenetic relationships were reconstructed from the CR sequences, excluding the variable number of tandem repeats (VNTRs) at the 39 end using three methods: neighbor-joining, maximum likelihood algorithm, and Bayesian inference. These data show that any two CRs within individuals were more genetically distant from orthologous genes in different individuals within the same subspecies. This suggests independent evolution of the two mtCRs within each P. megacephalum subspecies. Reconstruction of separate phylogenetic trees using different CR components (TAS, CD, CSB, and VNTRs) suggested the role of recombination in the evolution of duplicate CRs. Consequently, recombination events were detected using RDP software with break points at approximate to 290 bp and approximate to 1,080 bp. Based on these results, we hypothesize that duplicate CRs in P. megacephalum originated from heterological ancestral recombination of mtDNA. Subsequent recombination could have resulted in homogenization during independent evolutionary events, thus maintaining the functions of duplicate CRs in the mtDNA of P. megacephalum.	[Zheng, Chenfei; Nie, Liuwang; Wang, Jue; Zhou, Huaxing; Hou, Huazhen; Wang, Hao; Liu, Juanjuan] Anhui Normal Univ, Prov Key Lab Conservat & Exploitat Res Biol Resou, Wuhu, Anhui, Peoples R China	Anhui Normal University	Nie, LW (corresponding author), Anhui Normal Univ, Prov Key Lab Conservat & Exploitat Res Biol Resou, Wuhu, Anhui, Peoples R China.	lwnie@mail.ahnu.edu.cn		Nie, Liu-Wang/0000-0003-2660-5799; Zhou, Huaxing/0000-0002-5569-0083	National Natural Science Foundation of China (NSFC) [30770296, 30970351]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (NSFC, No. 30770296 and No. 30970351)(http://www.nsfc.gov.cn/Portal0/default152.htm).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CL, 2005, MOL ECOL, V14, P3605, DOI 10.1111/j.1365-294X.2005.02672.x; Arndt A, 1998, MOL BIOL EVOL, V15, P1009, DOI 10.1093/oxfordjournals.molbev.a025999; Boore JL, 2000, COMP GENOMICS, V1, P133, DOI DOI 10.1007/978-94-011-4309-7_13; Braband A, 2010, MOL PHYLOGENET EVOL, V57, P293, DOI 10.1016/j.ympev.2010.05.012; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Eberhard JR, 2001, MOL BIOL EVOL, V18, P1330, DOI 10.1093/oxfordjournals.molbev.a003917; Ernst CH, 2002, P BIOL SOC WASH, V115, P18; ERNST CH, 1987, P BIOL SOC WASH, V100, P624; Fan SG, 2011, SCI CHINA LIFE SCI, V54, P434, DOI 10.1007/s11427-011-4168-8; Gibson T, 2007, J MOL EVOL, V65, P308, DOI 10.1007/s00239-007-9007-y; Gray JE, 1870, CATALOGUE SHIELD 1 S; Gray JE, 1831, P ZOOL SOC LOND, V831, P106; Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006; GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0; HELL TA, 1999, NUCL ACIDS S SERIES, V41, P95; Hoarau G, 2002, MOL BIOL EVOL, V19, P2261, DOI 10.1093/oxfordjournals.molbev.a004049; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jang KH, 2011, MITOCHONDR DNA, V22, P77, DOI 10.3109/19401736.2011.624601; Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kumazawa Y, 1996, MOL BIOL EVOL, V13, P1242, DOI 10.1093/oxfordjournals.molbev.a025690; Kumazawa Y, 1998, GENETICS, V150, P313; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li XS, 2010, AMPHIBIA-REPTILIA, V31, P541, DOI 10.1163/017353710X530203; Lunt DH, 1997, NATURE, V387, P247, DOI 10.1038/387247a0; Macey JR, 1997, MOL BIOL EVOL, V14, P91, DOI 10.1093/oxfordjournals.molbev.a025706; MADSEN CS, 1993, MOL CELL BIOL, V13, P2162, DOI 10.1128/MCB.13.4.2162; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Morris-Pocock JA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-14; Ogoh K, 2004, GENE, V327, P131, DOI 10.1016/j.gene.2003.11.011; Okajima Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-141; Parham JF, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-11; Parham JF, 2006, MOL PHYLOGENET EVOL, V38, P50, DOI 10.1016/j.ympev.2005.07.015; Peng QL, 2006, GENE, V380, P14, DOI 10.1016/j.gene.2006.04.001; Phadnis N, 2005, GENETICS, V171, P1549, DOI 10.1534/genetics.105.047092; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Sammler S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-35; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Schirtzinger EE, 2012, MOL PHYLOGENET EVOL, V64, P342, DOI 10.1016/j.ympev.2012.04.009; Shao RF, 2005, MOL BIOL EVOL, V22, P620, DOI 10.1093/molbev/msi047; SMITH JM, 1992, J MOL EVOL, V34, P126; Swofford DL, 2002, PAUP PHYLOGENENC ANA; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ujvari B, 2007, BIOL LETTERS, V3, P189, DOI 10.1098/rsbl.2006.0587; Verkuil YI, 2010, MOL PHYLOGENET EVOL, V57, P411, DOI 10.1016/j.ympev.2010.06.010; White DJ, 2008, MOL ECOL, V17, P4925, DOI 10.1111/j.1365-294X.2008.03982.x; Xiong L, 2010, GENES GENOM, V32, P291, DOI 10.1007/s13258-010-0015-8; Zhang JF, 2009, GENE, V442, P119, DOI 10.1016/j.gene.2009.04.018; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang YY, 2009, GENES GENOM, V31, P349, DOI 10.1007/BF03191253; Zhuang X, 2010, MOL BIOL EVOL, V27, P1391, DOI 10.1093/molbev/msq026	51	16	17	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82854	10.1371/journal.pone.0082854	http://dx.doi.org/10.1371/journal.pone.0082854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367563	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300076
J	Amireault, P; Bayard, E; Launay, JM; Sibon, D; Le Van Kim, C; Colin, Y; Dy, M; Hermine, O; Cote, F				Amireault, Pascal; Bayard, Elisa; Launay, Jean-Marie; Sibon, David; Le Van Kim, Caroline; Colin, Yves; Dy, Michel; Hermine, Olivier; Cote, Francine			Serotonin Is a Key Factor for Mouse Red Blood Cell Survival	PLOS ONE			English	Article							OXIDATIVE STRESS; PROTEIN CARBONYLATION; ANAEROBIC STORAGE; CARDIAC-FUNCTION; 5-HT RECEPTORS; VITAMIN-E; TRANSFUSION; ANTIOXIDANT; ERYTHROCYTES; MELATONIN	Serotonin (5-HT) is a monoamine originally purified from blood as a vasoactive agent. In nonneuronal tissues, its presence is linked with the expression of tryptophan hydroxylase 1 (TPH1) that catalyzes the rate-limiting step of its synthesis. Targeted disruption in mice of the TPH1 gene results in very low levels of circulating 5-HT. Previous analysis of the TPH1 knockout (TPH1 2/2) mouse revealed that they develop a phenotype of macrocytic anemia with a reduced half-life of their circulating red blood cells (RBC). In this study, to establish whether the observed reduced half-life of TPH1 2/2 RBC is an intrinsic or an extrinsic characteristic, we compared their survival to RBC isolated from wild-type mice. Both in vivo and in vitro data converge to demonstrate an extrinsic protective effect of 5-HT since presence of 5-HT in the RBC environment protects RBC from senescence. The protective effect played by 5-HT is not mediated through activation of a classical pharmacological pathway as no 5-HT receptors were detected on isolated RBC. Rather, 5-HT acts as an effective antioxidant since reduction of 5-HT circulating levels are associated with a decrease in the plasma antioxidant capacity. We further demonstrate a link between oxidation and the removal of damaged RBC following transfusion, as supplementation with 5-HT improves RBC post-transfusion survival in a mouse model of blood banking.	[Amireault, Pascal; Bayard, Elisa; Sibon, David; Dy, Michel; Hermine, Olivier; Cote, Francine] Univ Paris 05, Fac Med, Hop Univ Necker Enfants Malades, Sorbonne Paris Cite,CNRS UMR 8147, Paris, France; [Amireault, Pascal; Bayard, Elisa; Sibon, David; Le Van Kim, Caroline; Colin, Yves; Hermine, Olivier; Cote, Francine] Lab Excellence GR Ex, Paris, France; [Amireault, Pascal; Le Van Kim, Caroline; Colin, Yves] Inst Natl Transfus Sanguine, Inserm UMR S665, F-75015 Paris, France; [Launay, Jean-Marie] Hop Lariboisiere, AP HP, Serv Biochim, F-75475 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Cote, F (corresponding author), Univ Paris 05, Fac Med, Hop Univ Necker Enfants Malades, Sorbonne Paris Cite,CNRS UMR 8147, Paris, France.	francine.cote@parisdescartes.fr	Amireault, Pascal/ABH-7300-2020; Sibon, David/AAX-5243-2020; Amireault, Pascal/H-9356-2015; Hermine, Olivier/Q-7072-2018; colin, yves/O-1910-2017; le van kim, caroline/O-7030-2017	Amireault, Pascal/0000-0002-5562-7586; Sibon, David/0000-0002-9205-625X; colin, yves/0000-0001-5196-4254; le van kim, caroline/0000-0002-3251-1310; Hermine, Olivier/0000-0003-2574-3874	Institut Arnault Tzanck and the Federation Francaise du Don de Sang Benevole; la Ligue contre le Cancer; l'Association Recherche Transfusion; Laboratory of Excellence GR-Ex [ANR-11-LABX-0051]; French National Research Agency [ANR-11-IDEX-0005-02]	Institut Arnault Tzanck and the Federation Francaise du Don de Sang Benevole; la Ligue contre le Cancer(Ligue nationale contre le cancer); l'Association Recherche Transfusion; Laboratory of Excellence GR-Ex; French National Research Agency(French National Research Agency (ANR))	PA was supported by the Institut Arnault Tzanck and the Federation Francaise du Don de Sang Benevole. This work was supported by grants from la Ligue contre le Cancer (to OH and FC) and l'Association Recherche Transfusion (to PA). This study was supported by grants from Laboratory of Excellence GR-Ex, reference ANR-11-LABX-0051. The labex GR-Ex is funded by the program "Investissements d'avenir'' of the French National Research Agency, reference ANR-11-IDEX-0005-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amireault P, 2011, P NATL ACAD SCI USA, V108, P13141, DOI 10.1073/pnas.1103964108; Antonelou MH, 2011, J PROTEOMICS, V74, P2441, DOI 10.1016/j.jprot.2011.04.009; Antonelou MH, 2010, TRANSFUSION, V50, P376, DOI 10.1111/j.1537-2995.2009.02449.x; Baek JH, 2012, J CLIN INVEST, V122, P1444, DOI 10.1172/JCI59770; Benabdeslam H, 1999, CLIN CHEM LAB MED, V37, P511, DOI 10.1515/CCLM.1999.082; Boyer EW, 2005, NEW ENGL J MED, V352, P1112, DOI 10.1056/NEJMra041867; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; D'Alessandro A, 2013, MOL BIOSYST, V9, P1196, DOI 10.1039/c3mb25575a; Daniels WMU, 1996, NEUROREPORT, V7, P1593, DOI 10.1097/00001756-199607080-00012; de Watering LV, 2006, TRANSFUSION, V46, P1712, DOI 10.1111/j.1537-2995.00958.x; Delobel J, 2012, J PROTEOMICS, V76, P181, DOI 10.1016/j.jprot.2012.05.004; Dumont LJ, 2008, TRANSFUSION, V48, P1053, DOI 10.1111/j.1537-2995.2008.01642.x; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Flegel WA, 2012, BLOOD TRANSFUS-ITALY, V10, P247, DOI 10.2450/2012.0105-12; Fligny C, 2008, FASEB J, V22, P2340, DOI 10.1096/fj.07-100743; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Gilson CR, 2009, TRANSFUSION, V49, P1546, DOI 10.1111/j.1537-2995.2009.02173.x; GRAF M, 1979, BRIT J PHARMACOL, V65, P601, DOI 10.1111/j.1476-5381.1979.tb07870.x; Gulcin I, 2008, J ENZYM INHIB MED CH, V23, P871, DOI [10.1080/14756360701626223, 10.1080/14756360701626223 ]; Hannon J, 2008, BEHAV BRAIN RES, V195, P198, DOI 10.1016/j.bbr.2008.03.020; Hess JR, 2012, TRANSFUSION, V52, P1827, DOI 10.1111/j.1537-2995.2011.03511.x; Hess JR, 2010, J PROTEOMICS, V73, P368, DOI 10.1016/j.jprot.2009.11.005; Hess JR, 2003, TRANSFUSION, V43, P867, DOI 10.1046/j.1537-2995.2003.00442.x; Hod EA, 2010, BLOOD, V115, P4284, DOI 10.1182/blood-2009-10-245001; Johnson RM, 2005, FREE RADICAL BIO MED, V39, P1407, DOI 10.1016/j.freeradbiomed.2005.07.002; Kang K, 2009, PLANT PHYSIOL, V150, P1380, DOI 10.1104/pp.109.138552; Karon BS, 2012, BLOOD TRANSFUS-ITALY, V10, P453, DOI 10.2450/2012.0099-11; Keller ME, 2002, J TRAUMA, V53, P1023, DOI 10.1097/00005373-200211000-00037; Kellermann O, 1996, BRIT J PHARMACOL, V118, P1161, DOI 10.1111/j.1476-5381.1996.tb15519.x; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Kriebardis AG, 2006, BLOOD CELL MOL DIS, V36, P279, DOI 10.1016/j.bcmd.2006.01.003; Lee JM, 2004, P NATL ACAD SCI USA, V101, P9751, DOI 10.1073/pnas.0403620101; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Lion N, 2010, J PROTEOMICS, V73, P374, DOI 10.1016/j.jprot.2009.11.001; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; Martin FM, 2006, ANTIOXID REDOX SIGN, V8, P1217, DOI 10.1089/ars.2006.8.1217; Murrell Z, 2005, AM SURGEON, V71, P781; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Peyrot F, 2008, J PINEAL RES, V45, P235, DOI 10.1111/j.1600-079X.2008.00580.x; Sakr Y, 2007, CRIT CARE MED, V35, P1639, DOI 10.1097/01.CCM.0000269936.73788.32; Swann IL, 1998, CLIN LAB HAEMATOL, V20, P61; Traber MG, 2007, FREE RADICAL BIO MED, V43, P4, DOI 10.1016/j.freeradbiomed.2007.03.024; Traber MG, 2011, FREE RADICAL BIO MED, V51, P1000, DOI 10.1016/j.freeradbiomed.2011.05.017; Trincavelli ML, 2008, NEUROCHEM RES, V33, P1292, DOI 10.1007/s11064-007-9582-8; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; WINTERBOURN CC, 1990, SEMIN HEMATOL, V27, P41; Yoshida T, 2007, VOX SANG, V92, P22, DOI 10.1111/j.1423-0410.2006.00860.x; Yoshida T, 2008, TRANSFUSION, V48, P2096, DOI 10.1111/j.1537-2995.2008.01812.x; Zimring JC, 2013, TRANSFUSION, V53, P2334, DOI 10.1111/trf.12131	49	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83010	10.1371/journal.pone.0083010	http://dx.doi.org/10.1371/journal.pone.0083010			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358245	gold, Green Published, Green Submitted			2022-12-27	WOS:000328737700042
J	Khait, R; Obolski, U; Hadany, L; Genin, A				Khait, Ruth; Obolski, Uri; Hadany, Lilach; Genin, Amatzia			Food Selectivity and Diet Switch Can Explain the Slow Feeding of Herbivorous Coral-Reef Fishes during the Morning	PLOS ONE			English	Article							FORAGING PERIODICITY; NUTRITIONAL ECOLOGY; MARINE; ACANTHURIDAE; TELEOSTEI	Most herbivorous coral-reef fishes feed slower in the morning than in the afternoon. Given the typical scarcity of algae in coral reefs, this behavior seems maladaptive. Here we suggest that the fishes' slow feeding during the morning is an outcome of highly selective feeding on scarcely found green algae. The rarity of the food requires longer search time and extended swimming tracks, resulting in lower bite rates. According to our findings by noon the fish seem to stop their search and switch to indiscriminative consumption of benthic algae, resulting in apparent higher feeding rates. The abundance of the rare preferable algae gradually declines from morning to noon and seems to reach its lowest levels around the switch time. Using in situ experiments we found that the feeding pattern is flexible, with the fish exhibiting fast feeding rates when presented with ample supply of preferable algae, regardless of the time of day. Analyses of the fish's esophagus content corroborated our conclusion that their feeding was highly selective in the morning and non-selective in the afternoon. Modeling of the fishes' behavior predicted that the fish should perform a diel diet shift when the preferred food is relatively rare, a situation common in most coral reefs found in a warm, oligotrophic ocean.	[Khait, Ruth; Genin, Amatzia] Interuniv Inst Marine Sci Eilat, Elat, Israel; [Khait, Ruth; Genin, Amatzia] Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, Jerusalem, Israel; [Obolski, Uri; Hadany, Lilach] Tel Aviv Univ, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel	Hebrew University of Jerusalem; Tel Aviv University	Khait, R (corresponding author), Interuniv Inst Marine Sci Eilat, Elat, Israel.	ruth.khait@mail.huji.ac.il			Israel Nature and Park Authority; Israel Science Foundation [840/08]	Israel Nature and Park Authority; Israel Science Foundation(Israel Science Foundation)	This research was supported by a grant from the Israel Nature and Park Authority and by a grant 840/08 from the Israel Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonaldo RM, 2005, BRAZ J BIOL, V65, P1; CACERES CW, 1994, OECOLOGIA, V99, P118, DOI 10.1007/BF00317091; Choat JH, 2004, MAR BIOL, V145, P445, DOI 10.1007/s00227-004-1341-7; Choat JH, 1998, ANNU REV ECOL SYST, V29, P375, DOI 10.1146/annurev.ecolsys.29.1.375; Clements Kendall D., 2006, P47; Clements KD, 2009, FUNCT ECOL, V23, P79, DOI 10.1111/j.1365-2435.2008.01524.x; Dubinsky Z, 1990, ECOSYSTEMS WORLD; Ferreira CEL, 1998, J FISH BIOL, V53, P222, DOI 10.1006/jfbi.1998.0824; FISHELSON L, 1985, SCIENCE, V229, P49; Genin A, 2009, LIMNOL OCEANOGR, V54, P938, DOI 10.4319/lo.2009.54.3.0938; Horn M.H., 1989, Oceanography and Marine Biology an Annual Review, V27, P167; Horn MH, 1990, 24TH P EUR MAR BIOL, P170; IRELAN CD, 1991, J EXP MAR BIOL ECOL, V153, P179, DOI 10.1016/0022-0981(91)90224-K; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MAZEROLL AI, 1995, ETHOLOGY, V99, P89; MONTGOMERY WL, 1980, J EXP MAR BIOL ECOL, V47, P9, DOI 10.1016/0022-0981(80)90134-3; MONTGOMERY WL, 1989, J EXP MAR BIOL ECOL, V132, P179, DOI 10.1016/0022-0981(89)90127-5; POLUNIN NVC, 1989, J EXP MAR BIOL ECOL, V126, P1, DOI 10.1016/0022-0981(89)90121-4; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Raubenheimer D, 2005, ECOLOGY, V86, P2601, DOI 10.1890/04-1472; Raubenheimer D., 2012, Aquaculture and behavior, P150; Rickel S, 2005, ANIM BEHAV, V70, P133, DOI 10.1016/j.anbehav.2004.10.014; Strickland J.D.H., 1972, PRACTICAL HDB SEWATE, DOI [10.2307/1979241, DOI 10.2307/1979241]; TABORSKY M, 1980, Marine Ecology, V1, P143, DOI 10.1111/j.1439-0485.1980.tb00216.x; Wassef EA, 2001, AQUAC RES, V32, P315, DOI 10.1046/j.1355-557x.2001.00043.x; Yahel R, 2002, LIMNOL OCEANOGR, V47, P1071, DOI 10.4319/lo.2002.47.4.1071; Zemke-White WL, 2002, MAR BIOL, V141, P571, DOI 10.1007/s00227-002-0849-y; Zemke-White WL, 1999, J EXP MAR BIOL ECOL, V240, P137, DOI 10.1016/S0022-0981(99)00056-8; ZOUFAL R, 1991, MAR BIOL, V108, P193, DOI 10.1007/BF01344333	29	6	7	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82391	10.1371/journal.pone.0082391	http://dx.doi.org/10.1371/journal.pone.0082391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358178	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700013
J	Villarreal, MLM; Padilha, M; Vieira, ADS; Franco, BDGD; Martinez, RCR; Saad, SMI				Morales Villarreal, Martha Lissete; Padilha, Marina; Silva Vieira, Antonio Diogo; Gombossy de Melo Franco, Bernadette Dora; Ruiz Martinez, Rafael Chacon; Isay Saad, Susana Marta			Advantageous Direct Quantification of Viable Closely Related Probiotics in Petit-Suisse Cheeses under In Vitro Gastrointestinal Conditions by Propidium Monoazide - qPCR	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; COMPLETE GENOME SEQUENCE; ANIMALIS SUBSP LACTIS; LACTOBACILLUS-ACIDOPHILUS LA-5; REAL-TIME PCR; SELECTIVE ENUMERATION; MOLECULAR TECHNIQUES; FERMENTED MILK; CULTURE-MEDIA; VIABILITY	Species-specific Quantitative Real Time PCR (qPCR) alone and combined with the use of propidium monoazide (PMA) were used along with the plate count method to evaluate the survival of the probiotic strains Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis Bb-12, and the bacteriocinogenic and potentially probiotic strain Lactobacillus sakei subsp. sakei 2a in synbiotic (F1) and probiotic (F2) petit-suisse cheeses exposed throughout shelf-life to in vitro simulated gastrointestinal tract conditions. The three strains studied showed a reduction in their viability after the 6 h assay. Bb-12 displayed the highest survival capacity, above 72.6 and 74.6% of the initial populations, respectively, by plate count and PMA-qPCR, maintaining population levels in the range or above 6 log CFU/g. The prebiotic mix of inulin and FOS did not offer any additional protection for the strains against the simulated gastrointestinal environment. The microorganisms' populations were comparable among the three methods at the initial time of the assay, confirming the presence of mainly viable and culturable cells. However, with the intensification of the stress induced throughout the various stages of the in vitro test, the differences among the methods increased. The qPCR was not a reliable enumeration method for the quantification of intact bacterial populations, mixed with large numbers of injured and dead bacteria, as confirmed by the scanning electron microscopy results. Furthermore, bacteria plate counts were much lower (P<0.05) than with the PMA-qPCR method, suggesting the accumulation of stressed or dead microorganisms unable to form colonies. The use of PMA overcame the qPCR inability to differentiate between dead and alive cells. The combination of PMA and species-specific qPCR in this study allowed a quick and unequivocal way of enumeration of viable closely related species incorporated into probiotic and synbiotic petit-suisse cheeses and under stress conditions.	[Morales Villarreal, Martha Lissete; Padilha, Marina; Silva Vieira, Antonio Diogo; Isay Saad, Susana Marta] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Biochem & Pharmaceut Technol, Sao Paulo, Brazil; [Gombossy de Melo Franco, Bernadette Dora; Ruiz Martinez, Rafael Chacon] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Food & Expt Nutr, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Saad, SMI (corresponding author), Univ Sao Paulo, Fac Pharmaceut Sci, Dept Biochem & Pharmaceut Technol, Sao Paulo, Brazil.	susaad@usp.br	Martinez, Rafael/H-3728-2016; Padilha, Marina/N-9749-2018; Franco, Bernadette D G M/E-1195-2012; Vieira, Antonio Diogo Silva/H-6881-2018; Saad, Susana Marta Isay/C-1354-2012; Franco, Bernadette/AAN-4205-2021	Martinez, Rafael/0000-0001-9427-8801; Padilha, Marina/0000-0002-1736-0411; Saad, Susana Marta Isay/0000-0001-9682-8491; Franco, Bernadette/0000-0002-9312-2888	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/52600-6, 2009/52599-8, 2011/05203-1, 2012/13535-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grant numbers: 2009/52600-6, 2009/52599-8, 2011/05203-1, and 2012/13535-7; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermann E, 2005, P NATL ACAD SCI USA, V102, P3906, DOI 10.1073/pnas.0409188102; Alves LL, 2013, INT J DAIRY TECHNOL, V66, P63, DOI 10.1111/j.1471-0307.2012.00880.x; Bae SW, 2009, APPL ENVIRON MICROB, V75, P2940, DOI 10.1128/AEM.01333-08; Bedani R, 2013, FOOD MICROBIOL, V34, P382, DOI 10.1016/j.fm.2013.01.012; Ben Amor K, 2002, APPL ENVIRON MICROB, V68, P5209, DOI 10.1128/AEM.68.11.5209-5216.2002; Bunthof CJ, 2002, APPL ENVIRON MICROB, V68, P2934, DOI 10.1128/AEM.68.6.2934-2942.2002; Buriti F. C. A., 2012, HDB ANIMAL BASED FER, P749; Buriti FCA, 2010, INT J FOOD MICROBIOL, V137, P121, DOI 10.1016/j.ijfoodmicro.2009.11.030; Cardarelli HR, 2008, LWT-FOOD SCI TECHNOL, V41, P1037, DOI 10.1016/j.lwt.2007.07.001; Carr FJ, 2002, CRIT REV MICROBIOL, V28, P281, DOI 10.1080/1040-840291046759; Chaillou S, 2005, NAT BIOTECHNOL, V23, P1527, DOI 10.1038/nbt1160; Champagn CP, 2011, INT J FOOD MICROBIOL, V149, P185, DOI 10.1016/j.ijfoodmicro.2011.07.005; Chr. Hansen A/S, 2011, STUD SUMM LA 5; Chr. Hansen A/S, 2011, STUD SUMM BB12; de Martinis ECP, 1997, REV MICROBIOL, V28, P284; De Vuyst L, 2007, J MOL MICROB BIOTECH, V13, P194, DOI 10.1159/000104752; Dommels YEM, 2009, APPL ENVIRON MICROB, V75, P6198, DOI 10.1128/AEM.01054-09; FAO/WHO, 2001, REG CLIN ASP DAIR PR; Felske A, 2001, MOL MICROBIAL ECOLOG, P1; Fiorentini AM, 2011, CIENCIA TECNOL ALIME, V31, P597, DOI 10.1590/S0101-20612011000300008; Furet JP, 2004, INT J FOOD MICROBIOL, V97, P197, DOI 10.1016/j.ijfoodmicro.2004.04.020; Garcia-Cayuela T, 2009, INT DAIRY J, V19, P405, DOI 10.1016/j.idairyj.2009.02.001; Garrigues C, 2010, J BACTERIOL, V192, P2467, DOI 10.1128/JB.00109-10; Ghadimi D, 2008, IMMUNOBIOLOGY, V213, P677, DOI 10.1016/j.imbio.2008.02.001; Giraffa Giorgio, 2008, P1; Hasler CM, 2002, J NUTR, V132, P3772, DOI 10.1093/jn/132.12.3772; IDF (International Dairy Federation), 1995, B IDF, V306, P23; Juste A, 2008, FOOD MICROBIOL, V25, P745, DOI 10.1016/j.fm.2008.04.009; Karimi R, 2011, DAIRY SCI TECHNOL, V91, P283, DOI 10.1007/s13594-011-0005-x; Kramer M, 2009, APPL MICROBIOL BIOT, V84, P1137, DOI 10.1007/s00253-009-2068-7; Lahtinen SJ, 2008, LETT APPL MICROBIOL, V46, P693, DOI 10.1111/j.1472-765X.2008.02374.x; Lahtinen SJ, 2006, FOOD MICROBIOL, V23, P571, DOI 10.1016/j.fm.2005.09.001; Lahtinen SJ, 2005, APPL ENVIRON MICROB, V71, P1662, DOI 10.1128/AEM.71.3.1662-1663.2005; Liserre AM, 2007, FOOD BIOTECHNOL, V21, P1, DOI 10.1080/08905430701191064; Madureira AR, 2011, FOOD RES INT, V44, P465, DOI 10.1016/j.foodres.2010.09.010; Martin B, 2006, APPL ENVIRON MICROB, V72, P6040, DOI 10.1128/AEM.02852-05; Masco L, 2007, J DAIRY SCI, V90, P3572, DOI 10.3168/jds.2006-548; Masood MI, 2011, CRIT REV MICROBIOL, V37, P91, DOI 10.3109/1040841X.2010.536522; Nocker A, 2007, J MICROBIOL METH, V70, P252, DOI 10.1016/j.mimet.2007.04.014; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; O' Shea EF, 2013, CURR OPIN BIOTECH, V24, P130, DOI 10.1016/j.copbio.2012.12.003; Oliver JD, 2005, J MICROBIOL, V43, P93; Pan Y, 2007, APPL ENVIRON MICROB, V73, P8028, DOI 10.1128/AEM.01198-07; Postollec F, 2011, FOOD MICROBIOL, V28, P848, DOI 10.1016/j.fm.2011.02.008; Reichert-Schwillinsky F, 2009, APPL ENVIRON MICROB, V75, P2132, DOI 10.1128/AEM.01796-08; Reid G, 2003, CLIN MICROBIOL REV, V16, P658, DOI 10.1128/CMR.16.4.658-672.2003; Roberfroid MB, 2007, J NUTR, V137, p2493S, DOI 10.1093/jn/137.11.2493S; Roy D, 2001, INT J FOOD MICROBIOL, V69, P167, DOI 10.1016/S0168-1605(01)00496-2; Sakar S, 2013, NUTR FOOD SCI, V43, P107; Saulnier DAA, 2007, APPL ENVIRON MICROB, V73, P1753, DOI 10.1128/AEM.01151-06; Savard P, 2011, INT J FOOD MICROBIOL, V149, P50, DOI 10.1016/j.ijfoodmicro.2010.12.026; Saxelin M, 2010, INT J FOOD MICROBIOL, V144, P293, DOI 10.1016/j.ijfoodmicro.2010.10.009; Souza CHB, 2009, ANN 25 C BRAS MICR; Tabasco R, 2007, INT DAIRY J, V17, P1107, DOI 10.1016/j.idairyj.2007.01.010; Taipale T, 2011, BRIT J NUTR, V105, P409, DOI 10.1017/S0007114510003685; Talwalkar A, 2004, INT DAIRY J, V14, P143, DOI 10.1016/S0958-6946(03)00172-9; Taverniti V, 2011, GENES NUTR, V6, P261, DOI 10.1007/s12263-011-0218-x; van Bokhorst-van de Veen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039053; Van de Casteele S, 2006, INT DAIRY J, V16, P1470, DOI 10.1016/j.idairyj.2005.12.002; Venema K, 2009, WOODHEAD PUBL FOOD S, P314, DOI 10.1533/9781845696603.2.314; Vinderola CG, 1999, INT DAIRY J, V9, P497, DOI 10.1016/S0958-6946(99)00120-X; Vinderola CG, 2000, INT DAIRY J, V10, P271, DOI 10.1016/S0958-6946(00)00045-5	62	32	33	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82102	10.1371/journal.pone.0082102	http://dx.doi.org/10.1371/journal.pone.0082102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358142	Green Submitted, Green Published, gold			2022-12-27	WOS:000328737700007
J	Alva, A; Aquino, F; Gilman, RH; Olivares, C; Requena, D; Gutierrez, AH; Caviedes, L; Coronel, J; Larson, S; Sheen, P; Moore, DAJ; Zimic, M				Alva, Alicia; Aquino, Fredy; Gilman, Robert H.; Olivares, Carlos; Requena, David; Gutierrez, Andres H.; Caviedes, Luz; Coronel, Jorge; Larson, Sandra; Sheen, Patricia; Moore, David A. J.; Zimic, Mirko			Morphological Characterization of Mycobacterium tuberculosis in a MODS Culture for an Automatic Diagnostics through Pattern Recognition	PLOS ONE			English	Article							DETECT EARLY GROWTH; MICROSCOPIC-OBSERVATION; SPUTUM; IDENTIFICATION	Tuberculosis control efforts are hampered by a mismatch in diagnostic technology: modern optimal diagnostic tests are least available in poor areas where they are needed most. Lack of adequate early diagnostics and MDR detection is a critical problem in control efforts. The Microscopic Observation Drug Susceptibility (MODS) assay uses visual recognition of cording patterns from Mycobacterium tuberculosis (MTB) to diagnose tuberculosis infection and drug susceptibility directly from a sputum sample in 7-10 days with a low cost. An important limitation that laboratories in the developing world face in MODS implementation is the presence of permanent technical staff with expertise in reading MODS. We developed a pattern recognition algorithm to automatically interpret MODS results from digital images. The algorithm using image processing, feature extraction and pattern recognition determined geometrical and illumination features used in an object-model and a photo-model to classify TB-positive images. 765 MODS digital photos were processed. The single-object model identified MTB (96.9% sensitivity and 96.3% specificity) and was able to discriminate non-tuberculous mycobacteria with a high specificity (97.1% M. avium, 99.1% M. chelonae, and 93.8% M. kansasii). The photo model identified TB-positive samples with 99.1% sensitivity and 99.7% specificity. This algorithm is a valuable tool that will enable automatic remote diagnosis using Internet or cellphone telephony. The use of this algorithm and its further implementation in a telediagnostics platform will contribute to both faster TB detection and MDR TB determination leading to an earlier initiation of appropriate treatment.	[Alva, Alicia; Aquino, Fredy; Olivares, Carlos; Requena, David; Gutierrez, Andres H.; Sheen, Patricia; Zimic, Mirko] Univ Peruana Cayetano Heredia, Lab Bioinformat & Biol Mol, Lab Invest & Desarrollo, Fac Ciencias & Filosofia, Lima, Peru; [Gilman, Robert H.; Caviedes, Luz; Coronel, Jorge; Sheen, Patricia; Moore, David A. J.; Zimic, Mirko] Univ Peruana Cayetano Heredia, Lab TB, Lab Invest & Desarrollo, Fac Ciencias & Filosofia, Lima, Peru; [Gilman, Robert H.] Johns Hopkins Univ, Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Larson, Sandra] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA; [Moore, David A. J.] Univ London Imperial Coll Sci Technol & Med, Wellcome Ctr Clin Trop Med, Dept Infect Dis & Immun, London, England	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Johns Hopkins University; Michigan State University; Michigan State University College of Osteopathic Medicine; Imperial College London	Zimic, M (corresponding author), Univ Peruana Cayetano Heredia, Lab Bioinformat & Biol Mol, Lab Invest & Desarrollo, Fac Ciencias & Filosofia, Lima, Peru.	mirko.zimic@upch.pe	Requena, David/AAF-4255-2019	Requena, David/0000-0002-5968-1133; Olivares Rodriguez, Carlos Enrique/0000-0002-6124-5672; Coronel, Jorge/0000-0002-4580-6716; Gutierrez, Andres/0000-0002-6127-8327; Alva, Alicia/0000-0001-6706-5966	Wellcome Trust [078067/Z/05]; Peruvian FINCYT Proyecto de Interes Nacional [PIN 061]; CONCYTEC PROCYT; MRC [MR/K007467/1] Funding Source: UKRI; Medical Research Council [MR/K007467/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Peruvian FINCYT Proyecto de Interes Nacional; CONCYTEC PROCYT; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The initial development of the algorithm was funded by a Wellcome Trust Career Development Fellowship awarded to DAJM [078067/Z/05] and by the Peruvian FINCYT Proyecto de Interes Nacional [PIN 061] and CONCYTEC PROCYT awarded to MZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel M, 2006, LANCET, V368, P2142; Attali D, 2009, MATH VIS, P109, DOI 10.1007/b106657_6; Castleman K. R., 1996, DIGITAL IMAGE PROCES; Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203, DOI 10.1128/JCM.38.3.1203-1208.2000; Comina G, 2011, J MICROSC-OXFORD, V242, P325, DOI 10.1111/j.1365-2818.2010.03477.x; COMSTOCK GW, 1982, AM REV RESPIR DIS, V125, P8; Costa LD, 1999, ELECTRON LETT, V35, P1829, DOI 10.1049/el:19991262; Forero MG, 2006, J MICROSC-OXFORD, V223, P120, DOI 10.1111/j.1365-2818.2006.01610.x; Jahne B., 2005, DIGITAL IMAGE PROCES; Khutlang R, 2010, IEEE T INF TECHNOL B, V14, P949, DOI 10.1109/TITB.2009.2028339; Lienhardt C, 2012, NAT REV MICROBIOL, V10, P407, DOI 10.1038/nrmicro2797; Lim J. S., 1990, 2 DIMENSIONAL SIGNAL; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Poynton CA, 1996, TECHN INTRO DIGITAL; Sadaphal R, 2008, INT J TUBERC LUNG D, V12, P579; Torres RS, 2002, SHAPE DESCRIPTION IM, P1089; van der Werf MJ, 2012, EUR RESPIR J, V39, P1511, DOI 10.1183/09031936.00125711; Veropoulos K, 1999, ANAL QUANT CYTOL, V21, P277; WHO, 2009, TREATM TUB GUID; WHO, 2012, GLOB TUR CONTR; World Health Organization, 2011, NONC CULT DRUG SUSC; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zimic M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009577; Zimic M, 2009, T ROY SOC TROP MED H, V103, P638, DOI 10.1016/j.trstmh.2008.10.015	25	12	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82809	10.1371/journal.pone.0082809	http://dx.doi.org/10.1371/journal.pone.0082809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358227	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700093
J	Cameron, ADS; Kroger, C; Quinn, HJ; Scally, IK; Daly, AJ; Kary, SC; Dorman, CJ				Cameron, Andrew D. S.; Kroeger, Carsten; Quinn, Heather J.; Scally, Isobel K.; Daly, Anne J.; Kary, Stefani C.; Dorman, Charles J.			Transmission of an Oxygen Availability Signal at the Salmonella enterica Serovar Typhimurium fis Promoter	PLOS ONE			English	Article							PHASE-DEPENDENT REGULATION; ESCHERICHIA-COLI; STRINGENT CONTROL; SIDD SITES; IN-VITRO; TRANSCRIPTION; EXPRESSION; GENE; IDENTIFICATION; SEQUENCE	The nucleoid-associated protein FIS is a global regulator of gene expression and chromosome structure in Escherichia coli and Salmonella enterica. Despite the importance of FIS for infection and intracellular invasion, very little is known about the regulation of S. enterica fis expression. Under standard laboratory growth conditions, fis is highly expressed during rapid growth but is then silenced as growth slows. However, if cells are cultured in non-aerated conditions, fis expression is sustained during stationary phase. This led us to test whether the redox-sensing transcription factors ArcA and FNR regulate S. enterica fis. Deletion of FNR had no detectable effect, whereas deletion of ArcA had the unexpected effect of further elevating fis expression in stationary phase. ArcA required RpoS for induction of fis expression, suggesting that ArcA indirectly affects fis expression. Other putative regulators were found to play diverse roles: FIS acted directly as an auto-repressor (as expected), whereas CRP had little direct effect on fis expression. Deleting regions of the fis promoter led to the discovery of a novel anaerobically-induced transcription start site (Pfis-2) upstream of the primary transcription start site (Pfis-1). Promoter truncation also revealed that the shortest functional fis promoter was incapable of sustained expression. Moreover, fis expression was observed to correlate directly with DNA supercoiling in non-aerated conditions. Thus, the full-length S. enterica fis promoter region may act as a topological switch that is sensitive to stress-induced duplex destabilisation and upregulates expression in non-aerated conditions.	[Cameron, Andrew D. S.; Kroeger, Carsten; Quinn, Heather J.; Scally, Isobel K.; Daly, Anne J.; Dorman, Charles J.] Univ Dublin Trinity Coll, Sch Genet & Microbiol, Moyne Inst Prevent Med, Dept Microbiol, Dublin 2, Ireland; [Cameron, Andrew D. S.; Kary, Stefani C.] Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada	Trinity College Dublin; University of Regina	Dorman, CJ (corresponding author), Univ Dublin Trinity Coll, Sch Genet & Microbiol, Moyne Inst Prevent Med, Dept Microbiol, Dublin 2, Ireland.	cjdorman@tcd.ie	Dorman, Charles J/N-9867-2015; Dorman, Charles/P-3481-2019; Kröger, Carsten/D-1863-2014	Dorman, Charles J/0000-0002-6018-9170; Dorman, Charles/0000-0002-6018-9170; Kröger, Carsten/0000-0003-0461-1530; Kary, Stefani/0000-0002-1757-7223; Cameron, Andrew/0000-0003-1560-8572	Science Foundation Ireland [07/IN1/B918]; University of Regina; Society for General Microbiology President's Fund Research Travel grant	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); University of Regina; Society for General Microbiology President's Fund Research Travel grant	This work was supported by Science Foundation Ireland grant number 07/IN1/B918 (CJD), a University of Regina startup grant and a Society for General Microbiology President's Fund Research Travel grant (ADSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeeva S, 2003, J BACTERIOL, V185, P204, DOI 10.1128/JB.185.1.204-209.2003; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; BALL CA, 1992, J BACTERIOL, V174, P8043, DOI 10.1128/JB.174.24.8043-8056.1992; Beach MB, 1998, J BACTERIOL, V180, P5932, DOI 10.1128/JB.180.22.5932-5946.1998; Berthoumieux S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.70; Bi CP, 2004, BIOINFORMATICS, V20, P1477, DOI 10.1093/bioinformatics/bth304; Bordes P, 2003, MOL MICROBIOL, V48, P561, DOI 10.1046/j.1365-2958.2003.03461.x; Cameron ADS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002615; Cameron ADS, 2011, MOL MICROBIOL, V80, P85, DOI 10.1111/j.1365-2958.2011.07560.x; Croinin TO, 2007, MOL MICROBIOL, V66, P237, DOI 10.1111/j.1365-2958.2007.05916.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dorman Charles J., 2006, Science Progress, V89, P151, DOI 10.3184/003685006783238317; DORMAN CJ, 1988, J BACTERIOL, V170, P2816, DOI 10.1128/jb.170.6.2816-2826.1988; Farewell A, 1998, MOL MICROBIOL, V29, P1039, DOI 10.1046/j.1365-2958.1998.00990.x; Faucher SP, 2006, P NATL ACAD SCI USA, V103, P1906, DOI 10.1073/pnas.0509183103; Grainger DC, 2008, MOL MICROBIOL, V68, P1366, DOI 10.1111/j.1365-2958.2008.06253.x; Guadarrama-Beltran S, 2013, SUSTAINED EXPRESSION; HSIEH LS, 1991, J MOL BIOL, V219, P443, DOI 10.1016/0022-2836(91)90185-9; Jin DJ, 2012, FEMS MICROBIOL REV, V36, P269, DOI 10.1111/j.1574-6976.2011.00279.x; Keane OM, 2003, MOL GENET GENOMICS, V270, P56, DOI 10.1007/s00438-003-0896-1; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Maciag A, 2011, NUCLEIC ACIDS RES, V39, P5338, DOI 10.1093/nar/gkr129; Mallik P, 2004, J BACTERIOL, V186, P122, DOI 10.1128/JB.186.1.122-135.2004; Mallik P, 2006, J BACTERIOL, V188, P5775, DOI 10.1128/JB.00276-06; Mika F, 2005, GENE DEV, V19, P2770, DOI 10.1101/gad.353705; Nasser W, 2002, EMBO J, V21, P715, DOI 10.1093/emboj/21.4.715; Nasser W, 2001, J BIOL CHEM, V276, P17878, DOI 10.1074/jbc.M100632200; Osborne SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021648; OSUNA R, 1995, J BACTERIOL, V177, P2021, DOI 10.1128/jb.177.8.2021-2032.1995; Pratt TS, 1997, J BACTERIOL, V179, P6367, DOI 10.1128/jb.179.20.6367-6377.1997; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Schneider R, 2000, MOL MICROBIOL, V38, P167, DOI 10.1046/j.1365-2958.2000.02129.x; STERNBERG NL, 1991, METHOD ENZYMOL, V204, P18; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; Walker KA, 2004, J BIOL CHEM, V279, P50818, DOI 10.1074/jbc.M406285200; Walker KA, 1999, J BACTERIOL, V181, P1269, DOI 10.1128/JB.181.4.1269-1280.1999; Wang HQ, 2004, GENOME RES, V14, P1575, DOI 10.1101/gr.2080004; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908	39	16	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84382	10.1371/journal.pone.0084382	http://dx.doi.org/10.1371/journal.pone.0084382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358360	gold, Green Submitted, Green Published			2022-12-27	WOS:000328735700163
J	Chen, LX; Xu, QL; Tu, JG; Ge, YH; Liu, J; Liang, FT				Chen, Linxu; Xu, Qilong; Tu, Jiagang; Ge, Yihe; Liu, Jun; Liang, Fang Ting			Increasing RpoS Expression Causes Cell Death in Borrelia burgdorferi	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEIN; LYME-DISEASE SPIROCHETE; GENE; BBK32; SEQUENCE; TICKS; INFECTIVITY; LIPOPROTEIN; ADAPTATION; VIRULENCE	RpoS, one of the two alternative sigma factors in Borrelia burgdorferi, is tightly controlled by multiple regulators and, in turn, determines expression of many critical virulence factors. Here we show that increasing RpoS expression causes cell death. The immediate effect of increasing RpoS expression was to promote bacterial division and as a consequence result in a rapid increase in cell number before causing bacterial death. No DNA fragmentation or degradation was observed during this induced cell death. Cryo-electron microscopy showed induced cells first formed blebs, which were eventually released from dying cells. Apparently blebbing initiated cell disintegration leading to cell death. These findings led us to hypothesize that increasing RpoS expression triggers intracellular programs and/or pathways that cause spirochete death. The potential biological significance of induced cell death may help B. burgdorferi regulate its population to maintain its life cycle in nature.	[Chen, Linxu; Xu, Qilong; Ge, Yihe; Liang, Fang Ting] Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Tu, Jiagang; Liu, Jun] Univ Texas Med Sch Houston, Dept Pathol & Lab Med, Houston, TX USA	Louisiana State University System; Louisiana State University; University of Texas System; University of Texas Health Science Center Houston	Liang, FT (corresponding author), Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	fliang@vetmed.lsu.edu			National Institutes of Health [R01 AI077733]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by R01 AI077733 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; ARON L, 1994, FEMS MICROBIOL LETT, V123, P75, DOI 10.1111/j.1574-6968.1994.tb07204.x; Banik S, 2011, INFECT IMMUN, V79, P1208, DOI 10.1128/IAI.01156-10; BARBOUR AG, 1988, J CLIN MICROBIOL, V26, P475, DOI 10.1128/JCM.26.3.475-478.1988; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Blevins JS, 2007, APPL ENVIRON MICROB, V73, P1501, DOI 10.1128/AEM.02454-06; Bos J, 2012, P NATL ACAD SCI USA, V109, P18096, DOI 10.1073/pnas.1213332109; Brooks CS, 2003, INFECT IMMUN, V71, P3371, DOI 10.1128/IAI.71.6.3371-3383.2003; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Charoenwong D, 2011, APPL ENVIRON MICROB, V77, P5220, DOI 10.1128/AEM.00648-11; Coburn J, 1999, MOL MICROBIOL, V34, P926, DOI 10.1046/j.1365-2958.1999.01654.x; DESILVA AM, 1995, AM J TROP MED HYG, V53, P397, DOI 10.4269/ajtmh.1995.53.397; Dunham-Ems SM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002532; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Engelberg-Kulka H, 2004, TRENDS MICROBIOL, V12, P66, DOI 10.1016/j.tim.2003.12.008; Engelberg-Kulka H, 2003, SCIENCE, V301, P467, DOI 10.1126/science.1088051; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Fisher MA, 2005, P NATL ACAD SCI USA, V102, P5162, DOI 10.1073/pnas.0408536102; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gautam A, 2008, MICROBIOL-SGM, V154, P275, DOI 10.1099/mic.0.2007/011676-0; Gilbert MA, 2007, MOL MICROBIOL, V63, P1259, DOI 10.1111/j.1365-2958.2007.05593.x; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Hazan R, 2004, MOL GENET GENOMICS, V272, P227, DOI 10.1007/s00438-004-1048-y; He M, 2007, J BACTERIOL, V189, P8377, DOI 10.1128/JB.01199-07; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Hyde JA, 2011, MOL MICROBIOL, V82, P99, DOI 10.1111/j.1365-2958.2011.07801.x; Hyde JA, 2009, MOL MICROBIOL, V74, P1344, DOI 10.1111/j.1365-2958.2009.06951.x; Joseleau-Petit D, 1999, J BACTERIOL, V181, P9, DOI 10.1128/JB.181.1.9-14.1999; Kenedy MR, 2012, FEMS IMMUNOL MED MIC, V66, P1, DOI 10.1111/j.1574-695X.2012.00980.x; Li X, 2006, INFECT IMMUN, V74, P3305, DOI 10.1128/IAI.02035-05; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Miller CL, 2013, MOL MICROBIOL, V88, P105, DOI 10.1111/mmi.12171; Ouyang Z, 2011, PLOS PATHOG, V7, DOI DOI 10.1371/J0URNAL.PPAT.1001272; Ouyang ZM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-44; PIESMAN J, 1990, AM J TROP MED HYG, V42, P352, DOI 10.4269/ajtmh.1990.42.352; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; Ramamoorthy R, 1996, INFECT IMMUN, V64, P1259, DOI 10.1128/IAI.64.4.1259-1264.1996; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Shi YL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003340; SIMPSON WJ, 1994, FEMS MICROBIOL LETT, V119, P381, DOI 10.1111/j.1574-6968.1994.tb06917.x; Skare JT, 1997, INFECT IMMUN, V65, P3654, DOI 10.1128/IAI.65.9.3654-3661.1997; Teng X, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.72; Vermeulen K, 2005, ANN HEMATOL, V84, P627, DOI 10.1007/s00277-005-1065-x; Wang JH, 2013, TRENDS PLANT SCI, V18, P133, DOI 10.1016/j.tplants.2012.09.004; Wickman G, 2012, CELL DEATH DIFFER, V19, P735, DOI 10.1038/cdd.2012.25; Xu HJ, 2010, INFECT IMMUN, V78, P2910, DOI 10.1128/IAI.00372-10; Xu QL, 2006, INFECT IMMUN, V74, P5177, DOI 10.1128/IAI.00713-06; Xu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053212; Xu Q, 2007, INFECT IMMUN, V75, P4272, DOI 10.1128/IAI.00560-07; Xu QL, 2005, INFECT IMMUN, V73, P7208, DOI 10.1128/IAI.73.11.7208-7215.2005; Zhiming OY, 2008, MICROBIOL-SGM, V154, P2641, DOI 10.1099/mic.0.2008/019992-0	52	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83276	10.1371/journal.pone.0083276	http://dx.doi.org/10.1371/journal.pone.0083276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358270	Green Submitted, gold, Green Published			2022-12-27	WOS:000328735700113
J	He, MM; Zhang, DS; Wang, F; Wang, ZQ; Luo, HY; Jin, Y; Wei, XL; Xu, RH				He, Ming-ming; Zhang, Dong-sheng; Wang, Feng; Wang, Zhi-qiang; Luo, Hui-yan; Jin, Ying; Wei, Xiao-li; Xu, Rui-hua			The Role of Non-Curative Surgery in Incurable, Asymptomatic Advanced Gastric Cancer	PLOS ONE			English	Article							TRIAL COMPARING GASTRECTOMY; QUALITY-OF-LIFE; PALLIATIVE GASTRECTOMY; STAGE-IV; INTRAPERITONEAL CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; SURGICAL-TREATMENT; CENTER EXPERIENCE; SURVIVAL BENEFIT; RESECTION	Background: Although general agreement exists on palliative surgery with intent of symptom palliation in advanced gastric cancer (AGC), the role of non-curative surgery for incurable, asymptomatic AGC is hotly debated. We aim to clarify the role of non-curative surgery in patients with incurable, asymptomatic AGC under the first-line chemotherapy. Methods: A total of 737 patients with incurable, asymptomatic advanced gastric adenocarcinoma between January 2008 and May 2012 at the Sun Yat-sen University Cancer Center were retrospectively analyzed, comprising 414 patients with non-curative surgery plus first-line chemotherapy, and 323 patients with first-line chemotherapy only. The clinicopathologic data, survival, and prognosis were evaluated, with propensity score adjustment for selection bias. Results: The median overall survival (OS) outcomes significantly favored non-curative surgery group over first-line chemotherapy only group in entire population (28.00 versus 10.37 months, P = 0.000), stage 4 patients (23.87 versus 10.37 months, P = 0.000), young patients (28.70 versus 10.37 months, P = 0.000) and elderly patients (23.07 versus 10.27 months, P = 0.031). The median OS advantages of non-curative surgery over first-line chemotherapy only were also maintained when the analyses were restricted to single organ metastasis (P = 0.001), distant lymph node metastasis (P = 0.002), peritoneal metastasis (P = 0.000), and multi-organ metastasis (P = 0.010). Significant OS advantages of non-curative surgery over chemotherapy only were confirmed solid by multivariate analyses before and after adjustment on propensity score (P = 0.000). Small subsets of patients with surgery of single metastatic lesion after previous curative gastrectomy, and with surgery of both primary and single metastatic sites showed sound median OS. Conclusions: There is a role for non-curative surgery plus first-line chemotherapy for incurable, asymptomatic AGC, in terms of survival. Randomized controlled trials are warranted to fill a gap in knowledge about the value of metastectomy and patient selection strategies.	[He, Ming-ming; Zhang, Dong-sheng; Wang, Feng; Wang, Zhi-qiang; Luo, Hui-yan; Jin, Ying; Wei, Xiao-li; Xu, Rui-hua] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [He, Ming-ming; Zhang, Dong-sheng; Wang, Feng; Wang, Zhi-qiang; Luo, Hui-yan; Jin, Ying; Wei, Xiao-li; Xu, Rui-hua] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Xu, RH (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	xurh@sysucc.org.cn	xu, rui/GRX-5734-2022; 骆, 卉妍/GWR-3383-2022; Xu, Rui-Hua/AAW-4766-2021	骆, 卉妍/0000-0001-6312-9299; Xu, Rui-Hua/0000-0001-9771-8534	National High Technology Research and Development Program of China (863 Program), China [2012AA02A506]; Science and Technology Department of Guangdong Province, China [2012B031800088]; Medical Scientific Research Foundation of Guangdong Province, China [C2011019]	National High Technology Research and Development Program of China (863 Program), China(National High Technology Research and Development Program of China); Science and Technology Department of Guangdong Province, China; Medical Scientific Research Foundation of Guangdong Province, China	This study was supported by National High Technology Research and Development Program of China (863 Program), China (No. 2012AA02A506), the Science and Technology Department of Guangdong Province, China (No. 2012B031800088), and Medical Scientific Research Foundation of Guangdong Province, China (No. C2011019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Amawi Tariq, 2011, Pol Przegl Chir, V83, P449, DOI 10.2478/v10035-011-0070-0; Amaral L, 2012, HEPATO-GASTROENTEROL, V59, P1651, DOI 10.5754/hge10201; An JY, 2009, ARCH SURG-CHICAGO, V144, P38, DOI 10.1001/archsurg.2008.502; Budisin NI, 2009, J BUON, V14, P593; Chen S, 2012, J SURG ONCOL, V106, P862, DOI 10.1002/jso.23158; Chen WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068974; Cheong JH, 2007, ANN SURG ONCOL, V14, P61, DOI 10.1245/s10434-006-9205-7; Coniglio A, 2004, J SURG ONCOL, V88, P201, DOI 10.1002/jso.20153; CROOKES PF, 1995, AM J SURG, V170, P602, DOI 10.1016/S0002-9610(99)80024-5; Dittmar Y, 2009, ZBL CHIR, V134, P77, DOI 10.1055/s-0028-1098793; Dittmar Y, 2012, LANGENBECK ARCH SURG, V397, P745, DOI 10.1007/s00423-012-0902-3; Fujitani K, 2008, JPN J CLIN ONCOL, V38, P504, DOI 10.1093/jjco/hyn058; Gastinger I, 2012, CHIRURG, V83, P472, DOI 10.1007/s00104-011-2143-3; Glockzin G, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-5; Hanazaki K, 2001, HEPATO-GASTROENTEROL, V48, P285; Hansson LE, 2000, EUR J SURG, V166, P787, DOI 10.1080/110241500447425; Hartgrink HH, 2002, BRIT J SURG, V89, P1438, DOI 10.1046/j.1365-2168.2002.02220.x; Heemskerk Vincent H, 2007, World J Surg Oncol, V5, P81, DOI 10.1186/1477-7819-5-81; Huang KH, 2010, WORLD J SURG, V34, P1015, DOI 10.1007/s00268-010-0467-7; Jacquet P, 1996, Cancer Treat Res, V82, P359; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/S101209800016; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Karoui M, 2011, DIS COLON RECTUM, V54, P930, DOI 10.1097/DCR.0b013e31821cced0; Kerkar SP, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-121; Kikuchi S, 1999, HEPATO-GASTROENTEROL, V46, P584; Kikuchi S, 2000, HEPATO-GASTROENTEROL, V47, P563; Kim DY, 2008, LANGENBECK ARCH SURG, V393, P31, DOI 10.1007/s00423-007-0206-1; Ko KJ, 2012, WORLD J SURG, V36, P1800, DOI 10.1007/s00268-012-1566-4; Kunisaki C, 2005, HEPATO-GASTROENTEROL, V52, P314; Kunisaki C, 2003, ANTICANCER RES, V23, P1853; Kunisaki C, 2008, ANTICANCER RES, V28, P1309; Li C, 2010, J GASTROINTEST SURG, V14, P282, DOI 10.1007/s11605-009-1095-0; Lin SZ, 2008, J CANCER RES CLIN, V134, P187, DOI 10.1007/s00432-007-0268-z; Liu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037284; Maetani I, 2005, J GASTROENTEROL, V40, P932, DOI 10.1007/s00535-005-1651-7; Mahar AL, 2012, GASTRIC CANCER, V15, pS125, DOI 10.1007/s10120-011-0088-3; Medina-Franco H, 2004, AM J SURG, V187, P543, DOI 10.1016/j.amjsurg.2003.12.045; Miner TJ, 2004, J AM COLL SURGEONS, V198, P1013, DOI 10.1016/j.jamcollsurg.2004.02.007; MONSON JRT, 1991, CANCER, V68, P1863, DOI 10.1002/1097-0142(19911101)68:9<1863::AID-CNCR2820680902>3.0.CO;2-1; Nazli O, 2007, HEPATO-GASTROENTEROL, V54, P298; Onate-Ocana LF, 2007, GASTRIC CANCER, V10, P215, DOI 10.1007/s10120-007-0437-4; Ouchi K, 1998, J SURG ONCOL, V69, P41, DOI 10.1002/(SICI)1096-9098(199809)69:1<41::AID-JSO8>3.0.CO;2-K; Saidi RF, 2006, WORLD J SURG, V30, P21, DOI 10.1007/s00268-005-0129-3; Saito H, 2009, LANGENBECK ARCH SURG, V394, P99, DOI 10.1007/s00423-008-0398-z; Samarasam I, 2006, ANZ J SURG, V76, P60, DOI 10.1111/j.1445-2197.2006.03649.x; Shen JG, 2006, WORLD J GASTROENTERO, V12, P3883, DOI 10.3748/wjg.v12.i24.3883; Shim JH, 2012, J SURG ONCOL, V106, P753, DOI 10.1002/jso.23121; Shiraishi Norio, 2000, Gastric Cancer, V3, P211, DOI 10.1007/PL00011719; Sougioultzis S, 2011, EJSO-EUR J SURG ONC, V37, P312, DOI 10.1016/j.ejso.2011.01.019; Stupart D, 2009, S AFR J SURG, V44, P52; Sugarbaker Paul H, 2003, Semin Surg Oncol, V21, P233, DOI 10.1002/ssu.10042; Tamura Shigeyuki, 2010, Gan To Kagaku Ryoho, V37, P2279; Wagner AD, 2006, J CLIN ONCOL, V24, P2903, DOI 10.1200/JCO.2005.05.0245; Zhang XF, 2004, WORLD J GASTROENTERO, V10, P3405	55	25	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83921	10.1371/journal.pone.0083921	http://dx.doi.org/10.1371/journal.pone.0083921			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358318	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700143
J	Kohnke, M; Delon, C; Hastie, ML; Nguyen, UTT; Wu, YW; Waldmann, H; Goody, RS; Gorman, JJ; Alexandrov, K				Koehnke, Monika; Delon, Christine; Hastie, Marcus L.; Nguyen, Uyen T. T.; Wu, Yao-Wen; Waldmann, Herbert; Goody, Roger S.; Gorman, Jeffrey J.; Alexandrov, Kirill			Rab GTPase Prenylation Hierarchy and Its Potential Role in Choroideremia Disease	PLOS ONE			English	Article							QUANTITATIVE MASS-SPECTROMETRY; RETINAL-PIGMENT EPITHELIUM; GERANYLGERANYL TRANSFERASE; PROTEIN ISOPRENYLATION; ESCORT PROTEIN-1; GENE; COMPLEX; INHIBITION; EXPRESSION; PROTEOMICS	Protein prenylation is a widespread post-translational modification in eukaryotes that plays a crucial role in membrane targeting and signal transduction. RabGTPases is the largest group of post-translationally C-terminally geranylgeranylated. All Rabs are processed by Rab geranylgeranyl-transferase and Rab escort protein (REP). Human genetic defects resulting in the loss one of two REP isoforms REP-1, lead to underprenylation of RabGTPases that manifests in retinal degradation and blindness known as choroideremia. In this study we used a combination of microinjections and chemo-enzymatic tagging to establish whether Rab GTPases are prenylated and delivered to their target cellular membranes with the same rate. We demonstrate that although all tested Rab GTPases display the same rate of membrane delivery, the extent of Rab prenylation in 5 hour time window vary by more than an order of magnitude. We found that Rab27a, Rab27b, Rab38 and Rab42 display the slowest prenylation in vivo and in the cell. Our work points to possible contribution of Rab38 to the emergence of choroideremia in addition to Rab27a and Rab27b.	[Koehnke, Monika; Nguyen, Uyen T. T.; Alexandrov, Kirill] Univ Queensland, Dept Cell & Mol Biol, Inst Mol Biosci, St Lucia, Qld, Australia; [Hastie, Marcus L.; Gorman, Jeffrey J.] PO Royal Brisbane Hosp, Queensland Berghofer Med Res Inst, Herston, Qld, Australia; [Waldmann, Herbert] Max Planck Inst Mol Physiol, Dept Biol Chem, D-44139 Dortmund, Germany; [Delon, Christine; Wu, Yao-Wen; Goody, Roger S.] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44139 Dortmund, Germany	University of Queensland; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; Max Planck Society; Max Planck Society	Alexandrov, K (corresponding author), Univ Queensland, Dept Cell & Mol Biol, Inst Mol Biosci, St Lucia, Qld, Australia.	k.alexandrov@uq.edu.au	Hastie, Marcus L/L-4366-2016; Alexandrov, Kirill/A-5830-2013; Wu, Yaowen/N-9802-2015; Waldmann, Herbert/B-7406-2017; Goody, Roger S/J-8845-2014	Hastie, Marcus L/0000-0002-8386-5549; Alexandrov, Kirill/0000-0002-0957-6511; Wu, Yaowen/0000-0002-2573-8736; Waldmann, Herbert/0000-0002-9606-7247; Goody, Roger S/0000-0002-0772-0444; Delon, Christine/0000-0001-5163-1716	Australian Research Counsel [DP1094080, FT0991611]; Australian National Health and Medical Research Counsel [569652]; Bioplatforms Australia; Queensland State Government	Australian Research Counsel; Australian National Health and Medical Research Counsel; Bioplatforms Australia; Queensland State Government	This work was supported in part by Australian Research Counsel grant DP1094080, FT0991611, and Australian National Health and Medical Research Counsel project grant 569652 to KA. Access to proteomic infrastructure was funded by Bioplatforms Australia and the Queensland State Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albagli-Curiel O, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-85; ALEXANDROV K, 1994, EMBO J, V13, P5262, DOI 10.1002/j.1460-2075.1994.tb06860.x; Alexandrov K, 1999, EUR J BIOCHEM, V265, P160, DOI 10.1046/j.1432-1327.1999.00699.x; Alory C, 2001, TRAFFIC, V2, P532, DOI 10.1034/j.1600-0854.2001.20803.x; ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; Arland V, 2003, VISION RES, V43, P919, DOI 10.1016/S0042-6989(02)00389-9; ARMSTRONG SA, 1995, METHOD ENZYMOL, V257, P30; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Brooks BP, 2007, INVEST OPHTH VIS SCI, V48, P3905, DOI 10.1167/iovs.06-1464; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; CREMERS FPM, 1994, J BIOL CHEM, V269, P2111; Crick DC, 1997, BIOCHEM BIOPH RES CO, V237, P483, DOI 10.1006/bbrc.1997.7145; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Gordiyenko NV, 2010, INVEST OPHTH VIS SCI, V51, P1143, DOI 10.1167/iovs.09-4117; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kalinin A, 2001, PROTEIN EXPRES PURIF, V22, P84, DOI 10.1006/prep.2001.1423; Larijani B, 2003, J BIOL CHEM, V278, P46798, DOI 10.1074/jbc.M307799200; Lopes VS, 2007, MOL BIOL CELL, V18, P3914, DOI 10.1091/mbc.E07-03-0268; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Martin P, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-4; Nguyen UTT, 2010, CHEMBIOCHEM, V11, P1194, DOI 10.1002/cbic.200900727; Nguyen UTT, 2009, NAT CHEM BIOL, V5, P227, DOI 10.1038/nchembio.149; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Osanai K, 2010, AM J PHYSIOL-LUNG C, V298, pL243, DOI 10.1152/ajplung.00242.2009; Ostrowski SM, 2007, J BIOL CHEM, V282, P26832, DOI 10.1074/jbc.M702640200; Ownby SE, 2003, LIPIDS, V38, P751, DOI 10.1007/s11745-003-1123-8; Rak A, 2004, CELL, V117, P749, DOI 10.1016/j.cell.2004.05.017; Rak A, 2002, PROTEIN EXPRES PURIF, V25, P23, DOI 10.1006/prep.2001.1605; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SEABRA MC, 1995, J BIOL CHEM, V270, P24420, DOI 10.1074/jbc.270.41.24420; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Storrie B, 2005, METHOD ENZYMOL, V404, P26, DOI 10.1016/S0076-6879(05)04004-8; Strunnikova NV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008402; Tolmachova T, 2012, J GENE MED; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Zhu WH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840518	38	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81758	10.1371/journal.pone.0081758	http://dx.doi.org/10.1371/journal.pone.0081758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358126	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700022
J	Liang, J; Zhang, B; Shen, RW; Liu, JB; Gao, MH; Li, Y; Li, YY; Zhang, W				Liang, Jie; Zhang, Bei; Shen, Ruo-wu; Liu, Jia-Bao; Gao, Mei-hua; Li, Ying; Li, Yuan-Yuan; Zhang, Wen			Preventive Effect of Halofuginone on Concanavalin A-Induced Liver Fibrosis	PLOS ONE			English	Article							NF-KAPPA-B; HEPATIC STELLATE CELLS; MATRIX METALLOPROTEINASES; HEPATOCELLULAR-CARCINOMA; CARDIAC FIBROBLASTS; COLLAGEN-SYNTHESIS; TISSUE INHIBITORS; REL PROTEINS; INJURY; GROWTH	Halofuginone (HF) is an active component of extracts derived from the plant alkaloid febrifugine and has shown therapeutic promise in animal models of fibrotic disease. Our main objectives were to clarify the suppressive effect of HF on concanavalin A (ConA)-induced liver fibrosis. ConA injection into the tail vein caused a great increase in the serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels, while orally administration of HF significantly decreased the levels of the transaminases. In addition, the levels of hyaluronic acid (HA), procollagen III (PCIII) and TGF-beta 1 in the serum and collagen I, alpha-SMA, tissue inhibitors of metalloproteinase 2 (TIMP2) and Smad3 in the liver tissue were significantly lowered with the treatment of HF. Histological examination also demonstrated that HF significantly reduced the severity of liver fibrosis. Since ConA-induced liver fibrosis is caused by the repeated activation of T cells, immunomodulatory substances might be responsible for the suppressive effect of HF. We found that the production of nuclear factor (NF)-kB in the serum was increased in ConA-treated group, while decreased significantly with the treatment of HF. The changes of inflammatory cytokines tumor necrosis factor (TNF-alpha), IL-6 and IL-1 beta in the serum followed the same rhythm. All together, our findings indicate that orally administration HF (10ppm) would attenuate the liver fibrosis by suppressing the synthesis of collagen I and inflammation-mediated liver injury.	[Liang, Jie; Zhang, Bei; Gao, Mei-hua; Li, Ying; Li, Yuan-Yuan; Zhang, Wen] Qingdao Univ, Dept Immunol, Coll Med, Qingdao 266071, Peoples R China; [Shen, Ruo-wu] Qingdao Univ, Dept Anat, Coll Med, Qingdao 266071, Peoples R China; [Liu, Jia-Bao] Qingdao Univ, Dept Radiol, Affiliated Hosp, Qingdao 266071, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Zhang, B (corresponding author), Qingdao Univ, Dept Immunol, Coll Med, Qingdao 266071, Peoples R China.	zhangbei124@aliyun.com; shenruowu@aliyun.com	Liu, Jia-Bao/C-7850-2015; li, jia/GVT-7587-2022	Liu, Jia-Bao/0000-0002-9620-7692; 	 [81072398]		This study was supported by grant-in-aids for The National Natural Science Foundation of China (81072398). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atamas SP, 2002, LIFE SCI, V72, P631, DOI 10.1016/S0024-3205(02)02299-3; Bansal R, 2011, HEPATOLOGY, V54, P586, DOI 10.1002/hep.24395; Benchetrit S, 2007, ISR MED ASSOC J, V9, P30; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Bruck R, 2001, HEPATOLOGY, V33, P379, DOI 10.1053/jhep.2001.21408; Claria J, 2012, GUT, V61, P792, DOI 10.1136/gutjnl-2011-301968; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gu Y-Y, 2011, ZHONGGUO HAIYANG DAX, V9; Gurantz D, 2005, J MOL CELL CARDIOL, V38, P505, DOI 10.1016/j.yjmcc.2004.12.015; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Iredale JP, 1997, INT J BIOCHEM CELL B, V29, P43, DOI 10.1016/S1357-2725(96)00118-5; Itoh A, 2009, BIOL PHARM BULL, V32, P1215, DOI 10.1248/bpb.32.1215; Jagavelu K, 2010, HEPATOLOGY, V52, P590, DOI 10.1002/hep.23739; Jaruga B, 2004, AM J PHYSIOL-GASTR L, V287, pG471, DOI 10.1152/ajpgi.00018.2004; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; KOPP EB, 1995, ADV IMMUNOL, V58, P1, DOI 10.1016/S0065-2776(08)60618-5; Leiba M, 2006, J LEUKOCYTE BIOL, V80, P399, DOI 10.1189/jlb.0705409; Liu C, 2010, LAB INVEST, V90, P1805, DOI 10.1038/labinvest.2010.123; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; McGaha TL, 2002, J INVEST DERMATOL, V118, P461, DOI 10.1046/j.0022-202x.2001.01690.x; Meindl-Beinker NM, 2012, DIGEST DIS, V30, P514, DOI 10.1159/000341704; Moon SK, 2008, ACTA OTO-LARYNGOL, V128, P144, DOI 10.1080/00016480701477610; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Nakamura T, 2000, HEPATOLOGY, V32, P247, DOI 10.1053/jhep.2000.9109; Nelson EF, 2012, MOL VIS, V18, P479; Nguyen-Pouplin J, 2007, J ETHNOPHARMACOL, V109, P417, DOI 10.1016/j.jep.2006.08.011; Park SY, 2010, J KOREAN MED SCI, V25, P570, DOI 10.3346/jkms.2010.25.4.570; Perepelyuk M, 2013, AM J PHYSIOL-GASTR L, V304, pG605, DOI 10.1152/ajpgi.00222.2012; Pines A, 2003, BIOL BLOOD MARROW TR, V9, P417, DOI 10.1016/S1083-8791(03)00151-4; Pines M, 1997, J HEPATOL, V27, P391, DOI 10.1016/S0168-8278(97)80186-9; Pines M, 1998, GEN PHARMACOL, V30, P445, DOI 10.1016/S0306-3623(97)00307-8; Ren ZH, 2012, INT IMMUNOPHARMACOL, V14, P698, DOI 10.1016/j.intimp.2012.10.008; Richard S, 2000, RHEUMATOLOGY, V39, P50, DOI 10.1093/rheumatology/39.1.50; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Shahar I, 1996, CLIN IMMUNOL IMMUNOP, V79, P244, DOI 10.1006/clin.1996.0075; Siwik DA, 2000, CIRC RES, V86, P1259, DOI 10.1161/01.RES.86.12.1259; Sun B, 2008, ONCOGENE, V27, P6228, DOI 10.1038/onc.2008.300; Thabut D, 2011, HEPATOLOGY, V54, P573, DOI 10.1002/hep.24427; Tiegs G, 2010, J AUTOIMMUN, V34, P1, DOI 10.1016/j.jaut.2009.08.008; Venugopal SK, 2010, AM J PHYSIOL-GASTR L, V298, pG101, DOI 10.1152/ajpgi.00220.2009; Wang C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070725, 10.1371/journal.pone.0060462, 10.1371/journal.pone.0077273, 10.1371/journal.pone.0081882]; Watanabe A, 2006, BIOL PHARM BULL, V29, P1651, DOI 10.1248/bpb.29.1651; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xavier S, 2004, J BIOL CHEM, V279, P15167, DOI 10.1074/jbc.M309798200; Xia YZ, 2013, EUR J PHARMACOL, V714, P105, DOI 10.1016/j.ejphar.2013.06.012; Yin MingShi, 2012, African Journal of Pharmacy and Pharmacology, V6, P2870	51	24	28	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82232	10.1371/journal.pone.0082232	http://dx.doi.org/10.1371/journal.pone.0082232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358159	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700048
J	Rahnama, L; Aris-Brosou, S				Rahnama, Leila; Aris-Brosou, Stephane			Phylodynamics of the Emergence of Influenza Viruses after Cross-Species Transmission	PLOS ONE			English	Article							CODON USAGE BIAS; A VIRUS; MAXIMUM-LIKELIHOOD; POSITIVE SELECTION; NUCLEAR EXPORT; EVOLUTION; PROTEIN; HOST; ORIGIN; PHYLOGENIES	Human populations are constantly exposed to emerging pathogens such as influenza A viruses that result from cross-species transmissions. Generally these sporadic events are evolutionary dead-ends, but occasionally, viruses establish themselves in a new host that offers a novel genomic context to which the virus must adjust to avoid attenuation. However, the dynamics of this process are unknown. Here we present a novel method to characterize the time it takes to G+C composition at third codon positions (GC3 content) of influenza viruses to adjust to that of a new host. We compare the inferred dynamics in two subtypes, H1N1 and H3N2, based on complete genomes of viruses circulating in humans, swine and birds between 1900-2009. Our results suggest that both subtypes have the same fast-adjusting genes, which are not necessarily those with the highest absolute rates of evolution, but those with the most relaxed selective pressures. Our analyses reveal that NA and NS2 genes adjust the fastest to a new host and that selective pressures of H3N2 viruses are relaxed faster than for H1N1. The asymmetric nature of these processes suggests that viruses with the greatest adjustment potential to humans are coming from both birds and swine for H3N2, but only from birds for H1N1.	[Rahnama, Leila; Aris-Brosou, Stephane] Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON, Canada; [Aris-Brosou, Stephane] Univ Ottawa, Dept Math & Stat, Ottawa, ON, Canada	University of Ottawa; University of Ottawa	Aris-Brosou, S (corresponding author), Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON, Canada.	sarisbro@uottawa.ca		Aris-Brosou, Stephane/0000-0003-4987-0296	Natural Sciences Research Council of Canada; Canada Foundation for Innovation	Natural Sciences Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was funded by the Natural Sciences Research Council of Canada (S.A.B.) and by the Canada Foundation for Innovation (S.A.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdussamad J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-6; Aris-Brosou S, 2010, LECT N BIOINFORMAT, V6398, P149, DOI 10.1007/978-3-642-16181-0_13; Aris-Brosou S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000879; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bastien N, 2010, J INFECT DIS, V201, P1178, DOI 10.1086/651507; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; dos Reis M, 2011, MOL BIOL EVOL, V28, P1755, DOI 10.1093/molbev/msq317; dos Reis M, 2009, J MOL EVOL, V69, P333, DOI 10.1007/s00239-009-9282-x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Huelsenbeck JP, 2002, SYST BIOL, V51, P32, DOI 10.1080/106351502753475862; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X; Kawada J, 2006, J GEN VIROL, V87, P1677, DOI 10.1099/vir.0.81670-0; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Kosakovsky Pond SL, 2011, MOL BIOL EVOL; Kryazhimskiy S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001301; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Lucks JB, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000001; McInerney JO, 1998, BIOINFORMATICS, V14, P372, DOI 10.1093/bioinformatics/14.4.372; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Neumann G, 2000, EMBO J, V19, P6751, DOI 10.1093/emboj/19.24.6751; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Paradis E, 2006, ANAL PHYLOGENETICS E; Plotkin SA, 2009, CLIN VACCINE IMMUNOL, V16, P1709, DOI 10.1128/CVI.00290-09; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rambaut A, 2000, BIOINFORMATICS, V16, P395, DOI 10.1093/bioinformatics/16.4.395; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Samji Tasleem, 2009, Yale Journal of Biology and Medicine, V82, P153; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Simonsen L, 2007, MOL BIOL EVOL, V24, P1811, DOI 10.1093/molbev/msm103; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Taubenberger JK, 1997, SCIENCE, V275, P1793, DOI 10.1126/science.275.5307.1793; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Vijaykrishna D, 2011, NATURE, V473, P519, DOI 10.1038/nature10004; Wertheim JO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011184; Wise HM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002998; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YOHAI VJ, 1987, ANN STAT, V15, P642, DOI 10.1214/aos/1176350366; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; ZUCKERKANDL EMILE, 1965, P97	63	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82486	10.1371/journal.pone.0082486	http://dx.doi.org/10.1371/journal.pone.0082486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358190	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700070
J	Zheng, WJ; Ma, L; Zhao, JM; Li, ZQ; Sun, FY; Lu, XC				Zheng, Wenjing; Ma, Li; Zhao, Jiaming; Li, Zhiqiang; Sun, Fuyu; Lu, Xiaochun			Comparative Transcriptome Analysis of Two Rice Varieties in Response to Rice Stripe Virus and Small Brown Planthoppers during Early Interaction	PLOS ONE			English	Article							JASMONIC ACID; DISEASE RESISTANCE; GENE-EXPRESSION; SALICYLIC-ACID; RNA-SEQ; TOBACCO; PEROXIDASE; TOOL; LIGNIFICATION; ARABIDOPSIS	Rice stripe, a virus disease, transmitted by a small brown planthopper (SBPH), has greatly reduced production of japonica rice in East Asia, especially in China. Although we have made great progress in mapping resistance genes, little is known about the mechanism of resistance. By de novo transcriptome assembling, we gained sufficient transcript data to analyze changes in gene expression of early interaction in response to SBPH and RSV infection in rice. Respectively 648 and 937 DEGs were detected from the disease-resistant (Liaonong 979) and the susceptible (Fengjin) varieties, most of which were up-regulated. We found 37 genes related to insect resistance, which mainly included genes for jasmonate-induced protein, TIFY protein, lipoxygenase, as well as trypsin inhibitor genes and transcription factor genes. In the interaction process between RSV and rice, 87 genes were thought to be related to RSV resistance; these primarily included 12 peroxidase biosynthesis genes, 12 LRR receptor-like protein kinase genes, 6 genes coding pathogenesis-related proteins, 4 glycine-rich cell wall structural protein genes, 2 xyloglucan hydrolase genes and a cellulose synthase. The results indicate that the rice-pathogen interaction happened both in disease-resistant and susceptible varieties, and some genes related to JA biosynthesis played key roles in the interaction between SBPHs and rice. When rice was infected by RSV a hypersensitive reaction (HR) in the disease-resistant variety was suppressed, which resulted from an increase in peroxidase expression and down-regulation of LRR receptor-like protein kinase and pathogenesis-related proteins, while, the changes of peroxidase biosynthesis, glycine-rich cell wall structural protein, cellulose synthase and xyloglucan endotransglucosylase/hydrolase could lead to the strengthening of physical barriers of rice, which may be an important resistance mechanism to RSV in rice.	[Zheng, Wenjing; Zhao, Jiaming; Lu, Xiaochun] Acad Agr Sci, Liaoning Innovat Ctr, Shenyang, Peoples R China; [Ma, Li] Shenyang Agr Univ, Plant Protect Coll, Shenyang 110161, Peoples R China; [Li, Zhiqiang; Sun, Fuyu] Acad Agr Sci, Liaoning Plant Protect Inst, Shenyang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Shenyang Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Sun, FY (corresponding author), Acad Agr Sci, Liaoning Plant Protect Inst, Shenyang, Peoples R China.	lnsfy@yahoo.com.cn; luxiaoc@yahoo.com.cn	Zheng, Wenjing/ABD-2105-2020		Liaoning provincial natural science fund [201202105]; Liaoning important technology developing program in China [2011208001]; special scientific research fund of agriculture public welfare profession of China [201003031]; National Natural Science Fund in China [C140104]	Liaoning provincial natural science fund; Liaoning important technology developing program in China; special scientific research fund of agriculture public welfare profession of China; National Natural Science Fund in China(National Natural Science Foundation of China (NSFC))	This work was supported by Liaoning provincial natural science fund (201202105), Liaoning important technology developing program in China(2011208001), the special scientific research fund of agriculture public welfare profession of China(201003031) and the National Natural Science Fund in China(C140104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BOWLES DJ, 1990, ANNU REV BIOCHEM, V59, P873, DOI 10.1146/annurev.bi.59.070190.004301; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CONTI GG, 1990, J PHYTOPATHOL, V128, P191, DOI 10.1111/j.1439-0434.1990.tb04265.x; CREELMAN RA, 1995, P NATL ACAD SCI USA, V92, P4114, DOI 10.1073/pnas.92.10.4114; FARMER EE, 1992, PLANT PHYSIOL, V98, P995, DOI 10.1104/pp.98.3.995; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hao ZN, 2011, PLANT PHYSIOL BIOCH, V49, P744, DOI 10.1016/j.plaphy.2011.01.014; Hayano-Saito Y, 2000, THEOR APPL GENET, V101, P59, DOI 10.1007/s001220051449; Iglesias VA, 2000, PLANT J, V21, P157, DOI 10.1046/j.1365-313x.2000.00658.x; Ishihara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046763; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KISO A, 1973, Review of Plant Protection Research, V6, P75; Kollarova Renata, 2013, Ceska Slov Farm, V62, P59; Kristensen BK, 1997, PLANT SCI, V122, P173, DOI 10.1016/S0168-9452(96)04554-2; KURIBAYASHI K., 1931, Journal of Plant Protection, V18, P565; Kuribayashi K., 1931, J PLANT PROT, V18, P636; Li Q, 2006, MOL PLANT MICROBE IN, V19, P655, DOI 10.1094/MPMI-19-0655; Li Z-Q, 2012, LIAONING AGR SCI, V6, P16; Lu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043447; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Satoh K, 2010, J GEN VIROL, V91, P294, DOI 10.1099/vir.0.015990-0; Savory EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035796; Shirasu K, 2000, PLANT MOL BIOL, V44, P371, DOI 10.1023/A:1026552827716; Staswick PE, 2008, TRENDS PLANT SCI, V13, P66, DOI 10.1016/j.tplants.2007.11.011; Sun DZ, 2006, CHIN AGR SCI B, V22, P318; Sun LJ, 2010, MOL PLANT MICROBE IN, V23, P1470, DOI 10.1094/MPMI-01-10-0029; Toriyama S, 1983, DESCRIPTION PLANT VI, V269, P15; VANCE CP, 1980, ANNU REV PHYTOPATHOL, V18, P259, DOI 10.1146/annurev.py.18.090180.001355; Wang Q, 2013, INT J MOL SCI, V14, P8406, DOI 10.3390/ijms14048406; YE XS, 1990, PHYTOPATHOLOGY, V80, P1295, DOI 10.1094/Phyto-80-1295; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zhang CZ, 2007, PHYTOPATHOLOGY, V155, P431; Zhang F, 2004, J PLANT PHYSIOL, V161, P53, DOI 10.1078/0176-1617-01179; Zhang YX, 2011, THEOR APPL GENET, V122, P1591, DOI 10.1007/s00122-011-1557-0; Zhang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045953	40	41	41	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82126	10.1371/journal.pone.0082126	http://dx.doi.org/10.1371/journal.pone.0082126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358146	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700036
J	Martirosyan, A; Von Bargen, K; Gorvel, VA; Zhao, WD; Hanniffy, S; Bonnardel, J; Meresse, S; Gorvel, JP				Martirosyan, Anna; Von Bargen, Kristine; Gorvel, Vilma Arce; Zhao, Weidong; Hanniffy, Sean; Bonnardel, Johnny; Meresse, Stephane; Gorvel, Jean-Pierre			In Vivo Identification and Characterization of CD4(+) Cytotoxic T Cells Induced by Virulent Brucella abortus Infection	PLOS ONE			English	Article							B-CELL; GAMMA-INTERFERON; LYMPHOCYTES; RESPONSES; IMMUNITY	CD4(+) T cells display a variety of helper functions necessary for an efficient adaptive immune response against bacterial invaders. This work reports the in vivo identification and characterization of murine cytotoxic CD4(+) T cells (CD4(+) CTL) during Brucella abortus infection. These CD4(+) CTLs express granzyme B and exhibit immunophenotypic features consistent with fully differentiated T cells. They express CD25, CD44, CD62L, CD43 molecules at their surface and produce IFN-gamma. Moreover, these cells express neither the co-stimulatory molecule CD27 nor the memory T cell marker CD127. We show here that CD4(+) CTLs are capable of cytolytic action against Brucella-infected antigen presenting cells (APC) but not against Mycobacterium-infected APC. Cytotoxic CD4(+) T cell population appears at early stages of the infection concomitantly with high levels of IFN-gamma and granzyme B expression. CD4(+) CTLs represent a so far uncharacterized immune cell sub-type triggered by early immune responses upon Brucella abortus infection.	[Martirosyan, Anna; Von Bargen, Kristine; Gorvel, Vilma Arce; Zhao, Weidong; Hanniffy, Sean; Bonnardel, Johnny; Meresse, Stephane; Gorvel, Jean-Pierre] Aix Marseille Univ, CIML, F-13288 Marseille, France; [Martirosyan, Anna; Von Bargen, Kristine; Gorvel, Vilma Arce; Zhao, Weidong; Hanniffy, Sean; Bonnardel, Johnny; Meresse, Stephane; Gorvel, Jean-Pierre] CNRS, UMR 7280, F-13288 Marseille, France; [Martirosyan, Anna; Von Bargen, Kristine; Gorvel, Vilma Arce; Zhao, Weidong; Hanniffy, Sean; Bonnardel, Johnny; Meresse, Stephane; Gorvel, Jean-Pierre] INSERM, U631, F-13288 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Gorvel, JP (corresponding author), Aix Marseille Univ, CIML, F-13288 Marseille, France.	gorvel@ciml.univ-mrs.fr	Meresse, Stephane/E-2192-2012; Gorvel, Jean-Pierre/O-1332-2018	Meresse, Stephane/0000-0001-6578-5177; Gorvel, Jean-Pierre/0000-0002-2829-9804; Bonnardel, Johnny/0000-0003-2359-3438; Arce-Gorvel, Vilma/0000-0003-0090-837X	Centre National de la Recherche Scientifique and Institut National de la Sante et de la Recherche Medicale, France; Foundation de la Recherche Medicale, FRM, France	Centre National de la Recherche Scientifique and Institut National de la Sante et de la Recherche Medicale, France; Foundation de la Recherche Medicale, FRM, France	This work was supported by the Centre National de la Recherche Scientifique and Institut National de la Sante et de la Recherche Medicale, France. AM was a recipient of the Foundation de la Recherche Medicale, FRM, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 1997, IMMUNOL TODAY, V18, P387, DOI 10.1016/S0167-5699(97)01102-X; Appay V, 2004, CLIN EXP IMMUNOL, V138, P10, DOI 10.1111/j.1365-2249.2004.02605.x; Appay V, 2002, J IMMUNOL, V168, P5954, DOI 10.4049/jimmunol.168.11.5954; Atluri VL, 2011, ANNU REV MICROBIOL, V65, P523, DOI 10.1146/annurev-micro-090110-102905; Baldwin CL, 2006, CRIT REV IMMUNOL, V26, P407, DOI 10.1615/CritRevImmunol.v26.i5.30; Bessoles S, 2011, EUR J IMMUNOL, V41, P1619, DOI 10.1002/eji.201041230; Brown DM, 2012, J VIROL, V86, P6792, DOI 10.1128/JVI.07172-11; Cannella AP, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00001; de Berg PJV, 2008, CURR OPIN IMMUNOL, V20, P339, DOI 10.1016/j.coi.2008.03.007; Durward M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034925; Fang M, 2012, P NATL ACAD SCI USA, V109, P9983, DOI 10.1073/pnas.1202143109; FLEISCHER B, 1984, NATURE, V308, P365, DOI 10.1038/308365a0; Glimcher LH, 2000, GENE DEV, V14, P1693; Goenka R, 2011, J INFECT DIS, V203, P1136, DOI 10.1093/infdis/jiq171; Grillo MJ, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-29; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; He YQ, 2001, INFECT IMMUN, V69, P5502, DOI 10.1128/IAI.69.9.5502-5508.2001; Hori S, 2003, ADV IMMUNOL, V81, P331, DOI 10.1016/S0065-2776(03)81008-8; HUANG Z, 1992, J VIROL, V66, P2664, DOI 10.1128/JVI.66.5.2664-2669.1992; Jellison ER, 2005, J IMMUNOL, V174, P614, DOI 10.4049/jimmunol.174.2.614; KRENSKY AM, 1982, J IMMUNOL, V129, P2001; MAHON BP, 1995, J EXP MED, V181, P1285, DOI 10.1084/jem.181.4.1285; Martirosyan A, 2013, FUTURE MICROBIOL, V8, P147, DOI [10.2217/FMB.12.140, 10.2217/fmb.12.140]; Martirosyan A, 2011, IMMUNOL REV, V240, P211, DOI 10.1111/j.1600-065X.2010.00982.x; Martorelli D, 2010, INT REV IMMUNOL, V29, P371, DOI 10.3109/08830185.2010.489658; Murphy EA, 2001, IMMUNOLOGY, V103, P511, DOI 10.1046/j.1365-2567.2001.01258.x; Namekawa T, 1998, ARTHRITIS RHEUM, V41, P2108; Omiya R, 2002, J IMMUNOL, V169, P2172, DOI 10.4049/jimmunol.169.4.2172; Porakishvili N, 2004, HAEMATOLOGICA, V89, P435; Skyberg JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021978; Soghoian DZ, 2010, EXPERT REV VACCINES, V9, P1453, DOI 10.1586/ERV.10.132; Stuller KA, 2009, J VIROL, V83, P4700, DOI 10.1128/JVI.02240-08; Suni MA, 2001, EUR J IMMUNOL, V31, P2512, DOI 10.1002/1521-4141(200108)31:8<2512::AID-IMMU2512>3.0.CO;2-M; Vitry MA, 2012, INFECT IMMUN, V80, P4271, DOI 10.1128/IAI.00761-12; Yue FY, 2004, J IMMUNOL, V172, P2476, DOI 10.4049/jimmunol.172.4.2476; Zaunders JJ, 2004, BLOOD, V103, P2238, DOI 10.1182/blood-2003-08-2765	36	14	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82508	10.1371/journal.pone.0082508	http://dx.doi.org/10.1371/journal.pone.0082508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367519	gold, Green Published, Green Submitted			2022-12-27	WOS:000328741900009
J	Wu, H; Zeng, H; Dong, AP; Li, FL; He, H; Senisterra, G; Seitova, A; Duan, S; Brown, PJ; Vedadi, M; Arrowsmith, CH; Schapira, M				Wu, Hong; Zeng, Hong; Dong, Aiping; Li, Fengling; He, Hao; Senisterra, Guillermo; Seitova, Alma; Duan, Shili; Brown, Peter J.; Vedadi, Masoud; Arrowsmith, Cheryl H.; Schapira, Matthieu			Structure of the Catalytic Domain of EZH2 Reveals Conformational Plasticity in Cofactor and Substrate Binding Sites and Explains Oncogenic Mutations	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE EZH2; LYSINE 27; FUNCTIONAL-ANALYSIS; BREAST-CANCER; H3; METHYLATION; SPECIFICITY; INHIBITION; MECHANISM; LYMPHOMA	Polycomb repressive complex 2 (PRC2) is an important regulator of cellular differentiation and cell type identity. Overexpression or activating mutations of EZH2, the catalytic component of the PRC2 complex, are linked to hyper-trimethylation of lysine 27 of histone H3 (H3K27me3) in many cancers. Potent EZH2 inhibitors that reduce levels of H3K27me3 kill mutant lymphoma cells and are efficacious in a mouse xenograft model of malignant rhabdoid tumors. Unlike most SET domain methyltransferases, EZH2 requires PRC2 components, SUZ12 and EED, for activity, but the mechanism by which catalysis is promoted in the PRC2 complex is unknown. We solved the 2.0 angstrom crystal structure of the EZH2 methyltransferase domain revealing that most of the canonical structural features of SET domain methyltransferase structures are conserved. The site of methyl transfer is in a catalytically competent state, and the structure clarifies the structural mechanism underlying oncogenic hyper-trimethylation of H3K27 in tumors harboring mutations at Y641 or A677. On the other hand, the I-SET and post-SET domains occupy atypical positions relative to the core SET domain resulting in incomplete formation of the cofactor binding site and occlusion of the substrate binding groove. A novel CXC domain N-terminal to the SET domain may contribute to the apparent inactive conformation. We propose that protein interactions within the PRC2 complex modulate the trajectory of the post-SET and I-SET domains of EZH2 in favor of a catalytically competent conformation.	[Wu, Hong; Zeng, Hong; Dong, Aiping; Li, Fengling; He, Hao; Senisterra, Guillermo; Seitova, Alma; Brown, Peter J.; Vedadi, Masoud; Arrowsmith, Cheryl H.; Schapira, Matthieu] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Vedadi, Masoud; Schapira, Matthieu] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Arrowsmith, CH (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	carrow@uhnresearch.ca; matthieu.schapira@utoronto.ca		Arrowsmith, Cheryl/0000-0002-4971-3250; Brown, Peter/0000-0002-8454-0367	AbbVie; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research, Genome Canada through Ontario Genomics Institute [OGI-055]; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry Research and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]	AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research, Genome Canada through Ontario Genomics Institute; GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry Research and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission)	The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada through the Ontario Genomics Institute [OGI-055], GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry Research and Innovation, Pfizer, Takeda, and the Wellcome Trust [092809/Z/10/Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campagna-Slater V, 2011, J CHEM INF MODEL, V51, P612, DOI 10.1021/ci100479z; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chang YQ, 2011, NUCLEIC ACIDS RES, V39, P6380, DOI 10.1093/nar/gkr256; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Ciferri C, 2012, ELIFE, V1, DOI 10.7554/eLife.00005; Copeland RA, 2013, CLIN CANCER RES, V19, P6344, DOI 10.1158/1078-0432.CCR-13-0223; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Joshi P, 2008, J BIOL CHEM, V283, P27757, DOI 10.1074/jbc.M804442200; Kim W, 2013, NAT CHEM BIOL, V9, P643, DOI [10.1038/NCHEMBIO.1331, 10.1038/nchembio.1331]; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Konze KD, 2013, ACS CHEM BIOL; Kunju LP, 2011, MODERN PATHOL, V24, P786, DOI 10.1038/modpathol.2011.8; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Kwon T, 2003, EMBO J, V22, P292, DOI 10.1093/emboj/cdg025; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Qiao Q, 2011, J BIOL CHEM, V286, P8361, DOI 10.1074/jbc.M110.204115; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schapira Matthieu, 2011, Curr Chem Genomics, V5, P85, DOI 10.2174/1875397301005010085; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Swalm BM, 2013, BIOCHEM J, V453, P241, DOI 10.1042/BJ20130439; Takawa M, 2011, CANCER SCI, V102, P1298, DOI 10.1111/j.1349-7006.2011.01958.x; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Wagener N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-524; Wang L, 2011, J BIOL CHEM, V286, P38725, DOI 10.1074/jbc.M111.262410; Wang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061341; Wigle TJ, 2011, FEBS LETT, V585, P3011, DOI 10.1016/j.febslet.2011.08.018; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Wu H, 2013, CELL REP, V5, P13, DOI 10.1016/j.celrep.2013.08.035; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Yamamoto K, 2004, J BIOL CHEM, V279, P401, DOI 10.1074/jbc.M307344200; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Zheng WH, 2012, J AM CHEM SOC, V134, P18004, DOI 10.1021/ja307060p	60	90	94	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e83737	10.1371/journal.pone.0083737	http://dx.doi.org/10.1371/journal.pone.0083737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367611	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900021
J	Al-Khulaidi, GA; Nakamura, K; Seino, K; Kizuki, M				Al-Khulaidi, Ghadah Abdulmajid; Nakamura, Keiko; Seino, Kaoruko; Kizuki, Masashi			Decline of Supportive Attitudes among Husbands toward Female Genital Mutilation and Its Association to Those Practices in Yemen	PLOS ONE			English	Article							REPRODUCTIVE HEALTH	Objectives: To elucidate the attitudes of women and their husband's towards female genital mutilation (FGM) and their associations with the continuation of FGM upon their daughters. Methods: Subjects were 10,345 (in 1997) and 11,252 (in 2003) ever married women aged 15 to 49 years from the Yemen Demographic Health Surveys. Performances of FGM on the most-recently-born daughters were investigated. Attitudes of women and their husbands were assessed by their opinions on the continuation of FGM. The association between the attitudes of women and their husbands and performance of FGM on the most-recently-born daughters were investigated after adjusting for age and education of the women. Findings: The percentage among the most-recently-born daughters who received FGM of women who had undergone FGM declined from 61.9% in 1997 to 56.5% in 2003 (p<0.001). The percentages of women who had undergone FGM and who supported the continuation of FGM and of husbands who also supported its continuation decreased from 78.2% and 60.1% in 1997 to 70.9% and 49.5% in 2003, respectively (both p<0.001). When the women or the husbands did not agree with FGM, it was less likely to be performed on their daughter than when the women or the husbands agreed in 1997 (odds ratio=0.11, 95% confidence interval 0.07-0.16 and odds ratio=0.07, 95% confidence interval 0.04-0.12, respectively) and in 2003 (odds ratio=0.12, 95% confidence interval 0.09-0.16 and odds ratio=0.11, 95% confidence interval 0.07-0.16, respectively). Conclusion: Non-supportive attitudes of women and their husbands towards the continuation of FGM have become common and were associated with their decision not to perform FGM upon their daughters.	[Al-Khulaidi, Ghadah Abdulmajid; Nakamura, Keiko; Seino, Kaoruko] Tokyo Med & Dent Univ, Dept Int Hlth & Med, Div Publ Hlth, Grad Sch, Tokyo, Japan; [Kizuki, Masashi] Tokyo Med & Dent Univ, Dept Hlth Promot, Div Publ Hlth, Grad Sch, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Nakamura, K (corresponding author), Tokyo Med & Dent Univ, Dept Int Hlth & Med, Div Publ Hlth, Grad Sch, Tokyo, Japan.	nakamura.ith@tmd.ac.jp		Seino, Kaoruko/0000-0003-3145-6396; Nakamura, Keiko/0000-0002-9119-4730	Yemen Central Statistical Organisation/Ministry of Planning & International Cooperation, Ministry of Public Health and Population and Yemen Safe Motherhood Alliance	Yemen Central Statistical Organisation/Ministry of Planning & International Cooperation, Ministry of Public Health and Population and Yemen Safe Motherhood Alliance	We would like to thank Yemen Central Statistical Organisation/Ministry of Planning & International Cooperation, Ministry of Public Health and Population and Yemen Safe Motherhood Alliance for the support and usage of DHS row data. The authors also would like to thank Dr. Nagiba Al-Shawafi for support and information related to Yemen.	Al-Shawafi N, 1999, CLIN BAS INV FEM GEN; Ali AS, 2010, ROLE POLICYMAKERS EN; Aven J, 2011, NURSING STUDENTS KNO; Cook R, 2010, REPROD HLTH HUMAN RI, P262; DeJong J, 2005, REPROD HEALTH MATTER, V13, P49, DOI 10.1016/S0968-8080(05)25181-9; Fgmnetwork, 2007, YEMEN 24 PERC YEM WO; FORWARD, 2007, FEM GEN MUT FGM; Lhbsu L, 2009, FEMALE GENITAL MUTIL; Maja TMM, 2006, MENS INVOLEMENT PROM; Mohammadi G, 2011, INT J WOMENS HEALTH, V3, P399, DOI 10.2147/IJWH.S26623; Moore Kirsten, 1997, Health Hum Rights, V2, P137; Pashael T., 2012, J WOMENS HLTH CARE, V1, DOI [10.4172/2167-0420.1000108, DOI 10.4172/2167-0420.1000108]; Payne S, 2008, HLTH MEN WOMEN, P22; Rahman A, 2000, FEMALE GENITAL MUTIL, P5; UN United Nations Department of Public Information, 1995, INT C POP DEV ICPD S; United Nation Millennium Project, 2002, PIL COUNTR INP; United Nation Population Fund, 2009, TECHNICAL REPORT, P112; United Nation: Women watch, 2010, COUNT ASS VIOL WOM C; United Nations Children's Fund, 2013, FEM GEN MUT CUTT STA; United Nations Children's Fund, 2005, FEM GEN MUT CUTT STA; United Nations Population Funds, 2007, HOL APPR AB FEM GEN; United States Agency for International Development, 2008, NUMB WOM CIRC AFR PR; Vuttanont U, 2006, LANCET, V368, P2068, DOI 10.1016/S0140-6736(06)69836-X; Wegner MN, 1998, INT FAM PLAN PERSPEC, V24, P38, DOI 10.2307/2991918; World Health Organisation, 2006, FEM GEN MUT NEW KNOW; World Health Organization, 2008, EL FEM GEN MUT INT S; World Health Organization, 2010, GLOB STRAT STOP HLTH; Yemen Central Statistical Organisation, 1997, YEM DEM HLTH SURV RE	28	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83140	10.1371/journal.pone.0083140	http://dx.doi.org/10.1371/journal.pone.0083140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367582	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300093
J	Burghel, GJ; Lin, WY; Whitehouse, H; Brock, I; Hammond, D; Bury, J; Stephenson, Y; George, R; Cox, A				Burghel, George J.; Lin, Wei-Yu; Whitehouse, Helen; Brock, Ian; Hammond, David; Bury, Jonathan; Stephenson, Yvonne; George, Rina; Cox, Angela			Identification of Candidate Driver Genes in Common Focal Chromosomal Aberrations of Microsatellite Stable Colorectal Cancer	PLOS ONE			English	Article							INTEGRATED ANALYSIS; TUMOR-SUPPRESSOR; KCNMA1 GENE; MUTATIONS; INSTABILITY; AMPLIFICATION; PROGRESSION; ADENOMA; BREAST; CLASSIFICATION	Colorectal cancer (CRC) is a leading cause of cancer deaths worldwide. Chromosomal instability (CIN) is a major driving force of microsatellite stable (MSS) sporadic CRC. CIN tumours are characterised by a large number of somatic chromosomal copy number aberrations (SCNA) that frequently affect oncogenes and tumour suppressor genes. The main aim of this work was to identify novel candidate CRC driver genes affected by recurrent and focal SCNA. High resolution genome-wide comparative genome hybridisation (CGH) arrays were used to compare tumour and normal DNA for 53 sporadic CRC cases. Context corrected common aberration (COCA) analysis and custom algorithms identified 64 deletions and 32 gains of focal minimal common regions (FMCR) at high frequency (>10%). Comparison of these FMCR with published genomic profiles from CRC revealed common overlap (42.2% of deletions and 34.4% of copy gains). Pathway analysis showed that apoptosis and p53 signalling pathways were commonly affected by deleted FMCR, and MAPK and potassium channel pathways by gains of FMCR. Candidate tumour suppressor genes in deleted FMCR included RASSF3, IFNAR1, IFNAR2 and NFKBIA and candidate oncogenes in gained FMCR included PRDM16, TNS1, RPA3 and KCNMA1. In conclusion, this study confirms some previously identified aberrations in MSS CRC and provides in silico evidence for some novel candidate driver genes.	[Burghel, George J.; Lin, Wei-Yu; Whitehouse, Helen; Brock, Ian; George, Rina; Cox, Angela] Univ Sheffield, Canc Res UK Yorkshire Canc Res Sheffield Canc Res, Inst Canc Studies, Dept Oncol, Sheffield, S Yorkshire, England; [Hammond, David] Univ Sheffield, Canc Res UK Yorkshire Canc Res Sheffield Canc Res, Acad Unit Surg Oncol, Dept Oncol, Sheffield, S Yorkshire, England; [Bury, Jonathan] Univ Sheffield, Canc Res UK Yorkshire Canc Res Sheffield Canc Res, Dept Histopathol, Sheffield Teaching Hosp Fdn Trust, Sheffield, S Yorkshire, England; [Stephenson, Yvonne] Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield	Burghel, GJ (corresponding author), Univ Sheffield, Canc Res UK Yorkshire Canc Res Sheffield Canc Res, Inst Canc Studies, Dept Oncol, Sheffield, S Yorkshire, England.	g.burghel@leeds.ac.uk	Lin, Wei-Yu/F-4505-2010	Lin, Wei-Yu/0000-0002-9267-7988; Cox, Angela/0000-0002-5138-1099	University of Sheffield (Faculty of Medicine Dentistry and Health) PhD scholarship; Research and Innovation award; Yorkshire Cancer Research PhD studentship [S003PHD]	University of Sheffield (Faculty of Medicine Dentistry and Health) PhD scholarship; Research and Innovation award; Yorkshire Cancer Research PhD studentship	This work was supported by a University of Sheffield (Faculty of Medicine Dentistry and Health) PhD scholarship, and Research and Innovation award, and a Yorkshire Cancer Research PhD studentship (S003PHD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2011, INT J CANCER, V129, P1848, DOI 10.1002/ijc.25841; Beroud C, 1996, NUCLEIC ACIDS RES, V24, P121, DOI 10.1093/nar/24.1.121; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; Bonfield JK, 1998, NUCLEIC ACIDS RES, V26, P3404, DOI 10.1093/nar/26.14.3404; Bredel M, 2011, NEW ENGL J MED, V364, P627, DOI 10.1056/NEJMoa1006312; Brink M, 2003, CARCINOGENESIS, V24, P703, DOI 10.1093/carcin/bgg009; Brosens RPM, 2010, J PATHOL, V221, P411, DOI 10.1002/path.2724; Cabannes E, 1999, ONCOGENE, V18, P3063, DOI 10.1038/sj.onc.1202893; Carvalho B, 2009, GUT, V58, P79, DOI 10.1136/gut.2007.143065; Chen HY, 2002, P NATL ACAD SCI USA, V99, P733, DOI 10.1073/pnas.022518699; Cheng YW, 2008, CLIN CANCER RES, V14, P6005, DOI 10.1158/1078-0432.CCR-08-0216; Derks S, 2008, CARCINOGENESIS, V29, P434, DOI 10.1093/carcin/bgm270; Diep CB, 2006, GENE CHROMOSOME CANC, V45, P31, DOI 10.1002/gcc.20261; Dyrso T, 2011, CANCER GENET-NY, V204, P84, DOI 10.1016/j.cancergencyto.2010.08.019; Hermsen M, 2002, GASTROENTEROLOGY, V123, P1109, DOI 10.1053/gast.2002.36051; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Issa JP, 2008, CLIN CANCER RES, V14, P5939, DOI 10.1158/1078-0432.CCR-08-1596; Jacquemart IC, 2009, INT J ONCOL, V34, P517, DOI 10.3892/ijo_00000177; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kabbarah O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010770; Khaitan D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-258; KOZMA L, 1994, CANCER LETT, V81, P165, DOI 10.1016/0304-3835(94)90198-8; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Man TK, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-45; Martin ES, 2007, CANCER RES, V67, P10736, DOI 10.1158/0008-5472.CAN-07-2742; Migliore L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/792362; Murphy KM, 2006, J MOL DIAGN, V8, P305, DOI 10.2353/jmoldx.2006.050092; Ogino S, 2008, J MOL DIAGN, V10, P13, DOI 10.2353/jmoldx.2008.070082; Oliveira C, 2007, ONCOGENE, V26, P158, DOI 10.1038/sj.onc.1209758; Ozakyol A, 2006, HEPATO-GASTROENTEROL, V53, P192; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Poulogiannis G, 2010, P NATL ACAD SCI USA, V107, P15145, DOI 10.1073/pnas.1009941107; Poulogiannis G, 2010, J PATHOL, V220, P338, DOI 10.1002/path.2640; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Shing DC, 2007, J CLIN INVEST, V117, P3696, DOI 10.1172/JCI32390; Tanaka T, 2006, BRIT J CANCER, V95, P1562, DOI 10.1038/sj.bjc.6603460; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Velho S, 2005, EUR J CANCER, V41, P1649, DOI 10.1016/j.ejca.2005.04.022; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zhang KX, 2010, INT J CANCER, V127, P830, DOI 10.1002/ijc.25088; Zhivotovsky B, 2004, NAT REV MOL CELL BIO, V5, P752, DOI 10.1038/nrm1443	47	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83859	10.1371/journal.pone.0083859	http://dx.doi.org/10.1371/journal.pone.0083859			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367615	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300119
J	Koch, Y; Wolf, T; Sorger, PK; Eils, R; Brors, B				Koch, Yvonne; Wolf, Thomas; Sorger, Peter K.; Eils, Roland; Brors, Benedikt			Decision-Tree Based Model Analysis for Efficient Identification of Parameter Relations Leading to Different Signaling States	PLOS ONE			English	Article							CASPASE ACTIVATION; INDUCED APOPTOSIS; CELL-DEATH; BCL-2; BISTABILITY; MECHANISM; PROTEIN; FATE; BAX	In systems biology, a mathematical description of signal transduction processes is used to gain a more detailed mechanistic understanding of cellular signaling networks. Such models typically depend on a number of parameters that have different influence on the model behavior. Local sensitivity analysis is able to identify parameters that have the largest effect on signaling strength. Bifurcation analysis shows on which parameters a qualitative model response depends. Most methods for model analysis are intrinsically univariate. They typically cannot consider combinations of parameters since the search space for such analysis would be too large. This limitation is important since activation of a signaling pathway often relies on multiple rather than on single factors. Here, we present a novel method for model analysis that overcomes this limitation. As input to a model defined by a system of ordinary differential equations, we consider parameters for initial chemical species concentrations. The model is used to simulate the system response, which is then classified into predefined classes (e.g., active or not active). This is combined with a scan of the parameter space. Parameter sets leading to a certain system response are subjected to a decision tree algorithm, which learns conditions that lead to this response. We compare our method to two alternative multivariate approaches to model analysis: analytical solution for steady states combined with a parameter scan, and direct Lyapunov exponent (DLE) analysis. We use three previously published models including a model for EGF receptor internalization and two apoptosis models to demonstrate the power of our approach. Our method reproduces critical parameter relations previously obtained by both steady-state and DLE analysis while being more generally applicable and substantially less computationally expensive. The method can be used as a general tool to predict multivariate control strategies for pathway activation and to suggest strategies for drug intervention.	[Koch, Yvonne; Wolf, Thomas; Eils, Roland; Brors, Benedikt] German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Germany; [Wolf, Thomas] Heidelberg Univ, Sch Med, Inst Gen Pathol, Heidelberg, Germany; [Sorger, Peter K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Eils, Roland] Heidelberg Univ, Dept Bioinformat & Funct Genom, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Eils, Roland] Heidelberg Univ, Bioquant Ctr, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Harvard University; Harvard Medical School; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Eils, R (corresponding author), German Canc Res Ctr, Div Theoret Bioinformat, Neuenheimer Feld 580, Heidelberg, Germany.	r.eils@dkfz.de	Brors, Benedikt/E-5620-2013; Eils, Roland/B-6121-2009	Brors, Benedikt/0000-0001-5940-3101; Eils, Roland/0000-0002-0034-4036; Sorger, Peter/0000-0002-3364-1838	Helmholtz Society of German Research Centers through the Helmholtz Alliance on Systems Biology (SB Cancer Network); German Federal Ministry of Research and Education through the National Genome Research Network [01 GS 0883]	Helmholtz Society of German Research Centers through the Helmholtz Alliance on Systems Biology (SB Cancer Network); German Federal Ministry of Research and Education through the National Genome Research Network	This study has been funded in part by a grant from the Helmholtz Society of German Research Centers through the Helmholtz Alliance on Systems Biology (SB Cancer Network), and by a grant from the German Federal Ministry of Research and Education through the National Genome Research Network (01 GS 0883). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Aldridge BB, 2006, IEE P SYST BIOL, V153, P425, DOI 10.1049/ip-syb:20050065; Bagci EZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002249; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Breiman L., 1984, CLASSIFICATION REGRE; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Hautaniemi S, 2005, BIOINFORMATICS, V21, P2027, DOI 10.1093/bioinformatics/bti278; Hornberg JJ, 2005, ONCOGENE, V24, P5533, DOI 10.1038/sj.onc.1208817; Hua F, 2005, J IMMUNOL, V175, P985, DOI 10.4049/jimmunol.175.2.985; Ishwaran H, 2007, ELECTRON J STAT, V1, P519, DOI 10.1214/07-EJS039; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Mahdavi A, 2007, PLOS COMPUT BIOL, V3, P1257, DOI 10.1371/journal.pcbi.0030130; Millat T, 2008, BIOSYSTEMS, V92, P270, DOI 10.1016/j.biosystems.2008.03.007; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schmidt-Glenewinkel H, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-32; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	25	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82593	10.1371/journal.pone.0082593	http://dx.doi.org/10.1371/journal.pone.0082593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367526	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300042
J	Traber, PG; Zomer, E				Traber, Peter G.; Zomer, Eliezer			Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors	PLOS ONE			English	Article							FATTY LIVER-DISEASE; ALTERNATIVE MACROPHAGE ACTIVATION; CARBOHYDRATE-BINDING DOMAIN; NITRIC-OXIDE SYNTHASE; NONALCOHOLIC STEATOHEPATITIS; HEPATIC-FIBROSIS; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; CELL-SURFACE; EXPRESSION	Non-alcoholic steatohepatitis (NASH) and resultant liver fibrosis is a major health problem without effective therapy. Some data suggest that galectin-3 null mice are resistant to the development of NASH with fibrosis. We examined the ability of two complex carbohydrate drugs that bind galectin-3, GM-CT-01 and GR-MD-02, to treat NASH with fibrosis in a murine model. GR-MD-02 treatment resulted in marked improvement in liver histology with significant reduction in NASH activity and collagen deposition. Treatments seemed also to improve both glomerulopathy and interstitial fibrosis observed in kidneys. The improvement in liver histology was evident when animals were treated early in disease or after establishment of liver fibrosis. In all measures, GM-CT-01 had an intermediate effect between vehicle and GR-MD-02. Galectin-3 protein expression was increased in NASH with highest expression in macrophages surrounding lipid laden hepatocytes, and reduced following treatment with GR-MD-02, while the number of macrophages was unchanged. Treatment with GR-MD-02 also reduced the expression of pathological indicators including iNOS, an important TH1 inflammatory mediator, CD36, a scavenger receptor for lipoproteins on macrophages, and a-smooth muscle actin, a marker for activated stellate cells which are the primary collagen producing cells in liver fibrosis. We conclude that treatment with these galectin-3 targeting drugs improved histopathological findings of NASH and markedly reduced fibrosis in a murine model of NASH. While the mechanisms require further investigation, the treatment effect is associated with a reduction of galectin-3 expressed by activated macrophages which was associated with regression of NASH, including hepatocellular fat accumulation, hepatocyte ballooning, intra-portal and intra-lobular inflammatory infiltrate, and deposition of collagen. Similar effects were found with GM-CT-01, but with approximately four-fold lower potency than GR-MD-02. The results, in combination with previous experiments in toxin-induced fibrosis, suggest that these galectin-targeting drugs may have potential in human NASH with fibrosis.	[Traber, Peter G.; Zomer, Eliezer] Galectin Therapeut Inc, Norcross, GA USA; [Traber, Peter G.] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA	Emory University	Traber, PG (corresponding author), Galectin Therapeut Inc, Norcross, GA USA.	traber@galectintherapeutics.com			Galectin Therapeutics	Galectin Therapeutics	Authors PGT and EZ are or have been employed by Galectin Therapeutics INC, a public company. Additionally, Galectin Therapeutics funded this work so the same authors have an affiliation to the commercial funders. Moreover, the company funders, beyond the employees involved in the study, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Ahmad N, 2004, GLYCOBIOLOGY, V14, P817, DOI 10.1093/glycob/cwh095; Angulo P, 2010, HEPATOLOGY, V51, P373, DOI 10.1002/hep.23521; Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558; Bhala N, 2011, HEPATOLOGY, V54, P1208, DOI 10.1002/hep.24491; Bieghs V, 2013, LIVER INT, V33, P1056, DOI 10.1111/liv.12170; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034378; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030668; Bieghs V, 2012, ATHEROSCLEROSIS, V220, P287, DOI 10.1016/j.atherosclerosis.2011.08.041; Bieghs V, 2010, GASTROENTEROLOGY, V138, P2477, DOI 10.1053/j.gastro.2010.02.051; Brenner DA, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S17; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; Caldwell S, 2010, DIGEST DIS, V28, P162, DOI 10.1159/000282081; Cederfur C, 2008, GLYCOBIOLOGY, V18, P384, DOI 10.1093/glycob/cwn015; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; de Boer RA, 2009, EUR J HEART FAIL, V11, P811, DOI 10.1093/eurjhf/hfp097; Di Lella S, 2011, BIOCHEMISTRY-US, V50, P7842, DOI 10.1021/bi201121m; Dragomir AC, 2012, TOXICOL SCI, V127, P609, DOI 10.1093/toxsci/kfs117; Dragomir ACD, 2012, J IMMUNOL, V189, P5934, DOI 10.4049/jimmunol.1201851; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1; Fujita K, 2010, ALCOHOL CLIN EXP RES, V34, pS18, DOI 10.1111/j.1530-0277.2008.00756.x; Garcia-Monzon C, 2000, J HEPATOL, V33, P716, DOI 10.1016/S0168-8278(00)80301-3; Haudek KC, 2010, BBA-GEN SUBJECTS, V1800, P181, DOI 10.1016/j.bbagen.2009.07.005; He JH, 2011, EXP BIOL MED, V236, P1116, DOI 10.1258/ebm.2011.011128; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Heymann Felix, 2009, Inflammation & Allergy Drug Targets, V8, P307; HO MK, 1982, J IMMUNOL, V128, P2281; Iacobini C, 2003, J AM SOC NEPHROL, V14, pS264, DOI 10.1097/01.ASN.0000077402.95720.B4; Iacobini C, 2011, J HEPATOL, V54, P975, DOI 10.1016/j.jhep.2010.09.020; Jiang JX, 2012, AM J PHYSIOL-GASTR L, V302, pG439, DOI 10.1152/ajpgi.00257.2011; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; Kim H, 2007, CELL BIOL INT, V31, P655, DOI 10.1016/j.cellbi.2006.11.036; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lippert E, 2008, CLIN EXP IMMUNOL, V152, P285, DOI 10.1111/j.1365-2249.2008.03618.x; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; MacKinnon AC, 2012, AM J RESP CRIT CARE, V185, P537, DOI 10.1164/rccm.201106-0965OC; Miller MC, 2011, GLYCOBIOLOGY, V21, P1627, DOI 10.1093/glycob/cwr083; Miller MC, 2009, GLYCOBIOLOGY, V19, P1034, DOI 10.1093/glycob/cwp084; Miller MC, 2009, BIOCHEM J, V421, P211, DOI 10.1042/BJ20090265; Nakanishi Y, 2008, HEPATOL RES, V38, P1241, DOI 10.1111/j.1872-034X.2008.00395.x; Nomoto K, 2006, J PATHOL, V210, P469, DOI 10.1002/path.2065; Nomoto K, 2012, SCI WORLD J, P1, DOI 10.1100/2012/959824; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; Papaspyridonos M, 2008, ARTERIOSCL THROM VAS, V28, P433, DOI 10.1161/ATVBAHA.107.159160; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Rinella ME, 2011, HEPATOLOGY, V54, P1118, DOI 10.1002/hep.24634; Salomonsson E, 2010, J BIOL CHEM, V285, P35079, DOI 10.1074/jbc.M109.098160; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; SATO S, 1992, J GEN MICROBIOL, V138, P1992, DOI 10.1099/00221287-138-9-1992; Stefater JA, 2011, TRENDS MOL MED, V17, P743, DOI 10.1016/j.molmed.2011.07.009; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Traber PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075361; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yoneda M, 2009, HEPATOL RES, V39, P963, DOI 10.1111/j.1872-034X.2009.00539.x; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	62	118	124	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83481	10.1371/journal.pone.0083481	http://dx.doi.org/10.1371/journal.pone.0083481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367597	gold, Green Submitted, Green Published			2022-12-27	WOS:000328740300106
J	Zhou, YL; Xu, F; Deng, HR; Bi, Y; Sun, WP; Zhao, Y; Chen, ZL; Weng, JP				Zhou, Yinli; Xu, Fen; Deng, Hongrong; Bi, Yan; Sun, Weiping; Zhao, Yi; Chen, Zonglan; Weng, Jianping			PEDF Expression Is Inhibited by Insulin Treatment in Adipose Tissue via Suppressing 11 beta-HSD1	PLOS ONE			English	Article							EPITHELIUM-DERIVED FACTOR; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; NF-KAPPA-B; SERUM-LEVELS; RESISTANCE; INFLAMMATION; OBESITY; OVEREXPRESSION; THERAPY; HYPOXIA	Early intensive insulin therapy improves insulin sensitivity in type 2 diabetic patients; while the underlying mechanism remains largely unknown. Pigment epithelium-derived factor (PEDF), an anti-angiogenic factor, is believed to be involved in the pathogenesis of insulin resistance. Here, we hypothesize that PEDF might be down regulated by insulin and then lead to the improved insulin resistance in type 2 diabetic patients during insulin therapy. We addressed this issue by investigating insulin regulation of PEDF expression in diabetic conditions. The results showed that serum PEDF was reduced by 15% in newly diagnosed type 2 diabetic patients after insulin therapy. In adipose tissue of diabetic Sprague-Dawley rats, PEDF expression was associated with TNF-alpha elevation and it could be decreased both in serum and in adipose tissue by insulin treatment. In adipocytes, PEDF was induced by TNF-alpha through activation of NF-kappa B. The response was inhibited by knockdown and enhanced by over expression of NF-kappa B p65. However, PEDF expression was indirectly, not directly, induced by NF-kappa B which promoted 11 beta-hydroxysteroid dehydrogenase 1 (11 beta-HSD1) expression in adipocytes. 11 beta-HSD1 is likely to stimulate PEDF expression through production of active form of glucocorticoids as dexamethasone induced PEDF expression in adipose tissue. Insulin inhibited PEDF by down-regulating 11 beta-HSD1 expression. The results suggest that PEDF activity is induced by inflammation and decreased by insulin through targeting 11 beta-HSD1/glucocorticoid pathway in adipose tissue of diabetic patients.	[Zhou, Yinli; Xu, Fen; Deng, Hongrong; Bi, Yan; Sun, Weiping; Zhao, Yi; Chen, Zonglan; Weng, Jianping] Sun Yat Sen Univ, Dept Endocrinol & Metab, Affiliated Hosp 3, Key Lab Diabetol Guangdong Prov, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Weng, JP (corresponding author), Sun Yat Sen Univ, Dept Endocrinol & Metab, Affiliated Hosp 3, Key Lab Diabetol Guangdong Prov, Guangzhou 510275, Guangdong, Peoples R China.	wjianp@mail.sysu.edu.cn	Zhou, yixin/HGE-2329-2022	Weng, Jianping/0000-0002-7889-1697; Xu, Fen/0000-0002-1662-0971; Sun, Weiping/0000-0003-4689-9659	National Natural Science Funds for Distinguished Young Scholar of China [81025005]; "973" project [2012CB517506]; Changjiang Scholars and Innovative Research Team in University of China (985 project) [IRT 0947]; 985 project [82000-3281901]; National Natural Science Foundation of China Grant Award [81000324]; Chinese Postdoctoral Scholarship [20090460807]	National Natural Science Funds for Distinguished Young Scholar of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); "973" project(National Basic Research Program of China); Changjiang Scholars and Innovative Research Team in University of China (985 project); 985 project(Jilin UniversityXiamen University); National Natural Science Foundation of China Grant Award(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Scholarship	National Natural Science Funds for Distinguished Young Scholar of China (81025005 to J.W.), "973" project (2012CB517506 to Y.G.), Changjiang Scholars and Innovative Research Team in University of China (985 project IRT 0947), 985 project (82000-3281901), the National Natural Science Foundation of China Grant Award (81000324 to Y.Z.), a Chinese Postdoctoral Scholarship (20090460807 to Y.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2007, MINI-REV MED CHEM, V7, P649; Bi Y, 2008, ACTA DIABETOL, V45, P167, DOI 10.1007/s00592-008-0038-7; Bohm A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034035; Borg ML, 2011, DIABETES, V60, P1458, DOI 10.2337/db10-0845; Chavan S, 2012, MOL MED; Choi KM, 2012, DIABETES, V61, P2932, DOI 10.2337/db12-0217; Crowe S, 2009, CELL METAB, V10, P40, DOI 10.1016/j.cmet.2009.06.001; Elayappan B, 2009, ANGIOGENESIS, V12, P313, DOI 10.1007/s10456-009-9153-5; Gao GQ, 2001, FEBS LETT, V489, P270, DOI 10.1016/S0014-5793(01)02110-X; Gao ZG, 2006, J BIOL CHEM, V281, P4540, DOI 10.1074/jbc.M507784200; Jenkins AJ, 2007, DIABETIC MED, V24, P1345, DOI 10.1111/j.1464-5491.2007.02281.x; Jenkins Alicia, 2008, Diabetes Res Clin Pract, V82, pe5, DOI 10.1016/j.diabres.2008.06.019; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Lee JH, 2013, AM J PHYSIOL-ENDOC M, V304, pE1035, DOI 10.1152/ajpendo.00029.2013; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Matsuoka M, 2006, EXP EYE RES, V82, P172, DOI 10.1016/j.exer.2005.05.011; Matsuoka M, 2007, MOL VIS, V13, P1058; Morton NM, 2008, FRONT HORM RES, V36, P146, DOI 10.1159/000115363; Nakamura K, 2009, DIABETES-METAB RES, V25, P52, DOI 10.1002/dmrr.820; Ogata N, 2007, J CLIN ENDOCR METAB, V92, P1176, DOI 10.1210/jc.2006-2249; Park K, 2011, AM J PATHOL, V178, P688, DOI 10.1016/j.ajpath.2010.10.014; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Perruccio EM, 2008, CURR EYE RES, V33, P507, DOI 10.1080/02713680802110208; Sabater M, 2010, J CLIN ENDOCR METAB, V95, P4720, DOI 10.1210/jc.2010-0630; Spranger J, 2001, DIABETES, V50, P2641, DOI 10.2337/diabetes.50.12.2641; Sunderland KL, 2012, J CLIN ENDOCR METAB, V97, pE2114, DOI 10.1210/jc.2012-1894; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; TOMBRANTINK J, 1989, INVEST OPHTH VIS SCI, V30, P1700; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Wang M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1378, DOI 10.1152/ajpendo.00252.2009; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; Yamagishi SI, 2010, CURR MOL MED, V10, P284, DOI 10.2174/156652410791065264; Yamagishi S, 2006, J CLIN ENDOCR METAB, V91, P2447, DOI 10.1210/jc.2005-2654; Yamagishi S, 2008, CURR DRUG TARGETS, V9, P1025, DOI 10.2174/138945008786786154	35	6	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84016	10.1371/journal.pone.0084016	http://dx.doi.org/10.1371/journal.pone.0084016			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367624	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300124
J	Cogo-Moreira, H; de Avila, CRB; Ploubidis, GB; Mari, JD				Cogo-Moreira, Hugo; Brandao de Avila, Clara Regina; Ploubidis, George B.; Mari, Jair de Jesus			Pathway Evidence of How Musical Perception Predicts Word-Level Reading Ability in Children with Reading Difficulties	PLOS ONE			English	Article							SPEECH; SKILLS; LANGUAGE	Objective: To investigate whether specific domains of musical perception (temporal and melodic domains) predict the word-level reading skills of eight-to ten-year-old children (n = 235) with reading difficulties, normal quotient of intelligence, and no previous exposure to music education classes. Method: A general-specific solution of the Montreal Battery of Evaluation of Amusia (MBEA), which underlies a musical perception construct and is constituted by three latent factors (the general, temporal, and the melodic domain), was regressed on word-level reading skills (rate of correct isolated words/non-words read per minute). Results: General and melodic latent domains predicted word-level reading skills.	[Cogo-Moreira, Hugo; Mari, Jair de Jesus] Univ Fed Sao Paulo, Dept Psychiat & Med Psychol, Sao Paulo, Brazil; [Brandao de Avila, Clara Regina] Univ Fed Sao Paulo, Dept Hearing & Speech Pathol, Sao Paulo, Brazil; [Ploubidis, George B.] Univ London London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1E 7HT, England	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); University of London; London School of Hygiene & Tropical Medicine	Cogo-Moreira, H (corresponding author), Univ Fed Sao Paulo, Dept Psychiat & Med Psychol, Sao Paulo, Brazil.	hugocogobr@gmail.com	Cogo-Moreira, Hugo/GSD-6132-2022; Cogo-Moreira, Hugo/U-6442-2019; Cogo-Moreira, Hugo/E-4602-2011; de Jesus Mari, Jair/A-7309-2008; Avila, Clara R B/J-6066-2012; Ploubidis, George B/G-9531-2011	Cogo-Moreira, Hugo/0000-0001-9411-9237; Cogo-Moreira, Hugo/0000-0001-9411-9237; Cogo-Moreira, Hugo/0000-0001-9411-9237; de Jesus Mari, Jair/0000-0002-5403-0112; Avila, Clara R B/0000-0002-5708-8299; Ploubidis, George B/0000-0002-8198-5790	National Council for Scientific and Technological Development (CNPq) [482321/2010-5]; ABCD Institute [a nongovernmental organisation (NGO) in Brazil]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ABCD Institute [a nongovernmental organisation (NGO) in Brazil]	We thank the National Council for Scientific and Technological Development (CNPq - grant no. 482321/2010-5) and the ABCD Institute [which is a nongovernmental organisation (NGO) that supports research on dyslexia in Brazil] for the grants that made this study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, EDUC PSYCHOL-UK, DOI [DOI 10.1080/0144341930130103, 10.1080/0144341930130103]; Anvari SH, 2002, J EXP CHILD PSYCHOL, V83, P111, DOI 10.1016/S0022-0965(02)00124-8; ASPAROUHOV T, 2005, P FCMS; ASPAROUHOV T, 2006, P JOINT STAT M SEATL; Barnett SM, 2002, PSYCHOL BULL, V128, P612, DOI 10.1037//0033-2909.128.4.612; BARROS M, 1995, JABUTI ONCA; Capovilla A. G. S., 1998, TEMAS DESENVOLVIMENT, V7, P14; CarrollPhelan B, 1996, MUSIC PERCEPT, V13, P517; Cogo-Moreira H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059984; Cogo-Moreira H, 2012, NEUROPSYCH DIS TREAT, V8, P443, DOI 10.2147/NDT.S36196; COGOMOREIRA H, 2012, COCHRANE DB SYST REV, V8; Corrigall KA, 2009, ANN NY ACAD SCI, V1169, P164, DOI 10.1111/j.1749-6632.2009.04769.x; Cuddy LL, 2005, ANN NY ACAD SCI, V1060, P311, DOI 10.1196/annals.1360.026; Dege F, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00124; Dellatolas G, 2009, ARCH CLIN NEUROPSYCH, V24, P555, DOI 10.1093/arclin/acp044; Douglas S., 1994, J RES READ, V17, p99?107, DOI [DOI 10.1111/J.1467-9817.1994.TB00057.X, 10.1111/j.1467-9817.1994.tb00057.x]; Echols CH, 1996, SIGNAL TO SYNTAX: BOOTSTRAPPING FROM SPEECH TO GRAMMAR IN EARLY ACQUISITION, P151; Figueiredo V, 2002, WISC 3 ESCALA INTELI; Fluss J, 2009, J DEV BEHAV PEDIATR, V30, P206, DOI 10.1097/DBP.0b013e3181a7ed6c; Foxton JM, 2003, NAT NEUROSCI, V6, P343, DOI 10.1038/nn1035; Gough P. B., 1986, REM SPEC EDUC, V7, P6, DOI [10.1177/074193258600700104, DOI 10.1177/074193258600700104]; Ho YC, 2003, NEUROPSYCHOLOGY, V17, P439, DOI 10.1037/0894-4105.17.3.439; Hotopf M, 1999, BRIT J PSYCHIAT, V175, P217, DOI 10.1192/bjp.175.3.217; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hulme C, 2012, PSYCHOL SCI, V23, P572, DOI 10.1177/0956797611435921; Huss M, 2011, CORTEX, V47, P674, DOI 10.1016/j.cortex.2010.07.010; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; Kolinsky R, 2009, MUSIC PERCEPT, V26, P235, DOI 10.1525/MP.2009.26.3.235; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Lawley D.N., 1962, J R STAT SOC, V12, P209, DOI [DOI 10.2307/2986915, https://doi.org/10.2307/2986915]; Magne C, 2006, J COGNITIVE NEUROSCI, V18, P199, DOI 10.1162/089892906775783660; Mancilla-Martinez J, 2010, J EDUC PSYCHOL, V102, P701, DOI 10.1037/a0019135; Marie C, 2011, J COGNITIVE NEUROSCI, V23, P2701, DOI 10.1162/jocn.2010.21585; Melby-Lervag M, 2012, PSYCHOL BULL, V138, P322, DOI 10.1037/a0026744; Moreno S, 2011, PSYCHOL SCI, V22, P1425, DOI 10.1177/0956797611416999; Moreno S, 2009, CEREB CORTEX, V19, P712, DOI 10.1093/cercor/bhn120; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Muthen B., 2010, MPLUS USERS GUIDE; Noble KG, 2006, COGNITIVE DEV, V21, P349, DOI 10.1016/j.cogdev.2006.01.007; NUNESSILVA M, 2012, BRAZIL DEMENTIA NEUR, V6, P244; Pasqua L, 2002, AVALIACAO PSICOLOGIC, V1, P95; Patel AD, 2008, NATURE, V453, P726, DOI 10.1038/453726a; Patel AD, 2012, ANN NY ACAD SCI, V1252, P124, DOI 10.1111/j.1749-6632.2011.06426.x; Patel AD, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00142; PEREIRA L, 1993, PROCESSAMENTO AUDITI, V2, P7; PEREIRA L, 1981, VET MALUCO; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; Peretz I, 2005, ANNU REV PSYCHOL, V56, P89, DOI 10.1146/annurev.psych.56.091103.070225; Rabelo Alessandra Terra Vasconcelos, 2011, J. Soc. Bras. Fonoaudiol., V23, P344, DOI 10.1590/S2179-64912011000400009; SCHBN D, 2004, PSYCHOPHYSIOLOGY, V41, P341, DOI DOI 10.1111/1469-8986.00172.X.PUBMED:15102118; Slevc LR, 2006, PSYCHOL SCI, V17, P675, DOI 10.1111/j.1467-9280.2006.01765.x; Strait DL, 2012, BRAIN LANG, V123, P191, DOI 10.1016/j.bandl.2012.09.001; Strait DL, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-44; Urbina S., 2004, ESSENTIALS PSYCHOL T, V1st ed; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Ziegler JC, 2012, BRAIN LANG, V120, P265, DOI 10.1016/j.bandl.2011.12.002	57	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84375	10.1371/journal.pone.0084375	http://dx.doi.org/10.1371/journal.pone.0084375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GT	24358358	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000328737700094
J	King, R; Barker, J; Nakayiwa, S; Katuntu, D; Lubwama, G; Bagenda, D; Lane, T; Opio, A; Hladik, W				King, Rachel; Barker, Joseph; Nakayiwa, Sylvia; Katuntu, David; Lubwama, George; Bagenda, Danstan; Lane, Tim; Opio, Alex; Hladik, Wolfgang			Men at Risk; a Qualitative Study on HIV Risk, Gender Identity and Violence among Men Who Have Sex with Men Who Report High Risk Behavior in Kampala, Uganda	PLOS ONE			English	Article							BISEXUAL MEN; WORKERS; HIV/AIDS; MOMBASA; GAY	In Uganda, men who have sex with men (MSM) are at high risk for HIV. Between May 2008 and February 2009 in Kampala, Uganda, we used respondent driven sampling (RDS) to recruit 295 MSM >= 18 years who reported having had sex with another man in the preceding three months. The parent study conducted HIV and STI testing and collected demographic and HIV-related behavioral data through audio computer-assisted self-administered interviews. We conducted a nested qualitative sub-study with 16 men purposively sampled from among the survey participants based on responses to behavioral variables indicating higher risk for HIV infection. Sub-study participants were interviewed face-to-face. Domains of inquiry included sexual orientation, gender identity, condom use, stigma, discrimination, violence and health seeking behavior. Emergent themes included a description of sexual orientation/gender identity categories. All groups of men described conflicting feelings related to their sexual orientation and contextual issues that do not accept same-sex identities or behaviors and non-normative gender presentation. The emerging domains for facilitating condom use included: lack of trust in partner and fear of HIV infection. We discuss themes in the context of social and policy issues surrounding homosexuality and HIV prevention in Uganda that directly affect men's lives, risk and health-promoting behaviors.	[King, Rachel; Lane, Tim] Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA; [King, Rachel; Barker, Joseph; Nakayiwa, Sylvia; Katuntu, David; Hladik, Wolfgang] Ctr Dis Control & Prevent CDC, Ctr Global Hlth, Div Global HIV AIDS, Entebbe, Uganda; [Lubwama, George; Bagenda, Danstan] Makerere Univ, Sch Publ Hlth MakSPH, Kampala, Uganda; [Opio, Alex; Hladik, Wolfgang] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol, NL-1012 WX Amsterdam, Netherlands; Minist Hlth, Kampala, Uganda; [Barker, Joseph; Hladik, Wolfgang] Ctr Dis Control & Prevent CDC, Ctr Global Hlth, Div Global HIV AIDS, Atlanta, GA USA	University of California System; University of California San Francisco; Makerere University; University of Amsterdam; Academic Medical Center Amsterdam; Centers for Disease Control & Prevention - USA	King, R (corresponding author), Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA.	rlking@psg.ucsf.edu			US President's Emergency Plan for AIDS Relief; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	US President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the US President's Emergency Plan for AIDS Relief. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APA, 2011, ANSW YOUR QUEST TRAN; Beyrer C, 2010, SEX TRANSM INFECT, V86, P323, DOI 10.1136/sti.2009.040162; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; Boyatzis R. E., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Creswell J. W., 2007, QUALITATIVE INQUIRY; Fay H, 2010, AIDS BEHAV; Geibel S, 2010, HIV VULNERABILITY ME; Heckathorn D, 2007, SOC PROBL, V44, P174; Hladik W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038143; Jaffe HW, 2007, JAMA-J AM MED ASSOC, V298, P2412, DOI 10.1001/jama.298.20.2412; Jobson GA, 2012, SAHARA J-J SOC ASP H, V9, P160, DOI 10.1080/17290376.2012.743829; Kajubi P, 2008, AIDS BEHAV, V12, P492, DOI 10.1007/s10461-007-9323-7; Kiyaga A, 2013, DAILY MONITOR; Knox J, 2013, AIDS BEHAV, V17, P350, DOI 10.1007/s10461-012-0337-4; Knox J, 2010, PSYCHOL HEALTH MED, V15, P660, DOI 10.1080/13548506.2010.507772; Lane T, 2008, SEX TRANSM INFECT, V84, P430, DOI 10.1136/sti.2008.031567; Larmarange J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013189; McIntyre J, 2013, AIDS BEHAV; Muraguri N, 2012, SAHARA J-J SOC ASP H, V9, P137, DOI 10.1080/17290376.2012.744176; Ngo DA, 2009, AIDS EDUC PREV, V21, P251, DOI 10.1521/aeap.2009.21.3.251; Okal J, 2009, CULT HEALTH SEX, V11, P811, DOI 10.1080/13691050902906488; Price MA, 2012, JAIDS-J ACQ IMM DEF, V59, P185, DOI 10.1097/QAI.0b013e31823d8693; Raymond HF, 2009, AIDS BEHAV, V13, P677, DOI 10.1007/s10461-009-9557-7; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Stephenson R, 2013, AIDS BEHAV, V17, pS43, DOI 10.1007/s10461-012-0293-z; Team M, 2013, DAILY MONITOR; Tucker A, 2013, AIDS CARE; van Griensven F, 2008, SEX TRANSM DIS, V35, P355, DOI 10.1097/OLQ.0b013e31816bf64c	29	47	48	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82937	10.1371/journal.pone.0082937	http://dx.doi.org/10.1371/journal.pone.0082937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GT	24358239	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700040
J	Song, M; Han, NG; Kim, YH; Ding, Y; Chambers, T				Song, Min; Han, Nam-Gi; Kim, Yong-Hwan; Ding, Ying; Chambers, Tamy			Discovering Implicit Entity Relation with the Gene-Citation-Gene Network	PLOS ONE			English	Article							PROTEIN; CTCF; PHOSPHORYLATION; CYTOKINESIS; ASSOCIATION; CENTRALITY; AXIN; NDE1	In this paper, we apply the entitymetrics model to our constructed Gene-Citation-Gene (GCG) network. Based on the premise there is a hidden, but plausible, relationship between an entity in one article and an entity in its citing article, we constructed a GCG network of gene pairs implicitly connected through citation. We compare the performance of this GCG network to a gene-gene (GG) network constructed over the same corpus but which uses gene pairs explicitly connected through traditional co-occurrence. Using 331,411 MEDLINE abstracts collected from 18,323 seed articles and their references, we identify 25 gene pairs. A comparison of these pairs with interactions found in BioGRID reveal that 96% of the gene pairs in the GCG network have known interactions. We measure network performance using degree, weighted degree, closeness, betweenness centrality and PageRank. Combining all measures, we find the GCG network has more gene pairs, but a lower matching rate than the GG network. However, combining top ranked genes in both networks produces a matching rate of 35.53%. By visualizing both the GG and GCG networks, we find that cancer is the most dominant disease associated with the genes in both networks. Overall, the study indicates that the GCG network can be useful for detecting gene interaction in an implicit manner.	[Song, Min; Han, Nam-Gi; Kim, Yong-Hwan] Yonsei Univ, Dept Lib & Informat Sci, Seoul 120749, South Korea; [Ding, Ying; Chambers, Tamy] Indiana Univ, Dept Informat & Lib Sci, Bloomington, IN USA	Yonsei University; Indiana University System; Indiana University Bloomington	Song, M (corresponding author), Yonsei Univ, Dept Lib & Informat Sci, Seoul 120749, South Korea.	min.song@yonsei.ac.kr	Han, Namgi/AAT-6380-2020	Song, Min/0000-0003-3255-1600; Chambers, Tamy/0000-0002-2891-6665	Bio & Medical Technology Development Program [2012048758]	Bio & Medical Technology Development Program	This research was supported by the Bio & Medical Technology Development Program (2012048758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian M, 2009, P INT AAAI C WEB SOC, V2009, P361, DOI 10.13140/2.1.1341.1520; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Blondel V. D., 2008, ARXIV08030476; Bradshaw NJ, 2011, J NEUROSCI, V31, P9043, DOI 10.1523/JNEUROSCI.5410-10.2011; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Burdick KE, 2008, HUM MOL GENET, V17, P2462, DOI 10.1093/hmg/ddn146; Chang JT, 2004, PHARMACOGENETICS, V14, P577, DOI 10.1097/00008571-200409000-00002; Cohen AM, 2005, BRIEF BIOINFORM, V6, P57, DOI 10.1093/bib/6.1.57; Cooper JW, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-143; Ding Y, 2013, PLOS ONE; Ding Y, 2008, J CELL BIOL, V182, P865, DOI 10.1083/jcb.200803147; Esteves LID, 2006, INT J MOL MED, V17, P397; Estrada E, 2010, J THEOR BIOL, V263, P556, DOI 10.1016/j.jtbi.2010.01.014; Galvez C, 2008, C PREC INT TECHN ED; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Goulet I, 2008, HUM MOL GENET, V17, P3055, DOI 10.1093/hmg/ddn203; Grbesa I, 2008, J MOL MED, V86, P1057, DOI 10.1007/s00109-008-0369-4; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Hay E, 2009, MOL CELL BIOL, V29, P953, DOI 10.1128/MCB.00349-08; Huang GT, 2011, NUCLEIC ACIDS RES, V39, pW416, DOI 10.1093/nar/gkr276; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; Kim MJ, 2008, FASEB J, V22, P3785, DOI 10.1096/fj.08-113910; Li J, 2010, J GENET GENOMICS, V37, P159, DOI 10.1016/S1673-8527(09)60034-5; Li S, 2006, BIOINFORMATICS, V22, P2143, DOI 10.1093/bioinformatics/btl363; Li X, 2007, J BIOMED INFORM, V40, P453, DOI 10.1016/j.jbi.2007.01.001; Lodish H., 2008, MOL CELL BIOL, V6th ed.; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; McCallum Andrew, 2003, P 7 C NATURAL LANGUA, P188; Moens LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023450; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Ozgur A, 2008, BIOINFORMATICS, V24, pI277, DOI 10.1093/bioinformatics/btn182; Patel M, 1997, PERSP NEURAL COMP, P199; Song M, J AM SOC INFORM SCI; Stapley B.J., 2000, P PAC S BIOC, V5, P526; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stephens M, 2001, Pac Symp Biocomput, P483; Tost J, 2006, NUCLEIC ACIDS RES, V34, P5438, DOI 10.1093/nar/gkl657; Wilkinson DM, 2004, P NATL ACAD SCI USA, V101, P5241, DOI 10.1073/pnas.0307740100; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110; Wren JD, 2004, BIOINFORMATICS, V20, P191, DOI 10.1093/bioinformatics/btg390; Zhao LH, 2010, HUM MOL GENET, V19, P25, DOI 10.1093/hmg/ddp464	42	14	16	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84639	10.1371/journal.pone.0084639	http://dx.doi.org/10.1371/journal.pone.0084639			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358368	Green Published, gold			2022-12-27	WOS:000328737700103
J	van der Leeuw, C; Marcelis, M; Peeters, SCT; Verbeek, MM; Menheere, PPCA; de Haan, L; van Os, J; van Beveren, NJM				van der Leeuw, Christine; Marcelis, Machteld; Peeters, Sanne C. T.; Verbeek, Marcel M.; Menheere, Paul P. C. A.; de Haan, Lieuwe; van Os, Jim; van Beveren, Nico J. M.		Genetic Risk Outcome Psychosis GRO	Replicated Evidence of Absence of Association between Serum S100B and (Risk of) Psychotic Disorder	PLOS ONE			English	Article							SCHIZOPHRENIC-PATIENTS; FRACTIONAL ANISOTROPY; VOLUME ABNORMALITIES; INSULIN-RESISTANCE; NEGATIVE SYMPTOMS; S-100B PROTEIN; BRAIN; ANTIPSYCHOTICS; SYMPTOMATOLOGY; BIOMARKERS	Background: S100B is a potential marker of neurological and psychiatric illness. In schizophrenia, increased S100B levels, as well as associations with acute positive and persisting negative symptoms, have been reported. It remains unclear whether S100B elevation, which possibly reflects glial dysfunction, is the consequence of disease or compensatory processes, or whether it is an indicator of familial risk. Methods: Serum samples were acquired from two large independent family samples (n = 348 and n = 254) in the Netherlands comprising patients with psychotic disorder (n = 140 and n = 82), non-psychotic siblings of patients with psychotic disorder (n = 125 and n = 94) and controls (n = 83 and n = 78). S100B was analyzed with a Liaison automated chemiluminescence system. Associations between familial risk of psychotic disorder and S100B were examined. Results: Results showed that S100B levels in patients (P) and siblings (S) were not significantly different from controls (C) (dataset 1: P vs. C: B = 0.004, 95% CI 20.005 to 0.013, p = 0.351; S vs. C: B = 0.000, 95% CI 20.009 to 0.008, p = 0.926; and dataset 2: P vs. C: B = 0.008, 95% CI -0.011 to 0.028, p = 0.410; S vs. C: B = 0.002, 95% CI -0.016 to 0.021, p = 0.797). In patients, negative symptoms were positively associated with S100B (B = 0.001, 95% CI 0.000 to 0.002, p = 0.005) in one of the datasets, however with failure of replication in the other. There was no significant association between S100B and positive symptoms or present use or type of antipsychotic medication. Conclusions: S100B is neither an intermediate phenotype, nor a trait marker for psychotic illness.	[van der Leeuw, Christine; Marcelis, Machteld; Peeters, Sanne C. T.; van Os, Jim] Maastricht Univ, Med Ctr, European Grad Sch Neurosci, Sch Mental Hlth & Neurosci,Dept Psychiat & Psycho, Maastricht, Netherlands; [Verbeek, Marcel M.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Verbeek, Marcel M.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands; [Verbeek, Marcel M.] Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Menheere, Paul P. C. A.] Maastricht Univ, Med Ctr, Cent Diagnost Lab, Maastricht, Netherlands; [de Haan, Lieuwe] Univ Amsterdam, Acad Med Ctr, Deparment Psychiat, NL-1105 AZ Amsterdam, Netherlands; [van Os, Jim] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, Kings Hlth Partners, London, England; [van Beveren, Nico J. M.] Erasmus MC, Dept Psychiat, Rotterdam, Netherlands; [van Beveren, Nico J. M.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [van Beveren, Nico J. M.] Delta Ctr Mental Hlth Care, Dept Nieuwe Kennis, Rotterdam, Netherlands	Maastricht University; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; University of London; King's College London; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Marcelis, M (corresponding author), Maastricht Univ, Med Ctr, European Grad Sch Neurosci, Sch Mental Hlth & Neurosci,Dept Psychiat & Psycho, Maastricht, Netherlands.	m.marcelis@maastrichtuniversity.nl	Peeters, Sanne/AAA-9523-2021; van Os, Jim/V-8884-2019; van Os, Jim/C-2113-2014; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Verbeek, Marcel M/D-1971-2010	van Os, Jim/0000-0002-7245-1586; Verbeek, Marcel M/0000-0003-4635-7876; Marcelis, Machteld/0000-0003-0045-9244; Peeters, Sanne/0000-0002-3004-4261	Dutch organization for scientific research NWO (Genetic Risk and Outcome of Psychosis [G.R.O.U.P.]); European Community's Seventh Framework Programme [HEALTH-F2-2009-241909]	Dutch organization for scientific research NWO (Genetic Risk and Outcome of Psychosis [G.R.O.U.P.])(Netherlands Organization for Scientific Research (NWO)); European Community's Seventh Framework Programme	This work was sponsored by the Dutch organization for scientific research NWO (Genetic Risk and Outcome of Psychosis [G.R.O.U.P.]) and the European Community's Seventh Framework Programme under Grant Agreement No. HEALTH-F2-2009-241909 (European Network of National Schizophrenia Networks Studying Gene-Environment Interactions Consortium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; [Anonymous], 2010, CARDIOVASC PSYCHIAT; Camchong J, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.035.2009; Clark KA, 2011, J PSYCHIATR RES, V45, P980, DOI 10.1016/j.jpsychires.2011.01.006; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato Rosario, 2010, Cardiovasc Psychiatry Neurol, V2010, P929712, DOI 10.1155/2010/929712; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Femandez-Egea E, 2008, SCHIZOPHR RES, V98, P302, DOI 10.1016/j.schres.2007.10.002; Fernandez-Egea E, 2008, SCHIZOPHR RES, V103, P110, DOI 10.1016/j.schres.2008.04.017; Gattaz WF, 2000, SCHIZOPHR RES, V43, P91, DOI 10.1016/S0920-9964(99)00146-2; Goldstein H., 1987, MULTILEVEL MODELS ED; Gos T, 2013, J PSYCHIAT RES; Guest PC, 2010, MOL PSYCHIATR, V15, P118, DOI 10.1038/mp.2009.81; Habets P, 2011, BIOL PSYCHIAT, V69, P487, DOI 10.1016/j.biopsych.2010.08.010; Hao YH, 2009, SCHIZOPHR RES, V114, P128, DOI 10.1016/j.schres.2009.07.001; Hills, 1993, STAT MODELS EPIDEMIO; Ioannidis JPA, 2011, ARCH GEN PSYCHIAT, V68, P773, DOI 10.1001/archgenpsychiatry.2011.28; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Knoche C, 2012, NEUROIMAGE, V59, P926, DOI 10.1016/j.neuroimage.2011.07.088; Korver N, 2012, INT J METH PSYCH RES, V21, P205, DOI 10.1002/mpr.1352; Lara DR, 2001, J PSYCHIATR RES, V35, P11, DOI 10.1016/S0022-3956(01)00003-6; Ling SH, 2007, J PSYCHIAT RES, V41, P36, DOI 10.1016/j.jpsychires.2005.11.006; Liu JX, 2005, BIOCHEM BIOPH RES CO, V328, P335, DOI 10.1016/j.bbrc.2004.12.175; Makris N, 2010, PSYCHIAT RES-NEUROIM, V183, P21, DOI 10.1016/j.pscychresns.2010.04.016; Michetti F, 2012, J NEUROCHEM, V120, P644, DOI 10.1111/j.1471-4159.2011.07612.x; MUKHERJEE S, 1989, LANCET, V1, P495; Nakamura K, 2012, PSYCHIAT RES-NEUROIM, V202, P233, DOI 10.1016/j.pscychresns.2011.09.006; Pham N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012691; Pillai A, 2012, PSYCHIAT CLIN N AM, V35, P645, DOI 10.1016/j.psc.2012.06.006; Rothermundt M, 2001, MOL PSYCHIATR, V6, P445, DOI 10.1038/sj.mp.4000889; Rothermundt M, 2004, NEUROPSYCHOPHARMACOL, V29, P1004, DOI 10.1038/sj.npp.1300403; Rothermundt M, 2004, MOL PSYCHIATR, V9, P897, DOI 10.1038/sj.mp.4001548; Rothermundt M, 2007, PROG NEURO-PSYCHOPH, V31, P361, DOI 10.1016/j.pnpbp.2006.09.013; Rothermundt M, 2009, GEN PHYSIOL BIOPHYS, V28, pF76; Schroeter ML, 2009, MOL PSYCHIATR, V14, P235, DOI 10.1038/mp.2008.85; Schroeter ML, 2009, PSYCHIAT RES, V167, P66, DOI 10.1016/j.psychres.2008.01.002; Schroeter ML, 2003, SCHIZOPHR RES, V62, P231, DOI 10.1016/S0920-9964(02)00383-3; Sen J, 2007, J NEUROSCI RES, V85, P1373, DOI 10.1002/jnr.21211; Smit LHM, 2005, INT J BIOL MARKER, V20, P34, DOI 10.1177/172460080502000106; Steiner J, 2006, J NEUROL NEUROSUR PS, V77, P1284, DOI 10.1136/jnnp.2006.093427; Steiner J, 2010, NEUROSCIENCE, V167, P1025, DOI 10.1016/j.neuroscience.2010.03.010; Steiner J, 2010, MOL PSYCHIATR, V15, P3, DOI 10.1038/mp.2009.87; Steiner J, 2008, J PSYCHIATR RES, V42, P868, DOI 10.1016/j.jpsychires.2007.10.001; Steiner J, 2010, PSYCHONEUROENDOCRINO, V35, P321, DOI 10.1016/j.psyneuen.2009.07.012; Streitburger DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043284; Szeszko PR, 2008, NEUROPSYCHOPHARMACOL, V33, P976, DOI 10.1038/sj.npp.1301480; van Beveren NJM, 2006, EUR NEUROPSYCHOPHARM, V16, P469, DOI 10.1016/j.euroneuro.2006.02.001; van Beveren NJM, 2011, INT REV NEUROBIOL, V101, P351, DOI 10.1016/B978-0-12-387718-5.00014-6; van Nimwegen LJM, 2008, J CLIN ENDOCR METAB, V93, P572, DOI 10.1210/jc.2007-1167; Voineskos AN, 2013, JAMA PSYCHIAT, V70, P472, DOI 10.1001/jamapsychiatry.2013.786; Wiesmann M, 1999, BIOL PSYCHIAT, V45, P1508, DOI 10.1016/S0006-3223(98)00217-0; Wolkin A, 2003, AM J PSYCHIAT, V160, P572, DOI 10.1176/appi.ajp.160.3.572; Yelmo-Cruz S, 2013, PSYCHIAT CLIN NEUROS, V67, P67, DOI 10.1111/pcn.12024; Zhai JG, 2012, SCHIZOPHR RES, V134, P89, DOI 10.1016/j.schres.2011.09.029; Zhang XY, 2010, J PSYCHIATR RES, V44, P1236, DOI 10.1016/j.jpsychires.2010.04.023	56	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82535	10.1371/journal.pone.0082535	http://dx.doi.org/10.1371/journal.pone.0082535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358202	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700020
J	Fitzakerley, JL; Michlin, ML; Paton, J; Dubinsky, JM				Fitzakerley, Janet L.; Michlin, Michael L.; Paton, John; Dubinsky, Janet M.			Neuroscientists' Classroom Visits Positively Impact Student Attitudes	PLOS ONE			English	Article							IMPLICIT THEORIES; SCIENCE; EDUCATION; SCIENTISTS; INQUIRY	The primary recommendation of the 2010 President's Council of Advisors on Science and Technology report on K-12 education was to inspire more students so that they are motivated to study science. Scientists' visits to classrooms are intended to inspire learners and increase their interest in science, but verifications of this impact are largely qualitative. Our primary goal was to evaluate the impact of a longstanding Brain Awareness classroom visit program focused on increasing learners understanding of their own brains. Educational psychologists have established that neuroscience training sessions can improve academic performance and shift attitudes of students from a fixed mindset to a growth mindset. Our secondary goal was to determine whether short interactive Brain Awareness scientist-in-the-classroom sessions could similarly alter learners' perceptions of their own potential to learn. Teacher and student surveys were administered in 4th-6th grade classrooms throughout Minnesota either before or after one-hour Brain Awareness sessions that engaged students in activities related to brain function. Teachers rated the Brain Awareness program as very valuable and said that the visits stimulated students' interest in the brain and in science. Student surveys probed general attitudes towards science and their knowledge of neuroscience concepts (particularly the ability of the brain to change). Significant favorable improvements were found on 10 of 18 survey statements. Factor analyses of 4805 responses demonstrated that Brain Awareness presentations increased positive attitudes toward science and improved agreement with statements related to growth mindset. Overall effect sizes were small, consistent with the short length of the presentations. Thus, the impact of Brain Awareness presentations was positive and proportional to the efforts expended, demonstrating that short, scientist-in-the-classroom visits can make a positive contribution to primary school students' attitudes toward science and learning.	[Fitzakerley, Janet L.] Univ Minnesota, Dept Biomed Sci, Duluth, MN 55812 USA; [Paton, John; Dubinsky, Janet M.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Michlin, Michael L.] Univ Minnesota, Ctr Appl Res & Educ Improvement, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Dubinsky, JM (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	Dubin001@umn.edu			Ramp Up to Readiness grant; University of Minnesota; Graduate Program in Neuroscience; Medical School and the Academic Health Center at the University of Minnesota; Minnesota Medical Foundation	Ramp Up to Readiness grant; University of Minnesota(University of Minnesota System); Graduate Program in Neuroscience; Medical School and the Academic Health Center at the University of Minnesota; Minnesota Medical Foundation	This research was supported by a Ramp Up to Readiness grant awarded by the University of Minnesota. The University of Minnesota Brain Awareness program is supported by the Graduate Program in Neuroscience, the Medical School and the Academic Health Center at the University of Minnesota, as well as the Minnesota Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews E., 2005, J GEOSCIENCE ED, V53, P281, DOI [DOI 10.5408/1089-9995-53.3.281, 10.5408/1089-9995-53.3.281]; [Anonymous], 2012, SCI SCH; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bauer MW, 2011, PUBLIC UNDERST SCI, V20, P3, DOI 10.1177/0963662510394457; Blackwell LS, 2007, CHILD DEV, V78, P246, DOI 10.1111/j.1467-8624.2007.00995.x; Brain Institute, 2000, BRAIN AW; BrainFacts.org, 2012, NEUR; Brinton RD, 2007, J NEUROSCI, V27, P11163, DOI 10.1523/JNEUROSCI.4208-07.2007; Cameron W, 2003, NAT REV NEUROSCI, V4, P763, DOI 10.1038/nrn1200; Chen JA, 2010, CONTEMP EDUC PSYCHOL, V35, P75, DOI 10.1016/j.cedpsych.2009.10.003; Chudler E, 2012, NEUR KIDS BRAIN AW; Dana Foundation, 2012, BRAIN AW WEEK; Dekker S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00429; Dimitrov DM, 2003, WORK, V20, P165; Dweck C. S., 2006, MINDSET NEW PSYCHOL; DWECK CS, 1988, PSYCHOL REV, V95, P256, DOI 10.1037/0033-295X.95.2.256; Dweck CS, 2010, MINDSET ONLINE; Ecklund EH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036240; Fitzakerley J, 2008, BRAIN AWARENESS ACTI; Fitzakerley JL, 2008, MINNESOTA MED; Fulop RM, 2012, ADV PHYSIOL EDUC, V36, P131, DOI 10.1152/advan.00093.2011; Gamse B, 2010, EVALUATION NATL SCI, VI; Geake J, 2013, ED RES, V50, P123; George R, 2006, INT J SCI EDUC, V28, P571, DOI 10.1080/09500690500338755; Gibson HL, 2002, SCI EDUC, V86, P693, DOI 10.1002/sce.10039; GOGOLIN L, 1992, J RES SCI TEACH, V29, P487, DOI 10.1002/tea.3660290505; Hazari Z, 2010, J RES SCI TEACH, V47, P978, DOI 10.1002/tea.20363; Herculano-Houzel S, 2003, NAT NEUROSCI, V6, P325, DOI 10.1038/nn0403-325; Herculano-Houzel S, 2002, NEUROSCIENTIST, V8, P98, DOI 10.1177/107385840200800206; Howard-Jones P, 2010, INTRO NEUROEDUCATION; IBRO, 2012, BRAIN CAMP; Jensen P, 2005, NATURE, V434, P956, DOI 10.1038/434956a; Jensen P., 2008, SCI PUBL POLICY, V35, P527, DOI [10.3152/030234208x329130, DOI 10.3152/030234208X329130]; Kane JM, 2012, SCI EDUC, V96, P457, DOI 10.1002/sce.20483; Kim C, 2008, J GREAT LAKES RES, V34, P98, DOI 10.3394/0380-1330(2008)34[98:GLSPOK]2.0.CO;2; Kline P., 1999, HDB PSYCHOL TESTING; Kwiek NC, 2007, SCIENCE, V317, P1871, DOI 10.1126/science.1146811; Labriole M, 2010, PROM BRAIN SCI LIT K; Laursen Sandra, 2007, CBE Life Sci Educ, V6, P49, DOI 10.1187/cbe.06-05-0165; MacNabb C., 2000, BRAINU NEUROSCIENCE; MacNabb C, 2006, LESSONS; Marshall PJ, 2012, EARLY EDUC DEV, V23, P4, DOI 10.1080/10409289.2011.616134; Melvin AD, 2006, WHY SCI MUST MOV K 1; National Center for Earth and Space Science Education, 2008, JOURN UN; National Research Council, 1996, ROL SCI PROF DEV SCI; National Research Council, 2012, FRAM FORM 12 SCI ED; Neresini F, 2011, PUBLIC UNDERST SCI, V20, P64, DOI 10.1177/0963662510388363; Nunnally JC, 1994, PSYCHOMETRIC THEORY, P113; O'Sullivan CY, 1999, DCNCES1999455; Osborne J, 2003, INT J SCI EDUC, V25, P1049, DOI 10.1080/0950069032000032199; PCAST, 2010, PEP INSP K 12 ED SCI; Pedretti E, 2006, SCI SCH IMP STUDY; Pelaez NJ, 2002, ADV PHYSIOL EDUC, V26, P158, DOI 10.1152/advan.00045.2002a; Pickering SJ, 2007, MIND BRAIN EDUC, V1, P109, DOI 10.1111/j.1751-228X.2007.00011.x; Romero-Calderon R, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001310; Royal Society, 2006, SCI COMM EXC SCI SUR; Royal Society, 1985, PUBLIC UNDERST SCI; Schneider W, 2008, MIND BRAIN EDUC, V2, P114, DOI 10.1111/j.1751-228X.2008.00041.x; Shanahan MC, 2011, SCHOOL SCI MATH, V111, P131, DOI 10.1111/j.1949-8594.2011.00071.x; Simons DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022757; Society for Neuroscience, 2012, BRAIN AWARENESS WEEK; Sperduti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047943; Tabernero C, 1999, ORGAN BEHAV HUM DEC, V78, P104, DOI 10.1006/obhd.1999.2829; Tai RH, 2006, SCIENCE, V312, P1143, DOI 10.1126/science.1128690; Tanner Kimberly D, 2003, Cell Biol Educ, V2, P195, DOI 10.1187/cbe.03-10-0044; Trochim W.M., 2006, RES METHODS KNOWLEDG; Ufnar JA, 2012, CBE-LIFE SCI EDUC, V11, P239, DOI 10.1187/cbe.11-12-0119; van Aalderen-Smeets S, 2013, INT J SCI EDUC, V35, P577, DOI 10.1080/09500693.2012.755576; Varma S, 2008, EDUC RESEARCHER, V37, P140, DOI 10.3102/0013189X08317687; Weisberg DS, 2008, J COGNITIVE NEUROSCI, V20, P470, DOI 10.1162/jocn.2008.20040; Yeager DS, 2012, EDUC PSYCHOL-US, V47, P302, DOI 10.1080/00461520.2012.722805; Zardetto-Smith AM, 2002, NEUROSCIENTIST, V8, P396, DOI 10.1177/107385802236965	72	20	20	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84035	10.1371/journal.pone.0084035	http://dx.doi.org/10.1371/journal.pone.0084035			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GD	24358325	gold, Green Submitted, Green Published			2022-12-27	WOS:000328735700147
J	Kaiser, JP; Roesslein, M; Diener, L; Wick, P				Kaiser, Jean-Pierre; Roesslein, Matthias; Diener, Liliane; Wick, Peter			Human Health Risk of Ingested Nanoparticles That Are Added as Multifunctional Agents to Paints: an In Vitro Study	PLOS ONE			English	Article							TOXICITY; PARTICLE; LUNG; AGGLOMERATION; MECHANISMS; INHALATION; DUST	Microorganisms growing on painted surfaces are not only an aesthetic problem, but also actively contribute to the weathering and deterioration of materials. A widely used strategy to combat microbial colonization is the addition of biocides to the paint. However, ecotoxic, non-degradable biocides with a broad protection range are now prohibited in Europe, so the paint industry is considering engineered nanoparticles (ENPs) as an alternative biocide. There is concern that ENPs in paint might be released in run-off water and subsequently consumed by animals and/or humans, potentially coming into contact with cells of the gastrointestinal tract and affecting the immune system. Therefore, in the present study we evaluated the cytotoxic effects of three ENPs (nanosilver, nanotitanium dioxide and nanosilicon dioxide) that have a realistic potential for use in paints in the near future. When exposed to nanotitanium dioxide and nanosilicon dioxide in concentrations up to 243 mu g/mL for 48 h, neither the gastrointestinal cells (CaCo-2) nor immune system cells (Jurkat) were significantly affected. However, when exposed to nanosilver, several cell parameters were affected, but far less than by silver ions used as a control. No differences in cytotoxicity were observed when cells were exposed to ENP-containing paint particles, compared with the same paint particles without ENPs. Paint particles containing ENPs did not affect cell morphology, the release of reactive oxygen species or cytokines, cell activity or cell death in a different manner to the same paint particles without ENPs. The results suggest that paints doped with ENPs do not pose an additional acute health hazard for humans.	[Kaiser, Jean-Pierre; Roesslein, Matthias; Diener, Liliane; Wick, Peter] Swiss Fed Labs Mat Sci & Technol, Empa, Mat Biol Interact Lab, St Gallen, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Kaiser, JP (corresponding author), Swiss Fed Labs Mat Sci & Technol, Empa, Mat Biol Interact Lab, St Gallen, Switzerland.	jean-pierre.kaiser@empa.ch	Roesslein, Matthias/V-4342-2019	Roesslein, Matthias/0000-0002-6858-4124	European Commission [207816]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The work has been financially supported by the Seventh Framework Program of the European Commission (NanoHouse project; Grant Agreement No. 207816). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Arts JHE, 2007, FOOD CHEM TOXICOL, V45, P1856, DOI 10.1016/j.fct.2007.04.001; AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; Bury NR, 1999, AM J PHYSIOL-REG I, V277, pR1385, DOI 10.1152/ajpregu.1999.277.5.R1385; Canesi L, 2010, AQUAT TOXICOL, V96, P151, DOI 10.1016/j.aquatox.2009.10.017; Cronholm P, 2013, SMALL, V9, P970, DOI 10.1002/smll.201201069; Donaldson K, 2003, FREE RADICAL BIO MED, V34, P1369, DOI 10.1016/S0891-5849(03)00150-3; Fortin C, 2001, ENVIRON SCI TECHNOL, V35, P2214, DOI 10.1021/es0017965; Gladis F, 2010, BIOFOULING, V26, P89, DOI 10.1080/08927010903278184; Hastings RH, 2004, AM J PHYSIOL-LUNG C, V286, pL679, DOI 10.1152/ajplung.00205.2003; Jacobsen NR, 2007, ENVIRON MOL MUTAGEN, V48, P451, DOI 10.1002/em.20300; Jin Y.H., 2009, NANOTECHNOLOGIES LIF, V2, P221; Johnston HJ, 2010, NANOTOXICOLOGY, V4, P207, DOI 10.3109/17435390903569639; Kaegi R, 2008, ENVIRON POLLUT, V156, P233, DOI 10.1016/j.envpol.2008.08.004; Kaiser J. -P., 2013, Journal of King Saud University Science, V25, P15, DOI 10.1016/j.jksus.2012.06.003; Kaiser JP, 2013, SCI TOTAL ENVIRON, V442, P282, DOI 10.1016/j.scitotenv.2012.10.009; Koponen IK, 2011, J EXPO SCI ENV EPID, V21, P408, DOI 10.1038/jes.2010.32; KREYLING WG, 1992, ENVIRON HEALTH PERSP, V97, P121, DOI 10.2307/3431339; Limbach LK, 2005, ENVIRON SCI TECHNOL, V39, P9370, DOI 10.1021/es051043o; Merget R, 2002, ARCH TOXICOL, V75, P625, DOI 10.1007/S002040100266; Michel K, 2013, NANOTOXICOLOGY, V7, P974, DOI 10.3109/17435390.2012.689881; Mikkelsen L, 2013, NANOTOXICOLOGY, V7, P117, DOI 10.3109/17435390.2011.641604; Mueller NC, 2008, ENVIRON SCI TECHNOL, V42, P4447, DOI 10.1021/es7029637; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nowack B, 2011, ENVIRON SCI TECHNOL, V45, P1177, DOI 10.1021/es103316q; Pietarinen VM, 2008, J ENVIRON MONITOR, V10, P655, DOI 10.1039/b716138g; Pujalte I, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-10; Saber AT, 2012, NANOTOXICOLOGY, V6, P453, DOI 10.3109/17435390.2011.587900; Saber AT, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-4; Schoknecht U, 2009, ENVIRON SCI TECHNOL, V43, P9321, DOI 10.1021/es9019832; Skebo JE, 2007, INT J TOXICOL, V26, P135, DOI 10.1080/10915810701226248; Smulders S, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-41; Som C, 2011, ENVIRON INT, V37, P1131, DOI 10.1016/j.envint.2011.02.013; Thurnherr T, 2011, TOXICOL LETT, V200, P176, DOI 10.1016/j.toxlet.2010.11.012; Welling I, 2009, J OCCUP ENVIRON HYG, V6, P90, DOI 10.1080/15459620802623073	34	42	42	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83215	10.1371/journal.pone.0083215	http://dx.doi.org/10.1371/journal.pone.0083215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358264	Green Published, gold			2022-12-27	WOS:000328735700111
J	Prendergast, G; Limbrick-Oldfield, E; Ingamells, E; Gathercole, S; Baddeley, A; Green, GGR				Prendergast, Garreth; Limbrick-Oldfield, Eve; Ingamells, Ed; Gathercole, Susan; Baddeley, Alan; Green, Gary G. R.			Differential Patterns of Prefrontal MEG Activation during Verbal & Visual Encoding and Retrieval	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; MATERIAL-SPECIFIC LATERALIZATION; EPISODIC MEMORY; FRONTAL-LOBE; GAMMA OSCILLATIONS; HERA MODEL; CORTEX; ASYMMETRY; STIMULATION; THETA	The spatiotemporal profile of activation of the prefrontal cortex in verbal and non-verbal recognition memory was examined using magnetoencephalography (MEG). Sixteen neurologically healthy right-handed participants were scanned whilst carrying out a modified version of the Doors and People Test of recognition memory. A pattern of significant prefrontal activity was found for non-verbal and verbal encoding and recognition. During the encoding, verbal stimuli activated an area in the left ventromedial prefrontal cortex, and non-verbal stimuli activated an area in the right. A region in the left dorsolateral prefrontal cortex also showed significant activation during the encoding of non-verbal stimuli. Both verbal and non-verbal stimuli significantly activated an area in the right dorsomedial prefrontal cortex and the right anterior prefrontal cortex during successful recognition, however these areas showed temporally distinct activation dependent on material, with non-verbal showing activation earlier than verbal stimuli. Additionally, non-verbal material activated an area in the left anterior prefrontal cortex during recognition. These findings suggest a material-specific laterality in the ventromedial prefrontal cortex during encoding for verbal and non-verbal but also support the HERA model for verbal material. The discovery of two process dependent areas during recognition that showed patterns of temporal activation dependent on material demonstrates the need for the application of more temporally sensitive techniques to the involvement of the prefrontal cortex in recognition memory.	[Prendergast, Garreth; Green, Gary G. R.] Univ York, York NeuroImaging Ctr, York YO10 5DD, N Yorkshire, England; [Limbrick-Oldfield, Eve] Univ Cambridge, Dept Psychol, Cambridge, England; [Ingamells, Ed; Baddeley, Alan] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Gathercole, Susan] Univ Cambridge, MRC, Cognit & Brain Sci Unit, Cambridge, England	University of York - UK; University of Cambridge; University of York - UK; University of Cambridge	Prendergast, G (corresponding author), Univ York, York NeuroImaging Ctr, York YO10 5DD, N Yorkshire, England.	garreth.prendergast@ynic.york.ac.uk	Green, Gary GR/D-3543-2009	Green, Gary GR/0000-0003-1977-7509; Prendergast, Garreth/0000-0002-7255-6708				ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Babiloni C, 2006, BRAIN RES BULL, V68, P203, DOI 10.1016/j.brainresbull.2005.04.019; Castillo EM, 2003, REV ESPANOLA NEUROPS, V5, P99; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; Company, 1994, DOORS PEOPLE TEST VI; Epstein CM, 2002, NEUROSCI LETT, V320, P5, DOI 10.1016/S0304-3940(01)02573-3; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Floel A, 2004, CEREB CORTEX, V14, P404, DOI 10.1093/cercor/bhh002; Friese U, 2013, NEUROIMAGE, V66, P642, DOI 10.1016/j.neuroimage.2012.11.002; Golby AJ, 2001, BRAIN, V124, P1841, DOI 10.1093/brain/124.9.1841; Habib R, 2003, TRENDS COGN SCI, V7, P241, DOI 10.1016/S1364-6613(03)00110-4; Heister D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066820; Huang MX, 2004, BRAIN TOPOGR, V16, P139; Hymers M, 2010, NEUROIMAGE, V49, P1385, DOI 10.1016/j.neuroimage.2009.09.055; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Kohler S, 2004, J COGNITIVE NEUROSCI, V16, P178, DOI 10.1162/089892904322984490; Kozinska D, 2001, CLIN NEUROPHYSIOL, V112, P1553, DOI 10.1016/S1388-2457(01)00556-9; Maris E, 2007, J NEUROSCI METH, V163, P161, DOI 10.1016/j.jneumeth.2007.02.011; McDermott KB, 1999, J COGNITIVE NEUROSCI, V11, P631, DOI 10.1162/089892999563698; McDonald CR, 2006, CORTEX, V42, P1080, DOI 10.1016/S0010-9452(08)70220-X; MILNER B, 1991, NEUROPSYCHOLOGIA, V29, P601, DOI 10.1016/0028-3932(91)90013-X; MORRIS RG, 1995, NEUROPSYCHOLOGY, V9, P464, DOI 10.1037/0894-4105.9.4.464; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nyberg L, 1996, PSYCHON B REV, V3, P135, DOI 10.3758/BF03212412; Opitz B, 2000, LEARN MEMORY, V7, P85, DOI 10.1101/lm.7.2.85; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Papanicolaou AC, 2002, LEARN MEMORY, V9, P99, DOI 10.1101/lm.44302; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Prendergast G, 2011, NEUROIMAGE, V54, P906, DOI 10.1016/j.neuroimage.2010.08.005; Riggs L, 2009, NEUROIMAGE, V45, P627, DOI 10.1016/j.neuroimage.2008.11.018; Rossi S, 2001, NAT NEUROSCI, V4, P948, DOI 10.1038/nn0901-948; Sandrini M, 2003, J COGNITIVE NEUROSCI, V15, P855, DOI 10.1162/089892903322370771; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Singh KD, 2003, NEUROIMAGE, V19, P1589, DOI 10.1016/S1053-8119(03)00249-0; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; Wagner AD, 1998, NEUROREPORT, V9, P3711, DOI 10.1097/00001756-199811160-00026	38	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82936	10.1371/journal.pone.0082936	http://dx.doi.org/10.1371/journal.pone.0082936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358238	Green Published, gold, Green Accepted			2022-12-27	WOS:000328735700097
J	Treydte, AC; Baumgartner, S; Heitkonig, IMA; Grant, CC; Getz, WM				Treydte, Anna Christina; Baumgartner, Sabine; Heitkoenig, Ignas M. A.; Grant, Catharina C.; Getz, Wayne M.			Herbaceous Forage and Selection Patterns by Ungulates across Varying Herbivore Assemblages in a South African Savanna	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; SPATIAL HETEROGENEITY; SEMIARID SAVANNA; DIET SELECTION; DRY SEASON; CATTLE; VEGETATION; LANDSCAPE; LIVESTOCK; FIRE	Herbivores generally have strong structural and compositional effects on vegetation, which in turn determines the plant forage species available. We investigated how selected large mammalian herbivore assemblages use and alter herbaceous vegetation structure and composition in a southern African savanna in and adjacent to the Kruger National Park, South Africa. We compared mixed and mono-specific herbivore assemblages of varying density and investigated similarities in vegetation patterns under wildlife and livestock herbivory. Grass species composition differed significantly, standing biomass and grass height were almost twice as high at sites of low density compared to high density mixed wildlife species. Selection of various grass species by herbivores was positively correlated with greenness, nutrient content and palatability. Nutrient-rich Urochloa mosambicensis Hack. and Panicum maximum Jacq. grasses were preferred forage species, which significantly differed in abundance across sites of varying grazing pressure. Green grasses growing beneath trees were grazed more frequently than dry grasses growing in the open. Our results indicate that grazing herbivores appear to base their grass species preferences on nutrient content cues and that a characteristic grass species abundance and herb layer structure can be matched with mammalian herbivory types.	[Treydte, Anna Christina; Baumgartner, Sabine] Univ Hohenheim, Stuttgart, Germany; [Heitkoenig, Ignas M. A.] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Grant, Catharina C.] Sci Serv Kruger Natl Pk, Syst Ecol, Skukuza, South Africa; [Getz, Wayne M.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa	University Hohenheim; Wageningen University & Research; University of California System; University of California Berkeley; University of Kwazulu Natal	Treydte, AC (corresponding author), Univ Hohenheim, Stuttgart, Germany.	anna.treydte@uni-hohenheim.de	; Getz, Wayne/I-4521-2013	Heitkonig, Ignas/0000-0001-7771-3111; Treydte, Anna/0000-0003-0605-3069; Getz, Wayne/0000-0001-8784-9354	Humboldt foundation; NIH [GM083863]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083863] Funding Source: NIH RePORTER	Humboldt foundation(Alexander von Humboldt Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Part of this study was funded by the "Feodor-Lynen-Stipendium fur Erfahrene Wissenschaftler'' of the Humboldt foundation to ACT (http://www.humboldt-foundation.de/web/feodor-lynen-fellowship-postdoc.html). WMG was supported by Grant NIH GM083863. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2000, APPL VEG SCI, V3, P213, DOI 10.2307/1479000; Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Anderson TM, 2007, AM NAT, V170, P343, DOI 10.1086/520120; Arsenault R, 2008, OIKOS, V117, P1711, DOI 10.1111/j.1600-0706.2008.16575.x; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Augustine DJ, 2003, ECOL APPL, V13, P1325, DOI 10.1890/02-5283; Augustine DJ, 2004, J APPL ECOL, V41, P45, DOI 10.1111/j.1365-2664.2004.00864.x; Bailey Derek W., 2008, V23, P7; Baumgartner SA, BASIC APPL IN PRESS; BELOVSKY GE, 1984, AM NAT, V124, P97, DOI 10.1086/284254; BENSHAHAR R, 1991, AFR J ECOL, V29, P302, DOI 10.1111/j.1365-2028.1991.tb00468.x; Botha MS, 2005, S AFR J SCI, V101, P371; Burns CE, 2009, BIODIVERS CONSERV, V18, P2327, DOI 10.1007/s10531-009-9590-x; Carlassare M, 2002, AGRON J, V94, P840; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Codron D, 2007, S AFR J WILDL RES, V37, P117, DOI 10.3957/0379-4369-37.2.117; Cromsigt JPGM, 2006, ECOLOGY, V87, P1532, DOI 10.1890/0012-9658(2006)87[1532:RPASGM]2.0.CO;2; Druce DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003979; DYKSTERHUIS E. J., 1949, JOUR RANGE MANAGEMENT, V2, P104, DOI 10.2307/3893680; EAST RM, 1993, AGROFOREST SYST, V22, P91, DOI 10.1007/BF00705139; Frank DA, 2005, OECOLOGIA, V143, P629, DOI 10.1007/s00442-005-0019-2; Fynn RWS, 2012, RANGELAND ECOL MANAG, V65, P319, DOI 10.2111/REM-D-11-00141.1; Fynn RWS, 2000, J APPL ECOL, V37, P491, DOI 10.1046/j.1365-2664.2000.00513.x; Gertenbach W. P. D., 1980, Koedoe, V23, P35; Grant CC, 2003, AFRICAN J RANGE FORA, V20, P1; Hanotte O, 2000, MOL ECOL, V9, P387, DOI 10.1046/j.1365-294x.2000.00858.x; Hayes GF, 2003, CONSERV BIOL, V17, P1694, DOI 10.1111/j.1523-1739.2003.00281.x; Hurlbert SH, 2004, OIKOS, V104, P591, DOI 10.1111/j.0030-1299.2004.12752.x; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Iason GR, 1999, HERBIVORES: BETWEEN PLANTS AND PREDATORS, P337; Jacobs SM, 2008, J ARID ENVIRON, V72, P891, DOI 10.1016/j.jaridenv.2007.11.015; JARRELL WM, 1981, ADV AGRON, V34, P197, DOI 10.1016/S0065-2113(08)60887-1; Jones WM, 2011, BIOL CONSERV, V144, P511, DOI 10.1016/j.biocon.2010.10.005; Kent M., 1994, VEGETATION DESCRIPTI; Lessard JP, 2012, BASIC APPL ECOL, V13, P59, DOI 10.1016/j.baae.2011.11.001; Letnic M, 2004, RANGELAND J, V26, P34, DOI 10.1071/RJ04003; Macandza VA, 2004, S AFR J WILDL RES, V34, P113; Murray M G, 2001, INFLUENCE LARGE ANIM; Musiega DE, 2006, ECOL RES, V21, P530, DOI 10.1007/s11284-006-0175-9; OCONNOR TG, 1994, J APPL ECOL, V31, P155, DOI 10.2307/2404608; Odadi WO, 2010, THESIS EGERTON U NJO; Oksanen L, 2001, OIKOS, V94, P27, DOI 10.1034/j.1600-0706.2001.11311.x; OWENSMITH N, 1989, J ZOOL, V219, P29, DOI 10.1111/j.1469-7998.1989.tb02563.x; PEEL MJS, 1999, AFRICAN J RANGE FORA, V15, P117, DOI DOI 10.1080/10220119.1998.9647953; Radloff FGT, 2007, J VEG SCI, V18, P719, DOI 10.1111/j.1654-1103.2007.tb02586.x; Redfern JV, 2003, ECOLOGY, V84, P2092, DOI 10.1890/01-0625; Reeder JD, 2002, ENVIRON POLLUT, V116, P457, DOI 10.1016/S0269-7491(01)00223-8; Shackleton CM, 2000, BIOL CONSERV, V94, P273, DOI 10.1016/S0006-3207(00)00001-X; Smit IPJ, 2007, BIOL CONSERV, V136, P85, DOI 10.1016/j.biocon.2006.11.009; Stock WD, 2010, PLANT ECOL, V206, P15, DOI 10.1007/s11258-009-9621-4; TAYLOR RD, 1978, J APPL ECOL, V15, P565, DOI 10.2307/2402611; THRASH I, 1995, J ARID ENVIRON, V29, P213, DOI 10.1016/S0140-1963(05)80091-6; Treydte AC, 2009, BIODIVERS CONSERV, V18, P3989, DOI 10.1007/s10531-009-9694-3; Treydte AC, 2007, PERSPECT PLANT ECOL, V8, P197, DOI 10.1016/j.ppees.2007.03.001; Van Oudtshoorn F.P., 2004, GUIDE GRASSES SO AFR; Van Rooyen J, 2011, THESIS U PRETORIA; van Wilgen BW, 2007, INT J WILDLAND FIRE, V16, P519, DOI 10.1071/WF06115; Vanak AT, 2012, ECOGRAPHY, V35, P315, DOI 10.1111/j.1600-0587.2011.07213.x; Veblen KE, 2010, J ECOL, V98, P993, DOI 10.1111/j.1365-2745.2010.01705.x; Venter F.J., 2003, KRUGER EXPERIENCE EC, P83, DOI DOI 10.2989/10220110409485835; Verweij RJT, 2006, OIKOS, V114, P108, DOI 10.1111/j.2006.0030-1299.14209.x; WESTOBY M, 1974, AM NAT, V108, P290, DOI 10.1086/282908; WONG CC, 1980, AUST J AGR RES, V31, P269, DOI 10.1071/AR9800269; Zar JH, 1999, BIOSTATISTICAL ANAL; [No title captured]	65	31	31	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82831	10.1371/journal.pone.0082831	http://dx.doi.org/10.1371/journal.pone.0082831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358228	gold, Green Published			2022-12-27	WOS:000328735700094
J	Zhang, XX; Fang, JZ; Xu, B; Zhang, SL; Su, SF; Song, Z; Deng, YF; Wang, HN; Zhao, D; Niu, XB; Wang, ZJ				Zhang, Xiangxiang; Fang, Jianzheng; Xu, Bin; Zhang, Shengli; Su, Shifeng; Song, Zhen; Deng, Yunfei; Wang, Hainan; Zhao, Dan; Niu, Xiaobing; Wang, Zengjun			Correlation of Epididymal Protease Inhibitor and Fibronectin in Human Semen	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; ARG-GLY-ASP; SEMENOGELIN-I; HUMAN SPERM; HUMAN SPERMATOZOA; EPPIN; PROTEINS; MOTILITY; CAPACITATION; LIQUEFACTION	Objective: Epididymal protease inhibitor (Eppin) was located on the surface of spermatozoa and modulates the liquefaction of human semen. Here, we identify the correlative protein partner of Eppin to explore the molecular mechanism of liquefaction of human semen. Methods: (1) Human seminal vesicle proteins were transferred on the membrane by Western blotting and separated by 2-D electrophoresis and incubated in recombinant Eppin. The correlative protein was identified by Mass Spectrometry (MS) (2). Western blotting was used to determine the relation of rEppin and rFibronectin(Fn); (3) Co-localization in spermatozoa were detected using immunofluorescence; (4) Correalation of Eppin and Fn was proved by co-immunoprecipitation. Results: Fn was identified as the binding partner of recombinant Eppin by MS. Recombinant of Eppin was made and demonstrated that the Eppin fragment binds the fn 607-1265 fragment. The Eppin-Fn complex presents on the sperm tail and particularly in the midpiece region of human ejaculated spermatozoa. Immunoprecipitation indicated that Eppin in the spermatozoa lysates was complexed with Fn. Conclusions: Our study demonstrates that Eppin and Fn bind to each other in human semen and on human ejaculated spermatozoa. Eppin-Fn complex may involve in semen coagulation, liquefaction and the survival and preparation of spermatozoa for fertility in the female reproductive tract.	[Zhang, Xiangxiang; Fang, Jianzheng; Zhang, Shengli; Su, Shifeng; Song, Zhen; Deng, Yunfei; Wang, Hainan; Zhao, Dan; Niu, Xiaobing; Wang, Zengjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Xu, Bin] Southeast Univ, Affiliated Zhongda Hosp, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiangxiang] Jiangsu Provice Official Hosp, Dept Urol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China	Wang, ZJ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	zengjunwang@njmu.edu.cn		Xu, Bin/0000-0001-5511-8055	National Natural Science Foundation of China [81270685]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (NO.81270685) (http://isisn.nsfc.gov.cn/egrantweb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA SK, 1995, CANCER METAST REV, V14, P173, DOI 10.1007/BF00690290; Attia AM, 2011, ANDROLOGIA, V43, P387, DOI 10.1111/j.1439-0272.2010.01056.x; Bronson RA, 1996, MOL HUM REPROD, V2, P153, DOI 10.1093/molehr/2.3.153; Clauss A, 2002, BIOCHEM J, V368, P233, DOI 10.1042/BJ20020869; De Lamirande E, 2001, J ANDROL, V22, P672; Diaz ES, 2007, HUM REPROD, V22, P1420, DOI 10.1093/humrep/dem023; Fung KYC, 2004, PROSTATE, V61, P171, DOI 10.1002/pros.20089; FUSI FM, 1993, MOL REPROD DEV, V36, P212, DOI 10.1002/mrd.1080360212; FUSI FM, 1992, J ANDROL, V13, P28; Jonsson M, 2005, BIOCHEM J, V387, P447, DOI 10.1042/BJ20041424; LILJA H, 1987, J CLIN INVEST, V80, P281, DOI 10.1172/JCI113070; LILJA H, 1985, J CLIN INVEST, V76, P1899, DOI 10.1172/JCI112185; Malm J, 1996, EUR J BIOCHEM, V238, P48, DOI 10.1111/j.1432-1033.1996.0048q.x; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; MIRANDA PV, 1992, MOL REPROD DEV, V33, P443, DOI 10.1002/mrd.1080330411; MOSHER DF, 1984, ANNU REV MED, V35, P561, DOI 10.1146/annurev.me.35.020184.003021; O'Rand MG, 2004, SCIENCE, V306, P1189, DOI 10.1126/science.1099743; O'Rand MG, 2009, BIOL REPROD, V80, P279, DOI 10.1095/biolreprod.108.072942; Olorundare OE, 2001, BLOOD, V98, P117, DOI 10.1182/blood.V98.1.117; Richardson RT, 2001, GENE, V270, P93, DOI 10.1016/S0378-1119(01)00462-0; Robert M, 1997, BIOCHEMISTRY-US, V36, P3811, DOI 10.1021/bi9626158; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; Thys M, 2009, REPRODUCTION, V138, P471, DOI 10.1530/REP-09-0094; Wang ZJ, 2008, ASIAN J ANDROL, V10, P770, DOI 10.1111/j.1745-7262.2008.00393.x; Wang ZJ, 2007, BIOL REPROD, V77, P476, DOI 10.1095/biolreprod.107.060194; Wang ZJ, 2005, BIOL REPROD, V72, P1064, DOI 10.1095/biolreprod.104.036483; Wennemuth G, 1997, INT J ANDROL, V20, P10, DOI 10.1046/j.1365-2605.1997.00005.x; Wennemuth G, 2001, ANDROLOGIA, V33, P43, DOI 10.1046/j.1439-0272.2001.00370.x	29	4	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82600	10.1371/journal.pone.0082600	http://dx.doi.org/10.1371/journal.pone.0082600			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358212	gold, Green Published			2022-12-27	WOS:000328735700085
J	Millier, A; Cohen, J; Toumi, M				Millier, Aurelie; Cohen, Joshua; Toumi, Mondher			Economic Impact of a triptan Rx-To-OTC Switch in Six EU Countries	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH-CARE UTILIZATION; MEDICATION OVERUSE; COST-EFFECTIVENESS; CHRONIC MIGRAINE; PREVALENCE; MANAGEMENT; DISABILITY; GUIDELINES; DIAGNOSIS	Introduction: Triptans have been safely and effectively used in the management of migraine for more than fifteen years, and it seems reasonable to wonder what would be the economic impact of moving a specific triptan to OTC availability. The objective of this study was then to examine the economic impact of payer policies of a triptan Rx-toOTC switch in six EU countries (France, UK, Spain, Italy, Germany and Poland). Methods: A decision model was used to model the budgetary impact of a triptan Rx-to-OTC switch from the thirdparty payer (TPP) and the societal perspectives, using a one-year timeframe. Results: From the TPP perspective, it is estimated that the current overall direct spending on the management of migraine attacks across the 6 EU Member States is (sic)582 million annually, and that the savings would reach (sic)75 million (13% of the overall direct economic burden of migraine). From the societal perspective, 86 million annually would be added. Conclusions: Given evidence of effectiveness and safety, and given the potential savings, a triptan Rx-to-OTC switch is a reasonable public policy decision.	[Millier, Aurelie] Creativ Ceut, Hlth Econ & Outcomes Res Dept, Paris, France; [Cohen, Joshua] Tufts Univ, Tufts Ctr, Study Drug Dev, Boston, MA 02111 USA; [Toumi, Mondher] Univ Lyon 1, Unite Format & Rech Odontol, F-69365 Lyon, France	Tufts University; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Millier, A (corresponding author), Creativ Ceut, Hlth Econ & Outcomes Res Dept, Paris, France.	ami@creativ-ceutical.com						Abel H, 2009, OPTOMETRY, V80, P138, DOI 10.1016/j.optm.2008.06.008; [Anonymous], 2011, BMC NEUROLOGY; [Anonymous], 2005, SOIK HEALTHC COSTS D; [Anonymous], EC PUBL HLTH VAL SEL; [Anonymous], 2010, ANN SURVEY HOURS EAR; [Anonymous], 2010, WART STAW KAP POR RY; Baggott M, 2000, JAMA-J AM MED ASSOC, V284, P2190, DOI 10.1001/jama.284.17.2190; Banque mondiale, 2011, BANQUE MONDIALE INDI; Bewertungsmalistab Einheitlicher, 2011, EBM; British. Association for the Study of Headache, 2007, GUID HEALTHC PROF DI; Brown JS, 2006, CEPHALALGIA, V26, P1473, DOI 10.1111/j.1468-2982.2006.01240.x; Christian Lucas, 2011, CEPH CHRON QUOT AB M; Cohen J, 2013, J Med Econ, V16, P835, DOI 10.3111/13696998.2013.793693; Creac'h C, 2009, HEADACHE, V49, P519, DOI 10.1111/j.1526-4610.2009.01365.x; D'Amico D, 2005, HEADACHE, V45, P553, DOI 10.1111/j.1526-4610.2005.05109.x; D'Amico D, 2003, NEUROL SCI, V24, pS97; Demarin V, 2005, ACTA MED CROATICA, V62, P99; Falagas ME, 2007, INT J CLIN PRACT, V61, P1569, DOI 10.1111/j.1742-1241.2007.01423.x; Food and Drug Administration, 2005, T0523 FAO; Gallai V, 2001, J HEADACHE PAIN, V2, P125; Geraud G, 2004, CLIN THER, V26, P1305; Gerth WC, 2001, PHARMACOECONOMICS, V19, P197, DOI 10.2165/00019053-200119020-00006; Gomez-Gerique Juan Antonio, 2004, Eur J Health Econ, V5, P278, DOI 10.1007/s10198-003-0222-1; Guidotti M, 2009, CLIN DRUG INVEST, V29, P693, DOI 10.2165/11315330-000000000-00000; Haag G, 2011, J HEADACHE PAIN, V12, P201, DOI 10.1007/s10194-010-0266-4; Ilioudi Stamatia, 2010, Int J Electron Healthc, V5, P327, DOI 10.1504/IJEH.2010.036205; Jamieson DG, 2002, AM J MED, V112, P135, DOI 10.1016/S0002-9343(01)01064-6; Jensen K, 1998, CEPHALALGIA, V18, P9, DOI 10.1046/j.1468-2982.1998.1801009.x; Johnston MM, 2010, DRUGS, V70, P1505, DOI 10.2165/11537990-000000000-00000; Kalra Arun A, 2007, Ther Clin Risk Manag, V3, P449; KOFOED LL, 1985, GERIATRICS, V40, P55; Lainez JM, 2007, REV CLIN ESP, V207, P190, DOI [10.1157/13101849, DOI 10.1157/13101849.PUBMED:17475183]; Lainez MJA, 2005, HEADACHE, V45, P883, DOI 10.1111/j.1526-4610.2005.05156.x; Landy SH, 2012, HEADACHE, V52, P363, DOI 10.1111/j.1526-4610.2011.02029.x; Lanteri-Minet M, 2011, CEPHALALGIA, V31, P837, DOI 10.1177/0333102411398400; Lipton RB, 2003, NEUROLOGY, V60, P441, DOI 10.1212/WNL.60.3.441; Lordick F, 2007, EUR J CANCER, V43, P299, DOI 10.1016/j.ejca.2006.09.019; MacGregor EA, 2004, CURR MED RES OPIN, V20, P1777, DOI 10.1185/030079904X10142; MacGregor EA, 1998, DRUG TODAY, V34, P1027, DOI 10.1358/dot.1998.34.12.487488; Matias-Guiu J, 2011, CEPHALALGIA, V31, P463, DOI 10.1177/0333102410382794; National Institute on Drug Abuse, 2001, NIH PUBLICATION; Navarro A, 2011, BMC NEUROLOGY BMC NE, V20, P11; Perearnau P, 2006, REV NEUROL-FRANCE, V162, P347, DOI 10.1016/S0035-3787(06)75021-4; Radtke A, 2009, HEADACHE, V49, P79, DOI 10.1111/j.1526-4610.2008.01263.x; Raybaud H, 2011, MIGRAINES CEPHALEES; Roncolato M, 2000, EUR NEUROL, V43, P102, DOI 10.1159/000008143; Scottish Intercollegiate Guidelines Network, 2008, DIAGN MAN HEAD AD GU; Societe Suisse pour l'etude des cephalees, 2008, CEPH ALG FAC REC THE; Stefanache F, 2006, HEADACHE CRANIAL NEU, P140; Steiner T, 2008, EC COST MIGRANINE HA; Steiner TJ, 2003, CEPHALALGIA, V23, P519, DOI 10.1046/j.1468-2982.2003.00568.x; Stepien A, 2003, BOL, P3; Stovner LJ, 2009, J HEADACHE PAIN, V10, P395, DOI 10.1007/s10194-009-0156-9; Tfelt-Hansen P, 2007, CNS DRUGS, V21, P877, DOI 10.2165/00023210-200721110-00001; Villalon Carlos M., 2003, Current Vascular Pharmacology, V1, P71, DOI 10.2174/1570161033386826; Williams AE, 2006, EUR RESPIR REV, V15, P4, DOI 10.1183/09059180.06.00009801; Winner P, 2005, CLIN THER, V27, P1785, DOI 10.1016/j.clinthera.2005.11.009; Yu J, 2009, J PAIN PALLIATIVE CA, V23, P693	58	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84088	10.1371/journal.pone.0084088	http://dx.doi.org/10.1371/journal.pone.0084088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367628	Green Published, gold, Green Submitted			2022-12-27	WOS:000328741900029
J	Bell, AV; Hinde, K; Newson, L				Bell, Adrian Viliami; Hinde, Katie; Newson, Lesley			Who Was Helping? The Scope for Female Cooperative Breeding in Early Homo	PLOS ONE			English	Article							MALE CHIMPANZEES; HUMAN ORIGINS; EVOLUTION; MORTALITY; SELECTION; HUNTER; MILK; COMPETITION; KINSHIP; CHOICE	Derived aspects of our human life history, such as short interbirth intervals and altricial newborns, have been attributed to male provisioning of nutrient-rich meat within monogamous relationships. However, many primatologists and anthropologists have questioned the relative importance of pair-bonding and biparental care, pointing to evidence that cooperative breeding better characterizes human reproductive and child-care relationships. We present a mathematical model with empirically-informed parameter ranges showing that natural selection favors cooperation among mothers over a wide range of conditions. In contrast, our analysis provides a far more narrow range of support for selection favoring male coalition-based monogamy over more promiscuous independent males, suggesting that provisioning within monogamous relationships may fall short of explaining the evolution of Homo life history. Rather, broader cooperative networks within and between the sexes provide the primary basis for our unique life history.	[Bell, Adrian Viliami] Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA; [Hinde, Katie] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Hinde, Katie] Univ Calif Davis, Brain Mind & Behav Unit, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Newson, Lesley] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Newson, Lesley] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England	Utah System of Higher Education; University of Utah; Harvard University; University of California System; University of California Davis; University of California System; University of California Davis; University of Exeter	Bell, AV (corresponding author), Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA.	adrian.bell@anthro.utah.edu		Hinde, Katie/0000-0002-0528-866X				Apostolou M, 2007, EVOL HUM BEHAV, V28, P403, DOI 10.1016/j.evolhumbehav.2007.05.007; Apostolou M, 2010, EVOL HUM BEHAV, V31, P39, DOI 10.1016/j.evolhumbehav.2009.06.010; Baldovino MC, 2008, FOLIA PRIMATOL, V79, P79, DOI 10.1159/000108780; Bell MBV, 2012, P ROY SOC B-BIOL SCI, V279, P619, DOI 10.1098/rspb.2011.1093; Bobe R, 2009, 1 HUMANS ORIGINS EAR; Boesch C, 2002, HUM NATURE-INT BIOS, V13, P27, DOI 10.1007/s12110-002-1013-6; Chapais Bernard, 2008, PRIMEVAL KINSHIP PAI, DOI DOI 10.1111/btp.12564; Cheney DL, 2004, INT J PRIMATOL, V25, P401, DOI 10.1023/B:IJOP.0000019159.75573.13; DeSilva JM, 2011, P NATL ACAD SCI USA, V108, P1022, DOI 10.1073/pnas.1003865108; Duffy KG, 2007, CURR BIOL, V17, pR586, DOI 10.1016/j.cub.2007.06.001; Eberle M, 2006, BEHAV ECOL SOCIOBIOL, V60, P582, DOI 10.1007/s00265-006-0203-3; Gangestad SW, 2011, NAT S FAM ISS BIOS F; Gavrilets S, 2012, P NATL ACAD SCI USA, V109, P9923, DOI 10.1073/pnas.1200717109; Gettler LT, 2012, AM ANTHROPOL, V112, P7; Gurven M, 2009, CURR ANTHROPOL, V50, P51, DOI 10.1086/595620; Hawkes K, 2002, EVOL ANTHROPOL, V11, P58, DOI 10.1002/evan.20005; HAWKES K, 1995, EVOL ECOL, V9, P662, DOI 10.1007/BF01237661; Hawkes K, 2001, CURR ANTHROPOL, V42, P681, DOI 10.1086/322559; Henrich J, 2012, PHILOS T R SOC B, V367, P657, DOI 10.1098/rstb.2011.0290; Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469; Hill K, 2007, J HUM EVOL, V52, P443, DOI 10.1016/j.jhevol.2006.11.003; Hill K, 2009, P ROY SOC B-BIOL SCI, V276, P3863, DOI 10.1098/rspb.2009.1061; Hinde K, 2011, EVOL ANTHROPOL, V20, P9, DOI 10.1002/evan.20289; Hodge SJ, 2011, BIOL LETTERS, V7, P54, DOI 10.1098/rsbl.2010.0555; Hrdy SarahBlaffer., 2009, MOTHERS OTHERS EVOLU; Hrdy SB., 1976, ADV STUD BEHAV, P101, DOI [DOI 10.1016/S0065-3454(08)60083-2, DOI 10.1002/AJP.22456]; Hrdy SB, 2010, ESTIMATING PREVALENC; Huck M., 2013, BUILDING BABIES PRIM, P361; Isler K, 2009, J HUM EVOL, V57, P392, DOI 10.1016/j.jhevol.2009.04.009; Jaeggi AV, 2011, BEHAV ECOL SOCIOBIOL, V65, P2125, DOI 10.1007/s00265-011-1221-3; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Kramer KL, 2010, EVOL ANTHROPOL, V19, P136, DOI 10.1002/evan.20265; Langergraber K, 2009, AM J PRIMATOL, V71, P840, DOI 10.1002/ajp.20711; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175834; Mace R., 2005, GRANDMOTHERHOOD EVOL, P143; Marlowe FW, 2001, CURR ANTHROPOL, V42, P755, DOI 10.1086/323820; MENDOZA SP, 1986, ANIM BEHAV, V34, P1336, DOI 10.1016/S0003-3472(86)80205-6; Mitani JC, 2001, ANIM BEHAV, V61, P915, DOI 10.1006/anbe.2000.1681; Packer C, 1998, NATURE, V392, P807, DOI 10.1038/33910; Parkes P, 2005, SOC ANTHROPOL, V13, P307, DOI 10.1017/S0964028205001564; Perry S, 1996, AM J PRIMATOL, V40, P167, DOI 10.1002/(SICI)1098-2345(1996)40:2<167::AID-AJP4>3.0.CO;2-W; Plavcan JM, 2012, HUM NATURE-INT BIOS, V23, P45, DOI 10.1007/s12110-012-9130-3; Potts R, 1999, EVOL ANTHROPOL, V7, P81, DOI 10.1002/(SICI)1520-6505(1998)7:3<81::AID-EVAN3>3.3.CO;2-1; Reichard Ulrich H., 2003, P3; Robson S, 2006, EVOLUTION HUMAN LIFE; Rusu AS, 2004, ACTA ETHOL, V6, P53; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Shaw R, 2007, WOMEN STUD INT FORUM, V30, P439, DOI 10.1016/j.wsif.2007.07.001; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; Silk JB, 2010, BEHAV ECOL SOCIOBIOL, V64, P1733, DOI 10.1007/s00265-010-0986-0; Thompson ME, 2007, CURR BIOL, V17, P2150, DOI 10.1016/j.cub.2007.11.033; Watts DP, 2001, BEHAVIOUR, V138, P299, DOI 10.1163/15685390152032488; Watts DP, 1998, BEHAV ECOL SOCIOBIOL, V44, P43, DOI 10.1007/s002650050513; Weidt A, 2008, ANIM BEHAV, V75, P801, DOI 10.1016/j.anbehav.2007.06.017; Winking J, 2011, EVOL HUM BEHAV, V32, P79, DOI 10.1016/j.evolhumbehav.2010.08.002	55	11	11	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83667	10.1371/journal.pone.0083667	http://dx.doi.org/10.1371/journal.pone.0083667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367605	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300112
J	Da, LS; Zhang, Y; Zhang, S; Qian, YC; Zhang, Q; Jiang, F; Xu, L				Da, Liang-Shan; Zhang, Ying; Zhang, Shuai; Qian, Yi-Chun; Zhang, Qin; Jiang, Feng; Xu, Lin			Association between MCP-1-2518A/G Polymorphism and Cancer Risk: Evidence from 19 Case-Control Studies	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; CHEMOKINE RECEPTOR 2; CCR2 GENE VARIANTS; CELL LUNG-CANCER; CLINICOPATHOLOGICAL CHARACTERISTICS; CHEMOTACTIC PROTEIN-1; MCP-1; SUSCEPTIBILITY; CCL2; METAANALYSIS	Background: Single nucleotide polymorphisms (SNPs) may affect the development of diseases. The -2518A/G polymorphism in the regulatory region of the monocyte chemo-attractant protein-1 (MCP-1) gene has been reported to be associated with cancer risk. However, the results of previous studies were inconsistent. Therefore, we performed a meta-analysis to obtain a more precise estimation of the relationship between the -2518A/G polymorphism and cancer risk. Methodology/Principal Findings: We performed a meta-analysis, including 4,162 cases and 5,173 controls, to evaluate the strength of the association between the 22518A/G polymorphism and cancer risk. Odds ratio (OR) and 95% confidence intervals (95% CIs) were used to assess the strength of association. Overall, the results indicated that the 22518A/G polymorphism was not statistically associated with cancer risk. However, sub-group analysis revealed that individuals with GG genotypes showed an increased risk of cancer in digestive system compared with carriers of the A allele (GG vs. AA: OR = 1.43, 95% CI = 1.05-1.96, Pheterogeneity = 0.08; GG vs. AG/AA: OR = 1.29, 95% CI = 1.02-1.64, Pheterogeneity = 0.14). In addition, the increased risk of GG genotype was also observed in Caucasians (GG vs. AG/AA: OR = 1.81, 95% CI = 1.10-2.96, Pheterogeneity = 0.02). Conclusion: This meta-analysis suggests that the MCP-1 22518A/G polymorphism may have some relation to digestive system cancer susceptibility or cancer development in Caucasian. Large-scale and well-designed case-control studies are needed to validate the findings.	[Da, Liang-Shan] Nanjing Med Univ, Clin Coll 1, Nanjing, Jiangsu, Peoples R China; [Da, Liang-Shan; Zhang, Shuai; Qian, Yi-Chun; Zhang, Qin; Jiang, Feng; Xu, Lin] Nanjing Med Univ Affiliated Canc Hosp Canc Inst J, Dept Thorac Surg, Nanjing, Jiangsu, Peoples R China; [Zhang, Ying] Wannan Med Coll, Wuhu, Anhui, Peoples R China; [Zhang, Ying] Wannan Med Coll Affiliated Yijishan Hosp, Dept Ultrason Med, Wuhu, Anhui, Peoples R China	Nanjing Medical University; Wannan Medical College; Wannan Medical College	Jiang, F (corresponding author), Nanjing Med Univ Affiliated Canc Hosp Canc Inst J, Dept Thorac Surg, Nanjing, Jiangsu, Peoples R China.	jiangfeng174@sohu.com; xulin83cn@gmail.com						Amann B, 1998, BRIT J UROL, V82, P118; Arenberg DA, 2000, CANCER IMMUNOL IMMUN, V49, P63, DOI 10.1007/s002620050603; Attar R, 2010, IN VIVO, V24, P243; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bektas-Kayhan K, 2012, ORAL DIS, V18, P55, DOI 10.1111/j.1601-0825.2011.01843.x; Cai Z, 2009, NEOPLASIA, V11, P228, DOI 10.1593/neo.81282; Chen MK, 2011, ORAL ONCOL, V47, P577, DOI 10.1016/j.oraloncology.2011.04.008; Chen W, 2012, BREAST CANCER RES TR, V136, P847, DOI 10.1007/s10549-012-2309-9; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; Craig MJ, 2006, CANCER METAST REV, V25, P611, DOI 10.1007/s10555-006-9027-x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gu HJ, 2011, MED ONCOL, V28, pS280, DOI 10.1007/s12032-010-9748-0; Kanavos P, 2006, ANN ONCOL, V17, P15, DOI 10.1093/annonc.mdl983; Kruszyna L, 2011, MOL BIOL REP, V38, P1263, DOI 10.1007/s11033-010-0225-9; Kucukgergin C, 2012, GENE, V511, P7, DOI 10.1016/j.gene.2012.09.011; Kucukgergin C, 2012, DNA CELL BIOL, V31, P1418, DOI 10.1089/dna.2012.1716; Landi S, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-15; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Liu GX, 2013, TUMOR BIOL, V34, P2741, DOI 10.1007/s13277-013-0827-7; Lu Y, 2006, PROSTATE, V66, P1311, DOI 10.1002/pros.20464; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; Narter KF, 2010, GENET MOL RES, V9, P685, DOI 10.4238/vol9-2gmr829; NEGUS RPM, 1995, J CLIN INVEST, V95, P2391, DOI 10.1172/JCI117933; Qin J-n, 2009, EXPLORATION RELATION; Riethdorf L, 1996, AM J PATHOL, V149, P1469; ROLLINS BJ, 1991, BLOOD, V78, P1112; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Saenz-Lopez P, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-382; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh V, 2012, MOL BIOL REP, V39, P9827, DOI 10.1007/s11033-012-1849-8; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Vazquez-Lavista LG, 2009, UROLOGY, V74, P414, DOI 10.1016/j.urology.2009.04.016; Wani MS, 2013, MOL CELL BIOL, V1, P1; Wu C, 2012, NAT GENET, V44, P62, DOI 10.1038/ng.1020; Wu HH, 2013, REPROD SCI, V20, P1175, DOI 10.1177/1933719113477481; Yang L, 2010, GENET MOL RES, V9, P765, DOI 10.4238/vol9-2gmr740; Yeh CB, 2010, J SURG ONCOL, V102, P264, DOI 10.1002/jso.21623; Zhong R, 2013, MOL CARCINOGEN, V52, P118, DOI 10.1002/mc.22043; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395	42	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82855	10.1371/journal.pone.0082855	http://dx.doi.org/10.1371/journal.pone.0082855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367564	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300077
J	Sivakumar, PM; Moritsugu, N; Obuse, S; Isoshima, T; Tashiro, H; Ito, Y				Sivakumar, Ponnurengam Malliappan; Moritsugu, Nozomi; Obuse, Sei; Isoshima, Takashi; Tashiro, Hideo; Ito, Yoshihiro			Novel Microarrays for Simultaneous Serodiagnosis of Multiple Antiviral Antibodies	PLOS ONE			English	Article							ANTIGEN MICROARRAYS; PHOTOIMMOBILIZED MICROARRAY; INFECTIOUS-DISEASES; ASSAY SYSTEM; REAGENTS; PHOTOPHORES; POLYMER; AZIDES; CELLS; ARRAY	We developed an automated diagnostic system for the detection of virus-specific immunoglobulin Gs (IgGs) that was based on a microarray platform. We compared efficacies of our automated system with conventional enzyme immunoassays (EIAs). Viruses were immobilized to microarrays using a radical cross-linking reaction that was induced by photo-irradiation. A new photoreactive polymer containing perfluorophenyl azide (PFPA) and poly(ethylene glycol) methacrylate was prepared and coated on plates. Inactivated measles, rubella, mumps, Varicella-Zoster and recombinant Epstein-Barr viruse antigen were added to coated plates, and irradiated with ultraviolet light to facilitate immobilization. Virus-specific IgGs in healthy human sera were assayed using these prepared microarrays and the results obtained compared with those from conventional EIAs. We observed high correlation (0.79-0.96) in the results between the automated microarray technique and EIAs. The microarray-based assay was more rapid, involved less reagents and sample, and was easier to conduct compared with conventional EIA techniques. The automated microarray system was further improved by introducing reagent storage reservoirs inside the chamber, thereby conserving the use of expensive reagents and antibodies. We considered the microarray format to be suitable for rapid and multiple serological diagnoses of viral diseases that could be developed further for clinical applications.	[Sivakumar, Ponnurengam Malliappan; Moritsugu, Nozomi; Obuse, Sei; Isoshima, Takashi; Tashiro, Hideo; Ito, Yoshihiro] RIKEN, Nano Med Engn Lab, Wako, Saitama, Japan; [Tashiro, Hideo; Ito, Yoshihiro] Consonal Biotechnol Co Ltd, Funabashi, Chiba, Japan; [Ito, Yoshihiro] RIKEN, Ctr Emergent Matter Sci, Emergent Bioengn Mat Res Team, Wako, Saitama, Japan	RIKEN; RIKEN	Ito, Y (corresponding author), RIKEN, Nano Med Engn Lab, Wako, Saitama, Japan.	y-ito@riken.jp	Isoshima, Takashi/S-5421-2017; Ito, Yoshihiro/F-4370-2012; Ito, Yoshihiro/T-1095-2019	Isoshima, Takashi/0000-0002-3421-036X; Ito, Yoshihiro/0000-0002-1154-253X; Sivakumar, Ponnurengam Malliappan/0000-0002-5880-9596	Japan Society for the Promotion of Science [22220009]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was sopported by Japan Society for the Promotion of Science KAKENHI Grant Number 22220009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacarese-Hamilton T, 2004, J APPL MICROBIOL, V96, P10, DOI 10.1046/j.1365-2672.2003.02111.x; BAYLEY H, 1978, BIOCHEMISTRY-US, V17, P2414, DOI 10.1021/bi00605a025; Blencowe A, 2005, SOFT MATTER, V1, P178, DOI 10.1039/b501989c; Caelen I, 2002, LANGMUIR, V18, P2463, DOI 10.1021/la0113217; Cismas C, 2008, TETRAHEDRON LETT, V49, P1336, DOI 10.1016/j.tetlet.2007.12.083; Desmet C, 2011, ANALYST, V136, P2918, DOI 10.1039/c1an15121e; Di Cristina M, 2010, NAT PROTOC, V5, P1932, DOI 10.1038/nprot.2010.161; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Fattal I, 2010, IMMUNOLOGY, V130, P337, DOI 10.1111/j.1365-2567.2010.03245.x; Hashimoto M, 2008, EUR J ORG CHEM, V2008, P2513, DOI 10.1002/ejoc.200701069; Hino N, 2005, NAT METHODS, V2, P201, DOI 10.1038/NMETH739; Ito Y, 2006, BIOMATERIALS, V27, P2502, DOI 10.1016/j.biomaterials.2005.11.030; Ito Y, 2005, BIOMATERIALS, V26, P211, DOI 10.1016/j.biomaterials.2004.02.019; Ito Y, 2003, BIOMATERIALS, V24, P3021, DOI 10.1016/S0142-9612(03)00134-0; Ito Y, 2012, J BIOTECHNOL, V161, P414, DOI 10.1016/j.jbiotec.2012.07.196; Jaaskelainen AJ, 2009, J VIROL METHODS, V160, P167, DOI 10.1016/j.jviromet.2009.05.013; Kanoh N, 2006, CHEM-ASIAN J, V1, P789, DOI 10.1002/asia.200600208; KEANA JFW, 1990, J ORG CHEM, V55, P3640, DOI 10.1021/jo00298a048; Liang L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01043; Liang M, 2010, ACS NANO, V4, P403, DOI 10.1021/nn9011237; Matsudaira T, 2008, BIOTECHNOL PROGR, V24, P1384, DOI 10.1002/btpr.63; Mezzasoma L, 2002, CLIN CHEM, V48, P121; Nakashima H, 2006, J AM CHEM SOC, V128, P15092, DOI 10.1021/ja066479y; Ohyama K., 2005, ALLERGOL INT, V54, P627, DOI [DOI 10.2332/ALLERGOLINT.54.627, 10.2332/allergolint.54.627]; Papp K, 2012, METHODS MOL BIOL, V815, P175, DOI 10.1007/978-1-61779-424-7_14; Quintana FJ, 2008, P NATL ACAD SCI USA, V105, P18889, DOI 10.1073/pnas.0806310105; SCHNAPP KA, 1993, BIOCONJUGATE CHEM, V4, P172, DOI 10.1021/bc00020a010; Sharma S, 2005, J NANOSCI NANOTECHNO, V5, P235, DOI 10.1166/jnn.2005.030; To Y, 2007, ACTA BIOMATER, V3, P1024, DOI 10.1016/j.actbio.2007.05.010; Tsuzuki S, 2009, BIOTECHNOL BIOENG, V102, P700, DOI 10.1002/bit.22102; Vigh-Conrad KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010174; Wadia PP, 2011, METHODS MOL BIOL, V723, P81, DOI 10.1007/978-1-61779-043-0_7; Yang P, 2013, CHEM REV, V113, P5547, DOI 10.1021/cr300246p; Zhao Y, 2012, LANGMUIR, V28, P6328, DOI 10.1021/la300281q	34	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81726	10.1371/journal.pone.0081726	http://dx.doi.org/10.1371/journal.pone.0081726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367491	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300011
J	Fan, RX; Lo, SH				Fan, Ruixue; Lo, Shaw-Hwa			A Robust Model-free Approach for Rare Variants Association Studies Incorporating Gene-Gene and Gene-Environmental Interactions	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MISSING HERITABILITY; COMPLEX DISEASES; COMMON DISEASES; SUSCEPTIBILITY; STRATEGIES	Recently more and more evidence suggest that rare variants with much lower minor allele frequencies play significant roles in disease etiology. Advances in next-generation sequencing technologies will lead to many more rare variants association studies. Several statistical methods have been proposed to assess the effect of rare variants by aggregating information from multiple loci across a genetic region and testing the association between the phenotype and aggregated genotype. One limitation of existing methods is that they only look into the marginal effects of rare variants but do not systematically take into account effects due to interactions among rare variants and between rare variants and environmental factors. In this article, we propose the summation of partition approach (SPA), a robust model-free method that is designed specifically for detecting both marginal effects and effects due to gene-gene (GxG) and gene-environmental (GxE) interactions for rare variants association studies. SPA has three advantages. First, it accounts for the interaction information and gains considerable power in the presence of unknown and complicated GxG or GxE interactions. Secondly, it does not sacrifice the marginal detection power; in the situation when rare variants only have marginal effects it is comparable with the most competitive method in current literature. Thirdly, it is easy to extend and can incorporate more complex interactions; other practitioners and scientists can tailor the procedure to fit their own study friendly. Our simulation studies show that SPA is considerably more powerful than many existing methods in the presence of GxG and GxE interactions.	[Fan, Ruixue; Lo, Shaw-Hwa] Columbia Univ, Dept Stat, New York, NY 10027 USA	Columbia University	Lo, SH (corresponding author), Columbia Univ, Dept Stat, New York, NY 10027 USA.	slo@stat.columbia.edu						Almasy Laura, 2011, BMC Proc, V5 Suppl 9, pS2, DOI 10.1186/1753-6561-5-S9-S2; Andreasen CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002872; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Chernoff H, 2009, ANN APPL STAT, V3, P1335, DOI 10.1214/09-AOAS265; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; Ding Yuejing, 2007, BMC Proc, V1 Suppl 1, pS13; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Frayling IM, 1998, P NATL ACAD SCI USA, V95, P10722, DOI 10.1073/pnas.95.18.10722; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Hu T, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-364; Huang Chien-Hsun, 2009, BMC Proc, V3 Suppl 7, pS75; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lo SH, 2008, P NATL ACAD SCI USA, V105, P12387, DOI 10.1073/pnas.0805242105; Madsen B.E., 2009, PLOS GENET, V5; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Makowsky R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002051; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Qiao Bo, 2009, BMC Proc, V3 Suppl 7, pS132; Thomas D, 2010, ANNU REV PUBL HEALTH, V31, P21, DOI 10.1146/annurev.publhealth.012809.103619; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; Wang HT, 2012, BIOINFORMATICS, V28, P2834, DOI 10.1093/bioinformatics/bts531; Witte JS, 2010, ANNU REV PUBL HEALTH, V31, P9, DOI 10.1146/annurev.publhealth.012809.103723; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zheng Tian, 2007, BMC Proc, V1 Suppl 1, pS10	40	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83057	10.1371/journal.pone.0083057	http://dx.doi.org/10.1371/journal.pone.0083057			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358248	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700044
J	Androutsopoulos, VP; Spyrou, I; Ploumidis, A; Papalampros, AE; Kyriakakis, M; Delakas, D; Spandidos, DA; Tsatsakis, AM				Androutsopoulos, Vasilis P.; Spyrou, Ioannis; Ploumidis, Achilles; Papalampros, Alexandros Eystathios; Kyriakakis, Michalis; Delakas, Demetrios; Spandidos, Demetrios A.; Tsatsakis, Aristidis M.			Expression Profile of CYP1A1 and CYP1B1 Enzymes in Colon and Bladder Tumors	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; BREAST-CANCER CELLS; CYTOCHROME-P450 ENZYMES; DIFFERENTIAL EXPRESSION; METABOLIC-ACTIVATION; DRUG DEVELOPMENT; OVARIAN-CANCER; CARCINOMA; P450; P450CYP1B1	Background: The cytochrome P450 CYP1A1 and CYP1B1 enzymes are involved in carcinogenesis via activation of pro-carcinogenic compounds to carcinogenic metabolites. CYP1A1 and CYP1B1 have shown elevated levels in human tumors as determined by qRT-PCR and immunohistochemical studies. However studies that have examined CYP1 expression by enzyme activity assays are limited. Results: In the current study the expression of CYP1A1 and CYP1B1 was investigated in a panel of human tumors of bladder and colorectal origin by qRT-PCR and enzyme activity assays. The results demonstrated that 35% (7/20) of bladder tumors and 35% (7/20) of colon tumors overexpressed active CYP1 enzymes. CYP1B1 mRNA was overexpressed in 65% and 60% of bladder and colon tumors respectively, whereas CYP1A1 was overexpressed in 65% and 80% of bladder and colon tumors. Mean mRNA levels of CYP1B1 and CYP1A1 along with mean CYP1 activity were higher in bladder and colon tumors compared to normal tissues (p<0.05). Statistical analysis revealed CYP1 expression levels to be independent of TNM status. Moreover, incubation of tumor microsomal protein in 4 bladder and 3 colon samples with a CYP1B1 specific antibody revealed a large reduction (72.5 +/- 5.5 % for bladder and 71.8 +/- 7.2% for colon) in catalytic activity, indicating that the activity was mainly attributed to CYP1B1 expression. Conclusions: The study reveals active CYP1 overexpression in human tumors and uncovers the potential use of CYP1 enzymes and mainly CYP1B1 as targets for cancer therapy.	[Androutsopoulos, Vasilis P.; Kyriakakis, Michalis; Tsatsakis, Aristidis M.] Univ Crete, Fac Med, Dept Morphol, Toxicol Lab, Iraklion, Crete, Greece; [Spyrou, Ioannis; Papalampros, Alexandros Eystathios] Univ Athens, Laiko Hosp, Dept Surg 1, Athens, Greece; [Ploumidis, Achilles; Delakas, Demetrios] Asklipeio Gen Hosp, Dept Urol, Athens, Greece; [Androutsopoulos, Vasilis P.; Spandidos, Demetrios A.] Univ Crete, Fac Med, Dept Lab Med, Lab Clin Virol, Iraklion, Crete, Greece	University of Crete; Laiko General Hospital; National & Kapodistrian University of Athens; University of Crete	Androutsopoulos, VP (corresponding author), Univ Crete, Fac Med, Dept Morphol, Toxicol Lab, Iraklion, Crete, Greece.	vandrou@med.uoc.gr	Tsatsakis, Aristidis M./H-2890-2013	Tsatsakis, Aristidis M./0000-0003-3824-2462; Spandidos, Demetrios/0000-0002-1146-931X; Androutsopoulos, Vasilis/0000-0001-7223-9369	charitable organization Reliable Cancer Therapies (RCT) (Verbier, Switzerland)	charitable organization Reliable Cancer Therapies (RCT) (Verbier, Switzerland)	This study was supported by the charitable organization Reliable Cancer Therapies (RCT) (Verbier, Switzerland). http://www.reliablecancertherapies.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklillu E, 2002, MOL PHARMACOL, V61, P586, DOI 10.1124/mol.61.3.586; Androutsopoulos V, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2090; Androutsopoulos VP, 2013, J NUTR BIOCHEM, V24, P496, DOI 10.1016/j.jnutbio.2012.01.012; Bandiera S, 2005, MOL PHARMACOL, V67, P435, DOI 10.1124/mol.104.006056; Braeuning A, 2011, TOXICOL SCI, V122, P16, DOI 10.1093/toxsci/kfr080; Bruno RD, 2007, BIOORGAN MED CHEM, V15, P5047, DOI 10.1016/j.bmc.2007.05.046; Callero MA, 2012, INT J ONCOL, V41, P125, DOI 10.3892/ijo.2012.1427; Carnell DM, 2004, INT J RADIAT ONCOL, V58, P500, DOI 10.1016/j.ijrobp.2003.09.064; Cheung YL, 1999, CANCER LETT, V139, P199, DOI 10.1016/S0304-3835(99)00045-2; Chiaro CR, 2008, MOL PHARMACOL, V74, P1649, DOI 10.1124/mol.108.049379; Crewe HK, 2002, DRUG METAB DISPOS, V30, P869, DOI 10.1124/dmd.30.8.869; Failli A, 2013, J BIOL REG HOMEOS AG, V27, P275; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Gibson P, 2003, MOL CANCER THER, V2, P527; Hevir N, 2011, MOL CELL ENDOCRINOL, V331, P158, DOI 10.1016/j.mce.2010.09.011; Huang ZQ, 1996, DRUG METAB DISPOS, V24, P899; Kasai S, 2013, BBA-GEN SUBJECTS, V1830, P2509, DOI 10.1016/j.bbagen.2012.11.007; Kisselev P, 2005, CANCER RES, V65, P2972, DOI 10.1158/0008-5472.CAN-04-3543; Kumarakulasingham M, 2005, CLIN CANCER RES, V11, P3758, DOI 10.1158/1078-0432.CCR-04-1848; Leung YK, 2005, CANCER RES, V65, P3726, DOI 10.1158/0008-5472.CAN-04-3771; LIEHR JG, 1995, P NATL ACAD SCI USA, V92, P9220, DOI 10.1073/pnas.92.20.9220; Liehr JG, 1996, P NATL ACAD SCI USA, V93, P3294, DOI 10.1073/pnas.93.8.3294; McFadyen MCE, 1999, J HISTOCHEM CYTOCHEM, V47, P1457, DOI 10.1177/002215549904701111; McFadyen MCE, 2004, BRIT J CANCER, V91, P966, DOI 10.1038/sj.bjc.6602053; McFadyen MCE, 2004, MOL CANCER THER, V3, P363; McFadyen MCE, 2003, BIOCHEM PHARMACOL, V65, P1663, DOI 10.1016/S0006-2952(03)00111-4; McFadyen MCE, 2001, BRIT J CANCER, V85, P242, DOI 10.1054/bjoc.2001.1907; Meng LH, 2005, CANCER RES, V65, P5337, DOI 10.1158/0008-5472.CAN-05-0003; Murray GI, 1997, CANCER RES, V57, P3026; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Patterson LH, 2002, CURR PHARM DESIGN, V8, P1335, DOI 10.2174/1381612023394502; Pavek P, 2008, CURR DRUG METAB, V9, P129, DOI 10.2174/138920008783571774; Pors K, 2011, CHEM COMMUN, V47, P12062, DOI 10.1039/c1cc15638a; Pradhan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027914; Rodriguez M, 2013, MOL CANCER RES; Schwarz D, 2004, BIOCHEM PHARMACOL, V67, P1445, DOI 10.1016/j.bcp.2003.12.023; Sheldrake HM, 2013, J MED CHEM, V56, P6273, DOI 10.1021/jm4000209; Shimada T, 2004, CANCER SCI, V95, P1, DOI 10.1111/j.1349-7006.2004.tb03162.x; Sissung TM, 2006, MOL CANCER RES, V4, P135, DOI 10.1158/1541-7786.MCR-05-0101; Spink DC, 1998, CARCINOGENESIS, V19, P291, DOI 10.1093/carcin/19.2.291; Sternberg CN, 2007, UROLOGY, V69, P62, DOI 10.1016/j.urology.2006.10.041; Surichan S, 2012, FOOD CHEM TOXICOL, V50, P3320, DOI 10.1016/j.fct.2012.06.030; Sutherland M, 2013, MOL CANCER THER, V12, P27, DOI 10.1158/1535-7163.MCT-12-0405; Travica S, 2013, CLIN CANCER RES, V12, P27; Yu LJ, 2001, DRUG METAB DISPOS, V29, P304	47	54	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82487	10.1371/journal.pone.0082487	http://dx.doi.org/10.1371/journal.pone.0082487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358191	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700071
J	Zheng, YH; Li, FD; Tian, C; Ren, HL; Du, J; Li, HH				Zheng, Yue-Hong; Li, Fang-Da; Tian, Cui; Ren, Hua-Liang; Du, Jie; Li, Hui-Hua			Notch gamma-Secretase Inhibitor Dibenzazepine Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm in ApoE Knockout Mice by Multiple Mechanisms	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; CARDIAC FIBROSIS; T-LYMPHOCYTES; EXPRESSION; INFLAMMATION; RECEPTORS; CYTOKINES; RESPONSES; MEMBRANE; DISEASE	Abdominal aortic aneurysm (AAA) is a life-threatening aortic disease in the elderly. Activation of Notch1 pathway plays a critical role in the development of AAA, but the underlying mechanisms remain poorly understood. In the present study, we explored the mechanisms by which Notch1 activation regulates angiotensin II (Ang II)-induced AAA formation and evaluated the therapeutic potential of a new Notch.-secretase inhibitor, dibenzazepine (DBZ), for the treatment of AAA. Apolipoprotein E knockout (Apo E-/-) mice infused for 4 weeks with Ang II (1000 ng/kg/min, IP) using osmotic mini-pumps were received an intraperitoneal injection of either vehicle or 1 mg/kg/d DBZ. Notch1 signaling was activated in AAA tissue from both Ang II-infused Apo E-/- mice and human undergoing AAA repair in vivo, with increased expression of Notch intracellular domain (NICD) and its target gene Hes1, and this effect was effectively blocked by DBZ. Moreover, infusion of Ang II markedly increased the incidence and severity of AAA in Apo E-/- mice. In contrast, inhibition of Notch activation by DBZ prevented AAA formation in vivo. Furthermore, DBZ markedly prevented Ang II-stimulated accumulation of macrophages and CD4(+) T cells, and ERK-mediated angiogenesis, simultaneously reversed Th2 response, in vivo. In conclusion, these findings provide new insight into the multiple mechanisms of Notch signaling involved in AAA formation and suggest that.-secretase inhibitor DBZ might be a novel therapeutic drug for treating AAAS.	[Zheng, Yue-Hong; Li, Fang-Da; Ren, Hua-Liang] Peking Union Med Hosp, Dept Vasc Surg, Beijing, Peoples R China; [Tian, Cui; Du, Jie; Li, Hui-Hua] Capital Med Univ, Sch Basic Med Sci,Beijing AnZhen Hosp, Beijing Key Lab Cardiovasc Dis Related Metab, Key Lab Remodeling Related Cardiovasc Dis,Dept Ph, Beijing, Peoples R China; [Tian, Cui; Du, Jie; Li, Hui-Hua] Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Capital Medical University	Zheng, YH (corresponding author), Peking Union Med Hosp, Dept Vasc Surg, Beijing, Peoples R China.	yuehongzheng@yahoo.com; hhli1995@yahoo.com			Natural Science Foundation of China [81270390, 81025001]; 973 program [2012CB517802]; Chang Jiang Scholar Program; Beijing High-level Talents Program (HL) [PH20110507]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); Chang Jiang Scholar Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Beijing High-level Talents Program (HL)	This work was supported by grants from the Natural Science Foundation of China (81270390 and 81025001), 973 program (2012CB517802), Chang Jiang Scholar Program and the Beijing High-level Talents Program (HL, PH20110507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027743; Aoyama T, 2009, BIOCHEM BIOPH RES CO, V383, P216, DOI 10.1016/j.bbrc.2009.03.154; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Bennett J Claude, 2008, Arthritis Rheum, V58, pS53, DOI 10.1002/art.23045; Bosse K, 2013, J MOL CELL CARDIOL, V60, P27, DOI 10.1016/j.yjmcc.2013.04.001; Boucher JM, 2013, CIRC RES, V113, P975, DOI 10.1161/CIRCRESAHA.113.301272; Cheng CY, 2012, STEM CELL RES, V9, P9, DOI 10.1016/j.scr.2012.02.005; Choke E, 2006, ARTERIOSCL THROM VAS, V26, P2077, DOI 10.1161/01.ATV.0000234944.22509.f9; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2001, BRIT J PHARMACOL, V134, P865, DOI 10.1038/sj.bjp.0704331; de La Coste A, 2005, J IMMUNOL, V174, P2730, DOI 10.4049/jimmunol.174.5.2730; Dees C, 2011, ARTHRITIS RHEUM-US, V63, P1396, DOI 10.1002/art.30254; Dong X, 2011, PLOS ONE, V4, P18481, DOI DOI 10.1371/J0URNAL.P0NE.0018481.PUBMED:21526177; Fischer S, 2001, EUR J PHARMACOL, V411, P231, DOI 10.1016/S0014-2999(00)00915-8; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Hans CP, 2012, ARTERIOSCL THROM VAS, V32, P3012, DOI 10.1161/ATVBAHA.112.254219; Heeneman S, 2007, CIRC RES, V101, P441, DOI 10.1161/CIRCRESAHA.107.148338; Henderson EL, 1999, CIRCULATION, V99, P96, DOI 10.1161/01.CIR.99.1.96; HERRON GS, 1991, ARTERIOSCLER THROMB, V11, P1667, DOI 10.1161/01.ATV.11.6.1667; Kang JH, 2009, AM J RESP CRIT CARE, V179, P875, DOI 10.1164/rccm.200806-893OC; Klein LW, 2009, JACC-CARDIOVASC INTE, V2, P136, DOI 10.1016/j.jcin.2008.09.012; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kuivaniemi H, 2008, CIRCULATION, V117, P242, DOI 10.1161/CIRCULATIONAHA.107.690982; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Li YL, 2012, ARTERIOSCL THROM VAS, V32, P1662, DOI 10.1161/ATVBAHA.112.249706; Ocana E, 2003, ATHEROSCLEROSIS, V170, P39, DOI 10.1016/S0021-9150(03)00282-X; Ozasa Y, 2013, HYPERTENS RES, V36, P859, DOI 10.1038/hr.2013.52; Pan LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035315; Piggott K, 2011, CIRCULATION, V123, P309, DOI 10.1161/CIRCULATIONAHA.110.936203; Shimizu K, 2004, J CLIN INVEST, V114, P300, DOI 10.1172/JCI200419855; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Yang K, 2012, AM J HYPERTENS, V25, P994, DOI 10.1038/ajh.2012.74; Yang M, 2012, ARTERIOSCL THROM VAS, V32, P1675, DOI 10.1161/ATVBAHA.112.248732; Zhang JD, 2012, CIRC RES, V110, P1604, DOI 10.1161/CIRCRESAHA.111.261768; Zhang YL, 2009, ARTERIOSCL THROM VAS, V29, P1764, DOI 10.1161/ATVBAHA.109.192609; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	36	33	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83310	10.1371/journal.pone.0083310	http://dx.doi.org/10.1371/journal.pone.0083310			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358274	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700117
J	Dolz-Gaiton, P; Nunez, M; Nunez, L; Barana, A; Amoros, I; Matamoros, M; Perez-Hernandez, M; de la Fuente, MG; Alvarez-Lopez, M; Macias-Ruiz, R; Tercedor-Sanchez, L; Jimenez-Jaimez, J; Delpon, E; Caballero, R; Tamargo, J				Dolz-Gaiton, Pablo; Nunez, Mercedes; Nunez, Lucia; Barana, Adriana; Amoros, Irene; Matamoros, Marcos; Perez-Hernandez, Marta; Gonzalez de la Fuente, Marta; Alvarez-Lopez, Miguel; Macias-Ruiz, Rosa; Tercedor-Sanchez, Luis; Jimenez-Jaimez, Juan; Delpon, Eva; Caballero, Ricardo; Tamargo, Juan			Functional Characterization of a Novel Frameshift Mutation in the C-terminus of the Nav1.5 Channel Underlying a Brugada Syndrome with Variable Expression in a Spanish Family	PLOS ONE			English	Article							IDIOPATHIC VENTRICULAR-FIBRILLATION; SCN5A MUTATION; INACTIVATION; COMPLEX; PATIENT; DOMAIN	Introduction: We functionally analyzed a frameshift mutation in the SCN5A gene encoding cardiac Na+ channels (Nav1.5) found in a proband with repeated episodes of ventricular fibrillation who presented bradycardia and paroxysmal atrial fibrillation. Seven relatives also carry the mutation and showed a Brugada syndrome with an incomplete and variable expression. The mutation (p.D1816VfsX7) resulted in a severe truncation (201 residues) of the Nav1.5 C-terminus. Methods and Results: Wild-type (WT) and mutated Nav1.5 channels together with hNav beta 1 were expressed in CHO cells and currents were recorded at room temperature using the whole-cell patch-clamp. Expression of p.D1816VfsX7 alone resulted in a marked reduction (approximate to 90%) in peak Na+ current density compared with WT channels. Peak current density generated by p.D1816VfsX7+WT was approximate to 50% of that generated by WT channels. p.D1816VfsX7 positively shifted activation and inactivation curves, leading to a significant reduction of the window current. The mutation accelerated current activation and reactivation kinetics and increased the fraction of channels developing slow inactivation with prolonged depolarizations. However, late I-Na was not modified by the mutation. p.D1816VfsX7 produced a marked reduction of channel trafficking toward the membrane that was not restored by decreasing incubation temperature during cell culture or by incubation with 300 mu M mexiletine and 5 mM 4-phenylbutirate. Conclusion: Despite a severe truncation of the C-terminus, the resulting mutated channels generate currents, albeit with reduced amplitude and altered biophysical properties, confirming the key role of the C-terminal domain in the expression and function of the cardiac Na+ channel.	[Dolz-Gaiton, Pablo; Nunez, Mercedes; Barana, Adriana; Amoros, Irene; Matamoros, Marcos; Perez-Hernandez, Marta; Gonzalez de la Fuente, Marta; Delpon, Eva; Caballero, Ricardo; Tamargo, Juan] Univ Complutense Madrid, Sch Med, Dept Pharmacol, Madrid, Spain; [Dolz-Gaiton, Pablo; Nunez, Mercedes; Amoros, Irene; Matamoros, Marcos; Delpon, Eva; Caballero, Ricardo] Univ Complutense, Sch Med, Inst Invest Sanitaria Gregorio Maranon, E-28040 Madrid, Spain; [Barana, Adriana; Perez-Hernandez, Marta; Gonzalez de la Fuente, Marta; Tamargo, Juan] Univ Complutense, Hosp Clin San Carlos, Sch Med, Inst Invest Sanitaria, E-28040 Madrid, Spain; [Nunez, Lucia] Univ A Coruna, Complejo Hosp, La Coruna, Spain; [Nunez, Lucia] Univ A Coruna, Inst Ciencias Salud, La Coruna, Spain; [Alvarez-Lopez, Miguel; Macias-Ruiz, Rosa; Tercedor-Sanchez, Luis; Jimenez-Jaimez, Juan] Hosp Univ Virgen Nieves, Dept Cardiol, Arrhytmias Unit, Granada, Spain	Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid; Hospital Clinico San Carlos; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Universidade da Coruna; Hospital Universitario Virgen de las Nieves	Delpon, E (corresponding author), Univ Complutense Madrid, Sch Med, Dept Pharmacol, Madrid, Spain.	edelpon@med.ucm.es	nunez, lucia/AAG-8018-2019; Caballero, Ricardo/K-3573-2014; Delpon, Eva/K-8631-2014; Núñez, Mercedes/L-1622-2014; Amoros, Irene/K-9886-2014; Tamargo, Juan/J-7772-2016	Caballero, Ricardo/0000-0002-6424-9687; Delpon, Eva/0000-0003-4499-8645; Amoros, Irene/0000-0001-6874-0564; Tamargo, Juan/0000-0002-7979-7758; Nunez, Lucia/0000-0002-6321-3439; Perez-Hernandez, Marta/0000-0001-6119-103X; Matamoros, Marcos/0000-0002-9191-3168; Macias-Ruiz, Rosa/0000-0003-4686-5678; Nunez, Lucia/0000-0002-9638-5747	Instituto de Salud Carlos III [PI11/01030, RD06/0009]; Red Espanola de Investigacion Cardiovascular [RD12/ 0042/0011]; Comunidad Autonoma de Madrid [S2012/BMD-2374]; Ministerio de Ciencia e Innovacion [SAF2011-30088, SAF2011-30112]; Centro Nacional de Investigaciones Cardiovasculares [CNIC-08-2009]; Sociedad Espanola de Cardiolog	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Red Espanola de Investigacion Cardiovascular; Comunidad Autonoma de Madrid(Comunidad de Madrid); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Centro Nacional de Investigaciones Cardiovasculares; Sociedad Espanola de Cardiolog	Financial support provided by Instituto de Salud Carlos III [PI11/01030, Red HERACLES RD06/0009 and Red Espanola de Investigacion Cardiovascular RD12/ 0042/0011], Comunidad Autonoma de Madrid (S2012/BMD-2374), Ministerio de Ciencia e Innovacion [SAF2011-30088, and SAF2011-30112], Centro Nacional de Investigaciones Cardiovasculares [CNIC-08-2009], and Sociedad Espanola de Cardiolog a grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akai J, 2000, FEBS LETT, V479, P29, DOI 10.1016/S0014-5793(00)01875-5; Amin AS, 2010, PFLUG ARCH EUR J PHY, V460, P223, DOI 10.1007/s00424-009-0761-0; Amoros I, 2011, HEART RHYTHM, V8, P463, DOI 10.1016/j.hrthm.2010.11.032; ATTWELL D, 1979, PFLUG ARCH EUR J PHY, V379, P137, DOI 10.1007/BF00586939; Balse E, 2012, PHYSIOL REV, V92, P1317, DOI 10.1152/physrev.00041.2011; Butters TD, 2010, CIRC RES, V107, P126, DOI 10.1161/CIRCRESAHA.110.219949; Clatot J, 2012, CARDIOVASC RES, V96, P53, DOI 10.1093/cvr/cvs211; Cormier JW, 2002, J BIOL CHEM, V277, P9233, DOI 10.1074/jbc.M110204200; Effinor PT, 2008, HEART RHYTHM, V5, P99, DOI [10.1016/j.hrthm.2007.09.015, 10.1016/j.hrthm.2008.01.014]; Glaaser IW, 2006, J BIOL CHEM, V281, P24015, DOI 10.1074/jbc.M605473200; Herfst LJ, 2003, J MOL CELL CARDIOL, V35, P549, DOI 10.1016/S0022-2828(03)00078-6; Hu D, 2010, PACE, V33, P274, DOI 10.1111/j.1540-8159.2009.02642.x; Huang H, 2011, AM J PHYSIOL-HEART C, V300, pH288, DOI 10.1152/ajpheart.00539.2010; Kapplinger JD, 2010, HEART RHYTHM, V7, P33, DOI 10.1016/j.hrthm.2009.09.069; Lei M, 2004, J PHYSIOL-LONDON, V559, P835, DOI 10.1113/jphysiol.2004.068643; Makiyama T, 2005, J AM COLL CARDIOL, V46, P2100, DOI 10.1016/j.jacc.2005.08.043; Mantegazza M, 2001, P NATL ACAD SCI USA, V98, P15348, DOI 10.1073/pnas.211563298; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; Muggenthaler M, 2011, EUROPACE, V13, P913, DOI 10.1093/europace/eur094; Munoz L, 2011, REV ESP CARDIOL, V64, P945, DOI 10.1016/j.recesp.2010.11.024; Nunez L, 2013, HEART RHYTHM, V10, P264, DOI 10.1016/j.hrthm.2012.10.025; Petitprez S, 2011, CIRC RES, V108, P294, DOI 10.1161/CIRCRESAHA.110.228312; Prystowsky EN, 2012, J AM COLL CARDIOL, V59, P1733, DOI 10.1016/j.jacc.2012.01.036; Remme CA, 2008, TRENDS CARDIOVAS MED, V18, P78, DOI 10.1016/j.tcm.2008.01.002; Remme CA, 2010, CARDIOVASC THER, V28, P287, DOI 10.1111/j.1755-5922.2010.00210.x; Rivolta I, 2001, J BIOL CHEM, V276, P30623, DOI 10.1074/jbc.M104471200; Rook MB, 2012, CARDIOVASC RES, V93, P12, DOI 10.1093/cvr/cvr252; Ruan YF, 2010, CIRC RES, V106, P1374, DOI 10.1161/CIRCRESAHA.110.218891; Tan BH, 2007, CARDIOVASC RES, V76, P409, DOI 10.1016/j.cardiores.2007.08.006; Valdivia CR, 2004, CARDIOVASC RES, V62, P53, DOI 10.1016/j.cardiores.2004.01.022; Wang CJ, 2012, STRUCTURE, V20, P1167, DOI 10.1016/j.str.2012.05.001; Watanabe H, 2011, CIRC-ARRHYTHMIA ELEC, V4, P874, DOI 10.1161/CIRCEP.111.963983; Wilde AAM, 2011, CIRC RES, V108, P884, DOI 10.1161/CIRCRESAHA.110.238469; Zimmer T, 2002, J MEMBRANE BIOL, V186, P1, DOI 10.1007/s00232-001-0130-1	34	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81493	10.1371/journal.pone.0081493	http://dx.doi.org/10.1371/journal.pone.0081493			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24363796	Green Submitted, gold, Green Published			2022-12-27	WOS:000327543500103
J	Gronli, O; Kvamme, JM; Friborg, O; Wynn, R				Gronli, Ole; Kvamme, Jan Magnus; Friborg, Oddgeir; Wynn, Rolf			Zinc Deficiency Is Common in Several Psychiatric Disorders	PLOS ONE			English	Article							LOWER SERUM ZINC; MAJOR DEPRESSION; HUMAN HEALTH; SUPPLEMENTATION; HYPERPARATHYROIDISM; SYMPTOMS; BEHAVIOR; CALCIUM; METALS; COPPER	Background: Mounting evidence suggests a link between low zinc levels and depression. There is, however, little knowledge about zinc levels in older persons with other psychiatric diagnoses. Therefore, we explore the zinc status of elderly patients suffering from a wide range of psychiatric disorders. Methods: Clinical data and blood samples for zinc analyzes were collected from 100 psychogeriatric patients over 64 of age. Psychiatric and cognitive symptoms were assessed using the Montgomery and Aasberg Depression Rating Scale, the Cornell Scale for Depression in Dementia, the Mini-Mental State Examination, the Clockdrawing Test, clinical interviews and a review of medical records. In addition, a diagnostic interview was conducted using the Mini International Neuropsychiatric Interview instrument. The prevalence of zinc deficiency in patients with depression was compared with the prevalence in patients without depression, and the prevalence in a control group of 882 older persons sampled from a population study. Results: There was a significant difference in zinc deficiency prevalence between the control group (14.4%) and the patient group (41.0%) (chi(2) = 44.81, df = 1, p<0.001). In a logistic model with relevant predictors, zinc deficiency was positively associated with gender and with serum albumin level. The prevalence of zinc deficiency in the patient group was significantly higher in patients without depression (i.e. with other diagnoses) than in patients with depression as a main diagnosis or comorbid depression (chi(2) = 4.36, df = 1, p = 0.037). Conclusions: Zinc deficiency is quite common among psychogeriatric patients and appears to be even more prominent in patients suffering from other psychiatric disorders than depression. Limitations: This study does not provide a clear answer as to whether the observed differences represent a causal relationship between zinc deficiency and psychiatric symptoms. The blood sample collection time points varied in both the control group and the patient group. No data regarding zinc supplementation were collected.	[Gronli, Ole; Kvamme, Jan Magnus; Wynn, Rolf] Univ Tromso, Fac Hlth Sci, Dept Clin Med, Tromso, Norway; [Gronli, Ole; Friborg, Oddgeir; Wynn, Rolf] Univ Hosp North Norway, Div Addict & Specialized Psychiat Serv, Tromso, Norway; [Friborg, Oddgeir] Univ Tromso, Fac Hlth Sci, Dept Psychol, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Gronli, O (corresponding author), Univ Tromso, Fac Hlth Sci, Dept Clin Med, Tromso, Norway.	ole.gronli@unn.no	Wynn, Rolf/ABE-8410-2020; Kvamme, Jan-Magnus/AAH-6578-2020	Wynn, Rolf/0000-0002-2254-3343; Kvamme, Jan-Magnus/0000-0002-5029-1606; Friborg, Oddgeir/0000-0001-6629-0782	Northern Norway Regional Health Authority	Northern Norway Regional Health Authority	The study was funded with grand from Northern Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALEXOPOULOS GS, 1988, BIOL PSYCHIAT, V23, P271, DOI 10.1016/0006-3223(88)90038-8; Amani R, 2010, BIOL TRACE ELEM RES, V137, P150, DOI 10.1007/s12011-009-8572-x; Barnett JB, 2010, NUTR REV, V68, P30, DOI 10.1111/j.1753-4887.2009.00253.x; Baune BT, 2011, WORLD J BIOL PSYCHIA, V12, P28, DOI 10.3109/15622975.2011.603223; CHAN AK, 1995, ANN SURG, V222, P402, DOI 10.1097/00000658-199509000-00017; Chasapis CT, 2012, ARCH TOXICOL, V86, P521, DOI 10.1007/s00204-011-0775-1; Cichy A, 2009, PHARMACOL REP, V61, P1184, DOI 10.1016/S1734-1140(09)70182-3; Cieslik K, 2007, PHARMACOL REP, V59, P46; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Corona C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.57; Debnath M, 2011, TRANSL NEUROSCI, V2, P121, DOI 10.2478/s13380-011-0019-0; Dong J, 2008, J ALZHEIMERS DIS, V15, P443; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gibson RS, 2008, BRIT J NUTR, V99, pS14, DOI 10.1017/S0007114508006818; Gronli O, 2013, PSYCHOSOMATICS, V54, P493, DOI 10.1016/j.psym.2012.10.008; HAINES A, 1991, CLIN CHIM ACTA, V198, P261, DOI 10.1016/0009-8981(91)90360-O; International Zinc Nutrition Consultative Group (IZiNCG), 2004, Food Nutr Bull, V25, pS99; Irmisch G, 2010, NEUROCHEM RES, V35, P1376, DOI 10.1007/s11064-010-0194-3; Jacka FN, 2012, J AFFECT DISORDERS, V141, P79, DOI 10.1016/j.jad.2012.02.018; King JC, 2011, AM J CLIN NUTR, V94, p679S, DOI 10.3945/ajcn.110.005744; Lachner C, 2012, J NEUROPSYCH CLIN N, V24, P5, DOI 10.1176/appi.neuropsych.11020052; Lai J, 2012, J AFFECT DISORDERS, V136, pE31, DOI 10.1016/j.jad.2011.06.022; MAES M, 1994, J AFFECT DISORDERS, V31, P135, DOI 10.1016/0165-0327(94)90117-1; Maes M, 1999, J AFFECT DISORDERS, V56, P189, DOI 10.1016/S0165-0327(99)00011-7; Maes M, 1997, BIOL PSYCHIAT, V42, P349, DOI 10.1016/S0006-3223(96)00365-4; Marcellini F, 2006, BIOGERONTOLOGY, V7, P339, DOI 10.1007/s10522-006-9048-4; Maserejian NN, 2012, J AFFECT DISORDERS, V136, P781, DOI 10.1016/j.jad.2011.09.039; Mlyniec K, 2012, PHARMACOL REP, V64, P567; Mlyniec K, 2012, PHARMACOL REP, V64, P249; Molina JA, 1998, J NEURAL TRANSM, V105, P479, DOI 10.1007/s007020050071; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; NARANG R L, 1991, Indian Journal of Physiology and Pharmacology, V35, P272; Nowak G, 2003, POL J PHARMACOL, V55, P1143; Pedersen Reidar, 2007, Tidsskr Nor Laegeforen, V127, P1644; Pepersack T, 2001, ARCH GERONTOL GERIAT, V33, P243, DOI 10.1016/S0167-4943(01)00186-8; Prasad AS, 2008, MOL MED, V14, P353, DOI 10.2119/2008-00033.Prasad; Rahman MA, 2009, BIOL TRACE ELEM RES, V127, P102, DOI 10.1007/s12011-008-8230-8; Rink L, 2000, P NUTR SOC, V59, P541, DOI 10.1017/S0029665100000781; Rosa AO, 2003, BEHAV BRAIN RES, V144, P87, DOI 10.1016/S0166-4328(03)00069-X; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Shcherbatykh I, 2007, J ALZHEIMERS DIS, V11, P191; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; SHORE D, 1984, J AM GERIATR SOC, V32, P892, DOI 10.1111/j.1532-5415.1984.tb00889.x; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Siwek M, 2010, J AFFECT DISORDERS, V126, P447, DOI 10.1016/j.jad.2010.04.024; Siwek M, 2009, J AFFECT DISORDERS, V118, P187, DOI 10.1016/j.jad.2009.02.014; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Stechmiller JK, 2010, NUTR CLIN PRACT, V25, P61, DOI 10.1177/0884533609358997; Stern RA, 1996, J NEUROPSYCH CLIN N, V8, P181; Szewczyk B, 2002, POL J PHARMACOL, V54, P681; Szewczyk B, 2011, PROG NEURO-PSYCHOPH, V35, P693, DOI 10.1016/j.pnpbp.2010.02.010; Takeda A, 2009, BRAIN RES REV, V62, P33, DOI 10.1016/j.brainresrev.2009.09.003; Tassabehji NM, 2008, PHYSIOL BEHAV, V95, P365, DOI 10.1016/j.physbeh.2008.06.017; Wang CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015349; Whittle N, 2009, AMINO ACIDS, V36, P147, DOI 10.1007/s00726-008-0195-6; Yanik M, 2004, BIOL TRACE ELEM RES, V98, P109, DOI 10.1385/BTER:98:2:109; Yary T, 2012, BIOL TRACE ELEM RES, V145, P286, DOI 10.1007/s12011-011-9202-y	57	44	45	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82793	10.1371/journal.pone.0082793	http://dx.doi.org/10.1371/journal.pone.0082793			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367556	Green Published, gold, Green Submitted			2022-12-27	WOS:000328741900013
J	Vincent-Bugnas, S; Vitale, S; Mouline, CC; Khaali, W; Charbit, Y; Mahler, P; Precheur, I; Hofman, P; Maryanski, JL; Doglio, A				Vincent-Bugnas, Severine; Vitale, Sebastien; Mouline, Caroline C.; Khaali, Wafa; Charbit, Yves; Mahler, Patrick; Precheur, Isabelle; Hofman, Paul; Maryanski, Janet L.; Doglio, Alain			EBV Infection Is Common in Gingival Epithelial Cells of the Periodontium and Worsens during Chronic Periodontitis	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HUMAN CYTOMEGALOVIRUS; NASOPHARYNGEAL CARCINOMA; JUNCTIONAL EPITHELIUM; IN-VITRO; REPLICATION; EXPRESSION; VIVO; DISEASES; TISSUES	An amplifying role for oral epithelial cells (ECs) in Epstein-Barr Virus (EBV) infection has been postulated to explain oral viral shedding. However, while lytic or latent EBV infections of oro/nasopharyngeal ECs are commonly detected under pathological conditions, detection of EBV-infected ECs in healthy conditions is very rare. In this study, a simple non-surgical tissue sampling procedure was used to investigate EBV infection in the periodontal epithelium that surrounds and attaches teeth to the gingiva. Surprisingly, we observed that the gingival ECs of the periodontium (pECs) are commonly infected with EBV and may serve as an important oral reservoir of latently EBV-infected cells. We also found that the basal level of epithelial EBV-infection is significantly increased in chronic periodontitis, a common inflammatory disease that undermines the integrity of tooth-supporting tissues. Moreover, the level of EBV infection was found to correlate with disease severity. In inflamed tissues, EBV-infected pECs appear to be prone to apoptosis and to produce larger amounts of CCL20, a pivotal inflammatory chemokine that controls tissue infiltration by immune cells. Our discovery that the periodontal epithelium is a major site of latent EBV infection sheds a new light on EBV persistence in healthy carriers and on the role of this ubiquitous virus in periodontitis. Moreover, the identification of this easily accessible site of latent infection may encourage new approaches to investigate and monitor other EBV-associated disorders.	[Vincent-Bugnas, Severine; Khaali, Wafa; Maryanski, Janet L.; Doglio, Alain] Univ Nice Sophia Antipolis, UFR Med, ImCelVir, URE004, F-06189 Nice, France; [Vincent-Bugnas, Severine; Charbit, Yves; Precheur, Isabelle] Univ Nice Sophia Antipolis, UFR Odontol, LSBV, URE001, F-06189 Nice, France; [Vincent-Bugnas, Severine; Charbit, Yves; Mahler, Patrick; Precheur, Isabelle] Ctr Hosp Univ Nice, Hop St Roch, Nice, France; [Vincent-Bugnas, Severine; Mouline, Caroline C.; Khaali, Wafa; Maryanski, Janet L.; Doglio, Alain] Ctr Hosp Univ Nice, Unite Therapie Cellulaire & Gen, Nice, France; [Vitale, Sebastien; Hofman, Paul] Ctr Hosp Univ Nice, INSERM, Cancerpole PACA, Biobanque IRCAN,Lab Pathol Clin & Expt, Nice, France; [Maryanski, Janet L.] INSERM, UMR 576, F-06202 Nice, France	UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CHU Nice; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Doglio, A (corresponding author), Univ Nice Sophia Antipolis, UFR Med, ImCelVir, URE004, F-06189 Nice, France.	doglio@unice.fr	Hofman, Paul/P-7654-2018; DOGLIO, Alain/ABF-2581-2020; Precheur, Isabelle/Q-2047-2019	Hofman, Paul/0000-0003-0431-9353; Precheur, Isabelle/0000-0001-8134-0127; VINCENT-BUGNAS, Severine/0000-0001-7782-0558; DOGLIO, Alain/0000-0002-5456-5598	Centre Hospitalier de Nice [AOI] [2010-A01119-30]; Agence Nationale de Recherche contre le SIDA [ANRS] [10338]; Sidaction; Agence Nationale de Recherche [ANR-2010-RFCS-007-02]	Centre Hospitalier de Nice [AOI]; Agence Nationale de Recherche contre le SIDA [ANRS](ANRSFrench National Research Agency (ANR)); Sidaction; Agence Nationale de Recherche(French National Research Agency (ANR))	This work was supported in part by the Centre Hospitalier de Nice [AOI No2010-A01119-30 to SVB] and the Agence Nationale de Recherche contre le SIDA [ANRS No 10338 to AD]. SV was the recipient of a fellowship from Sidaction, and CCM was the recipient of a fellowship from the Agence Nationale de Recherche [ANR-2010-RFCS-007-02 to AD]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Baumforth KRN, 2008, AM J PATHOL, V173, P195, DOI 10.2353/ajpath.2008.070845; Bollard CM, 2011, CYTOTHERAPY, V13, P518, DOI 10.3109/14653249.2011.561983; Borza CM, 2004, J VIROL, V78, P5007, DOI 10.1128/JVI.78.10.5007-5014.2004; Caton J, 2011, PHARMACOL RES, V63, P114, DOI 10.1016/j.phrs.2010.12.003; Chalabi M, 2010, MOL ORAL MICROBIOL, V25, P236, DOI 10.1111/j.2041-1014.2010.00571.x; Chang KP, 2008, CLIN CANCER RES, V14, P6979, DOI 10.1158/1078-0432.CCR-08-0090; Chen MR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00005; Chesnokova LS, 2011, J VIROL, V85, P13214, DOI 10.1128/JVI.05580-11; Comerford I, 2010, BIOESSAYS, V32, P1067, DOI 10.1002/bies.201000063; Contreras A, 1996, ORAL MICROBIOL IMMUN, V11, P381, DOI 10.1111/j.1399-302X.1996.tb00199.x; Das Sushma, 2012, J Oral Maxillofac Pathol, V16, P203, DOI 10.4103/0973-029X.98502; Frangou P, 2005, J INFECT DIS, V191, P238, DOI 10.1086/426823; Gourzones C, 2012, SEMIN CANCER BIOL, V22, P127, DOI 10.1016/j.semcancer.2012.01.002; Graves Dana T, 2011, J Oral Microbiol, V3, DOI 10.3402/jom.v3i0.5304; GREENSPAN JS, 1985, NEW ENGL J MED, V313, P1564, DOI 10.1056/NEJM198512193132502; Hadinoto V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000496; Hatakeyama S, 2006, J PERIODONTAL RES, V41, P322, DOI 10.1111/j.1600-0765.2006.00875.x; Hosokawa Y, 2002, CLIN EXP IMMUNOL, V128, P548, DOI 10.1046/j.1365-2249.2002.01865.x; Hudnall SD, 2005, MODERN PATHOL, V18, P519, DOI 10.1038/modpathol.3800369; Jacobsen J, 1999, EUR J ORAL SCI, V107, P138, DOI 10.1046/j.0909-8836.1999.eos107210.x; Jarnbring F, 2002, J CLIN PERIODONTOL, V29, P1065, DOI 10.1034/j.1600-051X.2002.291203.x; Kato A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071990; Kubar A, 2005, J PERIODONTAL RES, V40, P97, DOI 10.1111/j.1600-0765.2005.00770.x; Larjava H, 2011, J DENT RES, V90, P1367, DOI 10.1177/0022034511402207; Lmbronito AV, 2008, J PERIODONTOL, V79, P2313, DOI [10.1902/jop.2008.070388, 10.1902/jop.2008.070388 ]; MADINIER I, 1992, BRIT J ORAL MAX SURG, V30, P237, DOI 10.1016/0266-4356(92)90266-L; Pegtel DM, 2004, J VIROL, V78, P12613, DOI 10.1128/JVI.78.22.12613-12624.2004; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pollanen MT, 2003, PERIODONTOL 2000, V31, P12, DOI 10.1034/j.1600-0757.2003.03102.x; Raab-Traub N, 2012, CURR OPIN VIROL, V2, P453, DOI 10.1016/j.coviro.2012.07.001; RAABTRAUB N, 1983, J VIROL, V48, P580, DOI 10.1128/JVI.48.3.580-590.1983; Rotola A, 2008, J CLIN PERIODONTOL, V35, P831, DOI 10.1111/j.1600-051X.2008.01301.x; Ryan JL, 2004, J MOL DIAGN, V6, P378, DOI 10.1016/S1525-1578(10)60535-1; Shannon-Lowe C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001338; Shannon-Lowe C, 2009, J VIROL, V83, P7749, DOI 10.1128/JVI.00108-09; Shimono M, 2003, J ELECTRON MICROSC, V52, P627, DOI 10.1093/jmicro/52.6.627; SIXBEY JW, 1983, NATURE, V306, P480, DOI 10.1038/306480a0; SIXBEY JW, 1984, NEW ENGL J MED, V310, P1225, DOI 10.1056/NEJM198405103101905; Slots J, 2006, J PERIODONTAL RES, V41, P235, DOI 10.1111/j.1600-0765.2006.00865.x; Sunde PT, 2008, J CLIN VIROL, V42, P176, DOI 10.1016/j.jcv.2008.01.007; Teughels W, 2007, J DENT RES, V86, P1078, DOI 10.1177/154405910708601111; Tomaszewski-Flick MJ, 2007, VIRUS GENES, V35, P225, DOI 10.1007/s11262-007-0118-8; Tsao SW, 2012, SEMIN CANCER BIOL, V22, P137, DOI 10.1016/j.semcancer.2012.02.004; Tugizov S, 2007, J VIROL, V81, P5484, DOI 10.1128/JVI.00171-07; Tugizov SM, 2013, J VIROL, V87, P8179, DOI 10.1128/JVI.00443-13; Vitkov L, 2005, ULTRASTRUCT PATHOL, V29, P121, DOI 10.1080/01913120590916832; Walling DM, 2001, J INFECT DIS, V184, P1499, DOI 10.1086/323992; Wu YM, 2007, J CLIN MICROBIOL, V45, P3665, DOI 10.1128/JCM.00374-07; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zetterberg H, 1999, J GEN VIROL, V80, P457, DOI 10.1099/0022-1317-80-2-457	51	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e80336	10.1371/journal.pone.0080336	http://dx.doi.org/10.1371/journal.pone.0080336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367478	Green Published, gold, Green Submitted			2022-12-27	WOS:000328741900002
J	McLeod, EM; Guay, PJ; Taysom, AJ; Robinson, RW; Weston, MA				McLeod, Emily M.; Guay, Patrick-Jean; Taysom, Alice J.; Robinson, Randall W.; Weston, Michael A.			Buses, Cars, Bicycles and Walkers The Influence of the Type of Human Transport on the Flight Responses of Waterbirds	PLOS ONE			English	Article							BUFFER-ZONE DISTANCES; DOVES ZENAIDA-AURITA; RISK-TAKING BEHAVIOR; PERDIX-PERDIX L.; HUMAN DISTURBANCE; INITIATION DISTANCE; BALD EAGLES; INTERSPECIFIC VARIATION; THINORNIS-RUBRICOLLIS; ANTIPREDATOR BEHAVIOR	One way to manage disturbance to waterbirds in natural areas where humans require access is to promote the occurrence of stimuli for which birds tolerate closer approaches, and so cause fewer responses. We conducted 730 experimental approaches to 39 species of waterbird, using five stimulus types (single walker, three walkers, bicycle, car and bus) selected to mimic different human management options available for a controlled access, Ramsar-listed wetland. Across species, where differences existed (56% of 25 cases), motor vehicles always evoked shorter flight-initiation distances (FID) than humans on foot. The influence of stimulus type on FID varied across four species for which enough data were available for complete cross-stimulus analysis. All four varied FID in relation to stimuli, differing in 4 to 7 of 10 possible comparisons. Where differences occurred, the effect size was generally modest, suggesting that managing stimulus type (e. g. by requiring people to use vehicles) may have species-specific, modest benefits, at least for the waterbirds we studied. However, different stimulus types have different capacities to reduce the frequency of disturbance (i.e. by carrying more people) and vary in their capacity to travel around important habitat.	[McLeod, Emily M.; Guay, Patrick-Jean; Taysom, Alice J.; Robinson, Randall W.] Victoria Univ, Coll Engn & Sci, Appl Ecol Res Grp, Melbourne, Vic 8001, Australia; [McLeod, Emily M.; Guay, Patrick-Jean; Taysom, Alice J.; Robinson, Randall W.] Victoria Univ, Coll Engn & Sci, Inst Sustainabil & Innovat, Melbourne, Vic 8001, Australia; [Guay, Patrick-Jean] Victoria Univ, Coll Hlth & Biomed, Melbourne, Vic 8001, Australia; [Weston, Michael A.] Fac Sci Engn & Built Environm, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Australia	Victoria University; Victoria University; Victoria University	Weston, MA (corresponding author), Fac Sci Engn & Built Environm, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Australia.	mweston@deakin.edu.au		Robinson, Randall/0000-0001-8425-0709; McLeod, Emily/0000-0002-1811-6584	Melbourne Water; Victoria University; Faculty of Health Engineering and Science Collaborative Research Grant Scheme	Melbourne Water; Victoria University; Faculty of Health Engineering and Science Collaborative Research Grant Scheme	This research was funded by Melbourne Water, a Victoria University Fellowship and a Faculty of Health Engineering and Science Collaborative Research Grant Scheme to P. J. Guay (no URLs are available for these funding sources). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JT, 2004, WILSON BULL, V116, P146, DOI 10.1676/03-110; Adams JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P742, DOI 10.1007/s00265-006-0218-9; Albrecht T, 2004, ETHOLOGY, V110, P603, DOI 10.1111/j.1439-0310.2004.00992.x; ANDERSEN DE, 1989, CONDOR, V91, P296, DOI 10.2307/1368307; Antos MJ, 2007, LANDSCAPE URBAN PLAN, V80, P173, DOI 10.1016/j.landurbplan.2006.07.005; Atwell JW, 2012, BEHAV ECOL, V23, P960, DOI 10.1093/beheco/ars059; Baines D, 2007, IBIS, V149, P56, DOI 10.1111/j.1474-919X.2007.00638.x; Bateman PW, 2011, J ZOOL, V285, P316, DOI 10.1111/j.1469-7998.2011.00846.x; Baudains TP, 2007, ANIM CONSERV, V10, P400, DOI 10.1111/j.1469-1795.2007.00126.x; Beale CM, 2004, ANIM BEHAV, V68, P1065, DOI 10.1016/j.anbehav.2004.07.002; Blumstein DT, 2010, PRIMER OF CONSERVATION BEHAVIOR, P1; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Blumstein DT, 2004, ETHOLOGY, V110, P273, DOI 10.1111/j.1439-0310.2004.00970.x; Blumstein DT, 2003, J WILDLIFE MANAGE, V67, P852, DOI 10.2307/3802692; Blumstein DT, 2003, BIOL CONSERV, V110, P97, DOI 10.1016/S0006-3207(02)00180-5; Boogert NJ, 2010, BEHAV PROCESS, V85, P135, DOI 10.1016/j.beproc.2010.06.020; Boyer JS, 2006, AUST J ZOOL, V54, P363, DOI 10.1071/ZO05080; Bregnballe Thomas, 2009, Wildfowl, P115; BUEHLER DA, 1991, J WILDLIFE MANAGE, V55, P282, DOI 10.2307/3809151; BUICK AM, 1989, EMU, V89, P159, DOI 10.1071/MU9890159; Burger J, 1998, CONDOR, V100, P528, DOI 10.2307/1369719; BURGER J, 1988, AGGRESSIVE BEHAV, V14, P169, DOI 10.1002/1098-2337(1988)14:3<169::AID-AB2480140303>3.0.CO;2-D; Burger J, 2010, J WILDLIFE MANAGE, V74, P102, DOI 10.2193/2008-576; BURGER J, 1989, BEHAVIOUR, V111, P129, DOI 10.1163/156853989X00628; BURGER J, 1991, ENVIRON CONSERV, V18, P158, DOI 10.1017/S0376892900021743; Burhans DE, 2001, AUK, V118, P237, DOI 10.1642/0004-8038(2001)118[0237:ROSNCT]2.0.CO;2; Cardenas YL, 2005, ANIM BEHAV, V70, P1395, DOI 10.1016/j.anbehav.2005.03.022; Carrete M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018859; Carrete M, 2010, BIOL LETTERS, V6, P167, DOI 10.1098/rsbl.2009.0739; Chamaille-Jammes S, 2012, BEHAV ECOL SOCIOBIOL, V66, P985, DOI 10.1007/s00265-012-1354-z; Christidis L, 2008, SYSTEMATICS TAXONOMY; Clucas B, 2012, AUK, V129, P8, DOI 10.1525/auk.2011.11121; Cooper WE, 1997, HERPETOLOGICA, V53, P464; Delaney DK, 1999, J WILDLIFE MANAGE, V63, P60, DOI 10.2307/3802487; Eason P, 2010, ZOOL MIDDLE EAST, V51, P9, DOI 10.1080/09397140.2010.10638435; Eason PK, 2006, J WILDLIFE MANAGE, V70, P1796, DOI 10.2193/0022-541X(2006)70[1796:FAFIDI]2.0.CO;2; Evans J, 2010, ETHOLOGY, V116, P588, DOI 10.1111/j.1439-0310.2010.01771.x; Fernandez-Juricic E, 2005, BIOL CONSERV, V125, P225, DOI 10.1016/j.biocon.2005.03.020; Fernandez-Juricic E, 2004, BIOL CONSERV, V117, P407, DOI 10.1016/j.biocon.2003.02.001; Fernandez-Juricic E, 2003, APPL ANIM BEHAV SCI, V84, P219, DOI 10.1016/j.applanim.2003.08.004; Fernandez-Juricic E, 2002, CAN J ZOOL, V80, P1212, DOI 10.1139/Z02-104; Fernandez-Juricic E, 2006, EVOL ECOL RES, V8, P731; Fernandez-Juricic E, 2009, AVIAN CONSERV ECOL, V4; Fox AD, 1997, J APPL ECOL, V34, P1, DOI 10.2307/2404842; FRASER JD, 1985, J WILDLIFE MANAGE, V49, P585, DOI 10.2307/3801676; Ge C, 2011, TRANSPORT RES D-TR E, V16, P604, DOI 10.1016/j.trd.2011.08.003; Geist C., 2005, Animal Biodiversity and Conservation, V28, P69; Glover HK, 2011, LANDSCAPE URBAN PLAN, V103, P326, DOI 10.1016/j.landurbplan.2011.08.006; Gould ML, 2004, EMU, V104, P267, DOI 10.1071/MU03033; Greeney HF, 2008, ORNITOL NEOTROP, V19, P213; Guay PJ, 2013, AUSTRAL ECOL, V38, P516, DOI 10.1111/j.1442-9993.2012.02441.x; Gulbransen D, 2006, ETHOLOGY, V112, P1056, DOI 10.1111/j.1439-0310.2006.01265.x; Heil L, 2007, BIODIVERS CONSERV, V16, P1009, DOI 10.1007/s10531-006-9040-y; Hess MF, 2005, J WILDLIFE MANAGE, V69, P650, DOI 10.2193/0022-541X(2005)069[0650:DIFCOP]2.0.CO;2; Holmes N, 2005, BIOL CONSERV, V126, P339, DOI 10.1016/j.biocon.2005.06.009; HOLMES TL, 1993, WILDLIFE SOC B, V21, P461; Ikuta LA, 2003, BIOL CONSERV, V112, P447, DOI 10.1016/S0006-3207(02)00324-5; Javurkova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032522; Karp DS, 2009, BIODIVERS CONSERV, V18, P3733, DOI 10.1007/s10531-009-9675-6; Kerbiriou C, 2009, J APPL ECOL, V46, P657, DOI 10.1111/j.1365-2664.2009.01646.x; Keyel AC, 2012, CONDOR, V114, P212, DOI 10.1525/cond.2012.110095; Kirby JS, 1993, DISTURBANCE WATERFOW, P53; Kitchen Kim, 2010, Australian Field Ornithology, V27, P1; KUSHLAN JA, 1979, J WILDLIFE MANAGE, V43, P756, DOI 10.2307/3808757; Lee Jeong-Eun, 2012, [Korean Journal of Ornithology, 한국조류학회지], V19, P93; Levey DJ, 2009, P NATL ACAD SCI USA, V106, P8959, DOI 10.1073/pnas.0811422106; Lin T, 2012, ECOL INDIC, V15, P30, DOI 10.1016/j.ecolind.2011.09.018; Lord A, 2001, BIOL CONSERV, V98, P233, DOI 10.1016/S0006-3207(00)00158-0; Loyn R. H., 2002, USE SEWAGE TREATMENT; Madsen J, 2009, POLAR RES, V28, P376, DOI 10.1111/j.1751-8369.2009.00120.x; Magige FJ, 2009, BIODIVERS CONSERV, V18, P1361, DOI 10.1007/s10531-008-9481-6; Martin CA, 2010, ANIM CONSERV, V13, P383, DOI 10.1111/j.1469-1795.2010.00349.x; Martin J, 2006, BEHAV ECOL SOCIOBIOL, V60, P778, DOI 10.1007/s00265-006-0221-1; Martin J, 2004, POLAR BIOL, V27, P775, DOI 10.1007/s00300-004-0653-x; Martinez-Abrain A, 2008, ENVIRON CONSERV, V35, P104, DOI 10.1017/S0376892908004748; Miller SG, 2001, WILDLIFE SOC B, V29, P124; Moller AP, 2008, BEHAV ECOL, V19, P41, DOI 10.1093/beheco/arm098; Moller AP, 2010, J EVOLUTION BIOL, V23, P1689, DOI 10.1111/j.1420-9101.2010.02034.x; Moller AP, 2009, J EVOLUTION BIOL, V22, P2420, DOI 10.1111/j.1420-9101.2009.01850.x; Moller AP, 2010, ETHOLOGY, V116, P458, DOI 10.1111/j.1439-0310.2010.01754.x; Moller AP, 2008, BEHAV ECOL, V19, P1095, DOI 10.1093/beheco/arn103; Moller AP, 2013, BEHAV ECOL, V24, P267, DOI 10.1093/beheco/ars163; Moller AP, 2012, BEHAV ECOL, V23, P1030, DOI 10.1093/beheco/ars067; Moller AP, 2012, BEHAV ECOL, V23, P843, DOI 10.1093/beheco/ars040; Moller Anders Pape, 2011, Zoological Research, V32, P115, DOI 10.3724/SP.J.1141.2011.02115; Moller AP, 2010, BEHAV ECOL, V21, P365, DOI 10.1093/beheco/arp199; Mori Y, 2001, J ETHOL, V19, P115, DOI 10.1007/s101640170007; Mullner A, 2004, BIOL CONSERV, V118, P549, DOI 10.1016/j.biocon.2003.10.003; Navedo JG, 2012, J COAST CONSERV, V16, P373, DOI 10.1007/s11852-012-0208-1; Osiejuk TS, 2007, WILDLIFE BIOL, V13, P11, DOI 10.2981/0909-6396(2007)13[11:FAFDII]2.0.CO;2; Ramsar Convention Bureau, 1984, P 2 C PART GRON NETH; Randler C, 2008, J ETHOL, V26, P309, DOI 10.1007/s10164-007-0062-z; Randler C, 2006, EUR J WILDLIFE RES, V52, P265, DOI 10.1007/s10344-006-0049-z; RODGERS JA, 1995, CONSERV BIOL, V9, P89, DOI 10.1046/j.1523-1739.1995.09010089.x; Rodgers JA, 2002, CONSERV BIOL, V16, P216, DOI 10.1046/j.1523-1739.2002.00316.x; Rodgers JA, 2003, WATERBIRDS, V26, P437, DOI 10.1675/1524-4695(2003)026[0437:BZDTPF]2.0.CO;2; Rodgers JA, 1997, WILDLIFE SOC B, V25, P139; Rodriguez-Prieto I, 2008, BEHAVIOUR, V145, P1125, DOI 10.1163/156853908784474489; Rodriguez-Prieto I, 2009, BEHAV ECOL, V20, P371, DOI 10.1093/beheco/arn151; Rollinson Daniel J., 2006, Australian Field Ornithology, V23, P29; Scales J, 2011, ETHOLOGY, V117, P887, DOI 10.1111/j.1439-0310.2011.01943.x; Schwemmer P, 2011, ECOL APPL, V21, P1851, DOI 10.1890/10-0615.1; Seltmann MW, 2012, ANIM BEHAV, V84, P889, DOI 10.1016/j.anbehav.2012.07.012; Smith PA, 2007, AUK, V124, P276, DOI 10.1642/0004-8038(2007)124[276:AVITBO]2.0.CO;2; Smith-Castro JR, 2010, J FIELD ORNITHOL, V81, P130, DOI 10.1111/j.1557-9263.2010.00270.x; St Clair JJH, 2010, BEHAV ECOL, V21, P1285, DOI 10.1093/beheco/arq144; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Steidl RJ, 1996, ECOL APPL, V6, P482, DOI 10.2307/2269385; Thiel D, 2007, J WILDLIFE MANAGE, V71, P1784, DOI 10.2193/2006-268; Tillmann JE, 2009, BEHAVIOUR, V146, P999, DOI 10.1163/156853908X398924; Tillmann JE, 2009, J ETHOL, V27, P117, DOI 10.1007/s10164-008-0094-z; Valcarcel A, 2009, BEHAV ECOL SOCIOBIOL, V63, P673, DOI 10.1007/s00265-008-0701-6; Wang Yan-Ping, 2004, Zoological Research, V25, P214; WATSON JW, 1993, WILDLIFE SOC B, V21, P171; Webb NV, 2005, CONDOR, V107, P178, DOI 10.1650/7607; Weston MA, 2012, EMU, V112, P269, DOI 10.1071/MU12026; Weston MA, 2005, BIRD CONSERV INT, V15, P193; Weston MA, 2007, J COASTAL RES, V23, P569, DOI 10.2112/04-0151.1; Weston MA, 2011, J WILDLIFE MANAGE, V75, P252, DOI 10.1002/jwmg.7; Wood PB, 1999, J RAPTOR RES, V33, P97; Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908; Zuberogoitia I, 2010, ORNIS FENNICA, V87, P52	122	65	72	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82008	10.1371/journal.pone.0082008	http://dx.doi.org/10.1371/journal.pone.0082008			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367498	Green Published, gold			2022-12-27	WOS:000328740300017
J	Wang, K; Bhandari, V; Chepustanova, S; Huber, G; O'Hara, S; O'Hern, CS; Shattuck, MD; Kirby, M				Wang, Kun; Bhandari, Vineet; Chepustanova, Sofya; Huber, Greg; O'Hara, Stephen; O'Hern, Corey S.; Shattuck, Mark D.; Kirby, Michael			Which Biomarkers Reveal Neonatal Sepsis?	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SENSITIVE DIAGNOSTIC MARKER; NEUTROPHIL CD64 EXPRESSION; LATE-ONSET SEPSIS; PROCALCITONIN; INFECTION; COUNT; TESTS; SCORE	We address the identification of optimal biomarkers for the rapid diagnosis of neonatal sepsis. We employ both canonical correlation analysis (CCA) and sparse support vector machine (SSVM) classifiers to select the best subset of biomarkers from a large hematological data set collected from infants with suspected sepsis from Yale-New Haven Hospital's Neonatal Intensive Care Unit (NICU). CCA is used to select sets of biomarkers of increasing size that are most highly correlated with infection. The effectiveness of these biomarkers is then validated by constructing a sparse support vector machine diagnostic classifier. We find that the following set of five biomarkers capture the essential diagnostic information (in order of importance): Bands, Platelets, neutrophil CD64, White Blood Cells, and Segs. Further, the diagnostic performance of the optimal set of biomarkers is significantly higher than that of isolated individual biomarkers. These results suggest an enhanced sepsis scoring system for neonatal sepsis that includes these five biomarkers. We demonstrate the robustness of our analysis by comparing CCA with the Forward Selection method and SSVM with LASSO Logistic Regression.	[Wang, Kun; Chepustanova, Sofya; O'Hara, Stephen] Colorado State Univ, Dept Math, Ft Collins, CO 80523 USA; [Wang, Kun; O'Hern, Corey S.] Yale Univ, Dept Mech Engn & Mat Sci, New Haven, CT USA; [Bhandari, Vineet] Yale Univ, Sch Med, Dept Pediat, Div Perinatal Med, New Haven, CT 06510 USA; [Huber, Greg] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [O'Hern, Corey S.] Yale Univ, Dept Appl Phys, New Haven, CT USA; [O'Hern, Corey S.] Yale Univ, Dept Phys, New Haven, CT USA; [Shattuck, Mark D.] CUNY City Coll, Benjamin Levich Inst, New York, NY 10031 USA; [Shattuck, Mark D.] CUNY City Coll, Dept Phys, New York, NY 10031 USA	Colorado State University; Yale University; Yale University; University of California System; University of California Santa Barbara; Yale University; Yale University; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY)		kirby@math.colostate.edu	Shattuck, Mark D/F-5680-2015; Bhandari, Vineet/AAS-3365-2020; O'Hern, Corey S/I-3459-2014	Shattuck, Mark D/0000-0001-8473-2505; O'Hern, Corey S/0000-0002-8272-5640	DARPA (Space and Naval Warfare Systems Center Pacic) [N66001-11-1-4184]; Infectious Disease Supercluster, Colorado State University	DARPA (Space and Naval Warfare Systems Center Pacic); Infectious Disease Supercluster, Colorado State University	This material is based on work partially supported by DARPA (Space and Naval Warfare Systems Center Pacic) under Award No. N66001-11-1-4184 http://www.darpa.mil/. Additional support for this work was provided by Infectious Disease Supercluster, Colorado State University, 2012 seed grant http://infectiousdisease.colostate.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benitz WE, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e77; Benitz WE, 2010, CLIN PERINATOL, V37, P421, DOI 10.1016/j.clp.2009.12.001; Bhandari V, 2008, PEDIATRICS, V121, P129, DOI 10.1542/peds.2007-1308; BJORCK A, 1973, MATH COMPUT, V27, P579, DOI 10.2307/2005662; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Cetinkaya M, 2009, J PERINATOL, V29, P225, DOI 10.1038/jp.2008.207; Chepustanova S, 2013, BAND SELECTION UNPUB; Choo Young Kwang, 2012, Korean J Pediatr, V55, P11, DOI 10.3345/kjp.2012.55.1.11; DASILVA O, 1995, PEDIATR INFECT DIS J, V14, P362; Davis Bruce H, 2005, Lab Hematol, V11, P137, DOI 10.1532/LH96.04077; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Dilli D, 2010, J CLIN LAB ANAL, V24, P363, DOI 10.1002/jcla.20370; Efroymson M. A., 1960, MATH METHODS DIGITAL, P191; Fendler WM, 2008, J PAEDIATR CHILD H, V44, P114, DOI 10.1111/j.1440-1754.2007.01230.x; Ganatra HA, 2010, CLIN PERINATOL, V37, P501, DOI 10.1016/j.clp.2010.02.004; Garcia-Prats JA, 2000, PEDIATRICS, V105, P523, DOI 10.1542/peds.105.3.523; Gibot S, 2012, AM J RESP CRIT CARE, V186, P65, DOI 10.1164/rccm.201201-0037OC; Gonzalez BE, 2003, J PERINAT MED, V31, P60, DOI 10.1515/JPM.2003.009; Groselj-Grenc M, 2008, MEDIATORS INFLAMMATI; Groselj-Grenc M, 2009, INTENS CARE MED, V35, P1950, DOI 10.1007/s00134-009-1637-7; Hatherill M, 1999, ARCH DIS CHILD, V81, P417, DOI 10.1136/adc.81.5.417; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Klinger G, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.03.006; Kudawla M, 2008, J TROP PEDIATRICS, V54, P66, DOI 10.1093/tropej/fmm065; Layseca-Espinosa E, 2002, PEDIAT ALLERG IMM-UK, V13, P319, DOI 10.1034/j.1399-3038.2002.01064.x; Lopez Sastre Jose B, 2006, BMC Pediatr, V6, P16; Malik A, 2003, ARCH PEDIAT ADOL MED, V157, P511, DOI 10.1001/archpedi.157.6.511; Mangasarian OL, 1999, OPER RES LETT, V24, P15, DOI 10.1016/S0167-6377(98)00049-2; Mannan M A, 2010, Mymensingh Med J, V19, P259; Manucha V, 2002, J PAEDIATR CHILD H, V38, P459, DOI 10.1046/j.1440-1754.2002.00018.x; Mardia K.V, 1980, MULTIVARIATE ANAL; Milbrandt EB, 2006, CRIT CARE, V10, DOI 10.1186/cc4847; Monneret G, 1997, ACTA PAEDIATR, V86, P209, DOI 10.1111/j.1651-2227.1997.tb08870.x; Morik K, 1999, MACHINE LEARNING, PROCEEDINGS, P268; Morsy Amal A, 2008, Egypt J Immunol, V15, P53; Mussap M., 2012, J MATERN-FETAL NEO M, V25, P24; Naher B S, 2011, Bangladesh Med Res Counc Bull, V37, P40; Narasimha A, 2011, INDIAN J HEMATOL BLO, V27, P14, DOI 10.1007/s12288-010-0050-2; Ng A. Y., 2004, P 21 INT C MACH LEAR, P78, DOI DOI 10.1145/1015330.1015435; Ng PC, 2010, CLIN PERINATOL, V37, P599, DOI 10.1016/j.clp.2010.05.005; Ng PC, 2004, PEDIATR RES, V56, P796, DOI 10.1203/01.PDR.0000142586.47798.5E; Ng PC, 1997, ARCH DIS CHILD-FETAL, V77, pF221, DOI 10.1136/fn.77.3.F221; Ng PC, 2002, PEDIATR RES, V51, P296, DOI 10.1203/00006450-200203000-00006; Nigro KG, 2005, AM J CLIN PATHOL, V123, P618, DOI 10.1309/73H7K7UBW816PBJJ; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; RODWELL RL, 1988, J PEDIATR-US, V112, P761, DOI 10.1016/S0022-3476(88)80699-1; Selimovic A, 2010, TURKISH J PEDIATR, V52, P139; Singh SA, 2003, J TROP PEDIATRICS, V49, P235, DOI 10.1093/tropej/49.4.235; Sjostrand K, 2012, J STAT SOFT IN PRESS; Srinivasan L, 2012, CURR OPIN PEDIATR, V24, P165, DOI 10.1097/MOP.0b013e3283504df3; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Streimish I, 2013, AM J PERINATOLOGY; Streimish I, 2012, PEDIATR INFECT DIS J, V31, P777, DOI 10.1097/INF.0b013e318256fb07; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tofallis C, 1999, J ROY STAT SOC D-STA, V48, P371, DOI 10.1111/1467-9884.00195; Vouloumanou EK, 2011, INTENS CARE MED, V37, P747, DOI 10.1007/s00134-011-2174-8; Waliullah S M, 2010, Mymensingh Med J, V19, P41; Zeitoun AAH, 2010, SCAND J INFECT DIS, V42, P299, DOI 10.3109/00365540903449832	58	23	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82700	10.1371/journal.pone.0082700	http://dx.doi.org/10.1371/journal.pone.0082700			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367543	Green Published, gold			2022-12-27	WOS:000328740300058
J	Bao, B; Chen, YG; Zhang, L; Xu, YLN; Wang, X; Liu, J; Qu, W				Bao, Bin; Chen, Yan-Guang; Zhang, Lei; Xu, Yan Lin Na; Wang, Xin; Liu, Jian; Qu, Wei			Momordica charantia (Bitter Melon) Reduces Obesity-Associated Macrophage and Mast Cell Infiltration as well as Inflammatory Cytokine Expression in Adipose Tissues	PLOS ONE			English	Article							WILD VARIANT; RISK-FACTORS; INSULIN; ACCUMULATION; ACTIVATION; RATS; STABILIZATION; CONSTITUENTS; ADIPOCYTES; MICE	Obesity is a world-wide epidemic disease that correlates closely with type 2 diabetes and cardiovascular diseases. Obesity-induced chronic adipose tissue inflammation is now considered as a critical contributor to the above complications. Momordica charantia (bitter melon, BM) is a traditional Chinese food and well known for its function of reducing body weight gain and insulin resistance. However, it is unclear whether BM could alleviate adipose tissue inflammation caused by obesity. In this study, C57BL/6 mice were fed high fat diet (HFD) with or without BM for 12 weeks. BM-contained diets ameliorated HFD-induced obesity and insulin resistance. Histological and real-time PCR analysis demonstrated BM not only reduced macrophage infiltration into epididymal adipose tissues (EAT) and brown adipose tissues (BAT). Flow cytometry show that BM could modify the M1/M2 phenotype ratio of macrophages in EAT. Further study showed that BM lowered mast cell recruitments in EAT, and depressed pro-inflammatory cytokine monocyte chemotactic protein-1 (MCP-1) expression in EAT and BAT as well as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) expression in EAT. Finally, ELISA analysis showed BM-contained diets also normalized serum levels of the cytokines. In summary, in concert with ameliorated insulin resistance and fat deposition, BM reduced adipose tissue inflammation in diet-induced obese (DIO) mice.	[Bao, Bin; Chen, Yan-Guang; Zhang, Lei; Xu, Yan Lin Na; Wang, Xin; Liu, Jian; Qu, Wei] Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Peoples R China	Hefei University of Technology	Liu, J (corresponding author), Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Peoples R China.	liujian509@hfut.edu.cn; quweiok@gmail.com		Bao, Bin/0000-0001-7610-3426	National Natural Science Foundation of China [31171315]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20100111110009, 20110111120025]; Anhui Provincial Natural Science Foundation of China [11040606M92]; Fundamental Research Funds for the Central Universities, China [2012HGCX0003, 2011HGB21280, 2012HGQC0019]; China Postdoctoral Science Foundation [2013M541817]; Foundation of Anhui Educational Committee [KJ2011A214]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Anhui Provincial Natural Science Foundation of China(Natural Science Foundation of Anhui Province); Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Foundation of Anhui Educational Committee	This work was supported by a project from National Natural Science Foundation of China (Grant No. 31171315) (J.L.); Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20100111110009 and 20110111120025 to J.L. and W. Q.); Anhui Provincial Natural Science Foundation of China (Grant No. 11040606M92 to J.L.); The Fundamental Research Funds for the Central Universities, China (Grant No. 2012HGCX0003 and 2011HGB21280, 2012HGQC0019 to J.L. and B. B.); China Postdoctoral Science Foundation (Grant No. 2013M541817 to B. B.); and Foundation of Anhui Educational Committee (Grant No.KJ2011A214 to W. Q.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altintas MM, 2011, J LIPID RES, V52, P480, DOI 10.1194/jlr.M011338; Anila L, 2000, PHYTOTHER RES, V14, P592, DOI 10.1002/1099-1573(200012)14:8&lt;592::AID-PTR772&gt;3.0.CO;2-#; Chan LLY, 2005, J NUTR, V135, P2517, DOI 10.1093/jn/135.11.2517; Chang CI, 2011, FOOD CHEM, V125, P521, DOI 10.1016/j.foodchem.2010.09.043; Chao CY, 2011, J ETHNOPHARMACOL, V135, P156, DOI 10.1016/j.jep.2011.03.001; Chatzigeorgiou A, 2012, DIABETOLOGIA, V55, P2583, DOI 10.1007/s00125-012-2607-0; Chen PH, 2012, J NUTR, V142, P1197, DOI 10.3945/jn.112.159939; Chen QX, 2003, J NUTR, V133, P1088, DOI 10.1093/jn/133.4.1088; Chen QX, 2005, BRIT J NUTR, V93, P747, DOI 10.1079/BJN20051388; Cheng HL, 2012, EUR J PHARMACOL, V689, P241, DOI 10.1016/j.ejphar.2012.05.033; Dalmas E, 2011, TRENDS IMMUNOL, V32, P307, DOI 10.1016/j.it.2011.04.008; Fang EF, 2011, CURR MOL MED, V11, P417; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Gadang V, 2011, J MED FOOD, V14, P86, DOI 10.1089/jmf.2010.0010; Grover JK, 2004, J ETHNOPHARMACOL, V93, P123, DOI 10.1016/j.jep.2004.03.035; Grundy SM, 2002, CIRCULATION, V105, P2696, DOI 10.1161/01.CIR.0000020650.86137.84; Hageman RS, 2010, PHYSIOL GENOMICS, V42, P55, DOI 10.1152/physiolgenomics.00072.2009; Harinantenaina L, 2006, CHEM PHARM BULL, V54, P1017, DOI 10.1248/cpb.54.1017; Huang HL, 2008, BRIT J NUTR, V99, P230, DOI 10.1017/S0007114507793947; Iseli TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062309; Keller AC, 2011, PHYTOMEDICINE, V19, P32, DOI 10.1016/j.phymed.2011.06.019; Klomann SD, 2010, BRIT J NUTR, V104, P1613, DOI 10.1017/S0007114510002680; Leung L, 2009, BRIT J NUTR, V102, P1703, DOI 10.1017/S0007114509992054; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Nerurkar PV, 2008, BRIT J NUTR, V100, P751, DOI 10.1017/S0007114508937430; Nerurkar PV, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-64; Nerurkar PV, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-34; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Overman A, 2011, INT J OBESITY, V35, P1165, DOI 10.1038/ijo.2010.272; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Shih CC, 2008, DIABETES RES CLIN PR, V81, P134, DOI 10.1016/j.diabres.2008.04.023; Singh Jaipaul, 2011, Open Med Chem J, V5, P70, DOI 10.2174/1874104501105010070; Sismanopoulos N, 2012, CURR PHARM DESIGN, V18, P2261, DOI 10.2174/138161212800165997; Sridhar MG, 2008, BRIT J NUTR, V99, P806, DOI 10.1017/S000711450783176X; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Tan MJ, 2008, CHEM BIOL, V15, P263, DOI 10.1016/j.chembiol.2008.01.013; Wang J, 2011, DIABETES-METAB RES, V27, P919, DOI 10.1002/dmrr.1272; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wang ZQ, 2011, J NUTR BIOCHEM, V22, P1064, DOI 10.1016/j.jnutbio.2010.09.004; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Yu WF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013973	45	52	55	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84075	10.1371/journal.pone.0084075	http://dx.doi.org/10.1371/journal.pone.0084075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358329	gold, Green Submitted, Green Published			2022-12-27	WOS:000328737700078
J	Chen, YJ; Thang, MWC; Chan, YT; Huang, YF; Ma, NAH; Yu, AL; Wu, CY; Hu, ML; Chiu, KP				Chen, Yen-Ju; Thang, Mike W. C.; Chan, Yu-Tzu; Huang, Yu-Feng; Ma, Nianhan; Yu, Alice L.; Wu, Chung-Yi; Hu, Miao-Lin; Chiu, Kuo Ping			Global Assessment of Antrodia cinnamomea-Induced MicroRNA Alterations in Hepatocarcinoma Cells	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; FRUITING BODIES; DOWN-REGULATION; APOPTOSIS; INHIBITION; PI3K/AKT; SURVIVAL; PROTEIN; POLYSACCHARIDES; EXPRESSION	Recent studies have demonstrated a potent anticancer potential of medicinal fungus Antrodia cinnamomea, especially against hepatocarcinoma. These studies, however, were performed with prolonged treatments, and the early anticancer events remain missing. To probe the early anticancer mechanisms of A. cinnamomea, we treated SK-Hep-1 liver cancer cell with A. cinnamomea fruiting body extract for 2 and 4 hours, sequenced RNA samples with next-generation sequencing approach, and profiled the genome-wide miRNA and mRNA transcriptomes. Results unmistakably associated the early anticancer effect of A. cinnamomea fruiting body extract with a global downregulation of miRNAs which occurred solely in the A. cinnamomea fruiting body extract-treated SK-Hep-1 cells. Moreover, the inhibitory effect of A. cinnamomea fruiting body extract upon cancer miRNAs imposed no discrimination against any particular miRNA species, with oncomirs miR-21, miR-191 and major oncogenic clusters miR-17-92 and miR-106b-25 among the most severely downregulated. Western blotting further indicated a decrease in Drosha and Dicer proteins which play a key role in miRNA biogenesis, together with an increase of XRN2 known to participate in miRNA degradation pathway. Transcriptome profiling followed by GO and pathway analyses indicated that A. cinnamomea induced apoptosis, which was tightly associated with a downregulation of PI3K/AKT and MAPK pathways. Phosphorylation assay further suggested that JNK and c-Jun were closely involved in the apoptotic process. Taken together, our data indicated that the anticancer effect of A. cinnamomea can take place within a few hours by targeting multiple proteins and the miRNA system. A. cinnamomea indiscriminately induced a global downregulation of miRNAs by simultaneously inhibiting the key enzymes involved in miRNA maturation and activating XRN2 protein involved in miRNA degradation. Collapsing of the miRNA system together with downregulation of cell growth and survival pathways and activation of JNK signaling unleash the extrinsic and intrinsic apoptosis pathways, leading to the cancer cell death.	[Chen, Yen-Ju; Thang, Mike W. C.; Chan, Yu-Tzu; Huang, Yu-Feng; Wu, Chung-Yi; Chiu, Kuo Ping] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chen, Yen-Ju] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei 10764, Taiwan; [Chan, Yu-Tzu; Yu, Alice L.] Chang Gung Mem Hosp, Ctr Stem Cell & Translat Canc Res, Tao Yuan, Taiwan; [Ma, Nianhan] Natl Cent Univ, Inst Syst Biol & Bioinformat, Jhongli, Taiwan; [Yu, Alice L.] Chang Gung Univ, Tao Yuan, Taiwan; [Hu, Miao-Lin] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung 40227, Taiwan; [Chiu, Kuo Ping] Natl Taiwan Univ, Coll Life Sci, Dept Life Sci, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University; Chang Gung Memorial Hospital; National Central University; Chang Gung University; National Chung Hsing University; National Taiwan University	Chiu, KP (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	chiukp@gate.sinica.edu.tw	Ma, Nianhan/AAB-9869-2020; Wu, Chung-Yi/K-8334-2018; Chiu, Kuo-Ping/AAG-8855-2020; Huang, Yu-Feng/Y-5818-2019; Thang, Wai Cheng/D-6097-2017	Ma, Nianhan/0000-0003-1800-2306; Chiu, Kuo-Ping/0000-0001-9144-0674; Huang, Yu-Feng/0000-0001-5822-3635; Thang, Wai Cheng/0000-0002-1480-3563; yu, alice/0000-0003-2444-0505	Academia Sinica	Academia Sinica(Academia Sinica - Taiwan)	This study is supported by research grant from Academia Sinica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Chiang LC, 2006, CANCER LETT, V237, P207, DOI 10.1016/j.canlet.2005.06.002; Chuang SM, 2000, CARCINOGENESIS, V21, P1423, DOI 10.1093/carcin/21.7.1423; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Elyakim E, 2010, CANCER RES, V70, P8077, DOI 10.1158/0008-5472.CAN-10-1313; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Geethangili M, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep108; Gupta K, 1999, EXP CELL RES, V247, P495, DOI 10.1006/excr.1998.4359; Hsieh YC, 2010, CHEM RES TOXICOL, V23, P1256, DOI 10.1021/tx100116a; Hsu YL, 2007, FOOD CHEM TOXICOL, V45, P1249, DOI 10.1016/j.fct.2007.01.005; Hsu YL, 2005, CANCER LETT, V221, P77, DOI 10.1016/j.canlet.2004.08.012; Huang Y, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-48; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Kaikkonen MU, 2011, CARDIOVASC RES, V90, P430, DOI 10.1093/cvr/cvr097; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee ER, 2006, BBA-MOL CELL RES, V1763, P958, DOI 10.1016/j.bbamcr.2006.06.006; Li QH, 2013, INT J HEMATOL, V97, P617, DOI 10.1007/s12185-013-1317-9; Li W, 2012, MOL CELL BIOCHEM, V363, P135, DOI 10.1007/s11010-011-1166-x; Lima RT, 2011, EUR J CANCER, V47, P163, DOI 10.1016/j.ejca.2010.11.005; Liu CL, 2009, CHEM-BIOL INTERACT, V182, P165, DOI 10.1016/j.cbi.2009.08.017; Liu JJ, 2004, TOXICOL APPL PHARM, V201, P186, DOI 10.1016/j.taap.2004.05.016; Liu YM, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/569737; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Massaoka MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038698; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Murata M, 2005, EXP CELL RES, V310, P140, DOI 10.1016/j.yexcr.2005.07.017; Roy Sanjit K, 2010, J Mol Signal, V5, P10, DOI 10.1186/1750-2187-5-10; Shan RJ, 1999, BLOOD, V94, P4067, DOI 10.1182/blood.V94.12.4067.424k12_4067_4076; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Yang CM, 2009, J ETHNOPHARMACOL, V123, P407, DOI 10.1016/j.jep.2009.03.034	38	9	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82751	10.1371/journal.pone.0082751	http://dx.doi.org/10.1371/journal.pone.0082751			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358224	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700030
J	Kersulyte, D; Rossi, M; Berg, DE				Kersulyte, Dangeruta; Rossi, Mirko; Berg, Douglas E.			Sequence Divergence and Conservation in Genomes of Helicobacter cetorum Strains from a Dolphin and a Whale	PLOS ONE			English	Article							INSERTION SPECIFICITY; GASTRIC PATHOGEN; FUNCTIONAL-ORGANIZATION; BACTERIAL COMMUNITIES; TRANSPOSABLE ELEMENT; IV SECRETION; PYLORI VACA; DISEASE; EVOLUTION; UREASE	Background and Objectives: Strains of Helicobacter cetorum have been cultured from several marine mammals and have been found to be closely related in 16 S rDNA sequence to the human gastric pathogen H. pylori, but their genomes were not characterized further. Methods: The genomes of H. cetorum strains from a dolphin and a whale were sequenced completely using 454 technology and PCR and capillary sequencing. Results: These genomes are 1.8 and 1.95 mb in size, some 7-26% larger than H. pylori genomes, and differ markedly from one another in gene content, and sequences and arrangements of shared genes. However, each strain is more related overall to H. pylori and its descendant H. acinonychis than to other known species. These H. cetorum strains lack cag pathogenicity islands, but contain novel alleles of the virulence-associated vacuolating cytotoxin (vacA) gene. Of particular note are (i) an extra triplet of vacA genes with <= 50% protein-level identity to each other in the 59 two-thirds of the gene needed for host factor interaction; (ii) divergent sets of outer membrane protein genes; (iii) several metabolic genes distinct from those of H. pylori; (iv) genes for an iron-cofactored urease related to those of Helicobacter species from terrestrial carnivores, in addition to genes for a nickel co-factored urease; and (v) members of the slr multigene family, some of which modulate host responses to infection and improve Helicobacter growth with mammalian cells. Conclusions: Our genome sequence data provide a glimpse into the novelty and great genetic diversity of marine helicobacters. These data should aid further analyses of microbial genome diversity and evolution and infection and disease mechanisms in vast and often fragile ocean ecosystems.	[Kersulyte, Dangeruta; Berg, Douglas E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Rossi, Mirko] Univ Helsinki, Fac Vet Med, Helsinki, Finland	Washington University (WUSTL); University of Helsinki	Berg, DE (corresponding author), Univ Calif, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA.	berg@borcim.wustl.edu	Rossi, Mirko/D-1509-2012	Rossi, Mirko/0000-0002-1585-6384	US National Institutes of Health [R21 AI078237, R21 AI088337]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078237, R21AI088337] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants from the US National Institutes of Health R21 AI078237 and R21 AI088337. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Alm RA, 2000, INFECT IMMUN, V68, P4155, DOI 10.1128/IAI.68.7.4155-4168.2000; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Baltrus DA, 2009, J BACTERIOL, V191, P447, DOI 10.1128/JB.01416-08; Beinart RA, 2012, P NATL ACAD SCI USA, V109, pE3241, DOI 10.1073/pnas.1202690109; Blanchard Thomas G, 2012, Curr Protoc Microbiol, VChapter 8, DOI [10.1002/9780471729259.mc08b01s00, 10.1002/9780471729259.mc08b01s24]; Carter EL, 2011, P NATL ACAD SCI USA, V108, P13095, DOI 10.1073/pnas.1106915108; Chambers MG, 2013, J MOL BIOL, V425, P524, DOI 10.1016/j.jmb.2012.11.020; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; Dailidiene D, 2004, J BACTERIOL, V186, P356, DOI 10.1128/JB.186.2.356-365.2004; Doolittle WF, 2012, CURR BIOL, V22, pR451, DOI 10.1016/j.cub.2012.04.034; Dumrese C, 2009, FEBS LETT, V583, P1637, DOI 10.1016/j.febslet.2009.04.027; Dwivedi GR, 2013, NUCLEIC ACIDS RES, V41, P3274, DOI 10.1093/nar/gkt024; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; Fischer W, 2009, CURR TOP MICROBIOL, V337, P129, DOI 10.1007/978-3-642-01846-6_5; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Gangwer KA, 2010, J BACTERIOL, V192, P6126, DOI 10.1128/JB.01081-10; Garcia-Amado MA, 2007, HELICOBACTER, V12, P553, DOI 10.1111/j.1523-5378.2007.00526.x; Goldman CG, 2009, RES VET SCI, V86, P18, DOI 10.1016/j.rvsc.2008.04.001; Goldman CG, 2009, VET MICROBIOL, V133, P287, DOI 10.1016/j.vetmic.2008.06.023; Goldman CG, 2011, VET MICROBIOL, V152, P138, DOI 10.1016/j.vetmic.2011.04.023; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harper CG, 2003, DIS AQUAT ORGAN, V57, P1, DOI 10.3354/dao057001; Harper CG, 2002, J CLIN MICROBIOL, V40, P4536, DOI 10.1128/JCM.40.12.4536-4543.2002; Herrera PM, 2008, J CLIN MICROBIOL, V46, P3912, DOI 10.1128/JCM.01453-08; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kersulyte D, 1998, GENE, V223, P175, DOI 10.1016/S0378-1119(98)00164-4; Kersulyte D, 2004, J BACTERIOL, V186, P7521, DOI 10.1128/JB.186.22.7521-7528.2004; Kersulyte D, 2002, J BACTERIOL, V184, P992, DOI 10.1128/jb.184.4.992-1002.2002; Kersulyte D, 2000, J BACTERIOL, V182, P5300, DOI 10.1128/JB.182.19.5300-5308.2000; Kersulyte D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015076; Kersulyte D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006859; Kim IJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00037; LEE A, 1993, GASTROENTEROL CLIN N, V22, P21; Lehmann JS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002468; Lehours P, 2011, MBIO, V2, DOI 10.1128/mBio.00239-11; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Luo CH, 2012, J VIROL, V86, P8781, DOI 10.1128/JVI.00446-12; McLaughlin RW, 2011, DIS AQUAT ORGAN, V95, P241, DOI 10.3354/dao02364; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; Ogura M, 2007, PLOS COMPUT BIOL, V3, P1455, DOI 10.1371/journal.pcbi.0030151; Putty K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059560; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rohrer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045623; Roschitzki B, 2011, CURR MICROBIOL, V63, P239, DOI 10.1007/s00284-011-9969-2; Sachs G, 2003, ANNU REV PHYSIOL, V65, P349, DOI 10.1146/annurev.physiol.65.092101.142156; Sause WE, 2012, INFECT IMMUN, V80, P2286, DOI 10.1128/IAI.00312-12; Schott T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-534; SOLNICK JV, 2001, HELICOBACTER PYLORI, P39; Stoof J, 2008, ENVIRON MICROBIOL, V10, P2586, DOI 10.1111/j.1462-2920.2008.01681.x; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; Sweet M, 2012, ENVIRON MICROBIOL, V14, P2184, DOI 10.1111/j.1462-2920.2012.02746.x; Tan SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002050; Uchiyama J, 2012, J VIROL, V86, P11400, DOI 10.1128/JVI.01767-12; Webster NS, 2008, ENVIRON MICROBIOL, V10, P3366, DOI 10.1111/j.1462-2920.2008.01734.x; Wittekindt NE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013432; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Yamaoka Y, 2010, NAT REV GASTRO HEPAT, V7, P629, DOI 10.1038/nrgastro.2010.154	62	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83177	10.1371/journal.pone.0083177	http://dx.doi.org/10.1371/journal.pone.0083177			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358262	Green Published, gold			2022-12-27	WOS:000328737700051
J	Liao, LZ; Zhou, Q; Song, Y; Wu, WK; Yu, HM; Wang, S; Chen, YL; Ye, MH; Lu, LH				Liao, Lizhen; Zhou, Qin; Song, Yan; Wu, Weikang; Yu, Huimin; Wang, Sheng; Chen, Yanling; Ye, Meihong; Lu, Lihe			Ceramide Mediates Ox-LDL-Induced Human Vascular Smooth Muscle Cell Calcification via p38 Mitogen-Activated Protein Kinase Signaling	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; NEUTRAL SPHINGOMYELINASE; ATHEROSCLEROTIC LESIONS; ARTERIAL CALCIFICATION; EXTRACELLULAR-MATRIX; IN-VITRO; APOPTOSIS; DIFFERENTIATION; PROLIFERATION; DISEASE	Vascular calcification is associated with significant cardiovascular morbidity and mortality, and has been demonstrated as an actively regulated process resembling bone formation. Oxidized low density lipoprotein (Ox-LDL) has been identified as a regulatory factor involved in calcification of vascular smooth muscle cells (VSMCs). Additionally, over-expression of recombinant human neutral sphingomyelinase (N-SMase) has been shown to stimulate VSMC apoptosis, which plays an important role in the progression of vascular calcification. The aim of this study is to investigate whether ceramide regulates Ox-LDL-induced calcification of VSMCs via activation of p38 mitogen-activated protein kinase (MAPK) pathway. Ox-LDL increased the activity of N-SMase and the level of ceramide in cultured VSMCs. Calcification and the osteogenic transcription factor, Msx2 mRNA expression were reduced by N-SMase inhibitor, GW4869 in the presence of Ox-LDL. Usage of GW4869 inhibited Ox-LDL-induced apoptosis in VSMCs, an effect which was reversed by C2-ceramide. Additionally, C2-ceramide treatment accelerated VSMC calcification, with a concomitant increase in ALP activity. Furthermore, C2-ceramide treatment enhanced Ox-LDL-induced VSMC calcification. Addition of caspase inhibitor, ZVAD-fmk attenuated Ox-LDL-induced calcification. Both Ox-LDL and C2-ceramide treatment increased the phosphorylation of p38 MAPK. Inhibition of p38 MAPK by SB203580 attenuated Ox-LDL-induced calcification of VSMCs. These data suggest that Ox-LDL activates N-SMase-ceramide signaling pathway, and stimulates phosphorylation of p38 MAPK, leading to apoptosis in VSMCs, which initiates VSMC calcification.	[Liao, Lizhen; Song, Yan; Wu, Weikang; Chen, Yanling; Ye, Meihong; Lu, Lihe] Sun Yat Sen Univ, Zhongshan Med Sch, Dept Pathophysiol, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Qin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Huimin] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Yu, Huimin; Wang, Sheng] Guangdong Cardiovasc Inst, Guangzhou, Guangdong, Peoples R China; [Wang, Sheng] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Lu, LH (corresponding author), Sun Yat Sen Univ, Zhongshan Med Sch, Dept Pathophysiol, Guangzhou 510275, Guangdong, Peoples R China.	lulihe@mail.sysu.edu.cn	chen, yanling/GRE-8287-2022	Wang, Sheng/0000-0003-0065-0102	National Natural Science Foundation of China [81000124]; Fundamental Research Funds for the Central Universities [11ykpy8]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; Medical Science Foundation of Guangdong Province [A2010037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Medical Science Foundation of Guangdong Province	This work was supported by the grants from the National Natural Science Foundation of China (81000124 to L. H. L.), the Fundamental Research Funds for the Central Universities (11ykpy8 to L. H. L.), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (to L. H. L.) and the Medical Science Foundation of Guangdong Province (A2010037 to H.M.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Auge N, 1996, J BIOL CHEM, V271, P19251, DOI 10.1074/jbc.271.32.19251; Auge N, 1998, J BIOL CHEM, V273, P12893, DOI 10.1074/jbc.273.21.12893; Bachem MG, 1999, CLIN CHEM LAB MED, V37, P319, DOI 10.1515/CCLM.1999.054; Chatterjee S, 1998, ARTERIOSCL THROM VAS, V18, P1523, DOI 10.1161/01.ATV.18.10.1523; Chen W, 2013, BR J PHARM; Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976; Coll O, 2007, J LIPID RES, V48, P1924, DOI 10.1194/jlr.M700069-JLR200; Collett GDM, 2007, CIRC RES, V100, P502, DOI 10.1161/01.RES.0000258854.03388.02; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Duan XH, 2009, BIOCHEM BIOPH RES CO, V387, P694, DOI 10.1016/j.bbrc.2009.07.085; Endlich N, 2000, KIDNEY INT, V57, P2468, DOI 10.1046/j.1523-1755.2000.00105.x; Fadini GP, 2011, CIRC RES, V108, P1112, DOI 10.1161/CIRCRESAHA.110.234088; FITZGERALD PJ, 1992, CIRCULATION, V86, P64, DOI 10.1161/01.CIR.86.1.64; Giachelli CM, 2004, J AM SOC NEPHROL, V15, P2959, DOI 10.1097/01.ASN.0000145894.57533.C4; Goettsch C, 2011, DIABETOLOGIA, V54, P2690, DOI 10.1007/s00125-011-2219-0; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Han YL, 2010, J MOL CELL CARDIOL, V48, P1225, DOI 10.1016/j.yjmcc.2009.12.018; Hsieh CC, 2001, CARDIOVASC RES, V49, P135, DOI 10.1016/S0008-6363(00)00218-2; Ichi I, 2007, NUTRITION, V23, P570, DOI 10.1016/j.nut.2007.04.014; Ingueneau C, 2009, J CELL MOL MED, V13, P1620, DOI 10.1111/j.1582-4934.2008.00593.x; Jono S, 1997, ARTERIOSCL THROM VAS, V17, P1135, DOI 10.1161/01.ATV.17.6.1135; Kageyama A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068197; Kolmakova A, 2004, ARTERIOSCL THROM VAS, V24, P264, DOI 10.1161/01.ATV.0000112036.72200.ac; Lee CH, 2011, EUR J PHARMACOL, V668, P383, DOI 10.1016/j.ejphar.2011.06.059; Liu YW, 2011, FRONT BIOSCI-LANDMRK, V16, P1302, DOI 10.2741/3790; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marathe S, 1999, ARTERIOSCL THROM VAS, V19, P2648, DOI 10.1161/01.ATV.19.11.2648; Maupas-Schwalm F, 2004, FASEB J, V18, P1398, DOI 10.1096/fj.03-1123fje; Mondal S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-239; Nakagawa Y, 2010, ARTERIOSCL THROM VAS, V30, P1908, DOI 10.1161/ATVBAHA.110.206185; Okura Y, 2000, CIRCULATION, V102, P2680, DOI 10.1161/01.CIR.102.22.2680; Parhami F, 1997, ARTERIOSCL THROM VAS, V17, P680, DOI 10.1161/01.ATV.17.4.680; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Ruvolo PP, 2001, LEUKEMIA, V15, P1153, DOI 10.1038/sj.leu.2402197; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Schissel SL, 1996, J CLIN INVEST, V98, P1455, DOI 10.1172/JCI118934; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Shimizu T, 2012, INT HEART J, V53, P331, DOI 10.1536/ihj.53.331; Shroff RC, 2008, CIRCULATION, V118, P1748, DOI 10.1161/CIRCULATIONAHA.108.783738; Signorelli P, 2002, METHOD ENZYMOL, V345, P275; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Tanikawa T, 2009, J VASC RES, V46, P572, DOI 10.1159/000226225; Taylor J, 2011, J CELL BIOCHEM, V112, P581, DOI 10.1002/jcb.22948; WONG ND, 1994, AM J CARDIOL, V73, P223, DOI 10.1016/0002-9149(94)90223-2; Yabu T, 2008, J BIOL CHEM, V283, P29971, DOI 10.1074/jbc.M805402200; Yan JY, 2011, ARTERIOSCL THROM VAS, V31, P608, DOI 10.1161/ATVBAHA.110.220749	47	45	50	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82379	10.1371/journal.pone.0082379	http://dx.doi.org/10.1371/journal.pone.0082379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358176	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700062
J	Mesquita, RC; D'Souza, A; Bilfinger, TV; Galler, RM; Emanuel, A; Schenkel, SS; Yodh, AG; Floyd, TF				Mesquita, Rickson C.; D'Souza, Angela; Bilfinger, Thomas V.; Galler, Robert M.; Emanuel, Asher; Schenkel, Steven S.; Yodh, Arjun G.; Floyd, Thomas F.			Optical Monitoring and Detection of Spinal Cord Ischemia	PLOS ONE			English	Article							MOTOR-EVOKED-POTENTIALS; BLOOD-FLOW; INJURY; OUTCOMES; SURGERY; COMPLICATIONS; CATHETER; EPIDEMIOLOGY; PREVALENCE; WORLDWIDE	Spinal cord ischemia can lead to paralysis or paraparesis, but if detected early it may be amenable to treatment. Current methods use evoked potentials for detection of spinal cord ischemia, a decades old technology whose warning signs are indirect and significantly delayed from the onset of ischemia. Here we introduce and demonstrate a prototype fiber optic device that directly measures spinal cord blood flow and oxygenation. This technical advance in neurological monitoring promises a new standard of care for detection of spinal cord ischemia and the opportunity for early intervention. We demonstrate the probe in an adult Dorset sheep model. Both open and percutaneous approaches were evaluated during pharmacologic, physiological, and mechanical interventions designed to induce variations in spinal cord blood flow and oxygenation. The induced variations were rapidly and reproducibly detected, demonstrating direct measurement of spinal cord ischemia in real-time. In the future, this form of hemodynamic spinal cord diagnosis could significantly improve monitoring and management in a broad range of patients, including those undergoing thoracic and abdominal aortic revascularization, spine stabilization procedures for scoliosis and trauma, spinal cord tumor resection, and those requiring management of spinal cord injury in intensive care settings.	[Mesquita, Rickson C.; Schenkel, Steven S.; Yodh, Arjun G.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Mesquita, Rickson C.] Univ Estadual Campinas, Inst Phys, Campinas, SP, Brazil; [D'Souza, Angela; Emanuel, Asher; Floyd, Thomas F.] SUNY Stony Brook, Med Ctr, Dept Anesthesiol, Stony Brook, NY 11794 USA; [D'Souza, Angela; Floyd, Thomas F.] SUNY Stony Brook, Med Ctr, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Bilfinger, Thomas V.] SUNY Stony Brook, Med Ctr, Dept Surg, Stony Brook, NY 11794 USA; [Galler, Robert M.] SUNY Stony Brook, Med Ctr, Dept Neurosurg, Stony Brook, NY 11794 USA	University of Pennsylvania; Universidade Estadual de Campinas; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Floyd, TF (corresponding author), SUNY Stony Brook, Med Ctr, Dept Anesthesiol, Stony Brook, NY 11794 USA.	thomas.floyd@sbumed.org	Bilfinger, Thomas V./J-6392-2019; Mesquita, Rickson C/N-9119-2013; Floyd, Thomas/AAD-7818-2019	Mesquita, Rickson C/0000-0003-1945-6713; 	Stony Brook University's Department of Anesthesiology, Office of the Vice President for Research; Stony Brook Medicine's School of Medicine; Stony Brook University Hospital; National Institutes of Health [R01-NS060653, P41-EB015893]; Sao Paulo Research Foundation [2012/02500-8]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060653] Funding Source: NIH RePORTER	Stony Brook University's Department of Anesthesiology, Office of the Vice President for Research; Stony Brook Medicine's School of Medicine; Stony Brook University Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was partially supported by Stony Brook University's Department of Anesthesiology, Office of the Vice President for Research, and by Stony Brook Medicine's School of Medicine and Stony Brook University Hospital. This work was also supported by the National Institutes of Health (http://www.nih.gov) through R01-NS060653 (AGY) and P41-EB015893 (AGY), and the Sao Paulo Research Foundation (http://www.fapesp.br) through 2012/02500-8 (RCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOAS DA, 1995, PHYS REV LETT, V75, P1855, DOI 10.1103/PhysRevLett.75.1855; Bockler D, 2007, EUR J VASC ENDOVASC, V34, P461, DOI 10.1016/j.ejvs.2007.04.030; Cermik TF, 2006, BRAIN RES, V1109, P54, DOI 10.1016/j.brainres.2006.06.044; Coffey RJ, 2010, STEREOT FUNCT NEUROS, V88, P337, DOI 10.1159/000319034; Costa P, 2007, SPINAL CORD, V45, P86, DOI 10.1038/sj.sc.3101934; De Visscher G, 2003, ADV EXP MED BIOL, V540, P37; Deiner S, 2010, SEMIN CARDIOTHORAC V, V14, P51, DOI 10.1177/1089253210362792; Deletis V, 2008, CLIN NEUROPHYSIOL, V119, P248, DOI 10.1016/j.clinph.2007.09.135; Dimar JR, 2010, J TRAUMA, V69, P1497, DOI 10.1097/TA.0b013e3181cc853b; Drazin D, 2011, J NEUROIMAGING; Duhamel G, 2009, MAGN RESON MED, V62, P430, DOI 10.1002/mrm.22015; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Etz CD, 2008, EUR J CARDIO-THORAC, V33, P1030, DOI 10.1016/j.ejcts.2008.01.069; Eucker SA, 2010, BRAIN RES, V1326, P128, DOI 10.1016/j.brainres.2010.02.059; Furlan JC, 2011, J NEUROTRAUM, V28, P1371, DOI 10.1089/neu.2009.1147; Gradert TL, 2003, ANESTHESIOLOGY, V99, P188, DOI 10.1097/00000542-200307000-00029; Grady RE, 1999, ANESTH ANALG, V88, P388; Grono L R, 1966, Aust Vet J, V42, P58, DOI 10.1111/j.1751-0813.1966.tb04660.x; Gupta R, 2010, J AM ACAD ORTHOP SUR, V18, P210, DOI 10.5435/00124635-201004000-00004; Hong JY, 2010, SPINE, V35, pE912, DOI 10.1097/BRS.0b013e3181d8fabb; Hull EL, 1998, PHYS MED BIOL, V43, P3381, DOI 10.1088/0031-9155/43/11/014; Jia X, 2013, INJURY J INTENSIVE C, V28, P12, DOI [10.1177/0885066611403270, DOI 10.1177/0885066611403270]; Kakinohana M, 2008, J ANESTH, V22, P304, DOI 10.1007/s00540-008-0633-3; KAPLAN BJ, 1987, NEUROSURGERY, V21, P668, DOI 10.1227/00006123-198711000-00012; Kattail D, 2009, J TRAUMA, V67, P936, DOI 10.1097/TA.0b013e3181a8b431; LESSER RP, 1986, ANN NEUROL, V19, P22, DOI 10.1002/ana.410190105; Luchtel DL, 1998, BIOTECH HISTOCHEM, V73, P291, DOI 10.3109/10520299809141123; Mahmoud M, 2010, ANESTHESIOLOGY, V112, P1364, DOI 10.1097/ALN.0b013e3181d74f55; Mesquita R. C., 2011, PHIL T R SOC A, V369, P4358, DOI DOI 10.1098/RSTA.2011.0302.PUBMED:22006897; Mesquita RC, 2010, BIOMED OPT EXPRESS, V1, P1173, DOI 10.1364/BOE.1.001173; Messe SR, 2008, NEUROCRIT CARE, V9, P344, DOI 10.1007/s12028-008-9104-9; Modi Hitesh N, 2009, Spine (Phila Pa 1976), V34, pE896, DOI 10.1097/BRS.0b013e3181b40d4f; Moomiaie RMA, 2007, J CARDIOVASC SURG, V48, P103; Mun-Bryce S, 2001, BRAIN RES, V888, P248, DOI 10.1016/S0006-8993(00)03068-7; Olsson C, 2006, CIRCULATION, V114, P2611, DOI 10.1161/CIRCULATIONAHA.106.630400; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Pastorelli F, 2011, EUR SPINE J, V20, P105, DOI 10.1007/s00586-011-1756-z; Patil CG, 2008, SPINAL CORD, V46, P375, DOI 10.1038/sj.sc.3102155; Ratajczak-Enselme M, 2009, EUR J PHARM BIOPHARM, V72, P54, DOI 10.1016/j.ejpb.2008.11.003; Reames DL, 2011, SPINE, V36, P1484, DOI 10.1097/BRS.0b013e3181f3a326; Sheng SR, 2010, EUR SPINE J, V19, P46, DOI 10.1007/s00586-009-1192-5; Simonovich M, 2008, SPINE, V33, P2495, DOI 10.1097/BRS.0b013e3181859a92; ter Wolbeek C, 2010, THORAC CARDIOV SURG, V58, P260, DOI 10.1055/s-0030-1249904; Ture H, 2010, ANAESTHESIA, V65, P473, DOI 10.1111/j.1365-2044.2010.06309.x; Utzinger U, 2003, J BIOMED OPT, V8, P121, DOI 10.1117/1.1528207; van den Berg MEL, 2010, NEUROEPIDEMIOLOGY, V34, P184, DOI 10.1159/000279335; VANOOSTERHOUT NFM, 1995, AM J PHYSIOL-HEART C, V269, pH725, DOI 10.1152/ajpheart.1995.269.2.H725; Wang AC, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.8.FOCUS09145; Wang HW, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2743082; Wheatley RG, 2001, BRIT J ANAESTH, V87, P47, DOI 10.1093/bja/87.1.47; Wilson B. C., 1990, FUTURE DIRECTIONS AP, P219; Wilson JR, 2011, NEUROTHERAPEUTICS, V8, P187, DOI 10.1007/s13311-011-0027-3; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893	53	27	27	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83370	10.1371/journal.pone.0083370	http://dx.doi.org/10.1371/journal.pone.0083370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358279	gold, Green Submitted, Green Published			2022-12-27	WOS:000328735700122
J	Choi, JS; Baek, HM; Kim, S; Kim, MJ; Youk, JH; Moon, HJ; Kim, EK; Nam, YK				Choi, Ji Soo; Baek, Hyeon-Man; Kim, Suhkmann; Kim, Min Jung; Youk, Ji Hyun; Moon, Hee Jung; Kim, Eun-Kyung; Nam, Youn Ki			Magnetic Resonance Metabolic Profiling of Breast Cancer Tissue Obtained with Core Needle Biopsy for Predicting Pathologic Response to Neoadjuvant Chemotherapy	PLOS ONE			English	Article							SURGICAL ADJUVANT BREAST; PREOPERATIVE CHEMOTHERAPY; GENE-EXPRESSION; CHOLINE METABOLISM; DIAGNOSIS; SIGNATURES; SURVIVAL; MARKERS; WOMEN; PROGNOSIS	The purpose of this study was to determine whether metabolic profiling of core needle biopsy (CNB) samples using high-resolution magic angle spinning (HR-MAS) magnetic resonance spectroscopy (MRS) could be used for predicting pathologic response to neoadjuvant chemotherapy (NAC) in patients with locally advanced breast cancer. After institutional review board approval and informed consent were obtained, CNB tissue samples were collected from 37 malignant lesions in 37 patients before NAC treatment. The metabolic profiling of CNB samples were performed by HR-MAS MRS. Metabolic profiles were compared according to pathologic response to NAC using the Mann-Whitney test. Multivariate analysis was performed with orthogonal projections to latent structure-discriminant analysis (OPLS-DA). Various metabolites including choline-containing compounds were identified and quantified by HR-MAS MRS in all 37 breast cancer tissue samples obtained by CNB. In univariate analysis, the metabolite concentrations and metabolic ratios of CNB samples obtained with HR-MAS MRS were not significantly different between different pathologic response groups. However, there was a trend of lower levels of phosphocholine/creatine ratio and choline-containing metabolite concentrations in the pathologic complete response group compared to the non-pathologic complete response group. In multivariate analysis, the OPLS-DA models built with HR-MAS MR metabolic profiles showed visible discrimination between the pathologic response groups. This study showed OPLS-DA multivariate analysis using metabolic profiles of pretreatment CNB samples assessed by HR-MAS MRS may be used to predict pathologic response before NAC, although we did not identify the metabolite showing statistical significance in univariate analysis. Therefore, our preliminary results raise the necessity of further study on HR-MAS MR metabolic profiling of CNB samples for a large number of cancers.	[Choi, Ji Soo; Kim, Min Jung; Youk, Ji Hyun; Moon, Hee Jung; Kim, Eun-Kyung] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol, Seoul, South Korea; [Choi, Ji Soo] Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Baek, Hyeon-Man] Korea Basic Sci Inst, Div Magnet Resonance, Chungbuk, South Korea; [Baek, Hyeon-Man] Univ Sci & Technol, Dept Bioanalyt Sci, Taejon, South Korea; [Kim, Suhkmann] Pusan Natl Univ, Dept Chem, Busan, South Korea; [Kim, Suhkmann] Pusan Natl Univ, Chem Inst Funct Mat, Busan, South Korea; [Nam, Youn Ki] Agilent Technol Korea, Seoul, South Korea	Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center; Korea Basic Science Institute (KBSI); Pusan National University; Pusan National University	Kim, MJ (corresponding author), Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol, Seoul, South Korea.	mines@yuhs.ac	Kim, Eun-Kyung/E-5211-2017	Kim, Eun-Kyung/0000-0002-3368-5013; Moon, Hee Jung/0000-0002-5643-5885	Basic Science Research Program of the National Research Foundation of Korea; Ministry of Science, ICT&Future Planning, Republic of Korea [2013R1A1A3013165]	Basic Science Research Program of the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science, ICT&Future Planning, Republic of Korea(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by the Basic Science Research Program of the National Research Foundation of Korea funded by the Ministry of Science, ICT&Future Planning, Republic of Korea (preparation of the manuscript. grant 2013R1A1A3013165). The funders had no role in study design, data collection and analysis, decision to publish, or or preparation of the manuscript.	Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659; Alvarado-Cabrero I, 2009, ANN DIAGN PATHOL, V13, P151, DOI 10.1016/j.anndiagpath.2009.02.003; Amat S, 2005, BREAST CANCER RES TR, V94, P255, DOI 10.1007/s10549-005-9008-8; Baek HM, 2008, MAGN RESON IMAGING, V26, P523, DOI 10.1016/j.mri.2007.10.002; Baek HM, 2009, RADIOLOGY, V251, P653, DOI 10.1148/radiol.2512080553; Bassett LW, 2007, RADIOL CLIN N AM, V45, P881, DOI 10.1016/j.rcl.2007.06.010; Bathen TF, 2007, BREAST CANCER RES TR, V104, P181, DOI 10.1007/s10549-006-9400-z; Begley JKP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3132; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Bruening W, 2010, ANN INTERN MED, V152, P238, DOI 10.7326/0003-4819-152-1-201001050-00190; Cao MD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-39; Cao MD, 2012, NMR BIOMED, V25, P369, DOI 10.1002/nbm.1762; Cecil KM, 2001, BREAST CANCER RES TR, V68, P45, DOI 10.1023/A:1017911211090; Chang J, 1999, J CLIN ONCOL, V17, P3058, DOI 10.1200/JCO.1999.17.10.3058; Chen JH, 2011, NMR BIOMED, V24, P316, DOI 10.1002/nbm.1595; Chen YZ, 2011, CANCER LETT, V302, P63, DOI 10.1016/j.canlet.2010.12.014; Choi JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051712; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ellis P, 1998, J CLIN ONCOL, V16, P107, DOI 10.1200/JCO.1998.16.1.107; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Gianni L, 2005, J CLIN ONCOL, V23, P7265, DOI 10.1200/JCO.2005.02.0818; Glunde K, 2008, CANCER RES, V68, P172, DOI 10.1158/0008-5472.CAN-07-2678; Glunde K, 2006, EXPERT REV MOL DIAGN, V6, P821, DOI 10.1586/14737159.6.6.821; Goldhirsch A, 2001, J CLIN ONCOL, V19, P3817, DOI 10.1200/JCO.2001.19.18.3817; Hylton NM, 2012, RADIOLOGY, V263, P663, DOI 10.1148/radiol.12110748; Jones RL, 2006, BRIT J CANCER, V94, P358, DOI 10.1038/sj.bjc.6602950; Jones RL, 2006, LANCET ONCOL, V7, P869, DOI 10.1016/S1470-2045(06)70906-8; Katz-Brull R, 2002, CANCER RES, V62, P1966; Li M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025563; MacKinnon N, 2012, METABOLOMICS, V8, P1026, DOI 10.1007/s11306-012-0398-4; Makris A, 1998, ANN ONCOL, V9, P1179, DOI 10.1023/A:1008400706949; Moestue SA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-433; Mountford CE, 2001, BRIT J SURG, V88, P1234, DOI 10.1046/j.0007-1323.2001.01864.x; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Prevos R, 2012, EUR RADIOL, V22, P2607, DOI 10.1007/s00330-012-2653-5; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; Roebuck JR, 1998, RADIOLOGY, V209, P269, DOI 10.1148/radiology.209.1.9769842; Rouzier R, 2005, J CLIN ONCOL, V23, P8331, DOI 10.1200/JCO.2005.01.2898; Shah T, 2010, NMR BIOMED, V23, P633, DOI 10.1002/nbm.1510; Shin HJ, 2012, NMR BIOMED, V25, P1349, DOI 10.1002/nbm.2807; SINGER S, 1995, CANCER RES, V55, P5140; Sinha S, 2009, NMR BIOMED, V22, P3, DOI 10.1002/nbm.1270; Sitter B, 2006, NMR BIOMED, V19, P30, DOI 10.1002/nbm.992; Sitter B, 2010, NMR BIOMED, V23, P424, DOI 10.1002/nbm.1478; Somashekar BS, 2012, J PROTEOME RES, V11, P4873, DOI 10.1021/pr300345x; Somashekar BS, 2011, J PROTEOME RES, V10, P5232, DOI 10.1021/pr200800w; Symmans WF, 2007, J CLIN ONCOL, V25, P4414, DOI 10.1200/JCO.2007.10.6823; Thuerigen O, 2006, J CLIN ONCOL, V24, P1839, DOI 10.1200/JCO.2005.04.7019; Tripathi P, 2013, J PROTEOME RES, V12, P3519, DOI 10.1021/pr4004135; Tripathi P, 2012, INT J BIOCHEM CELL B, V44, P1852, DOI 10.1016/j.biocel.2012.06.025; Wen H, 2010, J HEPATOL, V52, P228, DOI 10.1016/j.jhep.2009.11.002; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wolmark N, 2001, J Natl Cancer Inst Monogr, P96	56	37	38	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e83866	10.1371/journal.pone.0083866	http://dx.doi.org/10.1371/journal.pone.0083866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367616	gold, Green Published, Green Submitted			2022-12-27	WOS:000328741900024
J	Singh, N; Choudhury, DR; Singh, AK; Kumar, S; Srinivasan, K; Tyagi, RK; Singh, NK; Singh, R				Singh, Nivedita; Choudhury, Debjani Roy; Singh, Amit Kumar; Kumar, Sundeep; Srinivasan, Kalyani; Tyagi, R. K.; Singh, N. K.; Singh, Rakesh			Comparison of SSR and SNP Markers in Estimation of Genetic Diversity and Population Structure of Indian Rice Varieties	PLOS ONE			English	Article							ORYZA-SATIVA; LINKAGE DISEQUILIBRIUM; CULTIVARS; WHEAT; IDENTIFICATION; COLLECTION; SOFTWARE; PATTERNS; REVEALS; TRAITS	Simple sequence repeat (SSR) and Single Nucleotide Polymorphic (SNP), the two most robust markers for identifying rice varieties were compared for assessment of genetic diversity and population structure. Total 375 varieties of rice from various regions of India archived at the Indian National GeneBank, NBPGR, New Delhi, were analyzed using thirty six genetic markers, each of hypervariable SSR (HvSSR) and SNP which were distributed across 12 rice chromosomes. A total of 80 alleles were amplified with the SSR markers with an average of 2.22 alleles per locus whereas, 72 alleles were amplified with SNP markers. Polymorphic information content (PIC) values for HvSSR ranged from 0.04 to 0.5 with an average of 0.25. In the case of SNP markers, PIC values ranged from 0.03 to 0.37 with an average of 0.23. Genetic relatedness among the varieties was studied; utilizing an unrooted tree all the genotypes were grouped into three major clusters with both SSR and SNP markers. Analysis of molecular variance (AMOVA) indicated that maximum diversity was partitioned between and within individual level but not between populations. Principal coordinate analysis (PCoA) with SSR markers showed that genotypes were uniformly distributed across the two axes with 13.33% of cumulative variation whereas, in case of SNP markers varieties were grouped into three broad groups across two axes with 45.20% of cumulative variation. Population structure were tested using K values from 1 to 20, but there was no clear population structure, therefore Ln(PD) derived Delta k was plotted against the K to determine the number of populations. In case of SSR maximum Delta k was at K=5 whereas, in case of SNP maximum Delta k was found at K=15, suggesting that resolution of population was higher with SNP markers, but SSR were more efficient for diversity analysis.	[Singh, Nivedita; Choudhury, Debjani Roy; Singh, Amit Kumar; Kumar, Sundeep; Singh, Rakesh] Natl Bur Plant Genet Resources, Div Genom Resources, Delhi, India; [Srinivasan, Kalyani; Tyagi, R. K.] Natl Bur Plant Genet Resources, Germplasm Conservat Div, Delhi, India; [Singh, N. K.] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB)	Singh, R (corresponding author), Natl Bur Plant Genet Resources, Div Genom Resources, Delhi, India.	singhnbpgr@yahoo.com	Singh, Rakesh/AAI-6165-2020; Singh, Nouratan/N-9377-2017; SINGH, AMIT KUMAR/Q-7438-2018; singh, navdeep/GZA-7750-2022	Singh, Rakesh/0000-0001-7269-6420; Singh, Nouratan/0000-0002-8063-8375; SINGH, AMIT KUMAR/0000-0001-8579-6519; 	Indian Council of Agricultural Research, New Delhi, India, under the NPTC project	Indian Council of Agricultural Research, New Delhi, India, under the NPTC project	Financial support granted by Indian Council of Agricultural Research, New Delhi, India, under the NPTC project, is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2008, EUPHYTICA, V160, P339, DOI 10.1007/s10681-007-9535-y; Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Cabezas JA, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-153; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Chen HD, 2011, THEOR APPL GENET, V123, P869, DOI 10.1007/s00122-011-1633-5; Coombs JJ, 2004, AM J POTATO RES, V81, P243, DOI 10.1007/BF02871765; Courtois B, 2012, CROP SCI, V52, P1663, DOI 10.2135/cropsci2011.11.0588; Dangl GS, 2009, EUPHYTICA, V168, P41, DOI 10.1007/s10681-008-9877-0; Dangl GS, 2001, GENOME, V44, P432, DOI 10.1139/gen-44-3-432; Emanuelli F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-39; Esteras C, 2013, THEOR APPL GENET, V126, P1285, DOI 10.1007/s00122-013-2053-5; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Garris AJ, 2003, GENETICS, V165, P759; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; Huang M, 2010, RICE SCI, V17, P257, DOI 10.1016/S1672-6308(09)60025-1; Jin L, 2010, THEOR APPL GENET, V121, P475, DOI 10.1007/s00122-010-1324-7; Kennedy G, 2003, FOOD CHEM, V80, P589, DOI 10.1016/S0308-8146(02)00507-1; Kovach MJ, 2008, CURR OPIN PLANT BIOL, V11, P193, DOI 10.1016/j.pbi.2007.12.006; Lapitan VC, 2007, BREEDING SCI, V57, P263, DOI 10.1270/jsbbs.57.263; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Louarn S, 2007, GENET RESOUR CROP EV, V54, P1717, DOI 10.1007/s10722-006-9181-6; Lu H, 2005, CROP SCI, V45, P66, DOI 10.2135/cropsci2005.0066; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Moriya S, 2011, EUPHYTICA, V177, P135, DOI 10.1007/s10681-010-0295-8; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrier X., 2006, DARWIN SOFTWARE; Pritchard JK, 2000, GENETICS, V155, P945; Rahman ML, 2009, THEOR APPL GENET, V119, P1237, DOI 10.1007/s00122-009-1125-z; Shah SM, 2013, PAK J BOT, V45, P423; Singh H, 2010, MOL BREEDING, V25, P359, DOI 10.1007/s11032-009-9328-1; Singh NK, 2007, FUNCT INTEGR GENOMIC, V7, P17, DOI 10.1007/s10142-006-0033-4; Van Inghelandt D, 2010, THEOR APPL GENET, V120, P1289, DOI 10.1007/s00122-009-1256-2; Vinita Pachauri, 2013, Australian Journal of Crop Science, V7, P923; Wang QS, 2009, J GENET GENOMICS, V36, P679, DOI 10.1016/S1673-8527(08)60160-5; Wurschum T, 2013, THEOR APPL GENET, V126, P1477, DOI 10.1007/s00122-013-2065-1; Yamasaki M, 2013, BREEDING SCI, V63, P49, DOI 10.1270/jsbbs.63.49; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhao WG, 2009, GENES GENOM, V31, P283, DOI 10.1007/BF03191201; Zhu YF, 2011, AUST J CROP SCI, V5, P846	42	121	124	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84136	10.1371/journal.pone.0084136	http://dx.doi.org/10.1371/journal.pone.0084136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367635	gold, Green Submitted, Green Published			2022-12-27	WOS:000328741900033
J	Desai, T; Shariff, A; Dhingra, V; Minhas, D; Eure, M; Kats, M				Desai, Tejas; Shariff, Afreen; Dhingra, Vibhu; Minhas, Deeba; Eure, Megan; Kats, Mark			Is Content Really King? An Objective Analysis of the Public's Response to Medical Videos on YouTube	PLOS ONE			English	Article							INFORMATION	Medical educators and patients are turning to YouTube to teach and learn about medical conditions. These videos are from authors whose credibility cannot be verified & are not peer reviewed. As a result, studies that have analyzed the educational content of YouTube have reported dismal results. These studies have been unable to exclude videos created by questionable sources and for non-educational purposes. We hypothesize that medical education YouTube videos, authored by credible sources, are of high educational value and appropriately suited to educate the public. Credible videos about cardiovascular diseases were identified using the Mayo Clinic's Center for Social Media Health network. Content in each video was assessed by the presence/absence of 7 factors. Each video was also evaluated for understandability using the Suitability Assessment of Materials (SAM). User engagement measurements were obtained for each video. A total of 607 videos (35 hours) were analyzed. Half of all videos contained 3 educational factors: treatment, screening, or prevention. There was no difference between the number of educational factors present & any user engagement measurement (p NS). SAM scores were higher in videos whose content discussed more educational factors (p<0.0001). However, none of the user engagement measurements correlated with higher SAM scores. Videos with greater educational content are more suitable for patient education but unable to engage users more than lower quality videos. It is unclear if the notion "content is king'' applies to medical videos authored by credible organizations for the purposes of patient education on YouTube.	[Desai, Tejas] E Carolina Univ, Div Nephrol & Hypertens, Greenville, NC 27858 USA; [Shariff, Afreen; Dhingra, Vibhu; Minhas, Deeba] E Carolina Univ, Dept Internal Med, Greenville, NC USA; [Eure, Megan] NC State Univ, Dept Physiol, Raleigh, NC USA; [Kats, Mark] Northeast Georgia Diagnost Clin, Gainseville, GA USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; North Carolina State University	Desai, T (corresponding author), E Carolina Univ, Div Nephrol & Hypertens, Greenville, NC 27858 USA.	tejas.p.desai@gmail.com						Ache KA, 2008, AM J PREV MED, V35, P389, DOI 10.1016/j.amepre.2008.06.029; [Anonymous], 2013, J AM MED ASS; [Anonymous], 2012, NATL VITAL STAT REPO, V61; [Anonymous], 2013, NBCNEWS COM; Azer SA, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-126; Azer SA, 2012, SURG RADIOL ANAT, V34, P465, DOI 10.1007/s00276-012-0935-x; Diem SJ, 1996, NEW ENGL J MED, V334, P1578, DOI 10.1056/NEJM199606133342406; Doak CC, 1996, TEACHING PATIENTS LO; Eglash Anne, 2009, Breastfeed Med, V4, P119, DOI 10.1089/bfm.2009.9994; Justice J, 2013, BIG BRAND THEORY MAY; Keelan J, 2007, JAMA-J AM MED ASSOC, V298, P2482, DOI 10.1001/jama.298.21.2482; Khamsi R., 2007, NEW SCI; Knosel M, 2011, J DENT EDUC, V75, P1558; Merrill M, 2010, HEALTHCARE IT NEWS; Murugiah K, 2011, RESUSCITATION, V82, P332, DOI 10.1016/j.resuscitation.2010.11.015; Pandey Ambarish, 2010, Am J Prev Med, V38, pe1, DOI 10.1016/j.amepre.2009.11.007; Pant S, 2012, CLIN CARDIOL, V35, P281, DOI 10.1002/clc.21981; Riley S., 2011, MAYO CLIN CTR SOCIAL; Rudd RE, 2012, GUIDELINES ASSESSING; Smith P T, 1998, Clin Nurse Spec, V12, P140, DOI 10.1097/00002800-199807000-00006; Snelson C., 2011, J ONLINE LEARNING TE, V7; Sood A, 2011, UROLOGY, V77, P558, DOI 10.1016/j.urology.2010.07.536; Stamelou M, 2011, NEW ENGL J MED, V365, P1160, DOI 10.1056/NEJMc1107673; Steinberg PL, 2010, UROLOGY, V75, P619, DOI 10.1016/j.urology.2008.07.059; Syed-Abdul S, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2237; Taylor-Clarke K, 2012, J CARDIOVASC NURS, V27, P485, DOI 10.1097/JCN.0b013e318220720c; Topps D, 2013, ACAD MED, V88, P192, DOI 10.1097/ACM.0b013e31827c5352; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]	28	134	135	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82469	10.1371/journal.pone.0082469	http://dx.doi.org/10.1371/journal.pone.0082469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367517	Green Submitted, Green Published, gold			2022-12-27	WOS:000328740300033
J	Lebrato, M; Molinero, JC; Cartes, JE; Lloris, D; Melin, F; Beni-Casadella, L				Lebrato, Mario; Molinero, Juan-Carlos; Cartes, Joan E.; Lloris, Domingo; Melin, Frederic; Beni-Casadella, Laia			Sinking Jelly-Carbon Unveils Potential Environmental Variability along a Continental Margin	PLOS ONE			English	Article							MASS DEPOSITION; DEEP-WATER; SEA; PYROSOMA; PHYTOPLANKTON; MEGAFAUNA; MORTALITY; RANGE; FLOOR; COLOR	Particulate matter export fuels benthic ecosystems in continental margins and the deep sea, removing carbon from the upper ocean. Gelatinous zooplankton biomass provides a fast carbon vector that has been poorly studied. Observational data of a large-scale benthic trawling survey from 1994 to 2005 provided a unique opportunity to quantify jelly-carbon along an entire continental margin in the Mediterranean Sea and to assess potential links with biological and physical variables. Biomass depositions were sampled in shelves, slopes and canyons with peaks above 1000 carcasses per trawl, translating to standing stock values between 0.3 and 1.4 mg C m(2) after trawling and integrating between 30,000 and 175,000 m(2) of seabed. The benthopelagic jelly-carbon spatial distribution from the shelf to the canyons may be explained by atmospheric forcing related with NAO events and dense shelf water cascading, which are both known from the open Mediterranean. Over the decadal scale, we show that the jelly-carbon depositions temporal variability paralleled hydroclimate modifications, and that the enhanced jelly-carbon deposits are connected to a temperature-driven system where chlorophyll plays a minor role. Our results highlight the importance of gelatinous groups as indicators of large-scale ecosystem change, where jelly-carbon depositions play an important role in carbon and energy transport to benthic systems.	[Lebrato, Mario; Molinero, Juan-Carlos] Helmholtz Ctr Ocean Res Kiel GEOMAR, Dept Biogeochem & Ecol, Kiel, Germany; [Lebrato, Mario] Scripps Inst Oceanog, Dept Geosci, San Diego, CA USA; [Cartes, Joan E.; Lloris, Domingo; Beni-Casadella, Laia] CSIC, Inst Ciencies Mar Barcelona, Barcelona, Spain; [Melin, Frederic] Commiss European Communities, Joint Res Ctr, I-21020 Ispra, Italy	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of California System; University of California San Diego; Scripps Institution of Oceanography; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); European Commission Joint Research Centre; EC JRC ISPRA Site	Lebrato, M (corresponding author), Helmholtz Ctr Ocean Res Kiel GEOMAR, Dept Biogeochem & Ecol, Kiel, Germany.	mlebrato13@gmail.com		MELIN, FREDERIC/0000-0003-4381-682X	European Project on Ocean Acidification (EPOCA); European Community [211384]; Kiel Cluster of Excellence "The Future Ocean" [D1067/87]	European Project on Ocean Acidification (EPOCA); European Community(European Commission); Kiel Cluster of Excellence "The Future Ocean"	This study was supported by the European Project on Ocean Acidification (EPOCA) funded by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 211384. This work was also funded by the Kiel Cluster of Excellence "The Future Ocean" (D1067/87). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELLO P, 2002, SCI MAR, V66, P1, DOI DOI 10.3989/SCIMAR.2002.66S2; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; Bethoux JP, 2002, J MARINE SYST, V33, P117, DOI 10.1016/S0924-7963(02)00055-6; Billett DSM, 2006, LIMNOL OCEANOGR, V51, P2077, DOI 10.4319/lo.2006.51.5.2077; BOUCHER J, 1987, J MAR RES, V45, P133, DOI 10.1357/002224087788400891; Buesseler KO, 2007, SCIENCE, V316, P567, DOI 10.1126/science.1137959; Canals M, 2013, PROG OCEANO IN PRESS; Carrasson M, 2002, MAR ECOL PROG SER, V241, P41, DOI 10.3354/meps241041; Cartes JE, 2009, PROG OCEANOGR, V82, P32, DOI 10.1016/j.pocean.2009.03.003; Cartes JE, 1998, MAR ECOL PROG SER, V171, P233, DOI 10.3354/meps171233; Cartes JE, 2004, DEEP-SEA RES PT I, V51, P263, DOI 10.1016/j.dsr.2003.10.001; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Company JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001431; Condon R.H., 2011, ECOLOGY, V92, P1704, DOI [10.1890/11-0302.1, DOI 10.1890/11-0302.1]; Condon RH, 2013, P NATL ACAD SCI USA, V110, P1000, DOI 10.1073/pnas.1210920110; Condon RH, 2011, P NATL ACAD SCI USA, V108, P10225, DOI 10.1073/pnas.1015782108; COWPER TR, 1960, NATURE, V187, P878, DOI 10.1038/187878b0; D'Alimonte D, 2003, IEEE T GEOSCI REMOTE, V41, P2833, DOI 10.1109/TGRS.2003.818020; D'Alimonte D, 2003, IEEE T GEOSCI REMOTE, V41, P2861, DOI 10.1109/TGRS.2003.817682; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; DELGADO M, 1990, Scientia Marina, V54, P169; Estrada M, 1999, J PLANKTON RES, V21, P1, DOI 10.1093/plankt/21.1.1; Fanelli E, 2011, DEEP-SEA RES PT I, V58, P98, DOI 10.1016/j.dsr.2010.12.005; Fiorentini L, 1999, AQUAT LIVING RESOUR, V12, P187, DOI 10.1016/S0990-7440(00)88470-3; FONT J, 1987, DEEP-SEA RES, V34, P1745, DOI 10.1016/0198-0149(87)90022-7; FRANQUEVILLE C, 1971, Tethys, V3, P11; Frost JR, 2012, HYDROBIOLOGIA, V690, P247, DOI 10.1007/s10750-012-1042-z; GOODAY AJ, 1990, PHILOS T R SOC A, V331, P119, DOI 10.1098/rsta.1990.0060; GRIFFIN DJG, 1970, NATURE, V226, P464, DOI 10.1038/226464a0; Harris PT, 2011, MAR GEOL, V285, P69, DOI 10.1016/j.margeo.2011.05.008; Henschke N, 2013, MAR ECOL PROG SER, V491, P165, DOI 10.3354/meps10450; Hofmann M, 2009, P NATL ACAD SCI USA, V106, P3017, DOI 10.1073/pnas.0813384106; HURLEY DE, 1959, NATURE, V183, P554, DOI 10.1038/183554a0; Lebrato M, 2009, LIMNOL OCEANOGR, V54, P1197, DOI 10.4319/lo.2009.54.4.1197; Lebrato M, 2013, LIMNOL OCEANOGR, V58, P1113, DOI 10.4319/lo.2013.58.3.1113; Lebrato M, 2012, HYDROBIOLOGIA, V690, P227, DOI 10.1007/s10750-012-1046-8; Lebrato M, 2011, LIMNOL OCEANOGR, V56, P1917, DOI 10.4319/lo.2011.56.5.1917; Lopez-Jurado JL, 2008, J MARINE SYST, V71, P303, DOI 10.1016/j.jmarsys.2007.03.007; Melin F, 2011, PROG OCEANOGR, V91, P229, DOI 10.1016/j.pocean.2010.12.001; Millot C, 1981, AM GEOPHYS UNION, V514; MILLS CE, 1993, B MAR SCI, V53, P194; MONNIOT C, 1966, CR ACAD SCI D NAT, V263, P368; Pitt KA, 2009, HYDROBIOLOGIA, V616, P133, DOI 10.1007/s10750-008-9584-9; PLOBERGER W, 1992, ECONOMETRICA, V60, P271, DOI 10.2307/2951597; Purcell J.E., 2001, DEV HYDROBIOL, P1; Reul A, 2005, CONT SHELF RES, V25, P589, DOI 10.1016/j.csr.2004.09.016; Riaux-Gobin C, 2004, SCI MAR, V68, P7, DOI 10.3989/scimar.2004.68n17; Riebesell U, 2009, P NATL ACAD SCI USA, V106, P20602, DOI 10.1073/pnas.0813291106; ROE HSJ, 1990, PROG OCEANOGR, V24, P127, DOI 10.1016/0079-6611(90)90025-W; Tinta T, 2010, HYDROBIOLOGIA, V645, P179, DOI 10.1007/s10750-010-0223-x; Vargas-Yanez M, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015306; Vazquez-Cuervo J, 2010, J CLIMATE, V23, P1047, DOI 10.1175/2009JCLI2839.1; Volpe G, 2007, REMOTE SENS ENVIRON, V107, P625, DOI 10.1016/j.rse.2006.10.017; West EJ, 2009, HYDROBIOLOGIA, V616, P151, DOI 10.1007/s10750-008-9586-7	55	18	18	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82070	10.1371/journal.pone.0082070	http://dx.doi.org/10.1371/journal.pone.0082070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367499	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000328740300018
J	Lindsey, PA; Barnes, J; Nyirenda, V; Pumfrett, B; Tambling, CJ; Taylor, WA; Rolfes, MT				Lindsey, Peter A.; Barnes, Jonathan; Nyirenda, Vincent; Pumfrett, Belinda; Tambling, Craig J.; Taylor, W. Andrew; Rolfes, Michael t'Sas			The Zambian Wildlife Ranching Industry: Scale, Associated Benefits, and Limitations Affecting Its Development	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; BUSHMEAT TRADE; CONSERVATION; IMPACTS; AFRICA; RAINFALL; ANTELOPE; DECLINE	The number and area of wildlife ranches in Zambia increased from 30 and 1,420 km 2 in 1997 to 177 and similar to 6,000 km(2) by 2012. Wild ungulate populations on wildlife ranches increased from 21,000 individuals in 1997 to similar to 91,000 in 2012, while those in state protected areas declined steeply. Wildlife ranching and crocodile farming have a turnover of similar to USD15.7 million per annum, compared to USD16 million from the public game management areas which encompass an area 29 times larger. The wildlife ranching industry employs 1,200 people (excluding jobs created in support industries), with a further similar to 1,000 individuals employed through crocodile farming. Wildlife ranches generate significant quantities of meat (295,000 kg/annum), of which 30,000 kg of meat accrues to local communities and 36,000 kg to staff. Projected economic returns from wildlife ranching ventures are high, with an estimated 20-year economic rate of return of 28%, indicating a strong case for government support for the sector. There is enormous scope for wildlife ranching in Zambia due to the availability of land, high diversity of wildlife and low potential for commercial livestock production. However, the Zambian wildlife ranching industry is small and following completion of field work for this study, there was evidence of a significant proportion of ranchers dropping out. The industry is performing poorly, due to inter alia: rampant commercial bushmeat poaching; failure of government to allocate outright ownership of wildlife to landowners; bureaucratic hurdles; perceived historical lack of support from the Zambia Wildlife Authority and government; a lack of a clear policy on wildlife ranching; and a ban on hunting on unfenced lands including game ranches. For the wildlife ranching industry to develop, these limitations need to be addressed decisively. These findings are likely to apply to other savanna countries with large areas of marginal land potentially suited to wildlife ranching.	[Lindsey, Peter A.] Panthera, Lion Program, New York, NY USA; [Lindsey, Peter A.] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, Gauteng, South Africa; [Barnes, Jonathan] Design & Dev Serv, Windhoek, Khomas Region, Namibia; [Nyirenda, Vincent] Zambia Wildlife Author, Chilanga, Lusaka Province, Zambia; [Pumfrett, Belinda] Kafue Trust, Lusaka, Lusaka Province, Zambia; [Tambling, Craig J.] Nelson Mandela Metropolitan Univ, Dept Zool, Ctr African Conservat Ecol, Port Elizabeth, Eastern Cape, South Africa; [Taylor, W. Andrew] Univ Pretoria, Fac Vet Sci, Ctr Vet Wildlife Studies, ZA-0002 Pretoria, Gauteng, South Africa	University of Pretoria; Nelson Mandela University; University of Pretoria	Lindsey, PA (corresponding author), Panthera, Lion Program, New York, NY USA.	plindsey@panthera.org	Tambling, Craig/H-3554-2019; Sas-Rolfes, Michael t/ABC-7132-2020; Lindsey, Peter A/J-8368-2012	Tambling, Craig/0000-0001-9830-5985; Sas-Rolfes, Michael t/0000-0002-2220-6072; Lindsey, Peter A/0000-0002-9197-2897; Nyirenda, Vincent Raphael/0000-0002-3506-3912	Wildlife Producers Association of Zambia	Wildlife Producers Association of Zambia	Research was funded by the Wildlife Producers Association of Zambia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EVOLUTION INNOVATION; Barnat Jiri, 2009, Proceedings of the 2009 IEEE 15th International Conference on Parallel and Distributed Systems (ICPADS 2009), P34, DOI 10.1109/ICPADS.2009.50; Barnes J, 1998, THESIS U COLL LONDON; Barnes J, 1994, SUGGESTED CRITERIA S, P7; Barnes J, 2010, EC VALUATION IMPACT, P37; Barnes J, 2003, EPHEMERAL CITY CITE, P73; Barnett R, 2006, SPORT HUNTING SO AFR, P128; Becker M, 2013, BIOL CONSERV, V158, P26, DOI 10.1016/j.biocon.2012.08.017; BOND I, 2004, PARKS TRANSITION BIO, P29; Carruthers Jane, 2008, Transactions of the Royal Society of South Africa, V63, P160; Child B., 2008, EVOLUTION INNOVATION, P103; Child Brian, 2009, P3; Child Brian, 2000, Conservation Biology Series (Dordrecht), V12, P335; Child BA, 2012, PASTORALISM, V2, DOI 10.1186/2041-7136-2-18; Child GFT, 1987, ZAMBEZIA, V14, P11; COE MJ, 1976, OECOLOGIA, V22, P341, DOI 10.1007/BF00345312; Cousins JA, 2008, ECOL SOC, V13; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Cumming DHM., 2004, PARKS TRANSITION BIO, P105; Davies R, 1997, STATUS PROSPECTS SUS; DNPWS, 1998, POL NAT PARKS WILDL; du P Bothma J., 2010, GAME RANCH MANAGEMEN, P979; du Toit R, 2004, REV WILDLIFE ISSUES, P67; Dunham KM, 2004, BIOL CONSERV, V117, P83, DOI 10.1016/S0006-3207(03)00267-2; Falkena H, 2003, GAME RANCH PROFITABI, P92; Frederick H, 2011, AERIAL SURVEY KAFUE, P71; Frederick H, 2013, AERIAL SURVEY REPORT, P30; Hamilton K, 2007, REAL EC IMPACT NATUR, P28; Harrington R, 1999, BIOL CONSERV, V90, P69, DOI 10.1016/S0006-3207(98)00120-7; Humavindu M, 2008, ESSAYS NAMIBIAN EC, P156; Jansen D, 1998, CATTLE WILDLIFE BOTH, P45; Kampamba G, 2005, MANAGEMENT GUIDELINE; Lindsey P., 2008, EVOLUTION INNOVATION, P163; Lindsey P., 2013, REASONS WHY ZAMBIAN; Lindsey P, 2012, ILLEGAL HUNTING BUSH, P84; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Lindsey PA, 2013, ORYX, V47, P41, DOI 10.1017/S0030605311001049; Lindsey PA, 2011, ORYX, V45, P96, DOI 10.1017/S0030605310000153; Lindsey PA, 2012, FENCING FOR CONSERVATION: RESTRICTION OF EVOLUTIONARY POTENTIAL OR A RIPOSTE TO THREATENING PROCESSES?, P215, DOI 10.1007/978-1-4614-0902-1_12; Lindsey PA, 2013, BIOL CONSERV, V160, P80, DOI 10.1016/j.biocon.2012.12.020; Lindsey PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052458; MacKenzie John, 1988, EMPIRE NATURE HUNTIN; Manning I, 2011, THESIS U PRETORIA S, P209; Manning I., 2012, NAT RESOUR J, V52, P61; Martin R, 2007, POTENTIAL TOUR UNPUB, P58; MEISSNER HH, 1982, S AFR J WILDL RES, V12, P41; Mozambique Ministry of Tourism, 2004, STRAT PLAN DEV TOUR, V1; Murombedzi J.C., 2003, PRECOLONIAL COLONIAL; National Institute of Nutrition Hyderabad, 2006, ROL NUTR ENV TOX, P62; Price Waterhouse, 1994, LOWVELD CONSERVANCIE, P39; SAS Institute, 2000, JMPIN; Siamudaala V, 1997, REPORT GAME RANCHING; Simasiku P, 2008, IMPACT WILDLIFE MANA; Simukonda C, 2011, WET SEASON SURVEY AF; Simwanza H, 2004, AERIAL SURVEY LARGE; Simwanza H, 2004, AERIAL SURVEY ESTABL; Simwanza H, 2005, AERIAL SURVEY LARGE; Sinclair AR, 2009, WILDLIFE ECOLOGY CON, P334; Smith N, 2002, CHANGING LAND USE TR, P29; Stringer EM, 2003, AIDS, V17, P1377, DOI 10.1097/00002030-200306130-00012; TAYLOR RD, 1987, ENVIRON MANAGE, V11, P327, DOI 10.1007/BF01867160; Thomas S, 2012, FINANCIAL MAIL  0406, P28; Thomson G, 2008, SHORT OVERVIEW REGIO, P24; Vinya R., 2011, PRLIMINARY STUDY DRI PRLIMINARY STUDY DRI; Watson FGR, HUMAN ENCRO IN PRESS; Wels H, 2003, PRIVATE WILDLIFE CON, P259; World Health Organization. Department of Reprodutive Health and Research, 2012, WHO REC PREV TREATM, P41; WTTC, 2021, TRAV TOUR EC IMP 202; WWF, 1987, QUOT SETT MAN, P43; Zambia Ministry of Finance, 2012, ANN EC REP 2011, P24; ZAWA, 2013, LIUW PLAIN NAT PARK	71	17	18	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81761	10.1371/journal.pone.0081761	http://dx.doi.org/10.1371/journal.pone.0081761			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367493	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300012
J	Sanchez-Fernandez, G; Cabezudo, S; Garcia-Hoz, C; Tobin, AB; Mayor, F; Ribas, C				Sanchez-Fernandez, Guzman; Cabezudo, Sofia; Garcia-Hoz, Carlota; Tobin, Andrew B.; Mayor, Federico, Jr.; Ribas, Catalina			ERK5 Activation by Gq-Coupled Muscarinic Receptors Is Independent of Receptor Internalization and beta-Arrestin Recruitment	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN; TRAFFICKING; ENDOCYTOSIS; G-ALPHA(Q); PATHWAY; BETA-ARRESTIN-2; CELLS; GPCR	G-protein-coupled receptors (GPCRs) are known to activate both G protein- and beta-arrestin-dependent signalling cascades. The initiation of mitogen-activated protein kinase (MAPK) pathways is a key downstream event in the control of cellular functions including proliferation, differentiation, migration and apoptosis. Both G proteins and beta-arrestins have been reported to mediate context-specific activation of ERK1/2, p38 and JNK MAPKs. Recently, the activation of ERK5 MAPK by Gq-coupled receptors has been described to involve a direct interaction between Gaq and two novel effectors, PKC zeta and MEK5. However, the possible contribution of beta-arrestin towards this pathway has not yet been addressed. In the present work we sought to investigate the role of receptor internalization processes and beta-arrestin recruitment in the activation of ERK5 by Gq-coupled GPCRs. Our results show that ERK5 activation is independent of M1 or M3 muscarinic receptor internalization. Furthermore, we demonstrate that phosphorylation-deficient muscarinic M1 and M3 receptors are still able to fully activate the ERK5 pathway, despite their reported inability to recruit beta-arrestins. Indeed, the overexpression of Gaq, but not that of beta-arrestin1 or beta-arrestin2, was found to potently enhance ERK5 activation by GPCRs, whereas silencing of beta-arrestin2 expression did not affect the activation of this pathway. Finally, we show that a beta-arrestin-biased mutant form of angiotensin II (SII; Sar1-Ile4-Ile8 AngII) failed to promote ERK5 phosphorylation in primary cardiac fibroblasts, as compared to the natural ligand. Overall, this study shows that the activation of ERK5 MAPK by model Gq-coupled GPCRs does not depend on receptor internalization, beta-arrestin recruitment or receptor phosphorylation but rather is dependent on Gaq-signalling.	[Sanchez-Fernandez, Guzman; Cabezudo, Sofia; Garcia-Hoz, Carlota; Mayor, Federico, Jr.; Ribas, Catalina] Univ Autonoma Madrid, UAM CSIC, Dept Biol Mol, Madrid, Spain; [Sanchez-Fernandez, Guzman; Cabezudo, Sofia; Garcia-Hoz, Carlota; Mayor, Federico, Jr.; Ribas, Catalina] Univ Autonoma Madrid, UAM CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Sanchez-Fernandez, Guzman; Cabezudo, Sofia; Garcia-Hoz, Carlota; Mayor, Federico, Jr.; Ribas, Catalina] Inst Invest Sanitaria La Princesa, Madrid, Spain; [Tobin, Andrew B.] Univ Leicester, Med Res Council Toxicol Unit, Leicester, Leics, England	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Leicester	Mayor, F (corresponding author), Univ Autonoma Madrid, UAM CSIC, Dept Biol Mol, Madrid, Spain.	fmayor@cbm.uam.es; cribas@cbm.uam.es	Cabezudo, Sofia/AAA-6434-2020; Mayor, Federico/N-7644-2016	Garcia-Hoz, Carlota/0000-0001-8268-4159; Cabezudo, Sofia/0000-0001-5675-458X; Mayor Menendez, Federico/0000-0003-1434-8449	Ministerio de Educacion y Ciencia [SAF2011-23800]; Fundacion Ramon Areces; Cardiovascular Diseases Network of Ministerio Sanidad y Consumo-Instituto Carlos III [RD12/0042/0012]; Comunidad de Madrid [S-2011/BMD-2332]; Instituto de Salud Carlos III [PI11/00126]; Wood-Whelan Research Felowship (IUMBM)	Ministerio de Educacion y Ciencia(Spanish Government); Fundacion Ramon Areces; Cardiovascular Diseases Network of Ministerio Sanidad y Consumo-Instituto Carlos III; Comunidad de Madrid(Comunidad de Madrid); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Wood-Whelan Research Felowship (IUMBM)	The study was funded by grants from Ministerio de Educacion y Ciencia (SAF2011-23800), Fundacion Ramon Areces, The Cardiovascular Diseases Network of Ministerio Sanidad y Consumo-Instituto Carlos III (RD12/0042/0012), Comunidad de Madrid (S-2011/BMD-2332) and Instituto de Salud Carlos III (PI11/00126). Collaboration with Dr. Andrew Tobin was possible thanks to a Wood-Whelan Research Felowship (IUMBM) awarded to GSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Budd DC, 1999, J BIOL CHEM, V274, P12355, DOI 10.1074/jbc.274.18.12355; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Fukuhara S, 2000, J BIOL CHEM, V275, P21730, DOI 10.1074/jbc.M002410200; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Garcia-Hoz C, 2012, J BIOL CHEM, V287, P7792, DOI 10.1074/jbc.M111.282210; Garcia-Hoz C, 2010, J BIOL CHEM, V285, P13480, DOI 10.1074/jbc.M109.098699; Geetha T, 2003, J BIOL CHEM, V278, P4730, DOI 10.1074/jbc.M208468200; Kim J, 2009, J BIOL CHEM, V284, P11953, DOI 10.1074/jbc.M808176200; Kong KC, 2010, P NATL ACAD SCI USA, V107, P21181, DOI 10.1073/pnas.1011651107; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Popova JS, 2004, J BIOL CHEM, V279, P30410, DOI 10.1074/jbc.M402871200; Shmuel M, 2007, MOL BIOL CELL, V18, P1570, DOI 10.1091/mbc.E06-07-0618; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Tolbert LM, 1996, J BIOL CHEM, V271, P17335, DOI 10.1074/jbc.271.29.17335; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Ward RJ, 2011, METHODS MOL BIOL, V746, P21, DOI 10.1007/978-1-61779-126-0_2; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100	23	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84174	10.1371/journal.pone.0084174	http://dx.doi.org/10.1371/journal.pone.0084174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358341	Green Published, gold			2022-12-27	WOS:000328737700084
J	Shah, D; Jonckers, E; Praet, J; Vanhoutte, G; Palacios, RDY; Bigot, C; D'Souza, DV; Verhoye, M; Van der Linden, A				Shah, Disha; Jonckers, Elisabeth; Praet, Jelle; Vanhoutte, Greetje; Delgado y Palacios, Rafael; Bigot, Christian; D'Souza, Dany V.; Verhoye, Marleen; Van der Linden, Annemie			Resting State fMRI Reveals Diminished Functional Connectivity in a Mouse Model of Amyloidosis	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; HIPPOCAMPUS; DEPOSITION; NETWORKS	Introduction: Functional connectivity (FC) studies have gained immense popularity in the evaluation of several neurological disorders, such as Alzheimer's disease (AD). AD is a complex disorder, characterised by several pathological features. The problem with FC studies in patients is that it is not straightforward to focus on a specific aspect of pathology. In the current study, resting state functional magnetic resonance imaging (rsfMRI) is applied in a mouse model of amyloidosis to assess the effects of amyloid pathology on FC in the mouse brain. Methods: Nine APP/PS1 transgenic and nine wild-type mice (average age 18.9 months) were imaged on a 7T MRI system. The mice were anesthetized with medetomidine and rsfMRI data were acquired using a gradient echo EPI sequence. The data were analysed using a whole brain seed correlation analysis and interhemispheric FC was evaluated using a pairwise seed analysis. Qualitative histological analyses were performed to assess amyloid pathology, inflammation and synaptic deficits. Results: The whole brain seed analysis revealed an overall decrease in FC in the brains of transgenic mice compared to wild-type mice. The results showed that interhemispheric FC was relatively preserved in the motor cortex of the transgenic mice, but decreased in the somatosensory cortex and the hippocampus when compared to the wild-type mice. The pairwise seed analysis confirmed these results. Histological analyses confirmed the presence of amyloid pathology, inflammation and synaptic deficits in the transgenic mice. Conclusions: In the current study, rsfMRI demonstrated decreased FC in APP/PS1 transgenic mice compared to wild-type mice in several brain regions. The APP/PS1 transgenic mice had advanced amyloid pathology across the brain, as well as inflammation and synaptic deficits surrounding the amyloid plaques. Future studies should longitudinally evaluate APP/PS1 transgenic mice and correlate the rsfMRI findings to specific stages of amyloid pathology.	[Shah, Disha; Jonckers, Elisabeth; Praet, Jelle; Vanhoutte, Greetje; Delgado y Palacios, Rafael; Bigot, Christian; D'Souza, Dany V.; Verhoye, Marleen; Van der Linden, Annemie] Univ Antwerp, Bioimaging Lab, B-2020 Antwerp, Belgium; [D'Souza, Dany V.] F Hoffmann La Roche Pharmaceut Ltd, Neurosci Discovery, Basel, Switzerland	University of Antwerp; Roche Holding	Shah, D (corresponding author), Univ Antwerp, Bioimaging Lab, B-2020 Antwerp, Belgium.	Disha.Shah@ua.ac.be	Vanhoutte, Greetje/GZG-7992-2022; Praet, Jelle/I-9181-2014; Van der Linden, Annemie/L-7855-2017	Van der Linden, Annemie/0000-0003-2941-6520; Verhoye, Marleen/0000-0002-6267-0611; Praet, Jelle/0000-0002-9484-4532; Shah, Disha/0000-0001-7946-8594	European Union [278850]; UA doctoral grant (BOF DOCPRO VERHOYE M); EC [CP-IP 212043-2]	European Union(European Commission); UA doctoral grant (BOF DOCPRO VERHOYE M); EC(European CommissionEuropean Commission Joint Research Centre)	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 278850 (INMiND), the UA doctoral grant (BOF DOCPRO 2013 VERHOYE M) and partial funding by the EC-FP7 project NAD, CP-IP 212043-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAANSE SM, 2012, HUM BRAIN MAPP, P38869; Bero AW, 2012, J NEUROSCI, V32, P4334, DOI 10.1523/JNEUROSCI.5845-11.2012; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bittner T, 2012, ACTA NEUROPATHOL, V124, P797, DOI 10.1007/s00401-012-1047-8; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; Brier MR, 2012, J NEUROSCI, V32, P8890, DOI 10.1523/JNEUROSCI.5698-11.2012; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Clark VH, 2012, NEUROBIOL AGING, V33, P2733, DOI 10.1016/j.neurobiolaging.2012.01.010; Filippi Massimo, 2012, Expert Opin Med Diagn, V6, P109, DOI 10.1517/17530059.2012.657624; Gengler S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009764; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Hutchison RM, 2011, NEUROIMAGE, V56, P1546, DOI 10.1016/j.neuroimage.2011.02.063; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Joel SE, 2011, MAGN RESON MED, V66, P644, DOI 10.1002/mrm.22818; Johnson KA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006213; Jonckers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018876; Little DM, 2012, J ALZHEIMERS DIS, V32, P101, DOI 10.3233/JAD-2012-111508; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Praet J, 2012, CELL TRANSPLANT, V21, P1867, DOI 10.3727/096368912X636920; Priller C, 2009, NEUROBIOL AGING, V30, P1227, DOI 10.1016/j.neurobiolaging.2007.10.016; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Reitz Christiane, 2012, Int J Alzheimers Dis, V2012, P369808, DOI 10.1155/2012/369808; Rupp NJ, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.08.014; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; SFORAZZINI F, 2013, NEUROIMAGE, P80504; SHELINE YI, 2013, J ALZHEIMERS DIS BIO; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Spires-Jones T, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/319836; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Vanhoutte G, 2013, MAGN RESON MED, V69, P1115, DOI 10.1002/mrm.24680; White BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016322; Wurina, 2012, NEUROSCI BULL, V28, P449, DOI 10.1007/s12264-012-1255-1; Zhang HY, 2010, RADIOLOGY, V256, P598, DOI 10.1148/radiol.10091701; Zhou YX, 2008, ALZHEIMERS DEMENT, V4, P265, DOI 10.1016/j.jalz.2008.04.006	36	39	39	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84241	10.1371/journal.pone.0084241	http://dx.doi.org/10.1371/journal.pone.0084241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358348	gold, Green Published, Green Submitted			2022-12-27	WOS:000328737700089
J	Zhang, ZY; Convertini, P; Shen, ML; Xu, X; Lemoine, F; de la Grange, P; Andres, DA; Stamm, S				Zhang, Zhaiyi; Convertini, Paolo; Shen, Manli; Xu, Xiu; Lemoine, Frederic; de la Grange, Pierre; Andres, Douglas A.; Stamm, Stefan			Valproic Acid Causes Proteasomal Degradation of DICER and Influences miRNA Expression	PLOS ONE			English	Article							HISTONE DEACETYLASE; GENE-EXPRESSION; MOOD STABILIZER; DOWN-REGULATION; SODIUM VALPROATE; CELLS; INHIBITOR; DRUG; DIVALPROEX; MICRORNAS	Valproic acid (VPA) is a commonly used drug to treat epilepsy and bipolar disorders. Known properties of VPA are inhibitions of histone deacetylases and activation of extracellular signal regulated kinases (ERK), which cannot fully explain VPA's clinical features. We found that VPA induces the proteasomal degradation of DICER, a key protein in the generation of micro RNAs. Unexpectedly, the concentration of several micro RNAs increases after VPA treatment, which is caused by the upregulation of their hosting genes prior to DICER degradation. The data suggest that a loss of DICER protein and changes in micro RNA concentration contributes to the clinical properties of VPA. VPA can be used experimentally to down regulate DICER protein levels, which likely reflects a natural regulation of DICER.	[Zhang, Zhaiyi; Convertini, Paolo; Shen, Manli; Xu, Xiu; Andres, Douglas A.; Stamm, Stefan] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Lemoine, Frederic; de la Grange, Pierre] Hop St Louis, GenoSplice Technol, Paris, France	University of Kentucky; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Stamm, S (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	stefan@stamms-lab.net		Convertini, Paolo/0000-0001-7250-0678	NIH [RO1 GM083187, 5P20RR020171-08]; Muscular Dystrophy Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083187] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the NIH [RO1 GM083187 and 5P20RR020171-08]; and a grant from the Muscular Dystrophy Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada S, 2008, AM J PHYSIOL-HEART C, V295, pH2512, DOI 10.1152/ajpheart.00233.2008; Bosetti F, 2005, BRAIN RES BULL, V65, P331, DOI 10.1016/j.brainresbull.2005.01.004; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Chetcuti A, 2006, INT J NEUROPSYCHOPH, V9, P267, DOI 10.1017/S1461145705005717; Chodurek E, 2012, CELL MOL BIOL LETT, V17, P616, DOI 10.2478/s11658-012-0033-4; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Duenas-Gonzalez A, 2008, CANCER TREAT REV, V34, P206, DOI 10.1016/j.ctrv.2007.11.003; Falaleeva M, 2013, CLIN MED CA IN PRESS; Frazee LA, 2008, ANN PHARMACOTHER, V42, P403, DOI 10.1345/aph.1K531; Fukuchi M, 2009, NEUROSCI RES, V65, P35, DOI 10.1016/j.neures.2009.05.002; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Gibbings D, 2012, NAT CELL BIOL, V14, P1314, DOI 10.1038/ncb2611; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kapur K, 2008, BIOINFORMATICS, V24, P2887, DOI 10.1093/bioinformatics/btn571; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kishore S, 2010, HUM MOL GENET, V19, P1153, DOI 10.1093/hmg/ddp585; Kissel JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021296; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; McKiernan RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035921; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Michaelis M, 2007, CURR PHARM DESIGN, V13, P3378, DOI 10.2174/138161207782360519; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nagaraja AK, 2008, MOL ENDOCRINOL, V22, P2336, DOI 10.1210/me.2008-0142; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; Petak I, 2000, CLIN CANCER RES, V6, P4119; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Reed RC, 2006, EPILEPSY BEHAV, V8, P391, DOI 10.1016/j.yebeh.2005.12.004; Reed RC, 2006, THER DRUG MONIT, V28, P413, DOI 10.1097/01.ftd.0000211814.12311.3f; Rosenberg G, 2007, CELL MOL LIFE SCI, V64, P2090, DOI 10.1007/s00018-007-7079-x; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Shen SH, 2010, BIOINFORMATICS, V26, P268, DOI 10.1093/bioinformatics/btp643; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; St-Germain JR, 2008, EPIGENETICS-US, V3, P342, DOI 10.4161/epi.3.6.7203; Stephen LJ, 2003, DRUG AGING, V20, P141, DOI 10.2165/00002512-200320020-00005; Swoboda KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005268; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wiesen JL, 2009, MOL IMMUNOL, V46, P1222, DOI 10.1016/j.molimm.2008.11.012; Wu JJ, 2010, CELL CYCLE, V9, P1809, DOI 10.4161/cc.9.9.11535; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Yuan PX, 2001, J BIOL CHEM, V276, P31674, DOI 10.1074/jbc.M104309200	48	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82895	10.1371/journal.pone.0082895	http://dx.doi.org/10.1371/journal.pone.0082895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358235	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700038
J	Atallah, J; Plachetzki, DC; Jasper, WC; Johnson, BR				Atallah, Joel; Plachetzki, David C.; Jasper, W. Cameron; Johnson, Brian R.			The Utility of Shallow RNA-Seq for Documenting Differential Gene Expression in Genes with High and Low Levels of Expression	PLOS ONE			English	Article							APIS-MELLIFERA; TRANSCRIPTION FACTORS; HONEY-BEE; CHIP-SEQ; GENERATION; GENOMICS; HYMENOPTERA; ANNOTATION; INSIGHTS; TOOL	The sequencing depth necessary for documenting differential gene expression using RNA-Seq has been little explored outside of model systems. In particular, the depth required to analyze large-scale patterns of differential transcription factor expression is not known. The goal of the present study is to explore the effectiveness of shallow (relatively low read depth) RNA-Seq. We focus on two tissues in the honey bee: the sting gland and the digestive tract. The sting gland is an experimentally well-understood tissue that we use to benchmark the utility of this approach. We use the digestive tract to test the results obtained with the sting gland, and to conduct RNA-Seq between tissue types. Using a list of experimentally verified genes conferring tissue-specific functions in the sting gland, we show that relatively little read depth is necessary to identify them. We argue that this result should be broadly applicable, since genes important for tissue-specific functions often have robust expression patterns, and because we obtained similar results in our analysis of the digestive tract. Furthermore, we demonstrate that the differential expression of transcription factors, which are transcribed at low levels compared to other genes, can nevertheless often be determined using shallow RNA-Seq. Overall, we find over 150 differentially expressed transcription factors in our tissues at a read depth of only 12 million. This work shows the utility of low-depth sequencing for identifying genes important for tissue-specific functions. It also verifies the often-held belief that transcription factors show low levels of expression, while demonstrating that, in spite of this, they are frequently amenable to shallow RNA-Seq. Our findings should be of benefit to researchers using RNA-Seq in many different biological systems.	[Atallah, Joel; Jasper, W. Cameron; Johnson, Brian R.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Plachetzki, David C.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Johnson, BR (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.	brnjohnson@ucdavis.edu			UC Davis	UC Davis	Lab startup funds from UC Davis funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Blencowe BJ, 2009, GENE DEV, V23, P1379, DOI 10.1101/gad.1788009; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hallegger M, 2010, FEBS J, V277, P856, DOI 10.1111/j.1742-4658.2009.07521.x; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Hoffman DR, 2006, CLIN REV ALLERG IMMU, V30, P109, DOI 10.1385/CRIAI:30:2:109; Hudson NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007249; Johnson BR, 2008, BEHAV ECOL SOCIOBIOL, V62, P777, DOI 10.1007/s00265-007-0503-2; Johnson BR, 2010, BEHAV ECOL SOCIOBIOL, V64, P305, DOI 10.1007/s00265-009-0874-7; King TP, 2000, INT ARCH ALLERGY IMM, V123, P99, DOI 10.1159/000024440; Kliebenstein DJ, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00213; Kumar R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00202; Li H, 2008, P NATL ACAD SCI USA, V105, P20179, DOI 10.1073/pnas.0807121105; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin M., 2011, EMBNET J N AM    MAY; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; OWEN MD, 1995, TOXICON, V33, P1181, DOI 10.1016/0041-0101(95)00054-P; OWEN MD, 1976, TOXICON, V14, P1, DOI 10.1016/0041-0101(76)90113-6; Peiren N, 2008, TOXICON, V52, P72, DOI 10.1016/j.toxicon.2008.05.003; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Perkins TT, 2009, PLOS GENET, P5; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Roat TC, 2004, SOCIOBIOLOGY, V43, P193; Sharma CM, 2009, CURR OPIN MICROBIOL, V12, P536, DOI 10.1016/j.mib.2009.07.006; Shpigler H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-120; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wegener J, 2009, INSECT SOC, V56, P85, DOI 10.1007/s00040-008-1042-1; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103; Xiong YY, 2010, NAT GENET, V42, P1043, DOI 10.1038/ng.711	46	7	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84160	10.1371/journal.pone.0084160	http://dx.doi.org/10.1371/journal.pone.0084160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358338	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700154
J	Belfiori, B; Riccioni, C; Paolocci, F; Rubini, A				Belfiori, Beatrice; Riccioni, Claudia; Paolocci, Francesco; Rubini, Andrea			Mating Type Locus of Chinese Black Truffles Reveals Heterothallism and the Presence of Cryptic Species within the T. indicum Species Complex	PLOS ONE			English	Article							TUBER-MELANOSPORUM; PHYLOGENETIC-RELATIONSHIPS; NATURAL-POPULATIONS; REPRODUCTIVE MODE; DISTANCE ANALYSIS; LIFE-CYCLE; SP-NOV; SEX; EVOLUTION; PATHOGEN	Tuber spp. are filamentous ascomycetes which establish symbiosis with the roots of trees and shrub species. By virtue of this symbiosis they produce hypogeous ascocarps, known as truffles. Filamentous ascomycetes can reproduce by homothallism or heterothallism depending on the structure and organization of their mating type locus. The first mating type locus in a truffle species has been recently characterized in Tuber melanosporum and it has been shown that this fungus, endemic in Europe, is heterothallic. The availability of sequence information for T. melanosporum mating type genes is seminal to cloning their orthologs from other Tuber species and assessing their reproductive mode. Here we report on the organization of the mating type region in T. indicum, the black truffle species present in Asia, which is the closest relative to T. melanosporum and is characterized by an high level of morphological and genetic variability. The present study shows that T. indicum is also heterothallic. Examination of Asiatic black truffles belonging to different genetic classes, sorted according to the sequence polymorphism of the internal transcribed spacer rDNA region, has revealed sequence variations and rearrangements in both coding and non-coding regions of the mating type locus, to suggest the existence of cryptic species within the T. indicum complex. The presence of transposable elements within or linked to the mating type region suggests a role of these elements in generating the genotypic diversity present among T. indicum strains. Overall, comparative analyses of the mating type locus have thus allowed us to tackle taxonomical and phylogenetic issues within black truffles and make inferences about the evolution of T. melanosporum-T. indicum lineage. Our results are not only of fundamental but also of applied relevance as T. indicum produces edible fruit bodies that are imported also into Europe and thus may represent a biological threat for T. melanosporum.	[Belfiori, Beatrice; Riccioni, Claudia; Paolocci, Francesco; Rubini, Andrea] CNR, Perugia Div, Inst Biosci & BioResources, Perugia, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR)	Rubini, A (corresponding author), CNR, Perugia Div, Inst Biosci & BioResources, Perugia, Italy.	andrea.rubini@cnr.it	Rubini, Andrea/AAB-3036-2021; Rubini, Andrea/AAE-2217-2022; Paolocci, Francesco/AAD-9484-2019; Riccioni, Claudia/AAX-1878-2020	Rubini, Andrea/0000-0003-3988-6294; Paolocci, Francesco/0000-0002-9394-876X; Riccioni, Claudia/0000-0003-1069-8943	Regione Umbria (project: "Indagini ecologiche, genetiche e molecolari per potenziare la produzione di tartufi pregiati in Umbria"); Italian Ministry of Education, Universities and Research (PRIN project: "Il ciclo biologico del tartufo: interazioni genotipo-ambiente")	Regione Umbria (project: "Indagini ecologiche, genetiche e molecolari per potenziare la produzione di tartufi pregiati in Umbria"); Italian Ministry of Education, Universities and Research (PRIN project: "Il ciclo biologico del tartufo: interazioni genotipo-ambiente")(Ministry of Education, Universities and Research (MIUR))	This study was supported by Regione Umbria (project: "Indagini ecologiche, genetiche e molecolari per potenziare la produzione di tartufi pregiati in Umbria") and Italian Ministry of Education, Universities and Research (PRIN 2008 project: "Il ciclo biologico del tartufo: interazioni genotipo-ambiente"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertault G, 1998, NATURE, V394, P734, DOI 10.1038/29428; Billiard S, 2012, J EVOLUTION BIOL, V25, P1020, DOI 10.1111/j.1420-9101.2012.02495.x; Bonito G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052765; Bonito G, 2011, FUNGAL ECOL, V4, P83, DOI 10.1016/j.funeco.2010.08.003; Brasier CM, 1998, MYCOL RES, V102, P45, DOI 10.1017/S0953756297004541; Brewer MT, 2011, FUNGAL GENET BIOL, V48, P704, DOI 10.1016/j.fgb.2011.04.004; Brown AJ, 2001, TRENDS GENET, V17, P393, DOI 10.1016/S0168-9525(01)02343-5; Butler Geraldine, 2007, P3; Casselton L, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P536; CHASE TE, 1990, MYCOLOGIA, V82, P67, DOI 10.2307/3759964; Chen JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014625; Clark NL, 2006, REPRODUCTION, V131, P11, DOI 10.1530/rep.1.00357; Comandini O, 1997, MYCOTAXON, V63, P77; Debuchy R, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P501; Dyer PS, 2012, FEMS MICROBIOL REV, V36, P165, DOI 10.1111/j.1574-6976.2011.00308.x; FOURRE G, 1996, B FED ASS MYCOL MEDI, V9, P3; Fraser JA, 2005, CURR OPIN GENET DEV, V15, P645, DOI 10.1016/j.gde.2005.09.002; Fraser MJ, 1996, INSECT MOL BIOL, V5, P141, DOI 10.1111/j.1365-2583.1996.tb00048.x; Geng LY, 2009, MYCORRHIZA, V19, P461, DOI 10.1007/s00572-009-0247-0; Gioti A, 2012, MOL BIOL EVOL, V29, P3215, DOI 10.1093/molbev/mss132; Gladieux P, 2011, MOL BIOL EVOL, V28, P459, DOI 10.1093/molbev/msq235; Gonthier P, 2007, MOL ECOL, V16, P1389, DOI 10.1111/j.1365-294X.2007.03250.x; Gross A, 2012, FUNGAL GENET BIOL, V49, P977, DOI 10.1016/j.fgb.2012.08.008; Gryganskyi AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015273; Hu H, 1992, J EXP FOR NATL TAIWA, V6, P79; Huang JY, 2009, FEMS MICROBIOL LETT, V294, P157, DOI 10.1111/j.1574-6968.2009.01571.x; Idnurm Alexander, 2011, Fungal Biology Reviews, V25, P121, DOI 10.1016/j.fbr.2011.07.003; JanexFavre MC, 1996, CR ACAD SCI III-VIE, V319, P517; Jeandroz S, 2008, J BIOGEOGR, V35, P815, DOI 10.1111/j.1365-2699.2007.01851.x; Kempken F, 1998, BIOESSAYS, V20, P652, DOI 10.1002/(SICI)1521-1878(199808)20:8&lt;652::AID-BIES8&gt;3.0.CO;2-K; Kronstad JW, 1997, ANNU REV GENET, V31, P245, DOI 10.1146/annurev.genet.31.1.245; Lengeler KB, 2002, EUKARYOT CELL, V1, P704, DOI 10.1128/EC.1.5.704-718.2002; Li WJ, 2010, EUKARYOT CELL, V9, P46, DOI 10.1128/EC.00259-09; Liu B, 1989, J SHANXI U NAT SCI E, V12, P215; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Martin F, 2012, European Patent Application, Patent No. 2426215; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Martin SH, 2011, MOL BIOL EVOL, V28, P1987, DOI 10.1093/molbev/msr022; Mayrhofer S, 2005, EUKARYOT CELL, V4, P661, DOI 10.1128/EC.4.4.661-672.2005; METZENBERG RL, 1990, BIOESSAYS, V12, P53, DOI 10.1002/bies.950120202; Moreno G, 1997, MYCOTAXON, V63, P217; Murat C, 2008, NEW PHYTOL, V180, P260, DOI 10.1111/j.1469-8137.2008.02634.x; Murat C, 2008, NEW PHYTOL, V178, P699, DOI 10.1111/j.1469-8137.2008.02449.x; Murat C, 2013, NEW PHYTOL, V199, P176, DOI 10.1111/nph.12264; Newcombe G, 2000, MYCOL RES, V104, P261, DOI 10.1017/S0953756299001665; Nygren K, 2011, MOL PHYLOGENET EVOL, V59, P649, DOI 10.1016/j.ympev.2011.03.023; Palumbi SR, 2009, HEREDITY, V102, P66, DOI 10.1038/hdy.2008.104; Paolocci F, 2000, FEMS MICROBIOL ECOL, V34, P139, DOI 10.1111/j.1574-6941.2000.tb00763.x; Paolocci F, 2006, APPL ENVIRON MICROB, V72, P2390, DOI 10.1128/AEM.72.4.2390-2393.2006; Paolocci F, 1997, FEMS MICROBIOL LETT, V153, P255, DOI 10.1111/j.1574-6968.1997.tb12582.x; Poggeler S, 2011, FUNGAL BIOL-UK, V115, P615, DOI 10.1016/j.funbio.2011.03.003; Riccioni C, 2008, NEW PHYTOL, V180, P466, DOI 10.1111/j.1469-8137.2008.02560.x; Robertson Hugh M., 2002, P1093; Roux C, 1999, FEMS MICROBIOL LETT, V180, P147, DOI 10.1111/j.1574-6968.1999.tb08789.x; Rubini A, 1998, FEMS MICROBIOL LETT, V164, P7, DOI 10.1016/S0378-1097(98)00183-9; Rubini A, 2005, APPL ENVIRON MICROB, V71, P6584, DOI 10.1128/AEM.71.11.6584-6589.2005; Rubini A, 2007, NEW PHYTOL, V174, P256, DOI 10.1111/j.1469-8137.2007.01976.x; Rubini A, 2011, NEW PHYTOL, V189, P710, DOI 10.1111/j.1469-8137.2010.03492.x; Rubini A, 2011, NEW PHYTOL, V189, P723, DOI 10.1111/j.1469-8137.2010.03493.x; Sarkar A, 2003, MOL GENET GENOMICS, V270, P173, DOI 10.1007/s00438-003-0909-0; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Swanson WJ, 2002, ANNU REV ECOL SYST, V33, P161, DOI 10.1146/annurev.ecolsys.33.010802.150439; Turgeon BG, 1998, ANNU REV PHYTOPATHOL, V36, P115, DOI 10.1146/annurev.phyto.36.1.115; Turgeon G, 2000, FUNGAL GENET BIOL, V31, P1, DOI 10.1006/fgbi.2000.1227; Wang X., 2012, EDIBLE ECTOMYCORRHIZ, P227, DOI [10.1007/978-3-642-33823-6_13, DOI 10.1007/978-3-642-33823-6_13]; Wang Y, 1998, CRYPTOGAMIE MYCOL, V19, P113; Wang YJ, 2006, MYCOL RES, V110, P1034, DOI 10.1016/j.mycres.2006.06.013; Wang YJ, 2006, FEMS MICROBIOL LETT, V259, P269, DOI 10.1111/j.1574-6968.2006.00283.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wik L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-109; YODER OC, 1986, PHYTOPATHOLOGY, V76, P383, DOI 10.1094/Phyto-76-383; Yuan YW, 2011, P NATL ACAD SCI USA, V108, P7884, DOI 10.1073/pnas.1104208108; Yun SH, 1999, P NATL ACAD SCI USA, V96, P5592, DOI 10.1073/pnas.96.10.5592; Zaffarano PL, 2010, FUNGAL GENET BIOL, V47, P761, DOI 10.1016/j.fgb.2010.06.001; ZHANG BC, 1988, T BRIT MYCOL SOC, V91, P593, DOI 10.1016/S0007-1536(88)80032-9; Zhang LF, 2005, FEMS MICROBIOL LETT, V245, P85, DOI 10.1016/j.femsle.2005.02.028	77	26	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82353	10.1371/journal.pone.0082353	http://dx.doi.org/10.1371/journal.pone.0082353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358175	gold, Green Submitted, Green Published			2022-12-27	WOS:000328735700061
J	Bisi, TL; Dorneles, PR; Lailson-Brito, J; Lepoint, G; Azevedo, ADF; Flach, L; Malm, O; Das, K				Bisi, Tatiana Lemos; Dorneles, Paulo Renato; Lailson-Brito, Jose; Lepoint, Gilles; Azevedo, Alexandre de Freitas; Flach, Leonardo; Malm, Olaf; Das, Krishna			Trophic Relationships and Habitat Preferences of Delphinids from the Southeastern Brazilian Coast Determined by Carbon and Nitrogen Stable Isotope Composition	PLOS ONE			English	Article							RIO-DE-JANEIRO; SOTALIA-GUIANENSIS; MARINE MAMMALS; SEPETIBA BAY; STENELLA-ATTENUATA; GRAMPUS-GRISEUS; FEEDING-HABITS; RISSOS DOLPHIN; FOOD-CHAINS; ATLANTIC	To investigate the foraging habitats of delphinids in southeastern Brazil, we analyzed stable carbon (delta C-13) and nitrogen (delta N-15) isotopes in muscle samples of the following 10 delphinid species: Sotalia guianensis, Stenella frontalis, Tursiops truncatus, Steno bredanensis, Pseudorca crassidens, Delphinus sp., Lagenodelphis hosei, Stenella attenuata, Stenella longirostris and Grampus griseus. We also compared the delta C-13 and delta N-15 values among four populations of S. guianensis. Variation in carbon isotope results from coast to ocean indicated that there was a significant decrease in delta C-13 values from estuarine dolphins to oceanic species. S. guianensis from Guanabara Bay had the highest mean delta C-13 value, while oceanic species showed significantly lower delta C-13 values. The highest delta N-15 values were observed for P. crassidens and T. truncatus, suggesting that these species occupy the highest trophic position among the delphinids studied here. The oceanic species S. attenuata, G. griseus and L. hosei had the lowest delta N-15 values. Stable isotope analysis showed that the three populations of S. guianensis in coastal bays had different delta C-13 values, but similar delta N-15 results. Guiana dolphins from Sepetiba and Ilha Grande bays had different foraging habitat, with specimens from Ilha Grande showing more negative delta C-13 values. This study provides further information on the feeding ecology of delphinids occurring in southeastern Brazil, with evidence of distinctive foraging habitats and the occupation of different ecological niches by these species in the study area.	[Bisi, Tatiana Lemos; Lailson-Brito, Jose; Azevedo, Alexandre de Freitas] Univ Estado Rio De Janeiro, Lab Mamiferos Aquat & Bioindicadores Profa Izabel, Fac Oceanog, Rio De Janeiro, Brazil; [Bisi, Tatiana Lemos] Univ Fed Rio de Janeiro, Programa Posgrad Ecol, Rio de Janeiro, Brazil; [Bisi, Tatiana Lemos; Dorneles, Paulo Renato; Malm, Olaf] Univ Fed Rio de Janeiro, Lab Radioisotopos Eduardo Penna Franca, Inst Biofis Carlos Chagas Filho, Rio de Janeiro, Brazil; [Lepoint, Gilles; Das, Krishna] Univ Liege, Lab Oceanol MARE, Liege, Belgium; [Flach, Leonardo] Inst Boto Cinza, Mangaratiba, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; University of Liege	Bisi, TL (corresponding author), Univ Estado Rio De Janeiro, Lab Mamiferos Aquat & Bioindicadores Profa Izabel, Fac Oceanog, Rio De Janeiro, Brazil.	tbisi@yahoo.com.br	AZEVEDO, ALEXANDRE/HII-5648-2022; Das, Krishna/AAB-7273-2020; Lepoint, Gilles/I-1130-2014; Azevedo, Alexandre/B-9660-2013; Lepoint, Gilles/N-4923-2019; Dorneles, Paulo R/M-2049-2013; Brito, Jose Lailson/B-3572-2013; Malm, Olaf/H-1724-2012; Bisi, Tatiana L/B-1330-2014	Das, Krishna/0000-0003-2689-3348; Lepoint, Gilles/0000-0003-4375-0357; Azevedo, Alexandre/0000-0002-3754-9035; Lepoint, Gilles/0000-0003-4375-0357; Brito, Jose Lailson/0000-0001-8366-458X; Bisi, Tatiana L/0000-0003-3480-6697; Malm, Olaf/0000-0002-4116-7160; Dorneles, Paulo/0000-0003-0296-739X	Rio de Janeiro State Government Research Agency - FAPERJ [Proc. E-26/110.371/2007, APQ1-2009/1 - Proc. E26-110.858-2009]; Ministry of Education of Brazil - CAPES [Proc. 23038.051661/2009-18]; Brazilian Research Council - CNPq [Proc. 482938/2007-2, Proc. 480701/2009-1]; Cetacean Society International grant; CNPq; F.R.S.-FNRS [Proc. 490471/2010-2 CNPq]; Ministry of Education of Brazil - CAPES; FAPERJ/UERJ; CNPq [305303/2010-4, 304826/2008-1]; FAPERJ [101.449/2010]	Rio de Janeiro State Government Research Agency - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Ministry of Education of Brazil - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Research Council - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Cetacean Society International grant; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); F.R.S.-FNRS(Fonds de la Recherche Scientifique - FNRS); Ministry of Education of Brazil - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ/UERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was supported by Rio de Janeiro State Government Research Agency - FAPERJ ("Pensa Rio" Program - Proc. E-26/110.371/2007 and APQ1-2009/1 - Proc. E26-110.858-2009), Ministry of Education of Brazil - CAPES ("Ciencias do Mar" - Proc. 23038.051661/2009-18), Brazilian Research Council - CNPq (Proc. 482938/2007-2 and Proc. 480701/2009-1) and Cetacean Society International grant. This study was also supported by a scientific cooperation established between CNPq and F.R.S.-FNRS (Proc. 490471/2010-2 CNPq). TLB had a scholarship from the Ministry of Education of Brazil - CAPES, JL-B has a research grant from FAPERJ/UERJ ("Prociencia" Program) and CNPq (grant #305303/2010-4), AFA has a research grant from CNPq (grant #304826/2008-1) and FAPERJ (JCNE #101.449/2010), OM has a research grant from CNPq and FAPERJ (CNE). GL and KD are F.R.S.-FNRS Research Associates. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nino-Torres CA, 2006, MAR MAMMAL SCI, V22, P831, DOI 10.1111/j.1748-7692.2006.00065.x; Andrade LG, 2010, THESIS U ESTADO RIO; ANP (Agencia Nacional de Petroleo), 2013, PORT CONJ ANP INMETR; Azevedo A.F., 2004, J CETACEAN RES MANAG, V6, P265; Azevedo Alexandre F., 2003, Aquatic Mammals, V29, P411, DOI 10.1578/01675420360736613; Baird RW, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P405; Barros N. B., 1993, FEEDING ECOLOGY FORA; Barros NB, 2010, MAR MAMMAL SCI, V26, P324, DOI 10.1111/j.1748-7692.2009.00315.x; Bastida R, 2007, MAMIFEROS ACUATICOS; Bisi TL, 2012, ECOL INDIC, V18, P291, DOI 10.1016/j.ecolind.2011.11.015; Blanco C, 2006, SCI MAR, V70, P407, DOI 10.3989/scimar.2006.70n3407; Botta S, 2012, J MAR BIOL ASSOC UK, V92, P1689, DOI 10.1017/S0025315411000610; BOUTTON T W, 1991, P173; BRANDINI FP, 1997, PLANCTONOLOGIA PLATA; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; Carpenter EJ, 1997, DEEP-SEA RES PT I, V44, P27, DOI 10.1016/S0967-0637(96)00091-X; Carpenter EJ, 1999, MAR ECOL PROG SER, V185, P273, DOI 10.3354/meps185273; COCKCROFT VG, 1993, Z SAUGETIERKD, V58, P286; Das K, 2003, MAR ECOL PROG SER, V263, P287, DOI 10.3354/meps263287; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Di Beneditto APM, 2007, J MAR BIOL ASSOC UK, V87, P253, DOI 10.1017/S0025315407053647; Di Beneditto APM, 2004, J MAR BIOL ASSOC UK, V84, P1245, DOI 10.1017/S0025315404010744h; Dias LA, 2009, J MAR BIOL ASSOC UK, V89, P967, DOI 10.1017/S0025315409000782; Dorneles PR, 2010, ENVIRON INT, V36, P60, DOI 10.1016/j.envint.2009.10.001; Flach L, 2008, MAR MAMMAL SCI, V24, P503, DOI 10.1111/j.1748-7692.2008.00198.x; Flores PAC, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P1188; GONZALEZ AF, 1994, FISH RES, V21, P179, DOI 10.1016/0165-7836(94)90103-1; HARVEY JT, 1994, MAR MAMMAL SCI, V10, P178, DOI 10.1111/j.1748-7692.1994.tb00259.x; Hobson KA, 1997, MAR MAMMAL SCI, V13, P359, DOI 10.1111/j.1748-7692.1997.tb00645.x; Hobson KA, 1997, MAR MAMMAL SCI, V13, P114, DOI 10.1111/j.1748-7692.1997.tb00615.x; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hollatz C, 2011, MAR BIOL, V158, P927, DOI 10.1007/s00227-010-1619-x; IFIAS, 1998, SEP BAY MAN STUD WOR; Ikeda Y., 1974, B I OCEANOGRAFICO, V23, P33, DOI DOI 10.1590/S0373-55241974000100003; INEA, 2009, EST TECN CRIAC AR PR, P15; Jefferson TA, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P990; Kiszka J, 2010, J EXP MAR BIOL ECOL, V395, P48, DOI 10.1016/j.jembe.2010.08.010; Kjerfve B, 1997, CONT SHELF RES, V17, P1609, DOI 10.1016/S0278-4343(97)00028-9; Lailson-Brito J, 2012, SCI TOTAL ENVIRON, V433, P123, DOI 10.1016/j.scitotenv.2012.06.030; LeDuc R., 2002, ENCY MARINE MAMMALS, P310; LIU KK, 1989, LIMNOL OCEANOGR, V34, P820, DOI 10.4319/lo.1989.34.5.0820; Lodi Liliane, 2003, Bioikos (Campinas), V17, P5; Marins RV, 2004, QUIM NOVA, V27, P763, DOI 10.1590/S0100-40422004000500016; McClelland JW, 2003, DEEP-SEA RES PT I, V50, P849, DOI 10.1016/S0967-0637(03)00073-6; Melo CLC, 2010, J MAR BIOL ASSOC UK, V90, P1509, DOI 10.1017/S0025315409991639; Melo CLC, 2010, THESIS U ESTADO RIO; Michener R.H., 1994, P138; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Moreno IB, 2005, MAR ECOL PROG SER, V300, P229, DOI 10.3354/meps300229; Nery MF, 2008, REV BRAS ZOOL, V25, P182, DOI 10.1590/S0101-81752008000200004; Ohizumi H, 2010, FISH OCEANOGR, V19, P257, DOI 10.1111/j.1365-2419.2010.00547.x; Peeters FJC, 2002, GLOBAL PLANET CHANGE, V34, P269, DOI 10.1016/S0921-8181(02)00120-0; Perin G, 1997, WATER RES, V31, P3017, DOI 10.1016/S0043-1354(97)00171-1; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pinela AM, 2010, MAR ECOL PROG SER, V416, P295, DOI 10.3354/meps08790; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Riccialdelli L, 2010, MAR ECOL PROG SER, V418, P235, DOI 10.3354/meps08826; Robertson KM, 1997, FISH B-NOAA, V95, P334; Santos MB, 1994, INT COUNC EXPL SEA C, P11; de Lima IMS, 2012, J ACOUST SOC AM, V131, P4173, DOI 10.1121/1.3701878; SEKIGUCHI K, 1992, S AFR J MARINE SCI, V12, P843; Sergio R.S., 1980, B I OCEANOGR MONACO, V29, P57, DOI DOI 10.1590/S0373-55241980000100005; Sigman DM, 2009, DEEP-SEA RES PT I, V56, P1419, DOI 10.1016/j.dsr.2009.04.007; Signorini SRA, 1980, BRAZ J OCEANOGR, V29, P41, DOI [DOI 10.1590/S1679-87591980000100004, 10.1590/S1679-87591980000100004, DOI 10.1590/S0373-55241980000100004]; Tavares M, 2010, MAMMAL REV, V40, P40, DOI 10.1111/j.1365-2907.2009.00154.x; Valentin JL, 2000, ECOLOGIA NUMERICA IN; Valentin JL, 1977, COAST UPWELLING ECOS, V6, P18; Vander Zanden MJ, 1996, ECOL MONOGR, V66, P451, DOI 10.2307/2963490; Vidal L, 2010, USO BOTO CINZA SOTAL; Wang MC, 2003, ZOOL STUD, V42, P368	72	34	36	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82205	10.1371/journal.pone.0082205	http://dx.doi.org/10.1371/journal.pone.0082205			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358155	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700044
J	Cao, HD; Wen, P; Ye, H; Sun, ZP; Shen, X; Wu, XC; Dai, CS; Yang, JW				Cao, Hongdi; Wen, Ping; Ye, Hong; Sun, Zhiping; Shen, Xia; Wu, Xiaochun; Dai, Chunsun; Yang, Junwei			A Study of the Immunoloregulation of Double Filtration Plasmapheresis in Maintenance Hemodialysis Patients with Chronic Hepatitis C	PLOS ONE			English	Article							REGULATORY T-CELLS; VIRUS-INFECTION; INTERFERON THERAPY; RENAL-DISEASE; RISK-FACTORS; METAANALYSIS; COMBINATION; PREVALENCE; INFLAMMATION; DYSFUNCTION	Although a large number of drugs have been used to treat chronic hepatitis C (CHC), there still remains a great challenge to treat maintenance hemodialysis (MHD) patients with chronic hepatitis C. To clarify the immunnoloregulation of double filtration plasmapheresis (DFPP) in MHD patients with CHC, DFPP was performed in 20 MHD patients with CHC (HCV-antibody positive, serum HCV RNA >500 IU/ml more than 6 months and HCV genotype 1b). The clinical data was collected and peripheral blood mononuclear cells (PBMCs) were analyzed by flow cytometry at the time of hour 0, hour 3, day 3, day 7 and day 28 after the DFPP, respectively. Serum HCV particles could be removed partially by the DFPP. The titer of serum HCV RNA could remain in a lower level even 28 days after the treatment. Compared to MHD patients without HCV infection, the frequencies of innate immune cells were similar in MHD patients with CHC, while Th1/Th2 was elevated and the frequencies of regulatory T (Treg) cells were higher in those MHD patients with CHC. The frequencies of monocytes and natural killer (NK) cells remained after the DFPP in MHD patients with CHC. There were no significant changes of Th1, Th2 and Th1/Th2 in PBMC after DFPP. DFPP could reduce the frequencies of Th17 cells and Treg cells in PBMC from 7 days after DFPP in MHD patients with CHC. DFPP could partially remove the serum HCV particles mechanically. The titer of HCV RNA could remain in a lower level at least for 28 days probably due to the redistribution of the immunocytes in circulation.	[Cao, Hongdi; Wen, Ping; Ye, Hong; Sun, Zhiping; Shen, Xia; Wu, Xiaochun; Dai, Chunsun; Yang, Junwei] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Yang, JW (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China.	jwyang@njmu.edu.cn			Ministry of Science and Technology, China [2011CB504000]	Ministry of Science and Technology, China(Ministry of Science and Technology, China)	This study was supported by "973'' Science Program of the Ministry of Science and Technology, China (2011CB504000) to Junwei Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Betjes MGH, 2013, NAT REV NEPHROL, V9, P255, DOI 10.1038/nrneph.2013.44; Chang Q, 2012, J GASTROEN HEPATOL, V27, P273, DOI 10.1111/j.1440-1746.2011.06782.x; Cohen G, 2012, TOXINS, V4, P962, DOI 10.3390/toxins4110962; Cui Y, 2013, J GASTROEN HEPATOL, V28, P7, DOI 10.1111/jgh.12220; Ebinuma H, 2008, J VIROL, V82, P5043, DOI 10.1128/JVI.01548-07; Fabrizi F, 2008, J VIRAL HEPATITIS, V15, P79, DOI [10.1111/j.1365-2893.2007.00907.x, 10.1111/j.1365-2893.2008.01039.x]; Fabrizi F, 2004, ALIMENT PHARM THER, V20, P1271, DOI 10.1111/j.1365-2036.2004.02290.x; Fabrizi F, 2007, SEMIN DIALYSIS, V20, P416, DOI 10.1111/j.1525-139X.2007.00311.x; Fissell RB, 2004, KIDNEY INT, V65, P2335, DOI 10.1111/j.1523-1755.2004.00649.x; Fujiwara K, 2007, HEPATOL RES, V37, P701, DOI 10.1111/j.1872-034X.2007.00117.x; Furusyo N, 2000, DIGEST DIS SCI, V45, P2221, DOI 10.1023/A:1026696721059; Gordon CE, 2008, AM J KIDNEY DIS, V52, P811, DOI 10.1053/j.ajkd.2008.08.005; Gordon CE, 2008, AM J KIDNEY DIS, V51, P263, DOI 10.1053/j.ajkd.2007.11.003; HURAIB S, 1995, NEPHROL DIAL TRANSPL, V10, P470, DOI 10.1093/ndt/10.4.470; Kalantar-Zadeh K, 2007, J AM SOC NEPHROL, V18, P1584, DOI 10.1681/ASN.2006070736; Kaneko S, 2010, HEPATOL RES, V40, P1072, DOI 10.1111/j.1872-034X.2010.00708.x; Knoll GA, 1997, AM J KIDNEY DIS, V29, P608, DOI 10.1016/S0272-6386(97)90345-0; Kondo Y, 2012, THER APHER DIAL, V16, P478, DOI 10.1111/j.1744-9987.2012.01113.x; Kondo Y, 2011, HEPATOL RES, V41, P1153, DOI 10.1111/j.1872-034X.2011.00878.x; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Levent F, 2011, HEPATOL RES, V41, P197, DOI 10.1111/j.1872-034X.2010.00759.x; Libetta C, 2010, NEPHROL DIAL TRANSPL, V25, P1723, DOI 10.1093/ndt/gfq055; Lim WH, 2007, KIDNEY INT, V72, P1138, DOI 10.1038/sj.ki.5002425; Meijers RWJ, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-19; Meyers CM, 2003, AM J KIDNEY DIS, V42, P631, DOI 10.1016/S0272-6386(03)00828-X; Okuda K, 2004, WORLD J GASTROENTERO, V10, P2209; Perico N, 2009, CLIN J AM SOC NEPHRO, V4, P207, DOI 10.2215/CJN.03710708; Perrella A, 2006, GUT, V55, P1370, DOI 10.1136/gut.2006.099887; Pol S, 2002, SEMIN NEPHROL, V22, P331, DOI 10.1053/snep.2002.33674; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Saison J, 2013, CYTOM PART B-CLIN CY, V84B, P50, DOI 10.1002/cyto.b.21047; Su YY, 2013, J MED VIROL, V85, P425, DOI 10.1002/jmv.23486; Takada Y, 2008, LIVER TRANSPLANT, V14, P1044, DOI 10.1002/lt.21441; Tang Sydney, 2005, Hemodial Int, V9, P169, DOI 10.1111/j.1492-7535.2005.01129.x; Tseng CTK, 2002, J EXP MED, V195, P43, DOI 10.1084/jem.20011145; Vacher-Coponat H, 2008, NEPHROL DIAL TRANSPL, V23, P1406, DOI 10.1093/ndt/gfm596	37	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82524	10.1371/journal.pone.0082524	http://dx.doi.org/10.1371/journal.pone.0082524			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358197	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700076
J	Ding, AP; Zhao, WW; Shi, XL; Yao, RY; Zhou, F; Yue, L; Liu, SH; Qiu, WS				Ding, Aiping; Zhao, Wenwen; Shi, Xiaoli; Yao, Ruyong; Zhou, Fang; Yue, Lu; Liu, Shihai; Qiu, Wensheng			Impact of NPM, TFF3 and TACC1 on the Prognosis of Patients with Primary Gastric Cancer	PLOS ONE			English	Article							TREFOIL FACTOR; BREAST-CANCER; TRANSCRIPTIONAL ACTIVITY; THERAPEUTIC TARGET; COILED-COIL; NUCLEOPHOSMIN; PROTEIN; CELLS; FAMILY; GENE	Background: NPM, TFF3 and TACC1 are molecular markers that play important roles in cell differentiation. Herein, we investigated their prognostic impact in patients with primary gastric cancer (GC) and determined whether they could be used as markers of more aggressive gastric carcinomas by detecting the extent of expression in human gastric carcinoma samples. Methodology/Principal Findings: Tumor tissue specimens from 142 GC patients were retrospectively retrieved and immunohistochemically evaluated. Correlations between NPM, TFF3 and TACC1 over-expression and clincopathologic parameters, and their prognostic values were investigated with x 2, Kaplan-Meier method, and Cox uni- and multivariate survival models. NPM, TFF3 and TACC1 expression was significantly higher in GC patients with poorly differentiated histologic type than that in patients with well differentiated histologic type. NPM expression was significantly higher in patients with hepatic metastasis or recurrence than that in patients without metastasis. TFF3 expression was significantly higher in patients with positive lymph node metastasis than that in patients with negative lymph node metastasis. Age, lymph node metastasis, and TFF3 and TACC1 over-expression were significantly correlated with low survival (P<0.05, P<0.05, P = 0.005 and P = 0.009, respectively). Multivariate analysis showed that lymph node metastasis and TFF3 and TACC1 over-expression were independent prognostic factors. Conclusions: TFF3 and TACC1 over-expression in epithelial cells of surgically resected GC tissues was an independent predictor of short survival in GC patients. The prognosis was poorer in patients with positive expression of both TFF3 and TACC1 than that in patients with positive expression of TFF3 or TACC1 alone, or with negative expression of TFF3 and TACC1.	[Ding, Aiping; Zhao, Wenwen; Shi, Xiaoli; Zhou, Fang; Yue, Lu; Qiu, Wensheng] Qingdao Univ, Dept Oncol, Affiliated Hosp, Sch Med, Qingdao 266071, Peoples R China; [Yao, Ruyong; Liu, Shihai] Qingdao Univ, Cent Lab, Affiliated Hosp, Sch Med, Qingdao 266071, Peoples R China; [Zhao, Wenwen] Qingdao Canc Hosp, Qingdao, Shandong, Peoples R China	Qingdao University; Qingdao University	Qiu, WS (corresponding author), Qingdao Univ, Dept Oncol, Affiliated Hosp, Sch Med, Qingdao 266071, Peoples R China.	qiuwenshengqd@163.com			Shandong Natural Science Foundation [2009HW024]; Shandong Excellent Young Scientist Research Award Fund Project [2006BSB14114, BS2010YY013]; Shandong Tackle Key Problems in Science and Technology [2010GSF10245, Y2006C23]	Shandong Natural Science Foundation(Natural Science Foundation of Shandong Province); Shandong Excellent Young Scientist Research Award Fund Project; Shandong Tackle Key Problems in Science and Technology	This study is supported by Shandong Natural Science Foundation (2009HW024); Shandong Excellent Young Scientist Research Award Fund Project (2006BSB14114; BS2010YY013). Shandong Tackle Key Problems in Science and Technology (2010GSF10245; Y2006C23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ARH, 2012, AM J PATHOL, V180, P904, DOI 10.1016/j.ajpath.2011.11.022; Bhat UG, 2011, J BIOL CHEM, V286, P41425, DOI 10.1074/jbc.M111.270843; Bignotti E, 2008, BRIT J CANCER, V99, P768, DOI 10.1038/sj.bjc.6604546; Casado E, 2012, INT J RADIAT ONCOL, V84, P1151, DOI 10.1016/j.ijrobp.2012.01.083; Chao A, 2013, J MOL MED, V91, P249, DOI 10.1007/s00109-012-0950-8; Chen HM, 2000, MOL BIOL CELL, V11, P1357, DOI 10.1091/mbc.11.4.1357; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Conte N, 2003, ONCOGENE, V22, P8102, DOI 10.1038/sj.onc.1206972; Cully M, 2005, CANCER RES, V65, P10363, DOI 10.1158/0008-5472.CAN-05-1633; de Martel C, 2013, GASTROENTEROL CLIN N, V42, P219, DOI 10.1016/j.gtc.2013.01.003; Gjerset RA, 2006, J MOL HISTOL, V37, P239, DOI 10.1007/s10735-006-9040-y; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hiscox JA, 2002, ARCH VIROL, V147, P1077, DOI 10.1007/s00705-001-0792-0; Hoffmann W, 2005, CELL MOL LIFE SCI, V62, P2932, DOI 10.1007/s00018-005-5481-9; Hoffmann W, 2001, HISTOL HISTOPATHOL, V16, P319, DOI 10.14670/HH-16.319; Hosogi H, 2012, J GASTRIC CANCER, V12, P133, DOI 10.5230/jgc.2012.12.3.133; Jian Y, 2009, ONCOGENE, V28, P4201, DOI 10.1038/onc.2009.275; Kong H, 2012, J GASTRIC CANCER, V12, P194, DOI 10.5230/jgc.2012.12.3.194; Lauffart Brenda, 2005, BMC Womens Health, V5, P8, DOI 10.1186/1472-6874-5-8; Leotoing L, 2008, ONCOGENE, V27, P2858, DOI 10.1038/sj.onc.1210942; Line A, 2002, CANCER GENET CYTOGEN, V139, P78, DOI 10.1016/S0165-4608(02)00607-6; Liu D, 1997, LAB INVEST, V77, P557; Muenphon K, 2006, WORLD J GASTROENTERO, V12, P4143, DOI 10.3748/wjg.v12.i26.4143; Park KS, 2009, CANCER LETT, V274, P201, DOI 10.1016/j.canlet.2008.09.007; Sadek CM, 2000, MECH DEVELOP, V97, P13, DOI 10.1016/S0925-4773(00)00415-9; Still IH, 1999, ONCOGENE, V18, P4032, DOI 10.1038/sj.onc.1202801; Still IH, 1999, GENOMICS, V58, P165, DOI 10.1006/geno.1999.5829; Takemura M, 1999, J BIOCHEM-TOKYO, V125, P904, DOI 10.1093/oxfordjournals.jbchem.a022367; Tsui KH, 2008, ACTA PHARMACOL SIN, V29, P364, DOI 10.1111/j.1745-7254.2008.00747.x	30	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82136	10.1371/journal.pone.0082136	http://dx.doi.org/10.1371/journal.pone.0082136			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358147	Green Submitted, gold, Green Published			2022-12-27	WOS:000328735700037
J	El Meouche, I; Peltier, J; Monot, M; Soutourina, O; Pestel-Caron, M; Dupuy, B; Pons, JL				El Meouche, Imane; Peltier, Johann; Monot, Marc; Soutourina, Olga; Pestel-Caron, Martine; Dupuy, Bruno; Pons, Jean-Louis			Characterization of the SigD Regulon of C. difficile and Its Positive Control of Toxin Production through the Regulation of tcdR	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE; BACILLUS-SUBTILIS; GENE-EXPRESSION; SALMONELLA-TYPHIMURIUM; FLAGELLAR REGULON; RNA-POLYMERASE; MOTILITY; TRANSCRIPTION; OPERON; SPORULATION	Clostridium difficile intestinal disease is mediated largely by the actions of toxins A (TcdA) and B (TcdB), whose production occurs after the initial steps of colonization involving different surface or flagellar proteins. In B. subtilis, the sigma factor SigD controls flagellar synthesis, motility, and vegetative autolysins. A homolog of SigD encoding gene is present in the C. difficile 630 genome. We constructed a sigD mutant in C. difficile 630.erm to analyze the regulon of SigD using a global transcriptomic approach. A total of 103 genes were differentially expressed between the wild- type and the sigD mutant, including genes involved in motility, metabolism and regulation. In addition, the sigD mutant displayed decreased expression of genes involved in flagellar biosynthesis, and also of genes encoding TcdA and TcdB as well as TcdR, the positive regulator of the toxins. Genomic analysis and RACE- PCR experiments allowed us to characterize promoter sequences of direct target genes of SigD including tcdR and to identify the SigD consensus. We then established that SigD positively regulates toxin expression via direct control of tcdR transcription. Interestingly, the overexpression of FlgM, a putative anti- SigD factor, inhibited the positive regulation of motility and toxin synthesis by SigD. Thus, SigD appears to be the first positive regulator of the toxin synthesis in C. difficile.	[El Meouche, Imane; Peltier, Johann; Pestel-Caron, Martine; Pons, Jean-Louis] Univ Rouen, Lab GRM EA IFR IHURBM 2656 23, Rouen, France; [Monot, Marc; Soutourina, Olga; Dupuy, Bruno] Inst Pasteur, Lab Pathogenese Bacteries Anaerobies, Paris, France; [Soutourina, Olga] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Pons, Jean-Louis] Univ Paris 05, Lab Ecosyst Intestinal, Antibiot EA 4065, IFR IMTCE, Paris, France	Universite de Rouen Normandie; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Peltier, J (corresponding author), Univ Rouen, Lab GRM EA IFR IHURBM 2656 23, Rouen, France.	j.peltier@imperial.ac.uk	Monot, Marc/F-3058-2015; Soutourina, Olga/F-2042-2015; Peltier, Johann/Q-2001-2017	Monot, Marc/0000-0003-0738-7335; Peltier, Johann/0000-0003-3207-9465; Soutourina, Olga/0000-0001-6439-7228; El Meouche, Imane/0000-0002-0886-6752	University of Rouen	University of Rouen	Funding was provided by the University of Rouen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmansberger R, 1997, J BACTERIOL, V179, P6531, DOI 10.1128/jb.179.20.6531-6535.1997; Andre G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-234; Antunes A, 2012, NUCLEIC ACIDS RES, V40, P10701, DOI 10.1093/nar/gks864; Antunes A, 2011, MOL MICROBIOL, V79, P882, DOI 10.1111/j.1365-2958.2010.07495.x; Aubry A, 2012, INFECT IMMUN, V80, P3521, DOI 10.1128/IAI.00224-12; Bakker D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043247; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Brunskill EW, 1996, J BACTERIOL, V178, P5810, DOI 10.1128/jb.178.19.5810-5812.1996; Caramori T, 1996, J BACTERIOL, V178, P3113, DOI 10.1128/jb.178.11.3113-3118.1996; Carter GP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002317; Chen R, 2009, J BACTERIOL, V191, P5775, DOI 10.1128/JB.00521-09; CHEN YF, 1992, P NATL ACAD SCI USA, V89, P5123, DOI 10.1073/pnas.89.11.5123; Courtney CR, 2012, J BACTERIOL, V194, P4619, DOI 10.1128/JB.00444-12; Cozy LM, 2010, MOL MICROBIOL, V76, P273, DOI 10.1111/j.1365-2958.2010.07112.x; Dineen SS, 2007, MOL MICROBIOL, V66, P206, DOI 10.1111/j.1365-2958.2007.05906.x; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; Estacio W, 1998, J BACTERIOL, V180, P3548, DOI 10.1128/JB.180.14.3548-3555.1998; Fagan RP, 2011, J BIOL CHEM, V286, P27483, DOI 10.1074/jbc.M111.263889; Fimlaid KA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003660; Fujita M, 2000, GENES CELLS, V5, P79, DOI 10.1046/j.1365-2443.2000.00307.x; GAUR NK, 1986, J BACTERIOL, V168, P860, DOI 10.1128/jb.168.2.860-869.1986; Govind R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002727; Guttenplan SB, 2013, MOL MICROBIOL, V87, P211, DOI 10.1111/mmi.12103; HALDENWANG WG, 1995, MICROBIOL REV, V59, P1; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; HELMANN JD, 1988, J BACTERIOL, V170, P1568, DOI 10.1128/jb.170.4.1568-1574.1988; Hundsberger T, 1997, EUR J BIOCHEM, V244, P735, DOI 10.1111/j.1432-1033.1997.t01-1-00735.x; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Iyoda S, 1995, MOL GEN GENET, V249, P417; Johnson S, 1998, CLIN INFECT DIS, V26, P1027, DOI 10.1086/520276; Karlinsey JE, 2000, MOL MICROBIOL, V37, P1220, DOI 10.1046/j.1365-2958.2000.02081.x; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; KURODA A, 1993, J BACTERIOL, V175, P795, DOI 10.1128/JB.175.3.795-801.1993; Layec S, 2008, RES MICROBIOL, V159, P507, DOI 10.1016/j.resmic.2008.06.008; Mani N, 2001, P NATL ACAD SCI USA, V98, P5844, DOI 10.1073/pnas.101126598; MARQUEZ LM, 1990, J BACTERIOL, V172, P3435, DOI 10.1128/jb.172.6.3435-3443.1990; Matamouros S, 2007, MOL MICROBIOL, V64, P1274, DOI 10.1111/j.1365-2958.2007.05739.x; MCKEE RW, 2013, J BACTERIOL, P13934; MIREL DB, 1989, J BACTERIOL, V171, P3095, DOI 10.1128/jb.171.6.3095-3101.1989; MIREL DB, 1992, J BACTERIOL, V174, P4197, DOI 10.1128/JB.174.13.4197-4204.1992; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; OHNISHI K, 1990, MOL GEN GENET, V221, P139, DOI 10.1007/BF00261713; OHNISHI K, 1992, MOL MICROBIOL, V6, P3149, DOI 10.1111/j.1365-2958.1992.tb01771.x; Olling A, 2012, MICROB PATHOGENESIS, V52, P92, DOI 10.1016/j.micpath.2011.10.009; Purcell EB, 2012, J BACTERIOL, V194, P3307, DOI 10.1128/JB.00100-12; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rosenbusch KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048608; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Roure S, 2012, MOL MICROBIOL, V86, P845, DOI 10.1111/mmi.12019; Saujet L, 2011, J BACTERIOL, V193, P3186, DOI 10.1128/JB.00272-11; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Sebaihia M, 2006, NAT REV MICROBIOL, V4, P882, DOI 10.1038/nrmicro1571; Serizawa M, 2004, GENE, V329, P125, DOI 10.1016/j.gene.2003.12.024; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001; TRIEUCUOT P, 1987, MICROBIOL SCI, V4, P263; Tulli L, 2013, CELL MICROBIOL, V15, P1674, DOI 10.1111/cmi.12139; Twine SM, 2009, J BACTERIOL, V191, P7050, DOI 10.1128/JB.00861-09; Underwood S, 2009, J BACTERIOL, V191, P7296, DOI 10.1128/JB.00882-09; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Walters Julian R F, 2010, Therap Adv Gastroenterol, V3, P349, DOI 10.1177/1756283X10377126; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; West JT, 2000, J BACTERIOL, V182, P4841, DOI 10.1128/JB.182.17.4841-4848.2000	67	70	71	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83748	10.1371/journal.pone.0083748	http://dx.doi.org/10.1371/journal.pone.0083748			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358307	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700136
J	Enck, P; Hefner, J; Herbert, BM; Mazurak, N; Weimer, K; Muth, ER; Zipfel, S; Martens, U				Enck, Paul; Hefner, Jochen; Herbert, Beate M.; Mazurak, Nazar; Weimer, Katja; Muth, Eric R.; Zipfel, Stephan; Martens, Ute			Sensitivity and Specificity of Hypnosis Effects on Gastric Myoelectrical Activity	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; GUT-DIRECTED HYPNOTHERAPY; FUNCTIONAL ABDOMINAL-PAIN; WATER LOAD TEST; COGNITIVE HYPNOTHERAPY; RECTAL SENSITIVITY; SPECTRAL-ANALYSIS; MECHANISM; MOTOR; SECRETION	Objectives: The effects of hypnosis on physiological (gastrointestinal) functions are incompletely understood, and it is unknown whether they are hypnosis-specific and gut-specific, or simply unspecific effects of relaxation. Design: Sixty-two healthy female volunteers were randomly assigned to either a single session of hypnotic suggestion of ingesting an appetizing meal and an unappetizing meal, or to relax and concentrate on having an appetizing or unappetizing meal, while the electrogastrogram (EGG) was recorded. At the end of the session, participants drank water until they felt full, in order to detect EGG-signal changes after ingestion of a true gastric load. During both conditions participants reported their subjective well-being, hunger and disgust at several time points. Results: Imagining eating food induced subjective feelings of hunger and disgust as well as changes in the EGG similar to, but more pronounced than those seen with a real gastric water load during both hypnosis and relaxation conditions. These effects were more pronounced when imagining an appetizing meal than with an unappetizing meal. There was no significant difference between the hypnosis and relaxation conditions. Conclusion: Imagination with and without hypnosis exhibits similar changes in subjective and objective measures in response to imagining an appetizing and an unappetizing food, indicating high sensitivity but low specificity.	[Enck, Paul; Weimer, Katja; Zipfel, Stephan; Martens, Ute] Univ Hosp, Dept Psychosomat Med, Tubingen, Germany; [Hefner, Jochen] Univ Hosp, Dept Internal Med 2, Wurzburg, Germany; [Herbert, Beate M.] Univ Ulm, Dept Hlth Psychol, Inst Psychol & Educ, D-89069 Ulm, Germany; [Mazurak, Nazar] Ivano Frankivsk Natl Med Univ, Cent Res Dept, Ivano Frankivsk, Ukraine; [Muth, Eric R.] Clemson Univ, Dept Psychol, Clemson, SC 29634 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Wurzburg; Ulm University; Ivano-Frankivsk National Medical University; Clemson University	Enck, P (corresponding author), Univ Hosp, Dept Psychosomat Med, Tubingen, Germany.	paul.enck@uni-tuebingen.de	Herbert, Beate/L-5036-2015	Zipfel, Stephan/0000-0003-1659-4440; Weimer, Katja/0000-0001-8656-607X; Herbert, Beate/0000-0002-3284-4529	Deutsche Forschungsgemeinschaft; Tuebingen University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University	We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University to the production costs of this paper. The study was supported by intramural (departmental) funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alladin A, 2012, AM J CLIN HYPN, V54, P275, DOI 10.1080/00029157.2012.654527; Askay Shelley Wiechman, 2009, Contemp Hypn, V26, P40; Aubert AE, 2009, NEUROPSYCHOBIOLOGY, V60, P104, DOI 10.1159/000239686; BONGARTZ W, 1985, INT J CLIN EXP HYP, V33, P131, DOI 10.1080/00207148508406643; Calvert EL, 2002, GASTROENTEROLOGY, V123, P1778, DOI 10.1053/gast.2002.37071; Chen Chien-Lin, 2006, Journal of Smooth Muscle Research, V42, P149, DOI 10.1540/jsmr.42.149; Chiarioni G, 2006, ALIMENT PHARM THER, V23, P1241, DOI 10.1111/j.1365-2036.2006.02881.x; Elkins G, 2012, AM J CLIN HYPN, V54, P294, DOI 10.1080/00029157.2011.654284; Enck P, 2010, EUR J GASTROEN HEPAT, V22, P1402, DOI 10.1097/MEG.0b013e3283405a17; FANDRIKS L, 1995, SCAND J GASTROENTERO, V30, P657, DOI 10.3109/00365529509096309; FISCHER U, 1976, EUR J CLIN INVEST, V6, P465, DOI 10.1111/j.1365-2362.1976.tb00544.x; Forbes A, 2000, INT J COLORECTAL DIS, V15, P328, DOI 10.1007/s003840000248; Ghoneim MM, 2000, ANESTH ANALG, V90, P64, DOI 10.1097/00000539-200001000-00016; Golden WL, 2012, AM J CLIN HYPN, V54, P263, DOI 10.1080/00029157.2011.650333; Gonsalkorale WM, 2006, INT J CLIN EXP HYP, V54, P27, DOI 10.1080/00207140500323030; Gonsalkorale WM, 2004, J PSYCHOSOM RES, V56, P271, DOI 10.1016/S0022-3999(03)00076-X; Goodwin L, 2013, PSYCHOSOM MED, V75, P202, DOI 10.1097/PSY.0b013e31827c351b; HALL WH, 1967, J PSYCHOSOM RES, V11, P263, DOI 10.1016/0022-3999(67)90019-0; HARVEY RF, 1989, LANCET, V1, P424; Hefner J, 2009, Z GASTROENTEROL, V47, P1153, DOI 10.1055/s-0028-1109697; Herbert BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036646; JANOWITZ HD, 1950, GASTROENTEROLOGY, V16, P104, DOI 10.1016/S0016-5085(19)36597-7; KATSCHINSKI M, 1992, GASTROENTEROLOGY, V103, P383, DOI 10.1016/0016-5085(92)90825-J; Keefer L, 2013, ALIMENT PHARM THER, V38, P761, DOI 10.1111/apt.12449; Kim DY, 2000, AM J GASTROENTEROL, V95, P3365; Kobayashi Yuka, 1997, Journal of Smooth Muscle Research, V33, P203; Koch KL, 2000, J CLIN GASTROENTEROL, V31, P125, DOI 10.1097/00004836-200009000-00007; Kong J, 2009, NEUROIMAGE, V45, P940, DOI 10.1016/j.neuroimage.2008.12.025; Lea R, 2003, ALIMENT PHARM THER, V17, P635, DOI 10.1046/j.1365-2036.2003.01486.x; Lowen MBO, 2013, ALIMENT PHARM THER, V37, P1184, DOI 10.1111/apt.12319; Mawdsley JE, 2008, AM J GASTROENTEROL, V103, P1460, DOI 10.1111/j.1572-0241.2008.01845.x; Meissner K, 2011, BIOL PSYCHOL, V86, P9, DOI 10.1016/j.biopsycho.2010.09.014; Muth ER, 1998, BIOL PSYCHOL, V47, P265, DOI 10.1016/S0301-0511(97)00030-6; Muth ER, 2007, AVIAT SPACE ENVIR MD, V78, P686; NADON R, 1987, J PERS SOC PSYCHOL, V53, P948; NOVIS BH, 1971, SCAND J GASTROENTERO, V6, P417, DOI 10.3109/00365527109180719; Palsson OS, 2006, INT J CLIN EXP HYP, V54, P51, DOI 10.1080/00207140500322933; Palsson OS, 2002, DIGEST DIS SCI, V47, P2605, DOI 10.1023/A:1020545017390; Pavlov I. P., 1910, WORK DIGESTIVE GLAND; PRIOR A, 1990, GUT, V31, P896, DOI 10.1136/gut.31.8.896; Raz A, 2011, TRENDS COGN SCI, V15, P555, DOI 10.1016/j.tics.2011.10.002; Revenstorf D, 2001, HYPNOSIS PSYCHOTHERA; Riezzo G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/282757; SCHILLER LR, 1980, GASTROENTEROLOGY, V78, P1472; SCHNECK J M, 1961, J Hist Med Allied Sci, V16, P297; Sebastiani L, 2007, INT J PSYCHOPHYSIOL, V63, P125, DOI 10.1016/j.ijpsycho.2006.10.001; Simren M, 2006, INT J CLIN EXP HYP, V54, P65, DOI 10.1080/00207140500327239; Simren M, 2004, PSYCHOSOM MED, V66, P233, DOI 10.1097/01.psy.0000116964.76529.6e; STERN RM, 1989, DIGEST DIS SCI, V34, P521, DOI 10.1007/BF01536327; Stern RM, 2001, NEUROGASTROENT MOTIL, V13, P151, DOI 10.1046/j.1365-2982.2001.00250.x; Stern RM, 1987, GASTROENTEROLOGY, V92, P92, DOI 10.1016/0016-5085(87)90843-2; Taggart P, 2005, PSYCHOSOM MED, V67, P376, DOI 10.1097/01.psy.0000160463.10583.88; Tan G, 2005, AM J CLIN HYPN, V47, P161, DOI 10.1080/00029157.2005.10401481; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; Vlieger AM, 2010, AM J GASTROENTEROL, V105, P213, DOI 10.1038/ajg.2009.613; Vlieger AM, 2012, AM J GASTROENTEROL, V107, P627, DOI 10.1038/ajg.2011.487; Weimer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049031; WHORWELL PJ, 1984, LANCET, V2, P1232, DOI 10.1016/S0140-6736(84)92793-4; WHORWELL PJ, 1992, LANCET, V340, P69, DOI 10.1016/0140-6736(92)90394-I; Wolf S.G., 1943, HUMAN GASTRIC FUNCTI; Zhou RL, 2006, PERCEPT MOTOR SKILL, V103, P829, DOI 10.2466/PMS.103.3.829-833; Zhou RL, 2004, PERCEPT MOTOR SKILL, V99, P785	62	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83486	10.1371/journal.pone.0083486	http://dx.doi.org/10.1371/journal.pone.0083486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358287	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700126
J	Pippucci, T; Parmeggiani, A; Palombo, F; Maresca, A; Angius, A; Crisponi, L; Cucca, F; Liguori, R; Valentino, ML; Seri, M; Carelli, V				Pippucci, Tommaso; Parmeggiani, Antonia; Palombo, Flavia; Maresca, Alessandra; Angius, Andrea; Crisponi, Laura; Cucca, Francesco; Liguori, Rocco; Valentino, Maria Lucia; Seri, Marco; Carelli, Valerio			A Novel Null Homozygous Mutation Confirms CACNA2D2 as a Gene Mutated in Epileptic Encephalopathy	PLOS ONE			English	Article							CHANNEL FUNCTION; PROTEIN; EXPRESSION; SEQUENCE; PRINCIPLE; BINDING; CELSR3; ATAXIA; DNA	Contribution to epileptic encephalopathy (EE) of mutations in CACNA2D2, encoding alpha 2 delta-2 subunit of Voltage Dependent Calcium Channels, is unclear. To date only one CACNA2D2 mutation altering channel functionality has been identified in a single family. In the same family, a rare CELSR3 polymorphism also segregated with disease. Involvement of CACNA2D2 in EE is therefore not confirmed, while that of CELSR3 is questionable. In a patient with epilepsy, dyskinesia, cerebellar atrophy, psychomotor delay and dysmorphic features, offspring to consanguineous parents, we performed whole exome sequencing (WES) for homozygosity mapping and mutation detection. WES identified extended autozygosity on chromosome 3, containing two novel homozygous candidate mutations: c.1295delA (p.Asn432fs) in CACNA2D2 and c.G6407A (p.Gly2136Asp) in CELSR3. Gene prioritization pointed to CACNA2D2 as the most prominent candidate gene. The WES finding in CACNA2D2 resulted to be statistically significant (p = 0.032), unlike that in CELSR3. CACNA2D2 homozygous c.1295delA essentially abolished alpha 2 delta-2 expression. In summary, we identified a novel null CACNA2D2 mutation associated to a clinical phenotype strikingly similar to the Cacna2d2 null mouse model. Molecular and statistical analyses together argued in favor of a causal contribution of CACNA2D2 mutations to EE, while suggested that finding in CELSR3, although potentially damaging, is likely incidental.	[Pippucci, Tommaso; Palombo, Flavia; Seri, Marco] Univ Bologna, UO Genet Med, Policlin St Orsola Malpighi, Bologna, Italy; [Parmeggiani, Antonia; Maresca, Alessandra; Liguori, Rocco; Valentino, Maria Lucia; Carelli, Valerio] IRCCS Ist Sci Neurol Bologna, Bologna, Italy; [Parmeggiani, Antonia; Seri, Marco] Univ Bologna, Dipartimento Sci Med Chirurg, Bologna, Italy; [Maresca, Alessandra; Liguori, Rocco; Valentino, Maria Lucia; Carelli, Valerio] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie DIBINEM, Bologna, Italy; [Angius, Andrea; Crisponi, Laura; Cucca, Francesco] CNR, Ist Ric Genet & Biomed, Cagliari, Italy; [Angius, Andrea] AGCT Program, Ctr Adv Studies Res & Dev Sardinia CRS4, Pula, Italy; [Cucca, Francesco] Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Sassari	Seri, M (corresponding author), Univ Bologna, UO Genet Med, Policlin St Orsola Malpighi, Bologna, Italy.	marco.seri@unibo.it	Maresca, Alessandra/J-7393-2016; Palombo, Flavia/GXV-7458-2022; Crisponi, Laura/AAC-2642-2019; Angius, Andrea/P-9549-2015; Liguori, Rocco/AAB-7860-2020; PALOMBO, FLAVIA/N-5208-2019; Angius, Andrea/B-8966-2015; Pippucci, Tommaso/M-8124-2019; Seri, Marco/A-4339-2014	Maresca, Alessandra/0000-0002-8959-8832; Crisponi, Laura/0000-0001-9128-8537; Angius, Andrea/0000-0003-2596-6461; PALOMBO, FLAVIA/0000-0002-1639-3764; PARMEGGIANI, ANTONIA/0000-0002-6849-0830; Angius, Andrea/0000-0001-9372-1162; Liguori, Rocco/0000-0002-1815-1013; CUCCA, Francesco/0000-0002-7414-1995; CARELLI, VALERIO/0000-0003-4923-6404; VALENTINO, MARIA LUCIA/0000-0001-5323-0115; Seri, Marco/0000-0003-2425-2176	Italian Ministry of Health, Young Investigators Award [GR-2009-1574072]	Italian Ministry of Health, Young Investigators Award	This work was funded by the Italian Ministry of Health, Young Investigators Award, Project GR-2009-1574072. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Asher YJT, 2012, EUR J MED GENET, V55, P299, DOI 10.1016/j.ejmg.2012.04.002; Barclay J, 2001, J NEUROSCI, V21, P6095, DOI 10.1523/JNEUROSCI.21-16-06095.2001; Bidaud I, 2006, BBA-MOL CELL RES, V1763, P1169, DOI 10.1016/j.bbamcr.2006.08.049; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodbeck J, 2002, J BIOL CHEM, V277, P7684, DOI 10.1074/jbc.M109404200; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dubowitz V., 2007, MUSCLE BIOPSY PRACTI; Edvardson S, 2013, J MED GENET, V50, P118, DOI 10.1136/jmedgenet-2012-101223; Gao BN, 2000, J BIOL CHEM, V275, P12237, DOI 10.1074/jbc.275.16.12237; Gong HC, 2001, J MEMBRANE BIOL, V184, P35, DOI 10.1007/s00232-001-0072-7; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Imbrici P, 2004, BRAIN, V127, P2682, DOI 10.1093/brain/awh301; Kullmann DM, 2010, J PHYSIOL-LONDON, V588, P1823, DOI 10.1113/jphysiol.2010.190652; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Pennisi E, 2012, SCIENCE, V337, P1159, DOI 10.1126/science.337.6099.1159; Pippucci T, 2011, HUM HERED, V72, P45, DOI 10.1159/000330164; Robinson PN, 2014, GENOME RES, V24, P340, DOI 10.1101/gr.160325.113; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Smedley D, 2013, DATABASE, V9; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Zhi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031358; Zhou LB, 2008, SCIENCE, V320, P946, DOI 10.1126/science.1155244	30	54	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82154	10.1371/journal.pone.0082154	http://dx.doi.org/10.1371/journal.pone.0082154			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358150	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700039
J	Sallee, M; Fontes, M; Louis, L; Cerini, C; Brunet, P; Burtey, S				Sallee, Marion; Fontes, Michel; Louis, Laurence; Cerini, Claire; Brunet, Philippe; Burtey, Stephane			Alternative Splicing Events Is Not a Key Event for Gene Expression Regulation in Uremia	PLOS ONE			English	Article							MESSENGER-RNA; DISEASE; PROFILE; CELLS; ASSOCIATION; FIBROBLASTS; MICROARRAY; CANCER; RISK	Background: The control of gene expression in the course of chronic kidney disease (CKD) is not well addressed. Alternative splicing is a common way to increase complexity of proteins. More than 90% of human transcripts are alternatively spliced. We hypothesised that CKD can induce modification of the alternative splicing machinery. Methods: During mutation screening in autosomal dominant polycystic kidney disease, we identified in mononuclear cells (PBMC), an alternative splicing event on the exon 30 of PKD1 gene, the gene implicated in this disease. This alternative splice variant was not correlated with the cystic disease but with CKD. To confirm the association between this variant and CKD, a monocentric clinical study was performed with 3 different groups according to their kidney function (CKD5D, CKD3-5 and normal kidney function). An exon microarray approach was used to highlight splicing events in whole human genome in a normal cell model (fibroblasts) incubated with uremic serum. Alternative splicing variants identified were confirmed by RTPCR. Results: The splicing variant of the exon 30 of PKD1 was more frequent in PBMCs from patients with CKD compared to control. With the microarray approach, despite the analysis of more than 230 000 probes, we identified 36 genes with an abnormal splicing index evocating splicing event in fibroblasts exposed to uremic serum. Only one abnormal splicing event in one gene, ADH1B, was confirmed by RT-PCR. Conclusion: We observed two alternative spliced genes in two different cell types associated with CKD. Alternative splicing could play a role in the control of gene expression during CKD but it does not seem to be a major mechanism.	[Sallee, Marion; Cerini, Claire; Brunet, Philippe; Burtey, Stephane] Aix Marseille Univ, INSERM, UMR S 1076, UFR Pharm, Marseille, France; [Sallee, Marion; Brunet, Philippe; Burtey, Stephane] Hop Conception, Assistance Publ Hop Marseille, Ctr Nephrol & Transplantat Renale, Marseille, France; [Fontes, Michel] Aix Marseille Univ, INSERM, UMR S 1062, UFR Med, Marseille, France; [Louis, Laurence] Aix Marseille Univ, UMR S 910, UFR Med, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Burtey, S (corresponding author), Aix Marseille Univ, INSERM, UMR S 1076, UFR Pharm, Marseille, France.	Stephane.burtey@univ-amu.fr	Burtey, Stéphane/S-2433-2019	Burtey, Stéphane/0000-0003-1813-7884	Aix-Marseille Universite; Fondation du Rein	Aix-Marseille Universite; Fondation du Rein	MS is supported by a PhD grant from Aix-Marseille Universite. This work was supported by Fondation du Rein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUEHLER R, 1982, AM J PATHOL, V108, P89; Burtey S, 2002, J MED GENET, V39, P422, DOI 10.1136/jmg.39.6.422; Freedman BI, 2006, HYPERTENSION, V48, P8, DOI 10.1161/01.HYP.0000227047.26988.3e; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Hendrikx TK, 2009, NEPHROL DIAL TRANSPL, V24, P1969, DOI 10.1093/ndt/gfp005; Ho J, 2008, J AM SOC NEPHROL, V19, P2069, DOI 10.1681/ASN.2008020162; Hori Y, 2007, J PATHOL, V212, P218, DOI 10.1002/path.2176; Ingrosso D, 2003, LANCET, V361, P1693, DOI 10.1016/S0140-6736(03)13372-7; Ishikawa I, 2003, CLIN NEPHROL, V59, P153; Jia CQ, 2007, THROMB RES, V120, P679, DOI 10.1016/j.thromres.2006.12.023; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Konishi T, 2004, ALCOHOL CLIN EXP RES, V28, P1145, DOI 10.1097/01.ALC.0000134231.48395.42; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Nechama M, 2009, J CLIN INVEST, V119, P3102, DOI 10.1172/JCI39522; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Petersen B J, 1980, Adv Exp Med Biol, V132, P533; Rittie L, 2005, METH MOLEC MED, V117, P83; Sciarretta S, 2010, J HYPERTENS, V28, P251, DOI 10.1097/HJH.0b013e3283326718; Shah VO, 2006, AM J KIDNEY DIS, V48, P616, DOI 10.1053/j.ajkd.2006.05.032; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Skjorringe T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018599; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; van der Velde M, 2010, CLIN J AM SOC NEPHRO, V5, P2053, DOI 10.2215/CJN.08851209; Vanholder R, 2005, NEPHROL DIAL TRANSPL, V20, P1048, DOI 10.1093/ndt/gfh813; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ZN, 2003, CANCER RES, V63, P655; Yalcindag C, 1999, J AM SOC NEPHROL, V10, P2562; Zhang XZ, 2012, ONCOL REP, V27, P1258, DOI 10.3892/or.2011.1601; Zhou WY, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-63	30	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82702	10.1371/journal.pone.0082702	http://dx.doi.org/10.1371/journal.pone.0082702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358217	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700090
J	Chan, KYK; Jiang, HS; Padilla, DK				Chan, Kit Yu Karen; Jiang, Houshuo; Padilla, Dianna K.			Swimming Speed of Larval Snail Does Not Correlate with Size and Ciliary Beat Frequency	PLOS ONE			English	Article							GASTROPOD CREPIDULA-FORNICATA; MARINE INVERTEBRATE LARVAE; METAMORPHIC COMPETENCE; DENDRASTER-EXCENTRICUS; FOOD LIMITATION; VELIGER LARVAE; FLOW-FIELDS; LOCOMOTION; EFFICIENCY; GROWTH	Many marine invertebrates have planktonic larvae with cilia used for both propulsion and capturing of food particles. Hence, changes in ciliary activity have implications for larval nutrition and ability to navigate the water column, which in turn affect survival and dispersal. Using high-speed high-resolution microvideography, we examined the relationship between swimming speed, velar arrangements, and ciliary beat frequency of freely swimming veliger larvae of the gastropod Crepidula fornicata over the course of larval development. Average swimming speed was greatest 6 days post hatching, suggesting a reduction in swimming speed towards settlement. At a given age, veliger larvae have highly variable speeds (0.8-4 body lengths s(-1)) that are independent of shell size. Contrary to the hypothesis that an increase in ciliary beat frequency increases work done, and therefore speed, there was no significant correlation between swimming speed and ciliary beat frequency. Instead, there are significant correlations between swimming speed and visible area of the velar lobe, and distance between centroids of velum and larval shell. These observations suggest an alternative hypothesis that, instead of modifying ciliary beat frequency, larval C. fornicata modify swimming through adjustment of velum extension or orientation. The ability to adjust velum position could influence particle capture efficiency and fluid disturbance and help promote survival in the plankton.	[Chan, Kit Yu Karen] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Jiang, Houshuo] Woods Hole Oceanog Inst, Dept Appl Ocean Phys & Engn, Woods Hole, MA 02543 USA; [Padilla, Dianna K.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Chan, KYK (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	kchan@whoi.edu	Jiang, Houshuo/I-1894-2013	Jiang, Houshuo/0000-0002-8175-3500	Postdoctoral Scholar 1 Program at the Woods Hole Oceanographic Institution (WHOI); Coastal Ocean Institute; Croucher Foundation; Royal Swedish Academy of Sciences; National Science Foundation [OCE-1129496]; WHOI's Ocean Life Institute; NSF [IOS-0920032]; Directorate For Geosciences [1129496] Funding Source: National Science Foundation	Postdoctoral Scholar 1 Program at the Woods Hole Oceanographic Institution (WHOI); Coastal Ocean Institute; Croucher Foundation; Royal Swedish Academy of Sciences; National Science Foundation(National Science Foundation (NSF)); WHOI's Ocean Life Institute; NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	K.Y.K. Chan was supported by the Postdoctoral Scholar 1 Program at the Woods Hole Oceanographic Institution (WHOI), with funding provided by the Coastal Ocean Institute, the Croucher Foundation, and the Royal Swedish Academy of Sciences. H. Jiang was supported by National Science Foundation grant NSF OCE-1129496 and an award from WHOI's Ocean Life Institute, and D. K. Padilla was supported by NSF IOS-0920032. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARKETT SA, 1987, BIOL BULL, V173, P513, DOI 10.2307/1541697; BARILE PJ, 1994, J EXP MAR BIOL ECOL, V183, P147; BAYNE BL, 1964, OIKOS, V15, P162, DOI 10.2307/3564753; Braubach OR, 2006, J EXP BIOL, V209, P4676, DOI 10.1242/jeb.02556; Chan KYK, 2012, INTEGR COMP BIOL, V52, P458, DOI 10.1093/icb/ics092; CHIA FS, 1984, CAN J ZOOL, V62, P1205, DOI 10.1139/z84-176; Conzelmann M, 2011, P NATL ACAD SCI USA, V108, pE1174, DOI 10.1073/pnas.1109085108; CRAGG SM, 1980, J MAR BIOL ASSOC UK, V60, P551, DOI 10.1017/S002531540004025X; Dickinson AJG, 1999, ZOOMORPHOLOGY, V119, P49, DOI 10.1007/s004350050080; Dimova S, 2005, J PHARM PHARMACOL, V57, P521, DOI 10.1211/0022357055777; EMLET RB, 1990, MAR ECOL PROG SER, V63, P211, DOI 10.3354/meps063211; EMLET RB, 1994, AM ZOOL, V34, P570; Fenchel T, 2002, OPHELIA, V56, P171, DOI 10.1080/00785236.2002.10409497; GALLAGER SM, 1993, J PLANKTON RES, V15, P1277, DOI 10.1093/plankt/15.11.1277; Grunbaum D, 2003, J MAR RES, V61, P659, DOI 10.1357/002224003771815990; Henry JJ, 2010, BIOL BULL-US, V218, P211, DOI 10.1086/BBLv218n3p211; Hilbish TJ, 1999, J EXP MAR BIOL ECOL, V239, P183, DOI 10.1016/S0022-0981(99)00009-X; Jiang HS, 2011, J R SOC INTERFACE, V8, P1090, DOI 10.1098/rsif.2010.0481; Jiang HS, 2011, J EXP BIOL, V214, P476, DOI 10.1242/jeb.049288; Jiang HS, 1999, J PLANKTON RES, V21, P1391, DOI 10.1093/plankt/21.8.1391; Katsu-Kimura Y, 2009, J EXP BIOL, V212, P1819, DOI 10.1242/jeb.028894; Kiorboe T, 2013, INTEGR COMP BIOL; Kuang SH, 2001, J NEUROBIOL, V47, P1, DOI 10.1002/neu.1011; LIMA GM, 1982, AM ZOOL, V22, P861; MACKIE GO, 1976, BIOL BULL-US, V151, P182, DOI 10.2307/1540713; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Metaxas A, 2001, CAN J FISH AQUAT SCI, V58, P86, DOI 10.1139/cjfas-58-1-86; MILLER SE, 1986, J EXP MAR BIOL ECOL, V97, P95, DOI 10.1016/0022-0981(86)90070-5; OLSON RR, 1989, ANNU REV ECOL SYST, V20, P225; Osterman N, 2011, P NATL ACAD SCI USA, V108, P15727, DOI 10.1073/pnas.1107889108; PECHENIK JA, 1985, AM ZOOL, V25, pA128; PECHENIK JA, 1993, J EXP MAR BIOL ECOL, V167, P59, DOI 10.1016/0022-0981(93)90184-P; Pechenik JA, 1996, MAR BIOL, V127, P267, DOI 10.1007/BF00942112; PODOLSKY RD, 1993, J EXP BIOL, V176, P207; Purcell EM, 1997, P NATL ACAD SCI USA, V94, P11307, DOI 10.1073/pnas.94.21.11307; Romero MR, 2010, BIOL BULL-US, V218, P145, DOI 10.1086/BBLv218n2p145; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; Strathmann RR, 2006, INTEGR COMP BIOL, V46, P312, DOI 10.1093/icb/icj031; STRATHMANN RR, 1979, BIOL BULL, V157, P524, DOI 10.2307/1541035; Vogel S., 1994, LIFE MOVING FLUIDS P; Wendt DE, 2000, BIOL BULL, V198, P346, DOI 10.2307/1542690	42	15	15	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82764	10.1371/journal.pone.0082764	http://dx.doi.org/10.1371/journal.pone.0082764			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367554	Green Submitted, Green Published, gold			2022-12-27	WOS:000328740300067
J	Imamura, M; Kato, N; Okada, H; Yoshioka, M; Iwamaru, Y; Shimizu, Y; Mohri, S; Yokoyama, T; Murayama, Y				Imamura, Morikazu; Kato, Nobuko; Okada, Hiroyuki; Yoshioka, Miyako; Iwamaru, Yoshifumi; Shimizu, Yoshihisa; Mohri, Shirou; Yokoyama, Takashi; Murayama, Yuichi			Insect Cell-Derived Cofactors Become Fully Functional after Proteinase K and Heat Treatment for High-Fidelity Amplification of Glycosylphosphatidylinositol-Anchored Recombinant Scrapie and BSE Prion Proteins	PLOS ONE			English	Article							IN-VITRO; PRESYMPTOMATIC DETECTION; CYCLIC AMPLIFICATION; SURFACE RETENTION; INFECTIOUS PRIONS; PRPSC; AGGREGATION; REPLICATION; PROPAGATION; ABSENCE	The central event in prion infection is the conformational conversion of host-encoded cellular prion protein (PrPC) into the pathogenic isoform (PrPSc). Diverse mammalian species possess the cofactors required for in vitro replication of PrPSc by protein-misfolding cyclic amplification (PMCA), but lower organisms, such as bacteria, yeasts, and insects, reportedly lack the essential cofactors. Various cellular components, such as RNA, lipids, and other identified cofactor molecules, are commonly distributed in both eukaryotes and prokaryotes, but the reasons for the absence of cofactor activity in lower organisms remain to be elucidated. Previously, we reported that brain-derived factors were necessary for the in vitro replication of glycosylphosphatidylinositol-anchored baculovirus-derived recombinant PrP (Bac-PrP). Here, we demonstrate that following protease digestion and heat treatment, insect cell lysates had the functional cofactor activity required for Bac-PrP replication by PMCA. Mammalian PrPSc seeds and Bac-PrPSc generated by PMCA using Bac-PrP and insect cell-derived cofactors showed similar pathogenicity and produced very similar lesions in the brains of inoculated mice. These results suggested that the essential cofactors required for the high-fidelity replication of mammalian PrPSc were present in the insect cells but that the cofactor activity was masked or inhibited in the native state. We suggest that not only RNA, but also DNA, are the key components of PMCA, although other cellular factors were necessary for the expression of the cofactor activity of nucleic acids. PMCA using only insect cell-derived substances (iPMCA) was highly useful for the ultrasensitive detection of PrPSc of some prion strains.	[Imamura, Morikazu; Kato, Nobuko; Okada, Hiroyuki; Yoshioka, Miyako; Iwamaru, Yoshifumi; Shimizu, Yoshihisa; Mohri, Shirou; Yokoyama, Takashi; Murayama, Yuichi] Natl Inst Anim Hlth, Influenza Prion Dis Res Ctr, Tsukuba, Ibaraki 305, Japan; [Yoshioka, Miyako] Natl Inst Anim Hlth, Res Area Pathol & Pathophysiol, Tsukuba, Ibaraki 305, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Murayama, Y (corresponding author), Natl Inst Anim Hlth, Influenza Prion Dis Res Ctr, Tsukuba, Ibaraki 305, Japan.	ymura@affrc.go.jp	Mohri, Shirou/AAK-1281-2020		BSE Control Project of the Ministry of Agriculture, Forestry and Fisheries of Japan; JSPS KAKENHI [25460575]; Grants-in-Aid for Scientific Research [25460575] Funding Source: KAKEN	BSE Control Project of the Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid from the BSE Control Project of the Ministry of Agriculture, Forestry and Fisheries of Japan and in part by JSPS KAKENHI Grant Number 25460575. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid K, 2010, FEBS LETT, V584, P2409, DOI 10.1016/j.febslet.2010.04.040; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Deleault NR, 2010, BIOCHEMISTRY-US, V49, P3928, DOI 10.1021/bi100370b; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Geiser DL, 2012, BBA-GEN SUBJECTS, V1820, P437, DOI 10.1016/j.bbagen.2011.07.011; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Hayashi H, 2004, J VET MED SCI, V66, P515, DOI 10.1292/jvms.66.515; Imamura M, 2011, J VIROL, V85, P2582, DOI 10.1128/JVI.02098-10; Iwamaru Y, 2008, J NEUROCHEM, V107, P636, DOI 10.1111/j.1471-4159.2008.05628.x; Kazlauskaite J, 2003, BIOCHEMISTRY-US, V42, P3295, DOI 10.1021/bi026872q; Kim CL, 2004, J GEN VIROL, V85, P3473, DOI 10.1099/vir.0.80113-0; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Lawson VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012351; Leucht C, 2003, EMBO REP, V4, P290, DOI 10.1038/sj.embor.embor768; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Murayama Y, 2007, J GEN VIROL, V88, P2890, DOI 10.1099/vir.0.82786-0; Murayama Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013152; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qin KF, 2000, J BIOL CHEM, V275, P19121, DOI 10.1074/jbc.275.25.19121; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Saa P, 2012, J VIROL, V86, P10494, DOI 10.1128/JVI.01286-12; Shi S, 2009, FEBS J, V276, P1536, DOI 10.1111/j.1742-4658.2009.06871.x; SHINAGAWA M, 1985, MICROBIOL IMMUNOL, V29, P543, DOI 10.1111/j.1348-0421.1985.tb00856.x; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Thakur AK, 2011, J BIOL CHEM, V286, P38533, DOI 10.1074/jbc.M111.265645; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Yokoyama T, 2011, NEUROSCI LETT, V498, P119, DOI 10.1016/j.neulet.2011.04.072; Yoshioka M, 2011, MICROBIOL IMMUNOL, V55, P331, DOI 10.1111/j.1348-0421.2011.00328.x	38	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82538	10.1371/journal.pone.0082538	http://dx.doi.org/10.1371/journal.pone.0082538			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367521	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300037
J	Kawano, F; Aono, Y; Suzuki, H; Sato, M				Kawano, Fuun; Aono, Yuki; Suzuki, Hideyuki; Sato, Moritoshi			Fluorescence Imaging-Based High-Throughput Screening of Fast- and Slow-Cycling LOV Proteins	PLOS ONE			English	Article							LIGHT PHOTORECEPTOR PHOTOTROPIN; CHLAMYDOMONAS-REINHARDTII; FLAVIN MONONUCLEOTIDE; SIGNALING STATE; BINDING DOMAINS; CELL BIOLOGY; OPTOGENETICS; ARABIDOPSIS; PHOTOCYCLE; RECEPTOR	Light-oxygen-voltage (LOV) domains function as blue light-inducible molecular switches. The photosensory LOV domains derived from plants and fungi have provided an indispensable tool for optogenetics. Here we develop a high-throughput screening system to efficiently improve switch-off kinetics of LOV domains. The present system is based on fluorescence imaging of thermal reversion of a flavin cofactor bound to LOV domains. We conducted multi site-directed random mutagenesis of seven amino acid residues surrounding the flavin cofactor of the second LOV domain derived from Avena sativa phototropin 1 (AsLOV2). The gene library was introduced into Escherichia coli cells. Then thermal reversion of AsLOV2 variants, respectively expressed in different bacterial colonies on agar plate, was imaged with a stereoscopic fluorescence microscope. Based on the mutagenesis and imaging-based screening, we isolated 12 different variants showing substantially faster thermal reversion kinetics than wild-type AsLOV2. Among them, AsLOV2-V416T exhibited thermal reversion with a time constant of 2.6 s, 21-fold faster than wild-type AsLOV2. With a slight modification of the present approach, we also have efficiently isolated 8 different decelerated variants, represented by AsLOV2-V416L that exhibited thermal reversion with a time constant of 4.3x10(3) s (78-fold slower than wild-type AsLOV2). The present approach based on fluorescence imaging of the thermal reversion of the flavin cofactor is generally applicable to a variety of blue light-inducible molecular switches and may provide a new opportunity for the development of molecular tools for emerging optogenetics.	[Kawano, Fuun; Aono, Yuki; Suzuki, Hideyuki; Sato, Moritoshi] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan	University of Tokyo	Sato, M (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan.	cmsato@mail.ecc.u-tokyo.ac.jp	Sato, Moritoshi/O-2735-2018; Kawano, Fuun/U-5777-2019	Sato, Moritoshi/0000-0002-3095-5831; 	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants to M. S. from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT), and Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 2007, BIOCHEMISTRY-US, V46, P9310, DOI 10.1021/bi700852w; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Kottke T, 2003, BIOPHYS J, V84, P1192, DOI 10.1016/S0006-3495(03)74933-9; Lungu OI, 2012, CHEM BIOL, V19, P507, DOI 10.1016/j.chembiol.2012.02.006; Mitre D, 2012, STRUCTURE, V20, P698, DOI 10.1016/j.str.2012.02.016; Muller K, 2013, MOL BIOSYST, V9, P596, DOI 10.1039/c3mb25590e; Pham E, 2011, CHEM BIOL, V18, P880, DOI 10.1016/j.chembiol.2011.04.014; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Strickland D, 2008, P NATL ACAD SCI USA, V105, P10709, DOI 10.1073/pnas.0709610105; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Toettcher JE, 2011, NAT METHODS, V8, P35, DOI [10.1038/nmeth.f.326, 10.1038/NMETH.F.326]; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Zayner JP, 2012, J MOL BIOL, V419, P61, DOI 10.1016/j.jmb.2012.02.037; Zikihara K, 2006, BIOCHEMISTRY-US, V45, P10828, DOI 10.1021/bi0607857; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P4, DOI 10.1021/bi101665s; Zoltowski BD, 2009, NAT CHEM BIOL, V5, P827, DOI 10.1038/nchembio.210	26	45	47	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82693	10.1371/journal.pone.0082693	http://dx.doi.org/10.1371/journal.pone.0082693			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367542	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300057
J	McCracken, KG; Wilson, RE; Martin, AR				McCracken, Kevin G.; Wilson, Robert E.; Martin, Anthony R.			Gene Flow and Hybridization between Numerically Imbalanced Populations of Two Duck Species on the Subantarctic Island of South Georgia	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; ANAS; INTROGRESSION; SPECIATION; EVOLUTION; CONSEQUENCES; DEGLACIATION; EXTINCTION; DIVERGENCE; COALESCENT	Hybridization is common between species of animals, particularly in waterfowl (Anatidae). One factor shown to promote hybridization is restricted mate choice, which can occur when 2 species occur in sympatry but one is rare. According to the Hubbs principle, or "desperation hypothesis," the rarer species is more likely to mate with heterospecifics. We report the second of 2 independent examples of hybridization between 2 species of ducks inhabiting island ecosystems in the Subantarctic and South Atlantic Ocean. Yellow-billed pintails (Anas georgica) and speckled teal (Anas flavirostris) are abundant in continental South America, where they are sympatric and coexist in mixed flocks. But on South Georgia, an isolated island in the Subantarctic, the pintail population of approximately 6000 pairs outnumbers a small breeding population of speckled teal 300:1. Using 6 genetic loci (mtDNA and 5 nuclear introns) and Bayesian assignment tests coupled with coalescent analyses, we identified hybrid-origin speckled teal alleles in 2 pintails on South Georgia. While it is unclear whether introgression has also occurred into the speckled teal population, our data suggest that this hybridization was not a recent event, but occurred some time ago. We also failed to identify unequivocal evidence of introgression in a much larger sample of pintails and speckled teal from Argentina using a 3-population "Isolation-with-Migration" coalescent analysis. Combined with parallel findings of hybridization between these same 2 duck species in the Falkland Islands, where population ratios are reversed and pintails are outnumbered by speckled teal 1: 10, our results provide further support for the desperation hypothesis, which predicts that scarcity in one population and abundance of another will often lead to hybridization. While the South Georgia pintail population appears to be thriving, it's possible that low density of conspecific mates and inverse density dependence (Allee effect) may be one factor limiting the reproductive output of the speckled teal population, and this situation may persist unless speckled teal increase in abundance on South Georgia.	[McCracken, Kevin G.; Wilson, Robert E.] Univ Alaska Fairbanks, Inst Arctic Biol, Univ Alaska Museum, Fairbanks, AK 99775 USA; [McCracken, Kevin G.; Wilson, Robert E.] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK USA; [Martin, Anthony R.] Univ Dundee, Ctr Remote Environm, Dundee, Scotland	University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Dundee	McCracken, KG (corresponding author), Univ Alaska Fairbanks, Inst Arctic Biol, Univ Alaska Museum, Fairbanks, AK 99775 USA.	kmccrack@iab.alaska.edu			Institute of Arctic Biology at the University of Alaska, Fairbanks, Experimental Program to Stimulate Competitive Research (National Science Foundation [NSF] [EPS-0092040, EPS-0346770]; Delta Waterfowl Foundation; Frank M. Chapman Fund at the American Museum of Natural History; NSF [DEB-0444748, IOS-0949439]	Institute of Arctic Biology at the University of Alaska, Fairbanks, Experimental Program to Stimulate Competitive Research (National Science Foundation [NSF](National Science Foundation (NSF)); Delta Waterfowl Foundation; Frank M. Chapman Fund at the American Museum of Natural History; NSF(National Science Foundation (NSF))	Funding was provided by the Institute of Arctic Biology at the University of Alaska, Fairbanks, Experimental Program to Stimulate Competitive Research (National Science Foundation [NSF] EPS-0092040 and EPS-0346770), grants from the Delta Waterfowl Foundation and Frank M. Chapman Fund at the American Museum of Natural History to R. E. W., and NSF grants DEB-0444748 and IOS-0949439 to KGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allee W., 1949, PRINCIPLES ANIMAL EC; Allee W.C, 1931, ANIMAL AGGREGATION S; ANDERSON E, 1954, EVOLUTION, V8, P378, DOI 10.2307/2405784; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bentley MJ, 2007, QUATERNARY SCI REV, V26, P644, DOI 10.1016/j.quascirev.2006.11.019; Bos DH, 2007, HEREDITAS, V144, P228, DOI 10.1111/j.2007.0018-0661.01994.x; BOTTEMA CDK, 1993, METHOD ENZYMOL, V218, P388; Carling MD, 2008, EVOLUTION, V62, P2600, DOI 10.1111/j.1558-5646.2008.00477.x; CAWKELL E. M., 1961, IBIS, V103a, P1, DOI 10.1111/j.1474-919X.1961.tb02417.x; Clapperton C. M., 1978, ANTARCTIC GLACIAL HI, P95; Clapperton C.M., 1971, 70 BRIT ANT SURV, V70; Clarke Andrew, 2012, British Birds, V105, P118; Convey P, 2008, BIOL REV, V83, P103, DOI 10.1111/j.1469-185X.2008.00034.x; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Edwards SV, 2000, EVOLUTION, V54, P1839; Fowler AC, 2009, CONSERV GENET, V10, P1747, DOI 10.1007/s10592-008-9778-8; Fretwell PT, 2009, ANTARCT SCI, V21, P171, DOI 10.1017/S0954102008001703; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Graham AGC, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001993; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Grant PR, 2005, AM NAT, V166, P56, DOI 10.1086/430331; Grant V., 1981, PLANT SPECIATION; Gray A.P., 1958, TECHNICAL COMMUNICAT; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Harrigan RJ, 2008, MOL ECOL RESOUR, V8, P1239, DOI 10.1111/j.1755-0998.2008.02241.x; Headland R.K., 1984, ISLAND S GEORGIA; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Holder MT, 2001, SYST BIOL, V50, P978, DOI 10.1080/106351501753462911; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; HUDSON RR, 1985, GENETICS, V111, P147; JOHNSGARD PAUL A., 1960, CONDOR, V62, P25, DOI 10.2307/1365656; Johnson KP, 1999, AUK, V116, P792, DOI 10.2307/4089339; Kulikova IV, 2010, RUSS J GENET+, V46, P976, DOI 10.1134/S1022795410080090; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mank JE, 2004, CONSERV GENET, V5, P395, DOI 10.1023/B:COGE.0000031139.55389.b1; Martin AR, 2005, BIRD FAMILIES WORLD, P590; McCarthy EM, 2006, HDB AVIAN HYBRIDS WO; McCracken KG, 2013, J BIOGEOGR, V40, P2348, DOI 10.1111/jbi.12162; McCracken KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023173; McCracken KG, 2009, AM NAT, V174, P631, DOI 10.1086/606020; McCracken KG, 2009, MOL BIOL EVOL, V26, P815, DOI 10.1093/molbev/msp007; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Munoz-Fuentes V, 2007, MOL ECOL, V16, P629, DOI 10.1111/j.1365-294X.2006.03170.x; Munoz-Fuentes V, 2010, CONSERV GENET, V11, P547, DOI 10.1007/s10592-009-9974-1; Newman L., 2009, PAGES (Past Global Changes) News, V17, P22; Panov, 1989, NATURAL HYBRIDIZATIO; Peters JL, 2007, EVOLUTION, V61, P1992, DOI 10.1111/j.1558-5646.2007.00149.x; Peters JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031972; Prince P. A., 1996, Bulletin of the British Ornithologists' Club, V116, P81; Prince P. A., 1996, S GEORGIA ECOLOGICAL; Pritchard JK, 2000, GENETICS, V155, P945; Randler C, 2002, ANIM BEHAV, V63, P103, DOI 10.1006/anbe.2001.1884; Randler C, 2008, WATERBIRDS, V31, P143, DOI 10.1675/1524-4695(2008)31[143:HWICEA]2.0.CO;2; Rheindt FE, 2011, AUK, V128, P620, DOI 10.1525/auk.2011.128.4.620; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; RHYMER JM, 1994, AUK, V111, P970, DOI 10.2307/4088829; Rogers AD, 2007, PHILOS T R SOC B, V362, P2191, DOI 10.1098/rstb.2006.1948; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saetre GP, 2003, P ROY SOC B-BIOL SCI, V270, P53, DOI 10.1098/rspb.2002.2204; Saetre GP, 2001, MOL ECOL, V10, P737, DOI 10.1046/j.1365-294x.2001.01208.x; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; SUGDEN DE, 1977, QUATERNARY RES, V7, P268, DOI 10.1016/0033-5894(77)90041-2; TEGELSTROM H, 1990, EVOLUTION, V44, P2012, DOI 10.1111/j.1558-5646.1990.tb04307.x; Tubaro PL, 2002, BIOL J LINN SOC, V77, P193, DOI 10.1046/j.1095-8312.2002.00096.x; TURELLI M, 1995, GENETICS, V140, P389; Van der Putten N, 2005, ANTARCT SCI, V17, P29, DOI 10.1017/S0954102005002397; Van der Putten N, 2009, QUATERNARY SCI REV, V28, P65, DOI 10.1016/j.quascirev.2008.09.023; Van der Putten N, 2010, J BIOGEOGR, V37, P582, DOI 10.1111/j.1365-2699.2009.02217.x; Wakeley J, 1996, THEOR POPUL BIOL, V49, P39, DOI 10.1006/tpbi.1996.0002; WELLER M W, 1972, Wildfowl, V23, P25; Weller M.W., 1972, Bulletin Br Antarct Surv, VNo. 30, P65; Weller M.W., 1980, ISLAND WATERFOWL; Wetlands International, 2019, WATERBIRD POPULATION; Williams CL, 2005, CONSERV GENET, V6, P445, DOI 10.1007/s10592-005-4978-y; Wolf DE, 2001, CONSERV BIOL, V15, P1039, DOI 10.1046/j.1523-1739.2001.0150041039.x; Woods RW, 1997, ATLAS BREEDING BIRDS; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	81	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82664	10.1371/journal.pone.0082664	http://dx.doi.org/10.1371/journal.pone.0082664			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367536	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300052
J	Nattier, R; Grandcolas, P; Pellens, R; Jourdan, H; Couloux, A; Poulain, S; Robillard, T				Nattier, Romain; Grandcolas, Philippe; Pellens, Roseli; Jourdan, Herve; Couloux, Arnaud; Poulain, Simon; Robillard, Tony			Climate and Soil Type Together Explain the Distribution of Microendemic Species in a Biodiversity Hotspot	PLOS ONE			English	Article							CALEDONIA SOUTHWEST PACIFIC; MOLECULAR PHYLOGENY; ORTHOPTERA; EVOLUTION; ACRIDIDAE; RADIATION; DIVERSIFICATION; TETTIGONIIDAE; CONSERVATION; DIVERGENCE	The grasshopper genus Caledonula, endemic to New Caledonia, was studied to understand the evolution of species distributions in relation to climate and soil types. Based on a comprehensive sampling of 80 locations throughout the island, the genus was represented by five species, four of which are new to science, of which three are described here. All the species have limited distributions in New Caledonia. Bioclimatic niche modelling shows that all the species were found in association with a wet climate and reduced seasonality, explaining their restriction to the southern half of the island. The results suggest that the genus was ancestrally constrained by seasonality. A molecular phylogeny was reconstructed using two mitochondrial and two nuclear markers. The partially resolved tree showed monophyly of the species found on metalliferous soils, and molecular dating indicated a rather recent origin for the genus. Adaptation to metalliferous soils is suggested by both morphological changes and radiation on these soils. The genus Caledonula is therefore a good model to understand the origin of microendemism in the context of recent and mixed influences of climate and soil type.	[Nattier, Romain; Grandcolas, Philippe; Pellens, Roseli; Poulain, Simon; Robillard, Tony] Museum Natl Hist Nat, Dept Systemat & Evolut, F-75231 Paris, France; [Nattier, Romain] UPR 9034 CNRS, Lab Evolut Genomes & Speciat, Gif Sur Yvette, France; [Nattier, Romain] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Jourdan, Herve] Aix Marseille Univ, UMR IRD 237, Inst Mediterrane Biodivers & Ecol Terr & Marine, CNRS IRD UAPV,Ctr IRD Noumea, Noumea, New Caledonia; [Couloux, Arnaud] Genoscope, Ctr Natl Sequencage, Evry, France	Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay	Nattier, R (corresponding author), Museum Natl Hist Nat, Dept Systemat & Evolut, F-75231 Paris, France.	romain.nattier@legs.cnrs-gif.fr	Jourdan, Herve/D-1452-2011; Nattier, Romain/C-7005-2016; Robillard, Tony/H-3523-2011	Jourdan, Herve/0000-0002-3756-4008; Robillard, Tony/0000-0002-2177-9549; Couloux, Arnaud/0000-0003-2356-0062; Grandcolas, Philippe/0000-0003-1374-1222	Consortium National de Recherche en Genomique; UMS 2700 CNRS; Genoscope [2005/67]; MNHN	Consortium National de Recherche en Genomique; UMS 2700 CNRS; Genoscope; MNHN	The authors are grateful to the following institutions or programs that made their work possible: the Directions de l'Environnement of New Caledonia's Province Nord and Province Sud for permits to work in natural parks and forest reserves; the Direction des Infrastructures, de la Topographie et des Transports Terrestres of the Gouvernement de la Nouvelle-Caledonie for kindly providing the GIS layers and electronic maps of New Caledonia (agreement number CS11-3170-865) and the IRD authorities for local support and hosting. The study was also made possible by the grant "ANR Bioneocal" to PG and by a PhD grant of the Gouvernement de Nouvelle-Caledonie and from the Prevost Fund of the Ecole Doctorale of the Museum national d'Histoire naturelle, Paristo RN. The molecular work was supported by the Consortium National de Recherche en Genomique and the UMS 2700 CNRS, and was carried out under agreement no. 2005/67 between Genoscope and the MNHN for the project 'Macrophylogeny of life' of Guillaume Lecointre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITCHISON JC, 1995, GEOLOGY, V23, P161, DOI 10.1130/0091-7613(1995)023<0161:EACCIN>2.3.CO;2; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Albrecht FO, 1953, ANATOMY MIGRATORY LO; Bauer Aaron M., 2006, Proceedings of the California Academy of Sciences, V57, P503; Boyd Robert S., 2006, Insect Science, V13, P271, DOI 10.1111/j.1744-7917.2006.00094.x; Bradford J, 2004, BIODIVERS CONSERV, V13, P2253, DOI 10.1023/B:BIOC.0000047901.33761.3c; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Butlin RK, 1998, BIOGEOGRAPHY GEOLOGI, P355; Chapco W, 1999, ANN ENTOMOL SOC AM, V92, P617, DOI 10.1093/aesa/92.5.617; Chapco William, 2002, Journal of Orthoptera Research, V11, P1, DOI 10.1665/1082-6467(2002)011[0001:AMPAOT]2.0.CO;2; Chazeau J., 1993, Biodiversity Letters, V1, P123, DOI 10.2307/2999756; Chevillotte V, 2006, GEOMORPHOLOGY, V81, P361, DOI 10.1016/j.geomorph.2006.04.020; Cluzel D, 2001, TECTONOPHYSICS, V340, P23, DOI 10.1016/S0040-1951(01)00148-2; Cluzell D, 2012, EPISODES, V35, P72, DOI 10.18814/epiiugs/2012/v35i1/007; Colombo P, 2005, CLADISTICS, V21, P375, DOI 10.1111/j.1096-0031.2005.00068.x; Crawford A., 2003, GEOLOGICAL SOC AUSTR, V22, P377; de Kok Rogier, 2002, Adansonia (Paris), V24, P229; De Laubenfels David J., 1996, P261; Desutter-Grandcolas L, 2006, SYST ENTOMOL, V31, P65, DOI 10.1111/j.1365-3113.2005.00299.x; Dirsh V. M., 1956, Transactions of the Royal Entomological Society of London, V108, P223; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edelman WC, 2010, INSECT SYST EVOL, V41, P303, DOI 10.1163/187631210X519709; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Espeland M, 2010, J BIOGEOGR, V37, P879, DOI 10.1111/j.1365-2699.2009.02263.x; Farris JS, 1996, CLADISTICS, V12, P99, DOI 10.1111/j.1096-0031.1996.tb00196.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gasc A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065311; GELLISSEN G, 1983, NATURE, V301, P631, DOI 10.1038/301631a0; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff P, 2008, CLADISTICS, V24, P91; Grandcolas P, 2001, P ACAD NAT SCI PHILA, V151, P61, DOI 10.1635/0097-3157(2001)151[0061:WDCKNS]2.0.CO;2; Grandcolas P, 2002, MEMOIRES MUSEUM NATL, P117; Grandcolas P, 2008, PHILOS T R SOC B, V363, P3309, DOI 10.1098/rstb.2008.0122; Grandcolas Philippe, 1997, Memoires du Museum National d'Histoire Naturelle, V171, P91; Haase M, 1998, HYDROBIOLOGIA, V367, P43, DOI 10.1023/A:1003219931171; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Hochkirch A, 2008, ZOOL STUD, V47, P495; Hochkirch A, 2009, SYST ENTOMOL, V34, P188, DOI 10.1111/j.1365-3113.2008.00449.x; Jaffre T., 1992, P101; Jaiswara R, 2012, ZOOL J LINN SOC-LOND, V164, P285, DOI 10.1111/j.1096-3642.2011.00769.x; KALTENBACH A, 1976, Annalen des Naturhistorischen Museums in Wien, V80, P657; KALTENBACH A, 1968, Annalen des Naturhistorischen Museums in Wien, V72, P539; Kumar S., 2009, J ECOLOGY NATURAL EN, V1, P94, DOI 10.5897/ JENE.9000071; Lowry PP, 1998, ACAD SINICA MONOGRAP, P181; MADDISON DR, 1991, SYST ZOOL, V40, P315, DOI 10.2307/2992325; Morat P., 1986, ADANSONIA, V4, P133; Moulton MJ, 2010, MOL ECOL RESOUR, V10, P615, DOI 10.1111/j.1755-0998.2009.02823.x; Murienne J, 2008, CLADISTICS, V24, P802, DOI 10.1111/j.1096-0031.2008.00204.x; Murienne J, 2005, CLADISTICS, V21, P2, DOI 10.1111/j.1096-0031.2004.00042.x; Murienne J, 2009, BIOL J LINN SOC, V97, P177, DOI 10.1111/j.1095-8312.2008.01184.x; Murienne J, 2008, ZOOLOGIA NEOCALEDONI, P261; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nattier R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048047; Nattier R, 2011, J BIOGEOGR, V38, P2195, DOI 10.1111/j.1365-2699.2011.02563.x; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Oneal E, 2010, J BIOGEOGR, V37, P530, DOI 10.1111/j.1365-2699.2009.02231.x; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Paris J.-P., 1981, Memoire du B.R.G.M., P1; Paris J.P., 1981, ATLAS NOUVELLE CALED; Pellens R, 2009, BIODIVERSITY HOTSPOT; Pelletier B., 2006, COMPENDIUM MARINE SP, VII, P19; Pfeiler E, 2007, HEREDITAS, V144, P63, DOI 10.1111/j.2007.0018-0661.01997.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pillon Y, 2012, BOT J LINN SOC, V170, P288, DOI 10.1111/j.1095-8339.2012.01274.x; Pillon Y, 2010, J ECOL, V98, P1108, DOI 10.1111/j.1365-2745.2010.01689.x; Pintaud JC, 2001, CR ACAD SCI III-VIE, V324, P453, DOI 10.1016/S0764-4469(01)01312-9; Pons J, 2005, MOL BIOL EVOL, V22, P991, DOI 10.1093/molbev/msi085; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER V1 4; RAVEN PH, 1972, SCIENCE, V176, P1379, DOI 10.1126/science.176.4042.1379; Ren ZM, 2004, MOL PHYLOGENET EVOL, V33, P516, DOI 10.1016/j.ympev.2004.06.003; Reusch DN, 2011, GEOLOGY, V39, P807, DOI 10.1130/G31981.1; Robillard Tony, 2010, Zootaxa, V2559, P17; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schultz O, 2007, SYST ENTOMOL, V32, P712, DOI 10.1111/j.1365-3113.2007.00395.x; Snyder RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007203; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Ullrich B, 2010, J ZOOL SYST EVOL RES, V48, P219, DOI 10.1111/j.1439-0469.2009.00553.x; Uvarov, 1939, ANN MAGAZINE NATURAL, V11, P459; Willemse C, 1923, NOVA CALEDONIA A, P99	86	19	19	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e80811	10.1371/journal.pone.0080811	http://dx.doi.org/10.1371/journal.pone.0080811			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367480	Green Submitted, Green Published, gold			2022-12-27	WOS:000328740300002
J	Bull, JK; Sands, CJ; Garrick, RC; Gardner, MG; Tait, NN; Briscoe, DA; Rowell, DM; Sunnucks, P				Bull, James K.; Sands, Chester J.; Garrick, Ryan C.; Gardner, Michael G.; Tait, Noel N.; Briscoe, David A.; Rowell, David M.; Sunnucks, Paul			Environmental Complexity and Biodiversity: The Multi-Layered Evolutionary History of a Log-Dwelling Velvet Worm in Montane Temperate Australia	PLOS ONE			English	Article							EUPERIPATOIDES-ROWELLI ONYCHOPHORA; CLIMATIC OSCILLATIONS; POPULATION-STRUCTURE; GENETIC-STRUCTURE; GIANT SPRINGTAIL; PHYLOGEOGRAPHY; PERIPATOPSIDAE; SOFTWARE; ZONE; PLANIPAPILLUS	Phylogeographic studies provide a framework for understanding the importance of intrinsic versus extrinsic factors in shaping patterns of biodiversity through identifying past and present microevolutionary processes that contributed to lineage divergence. Here we investigate population structure and diversity of the Onychophoran (velvet worm) Euperipatoides rowelli in southeastern Australian montane forests that were not subject to Pleistocene glaciations, and thus likely retained more forest cover than systems under glaciation. Over a similar to 100 km transect of structurally-connected forest, we found marked nuclear and mitochondrial (mt) DNA genetic structuring, with spatially-localised groups. Patterns from mtDNA and nuclear data broadly corresponded with previously defined geographic regions, consistent with repeated isolation in refuges during Pleistocene climatic cycling. Nevertheless, some E. rowelli genetic contact zones were displaced relative to hypothesized influential landscape structures, implying more recent processes overlying impacts of past environmental history. Major impacts at different timescales were seen in the phylogenetic relationships among mtDNA sequences, which matched geographic relationships and nuclear data only at recent timescales, indicating historical gene flow and/or incomplete lineage sorting. Five major E. rowelli phylogeographic groups were identified, showing substantial but incomplete reproductive isolation despite continuous habitat. Regional distinctiveness, in the face of lineages abutting within forest habitat, could indicate pre- and/or postzygotic gene flow limitation. A potentially functional phenotypic character, colour pattern variation, reflected the geographic patterns in the molecular data. Spatial-genetic patterns broadly match those in previously-studied, co-occurring low-mobility organisms, despite a variety of life histories. We suggest that for E. rowelli, the complex topography and history of the region has led to interplay among limited dispersal ability, historical responses to environmental change, local adaptation, and some resistance to free admixture at geographic secondary contact, leading to strong genetic structuring at fine spatial scale.	[Bull, James K.; Sunnucks, Paul] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Sands, Chester J.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Garrick, Ryan C.] Univ Mississippi, Dept Biol, Oxford, MS USA; [Gardner, Michael G.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Gardner, Michael G.] S Australian Museum, Evolutionary Biol Unit, Adelaide, SA 5000, Australia; [Tait, Noel N.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Briscoe, David A.; Rowell, David M.] Australian Natl Univ, Res Sch Biol Sci, Canberra, ACT 2601, Australia	Monash University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Mississippi; Flinders University South Australia; Macquarie University; Australian National University	Bull, JK (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	james.bull.au@gmail.com	Rowell, David/C-9751-2009; Gardner, Michael G/A-8280-2011	Rowell, David/0000-0002-2077-9774; Gardner, Michael G/0000-0002-8629-354X; Sunnucks, Paul/0000-0002-8139-7059; Sands, Chester/0000-0003-1028-0328; Bull, James/0000-0002-0274-4359; Garrick, Ryan/0000-0002-4057-7061	School of Biological Sciences, Monash; Australian Research Council [DP0211156]; Holsworth Wildlife Endowment awards; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	School of Biological Sciences, Monash; Australian Research Council(Australian Research Council); Holsworth Wildlife Endowment awards; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was funded in part by a small grant from the School of Biological Sciences, Monash, and drew on some materials from an Australian Research Council (www.arc.gov.au/) grant DP0211156 partially-funded in 2002-2004 awarded to PS and DMR. CJS and RCG were supported by Holsworth Wildlife Endowment awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; Allendorf F., 2007, CONSERVATION GENETIC; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Avise John C., 1994, pi; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barclay S, 2000, J ZOOL, V250, P425, DOI 10.1111/j.1469-7998.2000.tb00786.x; Barclay SD, 2000, J ZOOL, V250, P437; Barrows TT, 2001, QUATERNARY RES, V55, P179, DOI 10.1006/qres.2001.2216; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Beavis AS, 2011, BIOL J LINN SOC, V104, P805, DOI 10.1111/j.1095-8312.2011.01753.x; Blaxter M, 2011, CURR BIOL, V21, pR238, DOI 10.1016/j.cub.2011.02.017; BRISCOE DA, 1995, ZOOL J LINN SOC-LOND, V114, P91, DOI 10.1006/zjls.1995.0018; BULL JK, BIOL J LINNEAN SOC; Byrne M, 2008, QUATERNARY SCI REV, V27, P2576, DOI 10.1016/j.quascirev.2008.08.032; Byrne M, 2011, J BIOGEOGR, V38, P1635, DOI 10.1111/j.1365-2699.2011.02535.x; Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108; Canestrelli D, 2010, MOL ECOL, V19, P5432, DOI 10.1111/j.1365-294X.2010.04900.x; Coblentz DD, 2004, J BIOGEOGR, V31, P1125, DOI 10.1111/j.1365-2699.2004.00981.x; Curach N, 1999, MOL ECOL, V8, P1375, DOI 10.1046/j.1365-294x.1999.00698.x; Daniels SR, 2010, J ZOOL, V282, P171, DOI 10.1111/j.1469-7998.2010.00722.x; Daniels SR, 2009, BIOL J LINN SOC, V97, P200, DOI 10.1111/j.1095-8312.2009.01205.x; Davis J, 2013, GLOBAL CHANGE BIOL, V19, P1970, DOI 10.1111/gcb.12203; EAKIN RM, 1965, Z ZELLFORSCH MIK ANA, V68, P278, DOI 10.1007/BF00342434; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fortin MJ, 2000, LANDSCAPE ECOL, V15, P453, DOI 10.1023/A:1008194205292; Fu YX, 1997, GENETICS, V147, P915; Gardner MG, 2011, MOL ECOL RESOUR, V11, P1093, DOI 10.1111/j.1755-0998.2011.03037.x; Garrick RC, 2007, MOL ECOL, V16, P1865, DOI 10.1111/j.1365-294X.2006.03165.x; Garrick RC, 2004, MOL ECOL, V13, P3329, DOI 10.1111/j.1365-294X.2004.02340.x; Garrick RC, 2008, EVOLUTION, V62, P1103, DOI 10.1111/j.1558-5646.2008.00349.x; Garrick Ryan C., 2012, Insects, V3, P270, DOI 10.3390/insects3010270; Garrick RC, 2011, J INSECT CONSERV, V15, P469, DOI 10.1007/s10841-010-9349-4; GILL AM, 1994, AUSTR VEGETATION; Giribet G, 2012, ANNU REV ENTOMOL, V57, P167, DOI 10.1146/annurev-ento-120710-100659; Gleeson DM, 1998, MOL PHYLOGENET EVOL, V10, P237, DOI 10.1006/mpev.1998.0512; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hering L, 2012, MOL BIOL EVOL, V29, P3451, DOI 10.1093/molbev/mss148; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hodges KM, 2007, J ZOOL, V272, P64, DOI 10.1111/j.1469-7998.2006.00244.x; Hope G. S., 1994, HIST AUSTR VEGETATIO, P368; JACQUEZ GM, 1995, STAT MED, V14, P2343, DOI 10.1002/sim.4780142107; JACQUEZ GM, 2000, J GEOGRAPHICAL SYSTE, V2, P211; Kueppers LM, 2004, OECOLOGIA, V141, P641, DOI 10.1007/s00442-004-1689-x; Lemmon AR, 2008, SYST BIOL, V57, P544, DOI 10.1080/10635150802304761; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; Mayer G, 2009, ZOOL J LINN SOC-LOND, V157, P17, DOI 10.1111/j.1096-3642.2009.00523.x; McDonald DE, 2012, J EVOLUTION BIOL, V25, P824, DOI 10.1111/j.1420-9101.2012.02482.x; MEGLECZ E, 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0040861.PUBMED:22815847; Monge-Najera Julian, 1994, Biogeographica (Paris), V70, P111; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Moritz C, 2009, P ROY SOC B-BIOL SCI, V276, P1235, DOI 10.1098/rspb.2008.1622; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; ODEN NL, 1993, GEOGR ANAL, V25, P315; Oetting WS, 1995, GENOMICS, V30, P450, DOI 10.1006/geno.1995.1264; Oliveira IS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019973; PATTERSON C, 1988, MOL BIOL EVOL, V5, P603; Pritchard JK, 2000, GENETICS, V155, P945; Quinn G.P., 2002, EXPT DESIGN DATA ANA; R Core Team, 2021, R LANGUAGE ENV STAT; Reid AL, 1996, INVERTEBR TAXON, V10, P663, DOI 10.1071/IT9960663; REID AL, 1995, ZOOL J LINN SOC-LOND, V114, P115, DOI 10.1006/zjls.1995.0020; Reinhard J, 2005, J ZOOL, V267, P1, DOI 10.1017/S0952836905007090; Rockman MV, 2002, EVOLUTION, V56, P58; Rockman MV, 2001, MOL PHYLOGENET EVOL, V21, P103, DOI 10.1006/mpev.2001.0990; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rowell DM, 2002, J ZOOL, V257, P171, DOI 10.1017/S0952836902000778; ROWELL DM, 1995, ZONING, P139; Rozen S, 2000, Methods Mol Biol, V132, P365; Sands CJ, 2009, CONSERV GENET RESOUR, V1, P17, DOI 10.1007/s12686-009-9004-0; SCOTT IAW, 1991, AUST J ZOOL, V39, P499, DOI 10.1071/ZO9910499; Servedio MR, 2004, EVOLUTION, V58, P913, DOI 10.1111/j.0014-3820.2004.tb00425.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Siwek M, 2011, ANIM GENET, V42, P93, DOI 10.1111/j.1365-2052.2010.02080.x; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Sunnucks P, 1999, MOL ECOL, V8, P899; Sunnucks P, 2000, J ZOOL, V250, P447, DOI 10.1111/j.1469-7998.2000.tb00788.x; Sunnucks P, 2000, MOL ECOL, V9, P1699, DOI 10.1046/j.1365-294x.2000.01084.x; SUNNUCKS P, 2001, TALES UNEXPECTED; Sunnucks P, 2006, MOL ECOL, V15, P4513, DOI 10.1111/j.1365-294X.2006.03107.x; Tait Noel N., 1995, Memoir of the Association of Australasian Palaeontologists, V18, P21; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Trewick SA, 1998, BIOL J LINN SOC, V63, P307, DOI 10.1006/bijl.1997.0197; Weigand AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037089; Woodman JD, 2007, COMP BIOCHEM PHYS A, V147, P514, DOI 10.1016/j.cbpa.2007.01.024; Woodman JD, 2006, J ZOOL, V268, P325, DOI 10.1111/j.1469-7998.2005.00012.x	92	12	12	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84559	10.1371/journal.pone.0084559	http://dx.doi.org/10.1371/journal.pone.0084559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358365	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000328737700100
J	Javaremi, AN; Unsworth, CP; Graham, ES				Javaremi, Alireza Nejati; Unsworth, Charles P.; Graham, E. Scott			A Cell Derived Active Contour (CDAC) Method for Robust Tracking in Low Frame Rate, Low Contrast Phase Microscopy - an Example: The Human hNT Astrocyte	PLOS ONE			English	Article							IMAGE SEGMENTATION; SHAPE; RESOLUTION; MIGRATION; MODEL	The problem of automated segmenting and tracking of the outlines of cells in microscope images is the subject of active research. While great progress has been made on recognizing cells that are of high contrast and of predictable shape, many situations arise in practice where these properties do not exist and thus many interesting potential studies - such as the migration patterns of astrocytes to scratch wounds - have been relegated to being largely qualitative in nature. Here we analyse a select number of recent developments in this area, and offer an algorithm based on parametric active contours and formulated by taking into account cell movement dynamics. This Cell-Derived Active Contour (CDAC) method is compared with two state-of-the-art segmentation methods for phase-contrast microscopy. Specifically, we tackle a very difficult segmentation problem: human astrocytes that are very large, thin, and irregularly-shaped. We demonstrate quantitatively better results for CDAC as compared to similar segmentation methods, and we also demonstrate the reliable segmentation of qualitatively different data sets that were not possible using existing methods. We believe this new method will enable new and improved automatic cell migration and movement studies to be made.	[Javaremi, Alireza Nejati; Unsworth, Charles P.] Univ Auckland, Dept Engn Sci, Auckland, New Zealand; [Graham, E. Scott] Univ Auckland, Ctr Brain Res, Auckland 1, New Zealand	University of Auckland; University of Auckland	Javaremi, AN (corresponding author), Univ Auckland, Dept Engn Sci, Auckland, New Zealand.	anej001@aucklanduni.ac.nz		Nejati, Alireza/0000-0002-6560-3502; Graham, Scott/0000-0002-2925-9126	Maurice and Phyllis Paykel trust [3627058]	Maurice and Phyllis Paykel trust	Funding provided by the Maurice and Phyllis Paykel trust (http://www.paykeltrust.co.nz /#3627058: funding for cell cultures and microscopy equipment). The role of the funders was providing the cell cultures and microscopy equipment, through Dr. Scott Graham. They had no role in study design, analysis of data, or decision to publish.	Abercrombie M, 1980, J BIOL SCI, V207, P129, DOI [10.1098/rspb.1980.0017, DOI 10.1098/RSPB.1980.0017]; Ali S, 2012, IEEE T MED IMAGING, V31, P1448, DOI 10.1109/TMI.2012.2190089; Ambuhl ME, 2012, J MICROSC-OXFORD, V245, P161, DOI 10.1111/j.1365-2818.2011.03558.x; Amini A. A., 1988, Second International Conference on Computer Vision (IEEE Cat. No.88CH2664-1), P95, DOI 10.1109/CCV.1988.589976; AMINI AA, 1990, IEEE T PATTERN ANAL, V12, P855, DOI 10.1109/34.57681; Andrey P, 2006, P IMAGEJ C, P181; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Beucher S., 1993, MATH MORPHOLOGY IMAG, P433, DOI DOI 10.1201/9781482277234-12; Bradhurst C.J., 2008, P 23 INT C IM VIS CO; Bresson X, 2007, J MATH IMAGING VIS, V28, P151, DOI 10.1007/s10851-007-0002-0; Burkert K, 2012, NEUROCHEM INT, V60, P573, DOI 10.1016/j.neuint.2011.09.002; CASELLES V, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P694, DOI 10.1109/ICCV.1995.466871; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Chen XW, 2006, IEEE T BIO-MED ENG, V53, P762, DOI 10.1109/TBME.2006.870201; Cremers D, 2006, INT J COMPUT VISION, V66, P67, DOI 10.1007/s11263-005-3676-z; Debeir O, 2008, I S BIOMED IMAGING, P724, DOI 10.1109/ISBI.2008.4541098; DERICHE R, 1987, INT J COMPUT VISION, V1, P167, DOI 10.1007/BF00123164; Deriche R., 1988, 9th International Conference on Pattern Recognition (IEEE Cat. No.88CH2614-6), P434, DOI 10.1109/ICPR.1988.28260; Dunn J.C., 1973, J CYBERNETICS, V3, P32, DOI [10.1080/01969727308546046, DOI 10.1080/01969727308546046]; EVANS E, 1993, BIOPHYS J, V64, P1306, DOI 10.1016/S0006-3495(93)81497-8; Figueiredo IN, 2010, IEEE T MED IMAGING, V29, P998, DOI 10.1109/TMI.2009.2036258; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Goodfellow CE, 2011, J NEUROSCI RES, V89, P1685, DOI 10.1002/jnr.22692; Hand AJ, 2009, J MICROSC-OXFORD, V234, P62, DOI 10.1111/j.1365-2818.2009.03144.x; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; Jain V, 2010, PROC CVPR IEEE, P2488, DOI 10.1109/CVPR.2010.5539950; Kass M., 1987, Proceedings of the First International Conference on Computer Vision (Cat. No.87CH2465-3), P259, DOI 10.1007/BF00133570; Kaynig V, 2010, PROC CVPR IEEE, P2902, DOI 10.1109/CVPR.2010.5540029; Lang P, 2006, NAT REV DRUG DISCOV, V5, P343, DOI 10.1038/nrd2008; LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0; Li FH, 2009, LECT NOTES COMPUT SC, V5762, P609; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; McInerney T, 1996, PROCEEDINGS OF THE IEEE WORKSHOP ON MATHEMATICAL METHODS IN BIOMEDICAL IMAGE ANALYSIS, P171, DOI 10.1109/MMBIA.1996.534069; Mogilner A, 2001, FRONT APPLI MATH, V121, P269; Murphy D B, 2001, FUNDAMENTALS LIGHT M; Nejati A, 2012, IEEE ENG MED BIO, P5368, DOI 10.1109/EMBC.2012.6347207; Paragios N, 2000, IEEE T PATTERN ANAL, V22, P266, DOI 10.1109/34.841758; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Plueimpitiwiriyawej C, 2005, IEEE T MED IMAGING, V24, P593, DOI 10.1109/TMI.2005.843740; Pock T, 2009, PROC CVPR IEEE, P810, DOI 10.1109/CVPRW.2009.5206604; Ray N, 2002, IEEE T MED IMAGING, V21, P1222, DOI 10.1109/TMI.2002.806291; Schoenemann T, 2009, IEEE I CONF COMP VIS, P17, DOI 10.1109/ICCV.2009.5459209; TERZOPOULOS D, 1988, ARTIF INTELL, V36, P91, DOI 10.1016/0004-3702(88)90080-X; Tsai A, 2003, IEEE T MED IMAGING, V22, P137, DOI 10.1109/TMI.2002.808355; Unsworth CP, 2006, NEURAL COMPUT, V18, P2122, DOI 10.1162/neco.2006.18.9.2122; Unsworth CP, 2011, BIOMATERIALS, V32, P6541, DOI 10.1016/j.biomaterials.2011.05.041; Unsworth CR, 2011, BIOMATERIALS, V32, P2566, DOI 10.1016/j.biomaterials.2010.12.017; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vazquez-Reina A, 2009, PROC CVPR IEEE, P2020, DOI 10.1109/CVPRW.2009.5206524; Vese LA, 2002, INT J COMPUT VISION, V50, P271, DOI 10.1023/A:1020874308076; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Xie XH, 2008, IEEE T PATTERN ANAL, V30, P632, DOI 10.1109/TPAMI.2007.70737; Xu CY, 2000, CONF REC ASILOMAR C, P483, DOI 10.1109/ACSSC.2000.911003; Yarrow JC, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-21; Yin ZZ, 2011, I S BIOMED IMAGING, P909, DOI 10.1109/ISBI.2011.5872551; Yin ZZ, 2010, LECT NOTES COMPUT SC, V6361, P209; ZERLIN M, 1995, J NEUROSCI, V15, P7238	57	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82883	10.1371/journal.pone.0082883	http://dx.doi.org/10.1371/journal.pone.0082883			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358233	Green Submitted, gold, Green Published			2022-12-27	WOS:000328737700036
J	Jiang, GH; Wen, X; Qiu, YW; Zhang, RB; Wang, JJ; Li, M; Ma, XF; Tian, JZ; Huang, RW				Jiang, Guihua; Wen, Xue; Qiu, Yingwei; Zhang, Ruibin; Wang, Junjing; Li, Meng; Ma, Xiaofen; Tian, Junzhang; Huang, Ruiwang			Disrupted Topological Organization in Whole-Brain Functional Networks of Heroin-Dependent Individuals: A Resting-State fMRI Study	PLOS ONE			English	Article							SMALL-WORLD; DRUG-ADDICTION; DECISION-MAKING; CORTICAL NETWORKS; OPIOID RECEPTORS; COCAINE USERS; CONNECTIVITY; MEMORY; ABNORMALITIES; NEUROBIOLOGY	Neuroimaging studies have shown that heroin addiction is related to abnormalities in widespread local regions and in the functional connectivity of the brain. However, little is known about whether heroin addiction changes the topological organization of whole-brain functional networks. Seventeen heroin-dependent individuals (HDIs) and 15 age-, gender-matched normal controls (NCs) were enrolled, and the resting-state functional magnetic resonance images (RS-fMRI) were acquired from these subjects. We constructed the brain functional networks of HDIs and NCs, and compared the between-group differences in network topological properties using graph theory method. We found that the HDIs showed decreases in the normalized clustering coefficient and in small-worldness compared to the NCs. Furthermore, the HDIs exhibited significantly decreased nodal centralities primarily in regions of cognitive control network, including the bilateral middle cingulate gyrus, left middle frontal gyrus, and right precuneus, but significantly increased nodal centralities primarily in the left hippocampus. The between-group differences in nodal centralities were not corrected by multiple comparisons suggesting these should be considered as an exploratory analysis. Moreover, nodal centralities in the left hippocampus were positively correlated with the duration of heroin addiction. Overall, our results indicated that disruptions occur in the whole-brain functional networks of HDIs, findings which may be helpful in further understanding the mechanisms underlying heroin addiction.	[Jiang, Guihua; Qiu, Yingwei; Ma, Xiaofen; Tian, Junzhang] Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China; [Wen, Xue; Zhang, Ruibin; Wang, Junjing; Li, Meng; Huang, Ruiwang] S China Normal Univ, Sch Psychol, Key Lab Mental Hlth & Cognit Sci Guangdong Prov, Ctr Study Appl Psychol, Guangzhou, Guangdong, Peoples R China	South China Normal University	Tian, JZ (corresponding author), Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China.	jz.tian@163.com; ruiwang.huang@gmail.com	meng, li/GVT-2063-2022	Tian, Junzhang/0000-0002-6212-1882; Qiu, Yingwei/0000-0003-1298-8506	Guangdong No. 2 Provincial People's Hospital; National Natural Science Foundation of China [81071149, 81271548, 81371535]; Science and Technology Planning Project of Guangdong Province, China [2011B031800044, 2010B031600116]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	Guangdong No. 2 Provincial People's Hospital; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was partially supported by the Guangdong No. 2 Provincial People's Hospital, the funding of National Natural Science Foundation of China (Grant numbers: 81071149, 81271548, and 81371535), the Science and Technology Planning Project of Guangdong Province, China (Grant numbers: 2011B031800044 and 2010B031600116), and the Scientific Research Foundation for the Returned Overseas Chinese Scholars (RH), State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Baumgartner U, 2006, NEUROIMAGE, V30, P692, DOI 10.1016/j.neuroimage.2005.10.033; Becerra L, 2006, ANESTH ANALG, V103, P208, DOI 10.1213/01.ane.0000221457.71536.e0; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; DACKIS CA, 1985, NEUROSCI BIOBEHAV R, V9, P469, DOI 10.1016/0149-7634(85)90022-3; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Ersche KD, 2006, PSYCHOPHARMACOLOGY, V188, P364, DOI 10.1007/s00213-006-0515-z; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Gorelick DA, 2005, BIOL PSYCHIAT, V57, P1573, DOI 10.1016/j.biopsych.2005.02.026; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; Henriksen G, 2008, BRAIN, V131, P1171, DOI 10.1093/brain/awm255; Jager G, 2010, J AM ACAD CHILD PSY, V49, P561, DOI 10.1016/j.jaac.2010.02.001; Jiang GH, 2011, NEUROIMAGE, V57, P149, DOI 10.1016/j.neuroimage.2011.04.004; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kanayama G, 2004, PSYCHOPHARMACOLOGY, V176, P239, DOI 10.1007/s00213-004-1885-8; Kaufman JN, 2003, J NEUROSCI, V23, P7839; Khalili-Mahani N, 2012, HUM BRAIN MAPP, V33, P1003, DOI 10.1002/hbm.21265; Lee TMC, 2005, NEUROSCI LETT, V382, P211, DOI 10.1016/j.neulet.2005.03.053; Li XY, 2013, DRUG ALCOHOL DEPEN, V130, P61, DOI 10.1016/j.drugalcdep.2012.10.012; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Liu HH, 2008, AM J DRUG ALCOHOL AB, V34, P562, DOI 10.1080/00952990802295238; Liu JX, 2009, NEUROSCI LETT, V460, P72, DOI 10.1016/j.neulet.2009.05.038; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lopez-Larson MP, 2011, BEHAV BRAIN RES, V220, P164, DOI 10.1016/j.bbr.2011.02.001; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Ma N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016560; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; MacIntosh BJ, 2008, J CEREBR BLOOD F MET, V28, P1514, DOI 10.1038/jcbfm.2008.46; Prosser J, 2009, DRUG ALCOHOL DEPEN, V104, P228, DOI 10.1016/j.drugalcdep.2009.04.022; Qiu YW, 2011, RADIOLOGY, V261, P551, DOI 10.1148/radiol.11102466; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Riedel G, 2001, PROG NEURO-PSYCHOPH, V25, P835, DOI 10.1016/S0278-5846(01)00153-1; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Scott DJ, 2007, NEUROPSYCHOPHARMACOL, V32, P450, DOI 10.1038/sj.npp.1301238; Spreng RN, 2012, CEREB CORTEX, V22, P2610, DOI 10.1093/cercor/bhr339; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Sutherland MT, 2012, NEUROIMAGE, V62, P2281, DOI 10.1016/j.neuroimage.2012.01.117; Tang YL, 2006, ADDICTION, V101, P657, DOI 10.1111/j.1360-0443.2006.01367.x; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tononi G, 1998, TRENDS COGN SCI, V2, P474, DOI 10.1016/S1364-6613(98)01259-5; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vassileva J, 2007, DRUG ALCOHOL DEPEN, V86, P287, DOI 10.1016/j.drugalcdep.2006.06.015; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang YR, 2011, NEUROSCI LETT, V494, P49, DOI 10.1016/j.neulet.2011.02.053; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Yuan K, 2010, NEUROSCI LETT, V477, P37, DOI 10.1016/j.neulet.2010.04.032; Yuan K, 2010, NEUROSCI LETT, V475, P20, DOI 10.1016/j.neulet.2010.03.033; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhang Y, 2011, BRAIN RES, V1402, P46, DOI 10.1016/j.brainres.2011.05.054; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	66	96	100	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82715	10.1371/journal.pone.0082715	http://dx.doi.org/10.1371/journal.pone.0082715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358220	Green Submitted, Green Published, gold			2022-12-27	WOS:000328737700028
J	Latifi, K; Feygelman, V; Moros, EG; Dilling, TJ; Stevens, CW; Zhang, GG				Latifi, Kujtim; Feygelman, Vladimir; Moros, Eduardo G.; Dilling, Thomas J.; Stevens, Craig W.; Zhang, Geoffrey G.			Normalization of Ventilation Data from 4D-CT to Facilitate Comparison between Datasets Acquired at Different Times	PLOS ONE			English	Article							DEFORMABLE IMAGE REGISTRATION; COMPUTED-TOMOGRAPHY DENSITY; NONRIGID REGISTRATION; REGIONAL VENTILATION; LUNG-FUNCTION; CT; VALIDATION; SPECT	Purpose: The 4D-CT data used for comparing a patient's ventilation distributions before and after lung radiotherapy are acquired at different times. As a result, an additional variable - the tidal volume (TV) - can alter the results. Therefore, in this paper we propose to normalize the ventilation to the same TV to eliminate that uncertainty. Methods: Absolute ventilation (AV) data were generated for 6 stereotactic body radiation therapy (SBRT) cases before and after treatment, using the direct geometric algorithm and diffeomorphic morphons deformable image registration (DIR). Each pair of AV distributions was converted to TV-normalized, percentile ventilation (PV) and low-dose well-ventilated-normalized ventilation (LDWV) distributions. The ventilation change was calculated in various dose regions based on the treatment plans using the DIR-registered before and after treatment data sets. The ventilation change based on TV-normalized ventilation was compared with the AV as well as the data normalized by PV and LDWV. Results: AV change may be misleading when the TV differs before and after treatment, which was found to be up to 6.7%. All three normalization methods produced a similar trend in ventilation change: the higher the dose to a region of lung, the greater the degradation in ventilation. In low dose regions (<5 Gy), ventilation appears relatively improved after treatment due to the relative nature of the normalized ventilation. However, the LDWV may not be reliable when the ventilation in the low-dose regions varies. PV exhibited a similar ventilation change trend compared to the TV-normalized in all cases. However, by definition, the ventilation distribution in the PV is significantly different from the original distribution. Conclusion: Normalizing ventilation distributions by the TV is a simple and reliable method for evaluation of ventilation changes.	[Latifi, Kujtim; Feygelman, Vladimir; Moros, Eduardo G.; Dilling, Thomas J.; Stevens, Craig W.; Zhang, Geoffrey G.] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute	Zhang, GG (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA.	Geoffrey.Zhang@Moffitt.org	Moros, Eduardo G./AAY-2771-2020	Moros, Eduardo G./0000-0003-1964-2460	Varian Medical Systems, Inc., Palo Alto, California	Varian Medical Systems, Inc., Palo Alto, California	This work was partially supported by a research grant from Varian Medical Systems, Inc., Palo Alto, California. decision to publish, or preparation of the manuscript. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis,	Castillo R, 2010, PHYS MED BIOL, V55, P4661, DOI 10.1088/0031-9155/55/16/004; Chon D, 2005, RESP PHYSIOL NEUROBI, V148, P65, DOI 10.1016/j.resp.2005.06.003; Ding K, 2012, MED PHYS, V39, P5084, DOI 10.1118/1.4736808; Ding K, 2010, MED PHYS, V37, P1261, DOI 10.1118/1.3312210; Du KF, 2012, MED PHYS, V39, P1595, DOI 10.1118/1.3685589; Guerrero T, 2005, INT J RADIAT ONCOL, V62, P630, DOI 10.1016/j.ijrobp.2005.03.023; Huang TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058886; Janssens G, 2009, MED PHYS, V36, P4268, DOI 10.1118/1.3194750; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Latifi K, 2013, J APPL CLIN MED PHYS, V14, P19, DOI 10.1120/jacmp.v14i1.3834; Petersson J, 2004, J APPL PHYSIOL, V96, P1127, DOI 10.1152/japplphysiol.00092.2003; Reinhardt JM, 2008, MED IMAGE ANAL, V12, P752, DOI 10.1016/j.media.2008.03.007; Simon BA, 2000, J CLIN MONITOR COMP, V16, P433, DOI 10.1023/A:1011444826908; Suga K, 2002, ANN NUCL MED, V16, P303, DOI 10.1007/BF02988614; Vinogradskiy YY, 2012, MED PHYS, V39, P289, DOI 10.1118/1.3668056; Wang H, 2005, PHYS MED BIOL, V50, P2887, DOI 10.1088/0031-9155/50/12/011; Wang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064665; Wrangsjo A, 2005, LECT NOTES COMPUT SC, V3540, P501; Yin YB, 2009, MED PHYS, V36, P4213, DOI 10.1118/1.3193526; Zhang G. G., 2009, 11th International Congress of the IUPESM. World Congress on Medical Physics and Biomedical Engineering. Image Processing, Biosignal Processing, Modelling and Simulation, Biomechanics, P1834, DOI 10.1007/978-3-642-03882-2_487; Zhang G, 2008, J APPL CLIN MED PHYS, V9, P59, DOI 10.1120/jacmp.v9i1.2738; Zhang G, 2011, PHYS MED BIOL, V56, P3445, DOI 10.1088/0031-9155/56/11/N03; Zhang GG, 2008, COMPUT METH PROG BIO, V90, P25, DOI 10.1016/j.cmpb.2007.11.015	23	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84083	10.1371/journal.pone.0084083	http://dx.doi.org/10.1371/journal.pone.0084083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358330	Green Submitted, Green Published, gold			2022-12-27	WOS:000328737700079
J	Mantella, NM; Kent, PF; Youngentob, SL				Mantella, Nicole M.; Kent, Paul F.; Youngentob, Steven L.			Fetal Nicotine Exposure Increases Preference for Nicotine Odor in Early Postnatal and Adolescent, but Not Adult, Rats	PLOS ONE			English	Article							GESTATIONAL ETHANOL EXPOSURE; NEUROPHYSIOLOGIC OLFACTORY RESPONSE; PRENATAL ALCOHOL EXPOSURE; MUCOSAL ACTIVITY PATTERNS; MATERNAL SMOKING; RECEPTOR SENSITIVITY; CIGARETTE-SMOKING; INFANT RATS; PREGNANCY; BULB	Human studies demonstrate a four-fold increased possibility of smoking in the children of mothers who smoked during pregnancy. Nicotine is the active addictive component in tobacco-related products, crossing the placenta and contaminating the amniotic fluid. It is known that chemosensory experience in the womb can influence postnatal odor-guided preference behaviors for an exposure stimulus. By means of behavioral and neurophysiologic approaches, we examined whether fetal nicotine exposure, using mini-osmotic pumps, altered the response to nicotine odor in early postnatal (P17), adolescent (P35) and adult (P90) progeny. Compared with controls, fetal exposed rats displayed an altered innate response to nicotine odor that was evident at P17, declined in magnitude by P35 and was absent at P90 - these effects were specific to nicotine odor. The behavioral effect in P17 rats occurred in conjunction with a tuned olfactory mucosal response to nicotine odor along with an untoward consequence on the epithelial response to other stimuli - these P17 neural effects were absent in P35 and P90 animals. The absence of an altered neural effect at P35 suggests that central mechanisms, such as nicotine-induced modifications of the olfactory bulb, bring about the altered behavioral response to nicotine odor. Together, these findings provide insights into how fetal nicotine exposure influences the behavioral preference and responsiveness to the drug later in life. Moreover, they add to a growing literature demonstrating chemosensory mechanisms by which patterns of maternal drug use can be conveyed to offspring, thereby enhancing postnatal vulnerability for subsequent use and abuse.	[Mantella, Nicole M.; Youngentob, Steven L.] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA; [Kent, Paul F.] SUNY Upstate Med Univ, Dept Neurol, Syracuse, NY 13210 USA; [Youngentob, Steven L.] SUNY Dev Exposure Alcohol Res Ctr, Syracuse, NY USA; [Youngentob, Steven L.] SUNY Dev Exposure Alcohol Res Ctr, Binghamton, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) System	Youngentob, SL (corresponding author), SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA.	youngens@upstate.edu			NIH-NIDA [1R21DA027740-01]; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027740] Funding Source: NIH RePORTER	NIH-NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH-NIDA Grant # 1R21DA027740-01 to SL Youngentob. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate P, 2001, ALCOHOL CLIN EXP RES, V25, P989, DOI 10.1111/j.1530-0277.2001.tb02307.x; Abate P, 2000, ALCOHOL CLIN EXP RES, V24, P39, DOI 10.1111/j.1530-0277.2000.tb04551.x; Alati R, 2006, ARCH GEN PSYCHIAT, V63, P1009, DOI 10.1001/archpsyc.63.9.1009; Baer JS, 1998, J STUD ALCOHOL, V59, P533, DOI 10.15288/jsa.1998.59.533; Baer JS, 2003, ARCH GEN PSYCHIAT, V60, P377, DOI 10.1001/archpsyc.60.4.377; BILKO A, 1994, PHYSIOL BEHAV, V56, P907, DOI 10.1016/0031-9384(94)90322-0; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; Bryant B, 2010, ACS CHEM NEUROSCI, V1, P246, DOI 10.1021/cn900042c; Buka SL, 2003, AM J PSYCHIAT, V160, P1978, DOI 10.1176/appi.ajp.160.11.1978; BUTLER NR, 1973, BRIT MED J, V4, P573, DOI 10.1136/bmj.4.5892.573; CARR LA, 1989, NEUROCHEM RES, V14, P511, DOI 10.1007/BF00964911; Chotro MG, 2007, NEUROSCI BIOBEHAV R, V31, P181, DOI 10.1016/j.neubiorev.2006.06.021; Chotro MG, 1996, ALCOHOL, V13, P377, DOI 10.1016/0741-8329(96)00027-4; COOPERSMITH R, 1986, DEV BRAIN RES, V27, P191, DOI 10.1016/0165-3806(86)90245-2; Cornelius M D, 2000, Nicotine Tob Res, V2, P45; DENSON R, 1975, CAN PSYCHIAT ASSOC J, V20, P183, DOI 10.1177/070674377502000302; DIFRANZA JR, 1995, J FAM PRACTICE, V40, P385; Doucette W, 2008, PLOS BIOL, V6, P2266, DOI 10.1371/journal.pbio.0060258; Eade AM, 2010, ALCOHOL CLIN EXP RES, V34, P206, DOI 10.1111/j.1530-0277.2009.01083.x; Eade AM, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-3; EDWARDS DA, 1987, EXPERIENTIA, V43, P868, DOI 10.1007/BF01951644; Elliott BM, 2006, PRENATAL NICOTINE EX, P329; Ernst M, 2001, J AM ACAD CHILD PSY, V40, P630, DOI 10.1097/00004583-200106000-00007; ESKENAZI B, 1995, AM J EPIDEMIOL, V142, pS19, DOI 10.1093/aje/142.Supplement_9.S19; Faas AE, 2000, ALCOHOL, V22, P7, DOI 10.1016/S0741-8329(00)00103-8; Fielding JE, 1998, TOBACCO HLTH EFFECTS, P817; GERVAIS R, 1988, CHEM SENSES, V13, P3, DOI 10.1093/chemse/13.1.3; GESTELAND RC, 1982, NEUROSCIENCE, V7, P3127, DOI 10.1016/0306-4522(82)90235-4; Getchell TV., 1991, SMELL TASTE HLTH DIS, P19; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Hannigan JH, 1999, ALCOHOL ALCOHOLISM E; Hudson R, 1998, ANN NY ACAD SCI, V855, P109, DOI 10.1111/j.1749-6632.1998.tb10552.x; Hudson R, 1999, J COMP PHYSIOL A, V185, P297, DOI 10.1007/s003590050390; Hudson Robyn, 1993, Current Opinion in Neurobiology, V3, P548, DOI 10.1016/0959-4388(93)90054-3; Hussein J, 2007, TOXICOL APPL PHARM, V218, P1, DOI 10.1016/j.taap.2006.10.019; KANDEL DB, 1994, AM J PUBLIC HEALTH, V84, P1407, DOI 10.2105/AJPH.84.9.1407; KAUER JS, 1974, J PHYSIOL-LONDON, V243, P717, DOI 10.1113/jphysiol.1974.sp010773; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; KENT PF, 1995, J NEUROPHYSIOL, V74, P1777, DOI 10.1152/jn.1995.74.4.1777; Kent PF, 2003, BRAIN RES, V981, P1, DOI 10.1016/S0006-8993(03)02512-5; KRISTJANSSON EA, 1989, DRUG ALCOHOL DEPEN, V24, P11, DOI 10.1016/0376-8716(89)90003-3; LAING DG, 1980, PHYSIOL BEHAV, V25, P555, DOI 10.1016/0031-9384(80)90121-3; LAING DG, 1978, J COMP PHYSIOL, V124, P259, DOI 10.1007/BF00657057; LICHTENSTEIGER W, 1988, PROG BRAIN RES, V73, P137; MACKAYSIM A, 1994, J NEUROPHYSIOL, V71, P150, DOI 10.1152/jn.1994.71.1.150; Matta SG, 2007, PSYCHOPHARMACOLOGY, V193, P199, DOI 10.1007/s00213-007-0767-2; McLean JH, 2004, NEUROREPORT, V15, P1691, DOI 10.1097/01.wnr.0000134988.51310.c3; McLean JH, 1999, LEARN MEMORY, V6, P608, DOI 10.1101/lm.6.6.608; McMurray MS, 2008, NEUROTOXICOL TERATOL, V30, P475, DOI 10.1016/j.ntt.2008.07.001; Middleton FA, 2009, BRAIN RES, V1252, P105, DOI 10.1016/j.brainres.2008.11.023; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MURRIN LC, 1987, LIFE SCI, V40, P1699, DOI 10.1016/0024-3205(87)90020-8; NAEYE RL, 1992, J DEV BEHAV PEDIATR, V13, P425; Niaura R, 2001, AM J ADDICTION, V10, P16, DOI 10.1080/105504901750160420; Pritchard WS, 1996, PSYCHOPHARMACOLOGY, V127, P55, DOI 10.1007/BF02805975; ROSE JE, 1985, PHARMACOL BIOCHEM BE, V23, P289, DOI 10.1016/0091-3057(85)90572-6; Roth TL, 2003, PHYSIOL BEHAV, V78, P135, DOI 10.1016/S0031-9384(02)00961-7; Roth TL, 2001, DEV PSYCHOBIOL, V39, P188, DOI 10.1002/dev.1044; Salcedo E, 2005, CHEM SENSES, V30, P615, DOI 10.1093/chemse/bji055; SEMKE E, 1995, NATURWISSENSCHAFTEN, V82, P148; Slotkin TA, 1998, J PHARMACOL EXP THER, V285, P931; Smotherman W. P., 1987, PERINATAL DEV PSYCHO, P39; SMOTHERMAN WP, 1982, PHYSIOL BEHAV, V29, P769, DOI 10.1016/0031-9384(82)90322-5; SMOTHERMAN WP, 1988, BEHAV NEUROSCI, V102, P24, DOI 10.1037/0735-7044.102.1.24; SMOTHERMAN WP, 1985, BEHAV NEUROSCI, V99, P521, DOI 10.1037/0735-7044.99.3.521; SMOTHERMAN WP, 1990, PHYSIOL BEHAV, V47, P863, DOI 10.1016/0031-9384(90)90010-2; SMOTHERMAN WP, 1987, DEV PSYCHOBIOL, V20, P415, DOI 10.1002/dev.420200406; SMOTHERMAN WP, 1982, BEHAV NEURAL BIOL, V36, P61, DOI 10.1016/S0163-1047(82)90245-X; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Spear NE, 2005, ALCOHOL CLIN EXP RES, V29, P909, DOI 10.1097/01.ALC.0000171046.78556.66; STICKROD G, 1982, PHYSIOL BEHAV, V28, P5, DOI 10.1016/0031-9384(82)90093-2; Sullivan RM, 2000, BEHAV NEUROSCI, V114, P957, DOI 10.1037/0735-7044.114.5.957; SULLIVAN RM, 1989, J NEUROSCI, V9, P3998; Thapar A, 2003, AM J PSYCHIAT, V160, P1985, DOI 10.1176/appi.ajp.160.11.1985; Thuerauf N, 2006, NEUROPSYCHOPHARMACOL, V31, P450, DOI 10.1038/sj.npp.1300842; Trauth JA, 2000, BRAIN RES, V867, P29, DOI 10.1016/S0006-8993(00)02208-3; Ulrich YM, 1997, NEUROPHARMACOLOGY, V36, P1119, DOI 10.1016/S0028-3908(97)00107-X; Vaglenova J, 2004, BEHAV BRAIN RES, V150, P159, DOI 10.1016/j.bbr.2003.07.005; Voznessenskaya VV, 1995, ADV BIOSCI, V93, P399; WANG HW, 1993, SCIENCE, V260, P998, DOI 10.1126/science.8493539; Williams SK, 2009, NEUROTOXICOL TERATOL, V31, P291, DOI 10.1016/j.ntt.2009.06.001; WILSON DA, 1988, DEV BRAIN RES, V42, P69, DOI 10.1016/0165-3806(88)90202-7; WILSON DA, 1990, DEV BRAIN RES, V53, P215, DOI 10.1016/0165-3806(90)90009-N; WYSOCKI CJ, 1989, P NATL ACAD SCI USA, V86, P7976, DOI 10.1073/pnas.86.20.7976; Yates WR, 1998, ALCOHOL ALCOHOLISM, V33, P488, DOI 10.1093/alcalc/33.5.488; Youngentob SL, 2005, CHEM SENSES, V30, P219, DOI 10.1093/chemse/bji017; YOUNGENTOB SL, 1995, J NEUROPHYSIOL, V73, P387, DOI 10.1152/jn.1995.73.1.387; YOUNGENTOB SL, 1995, BRAIN RES, V670, P82, DOI 10.1016/0006-8993(94)01275-M; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4; Youngentob SL, 2007, BEHAV NEUROSCI, V121, P1293, DOI 10.1037/0735-7044.121.6.1293; Youngentob SL, 2007, BEHAV NEUROSCI, V121, P1306, DOI 10.1037/0735-7044.121.6.1306; Youngentob SL, 2012, EXP BIOL MED, V237, P1197, DOI 10.1258/ebm.2012.012132; Youngentob SL, 2006, BEHAV NEUROSCI, V120, P1346, DOI 10.1037/0735-7044.120.6.1346; Youngentob SL, 2009, P NATL ACAD SCI USA, V106, P5359, DOI 10.1073/pnas.0809804106	94	11	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84989	10.1371/journal.pone.0084989	http://dx.doi.org/10.1371/journal.pone.0084989			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358374	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700108
J	Boukary, AR; Saegerman, C; Abatih, E; Fretin, D; Bada, RA; De Deken, R; Harouna, HA; Yenikoye, A; Thys, E				Boukary, Abdou Razac; Saegerman, Claude; Abatih, Emmanuel; Fretin, David; Bada, Rianatou Alambedji; De Deken, Reginald; Harouna, Halimatou Adamou; Yenikoye, Alhassane; Thys, Eric			Seroprevalence and Potential Risk Factors for Brucella Spp. Infection in Traditional Cattle, Sheep and Goats Reared in Urban, Periurban and Rural Areas of Niger	PLOS ONE			English	Article							BOVINE BRUCELLOSIS; DIAGNOSIS; IDENTIFICATION; SEROPOSITIVITY; EPIDEMIOLOGY; PREVALENCE; LIVESTOCK; AFRICA; ZONE	Introduction: In Niamey, Niger, interactions within the interface between animals, humans and the environment induce a potential risk of brucellosis transmission between animals and from animals to humans. Currently, little is known about the transmission of Brucella in this context. Results: 5,192 animals from 681 herds were included in the study. Serum samples and hygroma fluids were collected. A household survey enabled to identify the risk factors for transmission of brucellosis. The true adjusted herd-level prevalence of brucellosis ranged between 11.2% and 17.2% and the true adjusted animal-population level prevalence was 1.3% (95% CI: 0.9-1.8%) based on indirect ELISA test for Brucella antibodies. Animals aged of 1-4 years were found to be more susceptible than animals less than 1 year old (Odds ratio [OR] of 2.7; 95% CI: 1.43-5.28). For cattle, the odds of brucellosis seropositivity were higher in rural compared to the periurban areas (OR of 2.8; 95% CI: 1.48-5.17) whereas for small ruminants the risk of seropositivity appeared to be higher in urban compared to periurban areas (OR of 5.5; 95% CI: 1.48-20.38). At herd level, the risk of transmission was increased by transhumance (OR of 5.4; 95% CI: 2.84-10.41), the occurrence of abortions (OR of 3.0; 95% CI: 1.40-6.41), and for herds having more than 50 animals (OR of 11.0; 95% CI: 3.75-32.46). Brucella abortus biovar 3 was isolated from the hygromas. Conclusion: brucellosis in Niger is a serious problem among cattle especially in the rural areas around Niamey and among sheep in the urban areas of Niamey. The seroprevalence varies across strata and animal species with important risk factors including herd size, abortion and transhumance at herd level and age at animal population level. For effective control of brucellosis, an integrated approach seems appropriate involving all stakeholders working in public and animal health.	[Boukary, Abdou Razac] ONG Karkara, Dept Livestock Promot & Management Nat Resources, Niamey, Niger; [Boukary, Abdou Razac; Saegerman, Claude] Univ Liege, Res Unit Epidemiol & Risk Anal Appl Vet Sci UREAR, Dept Infect & Parasit Dis, Liege, Belgium; [Boukary, Abdou Razac; Abatih, Emmanuel; De Deken, Reginald; Thys, Eric] Inst Trop Med, Unit Biostat & Epidemiol, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Fretin, David] Vet & Agrochem Res Ctr, Dept Bacteriol & Immunol, Uccle, Belgium; [Bada, Rianatou Alambedji] Interstate Sch Vet Sci & Med, Serv Microbiol Immunol Infect Pathol, Dakar, Senegal; [Harouna, Halimatou Adamou] Direct Anim Hlth, Minist Livestock, Maradi, Niger; [Boukary, Abdou Razac; Yenikoye, Alhassane] Univ Niamey, Fac Agron, Niamey, Niger	University of Liege; Institute of Tropical Medicine (ITM)	Thys, E (corresponding author), Inst Trop Med, Unit Biostat & Epidemiol, Dept Biomed Sci, B-2000 Antwerp, Belgium.	ethys@itg.be		Saegerman, Claude/0000-0001-9087-7436	Belgian Directorate for Development (DGD)	Belgian Directorate for Development (DGD)	The authors wish to thank the Belgian Directorate for Development (DGD) for funding this study and VAR-Belgium for the contribution in the laboratory tests. DGD had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. VAR had a role in the analysis and preparation of the manuscript.	ACHA P., 2005, ZOONOSES MALADIES TR; Akakpo A J, 1987, Rev Sci Tech, V6, P981, DOI 10.20506/rst.6.4.313; Akakpo A J, 1986, Rev Elev Med Vet Pays Trop, V39, P175; Alton GG, 1988, TECHNIQUES BRUCELLOS, p[29, 82]; Bankole AA, 2010, VET REC, V166, P753, DOI 10.1136/vr.b4862; Benkirane A., 2001, ORIENT REV SCI TECH, V20, P757; Bernard F, 2005, PREV VET MED, V67, P267, DOI 10.1016/j.prevetmed.2004.11.002; Bloch N, 1991, Rev Elev Med Vet Pays Trop, V44, P117; Boukary A. R., 2010, Globalization of tropical animal diseases and public health concerns. Proceedings of the 13th Association of Institutions for Tropical Veterinary Medicine (AITVM) Conference, Bangkok, Thailand, 23-26 August 2010, P22; Boukary AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024629; Boukary AR., 2007, REV ELEV MED VET PAY, V60, P113; Cadmus S.I.B., 2006, AFR J BIOMED RES, V9, P163, DOI DOI 10.4314/ajbr.v9i3.48900; Chimana HM, 2010, TROP ANIM HEALTH PRO, V42, P1541, DOI 10.1007/s11250-010-9604-4; Corbel M., 1988, BRUCELLOSIS FERTILIT, V4th, P190; Corbel MJ, 1984, BERGEYS MANUAL SYSTE, P377; DOMENECH J, 1983, REV ELEV MED VET PAY, V36, P19; Ferreira AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042514; Frankena K, 2009, PREV VET MED, V88, P150, DOI 10.1016/j.prevetmed.2008.08.004; Gidel R., 1974, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V27, P403; Halling SM, 1994, FOODBORNE DIS HDB DI, P63; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Holt HR, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-341; Ibrahim N, 2010, TROP ANIM HEALTH PRO, V42, P35, DOI 10.1007/s11250-009-9382-z; Kangethe EK, 2007, E AFR MED J, V84, P96; Kore H., 2005, REPOL; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; LIMET JN, 1988, ANN MED VET, V132, P565; LY C., 2007, AGR ELEVAGE PAUVRETE, P71; Makita K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-60; Mangen MJ, 2002, BOVINE BRUCELLOSIS S; Matope G, 2010, PREV VET MED, V94, P213, DOI 10.1016/j.prevetmed.2010.01.003; McDermott JJ, 2002, VET MICROBIOL, V90, P111, DOI 10.1016/S0378-1135(02)00249-3; Megersa B, 2011, TROP ANIM HEALTH PRO, V43, P651, DOI 10.1007/s11250-010-9748-2; Mekonnen H, 2010, PREV VET MED, V94, P28, DOI 10.1016/j.prevetmed.2009.12.001; MERLE F., 1953, BULL SOC PATH EXOT, V46, P211; Muendo EN, 2012, TROP ANIM HEALTH PRO, V44, P17, DOI 10.1007/s11250-011-9899-9; Muma JB, 2007, REV SCI TECH OIE, V26, P721, DOI 10.20506/rst.26.3.1782; Musa M. T., 2001, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V54, P11; Nielsen K, 2002, VET MICROBIOL, V90, P447, DOI 10.1016/S0378-1135(02)00229-8; Olsen S, 2010, VET CLIN N AM-FOOD A, V26, P15, DOI 10.1016/j.cvfa.2009.10.006; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Saegerman C, 2004, VET MICROBIOL, V100, P91, DOI 10.1016/j.vetmic.2004.02.003; Saegerman C., 2010, INFECT PARASITIC DIS, P971; Sanogo M., 2008, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V61, P147; Sanogo M, 2012, PREV VET MED, V107, P51, DOI 10.1016/j.prevetmed.2012.05.010; Schelling E, 2003, PREV VET MED, V61, P279, DOI 10.1016/j.prevetmed.2003.08.004; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Solorio-Rivera JL, 2007, PREV VET MED, V82, P282, DOI 10.1016/j.prevetmed.2007.05.024; Thrusfield M, 2005, VET EPIDEMIOLOGY, VThird, P228; Thys E., 2005, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V58, P205; Thys E, 2006, OUTLOOK AGR, V35, P7, DOI 10.5367/000000006776207654; TURKSON PK, 1992, ACTA TROP, V52, P39, DOI 10.1016/0001-706X(92)90005-I; Twisk JWR, 2003, APPL LONGITUDINAL DA; VERGER JM, 1979, REV ELEV MED VET PAY, V32, P25, DOI 10.19182/remvt.8185; Wagner B, 2004, PREV VET MED, V66, P1, DOI 10.1016/j.prevetmed.2004.07.008	55	50	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83175	10.1371/journal.pone.0083175	http://dx.doi.org/10.1371/journal.pone.0083175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358261	gold, Green Published			2022-12-27	WOS:000328735700109
J	Jarman, SN; McInnes, JC; Faux, C; Polanowski, AM; Marthick, J; Deagle, BE; Southwell, C; Emmerson, L				Jarman, Simon N.; McInnes, Julie C.; Faux, Cassandra; Polanowski, Andrea M.; Marthick, James; Deagle, Bruce E.; Southwell, Colin; Emmerson, Louise			Adelie Penguin Population Diet Monitoring by Analysis of Food DNA in Scats	PLOS ONE			English	Article							BECHERVAISE-ISLAND; TEMPORAL VARIATION; MARINE ECOSYSTEM; FORAGING EFFORT; PREY DNA; KRILL; INDICATORS; PREDATION; IDENTIFICATION; AMPLIFICATION	The Adelie penguin is the most important animal currently used for ecosystem monitoring in the Southern Ocean. The diet of this species is generally studied by visual analysis of stomach contents; or ratios of isotopes of carbon and nitrogen incorporated into the penguin from its food. There are significant limitations to the information that can be gained from these methods. We evaluated population diet assessment by analysis of food DNA in scats as an alternative method for ecosystem monitoring with Adelie penguins as an indicator species. Scats were collected at four locations, three phases of the breeding cycle, and in four different years. A novel molecular diet assay and bioinformatics pipeline based on nuclear small subunit ribosomal RNA gene (SSU rDNA) sequencing was used to identify prey DNA in 389 scats. Analysis of the twelve population sample sets identified spatial and temporal dietary change in Adelie penguin population diet. Prey diversity was found to be greater than previously thought. Krill, fish, copepods and amphipods were the most important food groups, in general agreement with other Adelie penguin dietary studies based on hard part or stable isotope analysis. However, our DNA analysis estimated that a substantial portion of the diet was gelatinous groups such as jellyfish and comb jellies. A range of other prey not previously identified in the diet of this species were also discovered. The diverse prey identified by this DNA-based scat analysis confirms that the generalist feeding of Adelie penguins makes them a useful indicator species for prey community composition in the coastal zone of the Southern Ocean. Scat collection is a simple and non-invasive field sampling method that allows DNA-based estimation of prey community differences at many temporal and spatial scales and provides significant advantages over alternative diet analysis approaches.	[Jarman, Simon N.; McInnes, Julie C.; Faux, Cassandra; Polanowski, Andrea M.; Deagle, Bruce E.; Southwell, Colin; Emmerson, Louise] Australian Antarctic Div, Kingston, Tas, Australia; [Marthick, James] Menzies Res Inst Tasmania, Hobart, Tas, Australia	Australian Antarctic Division; University of Tasmania	Jarman, SN (corresponding author), Australian Antarctic Div, Kingston, Tas, Australia.	simon.jarman@aad.gov.au	McInnes, Julie/C-2865-2014; Deagle, Bruce E/R-2999-2019; Jarman, Simon/H-9265-2016	Deagle, Bruce E/0000-0001-7651-3687; Polanowski, Andrea/0000-0002-9612-220X; Jarman, Simon/0000-0002-0792-9686; McInnes, Julie/0000-0001-8902-5199	Australian Antarctic Science projects [2926, 4014, 2722, 4088]	Australian Antarctic Science projects	This work was funded by Australian Antarctic Science projects numbers 2926, 4014, 2722 and 4088. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew DJ, 1997, ANTARCT SCI, V9, P235, DOI 10.1017/S095410209700031X; Ainley D.G., 1983, BREEDING BIOL ADELIE; Ainley D, 2010, ECOL MONOGR, V80, P49, DOI 10.1890/08-2289.1; Ainley DG, 2003, CONDOR, V105, P95, DOI 10.1650/0010-5422(2003)105[95:SATVOD]2.0.CO;2; Ainley DG, 1998, POLAR BIOL, V20, P311, DOI 10.1007/s003000050308; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ATES RML, 1991, HYDROBIOLOGIA, V216, P305, DOI 10.1007/BF00026479; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Bearhop S, 2006, MAR ECOL PROG SER, V311, P157, DOI 10.3354/meps311157; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Boyd IL, 2001, J ANIM ECOL, V70, P747, DOI 10.1046/j.0021-8790.2001.00534.x; Brierley AS, 2002, ADV MAR BIOL, V43, P171, DOI 10.1016/S0065-2881(02)43005-2; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cimino MA, 2013, GLOBAL CHANGE BIOL, V19, P136, DOI 10.1111/gcb.12016; Clarke J, 1998, POLAR BIOL, V20, P248, DOI 10.1007/s003000050301; Clarke J., 1994, CCAMLR SCI, V1, P155; Clarke JR, 2001, POLAR BIOL, V24, P16, DOI 10.1007/s003000000168; Constable AJ, 2000, ICES J MAR SCI, V57, P778, DOI 10.1006/jmsc.2000.0725; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Deagle BE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000831; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; Diamond AW, 2003, ENVIRON MONIT ASSESS, V88, P153, DOI 10.1023/A:1025560805788; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Emmerson LM, 2003, CCAMLR SCI, V10, P75; Emmerson L, 2008, ECOLOGY, V89, P2096, DOI 10.1890/08-0011.1; Emmerson L, 2011, OECOLOGIA, V167, P951, DOI 10.1007/s00442-011-2044-7; Emslie SD, 2007, P NATL ACAD SCI USA, V104, P11666, DOI 10.1073/pnas.0608477104; Griffiths R, 1996, P ROY SOC B-BIOL SCI, V263, P1251, DOI 10.1098/rspb.1996.0184; HARRISON NM, 1984, LIMNOL OCEANOGR, V29, P1335, DOI 10.4319/lo.1984.29.6.1335; Jarman SN, 2002, MOL ECOL, V11, P2679, DOI 10.1046/j.1365-294X.2002.01641.x; Kawaguchi S, 2011, BIOL LETTERS, V7, P288, DOI 10.1098/rsbl.2010.0777; Kozlov A.N., 1995, CCAMLR Science, V2, P71; Lynam CP, 2006, CURR BIOL, V16, pR492, DOI 10.1016/j.cub.2006.06.018; Lyver PO, 2011, POLAR BIOL, V34, P49, DOI 10.1007/s00300-010-0858-0; MANTEL N, 1967, CANCER RES, V27, P209; Morinha F, 2012, THERIOGENOLOGY, V78, P703, DOI 10.1016/j.theriogenology.2012.04.015; Murray DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025776; Nicol S, 2012, FISH FISH, V13, P30, DOI 10.1111/j.1467-2979.2011.00406.x; O'Rorke R, 2012, MOL ECOL RESOUR, V12, P5, DOI 10.1111/j.1755-0998.2011.03091.x; OFFREDO C, 1985, MAR BIOL, V86, P199, DOI 10.1007/BF00399027; Pakhomov EA, 1999, J MARINE SYST, V19, P47, DOI 10.1016/S0924-7963(98)00023-2; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Parsons M, 2008, ICES J MAR SCI, V65, P1520, DOI 10.1093/icesjms/fsn155; Polito MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026642; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; PUDDICOMBE RA, 1988, HYDROBIOLOGIA, V165, P239, DOI 10.1007/BF00025593; Reid K, 2005, ICES J MAR SCI, V62, P366, DOI 10.1016/j.icesjms.2004.11.003; Rombola E, 2003, POLAR BIOL, V26, P41, DOI 10.1007/s00300-002-0444-1; Schmidt K, 2003, LIMNOL OCEANOGR, V48, P277, DOI 10.4319/lo.2003.48.1.0277; Tierney M, 2009, MAR BIOL, V156, P1633, DOI 10.1007/s00227-009-1199-9; Vestheim H, 2011, METHODS MOL BIOL, V687, P265, DOI 10.1007/978-1-60761-944-4_19; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; Vinnikov KY, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025282; WILSON RP, 1984, J FIELD ORNITHOL, V55, P109	57	88	90	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82227	10.1371/journal.pone.0082227	http://dx.doi.org/10.1371/journal.pone.0082227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358158	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700047
J	Najafpanah, MJ; Sadeghi, M; Bakhtiarizadeh, MR				Najafpanah, Mohammad Javad; Sadeghi, Mostafa; Bakhtiarizadeh, Mohammad Reza			Reference Genes Selection for Quantitative Real-Time PCR Using RankAggreg Method in Different Tissues of Capra hircus	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; HUMAN ADIPOSE-TISSUE; RT-PCR; MESSENGER-RNA; CHROMIUM SUPPLEMENTATION; RELATIVE QUANTIFICATION; HOUSEKEEPING GENES; EXPRESSION; NORMALIZATION; VALIDATION	Identification of reference genes with stable levels of gene expression is an important prerequisite for obtaining reliable results in analysis of gene expression data using quantitative real time PCR (RT-qPCR). Since the underlying assumption of reference genes is that expressed at the exact same level in all sample types, in this study, we evaluated the expression stability of nine most commonly used endogenous controls (GAPDH, ACTB, 18S rRNA, RPS18, HSP-90, ALAS, HMBS, ACAC, and B2M) in four different tissues of the domestic goat, Capra hircus, including liver, visceral, subcutaneous fat and longissimus muscles, across different experimental treatments (a standard diet prepared using the NRC computer software as control and the same diet plus one mg chromium/day). We used six different software programs for ranking of reference genes and found that individual rankings of the genes differed among them. Additionally, there was a significant difference in ranking patterns of the studied genes among different tissues. A rank aggregation method was applied to combine the ranking lists of the six programs to a consensus ranking. Our results revealed that HSP-90 was nearly always among the two most stable genes in all studied tissues. Therefore, it is recommended for accurate normalization of RT-qPCR data in goats, while GAPDH, ACTB, and RPS18 showed the most varied expressions and should be avoided as reference genes.	[Najafpanah, Mohammad Javad; Sadeghi, Mostafa] Univ Tehran, Dept Anim Sci, Coll Agr & Nat Resources, Karaj, Iran; [Bakhtiarizadeh, Mohammad Reza] Univ Tehran, Dept Anim & Poultry Sci, Coll Aburaihan, Tehran, Iran	University of Tehran; University of Tehran	Najafpanah, MJ (corresponding author), Univ Tehran, Dept Anim Sci, Coll Agr & Nat Resources, Karaj, Iran.	mjnajafpanah@alumni.ut.ac.ir; sadeghimos@ut.ac.ir						Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson R.A., 1994, STRESS EFFECTS CHROM, P267; Becker C, 2011, ANALYST, V136, P1204, DOI 10.1039/c0an00703j; Beekman L, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-5; Bemeur C, 2004, NEUROSCI LETT, V357, P211, DOI 10.1016/j.neulet.2003.12.081; Bogaert L, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-24; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cankorur-Cetinkaya A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038351; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Condori Jose, 2011, BMC Res Notes, V4, P392, DOI 10.1186/1756-0500-4-392; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; El-Monem U. M. A., 2008, Egyptian Journal of Sheep and Goat Sciences, V3, P95; Emami A., 2012, Online Journal of Animal and Feed Research (OJAFR), V2, P127; Everaert BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023793; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Fulton L. K., 1994, ILAR News, V36, P21; Gabrielsson BG, 2005, OBES RES, V13, P649, DOI 10.1038/oby.2005.72; Haldar S, 2009, ANIMAL, V3, P209, DOI 10.1017/S1751731108003418; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Kadegowda AKG, 2009, J DAIRY SCI, V92, P2007, DOI 10.3168/jds.2008-1655; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kim Insook, 2011, BMC Res Notes, V4, P440, DOI 10.1186/1756-0500-4-440; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Lallemant B, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-78; Lardizabal MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036323; Lee JH, 2005, ARTHRITIS RHEUM-US, V52, P2386, DOI 10.1002/art.21215; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Maples NL, 2004, ENVIRON TOXICOL CHEM, V23, P626, DOI 10.1897/03-130; Mehta D, 2010, CURR PSYCHIAT REP, V12, P135, DOI 10.1007/s11920-010-0100-3; Neville MJ, 2011, OBESITY, V19, P888, DOI 10.1038/oby.2010.257; Ohl F, 2005, J MOL MED, V83, P1014, DOI 10.1007/s00109-005-0703-z; Ovesna J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041886; Pechova A, 2002, ACTA VET BRNO, V71, P9, DOI 10.2754/avb200271010009; Permenter MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027730; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Podevin N, 2012, MOL BREEDING, V30, P1237, DOI 10.1007/s11032-012-9711-1; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Sadeghi M, 2013, BIOL TRACE ELEMENT R, P1; Seol Dongrim, 2011, BMC Res Notes, V4, P162, DOI 10.1186/1756-0500-4-162; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Swijsen Ann, 2012, BMC Res Notes, V5, P685, DOI 10.1186/1756-0500-5-685; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Uddin Muhammad Jasim, 2011, BMC Res Notes, V4, P441, DOI 10.1186/1756-0500-4-441; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254; Zhang XZ, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-4	54	29	32	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83041	10.1371/journal.pone.0083041	http://dx.doi.org/10.1371/journal.pone.0083041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358246	Green Submitted, gold, Green Published			2022-12-27	WOS:000328735700102
J	Weenen, TC; Ramezanpour, B; Pronker, ES; Commandeur, H; Claassen, E				Weenen, Tamar C.; Ramezanpour, Bahar; Pronker, Esther S.; Commandeur, Harry; Claassen, Eric			Food-Pharma Convergence in Medical Nutrition - Best of Both Worlds?	PLOS ONE			English	Article							CROSS IMPACT ANALYSIS; FUNCTIONAL FOODS; PATENT CITATIONS; TECHNOLOGY; INNOVATION; INDUSTRY; NUTRACEUTICALS; ACCEPTANCE; DIFFUSION; PRODUCTS	At present, industries within the health and life science sector are moving towards one another resulting in new industries such as the medical nutrition industry. Medical nutrition products are specific nutritional compositions for intervention in disease progression and symptom alleviation. Industry convergence, described as the blurring of boundaries between industries, plays a crucial role in the shaping of new markets and industries. Assuming that the medical nutrition industry has emerged from the convergence between the food and pharma industries, it is crucial to research how and which distinct industry domains have contributed to establish this relatively new industry. The first two stages of industry convergence (knowledge diffusion and consolidation) are measured by means of patent analysis. First, the extent of knowledge diffusion within the medical nutrition industry is graphed in a patent citation interrelations network. Subsequently the consolidation based on technological convergence is determined by means of patent co-classification. Furthermore, the medical nutrition core domain and technology interrelations are measured by means of a cross impact analysis. This study proves that the medical nutrition industry is a result of food and pharma convergence. It is therefore crucial for medical nutrition companies to effectively monitor technological developments within as well as across industry boundaries. This study further reveals that although the medical nutrition industry's core technology domain is food, technological development is mainly driven by pharmaceutical/pharmacological technologies Additionally, the results indicate that the industry has surpassed the knowledge diffusion stage of convergence, and is currently in the consolidation phase of industry convergence. Nevertheless, while the medical nutrition can be classified as an industry in an advanced phase of convergence, one cannot predict that the pharma and food industry segments will completely converge or whether the medical industry will become an individual successful industry.	[Weenen, Tamar C.; Commandeur, Harry] Erasmus Univ, Fac Econ, Rotterdam, Netherlands; [Weenen, Tamar C.; Claassen, Eric] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Ramezanpour, Bahar; Claassen, Eric] Vrije Univ Amsterdam, Athena Inst, Amsterdam, Netherlands; [Pronker, Esther S.] Viroclin, Rotterdam, Netherlands; [Commandeur, Harry] Nyenrode Business Univ, Breukelen, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Nyenrode Business University	Weenen, TC (corresponding author), Erasmus Univ, Fac Econ, Rotterdam, Netherlands.	tamarchekaweenen@gmail.com	Han, KyungJu/J-5563-2014	Han, KyungJu/0000-0002-5006-1886				[Anonymous], 2001, 8498 NBER; Bagchi D, 2008, FOOD SCI TECHNOL-INT, P1; Blackman M, 1995, WORLD PATENT INFORM, V17, P115, DOI DOI 10.1016/0172-2190(95)00012-O; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; Bossink BAG, 2004, J CONSTR ENG M, V130, P337, DOI 10.1061/(ASCE)0733-9364(2004)130:3(337); Breschi S, 2003, RES POLICY, V32, P69, DOI 10.1016/S0048-7333(02)00004-5; Broring S, 2006, R&D MANAGE, V36, P487, DOI 10.1111/j.1467-9310.2006.00449.x; Broring S., 2007, CREAT INNOV MANAG, V16, P165, DOI DOI 10.1111/J.1467-8691.2007.00425.X; Chang SB, 2009, TECHNOL FORECAST SOC, V76, P107, DOI 10.1016/j.techfore.2008.03.014; Choi C, 2007, TECHNOL FORECAST SOC, V74, P1296, DOI 10.1016/j.techfore.2006.10.008; Csardi G, 2007, PHYSICA A, V374, P783, DOI 10.1016/j.physa.2006.08.022; Curran CS, 2011, TECHNOL FORECAST SOC, V78, P256, DOI 10.1016/j.techfore.2010.06.021; Curran CS, 2010, TECHNOL FORECAST SOC, V77, P385, DOI 10.1016/j.techfore.2009.10.002; Dahlin KB, 2005, RES POLICY, V34, P717, DOI 10.1016/j.respol.205.03.009; Dernis H, 2002, NEW SCI TECHNOLOGY I, V27, P129; Duysters G., 1998, INT J ECON BUS, V5, P355, DOI DOI 10.1080/13571519884431; El-Sohaimy S. A., 2012, World Applied Sciences Journal, V20, P691; ENZER S, 1972, FUTURES, V4, P30, DOI 10.1016/0016-3287(72)90023-7; Ernst H, 1997, SMALL BUS ECON, V9, P361, DOI 10.1023/A:1007921808138; Eussen SRBM, 2011, EUR J PHARMACOL, V668, pS2, DOI 10.1016/j.ejphar.2011.07.008; Furst P, 2000, NUTRITION, V16, P603, DOI 10.1016/S0899-9007(00)00321-X; Georgiou NA, 2011, EUR J PHARMACOL, V651, P1, DOI 10.1016/j.ejphar.2010.11.007; Geum Y, 2012, ETRI J, V34, P439, DOI 10.4218/etrij.12.1711.0010; Gilbert L., 1997, Journal of Nutraceuticals, Functional and Medical Foods, V1, P5; Greenstein S, 1997, COMPETING IN THE AGE OF DIGITAL CONVERGENCE, P201; Grunert KG, 2000, INT DAIRY J, V10, P575, DOI 10.1016/S0958-6946(00)00085-6; Hacklin F, 2008, CONTRIB MANAG SCI, P1, DOI 10.1007/978-3-7908-1990-8; Henry CJ, 2010, EUR J CLIN NUTR, V64, P657, DOI 10.1038/ejcn.2010.101; Howlett J, 2008, ILSI EUR CONCISE MON, P1; Hu AGZ, 2003, INT J IND ORGAN, V21, P849, DOI 10.1016/S0167-7187(03)00035-3; Jaffe A.B., 1999, EC INNOVATION NEW TE, V8, P105, DOI [DOI 10.1080/10438599900000006, 10.1080/10438599900000006]; Jeong GH, 1997, TECHNOL FORECAST SOC, V55, P203, DOI 10.1016/S0040-1625(96)00209-0; Johnstone N, 2010, ENVIRON RESOUR ECON, V45, P133, DOI 10.1007/s10640-009-9309-1; Karvonen M, 2012, TECHNOLOGICAL FORECA; KATZ L., 1996, IND CORP CHANG, V5, P1079, DOI DOI 10.1093/ICC/5.4.1079; Kim C, 2011, EXPERT SYST APPL, V38, P12559, DOI 10.1016/j.eswa.2011.04.042; Lee H, 2009, EXPERT SYST APPL, V36, P894, DOI 10.1016/j.eswa.2007.10.026; Lukach R., 2002, 754 CESIFO; Medical Nutrition International Industry (MNI), 2012, OR NUTR SUPPL TACKL; Nemet GF, 2012, RES POLICY, V41, P190, DOI 10.1016/j.respol.2011.08.009; OECD, 1994, US PAT DAT SCI TECHN; Pennings J. M., 2000, MARKET CONVERGENCE F; Phyllis Balch A, 2010, PRESCRIPTION NUTR HE; Prahalad CK, 1998, RES TECHNOL MANAGE, V41, P14, DOI 10.1080/08956308.1998.11671205; Pronker ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057755; SCHULER A, 1991, IEEE T ENG MANAGE, V38, P224, DOI 10.1109/17.83755; Shi XL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006547; Siro I, 2008, APPETITE, V51, P456, DOI 10.1016/j.appet.2008.05.060; Suzuki J, 2004, RES POLICY, V33, P531, DOI 10.1016/j.respol.2003.10.005; Teratanavat R, 2006, J FOOD SCI, V71, pS533, DOI 10.1111/j.1750-3841.2006.00120.x; Thorleuchter D, 2010, TECHNOL FORECAST SOC, V77, P1037, DOI 10.1016/j.techfore.2010.03.002; TRAJTENBERG M, 1990, RAND J ECON, V21, P172, DOI 10.2307/2555502; Tseng FM, 2011, TECHNOL FORECAST SOC, V78, P332, DOI 10.1016/j.techfore.2010.10.010; van Kreijl CF, 2006, OUR FOOD OUR HLTH HL, P189; Verhagen H, 2010, ARCH BIOCHEM BIOPHYS, V501, P6, DOI 10.1016/j.abb.2010.04.012; von Delft S, 2013, LETT EDITOR, V10, P67; Weaver B, 2007, RES PROPOSAL IND CON; Weenen T, 2013, PHARMANUTRITION; Weenen TC, 2013, BRIDGING PH IN PRESS; Weststrate JA, 2002, BRIT J NUTR, V88, pS233, DOI 10.1079/BJN2002688; Williams J, 2009, HLTH LIFESCIENCES IR; Yoon B., 2004, J HIGH TECHNOLOGY MA, V15, P37, DOI [DOI 10.1016/J.IPM.2006.11.011, 10.1016/j.hitech.2003.09.003, DOI 10.1016/J.HITECH.2003.09.003]	62	15	16	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82609	10.1371/journal.pone.0082609	http://dx.doi.org/10.1371/journal.pone.0082609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GD	24358214	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700087
J	Zhou, Z; Liu, HY; Gu, GS; Wang, GF; Wu, WY; Zhang, CL; Ren, JN				Zhou, Zheng; Liu, Haiyan; Gu, Guosheng; Wang, Gefei; Wu, Wenyong; Zhang, Changle; Ren, Jianan			Immunoproteomic to Identify Antigens in the Intestinal Mucosa of Crohn's Disease Patients	PLOS ONE			English	Article							PROTEIN DISULFIDE-ISOMERASE; MALIGNANT PLEURAL MESOTHELIOMA; INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; ULCERATIVE-COLITIS; INTELECTIN; INFECTION; IDENTIFICATION; AGGREGATION; PREVALENCE	Incidences of Crohn disease (CD) have increased significantly in the last decade. Immunoproteomics are a promising method to identify biomarkers of different diseases. In the present study, we used immunoproteomics to study proteins of intestinal mucosal lesions and neighboring normal intestinal mucosa of 8 CD patients. Reactive proteins were validated by Western blotting. Approximately 50 protein spots localized in the 4 to 7 pl range were detected on two-dimensional electrophoresis gels, and 6 differentially expressed protein spots between 10 and 100 kDa were identified. Reactive proteins were identified as prohibitin, calreticulin, apolipoprotein A-I, intelectin-1, protein disulfide isomerase, and glutathione s-transferase Pi. Western blotting was conducted on the intestinal mucosa of another 4 CD patients to validate the reactive proteins. We found that intestinal mucosal lesions had high levels of prohibitin expression. Glutathione s-transferase expression was detected in 100% of the intestinal mucosa examined. Thus, we report 6 autoantigens of CD, including 3 new and 3 previously reported autoantigens. Intelectin-1, protein disulfide isomerase, and glutathione-s-transferases may be used as biomarkers for CD pathogenesis.	[Zhou, Zheng; Wu, Wenyong; Zhang, Changle] Anhui Med Univ, Affiliated Hosp 1, Dept Gen Surg, Hefei, Anhui, Peoples R China; [Liu, Haiyan] Anhui Med Univ, Affiliated Hosp 1, Dept Crit Care, Hefei, Anhui, Peoples R China; [Gu, Guosheng; Wang, Gefei; Ren, Jianan] Nanjing Univ, Sch Med, Jinling Hosp, Res Inst Gen Surg, Nanjing 210008, Jiangsu, Peoples R China	Anhui Medical University; Anhui Medical University; Nanjing University	Ren, JN (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Res Inst Gen Surg, Nanjing 210008, Jiangsu, Peoples R China.	zhougnehz@sohu.com		Liu, Haiyan/0000-0002-4244-027X	National Natural Science Foundation of China [81101223]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81101223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abromaitis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000357; Amre DK, 2006, AM J GASTROENTEROL, V101, P1005, DOI 10.1111/j.1572-0241.2006.00526.x; Bennett TA, 2000, J IMMUNOL, V164, P4120, DOI 10.4049/jimmunol.164.8.4120; Bi SG, 2011, P NATL ACAD SCI USA, V108, P10650, DOI 10.1073/pnas.1017954108; Cassaro M, 2000, AM J GASTROENTEROL, V95, P1431, DOI 10.1111/j.1572-0241.2000.02074.x; Datta R, 2005, INFECT IMMUN, V73, P4025, DOI 10.1128/IAI.73.7.4025-4033.2005; Dubinsky M, 2009, DIGEST DIS, V27, P259, DOI 10.1159/000228559; Ernst A, 2010, SCAND J GASTROENTERO, V45, P1068, DOI 10.3109/00365521.2010.490594; Essex DW, 2009, ANTIOXID REDOX SIGN, V11, P1191, DOI [10.1089/ars.2008.2322, 10.1089/ARS.2008.2322]; French AT, 2008, INT J PARASITOL, V38, P467, DOI 10.1016/j.ijpara.2007.08.015; Gazouli Maria, 2013, J Crohns Colitis, V7, pe461, DOI 10.1016/j.crohns.2013.02.021; Gini B, 2008, J NEUROIMMUNOL, V196, P153, DOI 10.1016/j.jneuroim.2008.02.015; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Jungblut PR, 2001, MICROBES INFECT, V3, P831, DOI 10.1016/S1286-4579(01)01441-1; Kathiria AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031231; Klade CS, 2002, CURR OPIN MOL THER, V4, P216; Koutroubakis IE, 2009, EUR J GASTROEN HEPAT, V21, P283, DOI 10.1097/MEG.0b013e328325d42b; Lawrence DA, 1996, J LEUKOCYTE BIOL, V60, P611, DOI 10.1002/jlb.60.5.611; Lee YM, 2000, J GASTROEN HEPATOL, V15, P622, DOI 10.1046/j.1440-1746.2000.02212.x; Lefranc D, 2007, ARTHRITIS RHEUM-US, V56, P3420, DOI 10.1002/art.22863; Levy E, 2000, AM J CLIN NUTR, V71, P807, DOI 10.1093/ajcn/71.3.807; Li QF, 2011, CELL MOL NEUROBIOL, V31, P203, DOI 10.1007/s10571-010-9608-7; Loftus EV, 2002, ALIMENT PHARM THERAP, V16, P51, DOI 10.1046/j.1365-2036.2002.01140.x; Maeda R, 2007, BBA-PROTEINS PROTEOM, V1774, P1619, DOI 10.1016/j.bbapap.2007.08.016; Markovic I, 2004, BLOOD, V103, P1586, DOI 10.1182/blood-2003-05-1390; Melmed GY, 2008, DIS COLON RECTUM, V51, P100, DOI 10.1007/s10350-007-9158-3; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Mishra S, 2010, FEBS J, V277, P3937, DOI 10.1111/j.1742-4658.2010.07809.x; Mittal RD, 2007, J GASTROEN HEPATOL, V22, P920, DOI 10.1111/j.1440-1746.2006.04538.x; Pemberton AD, 2004, J IMMUNOL, V173, P1894, DOI 10.4049/jimmunol.173.3.1894; Pemberton AD, 2004, PROTEOMICS, V4, P1101, DOI 10.1002/pmic.200300658; Raturi A, 2008, BBA-BIOMEMBRANES, V1778, P2790, DOI 10.1016/j.bbamem.2008.07.003; Russo I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032841; Sakurai T, 2011, J NEUROIMMUNOL, V233, P175, DOI 10.1016/j.jneuroim.2010.11.003; Shah CM, 2007, NITRIC OXIDE-BIOL CH, V16, P135, DOI 10.1016/j.niox.2006.08.001; Sood A, 2003, GUT, V52, P1587, DOI 10.1136/gut.52.11.1587; Targan SR, 2005, GASTROENTEROLOGY, V128, P2020, DOI 10.1053/j.gastro.2005.03.046; Theiss AL, 2009, MOL BIOL CELL, V20, P4412, DOI 10.1091/mbc.E09-05-0361; Tsuji S, 2010, BRIT J CANCER, V103, P517, DOI 10.1038/sj.bjc.6605786; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; van Haaften RIM, 2003, DRUG METAB REV, V35, P215, DOI 10.1081/DMR-120024086; Wali A, 2005, LUNG CANCER, V48, P19, DOI 10.1016/j.lungcan.2004.10.011; Watanabe Kenya, 2006, Fukushima J Med Sci, V52, P1; Wolters FL, 2006, GUT, V55, P510, DOI 10.1136/gut.2005.072793	47	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81662	10.1371/journal.pone.0081662	http://dx.doi.org/10.1371/journal.pone.0081662			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358121	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700017
J	Hsu, WY; Chen, CJ; Huang, YC; Tsai, FJ; Jeng, LB; Lai, CC				Hsu, Wei-Yi; Chen, Chao-Jung; Huang, Yu-Chuen; Tsai, Fuu-Jen; Jeng, Long-Bin; Lai, Chien-Chen			Urinary Nucleosides as Biomarkers of Breast, Colon, Lung, and Gastric Cancer in Taiwanese	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; POTENTIAL TUMOR-MARKERS; LIQUID-CHROMATOGRAPHY; CLINICAL-DIAGNOSIS; TRANSFER-RNA; SEPARATION; SERUM	Urinary nucleosides are associated with many types of cancer. In this study, six targeted urinary nucleosides, namely adenosine, cytidine, 3-methylcytidine, 1-methyladenosine, inosine, and 2-deoxyguanosine, were chosen to evaluate their role as biomarkers of four different types of cancer: lung cancer, gastric cancer, colon cancer, and breast cancer. Urine samples were purified using solid-phase extraction (SPE) and then analyzed using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). The Mann-Whitney U test and Principal Component Analysis (PCA) were used to compare differences in urinary nucleosides between patients with one of four types of cancer and healthy controls. The diagnostic sensitivity of single nucleosides for different types of cancer ranged from 14% to 69%. In contrast, the diagnostic sensitivity of a set of six nucleosides ranged from 37% to 69%. The false-positive identification rate associated with the set of six nucleosides in urine was less than 2% compared with that of less than 5% for a single nucleoside. Furthermore, combining the set of six urinary nucleosides with carcinoembryonic antigen improved the diagnostic sensitivity for colon cancer. In summary, the study show that a set of six targeted nucleosides is a good diagnostic marker for breast and colon cancers but not for lung and gastric cancers.	[Hsu, Wei-Yi; Chen, Chao-Jung; Huang, Yu-Chuen; Tsai, Fuu-Jen] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Hsu, Wei-Yi] China Med Univ, Taichung, Taiwan; [Chen, Chao-Jung] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Huang, Yu-Chuen] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Tsai, Fuu-Jen] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Jeng, Long-Bin] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Lai, Chien-Chen] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan; [Lai, Chien-Chen] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Chung Hsing University; China Medical University Taiwan	Jeng, LB (corresponding author), China Med Univ Hosp, Dept Surg, Taichung, Taiwan.	longbin@mail.cmuh.org.tw; lailai@dragon.nchu.edu.tw	Tsai, Fuu-Jen/J-4140-2015; Chen, Chao-Jung/E-5481-2011; /AGZ-4617-2022	Chen, Chao-Jung/0000-0003-3834-9243; /0000-0002-7133-8266	China Medical University; National Science Council of the Republic of China	China Medical University(China Medical University); National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	The study was funded by a grant from China Medical University and the National Science Council of the Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTELS H, 1972, CLIN CHIM ACTA, V37, P193, DOI 10.1016/0009-8981(72)90432-9; BOREK E, 1971, CANCER RES, V31, P596; BOREK E, 1977, CANCER RES, V37, P3362; Cho SH, 2009, CLIN BIOCHEM, V42, P540, DOI 10.1016/j.clinbiochem.2008.12.026; DAVIS GE, 1977, CLIN CHEM, V23, P1427; GEHRKE CW, 1978, J CHROMATOGR, V150, P455, DOI 10.1016/S0021-9673(00)88205-9; Hsu WY, 2011, CLIN CHIM ACTA, V412, P1861, DOI 10.1016/j.cca.2011.06.027; Hsu WY, 2009, CLIN CHIM ACTA, V402, P31, DOI 10.1016/j.cca.2008.12.009; Li HY, 2009, J MASS SPECTROM, V44, P641, DOI 10.1002/jms.1539; Markuszewski MJ, 2010, ELECTROPHORESIS, V31, P2300, DOI 10.1002/elps.200900785; MCENTIRE JE, 1989, CANCER RES, V49, P1057; Rodriguez-Gonzalo E, 2011, J CHROMATOGR A, V1218, P9055, DOI 10.1016/j.chroma.2011.10.016; Seidel A, 2006, BRIT J CANCER, V94, P1726, DOI 10.1038/sj.bjc.6603164; Sova H, 2010, BRIT J CANCER, V102, P1018, DOI 10.1038/sj.bjc.6605565; Struck W, 2013, J CHROMATOGR A, V1283, P122, DOI 10.1016/j.chroma.2013.01.111; Struck W, 2011, ANAL BIOANAL CHEM, V401, P2039, DOI 10.1007/s00216-011-4789-6; Szymanska E, 2010, J PHARMACEUT BIOMED, V53, P1305, DOI 10.1016/j.jpba.2010.07.031; Woo HM, 2009, CLIN CHIM ACTA, V400, P63, DOI 10.1016/j.cca.2008.10.014	18	40	41	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e81701	10.1371/journal.pone.0081701	http://dx.doi.org/10.1371/journal.pone.0081701			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367489	gold, Green Published, Green Submitted			2022-12-27	WOS:000328741900004
J	Kline, C; Ndjomou, J; Franks, T; Kiser, R; Coalter, V; Smedley, J; Piatak, M; Mellors, JW; Lifson, JD; Ambrose, Z				Kline, Christopher; Ndjomou, Jean; Franks, Tamera; Kiser, Rebecca; Coalter, Vicky; Smedley, Jeremy; Piatak, Michael, Jr.; Mellors, John W.; Lifson, Jeffrey D.; Ambrose, Zandrea			Persistence of Viral Reservoirs in Multiple Tissues after Antiretroviral Therapy Suppression in a Macaque RT-SHIV Model	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; HIV-POSITIVE PATIENTS; CD4(+) T-LYMPHOCYTES; RALTEGRAVIR INTENSIFICATION; REVERSE-TRANSCRIPTASE; DRUG-RESISTANCE; GENITAL-TRACT; REPLICATION; EVOLUTION; VIREMIA	Although antiretroviral therapy (ART) can suppress HIV-1 replication sufficiently to eliminate measurable plasma viremia, infected cells remain and ensure viral recrudescence after discontinuation of ART. We used a macaque model of HIV-1/AIDS to evaluate the location of infected cells during ART. Twelve macaques were infected with RT-SHIVmne, a SIV containing HIV-1 reverse transcriptase, conferring sensitivity to non-nucleoside reverse transcriptase inhibitors (NNRTIs). Ten to fourteen weeks post-infection, 6 animals were treated with 3 or 4 antiretroviral drugs for 17-20 weeks; 6 control animals remained untreated. Viral DNA (vDNA) and RNA (vRNA) were measured in peripheral blood mononuclear cells (PBMC) and at necropsy in multiple tissues by quantitative PCR and RT-PCR. The majority of virally infected cells were located in lymphoid tissues with variable levels in the gastrointestinal tract of both treated and untreated animals. Tissue viral DNA levels correlated with week 1 plasma viremia, suggesting that tissues that harbor proviral DNA are established within the first week of infection. PBMC vDNA levels did not correlate with plasma viremia or tissue levels of vDNA. vRNA levels were high in lymphoid and gastrointestinal tissues of the untreated animals; animals on ART had little vRNA expressed in tissues and virus could not be cultured from lymph node resting CD4+ cells after 17-20 weeks on ART, indicating little or no ongoing viral replication. Strategies for eradication of HIV-1 will need to target residual virus in ART suppressed individuals, which may not be accurately reflected by frequencies of infected cells in blood.	[Kline, Christopher; Ndjomou, Jean; Franks, Tamera; Mellors, John W.; Ambrose, Zandrea] Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA 15213 USA; [Kiser, Rebecca; Coalter, Vicky; Piatak, Michael, Jr.; Lifson, Jeffrey D.] Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick Natl Lab Canc Res, Frederick, MD USA; [Smedley, Jeremy] Leidos Biomed Res Inc, Lab Anim Sci Program, Frederick Natl Lab Canc Res, Frederick, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ambrose, Z (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA 15213 USA.	zaa4@pitt.edu	; Kline, Christopher/B-1477-2012	Ambrose, Zandrea/0000-0002-8610-2766; Smedley, Jeremy/0000-0003-3369-4662; Kline, Christopher/0000-0003-1025-9430	American Foundation for AIDS Research (amfAR) [107149-44-RGRL]; Merck Co., Inc. [33665]; National Cancer Institute, National Institutes of Health (NIH) [HHSN261200800001E]	American Foundation for AIDS Research (amfAR); Merck Co., Inc.(Merck & Company); National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants 107149-44-RGRL from the American Foundation for AIDS Research (amfAR) and 33665 from Merck & Co., Inc. (Z.A.) and with federal funds from the National Cancer Institute, National Institutes of Health (NIH), under contract HHSN261200800001E (J.D.L.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose Z, 2004, J VIROL, V78, P13553, DOI 10.1128/JVI.78.24.13553-13561.2004; Ambrose Z, 2007, J VIROL, V81, P12145, DOI 10.1128/JVI.01301-07; Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; BALZARINI J, 1995, BIOCHEM BIOPH RES CO, V211, P850, DOI 10.1006/bbrc.1995.1890; Blackard JT, 2012, CURR HIV RES, V10, P133, DOI 10.2174/157016212799937245; Bourry O, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-78; Bull M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007122; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Clements JE, 2008, J NEUROVIROL, V14, P309, DOI 10.1080/13550280802132832; Clements JE, 2011, CURR OPIN HIV AIDS, V6, P37, DOI 10.1097/COH.0b013e3283412413; Cline AN, 2005, J MED PRIMATOL, V34, P303; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Evering TH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002506; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Gandhi RT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000321; Garcia F, 1999, AIDS, V13, pF79, DOI 10.1097/00002030-199907300-00002; Harrigan PR, 1999, AIDS, V13, pF59, DOI 10.1097/00002030-199905280-00001; Hatano H, 2013, J INFECT DIS, V208, P1436, DOI 10.1093/infdis/jit453; Hatano H, 2011, J INFECT DIS, V203, P960, DOI 10.1093/infdis/jiq138; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; Hazuda DJ, 2004, SCIENCE, V305, P528, DOI 10.1126/science.1098632; Hendrix CW, 2012, CURR OPIN HIV AIDS, V7, P498, DOI 10.1097/COH.0b013e32835847ae; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hofman MJ, 2004, ANTIMICROB AGENTS CH, V48, P3483, DOI 10.1128/AAC.48.9.3483-3490.2004; Hogan C, 2011, CLIN MED, V11, P571, DOI 10.7861/clinmedicine.11-6-571; Josefsson L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003432; Julias JG, 2001, J VIROL, V75, P6537, DOI 10.1128/JVI.75.14.6537-6546.2001; Kearney M, 2011, J VIROL, V85, P1067, DOI 10.1128/JVI.01701-10; Kieffer TL, 2004, J INFECT DIS, V189, P1452, DOI 10.1086/382488; Koelsch KK, 2008, J INFECT DIS, V197, P411, DOI 10.1086/525283; KORBER BTM, 1994, J VIROL, V68, P7467, DOI 10.1128/JVI.68.11.7467-7481.1994; Ledderose Carola, 2011, BMC Res Notes, V4, P427, DOI 10.1186/1756-0500-4-427; Lerner P, 2011, J VIROL, V85, P4772, DOI 10.1128/JVI.02409-10; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; McMahon D, 2010, CLIN INFECT DIS, V50, P912, DOI 10.1086/650749; Mexas AM, 2012, AIDS, V26, P2295, DOI 10.1097/QAD.0b013e32835a5c2f; Neumann AU, 1999, AIDS, V13, P677, DOI 10.1097/00002030-199904160-00008; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; Nottet HSLM, 2009, JAIDS-J ACQ IMM DEF, V50, P345, DOI 10.1097/QAI.0b013e318197eb04; Ohagen A, 2003, J VIROL, V77, P12336, DOI 10.1128/JVI.77.22.12336-12345.2003; Persaud D, 2007, AIDS RES HUM RETROV, V23, P381, DOI 10.1089/aid.2006.0175; Poss M, 1998, J VIROL, V72, P8240, DOI 10.1128/JVI.72.10.8240-8251.1998; Ramratnam B, 2004, JAIDS-J ACQ IMM DEF, V35, P33, DOI 10.1097/00126334-200401010-00004; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Shen AD, 2003, J VIROL, V77, P4938, DOI 10.1128/JVI.77.8.4938-4949.2003; Siliciano JD, 2005, ENHANCED CULTURE ASS; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; Strain MC, 2005, J INFECT DIS, V191, P1410, DOI 10.1086/428777; Telenti A, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007203; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; UBERLA K, 1995, P NATL ACAD SCI USA, V92, P8210, DOI 10.1073/pnas.92.18.8210; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yukl SA, 2013, J INFECT DIS, V208, P1212, DOI 10.1093/infdis/jit308; Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722; Yukl SA, 2010, AIDS, V24, P2450, DOI 10.1097/QAD.0b013e32833ef7bb; Zink MC, 2010, J INFECT DIS, V202, P161, DOI 10.1086/653213	62	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84275	10.1371/journal.pone.0084275	http://dx.doi.org/10.1371/journal.pone.0084275			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367650	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000328740300135
J	Place, TL; Nauseef, JT; Peterson, MK; Henry, MD; Mezhir, JJ; Domann, FE				Place, Trenton L.; Nauseef, Jones T.; Peterson, Maina K.; Henry, Michael D.; Mezhir, James J.; Domann, Frederick E.			Prolyl-4-Hydroxylase 3 (PHD3) Expression Is Downregulated during Epithelial-to-Mesenchymal Transition	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; PROLYL-HYDROXYLASE PHD3; CELL-MIGRATION; PANCREATIC-CANCER; E-CADHERIN; APOPTOSIS; PROMOTES; GROWTH; DEATH; GENE	Prolyl-4-hydroxylation by the intracellular prolyl-4-hydroxylase enzymes (PHD1-3) serves as a master regulator of environmental oxygen sensing. The activity of these enzymes is tightly tied to tumorigenesis, as they regulate cell metabolism and angiogenesis through their control of hypoxia-inducible factor (HIF) stability. PHD3 specifically, is gaining attention for its broad function and rapidly accumulating array of non-HIF target proteins. Data from several recent studies suggest a role for PHD3 in the regulation of cell morphology and cell migration. In this study, we aimed to investigate this role by closely examining the relationship between PHD3 expression and epithelial-to-mesenchymal transition (EMT); a transcriptional program that plays a major role in controlling cell morphology and migratory capacity. Using human pancreatic ductal adenocarcinoma (PDA) cell lines and Madin-Darby Canine Kidney (MDCK) cells, we examined the correlation between several markers of EMT and PHD3 expression. We demonstrated that loss of PHD3 expression in PDA cell lines is highly correlated with a mesenchymal-like morphology and an increase in cell migratory capacity. We also found that induction of EMT in MDCK cells resulted in the specific downregulation of PHD3, whereas the expression of the other HIF-PHD enzymes was not affected. The results of this study clearly support a model by which the basal expression and hypoxic induction of PHD3 is suppressed by the EMT transcriptional program. This may be a novel mechanism by which migratory or metastasizing cells alter signaling through specific pathways that are sensitive to regulation by O-2. The identification of downstream pathways that are affected by the suppression of PHD3 expression during EMT may provide important insight into the crosstalk between O-2 and the migratory and metastatic potential of tumor cells.	[Place, Trenton L.; Domann, Frederick E.] Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA 52242 USA; [Place, Trenton L.; Domann, Frederick E.] Univ Iowa, Dept Radiat Oncol, Iowa City, IA USA; [Nauseef, Jones T.; Henry, Michael D.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA; [Peterson, Maina K.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA USA; [Mezhir, James J.] Univ Iowa, Dept Surg, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Domann, FE (corresponding author), Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA 52242 USA.	frederick-domann@uiowa.edu		Domann, Frederick/0000-0002-0489-2179; Maina, Peterson/0000-0002-5909-190X; Henry, Michael/0000-0002-7871-245X	National Institutes of Health (NIH) [CA115438, NIH CA130916, TL1RR024981]; National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences, National Institutes of Health; American Medical Association Foundation Seed Grant; NATIONAL CANCER INSTITUTE [R01CA115438, R01CA130916, P30CA086862] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); American Medical Association Foundation Seed Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health (NIH) CA115438 (FED); NIH CA130916 (MDH); TLP received salary support from NIH TL1RR024981 from the National Center for Research Resources (NCRR) and the National Center for Advancing Translational Sciences, National Institutes of Health; the work was also partially supported by an American Medical Association Foundation Seed Grant (TLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bishop T, 2008, MOL CELL BIOL, V28, P3386, DOI 10.1128/MCB.02041-07; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen SF, 2011, MOL CELL BIOCHEM, V358, P257, DOI 10.1007/s11010-011-0976-1; Dukes JD, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-43; Dumont N, 2008, P NATL ACAD SCI USA, V105, P14867, DOI 10.1073/pnas.0807146105; Frank D, 2012, J MOL CELL CARDIOL, V52, P711, DOI 10.1016/j.yjmcc.2011.12.001; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiang JA, 2011, CANCER BIOL THER, V11, P714, DOI 10.4161/cbt.11.8.15274; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kiss J, 2012, J IMMUNOL, V189, P1955, DOI 10.4049/jimmunol.1103471; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lipscomb EA, 1999, J NEUROCHEM, V73, P429, DOI 10.1046/j.1471-4159.1999.0730429.x; Liu Y, 2010, BIOCHEM BIOPH RES CO, V401, P231, DOI 10.1016/j.bbrc.2010.09.037; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Nishioka R, 2010, EXP MOL PATHOL, V89, P149, DOI 10.1016/j.yexmp.2010.05.008; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Place T, J HYPOXIA; Place TL, 2013, HP, P13, DOI [10.2147/HP.S50091, DOI 10.2147/HP.S50091]; Place TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014617; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rantanen K, 2008, MOL BIOL CELL, V19, P2231, DOI 10.1091/mbc.E07-11-1124; Ridley AJ, 2001, J CELL SCI, V114, P2713; Rytkonen KT, 2011, MOL BIOL EVOL, V28, P1913, DOI 10.1093/molbev/msr012; Sato M, 2010, EXP CELL RES, V316, P2871, DOI 10.1016/j.yexcr.2010.06.018; Semenza GL, 2010, WIRES SYST BIOL MED, V2, P336, DOI 10.1002/wsbm.69; STERNFELD J, 1981, J CELL SCI, V50, P9; Straub JA, 2003, J NEUROCHEM, V85, P318, DOI 10.1046/j.1471-4159.2003.01688.x; Su Y, 2010, BRIT J CANCER, V103, P1571, DOI 10.1038/sj.bjc.6605936; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; TAN MH, 1986, CANCER INVEST, V4, P15, DOI 10.3109/07357908609039823; Tennant DA, 2010, J MOL MED, V88, P839, DOI 10.1007/s00109-010-0627-0; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vogel S, 2010, J BIOL CHEM, V285, P33756, DOI 10.1074/jbc.M110.132985; WAX SD, 1994, J BIOL CHEM, V269, P13041; West CM, 2007, DEVELOPMENT, V134, P3349, DOI 10.1242/dev.000893; Xie L, 2012, J CLIN INVEST, V122, P2827, DOI 10.1172/JCI62374; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Yang MH, 2008, CELL CYCLE, V7, P2090, DOI 10.4161/cc.7.14.6324	43	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83021	10.1371/journal.pone.0083021	http://dx.doi.org/10.1371/journal.pone.0083021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367580	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300091
J	Cheng, RB; Zheng, XD; Ma, YY; Li, Q				Cheng, Rubin; Zheng, Xiaodong; Ma, Yuanyuan; Li, Qi			The Complete Mitochondrial Genomes of Two Octopods Cistopus chinensis and Cistopus taiwanicus: Revealing the Phylogenetic Position of the Genus Cistopus within the Order Octopoda	PLOS ONE			English	Article							WATER OCTOPUSES CEPHALOPODA; MOLECULAR PHYLOGENY; EVOLUTION; SEQUENCE; GENES; SELECTION; ALIGNMENT; MOLLUSCA; PROGRAM	In the present study, we determined the complete mitochondrial DNA (mtDNA) sequences of two species of Cistopus, namely C. chinensis and C. taiwanicus, and conducted a comparative mt genome analysis across the class Cephalopoda. The mtDNA length of C. chinensis and C. taiwanicus are 15706 and 15793 nucleotides with an AT content of 76.21% and 76.5%, respectively. The sequence identity of mtDNA between C. chinensis and C. taiwanicus was 88%, suggesting a close relationship. Compared with C. taiwanicus and other octopods, C. chinensis encoded two additional tRNA genes, showing a novel gene arrangement. In addition, an unusual 23 poly (A) signal structure is found in the ATP8 coding region of C. chinensis. The entire genome and each protein coding gene of the two Cistopus species displayed notable levels of AT and GC skews. Based on sliding window analysis among Octopodiformes, ND1 and DN5 were considered to be more reliable molecular beacons. Phylogenetic analyses based on the 13 protein-coding genes revealed that C. chinensis and C. taiwanicus form a monophyletic group with high statistical support, consistent with previous studies based on morphological characteristics. Our results also indicated that the phylogenetic position of the genus Cistopus is closer to Octopus than to Amphioctopus and Callistoctopus. The complete mtDNA sequence of C. chinensis and C. taiwanicus represent the first whole mt genomes in the genus Cistopus. These novel mtDNA data will be important in refining the phylogenetic relationships within Octopodiformes and enriching the resource of markers for systematic, population genetic and evolutionary biological studies of Cephalopoda.	[Cheng, Rubin; Zheng, Xiaodong; Ma, Yuanyuan; Li, Qi] Ocean Univ China, Coll Fisheries, Qingdao, Peoples R China; [Cheng, Rubin] Zhejiang Chinese Med Univ, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China; [Zheng, Xiaodong] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao, Peoples R China	Ocean University of China; Zhejiang Chinese Medical University; Ocean University of China	Zheng, XD (corresponding author), Ocean Univ China, Coll Fisheries, Qingdao, Peoples R China.	xdzheng@mail.ouc.edu.cn			National Natural Science Foundation of China [31172058]; Fundamental Research Funds for the Central Universities [201362022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grant from the National Natural Science Foundation of China (31172058) and the Fundamental Research Funds for the Central Universities (201362022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Akasaki T, 2006, MOL PHYLOGENET EVOL, V38, P648, DOI 10.1016/j.ympev.2005.10.018; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Cai XQ, 2012, PARASITOL RES, V110, P235, DOI 10.1007/s00436-011-2477-2; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cheng RB, 2012, MOL BIOL REP, V39, P3461, DOI 10.1007/s11033-011-1118-2; Dai LN, 2012, MOL ECOL RESOUR, V12, P437, DOI 10.1111/j.1755-0998.2012.03118.x; Danic-Tchaleu Gwenaelle, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-400; DONOVAN DT, 1964, BIOL REV, V39, P259, DOI 10.1111/j.1469-185X.1964.tb01160.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Goloboff P, 2008, CLADISTICS, V24, P91; Guerra A, 2010, ICES J MAR SCI, V67, P1401, DOI 10.1093/icesjms/fsq040; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Kaneko N, 2011, MALACOLOGIA, V54, P97, DOI 10.4002/040.054.0102; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; LIAO JX, 2009, J MOLLUS STUD, V75, P1; Liu GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042172; Nateewathana Anuwat, 1997, Phuket Marine Biological Center Special Publication, V17, P407; Norman M.D., 2005, Phuket Marine Biological Center Research Bulletin, V66, P127; Norman MD, 2000, RAFFLES B ZOOL, P539; Norman MD, 1997, INVERTEBR TAXON, V11, P89, DOI 10.1071/IT95026; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Stoger I, 2013, MOL PHYLOGENET EVOL, V69, P376, DOI 10.1016/j.ympev.2012.11.017; Strugnell J, 2007, J MOLLUS STUD, V73, P399, DOI 10.1093/mollus/eym038; Strugnell JM, 2014, HYDROBIOLOGIA, V725, P215, DOI 10.1007/s10750-013-1517-6; Sun Y, 2012, MOL ECOL RESOUR, V12, P209, DOI 10.1111/j.1755-0998.2011.03085.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Xie Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027066; Yamazaki N, 1997, GENETICS, V145, P749; Yang JS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-257; Yokobori S, 2005, MOL PHYLOGENET EVOL, V34, P273, DOI 10.1016/j.ympev.2004.10.002; Yokobori S, 2004, MOL BIOL EVOL, V21, P2034, DOI 10.1093/molbev/msh227; Yokobori SI, 2007, MOL PHYLOGENET EVOL, V44, P898, DOI 10.1016/j.ympev.2007.05.009; ZHENG X, 2005, PHUKET MAR BIO CENT, P195; Zheng XD, 2004, J SHELLFISH RES, V23, P881; Zheng XD, 2012, J NAT HIST, V46, P355, DOI 10.1080/00222933.2011.639964; Zou SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026619	39	30	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84216	10.1371/journal.pone.0084216	http://dx.doi.org/10.1371/journal.pone.0084216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358345	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700087
J	Schmitt, F; Podevin, G; Poupon, J; Roux, J; Legras, P; Trocello, JM; Woimant, F; Laprevote, O; NGuyen, TH; El Balkhi, S				Schmitt, Francoise; Podevin, Guillaume; Poupon, Joel; Roux, Jerome; Legras, Pierre; Trocello, Jean-Marc; Woimant, France; Laprevote, Olivier; NGuyen, Tuan Huy; El Balkhi, Souleiman			Evolution of Exchangeable Copper and Relative Exchangeable Copper through the Course of Wilson's Disease in the Long Evans Cinnamon Rat	PLOS ONE			English	Article							LEC RATS; HEREDITARY HEPATITIS; BLOOD-PLASMA; ANIMAL-MODEL; ATP7B GENE; ACCUMULATION; RESTORATION; METABOLISM; DIAGNOSIS; ZINC	Background: Wilson's disease (WD) is an inherited disorder of copper metabolism leading to liver failure and/or neurological impairment. Its diagnosis often remains difficult even with genetic testing. Relative exchangeable copper (REC) has recently been described as a reliable serum diagnostic marker for WD. Methodology/Principal Findings: The aim of this study was to validate the use of REC in the Long Evans Cinnamon (LEC) rat, an animal model for WD, and to study its relevance under different conditions in comparison with conventional markers. Two groups of LEC rats and one group of Long-Evans (LE) rats were clinically and biologically monitored from 6 to 28 weeks of age. One group of LEC rats was given copper-free food. The other groups had normal food. Blood samples were collected each month and different serum markers for WD (namely ceruloplasmin oxidase activity, exchangeable copper (CuEXC), total serum copper and REC) and acute liver failure (serum transaminases and bilirubinemia) were tested. Every LEC rat under normal food developed acute liver failure (ALF), with 40% global mortality. Serum transaminases and bilirubinemia along with total serum copper and exchangeable copper levels increased with the onset of acute liver failure. A correlation was observed between CuEXC values and the severity of ALF. Cut-off values were different between young and adult rats and evolved because of age and/or liver failure. Only REC, with values > 19%, was able to discriminate LEC groups from the LE control group at every time point in the study. REC sensitivity and specificity reached 100% in adults rats. Conclusions/Significance: REC appears to be independent of demographic or clinical data in LEC rats. It is a very simple and reliable blood test for the diagnosis of copper toxicosis owing to a lack of ATP7B function. CuEXC can be used as an accurate biomarker of copper overload.	[Schmitt, Francoise; NGuyen, Tuan Huy] Jean Monnet Hosp, INSERM UMR1064, Nantes, France; [Schmitt, Francoise; Podevin, Guillaume] Univ Hosp Angers, HIFIH Pediat Hepatogastroenterol Team, Angers, France; [Poupon, Joel; Laprevote, Olivier; El Balkhi, Souleiman] Lariboisiere Hosp, AP HP, Lab Biol Toxicol, Paris, France; [Roux, Jerome; Legras, Pierre] Med Univ Angers, Anim Facil, SCAHU, Angers, France; [Trocello, Jean-Marc; Woimant, France] Lariboisiere Hosp, AP HP, Dept Neurol, Paris, France; [Trocello, Jean-Marc; Woimant, France; El Balkhi, Souleiman] Lariboisiere Hosp, AP HP, Ctr Natl Maladie Rare Wilson, Paris, France; [Laprevote, Olivier] Univ Paris 05, Fac Pharm, Sorbonne Paris Cite, Analyt & Expt Toxicol C TAC, Paris, France; [El Balkhi, Souleiman] Paris Descartes Univ, Sorbonne Paris Cite, INSERM U1144, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	El Balkhi, S (corresponding author), Lariboisiere Hosp, AP HP, Lab Biol Toxicol, Paris, France.	souleiman.el-balkhi@lrb.aphp.fr	Balkhi, Souleiman El/ABB-7385-2020; /A-2002-2017	/0000-0002-9743-5603; Schmitt, Francoise/0000-0002-3863-7694	Fondation de l'Avenir	Fondation de l'Avenir	This work has been partially funded by grants from the Fondation de l'Avenir. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anderson LA, 1998, ANN PHARMACOTHER, V32, P78, DOI 10.1345/aph.17075; Bahde R, 2012, J NUCL MED, V53, P961, DOI 10.2967/jnumed.111.092361; Bartee MY, 2007, BIOMETALS, V20, P627, DOI 10.1007/s10534-006-9074-3; Buckley WT, 2008, BIOMETALS, V21, P601, DOI 10.1007/s10534-008-9146-7; Carstens E, 2000, ILAR J, V41, P62; Chappuis P, 2007, J TRACE ELEM MED BIO, V21, P37, DOI 10.1016/j.jtemb.2006.11.002; El Balkhi S, 2011, CLIN CHIM ACTA, V412, P2254, DOI 10.1016/j.cca.2011.08.019; El Balkhi S, 2010, ANAL CHEM, V82, P6904, DOI 10.1021/ac101128x; El Balkhi S, 2009, ANAL BIOANAL CHEM, V394, P1477, DOI 10.1007/s00216-009-2809-6; Fong RN, 2004, TOXICOL APPL PHARM, V200, P121, DOI 10.1016/j.taap.2004.03.023; Gray LW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038327; Hayashi M, 2006, EXP ANIM TOKYO, V55, P419, DOI 10.1538/expanim.55.419; KASAI N, 1990, LAB ANIM SCI, V40, P502; Kenney SM, 2007, HUM MUTAT, V28, P1171, DOI 10.1002/humu.20586; Kim JW, 2013, WORLD J HEPATOL, V5, P156, DOI 10.4254/wjh.v5.i3.156; Lalioti V, 2010, J HEPATOL, V53, P1151, DOI 10.1016/j.jhep.2010.07.008; LI Y, 1991, J CLIN INVEST, V87, P1858, DOI 10.1172/JCI115208; MASUDA R, 1988, LAB ANIM, V22, P166, DOI 10.1258/002367788780864402; Medici V, 2005, LIVER TRANSPLANT, V11, P1056, DOI 10.1002/lt.20486; Meng Y, 2004, BBA-MOL BASIS DIS, V1690, P208, DOI 10.1016/j.bbadis.2004.06.022; Merle U, 2007, CURR GENE THER, V7, P217, DOI 10.2174/156652307780859053; Merle U, 2009, J HEPATOL, V51, P925, DOI 10.1016/j.jhep.2009.06.022; Schilsky ML, 2009, BIOCHIMIE, V91, P1278, DOI 10.1016/j.biochi.2009.07.012; SCHOSINSKY KH, 1974, CLIN CHEM, V20, P1556; Siaj R, 2012, WORLD J GASTROENTERO, V18, P5542, DOI 10.3748/wjg.v18.i39.5542; Sone H, 1996, HEPATOLOGY, V23, P764, DOI 10.1053/jhep.1996.v23.pm0008666330; SUZUKI KT, 1995, TOXICOLOGY, V97, P81, DOI 10.1016/0300-483X(94)02927-M; Terada K, 1998, J BIOL CHEM, V273, P1815, DOI 10.1074/jbc.273.3.1815; Venelinov TI, 2007, J TRACE ELEM MED BIO, V21, P138, DOI 10.1016/j.jtemb.2007.01.001; Vonk WIM, 2008, AM J CLIN NUTR, V88, p840S, DOI 10.1093/ajcn/88.3.840S; WU JS, 1994, NAT GENET, V7, P541, DOI 10.1038/ng0894-541; YOSHIDA MC, 1987, J HERED, V78, P361, DOI 10.1093/oxfordjournals.jhered.a110416; YUZBASIYANGURKAN V, 1992, J LAB CLIN MED, V120, P380	33	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82323	10.1371/journal.pone.0082323	http://dx.doi.org/10.1371/journal.pone.0082323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358170	gold, Green Published			2022-12-27	WOS:000328737700011
J	Anamnart, W; Pattanawongsa, A; Intapan, PM; Morakote, N; Janwan, P; Maleewong, W				Anamnart, Witthaya; Pattanawongsa, Attarat; Intapan, Pewpan Maleewong; Morakote, Nimit; Janwan, Penchom; Maleewong, Wanchai			Detrimental Effect of Water Submersion of Stools on Development of Strongyloides stercoralis	PLOS ONE			English	Article							FREE-LIVING GENERATIONS; AGAR PLATE CULTURE; DIAGNOSIS; INFECTION; RATTI	Strongyloidiasis is prevalent in Thailand, yet its prevalence in the south is lower than in other parts of the country. This might be due to the long rainy season in the south resulting in stool submersion in water inhibiting worm development. In this study, the effect of water submersion of fecal samples on development of Strongyloides stercoralis was investigated. Ten ml of a 1: 5 fecal suspension were placed in 15-ml tubes, 35-mm dishes, and 90-mm dishes producing the depths of 80 mm, 11 mm and 2 mm-suspensions, respectively. The worm development was followed at 1/6, 4, 6, 8, 10, 12, 14, 16, 24, and 36 h, by determining the number of filariform larva (FL) generated from agar-plate cultures (APC). Fecal suspensions kept in tubes and 35-mm dishes showed a decline in FL yield relative to incubation time and reached zero production 14 h after incubation. In contrast, the number of FL generated from the suspension kept in 90-mm dishes remained stable up to 36 h. Cumulatively, all tubes and 35-mm dishes became negative in APC after 14 h while 90-mm dishes remained APC-positive up to 36 h. Adding more water or stool suspension to dishes resulted in a decreased number of FL. Mechanical aeration of the suspensions in tubes restored an almost normal FL yield. It appears that the atmospheric air plays a significant role in growth and development of S. stercoralis in the environment and may be one of factors which contribute to a lower prevalence of human strongyloidiasis in the south of Thailand.	[Anamnart, Witthaya] Walailak Univ, Sch Allied Hlth Sci & Publ Hlth, Dept Med Technol, Nakhon Si Thammarat, Thailand; [Pattanawongsa, Attarat] Walailak Univ, Sch Pharm, Dept Preclin Sci, Nakhon Si Thammarat, Thailand; [Intapan, Pewpan Maleewong; Janwan, Penchom; Maleewong, Wanchai] Khon Kaen Univ, Fac Med, Dept Parasitol, Khon Kaen 40002, Thailand; [Intapan, Pewpan Maleewong; Janwan, Penchom; Maleewong, Wanchai] Khon Kaen Univ, Fac Med, Res & Diagnost Ctr Emerging Infect Dis, Khon Kaen, Thailand; [Morakote, Nimit] Chaing Mai Univ, Fac Med, Dept Parasitol, Chaing Mai, Thailand	Walailak University; Walailak University; Khon Kaen University; Khon Kaen University	Anamnart, W (corresponding author), Walailak Univ, Sch Allied Hlth Sci & Publ Hlth, Dept Med Technol, Nakhon Si Thammarat, Thailand.	awitthay@wu.ac.th		Maleewong, Wanchai/0000-0002-6726-3759; Janwan, Penchom/0000-0002-7500-5848	TRF Senior Researcher Scholar Grant, Thailand Research Fund [RTA 5580004]	TRF Senior Researcher Scholar Grant, Thailand Research Fund	This study was funded by TRF Senior Researcher Scholar Grant, Thailand Research Fund grant number RTA 5580004 to WM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anamnart W, 2010, ANN REPORT PREVALENC; Anamnart W, 2010, J CLIN MICROBIOL, V48, P97, DOI 10.1128/JCM.01613-09; Anantaphruti Malinee T., 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P378; Garcia LS, 1997, DIAGNOSTIC MED PARAS, P652; Grove DI, 1996, ADV PARASIT, V38, P251, DOI 10.1016/S0065-308X(08)60036-6; HANSEN EL, 1969, EXP PARASITOL, V26, P336, DOI 10.1016/0014-4894(69)90127-1; Harada U, 1955, YONAGO ACTA MED, V1, P177; Intapan PM, 2005, J CLIN MICROBIOL, V43, P1932, DOI 10.1128/JCM.43.4.1932-1933.2005; Jongsuksuntigul Praphasri, 2003, Journal of the Medical Association of Thailand, V86, P737; Jutin P, 2007, SENIOR PROJECT PREVA; KOGA K, 1991, AM J TROP MED HYG, V45, P518, DOI 10.4269/ajtmh.1991.45.518; Minato K, 2008, PARASITOL RES, V102, P315, DOI 10.1007/s00436-007-0773-7; Nontasut Ponganant, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P442; PITISUTTITHUM P, 1990, Journal of the Medical Association of Thailand, V73, P522; Siddiqui AA, 2001, CLIN INFECT DIS, V33, P1040, DOI 10.1086/322707; Sithithaworn P, 2003, T ROY SOC TROP MED H, V97, P398, DOI 10.1016/S0035-9203(03)90069-1; Uparanukraw P, 1999, AM J TROP MED HYG, V60, P967, DOI 10.4269/ajtmh.1999.60.967; Viney Mark E, 2007, WormBook, P1; Viney ME, 1999, PARASITOL TODAY, V15, P231, DOI 10.1016/S0169-4758(99)01452-0; YAMADA M, 1991, J PARASITOL, V77, P592, DOI 10.2307/3283165	20	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82339	10.1371/journal.pone.0082339	http://dx.doi.org/10.1371/journal.pone.0082339			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358173	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700060
J	Ghate, NB; Chaudhuri, D; Sarkar, R; Sajem, AL; Panja, S; Rout, J; Mandal, N				Ghate, Nikhil Baban; Chaudhuri, Dipankar; Sarkar, Rhitajit; Sajem, Albert L.; Panja, Sourav; Rout, Jayashree; Mandal, Nripendranath			An Antioxidant Extract of Tropical Lichen, Parmotrema reticulatum, Induces Cell Cycle Arrest and Apoptosis in Breast Carcinoma Cell Line MCF-7	PLOS ONE			English	Article							ANTICANCER; ANTIMYCOBACTERIAL; METABOLITES; INDUCTION; COMPLEX; DEATH	This report highlights the phytochemical analysis, antioxidant potential and anticancer activity against breast carcinoma of 70% methanolic extract of lichen, Parmotrema reticulatum (PRME). Phytochemical analysis of PRME confirms the presence of various phytoconstituents like alkaloids, carbohydrates, flavonoids, glycosides, phenols, saponins, tannins, anthraquinones, and ascorbic acid; among which alkaloids, phenols and flavonoids are found in abundant amount. High performance liquid chromatography (HPLC) analysis of PRME revealed the presence of catechin, purpurin, tannic acid and reserpine. Antioxidant activity was evaluated by nine separate methods. PRME showed excellent hydroxyl and hypochlorous radical scavenging as well as moderate DPPH, superoxide, singlet oxygen, nitric oxide and peroxynitrite scavenging activity. Cytotoxicity of PRME was tested against breast carcinoma (MCF-7), lung carcinoma (A549) and normal lung fibroblast (WI-38) using WST-1 method. PRME was found cytotoxic against MCF-7 cells with an IC50 value 130.03 +/- 3.11 mu g/ml while negligible cytotoxicity was observed on A549 and WI-38 cells. Further flow cytometric study showed that PRME halted the MCF-7 cells in S and G2/M phases and induces apoptosis in dose as well as time dependent manner. Cell cycle arrest was associated with downregulation of cyclin B1, Cdk-2 and Cdc25C as well as slight decrease in the expression of Cdk-1 and cyclin A1 with subsequent upregulation of p53 and p21. Moreover PRME induced Bax and inhibited Bcl-2 expression, which results in increasing Bax/Bcl-2 ratio and activation of caspase cascade. This ultimately leads to PARP degradation and induces apoptosis in MCF-7 cells. It can be hypothesised from the current study that the antioxidant and anticancer potential of the PRME may reside in the phytoconstitutents present in it and therefore, PRME may be used as a possible source of natural antioxidant that may be developed to an anticancer agent.	[Ghate, Nikhil Baban; Chaudhuri, Dipankar; Sarkar, Rhitajit; Panja, Sourav; Mandal, Nripendranath] Bose Inst, Div Mol Med, Kolkata, India; [Sajem, Albert L.; Rout, Jayashree] Assam Univ, Dept Ecol & Environm Sci, Silchar, Assam, India	Department of Science & Technology (India); Bose Institute; Assam University	Mandal, N (corresponding author), Bose Inst, Div Mol Med, Kolkata, India.	mandaln@rediffmail.com	Ghate, Nikhil/T-4153-2017; Panja, Sourav/AFO-5798-2022; Mandal, Nripendranath/ABC-3918-2020; Sarkar, Rhitajit/B-9567-2008; PANJA, SOURAV/AAA-7163-2022; Chudhuri, Dipankar/AAU-6215-2021	Ghate, Nikhil/0000-0002-4447-3737; Panja, Sourav/0000-0001-8540-5266; Mandal, Nripendranath/0000-0002-8733-3566; Sarkar, Rhitajit/0000-0001-7287-0388; Chaudhuri, Dipankar/0000-0001-7991-0469	Department of Biotechnology (DBT), Govt. of India [BT/183/NE/TBP/2011]	Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India)	The authors would like to acknowledge Department of Biotechnology (DBT), Govt. of India (Sanction order No.: BT/183/NE/TBP/2011 dated 23.04.2012 and URL: http://dbtindia.nic.in/index.asp) for funding to conduct this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GLOBOCAN 2008; Anto RJ, 2002, CARCINOGENESIS, V23, P143, DOI 10.1093/carcin/23.1.143; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Awasthi D. D., 1988, J HATTORI BOT LAB, V65, P207; Balaji P., 2007, Research Journal of Botany, V2, P54; Baral B, 2011, J MICROB BIOTEC FOOD, V1, P98; Begum S, 2012, NAT PROD RES, V26, P2084, DOI 10.1080/14786419.2011.625502; Behera BC, 2005, BIOTECHNOL LETT, V27, P991, DOI 10.1007/s10529-005-7847-3; Boustie Joel, 2005, Plant Genetic Resources Characterization and Utilization, V3, P273, DOI 10.1079/PGR200572; Brisdelli F, 2013, PHYTOTHER RES, V27, P431, DOI 10.1002/ptr.4739; Chaudhuri D, 2012, ASIAN J PHARM CLIN R, V5, P193, DOI DOI 10.1186/0717-6287-47-24; Divakar PK, 2005, LICHENOLOGIST, V37, P55, DOI 10.1017/S0024282904014586; Ghate NB, 2014, CYTOTECHNOLOGY, V66, P209, DOI 10.1007/s10616-013-9553-7; GOLDIN A, 1957, SCIENCE, V125, P156, DOI 10.1126/science.125.3239.156-a; HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7; Harborne JB, 1995, PHYTOCHEMICAL DICT H, V4; Hazra B, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-63; Honda NK, 2010, PHYTOMEDICINE, V17, P328, DOI 10.1016/j.phymed.2009.07.018; Hu WC, 2011, FOOD CHEM TOXICOL, V49, P799, DOI 10.1016/j.fct.2010.12.001; Isemura M, 2000, BIOFACTORS, V13, P81, DOI 10.1002/biof.5520130114; Kessler M, 2003, J PHARM PHARMACOL, V55, P131, DOI 10.1211/002235702559; Khan M, 2011, ASIAN PAC J CANCER P, V12, P3235; KINSELLA JE, 1993, FOOD TECHNOL-CHICAGO, V47, P85; Kochevar IE, 2000, METHOD ENZYMOL, V319, P20; Kokate CK, 2003, TEST BOOK PHARMACOGN, P105; Kumar M., 2012, ASIAN PAC J TROP DIS, V2S, pS692, DOI [DOI 10.1016/S2222-1808(12)60245-X, 10.1016/S2222-1808(12)60245-X]; Kurokawa S, 2001, MYCOTAXON, V77, P225; Lai LS, 2001, J AGR FOOD CHEM, V49, P963, DOI 10.1021/jf001146k; Li BH, 2010, CANCER LETT, V289, P62, DOI 10.1016/j.canlet.2009.08.002; Liu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038000; Manojlovic NT, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/452431; MARTINEZ V, 1987, PHYTOCHEMISTRY, V26, P2619, DOI 10.1016/S0031-9422(00)83891-1; Muller K, 2001, APPL MICROBIOL BIOT, V56, P9, DOI 10.1007/s002530100684; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nawar W. W., 1996, LIPIDS FOOD CHEM, P225; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Rankovic B., 2010, KRAGUJEVAC J SCI, V32, P65; Rankovic BR, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-97; Reddy VG, 2001, BIOCHEM BIOPH RES CO, V282, P409, DOI 10.1006/bbrc.2001.4593; RICEEVANS CA, 1995, FREE RADICAL RES, V22, P375, DOI 10.3109/10715769509145649; Sati S. C., 2011, British Microbiology Research Journal, V1, P26; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Sharma B. C., 2012, IOSR J PHARM, V2, P54; Shebaby WN, 2013, PHYTOTHER RES, V27, P737, DOI 10.1002/ptr.4776; Shrestha G, 2013, PHYTOCHEM REV, V12, P229, DOI 10.1007/s11101-013-9283-7; Sinha S.N., 2011, INT J PHARM BIO SCI, V2, P23; Stanly C., 2011, Journal of Pharmacy Research, V4, P2824; Su D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054505; Sun WM, 2008, ADV EXP MED BIOL, V614, P179, DOI 10.1007/978-0-387-74911-2_21; Tadhani MB, 2007, J FOOD COMPOS ANAL, V20, P323, DOI 10.1016/j.jfca.2006.08.004; de Jesus NZT, 2012, INT J MOL SCI, V13, P3203, DOI 10.3390/ijms13033203; Taylor BS, 1997, ARCH SURG-CHICAGO, V132, P1177; Tiwari P., 2011, NATURE SCI, V9, P167; Torres K, 1998, CANCER RES, V58, P3620; Triggiani D, 2009, BIOLOGIA, V64, P59, DOI 10.2478/s11756-009-0005-y; Verma N, 2008, APPL BIOCHEM BIOTECH, V151, P167, DOI 10.1007/s12010-008-8164-9; Wang XD, 2001, GENE DEV, V15, P2922; Yadav V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047796; Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	61	46	46	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82293	10.1371/journal.pone.0082293	http://dx.doi.org/10.1371/journal.pone.0082293			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358166	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700055
J	Gomez-Mestre, I; Kulkarni, S; Buchholz, DR				Gomez-Mestre, Ivan; Kulkarni, Saurabh; Buchholz, Daniel R.			Mechanisms and Consequences of Developmental Acceleration in Tadpoles Responding to Pond Drying	PLOS ONE			English	Article							ADAPTIVE PHENOTYPIC PLASTICITY; THYROID-HORMONE RECEPTOR; CORTICOTROPIN-RELEASING HORMONE; SCAPHIOPUS-COUCHII TADPOLES; OXIDATIVE STRESS; AMPHIBIAN METAMORPHOSIS; LARVAL DEVELOPMENT; SPADEFOOT TOADS; ECOLOGICAL CONSEQUENCES; COMPENSATORY GROWTH	Many amphibian species exploit temporary or even ephemeral aquatic habitats for reproduction by maximising larval growth under benign conditions but accelerating development to rapidly undergo metamorphosis when at risk of desiccation from pond drying. Here we determine mechanisms enabling developmental acceleration in response to decreased water levels in western spadefoot toad tadpoles (Pelobates cultripes), a species with long larval periods and large size at metamorphosis but with a high degree of developmental plasticity. We found that P. cultripes tadpoles can shorten their larval period by an average of 30% in response to reduced water levels. We show that such developmental acceleration was achieved via increased endogenous levels of corticosterone and thyroid hormone, which act synergistically to achieve metamorphosis, and also by increased expression of the thyroid hormone receptor TR., which increases tissue sensitivity and responsivity to thyroid hormone. However, developmental acceleration had morphological and physiological consequences. In addition to resulting in smaller juveniles with proportionately shorter limbs, tadpoles exposed to decreased water levels incurred oxidative stress, indicated by increased activity of the antioxidant enzymes catalase, superoxide dismutase, and gluthatione peroxidase. Such increases were apparently sufficient to neutralise the oxidative damage caused by presumed increased metabolic activity. Thus, developmental acceleration allows spadefoot toad tadpoles to evade drying ponds, but it comes at the expense of reduced size at metamorphosis and increased oxidative stress.	[Gomez-Mestre, Ivan] CSIC, Ecol Evolut & Dev Grp, Donana Biol Stn, E-41080 Seville, Spain; [Kulkarni, Saurabh; Buchholz, Daniel R.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA; [Kulkarni, Saurabh] Yale Univ, Dept Pediat, Yale Sch Med, New Haven, CT 06520 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University System of Ohio; University of Cincinnati; Yale University	Gomez-Mestre, I (corresponding author), CSIC, Ecol Evolut & Dev Grp, Donana Biol Stn, E-41080 Seville, Spain.	igmestre@ebd.csic.es	Gomez-Mestre, Ivan/F-8226-2014	Gomez-Mestre, Ivan/0000-0003-0094-8195; Kulkarni, Saurabh/0000-0002-0882-6478	Spanish Ministerio de Ciencia e Innovacion [CGL2009-11123]; NSF IOS [0950538]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); NSF IOS(National Science Foundation (NSF))	This research was supported by grant CGL2009-11123 from the Spanish Ministerio de Ciencia e Innovacion to IGM and by NSF IOS 0950538 to DRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford RA, 1999, TADPOLES, P240; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bonett RM, 2010, GEN COMP ENDOCR, V168, P209, DOI 10.1016/j.ygcen.2010.03.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown-Borg HM, 2009, MOL CELL ENDOCRINOL, V299, P64, DOI 10.1016/j.mce.2008.07.001; Buchholz DR, 2005, EVOL DEV, V7, P458, DOI 10.1111/j.1525-142X.2005.05049.x; Buchholz DR, 2002, COPEIA, P180, DOI 10.1643/0045-8511(2002)002[0180:EPODIS]2.0.CO;2; Buege J A, 1978, Methods Enzymol, V52, P302; COHEN G, 1969, J BACTERIOL, V98, P543, DOI 10.1128/JB.98.2.543-546.1969; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Costantini D, 2011, J COMP PHYSIOL B, V181, P447, DOI 10.1007/s00360-011-0566-2; CRUMP ML, 1989, COPEIA, P794, DOI 10.2307/1445521; De Block M, 2008, P ROY SOC B-BIOL SCI, V275, P781, DOI 10.1098/rspb.2007.1515; Denver RJ, 1997, HORM BEHAV, V31, P169, DOI 10.1006/hbeh.1997.1383; Denver RJ, 1998, ECOLOGY, V79, P1859, DOI 10.1890/0012-9658(1998)079[1859:APIAMR]2.0.CO;2; Denver RJ, 1997, AM ZOOL, V37, P172; Denver RJ, 1998, GEN COMP ENDOCR, V110, P326, DOI 10.1006/gcen.1998.7082; DENVER RJ, 1988, J EXP ZOOL, V246, P293, DOI 10.1002/jez.1402460309; DENVER RJ, 1993, GEN COMP ENDOCR, V91, P38, DOI 10.1006/gcen.1993.1102; DENVER RJ, 1996, METAMORPHOSIS POSTEM, P433, DOI DOI 10.1016/B978-012283245-1/50014-2; Denver RJ, 2013, CURR TOP DEV BIOL, V103, P195, DOI 10.1016/B978-0-12-385979-2.00007-1; Enriquez-Urzelai U, 2013, OECOLOGIA, V173, P117, DOI 10.1007/s00442-013-2596-9; Falnes PO, 2007, NEUROSCIENCE, V145, P1222, DOI 10.1016/j.neuroscience.2006.11.018; Galvan I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013369; Garcia-Paris M, 2004, AMPHIBIA; Gervasi SS, 2008, FUNCT ECOL, V22, P100, DOI 10.1111/j.1365-2435.2007.01340.x; GOATER CP, 1994, ECOLOGY, V75, P2264, DOI 10.2307/1940882; Gomez-Mestre I, 2003, EVOLUTION, V57, P1889; Gomez-Mestre I, 2010, J EVOLUTION BIOL, V23, P1364, DOI 10.1111/j.1420-9101.2010.02016.x; Gomez-Mestre I, 2006, P NATL ACAD SCI USA, V103, P19021, DOI 10.1073/pnas.0603562103; Gomez-Mestre I, 2012, EVOLUTION, V66, P3687, DOI 10.1111/j.1558-5646.2012.01715.x; Gosner K. L., 1960, Herpetologica, V16, P183; Hollar AR, 2011, GEN COMP ENDOCR, V173, P190, DOI 10.1016/j.ygcen.2011.05.013; Hurd T.R., 2009, REDOX SIGNALING REGU, P13, DOI DOI 10.1002/9783527627585.CH2; JOHANSSON F, 2013, EVOL BIOL, P1; Kappus H., 1985, OXIDATIVE STRESS, V40, P273, DOI [DOI 10.1016/B978-0-12-642760-8.50016-8, 10.1016/B978-0-12-642760-8.50016-8]; KIKUYAMA S, 1993, INT REV CYTOL, V145, P105, DOI 10.1016/S0074-7696(08)60426-X; Kulkarni SS, 2011, J EVOLUTION BIOL, V24, P2445, DOI 10.1111/j.1420-9101.2011.02370.x; Kulkarni SS, 2012, ENDOCRINOLOGY, V153, P5309, DOI 10.1210/en.2012-1432; Laurila A, 2002, EVOLUTION, V56, P617; Lind MI, 2007, J EVOLUTION BIOL, V20, P1288, DOI 10.1111/j.1420-9101.2007.01353.x; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Morey S, 2000, ECOLOGY, V81, P1736, DOI 10.2307/177320; Morey SR, 2004, OIKOS, V104, P172, DOI 10.1111/j.0030-1299.2004.12623.x; Nakajima K, 2012, GENES CELLS, V17, P645, DOI 10.1111/j.1365-2443.2012.01614.x; NEWMAN RA, 1988, EVOLUTION, V42, P774, DOI 10.1111/j.1558-5646.1988.tb02495.x; NEWMAN RA, 1989, ECOLOGY, V70, P1775, DOI 10.2307/1938111; NEWMAN RA, 1992, BIOSCIENCE, V42, P671, DOI 10.2307/1312173; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pigliucci M., 2001, SYN ECO EVO; Richter-Boix A, 2006, EVOL ECOL RES, V8, P309; Richter-Boix A, 2006, EVOL ECOL RES, V8, P1139; Richter-Boix A, 2011, ECOL EVOL, V1, P15, DOI 10.1002/ece3.2; Rizzo AM, 2007, COMP BIOCHEM PHYS B, V146, P94, DOI 10.1016/j.cbpb.2006.09.009; Rosa CE, 2008, COMP BIOCHEM PHYS B, V149, P209, DOI 10.1016/j.cbpb.2007.09.010; Sadeh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015602; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; SMITH DC, 1987, ECOLOGY, V68, P344, DOI 10.2307/1939265; Stoks R, 2006, ECOLOGY, V87, P1566, DOI 10.1890/0012-9658(2006)87[1566:PCOCGI]2.0.CO;2; Tejedo M, 2010, CLIM RES, V43, P31, DOI 10.3354/cr00878; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537; West-Eberhard Mary Jane, 2003, pi; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305; YAOITA Y, 1990, GENE DEV, V4, P1917, DOI 10.1101/gad.4.11.1917	69	81	86	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84266	10.1371/journal.pone.0084266	http://dx.doi.org/10.1371/journal.pone.0084266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358352	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700160
J	Kratholm, SK; Iversen, MB; Reinert, L; Jensen, SK; Hokland, M; Andersen, T; Rankin, A; Young, D; Frische, S; Paludan, SR; Holm, CK				Kratholm, Sine K.; Iversen, Marie B.; Reinert, Line; Jensen, Simon K.; Hokland, Marianne; Andersen, Thomas; Rankin, Andrew; Young, Deborah; Frische, Sebastian; Paludan, Soren R.; Holm, Christian K.			Interleukin-21 Receptor Signalling Is Important for Innate Immune Protection against HSV-2 Infections	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-2; COMMON GAMMA-CHAIN; CELL-PROLIFERATION; NATURAL-KILLER; NKT CELLS; IL-21 RECEPTOR; T-CELLS; CYTOKINE; ACTIVATION; EXPRESSION	Interleukin (IL)-21 is produced by Natural Killer T (NKT) cells and CD4(+) T cells and is produced in response to virus infections, where IL-21 has been shown to be essential in adaptive immune responses. Cells from the innate immune system such as Natural Killer (NK) cells and macrophages are also important in immune protection against virus. These cells express the IL-21 receptor (IL-21R) and respond to IL-21 with increased cytotoxicity and cytokine production. Currently, however it is not known whether IL-21 plays a significant role in innate immune responses to virus infections. The purpose of this study was to investigate the role of IL-21 and IL-21R in the innate immune response to a virus infection. We used C57BL/6 wild type (WT) and IL-21R knock out (KO) mice in a murine vaginal Herpes Simplex Virus type 2 (HSV-2) infection model to show that IL-21 - IL-21R signalling is indeed important in innate immune responses against HSV-2. We found that the IL-21R was expressed in the vaginal epithelium in uninfected (u.i) WT mice, and expression increased early after HSV-2 infection. IL-21R KO mice exhibited increased vaginal viral titers on day 2 and 3 post infection (p.i.) and subsequently developed significantly higher disease scores and a lower survival rate compared to WT mice. In addition, WT mice infected with HSV-2 receiving intra-vaginal pre-treatment with murine recombinant IL-21 (mIL-21) had decreased vaginal viral titers on day 2 p.i., significantly lower disease scores, and a higher survival rate compared to infected untreated WT controls. Collectively our data demonstrate the novel finding that the IL-21R plays a critical role in regulating innate immune responses against HSV-2 infection.	[Kratholm, Sine K.; Iversen, Marie B.; Reinert, Line; Jensen, Simon K.; Hokland, Marianne; Andersen, Thomas; Paludan, Soren R.; Holm, Christian K.] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Rankin, Andrew; Young, Deborah] Pfizer Inc, Immunol & Autoimmun, Cambridge, MA USA; [Frische, Sebastian] Aarhus Univ, Inst Anat, Water & Salt Res Ctr, Aarhus, Denmark	Aarhus University; Pfizer; Aarhus University	Holm, CK (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	chol@immunology.au.dk	Frische, Sebastian/B-2332-2009	Frische, Sebastian/0000-0002-0270-3602; Holm, Christian/0000-0002-2655-3362; Reinert, Line/0000-0002-8317-0886; Jensen, Simon Kok/0000-0002-0032-131X	Faculty of Health Sciences, Aarhus University; Danish Research Council for Health and Disease [09072636]; Thora og Viggo Groves Mindelegat and Fhv. Direktor Leo Nielsens legat for laegevidenskabelig grundforskning	Faculty of Health Sciences, Aarhus University; Danish Research Council for Health and Disease; Thora og Viggo Groves Mindelegat and Fhv. Direktor Leo Nielsens legat for laegevidenskabelig grundforskning	This work was supported by the Faculty of Health Sciences, Aarhus University, the Danish Research Council for Health and Disease (grant no 09072636), Thora og Viggo Groves Mindelegat and Fhv. Direktor Leo Nielsens legat for laegevidenskabelig grundforskning. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almerigogna F, 2011, INT J IMMUNOPATH PH, V24, P231, DOI 10.1177/039463201102400128; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Ashkar AA, 2003, J VIROL, V77, P10168, DOI 10.1128/JVI.77.18.10168-10171.2003; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Biron CA, 2001, CURR OPIN IMMUNOL, V13, P458, DOI 10.1016/S0952-7915(00)00241-7; Brady J, 2004, J IMMUNOL, V172, P2048, DOI 10.4049/jimmunol.172.4.2048; Brandt K, 2003, BLOOD, V102, P4090, DOI 10.1182/blood-2003-03-0669; Caruso R, 2007, GASTROENTEROLOGY, V132, P166, DOI 10.1053/j.gastro.2006.09.053; Chan T, 2011, J REPROD IMMUNOL, V88, P210, DOI 10.1016/j.jri.2011.01.001; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633; Dimke H, 2007, AM J PHYSIOL-RENAL, V292, pF723, DOI 10.1152/ajprenal.00276.2006; Distler JHW, 2005, ARTHRITIS RHEUM-US, V52, P856, DOI 10.1002/art.20883; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Habib T, 2002, BIOCHEMISTRY-US, V41, P8725, DOI 10.1021/bi0202023; Holm C, 2006, CYTOKINE, V33, P41, DOI 10.1016/j.cyto.2005.11.014; Iversen MB, 2010, J VIROL, V84, P4579, DOI 10.1128/JVI.02591-09; Iwasaki A, 2010, NAT REV IMMUNOL, V10, P699, DOI 10.1038/nri2836; Jin HL, 2004, J IMMUNOL, V173, P657, DOI 10.4049/jimmunol.173.1.657; Kasaian MT, 2002, IMMUNITY, V16, P559, DOI 10.1016/S1074-7613(02)00295-9; Milligan GN, 1997, VIROLOGY, V229, P259, DOI 10.1006/viro.1997.8441; MILLIGAN GN, 1995, VIROLOGY, V212, P481, DOI 10.1006/viro.1995.1506; Mogensen TH, 2001, MICROBIOL MOL BIOL R, V65, P131, DOI 10.1128/MMBR.65.1.131-150.2001; Monteleone G, 2006, GUT, V55, P1774, DOI 10.1136/gut.2006.093187; O'Loughlin EV, 2001, GUT, V49, P636, DOI 10.1136/gut.49.5.636; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Ozaki K, 2000, P NATL ACAD SCI USA, V97, P11439, DOI 10.1073/pnas.200360997; Paludan SR, 2011, NAT REV IMMUNOL, V11, P143, DOI 10.1038/nri2937; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Rakasz E, 1999, IMMUNOL LETT, V70, P89, DOI 10.1016/S0165-2478(99)00132-7; Rasheed MAU, 2013, J VIROL, V87, P7737, DOI 10.1128/JVI.00063-13; REINECKER HC, 1995, P NATL ACAD SCI USA, V92, P8353, DOI 10.1073/pnas.92.18.8353; Reinert LS, 2012, J CLIN INVEST, V122, P1368, DOI 10.1172/JCI60893; Ruckert R, 2008, CLIN EXP IMMUNOL, V151, P487, DOI 10.1111/j.1365-2249.2007.03581.x; Sivori S, 2003, EUR J IMMUNOL, V33, P3439, DOI 10.1002/eji.200324533; Strengeil M, 2002, J IMMUNOL, V169, P3600, DOI 10.4049/jimmunol.169.7.3600; Thapa M, 2007, J VIROL, V81, P3704, DOI 10.1128/JVI.02626-06; Watanabe D, 2010, J DERMATOL SCI, V57, P75, DOI 10.1016/j.jdermsci.2009.10.014; Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057	44	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81790	10.1371/journal.pone.0081790	http://dx.doi.org/10.1371/journal.pone.0081790			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358128	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700024
J	Molognoni, F; de Melo, FHM; da Silva, CT; Jasiulionis, MG				Molognoni, Fernanda; Machado de Melo, Fabiana Henriques; da Silva, Camila Tainah; Jasiulionis, Miriam Galvonas			Ras and Rac1, Frequently Mutated in Melanomas, Are Activated by Superoxide Anion, Modulate Dnmt1 Level and Are Causally Related to Melanocyte Malignant Transformation	PLOS ONE			English	Article							CONFERS ANOIKIS RESISTANCE; DNA METHYLATION; LIFE-SPAN; DRIVER MUTATIONS; OXIDATIVE STRESS; PATHWAY; CELLS; EXPRESSION; PROTEIN; MEDIATOR	A melanocyte malignant transformation model was developed in our laboratory, in which different melanoma cell lines were obtained after submitting the non-tumorigenic melanocyte lineage melan-a to sequential cycles of anchorage impediment. Our group has already showed that increased superoxide level leads to global DNA hypermemethylation as well increased Dnmt1 expression few hours after melanocyte anchorage blockade. Here, we showed that Ras/Rac1/ERK signaling pathway is activated in melanocytes submitted to anchorage impediment, regulating superoxide levels, global DNA methylation, and Dnmt1 expression. Interestingly, Ras and Rac1 activation is not related to codon mutations, but instead regulated by superoxide. Moreover, the malignant transformation was drastically compromised when melan-a melanocytes were submitted to sequential cycles of anchorage blockage in the presence of a superoxide scavenger. This aberrant signaling pathway associated with a sustained stressful condition, which might be similar to conditions such as UV radiation and inflammation, seems to be an early step in malignant transformation and to contribute to an epigenetic reprogramming and the melanoma development.	[Molognoni, Fernanda; Machado de Melo, Fabiana Henriques; da Silva, Camila Tainah; Jasiulionis, Miriam Galvonas] Univ Fed Sao Paulo, Dept Farmacol, UNIFESP, Sao Paulo, Brazil; [Machado de Melo, Fabiana Henriques] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, UNIFESP, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Jasiulionis, MG (corresponding author), Univ Fed Sao Paulo, Dept Farmacol, UNIFESP, Sao Paulo, Brazil.	mjasiulionis@gmail.com	Melo, Fabiana/M-6460-2013; Jasiulionis, Miriam/G-2207-2012; de Melo, Fabiana Henriques Machado/AAG-3096-2021	Jasiulionis, Miriam/0000-0002-4135-0440; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/51462-9, 2011/09676-1, 2011/12306-1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [2867/10]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2009/51462-9 to F.M., 2011/09676-1 to C. T. S. and 2011/12306-1 to M.G.J.) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (2867/10 to F. M. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; Barnett P, 2011, BIOCHEM BIOPH RES CO, V404, P34, DOI 10.1016/j.bbrc.2010.11.044; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Bigey P, 2000, GENE, V242, P407, DOI 10.1016/S0378-1119(99)00501-6; Bjornsson HT, 2004, COLD SPRING HARB SYM, V69, P447, DOI 10.1101/sqb.2004.69.447; Brar SS, 2002, AM J PHYSIOL-CELL PH, V282, pC1212, DOI 10.1152/ajpcell.00496.2001; Campos ACE, 2007, NEOPLASIA, V9, P1111, DOI 10.1593/neo.07712; Cho HJ, 2002, J BIOL CHEM, V277, P19358, DOI 10.1074/jbc.M200933200; Choudhary S, 2011, MOL CARCINOGEN, V50, P215, DOI 10.1002/mc.20708; Correa M, 2005, INT J CANCER, V114, P356, DOI 10.1002/ijc.20673; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; Diamond DA, 1999, J BIOL CHEM, V274, P16959, DOI 10.1074/jbc.274.24.16959; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dulic V, 2000, MOL CELL BIOL, V20, P6741, DOI 10.1128/MCB.20.18.6741-6754.2000; Esteller M, 2006, BRIT J CANCER, V94, P179, DOI 10.1038/sj.bjc.6602918; Flinder LI, 2011, J CELL PHYSIOL, V226, P2267, DOI 10.1002/jcp.22563; Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Goldstein NB, 2009, J INVEST DERMATOL, V129, P432, DOI 10.1038/jid.2008.227; Guo X, 2011, NEUROSCIENCE, V194, P272, DOI 10.1016/j.neuroscience.2011.07.012; Hitchler MJ, 2007, FREE RADICAL BIO MED, V43, P1023, DOI 10.1016/j.freeradbiomed.2007.06.027; Hmadcha A, 1999, J EXP MED, V190, P1595, DOI 10.1084/jem.190.11.1595; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Jeong WJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002242; Johnstone SE, 2010, NAT REV GENET, V11, P806, DOI 10.1038/nrg2881; KAUTIAINEN TL, 1986, J BIOL CHEM, V261, P1594; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Klatt P, 2000, BIOCHEM J, V349, P567, DOI 10.1042/0264-6021:3490567; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kwon GY, 2005, J KOREAN MED SCI, V20, P242, DOI 10.3346/jkms.2005.20.2.242; LANDER HM, 1995, J BIOL CHEM, V270, P21195, DOI 10.1074/jbc.270.36.21195; Li AE, 1999, CIRC RES, V85, P304, DOI 10.1161/01.RES.85.4.304; Lu R, 2007, J BIOL CHEM, V282, P12249, DOI 10.1074/jbc.M608525200; Lund P, 2006, ONCOGENE, V25, P4890, DOI 10.1038/sj.onc.1209502; Masaki H, 2010, J DERMATOL SCI, V58, P85, DOI 10.1016/j.jdermsci.2010.03.003; MCFARLAND GA, 1994, EXP CELL RES, V212, P167, DOI 10.1006/excr.1994.1132; Mehnert JM, 2012, CURR ONCOL REP, V14, P449, DOI 10.1007/s11912-012-0249-5; Melo FHM, 2011, FREE RADICAL BIO MED, V50, P1263, DOI 10.1016/j.freeradbiomed.2011.02.022; Mishra MV, 2008, MOL CANCER RES, V6, P243, DOI 10.1158/1541-7786.MCR-07-0373; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Molognoni F, 2011, EPIGENETICS-US, V6, P451, DOI 10.4161/epi.6.4.14917; Nandakumar V, 2011, CARCINOGENESIS, V32, P597, DOI 10.1093/carcin/bgq282; Oba-Shinjo SM, 2006, NEOPLASIA, V8, P231, DOI 10.1593/neo.05781; PACKER L, 1977, P NATL ACAD SCI USA, V74, P1640, DOI 10.1073/pnas.74.4.1640; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Pervaiz S, 2001, ONCOGENE, V20, P6263, DOI 10.1038/sj.onc.1204840; Pruitt K, 2005, J BIOL CHEM, V280, P23363, DOI 10.1074/jbc.M503083200; Qin SF, 2003, BIOCHEMISTRY-US, V42, P2995, DOI 10.1021/bi0205911; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Roy SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025166; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Seru R, 2004, J NEUROCHEM, V91, P613, DOI 10.1111/j.1471-4159.2004.02754.x; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Su F, 2012, CANCER RES, V72, P969, DOI 10.1158/0008-5472.CAN-11-1875; Sun LD, 2007, CELL SIGNAL, V19, P2255, DOI 10.1016/j.cellsig.2007.06.014; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Toricelli M, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-22; Tsai CL, 2006, CANCER RES, V66, P11668, DOI 10.1158/0008-5472.CAN-06-2194; Tsai WB, 2012, CANCER RES, V72, P2622, DOI 10.1158/0008-5472.CAN-11-3605; Wang FS, 2004, J BIOL CHEM, V279, P10331, DOI 10.1074/jbc.M308013200; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; WU JJ, 1993, P NATL ACAD SCI USA, V90, P8891, DOI 10.1073/pnas.90.19.8891; Wu RF, 2009, FREE RADICAL BIO MED, V47, P1276, DOI 10.1016/j.freeradbiomed.2009.05.037; Yang JQ, 1999, MOL CARCINOGEN, V26, P180; Yang JQ, 2001, ANTIOXID REDOX SIGN, V3, P697, DOI 10.1089/15230860152543032; Yoo BH, 2012, INT J CANCER, V131, P357, DOI 10.1002/ijc.26368; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018	71	24	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81937	10.1371/journal.pone.0081937	http://dx.doi.org/10.1371/journal.pone.0081937			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358134	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700028
J	Uthicke, S; Pecorino, D; Albright, R; Negri, AP; Cantin, N; Liddy, M; Dworjanyn, S; Kamya, P; Byrne, M; Lamare, M				Uthicke, Sven; Pecorino, Danilo; Albright, Rebecca; Negri, Andrew Peter; Cantin, Neal; Liddy, Michelle; Dworjanyn, Symon; Kamya, Pamela; Byrne, Maria; Lamare, Miles			Impacts of Ocean Acidification on Early Life-History Stages and Settlement of the Coral-Eating Sea Star Acanthaster planci	PLOS ONE			English	Article							LARVAL DEVELOPMENT; CLIMATE-CHANGE; URCHIN LARVAE; RECRUITMENT; FERTILIZATION; INDUCTION; CO2; PH; CALCIFICATION; METAMORPHOSIS	Coral reefs are marine biodiversity hotspots, but their existence is threatened by global change and local pressures such as land-runoff and overfishing. Population explosions of coral-eating crown of thorns sea stars (COTS) are a major contributor to recent decline in coral cover on the Great Barrier Reef. Here, we investigate how projected near-future ocean acidification (OA) conditions can affect early life history stages of COTS, by investigating important milestones including sperm motility, fertilisation rates, and larval development and settlement. OA (increased pCO(2) to 900-1200 mu atm pCO(2)) significantly reduced sperm motility and, to a lesser extent, velocity, which strongly reduced fertilization rates at environmentally relevant sperm concentrations. Normal development of 10 d old larvae was significantly lower under elevated pCO(2) but larval size was not significantly different between treatments. Settlement of COTS larvae was significantly reduced on crustose coralline algae (known settlement inducers of COTS) that had been exposed to OA conditions for 85 d prior to settlement assays. Effect size analyses illustrated that reduced settlement may be the largest bottleneck for overall juvenile production. Results indicate that reductions in fertilisation and settlement success alone would reduce COTS population replenishment by over 50%. However, it is unlikely that this effect is sufficient to provide respite for corals from other negative anthropogenic impacts and direct stress from OA and warming on corals.	[Uthicke, Sven; Albright, Rebecca; Negri, Andrew Peter; Cantin, Neal; Liddy, Michelle] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Pecorino, Danilo; Lamare, Miles] Univ Otago, Dept Marine Biol, Dunedin, New Zealand; [Dworjanyn, Symon; Kamya, Pamela] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Byrne, Maria] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [Byrne, Maria] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	Australian Institute of Marine Science; University of Otago; Southern Cross University; University of Sydney; University of Sydney	Uthicke, S (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	S.Uthicke@aims.gov.au	Uthicke, Sven/F-1810-2010; Byrne, Maria/K-6355-2016; Dworjanyn, Symon A/O-5633-2017; Negri, Andrew/G-9909-2017	Uthicke, Sven/0000-0002-3476-6595; Byrne, Maria/0000-0002-8902-9808; Dworjanyn, Symon A/0000-0002-6690-8033; Lamare, Miles/0000-0001-8656-7240; Negri, Andrew/0000-0003-1388-7395; Albright, Rebecca/0000-0003-3409-8766	Australian Institute of Marine Science	Australian Institute of Marine Science	The study was funded from appropriation funding of the Australian Institute of Marine Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056468; Albright R, 2011, GLOBAL CHANGE BIOL, V17, P2478, DOI 10.1111/j.1365-2486.2011.02404.x; Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; BABCOCK RC, 1994, BIOL BULL-US, V186, P17, DOI 10.2307/1542033; Byrne M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0439; Byrne M, 2013, MAR ECOL PROG SER, V473, P235, DOI 10.3354/meps10058; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Challener Roberta C., 2013, Journal of Applied Aquaculture, V25, P154, DOI 10.1080/10454438.2013.791911; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Doropoulos C, 2012, ECOL LETT, V15, P338, DOI 10.1111/j.1461-0248.2012.01743.x; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; Fabricius K, P ROYAL S B IN PRESS; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Foo SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042497; Gonzalez-Bernat MJ, 2013, POLAR BIOL, V36, P235, DOI 10.1007/s00300-012-1255-7; Havenhand JN, 2008, CURR BIOL, V18, pR651, DOI 10.1016/j.cub.2008.06.015; Hintze J., 2001, NCSS PASS NUMBER CRU; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; JOHNSON CR, 1991, MAR ECOL PROG SER, V71, P143, DOI 10.3354/meps071143; KANATANI H, 1969, EXP CELL RES, V57, P333, DOI 10.1016/0014-4827(69)90158-X; Kelly MW, 2013, GLOBAL CHANGE BIOL; Koch M, 2012, GLOBAL CHANGE BIOL; KROEKER KJ, 2013, GLOBAL CHANGE BIOL; MORSE ANC, 1984, J EXP MAR BIOL ECOL, V75, P191, DOI 10.1016/0022-0981(84)90166-7; Mortensen T., 1921, STUDIES DEV LARVAL F, DOI [10.5962/bhl.title.11376, DOI 10.5962/BHL.TITLE.11376]; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nakajima A, 2005, J EXP BIOL, V208, P4411, DOI 10.1242/jeb.01906; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; PEARCE CM, 1990, BIOL BULL-US, V179, P304, DOI 10.2307/1542322; Pespeni MH, 2013, P NATL ACAD SCI USA, V110, P6937, DOI 10.1073/pnas.1220673110; Reuter KE, 2011, GLOBAL CHANGE BIOL, V17, P163, DOI 10.1111/j.1365-2486.2010.02216.x; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; RUMRILL SS, 1990, OPHELIA, V32, P163, DOI 10.1080/00785236.1990.10422030; Russell BD, 2013, MARINE POLLUTION B; Schlegel P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053118; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P331, DOI 10.1016/j.cbpa.2011.06.022; Stumpp M, 2012, P NATL ACAD SCI USA, V109, P18192, DOI 10.1073/pnas.1209174109; Sunday JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022881; Team RC, 2012, R LANG ENV STAT COMP; Uthicke S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01769; Uthicke S, 2013, MAR BIOL, V160, P1913, DOI 10.1007/s00227-012-2023-5; Uthicke S, 2012, GLOBAL CHANGE BIOL, V18, P2781, DOI 10.1111/j.1365-2486.2012.02715.x; Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; Webster NS, 2013, GLOBAL CHANGE BIOL, V19, P303, DOI 10.1111/gcb.12008; Webster NS, 2011, ISME J, V5, P759, DOI 10.1038/ismej.2010.152; Witt V, 2011, ENVIRON MICROBIOL, V13, P2976, DOI 10.1111/j.1462-2920.2011.02571.x; ZANN L, 1987, B MAR SCI, V41, P561	51	64	65	1	144	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82938	10.1371/journal.pone.0082938	http://dx.doi.org/10.1371/journal.pone.0082938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358240	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700098
J	Horsley, H; Malone-Lee, J; Holland, D; Tuz, M; Hibbert, A; Kelsey, M; Kupelian, A; Rohn, JL				Horsley, Harry; Malone-Lee, James; Holland, David; Tuz, Madeleine; Hibbert, Andrew; Kelsey, Michael; Kupelian, Anthony; Rohn, Jennifer L.			Enterococcus faecalis Subverts and Invades the Host Urothelium in Patients with Chronic Urinary Tract Infection	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; INTRACELLULAR BACTERIAL COMMUNITIES; KLEBSIELLA-PNEUMONIAE; OVERACTIVE BLADDER; BIOFILM FORMATION; SYMPTOMS; EPIDEMIOLOGY; DIAGNOSIS; DIFFERENTIATION; PATHOGENESIS	Bacterial urinary tract infections (UTI) are a major growing concern worldwide. Uropathogenic Escherichia coli has been shown to invade the urothelium during acute UTI in mice and humans, forming intracellular reservoirs that can evade antibiotics and the immune response, allowing recurrence at a later date. Other bacterial species, such as Staphylococcus saprophyticus, Klebsiella pneumonia and Salmonella enterica have also been shown to be invasive in acute UTI. However, the role of intracellular infection in chronic UTI causing more subtle lower urinary tract symptoms (LUTS), a particular problem in the elderly population, is poorly understood. Moreover, the species of bacteria involved remains largely unknown. A previous study of a large cohort of non-acute LUTS patients found that Enterococcus faecalis was frequently found in urine specimens. E. faecalis accounts for a significant proportion of chronic bladder infections worldwide, although the invasive lifestyle of this uropathogen has yet to be reported. Here, we wanted to explore this question in more detail. We harvested urothelial cells shed in response to inflammation and, using advanced imaging techniques, inspected them for signs of bacterial pathology and invasion. We found strong evidence of intracellular E. faecalis harboured within urothelial cells shed from the bladder of LUTS patients. Furthermore, using a culture model system, these patient-isolated strains of E. faecalis were able to invade a transitional carcinoma cell line. In contrast, we found no evidence of cellular invasion by E. coli in the patient cells or the culture model system. Our data show that E. faecalis is highly competent to invade in this context; therefore, these results have implications for both the diagnosis and treatment of chronic LUTS.	[Horsley, Harry; Malone-Lee, James; Holland, David; Tuz, Madeleine; Kupelian, Anthony; Rohn, Jennifer L.] UCL, Ctr Clin Sci & Technol, Res Dept Clin Physiol, Div Med, London, England; [Hibbert, Andrew] Univ London Royal Vet Coll, London, England; [Kelsey, Michael] Whittington Hosp NHS Trust, Dept Microbiol, London, England	University of London; University College London; University of London; University of London Royal Veterinary College	Rohn, JL (corresponding author), UCL, Ctr Clin Sci & Technol, Res Dept Clin Physiol, Div Med, London, England.	j.rohn@ucl.ac.uk		Rohn, Jennifer/0000-0001-8766-6056	Research into Ageing [315]	Research into Ageing	This work was partially funded by Research into Ageing (grant number: 315; http://www.ageuk.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Anderson GG, 2004, MICROBES INFECT, V6, P1094, DOI 10.1016/j.micinf.2004.05.023; Anderson GG, 2004, TRENDS MICROBIOL, V12, P424, DOI 10.1016/j.tim.2004.07.005; Blango MG, 2010, ANTIMICROB AGENTS CH, V54, P1855, DOI 10.1128/AAC.00014-10; BRAUNER A, 1992, CLIN NEPHROL, V38, P318; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; CASS AS, 1985, UROLOGY, V25, P492, DOI 10.1016/0090-4295(85)90458-3; Chai Wen L, 2007, J Oral Sci, V49, P161, DOI 10.2334/josnusd.49.161; Chapple CR, 2008, EUR UROL, V54, P563, DOI 10.1016/j.eururo.2008.03.109; Colgan R, 2011, AM FAM PHYSICIAN, V84, P771; Coyne KS, 2009, BJU INT, V104, P352, DOI 10.1111/j.1464-410X.2009.08427.x; DALAL E, 1994, INFECT IMMUN, V62, P5505, DOI 10.1128/IAI.62.12.5505-5510.1994; Dukes C, 1928, Proc R Soc Med, V21, P1179; Edwards AM, 2011, JOVE-J VIS EXP, DOI 10.3791/2693; Eto DS, 2006, CELL MICROBIOL, V8, P704, DOI 10.1111/j.1462-5822.2006.00691.x; FELMINGHAM D, 1992, CLIN INFECT DIS, V15, P295, DOI 10.1093/clinids/15.2.295; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Foxman B, 2002, AM J MED, V113, p5S; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; Garofalo CK, 2007, INFECT IMMUN, V75, P52, DOI 10.1128/IAI.01123-06; Gill K, 2011, INT UROGYNECOL J, V22, P1769, DOI [10.1007/s00192-011-1521-1, DOI 10.1007/S00192-011-1521-1]; Gormley EA, 2012, J UROLOGY, V188, P2455, DOI 10.1016/j.juro.2012.09.079; Guiton PS, 2013, INFECT IMMUN, V81, P329, DOI 10.1128/IAI.00856-12; Hanin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011879; Hannan TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001042; Hooton TM, 2001, INT J ANTIMICROB AG, V17, P259, DOI 10.1016/S0924-8579(00)00350-2; Hunstad DA, 2010, ANNU REV MICROBIOL, V64, P203, DOI 10.1146/annurev.micro.112408.134258; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; Khasriya R, 2013, J CLIN MICROBIOL, V51, P2054, DOI 10.1128/JCM.03314-12; Khasriya R, 2010, J UROLOGY, V183, P1843, DOI 10.1016/j.juro.2010.01.008; Kupelian AS, 2013, BJU INT, V112, P231, DOI 10.1111/j.1464-410X.2012.11694.x; Lutters M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001535.pub2; MANDELL GL, 1973, J CLIN INVEST, V52, P1673, DOI 10.1172/JCI107348; Mohamed JA, 2007, J MED MICROBIOL, V56, P1581, DOI 10.1099/jmm.0.47331-0; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Nakipoglu GF, 2009, J CLIN NEUROSCI, V16, P1321, DOI 10.1016/j.jocn.2008.12.012; National Institute for Health and Clinical Excellence, 2006, URIN INC MAN UR INC; Nichol KA, 2006, INT J ANTIMICROB AG, V27, P392, DOI 10.1016/j.ijantimicag.2005.12.006; Perry S, 2000, J PUBLIC HEALTH MED, V22, P427, DOI 10.1093/pubmed/22.3.427; Poulsen LL, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-320; Pouwels KB, 2013, J ANTIMICROB CHEMOTH, V68, P708, DOI 10.1093/jac/dks419; Romero R, 2008, AM J OBSTET GYNECOL, V198, P1, DOI 10.1016/j.ajog.2007.11.031; Rosen DA, 2008, INFECT IMMUN, V76, P3337, DOI 10.1128/IAI.00090-08; Rosen DA, 2008, INFECT IMMUN, V76, P3346, DOI 10.1128/IAI.00340-08; Rosen DA, 2007, PLOS MED, V4, P1949, DOI 10.1371/journal.pmed.0040329; RUSSO TA, 1995, J INFECT DIS, V172, P440, DOI 10.1093/infdis/172.2.440; Sartingen S, 2000, INFECT IMMUN, V68, P6044, DOI 10.1128/IAI.68.10.6044-6047.2000; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Schembri MA, 2001, INFECT IMMUN, V69, P1322, DOI 10.1128/IAI.69.3.1322-1328.2001; SIZEMORE RK, 1990, APPL ENVIRON MICROB, V56, P2245, DOI 10.1128/AEM.56.7.2245-2247.1990; Smith YC, 2008, INFECT IMMUN, V76, P2978, DOI 10.1128/IAI.00075-08; Snyder JA, 2006, INFECT IMMUN, V74, P1387, DOI 10.1128/IAI.74.2.1387-1393.2006; STAMM WE, 1982, NEW ENGL J MED, V307, P463, DOI 10.1056/NEJM198208193070802; Stender H, 2003, EXPERT REV MOL DIAGN, V3, P649, DOI 10.1586/14737159.3.5.649; Swaminathan Subramanian, 2010, Curr Infect Dis Rep, V12, P455, DOI 10.1007/s11908-010-0138-8; Szabados F, 2008, FEMS MICROBIOL LETT, V285, P163, DOI 10.1111/j.1574-6968.2008.01218.x; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; Wright KJ, 2007, CELL MICROBIOL, V9, P2230, DOI 10.1111/j.1462-5822.2007.00952.x; Wright KJ, 2006, FUTURE MICROBIOL, V1, P75, DOI 10.2217/17460913.1.1.75; WU XR, 1994, J BIOL CHEM, V269, P13716; WU XR, 1990, J BIOL CHEM, V265, P19170	63	57	60	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83637	10.1371/journal.pone.0083637	http://dx.doi.org/10.1371/journal.pone.0083637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24363814	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400137
J	Zhou, AX; El Hed, A; Mercer, F; Kozhaya, L; Unutmaz, D				Zhou, Angela X.; El Hed, Aimee; Mercer, Frances; Kozhaya, Lina; Unutmaz, Derya			The Metalloprotease ADAM12 Regulates the Effector Function of Human Th17 Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; T-CELLS; CYTOKINE SIGNALS; MELTRIN ALPHA; T(H)17 CELLS; EX-VIVO; EXPRESSION; RECEPTOR; DIFFERENTIATION; INDUCTION	A key modulator of immune homeostasis, TGF beta has an important role in the differentiation of regulatory T cells (Tregs) and IL-17-secreting T cells (Th17). How TGF beta regulates these functionally opposing T cell subsets is not well understood. We determined that an ADAM family metalloprotease called ADAM12 is specifically and highly expressed in both Tregs and CCR6+ Th17 cells. ADAM12 is induced in vitro upon differentiation of naive T cells to Th17 cells or IL-17-secreting Tregs. Remarkably, silencing ADAM12 expression in CCR6+ memory T cells enhances the production of Th17 cytokines, similar to suppressing TGF beta signaling. Further, ADAM12 knockdown in naive human T cells polarized towards Th17/Treg cells, or ectopically expressing RORC, greatly enhances IL-17-secreting cell differentiation, more potently then inhibiting TGF beta signals. Together, our findings reveal a novel regulatory role for ADAM12 in Th17 cell differentiation or function and may have implications in regulating their aberrant responses during immune pathologies.	[Zhou, Angela X.; El Hed, Aimee; Mercer, Frances; Kozhaya, Lina; Unutmaz, Derya] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Unutmaz, Derya] NYU, Sch Med, Dept Pathol, New York, NY USA; [Unutmaz, Derya] NYU, Sch Med, Dept Med, New York, NY USA	New York University; New York University; New York University	Unutmaz, D (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	Derya@mac.com			National Institutes of Health (NIH) [R01AI065303]; NIH [R21AI087973, 5T32AI007647]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065303, T32AI007180, R21AI087973, T32AI007647] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by grants from National Institutes of Health (NIH) grant R01AI065303 and NIH R21AI087973 to DU and NIH training grant 5T32AI007647 to AZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046; Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Evans HG, 2007, P NATL ACAD SCI USA, V104, P17034, DOI 10.1073/pnas.0708426104; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gruel Jeremy, 2009, BMC Res Notes, V2, P193, DOI 10.1186/1756-0500-2-193; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kurisaki T, 1998, MECH DEVELOP, V73, P211, DOI 10.1016/S0925-4773(98)00043-4; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Le Pabic H, 2005, J HEPATOL, V43, P1038, DOI 10.1016/j.jhep.2005.05.025; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Loechel F, 1998, J BIOL CHEM, V273, P16993, DOI 10.1074/jbc.273.27.16993; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Mercer F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008639; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Oswald-Richter K, 2007, PLOS PATHOG, V3, P553, DOI 10.1371/journal.ppat.0030058; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Solomon E, 2010, J BIOL CHEM, V285, P21969, DOI 10.1074/jbc.M110.133314; Streeck H, 2008, J IMMUNOL METHODS, V333, P115, DOI 10.1016/j.jim.2008.01.018; Toft-Hansen H, 2004, J IMMUNOL, V173, P5209, DOI 10.4049/jimmunol.173.8.5209; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Valmori D, 2010, P NATL ACAD SCI USA, V107, P19402, DOI 10.1073/pnas.1008247107; Wan Q, 2011, J EXP MED, V208, P1875, DOI 10.1084/jem.20102516; Wang R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002705; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; White JM, 2003, CURR OPIN CELL BIOL, V15, P598, DOI 10.1016/j.ceb.2003.08.001; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zuniga LA, 2013, IMMUNOL REV, V252, P78, DOI 10.1111/imr.12036	37	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81146	10.1371/journal.pone.0081146	http://dx.doi.org/10.1371/journal.pone.0081146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24363794	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800106
J	Flowerdew, SE; Wick, D; Himmelein, S; Horn, AKE; Sinicina, I; Strupp, M; Brandt, T; Theil, D; Hufner, K				Flowerdew, Sarah E.; Wick, Desiree; Himmelein, Susanne; Horn, Anja K. E.; Sinicina, Inga; Strupp, Michael; Brandt, Thomas; Theil, Diethilde; Huefner, Katharina			Characterization of Neuronal Populations in the Human Trigeminal Ganglion and Their Association with Latent Herpes Simplex Virus-1 Infection	PLOS ONE			English	Article							PRIMARY SENSORY NEURONS; GENE-RELATED PEPTIDE; POLYMERASE CHAIN-REACTION; PRIMARY AFFERENT NEURONS; DORSAL-ROOT GANGLION; VARICELLA-ZOSTER; TRANSCRIPT GENE; TYPE-1 LATENCY; IMMUNOHISTOCHEMICAL ANALYSIS; CEREBROSPINAL-FLUID	Following primary infection Herpes simplex virus-1 (HSV-1) establishes lifelong latency in the neurons of human sensory ganglia. Upon reactivation HSV-1 can cause neurological diseases such as facial palsy, vestibular neuritis or encephalitis. Certain populations of sensory neurons have been shown to be more susceptible to latent infection in the animal model, but this has not been addressed in human tissue. In the present study, trigeminal ganglion (TG) neurons expressing six neuronal marker proteins were characterized, based on staining with antibodies against the GDNF family ligand receptor Ret, the high-affinity nerve growth factor receptor TrkA, neuronal nitric oxide synthase (nNOS), the antibody RT97 against 200kDa neurofilament, calcitonin gene-related peptide and peripherin. The frequencies of marker-positive neurons and their average neuronal sizes were assessed, with TrkA-positive (61.82%) neurons being the most abundant, and Ret-positive (26.93%) the least prevalent. Neurons positive with the antibody RT97 (1253 mm 2) were the largest, and those stained against peripherin (884 mu m(2)) were the smallest. Dual immunofluorescence revealed at least a 4.5% overlap for every tested marker combination, with overlap for the combinations TrkA/Ret, TrkA/RT97 and Ret/nNOS lower, and the overlap between Ret/CGRP being higher than would be expected by chance. With respect to latent HSV-1 infection, latency associated transcripts (LAT) were detected using in situ hybridization (ISH) in neurons expressing each of the marker proteins. In contrast to the mouse model, co-localization with neuronal markers Ret or CGRP mirrored the magnitude of these neuron populations, whereas for the other four neuronal markers fewer marker-positive cells were also LAT-ISH+. Ret and CGRP are both known to label neurons related to pain signaling.	[Flowerdew, Sarah E.; Wick, Desiree; Himmelein, Susanne; Strupp, Michael; Theil, Diethilde; Huefner, Katharina] Univ Munich, Klinikum Grosshadern, Dept Neurol, Munich, Germany; [Flowerdew, Sarah E.; Wick, Desiree; Himmelein, Susanne; Horn, Anja K. E.; Strupp, Michael; Brandt, Thomas; Huefner, Katharina] Univ Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Horn, Anja K. E.] Univ Munich, Inst Anat, Dept 1, Munich, Germany; [Sinicina, Inga] Univ Munich, Dept Legal Med, Munich, Germany; [Brandt, Thomas] Univ Munich, Klinikum Grosshadern, Inst Clin Neurosci, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich; University of Munich	Himmelein, S (corresponding author), Univ Munich, Klinikum Grosshadern, Dept Neurol, Munich, Germany.	susanne.himmelein@med.uni-muenchen.de		Hufner, Katharina/0000-0002-5453-8792; Horn, Anja/0000-0001-7797-1516	German Ministry for Education and Research [IFB 01EO0901]; Hertie Foundation	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Hertie Foundation	This study was funded by the German Ministry for Education and Research (IFB 01EO0901) and the Hertie Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ FJ, 1991, J NEUROCYTOL, V20, P716, DOI 10.1007/BF01187846; Arbusow V, 2010, J MED VIROL, V82, P1917, DOI 10.1002/jmv.21904; AURELIUS E, 1993, J MED VIROL, V39, P179, DOI 10.1002/jmv.1890390302; AURELIUS E, 1991, LANCET, V337, P189, DOI 10.1016/0140-6736(91)92155-U; Bergman E, 1999, BRAIN RES, V832, P63, DOI 10.1016/S0006-8993(99)01469-9; Bertke AS, 2011, J VIROL, V85, P6669, DOI 10.1128/JVI.00204-11; Borsani E, 2010, ACTA HISTOCHEM, V112, P444, DOI 10.1016/j.acthis.2009.04.006; Eftekhari S, 2010, NEUROSCIENCE, V169, P683, DOI 10.1016/j.neuroscience.2010.05.016; Fang X, 2005, J NEUROSCI, V25, P4868, DOI 10.1523/JNEUROSCI.0249-05.2005; Feldman LT, 2002, P NATL ACAD SCI USA, V99, P978, DOI 10.1073/pnas.022301899; FELIPE CD, 1999, EUR J PAIN, V3, P31; Flores CM, 1996, J NEUROSCI, V16, P7892; Gaspersic R, 2007, NEUROSCI LETT, V418, P253, DOI 10.1016/j.neulet.2007.03.060; Golden JP, 2010, J NEUROSCI, V30, P3983, DOI 10.1523/JNEUROSCI.5930-09.2010; Griffin BD, 2010, VET MICROBIOL, V143, P89, DOI 10.1016/j.vetmic.2010.02.017; HARBOUR DA, 1983, J GEN VIROL, V64, P1491, DOI 10.1099/0022-1317-64-7-1491; Held K, 2011, J NEUROVIROL, V17, P518, DOI 10.1007/s13365-011-0063-0; Held K, 2011, J VIROL, V85, P9680, DOI 10.1128/JVI.00874-11; HILL JM, 1990, VIROLOGY, V174, P117, DOI 10.1016/0042-6822(90)90060-5; Hilliges M, 1996, ANAT RECORD, V245, P621, DOI 10.1002/(SICI)1097-0185(199608)245:4<621::AID-AR2>3.0.CO;2-R; Hufner K, 2009, J VIROL, V83, P3696, DOI 10.1128/JVI.02464-08; KAIKAI MA, 1989, COMP BIOCHEM PHYS A, V93, P183, DOI 10.1016/0300-9629(89)90206-5; Lariviere RC, 2002, J NEUROCHEM, V81, P525, DOI 10.1046/j.1471-4159.2002.00853.x; Lazarov NE, 2002, PROG NEUROBIOL, V66, P19, DOI 10.1016/S0301-0082(01)00021-1; Margolis TP, 2007, J VIROL, V81, P1872, DOI 10.1128/JVI.02110-06; MARGOLIS TP, 1992, INVEST OPHTH VIS SCI, V33, P259; Mark KE, 2010, JAIDS-J ACQ IMM DEF, V54, P482, DOI 10.1097/QAI.0b013e3181d91322; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Perng GC, 2000, SCIENCE, V287, P1500, DOI 10.1126/science.287.5457.1500; Perng GC, 1999, J VIROL, V73, P9669, DOI 10.1128/JVI.73.11.9669-9672.1999; Perng GC, 2000, J VIROL, V74, P1885, DOI 10.1128/JVI.74.4.1885-1891.2000; PERNG GC, 1994, J VIROL, V68, P8045, DOI 10.1128/JVI.68.12.8045-8055.1994; PRICE J, 1985, J NEUROSCI, V5, P2051; Price TJ, 2007, J PAIN, V8, P263, DOI 10.1016/j.jpain.2006.09.005; Quartu M, 2006, BRAIN RES BULL, V69, P393, DOI 10.1016/j.brainresbull.2006.02.003; QUARTU M, 1992, J CHEM NEUROANAT, V5, P143, DOI 10.1016/0891-0618(92)90040-W; Quartu M, 1996, NEUROREPORT, V7, P1013, DOI 10.1097/00001756-199604100-00012; Quartu M, 1997, NEUROREPORT, V8, P3611, DOI 10.1097/00001756-199711100-00038; Rusu MC, 2011, ANN ANAT, V193, P403, DOI 10.1016/j.aanat.2011.06.005; Sheridan BS, 2007, EXPERT OPIN BIOL TH, V7, P1323, DOI 10.1517/14712598.7.9.1323; Sniderhan LF, 2009, EXP HEMATOL, V37, P1295, DOI 10.1016/j.exphem.2009.08.005; SOMMER EW, 1985, BRAIN RES, V346, P310, DOI 10.1016/0006-8993(85)90865-0; STEINER I, 1995, J NEUROVIROL, V1, P19, DOI 10.3109/13550289509111007; Steiner I, 2007, LANCET NEUROL, V6, P1015, DOI 10.1016/S1474-4422(07)70267-3; STEVENS JG, 1987, SCIENCE, V235, P1056, DOI 10.1126/science.2434993; Theil D, 2003, AM J PATHOL, V163, P2179, DOI 10.1016/S0002-9440(10)63575-4; Theil D, 2001, BRAIN PATHOL, V11, P408, DOI 10.1111/j.1750-3639.2001.tb00408.x; Thompson RL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000352; Thompson RL, 1997, J VIROL, V71, P5432, DOI 10.1128/JVI.71.7.5432-5440.1997; Vang Hue, 2012, Exp Neurobiol, V21, P68, DOI 10.5607/en.2012.21.2.68; Wang KN, 2005, J VIROL, V79, P14079, DOI 10.1128/JVI.79.22.14079-14087.2005; Wauters O, 2012, J AM ACAD DERMATOL, V66, pE217, DOI 10.1016/j.jaad.2010.07.011; Wilson AC, 2012, TRENDS MICROBIOL, V20, P604, DOI 10.1016/j.tim.2012.08.005; Xiao SX, 2006, BBA-MOL BASIS DIS, V1762, P1001, DOI 10.1016/j.bbadis.2006.09.003; Yang L, 2000, J VIROL, V74, P209, DOI 10.1128/JVI.74.1.209-217.2000; Zerboni L, 2012, J VIROL, V86, P578, DOI 10.1128/JVI.05950-11; Zylka MJ, 2005, NEURON, V47, P771, DOI 10.1016/j.neuron.2005.09.003	57	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e83603	10.1371/journal.pone.0083603	http://dx.doi.org/10.1371/journal.pone.0083603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367603	Green Submitted, Green Published, gold			2022-12-27	WOS:000328741900019
J	Chen, HX; Jin, ZL; Zhang, LM; Xue, R; Xu, XD; Zhao, N; Qiu, ZK; Wang, XW; Zhang, YZ; Yang, RF; Li, YF				Chen, Hong-xia; Jin, Zeng-liang; Zhang, Li-ming; Xue, Rui; Xu, Xiao-dan; Zhao, Nan; Qiu, Zhi-kun; Wang, Xian-wang; Zhang, You-zhi; Yang, Ri-fang; Li, Yun-feng			Antidepressant-Like Activity of YL-0919: A Novel Combined Selective Serotonin Reuptake Inhibitor and 5-HT1A Receptor Agonist	PLOS ONE			English	Article							MILD STRESS; AFFECTIVE-DISORDERS; BEHAVIORAL DESPAIR; RAT-BRAIN; VILAZODONE; PINDOLOL; 5-HYDROXYTRYPTAMINE; RECOMBINANT; TRANSPORTER; ANTAGONIST	It has been suggested that drugs combining activities of selective serotonin reuptake inhibitor and 5-HT1A receptor agonist may form a novel strategy for higher therapeutic efficacy of antidepressant. The present study aimed to examine the pharmacology of YL-0919, a novel synthetic compound with combined high affinity and selectivity for serotonin transporter and 5-HT1A receptors. We performed in vitro binding and function assays and in vivo behavioral tests to assess the pharmacological properties and antidepressant-like efficacy of YL-0919. YL-0919 displayed high affinity in vitro to both 5-HT1A receptor and 5-HT transporter prepared from rat cortical tissue. It exerted an inhibitory effect on forskolin-stimulated cAMP formation and potently inhibited 5-HT uptake in both rat cortical synaptosomes and recombinant cells. After acute p.o. administration, very low doses of YL-0919 reduced the immobility time in tail suspension test and forced swimming test in mice and rats, with no significant effect on locomotor activity in open field test. Furthermore, WAY-100635 (a selective 5HT(1A) receptor antagonist, 0.3 mg/kg) significantly blocked the effect of YL-0919 in tail suspension test and forced swimming test. In addition, chronic YL-0919 treatment significantly reversed the depressive-like behaviors in chronically stressed rats. These findings suggest that YL-0919, a novel structure compound, exerts dual effect on the serotonergic system, as both 5HT(1A) receptor agonist and 5-HT uptake blocker, showing remarkable antidepressant effects in animal models. Therefore, YL-0919 may be used as a new option for the treatment of major depressive disorder.	[Chen, Hong-xia; Jin, Zeng-liang; Zhang, Li-ming; Xue, Rui; Xu, Xiao-dan; Zhao, Nan; Qiu, Zhi-kun; Wang, Xian-wang; Zhang, You-zhi; Li, Yun-feng] Beijing Inst Pharmacol & Toxicol, Dept New Drug Evaluat, Beijing, Peoples R China; [Jin, Zeng-liang] Capital Med Univ, Sch Basic Med Scieneces, Dept Pharmacol, Beijing, Peoples R China; [Wang, Xian-wang] Chinese PLA 309 Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Yang, Ri-fang] Beijing Inst Pharmacol & Toxicol, Dept Med Chem, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Capital Medical University; Academy of Military Medical Sciences - China	Yang, RF (corresponding author), Beijing Inst Pharmacol & Toxicol, Dept Med Chem, Beijing, Peoples R China.	yangrf@yahoo.com; lyf619@aliyun.com		Yang, Rifang/0000-0001-8087-9614	National Natural Science Foundation of China [81102423, 81001653, 81173036]; National Key New Drug Creation Program [2012ZX09301003-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key New Drug Creation Program	This work was supported by the National Natural Science Foundation of China (No: 81102423, 81001653, and 81173036), and the National Key New Drug Creation Program (No: 2012ZX09301003-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L, 2008, PHARMACOL BIOCHEM BE, V89, P572, DOI 10.1016/j.pbb.2008.02.014; Andersen J, 2009, CHEM COMMUN, P3677, DOI 10.1039/b903035m; Beasley C M Jr, 1993, Ann Clin Psychiatry, V5, P199, DOI 10.3109/10401239309148983; Bekris S, 2005, BEHAV BRAIN RES, V161, P45, DOI 10.1016/j.bbr.2005.01.005; BLIER P, 1990, Journal of Clinical Psychopharmacology, V10, p13S; BLIER P, 1995, J CLIN PSYCHOPHARM, V15, P217, DOI 10.1097/00004714-199506000-00011; Bodnoff SR, 1998, PSYCHOPHARMACOLOGY B, V95, P298; Bondi CO, 2008, NEUROPSYCHOPHARMACOL, V33, P320, DOI 10.1038/sj.npp.1301410; BORSINI F, 1995, NEUROSCI BIOBEHAV R, V19, P377, DOI 10.1016/0149-7634(94)00050-B; [陈红霞 Chen Hongxia], 2011, [军事医学, Military Medical Sciences], V35, P676; CHENG CHK, 1993, EUR J PHARMACOL, V239, P211, DOI 10.1016/0014-2999(93)90996-U; Citrome L, 2012, INT J CLIN PRACT, V66, P356, DOI 10.1111/j.1742-1241.2011.02885.x; COOKSON J, 1993, BRIT J PSYCHIAT, V163, P20, DOI 10.1192/S0007125000292325; Crema L, 2010, NEUROCHEM RES, V35, P1787, DOI 10.1007/s11064-010-0245-9; Cruz Martin Paspe, 2012, P T, V37, P28; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Czeh B, 2008, BEHAV BRAIN RES, V190, P1, DOI 10.1016/j.bbr.2008.02.031; DAVIDSON C, 1995, BRIT J PHARMACOL, V114, P1107, DOI 10.1111/j.1476-5381.1995.tb13321.x; Dutta AK, 2008, EUR J PHARMACOL, V589, P73, DOI 10.1016/j.ejphar.2008.05.008; Engleman EA, 1996, J NEUROCHEM, V66, P599; Fava M, 2000, J CLIN PSYCHIAT, V61, P26; Goldstein BJ, 1998, J PSYCHOPHARMACOL, V12, pS55, DOI 10.1177/0269881198012003041; Guay David R P, 2012, Consult Pharm, V27, P857, DOI 10.4140/TCP.n.2012.857; Harvey K V, 1995, Ann Clin Psychiatry, V7, P143, DOI 10.3109/10401239509149042; Iversen L, 2000, MOL PSYCHIATR, V5, P357, DOI 10.1038/sj.mp.4000728; JANOWSKY A, 1986, J NEUROCHEM, V46, P1272, DOI 10.1111/j.1471-4159.1986.tb00649.x; [金艳燕 Jin Yanyan], 2010, [基础医学与临床, Basic & Clinical Medicine], V30, P487; Khan A, 2009, EXPERT OPIN INV DRUG, V18, P1753, DOI 10.1517/13543780903286396; Kwon S, 2009, BIOL PSYCHIAT, V34, P265; LUCKI I, 1994, NEUROSCI BIOBEHAV R, V18, P85, DOI 10.1016/0149-7634(94)90039-6; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mayorga AJ, 2001, J PHARMACOL EXP THER, V298, P1101; Millan MJ, 2012, J PHARMACOL EXP THER, V340, P750, DOI 10.1124/jpet.111.187468; Nemeroff CB, 1998, BIOL PSYCHIAT, V44, P517; Newman-Tancredi A, 1998, NEUROPSYCHOPHARMACOL, V18, P395; Page ME, 2002, J PHARMACOL EXP THER, V302, P1220, DOI 10.1124/jpet.102.034280; Papp M, 1996, EUR J PHARMACOL, V296, P129, DOI 10.1016/0014-2999(95)00697-4; PINDER RM, 1993, MED RES REV, V13, P259, DOI 10.1002/med.2610130304; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Portella MJ, 2009, EUR NEUROPSYCHOPHARM, V19, P516, DOI 10.1016/j.euroneuro.2009.04.004; Rabiner EA, 2004, NEUROPSYCHOPHARMACOL, V29, P1688, DOI 10.1038/sj.npp.1300472; Reed CR, 2012, CURR MED RES OPIN, V28, P27, DOI 10.1185/03007995.2011.628303; Romero L, 2003, NEUROPSYCHOPHARMACOL, V28, P445, DOI 10.1038/sj.npp.1300062; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schloss P, 1998, J PSYCHOPHARMACOL, V12, P115, DOI 10.1177/026988119801200201; Schoeffter P, 1997, NEUROPHARMACOLOGY, V36, P429, DOI 10.1016/S0028-3908(97)00043-9; Serrats J, 2004, INT J NEUROPSYCHOPH, V7, P27, DOI 10.1017/S1461145703003924; Sim-Selley LJ, 2000, EUR J PHARMACOL, V389, P147, DOI 10.1016/S0014-2999(99)00875-4; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Tordera RM, 2002, EUR J PHARMACOL, V442, P63, DOI 10.1016/S0014-2999(02)01504-2; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; van Borren MMGJ, 2010, BASIC RES CARDIOL, V105, P73, DOI 10.1007/s00395-009-0048-9; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Xue R, 2013, EUR NEUROPSYCHOPHARM, V23, P728, DOI 10.1016/j.euroneuro.2012.06.001; Zomkowski ADE, 2004, BRAIN RES, V1023, P253, DOI 10.1016/j.brainres.2004.07.041	57	21	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83271	10.1371/journal.pone.0083271	http://dx.doi.org/10.1371/journal.pone.0083271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367588	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300099
J	Li, GB; Petiwala, SM; Pierce, DR; Nonn, L; Johnson, JJ				Li, Gongbo; Petiwala, Sakina M.; Pierce, Dana R.; Nonn, Larisa; Johnson, Jeremy J.			Selective Modulation of Endoplasmic Reticulum Stress Markers in Prostate Cancer Cells by a Standardized Mangosteen Fruit Extract	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ALPHA-MANGOSTIN; DIETARY DITERPENE; INDUCED APOPTOSIS; CYCLE ARREST; XANTHONES; CARNOSOL; PATHWAY; DEATH	The increased proliferation of cancer cells is directly dependent on the increased activity of the endoplasmic reticulum (ER) machinery which is responsible for protein folding, assembly, and transport. In fact, it is so critical that perturbations in the endoplasmic reticulum can lead to apoptosis. This carefully regulated organelle represents a unique target of cancer cells while sparing healthy cells. In this study, a standardized mangosteen fruit extract (MFE) was evaluated for modulating ER stress proteins in prostate cancer. Two human prostate cancer cell lines, 22Rv1 and LNCaP, and prostate epithelial cells (PrECs) procured from two patients undergoing radical prostatectomy were treated with MFE. Flow cytometry, MTT, BrdU and Western blot were used to evaluate cell apoptosis, viability, proliferation and ER stress. Next, we evaluated MFE for microsomal stability and anti-cancer activity in nude mice. MFE induced apoptosis, decreased viability and proliferation in prostate cancer cells. MFE increased the expression of ER stress proteins. Interestingly, MFE selectively promotes ER stress in prostate cancer cells while sparing PrECs. MFE suppressed tumor growth in a xenograft tumor model without obvious toxicity. Mangosteen fruit extract selectively promotes endoplasmic reticulum stress in cancer cells while sparing non-tumorigenic prostate epithelial cells. Furthermore, in an in vivo setting mangosteen fruit extract significantly reduces xenograft tumor formation.	[Li, Gongbo; Petiwala, Sakina M.; Pierce, Dana R.; Johnson, Jeremy J.] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL 60607 USA; [Nonn, Larisa] Univ Illinois, Coll Med, Dept Pathol, Chicago, IL 60612 USA; [Nonn, Larisa; Johnson, Jeremy J.] Univ Illinois, Coll Med, Ctr Canc, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Johnson, JJ (corresponding author), Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL 60607 USA.	jjjohn@uic.edu	li, gongbo/C-6778-2008		National Institutes of Health/National Cancer Institute [1R03CA138953]; NATIONAL CANCER INSTITUTE [R03CA138953] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health/National Cancer Institute 1R03CA138953 (J. Johnson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNAU Z, 1990, NEUROTOXICOL TERATOL, V12, P547, DOI 10.1016/0892-0362(90)90021-4; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; Chen JJ, 2014, LEUKEMIA LYMPHOMA, V55, P628, DOI 10.3109/10428194.2013.802312; Gregersen N, 2010, METHODS MOL BIOL, V648, P3, DOI 10.1007/978-1-60761-756-3_1; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Johnson JJ, 2012, CARCINOGENESIS, V33, P413, DOI 10.1093/carcin/bgr291; Johnson JJ, 2010, CANCER PREV RES, V3, P1112, DOI 10.1158/1940-6207.CAPR-10-0168; Johnson JJ, 2008, PHARM RES-DORDR, V25, P2125, DOI 10.1007/s11095-008-9552-0; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Liu KC, 2014, ENVIRON TOXICOL, V29, P428, DOI 10.1002/tox.21769; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Matsumoto K, 2004, BIOORGAN MED CHEM, V12, P5799, DOI 10.1016/j.bmc.2004.08.034; Nabandith Viengvansay, 2004, Asian Pac J Cancer Prev, V5, P433; Nonn L, 2006, CANCER RES, V66, P4516, DOI 10.1158/0008-5472.CAN-05-3796; Obolskiy D, 2009, PHYTOTHER RES, V23, P1047, DOI 10.1002/ptr.2730; Pae HO, 2007, BIOCHEM BIOPH RES CO, V353, P1040, DOI 10.1016/j.bbrc.2006.12.133; Pedraza-Chaverri J, 2008, FOOD CHEM TOXICOL, V46, P3227, DOI 10.1016/j.fct.2008.07.024; Ramaiya A, 2012, CURR DRUG TARGETS, V13, P1698, DOI 10.2174/138945012804545524; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Sato A, 2004, J PHARMACOL SCI, V95, P33, DOI 10.1254/jphs.95.33; Suksamrarn S, 2006, CHEM PHARM BULL, V54, P301, DOI 10.1248/cpb.54.301; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Verfaillie T, 2010, CANC LETT, V332, P249; Walker EB, 2007, J SEP SCI, V30, P1229, DOI 10.1002/jssc.200700024; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373	29	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81572	10.1371/journal.pone.0081572	http://dx.doi.org/10.1371/journal.pone.0081572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367485	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300006
J	Ruan, GP; Xu, F; Li, ZA; Zhu, GX; Pang, RQ; Wang, JX; Cai, XM; He, J; Yao, X; Ruan, GH; Xu, XM; Pan, XH				Ruan, Guang-Ping; Xu, Fan; Li, Zi-An; Zhu, Guang-Xu; Pang, Rong-Qing; Wang, Jin-Xiang; Cai, Xue-Min; He, Jie; Yao, Xiang; Ruan, Guang-Hong; Xu, Xin-Ming; Pan, Xing-Hua			Induced Autologous Stem Cell Transplantation for Treatment of Rabbit Renal Interstitial Fibrosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SOMATIC-CELLS; MOUSE MODEL; CONTRIBUTE; REPAIR; PLURIPOTENCY; REGENERATION; INHIBITION; KIDNEY; INJURY	Introduction: Renal interstitial fibrosis (RIF) is a significant cause of end-stage renal failure. The goal of this study was to characterize the distribution of transplanted induced autologous stem cells in a rabbit model of renal interstitial fibrosis and evaluate its therapeutic efficacy for treatment of renal interstitial fibrosis. Methods: A rabbit model of renal interstitial fibrosis was established. Autologous fibroblasts were cultured, induced and labeled with green fluorescent protein (GFP). These labeled stem cells were transplanted into the renal artery of model animals at 8 weeks. Results: Eight weeks following transplantation of induced autologous stem cells, significant reductions (P < 0.05) were observed in serum creatinine (SCr) (14.8 +/- 1.9 mmol/L to 10.1 +/- 2.1 mmol/L) and blood urea nitrogen (BUN) (119 +/- 22 mu mol/L to 97 +/- 13 mu mol/L), indicating improvement in renal function. Conclusions: We successfully established a rabbit model of renal interstitial fibrosis and demonstrated that transplantation of induced autologous stem cells can repair kidney damage within 8 weeks. The repair occurred by both inhibition of further development of renal interstitial fibrosis and partial reversal of pre-existing renal interstitial fibrosis. These beneficial effects lead to the development of normal tissue structure and improved renal function.	[Ruan, Guang-Ping; Xu, Fan; Li, Zi-An; Zhu, Guang-Xu; Pang, Rong-Qing; Wang, Jin-Xiang; Cai, Xue-Min; He, Jie; Yao, Xiang; Ruan, Guang-Hong; Xu, Xin-Ming; Pan, Xing-Hua] Chengdu Mil Command, Kunming Gen Hosp, Stem Cell Engn Lab Yunnan Prov, Kunming, Peoples R China	Kunming General Hospital	Pan, XH (corresponding author), Chengdu Mil Command, Kunming Gen Hosp, Stem Cell Engn Lab Yunnan Prov, Kunming, Peoples R China.	ynkmry@163.com			National Natural Science Foundation of China [31172170]; 973 Projects [2012CB518106]; Special Project of High-new Technology Industrial Development in Yunnan Province [201204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Projects(National Basic Research Program of China); Special Project of High-new Technology Industrial Development in Yunnan Province	This work was supported by the National Natural Science Foundation of China (31172170), 973 Projects (2012CB518106) and Special Project of High-new Technology Industrial Development in Yunnan Province (201204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrion FA, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt64; Cochrane AL, 2005, J AM SOC NEPHROL, V16, P3623, DOI 10.1681/ASN.2004090771; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF4, DOI 10.1152/ajprenal.00045.2005; Hewitson TD, 2009, AM J PHYSIOL-RENAL, V296, pF1239, DOI 10.1152/ajprenal.90521.2008; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kale S, 2003, J CLIN INVEST, V112, P42, DOI 10.1172/JCI200317856; Klahr S, 2003, KIDNEY INT, V64, pS105, DOI 10.1046/j.1523-1755.64.s87.16.x; Kunter U, 2007, J AM SOC NEPHROL, V18, P1754, DOI 10.1681/ASN.2007010044; Kunter U, 2006, J AM SOC NEPHROL, V17, P2202, DOI 10.1681/ASN.2005080815; Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Li JH, 2006, AM J PATHOL, V169, P1527, DOI 10.2353/ajpath.2006.060169; Lin FM, 2003, J AM SOC NEPHROL, V14, P1188, DOI 10.1097/01.ASN.0000061595.28546.A0; Misseri R, 2004, J SURG RES, V119, P149, DOI 10.1016/j.jss.2004.02.016; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Prodromidi EI, 2006, STEM CELLS, V24, P2448, DOI 10.1634/stemcells.2006-0201; Rookmaaker MB, 2003, AM J PATHOL, V163, P553, DOI 10.1016/S0002-9440(10)63683-8; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Uchimura H, 2005, J AM SOC NEPHROL, V16, P997, DOI 10.1681/ASN.2004050367; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Wang WS, 2005, NEPHROLOGY, V10, P48, DOI 10.1111/j.1440-1797.2005.00334.x; Zhu XQ, 2010, BIOMATERIALS, V31, P2779, DOI 10.1016/j.biomaterials.2009.12.027	24	7	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83507	10.1371/journal.pone.0083507	http://dx.doi.org/10.1371/journal.pone.0083507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367598	Green Submitted, gold, Green Published			2022-12-27	WOS:000328740300107
J	Samji, H; Cescon, A; Hogg, RS; Modur, SP; Althoff, KN; Buchacz, K; Burchell, AN; Cohen, M; Gebo, KA; Gill, MJ; Justice, A; Kirk, G; Klein, MB; Korthuis, PT; Martin, J; Napravnik, S; Rourke, SB; Sterling, TR; Silverberg, MJ; Deeks, S; Jacobson, LP; Bosch, RJ; Kitahata, MM; Goedert, JJ; Moore, R; Gange, SJ				Samji, Hasina; Cescon, Angela; Hogg, Robert S.; Modur, Sharada P.; Althoff, Keri N.; Buchacz, Kate; Burchell, Ann N.; Cohen, Mardge; Gebo, Kelly A.; Gill, M. John; Justice, Amy; Kirk, Gregory; Klein, Marina B.; Korthuis, P. Todd; Martin, Jeff; Napravnik, Sonia; Rourke, Sean B.; Sterling, Timothy R.; Silverberg, Michael J.; Deeks, Stephen; Jacobson, Lisa P.; Bosch, Ronald J.; Kitahata, Mari M.; Goedert, James J.; Moore, Richard; Gange, Stephen J.		North Amer AIDS Cohort	Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INJECTING DRUG-USERS; INFECTED PERSONS; INCOME COUNTRIES; COHORT; INEQUALITIES; MORTALITY; SURVIVAL; TIME	Background: Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U. S.) and Canada, but gains in life expectancy for this region have not been well characterized. We aim to estimate temporal changes in life expectancy among HIV-positive adults on ART from 2000-2007 in the U. S. and Canada. Methods: Participants were from the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD), aged >= 20 years and on ART. Mortality rates were calculated using participants' person-time from January 1, 2000 or ART initiation until death, loss to follow-up, or administrative censoring December 31, 2007. Life expectancy at age 20, defined as the average number of additional years that a person of a specific age will live, provided the current age-specific mortality rates remain constant, was estimated using abridged life tables. Results: The crude mortality rate was 19.8/1,000 person-years, among 22,937 individuals contributing 82,022 person-years and 1,622 deaths. Life expectancy increased from 36.1 [standard error (SE) 0.5] to 51.4 [SE 0.5] years from 2000-2002 to 2006-2007. Men and women had comparable life expectancies in all periods except the last (2006-2007). Life expectancy was lower for individuals with a history of injection drug use, non-whites, and in patients with baseline CD4 counts <350 cells/mm(3). Conclusions: A 20-year-old HIV-positive adult on ART in the U. S. or Canada is expected to live into their early 70 s, a life expectancy approaching that of the general population. Differences by sex, race, HIV transmission risk group, and CD4 count remain.	[Samji, Hasina; Cescon, Angela; Hogg, Robert S.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Hogg, Robert S.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Modur, Sharada P.; Althoff, Keri N.; Gebo, Kelly A.; Kirk, Gregory; Jacobson, Lisa P.; Moore, Richard; Gange, Stephen J.] Johns Hopkins Univ, Baltimore, MD USA; [Buchacz, Kate] Ctr Dis Control & Prevent, Atlanta, GA USA; [Burchell, Ann N.; Rourke, Sean B.] Ontario HIV Treatment Network, Toronto, ON, Canada; [Cohen, Mardge] Bur Hlth Serv Cook Cty, Core Ctr, Chicago, IL USA; [Gill, M. John] Univ Calgary, Calgary, AB, Canada; [Justice, Amy] Vet Adm Connecticut Healthcare Syst, West Haven, CT USA; [Justice, Amy] Yale Univ, West Haven, CT USA; [Klein, Marina B.] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Korthuis, P. Todd] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Martin, Jeff] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Napravnik, Sonia] Univ N Carolina, Chapel Hill, NC USA; [Sterling, Timothy R.] Vanderbilt Univ, Nashville, TN 37235 USA; [Silverberg, Michael J.] Kaiser Permanente No Calif, Oakland, CA USA; [Deeks, Stephen] Univ Calif San Francisco, San Francisco Gen Hosp, San Francisco, CA USA; [Bosch, Ronald J.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Kitahata, Mari M.] Univ Washington, Seattle, WA 98195 USA; [Goedert, James J.] NCI, Rockville, MD USA	B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; Johns Hopkins University; Centers for Disease Control & Prevention - USA; University of Calgary; Yale University; McGill University; Oregon Health & Science University; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University; Kaiser Permanente; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hogg, RS (corresponding author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	rhogg@sfu.ca	Dodsley, Maria/G-7083-2016; Gange, Stephen/AGY-5004-2022; Althoff, Keri N/HGC-5595-2022; Gebo, Kelly/AHA-7533-2022; Gill, Michael John/G-7083-2016	Dodsley, Maria/0000-0001-7587-558X; Gange, Stephen/0000-0001-7842-512X; Gebo, Kelly/0000-0003-4010-398X; Korthuis, Philip/0000-0001-5556-3597; Klein, Marina/0000-0002-3063-8430; Hogg, Robert/0000-0003-3463-5488; Jacobson, Lisa P./0000-0003-1722-6826; Althoff, Keri/0000-0002-5068-6595; Samji, Hasina/0000-0002-4555-7609; Gill, Michael John/0000-0002-8546-8790	National Institutes of Health [U01-AI069918, U10-AA13566, U01-AI31834, U01-AI34989, U01-AI34993, U01-AI34994, U01-AI35004, U01-AI35039, U01-AI35040, U01-AI35041, U01-AI35042, U01-AI35043, U01-AI37613, U01-AI37984, U01-AI38855, U01-AI38858, U01-AI42590, U01-AI68634, U01-AI68636, U01-HD32632, U10-EY08057, U10-EY08052, U10-EY08067, UL1-RR024131, M01-RR-00052, M01-RR00071, M01-RR00079, M01-RR00083, M01-RR00722, M01-RR025747, P30-AI27757, P30-AI27767, P30-AI27763, P30-AI50410, P30-AI54999, R01-DA04334, R01-DA12568, R01-DA11602, R01-AA16893, R24-AI067039, Z01-CP010176, AHQ290-01-0012, N02-CP55504, AI-69432, AI-69434, K01-AI071725, K23-AI610320, K23-EY013707, K24-DA00432, K24 AI65298, K01-AI093197]; Agency for Healthcare Research and Quality [290-01-0012]; CDC [CDC200-2006-18797]; Canadian Institutes of Health Research [TGF-96118, HCP-97105, CBR-86906, CBR-94036, KRS-86251, 169621]; Canadian HIV Trials Network [24]; government of British Columbia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIACP010214, Z01CP010176] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079, M01RR000052, UL1RR024131, M01RR000083, UL1RR025747, M01RR000722, M01RR000071] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [U10EY008052, U10EY008057, U10EY008067, K23EY013707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069432, U01AI035039, U01AI035042, U01AI037613, U01AI035040, P30AI054999, U01AI031834, U01AI068636, P30AI027757, U01AI035004, U01AI034993, K01AI071725, U01AI069432, U01AI037984, U01AI038855, P30AI027767, U01AI034989, P30AI050410, P30AI027763, U01AI035043, U01AI069918, K01AI093197, K24AI065298, U01AI068634, U01AI038858, U01AI042590, UM1AI069434, U01AI034994, U01AI035041, U01AI069434, R24AI067039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016893, U01AA020790, U10AA013566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011602, K24DA000432, U01DA036935, R01DA004334, R01DA012568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian HIV Trials Network; government of British Columbia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants U01-AI069918, U10-AA13566, U01-AI31834, U01-AI34989, U01-AI34993, U01-AI34994, U01-AI35004, U01-AI35039, U01-AI35040, U01-AI35041, U01-AI35042, U01-AI35043, U01-AI37613, U01-AI37984, U01-AI38855, U01-AI38858, U01-AI42590, U01-AI68634, U01-AI68636, U01-HD32632, U10-EY08057, U10-EY08052, U10-EY08067, UL1-RR024131, UL1-RR024131, M01-RR-00052, M01-RR00071, M01-RR00079, M01-RR00083, M01-RR00722, M01-RR025747, P30-AI27757, P30-AI27767, P30-AI27763, P30-AI50410, P30-AI54999, R01-DA04334, R01-DA12568, R01-DA11602, R01-AA16893, R24-AI067039, Z01-CP010176, AHQ290-01-0012, N02-CP55504, AI-69432, AI-69434, K01-AI071725, K23-AI610320, K23-EY013707, K24-DA00432, K24 AI65298 and K01-AI093197 from the National Institutes of Health; contract 290-01-0012 from the Agency for Healthcare Research and Quality; contract CDC200-2006-18797 from the CDC; grants TGF-96118, HCP-97105, CBR-86906, CBR-94036, KRS-86251, and 169621 from the Canadian Institutes of Health Research; the Canadian HIV Trials Network, project 24; and the government of British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2012, ANN INTERN MED, V157, P325, DOI 10.7326/0003-4819-157-5-201209040-00005; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Boyd MA, 2009, CURR OPIN HIV AIDS, V4, P194, DOI 10.1097/COH.0b013e328329fc8d; Chiang, 1968, INTRO STOCHASTIC PRO, P189; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Department of Health and Human Services (DHHS) Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, GUIDELINES USE ANTIR; Gange SJ, 2007, INT J EPIDEMIOL, V36, P294, DOI 10.1093/ije/dyl286; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Justice Amy C, 2010, Curr HIV/AIDS Rep, V7, P69, DOI 10.1007/s11904-010-0041-9; King JT, 2003, MED DECIS MAKING, V23, P9, DOI 10.1177/0272989X02239652; Lima VD, 2007, AIDS, V21, P685, DOI 10.1097/QAD.0b013e32802ef30c; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Lloyd-Smith E, 2006, AIDS, V20, P445, DOI 10.1097/01.aids.0000206508.32030.92; Losina E, 2009, CLIN INFECT DIS, V49, P1570, DOI 10.1086/644772; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Minino A.M., 2011, NATL VITAL STAT REPO, V59; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Nakagawa F, 2013, CURR OPIN INFECT DIS, V26, P17, DOI 10.1097/QCO.0b013e32835ba6b1; Palella FJ, 2011, AIDS, V25, P1865, DOI 10.1097/QAD.0b013e32834b3537; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Robins JM, 2000, BIOMETRICS, V56, P779, DOI 10.1111/j.0006-341X.2000.00779.x; Rubin MS, 2010, AM J PUBLIC HEALTH, V100, P1053, DOI 10.2105/AJPH.2009.170241; Simard EP, 2012, ARCH INTERN MED, V172, P1591, DOI 10.1001/archinternmed.2012.4508; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Wada N, 2013, AM J EPIDEMIOL, V177, P116, DOI 10.1093/aje/kws321; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; World Health Organization, 2013, LIF EXP; World Health Organization, 2012, LIF TABL WHO MEMBR S	31	908	927	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81355	10.1371/journal.pone.0081355	http://dx.doi.org/10.1371/journal.pone.0081355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367482	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300004
J	Wan, L; Ma, JS; Wang, NL; Wang, DH; Xu, GY				Wan, Lu; Ma, Jisi; Wang, Nianlu; Wang, Daihua; Xu, Gangyi			Molecular Cloning and Characterization of Different Expression of MYOZ2 and MYOZ3 in Tianfu Goat	PLOS ONE			English	Article							MUSCLE-FIBER-TYPE; SKELETAL-MUSCLE; MEAT QUALITY; HYPERTROPHIC CARDIOMYOPATHY; GENE-EXPRESSION; FILAMIN-BINDING; ACTININ-BINDING; Z-DISC; CALSARCIN-1; PROTEIN	The myozenin family of proteins binds calcineurin, which is involved in myocyte differentiation of skeletal muscle. Moreover, gene expression of myozenin is closely related to meat quality. To further understand the functions and effects of myozenin2 (MYOZ2) and myozenin3 (MYOZ3) genes in goat, we cloned them from Tianfu goat longissimus dorsi muscle. Sequence analyses revealed that full-length coding sequence of MYOZ2 consisted of 795 bp and encoded 264 amino acids, and full-length coding sequence of MYOZ3 consisted of 735 bp and encoded 244 amino acids. RT-qPCR analyses revealed that mRNA expressions of MYOZ2 and MYOZ3 were detected in heart, liver, spleen, lung, kidney, leg muscle, abdominal muscle, and longissimus dorsi muscle. Particularly high expression levels of MYOZ2 were seen in abdominal muscle and heart (P<0.01), low expression levels were seen in leg muscle (P<0.01), longissimus dorsi muscle (P>0.05) and very little expression were detected in liver, spleen, lung and kidney (P>0.05). In addition, high expression levels of MYOZ3 were seen in abdominal muscle, leg muscle, lungs and kidney (P<0.01), low expression levels were found in longissimus dorsi muscle and spleen (P<0.01) and very little expression were detected in heart and liver (P>0.05). Temporal mRNA expression results showed that MYOZ2 and MYOZ3 gene expression varied across four muscle tissues with different ages of the goats. Western blotting further revealed that MYOZ2 and MYOZ3 proteins were only expressed in goat muscle, with notable temporal expression differences in specialized muscle tissues from five development age stages. This work provides the first evidence that MYOZ2 and MYOZ3 genes are expressed abundantly in Tianfu goat muscle tissues from different development age stages, and lay a foundation for understanding the functions of MYOZ2 and MYOZ3 genes in muscle fiber differentiation.	[Wan, Lu; Ma, Jisi; Wang, Nianlu; Xu, Gangyi] Sichuan Agr Univ, Inst Anim Genet & Breeding, Coll Anim Sci & Technol, Yaan, Sichuan, Peoples R China; [Wang, Daihua] Mianyang Agr Bur, Mianyang, Sichuan, Peoples R China	Sichuan Agricultural University	Xu, GY (corresponding author), Sichuan Agr Univ, Inst Anim Genet & Breeding, Coll Anim Sci & Technol, Yaan, Sichuan, Peoples R China.	goatsxgy@263.net			China Agricultural Research System [CARS-39]; Selecting Projects of New Breeds in Sichuan Province [01NG002-04]	China Agricultural Research System; Selecting Projects of New Breeds in Sichuan Province	This work was financially supported by the China Agricultural Research System (CARS-39) and the Selecting Projects of New Breeds in Sichuan Province (01NG002-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2000, GENOMICS, V70, P347, DOI 10.1006/geno.2000.6399; Arguello A, 2001, ANAT RECORD, V264, P284, DOI 10.1002/ar.1165; BROOKE MH, 1970, J HISTOCHEM CYTOCHEM, V18, P670, DOI 10.1177/18.9.670; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; EROBONBORMIOLI SP, 1981, J HISTOCHEM CYTOCHEM, V29, P1179, DOI 10.1177/29.10.7028858; Faulkner G, 2000, J BIOL CHEM, V275, P41234, DOI 10.1074/jbc.M007493200; Fiedler I, 1999, MEAT SCI, V53, P9, DOI 10.1016/S0309-1740(99)00030-3; Frank D, 2007, CIRCULATION, V116, P2587, DOI 10.1161/CIRCULATIONAHA.107.711317; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Frey N, 2008, J CLIN INVEST, V118, P3598, DOI 10.1172/JCI36277; Gentry JG, 2002, J ANIM SCI, V80, P2833; Karlsson AH, 1999, LIVEST PROD SCI, V60, P255, DOI 10.1016/S0301-6226(99)00098-6; Klont RE, 1998, MEAT SCI, V49, pS219; LIND A, 1991, J HISTOCHEM CYTOCHEM, V39, P589, DOI 10.1177/39.5.1826695; Liu YW, 2005, J MUSCLE RES CELL M, V26, P13, DOI 10.1007/s10974-005-9002-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Monin G., 1991, DEV MEAT SCI, V5, P157; Nii M, 2005, J ANIM SCI, V83, P308; Osio A, 2007, CIRC RES, V100, P766, DOI 10.1161/01.RES.0000263008.66799.aa; Pette D, 1997, Int Rev Cytol, V170, P143, DOI 10.1016/S0074-7696(08)61622-8; Ruggiero A, 2013, CARDIOVASC RES, V97, P44, DOI 10.1093/cvr/cvs294; Ryu YC, 2005, MEAT SCI, V71, P351, DOI 10.1016/j.meatsci.2005.04.015; Schiaffino S, 2002, TRENDS PHARMACOL SCI, V23, P569, DOI 10.1016/S0165-6147(02)02111-9; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; Swoap SJ, 2000, AM J PHYSIOL-CELL PH, V279, pC915, DOI 10.1152/ajpcell.2000.279.4.C915; SYROVY I, 1977, PFLUG ARCH EUR J PHY, V369, P85, DOI 10.1007/BF00580815; Takada F, 2001, P NATL ACAD SCI USA, V98, P1595, DOI 10.1073/pnas.041609698; TAUVERON I, 1994, AM J PHYSIOL-ENDOC M, V267, pE877, DOI 10.1152/ajpendo.1994.267.6.E877; Wang DH, 2011, SMALL RUMINANT RES, V95, P88, DOI 10.1016/j.smallrumres.2010.10.010; Wang H, 2006, GENE, V374, P104, DOI 10.1016/j.gene.2006.01.035; Xu HG, 2013, GENE, V515, P71, DOI 10.1016/j.gene.2012.11.025; Yan Z, 1998, J APPL PHYSIOL, V85, P973, DOI 10.1152/jappl.1998.85.3.973	34	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82550	10.1371/journal.pone.0082550	http://dx.doi.org/10.1371/journal.pone.0082550			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367523	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300039
J	Ferreira, P; Sant'Anna, O; Varejao, N; Lima, C; Novis, S; Barbosa, RV; Caldeira, CM; Rumjanek, FD; Ventura, S; Cruz, MW; Foguel, D				Ferreira, Priscila; Sant'Anna, Oliveira; Varejao, Nathalia; Lima, Cinthia; Novis, Shenia; Barbosa, Renata V.; Caldeira, Concy M.; Rumjanek, Franklin D.; Ventura, Salvador; Cruz, Marcia W.; Foguel, Debora			Structure-Based Analysis of A19D, a Variant of Transthyretin Involved in Familial Amyloid Cardiomyopathy	PLOS ONE			English	Article							X-RAY-ANALYSIS; PROTEIN; STABILITY; POLYNEUROPATHY; MONOMER; MUTATION; AMYLOIDOGENESIS; QUATERNARY; TERTIARY; PATHWAY	Transthyretin (TTR) is a tetrameric beta-sheet-rich protein. Its deposits have been implicated in four different amyloid diseases. Although aggregation of the wild-type sequence is responsible for the senile form of the disease, more than one hundred variants have been described thus far, most of which confer a more amyloidogenic character to TTR, mainly because they compromise the stability of the protein in relation to monomer formation, which upon misfolding is intrinsically aggregation-prone. We report the case of a Brazilian patient suffering from a severe cardiomyopathy who carries a rare mutation in exon 2 of the TTR gene that results in an Ala to Asp substitution at position 19 (A19D). The putative pathogenic mechanisms of this variant were analyzed in silico. We constructed a structural model for the A19D tetramer from which its thermodynamic stability was compared to that displayed by the V30M (more amyloidogenic than WT-TTR) and T119M (non-amyloidogenic) variants. The FoldX force field predicted that A19D and V30M are 10.88 and 8.07 kCal/mol less stable than the WT-TTR, while T119M is 5.15 kCal/mol more stable, which is consistent with the aggregation propensities exhibited by these variants. We analyzed the step in which the tetramer-dimer-monomer-unfolded monomer equilibrium might contribute the most to the increased or decreased amyloidogenicity in each variant. Our results suggest that the concentration of four non-native negative charges occur inside thyroxine-binding channels, and the loss of contacts at both the tetrameric and dimeric interfaces would account for an overall decreased stability of the tetramer and the consequent enhanced amyloidogenicity of the A19D variant. As far as we know, this is the first description of a non-V30M mutation in Brazil.	[Ferreira, Priscila; Sant'Anna, Oliveira; Varejao, Nathalia; Lima, Cinthia; Rumjanek, Franklin D.; Foguel, Debora] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Caldeira, Concy M.; Rumjanek, Franklin D.] Univ Fed Rio de Janeiro, SONDA, Rio De Janeiro, Brazil; [Novis, Shenia; Barbosa, Renata V.; Cruz, Marcia W.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Ctr Estudos Paramiloidose Antonio Rodrigues de Me, Rio De Janeiro, Brazil; [Ventura, Salvador] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra, Spain; [Ventura, Salvador] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Spain	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Autonomous University of Barcelona; Autonomous University of Barcelona	Foguel, D (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.	foguel@bioqmed.ufrj.br	Ventura, Salvador/AAY-3170-2021; Ventura, Salvador/C-7021-2008	Ventura, Salvador/0000-0002-9652-6351; Ventura, Salvador/0000-0002-9652-6351; Rumjanek, Franklin/0000-0002-6618-7096; Varejao, Nathalia/0000-0002-6952-8896; Foguel, Debora/0000-0001-7312-7115	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (CNPq INCT Program); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (CNPq INCT Program); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (CNPq INCT Program), and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA MR, 1991, BASIC RES CARDIOL, V86, P567, DOI 10.1007/BF02190707; Ando Y, 2005, ARCH NEUROL-CHICAGO, V62, P1057, DOI 10.1001/archneur.62.7.1057; Babbes ARH, 2008, BIOCHEMISTRY-US, V47, P6969, DOI 10.1021/bi800636q; Benson MD, 1996, AM J PATHOL, V148, P351; Blake CCF, 1978, BIOCHEM SOC T, V6, P1114, DOI 10.1042/bst0061114; BLAKE CCF, 1977, NATURE, V268, P115, DOI 10.1038/268115a0; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; Connors LH, 2004, AMYLOID, V11, P61, DOI 10.1080/13506120410001682569; Dolado I, 2005, J COMB CHEM, V7, P246, DOI 10.1021/cc049849s; Ferrao-Gonzales AD, 2000, P NATL ACAD SCI USA, V97, P6445, DOI 10.1073/pnas.97.12.6445; Ferrao-Gonzales AD, 2003, J MOL BIOL, V328, P963, DOI 10.1016/S0022-2836(03)00368-1; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Hornberg A, 2000, J MOL BIOL, V302, P649, DOI 10.1006/jmbi.2000.4078; Jacobson DR, 1997, TEX HEART I J, V24, P45; Jenne DE, 1996, P NATL ACAD SCI USA, V93, P6302, DOI 10.1073/pnas.93.13.6302; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; JONES LA, 1992, CLIN GENET, V41, P70; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Lobato L, 2003, J NEPHROL, V16, P438; MURAKAMI T, 1992, BIOCHEM BIOPH RES CO, V187, P397, DOI 10.1016/S0006-291X(05)81506-2; OATLEY SJ, 1984, BIOPOLYMERS, V23, P2931, DOI 10.1002/bip.360231215; Pace CN, 1996, FASEB J, V10, P75, DOI 10.1096/fasebj.10.1.8566551; Palaninathan SK, 2012, CURR MED CHEM, V19, P2324; Palhano FL, 2009, J BIOL CHEM, V284, P1443, DOI 10.1074/jbc.M807100200; Plante-Bordeneuve V, 2011, LANCET NEUROL, V10, P1086, DOI 10.1016/S1474-4422(11)70246-0; Quintas A, 1999, J BIOL CHEM, V274, P32943, DOI 10.1074/jbc.274.46.32943; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; Rakoczy EP, 2011, J MOL BIOL, V405, P584, DOI 10.1016/j.jmb.2010.11.003; Ramirez-Alvarado M, 2011, WILEY SERIES PROTEIN; Sant'Anna RO, 2013, INT J MOL SCI, V14, P5284, DOI 10.3390/ijms14035284; Saporta MAC, 2009, EUR J NEUROL, V16, P337, DOI 10.1111/j.1468-1331.2008.02429.x; SARAIVA MJM, 1984, J CLIN INVEST, V74, P104, DOI 10.1172/JCI111390; Sattianayagam PT, 2012, EUR HEART J, V33, P1120, DOI 10.1093/eurheartj/ehr383; Schonland SO, 2012, BLOOD, V119, P488, DOI 10.1182/blood-2011-06-358507; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Sebastiao MP, 2001, J MOL BIOL, V306, P733, DOI 10.1006/jmbi.2000.4415; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Tomar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043522	44	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82484	10.1371/journal.pone.0082484	http://dx.doi.org/10.1371/journal.pone.0082484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358189	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700018
J	Gillilan, RE; Kumar, VSS; O'Neall-Hennessey, E; Cohen, C; Brown, JH				Gillilan, Richard E.; Kumar, V. S. Senthil; O'Neall-Hennessey, Elizabeth; Cohen, Carolyn; Brown, Jerry H.			X-Ray Solution Scattering of Squid Heavy Meromyosin: Strengthening the Evidence for an Ancient Compact off State	PLOS ONE			English	Article							SMOOTH-MUSCLE MYOSIN; SMALL-ANGLE SCATTERING; ESSENTIAL LIGHT-CHAIN; SCALLOP MYOSIN; INDEPENDENT EVOLUTION; IMAGE-RECONSTRUCTION; MOLECULAR-WEIGHT; PHOSPHORYLATION; FILAMENTS; PROTEINS	The overall conformations of regulated myosins or heavy meromyosins from chicken/ turkey, scallop, tarantula, limulus, and scorpion sources have been studied by a number of techniques, including electron microscopy, sedimentation, and pulsed electron paramagnetic resonance. These studies have indicated that the binding of regulatory ions changes the conformation of the molecule from a compact shape found in the "off" state of the muscle to extended relationships between the tail and independently mobile heads that predominate in the "on" state. Here we strengthen the argument for the generality of this conformational change by using small angle X-ray scattering on heavy meromyosin from squid. Small angle X-ray scattering allows the protein to be visualized in solution under mild and relatively physiological conditions, and squid differs from the other species studied by at least 500 million years of evolution. Analysis of the data indicates that upon addition of Ca2+ the radius of gyration increases. Differences in the squid "on" and "off" states are clearly distinguishable as bimodal and unimodal pair distance distribution functions respectively. These observations are consistent with a Ca2+-free squid heavy meromyosin that is compact, but which becomes extended when Ca2+ is bound. Further, the scattering profile derived from the current model of tarantula heavy meromyosin in the "off'' state is in excellent agreement with the measured "off" state scattering profile for squid heavy meromyosin. The previous and current studies together provide significant evidence that regulated myosin's compact off-state conformation is an ancient trait, inherited from a common ancestor during divergent evolution.	[Gillilan, Richard E.] Cornell Univ, Cornell High Energy Synchrotron Source, Macromol Diffract Facil, Ithaca, NY 14853 USA; [Kumar, V. S. Senthil; O'Neall-Hennessey, Elizabeth; Cohen, Carolyn; Brown, Jerry H.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA	Cornell University; Brandeis University	Brown, JH (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA.	jhbrown@brandeis.edu			NIAMS/NIH [AR017346]; National Science Foundation; National Institutes of Health/National Institute of General Medical Sciences under NSF award [DMR-0936384]; National Institutes of Health NIGMS [GM-103485]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR017346, R01AR017346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485] Funding Source: NIH RePORTER	NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/National Institute of General Medical Sciences under NSF award; National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project was supported by grant number AR017346 from NIAMS/NIH to CC. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIAMS or NIH. This research was also conducted in part at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation and the National Institutes of Health/National Institute of General Medical Sciences under NSF award DMR-0936384, using the Macromolecular Diffraction at CHESS (MacCHESS) facility, which is supported by award GM-103485 from the National Institutes of Health NIGMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamkewicz SL, 1997, MOL BIOL EVOL, V14, P619, DOI 10.1093/oxfordjournals.molbev.a025801; Alamo L, 2008, J MOL BIOL, V384, P780, DOI 10.1016/j.jmb.2008.10.013; Brito R, 2011, J MOL BIOL, V414, P44, DOI 10.1016/j.jmb.2011.09.017; Burgess SA, 2007, J MOL BIOL, V372, P1165, DOI 10.1016/j.jmb.2007.07.014; CREMO CR, 1995, J BIOL CHEM, V270, P2171, DOI 10.1074/jbc.270.5.2171; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Freeman S., 2003, EVOLUTIONARY ANAL; Guinier A., 1955, SMALL ANGLE SCATTERI; Jung HS, 2008, J MOL BIOL, V383, P512, DOI 10.1016/j.jmb.2008.08.051; Jung HS, 2008, MOL BIOL CELL, V19, P3234, DOI 10.1091/mbc.E08-02-0206; Jung HS, 2008, P NATL ACAD SCI USA, V105, P6022, DOI 10.1073/pnas.0707846105; Kalabokis VN, 1997, BIOCHEMISTRY-US, V36, P15834, DOI 10.1021/bi971932r; Kalabokis VN, 1996, J BIOL CHEM, V271, P26779, DOI 10.1074/jbc.271.43.26779; Kozak M, 2005, J APPL CRYSTALLOGR, V38, P555, DOI 10.1107/S0021889805010472; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; KWON H, 1990, P NATL ACAD SCI USA, V87, P4771, DOI 10.1073/pnas.87.12.4771; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu J, 2003, J MOL BIOL, V329, P963, DOI 10.1016/S0022-2836(03)00516-3; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Nielsen SS, 2012, J APPL CRYSTALLOGR, V45, P213, DOI 10.1107/S0021889812000957; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; O'Neall-Hennessey E, 2013, ACTA CRYSTALLOGR F, V69, P248, DOI 10.1107/S1744309112049925; Sellers JR, 1991, CURR OPIN CELL BIOL, V3, P98, DOI 10.1016/0955-0674(91)90171-T; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; STAFFORD WF, 1979, BIOCHEMISTRY-US, V18, P5273, DOI 10.1021/bi00591a002; Stafford WF, 2001, J MOL BIOL, V307, P137, DOI 10.1006/jmbi.2000.4490; Steinmetz PRH, 2012, NATURE, V487, P231, DOI 10.1038/nature11180; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Szent-Gyorgyi AG, 2007, ADV EXP MED BIOL, V592, P253; TRYBUS KM, 1994, J BIOL CHEM, V269, P20819; Vileno B, 2011, P NATL ACAD SCI USA, V108, P8218, DOI 10.1073/pnas.1014137108; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Yang YT, 2007, STRUCTURE, V15, P553, DOI 10.1016/j.str.2007.03.010; Zhao FQ, 2009, J MOL BIOL, V385, P423, DOI 10.1016/j.jmb.2008.10.038	37	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e81994	10.1371/journal.pone.0081994	http://dx.doi.org/10.1371/journal.pone.0081994			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358137	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700004
J	Kawano, T; Prananingrum, W; Ishida, Y; Goto, T; Naito, Y; Watanabe, M; Tomotake, Y; Ichikawa, T				Kawano, Takanori; Prananingrum, Widyasri; Ishida, Yuichi; Goto, Takaharu; Naito, Yoshihito; Watanabe, Megumi; Tomotake, Yoritoki; Ichikawa, Tetsuo			Blue-Violet Laser Modification of Titania Treated Titanium: Antibacterial and Osteo-Inductive Effects	PLOS ONE			English	Article							UVA RADIATION; IN-VITRO; BONE; SURFACES; WATER; TIO2; BACTERIA; LESIONS	Background: Many studies on surface modifications of titanium have been performed in an attempt to accelerate osseointegration. Recently, anatase titanium dioxide has been found to act as a photocatalyst that expresses antibiotic properties and exhibits hydrophilicity after ultraviolet exposure. A blue-violet semiconductor laser (BV-LD) has been developed as near-ultraviolet light. The purpose of this study was to investigate the effects of exposure to this BV-LD on surface modifications of titanium with the goal of enhancing osteoconductive and antibacterial properties. Methods: The surfaces of pure commercial titanium were polished with #800 waterproof polishing papers and were treated with anatase titania solution. Specimens were exposed using BV-LD (lambda = 405 nm) or an ultraviolet light-emitting diode (UV-LED, lambda = 365 nm) at 6 mW/cm(2) for 3 h. The surface modification was evaluated physically and biologically using the following parameters or tests: surface roughness, surface temperature during exposure, X-ray diffraction (XRD) analysis, contact angle, methylene blue degradation tests, adherence of Porphyromonas gingivalis, osteoblast and fibroblast proliferation, and histological examination after implantation in rats. Results: No significant changes were found in the surface roughness or XRD profiles after exposure. BV-LD exposure did not raise the surface temperature of titanium. The contact angle was significantly decreased, and methylene blue was significantly degraded. The number of attached P. gingivalis organisms was significantly reduced after BV-LD exposure compared to that in the no exposure group. New bone was observed around exposed specimens in the histological evaluation, and both the bone-to-specimen contact ratio and the new bone area increased significantly in exposed groups. Conclusions: This study suggested that exposure of titanium to BV-LD can enhance the osteoconductivity of the titanium surface and induce antibacterial properties, similar to the properties observed following exposure to UV-LED.	[Kawano, Takanori; Prananingrum, Widyasri; Ishida, Yuichi; Goto, Takaharu; Naito, Yoshihito; Watanabe, Megumi; Tomotake, Yoritoki; Ichikawa, Tetsuo] Univ Tokushima, Inst Hlth, Dept Oral & Maxillofacial Prosthodont & Oral Impl, Tokushima 770, Japan	Tokushima University	Goto, T (corresponding author), Univ Tokushima, Inst Hlth, Dept Oral & Maxillofacial Prosthodont & Oral Impl, Tokushima 770, Japan.	tak510@tokushima-u.ac.jp	Goto, Takaharu/S-5766-2019	Goto, Takaharu/0000-0003-0962-7304				Ahn SJ, 2011, INT J ORAL MAX IMPL, V26, P39; Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004; Chen YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031212; Douki T, 2003, BIOCHEMISTRY-US, V42, P9221, DOI 10.1021/bi034593c; Fujishima A, 2006, CR CHIM, V9, P750, DOI 10.1016/j.crci.2005.02.055; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Fujishima A., 2000, J PHOTOCHEM PHOTOB C, V1, P1, DOI [10.1016/s1389-5567(00)00002-2, DOI 10.1016/S1389-5567(00)00002-2]; Hamamoto A, 2007, J APPL MICROBIOL, V103, P2291, DOI 10.1111/j.1365-2672.2007.03464.x; Han Y, 2008, ACTA BIOMATER, V4, P1518, DOI 10.1016/j.actbio.2008.03.005; Hayashi M, 2012, ACTA BIOMATER, V8, P2411, DOI 10.1016/j.actbio.2012.03.010; Hinoi E, 2006, MOL PHARMACOL, V70, P925, DOI 10.1124/mol.106.024398; Hirakawa Y, 2013, CLIN ORAL IMPLAN RES, V24, P139, DOI 10.1111/j.1600-0501.2011.02401.x; Lin HX, 2008, J BIOMED MATER RES B, V87B, P425, DOI 10.1002/jbm.b.31120; Liou JW, 2012, ARCH IMMUNOL THER EX, V60, P267, DOI 10.1007/s00005-012-0178-x; Mori M, 2007, MED BIOL ENG COMPUT, V45, P1237, DOI 10.1007/s11517-007-0263-1; Mouret S, 2006, P NATL ACAD SCI USA, V103, P13765, DOI 10.1073/pnas.0604213103; Omori S, 2009, J DENT RES, V88, P957, DOI 10.1177/0022034509343426; Sawase T, 2008, CLIN ORAL IMPLAN RES, V19, P491, DOI 10.1111/j.1600-0501.2007.01509.x; Skaleric U, 2000, EUR J ORAL SCI, V108, P130, DOI 10.1034/j.1600-0722.2000.90771.x; Takeshita F, 1997, J BIOMED MATER RES, V37, P235, DOI 10.1002/(SICI)1097-4636(199711)37:2<235::AID-JBM13>3.0.CO;2-D; Tsai TM, 2010, J CHEM TECHNOL BIOT, V85, P1642, DOI 10.1002/jctb.2476; Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233; Yoshinari M, 2000, J BIOMED MATER RES, V52, P388, DOI 10.1002/1097-4636(200011)52:2<388::AID-JBM20>3.0.CO;2-E	23	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84327	10.1371/journal.pone.0084327	http://dx.doi.org/10.1371/journal.pone.0084327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358355	Green Submitted, Green Published, gold			2022-12-27	WOS:000328737700091
J	Walker, CR; Hautefort, I; Dalton, JE; Overweg, K; Egan, CE; Bongaerts, RJ; Newton, DJ; Cruickshank, SM; Andrew, EM; Carding, SR				Walker, Catherine R.; Hautefort, Isabelle; Dalton, Jane E.; Overweg, Karin; Egan, Charlotte E.; Bongaerts, Roy J.; Newton, Darren J.; Cruickshank, Sheena M.; Andrew, Elizabeth M.; Carding, Simon R.			Intestinal Intraepithelial Lymphocyte-Enterocyte Crosstalk Regulates Production of Bactericidal Angiogenin 4 by Paneth Cells upon Microbial Challenge	PLOS ONE			English	Article							DELTA T-CELLS; ENTERICA SEROTYPE TYPHIMURIUM; GAMMA-DELTA; GENE-EXPRESSION; IL-17 PRODUCTION; IN-VITRO; SALMONELLA; IL-23; INFECTION; INNATE	Antimicrobial proteins influence intestinal microbial ecology and limit proliferation of pathogens, yet the regulation of their expression has only been partially elucidated. Here, we have identified a putative pathway involving epithelial cells and intestinal intraepithelial lymphocytes (iIELs) that leads to antimicrobial protein (AMP) production by Paneth cells. Mice lacking gamma delta iIELs (TCR delta(-/-)) express significantly reduced levels of the AMP angiogenin 4 (Ang4). These mice were also unable to up-regulate Ang4 production following oral challenge by Salmonella, leading to higher levels of mucosal invasion compared to their wild type counterparts during the first 2 hours post-challenge. The transfer of gamma delta iIELs from wild type (WT) mice to TCR delta(-/-) mice restored Ang4 production and Salmonella invasion levels were reduced to those obtained in WT mice. The ability to restore Ang4 production in TCR delta(-/-) mice was shown to be restricted to gamma delta iIELs expressing V gamma 7-encoded TCRs. Using a novel intestinal crypt co-culture system we identified a putative pathway of Ang4 production initiated by exposure to Salmonella, intestinal commensals or microbial antigens that induced intestinal epithelial cells to produce cytokines including IL-23 in a TLR-mediated manner. Exposure of TCR-V gamma 7(+) gamma delta iIELs to IL-23 promoted IL-22 production, which triggered Paneth cells to secrete Ang4. These findings identify a novel role for gamma delta iIELs in mucosal defence through sensing immediate epithelial cell cytokine responses and influencing AMP production. This in turn can contribute to the maintenance of intestinal microbial homeostasis and epithelial barrier function, and limit pathogen invasion.	[Walker, Catherine R.; Hautefort, Isabelle; Overweg, Karin; Bongaerts, Roy J.; Carding, Simon R.] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Walker, Catherine R.; Dalton, Jane E.; Egan, Charlotte E.; Newton, Darren J.; Cruickshank, Sheena M.; Andrew, Elizabeth M.; Carding, Simon R.] Univ Leeds, Fac Biol Sci, Leeds, W Yorkshire, England; [Dalton, Jane E.] Univ York, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; [Egan, Charlotte E.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Newton, Darren J.] St James Univ Hosp, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England; [Walker, Catherine R.; Cruickshank, Sheena M.; Andrew, Elizabeth M.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Carding, Simon R.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Leeds; University of York - UK; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Saint James's University Hospital; University of Manchester; University of East Anglia	Carding, SR (corresponding author), Inst Food Res, Norwich NR4 7UA, Norfolk, England.	simon.carding@ifr.ac.uk	Newton, Darren/CAA-0475-2022	Carding, Simon/0000-0002-2383-9701; Dalton, Jane/0000-0001-9115-8855; Cruickshank, Sheena/0000-0002-3047-5475	Biotechnology of Biological Sciences Research Council (BBSRC); Wellcome Trust; BBSRC-DTA studentship; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044446] Funding Source: researchfish; BBSRC [BBS/E/F/00044446] Funding Source: UKRI	Biotechnology of Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC-DTA studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by grants awarded by the Biotechnology of Biological Sciences Research Council (BBSRC) and the Wellcome Trust (SRC). Catherine Walker was supported by a BBSRC-DTA studentship awarded to the University of Leeds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew EM, 2005, J IMMUNOL, V175, P1741, DOI 10.4049/jimmunol.175.3.1741; Andrew EM, 2005, MICROBES INFECT, V7, P529, DOI 10.1016/j.micinf.2004.12.010; Arques JL, 2009, GASTROENTEROLOGY, V137, P579, DOI 10.1053/j.gastro.2009.04.010; Awoniyi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037311; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Baumgart DC, 1998, CELL IMMUNOL, V187, P52, DOI 10.1006/cimm.1998.1307; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Bens M, 1996, AM J PHYSIOL-CELL PH, V270, pC1666, DOI 10.1152/ajpcell.1996.270.6.C1666; BONNEVILLE M, 1988, NATURE, V336, P479, DOI 10.1038/336479a0; BUCY RP, 1988, J IMMUNOL, V141, P2200; Burns-Guydish SM, 2005, PEDIATR RES, V58, P153, DOI 10.1203/01.PDR.0000157725.44213.C4; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Cheroutre H, 2005, IMMUNOL REV, V206, P114, DOI 10.1111/j.0105-2896.2005.00284.x; Crabtree B, 2007, BIOCHEMISTRY-US, V46, P2431, DOI 10.1021/bi062158n; D'Elia R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-492; Dalton JE, 2006, GASTROENTEROLOGY, V131, P818, DOI 10.1053/j.gastro.2006.06.003; Datta R, 2005, INFECT IMMUN, V73, P4025, DOI 10.1128/IAI.73.7.4025-4033.2005; Dubin PJ, 2007, AM J PHYSIOL-LUNG C, V292, pL519, DOI 10.1152/ajplung.00312.2006; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Fahrer AM, 2001, P NATL ACAD SCI USA, V98, P10261, DOI 10.1073/pnas.171320798; FODOR SPA, 1993, NATURE, V364, P555, DOI 10.1038/364555a0; Godinez I, 2009, INFECT IMMUN, V77, P387, DOI 10.1128/IAI.00933-08; Gold MC, 2013, NAT REV MICROBIOL, V11, P14, DOI 10.1038/nrmicro2918; GOODMAN T, 1988, NATURE, V333, P855, DOI 10.1038/333855a0; GUYGRAND D, 1978, J EXP MED, V148, P1661, DOI 10.1084/jem.148.6.1661; GuyGrand D, 1996, EUR J IMMUNOL, V26, P2248, DOI 10.1002/eji.1830260942; HAVRAN WL, 2005, AM J PHYSIOL, V289, P627; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Inan MS, 2000, AM J PHYSIOL-GASTR L, V279, pG1282, DOI 10.1152/ajpgi.2000.279.6.G1282; Ismail AS, 2011, P NATL ACAD SCI USA, V108, P8743, DOI 10.1073/pnas.1019574108; Ismail AS, 2009, J IMMUNOL, V182, P3047, DOI 10.4049/jimmunol.0802705; Jabri B, 2007, IMMUNOL REV, V215, P202, DOI 10.1111/j.1600-065X.2006.00481.x; KawaguchiMiyashita M, 1996, IMMUNOLOGY, V89, P268, DOI 10.1046/j.1365-2567.1996.d01-740.x; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; KYES S, 1989, P NATL ACAD SCI USA, V86, P5527, DOI 10.1073/pnas.86.14.5527; LEFRANCOIS L, 1989, SCIENCE, V243, P1716, DOI 10.1126/science.2564701; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; MacLennan C, 2004, J INFECT DIS, V190, P1755, DOI 10.1086/425021; Manta C, 2013, MUCOSAL IMMUNOL, V6, P177, DOI 10.1038/mi.2012.61; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Matsuzaki G, 2007, MICROBIOL IMMUNOL, V51, P1139, DOI 10.1111/j.1348-0421.2007.tb04008.x; McGovern D, 2007, GUT, V56, P1333, DOI 10.1136/gut.2006.115402; MIXTER PF, 1994, INFECT IMMUN, V62, P4618, DOI 10.1128/IAI.62.10.4618-4621.1994; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; PEREIRA P, 1995, J EXP MED, V182, P1921, DOI 10.1084/jem.182.6.1921; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Rowley G, 2005, INFECT IMMUN, V73, P459, DOI 10.1128/IAI.73.1.459-463.2005; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Schechter LM, 1999, MOL MICROBIOL, V32, P629, DOI 10.1046/j.1365-2958.1999.01381.x; SHAPIRO R, 1987, P NATL ACAD SCI USA, V84, P8783, DOI 10.1073/pnas.84.24.8783; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Simonian PL, 2010, J EXP MED, V207, P2239, DOI 10.1084/jem.20100061; Singh JCI, 2005, AM J PHYSIOL-GASTR L, V288, pG514, DOI 10.1152/ajpgi.00377.2004; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Swidsinski A, 2009, J PHYSIOL PHARMACOL, V60, P61; TREJDOSIEWICZ LK, 1989, IMMUNOLOGY, V68, P7; Umemura M, 2004, INT IMMUNOL, V16, P1099, DOI 10.1093/intimm/dxh111; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2011, J IMMUNOL, V186, P1228, DOI 10.4049/jimmunol.0903907; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	81	36	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84553	10.1371/journal.pone.0084553	http://dx.doi.org/10.1371/journal.pone.0084553			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358364	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000328737700099
J	Becker, J; Maes, F; Wehenkel, L				Becker, Julien; Maes, Francis; Wehenkel, Louis			On the Encoding of Proteins for Disordered Regions Prediction	PLOS ONE			English	Article							SEQUENCE-BASED PREDICTION; ACCURATE PREDICTION; INTRINSIC DISORDER; FEATURES; DATABASE; SERVER	Disordered regions, i.e., regions of proteins that do not adopt a stable three-dimensional structure, have been shown to play various and critical roles in many biological processes. Predicting and understanding their formation is therefore a key sub-problem of protein structure and function inference. A wide range of machine learning approaches have been developed to automatically predict disordered regions of proteins. One key factor of the success of these methods is the way in which protein information is encoded into features. Recently, we have proposed a systematic methodology to study the relevance of various feature encodings in the context of disulfide connectivity pattern prediction. In the present paper, we adapt this methodology to the problem of predicting disordered regions and assess it on proteins from the 10th CASP competition, as well as on a very large subset of proteins extracted from PDB. Our results, obtained with ensembles of extremely randomized trees, highlight a novel feature function encoding the proximity of residues according to their accessibility to the solvent, which is playing the second most important role in the prediction of disordered regions, just after evolutionary information. Furthermore, even though our approach treats each residue independently, our results are very competitive in terms of accuracy with respect to the state-of-the-art. A web-application is available at http://m24.giga.ulg.ac.be:81/x3Disorder.	[Becker, Julien] Univ Liege, GIGA Res, Liege, Belgium; [Maes, Francis; Wehenkel, Louis] Univ Liege, Inst Montefiore, Dept Elect Engn & Comp Sci, B-4000 Liege, Belgium; [Maes, Francis] Univ Louvain, Dept Comp Wetenschappen, Louvain, Belgium	University of Liege; University of Liege	Wehenkel, L (corresponding author), Univ Liege, Inst Montefiore, Dept Elect Engn & Comp Sci, B-4000 Liege, Belgium.	L.Wehenkel@ulg.ac.be			FRIA (Fund for Research Training in Industry and Agriculture) fellowship; Belgian National Fund of Scientific Research (FNRS)	FRIA (Fund for Research Training in Industry and Agriculture) fellowship(Fonds de la Recherche Scientifique - FNRS); Belgian National Fund of Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS)	This work is supported by a FRIA (Fund for Research Training in Industry and Agriculture) fellowship (Julien Becker) granted by the Belgian National Fund of Scientific Research (FNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Becker J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056621; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cheng JL, 2005, DATA MIN KNOWL DISC, V11, P213, DOI 10.1007/s10618-005-0001-y; Deng X, 2012, MOL BIOSYST, V8, P114, DOI 10.1039/c1mb05207a; Deng X, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-436; Dondoshansky I, 2002, BLASTCLUST NCBI SOFT; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eickholt J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-88; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Hirose S, 2007, BIOINFORMATICS, V23, P2046, DOI 10.1093/bioinformatics/btm302; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Jones DT, 2003, PROTEINS, V53, P573, DOI 10.1002/prot.10528; Kim H, 2003, PROTEIN ENG, V16, P553, DOI 10.1093/protein/gzg072; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; Mika S, 2003, NUCLEIC ACIDS RES, V31, P3789, DOI 10.1093/nar/gkg620; Mizianty MJ, 2010, BIOINFORMATICS, V26, pi489, DOI 10.1093/bioinformatics/btq373; Monastyrskyy B, 2011, PROTEINS, V79, P107, DOI 10.1002/prot.23161; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Shimizu K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-78; Shimizu K, 2007, BIOINFORMATICS, V23, P2337, DOI 10.1093/bioinformatics/btm330; Uversky V. N., 2009, BIOMED RES INT, V2010; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vullo A, 2006, NUCLEIC ACIDS RES, V34, pW164, DOI 10.1093/nar/gkl166; Walsh I, 2012, BIOINFORMATICS, V28, P503, DOI 10.1093/bioinformatics/btr682; Wang LX, 2008, BIOINFORMATICS, V24, P1401, DOI 10.1093/bioinformatics/btn132; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang T, 2012, J BIOMOL STRUCT DYN, V29, P799, DOI 10.1080/073911012010525022	36	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82252	10.1371/journal.pone.0082252	http://dx.doi.org/10.1371/journal.pone.0082252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358161	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700050
J	Foroutan, P; Kreahling, JM; Morse, DL; Grove, O; Lloyd, MC; Reed, D; Raghavan, M; Altiok, S; Martinez, GV; Gillies, RJ				Foroutan, Parastou; Kreahling, Jenny M.; Morse, David L.; Grove, Olya; Lloyd, Mark C.; Reed, Damon; Raghavan, Meera; Altiok, Soner; Martinez, Gary V.; Gillies, Robert J.			Diffusion MRI and Novel Texture Analysis in Osteosarcoma Xenotransplants Predicts Response to Anti-Checkpoint Therapy	PLOS ONE			English	Article							SOFT-TISSUE SARCOMAS; BREAST-CANCER; CHEMOTHERAPY; IDENTIFICATION; SPECTROSCOPY; XENOGRAFTS; KINASE; TUMORS; ADC	Combinations of targeted drugs have been employed to treat sarcomas, however, response rates have not improved notably, therefore emphasizing the need for novel treatments. In addition, imaging approaches to assess therapeutic response is lacking, as currently measurable indices, such as volume and/or diameter, do not accurately correlate with changes in tumor biology. In this study, quantitative and profound analyses of magnetic resonance imaging (MRI) were developed to evaluate these as imaging biomarkers for MK1775 and Gem in an osteosarcoma xenotransplant model at early time-points following treatment. Notably, we showed that Gem and Gem+MK1775 groups had significantly inhibited tumor growth by day 4, which was presaged by elevations in mean ADC by 24 hours post treatment. Significant differences were also observed at later time points for the Gem+MK1775 combination and MK1775 therapy. ADC distribution and entropy (randomness of ADC values) were also elevated by 24 hours following therapy. Immunohistochemistry demonstrated that these treatment-related increases in ADC correlated with apoptosis and observed cell condensations (dense-and exploded bodies). These findings underline the role of ADC as a quantitative imaging biomarker for therapy-induced response and show promising clinical relevance in the sarcoma patient population.	[Foroutan, Parastou; Morse, David L.; Grove, Olya; Martinez, Gary V.; Gillies, Robert J.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Imaging & Metab, Tampa, FL 33612 USA; [Kreahling, Jenny M.; Reed, Damon; Altiok, Soner] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Expt Therapeut Program, Tampa, FL 33612 USA; [Lloyd, Mark C.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Analyt Microscopy Core, Tampa, FL 33612 USA; [Reed, Damon; Altiok, Soner] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Sarcoma Oncol, Tampa, FL 33612 USA; [Raghavan, Meera] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Diagnost Imaging, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Gillies, RJ (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Imaging & Metab, Tampa, FL 33612 USA.	Robert.Gillies@moffitt.org	Morse, David/L-7277-2018; Reed, Damon/R-8179-2019	Gillies, Robert/0000-0002-8888-7747; Reed, Damon/0000-0002-8238-2465	NIH/NCI [R01CA125627]; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA125627, U01CA143062] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH/NCI R01CA125627, Imaging Biomarkers for Response to Anti-Cancer Therapy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JH, 2010, BIOPHYSICS DIFFUSION, P110; Bajpai J, 2011, PEDIATR RADIOL, V41, P441, DOI 10.1007/s00247-010-1876-3; Benedict RHB, 2007, MULT SCLER, V13, P722, DOI 10.1177/1352458507075592; Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; Cardenas-Rodriguez J, 2012, MAGN RESON IMAGING, V30, P1002, DOI 10.1016/j.mri.2012.02.015; Farrar CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017228; Fujimoto H, 2014, BREAST CANCER-TOKYO, V21, P724, DOI 10.1007/s12282-013-0449-3; Galons Jean-Philippe, 1999, Neoplasia (New York), V1, P113, DOI 10.1038/sj.neo.7900009; Galons JP, 2003, ISRAEL J CHEM, V43, P91, DOI 10.1560/GJ5M-PP8R-GHUB-VUUP; Gerstner ER, 2010, NEURO-ONCOLOGY, V12, P466, DOI 10.1093/neuonc/nop051; Grant SC, 2001, MAGN RESON MED, V46, P1107, DOI 10.1002/mrm.1306; Guo JY, 2012, CANCER-AM CANCER SOC, V118, P3776, DOI 10.1002/cncr.26701; Hakumaki JM, 1998, CANCER RES, V58, P3791; Jennings D, 2002, NEOPLASIA, V4, P255, DOI 10.1038/sj.neo.7900225; Jordan BF, 2010, CONTRAST MEDIA MOL I, V5, P323, DOI 10.1002/cmmi.397; Jordan BF, 2005, NEOPLASIA, V7, P475, DOI 10.1593/neo.04628; Joseph L, 2008, TARGETED CANC THERAP; Kauppinen RA, 2002, NMR BIOMED, V15, P6, DOI 10.1002/nbm.742; Kierans AS, 2013, J MAGN RESON IMAGING, V37, P164, DOI 10.1002/jmri.23794; Kreahling JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057523; Kreahling JM, 2012, MOL CANCER THER, V11, P174, DOI 10.1158/1535-7163.MCT-11-0529; Kyriazi S, 2011, RADIOLOGY, V261, P182, DOI 10.1148/radiol.11110577; Leijen S, 2010, CURR CLIN PHARMACOL, V5, P186, DOI 10.2174/157488410791498824; Marulanda German A, 2008, Cancer Control, V15, P13; Moffat BA, 2004, MAGN RESON MATER PHY, V17, P249, DOI 10.1007/s10334-004-0079-z; Morse DL, 2007, NMR BIOMED, V20, P602, DOI 10.1002/nbm.1127; Nowosielski M, 2011, NEURORADIOLOGY, V53, P291, DOI 10.1007/s00234-010-0808-0; Oka K, 2010, SKELETAL RADIOL, V39, P141, DOI 10.1007/s00256-009-0830-7; Padhani AR, 2005, ABDOM IMAGING, V30, P324, DOI 10.1007/s00261-004-0265-5; Patterson DM, 2008, NAT CLIN PRACT ONCOL, V5, P220, DOI 10.1038/ncponc1073; Pope WB, 2009, RADIOLOGY, V252, P182, DOI 10.1148/radiol.2521081534; Rajeshkumar NV, 2011, CLIN CANCER RES, V17, P2799, DOI 10.1158/1078-0432.CCR-10-2580; Razek AAKA, 2013, EUR J RADIOL, V82, P982, DOI 10.1016/j.ejrad.2013.01.025; Seierstad T, 2007, NEOPLASIA, V9, P392, DOI 10.1593/neo.07154; Skubitz KM, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-23; Stacchiotti S, 2009, RADIOLOGY, V251, P447, DOI 10.1148/radiol.2512081403; Theilmann RJ, 2004, NEOPLASIA, V6, P831, DOI 10.1593/neo.03343; Tozer DJ, 2007, NMR BIOMED, V20, P49, DOI 10.1002/nbm.1091; Uhl M, 2006, PEDIATR RADIOL, V36, P1306, DOI 10.1007/s00247-006-0324-x; VanderGriend RA, 1996, ORTHOP CLIN N AM, V27, P575; Zhang XM, 2010, J NUCL MED, V51, P1167, DOI 10.2967/jnumed.109.068981	41	34	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82875	10.1371/journal.pone.0082875	http://dx.doi.org/10.1371/journal.pone.0082875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358232	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700095
J	Tsumura, M; Sobhan, U; Sato, M; Shimada, M; Nishiyama, A; Kawaguchi, A; Soya, M; Kuroda, H; Tazaki, M; Shibukawa, Y				Tsumura, Maki; Sobhan, Ubaidus; Sato, Masaki; Shimada, Miyuki; Nishiyama, Akihiro; Kawaguchi, Aya; Soya, Manabu; Kuroda, Hidetaka; Tazaki, Masakazu; Shibukawa, Yoshiyuki			Functional Expression of TRPM8 and TRPA1 Channels in Rat Odontoblasts	PLOS ONE			English	Article							SODIUM-CALCIUM EXCHANGERS; SENSORY TRANSDUCTION; ION CHANNELS; RECEPTOR; DENTIN; PAIN; STIMULATION; PULP	Odontoblasts produce dentin during development, throughout life, and in response to pathological conditions by sensing stimulation of exposed dentin. The functional properties and localization patterns of transient receptor potential (TRP) melastatin subfamily member 8 (TRPM8) and ankyrin subfamily member 1 (TRPA1) channels in odontoblasts remain to be clarified. We investigated the localization and the pharmacological, biophysical, and mechano-sensitive properties of TRPM8 and TRPA1 channels in rat odontoblasts. Menthol and icilin increased the intracellular free Ca2+ concentration ([Ca2+](i)). Icilin-, WS3-, or WS12-induced [Ca2+](i) increases were inhibited by capsazepine or 5-benzyloxytriptamine. The increase in [Ca2+](i) elicited by allyl isothiocyanate (AITC) was inhibited by HC030031. WS12 and AITC exerted a desensitizing effect on [Ca2+](i) increase. Low-temperature stimuli elicited [Ca2+](i) increases that are sensitive to both 5-benzyloxytriptamine and HC030031. Hypotonic stimulation-induced membrane stretch increased [Ca2+](i); HC030031 but not 5-benzyloxytriptamine inhibited the effect. The results suggest that TRPM8 channels in rat odontoblasts play a role in detecting low-temperature stimulation of the dentin surface and that TRPA1 channels are involved in sensing membrane stretching and low-temperature stimulation. The results also indicate that odontoblasts act as mechanical and thermal receptor cells, detecting the stimulation of exposed dentin to drive multiple cellular functions, such as sensory transduction.	[Tsumura, Maki; Sobhan, Ubaidus; Sato, Masaki; Tazaki, Masakazu; Shibukawa, Yoshiyuki] Tokyo Dent Coll, Dept Physiol, Chiba, Japan; [Sobhan, Ubaidus] Natl Ctr Child Hlth & Dev, Clin Res Ctr, Tokyo, Japan; [Shimada, Miyuki] Tokyo Dent Coll, Dept Clin Oral Hlth Sci, Tokyo, Japan; [Nishiyama, Akihiro] Tokyo Dent Coll, Dept Oral Med Oral & Maxillofacial Surg, Chiba, Japan; [Kawaguchi, Aya; Soya, Manabu] Tokyo Dent Coll, Dept Dent Anesthesiol, Chiba, Japan; [Kuroda, Hidetaka] Tokyo Univ Hosp, Dept Anesthesiol, Tokyo 113, Japan; [Kuroda, Hidetaka] Tokyo Univ Hosp, Pain Relief Ctr, Tokyo 113, Japan	Tokyo Dental College; National Center for Child Health & Development - Japan; Tokyo Dental College; Tokyo Dental College; Tokyo Dental College; University of Tokyo; University of Tokyo	Shibukawa, Y (corresponding author), Tokyo Dent Coll, Dept Physiol, Chiba, Japan.	yshibuka@tdc.ac.jp		Kuroda, Hidetaka/0000-0001-7521-8096	Oral Health Science Center Grant hrc8 from Tokyo Dental College; Ministry of Education, Culture, Sports, Science and Technology in Japan; Ministry of Education, Culture, Sports, Science and Technology in Japan [23592751/23792132]; Grants-in-Aid for Scientific Research [24792035] Funding Source: KAKEN	Oral Health Science Center Grant hrc8 from Tokyo Dental College; Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by an Oral Health Science Center Grant hrc8 from Tokyo Dental College, a Project for Private Universities matching fund subsidy from Ministry of Education, Culture, Sports, Science and Technology in Japan (2011-2013), and a Grant-in-Aid (No. 23592751/23792132) for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2006, NEUROSCI LETT, V397, P140, DOI 10.1016/j.neulet.2005.12.005; Ajcharanukul O, 2011, J DENT RES, V90, P678, DOI 10.1177/0022034510395022; Andrew D, 2000, J PHYSIOL-LONDON, V529, P791, DOI 10.1111/j.1469-7793.2000.00791.x; Bang S, 2010, ARCH PHARM RES, V33, P1509, DOI 10.1007/s12272-010-1004-9; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Bodding M, 2007, CELL CALCIUM, V42, P618, DOI 10.1016/j.ceca.2007.03.005; Brannstrom M, 1966, Annu Meet Am Inst Oral Biol, V23, P219; BRANNSTROM M, 1972, INT DENT J, V22, P219; Chidchuangchai W, 2007, ARCH ORAL BIOL, V52, P154, DOI 10.1016/j.archoralbio.2006.09.009; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; El Karim IA, 2011, PAIN, V152, P2211, DOI 10.1016/j.pain.2010.10.016; Fransson Helena, 2012, Swed Dent J Suppl, P9; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Goldberg M, 2004, CRIT REV ORAL BIOL M, V15, P13, DOI 10.1177/154411130401500103; Lin M, 2011, PLOS ONE, P6; LINDE A, 1995, INT J DEV BIOL, V39, P213; Linsulwanont P, 2007, ARCH ORAL BIOL, V52, P218, DOI 10.1016/j.archoralbio.2006.10.009; Magloire H, 2010, J OROFAC PAIN, V24, P335; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Okumura R, 2005, ARCH HISTOL CYTOL, V68, P251, DOI 10.1679/aohc.68.251; Raisinghani M, 2011, AM J PHYSIOL-CELL PH, V301, pC587, DOI 10.1152/ajpcell.00465.2010; Sato M, 2013, J ENDODONT, V39, P779, DOI 10.1016/j.joen.2013.01.012; Shibukawa Y, 2003, J BONE MINER RES, V18, P30, DOI 10.1359/jbmr.2003.18.1.30; Shibukawa Y, 2001, JPN J PHYSIOL, V51, P345, DOI 10.2170/jjphysiol.51.345; Shibukawa Yoshiyuki, 1997, Bulletin of Tokyo Dental College, V38, P177; Son AR, 2009, J DENT RES, V88, P1014, DOI 10.1177/0022034509343413; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tsumura M, 2012, CELL CALCIUM, V52, P124, DOI 10.1016/j.ceca.2012.05.002; Tsumura M, 2010, J ENDODONT, V36, P668, DOI 10.1016/j.joen.2010.01.006; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Yeon KY, 2009, J DENT RES, V88, P328, DOI 10.1177/0022034509334100	32	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82233	10.1371/journal.pone.0082233	http://dx.doi.org/10.1371/journal.pone.0082233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358160	Green Submitted, gold, Green Published			2022-12-27	WOS:000328735700049
J	Zohar, O; Shackleton, TM; Palmer, AR; Shamir, M				Zohar, Oran; Shackleton, Trevor M.; Palmer, Alan R.; Shamir, Maoz			The Effect of Correlated Neuronal Firing and Neuronal Heterogeneity on Population Coding Accuracy in Guinea Pig Inferior Colliculus	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; INTERNEURONAL CORRELATIONS; TEMPORAL SCALES; SINGLE NEURONS; AREA V4; MACAQUE; CODES; INFORMATION; VARIABILITY; PERFORMANCE	It has been suggested that the considerable noise in single-cell responses to a stimulus can be overcome by pooling information from a large population. Theoretical studies indicated that correlations in trial-to-trial fluctuations in the responses of different neurons may limit the improvement due to pooling. Subsequent theoretical studies have suggested that inherent neuronal diversity, i.e., the heterogeneity of tuning curves and other response properties of neurons preferentially tuned to the same stimulus, can provide a means to overcome this limit. Here we study the effect of spike-count correlations and the inherent neuronal heterogeneity on the ability to extract information from large neural populations. We use electrophysiological data from the guinea pig Inferior-Colliculus to capture inherent neuronal heterogeneity and single cell statistics, and introduce response correlations artificially. To this end, we generate pseudo-population responses, based on single-cell recording of neurons responding to auditory stimuli with varying binaural correlations. Typically, when pseudo-populations are generated from single cell data, the responses within the population are statistically independent. As a result, the information content of the population will increase indefinitely with its size. In contrast, here we apply a simple algorithm that enables us to generate pseudo-population responses with variable spike-count correlations. This enables us to study the effect of neuronal correlations on the accuracy of conventional rate codes. We show that in a homogenous population, in the presence of even low-level correlations, information content is bounded. In contrast, utilizing a simple linear readout, that takes into account the natural heterogeneity, even of neurons preferentially tuned to the same stimulus, within the neural population, one can overcome the correlated noise and obtain a readout whose accuracy grows linearly with the size of the population.	[Zohar, Oran; Shamir, Maoz] Ben Gurion Univ Negev, Fac Hlth Sci, Deptartment Physiol, Beer Sheva, Israel; [Shackleton, Trevor M.; Palmer, Alan R.] MRC Inst Hearing Res, Nottingham, England; [Shamir, Maoz] Ben Gurion Univ Negev, Dept Phys, Fac Nat Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Shamir, M (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Deptartment Physiol, Beer Sheva, Israel.	shmaoz@bgu.ac.il	SHAMIR, MAOZ/F-1641-2012	SHAMIR, MAOZ/0000-0002-1489-6704; Shackleton, Trevor/0000-0002-1751-7503; Palmer, Alan/0000-0001-5893-4525	Marie Curie International Reintegration Grants [FP7-PEOPLE-IRG-2008]; Israel Science Foundation ISF [722/10]; MRC [MC_U135097126] Funding Source: UKRI; Medical Research Council [MC_U135097126] Funding Source: researchfish	Marie Curie International Reintegration Grants(European Commission); Israel Science Foundation ISF(Israel Science Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MS is supported in part by the Marie Curie International Reintegration Grants (FP7-PEOPLE-IRG-2008) and by the Israel Science Foundation ISF grant No 722/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; ALBECK Y, 1995, J NEUROPHYSIOL, V74, P1689, DOI 10.1152/jn.1995.74.4.1689; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Dayan P, 2001, COMPUTATIONAL NEUROS; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; Ecker AS, 2011, J NEUROSCI, V31, P14272, DOI 10.1523/JNEUROSCI.2539-11.2011; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Eggermont JJ, 2000, J NEUROPHYSIOL, V83, P2708, DOI 10.1152/jn.2000.83.5.2708; Eggermont JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020046; Geis HRAP, 2011, J PHYSIOL-LONDON, V589, P3955, DOI 10.1113/jphysiol.2011.210278; Gordon N, 2008, J NEUROSCI METH, V169, P391, DOI 10.1016/j.jneumeth.2007.11.005; Gu Y, 2011, NEURON, V71, P750, DOI 10.1016/j.neuron.2011.06.015; Jeanne JM, 2013, NEURON, V78, P352, DOI 10.1016/j.neuron.2013.02.023; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Lee D, 1998, J NEUROSCI, V18, P1161; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Saberi K, 1998, NEURON, V21, P789, DOI 10.1016/S0896-6273(00)80595-4; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Shackleton TM, 2005, JARO-J ASSOC RES OTO, V6, P244, DOI 10.1007/s10162-005-0005-8; Shackleton TM, 2003, J NEUROSCI, V23, P716, DOI 10.1523/JNEUROSCI.23-02-00716.2003; Shamir M, 2004, NEURAL COMPUT, V16, P1105, DOI 10.1162/089976604773717559; Shamir M, 2006, NEURAL COMPUT, V18, P1951, DOI 10.1162/neco.2006.18.8.1951; Skottun BC, 2001, P NATL ACAD SCI USA, V98, P14050, DOI 10.1073/pnas.241513998; Smith MA, 2013, J NEUROSCI, V33, P5422, DOI 10.1523/JNEUROSCI.4782-12.2013; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445; Wilke SD, 2002, NEURAL COMPUT, V14, P155, DOI 10.1162/089976602753284482; Wu S, 2004, NEURAL NETWORKS, V17, P205, DOI 10.1016/j.neunet.2003.10.003; Wu S, 2002, NEURAL COMPUT, V14, P999, DOI 10.1162/089976602753633367; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	39	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81660	10.1371/journal.pone.0081660	http://dx.doi.org/10.1371/journal.pone.0081660			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358120	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700016
J	Lee, TS; Jeon, HW; Kim, YB; Kim, YA; Kim, MA; Kang, SB				Lee, Taek Sang; Jeon, Hye Won; Kim, Yong Beom; Kim, Young A.; Kim, Min A.; Kang, Soon Beom			Aberrant MicroRNA Expression in Endometrial Carcinoma Using Formalin-Fixed Paraffin-Embedded (FFPE) Tissues	PLOS ONE			English	Article							CANCER; RNA; IDENTIFICATION; TARGETS; PROFILE; FROZEN; GENES; CELLS	This study aimed to identify the candidate miRNAs in the carcinogenesis of endometrial carcinoma, and to explore whether FFPE material would be suitable for miRNA profiling. We identified the differences between miRNA expression profiles using human miRNA microarray in endometrioid endometrial adenocarcinomas (EECs) and normal endometria. Of those tested, miR-200a*, miR-200b*, miR-141, miR-182, and miR-205 were greatly enriched. The expressions of these five miRNAs were validated using quantitative real-time reverse transcription-PCR (qRT-PCR). We then performed qRT-PCR miR expression profiling in 30 FFPE specimens (20 EECs, 10 normal endometria) and re-confirmed the results of differential expression between cancer and normal tissue. Following this, we tested whether the specific inhibition of overexpressed miRNAs would alter chemosensitivity. In the in vitro cell viability assay, anti-miR200b* showed a trend toward enhanced cytotoxicity slightly in cisplatin compared to the negative control (p = 0.07). This information provided the candidate miRNAs for further confirmation of the role of miRNAs in the carcinogenesis of EECs, potentially serving as a diagnostic or therapeutic tool. FFPE specimens of endometrial tissues are suitable as a source for miRNA microarray profiling.	[Lee, Taek Sang; Jeon, Hye Won] SMG SNU Boramae Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Yong Beom] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Obstet & Gynecol, Songnam, South Korea; [Kim, Young A.] SMG SNU Boramae Med Ctr, Dept Pathol, Seoul, South Korea; [Kim, Min A.] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Kang, Soon Beom] Konkuk Univ, Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Konkuk University; Konkuk University Medical Center	Jeon, HW (corresponding author), SMG SNU Boramae Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea.	ljhw65@gmail.com			SNUH Research Fund [04-2009-0740]	SNUH Research Fund	The research was supported by grant number (04-2009-0740) from the SNUH Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boren T, 2008, GYNECOL ONCOL, V110, P206, DOI 10.1016/j.ygyno.2008.03.023; Chen XY, 2012, CANCER LETT, V314, P41, DOI 10.1016/j.canlet.2011.09.014; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chung TKH, 2009, INT J CANCER, V124, P1358, DOI 10.1002/ijc.24071; Cohn DE, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.051; Feng B, 2012, BIOMED PHARMACOTHER, V66, P397, DOI 10.1016/j.biopha.2012.06.002; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Hall JS, 2012, BRIT J CANCER, V107, P684, DOI 10.1038/bjc.2012.294; Hamano R, 2011, CLIN CANCER RES, V17, P3029, DOI 10.1158/1078-0432.CCR-10-2532; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jemal A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1672; Kang S, 2012, J GYNECOL ONCOL, V23, P251, DOI 10.3802/jgo.2012.23.4.251; Karaayvaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035158; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee JW, 2011, GYNECOL ONCOL, V120, P56, DOI 10.1016/j.ygyno.2010.09.022; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Majid S, 2010, CANCER-AM CANCER SOC, V116, P5637, DOI 10.1002/cncr.25488; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Pan Q, 2007, MOL HUM REPROD, V13, P797, DOI 10.1093/molehr/gam063; Pecorelli S, 2005, Cancer Chemother Biol Response Modif, V22, P515; Pogribny IP, 2010, INT J CANCER, V127, P1785, DOI 10.1002/ijc.25191; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Ratner ES, 2010, GYNECOL ONCOL, V118, P251, DOI 10.1016/j.ygyno.2010.05.010; Takano M, 2007, MOL ENDOCRINOL, V21, P2334, DOI 10.1210/me.2007-0058; Wright JA, 2010, J MAMMARY GLAND BIOL, V15, P213, DOI 10.1007/s10911-010-9183-z; Wu WG, 2009, EUR J CANCER PREV, V18, P50, DOI 10.1097/CEJ.0b013e328305a07a; Wu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029043; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Yu J, 2012, CANCER BIOL THER, V10, P748; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang X, 2008, J MOL DIAGN, V10, P513, DOI 10.2353/jmoldx.2008.080077	33	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81421	10.1371/journal.pone.0081421	http://dx.doi.org/10.1371/journal.pone.0081421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24363810	gold, Green Submitted, Green Published			2022-12-27	WOS:000328705200028
J	Sackett, O; Petrou, K; Reedy, B; De Grazia, A; Hill, R; Doblin, M; Beardall, J; Ralph, P; Heraud, P				Sackett, Olivia; Petrou, Katherina; Reedy, Brian; De Grazia, Adrian; Hill, Ross; Doblin, Martina; Beardall, John; Ralph, Peter; Heraud, Philip			Phenotypic Plasticity of Southern Ocean Diatoms: Key to Success in the Sea Ice Habitat?	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; PHOTOSYNTHETIC ENERGY-CONVERSION; BIOCHEMICAL-COMPOSITION; MARINE-PHYTOPLANKTON; EXTREME CONDITIONS; FTIR SPECTROSCOPY; PROTEIN-SYNTHESIS; LIMITED GROWTH; ALGAE; ANTARCTICA	Diatoms are the primary source of nutrition and energy for the Southern Ocean ecosystem. Microalgae, including diatoms, synthesise biological macromolecules such as lipids, proteins and carbohydrates for growth, reproduction and acclimation to prevailing environmental conditions. Here we show that three key species of Southern Ocean diatom (Fragilariopsis cylindrus, Chaetoceros simplex and Pseudo-nitzschia subcurvata) exhibited phenotypic plasticity in response to salinity and temperature regimes experienced during the seasonal formation and decay of sea ice. The degree of phenotypic plasticity, in terms of changes in macromolecular composition, was highly species-specific and consistent with each species' known distribution and abundance throughout sea ice, meltwater and pelagic habitats, suggesting that phenotypic plasticity may have been selected for by the extreme variability of the polar marine environment. We argue that changes in diatom macromolecular composition and shifts in species dominance in response to a changing climate have the potential to alter nutrient and energy fluxes throughout the Southern Ocean ecosystem.	[Sackett, Olivia; Petrou, Katherina; Doblin, Martina; Ralph, Peter] Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia; [Sackett, Olivia; Petrou, Katherina; Doblin, Martina; Ralph, Peter] Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster, Sydney, NSW 2007, Australia; [Sackett, Olivia; Heraud, Philip] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Reedy, Brian; De Grazia, Adrian] Univ Technol Sydney, Sch Chem & Forens Sci, Sydney, NSW 2007, Australia; [Hill, Ross] Univ New S Wales, Sch Biol Earth & Environm Sci, Ctr Marine Bioinnovat, Sydney, NSW 2052, Australia; [Hill, Ross] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney Inst Marine Sci, Sydney, NSW 2052, Australia; [Heraud, Philip] Monash Univ, Ctr Biospect, Clayton, Vic 3800, Australia	University of Technology Sydney; University of Technology Sydney; Monash University; University of Technology Sydney; University of New South Wales Sydney; Sydney Institute of Marine Science; University of New South Wales Sydney; Monash University	Heraud, P (corresponding author), Monash Univ, Ctr Biospect, Clayton, Vic 3800, Australia.	phil.heraud@monash.edu	Doblin, Martina A/E-8719-2013; Hill, Ross/E-6075-2013; Ralph, Peter J/C-5029-2009; Beardall, John/L-5262-2019; Doblin, Martina/L-1804-2019; Ralph, Peter/L-1527-2019	Doblin, Martina A/0000-0001-8750-3433; Hill, Ross/0000-0002-4623-1563; Ralph, Peter J/0000-0002-3103-7346; Beardall, John/0000-0001-7684-446X; Doblin, Martina/0000-0001-8750-3433; Ralph, Peter/0000-0002-3103-7346; Heraud, Philip/0000-0003-4377-9184; Petrou, Katherina/0000-0002-2703-0694				Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Almandoz GO, 2008, POLAR BIOL, V31, P429, DOI 10.1007/s00300-007-0369-9; Armand LK, 2005, PALAEOGEOGR PALAEOCL, V223, P93, DOI 10.1016/j.palaeo.2005.02.015; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Bayer-Giraldi M, 2010, ENVIRON MICROBIOL, V12, P1041, DOI 10.1111/j.1462-2920.2009.02149.x; Boyd PW, 2010, LIMNOL OCEANOGR, V55, P1353, DOI 10.4319/lo.2010.55.3.1353; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Carr ME, 2006, DEEP-SEA RES PT II, V53, P741, DOI 10.1016/j.dsr2.2006.01.028; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Devos N, 1998, J PHYCOL, V34, P655, DOI 10.1046/j.1529-8817.1998.340655.x; Diekmann ABS, 2009, J PLANKTON RES, V31, P1391, DOI 10.1093/plankt/fbp073; Domenighini A, 2009, J PHYCOL, V45, P522, DOI 10.1111/j.1529-8817.2009.00662.x; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; FAHL K, 1993, POLAR BIOL, V13, P405, DOI 10.1007/BF01681982; Falk-Petersen S, 1998, POLAR BIOL, V20, P41, DOI 10.1007/s003000050274; Flynn KJ, 2012, NAT CLIM CHANGE, V2, P510, DOI 10.1038/NCLIMATE1489; Giordano M, 2001, J PHYCOL, V37, P271, DOI 10.1046/j.1529-8817.2001.037002271.x; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Gwak IG, 2010, MAR BIOTECHNOL, V12, P630, DOI 10.1007/s10126-009-9250-x; Heraud P, 2005, FEMS MICROBIOL LETT, V249, P219, DOI 10.1016/j.femsle.2005.06.021; Heraud P, 2007, ACS SYM SER, V963, P85; Heraud P, 2008, J PHYCOL, V44, P1335, DOI 10.1111/j.1529-8817.2008.00564.x; HORNER R, 1992, POLAR BIOL, V12, P417; Jakob T, 2007, J EXP BOT, V58, P2101, DOI 10.1093/jxb/erm084; Jungandreas A, 2012, PLANT CELL PHYSIOL, V53, P2153, DOI 10.1093/pcp/pcs144; Krell A, 2008, EUR J PHYCOL, V43, P423, DOI 10.1080/09670260802348615; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; LAWS EA, 1991, DEEP-SEA RES, V38, P143, DOI 10.1016/0198-0149(91)90059-O; Lee SH, 2008, J EXP MAR BIOL ECOL, V367, P204, DOI 10.1016/j.jembe.2008.09.018; Lizotte MP, 2001, AM ZOOL, V41, P57, DOI 10.1668/0003-1569(2001)041[0057:TCOSIA]2.0.CO;2; LOHRENZ SE, 1987, MAR ECOL PROG SER, V35, P277, DOI 10.3354/meps035277; MacLeod N, 2010, NATURE, V467, P154, DOI 10.1038/467154a; Mock T, 2004, J PHYCOL, V40, P732, DOI 10.1111/j.1529-8817.2004.03224.x; Mock T, 2002, PHYTOCHEMISTRY, V61, P41, DOI 10.1016/S0031-9422(02)00216-9; Mock T, 2002, PHYTOCHEMISTRY, V61, P53, DOI 10.1016/S0031-9422(02)00215-7; Mock Thomas, 2007, V11; Murdock JN, 2009, APPL SPECTROSC REV, V44, P335, DOI 10.1080/05704920902907440; NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0; NICHOLS PD, 1989, ANTARCT SCI, V1, P133, DOI 10.1017/S0954102089000209; Petrou K, 2011, MAR ECOL PROG SER, V437, P27, DOI 10.3354/meps09291; Petrou K, 2011, MAR BIOL, V158, P1029, DOI 10.1007/s00227-011-1628-4; Pocock T, 2011, J EXP BOT, V62, P1169, DOI 10.1093/jxb/erq347; Ralph PJ, 2007, J PHYCOL, V43, P948, DOI 10.1111/j.1529-8817.2007.00382.x; Raymond JA, 2000, POLAR BIOL, V23, P721, DOI 10.1007/s003000000147; RIVKIN RB, 1987, LIMNOL OCEANOGR, V32, P249, DOI 10.4319/lo.1987.32.1.0249; RIVKIN RB, 1985, MAR BIOL, V89, P135, DOI 10.1007/BF00392884; Saibo NJM, 2009, ANN BOT-LONDON, V103, P609, DOI 10.1093/aob/mcn227; Sarthou G, 2005, J SEA RES, V53, P25, DOI 10.1016/j.seares.2004.01.007; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Suarez I, 2003, J SEA RES, V50, P285, DOI 10.1016/j.seares.2003.04.002; Tang KW, 2009, P ROY SOC B-BIOL SCI, V276, P81, DOI 10.1098/rspb.2008.0598; Thomas DN, 2002, SCIENCE, V295, P641, DOI 10.1126/science.1063391; Trovato M, 2008, REND LINCEI-SCI FIS, V19, P325, DOI 10.1007/s12210-008-0022-8; Twining BS, 2004, LIMNOL OCEANOGR, V49, P2115, DOI 10.4319/lo.2004.49.6.2115; Wagner H, 2010, J BIOPHOTONICS, V3, P557, DOI 10.1002/jbio.201000019; WHYTE JNC, 1987, AQUACULTURE, V60, P231, DOI 10.1016/0044-8486(87)90290-0; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wood AM., 2005, ALGAL CULTURING TECH, P269, DOI DOI 10.1016/B978-012088426-1/50019-6; Xie YP, 2012, J FOOD SAFETY, V32, P176, DOI 10.1111/j.1745-4565.2012.00365.x	62	42	42	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81185	10.1371/journal.pone.0081185	http://dx.doi.org/10.1371/journal.pone.0081185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24363795	gold, Green Published			2022-12-27	WOS:000327539800110
J	Chiefari, E; Arcidiacono, B; Possidente, K; Iiritano, S; Ventura, V; Pandolfo, R; Brunetti, FS; Greco, M; Foti, D; Brunetti, A				Chiefari, Eusebio; Arcidiacono, Biagio; Possidente, Katiuscia; Iiritano, Stefania; Ventura, Valeria; Pandolfo, Rosantony; Brunetti, Francesco Saverio; Greco, Manfredi; Foti, Daniela; Brunetti, Antonio			Transcriptional Regulation of the HMGA1 Gene by Octamer-Binding Proteins Oct-1 and Oct-2	PLOS ONE			English	Article							INSULIN-RECEPTOR GENE; IFN-BETA-GENE; ACTIVATION DOMAINS; VIRUS INDUCTION; EXPRESSION; PROMOTER; CANCER; ORGANIZATION; HMG-I(Y); MOTIF	The High-Mobility Group AT-Hook 1 (HMGA1) protein is an architectural transcription factor that binds to AT-rich sequences in the promoter region of DNA and functions as a specific cofactor for gene activation. Previously, we demonstrated that HMGA1 is a key regulator of the insulin receptor (INSR) gene and an important downstream target of the INSR signaling cascade. Moreover, from a pathogenic point of view, overexpression of HMGA1 has been associated with human cancer, whereas functional variants of the HMGA1 gene have been recently linked to type 2 diabetes mellitus and metabolic syndrome. However, despite of this biological and pathological relevance, the mechanisms that control HMGA1 gene expression remain unknown. In this study, to define the molecular mechanism(s) that regulate HMGA1 gene expression, the HMGA1 gene promoter was investigated by transient transfection of different cell lines, either before or after DNA and siRNA cotransfections. An octamer motif was identified as an important element of transcriptional regulation of this gene, the interaction of which with the octamer transcription factors Oct-1 and Oct-2 is crucial in modulating HMGA1 gene and protein expression. Additionally, we demonstrate that HMGA1 binds its own promoter and contributes to its transactivation by Oct-2 (but not Oct-1), supporting its role in an auto-regulatory circuit. Overall, our results provide insight into the transcriptional regulation of the HMGA1 gene, revealing a differential control exerted by both Oct-1 and Oct-2. Furthermore, they consistently support the hypothesis that a putative defect in Oct-1 and/or Oct-2, by affecting HMGA1 expression, may cause INSR dysfunction, leading to defects of the INSR signaling pathway.	[Chiefari, Eusebio; Arcidiacono, Biagio; Possidente, Katiuscia; Iiritano, Stefania; Ventura, Valeria; Pandolfo, Rosantony; Foti, Daniela; Brunetti, Antonio] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Brunetti, Francesco Saverio] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [Greco, Manfredi] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro	Brunetti, A (corresponding author), Magna Graecia Univ Catanzaro, Dept Hlth Sci, Viale Europa Loc Germaneto, Catanzaro, Italy.	brunetti@unicz.it	Arcidiacono, Biagio/I-6040-2019; Brunetti, Antonio/K-7756-2016; Chiefari, Eusebio/Y-2558-2019; Foti, Daniela P/K-8038-2016	Arcidiacono, Biagio/0000-0003-4343-678X; Chiefari, Eusebio/0000-0001-5329-3124; Brunetti, Antonio/0000-0003-1533-8779; VENTURA, Valeria/0000-0001-6378-9916; Foti, Daniela/0000-0002-9536-5736	MIUR Italy [2004062059-002]; Cultural Association "Compagnia dei Sognattori'' of Soverato	MIUR Italy(Ministry of Education, Universities and Research (MIUR)); Cultural Association "Compagnia dei Sognattori'' of Soverato	This work was supported by MIUR Italy (protocol 2004062059-002). Also, the authors acknowledge financial support received by the Cultural Association "Compagnia dei Sognattori'' of Soverato, led by the director Antonio Pittelli. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkadir SA, 1998, J LEUKOCYTE BIOL, V64, P681, DOI 10.1002/jlb.64.5.681; ASMAN DC, 1993, J BIOL CHEM, V268, P12530; Bianconcini A, 2009, INT J BIOCHEM CELL B, V41, P2189, DOI 10.1016/j.biocel.2009.04.011; Brunetti A, 2001, FASEB J, V15, P492, DOI 10.1096/fj.00-0190com; BRUNETTI A, 1993, J CLIN INVEST, V92, P1288, DOI 10.1172/JCI116702; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chiefari E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01491; Chiefari E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00251; Chiefari E, 2011, JAMA-J AM MED ASSOC, V305, P903, DOI 10.1001/jama.2011.207; Chiefari E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1040; Chiefari E, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-24; CLEARY MA, 1993, GENE DEV, V7, P72, DOI 10.1101/gad.7.1.72; Cleynen I, 2008, INT J ONCOL, V32, P289; Cleynen I, 2007, CANCER RES, V67, P4620, DOI 10.1158/0008-5472.CAN-06-4325; Costa V, 2008, ENDOCR-RELAT CANCER, V15, P325, DOI 10.1677/ERC-07-0226; Darville MI, 2004, ENDOCRINOLOGY, V145, P1130, DOI 10.1210/en.2003-1200; Fedele M, 2010, BBA-GENE REGUL MECH, V1799, P48, DOI 10.1016/j.bbagrm.2009.11.007; Foti D, 2005, NAT MED, V11, P765, DOI 10.1038/nm1254; Foti D, 2003, MOL CELL BIOL, V23, P2720, DOI 10.1128/MCB.23.8.2720-2732.2003; FRIEDMANN M, 1993, NUCLEIC ACIDS RES, V21, P4259, DOI 10.1093/nar/21.18.4259; Iiritano S, 2012, MOL ENDOCRINOL, V26, P1578, DOI 10.1210/me.2011-1379; JOHNSON KR, 1989, MOL CELL BIOL, V9, P2114, DOI 10.1128/MCB.9.5.2114; Liu L, 2012, DIABETOLOGIA, V55, P1685, DOI 10.1007/s00125-012-2518-0; Ng MCY, 2010, DIABETIC MED, V27, P1443, DOI 10.1111/j.1464-5491.2010.03124.x; OGRAM SA, 1995, J BIOL CHEM, V270, P14235, DOI 10.1074/jbc.270.23.14235; Paonessa F, 2006, CANCER RES, V66, P5085, DOI 10.1158/0008-5472.CAN-05-3678; Pullinger CR, 2013, METAB SYNDR RELAT DI; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Reeves R, 2002, BIOCHIM BIOPHYS ACTA, V1519, P13; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHAFFNER W, 1989, TRENDS GENET, V5, P37, DOI 10.1016/0168-9525(89)90017-6; Sgarra R, 2004, FEBS LETT, V574, P1, DOI 10.1016/j.febslet.2004.08.013; STAUDT LM, 1991, ANNU REV IMMUNOL, V9, P373; TANAKA M, 1992, CELL, V68, P755, DOI 10.1016/0092-8674(92)90150-B; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; Wang PX, 2010, ISLETS, V2, P46, DOI 10.4161/isl.2.1.10017; Wang PX, 2009, J BIOL CHEM, V284, P26456, DOI 10.1074/jbc.M109.030668; Zhao FQ, 2013, FRONT BIOSCI-LANDMRK, V18, P1051, DOI 10.2741/4162	41	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83969	10.1371/journal.pone.0083969	http://dx.doi.org/10.1371/journal.pone.0083969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367622	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300123
J	Zheng, RN; Rebolledo-Jaramillo, B; Zong, YW; Wang, LQ; Russo, P; Hancock, W; Stanger, BZ; Hardison, RC; Blobel, GA				Zheng, Rena; Rebolledo-Jaramillo, Boris; Zong, Yiwei; Wang, Liqing; Russo, Pierre; Hancock, Wayne; Stanger, Ben Z.; Hardison, Ross C.; Blobel, Gerd A.			Function of GATA Factors in the Adult Mouse Liver	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-1; STEROL TRANSPORTERS ABCG5; ZINC-FINGER PROTEINS; HEART TUBE FORMATION; GENE-EXPRESSION; VENTRAL MORPHOGENESIS; RAT HEPATOCYTES; FACTOR NETWORK; FOG COFACTORS; DIFFERENTIATION	GATA transcription factors and their Friend of Gata (FOG) cofactors control the development of diverse tissues. GATA4 and GATA6 are essential for the expansion of the embryonic liver bud, but their expression patterns and functions in the adult liver are unclear. We characterized the expression of GATA and FOG factors in whole mouse liver and purified hepatocytes. GATA4, GATA6, and FOG1 are the most prominently expressed family members in whole liver and hepatocytes. GATA4 chromatin immunoprecipitation followed by high throughput sequencing (ChIP-seq) identified 4409 occupied sites, associated with genes enriched in ontologies related to liver function, including lipid and glucose metabolism. However, hepatocyte-specific excision of Gata4 had little impact on gross liver architecture and function, even under conditions of regenerative stress, and, despite the large number of GATA4 occupied genes, resulted in relatively few changes in gene expression. To address possible redundancy between GATA4 and GATA6, both factors were conditionally excised. Surprisingly, combined Gata4,6 loss did not exacerbate the phenotype resulting from Gata4 loss alone. This points to the presence of an unusually robust transcriptional network in adult hepatocytes that ensures the maintenance of liver function.	[Zheng, Rena; Blobel, Gerd A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zheng, Rena; Blobel, Gerd A.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Rebolledo-Jaramillo, Boris] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Zong, Yiwei; Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Wang, Liqing; Hancock, Wayne] Childrens Hosp Philadelphia, Div Transplant Immunol, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wang, Liqing; Hancock, Wayne] Childrens Hosp Philadelphia, Biesecker Ctr Pediat Liver Dis, Philadelphia, PA 19104 USA; [Russo, Pierre] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Div Gastroenterol, Dept Med,Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Hardison, Ross C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Blobel, GA (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.	blobel@email.chop.edu	Hardison, Ross C/G-1142-2010; Rebolledo-Jaramillo, Boris/L-8144-2019	Hardison, Ross C/0000-0003-4084-7516; Rebolledo-Jaramillo, Boris/0000-0001-8059-3202	National Institutes of Health (NIH) [5R37DK058044, DK083355]; NIH training grant [T32 H107971]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058044, R01DK083355, R56DK065806, R01DK065806] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants 5R37DK058044 (to G.A.B.), DK083355 (to B.Z.S.), and NIH training grant T32 H107971 (to R.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back SS, 2013, BMB REP, V46, P322, DOI 10.5483/BMBRep.2013.46.6.246; Baik M, 2011, ANN NY ACAD SCI, V1229, P29, DOI 10.1111/j.1749-6632.2011.06100.x; Beuling E, 2008, DEV BIOL, V322, P179, DOI 10.1016/j.ydbio.2008.07.022; Bossard P, 1998, DEVELOPMENT, V125, P4909; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Cantor AB, 2005, SEMIN CELL DEV BIOL, V16, P117, DOI 10.1016/j.semcdb.2004.10.006; Castell JV, 2006, EXPERT OPIN DRUG MET, V2, P183, DOI 10.1517/17425255.2.2.183; Chang AN, 2002, P NATL ACAD SCI USA, V99, P9237, DOI 10.1073/pnas.142302099; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Chlon TM, 2012, DEVELOPMENT, V139, P3905, DOI 10.1242/dev.080440; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Crispino JD, 1999, MOL CELL, V3, P219, DOI 10.1016/S1097-2765(00)80312-3; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; DALET C, 1982, ANAL BIOCHEM, V122, P119, DOI 10.1016/0003-2697(82)90259-7; Dame C, 2004, J BIOL CHEM, V279, P2955, DOI 10.1074/jbc.M310404200; Denson LA, 2000, GENE, V246, P311, DOI 10.1016/S0378-1119(00)00082-2; Divine JK, 2004, AM J PHYSIOL-GASTR L, V287, pG1086, DOI 10.1152/ajpgi.00421.2003; Duncan SA, 1998, SCIENCE, V281, P692, DOI 10.1126/science.281.5377.692; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gregory GD, 2010, BLOOD, V115, P2156, DOI 10.1182/blood-2009-10-251280; Haworth KE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-74; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Holtzinger A, 2005, DEVELOPMENT, V132, P4005, DOI 10.1242/dev.01978; Hung HL, 2001, BLOOD, V97, P946, DOI 10.1182/blood.V97.4.946; Island ML, 2011, BIOCHEM J, V437, P477, DOI 10.1042/BJ20110225; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kitade M, 2013, GENE DEV, V27, P1706, DOI 10.1101/gad.214601.113; Krier M, 2009, CLIN LIVER DIS, V13, P167, DOI 10.1016/j.cld.2009.02.001; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Lorbek G, 2012, FEBS J, V279, P1516, DOI 10.1111/j.1742-4658.2011.08432.x; Lowry JA, 2000, J MOL EVOL, V50, P103, DOI 10.1007/s002399910012; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; MATSUDA K, 1994, FEBS LETT, V353, P269, DOI 10.1016/0014-5793(94)01062-5; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miccio A, 2010, MOL CELL BIOL, V30, P3460, DOI 10.1128/MCB.00001-10; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Mwinyi J, 2010, DRUG METAB DISPOS, V38, P415, DOI 10.1124/dmd.109.029405; Nemer G, 2003, DEV BIOL, V254, P131, DOI 10.1016/S0012-1606(02)00026-X; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; PERTOFT H, 1977, EXP CELL RES, V110, P449, DOI 10.1016/0014-4827(77)90311-1; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reinehr R, 2009, BIOL CHEM, V390, P1033, DOI 10.1515/BC.2009.106; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Sumi K, 2007, MOL CELL BIOL, V27, P4248, DOI 10.1128/MCB.01894-06; Sund NJ, 2000, MOL CELL BIOL, V20, P5175, DOI 10.1128/MCB.20.14.5175-5183.2000; Tevosian SG, 1999, P NATL ACAD SCI USA, V96, P950, DOI 10.1073/pnas.96.3.950; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Watt AJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-37; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Xin M, 2006, P NATL ACAD SCI USA, V103, P11189, DOI 10.1073/pnas.0604604103; Xuan SH, 2012, J CLIN INVEST, V122, P3516, DOI 10.1172/JCI63352; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao H, 2007, MOL CELL BIOL, V27, P5286, DOI 10.1128/MCB.00176-07; Zhao RO, 2005, MOL CELL BIOL, V25, P2622, DOI 10.1128/MCB.25.7.2622-2631.2005	79	29	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83723	10.1371/journal.pone.0083723	http://dx.doi.org/10.1371/journal.pone.0083723			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367609	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300116
J	Schubert, G; Vigilant, L; Boesch, C; Klenke, R; Langergraber, K; Mundry, R; Surbeck, M; Hohmann, G				Schubert, Grit; Vigilant, Linda; Boesch, Christophe; Klenke, Reinhard; Langergraber, Kevin; Mundry, Roger; Surbeck, Martin; Hohmann, Gottfried			Co-Residence between Males and Their Mothers and Grandmothers Is More Frequent in Bonobos Than Chimpanzees	PLOS ONE			English	Article							WILD CHIMPANZEES; PAN-PANISCUS; NATIONAL-PARK; KIN; PATERNITY; SUCCESS; DNA; TROGLODYTES; COMPETITION; EVOLUTION	In long-lived social mammals such as primates, individuals can benefit from social bonds with close kin, including their mothers. In the patrilocal chimpanzee (Pan troglodytes spp.) and bonobo (Pan paniscus), sexually mature males reside and reproduce in their natal groups and can retain post-dependency bonds with their mothers, while immatures of both sexes might also have their paternal grandmothers available. However, quantitative information on the proportion of males and immatures that co-reside with both types of these close female relatives is limited for both species. Combining genetic parentage determination and group composition data from five communities of wild chimpanzees and three communities of wild bonobos, we estimated the frequency of co-residence between (1) mature males and their mothers, and (2) immature males and females and their paternal grandmothers. We found that adult males resided twice as frequently with their mothers in bonobos than in chimpanzees, and that immature bonobos were three times more likely to possess a living paternal grandmother than were immature chimpanzees. Patterns of female and male survivorship from studbook records of captive individuals of both species suggest that mature bonobo females survive longer than their chimpanzee counterparts, possibly contributing to the differences observed in mother-son and grandmother-immature co-residency levels. Taking into account reports of bonobo mothers supporting their sons' mating efforts and females sharing food with immatures other than their own offspring, our findings suggest that life history traits may facilitate maternal and grandmaternal support more in bonobos than in chimpanzees.	[Schubert, Grit; Vigilant, Linda; Boesch, Christophe; Langergraber, Kevin; Mundry, Roger; Surbeck, Martin; Hohmann, Gottfried] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Schubert, Grit] Robert Koch Inst, Berlin, Germany; [Klenke, Reinhard] UFZ, Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany; [Langergraber, Kevin] Boston Univ, Dept Anthropol, Boston, MA 02215 USA	Max Planck Society; Robert Koch Institute; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Boston University	Schubert, G (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany.	schubertg@rki.de	Klenke, Reinhard/J-4686-2013	Klenke, Reinhard/0000-0002-6860-8085	Max Planck Society; LSB Leakey Foundation [2540]	Max Planck Society(Max Planck SocietyFoundation CELLEX); LSB Leakey Foundation	This work was funded by the Max Planck Society and a grant from the LSB Leakey Foundation to GS (grant number 2540). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann Stuart A., 1979, PRIMATE ECOLOGY HUMA; Arandjelovic M, 2009, MOL ECOL RESOUR, V9, P28, DOI 10.1111/j.1755-0998.2008.02387.x; Boesch C, 2006, AM J PHYS ANTHROPOL, V130, P103, DOI 10.1002/ajpa.20341; Boesch C, 2009, REAL CHIMPANZEE: SEX STRATEGIES IN THE FOREST, P1; Boesch C, 2000, CHIMPANZEES TAI FORE; Boesch C, 2008, AM J PRIMATOL, V70, P519, DOI 10.1002/ajp.20524; Borries C, 1988, HUM EVOL, V3, P239, DOI DOI 10.1007/BF02435856; Bronikowski AM, 2002, P NATL ACAD SCI USA, V99, P9591, DOI 10.1073/pnas.142675599; Buchan JC, 2003, NATURE, V425, P179, DOI 10.1038/nature01866; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Carlsen F, 2007, EUROPEAN STUDBOOK CH; Chapais B, 2001, INT J PRIMATOL, V22, P203, DOI 10.1023/A:1005619430744; Clay Z, 2013, P NATL ACAD SCI USA, V110, P18121, DOI 10.1073/pnas.1316449110; Clutton-Brock T. H., 1988, REPROD SUCCESS; COX DR, 1972, J R STAT SOC B, V34, P187; De Lathouwers M, 2005, INT J PRIMATOL, V26, P55, DOI 10.1007/s10764-005-0723-0; DYKE B, 1995, AM J PRIMATOL, V37, P25, DOI 10.1002/ajp.1350370104; Ellegren H, 2000, NAT GENET, V24, P400, DOI 10.1038/74249; FAIRBANKS LA, 1986, ANIM BEHAV, V34, P1710, DOI 10.1016/S0003-3472(86)80258-5; Fruth B, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P231, DOI 10.1017/CBO9780511606397.023; FURUICHI T, 1994, BEHAVIOUR, V130, P211, DOI 10.1163/156853994X00532; Furuichi T, 1997, INT J PRIMATOL, V18, P855, DOI 10.1023/A:1026327627943; Furuichi T, 2011, EVOL ANTHROPOL, V20, P131, DOI 10.1002/evan.20308; Furuichi T, 2009, PRIMATES, V50, P197, DOI 10.1007/s10329-009-0141-6; Gerloff U, 1999, P ROY SOC B-BIOL SCI, V266, P1189, DOI 10.1098/rspb.1999.0762; Gibson MA, 2005, EVOL HUM BEHAV, V26, P469, DOI 10.1016/j.evolhumbehav.2005.03.004; Goodall J, 1986, CHIMPANZEES GOMBE, DOI DOI 10.1002/AJPA.1330730313; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Gurven M, 2007, POPUL DEV REV, V33, P321, DOI 10.1111/j.1728-4457.2007.00171.x; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hare B, 2012, ANIM BEHAV, V83, P573, DOI 10.1016/j.anbehav.2011.12.007; Hashimoto C, 1996, PRIMATES, V37, P305, DOI 10.1007/BF02381862; Hashimoto C, 2008, DEV PRIMATOL-PROG PR, P107, DOI 10.1007/978-0-387-74787-3_6; Hawkes K, 2003, AM J HUM BIOL, V15, P380, DOI 10.1002/ajhb.10156; Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469; Hohmann G., 2003, PAN AFR NEWS, V10, P25, DOI DOI 10.5134/143430; Hohmann G, 2009, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-1-4020-9699-0_1; Huchard E, 2013, BEHAV ECOL, V24, P229, DOI 10.1093/beheco/ars158; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; KANO T, 1982, Primates, V23, P171, DOI 10.1007/BF02381159; Kappeler P M, 2003, PRIMATE LIFE HIST SO; Kuroda S., 1989, P184; Langergraber KE, 2013, BEHAV ECOL SOCIOBIOL, P1; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; Lehmann J, 2006, BEHAVIOUR, V143, P931, DOI 10.1163/156853906778623635; Lukas D, 2005, MOL ECOL, V14, P2181, DOI 10.1111/j.1365-294X.2005.02560.x; Medawar P., 1952, UNSOLVED PROBLEM BIO; Mitani JC, 2002, ANIM BEHAV, V64, P727, DOI 10.1006/anbe.2002.4014; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Mulder MB, 2007, EVOL HUM BEHAV, V28, P299, DOI 10.1016/j.evolhumbehav.2007.05.009; Murdock G. P., 1981, ATLAS WORLD CULTURES; Newton-Fisher NE, 2010, AM J PHYS ANTHROPOL, V142, P417, DOI 10.1002/ajpa.21241; Nishida T, 2003, AM J PRIMATOL, V59, P99, DOI 10.1002/ajp.10068; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; Parr LA, 1999, NATURE, V399, P647, DOI 10.1038/21345; Pavelka MSM, 2002, ANIM BEHAV, V64, P407, DOI 10.1006/anbe.2002.3085; Perebom ZJJM, 2008, INT STUDBOOK BONOBO; Pusey A., 1979, Perspectives on Human Evolution, V5, P465; R Development Core Team, 2012, R LANG ENV STAT COMP; Schulke O, 2010, CURR BIOL, V20, P2207, DOI 10.1016/j.cub.2010.10.058; Sear R, 2000, P ROY SOC B-BIOL SCI, V267, P1641, DOI 10.1098/rspb.2000.1190; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Silk JB, 2004, ANIM BEHAV, V67, P573, DOI 10.1016/j.anbehav.2003.07.001; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Silk JB, 2009, PHILOS T R SOC B, V364, P3243, DOI 10.1098/rstb.2009.0118; Stearns S.C., 1992, pi; Strassmann BI, 2011, HUM NATURE-INT BIOS, V22, P201, DOI 10.1007/s12110-011-9114-8; Strier KB, 2008, ANNU REV ANTHROPOL, V37, P21, DOI 10.1146/annurev.anthro.37.081407.085218; Strier KB, 2011, P NATL ACAD SCI USA, V108, P18915, DOI 10.1073/pnas.1116737108; Stumpf R, 2007, PRIMATES PERSPECTIVE, P321; Surbeck M, 2013, BEHAV ECOL SOCIOBIOL, P1; Surbeck M, 2012, HORM BEHAV, V62, P27, DOI 10.1016/j.yhbeh.2012.04.013; Surbeck M, 2011, P ROY SOC B-BIOL SCI, V278, P590, DOI 10.1098/rspb.2010.1572; Susman RL, 1984, PYGMY CHIMPANZEE EVO; Tan JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051922; Therneau T, 2009, PACKAGE COXME MIXED; Therneau T, 2009, PACKAGE SURVIVAL SUR; Thompson ME, 2007, CURR BIOL, V17, P2150, DOI 10.1016/j.cub.2007.11.033; VAN LAWICK-GOODALL JANE, 1967, P287; van Schaik C.P., 1989, Special Publication of the British Ecological Society, P195; Vigilant L, 2001, P NATL ACAD SCI USA, V98, P12890, DOI 10.1073/pnas.231320498; Voland E., 2005, GRANDMOTHERHOOD EVOL, P1; Widdig A, 2007, BIOL REV, V82, P319, DOI 10.1111/j.1469-185X.2007.00011.x; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Williams JM, 2008, AM J PRIMATOL, V70, P766, DOI 10.1002/ajp.20573; Wittiger L, 2013, BEHAV ECOL SOCIOBIOL, V67, P1097, DOI 10.1007/s00265-013-1534-5; Wobber Victoria, 2010, Communicative & Integrative Biology, V3, P337; Wobber V, 2010, P NATL ACAD SCI USA, V107, P12457, DOI 10.1073/pnas.1007411107; Wobber V, 2010, CURR BIOL, V20, P226, DOI 10.1016/j.cub.2009.11.070; Wrangham Richard W., 1996, P45, DOI 10.1017/CBO9780511752414.006; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014	92	17	19	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83870	10.1371/journal.pone.0083870	http://dx.doi.org/10.1371/journal.pone.0083870			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358316	Green Published, gold			2022-12-27	WOS:000328737700073
J	Zhang, QL; Ding, YX; Yao, YQ; Yu, Y; Yang, LJ; Cui, H				Zhang, Qiaoli; Ding, Yingxue; Yao, Yanqing; Yu, Yang; Yang, Lijun; Cui, Hong			Creating Rat Model for Hypoxic Brain Damage in Neonates by Oxygen Deprivation	PLOS ONE			English	Article							ISCHEMIC ENCEPHALOPATHY; NEUROPROTECTION; HYPOTHERMIA; INJURY	Current study explores the feasibility of using a non-surgical method of oxygen deprivation to create Hypoxic brain damage in neonatal rats for medical studies. 7-day-old Sprague Dowley (SD) rats were kept in a container with low oxygen level (8%) for 1.5h. A second group had bilateral cephalic artery ligation before the 1.5h-low oxygen treatment, a method similar to the popular Rice method, to expose the brain to both hypoxic and ischemic situations. Short term neural functions and brain water weights were evaluated 1 day after the hypoxic treatment. Brain pathology and histology were also examined at 1 day and 3 days after the hypoxic treatment. Both groups showed impaired neural functions and increased brain water weight compared to the controls. Histology studies also revealed injuries in the subcortex, hippocampus and lateral ventricle in the brains from both groups. There is no significant difference in the degree of brain damages observed in the two groups. Our work demonstrated that oxygen deprivation alone is sufficient to cause brain damages similar to those seen in Hypoxic-ischemic brain disease (HIBD). Because this method avoids the invasive surgical procedure and therefore reduces the stress and mortality of laboratory animals during the experiment, we recommend it to be the favorable method for creating rat models for HIBD studies.	[Zhang, Qiaoli; Ding, Yingxue; Yao, Yanqing; Yu, Yang; Yang, Lijun; Cui, Hong] Capital Med Univ, Beijing Friendship Hosp, Dept Pediat, Beijing, Peoples R China	Capital Medical University	Yang, LJ (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Pediat, Beijing, Peoples R China.	ljy20082008@126.com; cuihong6699@163.com	姚, 艳青/HHC-4907-2022		Natural Science Foundation of China [81241022, 81200407]; Natural Science Foundation of Beijing [7122045]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	The study was supported by Natural Science Foundation of China (81241022, 81200407); Natural Science Foundation of Beijing (7122045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlKharfy TM, 2013, NEUROSCIENCES, V18, P18; Douglas-Escobar Martha, 2012, Front Neurol, V3, P144, DOI 10.3389/fneur.2012.00144; Guo, 2005, TECHNIQUES NEURAL PA, P216; Jin RL, 2006, NEUROSCI RES, V55, P65, DOI 10.1016/j.neures.2006.01.006; Kim JJ, 2013, MED DEVICES-EVID RES, V6, P1, DOI 10.2147/MDER.S39254; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Pan R, 2012, PEDIATR RES, V72, P479, DOI 10.1038/pr.2012.107; Peliowski-Davidovich A, 2012, PAED CHILD HEALT-CAN, V17, P41, DOI 10.1093/pch/17.1.41; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Robertson NJ, 2013, BRAIN, V136, P90, DOI 10.1093/brain/aws285; Shian W J, 1994, Zhonghua Yi Xue Za Zhi (Taipei), V53, P154; Triulzi F, 2006, PEDIATR RADIOL, V36, P608, DOI 10.1007/s00247-006-0203-5; Triulzi F, 2001, Magn Reson Imaging Clin N Am, V9, P57; van Laerhoven H, 2013, PEDIATRICS, V131, P88, DOI 10.1542/peds.2012-1297; Wallin A, 2012, J NEUROL SCI, V322, P192, DOI 10.1016/j.jns.2012.07.068; Xinling Hou CZ, 2009, J PEKING U MED, P42; YJ W, 2005, DEV MODERN NEURAL PA, P35; Zhang L, 2012, NEUROTOX RES, V22, P280, DOI 10.1007/s12640-012-9312-0	18	9	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83589	10.1371/journal.pone.0083589	http://dx.doi.org/10.1371/journal.pone.0083589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358300	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700064
J	Zhang, ZH; Yao, YF; Wu, WL; Feng, RL; Wu, ZX; Cun, W; Dong, SZ				Zhang, Zhihui; Yao, Yufeng; Wu, Wenlong; Feng, Ruilin; Wu, Zhongxiang; Cun, Wei; Dong, Shaozhong			Hepatitis C Virus Genotype Diversity among Intravenous Drug Users in Yunnan Province, Southwestern China	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; INFECTION; HIV	Background: Recently, high proportions (15.6%-98.7%) of intravenous drug users (IDUs) in China were found to be positive for hepatitis C virus (HCV). Yunnan Province is located in southwestern China and borders one of the world's most important opium-producing regions, thus it is an important drug trafficking route to other regions of China. Methodology/Principal Findings: Here, we assessed 100 HCV-positive plasma samples from IDUs who were enrolled through the Kunming Center for Disease Control and Prevention in 2012. HCV C/E1 fragments were PCR-amplified and sequenced. We identified eight HCV subtypes (1a, 1b, 3a, 3b, 6a, 6n, 6u and 6v), of which genotype 6 was most predominant (frequency, 47%) followed by genotypes 3 (41%) and 1 (12%). HCV subtypes 6n (30%) and 3b (29%) were most common and were identified in 59% of the IDUs. We compared HCV genotypes among IDUs in Yunnan Province with those from other regions and found that the distribution patterns of HCV genotypes in Yunnan Province were similar to those in southern China, but different from those in eastern China. However, the distribution patterns of HCV subtypes varied among Yunnan Province and southern China, despite the shared similar genotypes. A comparison of the current data with those previously reported showed that the frequency of HCV genotype 6 increased from 25% to 47% within 5 years, especially subtypes 6a (5% to 15%) and 6n (11.2% to 30%). In contrast, the frequencies of subtypes 3b and 1b decreased by almost 50% within 5 years. Conclusion/Significance: Our results provided further information to support the assertion that drug trafficking routes influence HCV transmission patterns among IDUs in Yunnan Province. The frequency of HCV genotypes and subtypes changed rapidly among IDUs in Yunnan Province and subtypes 6a and 6n may have originated in Vietnam and Myanmar, respectively.	[Zhang, Zhihui; Yao, Yufeng; Wu, Zhongxiang; Cun, Wei; Dong, Shaozhong] Chinese Acad Med Sci, Yunnan Engn Res Ctr Vaccine Res & Dev Severe Infe, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Inst Med Biol, Kunming, Yunnan, Peoples R China; [Zhang, Zhihui; Yao, Yufeng; Wu, Zhongxiang; Cun, Wei; Dong, Shaozhong] Peking Union Med Coll, Kunming, Yunnan, Peoples R China; [Wu, Wenlong; Feng, Ruilin] Kunming Ctr Dis Control & Prevent, HIV Confirmatory Lab, Kunming, Yunnan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Cun, W (corresponding author), Chinese Acad Med Sci, Yunnan Engn Res Ctr Vaccine Res & Dev Severe Infe, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Inst Med Biol, Kunming, Yunnan, Peoples R China.	cunwei@gmail.com; shaozhongdong@gmail.com	zhang, zh/GWV-4677-2022		Fundamental Research Funds for the Central Universities [2012Y08]; Natural Science Foundation of Yunnan Province [2013FZ138, 2013FA053]; Fundamental Research Funds for the Institute of Pathogen Biology [2013IPB201]; State Project for Essential Drug Research and Development [2012ZX09105302]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province); Fundamental Research Funds for the Institute of Pathogen Biology; State Project for Essential Drug Research and Development	This work was supported by the Fundamental Research Funds for the Central Universities (2012Y08), Natural Science Foundation of Yunnan Province (2013FZ138, 2013FA053), Fundamental Research Funds for the Institute of Pathogen Biology (2013IPB201), and State Project for Essential Drug Research and Development (2012ZX09105302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YP, 2010, CURR OPIN PSYCHIATR, V23, P187, DOI 10.1097/YCO.0b013e328338658b; Du H, 2012, J CLIN VIROL, V54, P207, DOI 10.1016/j.jcv.2012.04.017; Dunford L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041266; Fu YSH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047324, 10.1371/journal.pone.0028006]; Garten RJ, 2004, INT J EPIDEMIOL, V33, P182, DOI 10.1093/ije/dyh019; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Liu JY, 2008, CLIN INFECT DIS, V46, P1761, DOI 10.1086/587992; Lwin AA, 2007, HEPATOL RES, V37, P337, DOI 10.1111/j.1872-034X.2007.00053.x; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Pybus Oliver G, 2005, Infect Genet Evol, V5, P131, DOI 10.1016/j.meegid.2004.08.001; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Sy Theodore, 2006, Int J Med Sci, V3, P41; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608; Xia XS, 2008, J MED VIROL, V80, P1142, DOI 10.1002/jmv.21204; Ye Y, 2013, ARCH VIROL, V158, P611, DOI 10.1007/s00705-012-1513-6; Zhang CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016817; Zhou YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042937	20	31	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82598	10.1371/journal.pone.0082598	http://dx.doi.org/10.1371/journal.pone.0082598			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358211	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700025
J	Zhu, LQ; Zhen, YF; Zhang, Y; Guo, ZX; Dai, J; Wang, XD				Zhu, Lun-qing; Zhen, Yun-fang; Zhang, Ya; Guo, Zhi-xiong; Dai, Jin; Wang, Xiao-dong			Salinomycin Activates AMP-Activated Protein Kinase-Dependent Autophagy in Cultured Osteoblastoma Cells: A Negative Regulator against Cell Apoptosis	PLOS ONE			English	Article							CANCER-CELLS; OXIDATIVE STRESS; GROWTH; DEATH; MTOR; PHOSPHORYLATION; OSTEOSARCOMA; DEGRADATION; INHIBITION; SURVIVAL	Background: The malignant osteoblastoma has poor prognosis, thus the search for novel and more efficient chemo-agents against this disease is urgent. Salinomycin induces broad anti-cancer effects both in vivo and in vitro, however, its role in osteoblastoma is still not clear. Key Findings: Salinomycin induced both apoptosis and autophagy in cultured U2OS and MG-63 osteoblastoma cells. Inhibition of autophagy by 3-methyladenine (3-MA), or by RNA interference (RNAi) of light chain 3B (LC3B), enhanced salinomycin-induced cytotoxicity and apoptosis. Salinomycin induced a profound AMP-activated protein kinase (AMPK) activation, which was required for autophagy induction. AMPK inhibition by compound C, or by AMPK alpha RNAi prevented salinomycin-induced autophagy activation, while facilitating cancer cell death and apoptosis. On the other hand, the AMPK agonist AICAR promoted autophagy activation in U2OS cells. Salinomycin-induced AMPK activation was dependent on reactive oxygen species (ROS) production in osteoblastoma cells. Antioxidant n-acetyl cysteine (NAC) significantly inhibited salinomycin-induced AMPK activation and autophagy induction. Conclusions: Salinomycin activates AMPK-dependent autophagy in osteoblastoma cells, which serves as a negative regulator against cell apoptosis. AMPK-autophagy inhibition might be a novel strategy to sensitize salinomycin's effect in cancer cells.	[Zhu, Lun-qing; Zhen, Yun-fang; Zhang, Ya; Guo, Zhi-xiong; Dai, Jin; Wang, Xiao-dong] Soochow Univ, Childrens Hosp, Ctr Diag & Treatment Childrens Bone Dis, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Zhen, YF (corresponding author), Soochow Univ, Childrens Hosp, Ctr Diag & Treatment Childrens Bone Dis, Suzhou, Jiangsu, Peoples R China.	orthowxd@hotmail.com; xiaodongwangsz@163.com			Suzhou Science and Technology Bureau, China [874531]	Suzhou Science and Technology Bureau, China	This study is supported by fund from Suzhou Science and Technology Bureau (874531), China (http://kjxm.szkj.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Chen MB, 2012, INT J CANC; Chen MB, 2011, J CELL PHYSIOL, V226, P1915, DOI 10.1002/jcp.22522; Chen ZY, 2013, MOL CELL BIOCHEM, V377, P35, DOI 10.1007/s11010-013-1568-z; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Fuchs D, 2010, BIOCHEM BIOPH RES CO, V394, P1098, DOI 10.1016/j.bbrc.2010.03.138; Galluzzi L, 2008, CURR MOL MED, V8, P78; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Ham SJ, 1998, EUR J SURG ONCOL, V24, P584, DOI 10.1016/S0748-7983(98)93896-3; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jangamreddy JR, 2013, BBA-MOL CELL RES, V1833, P2057, DOI 10.1016/j.bbamcr.2013.04.011; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Ji C, 2012, CELL SIGNAL, V24, P1781, DOI 10.1016/j.cellsig.2012.05.003; Kang MR, 2012, ONCOL REP, V27, P1407, DOI 10.3892/or.2012.1644; Ketola K, 2012, BRIT J CANCER, V106, P99, DOI 10.1038/bjc.2011.530; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim JH, 2011, BRIT J PHARMACOL, V162, P773, DOI 10.1111/j.1476-5381.2010.01089.x; Kim KY, 2011, BIOCHEM BIOPH RES CO, V413, P80, DOI 10.1016/j.bbrc.2011.08.054; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Lee HM, 2011, J IMMUNOL, V186, P1248, DOI 10.4049/jimmunol.1001954; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Li TL, 2013, AUTOPHAGY, V9, P1057, DOI 10.4161/auto.24632; Lu DS, 2011, P NATL ACAD SCI USA, V108, P13253, DOI 10.1073/pnas.1110431108; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Michaelson MD, 2005, J CLIN ONCOL, V23, P8219, DOI 10.1200/JCO.2005.02.9579; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moscat J, 2011, CELL, V147, P724, DOI 10.1016/j.cell.2011.10.021; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Nezis IP, 2012, ANTIOXID REDOX SIGN, V17, P786, DOI 10.1089/ars.2011.4394; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Riccioni R, 2010, BLOOD CELL MOL DIS, V45, P86, DOI 10.1016/j.bcmd.2010.03.008; Sakoda H, 2002, AM J PHYSIOL-ENDOC M, V282, pE1239, DOI 10.1152/ajpendo.00455.2001; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; TSUBOI R, 1993, J INVEST DERMATOL, V101, P49, DOI 10.1111/1523-1747.ep12358892; Verdoodt B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044132; Vicencio JM, 2008, GERONTOLOGY, V54, P92, DOI 10.1159/000129697; Wang SB, 2012, CLIN SCI, V122, P555, DOI 10.1042/CS20110625; Yao C, 2013, CELL BIOCHEM BIOPHYS, V65, P217, DOI 10.1007/s12013-012-9423-5; Yao C, 2012, MOL ONCOL, V6, P392, DOI 10.1016/j.molonc.2012.04.002; Zardawi SJ, 2009, HISTOL HISTOPATHOL, V24, P385, DOI 10.14670/HH-24.385; Zheng QY, 2012, BIOCHEM BIOPH RES CO, V419, P741, DOI 10.1016/j.bbrc.2012.02.093	52	44	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84175	10.1371/journal.pone.0084175	http://dx.doi.org/10.1371/journal.pone.0084175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358342	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700085
J	Sun, XQ; Pang, H; Li, MM; Peng, B; Guo, HS; Yan, QQ; Hang, YY				Sun, Xiaoqin; Pang, Hui; Li, Mimi; Peng, Bin; Guo, Haisong; Yan, Qinqin; Hang, Yueyu			Evolutionary Pattern of the FAE1 Gene in Brassicaceae and Its Correlation with the Erucic Acid Trait	PLOS ONE			English	Article							KETOACYL-COA SYNTHASE; FUNCTIONAL-CHARACTERIZATION; PHYLOGENY; BIOCHEMISTRY; COMPLEMENTS; MUTATION; CLONING; PLANTS; LOCUS; OIL	The fatty acid elongase 1 (FAE1) gene catalyzes the initial condensation step in the elongation pathway of VLCFA (very long chain fatty acid) biosynthesis and is thus a key gene in erucic acid biosynthesis. Based on a worldwide collection of 62 accessions representing 14 tribes, 31 genera, 51 species, 4 subspecies and 7 varieties, we conducted a phylogenetic reconstruction and correlation analysis between genetic variations in the FAE1 gene and the erucic acid trait, attempting to gain insight into the evolutionary patterns and the correlations between genetic variations in FAE1 and trait variations. The five clear, deeply diverged clades detected in the phylogenetic reconstruction are largely congruent with a previous multiple gene-derived phylogeny. The Ka/Ks ratio (< 1) and overall low level of nucleotide diversity in the FAE1 gene suggest that purifying selection is the major evolutionary force acting on this gene. Sequence variations in FAE1 show a strong correlation with the content of erucic acid in seeds, suggesting a causal link between the two. Furthermore, we detected 16 mutations that were fixed between the low and high phenotypes of the FAE1 gene, which constitute candidate active sites in this gene for altering the content of erucic acid in seeds. Our findings begin to shed light on the evolutionary pattern of this important gene and represent the first step in elucidating how the sequence variations impact the production of erucic acid in plants.	Chinese Acad Sci, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences		hangyueyu@gmail.com			Jiangsu Provincial Natural Science Foundation of China [BK2010476]; Funds of Jiangsu Province Key Laboratory for Plant Ex Situ Conservation [QIAN201202]	Jiangsu Provincial Natural Science Foundation of China(Natural Science Foundation of Jiangsu Province); Funds of Jiangsu Province Key Laboratory for Plant Ex Situ Conservation	This work was supported by Jiangsu Provincial Natural Science Foundation of China (Grant No. BK2010476) and Funds of Jiangsu Province Key Laboratory for Plant Ex Situ Conservation (Grant No. QIAN201202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Al-Shehbaz IA, 2012, TAXON, V61, P931, DOI 10.1002/tax.615002; Bailey CD, 2006, MOL BIOL EVOL, V23, P2142, DOI 10.1093/molbev/msl087; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barret P, 1998, THEOR APPL GENET, V96, P177, DOI 10.1007/s001220050725; Beilstein MA, 2006, AM J BOT, V93, P607, DOI 10.3732/ajb.93.4.607; Beilstein MA, 2008, AM J BOT, V95, P1307, DOI 10.3732/ajb.0800065; Carmona-Antonanzas G, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-85; Couvreur TLP, 2010, MOL BIOL EVOL, V27, P55, DOI 10.1093/molbev/msp202; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Ding J, 2007, GENETICA, V129, P235, DOI 10.1007/s10709-006-0002-9; Fourmann M, 1998, THEOR APPL GENET, V96, P852, DOI 10.1007/s001220050812; Franzke A, 2011, TRENDS PLANT SCI, V16, P108, DOI 10.1016/j.tplants.2010.11.005; Franzke A, 2009, TAXON, V58, P425, DOI 10.1002/tax.582009; Ghanevati M, 2002, EUR J BIOCHEM, V269, P3531, DOI 10.1046/j.1432-1033.2002.03039.x; Ghanevati M, 2001, BBA-MOL CELL BIOL L, V1530, P77, DOI 10.1016/S1388-1981(00)00168-2; Han JX, 2001, PLANT MOL BIOL, V46, P229, DOI 10.1023/A:1010665121980; HUDSON RR, 1992, GENETICS, V132, P583; Hutcheon C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-233; JAMES DW, 1995, PLANT CELL, V7, P309, DOI 10.2307/3869853; Katavic V, 2002, EUR J BIOCHEM, V269, P5625, DOI 10.1046/j.1432-1033.2002.03270.x; Koch MA, 2007, MOL BIOL EVOL, V24, P63, DOI 10.1093/molbev/msl130; KUMAR PR, 1978, J AM OIL CHEM SOC, V55, P320, DOI 10.1007/BF02669920; Lassner MW, 1996, PLANT CELL, V8, P281, DOI 10.1105/tpc.8.2.281; LYNCH DV, 1993, PLANT PHYSIOL, V103, P1421, DOI 10.1104/pp.103.4.1421; Mandal S, 2002, GENET RESOUR CROP EV, V49, P551, DOI 10.1023/A:1021210800414; Merrill AH, 1997, TOXICOL APPL PHARM, V142, P208, DOI 10.1006/taap.1996.8029; Mietkiewska E, 2007, PLANT SCI, V173, P198, DOI 10.1016/j.plantsci.2007.05.001; Mietkiewska E, 2007, PLANT BIOTECHNOL J, V5, P636, DOI 10.1111/j.1467-7652.2007.00268.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Pang Hui, 2013, Journal of Plant Resources and Environment, V22, P8; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; PostBeittenmiller D, 1996, ANNU REV PLANT PHYS, V47, P405, DOI 10.1146/annurev.arplant.47.1.405; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roscoe TJ, 2001, FEBS LETT, V492, P107, DOI 10.1016/S0014-5793(01)02243-8; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schulz O.E., 1936, NATURLICHEN PFLANZEN, V17B, P227; Sun XiaoQin, 2011, Chemistry and Industry of Forest Products, V31, P46; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Velasco L, 1998, GENET RESOUR CROP EV, V45, P371, DOI 10.1023/A:1008628624867; Wang NA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-137; Warwick SI, 2006, PLANT SYST EVOL, V259, P237, DOI 10.1007/s00606-006-0421-1; Warwick SI., 1997, OPERA BOT, V132, P159; Warwick SI, 2010, PLANT SYST EVOL, V285, P209, DOI 10.1007/s00606-010-0271-8; Wu G, 2008, THEOR APPL GENET, V116, P491, DOI 10.1007/s00122-007-0685-z; Wu YuHua, 2009, Scientia Agricultura Sinica, V42, P3819; [No title captured]	47	10	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83535	10.1371/journal.pone.0083535	http://dx.doi.org/10.1371/journal.pone.0083535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358289	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700128
J	Tammaro, A; Stroo, I; Rampanelli, E; Blank, F; Butter, LM; Claessen, N; Takai, T; Colonna, M; Leemans, JC; Florquin, S; Dessing, MC				Tammaro, Alessandra; Stroo, Ingrid; Rampanelli, Elena; Blank, Froilan; Butter, Loes M.; Claessen, Nike; Takai, Toshiyuki; Colonna, Marco; Leemans, Jaklien C.; Florquin, Sandrine; Dessing, Mark C.			Role of TREM1-DAP12 in Renal Inflammation during Obstructive Nephropathy	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PATHWAY MODULATION; TUBULAR DAMAGE; MESSENGER-RNA; MYELOID CELLS; TREM-1; FIBROSIS; EXPRESSION; MECHANISMS; DEGENERATION	Tubulo-interstitial damage is a common finding in the chronically diseased kidney and is characterized by ongoing inflammation and fibrosis leading to renal dysfunction and end-stage renal disease. Upon kidney injury, endogenous ligands can be released which are recognized by innate immune sensors to alarm innate immune system. A new family of innate sensors is the family of TREM (triggering receptor expressed on myeloid cell). TREM1 is an activating receptor and requires association with transmembrane adapter molecule DAP12 (DNAX-associated protein 12) for cell signaling. TREM1-DAP12 pathway has a cross-talk with intracellular signaling pathways of several Toll-like receptors (TLRs) and is able to amplify TLR signaling and thereby contributes to the magnitude of inflammation. So far, several studies have shown that TLRs play a role in obstructive nephropathy but the contribution of TREM1-DAP12 herein is unknown. Therefore, we studied TREM1 expression in human and murine progressive renal diseases and further investigated the role for TREM1-DAP12 by subjecting wild-type (WT), TREM1/3 double KO and DAP12 KO mice to murine unilateral ureter obstruction (UUO) model. In patients with hydronephrosis, TREM1 positive cells were observed in renal tissue. We showed that in kidneys from WT mice, DAP12 mRNA and TREM1 mRNA and protein levels were elevated upon UUO. Compared to WT mice, DAP12 KO mice displayed less renal MCP-1, KC and TGF-beta 1 levels and less influx of macrophages during progression of UUO, whereas TREM1/3 double KO mice displayed less renal MCP-1 level. Renal fibrosis was comparable in WT, TREM1/3 double KO and DAP12 KO mice. We conclude that DAP12, partly through TREM1/3, is involved in renal inflammation during progression of UUO.	[Tammaro, Alessandra; Stroo, Ingrid; Rampanelli, Elena; Blank, Froilan; Butter, Loes M.; Claessen, Nike; Leemans, Jaklien C.; Florquin, Sandrine; Dessing, Mark C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Takai, Toshiyuki] Tohoku Univ, Dept Expt Immunol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Florquin, Sandrine] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Tohoku University; Washington University (WUSTL); Radboud University Nijmegen	Dessing, MC (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	m.c.dessing@amc.uva.nl	Leemans, Jaklien/AAM-4958-2020; Rampanelli, Elena/AAJ-9119-2020	Rampanelli, Elena/0000-0002-7742-0092; Colonna, Marco/0000-0001-5222-4987; Tammaro, Alessandra/0000-0003-3128-5259; Florquin, Sandrine/0000-0002-9676-1722	Dutch Kidney Foundation [C08.2274]	Dutch Kidney Foundation	The Dutch Kidney Foundation funded the study (C08.2274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; Arts RJW, 2011, EUR CYTOKINE NETW, V22, P11, DOI 10.1684/ecn.2011.0274; Banerjee A, 2010, INFECT IMMUN, V78, P1353, DOI 10.1128/IAI.00969-09; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Braga TT, 2012, MOL MED, V18, P1231, DOI 10.2119/molmed.2012.00131; Cetin S, 2004, J BIOL CHEM, V279, P24592, DOI 10.1074/jbc.M313620200; Chen LC, 2008, EXP MOL PATHOL, V84, P145, DOI 10.1016/j.yexmp.2007.11.004; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Cheung R, 2011, J CLIN INVEST, V121, P4446, DOI 10.1172/JCI57682; Chevalier RL, 2010, PEDIATR NEPHROL, V25, P687, DOI 10.1007/s00467-009-1316-5; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Colonna M, 2003, J INFECT DIS, V187, pS397, DOI 10.1086/374754; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Correa-Costa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029004; El Mezayen R, 2007, IMMUNOL LETT, V111, P36, DOI 10.1016/j.imlet.2007.04.011; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Gibot S, 2008, CRIT CARE MED, V36, P504, DOI 10.1097/01.CCM.0B013E318161FAF3; Gibot S, 2009, SHOCK, V32, P633, DOI 10.1097/SHK.0b013e3181a53842; Gluba A, 2010, NAT REV NEPHROL, V6, P224, DOI 10.1038/nrneph.2010.16; Hyder LA, 2013, J INVEST DERMATOL, V133, P1742, DOI 10.1038/jid.2013.68; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kamei K, 2010, J HEPATO-BIL-PAN SCI, V17, P305, DOI 10.1007/s00534-009-0191-6; Klesney-Tait J, 2013, J CLIN INVEST, V123, P138, DOI 10.1172/JCI64181; Koth LL, 2010, J IMMUNOL, V184, P6522, DOI 10.4049/jimmunol.0901171; Kumagai N, 2005, INVEST OPHTH VIS SCI, V46, P114, DOI 10.1167/iovs.04-0922; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Lech M, 2012, INT J MOL SCI, V13, P10113, DOI 10.3390/ijms130810113; Leemans JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005704; Matesanz-Isabel J, 2011, IMMUNOL LETT, V134, P104, DOI 10.1016/j.imlet.2010.09.019; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Ornatowska M, 2007, AM J PHYSIOL-LUNG C, V293, pL1377, DOI 10.1152/ajplung.00140.2007; Pulskens WP, 2010, J AM SOC NEPHROL, V21, P1299, DOI 10.1681/ASN.2009070722; Ramaiah SKV, 2013, INT J MOL SCI, V14, P13213, DOI 10.3390/ijms140713213; Rigo I, 2012, INNATE IMMUN-LONDON, V18, P250, DOI 10.1177/1753425911399796; Rouschop KMA, 2006, J AM SOC NEPHROL, V17, P746, DOI 10.1681/ASN.2005080808; Rouschop KMA, 2004, J AM SOC NEPHROL, V15, P674, DOI 10.1097/01.ASN.0000115703.30835.96; Sawa Y, 2008, J HISTOCHEM CYTOCHEM, V56, P97, DOI 10.1369/jhc.7A7299.2007; Scholten EM, 2006, J AM SOC NEPHROL, V17, P2622, DOI 10.1681/ASN.2006030227; Sharif O, 2008, IMMUNOBIOLOGY, V213, P701, DOI 10.1016/j.imbio.2008.07.008; Stokman G, 2008, NEPHROL DIAL TRANSPL, V23, P483, DOI 10.1093/ndt/gfm607; Takamiya R, 2013, GLYCOBIOLOGY, V23, P178, DOI 10.1093/glycob/cws139; Wang SJ, 2010, DIS MODEL MECH, V3, P92, DOI 10.1242/dmm.003533; Wu J, 2012, CANCER RES, V72, P3977, DOI 10.1158/0008-5472.CAN-12-0938; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yamanishi Y, 2012, J IMMUNOL, V189, P1773, DOI 10.4049/jimmunol.1201139; Yamanishi Y, 2010, J EXP MED, V207, P1501, DOI 10.1084/jem.20090581; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhang JQ, 2006, BLOOD, V107, P3600, DOI 10.1182/blood-2005-09-3842	50	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82498	10.1371/journal.pone.0082498	http://dx.doi.org/10.1371/journal.pone.0082498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358193	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700072
J	Tatsumi, K; Sugimoto, M; Lillicrap, D; Shima, M; Ohashi, K; Okano, T; Matsui, H				Tatsumi, Kohei; Sugimoto, Mitsuhiko; Lillicrap, David; Shima, Midori; Ohashi, Kazuo; Okano, Teruo; Matsui, Hideto			A Novel Cell-Sheet Technology That Achieves Durable Factor VIII Delivery in a Mouse Model of Hemophilia A	PLOS ONE			English	Article							AAV-FACTOR-IX; GENE-THERAPY; TISSUES; RECONSTRUCTION; PROLIFERATION; EXPRESSION; TOXICITY; VECTORS; MUSCLE; LIVER	Gene- or cell-based therapies aimed at creating delivery systems for coagulation factor VIII (FVIII) protein have emerged as promising options for hemophilia A treatment. However, several issues remain to be addressed regarding the efficacies and adverse events of these new classes of therapies. To improve an existing cell-based therapy involving the subcutaneous transplantation of FVIII-transduced blood outgrowth endothelial cells (BOECs), we employed a novel cell-sheet technology that allows individual dispersed cells to form a thin and contiguous monolayer without traditional bioabsorbable scaffold matrices. Compared to the traditional methodology, our cell-sheet approach resulted in longer-term and 3-5-fold higher expression of FVIII (up to 11% of normal) in recipient hemophilia A mice that lacked a FVIII humoral immune response due to transient immunosuppression with cyclophosphamide. Histological studies revealed that the transplanted BOEC sheets were structured as flat clusters, supporting the long-term expression of therapeutic FVIII in plasma from an ectopic subcutaneous space. Our novel tissue-engineering approach using genetically modified BOEC sheets could aid in development of cell-based therapy that will allow safe and effective in vivo delivery of functional FVIII protein in patients with hemophilia A.	[Tatsumi, Kohei; Ohashi, Kazuo; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Sugimoto, Mitsuhiko; Matsui, Hideto] Nara Med Univ, Dept Regulatory Med Thrombosis, Kashihara, Nara 634, Japan; [Lillicrap, David] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Shima, Midori] Nara Med Univ, Dept Pediat, Kashihara, Nara 634, Japan	Tokyo Women's Medical University; Nara Medical University; McMaster University; Queens University - Canada; Nara Medical University	Sugimoto, M (corresponding author), Nara Med Univ, Dept Regulatory Med Thrombosis, Kashihara, Nara 634, Japan.	sugi-ped@naramed-u.ac.jp; hide-ped@naramed-u.ac.jp		Okano, Teruo/0000-0002-4470-9842	Program for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas in the Project for Developing Innovation Systems "Cell-Sheet Tissue-Engineering Center (CSTEC)''; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Bayer Hemophilia Awards Program	Program for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas in the Project for Developing Innovation Systems "Cell-Sheet Tissue-Engineering Center (CSTEC)''; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bayer Hemophilia Awards Program	This work was supported by the Program for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas in the Project for Developing Innovation Systems "Cell-Sheet Tissue-Engineering Center (CSTEC)'' (K.O. and T.O.); a Grant-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) (H. M.); and the Bayer Hemophilia Awards Program (H. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2007, J NANOSCI NANOTECHNO, V7, P796, DOI 10.1166/jnn.2007.509; Arruda VR, 2010, BLOOD, V115, P4678, DOI 10.1182/blood-2009-12-261156; BI L, 1995, NAT GENET, V10, P119, DOI 10.1038/ng0595-119; Brown BD, 2004, BLOOD, V103, P804, DOI 10.1182/blood-2003-05-1426; Chuah MKL, 2004, SEMIN THROMB HEMOST, V30, P249, DOI 10.1055/s-2004-825638; Chuah MKL, 2003, BLOOD, V101, P1734, DOI 10.1182/blood-2002-03-0823; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Haurigot V, 2010, MOL THER, V18, P1318, DOI 10.1038/mt.2010.73; Iwata T, 2010, J CLIN PERIODONTOL, V37, P1088, DOI 10.1111/j.1600-051X.2010.01597.x; Jiang HY, 2006, BLOOD, V108, P107, DOI 10.1182/blood-2005-12-5115; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P612; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Matsui H, 2007, STEM CELLS, V25, P2660, DOI 10.1634/stemcells.2006-0699; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576; Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Powell JS, 2003, BLOOD, V102, P2038, DOI 10.1182/blood-2003-01-0167; Roth DA, 2001, NEW ENGL J MED, V344, P1735, DOI 10.1056/NEJM200106073442301; Sabatino DE, 2011, MOL THER, V19, P442, DOI 10.1038/mt.2010.240; Saito T, 2011, TRANSPLANTATION, V92, P1231, DOI 10.1097/TP.0b013e3182375835; Sawa Y, 2012, SURG TODAY, V42, P181, DOI 10.1007/s00595-011-0106-4; Thakur A, 2010, J BIOMED MATER RES B, V94B, P296, DOI 10.1002/jbm.b.31648; Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052; Yokoyama T, 2006, AM J TRANSPLANT, V6, P50, DOI 10.1111/j.1600-6143.2005.01155.x	28	21	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83280	10.1371/journal.pone.0083280	http://dx.doi.org/10.1371/journal.pone.0083280			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358271	gold, Green Submitted, Green Published			2022-12-27	WOS:000328735700114
J	Yi, ZL; Su, XY; Revindran, V; Mackie, RI; Cann, I				Yi, Zhuolin; Su, Xiaoyun; Revindran, Vanessa; Mackie, Roderick I.; Cann, Isaac			Molecular and Biochemical Analyses of CbCel9A/Cel48A, a Highly Secreted Multi-Modular Cellulase by Caldicellulosiruptor bescii during Growth on Crystalline Cellulose	PLOS ONE			English	Article							PROCESSIVE ENDOCELLULASE CELF; FREE QUANTITATIVE PROTEOMICS; CLOSTRIDIUM-CELLULOLYTICUM; GLYCOSIDE HYDROLASE; ANAEROCELLUM-THERMOPHILUM; PLANT BIOMASS; FAMILY 48; ENDOGLUCANASE; THERMOCELLUM; GENE	During growth on crystalline cellulose, the thermophilic bacterium Caldicellulosiruptor bescii secretes several cellulose-degrading enzymes. Among these enzymes is CelA (CbCel9A/Cel48A), which is reported as the most highly secreted cellulolytic enzyme in this bacterium. CbCel9A/Cel48A is a large multi-modular polypeptide, composed of an N-terminal catalytic glycoside hydrolase family 9 (GH9) module and a C-terminal GH48 catalytic module that are separated by a family 3c carbohydrate-binding module (CBM3c) and two identical CBM3bs. The wild-type CbCel9A/Cel48A and its truncational mutants were expressed in Bacillus megaterium and Escherichia coli, respectively. The wild-type polypeptide released twice the amount of glucose equivalents from Avicel than its truncational mutant that lacks the GH48 catalytic module. The truncational mutant harboring the GH9 module and the CBM3c was more thermostable than the wild-type protein, likely due to its compact structure. The main hydrolytic activity was present in the GH9 catalytic module, while the truncational mutant containing the GH48 module and the three CBMs was ineffective in degradation of either crystalline or amorphous cellulose. Interestingly, the GH9 and/or GH48 catalytic modules containing the CBM3bs form low-density particles during hydrolysis of crystalline cellulose. Moreover, TM3 (GH9/CBM3c) and TM2 (GH48 with three CBM3 modules) synergistically hydrolyze crystalline cellulose. Deletion of the CBM3bs or mutations that compromised their binding activity suggested that these CBMs are important during hydrolysis of crystalline cellulose. In agreement with this observation, seven of nine genes in a C. bescii gene cluster predicted to encode cellulose-degrading enzymes harbor CBM3bs. Based on our results, we hypothesize that C. bescii uses the GH48 module and the CBM3bs in CbCel9A/Cel48A to destabilize certain regions of crystalline cellulose for attack by the highly active GH9 module and other endoglucanases produced by this hyperthermophilic bacterium.	[Yi, Zhuolin; Su, Xiaoyun; Revindran, Vanessa; Mackie, Roderick I.; Cann, Isaac] Univ Illinois, Energy Biosci Inst, Urbana, IL USA; [Yi, Zhuolin; Su, Xiaoyun; Revindran, Vanessa; Mackie, Roderick I.; Cann, Isaac] Univ Illinois, Inst Genom Biol, Urbana, IL USA; [Mackie, Roderick I.; Cann, Isaac] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Cann, Isaac] Univ Illinois, Dept Microbiol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cann, I (corresponding author), Univ Illinois, Energy Biosci Inst, Urbana, IL USA.	icann@illinois.edu			Energy Biosciences Institute, Discovery and Characterization of Hydrolytic Enzymes	Energy Biosciences Institute, Discovery and Characterization of Hydrolytic Enzymes	This work was funded by the Energy Biosciences Institute, Discovery and Characterization of Hydrolytic Enzymes to Improve Biocatalysis and Conversion of Plant Cell Wall Polysaccharides to Biofuels Program at the University of Illinois, Urbana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Berger E, 2007, FEMS MICROBIOL LETT, V268, P194, DOI 10.1111/j.1574-6968.2006.00583.x; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blumer-Schuette SE, 2010, APPL ENVIRON MICROB, V76, P8084, DOI 10.1128/AEM.01400-10; BRONNENMEIER K, 1991, EUR J BIOCHEM, V200, P379, DOI 10.1111/j.1432-1033.1991.tb16195.x; Bronnenmeier K, 1997, MICROBIOL-SGM, V143, P891, DOI 10.1099/00221287-143-3-891; Burstein T, 2009, FEBS LETT, V583, P879, DOI 10.1016/j.febslet.2009.02.013; Chiriac AI, 2010, APPL MICROBIOL BIOT, V86, P1125, DOI 10.1007/s00253-009-2350-8; Dam P, 2011, NUCLEIC ACIDS RES, V39, P3240, DOI 10.1093/nar/gkq1281; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Dodd D, 2010, J BACTERIOL, V192, P2335, DOI 10.1128/JB.01654-09; Fujita K, 2006, BIOCHEM BIOPH RES CO, V345, P502, DOI 10.1016/j.bbrc.2006.04.126; Gal L, 1997, J BACTERIOL, V179, P6595, DOI 10.1128/jb.179.21.6595-6601.1997; Gilad R, 2003, J BACTERIOL, V185, P391, DOI 10.1128/JB.185.2.391-398.2003; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Guimaraes BG, 2002, J MOL BIOL, V320, P587, DOI 10.1016/S0022-2836(02)00497-7; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hong J, 2007, LANGMUIR, V23, P12535, DOI 10.1021/la7025686; Iakiviak M, 2011, APPL ENVIRON MICROB, V77, P7541, DOI 10.1128/AEM.06088-11; Irwin DC, 2000, EUR J BIOCHEM, V267, P4988, DOI 10.1046/j.1432-1327.2000.01546.x; Kakiuchi M, 1998, J BACTERIOL, V180, P4303, DOI 10.1128/JB.180.16.4303-4308.1998; Kataeva IA, 2009, J BACTERIOL, V191, P3760, DOI 10.1128/JB.00256-09; KRUUS K, 1995, J BACTERIOL, V177, P1641, DOI 10.1128/jb.177.6.1641-1644.1995; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Liu CC, 1998, GENE, V211, P39, DOI 10.1016/S0378-1119(98)00081-X; Lochner A, 2011, J PROTEOME RES, V10, P5302, DOI 10.1021/pr200536j; Lochner A, 2011, APPL ENVIRON MICROB, V77, P4042, DOI 10.1128/AEM.02811-10; Mandelman D, 2003, J BACTERIOL, V185, P4127, DOI 10.1128/JB.185.14.4127-4135.2003; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5&lt;621::AID-BIT13&gt;3.0.CO;2-C; Olson DG, 2010, P NATL ACAD SCI USA, V107, P17727, DOI 10.1073/pnas.1003584107; Park S, 2009, CELLULOSE, V16, P641, DOI 10.1007/s10570-009-9321-1; Parsiegla G, 2000, BIOCHEMISTRY-US, V39, P11238, DOI 10.1021/bi001139p; Parsiegla G, 1998, EMBO J, V17, P5551, DOI 10.1093/emboj/17.19.5551; Parsiegla G, 2008, J MOL BIOL, V375, P499, DOI 10.1016/j.jmb.2007.10.039; Petkun S, 2010, ACTA CRYSTALLOGR D, V66, P33, DOI 10.1107/S0907444909043030; ReverbelLeroy C, 1997, J BACTERIOL, V179, P46, DOI 10.1128/jb.179.1.46-52.1997; Riedel K, 1998, MOL MICROBIOL, V28, P767, DOI 10.1046/j.1365-2958.1998.00834.x; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; SHEN H, 1995, BIOCHEM J, V311, P67, DOI 10.1042/bj3110067; Siddiqui MA, 1998, FEBS LETT, V434, P372, DOI 10.1016/S0014-5793(98)00998-3; Spiridonov NA, 1998, J BACTERIOL, V180, P3529, DOI 10.1128/JB.180.14.3529-3532.1998; Su XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043828; Su XY, 2012, APPL ENVIRON MICROB, V78, P2230, DOI 10.1128/AEM.06814-11; Wilson DB, 2010, P NATL ACAD SCI USA, V107, P17855, DOI 10.1073/pnas.1012746107; Yang SJ, 2010, INT J SYST EVOL MICR, V60, P2011, DOI 10.1099/ijs.0.017731-0; Yang SJ, 2009, APPL ENVIRON MICROB, V75, P4762, DOI 10.1128/AEM.00236-09; Yaniv O, 2012, ACTA CRYSTALLOGR F, V68, P8, DOI 10.1107/S174430911104807X; Ye LB, 2012, APPL ENVIRON MICROB, V78, P7048, DOI 10.1128/AEM.02009-12; Zhang XZ, 2010, APPL MICROBIOL BIOT, V86, P525, DOI 10.1007/s00253-009-2231-1; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003; Zverlov V, 1998, MICROBIOL-SGM, V144, P457, DOI 10.1099/00221287-144-2-457	52	55	58	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84172	10.1371/journal.pone.0084172	http://dx.doi.org/10.1371/journal.pone.0084172			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358340	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700155
J	Colombo, GL; Agabiti-Rosei, E; Margonato, A; Mencacci, C; Montecucco, CM; Trevisan, R				Colombo, Giorgio L.; Agabiti-Rosei, Enrico; Margonato, Alberto; Mencacci, Claudio; Montecucco, Carlo Maurizio; Trevisan, Roberto			Off-Patent Generic Medicines vs. Off-Patent Brand Medicines for Six Reference Drugs: A Retrospective Claims Data Study from Five Local Healthcare Units in the Lombardy Region of Italy	PLOS ONE			English	Article							ADHERENCE; THERAPY; STATIN; PRICE; DISCONTINUATION; SUBSTITUTION; COMPETITION; IMPACT; RATES; COST	The scientific documentation supporting the potential clinical and economic benefits of a growing use of off-patent generic drugs in clinical practice seems to be limited in Italy as yet. Methods: We compared differences in outcomes between off-patent generic drugs and off-patent brand drugs in real clinical practice. The outcomes were: persistence and compliance with therapy, mortality, and other health resources consumption (hospitalizations, specialist examinations, other drugs) and total costs. Retrospective analysis was carried out by using the administrative databases of five Local Healthcare Units (ASLs - Aziende Sanitarie Locali) in the Lombardy Region of Italy. Data from the five ASLs were aggregated through a meta-analysis, which produced an estimate indicator of the mean or percentage difference between the two groups (branded vs. generic) and their respective significance tests. The therapeutic areas and studied drugs were: diabetes: metformin - A10BA02; hypertension: amlodipine - C08CA01; dyslipidemia: simvastatin - C10AA01; psychiatry: sertraline - N06AB06; cardiology: propafenone - C01BC03; osteoporosis: alendronate - M05BA04. Results: The 5 Local Healthcare Units (ASL) represent a population of 3,847,004 inhabitants. The selected sample included 347,073 patients, or 9.02% of the total ASL population; 67% of the patients were treated with off-patent brand drugs. The average age was 68 years, with no difference between the two groups. After 34 months of observation, compliance and persistence were in favor to generic drugs in all therapeutic areas and statistically significant in the metformin, amlodipine, simvastatin, and sertraline groups. The clinical outcomes (hospitalizations, mortality, and other health costs) show no statistically significant differences between off-patent generic vs. off-patent brand medicines. Conclusions: Off-patent generic drugs appear to be a therapy option of choice in Italy as well, based on clinical outcomes and economic consequences, both for the National Health Service and patients, considering that the price difference between brand and generic drugs is completely charged on patients.	[Colombo, Giorgio L.] Univ Pavia, Dept Drug Sci, I-27100 Pavia, Italy; [Colombo, Giorgio L.] SAVE Anal Valutaz Econ, Milan, Italy; [Agabiti-Rosei, Enrico] Spedali Civil Brescia, Div Med & Surg, I-25125 Brescia, Italy; [Margonato, Alberto] San Raffaele Univ Hosp, Div Cardiol, Milan, Italy; [Mencacci, Claudio] AO Fatebenefratelli & Oftalm, Dept Neurosci, Milan, Italy; [Montecucco, Carlo Maurizio] Univ Pavia, Div Rheumatol, IRCCS Policlin S Matteo, I-27100 Pavia, Italy; [Trevisan, Roberto] Osped Riuniti Bergamo, Unit Diabetol, I-24100 Bergamo, Italy	University of Pavia; Hospital Spedali Civili Brescia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Fondazione San Matteo; University of Pavia; Ospedali Riuniti di Bergamo	Colombo, GL (corresponding author), Univ Pavia, Dept Drug Sci, Via Palestro 3, I-27100 Pavia, Italy.	giorgio.colombo@unipv.it	MARGONATO, ALBERTO/B-4185-2015; TREVISAN, ROBERTO/Q-8706-2016; MONTECUCCO, CARLOMAURIZIO/K-5236-2018	TREVISAN, ROBERTO/0000-0003-0420-4468; MONTECUCCO, CARLOMAURIZIO/0000-0001-8263-3925	DOC Generici, Milan (Italy)	DOC Generici, Milan (Italy)	This work was supported by a DOC Generici, Milan (Italy), non-discretionary educational grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens W, 2007, PHARMACOEPIDEM DR S, V16, P1298, DOI 10.1002/pds.1494; AIFA Italian Medicines Agency - Gruppo di lavoro OSMED L'uso dei farmaci in Italia, 2012, RAPP OSMED GENN SETT; Aronica A, 2011, CLINICOECONOMICS ITA, V6, P15; Atar D, 2009, ANN MED, V41, P242, DOI 10.1080/07853890902729786; Borenstein M., 2009, INTRO METAANALYSIS; Caetano PA, 2006, CLIN THER, V28, P1411, DOI 10.1016/j.clinthera.2006.09.021; Catapano AL, 2010, CARE, V6, P33; Cerra C, 2004, PHARMACOECONOMICS IT, V6, P141, DOI DOI 10.1007/BF03320632; Colombo GL, 2012, PATIENT PREFER ADHER, V6, P653, DOI 10.2147/PPA.S33968; CRAMER JA, 1995, AM J HEALTH-SYST PH, V52, pS27, DOI 10.1093/ajhp/52.14_Suppl_3.S27; Davit BM, 2009, ANN PHARMACOTHER, V43, P1583, DOI 10.1345/aph.1M141; DiMatteo MR, 2002, MED CARE, V40, P794, DOI 10.1097/01.MLR.0000024612.61915.2D; Dylst P, 2011, PHARMACOECONOMICS, V29, P875, DOI 10.2165/11585970-000000000-00000; Ellis JJ, 2004, J GEN INTERN MED, V19, P638, DOI 10.1111/j.1525-1497.2004.30516.x; Hess LM, 2006, ANN PHARMACOTHER, V40, P1280, DOI 10.1345/aph.1H018; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Lexchin J, 2004, HEALTH POLICY, V68, P47, DOI 10.1016/j.healthpol.2003.07.007; Mazzaglia G, 2009, CIRCULATION, V120, P1598, DOI 10.1161/CIRCULATIONAHA.108.830299; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Peters JR, 2009, DERMATOL THER, V22, P229, DOI 10.1111/j.1529-8019.2009.01236.x; Puig-Junoy J, 2010, PHARMACOECONOMICS, V28, P649, DOI 10.2165/11535360-000000000-00000; Roblin DW, 2005, MED CARE, V43, P951, DOI 10.1097/01.mlr.0000178216.23514.b7; Ruggeri I, 2012, CLINICOECONOMIC OUTC, V4, P375, DOI 10.2147/CEOR.S36499; SabatU E., 2003, ADHERENCE LONG TERM; Shrank WH, 2006, ARCH INTERN MED, V166, P332, DOI 10.1001/archinte.166.3.332; Simoens S, 2007, CURR MED RES OPIN, V23, P2647, DOI 10.1185/030079907X233395; Simoens Steven, 2008, J Med Econ, V11, P171, DOI 10.3111/13696990801939716; Van Wijk BLG, 2006, ANN PHARMACOTHER, V40, P15, DOI 10.1345/aph.1G163; Vlahiotis A, 2011, J MANAGE CARE PHARM, V17, P123; WHO, WORLD HLTH REP HLTH	31	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82990	10.1371/journal.pone.0082990	http://dx.doi.org/10.1371/journal.pone.0082990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367576	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300087
J	Corona, G; Giuliani, C; Parenti, G; Norello, D; Verbalis, JG; Forti, G; Maggi, M; Peri, A				Corona, Giovanni; Giuliani, Corinna; Parenti, Gabriele; Norello, Dario; Verbalis, Joseph G.; Forti, Gianni; Maggi, Mario; Peri, Alessandro			Moderate Hyponatremia Is Associated with Increased Risk of Mortality: Evidence from a Meta-Analysis	PLOS ONE			English	Article							SERUM SODIUM CONCENTRATION; UNIT-ACQUIRED HYPONATREMIA; WORSENING HEART-FAILURE; IN-HOSPITAL MORTALITY; CLINICAL-OUTCOMES; PROGNOSTIC VALUE; ADMISSION HYPONATREMIA; EJECTION FRACTION; CANCER-PATIENTS; TERM MORTALITY	Background: Hyponatremia is the most common electrolyte disorder in clinical practice, and evidence to date indicates that severe hyponatremia is associated with increased morbidity and mortality. The aim of our study was to perform a meta-analysis that included the published studies that compared mortality rates in subjects with or without hyponatremia of any degree. Methods and Findings: An extensive Medline, Embase and Cochrane search was performed to retrieve the studies published up to October 1st 2012, using the following words: "hyponatremia" and "mortality". Eighty-one studies satisfied inclusion criteria encompassing a total of 850222 patients, of whom 17.4% were hyponatremic. The identification of relevant abstracts, the selection of studies and the subsequent data extraction were performed independently by two of the authors, and conflicts resolved by a third investigator. Across all 81 studies, hyponatremia was significantly associated with an increased risk of overall mortality (RR = 2.60[2.31-2.93]). Hyponatremia was also associated with an increased risk of mortality in patients with myocardial infarction (RR = 2.83[2.23-3.58]), heart failure (RR = 2.47[2.09-2.92]), cirrhosis (RR = 3.34[1.91-5.83]), pulmonary infections (RR = 2.49[1.44-4.30]), mixed diseases (RR = 2.59[1.97-3.40]), and in hospitalized patients (RR = 2.48[2.09-2.95]). A mean difference of serum [Na+] of 4.8 mmol/L was found in subjects who died compared to survivors (130.165.6 vs 134.965.1 mmol/L). A meta-regression analysis showed that the hyponatremia-related risk of overall mortality was inversely correlated with serum [Na+]. This association was confirmed in a multiple regression model after adjusting for age, gender, and diabetes mellitus as an associated morbidity. Conclusions: This meta-analysis shows for the first time that even a moderate serum [Na+] decrease is associated with an increased risk of mortality in commonly observed clinical conditions across large numbers of patients.	[Corona, Giovanni] Maggiore Bellaria Hosp, Endocrinol Unit, Bologna, Italy; [Giuliani, Corinna; Parenti, Gabriele; Norello, Dario; Forti, Gianni; Peri, Alessandro] Univ Florence, Careggi Hosp, Dept Expt & Clin Biomed Sci,Endocrine Unit, Ctr Res Transfer & High Educ Chron Inflammatory D, Florence, Italy; [Maggi, Mario] Univ Florence, Careggi Hosp, Dept Expt & Clin Biomed Sci,Androl Unit, Ctr Res Transfer & High Educ Chron Inflammatory D, Florence, Italy; [Verbalis, Joseph G.] Georgetown Univ, Div Endocrinol & Metab, Washington, DC USA	AUSL di Bologna; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Azienda Ospedaliero Universitaria Careggi; Georgetown University	Peri, A (corresponding author), Univ Florence, Careggi Hosp, Dept Expt & Clin Biomed Sci,Endocrine Unit, Ctr Res Transfer & High Educ Chron Inflammatory D, Florence, Italy.	alessandro.peri@unifi.it	Peri, Alessandro/AAR-9664-2021; Parenti, Gabriele/AAX-9932-2020; Maggi, Mario/AAB-8284-2019	MAGGI, Mario/0000-0003-3267-4221				Adewole A. D., 1996, Central African Journal of Medicine, V42, P253; Adrogue HJ, 2005, AM J NEPHROL, V25, P240, DOI 10.1159/000086019; Agarwal Indira, 2004, J Indian Med Assoc, V102, P353; ARROYO V, 1976, AM J DIG DIS, V21, P249, DOI 10.1007/BF01095898; Asadollahi K, 2007, QJM-INT J MED, V100, P501, DOI 10.1093/qjmed/hcm055; Baldasseroni S, 2011, J CARDIOVASC MED, V12, P723, DOI 10.2459/JCM.0b013e32834ae87e; Balling L, 2011, EUR J HEART FAIL, V13, P968, DOI 10.1093/eurjhf/hfr086; Barsheshet A, 2010, EUR J HEART FAIL, V12, P833, DOI 10.1093/eurjhf/hfq079; Barsony J, 2012, AGE DORDR, V35, P271; Barsony J, 2011, J BIOL CHEM, V286, P10864, DOI 10.1074/jbc.M110.155002; Berghmans T, 2000, SUPPORT CARE CANCER, V8, P192, DOI 10.1007/s005200050284; Bonney GK, 2008, TRANSPL INT, V21, P1045, DOI 10.1111/j.1432-2277.2008.00722.x; Borroni G, 2000, DIGEST LIVER DIS, V32, P605, DOI 10.1016/S1590-8658(00)80844-0; Chawla A, 2011, CLIN J AM SOC NEPHRO, V6, P960, DOI 10.2215/CJN.10101110; Chen MC, 2003, CARDIOLOGY, V100, P136, DOI 10.1159/000073931; Chuah SK, 1996, J FORMOS MED ASSOC, V95, P446; CUSANO AJ, 1990, J ACQ IMMUN DEF SYND, V3, P949; DeWolfe A, 2010, CLIN CARDIOL, V33, pE13, DOI 10.1002/clc.20560; Dimopoulos K, 2010, EUR HEART J, V31, P595, DOI 10.1093/eurheartj/ehp495; ElEbiary M, 1997, AM J RESP CRIT CARE, V156, P1467, DOI 10.1164/ajrccm.156.5.97-04039; ERINOSO HO, 1993, TROP GEOGR MED, V45, P290; FLEAR CTG, 1979, BRIT MED J, V1, P1242, DOI 10.1136/bmj.1.6173.1242; Forfia PR, 2008, AM J RESP CRIT CARE, V177, P1364, DOI 10.1164/rccm.200712-1876OC; Funk GC, 2010, INTENS CARE MED, V36, P304, DOI 10.1007/s00134-009-1692-0; Gheorghiade M, 2007, ARCH INTERN MED, V167, P1998, DOI 10.1001/archinte.167.18.1998; Gheorghiade M, 2007, EUR HEART J, V28, P980, DOI 10.1093/eurheartj/ehl542; Gill G, 2006, CLIN ENDOCRINOL, V65, P246, DOI 10.1111/j.1365-2265.2006.02583.x; Goldberg A, 2006, ARCH INTERN MED, V166, P781, DOI 10.1001/archinte.166.7.781; Goldberg A, 2004, AM J MED, V117, P242, DOI 10.1016/j.amjmed.2004.03.022; Goldsmith SR, 2012, HEART, V98, P1761, DOI 10.1136/heartjnl-2012-302854; Hackworth WA, 2009, LIVER INT, V29, P1071, DOI 10.1111/j.1478-3231.2009.01982.x; Hampshire PA, 2009, CRIT CARE, V13, DOI 10.1186/cc8016; Hanson J, 2009, AM J TROP MED HYG, V80, P141, DOI 10.4269/ajtmh.2009.80.141; Havranek S, 2011, SCAND J CLIN LAB INV, V71, P38, DOI 10.3109/00365513.2010.535012; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hoorn EJ, 2006, NEPHROL DIAL TRANSPL, V21, P70, DOI 10.1093/ndt/gfi082; Hoorn EJ, 2011, J BONE MINER RES, V26, P1822, DOI 10.1002/jbmr.380; Hsu HH, 2009, INT J CLIN PRACT, V63, P751, DOI 10.1111/j.1742-1241.2006.01264.x; Hussain SF, 2004, INT J TUBERC LUNG D, V8, P493; Iseki K, 1996, AM J KIDNEY DIS, V28, P541, DOI 10.1016/S0272-6386(96)90465-5; Jenq CC, 2010, J CLIN GASTROENTEROL, V44, P220, DOI 10.1097/MCG.0b013e3181aabbcd; Kapoor R, 2010, BJU INT, V105, P986, DOI 10.1111/j.1464-410X.2009.08930.x; Kengne FG, 2008, QJM-INT J MED, V101, P583, DOI 10.1093/qjmed/hcn061; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Kinsella S, 2010, CLIN J AM SOC NEPHRO, V5, P275, DOI 10.2215/CJN.06120809; Klein L, 2005, CIRCULATION, V111, P2454, DOI 10.1161/01.CIR.0000165065.82609.3D; Klopotowski M, 2009, MED SCI MONITOR, V15, pCR477; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Konstam MA, 2011, EUR J HEART FAIL, V13, P242, DOI 10.1093/eurjhf/hfq236; Lee JH, 2005, BONE MARROW TRANSPL, V35, P63, DOI 10.1038/sj.bmt.1704708; Lee SE, 2012, HEART, V98, P1798, DOI 10.1136/heartjnl-2012-302334; Madan VD, 2011, CIRC-HEART FAIL, V4, P637, DOI 10.1161/CIRCHEARTFAILURE.111.961011; Manary MJ, 2000, ACTA PAEDIATR, V89, P203, DOI 10.1080/080352500750028843; MILLER M, 1995, J AM GERIATR SOC, V43, P1410, DOI 10.1111/j.1532-5415.1995.tb06623.x; Milo-Cotter O, 2008, EUR J HEART FAIL, V10, P196, DOI 10.1016/j.ejheart.2008.01.008; Nair V, 2007, AM J NEPHROL, V27, P184, DOI 10.1159/000100866; NATKUNAM A, 1991, J MED, V22, P83; Novack V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012184; Oguche S, 2002, West Afr J Med, V21, P276; Olotu AI, 2008, TROP DOCT, V38, P165, DOI 10.1258/td.2007.070095; PANCIROLI C, 1990, ANGIOLOGY, V41, P631, DOI 10.1177/000331979004100807; Peri A, 2010, J ENDOCRINOL INVEST, V33, P671, DOI 10.1007/BF03346668; Peri A, 2013, J CLIN ENDOCR METAB, V98, P1321, DOI 10.1210/jc.2012-4082; Porcel A, 2002, ARCH INTERN MED, V162, P323, DOI 10.1001/archinte.162.3.323; Radha Krishna Y, 2009, LIVER INT, V29, P392, DOI 10.1111/j.1478-3231.2008.01887.x; Renneboog B, 2006, AM J MED, V119, DOI [DOI 10.1016/J.AMJMED.2005.09.026, 10.1016/j.amjmed.2005.09.026]; Ruf AE, 2005, LIVER TRANSPLANT, V11, P336, DOI 10.1002/lt.20329; Rusinaru D, 2012, EUR J HEART FAIL, V14, P1139, DOI 10.1093/eurjhf/hfs099; Rusinaru D, 2009, AM J CARDIOL, V103, P405, DOI 10.1016/j.amjcard.2008.09.091; Saifudheen K, 2011, NEUROLOGY, V76, P701, DOI 10.1212/WNL.0b013e31820d8b40; Salvador VBDG, 2010, ASIAN J SURG, V33, P51, DOI 10.1016/S1015-9584(10)60009-7; SAMADI AR, 1985, BRIT MED J, V290, P1615, DOI 10.1136/bmj.290.6482.1615; Scherz N, 2010, AM J RESP CRIT CARE, V182, P1178, DOI 10.1164/rccm.201003-0481OC; SHARMA SK, 1995, QJM-MON J ASSOC PHYS, V88, P29; Sherlock M, 2006, CLIN ENDOCRINOL, V64, P250, DOI 10.1111/j.1365-2265.2006.02432.x; Shorr Andrew F, 2011, Congest Heart Fail, V17, P1, DOI 10.1111/j.1751-7133.2010.00206.x; Singhi S, 1994, Indian Pediatr, V31, P19; Singhi S, 1992, Indian Pediatr, V29, P735; Song JH, 2008, INT J ANTIMICROB AG, V31, P107, DOI 10.1016/j.ijantimicag.2007.09.014; Srivastava K L, 1998, Indian J Gastroenterol, V17, P43; Stelfox HT, 2010, CAN J ANAESTH, V57, P650, DOI 10.1007/s12630-010-9309-1; Stelfox HT, 2008, CRIT CARE, V12, DOI 10.1186/cc7162; SUNDERAM SG, 1983, AGE AGEING, V12, P77, DOI 10.1093/ageing/12.1.77; Tada Y, 2011, CIRC J, V75, P1927, DOI 10.1253/circj.CJ-10-0945; Tang Q, 2011, INTERNAL MED, V50, P969, DOI 10.2169/internalmedicine.50.4703; TANG WW, 1993, AM J MED, V94, P169, DOI 10.1016/0002-9343(93)90179-S; Terg R, 2009, LIVER INT, V29, P415, DOI 10.1111/j.1478-3231.2008.01877.x; TERZIAN C, 1994, J GEN INTERN MED, V9, P89, DOI 10.1007/BF02600208; TIERNEY WM, 1986, J GEN INTERN MED, V1, P380, DOI 10.1007/BF02596422; Tribouilloy C, 2008, EUR HEART J, V29, P339, DOI 10.1093/eurheartj/ehm554; Upadhyay A, 2006, AM J MED, V119, pS30, DOI 10.1016/j.amjmed.2006.05.005; Vaa BE, 2011, MAYO CLIN PROC, V86, P37, DOI 10.4065/mcp.2010.0281; Verbalis JG, 2007, AM J MED, V120, pS1, DOI 10.1016/j.amjmed.2007.09.001; Verbalis JG, 2010, J BONE MINER RES, V25, P554, DOI 10.1359/jbmr.090827; Vila MC, 1999, AM J GASTROENTEROL, V94, P2219; VITTING KE, 1990, JAMA-J AM MED ASSOC, V263, P973, DOI 10.1001/jama.263.7.973; Waikar SS, 2009, AM J MED, V122, P857, DOI 10.1016/j.amjmed.2009.01.027; Wald R, 2010, ARCH INTERN MED, V170, P294, DOI 10.1001/archinternmed.2009.513; Whelan B, 2009, QJM-INT J MED, V102, P175, DOI 10.1093/qjmed/hcn165; Whyte M, 2009, INT J CLIN PRACT, V63, P1451, DOI 10.1111/j.1742-1241.2009.02037.x; Zilberberg MD, 2008, CURR MED RES OPIN, V24, P1601, DOI 10.1185/03007990802081675; Zilberberg Marya D, 2008, BMC Pulm Med, V8, P16, DOI 10.1186/1471-2466-8-16	103	163	169	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e80451	10.1371/journal.pone.0080451	http://dx.doi.org/10.1371/journal.pone.0080451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367479	Green Published, gold			2022-12-27	WOS:000328740300001
J	He, PF; Han, Q; Liu, JJ; Liu, DJ; Zhao, X; Hu, T; Jiang, L; Dan, HX; Zeng, X; Li, J; Wang, JY; Chen, QM				He, Pengfei; Han, Qi; Liu, Jiajia; Liu, Dongjuan; Zhao, Xin; Hu, Ting; Jiang, Lu; Dan, Hongxia; Zeng, Xin; Li, Jing; Wang, Jiayi; Chen, Qianming			The Association between Hypoxia-Inducible Factor-1 alpha Gene C1772T Polymorphism and Cancer Risk: A Meta-Analysis of 37 Case-Control Studies	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; FACTOR-1-ALPHA GENE; HIF-1-ALPHA GENE; PROSTATE-CANCER; FACTOR 1-ALPHA; BREAST-CANCER; UP-REGULATION; SUSCEPTIBILITY; EXPRESSION; GROWTH	Background: The possible association between HIF-1 alpha C1772T polymorphism and cancer risk has been studied extensively. However, the results were controversial. In order to get a more precise conclusion of this association, a meta-analysis was performed. Methods: A total of 10186 cases and 10926 controls in 37 case-control studies were included in this meta-analysis. Allele and genotypic differences between cases and controls were evaluated. Subgroup analysis by cancer site, ethnicity, source of controls and gender was performed. Results: The T allele of HIF-1a gene C1772T was significantly associated with increased cancer risk in three genetic models: TT+CT vs. CC (dominant model OR=1.23, 95% CI=1.03-1.47), TT vs. CT+CC (recessive model OR=2.51, 95% CI=1.54-4.09), TT vs. CC (homozygote comparison OR=2.02, 95% CI=1.21-3.39). In subgroup analysis, the frequency of the T variant was found to be significantly increased in cervical cancer, pancreatic cancer, head and neck cancer, renal cell carcinoma, Asian and female subgroups. Conclusions: Our meta-analysis suggests that the substitution of C allele with T at HIF-1a gene C1772T polymorphism is a risk factor of cancer, especially for cervical, head and neck cancer, pancreatic cancer and renal cell carcinoma. It is also a risk factor of cancer in Asian group as well as in female group.	[He, Pengfei; Han, Qi; Liu, Jiajia; Liu, Dongjuan; Zhao, Xin; Hu, Ting; Jiang, Lu; Dan, Hongxia; Zeng, Xin; Li, Jing; Chen, Qianming] Sichuan Univ, State Key Lab Oral Dis, West China Coll Stomatol, Chengdu 610064, Peoples R China; [Wang, Jiayi] Sichuan Univ, Dept Oral Radiol, West China Hosp Stomatol, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Li, J (corresponding author), Sichuan Univ, State Key Lab Oral Dis, West China Coll Stomatol, Chengdu 610064, Peoples R China.	lijing19840108@126.com; jiayimail@163.com	Li, Jingyu/GSD-1924-2022	Dan, Hongxia/0000-0002-9765-0012	National Natural Science Foundation of China [81061120531, 81200791, 30930100, 81102060, 81001208]; International Science and Technology Cooperation Program of China [2012DFA31370]; Doctoral Program of the Ministry of Education of China [20110181110055, 20100181120057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation Program of China; Doctoral Program of the Ministry of Education of China(Ministry of Education, China)	This work was supported by grants from the National Natural Science Foundation of China (No. 81061120531, 81200791, 30930100, 81102060, and 81001208), the International Science and Technology Cooperation Program of China (No. 2012DFA31370), and Doctoral Program of the Ministry of Education of China (No. 20110181110055, 20100181120057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JAG, 2008, CURR DRUG METAB, V9, P520, DOI 10.2174/138920008784892083; Alves LR, 2012, HEAD NECK ONCOL, V4, P87; Apaydin I, 2008, ARCH MED RES, V39, P338, DOI 10.1016/j.arcmed.2007.11.012; Baldewijns MM, 2010, J PATHOL, V221, P125, DOI 10.1002/path.2689; Chai Dan, 2010, Sichuan Da Xue Xue Bao Yi Xue Ban, V41, P674; Chen MK, 2009, ORAL ONCOL, V45, pE222, DOI 10.1016/j.oraloncology.2009.07.015; Elson DA, 2000, CANCER RES, V60, P6189; Munoz-Guerra MF, 2009, ANN SURG ONCOL, V16, P2351, DOI 10.1245/s10434-009-0503-8; Foley R, 2009, CANCER BIOL THER, V8, P118, DOI 10.4161/cbt.8.2.7086; Fransen K, 2006, MOL CARCINOGEN, V45, P833, DOI 10.1002/mc.20209; Fu XYS, 2005, PROSTATE, V63, P215, DOI 10.1002/pros.20190; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hill RP, 2009, SEMIN RADIAT ONCOL, V19, P106, DOI 10.1016/j.semradonc.2008.12.002; Hsiao PC, 2010, J SURG ONCOL, V102, P163, DOI 10.1002/jso.21539; Hua KQ, 2009, ONCOL REP, V21, P893, DOI 10.3892/or_00000300; Katsuta M, 2005, EXP MOL PATHOL, V78, P123, DOI 10.1016/j.yexmp.2004.11.002; Kazi AA, 2005, MOL ENDOCRINOL, V19, P2006, DOI 10.1210/me.2004-0388; Kim HO, 2008, ONCOL REP, V20, P1181, DOI 10.3892/or_00000127; Kim YH, 2011, INT J GYNECOL CANCER, V21, P2, DOI 10.1097/IGC.0b013e318204f6e6; Knechtel G, 2010, MOL CARCINOGEN, V49, P805, DOI 10.1002/mc.20655; Konac E, 2007, CANCER DETECT PREV, V31, P102, DOI 10.1016/j.cdp.2007.01.001; Konac E, 2009, EXP BIOL MED, V234, P1109, DOI 10.3181/0902-RM-49; Kuo WH, 2012, TRANSL RES, V159, P42, DOI 10.1016/j.trsl.2011.09.003; Lee JY, 2008, CLIN CHIM ACTA, V389, P167, DOI 10.1016/j.cca.2007.12.005; Li K, 2009, BIOCHEM GENET, V47, P625, DOI 10.1007/s10528-009-9254-2; Li P, 2012, ASIAN J ANDROL, V14, P864, DOI 10.1038/aja.2012.101; Ling Ting Sheng, 2005, Chin J Dig Dis, V6, P155, DOI 10.1111/j.1443-9573.2005.00223.x; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Mera-Menendez F, 2013, CLIN TRANSL ONCOL, V15, P358, DOI 10.1007/s12094-012-0930-z; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Naidu R, 2009, NEOPLASMA, V56, P441, DOI 10.4149/neo_2009_05_441; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Putra AC, 2011, RESPIROLOGY, V16, P796, DOI 10.1111/j.1440-1843.2011.01972.x; Qin C, 2012, ANN ONCOL, V23, P981, DOI 10.1093/annonc/mdr325; Ribeiro AL, 2009, CANCER BIOMARK, V5, P273, DOI 10.3233/CBM-2009-0112; Ribeiro AL, 2013, ANTICANCER RES, V33, P2549; Ruiz-Tovar J, 2012, TUMORI J, V98, P364, DOI 10.1700/1125.12406; Ryan HE, 2000, CANCER RES, V60, P4010; Schaid DJ, 1999, AM J EPIDEMIOL, V149, P706; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2006, NOVART FDN SYMP, V272, P14; Shieh TM, 2010, ORAL ONCOL, V46, pE47, DOI 10.1016/j.oraloncology.2010.04.009; Spinola M, 2004, EUR J CANCER PREV, V13, P87, DOI 10.1097/00008469-200402000-00014; Tanimoto K, 2003, CARCINOGENESIS, V24, P1779, DOI 10.1093/carcin/bgg132; Wang JY, 2013, TOHOKU J EXP MED, V229, P245, DOI 10.1620/tjem.229.245; Wang XC, 2011, CANCER BIOL THER, V12, P383, DOI 10.4161/cbt.12.5.15982; Xu GF, 2011, GENET TEST MOL BIOMA, V15, P461, DOI 10.1089/gtmb.2010.0265; Zagouri F, 2012, MOL BIOL REP, V39, P10873, DOI 10.1007/s11033-012-1984-2; Zhao TF, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-159; Zhong H, 2004, CANCER DETECT PREV, V28, P88, DOI 10.1016/j.cdp.2003.12.009; Zintzaras E, 2008, J CLIN EPIDEMIOL, V61, P634, DOI 10.1016/j.jclinepi.2007.12.011	51	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83441	10.1371/journal.pone.0083441	http://dx.doi.org/10.1371/journal.pone.0083441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367595	gold, Green Published			2022-12-27	WOS:000328740300105
J	Simpson, EA; Paukner, A; Sclafani, V; Suomi, SJ; Ferrari, PF				Simpson, Elizabeth A.; Paukner, Annika; Sclafani, Valentina; Suomi, Stephen J.; Ferrari, Pier F.			Lipsmacking Imitation Skill in Newborn Macaques Is Predictive of Social Partner Discrimination	PLOS ONE			English	Article							NEONATAL IMITATION; MEMORY	Newborn rhesus macaques imitate facial gestures even after a delay, revealing the flexible nature of their early communicative exchanges. In the present study we examined whether newborn macaques are also sensitive to the identities of the social partners with whom they are interacting. We measured infant monkeys' (n = 90) lipsmacking and tongue protrusion gestures in a face-to-face interaction task with a human experimenter in the first week of life. After a one-minute delay, the same person who previously presented gestures or a different person returned and presented a still face to infants. We had two primary predictions: (1) infants would demonstrate higher rates of overall gesturing, and especially lipsmacking-an affiliative gesture-to a familiar person, compared to a novel person, and (2) infants' imitative skills would positively correlate with gestures to familiar, but not unfamiliar, social partners, as both abilities may reflect a strong general social interest. We found that overall infants did not produce more gestures or more lipsmacking when approached by a familiar person compared to a novel person; however, we did find individual differences in infants' social responsiveness: lipsmacking imitation was positively correlated with lipsmacking during the return period when the person was the same (p =.025), but not when the person was novel (p =.44). These findings are consistent with the notion that imitative skill is reflective of infants' more general interest in social interactions.	[Simpson, Elizabeth A.; Paukner, Annika; Suomi, Stephen J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Comparat Ethol Lab, Poolesville, MD USA; [Simpson, Elizabeth A.; Sclafani, Valentina; Ferrari, Pier F.] Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Parma	Simpson, EA (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Comparat Ethol Lab, Poolesville, MD USA.	simpsonea@mail.nih.gov	Simpson, Elizabeth A./H-5479-2019; Paukner, Annika/ABA-3275-2020; Ferrari, Pier Francesco/G-5547-2017	Simpson, Elizabeth A./0000-0003-2715-2533; Paukner, Annika/0000-0002-3421-1864; 	Division of Intramural Research; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01 HD064653]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001107, P01HD064653] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development. EAS, VS, and PFF were supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development P01 HD064653. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BJORKLUND DF, 1987, DEV REV, V7, P86, DOI 10.1016/0273-2297(87)90006-2; Braten S., 1998, INTERSUBJECTIVE COMM, P15; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Ferrari PF, 2012, J COGNITIVE NEUROSCI, V24, P1165, DOI 10.1162/jocn_a_00198; Ferrari PF, 2009, CHILD DEV, V80, P1057, DOI 10.1111/j.1467-8624.2009.01316.x; LEGERSTEE M, 1991, J EXP CHILD PSYCHOL, V51, P423, DOI 10.1016/0022-0965(91)90086-8; MAESTRIPIERI D, 1994, BEHAVIOUR, V131, P75, DOI 10.1163/156853994X00226; Maestripieri D, 1997, EVOL COMMUN, V1, P193, DOI [10.1075/eoc.1.2.03mae, DOI 10.1075/E0C.1.2.03MAE]; MELTZOFF AN, 1994, INFANT BEHAV DEV, V17, P83, DOI 10.1016/0163-6383(94)90024-8; MELTZOFF AN, 1992, INFANT BEHAV DEV, V15, P479, DOI 10.1016/0163-6383(92)80015-M; PAUKNER A, 2013, NAVIGATING SOCIAL WO, P133; Paukner A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028848; Schwartz BL, 2001, AM J PRIMATOL, V55, P71, DOI 10.1002/ajp.1041; Shannon C, 1998, AM J PRIMATOL, V46, P311, DOI 10.1002/(SICI)1098-2345(1998)46:4<311::AID-AJP3>3.0.CO;2-L; Simpson EA, 2014, DEV PSYCHOBIOL, V56, P864, DOI 10.1002/dev.21146; UZGIRIS IC, 1981, INT J BEHAV DEV, V4, P1, DOI 10.1177/016502548100400101	16	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82921	10.1371/journal.pone.0082921	http://dx.doi.org/10.1371/journal.pone.0082921			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367569	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000328740300080
J	Ud-Din, AMS; Wahid, SUH; Latif, HA; Shahnaij, M; Akter, M; Azmi, IJ; Hasan, TN; Ahmed, D; Hossain, MA; Faruque, AG; Faruque, SM; Talukder, KA				Ud-Din, Abu I. M. S.; Wahid, Syeda U. H.; Latif, Hasan A.; Shahnaij, Mohammad; Akter, Mahmuda; Azmi, Ishrat J.; Hasan, Trisheeta N.; Ahmed, Dilruba; Hossain, Mohammad A.; Faruque, Abu S. G.; Faruque, Shah M.; Talukder, Kaisar A.			Changing Trends in the Prevalence of Shigella Species: Emergence of Multi-Drug Resistant Shigella sonnei Biotype g in Bangladesh	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; CARRYING CLASS-2 INTEGRONS; ANTIMICROBIAL SUSCEPTIBILITY; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; FLUOROQUINOLONE RESISTANCE; PHYLOGENETIC ANALYSIS; GENETIC DIVERSITY; PATTERNS; STRAINS	Shigellosis, caused by Shigella species, is a major public health problem in Bangladesh. To determine the prevalence and distribution of different Shigella species, we analyzed 10,827 Shigella isolates from patients between 2001 and 2011. S. flexneri was the predominant species isolated throughout the period. However, the prevalence of S. flexneri decreased from 65.7% in 2001 to 47% in 2011, whereas the prevalence of S. sonnei increased from 7.2% in 2001 to 25% in 2011. S. boydii and S. dysenteriae accounted for 17.3% and 7.7% of the isolates respectively throughout the period. Of 200 randomly selected S. sonnei isolates for extensive characterization, biotype g strains were predominant (95%) followed by biotype a (5%). Resistance to commonly used antibiotics including trimethoprim-sulfamethoxazole, nalidixic acid, ciprofloxacin, mecillinam and ampicillin was 89.5%, 86.5%, 17%, 10.5%, and 9.5%, respectively. All isolates were susceptible to ceftriaxone, cefotaxime, ceftazidime and imipenem. Ninety-eight percent of the strains had integrons belonging to class 1, 2 or both. The class 1 integron contained only dfrA5 gene, whereas among class 2 integron, 16% contained dhfrAI-sat1-aadA1-orfX gene cassettes and 84% harbored dhfrA1-sat2 gene cassettes. Plasmids of similar to 5, similar to 1.8 and similar to 1.4 MDa in size were found in 92% of the strains, whereas only 33% of the strains carried the 120 MDa plasmid. PFGE analysis showed that strains having different integron patterns belonged to different clusters. These results show a changing trend in the prevalence of Shigella species with the emergence of multidrug resistant S. sonnei. Although S. flexneri continues to be the predominant species albeit with reduced prevalence, S. sonnei has emerged as the second most prevalent species replacing the earlier dominance by S. boydii and S. dysenteriae in Bangladesh.	[Ud-Din, Abu I. M. S.; Wahid, Syeda U. H.; Latif, Hasan A.; Shahnaij, Mohammad; Akter, Mahmuda; Azmi, Ishrat J.; Hasan, Trisheeta N.; Ahmed, Dilruba; Hossain, Mohammad A.; Faruque, Abu S. G.; Faruque, Shah M.; Talukder, Kaisar A.] Int Ctr Diarrhoeal Dis Res, Ctr Food & Water Borne Dis, Dhaka 1000, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR)	Talukder, KA (corresponding author), Int Ctr Diarrhoeal Dis Res, Ctr Food & Water Borne Dis, GPO Box 128, Dhaka 1000, Bangladesh.	kaisar@icddrb.org	Shahnaij, Mohammad/GMX-3978-2022	Mohammad, Shahnaij/0000-0002-3693-7239; Faruque, Shah/0000-0002-7006-622X; Ahmed, Dilruba/0000-0001-8961-2406	icddr,b; Government of the People's Republic of Bangladesh; Australian Agency for International Development (AusAID); Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	icddr,b; Government of the People's Republic of Bangladesh; Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	This study was funded by icddr,b and its donors which provide unrestricted support to icddr, b for its operations and research. Current donors providing unrestricted support include: Government of the People's Republic of Bangladesh, Australian Agency for International Development (AusAID), Canadian International Development Agency (CIDA), Swedish International Development Cooperation Agency (Sida), and the Department for International Development, UK (DFID). The authors gratefully acknowledge these donors for their support and commitment to icddr,b's research efforts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardhan P, 2010, EMERG INFECT DIS, V16, P1718, DOI 10.3201/eid1611.090934; BENNISH ML, 1990, J INFECT DIS, V162, P711, DOI 10.1093/infdis/162.3.711; Cambray G, 2010, ANNU REV GENET, V44, P141, DOI 10.1146/annurev-genet-102209-163504; Chiou CS, 2009, J CLIN MICROBIOL, V47, P1149, DOI 10.1128/JCM.01607-08; Church DL, 2004, CLIN LAB MED, V24, P559, DOI 10.1016/j.cll.2004.05.008; Clinical and Laboratory Standard Institute (CLSI), 2010, M100S20U CLSI; Dawes FE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012754; DeLappe N, 2003, J CLIN MICROBIOL, V41, P1919, DOI 10.1128/JCM.41.5.1919-1924.2003; Faruque ASG, 2008, J HEALTH POPUL NUTR, V26, P325; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Fluit AC, 2004, CLIN MICROBIOL INFEC, V10, P272, DOI 10.1111/j.1198-743X.2004.00858.x; Gassama-Sow A, 2010, J INFECT DEV COUNTR, V4, P207, DOI 10.3855/jidc.583; Goh K, 2011, ARCH MICROBIOL, V193, P179, DOI 10.1007/s00203-010-0656-7; HAIDER K, 1989, EPIDEMIOL INFECT, V102, P421, DOI 10.1017/S0950268800030132; Hoe CH, 2005, J APPL MICROBIOL, V99, P133, DOI 10.1111/j.1365-2672.2005.02581.x; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Islam MA, 2012, EUR J CLIN MICROBIOL, V31, P2593, DOI 10.1007/s10096-012-1601-2; Izumiya H, 2009, J MED MICROBIOL, V58, P1486, DOI 10.1099/jmm.0.011809-0; Jin YH, 2010, J MICROBIOL, V48, P236, DOI 10.1007/s12275-010-9220-z; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Ke X, 2011, ARCH MICROBIOL, V193, P767, DOI 10.1007/s00203-011-0744-3; Khatun F, 2011, EPIDEMIOL INFECT, V139, P446, DOI 10.1017/S0950268810001093; Koh XP, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-122; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; LIU PYF, 1995, J CLIN MICROBIOL, V33, P1779, DOI 10.1128/JCM.33.7.1779-1783.1995; Madiyarov RS, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-18; Mammina C, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-117; McIver CJ, 2002, J CLIN MICROBIOL, V40, P1538, DOI 10.1128/JCM.40.4.1538-1540.2002; NASTASI A, 1993, EPIDEMIOL INFECT, V110, P23, DOI 10.1017/S0950268800050640; Niyogi SK, 2005, J MICROBIOL, V43, P133; Oh JY, 2003, J CLIN MICROBIOL, V41, P421, DOI 10.1128/JCM.41.1.421-423.2003; Putnam SD, 2004, CLIN MICROBIOL INFEC, V10, P804, DOI 10.1111/j.1469-0691.2004.00927.x; Ranjbar R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-62; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rowe-Magnus DA, 2002, INT J MED MICROBIOL, V292, P115, DOI 10.1078/1438-4221-00197; Sabat A.J., 2013, EURO SURVEILL, V18; SAYEED S, 1992, J MED MICROBIOL, V37, P382, DOI 10.1099/00222615-37-6-382; Seol SY, 2006, J MED MICROBIOL, V55, P871, DOI 10.1099/jmm.0.46441-0; Shiferaw B, 2012, CLIN INFECT DIS, V54, pS458, DOI 10.1093/cid/cis230; Talukder KA, 2006, EPIDEMIOL INFECT, V134, P1249, DOI 10.1017/S0950268806006029; Talukder KA, 2006, CURR MICROBIOL, V52, P108, DOI 10.1007/s00284-005-0140-9; Talukder KA, 2002, J CLIN MICROBIOL, V40, P2490, DOI 10.1128/JCM.40.7.2490-2497.2002; Talukder KA, 2006, J MED MICROBIOL, V55, P1257, DOI 10.1099/jmm.0.46641-0; Talukder KA, 2012, FOODBORNE AND WATERBORNE BACTERIAL PATHOGENS: EPIDEMIOLOGY, EVOLUTION AND MOLECULAR BIOLOGY, P63; van Essen-Zandbergen A, 2007, J ANTIMICROB CHEMOTH, V59, P746, DOI 10.1093/jac/dkl549; Vargas M, 1999, J CLIN MICROBIOL, V37, P3608, DOI 10.1128/JCM.37.11.3608-3611.1999; Vrints M, 2009, J CLIN MICROBIOL, V47, P1379, DOI 10.1128/JCM.02460-08; WEISSMAN JB, 1975, LANCET, V1, P88; Wen X., 2012, AFR J MICROBIOL RES, V6, P6987; White PA, 2001, ANTIMICROB AGENTS CH, V45, P2658, DOI 10.1128/AAC.45.9.2658-2661.2001; World Health Organization, 1987, MAN LAB INV AC ENT I, P9; Zafar A, 2009, INT J INFECT DIS, V13, P668, DOI 10.1016/j.ijid.2008.10.005	54	52	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82601	10.1371/journal.pone.0082601	http://dx.doi.org/10.1371/journal.pone.0082601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367527	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300043
J	Herzmann, G; Curran, T				Herzmann, Grit; Curran, Tim			Neural Correlates of the In-Group Memory Advantage on the Encoding and Recognition of Faces	PLOS ONE			English	Article							MERE SOCIAL CATEGORIZATION; GROUP BIAS; OWN-RACE; RECOLLECTION; FAMILIARITY; RETRIEVAL; IDENTIFICATION; POTENTIALS; ATTENTION; FMRI	People have a memory advantage for faces that belong to the same group, for example, that attend the same university or have the same personality type. Faces from such in-group members are assumed to receive more attention during memory encoding and are therefore recognized more accurately. Here we use event-related potentials related to memory encoding and retrieval to investigate the neural correlates of the in-group memory advantage. Using the minimal group procedure, subjects were classified based on a bogus personality test as belonging to one of two personality types. While the electroencephalogram was recorded, subjects studied and recognized faces supposedly belonging to the subject's own and the other personality type. Subjects recognized in-group faces more accurately than out-group faces but the effect size was small. Using the individual behavioral in-group memory advantage in multivariate analyses of covariance, we determined neural correlates of the in-group advantage. During memory encoding (300 to 1000 ms after stimulus onset), subjects with a high in-group memory advantage elicited more positive amplitudes for subsequently remembered in-group than out-group faces, showing that in-group faces received more attention and elicited more neural activity during initial encoding. Early during memory retrieval (300 to 500 ms), frontal brain areas were more activated for remembered in-group faces indicating an early detection of group membership. Surprisingly, the parietal old/new effect (600 to 900 ms) thought to indicate recollection processes differed between in-group and out-group faces independent from the behavioral in-group memory advantage. This finding suggests that group membership affects memory retrieval independent of memory performance. Comparisons with a previous study on the other-race effect, another memory phenomenon influenced by social classification of faces, suggested that the in-group memory advantage is dominated by top-down processing whereas the other-race effect is also influenced by extensive perceptual experience.	[Herzmann, Grit] Coll Wooster, Dept Psychol, Wooster, OH 44691 USA; [Curran, Tim] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA	College of Wooster; University of Colorado System; University of Colorado Boulder	Herzmann, G (corresponding author), Coll Wooster, Dept Psychol, Wooster, OH 44691 USA.	grit.herzmann@gmail.com			NIH [MH64812, MH096698]; NSF [SMA-1041755]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096698, R01MH064812] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for this research was provided by NIH Grants MH64812 and MH096698 and NSF grant #SMA-1041755 to the Temporal Dynamics of Learning Center, an NSF Science of Learning Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ND, 2000, J COGNITIVE NEUROSCI, V12, P775, DOI 10.1162/089892900562598; Bernstein MJ, 2007, PSYCHOL SCI, V18, P706, DOI 10.1111/j.1467-9280.2007.01964.x; Cruse D, 2009, NEUROPSYCHOLOGIA, V47, P2779, DOI 10.1016/j.neuropsychologia.2009.06.003; Curran T, 2000, MEM COGNITION, V28, P923, DOI 10.3758/BF03209340; Curran T, 2007, NEUROIMAGE, V36, P464, DOI 10.1016/j.neuroimage.2006.12.016; Friedman D, 2000, MICROSC RES TECHNIQ, V51, P6, DOI 10.1002/1097-0029(20001001)51:1<6::AID-JEMT2>3.0.CO;2-R; GOLDBERG LR, 1993, AM PSYCHOL, V48, P26, DOI 10.1037/0003-066X.48.1.26; Green DM, 1966, SIGNAL DETECTION THE; Herzmann G, 2013, PSYCHONEURO IN PRESS; Herzmann G, 2011, NEUROPSYCHOLOGIA, V49, P3103, DOI 10.1016/j.neuropsychologia.2011.07.019; Herzmann G, 2011, MEM COGNITION, V39, P412, DOI 10.3758/s13421-010-0036-1; Hugenberg K, 2009, COGNITIVE SCI, V33, P1173, DOI 10.1111/j.1551-6709.2009.01048.x; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Kim H, 2011, NEUROIMAGE, V54, P2446, DOI 10.1016/j.neuroimage.2010.09.045; Levin DT, 1996, J EXP PSYCHOL LEARN, V22, P1364, DOI 10.1037/0278-7393.22.6.1364; Levin DT, 2000, J EXP PSYCHOL GEN, V129, P559, DOI 10.1037//0096-3445.129.4.559; MacKenzie G, 2007, NEUROIMAGE, V36, P454, DOI 10.1016/j.neuroimage.2006.12.005; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; PALLER KA, 1987, ELECTROEN CLIN NEURO, V67, P360, DOI 10.1016/0013-4694(87)90124-6; Phillips PJ, 2000, IEEE T PATTERN ANAL, V22, P1090, DOI 10.1109/34.879790; Ratner KG, 2013, J EXP SOC PSYCHOL, V49, P298, DOI 10.1016/j.jesp.2012.10.017; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Shriver ER, 2008, PERS SOC PSYCHOL B, V34, P260, DOI 10.1177/0146167207310455; Spaniol J, 2009, NEUROPSYCHOLOGIA, V47, P1765, DOI 10.1016/j.neuropsychologia.2009.02.028; Sporer SL, 2001, PSYCHOL PUBLIC POL L, V7, P36, DOI 10.1038//1076-8971.7.1.36; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Uncapher MR, 2009, NEUROBIOL LEARN MEM, V91, P139, DOI 10.1016/j.nlm.2008.10.011; Van Bavel JJ, 2012, PERS SOC PSYCHOL B, V38, P1566, DOI 10.1177/0146167212455829; Van Bavel JJ, 2011, J COGNITIVE NEUROSCI, V23, P3343, DOI 10.1162/jocn_a_00016; Van Bavel JJ, 2008, PSYCHOL SCI, V19, P1131, DOI 10.1111/j.1467-9280.2008.02214.x; Vilberg KL, 2006, BRAIN RES, V1122, P161, DOI 10.1016/j.brainres.2006.09.023; Wilding EL, 2000, INT J PSYCHOPHYSIOL, V35, P81, DOI 10.1016/S0167-8760(99)00095-1; Woodruff CC, 2006, BRAIN RES, V1100, P125, DOI 10.1016/j.brainres.2006.05.019; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Young SG, 2012, PERS SOC PSYCHOL REV, V16, P116, DOI 10.1177/1088868311418987; Young SG, 2010, J PERS SOC PSYCHOL, V99, P964, DOI 10.1037/a0020400; Young SG, 2010, SOC COGNITION, V28, P240, DOI 10.1521/soco.2010.28.2.240; Zhao K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032932	39	8	8	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82797	10.1371/journal.pone.0082797	http://dx.doi.org/10.1371/journal.pone.0082797			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GT	24358226	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700032
J	Kostic, S; Perc, M; Vasovic, N; Trajkovic, S				Kostic, Srdan; Perc, Matjaz; Vasovic, Nebojsa; Trajkovic, Slobodan			Predictions of Experimentally Observed Stochastic Ground Vibrations Induced by Blasting	PLOS ONE			English	Article							ENVIRONMENTAL IMPACTS; NEURAL-NETWORK; TIME-SERIES; NONLINEARITY	In the present paper, we investigate the blast induced ground motion recorded at the limestone quarry "Suva Vrela" near Kosjeric, which is located in the western part of Serbia. We examine the recorded signals by means of surrogate data methods and a determinism test, in order to determine whether the recorded ground velocity is stochastic or deterministic in nature. Longitudinal, transversal and the vertical ground motion component are analyzed at three monitoring points that are located at different distances from the blasting source. The analysis reveals that the recordings belong to a class of stationary linear stochastic processes with Gaussian inputs, which could be distorted by a monotonic, instantaneous, time-independent nonlinear function. Low determinism factors obtained with the determinism test further confirm the stochastic nature of the recordings. Guided by the outcome of time series analysis, we propose an improved prediction model for the peak particle velocity based on a neural network. We show that, while conventional predictors fail to provide acceptable prediction accuracy, the neural network model with four main blast parameters as input, namely total charge, maximum charge per delay, distance from the blasting source to the measuring point, and hole depth, delivers significantly more accurate predictions that may be applicable on site. We also perform a sensitivity analysis, which reveals that the distance from the blasting source has the strongest influence on the final value of the peak particle velocity. This is in full agreement with previous observations and theory, thus additionally validating our methodology and main conclusions.	[Kostic, Srdan] Univ Belgrade, Fac Min & Geol, Dept Geol, Belgrade, Serbia; [Perc, Matjaz] Univ Maribor, Fac Nat Sci & Math, Dept Phys, SLO-2000 Maribor, Slovenia; [Vasovic, Nebojsa] Univ Belgrade, Fac Min & Geol, Dept Appl Math, Belgrade, Serbia; [Trajkovic, Slobodan] Univ Belgrade, Fac Min & Geol, Dept Underground Min, Belgrade, Serbia	University of Belgrade; University of Maribor; University of Belgrade; University of Belgrade	Kostic, S (corresponding author), Univ Belgrade, Fac Min & Geol, Dept Geol, Belgrade, Serbia.	srdjan.kostic@rgf.bg.ac.rs; matjaz.perc@uni-mb.si	Kostic, Srdjan Dragan/AHA-9130-2022; Perc, Matjaz/A-5148-2009	Kostic, Srdjan Dragan/0000-0002-3705-3080; Perc, Matjaz/0000-0002-3087-541X	Serbian Ministry of Education and Science [176016, 171017, 33025]; Slovenian Research Agency [J1-4055]	Serbian Ministry of Education and Science(Ministry of Education, Science & Technological Development, Serbia); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This research was supported by the Serbian Ministry of Education and Science (Grants 176016, 171017 and 33025) and the Slovenian Research Agency (Grant J1-4055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afeni TB., 2009, MIN SCI TECHNOL, V19, P420, DOI [10.1016/S1674-5264(09)60078-8, DOI 10.1016/S1674-5264(09)60078-8]; Ambraseys NR., 1968, ROCK MECH ENG PRACTI, P203; [Anonymous], 1987, BLASTING GUIDANCE MA; Attewell PB, 1964, ENGINEER, V217, P553; De Santis A, 2010, TECTONOPHYSICS, V496, P44, DOI 10.1016/j.tecto.2010.10.005; Dennis JE, 1987, NUMERICAL METHODS UN; DIN-German Standards Organization, 1983, 4150 DIN; Dolan KT, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046128; Donges JF, 2011, P NATL ACAD SCI USA, V108, P20422, DOI 10.1073/pnas.1117052108; Donner R, 2009, EUR PHYS J-SPEC TOP, V174, P1, DOI 10.1140/epjst/e2009-01086-6; Dowding C. H, 2000, CONSTRUCTION VIBRATI, V2nd; Duvall WI, 1959, RI5483 USBM, P21; FRASER AM, 1986, PHYS REV A, V33, P1134, DOI 10.1103/PhysRevA.33.1134; Ghosh A, 1983, P 24 US S ROCK MECH, P151; Hao H, 2001, SOIL DYN EARTHQ ENG, V21, P85, DOI 10.1016/S0267-7261(00)00104-4; Henrych J., 1979, EXPLOSION DYNAMICS I; Kahriman A, 2004, SOIL DYN EARTHQ ENG, V24, P887, DOI 10.1016/j.soildyn.2004.06.018; Kantz H., 2004, NONLINEAR TIME SERIE; KAPLAN DT, 1992, PHYS REV LETT, V68, P427, DOI 10.1103/PhysRevLett.68.427; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Kesimal A, 2008, ENVIRON GEOL, V54, P381, DOI 10.1007/s00254-007-0825-4; Khandelwal M, 2006, J SOUND VIB, V289, P711, DOI 10.1016/j.jsv.2005.02.044; Khandelwal M, 2007, SOIL DYN EARTHQ ENG, V27, P116, DOI 10.1016/j.soildyn.2006.06.004; Khandelwal M, 2009, INT J ROCK MECH MIN, V46, P1214, DOI 10.1016/j.ijrmms.2009.03.004; Kodba S, 2005, EUR J PHYS, V26, P205, DOI 10.1088/0143-0807/26/1/021; Kostic S, 2013, PHYSICA A, V392, P4134, DOI 10.1016/j.physa.2013.04.045; Kugiumtzis D, 2010, J STAT SOFTW, V33, P1; Kuzu C, 2008, SOIL DYN EARTHQ ENG, V28, P405, DOI 10.1016/j.soildyn.2007.06.013; Langefors U., 1963, MODERN TECHNIQUES RO; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Mohamadnejad M, 2012, TUNN UNDERGR SP TECH, V28, P238, DOI 10.1016/j.tust.2011.12.001; Mohamed MT, 2009, INT J ROCK MECH MIN, V46, P426, DOI 10.1016/j.ijrmms.2008.06.004; Monjezi M, 2011, TUNN UNDERGR SP TECH, V26, P46, DOI 10.1016/j.tust.2010.05.002; Monjezi M, 2013, NEURAL COMPUT APPL, V22, P1637, DOI 10.1007/s00521-012-0856-y; Ozer U, 2008, ENG GEOL, V100, P82, DOI 10.1016/j.enggeo.2008.03.006; Ozkahraman HT, 2006, INT J ROCK MECH MIN, V43, P628, DOI 10.1016/j.ijrmms.2005.09.004; Perc M, 2008, BIOPHYS CHEM, V132, P33, DOI 10.1016/j.bpc.2007.10.002; Roy, 1993, COLLIERY GUARDIAN, V241, P63, DOI DOI 10.1016/0148-9062(93)92499-g; Schreiber T, 1996, PHYS REV LETT, V77, P635, DOI 10.1103/PhysRevLett.77.635; Siskind D.E., 1980, REPORT INVESTIGATION, V74; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Tsoukalas L. H., 1996, FUZZY NEURAL APPROAC; Watrous R. L., 1987, IEEE First International Conference on Neural Networks, P619; WISS JF, 1981, J GEOTECH ENG-ASCE, V107, P167	45	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82056	10.1371/journal.pone.0082056	http://dx.doi.org/10.1371/journal.pone.0082056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358140	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700006
J	Chalmey, C; Giton, F; Chalmel, F; Fiet, J; Jegou, B; Mazaud-Guittot, S				Chalmey, Clementine; Giton, Franck; Chalmel, Frederic; Fiet, Jean; Jegou, Bernard; Mazaud-Guittot, Severine			Systemic Compensatory Response to Neonatal Estradiol Exposure Does Not Prevent Depletion of the Oocyte Pool in the Rat	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; PRIMORDIAL FOLLICLE FORMATION; MESSENGER-RNA EXPRESSION; BISPHENOL-A; GERM-CELLS; GENE-EXPRESSION; SEXUAL-DIFFERENTIATION; POLYOVULAR FOLLICLES; REPRODUCTIVE-ORGANS; MEIOTIC PROGRESSION	The formation of ovarian follicles is a finely tuned process that takes place within a narrow time-window in rodents. Multiple factors and pathways have been proposed to contribute to the mechanisms triggering this process but the role of endocrine factors, especially estrogens, remains elusive. It is currently hypothesized that removal from the maternal hormonal environment permits follicle formation at birth. However, experimentally-induced maintenance of high 17 beta-estradiol (E2) levels leads to subtle, distinct, immediate effects on follicle formation and oocyte survival depending on the species and dose. In this study, we examined the immediate effects of neonatal E2 exposure from post-natal day (PND) 0 to PND2 on the whole organism and on ovarian follicle formation in rats. Measurements of plasma E2, estrone and their sulfate conjugates after E2 exposure showed that neonatal female rats rapidly acquire the capability to metabolize and clear excessive E2 levels. Concomitant modifications to the mRNA content of genes encoding selected E2 metabolism enzymes in the liver and the ovary in response to E2 exposure indicate that E2 may modify the neonatal maturation of these organs. In the liver, E2 treatment was associated with lower acquisition of the capability to metabolize E2. In the ovary, E2 depleted the oocyte pool in a dose dependent manner by PND3. In 10 mu g/day E2-treated ovaries, apoptotic oocytes were observed in newly formed follicles in addition to areas of ovarian cord remodeling. At PND6, follicles without any visible oocyte were present and multi-oocyte follicles were not observed. Our study reveals a major species-difference. Indeed, neonatal exposure to E2 depletes the oocyte pool in the rat ovary, whereas in the mouse it is well known to increase oocyte survival.	[Chalmey, Clementine; Chalmel, Frederic; Jegou, Bernard; Mazaud-Guittot, Severine] Univ Rennes 1, INSERM, U1085, Inst Rech Sante Environm & Travail,Inst Federatif, Rennes, France; [Giton, Franck] Hop H Mondor A Chenevier, AP HP, Serv Biochim & Genet, Creteil, France; [Giton, Franck; Fiet, Jean] Hop Henri Mondor, INSERM, U955, Equipe 07, F-94010 Creteil, France; [Jegou, Bernard] Ecole Hautes Etud Sante Publ, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Mazaud-Guittot, S (corresponding author), Univ Rennes 1, INSERM, U1085, Inst Rech Sante Environm & Travail,Inst Federatif, Rennes, France.	severine.mazaud@univ-rennes1.fr	Chalmel, Frédéric/L-5360-2018; Mazaud-Guittot, Severine/I-4694-2015; Chalmel, Frédéric/AAM-1079-2021; Chalmel, Frederic/M-1297-2016; Jégou, Bernard/I-4742-2015	Chalmel, Frédéric/0000-0002-0535-3628; Mazaud-Guittot, Severine/0000-0003-0566-4124; Chalmel, Frédéric/0000-0002-0535-3628; GITON, Frank/0000-0002-4959-1214; Chalmey, Clementine/0000-0002-1874-2876; JEGOU, Bernard/0000-0003-0623-3609	Region Bretagne [10022]; Inserm; University Rennes 1 (Defits scientifiques emergents); Rennes Metropole [10-705]	Region Bretagne(Region Bretagne); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Rennes 1 (Defits scientifiques emergents); Rennes Metropole(Region Bretagne)	C. Chalmey is funded by Region Bretagne (Doctoral research grant # 10022). This study was funded by Inserm, University Rennes 1 (Defits scientifiques emergents -2010) and Rennes Metropole (# 10-705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewale HB, 2009, BIOL REPROD, V81, P690, DOI 10.1095/biolreprod.109.078261; Akinola LA, 1997, ENDOCRINOLOGY, V138, P2886, DOI 10.1210/en.138.7.2886; Bateman HL, 2008, NEUROTOXICOLOGY, V29, P988, DOI 10.1016/j.neuro.2008.06.008; BEAUMONT HM, 1962, PROC R SOC SER B-BIO, V155, P557, DOI 10.1098/rspb.1962.0019; Bertolasio J, 2011, NEUROTOXICOLOGY, V32, P809, DOI 10.1016/j.neuro.2011.06.007; Blair IA, 2010, STEROIDS, V75, P297, DOI 10.1016/j.steroids.2010.01.012; Brieno-Enriquez MA, 2011, HUM REPROD, V26, P2807, DOI 10.1093/humrep/der249; Buckley DB, 2009, DRUG METAB DISPOS, V37, P834, DOI 10.1124/dmd.108.024224; BURGOYNE PS, 1985, J REPROD FERTIL, V75, P633, DOI 10.1530/jrf.0.0750633; Chalmel F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-86; Chapple RH, 2013, PHYSIOL GENOMICS, V45, P301, DOI 10.1152/physiolgenomics.00128.2012; Chen Y, 2007, ENDOCRINOLOGY, V148, P3580, DOI 10.1210/en.2007-0088; Choi YS, 2007, BIOL REPROD, V77, P312, DOI 10.1095/biolreprod.107.060459; Daston GP, 2005, REPROD TOXICOL, V19, P381, DOI 10.1016/j.reprotox.2004.09.004; De Pol A, 2001, MARC MALPIG SYMP SER, V8, P233; de Zwart L, 2008, REPROD TOXICOL, V26, P220, DOI 10.1016/j.reprotox.2008.09.010; Deb S, 2011, MOL CELL BIOCHEM, V358, P387, DOI 10.1007/s11010-011-0994-z; Diel P, 2002, TOXICOL LETT, V127, P217, DOI 10.1016/S0378-4274(01)00503-3; Escobar ML, 2008, APOPTOSIS, V13, P1253, DOI 10.1007/s10495-008-0248-z; Gawriluk TR, 2011, REPRODUCTION, V141, P759, DOI 10.1530/REP-10-0489; Gershon E, 2007, FASEB J, V21, P1893, DOI 10.1096/fj.06-7688com; Ghafari F, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-87; Giton F, 2011, EUR J ENDOCRINOL, V165, P917, DOI 10.1530/EJE-11-0551; Giton F, 2010, CLIN CHIM ACTA, V411, P1208, DOI 10.1016/j.cca.2010.04.022; Guigon CJ, 2006, BIOL REPROD, V74, P450, DOI 10.1095/biolreprod.105.047134; Guigon CJ, 2005, ENDOCRINOLOGY, V146, P2992, DOI 10.1210/en.2005-0045; Guittot SM, 2006, BIOL REPROD, V75, P749, DOI 10.1095/biolreprod.105.050633; Hazell GGJ, 2009, J ENDOCRINOL, V202, P223, DOI 10.1677/JOE-09-0066; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43, DOI 10.1016/s0074-7696(08)61524-7; IGUCHI T, 1990, BIOL REPROD, V43, P478, DOI 10.1095/biolreprod43.3.478; IGUCHI T, 1991, In Vivo (Attiki), V5, P359; Ikeda Y, 2002, ENDOCRINOLOGY, V143, P304, DOI 10.1210/en.143.1.304; Ikeda Y, 2001, DEV DYNAM, V221, P443, DOI 10.1002/dvdy.1162; Jefferson W, 2006, BIOL REPROD, V74, P161, DOI 10.1095/biolreprod.105.045724; Jefferson WN, 2000, BIOL REPROD, V62, P310, DOI 10.1095/biolreprod62.2.310; Karavan JR, 2012, REPROD TOXICOL, V34, P51, DOI 10.1016/j.reprotox.2012.02.005; Kato H, 2003, REPROD TOXICOL, V17, P283, DOI 10.1016/S0890-6238(03)00002-9; Kezele P, 2003, ENDOCRINOLOGY, V144, P3329, DOI 10.1210/en.2002-0131; Kezele PR, 2005, BIOL REPROD, V72, P241, DOI 10.1095/biolreprod.104.032060; Kim H, 2009, BIOL REPROD, V81, P1002, DOI 10.1095/biolreprod.108.070599; Kipp JL, 2007, ENDOCRINOLOGY, V148, P1968, DOI 10.1210/en.2006-1083; Konkle ATM, 2011, ENDOCRINOLOGY, V152, P223, DOI 10.1210/en.2010-0607; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Labrie F, 2007, J STEROID BIOCHEM, V103, P178, DOI 10.1016/j.jsbmb.2006.09.034; Lechowska A, 2011, J ASSIST REPROD GEN, V28, P583, DOI 10.1007/s10815-011-9553-5; Lee JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024381; Lei L, 2010, BIOL REPROD, V82, P13, DOI 10.1095/biolreprod.109.077404; Lepine J, 2004, J CLIN ENDOCR METAB, V89, P5222, DOI 10.1210/jc.2004-0331; Leung GS, 2009, DRUG METAB DISPOS, V37, P523, DOI 10.1124/dmd.108.025635; LIEVERTZ RW, 1987, AM J OBSTET GYNECOL, V156, P1289, DOI 10.1016/0002-9378(87)90166-9; Losa SM, 2011, REPROD TOXICOL, V31, P280, DOI 10.1016/j.reprotox.2010.10.002; Luu-The V, 2005, J STEROID BIOCHEM, V93, P269, DOI 10.1016/j.jsbmb.2005.01.003; Marzona L, 2001, IN VIVO, V15, P271; Masuyama H, 2001, MOL CELL ENDOCRINOL, V172, P47, DOI 10.1016/S0303-7207(00)00395-6; Mazatid S, 2005, DEV BIOL, V277, P403, DOI 10.1016/j.ydbio.2004.10.001; Mazaud S, 2002, ENDOCRINOLOGY, V143, P4775, DOI 10.1210/en.2002-220464; MEIJSROE.HM, 1973, J ENDOCRINOL, V59, P295, DOI 10.1677/joe.0.0590295; Miyagi Y, 1995, LAB INVEST, V73, P890; Mnif W, 2007, TOXICOL LETT, V170, P19, DOI 10.1016/j.toxlet.2006.11.016; MONTANO MM, 1995, BIOL REPROD, V53, P1198, DOI 10.1095/biolreprod53.5.1198; Mowa CN, 2000, J ENDOCRINOL, V167, P363, DOI 10.1677/joe.0.1670363; Naciff JM, 2005, TOXICOL SCI, V86, P396, DOI 10.1093/toxsci/kfi198; Naciff JM, 2007, TOXICOL SCI, V97, P467, DOI 10.1093/toxsci/kfm046; Navarro VM, 2009, ENDOCRINOLOGY, V150, P2359, DOI 10.1210/en.2008-0580; Navarro VM, 2004, ENDOCRINOLOGY, V145, P4565, DOI 10.1210/en.2004-0413; Nilsson EE, 2009, MOL CELL ENDOCRINOL, V313, P9, DOI 10.1016/j.mce.2009.09.004; ODUM J, 1983, BIOCHEM PHARMACOL, V32, P3565, DOI 10.1016/0006-2952(83)90304-0; ORIOWO MA, 1980, CONTRACEPTION, V21, P415, DOI 10.1016/S0010-7824(80)80018-7; Paredes A, 2005, ENDOCRINOLOGY, V146, P5267, DOI 10.1210/en.2005-0965; Patisaul HB, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-2; Pepling ME, 2012, REPRODUCTION, V143, P139, DOI 10.1530/REP-11-0299; Raftogianis R, 2000, J Natl Cancer Inst Monogr, P113; RAJAH R, 1992, DEV DYNAM, V194, P177, DOI 10.1002/aja.1001940303; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Reddy P, 2005, DEV BIOL, V281, P160, DOI 10.1016/j.ydbio.2005.02.013; Ritter JK, 2000, CHEM-BIOL INTERACT, V129, P171, DOI 10.1016/S0009-2797(00)00198-8; Rodriguez HA, 2010, REPROD TOXICOL, V30, P550, DOI 10.1016/j.reprotox.2010.07.008; Sar M, 1999, ENDOCRINOLOGY, V140, P963, DOI 10.1210/en.140.2.963; SHAIKH AA, 1971, BIOL REPROD, V5, P297, DOI 10.1093/biolreprod/5.3.297; Shibutani M, 2005, TOXICOLOGY, V208, P35, DOI 10.1016/j.tox.2004.11.007; Singhal R, 2009, J ENDOCRINOL, V202, P141, DOI 10.1677/JOE-09-0059; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Stahlberg Nina, 2005, BMC Physiol, V5, P8, DOI 10.1186/1472-6793-5-8; Suchar LA, 1996, ENDOCRINOLOGY, V137, P663, DOI 10.1210/en.137.2.663; Suzuki A, 2002, REPROD TOXICOL, V16, P107, DOI 10.1016/S0890-6238(02)00005-9; Tanaka H, 1997, INT J ANDROL, V20, P361; TELFER E, 1987, J REPROD FERTIL, V81, P137, DOI 10.1530/jrf.0.0810137; Udomsuk L, 2011, J ETHNOPHARMACOL, V137, P902, DOI 10.1016/j.jep.2011.06.047; Wang C, 2008, ENDOCRINOLOGY, V149, P4452, DOI 10.1210/en.2008-0441; Wang C, 2007, ENDOCRINOLOGY, V148, P1707, DOI 10.1210/en.2006-1193; Wang NL, 2011, ENDOCRINOLOGY, V152, P1024, DOI 10.1210/en.2010-0797; WEISZ J, 1980, ENDOCRINOLOGY, V106, P306, DOI 10.1210/endo-106-1-306; WENIGER JP, 1993, REPROD NUTR DEV, V33, P129, DOI 10.1051/rnd:19930205; Whitworth DJ, 1998, TRENDS ENDOCRIN MET, V9, P2, DOI 10.1016/S1043-2760(98)00002-2; Wiegand Heike, 2009, Cancer Genomics & Proteomics, V6, P85; You L, 1999, TOXICOL APPL PHARM, V158, P197, DOI 10.1006/taap.1999.8694; Zachos NC, 2002, BIOL REPROD, V67, P1148, DOI 10.1095/biolreprod67.4.1148; Zhang HQ, 2012, MOL BIOL REP, V39, P5651, DOI 10.1007/s11033-011-1372-3; Zhu BT, 1998, CARCINOGENESIS, V19, P1, DOI 10.1093/carcin/19.1.1	99	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82175	10.1371/journal.pone.0082175	http://dx.doi.org/10.1371/journal.pone.0082175			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358151	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700040
J	Hiyama, T; Ozeki, N; Mogi, M; Yamaguchi, H; Kawai, R; Nakata, K; Kondo, A; Nakamura, H				Hiyama, Taiki; Ozeki, Nobuaki; Mogi, Makio; Yamaguchi, Hideyuki; Kawai, Rie; Nakata, Kazuhiko; Kondo, Ayami; Nakamura, Hiroshi			RETRACTED: Matrix Metalloproteinase-3 in Odontoblastic Cells Derived from Ips Cells: Unique Proliferation Response as Odontoblastic Cells Derived from ES Cells (Retracted article. See vol. 13, art no E0198542 , 2018)	PLOS ONE			English	Article; Retracted Publication							NECROSIS-FACTOR-ALPHA; DENTAL-PULP CELLS; DIFFERENTIAL EXPRESSION; STEM-CELLS; TISSUE; INTERLEUKIN-1-BETA; ACTIVATION; INHIBITORS; PROCOLLAGENASE; INFLAMMATION	We previously reported that matrix metalloproteinase (MMP)-3 accelerates wound healing following dental pulp injury. In addition, we reported that a proinflammatory cytokine mixture (tumor necrosis factor-alpha, interleukin (IL)-1 beta and interferon-gamma) induced MMP-3 activity in odontoblast-like cells derived from mouse embryonic stem (ES) cells, suggesting that MMP-3 plays a potential unique physiological role in wound healing and regeneration of dental pulp in odontoblast-like cells. In this study, we tested the hypothesis that upregulation of MMP-3 activity by IL-1 beta promotes proliferation and apoptosis of purified odontoblast-like cells derived from induced pluripotent stem (iPS) and ES cells. Each odontoblast-like cell was isolated and incubated with different concentrations of IL-1 beta. MMP-3 mRNA and protein expression were assessed using RTPCR and western blotting, respectively. MMP-3 activity was measured using immunoprecipitation and a fluorescence substrate. Cell proliferation and apoptosis were determined using ELISA for BrdU and DNA fragmentation, respectively. siRNA was used to reduce MMP-3 transcripts in these cells. Treatment with IL-1 beta increased MMP-3 mRNA and protein levels, and MMP-3 activity in odontoblast-like cells. Cell proliferation was found to markedly increase with no changes in apoptosis. Endogenous tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 were constitutively expressed during all experiments. The exocytosis inhibitor, Exo1, potently suppressed the appearance of MMP-3 in the conditioned medium. Treatment with siRNA against MMP-3 suppressed an IL-1 beta-induced increase in MMP-3 expression and activity, and also suppressed cell proliferation, but unexpectedly increased apoptosis in these cells (P<0.05). Exogenous MMP-3 was found to induce cell proliferation in odontoblast-like cells derived from iPS cells and ES cells. This siRNA-mediated increase in apoptosis could be reversed with exogenous MMP-3 stimulation (P<0.05). Taken together, IL-1 beta induced MMP-3-regulated cell proliferation and suppressed apoptosis in odontoblast-like cells derived from iPS and ES cells.	[Hiyama, Taiki; Ozeki, Nobuaki; Yamaguchi, Hideyuki; Kawai, Rie; Nakata, Kazuhiko; Nakamura, Hiroshi] Aichi Gakuin Univ, Sch Dent, Dept Endodont, Nagoya, Aichi 464, Japan; [Mogi, Makio; Kondo, Ayami] Aichi Gakuin Univ, Sch Pharm, Dept Med Biochem, Nagoya, Aichi 464, Japan	Aichi Gakuin University; Aichi Gakuin University	Ozeki, N (corresponding author), Aichi Gakuin Univ, Sch Dent, Dept Endodont, 1-100 Kusumoto Cho, Nagoya, Aichi 464, Japan.	ozeki@g.agu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22791853]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant (No. 22791853 to NO) from the program Grants-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Elmeguid A, 2012, J ENDODONT, V38, P75, DOI 10.1016/j.joen.2011.10.005; BRINCKERHOFF CE, 1990, J BIOL CHEM, V265, P22262; Candelario-Jalil E, 2007, J PHARMACOL EXP THER, V323, P488, DOI 10.1124/jpet.107.127035; Cheng WD, 2013, INT ORTHOP, V37, P2065, DOI 10.1007/s00264-013-1990-6; Eba H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052523; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; Paula-Silva FWG, 2010, J ENDODONT, V36, P231, DOI 10.1016/j.joen.2009.10.030; Ge XP, 2009, ARTHRITIS RHEUM-US, V60, P2714, DOI 10.1002/art.24779; Goda S, 2008, J DENT RES, V87, P782, DOI 10.1177/154405910808700805; Gusman H, 2002, EUR J ORAL SCI, V110, P353, DOI 10.1034/j.1600-0722.2002.21347.x; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; Kawai R, 2013, ORAL DIS; Kessenbrock K, 2013, CELL STEM CELL, V13, P300, DOI 10.1016/j.stem.2013.06.005; Kim RH, 2013, J ENDODONT, V39, P57, DOI 10.1016/j.joen.2012.09.006; Koyama N, 2009, J MED INVESTIG, V56, P247, DOI 10.2152/jmi.56.247; Koyama Y, 2008, BIOCHEM BIOPH RES CO, V371, P659, DOI 10.1016/j.bbrc.2008.04.064; Ma B, 2012, ARTHRITIS RHEUM-US, V64, P2589, DOI 10.1002/art.34425; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Mogi M, 2004, BONE, V35, P507, DOI 10.1016/j.bone.2004.03.003; Mogi M, 2003, J BIOL CHEM, V278, P47477, DOI 10.1074/jbc.M307055200; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Noguchi F, 2009, J ENDODONT, V35, P668, DOI 10.1016/j.joen.2009.01.016; Ozeki N, 2002, ARCH ORAL BIOL, V47, P511, DOI 10.1016/S0003-9969(02)00035-3; Ozeki N., 2013, ORAL DIS; Ozeki N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080026; Palosaari H, 2003, EUR J ORAL SCI, V111, P117, DOI 10.1034/j.1600-0722.2003.00026.x; Shimizukawa R, 2005, GENESIS, V42, P47, DOI 10.1002/gene.20122; Shin SJ, 2002, J ENDODONT, V28, P313, DOI 10.1097/00004770-200204000-00013; Song Z, 2012, J ENDODONT, V38, P1592, DOI 10.1016/j.joen.2012.09.023; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; SUZUKI K, 1990, BIOCHEMISTRY-US, V29, P10261, DOI 10.1021/bi00496a016; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TANIISHII N, 1995, ORAL MICROBIOL IMMUN, V10, P213, DOI 10.1111/j.1399-302X.1995.tb00145.x; Teles J C, 1967, Rev Bras Odontol, V25, P305; Tseng WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063963; Vanderford NL, 2010, ISLETS, V2, P334, DOI 10.4161/isl.2.5.13095; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wahlgren J, 2002, INT ENDOD J, V35, P897, DOI 10.1046/j.1365-2591.2002.00587.x; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wisithphrom K, 2006, J ENDODONT, V32, P853, DOI 10.1016/j.joen.2006.03.017; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Yamaguchi H, 2013, J ENDOD IN PRESS; Zheng L, 2009, AM J PATHOL, V175, P1905, DOI 10.2353/ajpath.2009.080705; Zhong S, 2012, J ENDODONT, V38, P746, DOI 10.1016/j.joen.2012.02.020	46	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83563	10.1371/journal.pone.0083563	http://dx.doi.org/10.1371/journal.pone.0083563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358294	gold, Green Published			2022-12-27	WOS:000328735700132
J	Liao, XM; Zhou, XL; Mak, NK; Leung, KN				Liao, Xuemei; Zhou, Xuelin; Mak, Nai-ki; Leung, Kwok-nam			Tryptanthrin Inhibits Angiogenesis by Targeting the VEGFR2-Mediated ERK1/2 Signalling Pathway	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; GROWTH-FACTOR RECEPTORS; IN-VIVO; ENDOTHELIAL-CELLS; TUMOR ANGIOGENESIS; KINASE INHIBITORS; LEUKEMIA-CELLS; MECHANISMS; VEGFR2; VITRO	Angiogenesis is a key step for tumour growth and metastasis, and anti-angiogenesis has been proposed as an important strategy for cancer therapy. Tryptanthrin is a weakly basic alkaloid isolated from the dried roots of medicinal indigo plants and has been shown to possess anti-tumour activities on various cancer cell types. This study aims to investigate the in vitro and in vivo anti-angiogenic activities of tryptanthrin and to unravel its underlying molecular action mechanisms. Our results show that tryptanthrin inhibited the in vitro proliferation, migration, and tube formation of the human microvascular endothelial cells (HMEC-1) in a concentration-dependent manner and significantly suppressed angiogenesis in Matrigel plugs in mice. Mechanistic studies indicated that tryptanthrin reduced the expression of several pro-angiogenic factors (Ang-1, PDGFB and MMP2). Tryptanthrin was also found to suppress the VEGFR2-mediated ERK1/2 signalling pathway in HMEC-1 cells and molecular docking simulation indicated that tryptanthrin could bound to the ATP-binding site of VEGFR2. Collectively, the present study demonstrated that tryptanthrin exhibited both in vitro and in vivo anti-angiogenic activities by targeting the VEGFR2-mediated ERK1/2 signalling pathway and might have therapeutic potential for the treatment of angiogenesis-related diseases.	[Liao, Xuemei; Leung, Kwok-nam] Chinese Univ Hong Kong, Sch Life Sci, Biochem Programme, Shatin, Hong Kong, Peoples R China; [Zhou, Xuelin] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Mak, Nai-ki] Hong Kong Baptist Univ, Dept Biol, Kowloon Tong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Hong Kong Baptist University	Leung, KN (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Biochem Programme, Shatin, Hong Kong, Peoples R China.	knleung@cuhk.edu.hk	ZHOU, Xuelin/L-4359-2013	ZHOU, Xuelin/0000-0002-4051-7851	School of Life Sciences, The Chinese University of Hong Kong	School of Life Sciences, The Chinese University of Hong Kong	This work was supported by the general research funding of the School of Life Sciences, The Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; BAR RS, 1989, ENDOCRINOLOGY, V124, P1841, DOI 10.1210/endo-124-4-1841; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Cattaneo MG, 2003, BRIT J PHARMACOL, V138, P377, DOI 10.1038/sj.bjp.0705051; Chan HL, 2009, CELL MOL IMMUNOL, V6, P335, DOI 10.1038/cmi.2009.44; Chan JYW, 2011, J ETHNOPHARMACOL, V137, P64, DOI 10.1016/j.jep.2011.04.021; Chan YK, 2012, BIOCHEM PHARMACOL, V83, P598, DOI 10.1016/j.bcp.2011.12.003; Eggert A, 2000, CLIN CANCER RES, V6, P1900; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; He MF, 2010, INT J CANCER, V126, P266, DOI 10.1002/ijc.24694; HONDA G, 1979, PLANTA MED, V37, P172, DOI 10.1055/s-0028-1097320; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hurwitz HI, 2005, J CLIN ONCOL, V23, P3502, DOI 10.1200/JCO.2005.10.017; KANEKO T, 1992, STROKE, V23, P1637, DOI 10.1161/01.STR.23.11.1637; Kankanala J, 2012, BRIT J PHARMACOL, V166, P737, DOI 10.1111/j.1476-5381.2011.01801.x; Karkkainen MJ, 2000, ONCOGENE, V19, P5598, DOI 10.1038/sj.onc.1203855; Kimoto T, 2001, PATHOL INT, V51, P315, DOI 10.1046/j.1440-1827.2001.01204.x; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Lai L, 2012, BRIT J PHARMACOL, V165, P1084, DOI 10.1111/j.1476-5381.2011.01532.x; Lee K, 2010, EUR J MED CHEM, V45, P5420, DOI 10.1016/j.ejmech.2010.09.002; Liao XM, 2013, CHEM-BIOL INTERACT, V203, P512, DOI 10.1016/j.cbi.2013.03.001; Lin YK, 2009, J ETHNOPHARMACOL, V125, P51, DOI 10.1016/j.jep.2009.06.014; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; McTigue MA, 1999, STRUCT FOLD DES, V7, P319, DOI 10.1016/S0969-2126(99)80042-2; Mu XM, 2012, MOLECULES, V17, P6854, DOI 10.3390/molecules17066854; Nanobashvili J., 2003, EUR SURG, V35, P214, DOI 10.1007/s10353-003-0012-0; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Paz K, 2005, FRONT BIOSCI-LANDMRK, V10, P1415, DOI 10.2741/1629; Pedram A, 1998, J BIOL CHEM, V273, P26722, DOI 10.1074/jbc.273.41.26722; Recio MC, 2006, PLANTA MED, V72, P539, DOI 10.1055/s-2006-931562; Risau W, 1992, GROWTH FACTORS, V7, P261, DOI 10.3109/08977199209046408; Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661; Schrenk D, 1997, BIOCHEM PHARMACOL, V54, P165, DOI 10.1016/S0006-2952(97)00150-0; Shojaei F, 2012, CANCER LETT, V320, P130, DOI 10.1016/j.canlet.2012.03.008; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Takahashi S, 2011, BIOL PHARM BULL, V34, P1785, DOI 10.1248/bpb.34.1785; Thakker GD, 1999, J BIOL CHEM, V274, P10002, DOI 10.1074/jbc.274.15.10002; Tong YG, 2005, INT J CANCER, V114, P843, DOI 10.1002/ijc.20804; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Yu ST, 2007, BIOCHEM BIOPH RES CO, V358, P79, DOI 10.1016/j.bbrc.2007.04.107; Yue GGL, 2011, BRIT J PHARMACOL, V164, P1883, DOI 10.1111/j.1476-5381.2011.01458.x; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6; Zhou XL, 2013, PHYTOMEDICINE, V20, P367, DOI 10.1016/j.phymed.2012.09.021; Zhu XG, 2011, J PHARM PHARM SCI, V14, P325, DOI 10.18433/J3501W	48	44	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82294	10.1371/journal.pone.0082294	http://dx.doi.org/10.1371/journal.pone.0082294			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358167	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700056
J	Mahro, M; Bras, NF; Cerqueira, NMFSA; Teutloff, C; Coelho, C; Romao, MJ; Leimkuhler, S				Mahro, Martin; Bras, Natercia F.; Cerqueira, Nuno M. F. S. A.; Teutloff, Christian; Coelho, Catarina; Romao, Maria Joao; Leimkuehler, Silke			Identification of Crucial Amino Acids in Mouse Aldehyde Oxidase 3 That Determine Substrate Specificity	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; XANTHINE-OXIDASE; ACTIVE-SITE; MOLYBDO-FLAVOENZYMES; CRYSTAL-STRUCTURE; DEHYDROGENASE; EXPRESSION; RESIDUES; FAMILY; ALDEHYDE-OXIDASE-1	In order to elucidate factors that determine substrate specificity and activity of mammalian molybdo-flavoproteins we performed site directed mutagenesis of mouse aldehyde oxidase 3 (mAOX3). The sequence alignment of different aldehyde oxidase (AOX) isoforms identified variations in the active site of mAOX3 in comparison to other AOX proteins and xanthine oxidoreductases (XOR). Based on the structural alignment of mAOX3 and bovine XOR, differences in amino acid residues involved in substrate binding in XORs in comparison to AOXs were identified. We exchanged several residues in the active site to the ones found in other AOX homologues in mouse or to residues present in bovine XOR in order to examine their influence on substrate selectivity and catalytic activity. Additionally we analyzed the influence of the [2Fe-2S] domains of mAOX3 on its kinetic properties and cofactor saturation. We applied UV-VIS and EPR monitored redox-titrations to determine the redox potentials of wild type mAOX3 and mAOX3 variants containing the iron-sulfur centers of mAOX1. In addition, a combination of molecular docking and molecular dynamic simulations (MD) was used to investigate factors that modulate the substrate specificity and activity of wild type and AOX variants. The successful conversion of an AOX enzyme to an XOR enzyme was achieved exchanging eight residues in the active site of mAOX3. It was observed that the absence of the K889H exchange substantially decreased the activity of the enzyme towards all substrates analyzed, revealing that this residue has an important role in catalysis.	[Mahro, Martin; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, Dept Mol Enzymol, Potsdam, Germany; [Bras, Natercia F.; Cerqueira, Nuno M. F. S. A.] Univ Porto, Fac Ciencias, Dept Quim, REQUIMTE, P-4100 Oporto, Portugal; [Teutloff, Christian] Free Univ Berlin, Inst Experimentalphys, Berlin, Germany; [Coelho, Catarina; Romao, Maria Joao] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, REQUIMTE, Caparica, Portugal	University of Potsdam; Universidade do Porto; Free University of Berlin; Universidade Nova de Lisboa	Leimkuhler, S (corresponding author), Univ Potsdam, Inst Biochem & Biol, Dept Mol Enzymol, Potsdam, Germany.	sleim@uni-potsdam.de	Cerqueira, Nuno M. F. Sousa A. MFSA/A-5182-2008; Romao, Maria J/A-4115-2013; UCIBIO, U Cienc Biom Apl/F-7948-2017; Fernandes, Pedro A/D-6327-2013; Bras, Natercia/D-5493-2013; Coelho, Catarina M C/D-2073-2013	Cerqueira, Nuno M. F. Sousa A. MFSA/0000-0003-0342-7424; Romao, Maria J/0000-0002-3004-0543; UCIBIO, U Cienc Biom Apl/0000-0002-3004-0543; Fernandes, Pedro A/0000-0003-2748-4722; Bras, Natercia/0000-0002-3130-9807; Coelho, Catarina M C/0000-0003-1852-5406; Leimkuhler, Silke/0000-0003-3238-2122	Cluster of Excellence "Unifying Concepts in Catalysis"; Deutsche Forschungsgemeinschaft; DAAD-GRICES program	Cluster of Excellence "Unifying Concepts in Catalysis"(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DAAD-GRICES program	This work was supported by the Cluster of Excellence "Unifying Concepts in Catalysis" (to C. T. and S. L.) coordinated by the Technische Universitat Berlin and funded by the Deutsche Forschungsgemeinschaft. The exchange of researchers among laboratories involved in the work was funded by the DAAD-GRICES program (to MJ Romao and S Leimkuhler). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; BARBER MJ, 1982, BIOCHEMISTRY-US, V21, P3561, DOI 10.1021/bi00258a006; BARBER MJ, 1977, BIOCHEM J, V163, P279, DOI 10.1042/bj1630279; Batsanov SS, 2001, INORG MATER+, V37, P871, DOI 10.1023/A:1011625728803; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Becke AD, 1996, J CHEM PHYS, V104, P1040, DOI 10.1063/1.470829; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Caldeira J, 2000, BIOCHEMISTRY-US, V39, P2700, DOI 10.1021/bi9921485; Carvalho ATP, 2013, J COMPUT CHEM, V34, P1540, DOI 10.1002/jcc.23287; Cerqueira NMFSA, 2011, INT J QUANTUM CHEM, V111, P1208, DOI 10.1002/qua.22738; Coelho C, 2012, J BIOL CHEM, V287, P40690, DOI 10.1074/jbc.M112.390419; Coughlan M. P., 1980, Molybdenum and molybdenum-containing enzymes, P119; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Eswar N., 2006, CURR PROT BIOINF, V15, P1, DOI [10.1002/0471250953.bi0506s15, DOI 10.1002/0471250953.BI0506S15]; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Frisch M.J., 2009, GAUSSIAN09; Garattini E, 2008, CELL MOL LIFE SCI, V65, P1019, DOI 10.1007/s00018-007-7398-y; Garattini E, 2003, BIOCHEM J, V372, P15, DOI 10.1042/BJ20030121; Garattini Enrico, 2009, Human Genomics, V4, P119; Hartmann T, 2012, DRUG METAB DISPOS, V40, P856, DOI 10.1124/dmd.111.043828; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Itoh K, 2009, BIOL PHARM BULL, V32, P31, DOI 10.1248/bpb.32.31; Izaguirre JA, 2001, J CHEM PHYS, V114, P2090, DOI 10.1063/1.1332996; JOHNSON JL, 1991, BIOFACTORS, V3, P103; Kitamura S, 2006, DRUG METAB PHARMACOK, V21, P83, DOI 10.2133/dmpk.21.83; Koiwai H, 2000, J BIOCHEM-TOKYO, V127, P659, DOI 10.1093/oxfordjournals.jbchem.a022654; KRENITSKY TA, 1972, ARCH BIOCHEM BIOPHYS, V150, P585, DOI 10.1016/0003-9861(72)90078-1; Kurosaki M, 2004, J BIOL CHEM, V279, P50482, DOI 10.1074/jbc.M408734200; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Leimkuhler S, 2004, J BIOL CHEM, V279, P40437, DOI 10.1074/jbc.M405778200; Mahro M, 2011, DRUG METAB DISPOS, V39, P1939, DOI 10.1124/dmd.111.040873; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Merlin C, 2005, BIOCHEM BIOPH RES CO, V332, P4, DOI 10.1016/j.bbrc.2005.04.084; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Neumann M, 2009, J BIOL CHEM, V284, P21891, DOI 10.1074/jbc.M109.008565; Neves RPP, 2013, J CHEM THEORY COMPUT, V9, P2718, DOI 10.1021/ct400055v; Obach RS, 2004, DRUG METAB DISPOS, V32, P89, DOI 10.1124/dmd.32.1.89; Okamoto K, 2010, J AM CHEM SOC; ROMAO MJ, 1995, SCIENCE, V270, P1170, DOI 10.1126/science.270.5239.1170; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schrodinger L., 2020, PYMOL; Schumann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005348; Sigruener A, 2007, HORM METAB RES, V39, P781, DOI 10.1055/s-2007-992129; STESMANS A, 1989, REV SCI INSTRUM, V60, P2949, DOI 10.1063/1.1140633; Team RDC, 2010, R LANG ENV STAT COMP; Terao M, 2006, J BIOL CHEM, V281, P19748, DOI 10.1074/jbc.M600850200; Terao M, 2009, MOL CELL BIOL, V29, P357, DOI 10.1128/MCB.01385-08; Vila R, 2004, J BIOL CHEM, V279, P8668, DOI 10.1074/jbc.M308137200; WAHL RC, 1982, J BIOL CHEM, V257, P1354; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weigert J, 2008, FEBS LETT, V582, P2965, DOI 10.1016/j.febslet.2008.07.034; Xia M, 1999, J BIOL CHEM, V274, P3323, DOI 10.1074/jbc.274.6.3323; Yamaguchi Y, 2007, J BIOCHEM, V141, P513, DOI 10.1093/jb/mvm053	55	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82285	10.1371/journal.pone.0082285	http://dx.doi.org/10.1371/journal.pone.0082285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358164	Green Submitted, gold, Green Published			2022-12-27	WOS:000328735700053
J	Tecilazich, F; Dinh, T; Pradhan-Nabzdyk, L; Leal, E; Tellechea, A; Kafanas, A; Gnardellis, C; Magargee, ML; Dejam, A; Toxavidis, V; Tigges, JC; Carvalho, E; Lyons, TE; Veves, A				Tecilazich, Francesco; Thanh Dinh; Pradhan-Nabzdyk, Leena; Leal, Ermelindo; Tellechea, Ana; Kafanas, Antonios; Gnardellis, Charalambos; Magargee, Mary L.; Dejam, Andre; Toxavidis, Vasilis; Tigges, John C.; Carvalho, Eugenia; Lyons, Thomas E.; Veves, Aristidis			Role of Endothelial Progenitor Cells and Inflammatory Cytokines in Healing of Diabetic Foot Ulcers	PLOS ONE			English	Article							BONE-MARROW; MOBILIZATION; ISCHEMIA; EXPRESSION; MARKER; NUMBER; BLOOD	Background: To evaluate changes in endothelial progenitor cells (EPCs) and cytokines in patients with diabetic foot ulceration (DFU) in association with wound healing. Methods: We studied healthy subjects, diabetic patients not at risk of DFU, at risk of DFU and with active DFU. We prospectively followed the DFU patients over a 12-week period. We also investigated similar changes in diabetic rabbit and mouse models of wound healing. Results: All EPC phenotypes except the kinase insert domain receptor (KDR)(+)CD133(+) were reduced in the at risk and the DFU groups compared to the controls. There were no major EPC differences between the control and not at risk group, and between the at risk and DFU groups. Serum stromal-cell derived factor-1 (SDF-1) and stem cell factor (SCF) were increased in DFU patients. DFU patients who healed their ulcers had lower CD34(+)KDR(+) count at visits 3 and 4, serum c-reactive protein (CRP) and granulocyte-macrophage colony-stimulating factor (GM-CSF) at visit 1, interleukin-1 (IL-1) at visits 1 and 4. EPCs tended to be higher in both diabetic animal models when compared to their non-diabetic counterparts both before and ten days after wounding. Conclusions: Uncomplicated diabetes does not affect EPCs. EPCs are reduced in patients at risk or with DFU while complete wound healing is associated with CD34(+)KDR(+) reduction, suggesting possible increased homing. Low baseline CRP, IL-1 alpha and GM-CSF serum levels were associated with complete wound healing and may potentially serve as prognostic markers of DFU healing. No animal model alone is representative of the human condition, indicating the need for multiple experimental models.	[Tecilazich, Francesco; Thanh Dinh; Pradhan-Nabzdyk, Leena; Leal, Ermelindo; Tellechea, Ana; Kafanas, Antonios; Magargee, Mary L.; Carvalho, Eugenia; Lyons, Thomas E.; Veves, Aristidis] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Microcirculat Lab, Boston, MA 02215 USA; [Tecilazich, Francesco; Thanh Dinh; Pradhan-Nabzdyk, Leena; Leal, Ermelindo; Tellechea, Ana; Kafanas, Antonios; Magargee, Mary L.; Carvalho, Eugenia; Lyons, Thomas E.; Veves, Aristidis] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Joslin Beth Israel Deaconess Foot Ctr, Boston, MA 02215 USA; [Tellechea, Ana] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Gnardellis, Charalambos] Technol Educ Inst Messolonghi, Mesolongion, Greece; [Dejam, Andre] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Cardiol, Boston, MA 02215 USA; [Toxavidis, Vasilis; Tigges, John C.] Beth Israel Deaconess Med Ctr, Flow Cytometry Core Facil, Boston, MA 02215 USA; [Toxavidis, Vasilis; Tigges, John C.] Harvard Stem Cell Inst, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Joslin Diabetes Center, Inc.; Universidade de Coimbra; Western Greece University of Applied Sciences (TEI of Western Greece); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University	Veves, A (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Microcirculat Lab, Boston, MA 02215 USA.	aveves@bidmc.harvard.edu	Carvalho, Eugenia/AAV-6868-2021; Tellechea, Ana/O-8325-2019; Leal, Ermelindo/G-3051-2010	Carvalho, Eugenia/0000-0001-6264-3632; Tellechea, Ana/0000-0001-9387-7706; Leal, Ermelindo/0000-0003-1748-9861; GNARDELLIS, CHARALAMPOS/0000-0001-8862-7868	National Institutes of Health [R01-DK076937, R21-DK082987, R01 NS066205]; FCT [SFRH/BPD/46341/2008, SFRH/BD/48624/2008]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK082987, R01DK076937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01-DK076937, R21-DK082987 and R01 NS066205 to AV, as well as FCT fellowships SFRH/BPD/46341/2008 (EL) and SFRH/BD/48624/2008 (AT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiero M, 2011, DIABETOLOGIA, V54, P945, DOI 10.1007/s00125-010-2007-2; Association A.D., 1999, DIABETES CARE, V22, P1354, DOI DOI 10.2337/DIACARE.22.8.1354; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Beidler SK, 2009, J VASC SURG, V49, P1013, DOI 10.1016/j.jvs.2008.11.049; Bermudez DM, 2011, J VASC SURG, V53, P774, DOI 10.1016/j.jvs.2010.10.056; Bertolini F, 2009, BBA-REV CANCER, V1796, P27, DOI 10.1016/j.bbcan.2009.04.003; Blann AD, 2006, ATHEROSCLEROSIS, V188, P12, DOI 10.1016/j.atherosclerosis.2005.12.024; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Fadini GP, 2006, DIABETOLOGIA, V49, P3075, DOI 10.1007/s00125-006-0401-6; Fadini GP, 2007, DIABETES CARE, V30, P1305, DOI 10.2337/dc06-2305; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Flammer AJ, 2012, J CLIN ENDOCR METAB, V97, P4761, DOI 10.1210/jc.2012-2642; GAHRING LC, 1985, J CLIN INVEST, V76, P1585, DOI 10.1172/JCI112141; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Greenman RL, 2005, LANCET, V366, P1711, DOI 10.1016/S0140-6736(05)67696-9; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Huang PP, 2005, DIABETES CARE, V28, P2155, DOI 10.2337/diacare.28.9.2155; Khaodhiar L, 2007, DIABETES CARE, V30, P903, DOI 10.2337/dc06-2209; Liao YF, 2010, VASC MED, V15, P279, DOI 10.1177/1358863X10367537; Nishimura Y, 2012, J INVEST DERMATOL, V132, P711, DOI 10.1038/jid.2011.356; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pham H, 2000, DIABETES CARE, V23, P606, DOI 10.2337/diacare.23.5.606; Pradhan L, 2011, J SURG RES, V167, P336, DOI 10.1016/j.jss.2009.09.012; Ramsey SD, 1999, DIABETES CARE, V22, P382, DOI 10.2337/diacare.22.3.382; Saito H, 2012, AM J PHYSIOL-CELL PH, V302, pC892, DOI 10.1152/ajpcell.00380.2011; Schomig K, 2006, EUR HEART J, V27, P1032, DOI 10.1093/eurheartj/ehi761; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Dinh T, 2012, DIABETES, V61, P2937, DOI 10.2337/db12-0227; Timmermans F, 2007, ARTERIOSCL THROM VAS, V27, P1572, DOI 10.1161/ATVBAHA.107.144972; van Ark J, 2012, DIABETOLOGIA, V55, P2501, DOI 10.1007/s00125-012-2590-5; Veves A, 1998, DIABETES, V47, P457, DOI 10.2337/diabetes.47.3.457; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Zerbini G, 2012, DIABETES, V61, P908, DOI 10.2337/db11-1197	37	49	51	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83314	10.1371/journal.pone.0083314	http://dx.doi.org/10.1371/journal.pone.0083314			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358275	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700118
J	Brainard, RE; Watson, LJ; DeMartino, AM; Brittian, KR; Readnower, RD; Boakye, AA; Zhang, DQ; Hoetker, JD; Bhatnagar, A; Baba, SP; Jones, SP				Brainard, Robert E.; Watson, Lewis J.; DeMartino, Angelica M.; Brittian, Kenneth R.; Readnower, Ryan D.; Boakye, Adjoa Agyemang; Zhang, Deqing; Hoetker, Joseph David; Bhatnagar, Aruni; Baba, Shahid Pervez; Jones, Steven P.			High Fat Feeding in Mice Is Insufficient to Induce Cardiac Dysfunction and Does Not Exacerbate Heart Failure	PLOS ONE			English	Article							MYOCARDIAL REPERFUSION INJURY; GENE; DIET; CARBOHYDRATE; HYPERTROPHY; INHIBITION; EXPRESSION; MORTALITY	Preclinical studies of animals with risk factors, and how those risk factors contribute to the development of cardiovascular disease and cardiac dysfunction, are clearly needed. One such approach is to feed mice a diet rich in fat (i.e. 60%). Here, we determined whether a high fat diet was sufficient to induce cardiac dysfunction in mice. We subjected mice to two different high fat diets (lard or milk as fat source) and followed them for over six months and found no significant decrement in cardiac function (via echocardiography), despite robust adiposity and impaired glucose disposal. We next determined whether antecedent and concomitant exposure to high fat diet (lard) altered the murine heart's response to infarct-induced heart failure; high fat feeding during, or before and during, heart failure did not significantly exacerbate cardiac dysfunction. Given the lack of a robust effect on cardiac dysfunction with high fat feeding, we then examined a commonly used mouse model of overt diabetes, hyperglycemia, and obesity (db/db mice). db/db mice (or STZ treated wild-type mice) subjected to pressure overload exhibited no significant exacerbation of cardiac dysfunction; however, ischemia-reperfusion injury significantly depressed cardiac function in db/db mice compared to their non-diabetic littermates. Thus, we were able to document a negative influence of a risk factor in a relevant cardiovascular disease model; however, this did not involve exposure to a high fat diet. High fat diet, obesity, or hyperglycemia does not necessarily induce cardiac dysfunction in mice. Although many investigators use such diabetes/obesity models to understand cardiac defects related to risk factors, this study, along with those from several other groups, serves as a cautionary note regarding the use of murine models of diabetes and obesity in the context of heart failure.	[Brainard, Robert E.; Watson, Lewis J.; DeMartino, Angelica M.; Brittian, Kenneth R.; Readnower, Ryan D.; Boakye, Adjoa Agyemang; Zhang, Deqing; Hoetker, Joseph David; Bhatnagar, Aruni; Baba, Shahid Pervez; Jones, Steven P.] Univ Louisville, Dept Med, Dept Physiol & Biophys, Inst Mol Cardiol, Louisville, KY 40292 USA	University of Louisville	Jones, SP (corresponding author), Univ Louisville, Dept Med, Dept Physiol & Biophys, Inst Mol Cardiol, Louisville, KY 40292 USA.	Steven.P.Jones@Louisville.edu	Watson, Lewis J/F-3688-2011; Jones, Steven P./D-5092-2009	Watson, Lewis J/0000-0002-8273-7676; Jones, Steven P./0000-0001-5376-8089	NIH [R01 HL083320, R01 HL094419, P20 RR024489, P01 HL078825]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094419, R01HL055477, P01HL078825, R01HL083320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103492] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH (R01 HL083320, R01 HL094419, P20 RR024489, P01 HL078825). REB was an American Heart Association Predoctoral Fellow, Great Rivers Affiliate. LJW was an American Heart Association Predoctoral Fellow, Great Rivers Affiliate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Chess DJ, 2008, J CARD FAIL, V14, P82, DOI 10.1016/j.cardfail.2007.09.004; Chess DJ, 2007, AM J PHYSIOL-HEART C, V293, pH1853, DOI 10.1152/ajpheart.00544.2007; Chess DJ, 2009, AM J PHYSIOL-HEART C, V297, pH1585, DOI 10.1152/ajpheart.00599.2009; Christopher BA, 2010, AM J PHYSIOL-HEART C, V299, pH1917, DOI 10.1152/ajpheart.00687.2010; Facundo HT, 2012, AM J PHYSIOL-HEART C, V302, pH2122, DOI 10.1152/ajpheart.00775.2011; Greer JJM, 2006, AM J PHYSIOL-HEART C, V291, pH2743, DOI 10.1152/ajpheart.00347.2006; Greer JJM, 2006, AM J PHYSIOL-HEART C, V290, pH146, DOI 10.1152/ajpheart.00583.2005; Jones S., 1999, AM J PHYSIOL, V46, P763; Jones SP, 2000, CORONARY ARTERY DIS, V11, P593, DOI 10.1097/00019501-200012000-00004; Jones SP, 2001, ACTA PHYSIOL SCAND, V173, P139, DOI 10.1046/j.1365-201X.2001.00899.x; Jones SP, 2005, AM J PHYSIOL-HEART C, V288, pH365, DOI 10.1152/ajpheart.00245.2004; Jones SP, 2004, AM J PHYSIOL-HEART C, V286, pH276, DOI 10.1152/ajpheart.00129.2003; Jones SP, 2003, P NATL ACAD SCI USA, V100, P4891, DOI 10.1073/pnas.0837428100; Jones SP, 2003, AM J PHYSIOL-HEART C, V284, pH277, DOI 10.1152/ajpheart.00236.2002; Jones SP, 2001, CORONARY ARTERY DIS, V12, P37, DOI 10.1097/00019501-200102000-00006; Jones SP, 2000, NEWS PHYSIOL SCI, V15, P303; Jones SP, 2000, AM J PHYSIOL-HEART C, V279, pH2196; Jones SP, 1999, AM J PHYSIOL-HEART C, V276, pH1567, DOI 10.1152/ajpheart.1999.276.5.H1567; Khairallah RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034402; Krentz AJ, 1996, DIABETIC MED, V13, P30, DOI 10.1002/(SICI)1096-9136(199601)13:1<30::AID-DIA5>3.0.CO;2-I; Lionetti V, 2011, CARDIOVASC RES, V90, P202, DOI 10.1093/cvr/cvr038; Lopaschuk GD, 2008, CARDIOVASC RES, V79, P205, DOI 10.1093/cvr/cvn134; Morgan EE, 2006, EUR J HEART FAIL, V8, P687, DOI 10.1016/j.ejheart.2006.01.005; Ngoh GA, 2008, J MOL CELL CARDIOL, V45, P313, DOI 10.1016/j.yjmcc.2008.04.009; Ngoh GA, 2011, AMINO ACIDS, V40, P895, DOI 10.1007/s00726-010-0728-7; Ngoh GA, 2009, CIRC RES, V104, P41, DOI 10.1161/CIRCRESAHA.108.189431; Ogden CL, 2009, PREVALENCE OBESITY U; Rennison JH, 2007, AM J PHYSIOL-HEART C, V292, pH1498, DOI 10.1152/ajpheart.01021.2006; Rennison JH, 2009, J MOL CELL CARDIOL, V46, P883, DOI 10.1016/j.yjmcc.2009.02.019; Russo SB, 2012, J CLIN INVEST, V122, P3919, DOI 10.1172/JCI63888; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Sharma N, 2008, J HYPERTENS, V26, P1402, DOI 10.1097/HJH.0b013e3283007dda; Sharma N, 2007, AM J HYPERTENS, V20, P403, DOI 10.1016/j.amjhyper.2006.09.022; Taegtmeyer H, 2004, ANN NY ACAD SCI, V1015, P202, DOI 10.1196/annals.1302.017; TAEGTMEYER H, 1994, CURR PROB CARDIOLOGY, V19, P61, DOI 10.1016/0146-2806(94)90008-6; Wang XY, 2009, AM J PHYSIOL-CELL PH, V297, pC1490, DOI 10.1152/ajpcell.00049.2009; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107	38	62	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83174	10.1371/journal.pone.0083174	http://dx.doi.org/10.1371/journal.pone.0083174			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367585	Green Published, gold			2022-12-27	WOS:000328740300096
J	Lo, SC; Li, BJ; Hung, GC; Lei, HY; Li, TW; Zhang, J; Nagamine, K; Tsai, SE; Zucker, MJ; Olesnicky, L				Lo, Shyh-Ching; Li, Bingjie; Hung, Guo-Chiuan; Lei, Haiyan; Li, Tianwei; Zhang, Jing; Nagamine, Kenjiro; Tsai, Shien; Zucker, Mark J.; Olesnicky, Ludmilla			Isolation and Characterization of Two Novel Bacteria Afipia cberi and Mesorhizobium hominis from Blood of a Patient Afflicted with Fatal Pulmonary Illness	PLOS ONE			English	Article							SP-NOV; SEQUENCE; INFECTIONS; STABILITY; STRAIN; FELIS	We recently isolated and discovered new Bradyrhizobiaceae microbes from the cryopreserved culture broth of blood samples from 3 patients with poorly defined illnesses using modified SP4 media and culture conditions coupled with genomic sequencing. Using a similar protocol, we studied a previously cryopreserved culture broth of blood sample from a patient who had succumbed to an acute onset of fulminant pulmonary illness. We report that two phases of microbial growth were observed in the re-initiated culture. Biochemical and genomic characterization revealed microbes isolated from the first phase of growth were new Afipia species of Bradyrhizobiaceae, tentatively named A. cberi with a similar to 5 MB chromosome that was different from those of all previously known Afipia microbes including the newly discovered A. septicemium. The microbes isolated from the second phase of growth were prominent sugar assimilators, novel Phyllobacteriaceae, phylogenetically most closely related to Mesorhizobium and tentatively named M. hominis with a similar to 5.5 MB chromosome. All A. cberi isolates carry a circular similar to 140 KB plasmid. Some M. hominis isolates possess a circular similar to 412 KB plasmid that can be lost in prolonged culture or passage. No antibiotics resistant genes could be identified in both of the A. cberi and M. hominis plasmids. Antibiotic susceptibility studies using broth culture systems revealed isolates of A. cberi could be sensitive to some antibiotics, but all isolates of M. hominis were resistant to essentially all tested antibiotics. However, the cell-free antibiotics susceptibility test results may not be applicable to clinical treatment against the microbes that are known to be capable of intracellular growth. It remains to be determined if the 2 previously unknown Rhizobiales were indeed pathogenic and played a role in the pulmonary disease process in this patient. Specific probes and methods will be developed to re-examine the diseased lungs from patient's autopsy.	[Lo, Shyh-Ching; Li, Bingjie; Hung, Guo-Chiuan; Lei, Haiyan; Li, Tianwei; Zhang, Jing; Nagamine, Kenjiro; Tsai, Shien] US FDA, Tissue Microbiol Lab, Div Cellular & Gene Therapies, Off Cellular Tissue & Gene Therapies,Ctr Biol Eva, Bethesda, MD 20014 USA; [Zucker, Mark J.] Newark Beth Israel Med Ctr, Dept Med, Newark, NJ USA; [Olesnicky, Ludmilla] Newark Beth Israel Med Ctr, Dept Pathol, Newark, NJ USA	US Food & Drug Administration (FDA); Newark Beth Israel Medical Center; Newark Beth Israel Medical Center	Lo, SC (corresponding author), US FDA, Tissue Microbiol Lab, Div Cellular & Gene Therapies, Off Cellular Tissue & Gene Therapies,Ctr Biol Eva, Bethesda, MD 20014 USA.	shyhching.lo@fda.hhs.gov			FDA Modernizing Science Intramural Grant	FDA Modernizing Science Intramural Grant	The study was supported in part by FDA Modernizing Science Intramural Grant entitled "A new approach of detection and/or discovery of previously unknown pathogens". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Batut J, 2004, NAT REV MICROBIOL, V2, P933, DOI 10.1038/nrmicro1044; Bhatt AS, 2013, NEW ENGL J MED, V369, P517, DOI 10.1056/NEJMoa1211115; Biesecker LG, 2012, GENET MED, V14, P393, DOI 10.1038/gim.2011.78; BRENNER DJ, 1991, J CLIN MICROBIOL, V29, P2450, DOI 10.1128/JCM.29.11.2450-2460.1991; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Galardini M, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-11; Graham PH, 1998, PRINCIPALS APPL SOIL; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; HULSE M, 1993, CLIN INFECT DIS, V16, P112, DOI 10.1093/clinids/16.1.112; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; La Scola B, 2000, FEMS MICROBIOL ECOL, V34, P129, DOI 10.1016/S0168-6496(00)00084-2; Lai CC, 2004, CLIN INFECT DIS, V38, P149, DOI 10.1086/380463; LO SC, 1991, MODERN PATHOL, V4, P750; LO SC, 1991, LANCET, V338, P1415, DOI 10.1016/0140-6736(91)92721-D; Lo SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076142; Loman NJ, 2013, JAMA-J AM MED ASSOC, V309, P1502, DOI 10.1001/jama.2013.3231; Lopez-Guerrero MG, 2012, PLASMID, V68, P149, DOI 10.1016/j.plasmid.2012.07.002; McCook A, 2011, NATURE, V476, P270, DOI 10.1038/476270a; McDonald IR, 2005, INT J SYST EVOL MICR, V55, P1827, DOI 10.1099/ijs.0.63716-0; Pearce SL, 2011, J BACTERIOL, V193, P5057, DOI 10.1128/JB.05647-11; PLOTKIN GR, 1980, ANN INTERN MED, V93, P839, DOI 10.7326/0003-4819-93-6-839; Pulliainen AT, 2012, FEMS MICROBIOL REV, V36, P563, DOI 10.1111/j.1574-6976.2012.00324.x; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Sohn AH, 2003, EMERG INFECT DIS, V9, P485, DOI 10.3201/eid0904.020576; Velazquez E, 2001, INT J SYST EVOL MICR, V51, P1011, DOI 10.1099/00207713-51-3-1011; WEAVER RW, 1972, PLANT SOIL, V36, P219, DOI 10.1007/BF01373474; WEAVER RW, 1990, SOIL BIOL BIOCHEM, V22, P465, DOI 10.1016/0038-0717(90)90179-4	30	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82673	10.1371/journal.pone.0082673	http://dx.doi.org/10.1371/journal.pone.0082673			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367538	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300054
J	Okubo, N; Mezaki, T; Nozawa, Y; Nakano, Y; Lien, YT; Fukami, H; Hayward, DC; Ball, EE				Okubo, Nami; Mezaki, Takuma; Nozawa, Yoko; Nakano, Yoshikatsu; Lien, Yi-Ting; Fukami, Hironobu; Hayward, David C.; Ball, Eldon E.			Comparative Embryology of Eleven Species of Stony Corals (Scleractinia)	PLOS ONE			English	Article							ZOOXANTHELLA-CONTAINING EGGS; LARVAL DEVELOPMENT; SEXUAL REPRODUCTION; MORPHOLOGICAL ASPECTS; ANTHOZOA; GAMETOGENESIS; GASTRULATION; LOCALIZATION; PHYLOGENY; EVOLUTION	A comprehensive understanding of coral reproduction and development is needed because corals are threatened in many ways by human activity. Major threats include the loss of their photosynthetic symbionts (Symbiodinium) caused by rising temperatures (bleaching), reduced ability to calcify caused by ocean acidification, increased storm severity associated with global climate change and an increase in predators caused by runoff from human agricultural activity. In spite of these threats, detailed descriptions of embryonic development are not available for many coral species. The current consensus is that there are two major groups of stony corals, the "complex" and the "robust". In this paper we describe the embryonic development of four "complex" species, Pseudosiderastrea tayamai, Galaxea fascicularis, Montipora hispida, and Pavona Decussata, and seven "robust" species, Oulastrea crispata, Platygyra contorta, Favites abdita, Echinophyllia aspera, Goniastrea favulus, Dipsastraea speciosa (previously Favia speciosa), and Phymastrea valenciennesi (previously Montastrea valenciennesi). Data from both histologically sectioned embryos and whole mounts are presented. One apparent difference between these two major groups is that before gastrulation the cells of the complex corals thus far described (mainly Acropora species) spread and flatten to produce the so-called prawn chip, which lacks a blastocoel. Our present broad survey of robust and complex corals reveals that prawn chip formation is not a synapomorphy of complex corals, as Pavona Decussata does not form a prawn chip and has a well-developed blastocoel. Although prawn chip formation cannot be used to separate the two clades, none of the robust corals which we surveyed has such a stage. Many robust coral embryos pass through two periods of invagination, separated by a return to a spherical shape. However, only the second of these periods is associated with endoderm formation. We have therefore termed the first invagination a pseudo-blastopore.	[Okubo, Nami] Keio Univ, Res & Educ Ctr Nat Sci, Yokohama, Kanagawa 223, Japan; [Mezaki, Takuma] Kuroshio Biol Res Fdn, Kochi, Japan; [Nozawa, Yoko] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Nakano, Yoshikatsu] Univ Ryukyus, Sesoko Stn, Trop Biosphere Res Ctr, Motobu, Okinawa, Japan; [Okubo, Nami; Lien, Yi-Ting] Kyoto Univ, Field Sci Educ & Res Ctr, Seto Marine Biol Lab, Wakayama, Japan; [Fukami, Hironobu] Miyazaki Univ, Fac Agr, Miyazaki 88921, Japan; [Hayward, David C.; Ball, Eldon E.] Australian Natl Univ, Res Sch Biol, Evolut Ecol & Genet Grp, Canberra, ACT, Australia	Keio University; Academia Sinica - Taiwan; University of the Ryukyus; Kyoto University; University of Miyazaki; Australian National University	Okubo, N (corresponding author), Tokyo Keizai Univ, Dept Econ, Kokubunji, Tokyo, Japan.	nokubo@tku.ac.jp	Ball, Eldon E/C-9261-2009	Ball, Eldon E/0000-0002-6052-1495; Hayward, David/0000-0003-2937-2425	Japan Society for the Promotion of Science [222948, 13221488]; Tokyo Keizai University [12-01]; Australian Research Council [DP1095343]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokyo Keizai University; Australian Research Council(Australian Research Council)	NO was supported for this study by a Grant-in-Aid for JSPS Fellows (Grant No. 222948) and a Grant-in-Aid for Young Scientists (B) (Grant No. 13221488) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp). Further support was received from Tokyo Keizai University (Research Grant 12-01). EEB and DCH were supported by the Australian Research Council (http://www.arc.gov.au/) through Discovery Grant (#DP1095343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABCOCK RC, 1986, CORAL REEFS, V5, P111, DOI 10.1007/BF00298178; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Ball EE, 2002, INT J DEV BIOL, V46, P671; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Budd AF, 2010, INTEGR COMP BIOL, V50, P411, DOI 10.1093/icb/icq062; Byrum C.A., 2004, P33; Fadlallah Y.H., 1983, Coral Reefs, V2, P129, DOI 10.1007/BF00336720; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; FUKUI Y, 1991, HYDROBIOLOGIA, V216, P137, DOI 10.1007/BF00026454; Gilmour J, 1999, MAR BIOL, V135, P451, DOI 10.1007/s002270050645; Goffredo S, 2005, MAR BIOL, V147, P485, DOI 10.1007/s00227-005-1567-z; Goffredo S, 2010, MAR BIOL RES, V6, P421, DOI 10.1080/17451000903428488; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; Harrison PL, 1989, P 6 INT COR REEF S T, P699; Hayashibara T., 1997, P 8 INT COR REEF S, V2, P1231; Hayward DC, 2002, P NATL ACAD SCI USA, V99, P8106, DOI 10.1073/pnas.112021499; Heltzel PS, 2002, MAR BIOL, V140, P659, DOI 10.1007/s00227-001-0745-x; Heyward A., 1987, Galaxea, V6, P331; Hirose M, 2000, BIOL BULL, V199, P68, DOI 10.2307/1542708; Hirose M, 2006, ZOOL SCI, V23, P873, DOI 10.2108/zsj.23.873; Hirose M, 2011, BIOL BULL-US, V220, P23, DOI 10.1086/BBLv220n1p23; Huang DW, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-37; Kayal E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-5; Keshavmurthy S, 2012, ZOOL STUD, V51, P143; Kitahara MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011490; Kraus Y, 2006, DEV GENES EVOL, V216, P119, DOI 10.1007/s00427-005-0038-3; Lam KKY, 2000, MAR ECOL PROG SER, V205, P101, DOI 10.3354/meps205101; Marlow HQ, 2007, EVOL DEV, V9, P355, DOI 10.1111/j.1525-142X.2007.00173.x; Martindale MQ, 2009, DEV CELL, V17, P162, DOI 10.1016/j.devcel.2009.07.024; Mergner H., 1971, P1; Mita M, 2008, INT M REPR GROWTH BE; Nakano Y, 2000, JAP COR REEF S KEIO; Nakano Y, 2008, S CNID RES JAP ATM O; Nakano Y, 1993, ZOOL SCI, V68, P85; Okubo N, 2007, ZOOL SCI, V24, P1169, DOI 10.2108/zsj.24.1169; Padilla-Gamino JL, 2011, CORAL REEFS, V30, P371, DOI 10.1007/s00338-010-0700-8; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; SPAULDING JG, 1974, AM ZOOL, V14, P511; Stolarski J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-316; SZMANTFROELICH A, 1980, BIOL BULL, V158, P257, DOI 10.2307/1540935; Veron JEN, 1996, CORAL REEFS, V15, P1; Wells J. W., 1957, P1087	44	27	30	7	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84115	10.1371/journal.pone.0084115	http://dx.doi.org/10.1371/journal.pone.0084115			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367633	Green Published, gold			2022-12-27	WOS:000328740300128
J	Porkka, M; Kummu, M; Siebert, S; Varis, O				Porkka, Miina; Kummu, Matti; Siebert, Stefan; Varis, Olli			From Food Insufficiency towards Trade Dependency: A Historical Analysis of Global Food Availability	PLOS ONE			English	Article							CLIMATE-CHANGE; VIRTUAL WATER; SECURITY; URBANIZATION; AGRICULTURE; SCARCITY; DEMAND; FUTURE; DIETS; REQUIREMENTS	Achieving global food security is one of the major challenges of the coming decades. In order to tackle future food security challenges we must understand the past. This study presents a historical analysis of global food availability, one of the key elements of food security. By calculating national level dietary energy supply and production for nine time steps during 1965-2005 we classify countries based on their food availability, food self-sufficiency and food trade. We also look at how diets have changed during this period with regard to supply of animal based calories. Our results show that food availability has increased substantially both in absolute and relative terms. The percentage of population living in countries with sufficient food supply (> 2500 kcal/cap/d) has almost doubled from 33% in 1965 to 61% in 2005. The population living with critically low food supply (< 2000 kcal/cap/d) has dropped from 52% to 3%. Largest improvements are seen in the MENA region, Latin America, China and Southeast Asia. Besides, the composition of diets has changed considerably within the study period: the world population living with high supply of animal source food (> 15% of dietary energy supply) increased from 33% to over 50%. While food supply has increased globally, food self-sufficiency (domestic production > 2500 kcal/cap/d) has not changed remarkably. In the beginning of the study period insufficient domestic production meant insufficient food supply, but in recent years the deficit has been increasingly compensated by rising food imports. This highlights the growing importance of food trade, either for food supply in importing countries or as a source of income for exporters. Our results provide a basis for understanding past global food system dynamics which, in turn, can benefit research on future food security.	[Porkka, Miina; Kummu, Matti; Varis, Olli] Aalto Univ, Water & Dev Res Grp, Espoo, Finland; [Siebert, Stefan] Univ Bonn, Inst Crop Sci & Resource Conservat INRES, Bonn, Germany	Aalto University; University of Bonn	Porkka, M (corresponding author), Aalto Univ, Water & Dev Res Grp, Espoo, Finland.	miina.porkka@aalto.fi	Kummu, Matti/C-4797-2011; Porkka, Miina S/M-6106-2014; Siebert, Stefan/B-8621-2009	Kummu, Matti/0000-0001-5096-0163; Porkka, Miina S/0000-0002-8285-6122; Siebert, Stefan/0000-0002-9998-0672	Maa-ja vesitekniikan tuki ry; Academy of Finland project SCART [267463]; German Federal Ministry of Education and Research [031A258B]	Maa-ja vesitekniikan tuki ry; Academy of Finland project SCART; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Research support was provided by Maa-ja vesitekniikan tuki ry., the Academy of Finland project SCART (grant no. 267463) and the GlobE-project funded by the German Federal Ministry of Education and Research (grant no. 031A258B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandratos N., 2012, WORLD AGRICULTURE TO; Carr JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055825; Chen J, 2007, CATENA, V69, P1, DOI 10.1016/j.catena.2006.04.019; Chopra M, 2002, B WORLD HEALTH ORGAN, V80, P952; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Fader M, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014046; FAO, 2013, AQUASTAT FAOS GLOBAL; FAO, 2011, THE STATE OF FOOD IN; FAO, 2013, RESOURCE STATISTICS; FAO, 2013, FOOD SECURITY INDICA; FAO, 2012, PART OF FAOSTAT FAO; FAO Food and Agriculture Organization UN., 2006, LIVESTOCKS LONG SHAD; FAO WFP & IFAD, 2012, THE STATE OF FOOD IN; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Garrido A, 2010, FOOD SECUR, P3, DOI DOI 10.1201/B10541-3.ACCESSED; Gerten D, 2011, J HYDROMETEOROL, V12, P885, DOI 10.1175/2011JHM1328.1; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gonzalez AD, 2011, FOOD POLICY, V36, P562, DOI 10.1016/j.foodpol.2011.07.003; Gregory PJ, 2005, PHILOS T R SOC B, V360, P2139, DOI 10.1098/rstb.2005.1745; Gustavsson J., 2011, GLOBAL FOOD LOSSES A; Hanjra MA, 2010, FOOD POLICY, V35, P365, DOI 10.1016/j.foodpol.2010.05.006; Hazell P, 2008, PHILOS T R SOC B, V363, P495, DOI 10.1098/rstb.2007.2166; Hertel TW, 2011, AM J AGR ECON, V93, P259, DOI 10.1093/ajae/aaq189; Hertel TW, 2010, GLOBAL ENVIRON CHANG, V20, P577, DOI 10.1016/j.gloenvcha.2010.07.001; Kastner T, 2012, P NATL ACAD SCI USA, V109, P6868, DOI 10.1073/pnas.1117054109; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Kessler A, 2011, FOOD SECUR, V3, P195, DOI [10.1007/s12571-011-0125-4, DOI 10.1007/S12571-011-0125-4]; Koning NBJ, 2008, NJAS-WAGEN J LIFE SC, V55, P229, DOI 10.1016/S1573-5214(08)80001-2; Kumar MD, 2005, WATER RESOUR MANAG, V19, P759, DOI 10.1007/s11269-005-3278-0; Kummu M, 2012, SCI TOTAL ENVIRON, V438, P477, DOI 10.1016/j.scitotenv.2012.08.092; Luan Y, 2013, FOOD SECURITY; Matsumura Y, 2001, NUTRITION, V10, pS40, DOI [10.1046/j.1440-6047.2001.0100s1S40.x, DOI 10.1046/J.1440-6047.2001.0100S1S40.X]; Nonhebel S, 2011, LIVEST SCI, V139, P3, DOI 10.1016/j.livsci.2011.03.021; Parry M, 2005, PHILOS T R SOC B, V360, P2125, DOI 10.1098/rstb.2005.1751; Parry ML, 2004, GLOBAL ENVIRON CHANG, V14, P53, DOI 10.1016/j.gloenvcha.2003.10.008; Porkka M, 2012, INT J WATER RESOUR D, V28, P453, DOI 10.1080/07900627.2012.684310; Pradhan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062228; Rae AN, 1998, AGR ECON, V18, P291, DOI 10.1016/S0169-5150(97)00051-0; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rosegrant MW, 2009, ANNU REV ENV RESOUR, V34, P205, DOI 10.1146/annurev.environ.030308.090351; Satterthwaite D, 2010, PHILOS T R SOC B, V365, P2809, DOI 10.1098/rstb.2010.0136; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Smil V, 2002, POPUL DEV REV, V28, P599, DOI 10.1111/j.1728-4457.2002.00599.x; Smil V, 2002, ENZYME MICROB TECH, V30, P305, DOI 10.1016/S0141-0229(01)00504-X; Smil V, 2002, AMBIO, V31, P126, DOI 10.1639/0044-7447(2002)031[0126:NAFPPF]2.0.CO;2; Smil V, 2001, FEEDING THE WORLD A; Thornton PK, 2010, PHILOS T R SOC B, V365, P2853, DOI 10.1098/rstb.2010.0134; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tome D, 2012, BRIT J NUTR, V108, pS222, DOI 10.1017/S0007114512002565; UN, 2010, UNITED NATIONS STATI; United Nations, 2011, WORLD POPULATION PRO; WTO, 2012, INTERNATIONAL TRADE	53	148	153	8	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82714	10.1371/journal.pone.0082714	http://dx.doi.org/10.1371/journal.pone.0082714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367545	Green Submitted, Green Published, gold			2022-12-27	WOS:000328740300059
J	Ghosal, R; Ganswindt, A; Seshagiri, PB; Sukumar, R				Ghosal, Ratna; Ganswindt, Andre; Seshagiri, Polani B.; Sukumar, Raman			Endocrine Correlates of Musth in Free-Ranging Asian Elephants (Elephas maximus) Determined by Non-Invasive Faecal Steroid Hormone Metabolite Measurements	PLOS ONE			English	Article							MALE AFRICAN ELEPHANTS; LOXODONTA-AFRICANA; CORTISOL METABOLITES; TESTOSTERONE; BEHAVIOR; SIGNALS; STATE; CYCLE	The occurrence of musth, a period of elevated levels of androgens and heightened sexual activity, has been well documented for the male Asian elephant (Elephas maximus). However, the relationship between androgen-dependent musth and adrenocortical function in this species is unclear. The current study is the first assessment of testicular and adrenocortical function in free-ranging male Asian elephants by measuring levels of testosterone (androgen) and cortisol (glucocorticoid - a physiological indicator of stress) metabolites in faeces. During musth, males expectedly showed significant elevation in faecal testosterone metabolite levels. Interestingly, glucocorticoid metabolite concentrations remained unchanged between musth and non-musth periods. This observation is contrary to that observed with wild and captive African elephant bulls and captive Asian bull elephants. Our results show that musth may not necessarily represent a stressful condition in free-ranging male Asian elephants.	[Ghosal, Ratna; Sukumar, Raman] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [Ganswindt, Andre] Univ Pretoria, Fac Vet Sci, Endocrine Res Lab, Dept Anat & Physiol, ZA-0110 Onderstepoort, South Africa; [Ganswindt, Andre] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Seshagiri, Polani B.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; University of Pretoria; University of Pretoria; Indian Institute of Science (IISC) - Bangalore	Sukumar, R (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India.	rsuku@ces.iisc.ernet.in	GHOSAL, RATNA/AAB-9470-2020; Raman, Sukumar/C-9809-2013; Ganswindt, Andre/G-9856-2014	Ganswindt, Andre/0000-0002-1474-7602; Ghosal, RATNA/0000-0002-2295-453X	The Rufford Small Grants Foundation, London, U.K. [8350-1]	The Rufford Small Grants Foundation, London, U.K.	The Rufford Small Grants Foundation, London, U.K. Grant # 8350-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JL, 2007, GEN COMP ENDOCR, V151, P153, DOI 10.1016/j.ygcen.2007.01.006; Chelliah K, 2013, ANIM BEHAV, V86, P1207, DOI 10.1016/j.anbehav.2013.09.022; Fanson KV, 2013, EUR J WILDLIFE RES, V59, P655, DOI 10.1007/s10344-013-0718-7; Fernando P, 2008, MAMM BIOL, V73, P2, DOI 10.1016/j.mambio.2007.07.007; Fowler M, 2006, BIOL MED SURG ELEPHA; Ganswindt A, 2005, PHYSIOL BIOCHEM ZOOL, V78, P505, DOI 10.1086/430237; Ganswindt A, 2005, HORM BEHAV, V47, P83, DOI 10.1016/j.yhbeh.2004.09.002; Ganswindt A, 2003, GEN COMP ENDOCR, V134, P156, DOI 10.1016/S0016-6480(03)00251-X; Ganswindt A, 2010, HORM BEHAV, V57, P506, DOI 10.1016/j.yhbeh.2010.02.009; Ghosal R, 2010, THERIOGENOLOGY, V73, P1051, DOI 10.1016/j.theriogenology.2010.01.004; GHOSH R, 2005, GODS CHAINS; HALLMARTIN AJ, 1987, S AFR J SCI, V83, P616; Huber S, 2003, GEN COMP ENDOCR, V130, P48, DOI 10.1016/S0016-6480(02)00535-X; JAINUDEEN M R, 1972, Mammalia, V36, P247, DOI 10.1515/mamm.1972.36.2.247; JAINUDEEN MR, 1972, J REPROD FERTIL, V29, P99, DOI 10.1530/jrf.0.0290099; Kenagy GJ, 1999, GEN COMP ENDOCR, V115, P236, DOI 10.1006/gcen.1999.7307; Kushwaha S.P.S., 2008, MAPPING KAZIRANGA CO; Laws N, 2007, J APPL ANIM WELF SCI, V10, P349, DOI 10.1080/10888700701555600; Mohle U, 2002, GEN COMP ENDOCR, V129, P135, DOI 10.1016/S0016-6480(02)00525-7; Mostl E, 2002, VET RES COMMUN, V26, P127, DOI 10.1023/A:1014095618125; MULLER A, 2008, THESIS HUMBOLDT U BE; PALME R, 1994, ADVANCES IN STEROID ANALYSIS '93, P111; Palme R, 2013, WIEN TIERARZTL MONAT, V100, P238; Patton ML, 1999, ZOO BIOL, V18, P111, DOI 10.1002/(SICI)1098-2361(1999)18:2&lt;111::AID-ZOO3&gt;3.0.CO;2-0; POOLE JH, 1981, NATURE, V292, P830, DOI 10.1038/292830a0; POOLE JH, 1989, ANIM BEHAV, V37, P140, DOI 10.1016/0003-3472(89)90014-6; POOLE JH, 1987, BEHAVIOUR, V102, P283, DOI 10.1163/156853986X00171; Rasmussen HB, 2008, HORM BEHAV, V54, P539, DOI 10.1016/j.yhbeh.2008.05.008; Rasmussen LEL, 1998, ANIM REPROD SCI, V53, P19, DOI 10.1016/S0378-4320(98)00124-9; Rasmussen LEL, 1996, J MAMMAL, V77, P422, DOI 10.2307/1382819; Schwarzenberger F, 2013, WIEN TIERARZTL MONAT, V100, P209; Schwarzenberger F, 1998, ANIM REPROD SCI, V53, P173, DOI 10.1016/S0378-4320(98)00112-2; Sukumar R., 2003, LIVING ELEPHANTS EVO; Sukumar R., 1989, ASIAN ELEPHANT ECOLO; Sukumar R., 2011, STORY ASIAS ELEPHANT; Viljoen Jozua J., 2008, Koedoe, V50, P18; Yon L, 2008, GEN COMP ENDOCR, V155, P109, DOI 10.1016/j.ygcen.2007.03.006	37	17	17	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84787	10.1371/journal.pone.0084787	http://dx.doi.org/10.1371/journal.pone.0084787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358371	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000328737700105
J	Komareji, M; Bouffanais, R				Komareji, Mohammad; Bouffanais, Roland			Resilience and Controllability of Dynamic Collective Behaviors	PLOS ONE			English	Article							DECISION-MAKING; ANIMAL GROUPS; NETWORKS; SYSTEMS; SYNCHRONIZATION; CONNECTIVITY; SIMULATIONS; EMERGENCE; FLOCKING; MODELS	The network paradigm is used to gain insight into the structural root causes of resilience of consensus in dynamic collective behaviors, and to analyze the on Habil! h swarm dynamics. Here we devise network which is the information transfer channel underpinning the swarm dynamics of the connectivity based on a topological neighborhood of interactions. The study of the connectedness of network reveals the profound relationship between group size and number of interacting neighbors good agreement with field observations on flock of starlings [Ballerini et al. (2008) Proc. Natl. Acad. Sci sing a dynamical model, we generate dynamic collective behaviors enabling us to uncover that the network is a homogeneous clustered small-world network, thus facilitating emergent outcomes if connectedness is aintained. Resilience of the emergent consensus is tested by introducing exogenous environmental noise, which irnately stresses how deeply intertwined are the swarm dynamics in the physical and network spaces. The availability signaling network allows us to analytically establish for the first time the number of driver agents necessary to fully control the swarm dynamics.	[Komareji, Mohammad; Bouffanais, Roland] Singapore Univ Technol & Design, Singapore, Singapore	Singapore University of Technology & Design	Bouffanais, R (corresponding author), Singapore Univ Technol & Design, Singapore, Singapore.	bouffanais@sutd.edu.sg	Bouffanais, Roland/L-3460-2013	Bouffanais, Roland/0000-0002-2507-4642	SUTD-MIT International Design Centre (IDC)	SUTD-MIT International Design Centre (IDC)(Singapore University of Technology & Design)	This study is funded by a grant from the SUTD-MIT International Design Centre (IDC) under the research project titled "Real-time Distributed Control and Design in Complex Systems Using Collective Intelligence." Prof. Roland Bouffanais is the PI and Dr. Mohammad Komareji is a team member (http://www.sutd.edu.sg/idc_projects.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamgir M, 2012, 12066381V2CSLG; Aragues R, 2012, P AMER CONTR CONF, P32; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Bak P, 1999, NATURE WORKS; Balister P, 2005, ADV APPL PROBAB, V37, P1, DOI 10.1239/aap/1113402397; Balister P, 2009, ADV APPL PROBAB, V41, P1, DOI 10.1239/aap/1240319574; Balister P, 2009, DISCRETE APPL MATH, V157, P309, DOI 10.1016/j.dam.2008.03.001; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; BarabSSsi, 2003, LINKED; Barahona M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.054101; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Bode NWF, 2011, J R SOC INTERFACE, V8, P301, DOI 10.1098/rsif.2010.0397; Bode NWF, 2011, BEHAV ECOL SOCIOBIOL, V65, P117, DOI 10.1007/s00265-010-1111-0; Bornholdt S, 2005, HDB GRAPHS NETWORKS; Borrel V, 2009, IEEE ACM T NETWORKIN, V17; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Cheng Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022123; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Croft DP, 2005, OECOLOGIA, V143, P211, DOI 10.1007/s00442-004-1796-8; Cucker F, 2007, IEEE T AUTOMAT CONTR, V52, P852, DOI 10.1109/TAC.2007.895842; Cucker F, 2010, IEEE T AUTOMAT CONTR, V55, P1238, DOI 10.1109/TAC.2010.2042355; Dusenbery D.B., 1992, SENSORY ECOLOGY ORGA; Emmerton Jacky, 1993, P377; Eppstein D, 1997, DISCRETE COMPUT GEOM, V17, P263, DOI 10.1007/PL00009293; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Gell-Mann M, 1996, QUARK JAGUAR ADVENTU; Giardina I, 2008, HFSP J, V2, P205, DOI 10.2976/1.2961038; Ginelli F, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.168103; Helbing D, 1997, NATURE, V388, P47, DOI 10.1038/40353; Helbing D, 2012, SOCIAL SELF ORG; Hsieh MA, 2008, ROBOTICA, V26, P691, DOI 10.1017/S0263574708004323; Jadbabaie A, 2003, IEEE T AUTOM CONTROL, V48; Jia T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02354; Jia T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3002; Kattas GD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002449; Krause J., 2002, LIVING GROUPS; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; Lee JM, 2010, INFORM PROCESS LETT, V110, P576, DOI 10.1016/j.ipl.2010.04.024; Li W, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.021920; Liu B, 2008, IEEE T AUTOMAT CONTR, V53, P1009, DOI 10.1109/TAC.2008.919548; Liu XM, 2010, I C CONT AUTOMAT ROB, P549, DOI 10.1109/ICARCV.2010.5707320; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Liu YL, 2012, NEUROIMAGE, V59, P109, DOI 10.1016/j.neuroimage.2011.05.027; Lizier JT, 2018, COMPLEXITY, DOI 10.1155/2018/7306871; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; Miller P., 2010, SMART SWARM; Mirabet V, 2007, ECOL MODEL, V201, P468, DOI 10.1016/j.ecolmodel.2006.10.018; Mostofi Y, 2009, P AMER CONTR CONF, P1821, DOI 10.1109/ACC.2009.5159843; Nagel K, 1996, PHYS REV E, V53, P4655, DOI 10.1103/PhysRevE.53.4655; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Newman ME, 2001, PHYS REV E, V64; Nishikawa T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.014101; Olfati-Saber R, 2006, IEEE T AUTOMAT CONTR, V51, P401, DOI 10.1109/TAC.2005.864190; Olfati-Saber R, 2004, IEEE T AUTOMAT CONTR, V49, P1520, DOI 10.1109/TAC.2004.834113; Parrish JK, 2002, BIOL BULL-US, V202, P296, DOI 10.2307/1543482; Raley D, 2007, IEEE CONTROL SYSTEMS; Ren W, 2005, IEEE T AUTOMAT CONTR, V50, P655, DOI 10.1109/TAC.2005.846556; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Shang Y, 2013, INFLUENCE N IN PRESS; Steen MV, 2010, GRAPH THEORY COMPLEX; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Sun ZD, 2002, AUTOMATICA, V38, P775, DOI 10.1016/S0005-1098(01)00267-9; Tian BM, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.052102; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Wang W, 2006, IEEE T AUTOMAT CONTR, V51, P1156, DOI 10.1109/TAC.2006.878754; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wood AJ, 2010, J THEOR BIOL, V264, P1102, DOI 10.1016/j.jtbi.2010.03.035; Youseff L, 2008, P CSE; Yu WW, 2010, IEEE T SYST MAN CY B, V40, P881, DOI 10.1109/TSMCB.2009.2031624; Yuan ZZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3447; Zamani M, 2009, P AMER CONTR CONF, P5743, DOI 10.1109/ACC.2009.5160170	76	24	24	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82578	10.1371/journal.pone.0082578	http://dx.doi.org/10.1371/journal.pone.0082578			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358209	Green Submitted, gold, Green Published			2022-12-27	WOS:000328737700024
J	Pasini, AF; Stranieri, C; Pasini, A; Vallerio, P; Mozzini, C; Solani, E; Cominacini, M; Cominacini, L; Garbin, U				Pasini, Anna Fratta; Stranieri, Chiara; Pasini, Andrea; Vallerio, Paola; Mozzini, Chiara; Solani, Erika; Cominacini, Mattia; Cominacini, Luciano; Garbin, Ulisse			Lysophosphatidylcholine and Carotid Intima-Media Thickness in Young Smokers: A Role for Oxidized LDL-Induced Expression of PBMC Lipoprotein-Associated Phospholipase A2?	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; CIGARETTE-SMOKING; RISK-FACTOR; ATHEROSCLEROSIS; A(2); PROTEOGLYCANS; CORONARY; PATHOPHYSIOLOGY; EPIDEMIOLOGY	Background: Although cigarette smoking has been associated with carotid intima-media thickness (CIMT) the mechanisms are yet not completely known. Lysophosphatidylcholine (lysoPC), a main product of lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, appears to be a major determinant of the pro-atherogenic properties of oxidized LDL (oxLDL) and to induce proteoglycan synthesis, a main player in intimal thickening. In this study we assessed whether cigarette smoking-induced oxidative stress may influence plasma Lp-PLA2 and lysoPC and Lp-PLA2 expression in peripheral blood mononuclear cells (PBMC), as well as the relationship between lysoPC and CIMT. Methods/Results: 45 healthy smokers and 45 age and sex-matched subjects participated in this study. Smokers, compared to non-smokers, showed increased plasma concentrations of oxLDL, Lp-PLA2 and lysoPC together with up-regulation of Lp-PLA2 (mRNA and protein) expression in PBMC (P<0.001). Plasma Lp-PLA2 positively correlated with both lysoPC (r=0.639, P<0.001) and PBMC mRNA Lp-PLA2 (r=0.484, P<0.001) in all subjects. Moreover CIMT that was higher in smokers (P<0.001), positively correlated with lysoPC (r=0.55, P<0.001). Then in in vitro study we demonstrated that both oxLDL (at concentrations similar to those found in smoker's serum) and oxidized phospholipids contained in oxLDL, were able to up-regulate mRNA Lp-PLA2 in PBMC. This effect was likely due, at least in part, to the enrichment in oxidized phospholipids found in PBMC after exposure to oxLDL. Our results also showed that in human aortic smooth muscle cells lysoPC, at concentrations similar to those found in smokers, increased the expression of biglycan and versican, two main proteoglycans. Conclusions: In smokers a further effect of raised oxidative stress is the up-regulation of Lp-PLA2 expression in PBMC with subsequent increase of plasma Lp-PLA2 and lysoPC. Moreover the correlation between lysoPC and CIMT together with the finding that lysoPC up-regulates proteoglycan synthesis suggests that lysoPC may be a link between smoking and intimal thickening.	[Pasini, Anna Fratta; Stranieri, Chiara; Pasini, Andrea; Vallerio, Paola; Mozzini, Chiara; Solani, Erika; Cominacini, Mattia; Cominacini, Luciano; Garbin, Ulisse] Univ Verona, Dept Med, Sect Internal Med D, I-37100 Verona, Italy	University of Verona	Pasini, AF (corresponding author), Univ Verona, Dept Med, Sect Internal Med D, I-37100 Verona, Italy.	anna.frattapasini@univr.it	Vallerio, Paola/AAC-4874-2022; mozzini, chiara/AAW-3028-2021; Stranieri, Chiara/GWV-1749-2022; cominacini, luciano/B-2775-2011		Fondazione Cariverona, Verona, Italy; Ministry of University and Scientific Research of Italy	Fondazione Cariverona, Verona, Italy(Fondazione Cariverona); Ministry of University and Scientific Research of Italy(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by Fondazione Cariverona, Verona, Italy; by grants from the Ministry of University and Scientific Research of Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Benowitz NL, 2003, PROG CARDIOVASC DIS, V46, P91, DOI 10.1016/S0033-0620(03)00087-2; Bianchini E, 2010, J ULTRAS MED, V29, P1169, DOI 10.7863/jum.2010.29.8.1169; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; Burns DM, 2003, PROG CARDIOVASC DIS, V46, P11, DOI 10.1016/S0033-0620(03)00079-3; Chang MY, 2000, J BIOL CHEM, V275, P4766, DOI 10.1074/jbc.275.7.4766; Chang MY, 2006, ARTERIOSCL THROM VAS, V26, P494, DOI 10.1161/01.ATV.0000200135.61362.27; Chang MY, 2003, ARTERIOSCL THROM VAS, V23, P809, DOI 10.1161/01.ATV.0000069208.20268.D0; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; Csiszar A, 2009, FRONT BIOSCI-LANDMRK, V14, P3128, DOI 10.2741/3440; De Keyzer D, 2009, ARTERIOSCL THROM VAS, V29, P2041, DOI 10.1161/ATVBAHA.109.196592; Epps KC, 2011, J INTERN MED, V269, P94, DOI 10.1111/j.1365-2796.2010.02297.x; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P177, DOI 10.1161/ATVBAHA.108.173609; Fratta Pasini A, 2007, ARTERIOSCL THROM VAS, V27, P1991, DOI 10.1161/ATVBAHA.107.142695; Fratta Pasini A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030291; Garbin U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008225; Gruber F, 2007, J BIOL CHEM, V282, P16934, DOI 10.1074/jbc.M702523200; Holvoet P, 2001, ARTERIOSCL THROM VAS, V21, P844, DOI 10.1161/01.ATV.21.5.844; Howard G, 1998, JAMA-J AM MED ASSOC, V279, P119, DOI 10.1001/jama.279.2.119; Johnson Heather M, 2010, Prev Cardiol, V13, P166, DOI 10.1111/j.1751-7141.2010.00068.x; Kardys I, 2006, ARTERIOSCL THROM VAS, V26, P631, DOI 10.1161/01.ATV.0000201289.83256.cf; Kiortsis DN, 2005, ANGIOLOGY, V56, P451, DOI 10.1177/000331970505600413; Little PJ, 2007, VASC HEALTH RISK MAN, V3, P117; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Matsumoto T, 2007, CURR MED CHEM, V14, P3209, DOI 10.2174/092986707782793899; Nakashima Y, 2002, VIRCHOWS ARCH, V441, P279, DOI 10.1007/s00428-002-0605-1; Nakashima Y, 2008, CARDIOVASC RES, V79, P14, DOI 10.1093/cvr/cvn099; Nakashima Y, 2007, ARTERIOSCL THROM VAS, V27, P1159, DOI 10.1161/ATVBAHA.106.134080; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Paik JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029675; Persson M, 2007, ATHEROSCLEROSIS, V190, P388, DOI 10.1016/j.atherosclerosis.2006.02.016; Shi Y, 2007, ATHEROSCLEROSIS, V191, P54, DOI 10.1016/j.atherosclerosis.2006.05.001; Tao Z, 1997, ATHEROSCLEROSIS, V135, P171, DOI 10.1016/S0021-9150(97)00158-5; Touboul PJ, 2007, CEREBROVASC DIS, V23, P75, DOI 10.1159/000097034; Tselepis AD, 2009, ATHEROSCLEROSIS, V206, P303, DOI 10.1016/j.atherosclerosis.2009.02.016; Wang WY, 2010, CARDIOVASC RES, V85, P845, DOI 10.1093/cvr/cvp367; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; WIGHT TN, 1996, ATHEROSCLEROSIS CORO, P421; Wilensky RL, 2009, CURR OPIN LIPIDOL, V20, P415, DOI 10.1097/MOL.0b013e3283307c16; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179	41	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83092	10.1371/journal.pone.0083092	http://dx.doi.org/10.1371/journal.pone.0083092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358251	Green Submitted, Green Published, gold			2022-12-27	WOS:000328737700047
J	Popescu, CR; Sutherland, MR; Cloutier, A; Benoit, G; Bertagnolli, M; Yzydorczyk, C; Germain, N; Phan, V; Lelievre-Pegorier, M; Sartelet, H; Nuyt, AM				Popescu, Constantin R.; Sutherland, Megan R.; Cloutier, Anik; Benoit, Genevieve; Bertagnolli, Mariane; Yzydorczyk, Catherine; Germain, Nathalie; Phan, Veronique; Lelievre-Pegorier, Martine; Sartelet, Herve; Nuyt, Anne Monique			Hyperoxia Exposure Impairs Nephrogenesis in the Neonatal Rat: Role of HIF-1 alpha	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; OXIDATIVE STRESS; BLOOD-PRESSURE; RENAL-FUNCTION; MOLECULAR-MECHANISMS; CHILDREN BORN; HIF-ALPHA; HYPOXIA; EXPRESSION; NUMBER	Preterm neonates are exposed at birth to high oxygen concentrations relative to the intrauterine environment. We have previously shown in a rat model that a hyperoxic insult results in a reduced nephron number in adulthood. Therefore, the aim of this study was to determine the effects of transient neonatal hyperoxia exposure on nephrogenesis. Sprague-Dawley rat pups were raised in 80% O-2 or room air from P3 to P10. Pups (n = 12/group, 6 males and 6 females) were sacrificed at P5 (during active nephrogenesis) and at P10 (after the completion of nephrogenesis). Hyperoxia exposure resulted in a significant reduction in both nephrogenic zone width and glomerular diameter at P5, and a significantly increased apoptotic cell count; however, nephron number at P10 was not affected. HIF-1 alpha expression in the developing kidney was significantly reduced following hyperoxia exposure. Systemic administration of the HIF-1 alpha stabilizer dimethyloxalylglycine (DMOG) resulted in enhanced expression of HIF-1 alpha and improved nephrogenesis: kidneys from hyperoxia-exposed pups treated with DMOG exhibited a nephrogenic zone width and glomerular diameter similar to room-air controls. These findings demonstrate that neonatal hyperoxia exposure results in impaired nephrogenesis, which may be at least in part HIF-1 alpha-mediated. Although nephron number was not significantly reduced at the completion of nephrogenesis, early indicators of maldevelopment suggest the potential for accelerated nephron loss in adulthood. Overall, this study supports the premise that prematurely born neonates exposed to high oxygen levels after birth are vulnerable to impaired renal development.	[Popescu, Constantin R.; Sutherland, Megan R.; Cloutier, Anik; Benoit, Genevieve; Bertagnolli, Mariane; Yzydorczyk, Catherine; Germain, Nathalie; Phan, Veronique; Sartelet, Herve; Nuyt, Anne Monique] Univ Montreal, St Justine Univ Hosp & Res Ctr, Montreal, PQ, Canada; [Popescu, Constantin R.; Sutherland, Megan R.; Cloutier, Anik; Benoit, Genevieve; Bertagnolli, Mariane; Yzydorczyk, Catherine; Germain, Nathalie; Phan, Veronique; Nuyt, Anne Monique] Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Sartelet, Herve] Univ Montreal, Dept Pathol, Montreal, PQ H3C 3J7, Canada; [Lelievre-Pegorier, Martine] Univ Paris 06, Ctr Rech Cordeliers, INSERM U872, Paris, France; [Lelievre-Pegorier, Martine] Univ Paris 05, UMR S 872, Paris, France	Universite de Montreal; Universite de Montreal; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Nuyt, AM (corresponding author), Univ Montreal, St Justine Univ Hosp & Res Ctr, Montreal, PQ, Canada.	anne-monique.nuyt@recherche-ste-justine.qc.ca		Sutherland, Megan/0000-0002-0841-1635; YZYDORCZYK, Catherine/0000-0002-0617-7558; Bertagnolli, Mariane/0000-0002-1093-1445	Canadian Institutes of Health Research [101766]; Heart and Stroke Foundation of Canada; Fonds de la Recherche en Sante du Quebec; Fondation des Etoiles-Fondation CHU Ste-Justine	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Fondation des Etoiles-Fondation CHU Ste-Justine	This work was supported by the Canadian Institutes of Health Research (101766) and the Heart and Stroke Foundation of Canada. Constantin Popescu was supported by a fellowship from from the Fonds de la Recherche en Sante du Quebec, Mariane Bertagnolli by a fellowship from the Fonds de la Recherche en Sante du Quebec, and Catherine Yzydorczyk by a fellowship from the Fondation des Etoiles-Fondation CHU Ste-Justine. Anne Monique Nuyt was supported by a salary award from the Fonds de la Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacchetta J, 2009, KIDNEY INT, V76, P445, DOI 10.1038/ki.2009.201; Balasubramaniam V, 2007, AM J PHYSIOL-LUNG C, V292, pL1073, DOI 10.1152/ajplung.00347.2006; Bernhardt WM, 2006, KIDNEY INT, V69, P114, DOI 10.1038/sj.ki.5000062; Bonamy AKE, 2007, J INTERN MED, V262, P635, DOI 10.1111/j.1365-2796.2007.01868.x; Brunskill EW, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-15; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Clark RH, 2003, PEDIATRICS, V111, P986, DOI 10.1542/peds.111.5.986; Compernolle V, 2003, CARDIOVASC RES, V60, P569, DOI 10.1016/j.cardiores.2003.07.003; Cooper R, 2009, INT J EPIDEMIOL, V38, P235, DOI 10.1093/ije/dyn154; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Davis JM, 2010, SEMIN FETAL NEONAT M, V15, P191, DOI 10.1016/j.siny.2010.04.001; Doyle LW, 2003, PEDIATRICS, V111, P252, DOI 10.1542/peds.111.2.252; DREHER D, 1992, AM J PHYSIOL, V262, pC358, DOI 10.1152/ajpcell.1992.262.2.C358; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Freeburg PB, 2003, J AM SOC NEPHROL, V14, P927, DOI 10.1097/01.ASN.0000059308.82322.4F; Georgeson GD, 2002, EUR J OBSTET GYN R B, V103, P136, DOI 10.1016/S0301-2115(02)00050-7; Gore A, 2010, J IMMUNOTOXICOL, V7, P239, DOI 10.3109/1547691X.2010.492254; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Gubhaju L, 2009, AM J PHYSIOL-RENAL, V297, pF1668, DOI 10.1152/ajprenal.00163.2009; Gunaratnam L, 2009, J AM SOC NEPHROL, V20, P1877, DOI 10.1681/ASN.2008070804; HINCHLIFFE SA, 1991, LAB INVEST, V64, P777; Iacobelli S, 2007, AM J PERINAT, V24, P587, DOI 10.1055/s-2007-992173; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Karihaloo A, 2005, MOL CELL BIOL, V25, P7441, DOI 10.1128/MCB.25.17.7441-7448.2005; Keijzer-Veen MG, 2010, PEDIATR NEPHROL, V25, P499, DOI 10.1007/s00467-009-1371-y; Kojima I, 2007, J AM SOC NEPHROL, V18, P1218, DOI 10.1681/ASN.2006060639; Kwinta P, 2011, PEDIATR NEPHROL, V26, P1095, DOI 10.1007/s00467-011-1840-y; Lee Yuan-Shun, 2005, Chang Gung Med J, V28, P846; Li NJ, 2007, AM J PHYSIOL-RENAL, V292, pF207, DOI 10.1152/ajprenal.00457.2005; Little MH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008300; Manalich R, 2000, KIDNEY INT, V58, P770, DOI 10.1046/j.1523-1755.2000.00225.x; Mattot V, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013925.19218.7B; Murawski IJ, 2010, ORGANOGENESIS, V6, P189, DOI 10.4161/org.6.3.12125; Nuyt AM, 2008, CLIN SCI, V114, P1, DOI 10.1042/CS20070113; Nuyt AM, 2009, CURR OPIN NEPHROL HY, V18, P144, DOI 10.1097/MNH.0b013e328326092c; Pagano A, 2003, ANN NY ACAD SCI, V1010, P405, DOI 10.1196/annals.1299.074; Park AM, 2010, SEMIN FETAL NEONAT M, V15, P196, DOI 10.1016/j.siny.2010.05.006; Prabhakar NR, 2012, PHYSIOL REV, V92, P967, DOI 10.1152/physrev.00030.2011; Puelles VG, 2011, CURR OPIN NEPHROL HY, V20, P7, DOI 10.1097/MNH.0b013e3283410a7d; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rodriguez MM, 2004, PEDIATR DEVEL PATHOL, V7, P17, DOI 10.1007/s10024-003-3029-2; Rodriguez-Soriano J, 2005, PEDIATR NEPHROL, V20, P579, DOI 10.1007/s00467-005-1828-6; Saugstad OD, 2001, CURR OPIN OBSTET GYN, V13, P147, DOI 10.1097/00001703-200104000-00009; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Sears JE, 2008, P NATL ACAD SCI USA, V105, P19898, DOI 10.1073/pnas.0805817105; Song YR, 2010, NEPHROL DIAL TRANSPL, V25, P77, DOI 10.1093/ndt/gfp454; Sutherland MR, 2013, AM J PHYSIOL-RENAL, V304, pF1308, DOI 10.1152/ajprenal.00172.2012; Sutherland MR, 2011, J AM SOC NEPHROL, V22, P1365, DOI 10.1681/ASN.2010121266; Tufro A, 1999, J AM SOC NEPHROL, V10, P2125; TufroMcReddie A, 1997, DEV BIOL, V183, P139, DOI 10.1006/dbio.1997.8513; Vento M, 2003, J PEDIATR-US, V142, P240, DOI 10.1067/mpd.2003.91; Vento M, 2001, PEDIATRICS, V107, P642, DOI 10.1542/peds.107.4.642; Yzydorczyk C, 2008, HYPERTENSION, V52, P889, DOI 10.1161/HYPERTENSIONAHA.108.116251; Zaffanello M, 2010, ACTA PAEDIATR, V99, P1192, DOI 10.1111/j.1651-2227.2010.01799.x	57	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82421	10.1371/journal.pone.0082421	http://dx.doi.org/10.1371/journal.pone.0082421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358181	Green Submitted, Green Published, gold			2022-12-27	WOS:000328737700015
J	Printz, AD; Chan, E; Liong, C; Martinez, RS; Lipomi, DJ				Printz, Adam D.; Chan, Esther; Liong, Celine; Martinez, Rene S.; Lipomi, Darren J.			Photoresist-Free Patterning by Mechanical Abrasion of Water-Soluble Lift-Off Resists and Bare Substrates: Toward Green Fabrication of Transparent Electrodes	PLOS ONE			English	Article							ORGANIC SOLAR-CELLS; SHRINKY-DINK MICROFLUIDICS; CARBON NANOTUBES; CONDUCTING FILMS; NANOWIRES; ULTRATHIN; EFFICIENCY; PEDOT/PSS	This paper describes the fabrication of transparent electrodes based on grids of copper microwires using a non-photolithographic process. The process-"abrasion lithography''-takes two forms. In the first implementation (Method I), a water-soluble commodity polymer film is abraded with a sharp tool, coated with a conductive film, and developed by immersion in water. Water dissolves the polymer film and lifts off the conductive film in the unabraded areas. In the second implementation (Method II), the substrate is abraded directly by scratching with a sharp tool (i.e., no polymer film necessary). The abraded regions of the substrate are recessed and roughened. Following deposition of a conductive film, the lower profile and roughened topography in the abraded regions prevents mechanical exfoliation of the conductive film using adhesive tape, and thus the conductive film remains only where the substrate is scratched. As an application, conductive grids exhibit average sheet resistances of 17 Omega sq(-1) and transparencies of 86% are fabricated and used as the anode in organic photovoltaic cells in concert with the conductive polymer, poly(3,4-ethylenedioxythiophene):poly(styrenesulfonate) (PEDOT:PSS). Compared to devices in which PEDOT:PSS alone serves as an anode, devices comprising grids of copper/nickel microwires and PEDOT: PSS exhibit lowered series resistance, which manifests in greater fill factor and power conversion efficiency. This simple method of forming micropatterns could find use in applications where cost and environmental impact should be minimized, especially as a potential replacement for the transparent electrode indium tin oxide (ITO) in thin-film electronics over large areas (i.e., solar cells) or as a method of rapid prototyping for laboratory-scale devices.	[Printz, Adam D.; Chan, Esther; Liong, Celine; Martinez, Rene S.; Lipomi, Darren J.] Univ Calif San Diego, Dept NanoEngn, San Diego, CA 92103 USA	University of California System; University of California San Diego	Lipomi, DJ (corresponding author), Univ Calif San Diego, Dept NanoEngn, San Diego, CA 92103 USA.	dlipomi@ucsd.edu	Printz, Adam/O-3440-2017	Printz, Adam/0000-0002-5264-7792	University of California, San Diego; Calit2 Summer Undergraduate Research Scholars Program	University of California, San Diego(University of California System); Calit2 Summer Undergraduate Research Scholars Program	This work was supported by laboratory startup funds from the University of California, San Diego. E. C. acknowledges a fellowship from the Calit2 Summer Undergraduate Research Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaca BE, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/5/055301; Alcalde H, 2013, P IEEE, V101, P1793, DOI 10.1109/JPROC.2013.2263112; Alharbi F, 2011, RENEW ENERG, V36, P2753, DOI 10.1016/j.renene.2011.03.010; Anctil A, 2012, PROG PHOTOVOLTAICS, V21, P1541, DOI DOI 10.1002/PIP.2226; Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/NNANO.2010.132, 10.1038/nnano.2010.132]; Becerril HA, 2008, ACS NANO, V2, P463, DOI 10.1021/nn700375n; Burke DJ, 2013, ENERG ENVIRON SCI, V6, P2053, DOI 10.1039/c3ee41096j; Cao Q, 2009, ADV MATER, V21, P29, DOI 10.1002/adma.200801995; Carrilho E, 2009, ANAL CHEM, V81, P7091, DOI 10.1021/ac901071p; Catrysse PB, 2010, NANO LETT, V10, P2944, DOI 10.1021/nl1011239; Chen CS, 2008, LAB CHIP, V8, P622, DOI 10.1039/b719029h; Choi YY, 2012, SOL ENERG MAT SOL C, V96, P281, DOI 10.1016/j.solmat.2011.09.031; Chou SY, 2013, OPT EXPRESS, V21, pA60, DOI 10.1364/OE.21.000A60; Chun KY, 2010, NAT NANOTECHNOL, V5, P853, DOI 10.1038/NNANO.2010.232; Crispin X, 2006, CHEM MATER, V18, P4354, DOI 10.1021/cm061032+; Dattoli EN, 2011, MRS BULL, V36, P782, DOI 10.1557/mrs.2011.212; De S, 2009, ACS NANO, V3, P1767, DOI 10.1021/nn900348c; Du Pasquier A, 2006, SOL ENERG MAT SOL C, V90, P1828, DOI 10.1016/j.solmat.2005.11.003; Elbahri M, 2009, ADV SOLID STATE PHYS, V48, P27, DOI 10.1007/978-3-540-85859-1_3; Elschner A., 2010, PEDOT PRINCIPLES APP, P1, DOI 10.1201/b10318; Garnett EC, 2012, NAT MATER, V11, P241, DOI [10.1038/nmat3238, 10.1038/NMAT3238]; Geissler M, 2003, LANGMUIR, V19, P6301, DOI 10.1021/la034464x; *GEOL SURV US, 2012, MET PRIC US 2010; Grimes A, 2008, LAB CHIP, V8, P170, DOI 10.1039/b711622e; Hecht DS, 2011, ADV MATER, V23, P1482, DOI 10.1002/adma.201003188; Hecht DS, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/7/075201; Hrehorova E, 2011, J DISP TECHNOL, V7, P318, DOI 10.1109/JDT.2010.2065214; Hu LB, 2010, ACS NANO, V4, P2955, DOI 10.1021/nn1005232; Junbo Wu, 2008, Applied Physics Letters, V92, P263302, DOI 10.1063/1.2924771; Kaltenbrunner M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1772; Kang MG, 2010, ADV MATER, V22, P4378, DOI 10.1002/adma.201001395; Kang MG, 2008, ADV MATER, V20, P4408, DOI 10.1002/adma.200800750; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; Kim YH, 2011, ADV FUNCT MATER, V21, P1076, DOI 10.1002/adfm.201002290; Kylberg W, 2011, ADV MATER, V23, P1015, DOI 10.1002/adma.201003391; Lacour SP, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2201874; Layani M, 2009, ACS NANO, V3, P3537, DOI 10.1021/nn901239z; Lee JY, 2008, NANO LETT, V8, P689, DOI 10.1021/nl073296g; Lewis NS, 2007, SCIENCE, V315, P798, DOI 10.1126/science.1137014; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Li G, 2012, NAT PHOTONICS, V6, P153, DOI [10.1038/NPHOTON.2012.11, 10.1038/nphoton.2012.11]; Linder V, 2005, SMALL, V1, P730, DOI 10.1002/smll.200400159; Lipomi DJ, 2012, CHEM MATER, V24, P373, DOI 10.1021/cm203216m; Lipomi DJ, 2011, ADV MATER, V23, P1771, DOI 10.1002/adma.201004426; Lo CY, 2009, MICROELECTRON ENG, V86, P979, DOI 10.1016/j.mee.2009.02.001; Madaria AR, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/24/245201; Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989; Mirri F, 2012, ACS NANO, V6, P9737, DOI 10.1021/nn303201g; Mondin G, 2013, MICROELECTRON ENG, V104, P100, DOI 10.1016/j.mee.2012.11.022; Na SI, 2009, J MATER CHEM, V19, P9045, DOI 10.1039/b915756e; Pearce Joshua M., 2008, International Journal of Nuclear Governance, Economy and Ecology, V2, P113, DOI 10.1504/IJNGEE.2008.017358; Rathmell AR, 2012, NANO LETT, V12, P3193, DOI 10.1021/nl301168r; Rathmell AR, 2011, ADV MATER, V23, P4798, DOI 10.1002/adma.201102284; Rathmell AR, 2010, ADV MATER, V22, P3558, DOI 10.1002/adma.201000775; Stec HM, 2011, ADV FUNCT MATER, V21, P1709, DOI 10.1002/adfm.201002021; Vosgueritchian M, 2012, ADV FUNCT MATER, V22, P421, DOI 10.1002/adfm.201101775; Winkleman A, 2007, SOFT MATTER, V3, P108, DOI 10.1039/b611630b; Wu H, 2013, NAT NANOTECHNOL, V8, P421, DOI [10.1038/nnano.2013.84, 10.1038/NNANO.2013.84]; Wu H, 2010, NANO LETT, V10, P4242, DOI 10.1021/nl102725k; Wu ZC, 2004, SCIENCE, V305, P1273, DOI 10.1126/science.1101243	60	7	7	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83939	10.1371/journal.pone.0083939	http://dx.doi.org/10.1371/journal.pone.0083939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358321	gold, Green Published, Green Submitted			2022-12-27	WOS:000328737700074
J	Xie, Y; Niu, LL; Zhao, B; Wang, Q; Nong, X; Chen, L; Zhou, X; Gu, XB; Wang, SX; Peng, XR; Yang, GY				Xie, Yue; Niu, Lili; Zhao, Bo; Wang, Qiang; Nong, Xiang; Chen, Lin; Zhou, Xuan; Gu, Xiaobin; Wang, Shuxian; Peng, Xuerong; Yang, Guangyou			Complete Mitochondrial Genomes of Chimpanzee- and Gibbon-Derived Ascaris Isolated from a Zoological Garden in Southwest China	PLOS ONE			English	Article							COMPLETE SEQUENCE; CAENORHABDITIS-ELEGANS; PHYLOGENETIC ANALYSIS; INTESTINAL PARASITES; POPULATION-GENETICS; ANIMAL HEALTH; CODON USAGE; NEMATODES; DNA; EVOLUTION	Roundworms (Ascaridida: Nematoda), one of the most common soil-transmitted helminths (STHs), can cause ascariasis in various hosts worldwide, ranging from wild to domestic animals and humans. Despite the veterinary and health importance of the Ascaridida species, little or no attention has been paid to roundworms infecting wild animals including non-human primates due to the current taxon sampling and survey bias in this order. Importantly, there has been considerable controversy over the years as to whether Ascaris species infecting non-human primates are the same as or distinct from Ascaris lumbricoides infecting humans. Herein, we first characterized the complete mitochondrial genomes of two representative Ascaris isolates derived from two non-human primates, namely, chimpanzees (Pan troglodytes) and gibbons (Hylobates hoolock), in a zoological garden of southwest China and compared them with those of A. lumbricoides and the congeneric Ascaris suum as well as other related species in the same order, and then used comparative mitogenomics, genome-wide nucleotide sequence identity analysis, and phylogeny to determine whether the parasites from chimpanzees and gibbons represent a single species and share genetic similarity with A. lumbricoides. Taken together, our results yielded strong statistical support for the hypothesis that the chimpanzee-and gibbon-derived Ascaris represent a single species that is genetically similar to A. lumbricoides, consistent with the results of previous morphological and molecular studies. Our finding should enhance public alertness to roundworms originating from chimpanzees and gibbons and the mtDNA data presented here also serves to enrich the resource of markers that can be used in molecular diagnostic, systematic, population genetic, and evolutionary biological studies of parasitic nematodes from either wild or domestic hosts.	[Xie, Yue; Nong, Xiang; Chen, Lin; Zhou, Xuan; Gu, Xiaobin; Wang, Shuxian; Yang, Guangyou] Sichuan Agr Univ, Coll Vet Med, Dept Parasitol, Yaan, Sichuan, Peoples R China; [Niu, Lili; Zhao, Bo; Wang, Qiang] Vet Hosp, Chengdu, Sichuan, Peoples R China; [Peng, Xuerong] Sichuan Agr Univ, Coll Life & Basic Sci, Dept Chem, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Yang, GY (corresponding author), Sichuan Agr Univ, Coll Vet Med, Dept Parasitol, Yaan, Sichuan, Peoples R China.	guangyou1963@aliyun.com	zhou, xuan/GZA-8157-2022		Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT0848]; Research Fund for the Chengdu Research of Giant Panda Breeding [CPF2012-13]	Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Research Fund for the Chengdu Research of Giant Panda Breeding	This work was supported by grants from the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) (Grant no. IRT0848) and the Research Fund for the Chengdu Research of Giant Panda Breeding (Project no. CPF2012-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha PN, 2003, ZOONOSES COMMUNICABL, P285; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Blouin MS, 2002, INT J PARASITOL, V32, P527, DOI 10.1016/S0020-7519(01)00357-5; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chowdhury N., 2001, HELMINTHS WILDLIFE; Dangoudoubiyam S, 2009, J PARASITOL, V95, P571, DOI 10.1645/GE-1905.1; Douglas SE, 1999, J MOL EVOL, V48, P236, DOI 10.1007/PL00006462; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gasser RB, 2000, INT J PARASITOL, V30, P509, DOI 10.1016/S0020-7519(00)00021-7; Gasser RB, 2012, INFECT GENET EVOL, V12, P1884, DOI 10.1016/j.meegid.2012.07.022; Gatcombe RR, 2010, PARASITOL RES, V106, P499, DOI 10.1007/s00436-009-1692-6; Ghikas DV, 2006, ARCH MICROBIOL, V185, P393, DOI 10.1007/s00203-006-0104-x; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Hartwich G., 1974, CIH Keys Nematode Parasites Vert, VNo. 2,1974, P1; Hu M, 2006, TRENDS PARASITOL, V22, P78, DOI 10.1016/j.pt.2005.12.003; Hu M, 2004, ADV PARASIT, V56, P133, DOI 10.1016/S0065-308X(03)56003-1; Hu M, 2007, NAT PROTOC, V2, P2339, DOI 10.1038/nprot.2007.358; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Jeon HK, 2005, PARASITOLOGY, V130, P717, DOI 10.1017/S0031182004007164; Jex AR, 2010, BIOTECHNOL ADV, V28, P151, DOI 10.1016/j.biotechadv.2009.11.002; Jex AR, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000273; Jex AR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-79; Jia WanZhong, 2011, Scientia Agricultura Sinica, V44, P1255; Kalema-Zikusoka G, 2005, PRIMATES, V46, P59, DOI 10.1007/s10329-004-0103-y; Kim KH, 2006, INT J PARASITOL, V36, P319, DOI 10.1016/j.ijpara.2005.10.004; Kurabayashi A, 2000, MOL BIOL EVOL, V17, P266, DOI 10.1093/oxfordjournals.molbev.a026306; LANDSOUDSOUKATE J, 1995, ANN TROP MED PARASIT, V89, P73, DOI 10.1080/00034983.1995.11812931; Li MW, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-224; Li Y, 2012, PARASITOLOGY, V139, P1329, DOI 10.1017/S003118201200056X; Lin RQ, 2012, EXP PARASITOL, V130, P135, DOI 10.1016/j.exppara.2011.11.003; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; Liu GH, 2012, GENE, V492, P110, DOI 10.1016/j.gene.2011.10.043; Nadler SA, 1998, MOL PHYLOGENET EVOL, V10, P221, DOI 10.1006/mpev.1998.0514; Nejsum P, 2006, VET PARASITOL, V139, P203, DOI 10.1016/j.vetpar.2006.02.025; Nejsum P, 2010, VET PARASITOL, V171, P273, DOI 10.1016/j.vetpar.2010.03.030; [牛李丽 Niu Lili], 2012, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V43, P1645; Ocaido M, 2003, AFR J ECOL, V41, P356, DOI 10.1111/j.1365-2028.2003.00483.x; OKIMOTO R, 1994, J MOL EVOL, V39, P598, DOI 10.1007/BF00160405; OKIMOTO R, 1992, GENETICS, V130, P471; Okulewicz A., 2002, Polish Journal of Veterinary Sciences, V5, P277; Park JK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-392; Park YC, 2011, MITOCHONDR DNA, V22, P91, DOI 10.3109/19401736.2011.624608; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saccone C, 2000, GENE, V261, P153, DOI 10.1016/S0378-1119(00)00484-4; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Shao R, 2001, MOL BIOL EVOL, V18, P858, DOI 10.1093/oxfordjournals.molbev.a003867; SHARP PM, 1994, CURR OPIN GENET DEV, V4, P851, DOI 10.1016/0959-437X(94)90070-1; SPRENT JFA, 1968, PARASITOLOGY, V58, P185, DOI 10.1017/S0031182000073534; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wickramasinghe S, 2009, MOL BIOCHEM PARASIT, V166, P89, DOI 10.1016/j.molbiopara.2009.02.012; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xie Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027066; Xie Y, 2011, GENE, V482, P59, DOI 10.1016/j.gene.2011.05.004; Yang GY, 2013, PARASITIC DIS WILDLI; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yatawara L, 2010, MOL BIOCHEM PARASIT, V173, P32, DOI 10.1016/j.molbiopara.2010.05.004	65	13	13	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82795	10.1371/journal.pone.0082795	http://dx.doi.org/10.1371/journal.pone.0082795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358225	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700031
J	Gorini, G; Roberts, AJ; Mayfield, RD				Gorini, Giorgio; Roberts, Amanda J.; Mayfield, R. Dayne			Neurobiological Signatures of Alcohol Dependence Revealed by Protein Profiling	PLOS ONE			English	Article							SUPERIOR FRONTAL GYRUS; GENE-EXPRESSION; HUMAN BRAIN; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; SYNAPTIC PROTEOME; ETHANOL EXPOSURE; NETWORK ANALYSIS; C57BL/6J MICE; DRINKING	Alcohol abuse causes dramatic neuroadaptations in the brain, which contribute to tolerance, dependence, and behavioral modifications. Previous proteomic studies in human alcoholics and animal models have identified candidate alcoholism-related proteins. However, recent evidences suggest that alcohol dependence is caused by changes in co-regulation that are invisible to single protein-based analysis. Here, we analyze global proteomics data to integrate differential expression, co-expression networks, and gene annotations to unveil key neurobiological rearrangements associated with the transition to alcohol dependence modeled by a Chronic Intermittent Ethanol (CIE), two-bottle choice (2BC) paradigm. We analyzed cerebral cortices (CTX) and midbrains (MB) from male C57BL/6J mice subjected to a CIE, 2BC paradigm, which induces heavy drinking and represents one of the best available animal models for alcohol dependence and relapse drinking. CIE induced significant changes in protein levels in dependent mice compared with their non-dependent controls. Multiple protein isoforms showed region-specific differential regulation as a result of post-translational modifications. Our integrative analysis identified modules of co-expressed proteins that were highly correlated with CIE treatment. We found that modules most related to the effects of CIE treatment coordinate molecular imbalances in endocytic- and energy-related pathways, with specific proteins involved, such as dynamin-1. The qRT-PCR experiments validated both differential and co-expression analyses, and the correspondence among our data and previous genomic and proteomic studies in humans and rodents substantiates our findings. The changes identified above may play a key role in the escalation of ethanol consumption associated with dependence. Our approach to alcohol addiction will advance knowledge of brain remodeling mechanisms and adaptive changes in response to drug abuse, contribute to understanding of organizational principles of CTX and MB proteomes, and define potential new molecular targets for treating alcohol addiction. The integrative analysis employed here highlight the advantages of systems approaches in studying the neurobiology of alcohol addiction.	[Gorini, Giorgio; Mayfield, R. Dayne] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA; [Roberts, Amanda J.] Scripps Res Inst, Mol & Cellular Neurosci Dept, La Jolla, CA 92037 USA	University of Texas System; University of Texas Austin; Scripps Research Institute	Gorini, G (corresponding author), Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA.	gorini@utexas.edu	Gorini, Giorgio/D-7053-2014	Gorini, Giorgio/0000-0002-0893-5922	NIAAA [AA016648, AA0107838, AA019382, AA020683]; Integrative Neuroscience Initiative on Alcoholism (INIA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016648, RC2AA019382, R01AA012404, U01AA020926, U01AA020893, P01AA020683] Funding Source: NIH RePORTER	NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Integrative Neuroscience Initiative on Alcoholism (INIA)(Instituto de Investigacion Agropecuaria (INIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIAAA grants AA016648, AA0107838, AA019382, AA020683, and Integrative Neuroscience Initiative on Alcoholism (INIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander-Kaufman K, 2007, PROTEOM CLIN APPL, V1, P62, DOI 10.1002/prca.200600417; Bell RL, 2006, ALCOHOL, V40, P3, DOI 10.1016/j.alcohol.2006.10.001; Bell RL, 2009, PHARMACOL BIOCHEM BE, V94, P131, DOI 10.1016/j.pbb.2009.07.019; Calabrese V, 2000, BIOCHEM BIOPH RES CO, V269, P397, DOI 10.1006/bbrc.2000.2311; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; D'haene Barbara, 2012, Methods Mol Biol, V822, P261, DOI 10.1007/978-1-61779-427-8_18; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Dood PR, 1998, ANN NY ACAD SCI, V844, P50, DOI 10.1111/j.1749-6632.1998.tb08221.x; Etheridge N, 2011, CURR NEUROPHARMACOL, V9, P122, DOI 10.2174/157015911795017164; Etheridge N, 2009, PROTEOM CLIN APPL, V3, P730, DOI 10.1002/prca.200800202; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Finn DA, 2007, ALCOHOL CLIN EXP RES, V31, P939, DOI 10.1111/j.1530-0277.2007.00379.x; Fodor IK, 2005, BIOINFORMATICS, V21, P3733, DOI 10.1093/bioinformatics/bti612; Gorini G, 2011, PROG MOL BIOL TRANSL, V98, P293, DOI 10.1016/B978-0-12-385506-0.00007-7; Gorini G, 2010, FEBS LETT, V584, P845, DOI 10.1016/j.febslet.2009.12.061; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Griffin WC, 2009, ALCOHOL CLIN EXP RES, V33, P1893, DOI 10.1111/j.1530-0277.2009.01027.x; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kimpel MW, 2007, ALCOHOL, V41, P95, DOI 10.1016/j.alcohol.2007.03.003; Koob GF, 2006, ADDICTION, V101, P23, DOI 10.1111/j.1360-0443.2006.01586.x; Koob GF, 2004, NEUROSCI BIOBEHAV R, V27, P739, DOI 10.1016/j.neubiorev.2003.11.007; Kril JJ, 1997, NEUROSCIENCE, V79, P983, DOI 10.1016/S0306-4522(97)00083-3; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lewohl JM, 2004, ANN NY ACAD SCI, V1025, P14, DOI 10.1196/annals.1316.002; Lewohl JM, 2011, ALCOHOL CLIN EXP RES, V35, P1928, DOI 10.1111/j.1530-0277.2011.01544.x; Li MD, 2007, PROTEOM CLIN APPL, V1, P1406, DOI 10.1002/prca.200700321; Liu JW, 2006, NEUROPSYCHOPHARMACOL, V31, P1574, DOI 10.1038/sj.npp.1300947; Liu JW, 2004, J NEUROCHEM, V90, P1050, DOI 10.1111/j.1471-4159.2004.02570.x; Lopez MF, 2005, PSYCHOPHARMACOLOGY, V181, P688, DOI 10.1007/s00213-005-0026-3; Mayfield RD, 2008, BRIT J PHARMACOL, V154, P275, DOI 10.1038/bjp.2008.88; Mayfield RD, 2002, J NEUROCHEM, V81, P802, DOI 10.1046/j.1471-4159.2002.00860.x; McBride WJ, 2009, PHARMACOL BIOCHEM BE, V92, P304, DOI 10.1016/j.pbb.2008.12.019; Mulligan MK, 2011, ALCOHOL CLIN EXP RES, V35, P659, DOI 10.1111/j.1530-0277.2010.01384.x; Mulligan MK, 2006, P NATL ACAD SCI USA, V103, P6368, DOI 10.1073/pnas.0510188103; Nestler EJ, 2004, NEUROPHARMACOLOGY, V47, P24, DOI 10.1016/j.neuropharm.2004.06.031; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Phillips TJ, 2002, GENES BRAIN BEHAV, V1, P14, DOI 10.1046/j.1601-1848.2001.00011.x; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Pignataro L, 2007, J NEUROSCI, V27, P12957, DOI 10.1523/JNEUROSCI.4142-07.2007; Ponomarev I, 2012, J NEUROSCI, V32, P1884, DOI 10.1523/JNEUROSCI.3136-11.2012; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rogowska-Wrzesinska A, 2013, J PROTEOMICS, V88, P4, DOI 10.1016/j.jprot.2013.01.010; Sullivan EV, 2005, PSYCHOPHARMACOLOGY, V180, P583, DOI 10.1007/s00213-005-2267-6; Sullivan EV, 2002, NEUROPSYCHOLOGY, V16, P74, DOI 10.1037//0894-4105.16.1.74; Sutherland GT, 2014, ALCOHOL CLIN EXP RES, V38, P1, DOI 10.1111/acer.12243; Tapocik JD, 2013, PHARMACOGENOMICS J, V13, P286, DOI 10.1038/tpj.2012.17; Treistman SN, 2009, TRENDS NEUROSCI, V32, P629, DOI 10.1016/j.tins.2009.08.001; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Volkow ND, 2008, PSYCHIAT RES-NEUROIM, V162, P205, DOI 10.1016/j.pscychresns.2007.04.010; Wang J, 2011, MOL NEUROBIOL, V44, P269, DOI 10.1007/s12035-011-8202-4; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	53	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82656	10.1371/journal.pone.0082656	http://dx.doi.org/10.1371/journal.pone.0082656			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358215	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700088
J	Hasebe, N; Fujita, Y; Ueno, M; Yoshimura, K; Fujino, Y; Yamashita, T				Hasebe, Noriko; Fujita, Yuki; Ueno, Masaki; Yoshimura, Kazuhiro; Fujino, Yuji; Yamashita, Toshihide			Soluble beta-amyloid Precursor Protein Alpha Binds to p75 Neurotrophin Receptor to Promote Neurite Outgrowth	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; NERVE GROWTH-FACTOR; ALZHEIMERS-DISEASE; CELL-DEATH; APP BINDS; NEURONS; P75(NTR); MICE; RHO; EXPRESSION	Background: The cleavage of beta-amyloid precursor protein (APP) generates multiple proteins: Soluble beta-amyloid Precursor Protein Alpha (sAPP alpha), sAPP beta, and amyloid beta (A beta). Previous studies have shown that sAPP alpha and sAPP beta possess neurotrophic properties, whereas A beta is neurotoxic. However, the underlying mechanism of the opposing effects of APP fragments remains poorly understood. In this study, we have investigated the mechanism of sAPP alpha-mediated neurotrophic effects. sAPP alpha and sAPP beta interact with p75 neurotrophin receptor (p75(NTR)), and sAPP alpha promotes neurite outgrowth. Methods and Findings: First, we investigated whether APP fragments interact with p75(NTR), because full-length APP and A beta have been shown to interact with p75(NTR) in vitro. Both sAPP alpha and sAPP beta were co-immunoprecipitated with p75(NTR) and co-localized with p75(NTR) on COS-7 cells. The binding affinity of sAPP alpha and sAPP beta for p75(NTR) was confirmed by enzyme-linked immunosorbent assay (ELISA). Next, we investigated the effect of sAPP alpha on neurite outgrowth in mouse cortical neurons. Neurite outgrowth was promoted by sAPP alpha, but sAPP alpha was uneffective in a knockdown of p75(NTR). Conclusion: We conclude that p75(NTR) is the receptor for sAPP alpha to mediate neurotrophic effects.	[Hasebe, Noriko; Fujita, Yuki; Ueno, Masaki; Yoshimura, Kazuhiro; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Osaka, Japan; [Hasebe, Noriko; Fujino, Yuji] Osaka Univ, Grad Sch Med, Dept Anesthesiol & Crit Care Med, Osaka, Japan; [Hasebe, Noriko; Fujita, Yuki; Ueno, Masaki; Yamashita, Toshihide] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan; [Ueno, Masaki] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Yoshimura, Kazuhiro] Osaka Univ, Grad Sch Med, Dept Neurosurg, Osaka, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST); Cincinnati Children's Hospital Medical Center; Osaka University	Yamashita, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Osaka, Japan.	yamashita@molneu.med.osaka-u.ac.jp	Ueno, Masaki/J-1216-2019	Yamashita, Toshihide/0000-0003-4559-7018; Ueno, Masaki/0000-0003-1484-9921	JSPS [25221309]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (S) from JSPS (25221309) to T.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar CA, 1998, MOL BRAIN RES, V56, P125, DOI 10.1016/S0169-328X(98)00037-0; Ben-Zvi A, 2007, J NEUROSCI, V27, P13000, DOI 10.1523/JNEUROSCI.3373-07.2007; Chasseigneaux S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016301; Clarris HJ, 1997, J NEUROCHEM, V68, P1164; Corrigan F, 2011, BRAIN RES, V1378, P137, DOI 10.1016/j.brainres.2010.12.077; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Fombonne J, 2009, ANN NEUROL, V65, P294, DOI 10.1002/ana.21578; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Hartmann D, 1999, CURR BIOL, V9, P719, DOI 10.1016/S0960-9822(99)80331-5; Hashimoto Y, 2004, J NEUROSCI RES, V75, P417, DOI 10.1002/jnr.10861; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Higuchi H, 2003, EMBO J, V22, P1790, DOI 10.1093/emboj/cdg177; Higuchi H, 2003, BIOCHEM BIOPH RES CO, V301, P804, DOI 10.1016/S0006-291X(03)00029-9; JIN LW, 1994, J NEUROSCI, V14, P5461; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kim D, 2009, CELL, V137, P997, DOI 10.1016/j.cell.2009.05.042; Knowles JK, 2009, J NEUROSCI, V29, P10627, DOI 10.1523/JNEUROSCI.0620-09.2009; Kobayashi S, 2010, NEUROCHEM INT, V56, P387, DOI 10.1016/j.neuint.2009.11.005; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; LOFFLER J, 1992, J NEUROCHEM, V59, P1316, DOI 10.1111/j.1471-4159.1992.tb08443.x; Luo JJ, 2001, J NEUROSCI RES, V63, P410, DOI 10.1002/1097-4547(20010301)63:5<410::AID-JNR1036>3.3.CO;2-2; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; Nakazawa H, 2012, J NEUROSCI, V32, P12712, DOI 10.1523/JNEUROSCI.0989-12.2012; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; NINOMIYA H, 1994, J NEUROCHEM, V63, P495; Rossner S, 1998, J NEUROCHEM, V71, P757; SALBAUM JM, 1994, J EXP ZOOL, V269, P116, DOI 10.1002/jez.1402690205; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; SMALL DH, 1994, J NEUROSCI, V14, P2117; Sotthibundhu A, 2008, J NEUROSCI, V28, P3941, DOI 10.1523/JNEUROSCI.0350-08.2008; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Ueno M, 2013, NAT NEUROSCI, V16, P543, DOI 10.1038/nn.3358; Wallace WC, 1997, MOL BRAIN RES, V52, P201, DOI 10.1016/S0169-328X(97)00258-1; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Yaar M, 2007, NEUROPATH APPL NEURO, V33, P533, DOI 10.1111/j.1365-2990.2007.00844.x; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Yoshimura K, 2011, NEUROSCI RES, V71, P266, DOI 10.1016/j.neures.2011.07.1830	41	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82321	10.1371/journal.pone.0082321	http://dx.doi.org/10.1371/journal.pone.0082321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358169	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700057
J	Nomachi, A; Yoshinaga, M; Liu, J; Kanchanawong, P; Tohyama, K; Thumkeo, D; Watanabe, T; Narumiya, S; Hirata, T				Nomachi, Akira; Yoshinaga, Masanori; Liu, Jaron; Kanchanawong, Pakorn; Tohyama, Kiyoshi; Thumkeo, Dean; Watanabe, Takeshi; Narumiya, Shuh; Hirata, Takako			Moesin Controls Clathrin-Mediated S1PR1 Internalization in T Cells	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTORS; LYMPHOCYTE EGRESS; STRUCTURED ILLUMINATION; EZRIN; ENDOCYTOSIS; TRAFFICKING; SPHINGOSINE-1-PHOSPHATE; CYTOSKELETON; AGONISTS; RADIXIN	The lipid mediator sphingosine 1-phosphate (S1P) regulates a wide range of cellular activities, including vascular maturation, angiogenesis, and immune-cell trafficking. Among the five known receptors for S1P (S1PR1-S1PR5), S1PR1 is a critical regulator of lymphocyte trafficking: its signaling is required for lymphocyte egress from lymphoid organs, while its down-modulation by agonist-induced internalization is a prerequisite for lymphocyte entry into lymphoid organs from the bloodstream. Despite the importance of S1PR1 down-regulation in determining lymphocyte behavior, the molecular mechanism of its internalization in lymphocytes has not been defined. Here we show that agonist-induced S1PR1 internalization in T cells occurs via clathrin-mediated endocytosis and is regulated by moesin, an ezrin-radixin-moesin (ERM) family member. In S1P-stimulated T cells, S1PR1 relocalized within clathrin-coated vesicles (CCVs) and early endosomes, and S1PR1 internalization was blocked when clathrin was pharmacologically inhibited. Stimulating moesin-deficient T cells with S1P failed to induce S1PR1 internalization and CCV formation. Furthermore, treating moesin-deficient mice with FTY720, an S1P receptor agonist known to internalize S1PR1, caused delayed lymphopenia, and lymphocytes isolated from FTY720-treated moesin-deficient mice still responded to S1P ex vivo in chemotaxis assays. These results reveal a novel role for moesin in regulating clathrin-dependent S1PR1 internalization through CCV formation.	[Nomachi, Akira; Watanabe, Takeshi; Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan; [Yoshinaga, Masanori; Tohyama, Kiyoshi; Thumkeo, Dean; Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan; [Liu, Jaron; Kanchanawong, Pakorn] Mechanobiol Inst, Singapore, Singapore; [Kanchanawong, Pakorn] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore; [Hirata, Takako] Shiga Univ Med Sci, Dept Fundamental Biosci, Otsu, Shiga 52021, Japan	Kyoto University; Kyoto University; National University of Singapore; Shiga University of Medical Science	Hirata, T (corresponding author), Shiga Univ Med Sci, Dept Fundamental Biosci, Otsu, Shiga 52021, Japan.	tahirata@belle.shiga-med.ac.jp	Kanchanawong, Pakorn/M-1315-2017	Kanchanawong, Pakorn/0000-0001-8765-3861; Yoshinaga, Masanori/0000-0001-5642-9752; Hirata, Takako/0000-0002-1740-6168	Ministry of Education, Culture, Sports, Science and Technology, Japan [22590433, 33021022]; Japanese Government; Astellas Pharma Inc. in the Formation of the Innovation Center for Fusion and Advanced Technologies Program; Grants-in-Aid for Scientific Research [24111009] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Government; Astellas Pharma Inc. in the Formation of the Innovation Center for Fusion and Advanced Technologies Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (22590433 and 33021022), and by Special Coordination Funds for Promoting Science and Technology of the Japanese Government and Astellas Pharma Inc. in the Formation of the Innovation Center for Fusion and Advanced Technologies Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnon TI, 2011, SCIENCE, V333, P1898, DOI 10.1126/science.1208248; Barroso-Gonzalez J, 2009, J BIOL CHEM, V284, P2419, DOI 10.1074/jbc.M805311200; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Deckert M, 1996, J CELL BIOL, V133, P791, DOI 10.1083/jcb.133.4.791; Doi Y, 1999, J BIOL CHEM, V274, P2315, DOI 10.1074/jbc.274.4.2315; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Gonzalez-Cabrera PJ, 2007, J BIOL CHEM, V282, P7254, DOI 10.1074/jbc.M610581200; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hansen CG, 2009, J CELL SCI, V122, P1713, DOI 10.1242/jcs.033951; Hirata T, 2012, INT IMMUNOL, V24, P705, DOI 10.1093/intimm/dxs077; Jean-Alphonse F, 2011, MOL CELL ENDOCRINOL, V331, P205, DOI 10.1016/j.mce.2010.07.010; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Kanchanawong P, 2012, CURR OPIN CELL BIOL, V24, P125, DOI 10.1016/j.ceb.2011.11.010; Kharel Y, 2005, J BIOL CHEM, V280, P36865, DOI 10.1074/jbc.M506293200; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Shcherbina A, 1999, FEBS LETT, V443, P31, DOI 10.1016/S0014-5793(98)01674-3; Shigeta A, 2008, BLOOD, V112, P4915, DOI 10.1182/blood-2008-04-153866; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Stanasila L, 2006, J BIOL CHEM, V281, P4354, DOI 10.1074/jbc.M511989200; Thangada S, 2010, J EXP MED, V207, P1475, DOI 10.1084/jem.20091343; Van der Lee MMC, 2008, J BIOMOL SCREEN, V13, P986, DOI 10.1177/1087057108326144; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Watterson KR, 2002, J BIOL CHEM, V277, P5767, DOI 10.1074/jbc.M110647200; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628	41	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82590	10.1371/journal.pone.0082590	http://dx.doi.org/10.1371/journal.pone.0082590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358210	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700084
J	Samo, RN; Altaf, A; Agha, A; Pasha, O; Rozi, S; Memon, A; Azam, S; Blevins, M; Vermund, SH; Shah, SA				Samo, Rab Nawaz; Altaf, Arshad; Agha, Ajmal; Pasha, Omrana; Rozi, Shafquat; Memon, Ashraf; Azam, Saleem; Blevins, Meridith; Vermund, Sten H.; Shah, Sharaf Ali			High HIV Incidence among Persons Who Inject Drugs in Pakistan: Greater Risk with Needle Sharing and Injecting Frequently among the Homeless	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; HIV/AIDS SURVEILLANCE PROJECT; SYRINGE EXCHANGE PROGRAMS; HEPATITIS-C; USERS; PREVENTION; BEHAVIORS; EPIDEMIC; PREVALENCE; SERVICES	Background: The incidence of HIV among persons who inject drugs (PWIDU) has fallen in many nations, likely due to successes of clean needle/syringe exchange and substance abuse treatment and service programs. However in Pakistan, prevalence rates for PWID have risen dramatically. In several cities, prevalence exceeded 20% by 2009 compared to a 2003 baseline of just 0.5%. However, no cohort study of PWID has ever been conducted. Methods: We enrolled a cohort of 636 HIV seronegative PWID registered with three drop-in centers that focus on risk reduction and basic social services in Karachi. Recruitment began in 2009 (March to June) and PWID were followed for two years. We measured incidence rates and risk factors associated with HIV seroconversion. Results: Incidence of HIV was 12.4 per 100 person-years (95% exact Poisson confidence interval [CI]: 10.3-14.9). We followed 474 of 636 HIV seronegative persons (74.5%) for two years, an annual loss to follow-up of < 13 per 100 person years. In multivariable Cox regression analysis, HIV seroconversion was associated with non-Muslim religion (Adjusted risk ratio [ARR] = 1.7, 95% CI:1.4, 2.7, p = 0.03), sharing of syringes (ARR = 2.3, 95% CI: 1.5, 3.3, p < 0.0001), being homeless (ARR = 1.7, 95% CI:1.1, 2.5, p = 0.009), and daily injection of drugs (ARR = 1.1, 95% CI:1.0, 1.3, p = 0.04). Conclusions: Even though all members of the cohort of PWID were attending risk reduction programs, the HIV incidence rate was very high in Karachi from 2009-2011. The project budget was low, yet we were able to retain three-quarters of the population over two years. Absence of opiate substitution therapy and incomplete needle/syringe exchange coverage undermines success in HIV risk reduction.	[Samo, Rab Nawaz; Altaf, Arshad; Shah, Sharaf Ali] Bridge Consultants Fdn, Karachi, Pakistan; [Samo, Rab Nawaz; Agha, Ajmal; Pasha, Omrana; Rozi, Shafquat] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Memon, Ashraf] Sindh AIDS Control Programme, Karachi, Pakistan; [Blevins, Meridith; Vermund, Sten H.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Blevins, Meridith; Vermund, Sten H.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Blevins, Meridith; Vermund, Sten H.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Azam, Saleem] Pakistan Soc, Karachi, Pakistan	Aga Khan University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Altaf, A (corresponding author), Bridge Consultants Fdn, Karachi, Pakistan.	arshad.altaf@gmail.com	Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698; Pasha, Omrana/0000-0003-4046-3918; Blevins, Meridith/0000-0002-3861-9859	National Institutes of Health Vanderbilt-Centre for Infectious Disease Research in Zambia AIDS International Training and Research Program, National Institutes of Health Fogarty International Center [D43TW001035]; FOGARTY INTERNATIONAL CENTER [D43TW001035] Funding Source: NIH RePORTER	National Institutes of Health Vanderbilt-Centre for Infectious Disease Research in Zambia AIDS International Training and Research Program, National Institutes of Health Fogarty International Center; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The study was supported through National Institutes of Health Vanderbilt-Centre for Infectious Disease Research in Zambia AIDS International Training and Research Program, National Institutes of Health Fogarty International Center grant #D43TW001035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Mujeeb S, 1988, J Pak Med Assoc, V38, P221; Afridi NK, 2010, J PAK MED ASSOC, V60, P265; Agha A., 2003, JPMA Journal of the Pakistan Medical Association, V53, P511; Ahmed MA, 2003, J URBAN HEALTH, V80, P321, DOI 10.1093/jurban/jtg034; Ali SA, 2009, INT J INFECT DIS, V13, P9, DOI 10.1016/j.ijid.2008.06.019; Altaf A, 2009, PUBLIC HEALTH, V123, P470, DOI 10.1016/j.puhe.2009.06.001; Altaf Arshad, 2007, Harm Reduct J, V4, P7, DOI 10.1186/1477-7517-4-7; Altaf Arshad, 2009, J Pak Med Assoc, V59, P136; Archibald CP, 2013, SEX TRANSM INFECT; Baqi S, 1998, J ACQ IMMUN DEF SYND, V18, P73, DOI 10.1097/00042560-199805010-00011; Baqi Shehla, 2006, J Pak Med Assoc, V56, pS17; Birkhead GS, 2007, INT J DRUG POLICY, V18, P417, DOI 10.1016/j.drugpo.2007.01.013; Bluthenthal RN, 2007, ADDICTION, V102, P638, DOI 10.1111/j.1360-0443.2006.01741.x; Bluthenthal RN, 2004, ADDICTION, V99, P1136, DOI 10.1111/j.1360-0443.2004.00694.x; Bokhari A, 2007, INT J STD AIDS, V18, P486, DOI 10.1258/095646207781147201; Burns DN, 2010, CLIN INFECT DIS, V51, P725, DOI 10.1086/655889; Emmanuel F., 2011, Eastern Mediterranean Health Journal, V17, P712; Emmanuel Faran, 2006, J Pak Med Assoc, V56, P119; Emmanuel Faran, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P940; Emmanuel F, 2008, INT J DRUG POLICY, V19, pS59, DOI 10.1016/j.drugpo.2007.12.012; Emmanuel F, 2010, AIDS, V24, pS77, DOI 10.1097/01.aids.0000386737.25296.c4; Emmanuel F, 2009, JAIDS-J ACQ IMM DEF, V51, P85, DOI 10.1097/QAI.0b013e31819906f3; Friedman SR, 2000, AM J EPIDEMIOL, V152, P913, DOI 10.1093/aje/152.10.913; Haque N, 2004, INT J STD AIDS, V15, P601, DOI 10.1258/0956462041724172; Heinzerling KG, 2006, DRUG ALCOHOL DEPEN, V81, P167, DOI 10.1016/j.drugalcdep.2005.06.008; HIV/AIDS Outbreak Investigation at Jalalpur Jatan (JPJ) Gujrat, 2009, HIV AIDS OUTBR INV J; HIV Second Generation Surveillance in Pakistan. National Report Round IV, 2011, HIV 2 GEN SURV PAK N; Iqbal Jamila, 1996, JPMA (Journal of the Pakistan Medical Association), V46, P255; Kayani Naila, 2006, J Pak Med Assoc, V56, pS7; Kazi AM, 2010, INT J INFECT DIS, V14, pE60, DOI 10.1016/j.ijid.2009.11.012; Kerr T, 2010, AM J PUBLIC HEALTH, V100, P1449, DOI 10.2105/AJPH.2009.178467; Khan AA, 2011, INT J DRUG POLICY, V22, P219, DOI 10.1016/j.drugpo.2011.03.005; Khan AA, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-13; Khan AA, 2010, J PAK MED ASSOC, V60, P300; Khanani R M, 1990, J Pak Med Assoc, V40, P82; KHANANI RM, 1988, AIDS RES HUM RETROV, V4, P149, DOI 10.1089/aid.1988.4.149; Kidorf M, 2008, CAN J PSYCHIAT, V53, P487, DOI 10.1177/070674370805300803; Kozlov AP, 2006, AIDS, V20, P901, DOI 10.1097/01.aids.0000218555.36661.9c; Kral AH, 2004, JAIDS-J ACQ IMM DEF, V37, P1307, DOI 10.1097/01.qai.0000127054.60503.9a; Kuo Irene, 2006, Harm Reduct J, V3, P26, DOI 10.1186/1477-7517-3-26; Larance B, 2011, DRUG ALCOHOL REV, V30, P246, DOI 10.1111/j.1465-3362.2011.00304.x; Mahmud Ghazala, 2009, J Ayub Med Coll Abbottabad, V21, P124; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Noori R, 2012, SUBST USE MISUSE, V47, P767, DOI 10.3109/10826084.2010.517726; Pandey A, 2008, AIDS, V22, pS81, DOI 10.1097/01.aids.0000343766.00573.15; Parviz S, 2006, INT J INFECT DIS, V10, P364, DOI 10.1016/j.ijid.2005.07.010; Patrick DM, 1997, INT J STD AIDS, V8, P437, DOI 10.1258/0956462971920497; Platt L, 2009, SEX TRANSM INFECT, V85, P17, DOI 10.1136/sti.2008.034090; Rai MA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-7; Rehman NU, 2007, TROP DOCT, V37, P58, DOI 10.1258/004947507779952096; Rich JD, 2013, JAIDS-J ACQ IMM DEF, V63, pS49, DOI 10.1097/QAI.0b013e318292fe4c; Riley ED, 2010, J URBAN HEALTH, V87, P534, DOI 10.1007/s11524-010-9468-y; Ruan YH, 2005, JAIDS-J ACQ IMM DEF, V39, P459, DOI 10.1097/01.qai.0000152398.47025.0f; Safdar Salman, 2009, J Pak Med Assoc, V59, P111; Saleem Naeem Hassan, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P642; Saranga A, 2008, INT J DRUG POLICY, V19, pS25, DOI 10.1016/j.drugpo.2007.11.008; Shah SA, 2004, INT J STD AIDS, V15, P209, DOI 10.1258/095646204322916713; Shah SA, 1999, INT J STD AIDS, V10, P812, DOI 10.1258/0956462991913600; Shah S, 2011, AIDS RES HUM RETROV, V27, P1278, DOI 10.1089/aid.2010.0324; Siddiqui AUR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000154; Singh Rajiv Kumar, 2012, Indian J Public Health, V56, P53, DOI 10.4103/0019-557X.96976; Singh S, 2013, INT J DRUG POLICY, DOI [10.1016/j.drugpo.2013.05.011, DOI 10.1016/J.DRUGP0.2013.05.011.[]; Sista Nirupama Deshmane, 2011, Clin Investig (Lond), V1, P1609; Slesak G, 2012, INT J STD AIDS, V23, P570, DOI 10.1258/ijsa.2012.011416; Strathdee SA, 2003, DRUG ALCOHOL DEPEN, V71, P17, DOI 10.1016/S0376-8716(03)00072-3; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Vanichseni S, 2001, AIDS, V15, P397, DOI 10.1097/00002030-200102160-00013; Vermund SH, 2013, JAIDS-J ACQ IMM DEF, V63, pS12, DOI 10.1097/QAI.0b013e31829202a2; Vermund SH, 2013, CURR HIV-AIDS REP, V10, P169, DOI 10.1007/s11904-013-0155-y; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Yin Lu, 2007, Harm Reduct J, V4, P6, DOI 10.1186/1477-7517-4-6; Zhang YZ, 2007, INT J INFECT DIS, V11, P318, DOI 10.1016/j.ijid.2006.09.001	72	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81715	10.1371/journal.pone.0081715	http://dx.doi.org/10.1371/journal.pone.0081715			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GD	24358123	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700019
J	Wang, Z; He, ML; Xiao, ZM; Wu, H; Wu, Y				Wang, Zhe; He, Maolin; Xiao, Zengming; Wu, Hao; Wu, Yang			Quantitative Assessment of the Association of COX-2 (Cyclooxygenase-2) Immunoexpression with Prognosis in Human Osteosarcoma: A Meta-Analysis	PLOS ONE			English	Article							EXPRESSION; SURVIVAL; CHEMOTHERAPY; CANCER; TUMOR; MARKERS; GENE	Background: Numerous studies examining the relationship between Cyclooxygenase-2 (COX-2) immunoexpression and clinical outcome in osteosarcoma patients have yielded inconclusive results. Methods: We accordingly conducted a meta-analysis of 9 studies (442 patients) that evaluated the correlation between COX-2 immunoexpression and clinical prognosis (death). Pooled odds ratios (OR) and risk ratios (RR) with 95% confidence intervals (95% CI) were calculated using the random-effects or fixed-effects model. Results: Meta-analysis showed no significant association between COX-2 positivity and age, gender, tumor location, histology, stage, metastasis or 90% necrosis. Conversely, COX-2 immunoexpression was associated with overall survival rate (RR=2.12; 95% CI: 1.10-3.74; P=0.009) and disease-free survival rate (RR=1.63; 95% CI: 1.17-2.28; P=0.004) at 2 years. Sensitivity analysis performed by omitting low quality studies showed that the pooled results were stable. Conclusions: COX-2 positivity was associated with a lower 2-year overall survival rate and disease-free survival rate. COX-2 expression change is an independent prognostic factor in patients with osteosarcoma.	[Wang, Zhe; He, Maolin; Xiao, Zengming; Wu, Hao; Wu, Yang] Guangxi Med Univ, Affiliated Hosp 1, Div Spine & Osteopathy Surg, Nanning, Guangxi, Peoples R China	Guangxi Medical University	Xiao, ZM (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Div Spine & Osteopathy Surg, Nanning, Guangxi, Peoples R China.	zmxiao_gxmu@foxmail.com	Wang, Zhe/K-1663-2016		National Natural Science Foundation of China [81160323]; Guangxi Innovative Program of Graduate Education [YCSZ2012041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Innovative Program of Graduate Education	This research was supported by the National Natural Science Foundation of China (Grant No. 81160323) and the Guangxi Innovative Program of Graduate Education (Grant No. YCSZ2012041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertucci F, 2013, SCAND J GASTROENTERO, V48, P4, DOI 10.3109/00365521.2012.711852; Boulytcheva IV, 2010, B EXP BIOL MED+, V150, P237, DOI 10.1007/s10517-010-1114-x; Chen Y, 2012, ONCOL LETT, V3, P1011, DOI 10.3892/ol.2012.604; Dickens DS, 2003, J PEDIAT HEMATOL ONC, V25, P282, DOI 10.1097/00043426-200304000-00003; Durnali A, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0624-6; Foster L, 2007, J BONE JOINT SURG BR, V89B, P1234, DOI 10.1302/0301-620X.89B9; Fuchs B, 2001, GENE, V278, P245, DOI 10.1016/S0378-1119(01)00731-4; Gorlick R., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P549; Gorlick R, 2009, CANC TREAT, V152, P467, DOI 10.1007/978-1-4419-0284-9_27; Hagleitner Melanie M., 2012, Sarcoma, V2012, P636405, DOI 10.1155/2012/636405; Huang ML, 2013, INT J CANCER, V132, P363, DOI 10.1002/ijc.27686; Jiao GJ, 2013, TUMOR BIOL, V34, P2489, DOI 10.1007/s13277-013-0998-2; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lee JW, 2012, KOREAN J PATHOL, V46, P237, DOI 10.4132/KoreanJPathol.2012.46.3.237; Lee JY, 2013, GYNECOL ONCOL, V129, P613, DOI 10.1016/j.ygyno.2013.02.011; LI JQ, 2004, ZHONGGUO LINCHUANG K, V8, P1488; Li L, 2009, ALIMENT PHARM THER, V30, P589, DOI 10.1111/j.1365-2036.2009.04069.x; Li YG, 2010, EUR J CANCER CARE, V19, P313, DOI 10.1111/j.1365-2354.2008.00970.x; Liao Y, 2007, CHIN GER J CLIN ONCO, V6, P378, DOI DOI 10.1007/S10330-007-0004-9; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moher D, 2011, EPIDEMIOLOGY, V22, P128, DOI 10.1097/EDE.0b013e3181fe7825; Ottaviani G, 2009, CANCER TREAT RES, V152, P421, DOI 10.1007/978-1-4419-0284-9_2; Pakos EE, 2004, CLIN CANCER RES, V10, P6208, DOI 10.1158/1078-0432.CCR-04-0246; Pakos EE, 2003, CANCER-AM CANCER SOC, V98, P581, DOI 10.1002/cncr.11546; PETITTI DB, 2000, METAANALYSIS DECISIO; Qu JT, 2012, J CANCER RES CLIN, V138, P819, DOI 10.1007/s00432-012-1149-7; Rodriguez NI, 2008, J PEDIAT HEMATOL ONC, V30, P507, DOI 10.1097/MPH.0b013e31816e238c; ROSEN G, 1976, CANCER-AM CANCER SOC, V37, P1, DOI 10.1002/1097-0142(197601)37:1<1::AID-CNCR2820370102>3.0.CO;2-3; Scotlandi K, 1996, CANCER RES, V56, P2434; Shao N, 2012, MOL BIOL REP, V39, P10997, DOI 10.1007/s11033-012-2001-5; SPROVIERO D, 2012, J BIOL CHEM; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Urakawa H, 2009, CLIN ORTHOP RELAT R, V467, P2932, DOI 10.1007/s11999-009-0814-x; Wang Z, 2013, ASIAN PAC J CANCER P, V14, P2753, DOI 10.7314/APJCP.2013.14.5.2753; XIANBIN W, 2008, CHINESE J CLIN PRACT, V9, P19; Yamauchi M, 2013, CANCER EPIDEM BIOMAR, V22, P1142, DOI 10.1158/1055-9965.EPI-13-0108; YANHUA G, 2008, TUMOR, V28, P427; Zhan P, 2013, J THORAC DIS, V5, P40, DOI 10.3978/j.issn.2072-1439.2013.01.02	38	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82907	10.1371/journal.pone.0082907	http://dx.doi.org/10.1371/journal.pone.0082907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358237	gold, Green Submitted, Green Published			2022-12-27	WOS:000328735700096
J	Xue, M; Shi, XM; Zhao, Y; Cui, HY; Hu, SL; Cui, XL; Wang, YF				Xue, Mei; Shi, Xingming; Zhao, Yan; Cui, Hongyu; Hu, Shunlei; Cui, Xianlan; Wang, Yunfeng			Effects of Reticuloendotheliosis Virus Infection on Cytokine Production in SPF Chickens	PLOS ONE			English	Article							TYPE-1 INFECTION; IMMUNE-RESPONSE; GENE-EXPRESSION; GROWTH-FACTOR; TNF-ALPHA; INTERLEUKIN-10; TRANSFORMATION; CHEMOKINES; RECEPTORS; GENOME	Infection with reticuloendotheliosis virus (REV), a gammaretrovirus in the Retroviridae family, can result in immunosuppression and subsequent increased susceptibility to secondary infections. The effects of REV infection on expression of mRNA for cytokine genes in chickens have not been completely elucidated. In this study, using multiplex branched DNA (bDNA) technology, we identified molecular mediators that participated in the regulation of the immune response during REV infection in chickens. Cytokine and chemokine mRNA expression levels were evaluated in the peripheral blood mononuclear cells (PBMCs). Expression levels of interleukin (IL)-4, IL-10, IL-13 and tumor necrosis factor (TNF)-alpha were significantly up-regulated while interferon (IFN)-alpha, IFN-beta, IFN-gamma, IL-1 beta square IL-2, IL-3, IL-15, IL-17F, IL-18 and colony-stimulating factor (CSF)-1 were markedly decreased in PBMCs at all stages of infection. Compared with controls, REV infected chickens showed greater expression levels of IL-8 in PBMCs 21 and 28 days post infection. In addition, REV regulates host immunity as a suppressor of T cell proliferative responses. The results in this study will help us to understand the host immune response to virus pathogens.	[Xue, Mei; Shi, Xingming; Zhao, Yan; Cui, Hongyu; Hu, Shunlei; Wang, Yunfeng] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China; [Xue, Mei; Shi, Xingming; Zhao, Yan; Cui, Hongyu; Hu, Shunlei; Wang, Yunfeng] Natl Engn Res Ctr Vet Biol, Harbin, Peoples R China; [Cui, Xianlan] Dept Primary Ind Pk Water & Environm, Hlth Anim Lab, Hobart, Tas, Australia	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Wang, YF (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China.	yfwang@hvri.ac.cn	Cui, Xianlan/N-1734-2017	Cui, Xianlan/0000-0002-5029-1286	National Key Laboratory of Veterinary Biotechnology as Basic Research Programs of China [SKLVBP201317]	National Key Laboratory of Veterinary Biotechnology as Basic Research Programs of China	The study was supported by a grant from the National Key Laboratory of Veterinary Biotechnology as Basic Research Programs of China (SKLVBP201317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUKRUST P, 1994, J INFECT DIS, V169, P420, DOI 10.1093/infdis/169.2.420; Avery S, 2004, J INTERF CYTOK RES, V24, P600, DOI 10.1089/1079990042280865; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Becker Y, 2004, VIRUS GENES, V29, P147, DOI 10.1023/B:VIRU.0000032797.43537.d3; Becker Y, 2004, VIRUS GENES, V28, P5, DOI 10.1023/B:VIRU.0000012260.32578.72; BEEMON KL, 1976, J VIROL, V17, P525, DOI 10.1128/JVI.17.2.525-537.1976; BELARDELLI F, 1995, APMIS, V103, P161, DOI 10.1111/j.1699-0463.1995.tb01092.x; Bohls RL, 2006, VIRUS RES, V119, P187, DOI 10.1016/j.virusres.2006.01.011; Calzascia T, 2007, J CLIN INVEST, V117, P3833, DOI 10.1172/JCI32567; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; CHEN PY, 1987, ARCH VIROL, V93, P233, DOI 10.1007/BF01310977; Coffin JM, 1996, NATURE, V382, P762, DOI 10.1038/382762a0; Conrad CT, 1999, J EXP CLIN CANC RES, V18, P225; COOK MK, 1969, J NATL CANCER I, V43, P203; Cui ZZ, 2009, AVIAN PATHOL, V38, P443, DOI 10.1080/03079450903349188; Davidson I, 2008, J GEN VIROL, V89, P2456, DOI 10.1099/vir.0.2008/001313-0; Dinarello CA, 2003, J INFECT DIS, V187, pS370, DOI 10.1086/374751; Ebnet K, 1999, HISTOCHEM CELL BIOL, V112, P1, DOI 10.1007/s004180050387; EPSTEIN LG, 1993, ANN NEUROL, V33, P429, DOI 10.1002/ana.410330502; HAMILTON JA, 1993, LANCET, V342, P536, DOI 10.1016/0140-6736(93)91653-4; HOELZER JD, 1979, VIROLOGY, V93, P20, DOI 10.1016/0042-6822(79)90272-1; HOELZER JD, 1980, VIROLOGY, V100, P462, DOI 10.1016/0042-6822(80)90536-X; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Jarosinski KW, 2005, VIRAL IMMUNOL, V18, P148, DOI 10.1089/vim.2005.18.148; KAWAMURA H, 1976, NATL I ANIM HEALTH Q, V16, P135; Khatri M, 2006, VIRUS RES, V118, P70, DOI 10.1016/j.virusres.2005.11.015; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kim R, 2005, CANCER BIOL THER, V4, P924, DOI 10.4161/cbt.4.9.2101; Knudsen BS, 2008, J MOL DIAGN, V10, P169, DOI 10.2353/jmoldx.2008.070127; Lillehoj HS, 2001, VET IMMUNOL IMMUNOP, V82, P229, DOI 10.1016/S0165-2427(01)00360-9; LUDFORD CG, 1972, EXP PARASITOL, V31, P29, DOI 10.1016/0014-4894(72)90044-6; LUSCHER U, 1994, INT J CANCER, V57, P612, DOI 10.1002/ijc.2910570428; MALEFYT RD, 1991, J EXP MED, V174, P915; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Markowski-Grimsrud CJ, 2003, IMMUNOLOGY, V109, P283, DOI 10.1046/j.1365-2567.2003.01643.x; Marzi M, 1996, CLIN EXP IMMUNOL, V106, P127, DOI 10.1046/j.1365-2249.1996.d01-809.x; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; Mocellin S, 2001, J IMMUNOTHER, V24, P392, DOI 10.1097/00002371-200109000-00002; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murtaugh MP, 1996, VET IMMUNOL IMMUNOP, V54, P45, DOI 10.1016/S0165-2427(96)05698-X; Ortegel JW, 2002, LUNG CANCER, V36, P17, DOI 10.1016/S0169-5002(01)00472-X; Osakwe Chukwunomso E, 2010, Roum Arch Microbiol Immunol, V69, P24; Peterson KE, 2001, J VIROL, V75, P2848, DOI 10.1128/JVI.75.6.2848-2856.2001; Sun AJ, 2010, VIROLOGY, V397, P270, DOI 10.1016/j.virol.2009.11.017; Sundick RS, 1997, J IMMUNOL, V159, P720; TRAGER W, 1959, P SOC EXP BIOL MED, V101, P578, DOI 10.3181/00379727-101-25023; Withanage GSK, 2004, INFECT IMMUN, V72, P2152, DOI 10.1128/IAI.72.4.2152-2159.2004; WITTER RL, 1981, AVIAN DIS, V25, P374, DOI 10.2307/1589930; Xue M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049842; Yue FY, 1997, INT J CANCER, V71, P630, DOI 10.1002/(SICI)1097-0215(19970516)71:4<630::AID-IJC20>3.3.CO;2-H; Zheng YS, 2007, J VET MED SCI, V69, P213, DOI 10.1292/jvms.69.213	53	10	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83918	10.1371/journal.pone.0083918	http://dx.doi.org/10.1371/journal.pone.0083918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358317	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700142
J	Barupal, DK; Lee, SJ; Karoly, ED; Adhya, S				Barupal, Dinesh Kumar; Lee, Sang Jun; Karoly, Edward D.; Adhya, Sankar			Inactivation of Metabolic Genes Causes Short- and Long-Range dys-Regulation in Escherichia coli Metabolic Network	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; EVOLUTION; GLUCOSE; STRESS; FLUX; EXPRESSION; MODULARITY; CONVERSION; PATHWAYS; BACTERIA	The metabolic network in E. coli can be severely affected by the inactivation of metabolic genes that are required to catabolize a nutrient (D-galactose). We hypothesized that the resulting accumulation of small molecules can yield local as well as systemic effects on the metabolic network. Analysis of metabolomics data in wild-type and D-galactose non-utilizing mutants, galT, galU and galE, reveal the large metabolic differences between the wild-type and the mutants when the strains were grown in D-galactose. Network mapping suggested that the enzymatic defects affected the metabolic modules located both at short-and long-ranges from the D-galactose metabolic module. These modules suggested alterations in glutathione, energy, nucleotide and lipid metabolism and disturbed carbon to nitrogen ratio in mutant strains. The altered modules are required for normal cell growth for the wild-type strain, explaining why the cell growth is inhibited in the mutants in the presence of D-galactose. Identification of these distance-based dys-regulations would enhance the systems level understanding of metabolic networks of microorganisms having importance in biomedical and biotechnological research.	[Barupal, Dinesh Kumar] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Lee, Sang Jun] KRIBB, Infect & Immun Res Ctr, Taejon, South Korea; [Lee, Sang Jun] Univ Sci & Technol, Taejon, South Korea; [Lee, Sang Jun; Adhya, Sankar] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Karoly, Edward D.] Metabolon Inc, Durham, NC USA	University of California System; University of California Davis; Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Metabolon	Adhya, S (corresponding author), NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.	sadhya@helix.nih.gov	Barupal, Dinesh K/A-9341-2010	barupal, dinesh/0000-0002-9954-8628; Lee, Sang Jun/0000-0002-2803-753X	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC008751] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHYA SL, 1969, GENETICS, V62, P231; Arita M, 2004, P NATL ACAD SCI USA, V101, P1543, DOI 10.1073/pnas.0306458101; Barupal DK, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-99; BOHRINGER J, 1995, J BACTERIOL, V177, P413; BROUQUISSE R, 1992, PLANTA, V188, P384, DOI 10.1007/BF00192806; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Charusanti P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001186; Covert MW, 2008, BIOINFORMATICS, V24, P2044, DOI 10.1093/bioinformatics/btn352; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; DECKER K, 1993, J BACTERIOL, V175, P5655, DOI 10.1128/JB.175.17.5655-5665.1993; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Fiehn O, 2011, J BIOL CHEM, V286, P23637, DOI 10.1074/jbc.R110.173617; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kreimer A, 2008, P NATL ACAD SCI USA, V105, P6976, DOI 10.1073/pnas.0712149105; Lee DH, 2010, APPL ENVIRON MICROB, V76, P4158, DOI 10.1128/AEM.00373-10; Lee SJ, 2009, P NATL ACAD SCI USA, V106, P19515, DOI 10.1073/pnas.0910586106; MacRae JI, 2012, CELL HOST MICROBE, V12, P682, DOI 10.1016/j.chom.2012.09.013; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Murphy DJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-84; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Plaimas K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-56; Rahman SA, 2006, BIOINFORMATICS, V22, P1767, DOI 10.1093/bioinformatics/btl181; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; ROSENBERG H, 1984, J BACTERIOL, V158, P69, DOI 10.1128/JB.158.1.69-72.1984; Seshasayee ASN, 2009, GENOME RES, V19, P79, DOI 10.1101/gr.079715.108; Spirin V, 2006, P NATL ACAD SCI USA, V103, P8774, DOI 10.1073/pnas.0510258103; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; Yeh W, 2004, GENOME RES, V14, P917, DOI 10.1101/gr.2050304	37	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e78360	10.1371/journal.pone.0078360	http://dx.doi.org/10.1371/journal.pone.0078360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24363806	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100003
J	Barelli, C; Mundry, R; Heistermann, M; Hammerschmidt, K				Barelli, Claudia; Mundry, Roger; Heistermann, Michael; Hammerschmidt, Kurt			Cues to Androgens and Quality in Male Gibbon Songs	PLOS ONE			English	Article							WHITE-HANDED GIBBONS; FORMANT FREQUENCIES INFLUENCE; SEX-RELATED VARIATIONS; REFLECT BODY-SIZE; BABOON LOUD CALLS; ACOUSTIC FEATURES; VOCAL FOLD; VOICE PITCH; FUNDAMENTAL-FREQUENCY; TESTOSTERONE LEVELS	Animal vocal signals may provide information about senders and mediate important social interactions like sexual competition, territory maintenance and mate selection. Hence, it is important to understand whether vocal signals provide accurate information about animal attributes or status. Gibbons are non-human primates that produce loud, distinctive and melodious vocalizations resembling more those of birds than of other non-human primates. Wild gibbons are characterized by flexibility in social organization (i.e., pairs and multimale units) as well as in mating system (i.e., monogamy and polyandry). Such features make them a suitable model to investigate whether the physiology (hormonal status) and socio-demographic features find their correspondence in the structure of their songs. By combining male solo song recordings, endocrine outputs using non-invasive fecal androgen measures and behavioral observations, we studied 14 groups (10 pair-living, 4 multimale) of wild white-handed gibbons (Hylobates lar) residing at Khao Yai National Park, Thailand. We collected a total of 322 fecal samples and recorded 48 songs from 18 adult animals. Our results confirmed inter-individuality in male gibbon songs, and showed a clear correlation between androgen levels and song structures. Gibbons with higher androgen levels produced calls having higher pitch, and similarly adult individuals produced longer calls than senior males. Thus, it is plausible that gibbon vocalizations provide receivers with information about singers' attributes.	[Barelli, Claudia] German Primate Ctr, Reprod Biol Unit, Gottingen, Germany; [Mundry, Roger] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Mundry, Roger] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany; [Heistermann, Michael] German Primate Ctr, Endocrinol Lab, Gottingen, Germany; [Hammerschmidt, Kurt] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany	Deutsches Primatenzentrum (DPZ); Max Planck Society; Max Planck Society; Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ)		claudia.barelli@muse.it; KHammerschmidt@dpz.eu			Alexander von Humboldt Foundation; German Research Foundation [HE2699/6-1]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Research Foundation(German Research Foundation (DFG))	This research was supported by grants from Alexander von Humboldt Foundation (post-doctoral fellowship to CB) and the German Research Foundation (grant HE2699/6-1 to MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella CL, 2007, BIOL LETTERS, V3, P682, DOI 10.1098/rsbl.2007.0410; Apicella CL, 2009, P ROY SOC B-BIOL SCI, V276, P1077, DOI 10.1098/rspb.2008.1542; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Baayen RH, 2011, LANGUAGER DATA SETS; Ball GF, 2002, FRONT NEUROENDOCRIN, V23, P137, DOI 10.1006/frne.2002.0230; Ballentine B, 2009, ANIM BEHAV, V77, P973, DOI 10.1016/j.anbehav.2008.12.027; Barelli C, 2008, ANIM BEHAV, V75, P991, DOI 10.1016/j.anbehav.2007.08.012; Barelli C, 2007, HORM BEHAV, V51, P221, DOI 10.1016/j.yhbeh.2006.10.008; Barelli C, 2013, AM J PRIMATOL, V75, P1185, DOI 10.1002/ajp.22180; Barelli C, 2012, INT J PRIMATOL, V33, P784, DOI 10.1007/s10764-012-9606-3; Barelli C, 2011, ANIM BEHAV, V82, P801, DOI 10.1016/j.anbehav.2011.07.012; Bass AH, 2008, HORM BEHAV, V53, P659, DOI 10.1016/j.yhbeh.2007.12.010; Bates D., 2013, LME4 LINEAR MIXED EF; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Botero CA, 2009, ANIM BEHAV, V77, P701, DOI 10.1016/j.anbehav.2008.11.020; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Chan RW, 2007, ANN BIOMED ENG, V35, P1471, DOI 10.1007/s10439-007-9314-x; Charlton BD, 2011, BIOL LETTERS, V7, P71, DOI 10.1098/rsbl.2010.0582; CHENEY DL, 1980, ANIM BEHAV, V28, P362, DOI 10.1016/S0003-3472(80)80044-3; Christie PJ, 2004, BEHAV ECOL SOCIOBIOL, V55, P341, DOI 10.1007/s00265-003-0711-3; Collins SA, 2000, ANIM BEHAV, V60, P773, DOI 10.1006/anbe.2000.1523; Dabbs JM, 1999, PERS INDIV DIFFER, V27, P801, DOI 10.1016/S0191-8869(98)00272-4; de Kort SR, 2009, P ROY SOC B-BIOL SCI, V276, P2315, DOI 10.1098/rspb.2009.0127; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; ENQUIST M, 1990, ANIM BEHAV, V40, P1, DOI 10.1016/S0003-3472(05)80660-8; Evans S, 2008, PHYSIOL BEHAV, V93, P783, DOI 10.1016/j.physbeh.2007.11.033; Ey E, 2007, PRIMATES, V48, P253, DOI 10.1007/s10329-006-0033-y; Ey E, 2007, INT J PRIMATOL, V28, P947, DOI 10.1007/s10764-007-9139-3; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Fichtel C, 2003, J ACOUST SOC AM, V113, P2927, DOI 10.1121/1.1548158; Fischer J, 2004, BEHAV ECOL SOCIOBIOL, V56, P140, DOI 10.1007/s00265-003-0739-4; Fischer J, 2002, J ACOUST SOC AM, V111, P1465, DOI 10.1121/1.1433807; Fischer J, 2001, ETHOLOGY, V107, P33, DOI 10.1046/j.1439-0310.2001.00630.x; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; Geissmann T, 2000, ANIM BEHAV, V60, P805, DOI 10.1006/anbe.2000.1540; Geissmann T, 1999, BEHAVIOUR, V136, P1005, DOI 10.1163/156853999501694; Geissmann T, 2000, ORIGINS OF MUSIC, P103; Gesquiere LR, 2011, SCIENCE, V333, P357, DOI 10.1126/science.1207120; Girard-Buttoz C, 2009, PHYSIOL BEHAV, V98, P168, DOI 10.1016/j.physbeh.2009.05.005; Hammerschmidt K, 1998, ETHOLOGY, V104, P203; Harries M, 1998, J LARYNGOL OTOL, V112, P451, DOI 10.1017/S0022215100140757; Harries MLL, 1997, ARCH DIS CHILD, V77, P445, DOI 10.1136/adc.77.5.445; Jenkins JS, 1998, LANCET, V351, P1877, DOI 10.1016/S0140-6736(97)10198-2; Kappeler PM, 2002, INT J PRIMATOL, V23, P707, DOI 10.1023/A:1015520830318; King A, 2001, J VOICE, V15, P553, DOI 10.1016/S0892-1997(01)00055-8; Kitchen DM, 2009, AM J PHYS ANTHROPOL, P166; Koda H, 2012, AM J PHYS ANTHROPOL, V149, P347, DOI 10.1002/ajpa.22124; Koren L, 2009, BEHAV ECOL SOCIOBIOL, V63, P581, DOI 10.1007/s00265-008-0693-2; Lappan S., 2009, GIBBONS NEW PERSPECT; Lynam A.J., 2006, STATUS BIRDS LARGE M; MARSHALL JT, 1976, SCIENCE, V193, P235, DOI 10.1126/science.193.4249.235; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; McCowan B, 2002, J ACOUST SOC AM, V111, P1157, DOI 10.1121/1.1446048; McGregor PK., 1992, PLAYBACK STUDIES ANI; MITANI JC, 1987, BEHAV ECOL SOCIOBIOL, V20, P265, DOI 10.1007/BF00292179; MITANI JC, 1985, INT J PRIMATOL, V6, P193; Mohle U, 2002, GEN COMP ENDOCR, V129, P135, DOI 10.1016/S0016-6480(02)00525-7; Moore FL, 2005, HORM BEHAV, V48, P373, DOI 10.1016/j.yhbeh.2005.05.011; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; Mundry R, 2007, ANIM BEHAV, V74, P965, DOI 10.1016/j.anbehav.2006.12.028; Nemeth E, 2006, J ACOUST SOC AM, V119, P620, DOI 10.1121/1.2139072; Newman SR, 2000, J VOICE, V14, P72, DOI 10.1016/S0892-1997(00)80096-X; Notman H, 2005, ANIM BEHAV, V70, P177, DOI 10.1016/j.anbehav.2004.08.024; Owings D. H., 1998, ANIMAL VOCAL COMMUNI; Owren MJ, 1997, J ACOUST SOC AM, V101, P2951, DOI 10.1121/1.418523; Owren MJ, 2003, J COMP PSYCHOL, V117, P380, DOI 10.1037/0735-7036.117.4.380; Oyakawa C, 2007, AM J PRIMATOL, V69, P777, DOI 10.1002/ajp.20390; Padgham M, 2004, J ACOUST SOC AM, V115, P402, DOI 10.1121/1.1629304; Pasch B, 2011, ANIM BEHAV, V82, P177, DOI 10.1016/j.anbehav.2011.04.018; Pfefferle D, 2006, ANIM BEHAV, V72, P43, DOI 10.1016/j.anbehav.2005.08.021; Pirovino M, 2011, INT J PRIMATOL, V32, P1161, DOI 10.1007/s10764-011-9532-9; Price T, 2009, BEHAVIOUR, V146, P871, DOI 10.1163/156853908X396610; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; R Core Team, 2012, R LANG ENV STAT COMP; RAEMAEKERS JJ, 1985, ANIM BEHAV, V33, P481, DOI 10.1016/S0003-3472(85)80071-3; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Reby D, 2010, P ROY SOC B-BIOL SCI, V277, P2747, DOI 10.1098/rspb.2010.0467; Reichard Ulrich H., 2009, P347, DOI 10.1007/978-0-387-88604-6_17; Riede T., 2013, NOVA ACTA LEOPOLDINA, V111, P1, DOI DOI 10.1007/3-540-32504-2_10; Riede T, 2008, J EXP BIOL, V211, P2144, DOI 10.1242/jeb.017004; Riede T, 2007, J ACOUST SOC AM, V121, P1758, DOI 10.1121/1.2427115; Riede T, 2010, J EXP BIOL, V213, P2924, DOI 10.1242/jeb.044404; Sarkar SK, 1997, J AM STAT ASSOC, V92, P1601, DOI 10.2307/2965431; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Schneider C, 2008, INT J PRIMATOL, V29, P601, DOI 10.1007/s10764-007-9181-1; Semple S, 2001, ANIM BEHAV, V61, P1023, DOI 10.1006/anbe.2001.1692; Smith JM, 1995, J THEOR BIOL, V177, P305; Sun GZ, 2011, AM J PRIMATOL, V73, P431, DOI 10.1002/ajp.20917; Taylor AM, 2010, ANIM BEHAV, V79, P205, DOI 10.1016/j.anbehav.2009.10.030; ten Cate C, 2002, ADV STUD BEHAV, V31, P31; Titze I. R., 2000, PRINCIPLES VOICE PRO; Titze IR, 2011, J SPEECH LANG HEAR R, V54, P520, DOI 10.1044/1092-4388(2010/09-0284); van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; Thinh VN, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-36; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; Venables WN., 2002, MODERN APPL STAT S 4; Voelter C, 2008, EUR ARCH OTO-RHINO-L, V265, P1239, DOI 10.1007/s00405-008-0632-x; Voigt C, 2013, HORM BEHAV, V63, P122, DOI 10.1016/j.yhbeh.2012.10.006; Weingrill T, 2011, GEN COMP ENDOCR, V172, P446, DOI 10.1016/j.ygcen.2011.04.008; Wich SA, 2003, INT J PRIMATOL, V24, P1251, DOI 10.1023/B:IJOP.0000005991.97232.2a; Yin S, 2004, ANIM BEHAV, V68, P343, DOI 10.1016/j.anbehav.2003.07.016; [No title captured]; [No title captured]	105	38	38	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82748	10.1371/journal.pone.0082748	http://dx.doi.org/10.1371/journal.pone.0082748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367551	Green Submitted, Green Published, gold			2022-12-27	WOS:000328740300064
J	Coburn, LA; Horst, SN; Chaturvedi, R; Brown, CT; Allaman, MM; Scull, BP; Singh, K; Piazuelo, MB; Chitnavis, MV; Hodges, ME; Rosen, MJ; Williams, CS; Slaughter, JC; Beaulieu, DB; Schwartz, DA; Wilson, KT				Coburn, Lori A.; Horst, Sara N.; Chaturvedi, Rupesh; Brown, Caroline T.; Allaman, Margaret M.; Scull, Brooks P.; Singh, Kshipra; Piazuelo, M. Blanca; Chitnavis, Maithili V.; Hodges, Mallary E.; Rosen, Michael J.; Williams, Christopher S.; Slaughter, James C.; Beaulieu, Dawn B.; Schwartz, David A.; Wilson, Keith T.			High-Throughput Multi-Analyte Luminex Profiling Implicates Eotaxin-1 in Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; HELICOBACTER-PYLORI; MACROPHAGE APOPTOSIS; MOUSE MODEL; ARGINASE; ACTIVATION; CELLS	Accurate and high-throughput technologies are needed for identification of new therapeutic targets and for optimizing therapy in inflammatory bowel disease. Our aim was to assess multi-analyte protein-based assays of cytokines/chemokines using Luminex technology. We have reported that Luminex-based profiling was useful in assessing response to L-arginine therapy in the mouse model of dextran sulfate sodium colitis. Therefore, we studied prospectively collected samples from ulcerative colitis (UC) patients and control subjects. Serum, colon biopsies, and clinical information were obtained from subjects undergoing colonoscopy for evaluation of UC or for non-UC indications. In total, 38 normal controls and 137 UC cases completed the study. Histologic disease severity and the Mayo Disease Activity Index (DAI) were assessed. Serum and colonic tissue cytokine/chemokine profiles were measured by Luminex-based multiplex testing of 42 analytes. Only eotaxin-1 and G-CSF were increased in serum of patients with histologically active UC vs. controls. While 13 cytokines/chemokines were increased in active UC vs. controls in tissues, only eotaxin-1 was increased in all levels of active disease in both serum and tissue. In tissues, eotaxin-1 correlated with the DAI and with eosinophil counts. Increased eotaxin-1 levels were confirmed by real-time PCR. Tissue eotaxin-1 levels were also increased in experimental murine colitis induced by dextran sulfate sodium, oxazolone, or Citrobacter rodentium, but not in murine Helicobacter pylori infection. Our data implicate eotaxin-1 as an etiologic factor and therapeutic target in UC, and indicate that Luminex-based assays may be useful to assess IBD pathogenesis and to select patients for anti-cytokine/chemokine therapies.	[Coburn, Lori A.; Horst, Sara N.; Chaturvedi, Rupesh; Brown, Caroline T.; Allaman, Margaret M.; Scull, Brooks P.; Singh, Kshipra; Piazuelo, M. Blanca; Chitnavis, Maithili V.; Hodges, Mallary E.; Williams, Christopher S.; Beaulieu, Dawn B.; Schwartz, David A.; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37212 USA; [Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Williams, Christopher S.; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Coburn, Lori A.; Horst, Sara N.; Allaman, Margaret M.; Williams, Christopher S.; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA; [Rosen, Michael J.] Vanderbilt Univ, Med Ctr, Dept Pediat Gastroenterol Hepatol & Nutr, Nashville, TN USA; [Slaughter, James C.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University	Wilson, KT (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37212 USA.	keith.wilson@vanderbilt.edu	Allaman, Margaret/GNO-9854-2022; Williams, Christopher/W-3524-2019	Williams, Christopher/0000-0002-1541-579X; Coburn, Lori/0000-0003-3249-9806; Wilson, Keith/0000-0003-4421-1830; Rosen, Michael/0000-0002-5149-718X; Schwartz, David/0000-0002-7026-7099; Slaughter, James/0000-0002-8770-980X; Allaman, Margaret M./0000-0002-2803-1365	National Institutes of Health (NIH) [R01AT004821, 3R01AT004821-02S1, 5T32DK007673, K23DK094832, K01AT007324, P30DK058404, UL1TR000445]; Vanderbilt Physician Scientist Development Award; Thomas F. Frist, Sr. Endowment; NATIONAL CANCER INSTITUTE [P01CA116087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [K01AT007324] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK094832, P30DK058404, T32DK007673, R01DK053620] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001453] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Physician Scientist Development Award; Thomas F. Frist, Sr. Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health (NIH) grants R01AT004821 and 3R01AT004821-02S1 to KTW. LAC was supported by NIH training grant 5T32DK007673 as well as a Vanderbilt Physician Scientist Development Award. Additional support was provided by NIH grant K23DK094832 to MJR, K01AT007324 to RC, NIH Grant P30DK058404 (Vanderbilt Digestive Disease Research Center), NIH grant UL1TR000445 (Vanderbilt CTSA), and the Thomas F. Frist, Sr. Endowment to KTW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens R, 2008, J IMMUNOL, V181, P7390, DOI 10.4049/jimmunol.181.10.7390; Atreya R, 2010, DIGEST DIS, V28, P386, DOI 10.1159/000320392; Barrie A, 2013, DIGEST DIS SCI, V58, P222, DOI 10.1007/s10620-012-2329-7; Barry DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029046; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Chaturvedi R, 2004, J BIOL CHEM, V279, P40161, DOI 10.1074/jbc.M401370200; Chaturvedi R, 2007, INFECT IMMUN, V75, P4305, DOI 10.1128/IAI.00578-07; Chaturvedi R, 2010, GASTROENTEROLOGY, V139, P1686, DOI 10.1053/j.gastro.2010.06.060; Chen W, 2001, SCAND J GASTROENTERO, V36, P515, DOI 10.1080/003655201750153377; Cheng Y, 2005, J BIOL CHEM, V280, P22492, DOI 10.1074/jbc.C500122200; Christophi GP, 2012, INFLAMM BOWEL DIS, V18, P2342, DOI 10.1002/ibd.22957; Coburn LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033546; Forbes E, 2004, J IMMUNOL, V172, P5664, DOI 10.4049/jimmunol.172.9.5664; Gobert AP, 2004, J IMMUNOL, V173, P2109, DOI 10.4049/jimmunol.173.3.2109; Gobert AP, 2002, J IMMUNOL, V168, P4692, DOI 10.4049/jimmunol.168.9.4692; Gobert AP, 2001, P NATL ACAD SCI USA, V98, P13844, DOI 10.1073/pnas.241443798; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kumawat AK, 2013, MOL IMMUNOL, V55, P355, DOI 10.1016/j.molimm.2013.03.007; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Mir A, 2002, AM J GASTROENTEROL, V97, P1452, DOI 10.1016/S0002-9270(02)04043-1; Ohman L, 2013, INFLAMM BOWEL DIS, V19, P2433, DOI 10.1097/MIB.0b013e3182a563cb; Rosen MJ, 2013, J IMMUNOL, V190, P1849, DOI 10.4049/jimmunol.1201373; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; SARTOR RB, 1994, GASTROENTEROLOGY, V106, P533, DOI 10.1016/0016-5085(94)90614-9; Singh K, 2008, J BIOL CHEM, V283, P16752, DOI 10.1074/jbc.M710530200; Singh K, 2013, AM J PHYSIOL-GASTR L, V305, pG225, DOI 10.1152/ajpgi.00091.2013; Singh K, 2011, J BIOL CHEM, V286, P3839, DOI 10.1074/jbc.M110.176719; Waddell A, 2011, J IMMUNOL, V186, P5993, DOI 10.4049/jimmunol.1003844; Wenzel S, 2012, CLIN EXP ALLERGY, V42, P650, DOI 10.1111/j.1365-2222.2011.03929.x; Williams CS, 2013, GUT, V62, P1446, DOI 10.1136/gutjnl-2011-301439	33	38	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82300	10.1371/journal.pone.0082300	http://dx.doi.org/10.1371/journal.pone.0082300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367513	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300029
J	Jeffries, DL; Chapman, J; Roy, HE; Humphries, S; Harrington, R; Brown, PMJ; Handley, LJL				Jeffries, Daniel L.; Chapman, Jason; Roy, Helen E.; Humphries, Stuart; Harrington, Richard; Brown, Peter M. J.; Handley, Lori-J. Lawson			Characteristics and Drivers of High-Altitude Ladybird Flight: Insights from Vertical-Looking Entomological Radar	PLOS ONE			English	Article							COCCINELLA-SEPTEMPUNCTATA COLEOPTERA; HARMONIA-AXYRIDIS COLEOPTERA; BEETLES COCCINELLIDAE; MIGRATION; DISPERSAL; PREY; PREDATION; APHIDS; AGGREGATION; MOVEMENT	Understanding the characteristics and drivers of dispersal is crucial for predicting population dynamics, particularly in range-shifting species. Studying long-distance dispersal in insects is challenging, but recent advances in entomological radar offer unique insights. We analysed 10 years of radar data collected at Rothamsted Research, U.K., to investigate characteristics (altitude, speed, seasonal and annual trends) and drivers (aphid abundance, air temperature, wind speed and rainfall) of high-altitude flight of the two most abundant U.K. ladybird species (native Coccinella septempunctata and invasive Harmonia axyridis). These species cannot be distinguished in the radar data since their reflectivity signals overlap, and they were therefore analysed together. However, their signals do not overlap with other, abundant insects so we are confident they constitute the overwhelming majority of the analysed data. The target species were detected up to similar to 1100 m above ground level, where displacement speeds of up to similar to 60 km/h were recorded, however most ladybirds were found between similar to 150 and 500 m, and had a mean displacement of 30 km/h. Average flight time was estimated, using tethered flight experiments, to be 36.5 minutes, but flights of up to two hours were observed. Ladybirds are therefore potentially able to travel 18 km in a "typical'' high-altitude flight, but up to 120 km if flying at higher altitudes, indicating a high capacity for long-distance dispersal. There were strong seasonal trends in ladybird abundance, with peaks corresponding to the highest temperatures of mid-summer, and warm air temperature was the key driver of ladybird flight. Climatic warming may therefore increase the potential for long-distance dispersal in these species. Low aphid abundance was a second significant factor, highlighting the important role of aphid population dynamics in ladybird dispersal. This research illustrates the utility of radar for studying high-altitude insect flight and has important implications for predicting long-distance dispersal.	[Jeffries, Daniel L.; Humphries, Stuart; Handley, Lori-J. Lawson] Univ Hull, Dept Biol Sci, Kingston Upon Hull, Humberside, England; [Chapman, Jason; Harrington, Richard] Rothamsted Res, Harpenden, Herts, England; [Chapman, Jason] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Roy, Helen E.] NERC Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Brown, Peter M. J.] Anglia Ruskin Univ, Dept Life Sci, Cambridge, England	University of Hull; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Exeter; UK Centre for Ecology & Hydrology (UKCEH); Anglia Ruskin University	Handley, LJL (corresponding author), Univ Hull, Dept Biol Sci, Kingston Upon Hull, Humberside, England.	l.lawson-handley@hull.ac.uk	Humphries, Stuart/A-5664-2008; Roy, Helen/A-1488-2010	Humphries, Stuart/0000-0001-9766-6404; Lawson Handley, Lori/0000-0002-8153-5511; Brown, Peter Michael James/0000-0002-6163-4504; Chapman, Jason/0000-0002-7475-4441	Department of Biological Sciences, University of Hull; UK Biotechnology and Biological Sciences Research Council (BBSRC); Natural Environment Research Council; Joint Nature Conservation Committee; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005191, BBS/E/C/00005195, BBS/E/C/00006003] Funding Source: researchfish; Natural Environment Research Council [CEH010021] Funding Source: researchfish; BBSRC [BBS/E/C/00005191, BBS/E/C/00005195] Funding Source: UKRI	Department of Biological Sciences, University of Hull(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Joint Nature Conservation Committee; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was primarily funded by the Department of Biological Sciences, University of Hull. In addition, Rothamsted Research is a national institute of bioscience strategically funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC). HER is funded by the Natural Environment Research Council and also receives funding from the Joint Nature Conservation Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054202; Brown PMJ, 2008, BIOCONTROL, V53, P5, DOI 10.1007/s10526-007-9132-y; Brown PMJ, 2011, BIOCONTROL, V56, P623, DOI 10.1007/s10526-011-9379-1; Brown PMJ, 2011, ECOL ENTOMOL, V36, P231, DOI 10.1111/j.1365-2311.2011.01264.x; Cardinale BJ, 2006, J ANIM ECOL, V75, P497, DOI 10.1111/j.1365-2656.2006.01070.x; Chapman JW, 2008, CURR BIOL, V18, P514, DOI 10.1016/j.cub.2008.02.080; Chapman JW, 2006, ECOL ENTOMOL, V31, P378, DOI 10.1111/j.1365-2311.2006.00797.x; Chapman JW, 2012, P NATL ACAD SCI USA, V109, P14924, DOI 10.1073/pnas.1207255109; Chapman JW, 2010, SCIENCE, V327, P682, DOI 10.1126/science.1182990; Chapman JW, 2004, INT J PEST MANAGE, V50, P225, DOI 10.1080/09670870410001731961; Chapman JW, 2003, BIOSCIENCE, V53, P503, DOI 10.1641/0006-3568(2003)053[0503:VRANTF]2.0.CO;2; Chapman JW, 2002, COMPUT ELECTRON AGR, V35, P95, DOI 10.1016/S0168-1699(02)00013-3; Crawley MJ, 2007, TIME SERIES ANAL R B; DAVIDSON W. M., 1924, Transactions Amer. ent. Soc., V50, P163; Dingle Hugh, 1996, P1; DRAKE VA, 1995, INSECT MIGRATION: TRACKING RESOURCES THROUGH SPACE AND TIME, P427, DOI 10.1017/CBO9780511470875.022; Elliott N, 1996, OECOLOGIA, V105, P537, DOI 10.1007/BF00330017; Elliott NC, 2000, BIOL CONTROL, V17, P218, DOI 10.1006/bcon.1999.0797; Evans EW, 2007, POPUL ECOL, V49, P29, DOI 10.1007/s10144-006-0022-4; Evans EW, 2011, BIOCONTROL, V56, P597, DOI 10.1007/s10526-011-9374-6; EVANS EW, 1991, OECOLOGIA, V87, P401, DOI 10.1007/BF00634598; Evans EW, 2003, EUR J ENTOMOL, V100, P1, DOI 10.14411/eje.2003.001; EVANS EW, 1986, J ANIM ECOL, V55, P1027, DOI 10.2307/4431; Evans WE, 1992, UTAH ALFALFA FIELDS, V65, P30; Fabre F, 2010, ECOL MODEL, V221, P1770, DOI 10.1016/j.ecolmodel.2010.04.006; Frazer B.D., 1988, P231; FRAZER BD, 1981, CAN ENTOMOL, V113, P1025, DOI 10.4039/Ent1131025-11; Grez AA, 2005, EUR J ENTOMOL, V102, P209, DOI 10.14411/eje.2005.033; HAGEN KS, 1962, ANNU REV ENTOMOL, V7, P289, DOI 10.1146/annurev.en.07.010162.001445; Handley LJL, 2011, BIOCONTROL, V56, P409, DOI 10.1007/s10526-011-9386-2; HEMPTINNE JL, 1992, OECOLOGIA, V90, P238, DOI 10.1007/BF00317181; HODEK I, 1993, EUR J ENTOMOL, V90, P403; Hodek I, 1996, ECOLOGY COCCINELLIDA; Huelsman MF., 2002, P 4 INT C URB PESTS, P243; IVES AR, 1993, ECOLOGY, V74, P1929, DOI 10.2307/1940836; IVES PM, 1981, CAN ENTOMOL, V113, P981, DOI 10.4039/Ent113981-11; Johnson C.G., 1969, MIGRATION DISPERSAL; Kadoya T, 2010, BIOL CONSERV, V143, P1228, DOI 10.1016/j.biocon.2010.02.030; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; KAREIVA P, 1987, NATURE, V326, P388, DOI 10.1038/326388a0; KIECKHEF.RW, 1974, J ECON ENTOMOL, V67, P52, DOI 10.1093/jee/67.1.52; Krivan V, 2008, EUR J ENTOMOL, V105, P405, DOI 10.14411/eje.2008.051; MACAULAY EDM, 1988, B ENTOMOL RES, V78, P121, DOI 10.1017/S0007485300016126; NAKAMUTA K, 1987, PHYSIOL ENTOMOL, V12, P91, DOI 10.1111/j.1365-3032.1987.tb00727.x; Okuda T, 1986, ECOLOGY APHIDOPHAGA, P217; Osawa N, 2000, POPUL ECOL, V42, P115, DOI 10.1007/PL00011990; R Core Development Team, 2008, R LANG ENV STAT COMP; RANKIN MA, 1980, BIOL BULL, V158, P356, DOI 10.2307/1540862; Reynolds AM, 2010, P R SOC B, V277, P765, DOI 10.1098/rspb.2009.1221; RILEY JR, 1985, P IEEE, V73, P228, DOI 10.1109/PROC.1985.13135; Roy H., 2011, LADYBIRDS COCCINELLI; Roy HE, 2012, DIVERS DISTRIB, V18, P717, DOI 10.1111/j.1472-4642.2012.00883.x; SAROSPATAKI M, 1995, EUR J ENTOMOL, V92, P415; Smith AD, 1996, COMPUT ELECTRON AGR, V15, P267, DOI 10.1016/0168-1699(96)00021-X; Smith AD, 2000, B ENTOMOL RES, V90, P265, DOI 10.1017/S0007485300000389; SMITH AD, 1993, PHILOS T R SOC B, V340, P393, DOI 10.1098/rstb.1993.0081; SOLBRECK C, 1974, OECOLOGIA, V17, P265, DOI 10.1007/BF00344926; Sparks TH, 2005, GLOBAL CHANGE BIOL, V11, P507, DOI 10.1111/j.1365-2486.2005.00910.x; Stals R, 2009, IOBC WPRS B, V58, P125; Sullivan MJP, 2012, METHODS ECOL EVOL, V3, P870, DOI 10.1111/j.2041-210X.2012.00219.x; TAYLOR LR, 1974, J ANIM ECOL, V43, P225, DOI 10.2307/3169; TAYLOR LR, 1963, J ANIM ECOL, V32, P99, DOI 10.2307/2520; TURCHIN P, 1989, ECOLOGY, V70, P1008, DOI 10.2307/1941369; Van der Werf W, 2000, EUR J ENTOMOL, V97, P487; WOIWOD IP, 1994, LONG-TERM EXPERIMENTS IN AGRICULTURAL AND ECOLOGICAL SCIENCES, P321; Wood CR, 2006, INT J BIOMETEOROL, V50, P193, DOI 10.1007/s00484-005-0014-7; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	67	33	43	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82278	10.1371/journal.pone.0082278	http://dx.doi.org/10.1371/journal.pone.0082278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367512	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000328740300028
J	Kotaki, T; Khairunisa, SQ; Sukartiningrum, SD; Arfijanto, MV; Utsumi, T; Normalina, I; Handajani, R; Widiyanti, P; Rusli, M; Rahayu, RP; Lusida, MI; Hayashi, Y; Nasronudin; Kameoka, M				Kotaki, Tomohiro; Khairunisa, Siti Qamariyah; Sukartiningrum, Septhia Dwi; Arfijanto, M. Vitanata; Utsumi, Takako; Normalina, Irine; Handajani, Retno; Widiyanti, Prihartini; Rusli, Musofa; Rahayu, Retno Pudji; Lusida, Maria Inge; Hayashi, Yoshitake; Nasronudin; Kameoka, Masanori			High Prevalence of HIV-1 CRF01_AE Viruses among Female Commercial Sex Workers Residing in Surabaya, Indonesia	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; SEXUALLY-TRANSMITTED INFECTIONS; C VIRUS; EPIDEMIOLOGY; IDENTIFICATION; PREVENTION; THAILAND; BANGKOK	Background: Human immunodeficiency virus (HIV) infection and acquired immune deficiency syndrome (AIDS) cause serious health problems and have an impact on the Indonesian economy. In addition, the rapid epidemic growth of HIV is continuing in Indonesia. Commercial sex plays a significant role in the spread of HIV; therefore, in order to reveal the current HIV prevalence rate among commercial sex workers (CSWs), we conducted an epidemiological study on HIV infection among CSWs residing in Surabaya, the capital of East Java province of Indonesia with large communities of CSWs. Methodology/Principal Findings: The prevalence of HIV infection among 200 CSWs was studied. In addition, the subtype of HIV type 1 (HIV-1) and the prevalence of other blood-borne viruses, hepatitis B virus (HBV), hepatitis C virus (HCV) and GB virus C (GBV-C), were studied. The prevalence rates of HIV, hepatitis B core antibody, hepatitis B surface antigen, anti-HCV antibodies and anti-GBV-C antibodies were 11%, 64%, 4%, 0.5% and 0% among CSWs involved in this study, respectively. HIV-1 CRF01_AE viral gene fragments were detected in most HIV-positive samples. In addition, most CSWs showed low awareness of sexually transmitted diseases and had unprotected sex with their clients. Conclusions/Significance: The HIV prevalence rate among CSWs was significantly higher than that among the general population in Indonesia (0.2-0.4%). In addition, CSWs were at a high risk of exposure to HBV, although chronic HBV infection was less frequently established. Our results suggest the necessity of efficient prevention programs for HIV and other blood-borne viral infections among CSWs in Surabaya, Indonesia.	[Kotaki, Tomohiro; Khairunisa, Siti Qamariyah; Sukartiningrum, Septhia Dwi; Arfijanto, M. Vitanata; Utsumi, Takako; Normalina, Irine; Handajani, Retno; Widiyanti, Prihartini; Rusli, Musofa; Rahayu, Retno Pudji; Lusida, Maria Inge; Nasronudin] Airlangga Univ, Indonesia Japan Collaborat Res Ctr Emerging & Ree, Inst Trop Dis, Surabaya, Indonesia; [Kotaki, Tomohiro; Utsumi, Takako; Hayashi, Yoshitake; Kameoka, Masanori] Kobe Univ, Grad Sch Med, Ctr Infect Dis, Kobe, Hyogo, Japan; [Arfijanto, M. Vitanata; Handajani, Retno; Rusli, Musofa; Lusida, Maria Inge; Nasronudin] Airlangga Univ, Fac Med, Surabaya, Indonesia; [Kameoka, Masanori] Kobe Univ, Dept Int Hlth, Grad Sch Hlth Sci, Kobe, Hyogo, Japan	Airlangga University; Kobe University; Airlangga University; Kobe University	Kameoka, M (corresponding author), Kobe Univ, Grad Sch Med, Ctr Infect Dis, Kobe, Hyogo, Japan.	mkameoka@port.kobe-u.ac.jp	Khairunisa, Siti Qamariyah/AAM-6019-2021; Khairunisa, Siti Qamariyah/AAK-8975-2021; Rusli, Musofa/ABC-3885-2020; Widiyanti, Prihartini/G-7385-2017; Handajani, Retno/AAQ-3664-2021	Khairunisa, Siti Qamariyah/0000-0002-0006-4229; Rusli, Musofa/0000-0002-4834-2259; Widiyanti, Prihartini/0000-0002-5636-5100; nasronudin, nasronudin/0000-0001-7882-9992; effendi, wiwin is/0000-0003-3716-2452; Kameoka, Masanori/0000-0001-5525-9915	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); Ministry of Education, Culture, Sports, Science and Technology of Japan; Center of Excellence (COE) program by the Ministry for Research and Technology (RISTEK) of Indonesia	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center of Excellence (COE) program by the Ministry for Research and Technology (RISTEK) of Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	This work was supported by the program of the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); by the Ministry of Education, Culture, Sports, Science and Technology of Japan; and the Center of Excellence (COE) program by the Ministry for Research and Technology (RISTEK) of Indonesia. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afriandi Irvan, 2009, Acta Med Indones, V41 Suppl 1, P75; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Anggorowati N, 2013, MICROBIOL IMMUNOL, V57, P298, DOI 10.1111/1348-0421.12033; Anggorowati N, 2012, J MED VIROL, V84, P857, DOI 10.1002/jmv.23293; Couture MC, 2011, SEX TRANSM DIS, V38, P33, DOI 10.1097/OLQ.0b013e3182000e47; Cuong HN, 2011, J MED VIROL, V83, P399, DOI 10.1002/jmv.21978; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021151; Guy R, 2011, INT J STD AIDS, V22, P505, DOI 10.1258/ijsa.2009.009445; Gyarmathy VA, 2002, J ACQ IMMUN DEF SYND, V30, P448, DOI [10.1097/00042560-200208010-00011, 10.1097/01.QAI.0000018880.78058.98]; Handajani R, 2000, J CLIN MICROBIOL, V38, P662, DOI 10.1128/JCM.38.2.662-668.2000; Hasan Irsan, 2005, Acta Med Indones, V37, P231; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Ibrahim K, 2010, INT J NURS PRACT, V16, P87, DOI 10.1111/j.1440-172X.2010.01816.x; Khamduang W, 2013, CLIN INFECT DIS, V56, P1704, DOI 10.1093/cid/cit166; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lau KA, 2007, AIDS REV, V9, P218; Magnani R, 2010, SEX TRANSM INFECT, V86, P393, DOI 10.1136/sti.2009.038059; Manopaiboon C, 2013, INT J STD AIDS, V24, P34, DOI 10.1177/0956462412472300; MIURA T, 1990, AIDS, V4, P1257, DOI 10.1097/00002030-199012000-00012; Morineau G, 2011, SE ASIAN J TROP MED, V42, P634; Nasronudin, 2008, FOLIA MED INDONESIA, V44, P93; Nhurod P, 2010, SE ASIAN J TROP MED, V41, P153; Panigrahi R, 2012, ANN HEPATOL, V11, P870, DOI 10.1016/S1665-2681(19)31412-7; Pisani E, 2003, JAIDS-J ACQ IMM DEF, V34, P403, DOI 10.1097/00126334-200312010-00007; SahBandar IN, 2011, AIDS RES HUM RETROV, V27, P97, DOI 10.1089/aid.2010.0163; Sahbandar IN, 2009, AIDS RES HUM RETROV, V25, P637, DOI 10.1089/aid.2008.0266; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Soetjipto, 1996, J CLIN MICROBIOL, V34, P2875, DOI 10.1128/JCM.34.12.2875-2880.1996; Takehisa J, 1998, VIROLOGY, V245, P1, DOI 10.1006/viro.1998.9141; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thedja MD, 2010, HEPATOL INT, V4, P608, DOI 10.1007/s12072-010-9203-5; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Utachee P, 2009, AIDS RES HUM RETROV, V25, P229, DOI 10.1089/aid.2008.0232; Utsumi T, 2013, HEPATOL RES, V43, P1032, DOI 10.1111/hepr.12053; Yan YX, 2011, EPIDEMIOL INFECT, V139, P354, DOI 10.1017/S0950268810001597	36	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82645	10.1371/journal.pone.0082645	http://dx.doi.org/10.1371/journal.pone.0082645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367533	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000328740300049
J	Smith, SDA; Markic, A				Smith, Stephen D. A.; Markic, Ana			Estimates of Marine Debris Accumulation on Beaches Are Strongly Affected by the Temporal Scale of Sampling	PLOS ONE			English	Article							LITTER POLLUTION; PLASTIC LITTER; ISLAND; SEA; ARCHIPELAGO; ENVIRONMENT; ABUNDANCE; DYNAMICS; IMPACTS; SHORES	Marine debris is a global issue with impacts on marine organisms, ecological processes, aesthetics and economies. Consequently, there is increasing interest in quantifying the scale of the problem. Accumulation rates of debris on beaches have been advocated as a useful proxy for at-sea debris loads. However, here we show that past studies may have vastly underestimated the quantity of available debris because sampling was too infrequent. Our study of debris on a small beach in eastern Australia indicates that estimated daily accumulation rates decrease rapidly with increasing intervals between surveys, and the quantity of available debris is underestimated by 50% after only 3 days and by an order of magnitude after 1 month. As few past studies report sampling frequencies of less than a month, estimates of the scale of the marine debris problem need to be critically re-examined and scaled-up accordingly. These results reinforce similar, recent work advocating daily sampling as a standard approach for accurate quantification of available debris in coastal habitats. We outline an alternative approach whereby site-specific accumulation models are generated to correct bias when daily sampling is impractical.	[Smith, Stephen D. A.; Markic, Ana] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia	Southern Cross University	Smith, SDA (corresponding author), So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia.	steve.smith@scu.edu.au	Smith, Stephen D A/I-1945-2012	Smith, Stephen D A/0000-0002-3372-5441				Ariza E, 2008, WASTE MANAGE, V28, P2604, DOI 10.1016/j.wasman.2007.11.012; Ballance A, 2000, S AFR J SCI, V96, P210; Bowman D, 1998, J COASTAL RES, V14, P418; Bravo M, 2009, MAR POLLUT BULL, V58, P1718, DOI 10.1016/j.marpolbul.2009.06.017; Cheshire A. C., 2009, UNEP REGIONAL SEAS R, V83; Cheshire A.C., 2009, UNEP REGIONAL SEAS R, V186; Convey P, 2002, POLAR BIOL, V25, P612, DOI 10.1007/s00300-002-0391-x; Cooper DA, 2010, MAR POLLUT BULL, V60, P650, DOI 10.1016/j.marpolbul.2009.12.026; Debrot AO, 2013, MAR POLLUT BULL, V72, P1, DOI 10.1016/j.marpolbul.2013.03.023; Eastman LB, 2013, OCEAN COAST MANAGE, V78, P18, DOI 10.1016/j.ocecoaman.2013.02.014; Eriksson C, 2013, MAR POLLUT BULL, V66, P199, DOI 10.1016/j.marpolbul.2012.08.026; Frost A, 1997, MAR POLLUT BULL, V34, P348, DOI 10.1016/S0025-326X(96)00149-X; GARRITY SD, 1993, MAR POLLUT BULL, V26, P317, DOI 10.1016/0025-326X(93)90574-4; Gregory MR, 2009, PHILOS T R SOC B, V364, P2013, DOI 10.1098/rstb.2008.0265; Hammer J, 2012, REV ENVIRON CONTAM T, V220, P1, DOI 10.1007/978-1-4614-3414-6_1; Hinojosa IA, 2009, MAR POLLUT BULL, V58, P341, DOI 10.1016/j.marpolbul.2008.10.020; Hong S, 2013, MAR POLLUT BULL, V66, P117, DOI 10.1016/j.marpolbul.2012.10.022; Kusui T, 2003, MAR POLLUT BULL, V47, P175, DOI 10.1016/S0025-326X(02)00478-2; Madzena A, 1997, MAR POLLUT BULL, V34, P900, DOI 10.1016/S0025-326X(97)00052-0; Martin JM, 2013, MAR POLLUT BULL, V74, P165, DOI 10.1016/j.marpolbul.2013.07.009; Martinez E, 2009, MAR POLLUT BULL, V58, P1347, DOI 10.1016/j.marpolbul.2009.04.022; Martinez-Ribes L, 2007, SCI MAR, V71, P305, DOI 10.3989/scimar.2007.71n2305; MERRELL TR, 1980, MAR ENVIRON RES, V3, P171, DOI 10.1016/0141-1136(80)90025-2; Moore CJ, 2001, MAR POLLUT BULL, V42, P1297, DOI 10.1016/S0025-326X(01)00114-X; Moore E, 2009, MAR POLLUT BULL, V58, P1045, DOI 10.1016/j.marpolbul.2009.02.006; Moore SL, 2001, MAR POLLUT BULL, V42, P241, DOI 10.1016/S0025-326X(00)00148-X; Morishige C, 2007, MAR POLLUT BULL, V54, P1162, DOI 10.1016/j.marpolbul.2007.04.014; Pichel WG, 2007, MAR POLLUT BULL, V54, P1207, DOI 10.1016/j.marpolbul.2007.04.010; Ribic C. A., 1992, MARINE DEBRIS SURVEY; Ribic CA, 2012, MAR POLLUT BULL, V64, P1726, DOI 10.1016/j.marpolbul.2012.04.001; Rollason V., 2009, COFFS HARBOUR COASTA; Ryan PG, 2009, PHILOS T R SOC B, V364, P1999, DOI 10.1098/rstb.2008.0207; Santos IR, 2005, OCEAN COAST MANAGE, V48, P742, DOI 10.1016/j.ocecoaman.2005.08.006; Santos IR, 2009, ENVIRON MONIT ASSESS, V148, P455, DOI 10.1007/s10661-008-0175-z; Short AD, 2003, J COASTAL RES, P7; Silva-Cavalcanti JS, 2009, WASTE MANAGE RES, V27, P93, DOI 10.1177/0734242X08088705; Smith SDA, 2008, MAR POLLUT BULL, V56, P525, DOI 10.1016/j.marpolbul.2007.11.016; Smith SDA, 2012, MAR POLLUT BULL, V64, P1880, DOI 10.1016/j.marpolbul.2012.06.013; Smith V. K., 1997, Environmental and Resource Economics, V10, P223, DOI 10.1023/A:1026465413899; Somerville SE, 2003, MAR POLLUT BULL, V46, P1184, DOI 10.1016/S0025-326X(03)00126-7; Thiel M, 2013, MAR POLLUT BULL, V71, P307, DOI 10.1016/j.marpolbul.2013.01.005; Thompson RC, 2009, PHILOS T R SOC B, V364, P1973, DOI 10.1098/rstb.2009.0054; Thornton L, 1998, MAR POLLUT BULL, V36, P705, DOI 10.1016/S0025-326X(98)00041-1; Uneputty PA, 1997, MAR POLLUT BULL, V34, P652, DOI 10.1016/S0025-326X(97)00006-4; VAUK GJM, 1987, MAR POLLUT BULL, V18, P316, DOI 10.1016/S0025-326X(87)80018-8; Williams AT, 2001, J COASTAL RES, V17, P137; WILLOUGHBY NG, 1986, MAR POLLUT BULL, V17, P224, DOI 10.1016/0025-326X(86)90605-3	47	39	39	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83694	10.1371/journal.pone.0083694	http://dx.doi.org/10.1371/journal.pone.0083694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367607	Green Submitted, Green Published, gold			2022-12-27	WOS:000328740300114
J	Khanna, N; Godbold, JA; Austin, WEN; Paterson, DM				Khanna, Nikki; Godbold, Jasmin A.; Austin, William E. N.; Paterson, David M.			The Impact of Ocean Acidification on the Functional Morphology of Foraminifera	PLOS ONE			English	Article							BENTHIC FORAMINIFERA; CLIMATE-CHANGE	Culturing experiments were performed on sediment samples from the Ythan Estuary, N. E. Scotland, to assess the impacts of ocean acidification on test surface ornamentation in the benthic foraminifer Haynesina germanica. Specimens were cultured for 36 weeks at either 380, 750 or 1000 ppm atmospheric CO2. Analysis of the test surface using SEM imaging reveals sensitivity of functionally important ornamentation associated with feeding to changing seawater CO2 levels. Specimens incubated at high CO2 levels displayed evidence of shell dissolution, a significant reduction and deformation of ornamentation. It is clear that these calcifying organisms are likely to be vulnerable to ocean acidification. A reduction in functionally important ornamentation could lead to a reduction in feeding efficiency with consequent impacts on this organism's survival and fitness.	[Khanna, Nikki; Paterson, David M.] Univ St Andrews, Sch Biol, Scottish Oceans Inst, St Andrews, Fife, Scotland; [Godbold, Jasmin A.] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [Khanna, Nikki; Austin, William E. N.] Univ St Andrews, Sch Geog & Geosci, St Andrews, Fife, Scotland; [Austin, William E. N.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Khanna, Nikki] Ichron Ltd, Northwich, England	University of St Andrews; NERC National Oceanography Centre; University of Southampton; University of St Andrews; UHI Millennium Institute	Khanna, N (corresponding author), Univ St Andrews, Sch Biol, Scottish Oceans Inst, St Andrews, Fife, Scotland.	nk274@st-andrews.ac.uk	Godbold, Jasmin/AAB-2522-2022; Godbold, Jasmin A/F-1577-2012; Paterson, David/D-5202-2013	Godbold, Jasmin/0000-0001-5558-8188; Godbold, Jasmin A/0000-0001-5558-8188; Paterson, David/0000-0003-1174-6476	NERC UK Ocean Acidification Research Programme [NE/H017445/1]; NERC [NE/G018502/1]; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council [HR09011]; Natural Environment Research Council [NE/E006795/1, NE/H017135/1, NE/H017445/2, NE/G018502/1] Funding Source: researchfish; NERC [NE/H017445/2, NE/H017135/1, NE/E006795/1] Funding Source: UKRI	NERC UK Ocean Acidification Research Programme(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the NERC UK Ocean Acidification Research Programme grant NE/H017445/1. WENA acknowledges NERC support (NE/G018502/1). DMP received funding from the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland). MASTS is funded by the Scottish Funding Council (grant reference HR09011) and contributing institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin HA, 2005, MAR MICROPALEONTOL, V57, P68, DOI 10.1016/j.marmicro.2005.07.002; Bernhard JM, 1999, EARTH-SCI REV, V46, P149, DOI 10.1016/S0012-8252(99)00017-3; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Dissard D, 2010, BIOGEOSCIENCES, V7, P81, DOI 10.5194/bg-7-81-2010; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Form AU, 2012, GLOBAL CHANGE BIOL, V18, P843, DOI 10.1111/j.1365-2486.2011.02583.x; Godbold JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0186; Goldstein ST, 1999, MODERN FORAMINIFERA, P37; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; Hallock P., 1991, P41; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Hansen HJ, 1999, MODERN FORAMINIFERA, P57; Haynert K, 2011, MAR ECOL PROG SER, V432, P53, DOI 10.3354/meps09138; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Le Cadre V, 2003, J FORAMIN RES, V33, P1, DOI 10.2113/0330001; Lee J.J., 1980, BIOCH PHYSL PROTOZOA, V3, P43; Loeblich Jr A.R., 2015, FORAMINIFERAL GENERA; Marszalek D. S, 1969, Transactions Gulf Coast Ass Geol Socs, V19, P341; Moodley L, 2000, MAR ECOL PROG SER, V202, P289, DOI 10.3354/meps202289; Murray J. W., 1991, ECOLOGY PALAEOECOLOG; Murray JW, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1, DOI 10.1017/CBO9780511535529; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; R Development Core Team, 2012, R LANG ENV STAT COMP	24	22	25	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83118	10.1371/journal.pone.0083118	http://dx.doi.org/10.1371/journal.pone.0083118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358253	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000328737700048
J	Ye, GB; Tang, MF; Cai, JF; Nie, Q; Xie, XH				Ye, Guibo; Tang, Mengfan; Cai, Jian-Feng; Nie, Qing; Xie, Xiaohui			Low-Rank Regularization for Learning Gene Expression Programs	PLOS ONE			English	Article							THRESHOLDING ALGORITHM; NETWORKS; INFORMATION; SHRINKAGE; INFERENCE	Learning gene expression programs directly from a set of observations is challenging due to the complexity of gene regulation, high noise of experimental measurements, and insufficient number of experimental measurements. Imposing additional constraints with strong and biologically motivated regularizations is critical in developing reliable and effective algorithms for inferring gene expression programs. Here we propose a new form of regulation that constrains the number of independent connectivity patterns between regulators and targets, motivated by the modular design of gene regulatory programs and the belief that the total number of independent regulatory modules should be small. We formulate a multi-target linear regression framework to incorporate this type of regulation, in which the number of independent connectivity patterns is expressed as the rank of the connectivity matrix between regulators and targets. We then generalize the linear framework to nonlinear cases, and prove that the generalized low-rank regularization model is still convex. Efficient algorithms are derived to solve both the linear and nonlinear low-rank regularized problems. Finally, we test the algorithms on three gene expression datasets, and show that the low-rank regularization improves the accuracy of gene expression prediction in these three datasets.	[Ye, Guibo; Tang, Mengfan; Xie, Xiaohui] Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92717 USA; [Ye, Guibo; Nie, Qing] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA; [Cai, Jian-Feng] Univ Iowa, Dept Math, Iowa City, IA 52242 USA; [Nie, Qing; Xie, Xiaohui] Univ Calif Irvine, Ctr Complex Biol Syst, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Iowa; University of California System; University of California Irvine	Xie, XH (corresponding author), Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92717 USA.	xhx@ics.uci.edu	Cai, Jianfeng/AAB-9478-2019; Cai, Jian-Feng/L-1808-2016	Cai, Jian-Feng/0000-0003-2571-570X; Ye, Guibo/0000-0001-5660-4338; Xie, Xiaohui/0000-0002-5479-6345	National Institute of Health; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was partly supported by a grant from National Institute of Health and a grant from National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONSZAJN N, 1950, T AM MATH SOC, V68, P337, DOI 10.1090/s0002-9947-1950-0051437-7; Bansal M., 2007, MOL SYSTEMS BIOL, V3; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Cai JF, 2010, SIAM J OPTIMIZ, V20, P1956, DOI 10.1137/080738970; Candes EJ, 2011, J ACM, V58, DOI 10.1145/1970392.1970395; Candes EJ, 2009, FOUND COMPUT MATH, V9, P717, DOI 10.1007/s10208-009-9045-5; Chen JH, 2012, ACM T KNOWL DISCOV D, V5, DOI 10.1145/2086737.2086742; Chiquet J, 2009, BIOINFORMATICS, V25, P417, DOI 10.1093/bioinformatics/btn637; Christley S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006799; Cristianini N., 2004, INTRO SUPPORT VECTOR; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Grzegorczyk M, 2011, BIOINFORMATICS, V27, P693, DOI 10.1093/bioinformatics/btq711; Gustafsson M, 2005, IEEE ACM T COMPUT BI, V2, P254, DOI 10.1109/TCBB.2005.35; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Hofmann T, 2008, ANN STAT, V36, P1171, DOI 10.1214/009053607000000677; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Nesterov Y, 2005, MATH PROGRAM, V103, P127, DOI 10.1007/s10107-004-0552-5; Nesterov Y, 2007, 76 CATH U LOUV CORE; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Peters J, 2017, ADAPT COMPUT MACH LE; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vapnik V., 1998, STAT LEARNING THEORY; Ye GB, 2011, ARXIV11103076; Ying Y., 2009, ADV NEURAL INFORM PR, V22	33	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82146	10.1371/journal.pone.0082146	http://dx.doi.org/10.1371/journal.pone.0082146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358148	gold, Green Submitted, Green Published			2022-12-27	WOS:000328737700008
J	Arai, M; Tokunaga, Y; Takagi, A; Tobita, Y; Hirata, Y; Ishida, Y; Tateno, C; Kohara, M				Arai, Masaaki; Tokunaga, Yuko; Takagi, Asako; Tobita, Yoshimi; Hirata, Yuichi; Ishida, Yuji; Tateno, Chise; Kohara, Michinori			Isolation and Characterization of Highly Replicable Hepatitis C Virus Genotype 1a Strain HCV-RMT	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN 5A; B TYPE-I; EFFICIENT REPLICATION; RNA REPLICATION; LIPID DROPLET; CORE PROTEIN; HUMAN LIVER; CDNA-CLONE; INFECTION; CULTURE	Multiple genotype 1a clones have been reported, including the very first hepatitis C virus (HCV) clone called H77. The replication ability of some of these clones has been confirmed in vitro and in vivo, although this ability is somehow compromised. We now report a newly isolated genotype 1a clone, designated HCV-RMT, which has the ability to replicate efficiently in patients, chimeric mice with humanized liver, and cultured cells. An authentic subgenomic replicon cell line was established from the HCV-RMT sequence with spontaneous introduction of three adaptive mutations, which were later confirmed to be responsible for efficient replication in HuH-7 cells as both subgenomic replicon RNA and viral genome RNA. Following transfection, the HCV-RMT RNA genome with three adaptive mutations was maintained for more than 2 months in HuH-7 cells. One clone selected from the transfected cells had a high copy number, and its supernatant could infect naive HuH-7 cells. Direct injection of wild-type HCV-RMT RNA into the liver of chimeric mice with humanized liver resulted in vigorous replication, similar to inoculation with the parental patient's serum. A study of virus replication using HCV-RMT derivatives with various combinations of adaptive mutations revealed a clear inversely proportional relationship between in vitro and in vivo replication abilities. Thus, we suggest that HCV-RMT and its derivatives are important tools for HCV genotype 1a research and for determining the mechanism of HCV replication in vitro and in vivo.	[Arai, Masaaki; Tokunaga, Yuko; Takagi, Asako; Tobita, Yoshimi; Hirata, Yuichi; Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Tokyo 113, Japan; [Ishida, Yuji; Tateno, Chise] PhoenixBio Co Ltd, Hiroshima, Japan	Tokyo Metropolitan Institute of Medical Science; PHOENIXBIO CO. LTD.	Kohara, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Tokyo 113, Japan.	kohara-mc@igakuken.or.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan and a grant from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Arai M, 2011, ARCH VIROL, V156, P295, DOI 10.1007/s00705-010-0859-x; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blight KJ, 2003, J VIROL, V77, P3181, DOI 10.1128/JVI.77.5.3181-3190.2003; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Bukh J, 2002, P NATL ACAD SCI USA, V99, P14416, DOI 10.1073/pnas.212532699; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Date T, 2004, J BIOL CHEM, V279, P22371, DOI 10.1074/jbc.M311120200; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Hiraga N, 2007, FEBS LETT, V581, P1983, DOI 10.1016/j.febslet.2007.04.021; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Ikeda M, 2002, J VIROL, V76, P2997, DOI 10.1128/JVI.76.6.2997-3006.2002; Kamiya N, 2010, J GEN VIROL, V91, P1668, DOI 10.1099/vir.0.019315-0; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Kolykhalov AA, 1997, SCIENCE, V277, P570, DOI 10.1126/science.277.5325.570; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Koutsoudakis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023587; Li YP, 2012, P NATL ACAD SCI USA, V109, P19757, DOI 10.1073/pnas.1218260109; Lin C., 2006, Infectious Disorders - Drug Targets, V6, P3, DOI 10.2174/187152606776056706; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Meuleman P, 2005, HEPATOLOGY, V41, P847, DOI 10.1002/hep.20657; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Nishimura T, 2009, J BIOL CHEM, V284, P36442, DOI 10.1074/jbc.M109.043232; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pietschmann T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000475; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; SHIMIZU YK, 1990, P NATL ACAD SCI USA, V87, P6441, DOI 10.1073/pnas.87.16.6441; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; Tsukiyama-Kohara K, 2004, J BIOL CHEM, V279, P14531, DOI 10.1074/jbc.M312822200; Venkatraman S, 2006, J MED CHEM, V49, P6074, DOI 10.1021/jm060325b; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Yi MK, 2004, J VIROL, V78, P7904, DOI 10.1128/JVI.78.15.7904-7915.2004; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	46	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82527	10.1371/journal.pone.0082527	http://dx.doi.org/10.1371/journal.pone.0082527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358200	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700079
J	Koffi, AA; Alou, LPA; Kabran, JPK; N'Guessan, R; Pennetier, C				Koffi, Alphonsine A.; Alou, Ludovic P. Ahoua; Kabran, Jean-Paul K.; N'Guessan, Raphael; Pennetier, Cedric			Re-Visiting Insecticide Resistance Status in Anopheles gambiae from Cote d'Ivoire: A Nation-Wide Informative Survey	PLOS ONE			English	Article							RUBBER CULTIVATED AREA; PYRETHROID RESISTANCE; TREATED NETS; MALARIA VECTORS; PERMANET(R) 3.0; CULEX-QUINQUEFASCIATUS; POLITICAL CRISIS; MOLECULAR-BASIS; SOUTH REGION; POPULATION	Insecticide resistance constitutes a major threat that may undermine current gain in malaria control in most endemic countries. National Malaria Control Programmes (NMCPs) need as much information as possible on the resistance status of malaria vectors and underlying mechanisms in order to implement the most relevant and efficient control strategy. Bioassays, biochemical and molecular analysis were performed on An. gambiae collected in six sentinel sites in Cote d'Ivoire. The sites were selected on the basis of their bioclimatic status and agricultural practices. An. gambiae populations across sites showed high levels of resistance to organochloride, pyrethroid and carbamate insecticides. The kdr and ace-1(R) mutations were detected in almost all sentinel sites with mosquitoes on the coastal and cotton growing areas mostly affected by these mutations. At almost all sites, the levels of detoxifying enzymes (mixed-function oxidases (MFOs), non-specific esterases (NSE) and glutathione-S-transferases (GSTs)) in An. gambiae populations were significantly higher than the levels found in the susceptible strain Kisumu. Pre-exposure of mosquitoes to PBO, an inhibitor of MFOs and NSEs, significantly increased mortality rates to pyrethroids and carbamates in mosquitoes but resistance in most cases was not fully synergised by PBO, inferring a residual role of additional mechanisms, including kdr and ace-1 site insensitivity. The large distribution of resistance in Cote d'Ivoire raises an important question of whether to continue to deploy pyrethroid-based long-lasting insecticidal nets (LLINs) and insecticide residual spraying (IRS) towards which resistance continues to rise with no guarantee that the level of resistance would not compromise their efficacy. Innovative strategies that combine insecticide and synergists in LLINs or spatially LLIN and an effective non-pyrethroid insecticide for IRS could be in the short term the best practice for the NMCP to manage insecticide resistance in malaria vectors in Cote d'Ivoire and other endemic countries facing resistance.	[Koffi, Alphonsine A.; Alou, Ludovic P. Ahoua; Kabran, Jean-Paul K.] IPR, Bouake, Cote Ivoire; [Alou, Ludovic P. Ahoua] Univ Felix Houphouet Boigny, Lab Zool & Biol Anim, Abidjan, Cote Ivoire; [N'Guessan, Raphael] London Sch Hyg & Trop Med, London WC1, England; [Pennetier, Cedric] UM1 UM2 CNRS 5290 IRD 224, IRD, Montpellier, France; [N'Guessan, Raphael; Pennetier, Cedric] CREC, Cotonou 04, Benin	University of London; London School of Hygiene & Tropical Medicine; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Entomological Research Center of Cotonou (CREC)	Koffi, AA (corresponding author), IPR, Bouake, Cote Ivoire.	koffi_alphonsine@yahoo.fr; cedric.pennetier@ird.fr	Pennetier, Cedric/K-2010-2016	Pennetier, Cedric/0000-0002-3362-6371	National Malaria Control Programme of Cote d'Ivoire as a part of a work package of the Global Fund initiative in the country	National Malaria Control Programme of Cote d'Ivoire as a part of a work package of the Global Fund initiative in the country	The study was supported by the National Malaria Control Programme of Cote d'Ivoire as a part of a work package of the Global Fund initiative in the country. The NMCP of Cote d'Ivoire participated to the study design and approved the decision to publish. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alou LPA, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-289; Alou LPA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-167; Antonio-Nkondjio C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-154; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Aultman K, 2011, PLOS MED, V8; Badolo A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-232; Bigoga JD, 2012, ACTA TROP, V124, P210, DOI 10.1016/j.actatropica.2012.08.010; Bigoga JD, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-197; Chouaibou M, 2008, TROP MED INT HEALTH, V13, P476, DOI 10.1111/j.1365-3156.2008.02025.x; Collins F.H., 1988, Parassitologia (Rome), V30, P231; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Corbel V, 2012, LANCET INFECT DIS; Corbel V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-113; Dabire RK, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-127; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Djegbe I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-261; Djogbenou L, 2010, MED VET ENTOMOL; Djogbenou L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-70; Edi CVA, 2012, EMERG INFECT DIS, V18, P1508, DOI 10.3201/eid1809.120262; Fane M, 2012, ACTA TROP, V122, P1, DOI 10.1016/j.actatropica.2011.11.013; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Hemingway J, 2000, INSECT BIOCHEM MOLEC, V30, P1009, DOI 10.1016/S0965-1748(00)00079-5; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Henry MC, 2005, AM J TROP MED HYG, V73, P859, DOI 10.4269/ajtmh.2005.73.859; Jones CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045995; Koffi AA, BMC INFECT DIS UNPUB; Koffi AA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-151; Koffi AA, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-68; Koudou BG, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-172; Lapied B, 2009, TRENDS BIOTECHNOL, V27, P190, DOI 10.1016/j.tibtech.2008.12.005; Lenormand T, 1998, EVOLUTION, V52, P1705, DOI [10.2307/2411343, 10.1111/j.1558-5646.1998.tb02250.x]; Lynd A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-16; Moiroux N, 2012, J INFECT DIS, V206, P1622, DOI 10.1093/infdis/jis565; Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; N'Guessan R, 2010, T ROY SOC TROP MED H, V104, P758, DOI 10.1016/j.trstmh.2010.08.008; Namountougou M, 2012, ACTA TROP; Namountougou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048412; Pennetier C, 2013, PLOS ONE UNPUB; PNLP_Cote_d'Ivoire, 2012, PLAN STRAT 2012 2015; Ranson H, 2010, TRENDS PARASITOL; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Raymond-Delpech Valerie, 2005, Invertebrate Neuroscience, V5, P119; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; Rowland M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069516; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Tia E, 2006, Bull Soc Pathol Exot, V99, P278; Van Bortel W, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-248; VectorBase, 2012, ANOBASE AN DAT INS R; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 1998, TECHN DET RES MECH F; WHO, 1998, WHOCDSCPCMAL199812; WHO, 2006, WHOCDSNTDWHOPESGCDDP; [WHO] World Health Organization, 2009, WHO REC INS IND RES; World Health Organisation WHO, 2012, WHO REC LONG LAST IN; Yadouleton A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-60; Yadouleton A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-118	59	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82387	10.1371/journal.pone.0082387	http://dx.doi.org/10.1371/journal.pone.0082387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358177	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700063
J	Lee, YS; Ju, HK; Kim, YJ; Lim, TG; Uddin, MR; Kim, YB; Baek, JH; Kwon, SW; Lee, KW; Seo, HS; Park, SU; Yang, TJ				Lee, Yun Sun; Ju, Hyun Kyoung; Kim, Yeon Jeong; Lim, Tae-Gyu; Uddin, Md Romij; Kim, Yeon Bok; Baek, Jin Hong; Kwon, Sung Won; Lee, Ki Won; Seo, Hak Soo; Park, Sang Un; Yang, Tae-Jin			Enhancement of Anti-Inflammatory Activity of Aloe vera Adventitious Root Extracts through the Alteration of Primary and Secondary Metabolites via Salicylic Acid Elicitation	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; SUSPENSION-CULTURES; BARBADENSIS MILLER; PHENOLIC-COMPOUNDS; MASS-SPECTROMETRY; METHYL JASMONATE; ANTHRAQUINONES; GROWTH; ACCUMULATION; TISSUE	Aloe vera (Asphodeloideae) is a medicinal plant in which useful secondary metabolites are plentiful. Among the representative secondary metabolites of Aloe vera are the anthraquinones including aloe emodin and chrysophanol, which are tricyclic aromatic quinones synthesized via a plant-specific type III polyketide biosynthesis pathway. However, it is not yet clear which cellular responses can induce the pathway, leading to production of tricyclic aromatic quinones. In this study, we examined the effect of endogenous elicitors on the type III polyketide biosynthesis pathway and identified the metabolic changes induced in elicitor-treated Aloe vera adventitious roots. Salicylic acid, methyl jasmonate, and ethephon were used to treat Aloe vera adventitious roots cultured on MS liquid media with 0.3 mg/L IBA for 35 days. Aloe emodin and chrysophanol were remarkably increased by the SA treatment, more than 10-11 and 5-13 fold as compared with untreated control, respectively. Ultra-performance liquid chromatography-electrospray ionization mass spectrometry analysis identified a total of 37 SA-induced compounds, including aloe emodin and chrysophanol, and 3 of the compounds were tentatively identified as tricyclic aromatic quinones. Transcript accumulation analysis of polyketide synthase genes and gas chromatography mass spectrometry showed that these secondary metabolic changes resulted from increased expression of octaketide synthase genes and decreases in malonyl-CoA, which is the precursor for the tricyclic aromatic quinone biosynthesis pathway. In addition, anti-inflammatory activity was enhanced in extracts of SA-treated adventitious roots. Our results suggest that SA has an important role in activation of the plant specific-type III polyketide biosynthetic pathway, and therefore that the efficacy of Aloe vera as medicinal agent can be improved through SA treatment.	[Lee, Yun Sun; Kim, Yeon Jeong; Seo, Hak Soo; Yang, Tae-Jin] Seoul Natl Univ, Coll Agr & Life Sci, Plant Genom & Breeding Inst, Dept Plant Sci, Seoul, South Korea; [Lee, Yun Sun; Kim, Yeon Jeong; Seo, Hak Soo; Yang, Tae-Jin] Seoul Natl Univ, Coll Agr & Life Sci, Res Inst Agr & Life Sci, Seoul, South Korea; [Ju, Hyun Kyoung; Kwon, Sung Won] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Ju, Hyun Kyoung; Kwon, Sung Won] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea; [Lim, Tae-Gyu] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang, South Korea; [Uddin, Md Romij; Kim, Yeon Bok; Park, Sang Un] Chungnam Natl Univ, Dept Crop Sci, Taejon, South Korea; [Baek, Jin Hong] Kim Jeong Moon Aloe Co LTD, Seoul, South Korea; [Lee, Ki Won] Seoul Natl Univ, Ctr Agr Biomat, Dept Agr Biotechnol, Seoul, South Korea; [Seo, Hak Soo] Seoul Natl Univ, BioMAX Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Chungnam National University; Seoul National University (SNU); Seoul National University (SNU)	Yang, TJ (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Plant Genom & Breeding Inst, Dept Plant Sci, Seoul, South Korea.	tjyang@snu.ac.kr	Yang, Tae-Jin/AAT-5274-2020; Lim, Tae-Gyu/AAO-8475-2020; Lee, Yun Sun/AAF-2932-2021; Lee, Ki Won/M-4114-2018	Lim, Tae-Gyu/0000-0001-6930-9565; Uddin, Md. Romij/0000-0003-2188-7619	Kim Jeong Moon Aloe Co; Rural Development Administration, Republic of Korea [PJ008202]	Kim Jeong Moon Aloe Co; Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the Kim Jeong Moon Aloe Co and Next-Generation BioGreen21 Program (No. PJ008202), Rural Development Administration, Republic of Korea (http://atis.rda.go.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe I, 2005, J AM CHEM SOC, V127, P12709, DOI 10.1021/ja053945v; Ali MB, 2006, PLANT CELL REP, V25, P613, DOI 10.1007/s00299-005-0065-6; ALTENBACH SB, 1981, VIROLOGY, V112, P25, DOI 10.1016/0042-6822(81)90608-5; Benhamou N, 1996, TRENDS PLANT SCI, V1, P233; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Boudreau MD, 2006, J ENVIRON SCI HEAL C, V24, P103, DOI 10.1080/10590500600614303; Bulgakov VP, 2002, J BIOTECHNOL, V97, P213, DOI 10.1016/S0168-1656(02)00067-6; Chiang L, 2007, PROCESS BIOCHEM, V42, P757, DOI 10.1016/j.procbio.2007.01.005; Coste A, 2011, PLANT CELL TISS ORG, V106, P279, DOI 10.1007/s11240-011-9919-5; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; DICOSMO F, 1985, TRENDS BIOTECHNOL, V3, P318, DOI 10.1016/0167-7799(85)90036-8; Dong JA, 2010, J BIOTECHNOL, V148, P99, DOI 10.1016/j.jbiotec.2010.05.009; Farag MA, 2008, PLANT PHYSIOL, V146, P387, DOI 10.1104/pp.107.108431; Farag MA, 2009, PLANT PHYSIOL, V151, P1096, DOI 10.1104/pp.109.141481; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; He ZH, 2009, J ETHNOPHARMACOL, V121, P313, DOI 10.1016/j.jep.2008.11.008; Jung H, 2002, KOREAN J BIOTECHNOL, V7, P525; Jung SK, 2008, CANCER RES, V68, P6021, DOI 10.1158/0008-5472.CAN-08-0899; Jung SK, 2013, FOOD SCI BIOTECHNOL, V22, P507, DOI 10.1007/s10068-013-0108-7; KAWAI K, 1993, PHYTOTHER RES, V7, pS5, DOI 10.1002/ptr.2650070705; Kiehne A, 1996, Z LEBENSM UNTERS FOR, V202, P48, DOI 10.1007/BF01229684; Kovacik J, 2009, PLANT CELL REP, V28, P135, DOI 10.1007/s00299-008-0627-5; Kwon JY, 2009, CARCINOGENESIS, V30, P1932, DOI 10.1093/carcin/bgp216; Lee KM, 2009, CANCER RES, V69, P8043, DOI 10.1158/0008-5472.CAN-09-2316; Lee S, 2012, J AGR FOOD CHEM, V60, P11222, DOI 10.1021/jf3026309; Lee YS, 2011, PLANT OMICS, V4, P190; Matsuda F, 2009, PLANT J, V57, P555, DOI 10.1111/j.1365-313X.2008.03705.x; Mizuuchi Y, 2009, FEBS J, V276, P2391, DOI 10.1111/j.1742-4658.2009.06971.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ong ES, 2009, MOL BIOSYST, V5, P288, DOI 10.1039/b811850g; Park MY, 2009, BIOSCI BIOTECH BIOCH, V73, P828, DOI 10.1271/bbb.80714; Pu GB, 2009, PLANT CELL REP, V28, P1127, DOI 10.1007/s00299-009-0713-3; Pussa T, 2009, PHYTOCHEM ANALYSIS, V20, P98, DOI 10.1002/pca.1102; Rao SR, 2002, BIOTECHNOL ADV, V20, P101, DOI 10.1016/S0734-9750(02)00007-1; Reynolds T, 1999, J ETHNOPHARMACOL, V68, P3, DOI 10.1016/S0378-8741(99)00085-9; ROY SC, 1991, SCI HORTIC-AMSTERDAM, V47, P107, DOI 10.1016/0304-4238(91)90032-T; Rozen S, 2000, Methods Mol Biol, V132, P365; Sawada Y, 2009, PLANT CELL PHYSIOL, V50, P37, DOI 10.1093/pcp/pcn183; SCHENK RU, 1972, CAN J BOTANY, V50, P199, DOI 10.1139/b72-026; Song R, 2011, BIOMED CHROMATOGR, V25, P417, DOI 10.1002/bmc.1467; Song R, 2009, RAPID COMMUN MASS SP, V23, P537, DOI 10.1002/rcm.3907; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Tamarat R, 2002, LAB INVEST, V82, P747, DOI 10.1097/01.LAB.0000017372.76297.EB; Tan ZJ, 2011, SEP SCI TECHNOL, V46, P1503, DOI 10.1080/01496395.2011.563766; Xie Y, 2007, J LIQ CHROMATOGR R T, V30, P1475, DOI 10.1080/10826070701277117; Yagi A, 1998, PHYTOCHEMISTRY, V47, P1267, DOI 10.1016/S0031-9422(97)00745-0; Ye M, 2007, J AM SOC MASS SPECTR, V18, P82, DOI 10.1016/j.jasms.2006.08.009; Yen GC, 2000, FOOD CHEM, V70, P437, DOI 10.1016/S0308-8146(00)00108-4; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040; Yousefzadi M, 2010, BIOTECHNOL LETT, V32, P1739, DOI 10.1007/s10529-010-0343-4; Yu DH, 2011, J SEP SCI, V34, P1133, DOI 10.1002/jssc.201100012; Zhao J, 2005, BIOTECHNOL ADV, V23, P283, DOI 10.1016/j.biotechadv.2005.01.003	52	24	28	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82479	10.1371/journal.pone.0082479	http://dx.doi.org/10.1371/journal.pone.0082479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358188	Green Submitted, gold, Green Published			2022-12-27	WOS:000328735700069
J	Wimmer, ME; Rising, J; Galante, RJ; Wyner, A; Pack, AI; Abel, T				Wimmer, Mathieu E.; Rising, Justin; Galante, Raymond J.; Wyner, Abraham; Pack, Allan I.; Abel, Ted			Aging in Mice Reduces the Ability to Sustain Sleep/Wake States	PLOS ONE			English	Article							AGE-RELATED-CHANGES; SLOW-WAVE ACTIVITY; HOMEOSTATIC REGULATION; CORTICAL TEMPERATURE; EEG; YOUNG; MEMORY; RATS; SENESCENCE; BEHAVIOR	One of the most significant problems facing older individuals is difficulty staying asleep at night and awake during the day. Understanding the mechanisms by which the regulation of sleep/wake goes awry with age is a critical step in identifying novel therapeutic strategies to improve quality of life for the elderly. We measured wake, non-rapid eye movement (NREM) and rapid-eye movement (REM) sleep in young (2-4 months-old) and aged (22-24 months-old) C57BL6/NIA mice. We used both conventional measures (i.e., bout number and bout duration) and an innovative spike-and-slab statistical approach to characterize age-related fragmentation of sleep/wake. The short (spike) and long (slab) components of the spike-and-slab mixture model capture the distribution of bouts for each behavioral state in mice. Using this novel analytical approach, we found that aged animals are less able to sustain long episodes of wakefulness or NREM sleep. Additionally, spectral analysis of EEG recordings revealed that aging slows theta peak frequency, a correlate of arousal. These combined analyses provide a window into the mechanisms underlying the destabilization of long periods of sleep and wake and reduced vigilance that develop with aging.	[Wimmer, Mathieu E.] Univ Penn, Neurosci Grad Grp, Philadelphia, PA 19104 USA; [Wimmer, Mathieu E.; Abel, Ted] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Rising, Justin; Wyner, Abraham] Univ Penn, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA; [Galante, Raymond J.; Pack, Allan I.; Abel, Ted] Univ Penn, Ctr Sleep & Circadian Neurobiol, Philadelphia, PA 19104 USA; [Pack, Allan I.] Univ Penn, Div Sleep Med, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Abel, T (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	abele@sas.upenn.edu	Abel, Ted/AAX-2825-2021; Wimmer, Mathieu E/P-8091-2018	Abel, Ted/0000-0003-2423-4592; Pack, Allan/0000-0002-2879-0484; Rising, Justin/0000-0002-4595-7514	National Institute on Aging (NIA) [5P01AG017628]; National Heart, Lung, and Blood Institute (NHLBI) [T32HL007953]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017628] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from National Institute on Aging (NIA, 5P01AG017628 to T. A., Principal Investigator A. P.) and National Heart, Lung, and Blood Institute (NHLBI, T32HL007953 to M. W., Principal Investigator A. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancoli-Israel S, 2009, SLEEP MED, V10, pS7, DOI 10.1016/j.sleep.2009.07.004; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Behn CGD, 2007, J NEUROPHYSIOL, V97, P3828, DOI 10.1152/jn.01184.2006; BLIWISE DL, 1993, SLEEP, V16, P40, DOI 10.1093/sleep/16.1.40; BORBELY AA, 1981, ELECTROEN CLIN NEURO, V51, P483, DOI 10.1016/0013-4694(81)90225-X; Brightwell JJ, 2004, NEUROBIOL LEARN MEM, V81, P19, DOI 10.1016/j.nlm.2003.08.001; Chu-Shore J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014204; Cirelli C, 2005, J NEUROSCI, V25, P4503, DOI 10.1523/JNEUROSCI.4845-04.2005; Colas D, 2005, NEUROBIOL AGING, V26, P265, DOI 10.1016/j.neurobiolaging.2004.03.004; Cooke JR, 2011, HDB CLIN NEUROLOGY, V98, P653; Deboer T, 1996, J COMP PHYSIOL A, V179, P483; Desarnaud F, 2004, SLEEP, V27, P851, DOI 10.1093/sleep/27.5.851; Dijk DJ, 2000, CHRONOBIOL INT, V17, P285, DOI 10.1081/CBI-100101049; DIJK DJ, 1989, NEUROBIOL AGING, V10, P677, DOI 10.1016/0197-4580(89)90004-3; EHLERS CL, 1989, ELECTROEN CLIN NEURO, V72, P118, DOI 10.1016/0013-4694(89)90172-7; ELEFTHERIOU BE, 1975, GERONTOLOGY, V21, P21, DOI 10.1159/000212027; Farajnia S, 2012, J NEUROSCI, V32, P5891, DOI 10.1523/JNEUROSCI.0469-12.2012; Fillit HM, 2002, MAYO CLIN PROC, V77, P681, DOI 10.4065/77.7.681; FRANKEN P, 1992, PFLUG ARCH EUR J PHY, V420, P500, DOI 10.1007/BF00374625; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; Franken P, 1998, AM J PHYSIOL-REG I, V275, pR1127, DOI 10.1152/ajpregu.1998.275.4.R1127; Gerrard JL, 2008, J NEUROSCI, V28, P7883, DOI 10.1523/JNEUROSCI.1265-08.2008; Hasan S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.010; Huber R, 2007, SLEEP, V30, P129, DOI 10.1093/sleep/30.2.129; INGRAM DK, 1982, NEUROBIOL AGING, V3, P287, DOI 10.1016/0197-4580(82)90017-3; Joho RH, 2006, EUR J NEUROSCI, V23, P1567, DOI 10.1111/j.1460-9568.2006.04672.x; Kerkhof GA, 2010, PROG BRAIN RES, V185, P181, DOI 10.1016/B978-0-444-53702-7.00011-7; Kryger M, 2004, GERIATRICS-US, V59, P24; Landolt HP, 1996, BRAIN RES, V738, P205, DOI 10.1016/S0006-8993(96)00770-6; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Mander BA, 2013, NAT NEUROSCI, V16, P357, DOI 10.1038/nn.3324; MARKOWSKA AL, 1989, NEUROBIOL AGING, V10, P31, DOI 10.1016/S0197-4580(89)80008-9; McShane BB, 2010, J NEUROSCI METH, V193, P321, DOI 10.1016/j.jneumeth.2010.08.024; Mendelson WB, 1999, SLEEP, V22, P145, DOI 10.1093/sleep/22.2.145; Mochizuki T, 2004, J NEUROSCI, V24, P6291, DOI 10.1523/JNEUROSCI.0586-04.2004; Naidoo N, 2011, AGING CELL, V10, P640, DOI 10.1111/j.1474-9726.2011.00699.x; Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011; Nygard M, 2005, BRAIN RES BULL, V65, P149, DOI 10.1016/j.brainresbull.2004.12.006; Ouyang M, 2004, J NEUROPHYSIOL, V92, P2071, DOI 10.1152/jn.00226.2004; Pang KCH, 2006, AGE, V28, P283, DOI 10.1007/s11357-006-9013-9; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; PRINZ PN, 1995, J CLIN NEUROPHYSIOL, V12, P139, DOI 10.1097/00004691-199503000-00004; Qiu MH, 2010, EUR J NEUROSCI, V31, P499, DOI 10.1111/j.1460-9568.2009.07062.x; Qu WM, 2010, J NEUROSCI, V30, P4382, DOI 10.1523/JNEUROSCI.4936-09.2010; ROSENBERG RS, 1979, J GERONTOL, V34, P525, DOI 10.1093/geronj/34.4.525; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Shen JM, 1997, J NEUROSCI, V17, P6769; Simasko SM, 2009, BEHAV BRAIN RES, V196, P228, DOI 10.1016/j.bbr.2008.09.003; Stone W S, 1989, Clin Geriatr Med, V5, P363; STONE WS, 1989, BEHAV NEUROSCI, V103, P755, DOI 10.1037/0735-7044.103.4.755; Takahashi K, 2010, NEUROSCIENCE, V169, P1115, DOI 10.1016/j.neuroscience.2010.06.009; VANGOOL WA, 1983, BRAIN RES, V279, P394, DOI 10.1016/0006-8993(83)90217-2; Weinert H, 2001, CHRONOBIOL INT, V18, P559, DOI 10.1081/CBI-100103976; WELSH DK, 1986, J GERONTOL, V41, P579, DOI 10.1093/geronj/41.5.579; Wyble BP, 2004, HIPPOCAMPUS, V14, P662, DOI 10.1002/hipo.20012; ZEPELIN H, 1972, BEHAV BIOL, V7, P65, DOI 10.1016/S0091-6773(72)80189-5	56	56	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81880	10.1371/journal.pone.0081880	http://dx.doi.org/10.1371/journal.pone.0081880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358130	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700026
J	Zhou, X; Xie, WH; Li, Q; Zhang, YF; Zhang, J; Zhao, XP; Liu, JJ; Huang, G				Zhou, Xiang; Xie, Wenhui; Li, Qian; Zhang, Yifan; Zhang, Jie; Zhao, Xiaoping; Liu, Jianjun; Huang, Gang			TIGAR Is Correlated with Maximal Standardized Uptake Value on FDG-PET and Survival in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; GLUCOSE-TRANSPORTER; METABOLISM; EXPRESSION; APOPTOSIS	Objective: Evaluation of F-18-FDG uptake value via PET is central to current methods of diagnosis and staging of non-small cell lung cancer (NSCLC) due to its ability to evaluate expression levels of key regulators associated with glucose metabolism in tumor cells. Tp53-induced glycolysis and apoptosis regulator (TIGAR) is an important P53-induced protein that can inhibit glycolysis; however, there have been few clinical studies on its mechanism. Here we have investigated the relationship between TIGAR expression and F-18-FDG PET in tumors, along with its relationship with the clinical characteristics of NSCLC. Methods: We analyzed SUVmax in 79 patients with NSCLC through immunohistochemical staining of TIGAR and five other biological markers associated with tumor cell glycolysis, in order to evaluate the correlation between their expression and SUVmax. We also plotted Kaplan-Meier survival curves to assess TIGAR expression with the prognosis and survival of patients with NSCLC. Results: The key findings were as follows: SUVmax was negatively correlated with the expression of TIGAR (r = 20.31, p<0.01); TIGAR expression was correlated with tumor size (p = 0.01), histological type (p<0.01), differentiation degree (p<0.01) and lymph node metastasis(p<0.01) in patients with NSCLC; and the survival time of patients whose TIGAR was negatively expressed was significantly shorter than for those whose TIGAR was positively expressed (P = 0.023). Conclusions: The expression of TIGAR in primary tumors is significantly correlated with SUVmax, and low expression of TIGAR may predict a worse clinical outcome in patients with NSCLC.	[Zhou, Xiang; Li, Qian; Zhao, Xiaoping; Liu, Jianjun; Huang, Gang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China; [Xie, Wenhui] Shanghai Jiao Tong Univ, Sch Med, Shanghai Chest Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China; [Zhang, Yifan] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China; [Zhang, Jie] Shanghai Jiao Tong Univ, Dept Pathol, Shanghai Chest Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, JJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China.	ljjsh@133sh.com; huang2802@163.com	Zhang, Yifan/AGT-8799-2022	Yifan, Zhang/0000-0001-6488-6232	National Natural Science Foundation of China [30830038, 30970842, 81071180]; Major State Basic Research Development Program of China (973 Program) [2012CB932604]; New Drug Discovery Project [2012ZX09506-001-005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); New Drug Discovery Project	This work was supported by grants from the National Natural Science Foundation of China (Nos. 30830038, 30970842, and 81071180), the Major State Basic Research Development Program of China (973 Program) (No. 2012CB932604), and the New Drug Discovery Project (No. 2012ZX09506-001-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bensinger SJ, 2012, SEMIN CELL DEV BIOL, V23, P352, DOI 10.1016/j.semcdb.2012.02.003; Bille A, 2009, EUR J CARDIO-THORAC, V36, P440, DOI 10.1016/j.ejcts.2009.04.003; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Corcoran CA, 2006, CANCER BIOL THER, V5, P1610, DOI 10.4161/cbt.5.12.3617; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hasegawa H, 2009, LEUKEMIA, V23, P2090, DOI 10.1038/leu.2009.171; Herling A, 2011, FEBS J, V278, P2436, DOI 10.1111/j.1742-4658.2011.08174.x; Kobayashi M, 2012, CLIN NUCL MED, V37, P447, DOI 10.1097/RLU.0b013e31823924bb; Lemarie A, 2011, ONCOGENE, V30, P3985, DOI 10.1038/onc.2011.167; Li H, 2009, J BIOL CHEM, V284, P1748, DOI 10.1074/jbc.M807821200; Li L, 2013, LUNG CANCER, V81, P213, DOI 10.1016/j.lungcan.2013.04.012; Li MH, 2009, LUNG CANCER, V63, P383, DOI 10.1016/j.lungcan.2008.06.004; Lopez-Guerra M, 2008, HAEMATOL-HEMATOL J, V93, P1843, DOI 10.3324/haematol.13186; Madan E, 2012, BRIT J CANCER, V107, P516, DOI 10.1038/bjc.2012.260; Nguyen XC, 2008, EUR J CANCER, V44, P692, DOI 10.1016/j.ejca.2008.02.009; Shimizu K, 2012, ANN THORAC SURG, V93, P398, DOI 10.1016/j.athoracsur.2011.10.033; Tateishi U, 2006, EUR J NUCL MED MOL I, V33, P683, DOI 10.1007/s00259-005-0044-8; Taylor MD, 2009, J THORAC CARDIOV SUR, V137, P43, DOI 10.1016/j.jtcvs.2008.10.014; Tohma T, 2005, HEPATO-GASTROENTEROL, V52, P486; Vesselle H, 2007, CLIN CANCER RES, V13, P3105; Watanabe Yoh, 2003, Ann Thorac Cardiovasc Surg, V9, P343; Wu CD, 2004, ENDOCRINOLOGY, V145, P650, DOI 10.1210/en.2003-1290; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462	24	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e80576	10.1371/journal.pone.0080576	http://dx.doi.org/10.1371/journal.pone.0080576			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24363807	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400004
J	de Wilde, JA; van Dommelen, P; Middelkoop, BJC				de Wilde, Jeroen A.; van Dommelen, Paula; Middelkoop, Barend J. C.			Appropriate Body Mass Index Cut-Offs to Determine Thinness, Overweight and Obesity in South Asian Children in The Netherlands	PLOS ONE			English	Article							NONCOMMUNICABLE DISEASES; CHILDHOOD OVERWEIGHT; ETHNIC-DIFFERENCES; DIABETES-MELLITUS; ABDOMINAL OBESITY; GROWTH REFERENCE; PREVALENCE; RISK; RECOMMENDATIONS; ANTHROPOMETRY	Background: Asian populations have an increased risk of developing cardiometabolic disorders at a lower body mass index (BMI) than other ethnic groups. Therefore, lower adult BMI cut-offs to determine overweight and obesity are recommended to assess the associated health risks for Asian (23 and 27.5 kg/m(2) respectively) and Asian Indian (23, 25 kg/m(2)) populations. The objective of this study was to develop BMI cut-offs for thinness, overweight, and obesity for South Asian children in the Netherlands, and to compare the BMI cut-offs and distribution with an Asian Indian reference, the WHO Child Growth Reference, and universal BMI cut-offs. Methods: A reference cohort of 546 Surinamese South Asian boys and 521 girls, born between 1974-1976 (during the pre-obesity era) with 3408 and 3267 BMI measurements respectively, was retrospectively analysed. BMI-for-age charts were created with the LMS method. BMI centile curves passing through the cut-off points of 15 (thinness), 23 (overweight), 25 and 27.5 kg/m(2) (obesity) at 18y were drawn as cut-off levels. Results: The BMI of Surinamese South Asian children had a similar distribution to the Asian Indian reference, apart from a lower mean and less variation. The BMI distribution differed considerably from the WHO reference and universal BMI criteria. The calculated BMI cut-offs corresponding to a BMI of 15, 23, 25, and 27.5 kg/m(2) at 18y were at the 7.1, 81.1, 89.8, and 95.5 percentile respectively in boys, and at the 2.7, 79.5, 89.2, and 95.2 percentile in girls. Conclusions: This is the first study proposing BMI cut-offs for South Asian children based on measurements from a prosperous population unaffected by the obesity epidemic. We recommend the use of these cut-offs in South Asian children in the Netherlands as these better reflect the health risks associated with thinness, overweight and obesity, and therefore may prevent the development of cardiometabolic disorders.	[de Wilde, Jeroen A.] Municipal Hlth Serv The Hague GGD Den Haag, Dept Youth Hlth Care, The Hague, Netherlands; [de Wilde, Jeroen A.] Netherlands Org Appl Sci Res TNO, Dept Child Hlth, Leiden, Netherlands; [van Dommelen, Paula] Netherlands Org Appl Sci Res TNO, Dept Life Style, Leiden, Netherlands; [Middelkoop, Barend J. C.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Middelkoop, Barend J. C.] Municipal Hlth Serv The Hague GGD Den Haag, Dept Epidemiol, The Hague, Netherlands	Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Wilde, JA (corresponding author), Municipal Hlth Serv The Hague GGD Den Haag, Dept Youth Hlth Care, The Hague, Netherlands.	Jeroen.deWilde@denhaag.nl						Agyemang C, 2011, EPIDEMIOLOGY, V22, P563, DOI 10.1097/EDE.0b013e31821d1096; Agyemang C, 2010, AM J HYPERTENS, V23, P639, DOI 10.1038/ajh.2010.39; Balchin I, 2007, EARLY HUM DEV, V83, P749, DOI 10.1016/j.earlhumdev.2007.09.003; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bindraban NR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-271; Central Committee on Research Involving Human Subjects, 2012, STEP BY STEP PLAN RC; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; De Klerk C. J M., 1953, IMMIGRATIE HINDOSTAN; de Onis M, 2004, INT J OBESITY, V28, pS81, DOI 10.1038/sj.ijo.0802810; de Onis M, 2004, JAMA-J AM MED ASSOC, V291, P2600, DOI 10.1001/jama.291.21.2600; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; de Onis M, 2009, INDIAN PEDIATR, V46, P463; de Wilde JA, 2013, ARCH DIS CHILD, V98, P280, DOI 10.1136/archdischild-2012-303045; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Deurenberg-Yap M, 2002, Obes Rev, V3, P209, DOI 10.1046/j.1467-789X.2002.00069.x; Deurenberg-Yap M, 2001, INT J OBESITY, V25, P1554, DOI 10.1038/sj.ijo.0801739; Duncan JS, 2010, NEW ZEAL MED J, V123, P22; Duncan JS, 2009, ASIA PAC J CLIN NUTR, V18, P404; Ehtisham S, 2005, J CLIN ENDOCR METAB, V90, P3963, DOI 10.1210/jc.2004-2001; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Ganzeboom HBG, 2012, SOCIALE MOBILITEIT S; Garduno-Diaz SD, 2012, DIABETES-METAB RES, V28, P6, DOI 10.1002/dmrr.1219; Ghaffar A, 2004, BMJ-BRIT MED J, V328, P807, DOI 10.1136/bmj.328.7443.807; Gray LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026464; Khadilkar VV, 2012, INDIAN PEDIATR, V49, P29, DOI 10.1007/s13312-012-0011-y; Khadilkar VV, 2009, INDIAN PEDIATR, V46, P477; Low S, 2009, ANN ACAD MED SINGAP, V38, P66; Middelkoop BJC, 1999, INT J EPIDEMIOL, V28, P1119, DOI 10.1093/ije/28.6.1119; Misra A, 2011, INT J OBESITY, V35, P167, DOI 10.1038/ijo.2010.135; Misra A, 2009, J Assoc Physicians India, V57, P163; Misra A, 2011, ANN NUTR METAB, V58, P203, DOI 10.1159/000329431; Mungra G., 1990, HINDOESTAANSE GEZINN; Nube M, 2009, PUBLIC HEALTH NUTR, V12, P507, DOI 10.1017/S1368980008002826; Pandey RM, 2009, METAB SYNDR RELAT D, V7, P133, DOI 10.1089/met.2008.0053; Patel RR, 2004, INT J EPIDEMIOL, V33, P107, DOI 10.1093/ije/dyg238; Schweitz R, 1996, Ned Tijdschr Geneeskd, V140, P717; Tambyraja R L, 1991, Indian J Pediatr, V58, P415, DOI 10.1007/BF02750921; UN Inter-agency Group for Child Mortality Estimation, 2010, LEV TRENDS CHILD MOR; van Buuren S, 2001, STAT MED, V20, P1259, DOI 10.1002/sim.746; van Steijn L, 2009, INT J OBESITY, V33, P1326, DOI 10.1038/ijo.2009.154; Whincup PH, 2002, BRIT MED J, V324, P635, DOI 10.1136/bmj.324.7338.635; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; Wickramasinghe VP, 2013, ANN HUM BIOL, V40, P168, DOI 10.3109/03014460.2012.753109; Wickramasinghe VP, 2011, ANN HUM BIOL, V38, P537, DOI 10.3109/03014460.2011.573505; Yajnik CS, 2002, J CLIN ENDOCR METAB, V87, P5575, DOI 10.1210/jc.2002-020434	49	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82822	10.1371/journal.pone.0082822	http://dx.doi.org/10.1371/journal.pone.0082822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367559	Green Published, gold, Green Submitted			2022-12-27	WOS:000328741900014
J	Ventura, E; Riondato, M; Sambuceti, G; Salis, A; Damonte, G; Cordazzo, C; Besir, H; Pistoia, V; Zardi, L				Ventura, Elisa; Riondato, Mattia; Sambuceti, Gianmario; Salis, Annalisa; Damonte, Gianluca; Cordazzo, Cinzia; Besir, Hueseyin; Pistoia, Vito; Zardi, Luciano			Use of the Uteroglobin Platform for the Expression of a Bivalent Antibody against Oncofetal Fibronectin in Escherichia coli	PLOS ONE			English	Article							SELECTIVE TARGETED DELIVERY; ED-B DOMAIN; MESSENGER-RNA; TNF-ALPHA; ANGIOGENESIS; ISOFORM; MARKER; PHAGE; RADIOIMMUNOTHERAPY; VASCULATURE	Escherichia coli is a robust, economic and rapid expression system for the production of recombinant therapeutic proteins. However, the expression in bacterial systems of complex molecules such as antibodies and fusion proteins is still affected by several drawbacks. We have previously described a procedure based on uteroglobin (UG) for the engineering of very soluble and stable polyvalent and polyspecific fusion proteins in mammalian cells (Ventura et al. 2009. J. Biol. Chem. 284:26646-26654.) Here, we applied the UG platform to achieve the expression in E. coli of a bivalent human recombinant antibody (L19) toward the oncofetal fibronectin (B-FN), a pan-tumor target. Purified bacterial L19-UG was highly soluble, stable, and, in all molecules, the L19 moiety maintained its immunoreactivity. About 50-70% of the molecules were covalent homodimer, however after refolding with the redox couple reduced-glutathione/oxidized-glutathione (GSH/GSSG), 100% of molecules were covalent dimers. Mass spectrometry studies showed that the proteins produced by E. coli and mammalian cells have an identical molecular mass and that both proteins are not glycosylated. L19-UG from bacteria can be freeze-dried without any loss of protein and immunoreactivity. In vivo, in tumor-bearing mice, radio-iodinated L19-UG selectively accumulated in neoplastic tissues showing the same performance of L19-UG from mammalian cells. The UG-platform may represent a general procedure for production of various biological therapeutics in E. coli.	[Ventura, Elisa; Pistoia, Vito] G Gaslini Inst Children, Lab Oncol, Genoa, Italy; [Riondato, Mattia; Sambuceti, Gianmario] Univ Genoa, IRCCS AOU San Martino, IST, Dept Hlth Sci Nucl Med, Genoa, Italy; [Salis, Annalisa] Ctr Excellence Biomed Res, Dept Hearth Environm & Life Sci, Genoa, Italy; [Damonte, Gianluca] Dept Expt Med, Genoa, Italy; [Damonte, Gianluca] Ctr Excellence Biomed Res, Genoa, Italy; [Cordazzo, Cinzia; Zardi, Luciano] Sirius Biotech, Adv Biotechnol Ctr, Genoa, Italy; [Besir, Hueseyin] EMBL Heidelberg, Prot Express & Purificat Core Facil, Heidelberg, Germany	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Genoa; European Molecular Biology Laboratory (EMBL)	Zardi, L (corresponding author), Sirius Biotech, Adv Biotechnol Ctr, Genoa, Italy.	luciano.zardi@sirius-biotech.com	Sambuceti, Gianmario/H-7767-2018; Salis, Annalisa/R-9241-2018	Sambuceti, Gianmario/0000-0003-2979-6500; RIONDATO, MATTIA/0000-0001-9046-7170; Ventura, Elisa/0000-0002-5999-7613; Salis, Annalisa/0000-0002-3082-2908; Besir, Huseyin/0000-0002-7249-4762	"Cinque per mille e Ricerca Corrente, Ministero della Salute" from the Italian Ministry of Health; "8 fellowship - Lenino Fontana e Maria Lionello" from FIRC (Fondazione Italiana per la Ricerca sul Cancro); EMBO Short Term Fellowship; Regione Liguria-Italy [PO CRO FSE 2007/13]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	"Cinque per mille e Ricerca Corrente, Ministero della Salute" from the Italian Ministry of Health; "8 fellowship - Lenino Fontana e Maria Lionello" from FIRC (Fondazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); EMBO Short Term Fellowship(European Molecular Biology Organization (EMBO)); Regione Liguria-Italy; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This study was partially supported by "Cinque per mille e Ricerca Corrente, Ministero della Salute" from the Italian Ministry of Health. EV was supported by the "8 fellowship - Lenino Fontana e Maria Lionello" from FIRC (Fondazione Italiana per la Ricerca sul Cancro) and by an "EMBO Short Term Fellowship." CC and MR were supported by post-doctoral fellowships from Regione Liguria-Italy (PO CRO FSE 2007/13). Sirius-biotech S. R. L. financed the article-processing charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALZA E, 1988, FEBS LETT, V228, P42, DOI 10.1016/0014-5793(88)80580-5; Balza E, 2009, INT J CANCER, V125, P751, DOI 10.1002/ijc.24473; BORSI L, 1994, CELL ADHES COMMUN, V1, P307, DOI 10.3109/15419069409097262; BORSI L, 1995, J BIOL CHEM, V270, P6243, DOI 10.1074/jbc.270.11.6243; Borsi L, 2003, BLOOD, V102, P4384, DOI 10.1182/blood-2003-04-1039; Borsi L, 2002, INT J CANCER, V102, P75, DOI 10.1002/ijc.10662; Carnemolla B, 2002, BLOOD, V99, P1659, DOI 10.1182/blood.V99.5.1659; CARNEMOLLA B, 1989, J CELL BIOL, V108, P1139, DOI 10.1083/jcb.108.3.1139; Carnemolla B, 1996, INT J CANCER, V68, P397, DOI 10.1002/(SICI)1097-0215(19961104)68:3<397::AID-IJC20>3.3.CO;2-D; CARNEMOLLA B, 1992, J BIOL CHEM, V267, P24689; Castellani P, 2002, AM J PATHOL, V161, P1695, DOI 10.1016/S0002-9440(10)64446-X; CASTELLANI P, 1994, INT J CANCER, V59, P612, DOI 10.1002/ijc.2910590507; Eigentler TK, 2011, CLIN CANCER RES, V17, P7732, DOI 10.1158/1078-0432.CCR-11-1203; Erba PA, 2012, J NUCL MED, V53, P922, DOI 10.2967/jnumed.111.101006; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; Huang CJ, 2012, J IND MICROBIOL BIOT, V39, P383, DOI 10.1007/s10295-011-1082-9; Hynes RO, 1990, FIBRONECTINS; Johannsen M, 2010, EUR J CANCER, V46, P2926, DOI 10.1016/j.ejca.2010.07.033; Kosmehl H, 1996, VIRCHOWS ARCH, V429, P311; Mariani G, 1997, CANCER, V80, P2378, DOI 10.1002/(SICI)1097-0142(19971215)80:12+<2378::AID-CNCR7>3.0.CO;2-7; Mazor Y, 2007, NAT BIOTECHNOL, V25, P563, DOI 10.1038/nbt1296; Miura K, 2012, CARCINOGENESIS, V33, P2311, DOI 10.1093/carcin/bgs347; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Neri D, 1998, ADV DRUG DELIVER REV, V31, P43, DOI 10.1016/S0169-409X(97)00093-8; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Papadia F, 2013, J SURG ONCOL, V107, P173, DOI 10.1002/jso.23168; Pini A, 1998, J BIOL CHEM, V273, P21769, DOI 10.1074/jbc.273.34.21769; Santimaria M, 2003, CLIN CANCER RES, V9, P571; Sauer S, 2009, BLOOD, V113, P2265, DOI 10.1182/blood-2008-06-160416; Ventura E, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-104; Ventura E, 2009, J BIOL CHEM, V284, P26646, DOI 10.1074/jbc.M109.025924; ZARDI L, 1982, EMBO J, V1, P929, DOI 10.1002/j.1460-2075.1982.tb01273.x; ZARDI L, 1987, EMBO J, V6, P2337, DOI 10.1002/j.1460-2075.1987.tb02509.x	34	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82878	10.1371/journal.pone.0082878	http://dx.doi.org/10.1371/journal.pone.0082878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367567	Green Submitted, Green Published, gold			2022-12-27	WOS:000328741900016
J	Chowdhury, UR; Holman, BH; Fautsch, MP				Chowdhury, Uttio Roy; Holman, Bradley H.; Fautsch, Michael P.			A Novel Rat Model to Study the Role of Intracranial Pressure Modulation on Optic Neuropathies	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PRESSURE; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; OCULAR HYPERTENSION; LAMINA-CRIBROSA; SPACE; PEOPLE; NUMBER	Reduced intracranial pressure is considered a risk factor for glaucomatous optic neuropathies. All current data supporting intracranial pressure as a glaucoma risk factor comes from retrospective and prospective studies. Unfortunately, there are no relevant animal models for investigating this link experimentally. Here we report a novel rat model that can be used to study the role of intracranial pressure modulation on optic neuropathies. Stainless steel cannulae were inserted into the cisterna magna or the lateral ventricle of Sprague-Dawley and Brown Norway rats. The cannula was attached to a pressure transducer connected to a computer that recorded intracranial pressure in real-time. Intracranial pressure was modulated manually by adjusting the height of a column filled with artificial cerebrospinal fluid in relation to the animal's head. After data collection the morphological appearance of the brain tissue was analyzed. Based on ease of surgery and ability to retain the cannula, Brown Norway rats with the cannula implanted in the lateral ventricle were selected for further studies. Baseline intracranial pressure for rats was 5.5 +/- 1.5 cm water (n=5). Lowering of the artificial cerebrospinal fluid column by 2 cm and 4 cm below head level reduced ICP to 3.7 +/- 1.0 cm water (n=5) and 1.5 +/- 0.6 cm water (n=4), a reduction of 33.0% and 72.7% below baseline. Raising the cerebrospinal fluid column by 4 cm increased ICP to 7.5 +/- 1.4 cm water (n=2) corresponding to a 38.3% increase in intracranial pressure. Histological studies confirmed correct cannula placement and indicated minimal invasive damage to brain tissues. Our data suggests that the intraventricular cannula model is a unique and viable model that can be used to study the effect of altered intracranial pressure on glaucomatous optic neuropathies.	[Chowdhury, Uttio Roy; Holman, Bradley H.; Fautsch, Michael P.] Mayo Clin, Dept Ophthalmol, Rochester, MN USA	Mayo Clinic	Fautsch, MP (corresponding author), Mayo Clin, Dept Ophthalmol, Rochester, MN USA.	fautsch.michael@mayo.edu			Bright Focus Foundation [G2010019]; NIH [EY21727]; Mayo Foundation, Rochester, MN; Research to Prevent Blindness, New York, NY; NATIONAL EYE INSTITUTE [R01EY021727] Funding Source: NIH RePORTER	Bright Focus Foundation(BrightFocus Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation, Rochester, MN; Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported in part by Bright Focus Foundation grant G2010019; NIH research grant EY21727; Mayo Foundation, Rochester, MN; and Research to Prevent Blindness, New York, NY (MPF is a recipient of a Lew R. Wasserman Merit Award and the Department of Ophthalmology, Mayo Clinic is the recipient of an unrestricted grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahler CK, 2012, AM J OPHTHALMOL, V153, P1206, DOI 10.1016/j.ajo.2011.12.017; Basati S, 2012, J NEUROSURG-PEDIATR, V10, P347, DOI 10.3171/2012.6.PEDS11457; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2012, MED HYPOTHESES, V79, P719, DOI 10.1016/j.mehy.2012.08.009; Berdahl JP, 2012, INVEST OPHTH VIS SCI, V53, P1422, DOI 10.1167/iovs.11-8220; Berdahl JP, 2010, CURR OPIN OPHTHALMOL, V21, P106, DOI 10.1097/ICU.0b013e32833651d8; Berdahl JP, 2009, AM J OPHTHALMOL, V148, P623, DOI 10.1016/j.ajo.2009.06.002; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; BERDAHL JP, 2009, A VONGRAEFES ARCH KL, V247, P1284; Bragin DE, 2013, STROKE, V44, P177, DOI 10.1161/STROKEAHA.112.668293; Chowdhury UR, 2011, INVEST OPHTH VIS SCI, V52, P6435, DOI 10.1167/iovs.11-7523; FECHTNER RD, 1994, SURV OPHTHALMOL, V39, P23, DOI 10.1016/S0039-6257(05)80042-6; Fleischman D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052664; Goetz C.G., 2003, TXB CLIN NEUROLOGY, V2nd ed., P511; Grieshaber Matthias C, 2005, Curr Opin Ophthalmol, V16, P79, DOI 10.1097/01.icu.0000156134.38495.0b; Hoffmann J, 2013, CURR OPIN NEUROL, V26, P240, DOI 10.1097/WCO.0b013e328360eccc; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Johnston Miles, 2004, Cerebrospinal Fluid Res, V1, P2, DOI 10.1186/1743-8454-1-2; Jonas JB, 2004, INVEST OPHTH VIS SCI, V45, P2660, DOI 10.1167/iovs.03-1363; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; Jonas Jost B, 2013, J Glaucoma, V22 Suppl 5, pS13, DOI 10.1097/IJG.0b013e31829349bf; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Koh L, 2005, FLUIDS BARRIERS CNS, V2, DOI 10.1186/1743-8454-2-6; Lenfeldt N, 2007, NEUROLOGY, V68, P155, DOI 10.1212/01.wnl.0000250270.54587.71; Li Z, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-66; Miller Janet M, 2007, Cerebrospinal Fluid Res, V4, P5, DOI 10.1186/1743-8454-4-5; Morgan WH, 1998, INVEST OPHTH VIS SCI, V39, P1419; Morgan WH, 2003, CLIN EXP OPHTHALMOL, V31, P167, DOI 10.1046/j.1442-9071.2003.00629.x; Morgan WH, 2008, J GLAUCOMA, V17, P408, DOI 10.1097/IJG.0b013e31815c5f7c; MORROW BA, 1990, AM J PHYSIOL, V258, pR1170; Park YS, 2011, CHILD NERV SYST, V27, P903, DOI 10.1007/s00381-011-1398-9; Parrish RK, 2009, AM J OPHTHALMOL, V147, P717, DOI 10.1016/j.ajo.2008.10.007; Pollay M, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-9; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Richling B, 1982, Neurosurg Rev, V5, P41, DOI 10.1007/BF01793630; Samuels BC, 2012, INVEST OPHTH VIS SCI, V53, P7328, DOI 10.1167/iovs.12-10632; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090, DOI 10.1001/archopht.1991.01080080050026; Szymanski JW., 1925, KLIN OCZ, V3, P145; VOGEL R, 1990, BRIT J OPHTHALMOL, V74, P3, DOI 10.1136/bjo.74.1.3; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wostyn P, 2011, MED HYPOTHESES, V77, P598, DOI 10.1016/j.mehy.2011.06.043; WOZNIAK M, 1975, J NEUROSURG, V43, P535, DOI 10.3171/jns.1975.43.5.0535; Xu H, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-148; YAMADA S, 1975, CHILD BRAIN, V1, P187; Yang Y, 2010, MED HYPOTHESES, V74, P31, DOI 10.1016/j.mehy.2009.08.024	47	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82151	10.1371/journal.pone.0082151	http://dx.doi.org/10.1371/journal.pone.0082151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367501	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300019
J	Pease, M; Ling, C; Mack, WJ; Wang, K; Zada, G				Pease, Matthew; Ling, Chao; Mack, William J.; Wang, Kai; Zada, Gabriel			The Role of Epigenetic Modification in Tumorigenesis and Progression of Pituitary Adenomas: A Systematic Review of the Literature	PLOS ONE			English	Review							TUMOR-SUPPRESSOR GENE; PROMOTER HYPERMETHYLATION; RETINOBLASTOMA GENE; MOLECULAR PATHOGENESIS; DNA METHYLATION; GROWTH-HORMONE; P16 GENE; EXPRESSION; INACTIVATION; HETEROZYGOSITY	Background: Pituitary adenomas (PAs) are commonly occurring neoplasms with diverse endocrine and neurological effects. Although somatic gene mutations are uncommon in sporadic PAs, recent studies lend support to epigenetic modification as a potential cause of tumorigenesis and tumor progression. Methods: A systematic literature review of the PubMed and Google Scholar databases was conducted to identify abstracts (n=1,082) pertaining to key targets and mechanisms implicated in epigenetic dysregulation of PAs published between 1993-2013. Data regarding histopathological subtype, target genes, mode of epigenetic modification, and clinical correlation were recorded and analyzed. Results: Of the 47 that studies met inclusion criteria and focused on epigenomic assessment of PAs, only 2 were genome-scale analyses. Current evidence supports epigenetic alteration in at least 24 PA genes, which were categorized into four groups based on function and epigenetic alteration: 1) Sixteen tumor suppressor genes silenced via DNA methylation; 2) Two oncogenes overexpressed via histone acetylation and hypomethylation; 3) Three imprinted genes with selective allelic silencing; and 4) One epigenome writer inducing abnormal genome-scale activity and 5) Two transcription regulators indirectly modifying the genome. Of these, 5 genes (CDKN2A, GADD45y, FGFR2, caspase-8, and PTAG) showed particular susceptibility to epigenetic modification, with abnormal DNA methylation in >50% of PA samples. Several genes displayed correlations between epigenetic modification and clinically relevant parameters, including invasiveness (CDKN2A; DAPK; Rb1), sex (MAGE-A3), tumor size (GNAS1), and histopathological subtype (CDKN2A; MEG3; p27; RASSF1A; Rb1). Conclusions: Epigenetic modification of selected PA genes may play a key role in tumorigenesis and progression, which may translate into important diagnostic and therapeutic applications.	[Pease, Matthew; Mack, William J.; Zada, Gabriel] Univ So Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA 90033 USA; [Ling, Chao; Mack, William J.; Wang, Kai; Zada, Gabriel] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Wang, Kai] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA 90033 USA; [Wang, Kai] Univ So Calif, Keck Sch Med, Div Bioinformat, Dept Prevent Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Zada, G (corresponding author), Univ So Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA 90033 USA.	gzada@usc.edu	LING, CHAO/W-3528-2019	LING, CHAO/0000-0001-5328-4906	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000131] Funding Source: NIH RePORTER; NCATS NIH HHS [KL2 TR000131] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Abd El-Moneim Hanan M, 2009, J Egypt Natl Canc Inst, V21, P351; Bahar A, 2004, MOL ENDOCRINOL, V18, P1827, DOI 10.1210/me.2004-0087; Bates AS, 1997, J CLIN ENDOCR METAB, V82, P818, DOI 10.1210/jc.82.3.818; Baylin SB, 1998, ADV CANCER RES, V72, P141; Bello MJ, 2006, ONCOL REP, V15, P443; Bender CM, 1998, CANCER RES, V58, P95; Chang EF, 2008, J NEUROSURG, V108, P736, DOI 10.3171/JNS/2008/108/4/0736; Chesnokova V, 2009, HORM RES, V71, P82, DOI 10.1159/000192443; CRYNS VL, 1993, J CLIN ENDOCR METAB, V77, P644, DOI 10.1210/jc.77.3.644; Davis JRE, 2001, REPRODUCTION, V121, P363, DOI 10.1530/rep.0.1210363; Dudley KJ, 2009, J MOL ENDOCRINOL, V42, P461, DOI 10.1677/JME-09-0009; Dudley KJ, 2008, MOL CANCER RES, V6, P1567, DOI 10.1158/1541-7786.MCR-08-0234; Ebrahimi A, 2011, J NEUROENDOCRINOL, V23, P525, DOI 10.1111/j.1365-2826.2011.02129.x; Esteller M, 2000, EUR J CANCER, V36, P2294, DOI 10.1016/S0959-8049(00)00303-8; Ezzat S, 2005, MOL ENDOCRINOL, V19, P1004, DOI 10.1210/me.2004-0432; Ezzat S, 2008, J MOL ENDOCRINOL, V41, P45, DOI 10.1677/JME-08-0045; Ezzat S, 2006, MOL ENDOCRINOL, V20, P2976, DOI 10.1210/me.2006-0265; Ezzat S, 2008, ENDOCR J, V55, P951, DOI 10.1507/endocrj.K08E-082; Farrell WE, 2003, ENDOCR-RELAT CANCER, V10, P323, DOI 10.1677/erc.0.0100323; Farrell WE, 1999, ENDOCR-RELAT CANCER, V6, P437, DOI 10.1677/erc.0.0060437; Farrell WE, 2000, FRONT NEUROENDOCRIN, V21, P174, DOI 10.1006/frne.1999.0195; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Fedele M, 2006, CELL CYCLE, V5, P2045, DOI 10.4161/cc.5.18.3211; Gejman R, 2008, J CLIN ENDOCR METAB, V93, P4119, DOI 10.1210/jc.2007-2633; Greally JM, 2013, ELIFE, V2, DOI 10.7554/eLife.00593; Hayward BE, 2001, J CLIN INVEST, V107, pR31, DOI 10.1172/JCI11887; HERMANBONERT V, 1995, BAILLIERE CLIN ENDOC, V9, P203, DOI 10.1016/S0950-351X(95)80290-8; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Jaffrain-Rea ML, 1999, CLIN ENDOCRINOL, V51, P317; Kaltsas GA, 2005, J CLIN ENDOCR METAB, V90, P3089, DOI 10.1210/jc.2004-2231; Kawamoto H, 1997, J NEURO-ONCOL, V34, P105, DOI 10.1023/A:1005709014239; KNOSP E, 1993, NEUROSURGERY, V33, P610, DOI 10.1227/00006123-199310000-00008; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Li T, 2009, J GENET GENOMICS, V36, P335, DOI 10.1016/S1673-8527(08)60122-8; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Machiavelli G, 2008, PITUITARY, V11, P71, DOI 10.1007/s11102-007-0077-z; Mantovani G, 2010, MOL CELL ENDOCRINOL, V326, P15, DOI 10.1016/j.mce.2010.04.009; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Ogino A, 2005, J NEUROPATH EXP NEUR, V64, P398, DOI 10.1093/jnen/64.5.398; Panguluri SK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-577; PEI L, 1995, CANCER RES, V55, P1613; Qian ZR, 2005, LAB INVEST, V85, P464, DOI 10.1038/labinvest.3700248; Revill K, 2009, ENDOCR-RELAT CANCER, V16, P537, DOI 10.1677/ERC-09-0008; Ruebel KH, 2001, ENDOCR PATHOL, V12, P281, DOI 10.1385/EP:12:3:281; Seemann N, 2001, J PATHOL, V193, P491, DOI 10.1002/path.833; Simpson DJ, 2004, CLIN CANCER RES, V10, P1780, DOI 10.1158/1078-0432.CCR-1127-3; Simpson DJ, 1999, GENE CHROMOSOME CANC, V24, P328; Simpson DJ, 2002, ONCOGENE, V21, P1217, DOI 10.1038/sj.onc.1205195; Simpson DJ, 2001, CARCINOGENESIS, V22, P1149, DOI 10.1093/carcin/22.8.1149; Simpson DJ, 2000, CANCER RES, V60, P1211; So KJ, 2006, CANCER SCI, V97, P1155, DOI 10.1111/j.1349-7006.2006.00302.x; THOMAS L, 2013, CURR OPIN ONCOL US; Weichenhan D, 2013, HUM MOL GENET, V22, pR1, DOI 10.1093/hmg/ddt348; Woloschak M, 1996, INT J CANCER, V67, P16, DOI 10.1002/(SICI)1097-0215(19960703)67:1<16::AID-IJC4>3.0.CO;2-2; Woloschak M, 1997, MOL CARCINOGEN, V19, P221, DOI 10.1002/(SICI)1098-2744(199708)19:4<221::AID-MC1>3.0.CO;2-F; WOLOSCHAK M, 1994, CANCER, V74, P693, DOI 10.1002/1097-0142(19940715)74:2<693::AID-CNCR2820740223>3.0.CO;2-P; Xu B, 2002, ENDOCR PATHOL, V13, P341, DOI 10.1385/EP:13:4:341; Yacqub-Usman K, 2012, NAT REV ENDOCRINOL, V8, P486, DOI 10.1038/nrendo.2012.54; Ying JM, 2005, CLIN CANCER RES, V11, P6442, DOI 10.1158/1078-0432.CCR-05-0267; Yoshimoto K, 1997, EUR J ENDOCRINOL, V136, P74, DOI 10.1530/eje.0.1360074; Yoshino A, 2007, J NEURO-ONCOL, V83, P153, DOI 10.1007/s11060-006-9316-9; Zada G, 2003, J NEUROSURG, V98, P350, DOI 10.3171/jns.2003.98.2.0350; Zada G, 2011, J NEUROSURG, V114, P336, DOI 10.3171/2010.8.JNS10290; Zhang X, 2002, J CLIN ENDOCR METAB, V87, P1262, DOI 10.1210/jc.87.3.1262; Zhang X, 1999, MOL ENDOCRINOL, V13, P156, DOI 10.1210/me.13.1.156; Zhao J, 2005, J CLIN ENDOCR METAB, V90, P2179, DOI 10.1210/jc.2004-1848; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200; ZHU JG, 1994, J CLIN ENDOCR METAB, V78, P922, DOI 10.1210/jc.78.4.922; Zhu XG, 2008, J CLIN ENDOCR METAB, V93, P3610, DOI 10.1210/jc.2008-0578; Zhu XG, 2008, CLIN CANCER RES, V14, P1984, DOI 10.1158/1078-0432.CCR-07-2003; Zhu X, 2007, AM J PATHOL, V170, P1618, DOI 10.2353/ajpath.2007.061111; Zhu XG, 2007, MOL ENDOCRINOL, V21, P1205, DOI 10.1210/me.2007-0053	72	34	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82619	10.1371/journal.pone.0082619	http://dx.doi.org/10.1371/journal.pone.0082619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367530	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300046
J	Rotman, N; Guex, N; Gouranton, E; Wahli, W				Rotman, Nicolas; Guex, Nicolas; Gouranton, Erwan; Wahli, Walter			PPAR beta Interprets a Chromatin Signature of Pluripotency to Promote Embryonic Differentiation at Gastrulation	PLOS ONE			English	Article							ACTIVATED RECEPTOR-BETA/DELTA; STEM-CELLS; TARGET GENES; PCR DATA; METHYLATION; REPRESSION; REGULATORS; PRC2; FATE; EZH2	Epigenetic post-transcriptional modifications of histone tails are thought to help in coordinating gene expression during development. An epigenetic signature is set in pluripotent cells and interpreted later at the onset of differentiation. In pluripotent cells, epigenetic marks normally associated with active genes (H3K4me3) and with silent genes (H3K27me3) atypically co-occupy chromatin regions surrounding the promoters of important developmental genes. However, it is unclear how these epigenetic marks are recognized when cell differentiation starts and what precise role they play. Here, we report the essential role of the nuclear receptor peroxisome proliferator-activated receptor beta (PPAR beta, NR1C2) in Xenopus laevis early development. By combining loss-of-function approaches, large throughput transcript expression analysis by the mean of RNA-seq and intensive chromatin immunoprecipitation experiments, we unveil an important cooperation between epigenetic marks and PPAR beta. During Xenopus laevis gastrulation PPAR beta recognizes H3K27me3 marks that have been deposited earlier at the pluripotent stage to activate early differentiation genes. Thus, PPAR beta is the first identified transcription factor that interprets an epigenetic signature of pluripotency, in vivo, during embryonic development. This work paves the way for a better mechanistic understanding of how the activation of hundreds of genes is coordinated during early development.	[Rotman, Nicolas; Gouranton, Erwan; Wahli, Walter] Univ Lausanne, Natl Res Ctr Frontiers Genet, Ctr Integrat Genom, Lausanne, Switzerland; [Guex, Nicolas] Swiss Inst Bioinformat, Vital IT Grp, Lausanne, Switzerland; [Wahli, Walter] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore	University of Lausanne; Swiss Institute of Bioinformatics; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Wahli, W (corresponding author), Univ Lausanne, Natl Res Ctr Frontiers Genet, Ctr Integrat Genom, Lausanne, Switzerland.	walter.wahli@unil.ch	Wahli, Walter/I-3194-2019; Wahli, Walter/B-1398-2009	Wahli, Walter/0000-0002-5966-9089; GUEX, Nicolas/0000-0001-6023-0519	Swiss National Science Foundation [NRP50]; Bonizzi-Theler-Stiftung; Etat de Vaud	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bonizzi-Theler-Stiftung; Etat de Vaud	This work was supported by grants from the Swiss National Science Foundation (NRP50, NCCR Frontiers in Genetics, individual grants to WW), the Bonizzi-Theler-Stiftung (WW), and the Etat de Vaud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizu N, 2010, DEVELOPMENT, V137, P2915, DOI 10.1242/dev.049395; Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blythe SA, 2009, DEV DYNAM, V238, P1422, DOI 10.1002/dvdy.21931; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Christophersen NS, 2010, J EXP MED, V207, P2287, DOI 10.1084/jem.20101438; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dahle O, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000841; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Heinaniemi M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r147; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Irie N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1248; Iseli C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000579; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Nadra K, 2006, MOL CELL BIOL, V26, P3266, DOI 10.1128/MCB.26.8.3266-3281.2006; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rotman N, 2006, ADV DEV BIOL; Schneider TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022548; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tan NS, 2007, MOL CELL BIOL, V27, P7161, DOI 10.1128/MCB.00436-07; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Xi QR, 2011, CELL, V147, P1511, DOI 10.1016/j.cell.2011.11.032	33	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83300	10.1371/journal.pone.0083300	http://dx.doi.org/10.1371/journal.pone.0083300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367589	Green Published, gold			2022-12-27	WOS:000328740300100
J	Yamanaka, O; Yuan, Y; Coulson-Thomas, VJ; Gesteira, TF; Call, MK; Zhang, YJ; Zhang, JH; Chang, SH; Xie, CC; Liu, CY; Saika, S; Jester, JV; Kao, WWY				Yamanaka, Osamu; Yuan, Yong; Coulson-Thomas, Vivien Jane; Gesteira, Tarsis Ferreira; Call, Mindy K.; Zhang, Yujin; Zhang, Jianhua; Chang, Shao-Hsuan; Xie, Changchun; Liu, Chia-Yang; Saika, Shizuya; Jester, James V.; Kao, Winston W-Y			Lumican Binds ALK5 to Promote Epithelium Wound Healing	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MOLECULAR-DYNAMICS SIMULATIONS; KERATAN SULFATE PROTEOGLYCAN; P38 MAP KINASE; TGF-BETA; CORNEAL EPITHELIUM; FACTOR RECEPTOR; CELL-MIGRATION; DEFICIENT MICE; UP-REGULATION	Lumican (Lum), a small leucine-rich proteoglycan (SLRP) family member, has multiple matricellular functions both as an extracellular matrix component and as a matrikine regulating cell proliferation, gene expression and wound healing. To date, no cell surface receptor has been identified to mediate the matrikine functions of Lum. This study aimed to identify a perspective receptor that mediates Lum effects on promoting wound healing. Transforming growth factor-beta receptor 1 (ALK5) was identified as a potential Lum-interacting protein through in silico molecular docking and molecular dynamics. This finding was verified by biochemical pull-down assays. Moreover, the Lum function on wound healing was abrogated by an ALK5-specific chemical inhibitor as well as by ALK5 shRNAi. Finally, we demonstrated that eukaryote-specific post-translational modifications are not required for the wound healing activity of Lum, as recombinant GST-Lum fusion proteins purified from E. coli and a chemically synthesized LumC(13) peptide (the last C-terminal 13 amino acids of Lum) have similar effects on wound healing in vitro and in vivo.	[Yamanaka, Osamu; Yuan, Yong; Coulson-Thomas, Vivien Jane; Call, Mindy K.; Zhang, Yujin; Zhang, Jianhua; Chang, Shao-Hsuan; Liu, Chia-Yang; Kao, Winston W-Y] Univ Cincinnati, Deparment Ophthalmol, Cincinnati, OH 45221 USA; [Gesteira, Tarsis Ferreira] Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH USA; [Xie, Changchun] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA; [Saika, Shizuya] Wakayama Med Coll, Dept Ophthalmol, Wakayama 640, Japan; [Jester, James V.] Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Wakayama Medical University; University of California System; University of California Irvine	Kao, WWY (corresponding author), Univ Cincinnati, Deparment Ophthalmol, Cincinnati, OH 45221 USA.	Winston.Kao@UC.Edu		Jester, James/0000-0002-9246-0981; Liu, Chia-yang/0000-0002-8398-5516	NEI/NIH [011845, 013755]; Research to Prevent Blindness; Ohio Lions Eye Research Foundation; Grants-in-Aid for Scientific Research [25462759] Funding Source: KAKEN; NATIONAL EYE INSTITUTE [R01EY013755, R01EY011845] Funding Source: NIH RePORTER	NEI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The studies were in part supported by NEI/NIH grants EY#011845, EY#013755, Research to Prevent Blindness, and Ohio Lions Eye Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin BA, 2002, INVEST OPHTH VIS SCI, V43, P1695; BERENDSEN HJC, 1987, COMPUT PHYS COMMUN, V44, P233, DOI 10.1016/0010-4655(87)90078-6; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BIDANSET DJ, 1992, J BIOL CHEM, V267, P5250; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; Carlson EC, 2003, BIOCHEM J, V369, P461, DOI 10.1042/BJ20020593; Carlson EC, 2007, J BIOL CHEM, V282, P35502, DOI 10.1074/jbc.M705823200; Carlson EC, 2010, J LEUKOCYTE BIOL, V88, P517, DOI 10.1189/jlb.0310134; Casar JC, 2004, DEV BIOL, V268, P358, DOI 10.1016/j.ydbio.2003.12.025; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chen SJ, 2013, AM J PATHOL, V183, P247, DOI 10.1016/j.ajpath.2013.04.001; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Chen YG, 1997, EMBO J, V16, P3866, DOI 10.1093/emboj/16.13.3866; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; CIACCI C, 1993, GASTROENTEROLOGY, V105, P93, DOI 10.1016/0016-5085(93)90014-4; Coulson-Thomas VJ, 2013, EXP CELL RES, V319, P967, DOI 10.1016/j.yexcr.2013.01.023; Csordas G, 2000, J BIOL CHEM; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; Dellett M, 2012, DEV GROWTH DIFFER, V54, P327, DOI 10.1111/j.1440-169X.2012.01339.x; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ehnis T, 1997, J BIOL CHEM, V272, P20414, DOI 10.1074/jbc.272.33.20414; Everitt B. S., 2002, CAMBRIDGE DICT STAT; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Feugaing DDS, 2007, BIOCHIMIE, V89, P637, DOI 10.1016/j.biochi.2006.12.012; FONT B, 1993, J BIOL CHEM, V268, P25015; Font B, 1996, MATRIX BIOL, V15, P341, DOI 10.1016/S0945-053X(96)90137-7; Fraternali F, 1996, J MOL BIOL, V256, P939, DOI 10.1006/jmbi.1996.0139; Funderburgh JL, 1997, INVEST OPHTH VIS SCI, V38, P1159; Gesteira TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070880; Gesteira TF, 2011, BBA-PROTEINS PROTEOM, V1814, P1862, DOI 10.1016/j.bbapap.2011.07.024; GRESSNER AM, 1994, PATHOL RES PRACT, V190, P864; Groeneveld TWL, 2005, J IMMUNOL, V175, P4715, DOI 10.4049/jimmunol.175.7.4715; Hayashi Y, 2005, DEV BIOL, V277, P222, DOI 10.1016/j.ydbio.2004.09.022; Hayashi Y, 2010, INVEST OPHTH VIS SCI, V51, P4562, DOI 10.1167/iovs.10-5331; Hayashi Y, 2010, J CELL SCI, V123, P2987, DOI 10.1242/jcs.068221; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; Hutcheon AEK, 2005, INVEST OPHTH VIS SCI, V46, P2362, DOI 10.1167/iovs.04-0759; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; KANE CJM, 1991, J CELL PHYSIOL, V148, P157, DOI 10.1002/jcp.1041480119; Kao WWY, 2006, EXP EYE RES, V82, P3, DOI 10.1016/j.exer.2005.08.012; Kao WWY, 2002, GLYCOCONJUGATE J, V19, P275, DOI 10.1023/A:1025396316169; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Liu HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010707; Lohr K, 2012, INFLAMM BOWEL DIS, V18, P143, DOI 10.1002/ibd.21713; London NaS-FO, 2012, PROTEIN PROTEN COMPL, P209; Meij JTA, 2007, MOL VIS, V13, P2012; Moreno M, 2005, EMBO J, V24, P1397, DOI 10.1038/sj.emboj.7600615; Moreth K, 2012, CELL CYCLE, V11, P2084, DOI 10.4161/cc.20316; Nikitovic D, 2011, INT J BIOCHEM CELL B, V43, P928, DOI 10.1016/j.biocel.2011.03.008; Peng JW, 1996, J BIOMOL NMR, V8, P453, DOI 10.1007/BF00228147; Radaev S, 2010, J BIOL CHEM, V285, P14806, DOI 10.1074/jbc.M109.079921; Radwanska A, 2008, LIFE SCI, V83, P651, DOI 10.1016/j.lfs.2008.09.008; Radwanska A, 2012, EXP CELL RES, V318, P2312, DOI 10.1016/j.yexcr.2012.07.005; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Roth GJ, 2010, J MED CHEM, V53, P7287, DOI 10.1021/jm100812a; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Saika S, 2003, INVEST OPHTH VIS SCI, V44, P2094, DOI 10.1167/iovs.02-1059; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; Saika S, 2001, EXP EYE RES, V72, P679, DOI 10.1006/exer.2001.1002; Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200; Santra M, 2000, J BIOL CHEM; Schaefer L, 2000, KIDNEY INT, V58, P1557, DOI 10.1046/j.1523-1755.2000.00317.x; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; SCHMIDT G, 1991, BIOCHEM J, V280, P411, DOI 10.1042/bj2800411; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Secker GA, 2008, EXP CELL RES, V314, P131, DOI 10.1016/j.yexcr.2007.09.001; Seomun Y, 2008, BIOCHEM BIOPH RES CO, V372, P221, DOI 10.1016/j.bbrc.2008.05.014; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sulochana KN, 2005, J BIOL CHEM; Terai K, 2011, INVEST OPHTH VIS SCI, V11-8017, DOI DOI 10.1167/I0VS.11-8017; Tralhao JG, 2003, FASEB J, V17, P464, DOI 10.1096/fj.02-0534fje; Tuli SS, 2006, CURR EYE RES, V31, P709, DOI 10.1080/02713680600837390; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang TW, 1996, CELL, V86, P435, DOI 10.1016/S0092-8674(00)80116-6; Wu F, 2007, J IMMUNOL, V179, P6988, DOI 10.4049/jimmunol.179.10.6988; Wu F, 2007, J BIOL CHEM, V282, P26409, DOI 10.1074/jbc.M702402200; Yamamoto T, 2012, CANCER LETT, V320, P31, DOI 10.1016/j.canlet.2012.01.023; Yeh JT, 2010, BRIT J DERMATOL, V163, P1174, DOI 10.1111/j.1365-2133.2010.10008.x; Yeh LK, 2005, INVEST OPHTH VIS SCI, V46, P479, DOI 10.1167/iovs.04-1014; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zelenka PS, 2008, SEMIN CELL DEV BIOL, V19, P113, DOI 10.1016/j.semcdb.2007.10.001; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhang YJ, 2011, J CELL SCI, V124, P2561, DOI 10.1242/jcs.085001; Zieske JD, 2001, INVEST OPHTH VIS SCI, V42, P1465	89	47	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82730	10.1371/journal.pone.0082730	http://dx.doi.org/10.1371/journal.pone.0082730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367547	Green Published, gold			2022-12-27	WOS:000328740300060
J	Depner, CM; Traber, MG; Bobe, G; Kensicki, E; Bohren, KM; Milne, G; Jump, DB				Depner, Christopher M.; Traber, Maret G.; Bobe, Gerd; Kensicki, Elizabeth; Bohren, Kurt M.; Milne, Ginger; Jump, Donald B.			A Metabolomic Analysis of Omega-3 Fatty Acid-Mediated Attenuation of Western Diet-Induced Nonalcoholic Steatohepatitis in LDLR-/- Mice	PLOS ONE			English	Article							LIVER-DISEASE; VITAMIN-E; MOUSE MODEL; INFLAMMATION; ENDOTOXEMIA; PATHOGENESIS; PROGRESSION; MANAGEMENT; STEATOSIS; DECREASES	Background: Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease and a risk factor for cirrhosis, hepatocellular carcinoma and liver failure. Previously, we reported that dietary docosahexaenoic acid (DHA, 22:6, n-3) was more effective than eicosapentaenoic acid (EPA, 20:5, n-3) at reversing western diet (WD) induced NASH in LDLR-/- mice. Methods: Using livers from our previous study, we carried out a global non-targeted metabolomic approach to quantify diet-induced changes in hepatic metabolism. Results: Livers from WD + olive oil (WD + O)-fed mice displayed histological and gene expression features consistent with NASH. The metabolomic analysis of 320 metabolites established that the WD and n-3 polyunsaturated fatty acid (PUFA) supplementation had broad effects on all major metabolic pathways. Livers from WD + O-fed mice were enriched in saturated (SFA) and monounsaturated fatty acids (MUFA), palmitoylsphingomyelin, cholesterol, n-6 PUFA, n-6 PUFA-containing phosphoglycerolipids, n-6 PUFA-derived oxidized lipids (12-HETE) and depleted of C20-22 n-3 PUFA-containing phosphoglycerolipids, C20-22 n-3 PUFA-derived oxidized lipids (18-HEPE, 17,18-DiHETE) and S-lactoylglutathione, a methylglyoxal detoxification product. WD + DHA was more effective than WD + EPA at attenuating WD + O-induced changes in NASH gene expression markers, n-6 PUFA and oxidized lipids, citrate and S-lactosyl glutathione. Diet-induced changes in hepatic MUFA and sphingolipid content were associated with changes in expression of enzymes involved in MUFA and sphingolipid synthesis. Changes in hepatic oxidized fatty acids and S-lactoylglutathione, however, correlated with hepatic n-3 and n-6 C20-22 PUFA content. Hepatic C20-22 n-3 PUFA content was inversely associated with hepatic a-tocopherol and ascorbate content and positively associated with urinary F2- and F3-isoprostanes, revealing diet effects on whole body oxidative stress. Conclusion: DHA regulation of hepatic SFA, MUFA, PUFA, sphingomyelin, PUFA-derived oxidized lipids and S-lactoylglutathione may explain the protective effects of DHA against WD-induced NASH in LDLR-/- mice.	[Depner, Christopher M.; Traber, Maret G.; Jump, Donald B.] Oregon State Univ, Sch Biol & Populat Hlth Sci, Nutr Program, Corvallis, OR 97331 USA; [Bobe, Gerd] Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA; [Depner, Christopher M.; Traber, Maret G.; Bobe, Gerd; Jump, Donald B.] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Kensicki, Elizabeth] Metabolon Inc, Durham, NC USA; [Bohren, Kurt M.] Baylor Univ, USDA ARS, Childrens Nutr Res Ctr, Baylor Coll Med, Houston, TX USA; [Milne, Ginger] Vanderbilt Univ, Med Ctr, Div Clin Pharmacol, Eicosanoid Core Lab, Nashville, TN USA	Oregon State University; Oregon State University; Oregon State University; Metabolon; Baylor College of Medicine; Baylor University; United States Department of Agriculture (USDA); Vanderbilt University	Jump, DB (corresponding author), Oregon State Univ, Sch Biol & Populat Hlth Sci, Nutr Program, Corvallis, OR 97331 USA.	Donald.Jump@oregonstate.edu	Traber, Maret G./ABI-2511-2020; Milne, Ginger/D-7648-2014	Traber, Maret G./0000-0002-2892-4024; Milne, Ginger/0000-0003-3890-151X; Bohren, Kurt/0000-0002-3183-4118	United States Department of Agriculture National Institute of Food and Agriculture [2009-65200-05846]; National Institutes of Health [DK043220, DK094600]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094600] Funding Source: NIH RePORTER	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the United States Department of Agriculture National Institute of Food and Agriculture (2009-65200-05846) and the National Institutes of Health Grants to DBJ (DK043220; DK094600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold C, 2010, J BIOL CHEM, V285, P32720, DOI 10.1074/jbc.M110.118406; Barr J, 2010, J PROTEOME RES, V9, P4501, DOI 10.1021/pr1002593; Bikman BT, 2011, ADV EXP MED BIOL, V721, P87, DOI 10.1007/978-1-4614-0650-1_6; Botolin D, 2006, J LIPID RES, V47, P181, DOI 10.1194/jlr.M500365-JLR200; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; de Wit NJW, 2012, J HEPATOL, V57, P1370, DOI 10.1016/j.jhep.2012.07.003; Depner CM, 2013, J NUTR, V143, P315, DOI 10.3945/jn.112.171322; Depner CM, 2012, J NUTR, V142, P1495, DOI 10.3945/jn.112.158865; Dobrzyn A, 2005, AM J PHYSIOL-ENDOC M, V288, pE599, DOI 10.1152/ajpendo.00439.2004; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; GARCIAHEREDIA A, 2013, APPROACH J IN PRESS; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Ikeda R, 2011, INFLAMM RES, V60, P597, DOI 10.1007/s00011-011-0309-6; Jump DB, 2013, ANNU REV NUTR, V33, P249, DOI 10.1146/annurev-nutr-071812-161139; Kalhan SC, 2011, METABOLISM, V60, P404, DOI 10.1016/j.metabol.2010.03.006; Kalish BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059653; KIM HY, 1990, J LIPID RES, V31, P2285; Lam BP, 2009, ANN HEPATOL, V8, pS51, DOI 10.1016/S1665-2681(19)31827-7; Laugerette F, 2011, J NUTR BIOCHEM, V22, P53, DOI 10.1016/j.jnutbio.2009.11.011; Lavine JE, 2011, JAMA-J AM MED ASSOC, V305, P1659, DOI 10.1001/jama.2011.520; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Martel C, 2012, CURR PHARM BIOTECHNO, V13, P726, DOI 10.2174/138920112799857558; McCullough AJ, 2006, J CLIN GASTROENTEROL, V40, pS17; Milne GL, 2008, J BIOL CHEM, V283, P15533, DOI 10.1074/jbc.R700047200; Musso G, 2010, OBES REV, V11, P430, DOI 10.1111/j.1467-789X.2009.00657.x; Nobili V, 2011, ARCH DIS CHILD, V96, P350, DOI 10.1136/adc.2010.192401; Pawar A, 2003, J BIOL CHEM, V278, P35931, DOI 10.1074/jbc.M306238200; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Saraswathi V, 2007, J NUTR, V137, P1776, DOI 10.1093/jn/137.7.1776; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Traber MG, 2007, ANNU REV NUTR, V27, P347, DOI 10.1146/annurev.nutr.27.061406.093819; Tripathy S, 2010, J LIPID RES, V51, P2642, DOI 10.1194/jlr.M006080; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Walenbergh SMA, 2013, J HEPATOL, V58, P801, DOI 10.1016/j.jhep.2012.11.014; Wassall SR, 2008, CHEM PHYS LIPIDS, V153, P57, DOI 10.1016/j.chemphyslip.2008.02.010; Wei YR, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-32; Weylandt KH, 2012, PROSTAG OTH LIPID M, V97, P73, DOI 10.1016/j.prostaglandins.2012.01.005	46	40	41	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83756	10.1371/journal.pone.0083756	http://dx.doi.org/10.1371/journal.pone.0083756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358308	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700070
J	Forthmann, B; van Bergeijk, J; Lee, YW; Lubben, V; Schill, Y; Brinkmann, H; Ratzka, A; Stachowiak, MK; Hebert, M; Grothe, C; Claus, P				Foerthmann, Benjamin; van Bergeijk, Jeroen; Lee, Yu-Wei; Luebben, Verena; Schill, Yvonne; Brinkmann, Hella; Ratzka, Andreas; Stachowiak, Michal K.; Hebert, Michael; Grothe, Claudia; Claus, Peter			Regulation of Neuronal Differentiation by Proteins Associated with Nuclear Bodies	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; TYROSINE-HYDROXYLASE GENE; GROWTH FACTOR-2 ISOFORMS; FGFR1 SIGNALING INFS; CAJAL BODY NUMBER; MOTONEURON PROTEIN; SMN PROTEIN; ZEBRAFISH EMBRYOGENESIS; NEURITE OUTGROWTH; FACTOR RECEPTOR	Nuclear bodies are large sub-nuclear structures composed of RNA and protein molecules. The Survival of Motor Neuron (SMN) protein localizes to Cajal bodies (CBs) and nuclear gems. Diminished cellular concentration of SMN is associated with the neurodegenerative disease Spinal Muscular Atrophy (SMA). How nuclear body architecture and its structural components influence neuronal differentiation remains elusive. In this study, we analyzed the effects of SMN and two of its interaction partners in cellular models of neuronal differentiation. The nuclear 23 kDa isoform of Fibroblast Growth Factor 2 (FGF-2(23)) is one of these interacting proteins - and was previously observed to influence nuclear bodies by destabilizing nuclear gems and mobilizing SMN from Cajal bodies (CBs). Here we demonstrate that FGF-2(23) blocks SMN-promoted neurite outgrowth, and also show that SMN disrupts FGF-2(23) - dependent transcription. Our results indicate that FGF-2(23) and SMN form an inactive complex that interferes with neuronal differentiation by mutually antagonizing nuclear functions. Coilin is another nuclear SMN binding partner and a marker protein for Cajal bodies (CBs). In addition, coilin is essential for CB function in maturation of small nuclear ribonucleoprotein particles (snRNPs). The role of coilin outside of Cajal bodies and its putative impacts in tissue differentiation are poorly defined. The present study shows that protein levels of nucleoplasmic coilin outside of CBs decrease during neuronal differentiation. Overexpression of coilin has an inhibitory effect on neurite outgrowth. Furthermore, we find that nucleoplasmic coilin inhibits neurite outgrowth independent of SMN binding revealing a new function for coilin in neuronal differentiation.	[Foerthmann, Benjamin; van Bergeijk, Jeroen; Luebben, Verena; Schill, Yvonne; Brinkmann, Hella; Ratzka, Andreas; Grothe, Claudia; Claus, Peter] Hannover Med Sch, Inst Neuroanat, Hannover, Germany; [Foerthmann, Benjamin; Grothe, Claudia; Claus, Peter] Univ Vet Med Hannover, Ctr Syst Neurosci, Hannover, Germany; [Lee, Yu-Wei; Stachowiak, Michal K.] SUNY Buffalo, Dept Pathol & Anat Sci, Buffalo, NY 14260 USA; [Hebert, Michael] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Mississippi; University of Mississippi Medical Center	Claus, P (corresponding author), Hannover Med Sch, Inst Neuroanat, Hannover, Germany.	claus.peter@mh-hannover.de	Claus, Peter/A-7978-2008; Ratzka, Andreas/H-7917-2012	Claus, Peter/0000-0003-3824-9445; 	German National Academic Foundation	German National Academic Foundation	The work was partially financed by the German National Academic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANDRADE LEC, 1991, J EXP MED, V173, P1407, DOI 10.1084/jem.173.6.1407; Baron O, 2012, J BIOL CHEM, V287, P19827, DOI 10.1074/jbc.M112.347831; Bellini M, 1998, MOL BIOL CELL, V9, P2987, DOI 10.1091/mbc.9.10.2987; Broome HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036300; Bruns AF, 2009, P NATL ACAD SCI USA, V106, P12747, DOI 10.1073/pnas.0900122106; Buhler D, 1999, HUM MOL GENET, V8, P2351, DOI 10.1093/hmg/8.13.2351; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Claus P, 2003, J BIOL CHEM, V278, P479, DOI 10.1074/jbc.M206056200; Claus P, 2004, BIOCHEM J, V384, P559, DOI 10.1042/BJ20040801; Clelland AK, 2009, TRAFFIC, V10, P1585, DOI 10.1111/j.1600-0854.2009.00972.x; Dundr M, 2001, BIOCHEM J, V356, P297, DOI 10.1042/0264-6021:3560297; Fang XH, 2005, J BIOL CHEM, V280, P28451, DOI 10.1074/jbc.M504400200; Farias GG, 2007, J NEUROSCI, V27, P5313, DOI 10.1523/JNEUROSCI.3934-06.2007; Forthmann B, 2013, CELL MOL LIFE SCI, V70, P2555, DOI 10.1007/s00018-012-1242-8; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; Gangwani L, 2001, NAT CELL BIOL, V3, P376, DOI 10.1038/35070059; Gilder AS, 2011, MOL BIOL CELL, V22, P1070, DOI 10.1091/mbc.E10-08-0731; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grothe C, 1998, MOL BRAIN RES, V57, P97, DOI 10.1016/S0169-328X(98)00076-X; Hebert MD, 2002, DEV CELL, V3, P329, DOI 10.1016/S1534-5807(02)00222-8; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; Hebert MD, 2000, MOL BIOL CELL, V11, P4159, DOI 10.1091/mbc.11.12.4159; Janevski J, 1997, J HISTOCHEM CYTOCHEM, V45, P1523, DOI 10.1177/002215549704501109; Jungnickel J, 2004, MOL CELL NEUROSCI, V25, P444, DOI 10.1016/j.mcn.2003.11.007; Jungnickel J, 2010, EXP NEUROL, V223, P166, DOI 10.1016/j.expneurol.2009.06.003; Kim EL, 1996, J NEUROCHEM, V67, P26; Lam YW, 2002, MOL BIOL CELL, V13, P2461, DOI 10.1091/mbc.02-03-0034; Lee JH, 2004, J NEUROCHEM, V91, P634, DOI 10.1111/j.1471-4159.2004.02770.x; Lee YW, 2012, J CELL BIOCHEM, V113, P2920, DOI 10.1002/jcb.24170; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Mahmoudi S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000521; Maira M, 1999, MOL CELL BIOL, V19, P7549; Matera AG, 2009, DEV CELL, V17, P639, DOI 10.1016/j.devcel.2009.10.017; Meisinger C, 1997, J NEUROCHEM, V68, P1150; Morency E, 2007, J CELL BIOL, V177, P757, DOI 10.1083/jcb.200612107; Muller-Ostermeyer F, 2001, GROWTH FACTORS, V19, P175; Navascues J, 2004, CHROMOSOMA, V112, P398, DOI 10.1007/s00412-004-0285-5; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nolle A, 2011, HUM MOL GENET, V20, P4865, DOI 10.1093/hmg/ddr425; Pena E, 2001, J COMP NEUROL, V430, P250, DOI 10.1002/1096-9861(20010205)430:2<250::AID-CNE1029>3.0.CO;2-L; Peng H, 2002, J NEUROCHEM, V81, P506, DOI 10.1046/j.1471-4159.2002.00833.x; Ramon y Cajal S., 1903, TRAD LAB INVEST BIOL, V2, P129; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Rohwedel J, 1999, CELLS TISSUES ORGANS, V165, P190, DOI 10.1159/000016699; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Santama N, 1996, EUR J NEUROSCI, V8, P892, DOI 10.1111/j.1460-9568.1996.tb01576.x; Shpargel KB, 2003, J CELL SCI, V116, P303, DOI 10.1242/jcs.00211; Sleeman JE, 2001, J CELL SCI, V114, P4407; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; Stachowiak MK, 2007, DNA CELL BIOL, V26, P811, DOI 10.1089/dna.2007.0664; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Strzelecka M, 2010, NUCLEUS-PHILA, V1, P96, DOI 10.4161/nucl.1.1.10680; Strzelecka M, 2010, NAT STRUCT MOL BIOL, V17, P403, DOI 10.1038/nsmb.1783; Takata H, 2012, J CELL SCI, V125, P166, DOI 10.1242/jcs.090837; Takizawa T, 2008, TRENDS NEUROSCI, V31, P343, DOI 10.1016/j.tins.2008.03.005; Tapia O, 2010, CHROMOSOMA, V119, P527, DOI 10.1007/s00412-010-0276-7; Toyota CG, 2010, CHROMOSOMA, V119, P205, DOI 10.1007/s00412-009-0249-x; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; van Bergeijk J, 2006, CHEM BIOL DRUG DES, V67, P244, DOI 10.1111/j.1747-0285.2006.00369.x; van Bergeijk J, 2007, FASEB J, V21, P1492, DOI 10.1096/fj.06-7136com; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Velma V, 2010, FEBS LETT, V584, P4735, DOI 10.1016/j.febslet.2010.11.004; Yoon JH, 2010, NAT STRUCT MOL BIOL, V17, P391, DOI 10.1038/nsmb0410-391; Young PJ, 2001, EXP CELL RES, V265, P252, DOI 10.1006/excr.2001.5186; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	67	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82871	10.1371/journal.pone.0082871	http://dx.doi.org/10.1371/journal.pone.0082871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358231	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700035
J	Rojas, M; Zhang, WB; Xu, ZM; Lemtalsi, T; Chandler, P; Toque, HA; Caldwell, RW; Caldwell, RB				Rojas, Modesto; Zhang, Wenbo; Xu, Zhimin; Lemtalsi, Tahira; Chandler, Phillip; Toque, Haroldo A.; Caldwell, Robert W.; Caldwell, Ruth B.			Requirement of NOX2 Expression in Both Retina and Bone Marrow for Diabetes-Induced Retinal Vascular Injury	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE; NADPH OXIDASE; TYROSINE NITRATION; OXIDATIVE STRESS; RETINOPATHY; PEROXYNITRITE; INCREASES; CELLS; DYSFUNCTION	Objective: Diabetic retinopathy, a major cause of blindness, is characterized by increased expression of vascular endothelial growth factor (VEGF), leukocyte attachment to the vessel walls and increased vascular permeability. Previous work has shown that reactive oxygen species (ROS) produced by the superoxide generating enzyme NOX2/NADPH oxidase play a crucial role in the vascular pathology. The aim of this work was to identify the cellular sources of the damaging NOX2 activity by studies using bone marrow chimera mice. Methods: Bone marrow cells were collected from the femurs and tibias of wild type and NOX2 deficient (NOX2(-/-)) donor mice and injected intravenously into lethally irradiated NOX2(-/-) and wild type recipients. Following recovery from radiation, mice were rendered diabetic by streptozotocin injections. The following groups of bone marrow chimeras were studied: non-diabetic WT -> WT, diabetic WT -> WT, diabetic WT -> NOX2(-/-), diabetic NOX2(-/-)-> WT. After 4 weeks of diabetes, early signs of retinopathy were examined by measuring ROS, expression of VEGF and ICAM-1, leukocyte attachment to the vessel wall and vascular permeability. Results: The retinas of the diabetic WT -> WT chimeras showed significant increases in ROS as compared with the non-diabetic chimeras. These diabetes-induced alterations were correlated with increases in expression of VEGF and ICAM-1, leukocyte adhesion and vascular permeability. Each of these diabetes-induced alterations were significantly attenuated in the diabetic WT -> NOX2(-/-) and NOX2(-/-)-> WT chimera groups (p<0.05). Conclusion: NOX2-generated ROS produced by both bone marrow-derived cells and resident retinal cells contribute importantly to retinal vascular injury in the diabetic retina. Targeting NOX2 in bone marrow and/or retinal cells may represent a novel therapeutic strategy for the treatment/prevention of vascular injury in the diabetic retina.	[Rojas, Modesto; Zhang, Wenbo; Xu, Zhimin; Lemtalsi, Tahira; Caldwell, Ruth B.] VA Med Ctr, Augusta, GA USA; [Rojas, Modesto; Zhang, Wenbo; Xu, Zhimin; Lemtalsi, Tahira; Caldwell, Ruth B.] Georgia Regents Univ, Vasc Biol Ctr, Augusta, GA USA; [Chandler, Phillip] Georgia Reagents Univ, Immunotherapy Ctr, Augusta, GA USA; [Toque, Haroldo A.; Caldwell, Robert W.] Georgia Reagents Univ, Dept Pharmacol & Toxicol, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Caldwell, RB (corresponding author), VA Med Ctr, Augusta, GA USA.	rcaldwel@gru.edu		Rojas, Modesto/0000-0002-9441-3302; Caldwell, Ruth/0000-0003-0168-0354	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, National Institute of Health (NIH) [R01-EY11766, R01-EY04618, R01-HL70215]; American Heart Association [11SDG4960005]; Culver Vision Discovery Institute at Georgia Regents University; NIH [EY022694]; International Retinal Research Foundation; Juvenile Diabetes Research Foundation JDRF [10-2009-575]; NATIONAL EYE INSTITUTE [R01EY004618, R01EY022694, R01EY011766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070215] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, National Institute of Health (NIH)(US Department of Veterans Affairs); American Heart Association(American Heart Association); Culver Vision Discovery Institute at Georgia Regents University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Retinal Research Foundation; Juvenile Diabetes Research Foundation JDRF(Juvenile Diabetes Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This material is based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, National Institute of Health (NIH grants R01-EY11766, R01-EY04618, R01-HL70215), American Heart Association and the Culver Vision Discovery Institute at Georgia Regents University. Wenbo Zhang is supported by the American Heart Association 11SDG4960005, NIH grant EY022694, the International Retinal Research Foundation, and Juvenile Diabetes Research Foundation JDRF 10-2009-575. The contents do not represent the views of the Department of Veterans Affairs or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko T, 2003, DIABETES, V52, P829, DOI 10.2337/diabetes.52.3.829; Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3239, DOI 10.1167/iovs.08-1755; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3231, DOI 10.1167/iovs.08-1754; Alexandraki K, 2006, ANN NY ACAD SCI, V1084, P89, DOI 10.1196/annals.1372.039; Antonetti DA, 1998, DIABETES, V47, P1953, DOI 10.2337/diabetes.47.12.1953; Babior BM, 2002, ISRAEL MED ASSOC J, V4, P1023; Banumathi E, 2010, EXP EYE RES, V90, P89, DOI 10.1016/j.exer.2009.09.014; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; DARLEYUSMAR V, 1995, FEBS LETT, V369, P131, DOI 10.1016/0014-5793(95)00764-Z; El-Remessy AB, 2003, INVEST OPHTH VIS SCI, V44, P3135, DOI 10.1167/iovs.02-1022; El-Remessy AB, 2003, AM J PATHOL, V162, P1995, DOI 10.1016/S0002-9440(10)64332-5; Ellis EA, 1998, FREE RADICAL BIO MED, V24, P111, DOI 10.1016/S0891-5849(97)00202-5; Ellis EA, 2002, NITRIC OXIDE-BIOL CH, V6, P295, DOI 10.1006/niox.2001.0419; Flaquer M, 2009, TRANSPL P, V41, P2282, DOI 10.1016/j.transproceed.2009.06.034; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Hazra S, 2013, DIABETOLOGIA, V56, P644, DOI 10.1007/s00125-012-2781-0; Huang XQ, 2011, DIABETES RES CLIN PR, V91, P371, DOI 10.1016/j.diabres.2010.12.026; Jarajapu YPR, 2011, INVEST OPHTH VIS SCI, V52, P5093, DOI 10.1167/iovs.10-70911; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Klein R, 1998, OPHTHALMOLOGY, V105, P1801, DOI 10.1016/S0161-6420(98)91020-X; Li GY, 2012, DIABETES, V61, P3294, DOI 10.2337/db11-1249; Miyamoto K, 2000, AM J PATHOL, V156, P1733, DOI 10.1016/S0002-9440(10)65044-4; Nicoletti VG, 2003, EXP CLIN ENDOCR DIAB, V111, P209, DOI 10.1055/s-2003-40465; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Platt DH, 2005, FREE RADICAL BIO MED, V39, P1353, DOI 10.1016/j.freeradbiomed.2005.06.015; Qaum T, 2001, INVEST OPHTH VIS SCI, V42, P2408; Rojas M, 2010, INVEST OPHTH VIS SCI, V51, P1709, DOI 10.1167/iovs.09-3375; Romero MJ, 2012, AM J PHYSIOL-HEART C, V302, pH159, DOI 10.1152/ajpheart.00774.2011; Santos JM, 2011, CURR PHARM BIOTECHNO, V12, P352; Schafer A, 2004, ARTERIOSCL THROM VAS, V24, P1720, DOI 10.1161/01.ATV.0000138072.76902.dd; Sivaprasad S, 2012, SURV OPHTHALMOL, V57, P347, DOI 10.1016/j.survophthal.2012.01.004; Vinores SA, 1999, DOC OPHTHALMOL, V97, P217, DOI 10.1023/A:1002136712070; WARD JM, 2010, VET PATHOL; Wuensch T, 2010, DIABETES, V59, P844, DOI 10.2337/db09-1100; Zhang CX, 2004, DIABETES, V53, P2950, DOI 10.2337/diabetes.53.11.2950; Zhang WB, 2009, AM J PATHOL, V175, P891, DOI 10.2353/ajpath.2009.081115; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111; Zheng L, 2009, FRONT BIOSCI-LANDMRK, V14, P3974, DOI [10.2735/3505, 10.2741/3505]	41	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84357	10.1371/journal.pone.0084357	http://dx.doi.org/10.1371/journal.pone.0084357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358357	gold, Green Submitted, Green Published			2022-12-27	WOS:000328737700093
J	Chen, Z; Tao, ZZ; Chen, SM; Chen, C; Li, F; Xiao, BK				Chen, Zhe; Tao, Ze-Zhang; Chen, Shi-Ming; Chen, Chen; Li, Fen; Xiao, Bo-kui			Indole-3-Carbinol Inhibits Nasopharyngeal Carcinoma Growth through Cell Cycle Arrest In Vivo and In Vitro	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; ACID CONDENSATION PRODUCTS; FACTOR-KAPPA-B; INDUCE APOPTOSIS; DOWN-REGULATION; EXPRESSION; PATHWAY; 3,3'-DIINDOLYLMETHANE; PHARMACOKINETICS; PROLIFERATION	Nasopharyngeal carcinoma is a common malignant tumor in the head and neck. Because of frequent recurrence and distant metastasis which are the main causes of death, better treatment is needed. Indole-3-carbinol (I3C), a natural phytochemical found in the vegetables of the cruciferous family, shows anticancer effect through various signal pathways. I3C induces G1 arrest in NPC cell line with downregulation of cell cycle-related proteins, such as CDK4, CDK6, cyclin D1 and pRb. In vivo, nude mice receiving I3C protectively or therapeutically exhibited smaller tumors than control group after they were inoculated with nasopharyngeal carcinoma cells. The expression of CDK4, CDK6, cyclin D1 and pRb in preventive treatment group and drug treatment group both decreased compared with the control group. We conclude that I3C can inhibit the growth of NPC in vitro and in vivo by suppressing the expression of CDK and cyclin families. The drug was safe and had no toxic effects on normal tissues and organs.	[Chen, Zhe; Tao, Ze-Zhang; Chen, Shi-Ming; Chen, Chen; Li, Fen; Xiao, Bo-kui] Wuhan Univ, Renmin Hosp, Dept Otolaryngol Head & Neck Surg, Wuhan 430072, Peoples R China	Wuhan University	Tao, ZZ (corresponding author), Wuhan Univ, Renmin Hosp, Dept Otolaryngol Head & Neck Surg, Wuhan 430072, Peoples R China.	taozezhang@hotmail.com		Chen, Shi-Ming/0000-0002-1216-004X	Fundamental Research Funds for the Central Universities [201130202020009]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study supported by the Fundamental Research Funds for the Central Universities 201130202020009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2005, CELL CYCLE, V4, P1201, DOI 10.4161/cc.4.9.1993; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Anderton MJ, 2004, CLIN CANCER RES, V10, P5233, DOI 10.1158/1078-0432.CCR-04-0163; Anderton MJ, 2003, J CHROMATOGR B, V787, P281, DOI 10.1016/S1570-0232(02)00923-6; Chan ATC, 2010, ANN ONCOL, V21, P308, DOI 10.1093/annonc/mdq277; Chen DZ, 2001, J NUTR, V131, P3294, DOI 10.1093/jn/131.12.3294; Chinni SR, 2001, ONCOGENE, V20, P2927, DOI 10.1038/sj.onc.1204365; Choi HS, 2010, FOOD CHEM TOXICOL, V48, P883, DOI 10.1016/j.fct.2009.12.028; GROSE KR, 1992, CHEM RES TOXICOL, V5, P188, DOI 10.1021/tx00026a007; Han JB, 2011, CANCER LETT, V309, P162, DOI 10.1016/j.canlet.2011.05.028; HIRAMA T, 1995, BLOOD, V86, P841; Hsu JC, 2006, BIOCHEM PHARMACOL, V72, P1714, DOI 10.1016/j.bcp.2006.08.012; Kim DS, 2006, CELL MOL LIFE SCI, V63, P2661, DOI 10.1007/s00018-006-6306-1; Lee AWM, 2005, INT J RADIAT ONCOL, V61, P1107, DOI 10.1016/j.ijrobp.2004.07.702; Liu DB, 2012, ACTA PHARMACOL SIN, V33, P682, DOI 10.1038/aps.2012.18; Ma BBY, 2005, CANCER-AM CANCER SOC, V103, P22, DOI 10.1002/cncr.20768; Marconett CN, 2011, CARCINOGENESIS, V32, P1315, DOI 10.1093/carcin/bgr116; Moiseeva EP, 2006, APOPTOSIS, V11, P799, DOI 10.1007/s10495-006-5877-5; Nachshon-Kedmi M, 2003, FOOD CHEM TOXICOL, V41, P745, DOI 10.1016/S0278-6915(03)00004-8; Ong CS, 2010, CANCER LETT, V298, P167, DOI 10.1016/j.canlet.2010.07.001; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Paggi MG, 1996, J CELL BIOCHEM, V62, P418; Ping J, 2011, J PHARMACOL EXP THER, V339, P694, DOI 10.1124/jpet.111.179820; Ping J, 2011, EUR J PHARMACOL, V650, P656, DOI 10.1016/j.ejphar.2010.10.057; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reed GA, 2005, CANCER EPIDEM BIOMAR, V14, P1953, DOI 10.1158/1055-9965.EPI-05-0121; Reed GA, 2006, CANCER EPIDEM BIOMAR, V15, P2477, DOI 10.1158/1055-9965.EPI-06-0396; SHAM JST, 1990, BRIT J RADIOL, V63, P108, DOI 10.1259/0007-1285-63-746-108; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Takada Y, 2005, BLOOD, V106, P641, DOI 10.1182/blood-2004-12-4589; Teo PML, 1996, CANCER-AM CANCER SOC, V77, P2423, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2423::AID-CNCR2>3.0.CO;2-N; Wang Y, 2008, CANCER BIOL THER, V7, P896, DOI 10.4161/cbt.7.6.5910; Weng JR, 2007, CANCER RES, V67, P7815, DOI 10.1158/0008-5472.CAN-07-0794; Wu AB, 2013, CANCER LETT, V330, P181, DOI 10.1016/j.canlet.2012.11.046; Wu HT, 2005, J AGR FOOD CHEM, V53, P5164, DOI 10.1021/jf050034w; Xie Y, 2013, ORAL ONCOL; Xu Y, 2011, MED ONCOL, V28, P1343, DOI 10.1007/s12032-010-9619-8; Yang YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062869; Ye M, 2007, CANCER LETT, V258, P199, DOI 10.1016/j.canlet.2007.09.001; Zhang J, 2003, CANCER-AM CANCER SOC, V98, P2511, DOI 10.1002/cncr.11844; Zhang WL, 2009, ACTA BIOCH BIOPH SIN, V41, P414, DOI 10.1093/abbs/gmp025; Zhao P, 2013, CHEM-BIOL INTERACT, V205, P81, DOI 10.1016/j.cbi.2013.06.014; Zhu W, 2010, INT J TOXICOL, V29, P185, DOI 10.1177/1091581809356481; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	45	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82288	10.1371/journal.pone.0082288	http://dx.doi.org/10.1371/journal.pone.0082288			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358165	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700054
J	Gorini, G; Nunez, YO; Mayfield, RD				Gorini, Giorgio; Nunez, Yury O.; Mayfield, R. Dayne			Integration of miRNA and Protein Profiling Reveals Coordinated Neuroadaptations in the Alcohol-Dependent Mouse Brain	PLOS ONE			English	Article							INTERMITTENT ETHANOL EXPOSURE; GENE-EXPRESSION; MESSENGER-RNA; FRONTAL-CORTEX; MICRORNAS; PROTEOMICS; NETWORK; IDENTIFICATION; DYSREGULATION; INTERACTOME	The molecular mechanisms underlying alcohol dependence involve different neurochemical systems and are brain region-dependent. Chronic Intermittent Ethanol (CIE) procedure, combined with a Two-Bottle Choice voluntary drinking paradigm, represents one of the best available animal models for alcohol dependence and relapse drinking. MicroRNAs, master regulators of the cellular transcriptome and proteome, can regulate their targets in a cooperative, combinatorial fashion, ensuring fine tuning and control over a large number of cellular functions. We analyzed cortex and midbrain microRNA expression levels using an integrative approach to combine and relate data to previous protein profiling from the same CIE-subjected samples, and examined the significance of the data in terms of relative contribution to alcohol consumption and dependence. MicroRNA levels were significantly altered in CIE-exposed dependent mice compared with their non-dependent controls. More importantly, our integrative analysis identified modules of coexpressed microRNAs that were highly correlated with CIE effects and predicted target genes encoding differentially expressed proteins. Coexpressed CIE-relevant proteins, in turn, were often negatively correlated with specific microRNA modules. Our results provide evidence that microRNA-orchestrated translational imbalances are driving the behavioral transition from alcohol consumption to dependence. This study represents the first attempt to combine ex vivo microRNA and protein expression on a global scale from the same mammalian brain samples. The integrative systems approach used here will improve our understanding of brain adaptive changes in response to drug abuse and suggests the potential therapeutic use of microRNAs as tools to prevent or compensate multiple neuroadaptations underlying addictive behavior.	[Gorini, Giorgio; Nunez, Yury O.; Mayfield, R. Dayne] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Gorini, G (corresponding author), Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA.	gorini@utexas.edu	Lopez, Yury O. Nunez/B-9382-2019; Gorini, Giorgio/D-7053-2014	Lopez, Yury O. Nunez/0000-0003-0382-9124; Gorini, Giorgio/0000-0002-0893-5922	NIAAA [AA016648, AA0107838, AA019382, AA020683]; Integrative Neuroscience Initiative on Alcoholism (INIA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016648, R01AA012404, RC2AA019382, U01AA020926, P01AA020683] Funding Source: NIH RePORTER	NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Integrative Neuroscience Initiative on Alcoholism (INIA)(Instituto de Investigacion Agropecuaria (INIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIAAA grants AA016648, AA0107838, AA019382, AA020683, and Integrative Neuroscience Initiative on Alcoholism (INIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinoff B, 2004, HARVARD REV PSYCHIAT, V12, P305, DOI 10.1080/10673220490910844; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Ballard IC, 2011, J NEUROSCI, V31, P10340, DOI 10.1523/JNEUROSCI.0895-11.2011; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhardwaj N, 2005, BIOINFORMATICS, V21, P2730, DOI 10.1093/bioinformatics/bti398; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Ceman S, 2011, PHARMACOL THERAPEUT, V130, P26, DOI 10.1016/j.pharmthera.2011.01.004; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Chin CS, 2003, BIOINFORMATICS, V19, P2413, DOI 10.1093/bioinformatics/btg339; Clarke C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-656; D'haene Barbara, 2012, Methods Mol Biol, V822, P261, DOI 10.1007/978-1-61779-427-8_18; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Dood PR, 1998, ANN NY ACAD SCI, V844, P50, DOI 10.1111/j.1749-6632.1998.tb08221.x; Elkan-Miller T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018195; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Finn DA, 2007, ALCOHOL CLIN EXP RES, V31, P939, DOI 10.1111/j.1530-0277.2007.00379.x; Flatscher-Bader T, 2005, J NEUROCHEM, V93, P359, DOI 10.1111/j.1471-4159.2004.03021.x; Fodor IK, 2005, BIOINFORMATICS, V21, P3733, DOI 10.1093/bioinformatics/bti612; Gorini G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082656; Gorini G, 2011, PROG MOL BIOL TRANSL, V98, P293, DOI 10.1016/B978-0-12-385506-0.00007-7; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Griffin WC, 2009, ALCOHOL CLIN EXP RES, V33, P1893, DOI 10.1111/j.1530-0277.2009.01027.x; Grosshans H, 2008, CELL, V134, P560, DOI 10.1016/j.cell.2008.08.008; Guo YQ, 2012, ALCOHOL CLIN EXP RES, V36, P1058, DOI 10.1111/j.1530-0277.2011.01689.x; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Hsu CW, 2008, PROTEOMICS, V8, P1975, DOI 10.1002/pmic.200701004; Huang TC, 2013, PROTEOMICS, V13, P558, DOI 10.1002/pmic.201200339; Huang WH, 2009, INT J NEUROPSYCHOPH, V12, P537, DOI 10.1017/S1461145708009528; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Koob GF, 2004, NEUROSCI BIOBEHAV R, V27, P739, DOI 10.1016/j.neubiorev.2003.11.007; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Kril JJ, 1997, NEUROSCIENCE, V79, P983, DOI 10.1016/S0306-4522(97)00083-3; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Lewohl JM, 2000, ALCOHOL CLIN EXP RES, V24, P1873, DOI 10.1111/j.1530-0277.2000.tb01993.x; Lewohl JM, 2011, ALCOHOL CLIN EXP RES, V35, P1928, DOI 10.1111/j.1530-0277.2011.01544.x; Li CY, 2012, EXPERT REV PROTEOMIC, V9, P549, DOI [10.1586/EPR.12.49, 10.1586/epr.12.49]; Liang H, 2007, RNA, V13, P1402, DOI 10.1261/rna.634607; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Liu JW, 2006, NEUROPSYCHOPHARMACOL, V31, P1574, DOI 10.1038/sj.npp.1300947; Liu JW, 2004, J NEUROCHEM, V90, P1050, DOI 10.1111/j.1471-4159.2004.02570.x; Lopez MF, 2005, PSYCHOPHARMACOLOGY, V181, P688, DOI 10.1007/s00213-005-0026-3; Lu LJ, 2005, GENOME RES, V15, P945, DOI 10.1101/gr.3610305; Matsumoto I, 2009, ALCOHOL ALCOHOLISM, V44, P171, DOI 10.1093/alcalc/agn104; Mayfield RD, 2008, BRIT J PHARMACOL, V154, P275, DOI 10.1038/bjp.2008.88; Mayfield RD, 2002, J NEUROCHEM, V81, P802, DOI 10.1046/j.1471-4159.2002.00860.x; Miranda RC, 2010, ALCOHOL CLIN EXP RES, V34, P575, DOI 10.1111/j.1530-0277.2009.01126.x; Nestler EJ, 2004, NEUROPHARMACOLOGY, V47, P24, DOI 10.1016/j.neuropharm.2004.06.031; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Nunez Yury O., 2012, Frontiers in Genetics, V3, P43, DOI 10.3389/fgene.2012.00043; O'Carroll D, 2013, NEUROPSYCHOPHARMACOL, V38, P39, DOI 10.1038/npp.2012.87; Ponomarev I, 2012, J NEUROSCI, V32, P1884, DOI 10.1523/JNEUROSCI.3136-11.2012; Ramani AK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-R40; Sass S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-136; Schaefer A, 2010, J EXP MED, V207, P1843, DOI 10.1084/jem.20100451; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sullivan EV, 2005, PSYCHOPHARMACOLOGY, V180, P583, DOI 10.1007/s00213-005-2267-6; Sutherland GT, 2014, ALCOHOL CLIN EXP RES, V38, P1, DOI 10.1111/acer.12243; Tapocik JD, 2013, PHARMACOGENOMICS J, V13, P286, DOI 10.1038/tpj.2012.17; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Xu SJ, 2012, INT J MOL SCI, V13, P16945, DOI 10.3390/ijms131216945; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Yuan XY, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-65; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zheng H, 2010, MOL PHARMACOL, V77, P102, DOI 10.1124/mol.109.060848	72	32	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82565	10.1371/journal.pone.0082565	http://dx.doi.org/10.1371/journal.pone.0082565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358208	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700083
J	Kish, LB; Abbott, D; Granqvist, CG				Kish, Laszlo B.; Abbott, Derek; Granqvist, Claes G.			Critical Analysis of the Bennett-Riedel Attack on Secure Cryptographic Key Distributions via the Kirchhoff-Law-Johnson-Noise Scheme	PLOS ONE			English	Article							NETWORKS; DETECTOR	Recently, Bennett and Riedel (BR) (http://arxiv.org/abs/1303.7435v1) argued that thermodynamics is not essential in the Kirchhoff-law-Johnson-noise (KLJN) classical physical cryptographic exchange method in an effort to disprove the security of the KLJN scheme. They attempted to demonstrate this by introducing a dissipation-free deterministic key exchange method with two batteries and two switches. In the present paper, we first show that BR's scheme is unphysical and that some elements of its assumptions violate basic protocols of secure communication. All our analyses are based on a technically unlimited Eve with infinitely accurate and fast measurements limited only by the laws of physics and statistics. For non-ideal situations and at active (invasive) attacks, the uncertainly principle between measurement duration and statistical errors makes it impossible for Eve to extract the key regardless of the accuracy or speed of her measurements. To show that thermodynamics and noise are essential for the security, we crack the BR system with 100% success via passive attacks, in ten different ways, and demonstrate that the same cracking methods do not function for the KLJN scheme that employs Johnson noise to provide security underpinned by the Second Law of Thermodynamics. We also present a critical analysis of some other claims by BR; for example, we prove that their equations for describing zero security do not apply to the KLJN scheme. Finally we give mathematical security proofs for each BR-attack against the KLJN scheme and conclude that the information theoretic (unconditional) security of the KLJN method has not been successfully challenged.	[Kish, Laszlo B.] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA; [Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia; [Granqvist, Claes G.] Uppsala Univ, Dept Engn Sci, Angstrom Lab, Uppsala, Sweden	Texas A&M University System; Texas A&M University College Station; University of Adelaide; Uppsala University	Kish, LB (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA.	Laszlokish@tamu.edu	Abbott, Derek/E-8352-2011	Abbott, Derek/0000-0002-0945-2674				ANTILLI D, 2005, Patent No. 1952573; Arora S, 2009, COMPUTATIONAL COMPLEXITY: A MODERN APPROACH, P1, DOI 10.1017/CBO9780511804090; BENNETT CH, 2013, SECURITY KEY DISTRIB, P13934; Brassard G, 1984, P IEEE INT C COMP SY, V175, P8; Cho A, 2005, SCIENCE, V309, P2148; Gerhardt I, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.170404; Gerhardt I, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1348; GONZALEZ E, 2013, INFORM THEORETICALLY, P13934; Hao F., 2006, IEE P INFORM SECURIT, V153, P141, DOI [10.1049/ip-ifs:20060068, DOI 10.1049/IP-IFS:20060068]; HIROTA O, 2012, ARXIV12082106V2, P13934; Horvath T, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/28002; Jain N, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.110501; Kish LB, 2006, FLUCT NOISE LETT, V6, pC37, DOI 10.1142/S021947750600363X; Kish LB, 2006, PHYS LETT A, V359, P741, DOI 10.1016/j.physleta.2006.07.037; Kish LB, 2008, FLUCT NOISE LETT, V8, pL95, DOI 10.1142/S0219477508004362; Kish LB, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2359293; Kish LB, 2006, FLUCT NOISE LETT, V6, pC9, DOI 10.1142/S021947750600332X; Kish LB, 2012, IEICE T COMMUN, VE95B, P1501, DOI 10.1587/transcom.E95.B.1501; Kish LB, 2010, PHYS LETT A, V374, P2140, DOI 10.1016/j.physleta.2010.03.021; Kish LB, 2009, PHYS LETT A, V373, P2858, DOI 10.1016/j.physleta.2009.05.077; Kish LB, 2013, METROL MEAS SYST, V20, P191, DOI 10.2478/mms-2013-0017; Kish LL, 2010, FLUCT NOISE LETT, V9, P37, DOI 10.1142/S0219477510000058; Kish LB, 2006, PHYS LETT A, V352, P178, DOI 10.1016/j.physleta.2005.11.062; Kish LB, 2006, FLUCT NOISE LETT, V6, pL57, DOI 10.1142/S0219477506003148; KISH LB, 2013, SECURITY KIRCHHOFF L, P13934; KISH LB, 2013, PHYS UNCLONEABLE FUN, P13934; Liang YB, 2008, FOUND TRENDS COMMUN, V5, P355, DOI 10.1561/0100000036; Liu PL, 2009, J LIGHTWAVE TECHNOL, V27, P5230, DOI 10.1109/JLT.2009.2031421; Liu PL, 2009, PHYS LETT A, V373, P3207, DOI 10.1016/j.physleta.2009.07.030; Liu PL, 2009, PHYS LETT A, V373, P901, DOI 10.1016/j.physleta.2009.01.022; Lydersen L, 2011, J MOD OPTIC, V58, P680, DOI 10.1080/09500340.2011.565889; Lydersen L, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3658806; Lydersen L, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/11/113042; Lydersen L, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.032320; Lydersen L, 2010, OPT EXPRESS, V18, P27938, DOI 10.1364/OE.18.027938; Lydersen L, 2010, NAT PHOTONICS, V4, P801, DOI 10.1038/nphoton.2010.278; Lydersen L, 2010, NAT PHOTONICS, V4, P686, DOI 10.1038/NPHOTON.2010.214; Makarov V, 2008, QUANTUM INF COMPUT, V8, P622; Makarov V, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/6/065003; Matthaei G.L., 1964, MICROWAVE FILTERS IM; MERALI Z, 2009, NATURE NEWS, P13934, DOI DOI 10.1038/NEWS.2010.436; Mingesz R, 2008, PHYS LETT A, V372, P978, DOI 10.1016/j.physleta.2007.07.086; Mingesz R, 2013, METROL MEAS SYST, V20, P3, DOI 10.2478/mms-2013-0001; Palmer DJ, 2007, NEW SCI, V194, P32, DOI 10.1016/S0262-4079(07)61314-1; PAULI W, 2000, ELECTRODYNAMICS, P13934; RENNER R, 2012, ARXIV12092423V1, P13934; SAEZ Y, 2013, CURRENT VOLTAGE BASE, P13934; Salih H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.170502; Sauge S, 2011, OPT EXPRESS, V19, P23590, DOI 10.1364/OE.19.023590; Scheuer J, 2006, PHYS LETT A, V359, P737, DOI 10.1016/j.physleta.2006.07.013; Wiechers C, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/013043; Yuen HP, 2009, IEEE J SEL TOP QUANT, V15, P1630, DOI 10.1109/JSTQE.2009.2025698; YUEN HP, 2012, ARXIV11092675V3, P13934; YUEN HP, 2012, ARXIV12102804, P13934	54	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81810	10.1371/journal.pone.0081810	http://dx.doi.org/10.1371/journal.pone.0081810			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358129	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700025
J	Valentova, JV; Havlicek, J				Valentova, Jaroslava Varella; Havlicek, Jan			Perceived Sexual Orientation Based on Vocal and Facial Stimuli Is Linked to Self-Rated Sexual Orientation in Czech Men	PLOS ONE			English	Article							GAY; ACCURACY; MASCULINITY; CATEGORIZATION; FEMININITY; PERCEPTION; JUDGMENTS; GENDER	Previous research has shown that lay people can accurately assess male sexual orientation based on limited information, such as face, voice, or behavioral display. Gender-atypical traits are thought to serve as cues to sexual orientation. We investigated the presumed mechanisms of sexual orientation attribution using a standardized set of facial and vocal stimuli of Czech men. Both types of stimuli were rated for sexual orientation and masculinity-femininity by non-student heterosexual women and homosexual men. Our data showed that by evaluating vocal stimuli both women and homosexual men can judge sexual orientation of the target men in agreement with their self-reported sexual orientation. Nevertheless, only homosexual men accurately attributed sexual orientation of the two groups from facial images. Interestingly, facial images of homosexual targets were rated as more masculine than heterosexual targets. This indicates that attributions of sexual orientation are affected by stereotyped association between femininity and male homosexuality; however, reliance on such cues can lead to frequent misjudgments as was the case with the female raters. Although our study is based on a community sample recruited in a non-English speaking country, the results are generally consistent with the previous research and thus corroborate the validity of sexual orientation attributions.	[Valentova, Jaroslava Varella] Charles Univ Prague, Ctr Theoret Study, Prague, Czech Republic; [Valentova, Jaroslava Varella] Acad Sci Czech Republ, Prague, Czech Republic; [Havlicek, Jan] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic	Charles University Prague; Czech Academy of Sciences; Charles University Prague	Valentova, JV (corresponding author), Charles Univ Prague, Ctr Theoret Study, Prague, Czech Republic.	valentova@cts.cuni.cz	Havlíček, Jan/F-8985-2011; Valentova, Jaroslava Varella/K-8765-2012	Havlíček, Jan/0000-0003-2374-7337; Valentova, Jaroslava Varella/0000-0002-2113-3385	Czech Science Foundation [13-16959P, P407/10/1303]; Charles University Research Center [UNCE 204004]	Czech Science Foundation(Grant Agency of the Czech Republic); Charles University Research Center	JV was supported by the Czech Science Foundation grant (13-16959P), JH was supported by the Czech Science Foundation grant (P407/10/1303) and both JV and JH were supported by Charles University Research Center (UNCE 204004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambady N, 1999, J PERS SOC PSYCHOL, V77, P538, DOI 10.1037/0022-3514.77.3.538; Avery JD, 1996, J ACOUST SOC AM, V99, P3738, DOI 10.1121/1.414970; BAILEY JM, 1995, DEV PSYCHOL, V31, P43, DOI 10.1037/0012-1649.31.1.43; Brambilla M, 2013, PERS INDIV DIFFER, V55, P193, DOI 10.1016/j.paid.2013.02.023; Cartei V, 2012, J NONVERBAL BEHAV, V36, P79, DOI 10.1007/s10919-011-0123-4; DUNKLE JH, 1990, SEX ROLES, V23, P157, DOI 10.1007/BF00289863; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Freeman JB, 2010, PERS SOC PSYCHOL B, V36, P1318, DOI 10.1177/0146167210378755; GAUDIO RP, 1994, AM SPEECH, V69, P30, DOI 10.2307/455948; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; JACOBS G, 2006, TORONTO WORKING PAPE, V18, P46; Johnson KL, 2007, J PERS SOC PSYCHOL, V93, P321, DOI 10.1037/0022-3514.93.3.321; Johnson KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018025; Kulick D, 2000, ANNU REV ANTHROPOL, V29, P243, DOI 10.1146/annurev.anthro.29.1.243; Linville SE, 1998, FOLIA PHONIATR LOGO, V50, P35, DOI 10.1159/000021447; Moskowitz DA, 2013, ARCH SEX BEHAV, V42, P775, DOI 10.1007/s10508-013-0095-z; Munson B, 2007, LANG SPEECH, V50, P125, DOI 10.1177/00238309070500010601; Munson B, 2006, J PHONETICS, V34, P202, DOI 10.1016/j.wocn.2005.05.003; Novakova L, PLOS ONE IN PRESS; Pierrehumbert JB, 2004, J ACOUST SOC AM, V116, P1905, DOI 10.1121/1.1788729; Rahman Q, 2003, PERS INDIV DIFFER, V34, P1337, DOI 10.1016/S0191-8869(02)00140-X; Rendall D, 2008, ARCH SEX BEHAV, V37, P188, DOI 10.1007/s10508-007-9269-x; Rieger G, 2008, DEV PSYCHOL, V44, P46, DOI 10.1037/0012-1649.44.1.46; Rieger G, 2010, ARCH SEX BEHAV, V39, P124, DOI 10.1007/s10508-008-9405-2; Rule NO, 2008, J PERS SOC PSYCHOL, V95, P1019, DOI 10.1037/a0013194; Rule NO, 2008, J EXP SOC PSYCHOL, V44, P1100, DOI 10.1016/j.jesp.2007.12.001; Rule NO, 2011, PERS SOC PSYCHOL B, V37, P1499, DOI 10.1177/0146167211415630; Sandfort TGM, 2005, ARCH SEX BEHAV, V34, P595, DOI 10.1007/s10508-005-7907-8; Shelp SG, 2002, J HOMOSEXUAL, V44, P1, DOI 10.1300/J082v44n01_01; Tabak JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036671; Tskhay KO, 2013, PERS SOC PSYCHOL REV, V17, P72, DOI 10.1177/1088868312461308; Valentova J, 2013, PERCEPTION, V42, P187, DOI 10.1068/p6909; Valentova J, 2011, ARCH SEX BEHAV, V40, P1145, DOI 10.1007/s10508-011-9818-1; Valentova JV, 2014, ARCH SEX BEHAV, V43, P353, DOI 10.1007/s10508-013-0194-x; Valentova JV, J APPL SOC PSYCH; van Borsel J, 2009, J COMMUN DISORD, V42, P100, DOI 10.1016/j.jcomdis.2008.08.004	36	29	31	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82417	10.1371/journal.pone.0082417	http://dx.doi.org/10.1371/journal.pone.0082417			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GD	24358180	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700064
J	Yasuda, K; Ohyama, K; Onga, K; Kakizuka, A; Mori, N				Yasuda, Kunihiko; Ohyama, Kyoji; Onga, Kazuko; Kakizuka, Akira; Mori, Nozomu			Mdm20 Stimulates PolyQ Aggregation via Inhibiting Autophagy Through Akt-Ser473 Phosphorylation	PLOS ONE			English	Article							N-TERMINAL ACETYLTRANSFERASES; PROTEIN-KINASE-B; MOLECULAR CHAPERONES; YEAST; ACETYLATION; COMPLEX; HDAC6; IDENTIFICATION; HIF-1-ALPHA; ACTIVATION	Mdm20 is an auxiliary subunit of the NatB complex, which includes Nat5, the catalytic subunit for protein N-terminal acetylation. The NatB complex catalyzes N-acetylation during de novo protein synthesis initiation; however, recent evidence from yeast suggests that NatB also affects post-translational modification of tropomyosin, which is involved in intracellular sorting of aggregated proteins. We hypothesized that an acetylation complex such as NatB may contribute to protein clearance and/or proteostasis in mammalian cells. Using a poly glutamine (polyQ) aggregation system, we examined whether the NatB complex or its components affect protein aggregation in rat primary cultured hippocampal neurons and HEK293 cells. The number of polyQ aggregates increased in Mdm20 over-expressing (OE) cells, but not in Nat5-OE cells. Conversely, in Mdm20 knockdown (KD) cells, but not in Nat5-KD cells, polyQ aggregation was significantly reduced. Although Mdm20 directly associates with Nat5, the overall cellular localization of the two proteins was slightly distinct, and Mdm20 apparently co-localized with the polyQ aggregates. Furthermore, in Mdm20-KD cells, a punctate appearance of LC3 was evident, suggesting the induction of autophagy. Consistent with this notion, phosphorylation of Akt, most notably at Ser473, was greatly reduced in Mdm20-KD cells. These results demonstrate that Mdm20, the so-called auxiliary subunit of the translation-coupled protein N-acetylation complex, contributes to protein clearance and/or aggregate formation by affecting the phosphorylation level of Akt indepenently from the function of Nat5.	[Yasuda, Kunihiko; Ohyama, Kyoji; Onga, Kazuko; Mori, Nozomu] Nagasaki Univ, Sch Med, Dept Anat & Neurobiol, Nagasaki 852, Japan; [Kakizuka, Akira] Kyoto Univ, Grad Sch Biostudies, Lab Funct Biol, Kyoto, Japan	Nagasaki University; Kyoto University	Mori, N (corresponding author), Nagasaki Univ, Sch Med, Dept Anat & Neurobiol, Nagasaki 852, Japan.	morinosm@nagasaki-u.ac.jp			MEXT Japan (Kiban B); Smoking Research Foundation; Asian CORE program of JSPS	MEXT Japan (Kiban B)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation; Asian CORE program of JSPS	This work was supported by Grants-in-Aid for Scientific Research from MEXT Japan (Kiban B) and also, in part, by a fund from Smoking Research Foundation (http://www.srf.or.jp/) and the Asian CORE program of JSPS (to N.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Arnesen T, 2005, FEBS LETT, V579, P6428, DOI 10.1016/j.febslet.2005.10.036; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Asaumi M, 2005, J BIOCHEM, V137, P147, DOI 10.1093/jb/mvi014; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Bobrowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034805; Bobrowska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020696; Caesar R, 2004, J BIOL CHEM, V279, P38532, DOI 10.1074/jbc.M402939200; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Fisher TS, 2005, J BIOL CHEM, V280, P17749, DOI 10.1074/jbc.M412055200; Gan L, 2008, NEURON, V58, P10, DOI 10.1016/j.neuron.2008.03.015; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Harting K, 2010, EUR J CELL BIOL, V89, P262, DOI 10.1016/j.ejcb.2009.11.006; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Helbig AO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-685; Hermann GJ, 1997, J CELL BIOL, V137, P141, DOI 10.1083/jcb.137.1.141; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Hole K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024713; Hook SS, 2002, P NATL ACAD SCI USA, V99, P13425, DOI 10.1073/pnas.172511699; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kikis EA, 2010, ADV EXP MED BIOL, V694, P138; Kimura Y, 2003, ARCH BIOCHEM BIOPHYS, V409, P341, DOI 10.1016/S0003-9861(02)00639-2; Kimura Y, 2000, J BIOL CHEM, V275, P4635, DOI 10.1074/jbc.275.7.4635; Koike M, 2010, J BIOL CHEM, V285, P21736, DOI 10.1074/jbc.M109.099283; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kuo HP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000590; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Liao Y, 2010, AM J TRANSL RES, V2, P19; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Matsuzaki H, 2004, BIOCHEMISTRY-US, V43, P4284, DOI 10.1021/bi0498712; Mischerikow N, 2011, PROTEOMICS, V11, P571, DOI 10.1002/pmic.201000397; Morii H, 2006, J NEUROBIOL, V66, P1101, DOI 10.1002/neu.20295; Murray-Rust TA, 2006, FEBS LETT, V580, P1911, DOI 10.1016/j.febslet.2006.02.012; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Ohyama K, 2012, GENE EXPR PATTERNS, V12, P36, DOI 10.1016/j.gep.2011.11.001; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Polevoda B, 2003, BIOCHEM BIOPH RES CO, V308, P1, DOI 10.1016/S0006-291X(03)01316-0; Polevoda B, 1999, EMBO J, V18, P6155, DOI 10.1093/emboj/18.21.6155; Polevoda B, 2008, J CELL BIOCHEM, V103, P492, DOI 10.1002/jcb.21418; Polevoda Bogdan, 2009, BMC Proc, V3 Suppl 6, pS2, DOI 10.1186/1753-6561-3-S6-S2; Salminen A, 2010, CELL SIGNAL, V22, P573, DOI 10.1016/j.cellsig.2009.10.006; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Singer JM, 2000, GENETICS, V156, P523; Singer JM, 2003, P NATL ACAD SCI USA, V100, P7644, DOI 10.1073/pnas.1232343100; Starheim KK, 2008, BIOCHEM J, V415, P325, DOI 10.1042/BJ20080658; Tanaka K, 1998, MOL CELLS, V8, P503; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028950	68	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82523	10.1371/journal.pone.0082523	http://dx.doi.org/10.1371/journal.pone.0082523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358196	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700075
J	Frisvad, JC; Yilmaz, N; Thrane, U; Rasmussen, KB; Houbraken, J; Samson, RA				Frisvad, Jens C.; Yilmaz, Neriman; Thrane, Ulf; Rasmussen, Kasper Bowig; Houbraken, Jos; Samson, Robert A.			Talaromyces atroroseus, a New Species Efficiently Producing Industrially Relevant Red Pigments	PLOS ONE			English	Article							PENICILLIUM-PURPUROGENUM; PP-V; SUBMERGED CULTURE; INDOLE ALKALOIDS; B HYDROCHLORIDE; ACYL-COA; COLORANTS; ACID; RUGULOVASINE; ASSIMILATION	Some species of Talaromyces secrete large amounts of red pigments. Literature has linked this character to species such as Talaromyces purpurogenus, T. albobiverticillius, T. marneffei, and T. minioluteus often under earlier Penicillium names. Isolates identified as T. purpurogenus have been reported to be interesting industrially and they can produce extracellular enzymes and red pigments, but they can also produce mycotoxins such as rubratoxin A and B and luteoskyrin. Production of mycotoxins limits the use of isolates of a particular species in biotechnology. Talaromyces atroroseus sp. nov., described in this study, produces the azaphilone biosynthetic families mitorubrins and Monascus pigments without any production of mycotoxins. Within the red pigment producing clade, T. atroroseus resolved in a distinct clade separate from all the other species in multigene phylogenies ( ITS, beta-tubulin and RPB1), which confirm its unique nature. Talaromyces atroroseus resembles T. purpurogenus and T. albobiverticillius in producing red diffusible pigments, but differs from the latter two species by the production of glauconic acid, purpuride and ZG-1494 alpha and by the dull to dark green, thick walled ellipsoidal conidia produced. The type strain of Talaromyces atroroseus is CBS 133442	[Frisvad, Jens C.; Thrane, Ulf; Rasmussen, Kasper Bowig] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Yilmaz, Neriman; Houbraken, Jos; Samson, Robert A.] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands; [Yilmaz, Neriman] Univ Utrecht, Dept Biol, Utrecht, Netherlands	Technical University of Denmark; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); Utrecht University	Frisvad, JC (corresponding author), Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark.	jcf@bio.dtu.dk	Frisvad, Jens C/K-2818-2017; Houbraken, Jos/AAE-7955-2019; Yilmaz, Neriman/AAF-6814-2021; Samson, Robert/ABE-6704-2020; Thrane, Ulf/G-2978-2016	Frisvad, Jens C/0000-0002-0573-4340; Houbraken, Jos/0000-0003-4893-4438; Yilmaz, Neriman/0000-0002-4396-4630; Thrane, Ulf/0000-0002-6040-4141; Samson, Robert A./0000-0002-2979-3097	Danish Research Agency for Technology and Production [09-064967]; Agilent Technologies	Danish Research Agency for Technology and Production; Agilent Technologies	Part of this work was supported by the Danish Research Agency for Technology and Production Grant 09-064967 and an equipment grant from Agilent Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-19; Arai T, 2012, BIOSCI BIOTECH BIOCH, V76, P120, DOI 10.1271/bbb.110589; BALDWIN J E, 1962, Experientia, V18, P345, DOI 10.1007/BF02172243; BARTON DHR, 1965, J CHEM SOC, P1779, DOI 10.1039/jr9650001779; BARTON DHR, 1965, J CHEM SOC, P1772, DOI 10.1039/jr9650001772; BARTON DHR, 1965, J CHEM SOC, P1769, DOI 10.1039/jr9650001769; Bollinger P, 1972, US Pat., Patent No. [3,655,880, 3655880]; BUCHI G, 1965, J AM CHEM SOC, V87, P3484, DOI 10.1021/ja01093a036; de Silva ED, 2011, ORG LETT, V13, P1174, DOI 10.1021/ol200031t; Espinoza-Hernandez T. C., 2013, African Journal of Biotechnology, V12, P3405; Feng YL, 2012, APPL MICROBIOL BIOT, V96, P1421, DOI 10.1007/s00253-012-4504-3; FRISVAD JC, 1990, ANTON LEEUW INT J G, V57, P179, DOI 10.1007/BF00403953; FRISVAD JC, 1987, J CHROMATOGR, V404, P195, DOI 10.1016/S0021-9673(01)86850-3; Fujimoto H., 1988, Proceedings of the Japanese Association of Mycotoxicology, P15; Gao JM, 2013, CHEM REV, V113, P4755, DOI 10.1021/cr300402y; Gunasekaran S, 2008, AFR J BIOTECHNOL, V7, P1894; Herrick HT, 1928, J BIOL CHEM, V77, P185; Houbraken J, 2007, STUD MYCOL, P107, DOI 10.3114/sim.2007.59.12; Houbraken J, 2012, ANTON LEEUW INT J G, V101, P403, DOI 10.1007/s10482-011-9647-1; Houbraken J, 2011, STUD MYCOL, P1, DOI 10.3114/sim.2011.70.01; Houbraken J, 2011, INT J SYST EVOL MICR, V61, P1462, DOI 10.1099/ijs.0.025098-0; Hsieh HM, 2010, FUNG SCI, V25, P25; HUFF RK, 1972, J CHEM SOC PERK T 1, P2584, DOI 10.1039/p19720002584; Huff RK, 1968, J CHEM SOC CHEM COMM, V1968, P1192; Jiang Y., 2005, J AGR TECHNOL, V1, P113; KING TJ, 1970, J CHEM SOC CHEM COMM, P1499; KING TJ, 1973, J CHEM SOC PERK T 1, P78, DOI 10.1039/p19730000078; Kondo H, 1993, New substance BE-25327 which is an estradiol agonist - useful for treating oestrogen-deficient gynaecological diseases, osteoporous, prostatic cancer and prostatomegaly. Jpn. Kokai Tokkyo Koho, Patent No. [JP05032579 A2, 05032579]; Lin YL, 2008, APPL MICROBIOL BIOT, V77, P965, DOI 10.1007/s00253-007-1256-6; Liu BH, 2005, J AGR FOOD CHEM, V53, P170, DOI 10.1021/jf048878n; Mapari SAS, 2008, J AGR FOOD CHEM, V56, P9981, DOI 10.1021/jf801817q; Mapari SAS, 2010, TRENDS BIOTECHNOL, V28, P300, DOI 10.1016/j.tibtech.2010.03.004; Mapari SAS, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-24; Mapari SAS, 2005, CURR OPIN BIOTECH, V16, P231, DOI 10.1016/j.copbio.2005.03.004; Marsini MA, 2006, ORG LETT, V8, P3481, DOI 10.1021/ol0610993; Mendez A, 2011, J ZHEJIANG UNIV-SC B, V12, P961, DOI 10.1631/jzus.B1100039; Mendez-Zavala A, 2007, REV MEX ING QUIM, V6, P267; NAGAOKA A, 1972, ARZNEI-FORSCHUNG, V22, P137; NAGAOKA A, 1972, ARZNEI-FORSCHUNG, V22, P143; NATSUME M, 1985, AGR BIOL CHEM TOKYO, V49, P2517, DOI 10.1080/00021369.1985.10867121; Nielsen KF, 2011, J NAT PROD, V74, P2338, DOI 10.1021/np200254t; NISHIDA H, 1991, J ANTIBIOT, V44, P144, DOI 10.7164/antibiotics.44.144; Ogihara J, 2002, J BIOSCI BIOENG, V93, P54, DOI 10.1263/jbb.93.54; Ogihara J, 2001, J BIOSCI BIOENG, V91, P44, DOI 10.1263/jbb.91.44; Ogihara J, 2000, J BIOSCI BIOENG, V90, P549, DOI 10.1263/jbb.90.549; Osmanova N, 2010, PHYTOCHEM REV, V9, P315, DOI 10.1007/s11101-010-9171-3; Patakova P, 2013, J IND MICROBIOL BIOT, V40, P169, DOI 10.1007/s10295-012-1216-8; Pharm Amano, 1974, Jap. Pat. JP, Patent No. [49093587-A, 49093587]; Pitt J. I., 1980, GENUS PENICILLIUM IT; Qiu M, 2010, WORLD J MICROB BIOT, V26, P993, DOI 10.1007/s11274-009-0261-6; Raper KB, 1949, MANUAL PENICILLIA; ROBERTS JC, 1971, J CHEM SOC C, P3493, DOI 10.1039/j39710003493; ROBERTS JC, 1971, J CHEM SOC C, P3488, DOI 10.1039/j39710003488; ROBERTS JC, 1955, J CHEM SOC, P2992, DOI 10.1039/jr9550002992; Samson RA, 2011, STUD MYCOL, P159, DOI 10.3114/sim.2011.70.04; SAMSON RA, 1989, STUD MYCOL, P133; Samson RA, 2010, FOOD INDOOR FUNGI; Santos-Ebinuma VC, 2013, J MICROBIOL BIOTECHN, V23, P802, DOI 10.4014/jmb.1211.11057; Santos-Ebinuma VC, 2013, BIOTECHNOL PROGR, V29, P778, DOI 10.1002/btpr.1720; Steglich W, 1974, PHYTOCHEMISTRY; Stoll O, 1903, THESIS WURZBERG; Suzuki S, 1999, J NAT PROD, V62, P1328, DOI 10.1021/np990146f; Takashima M, 1955, J AGRIC CHEM SOC, V29, P25; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TOMODA H, 1991, J ANTIBIOT, V44, P136, DOI 10.7164/antibiotics.44.136; VANREENENHOEKSTRA ES, 1990, NATO ADV SCI I A-LIF, V185, P173; Velmurugan P, 2010, J BIOSCI BIOENG, V109, P346, DOI 10.1016/j.jbiosc.2009.10.003; Velmurugan P, 2010, CARBOHYD POLYM, V79, P262, DOI 10.1016/j.carbpol.2009.07.058; Wang H, 2011, J NAT PROD, V74, P2014, DOI 10.1021/np2004769; West RR, 1996, J ANTIBIOT, V49, P967, DOI 10.7164/antibiotics.49.967; Wijkman N, 1931, LIEBIGS ANN CHEM, V485, P61; Yilmaz N, 2012, PERSOONIA, V29, P39, DOI 10.3767/003158512X659500; Yuill JL, 1934, BIOCHEM J, V28, P222, DOI 10.1042/bj0280222	73	86	95	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84102	10.1371/journal.pone.0084102	http://dx.doi.org/10.1371/journal.pone.0084102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367630	gold, Green Published, Green Submitted			2022-12-27	WOS:000328741900031
J	Teschler, S; Bartkuhn, M; Kunzel, N; Schmidt, C; Kiehl, S; Dammann, G; Dammann, R				Teschler, Stefanie; Bartkuhn, Marek; Kuenzel, Natascha; Schmidt, Christian; Kiehl, Steffen; Dammann, Gerhard; Dammann, Reinhard			Aberrant Methylation of Gene Associated CpG Sites Occurs in Borderline Personality Disorder	PLOS ONE			English	Article							DNA METHYLATION; SEXUAL ABUSE; PROMOTER; DIAGNOSIS; PROTEIN; STRESS; EPIGENOMICS; SEVERITY; SYMPTOMS; CHILDREN	Borderline personality disorder (BPD) is a complex psychiatric disease with an increased impact in the last years. While the diagnosis and therapy are well established, little is known on the pathogenesis of borderline personality disorder. Previously, a significant increase in DNA methylation of relevant neuropsychiatric genes in BPD patients has been reported. In our study we performed genome wide methylation analysis and revealed specific CpG sites that exhibited increased methylation in 24 female BPD patients compared to 11 female healthy controls. Bead chip technology and quantitative bisulfite pyrosequencing showed a significantly increased methylation at CpG sites of APBA2 (1.1 fold) and APBA3 (1.1 fold), KCNQ1 (1.5 fold), MCF2 (1.1 fold) and NINJ2 (1.2 fold) in BPD patients. For the CpG sites of GATA4 and HLCS an increase in DNA methylation was observed, but was only significant in the bead chip assay. Moreover genome wide methylation levels of blood samples of BPD patients and control samples are similar. In summary, our results show a significant 1.26 fold average increase in methylation at the analyzed gene associated CpG sites in the blood of BPD patients compared to controls samples (p<0.001). This data may provide new insights into epigenetic mechanisms underlying the pathogenesis of BPD.	[Teschler, Stefanie; Bartkuhn, Marek; Kuenzel, Natascha; Schmidt, Christian; Kiehl, Steffen; Dammann, Reinhard] Univ Giessen, Inst Genet, D-35390 Giessen, Germany; [Dammann, Gerhard] Spital Thurgau AG, Hosp Psychiat, Munsterlingen, Switzerland; [Dammann, Gerhard] Univ Basel, Sch Med, Dept Psychiat, Basel, Switzerland	Justus Liebig University Giessen; University of Basel	Dammann, R (corresponding author), Univ Giessen, Inst Genet, D-35390 Giessen, Germany.	reinhard.dammann@gen.bio.uni-giessen.de		Kunzel, Natascha Andrea/0000-0001-8885-5123; Bartkuhn, Marek/0000-0001-6872-9082	Land Hessen (LOEWE); Deutsche Forschungsgemeinschaft [TRR81]	Land Hessen (LOEWE); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Research in Reinhard Dammann's laboratory is funded by Land Hessen (LOEWE) and Deutsche Forschungsgemeinschaft (TRR81). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleky Hamid Mostafavi, 2008, V448, P187, DOI 10.1007/978-1-59745-205-2_9; Adalsteinsson BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046705; APA, 1994, DIAGN STAT MAN MENT; Araki T, 2000, J NEUROSCI, V20, P187, DOI 10.1523/JNEUROSCI.20-01-00187.2000; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; Dammann G, 2003, PSYCHIAT PRAX, V30, P304; Dammann G, 2011, EPIGENETICS-US, V6, P1454, DOI 10.4161/epi.6.12.18363; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Dansranjavin T, 2009, CELL CYCLE, V8, P916, DOI 10.4161/cc.8.6.7934; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; FAMULARO R, 1991, J NERV MENT DIS, V179, P428, DOI 10.1097/00005053-199107000-00007; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Gabbard GO, 2001, AM J PSYCHIAT, V158, P1, DOI 10.1176/appi.ajp.158.1.1; GOLDMAN SJ, 1992, AM J PSYCHIAT, V149, P1723; Grant BF, 2008, J CLIN PSYCHIAT, V69, P533, DOI 10.4088/JCP.v69n0404; Gunnar M, 2007, ANNU REV PSYCHOL, V58, P145, DOI 10.1146/annurev.psych.58.110405.085605; Hammoud SS, 2010, FERTIL STERIL, V94, P1728, DOI 10.1016/j.fertnstert.2009.09.010; Hao Y, 2012, NEUROREPORT, V23, P146, DOI 10.1097/WNR.0b013e32834f1934; HERMAN JL, 1989, AM J PSYCHIAT, V146, P490; Hirsch E, 2002, AM POETRY REV, V31, P22; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Johansson L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003142; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kaffman A, 2007, J CHILD PSYCHOL PSYC, V48, P224, DOI 10.1111/j.1469-7610.2007.01730.x; KARPYAK VM, 2012, ADDICT BIOL, P62823; Kraus A, 2009, BIOL PSYCHIAT, V65, P819, DOI 10.1016/j.biopsych.2008.10.028; Leichsenring F, 2011, LANCET, V377, P74, DOI 10.1016/S0140-6736(10)61422-5; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; Lin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020573; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; McGowan PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014739; Miller CCJ, 2006, TRENDS NEUROSCI, V29, P280, DOI 10.1016/j.tins.2006.03.001; Murphy BC, 2005, AM J MED GENET B, V133B, P37, DOI 10.1002/ajmg.b.30134; PARIS J, 1994, J NERV MENT DIS, V182, P375, DOI 10.1097/00005053-199407000-00002; Peroz D, 2008, J PHYSIOL-LONDON, V586, P1785, DOI 10.1113/jphysiol.2007.148254; Perroud N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.140; Perroud N, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.60; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Piton A, 2011, MOL PSYCHIATR, V16, P867, DOI 10.1038/mp.2010.54; Rashid A, 2001, AM J PATHOL, V159, P1129, DOI 10.1016/S0002-9440(10)61789-0; Sastre M, 1998, J BIOL CHEM, V273, P22351, DOI 10.1074/jbc.273.35.22351; Schilling E, 2007, GENOMICS, V90, P314, DOI 10.1016/j.ygeno.2007.04.011; Siever LJ, 2002, BIOL PSYCHIAT, V51, P964, DOI 10.1016/S0006-3223(02)01326-4; SILK KR, 1995, AM J PSYCHIAT, V152, P1059; Skodol AE, 2002, AM J PSYCHIAT, V159, P276, DOI 10.1176/appi.ajp.159.2.276; Skodol AE, 2002, BIOL PSYCHIAT, V51, P951, DOI 10.1016/S0006-3223(02)01325-2; Soloff PH, 2002, J PERS DISORD, V16, P201, DOI 10.1521/pedi.16.3.201.22542; Staubert C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011133; Steiger H, 2013, INT J EAT DISORDER, V46, P246, DOI 10.1002/eat.22113; Swistowski A, 2009, J NEUROSCI, V29, P15703, DOI 10.1523/JNEUROSCI.4351-09.2009; Tanaka K, 2001, ONCOLOGY-BASEL, V60, P268, DOI 10.1159/000055328; Torgersen S, 2008, PSYCHOL MED, V38, P1617, DOI 10.1017/S0033291708002924; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; van Vliet J, 2007, CELL MOL LIFE SCI, V64, P1531, DOI 10.1007/s00018-007-6526-z; WALLER G, 1994, CHILD ABUSE NEGLECT, V18, P97, DOI 10.1016/0145-2134(94)90099-X; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P64; Walter M, 2009, PSYCHOPATHOLOGY, V42, P399, DOI 10.1159/000241196; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WIDIGER TA, 1991, HOSP COMMUNITY PSYCH, V42, P1015; Yuferov V, 2011, PHARMACOGENET GENOM, V21, P185, DOI 10.1097/FPC.0b013e32833eecbc; ZIMMERMAN M, 1994, ARCH GEN PSYCHIAT, V51, P225	66	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84180	10.1371/journal.pone.0084180	http://dx.doi.org/10.1371/journal.pone.0084180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367640	gold, Green Published, Green Submitted			2022-12-27	WOS:000328741900036
J	Bergerot, B; Hugueny, B; Belliard, J				Bergerot, Benjamin; Hugueny, Bernard; Belliard, Jerome			When Local Extinction and Colonization of River Fishes Can Be Predicted by Regional Occupancy: the Role of Spatial Scales	PLOS ONE			English	Article							HABITAT MODEL OUTPUTS; RISK; ASSEMBLAGES; RARITY; FRAGMENTATION; VARIABILITY; POPULATIONS; FRAMEWORK; RICHNESS; DYNAMICS	Background: Predicting which species are likely to go extinct is perhaps one of the most fundamental yet challenging tasks for conservation biologists. This is particularly relevant for freshwater ecosystems which tend to have the highest proportion of species threatened with extinction. According to metapopulation theories, local extinction and colonization rates of freshwater subpopulations can depend on the degree of regional occupancy, notably due to rescue effects. However, relationships between extinction, colonization, regional occupancy and the spatial scales at which they operate are currently poorly known. Methods: And Findings: We used a large dataset of freshwater fish annual censuses in 325 stream reaches to analyse how annual extinction/colonization rates of subpopulations depend on the regional occupancy of species. For this purpose, we modelled the regional occupancy of 34 fish species over the whole French river network and we tested how extinction/colonization rates could be predicted by regional occupancy described at five nested spatial scales. Results show that extinction and colonization rates depend on regional occupancy, revealing existence a rescue effect. We also find that these effects are scale dependent and their absolute contribution to colonization and extinction tends to decrease from river section to larger basin scales. Conclusions: In terms of management, we show that regional occupancy quantification allows the evaluation of local species extinction/colonization dynamics and reduction of local extinction risks for freshwater fish species implies the preservation of suitable habitats at both local and drainage basin scales.	[Bergerot, Benjamin; Belliard, Jerome] Inst Natl Rech Sci & Technol Environm & Agr, Dept Hydrosyst & Bioproc Res Unit, Antony, France; [Bergerot, Benjamin] Univ Appl Sci Western Switzerland, Hepia Geneva, Dept Technol Architecture & Landscape, Jussey, Switzerland; [Hugueny, Bernard] Museum Natl Hist Nat, Dept Biol Organismes & Ecosyst Aquat, F-75231 Paris, France	INRAE; University of Applied Sciences & Arts Western Switzerland; Museum National d'Histoire Naturelle (MNHN)	Bergerot, B (corresponding author), Inst Natl Rech Sci & Technol Environm & Agr, Dept Hydrosyst & Bioproc Res Unit, Antony, France.	benjamin.bergerot@hesge.ch	bergerot, benjamin/AAD-4591-2021	Jerome, Belliard/0000-0001-8757-125X; bergerot, benjamin/0000-0003-4313-4925	Agence Nationale de la Recherche [ANR-09-PEXT-008]; Office National de l'Eau et des Milieux Aquatiques	Agence Nationale de la Recherche(French National Research Agency (ANR)); Office National de l'Eau et des Milieux Aquatiques	Financial support was provided by the Agence Nationale de la Recherche under the project named "6th Extinction 2009"(ANR-09-PEXT-008). BB was also supported by a research grant of the Office National de l'Eau et des Milieux Aquatiques ("Fish-Hydro" project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1981, CC ENG TECHNOL APPL, V51, P22; Albanese B, 2009, FRESHWATER BIOL, V54, P1444, DOI 10.1111/j.1365-2427.2009.02194.x; Bayley PB, 2001, T AM FISH SOC, V130, P620, DOI 10.1577/1548-8659(2001)130<0620:AATEPO>2.0.CO;2; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Driscoll DA, 2010, J ANIM ECOL, V79, P294, DOI 10.1111/j.1365-2656.2009.01609.x; Duncan JR, 2001, BIOL CONSERV, V102, P97, DOI 10.1016/S0006-3207(01)00077-5; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Fagan WE, 2005, ECOLOGY, V86, P34, DOI 10.1890/04-0491; Fagan WF, 2002, ECOLOGY, V83, P3250, DOI 10.1890/0012-9658(2002)083[3250:RFAERI]2.0.CO;2; Falke JA, 2010, AM FISH S S, V73, P207; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; FRISSELL CA, 1986, ENVIRON MANAGE, V10, P199, DOI 10.1007/BF01867358; GOTELLI NJ, 1993, OIKOS, V68, P36, DOI 10.2307/3545306; Gotelli NJ, 1999, EVOL ECOL RES, V1, P835; HANSKI I, 1982, OIKOS, V38, P210, DOI 10.2307/3544021; Hanski I, 1999, METAPOPULATION ECOLO; Hitt NP, 2008, J N AM BENTHOL SOC, V27, P304, DOI 10.1899/07-096.1; Hitt NP, 2012, OIKOS, V121, P127, DOI 10.1111/j.1600-0706.2011.19482.x; Ibarra AA, 2005, ECOL FRESHW FISH, V14, P233, DOI 10.1111/j.1600-0633.2005.00096.x; Lamouroux N, 2002, FRESHWATER BIOL, V47, P1531, DOI 10.1046/j.1365-2427.2002.00880.x; Lamouroux N, 2002, FRESHWATER BIOL, V47, P1543, DOI 10.1046/j.1365-2427.2002.00879.x; Leopold L.B., 1992, FLUVIAL PROCESSES GE; Levins R., 1970, SOME MATH PROBLEMS B, P77; MINNS CK, 1995, CAN J FISH AQUAT SCI, V52, P1499, DOI 10.1139/f95-144; Minto C, 2008, NATURE, V452, P344, DOI 10.1038/nature06605; Oberdorff T, 2002, FRESHWATER BIOL, V47, P1720, DOI 10.1046/j.1365-2427.2002.00884.x; Oberdorff T, 2002, B FR PECHE PISCIC, P405, DOI 10.1051/kmae:2002043; Oberdorff T, 2001, FRESHWATER BIOL, V46, P399, DOI 10.1046/j.1365-2427.2001.00669.x; Olden JD, 2008, ECOLOGY, V89, P847, DOI 10.1890/06-1864.1; OSBORNE LL, 1992, CAN J FISH AQUAT SCI, V49, P671, DOI 10.1139/f92-076; Pella H, 2012, GEOMORPHOLOGIE, P317; Pfister CA, 1998, OECOLOGIA, V114, P118, DOI 10.1007/s004420050427; Poulet N, 2011, J FISH BIOL, V79, P1436, DOI 10.1111/j.1095-8649.2011.03084.x; Pretty JL, 2003, J APPL ECOL, V40, P251, DOI 10.1046/j.1365-2664.2003.00808.x; Reynolds JD, 2005, CAN J FISH AQUAT SCI, V62, P854, DOI 10.1139/F05-066; Sauquet E, 2006, J HYDROL, V331, P300, DOI 10.1016/j.jhydrol.2006.05.018; Scheurer JA, 2003, T AM FISH SOC, V132, P840, DOI 10.1577/T02-037; STOTT B, 1967, J ANIM ECOL, V36, P407, DOI 10.2307/2922; Taylor CM, 1997, OECOLOGIA, V110, P560, DOI 10.1007/s004420050196; Taylor CM, 2001, ECOLOGY, V82, P2320, DOI 10.2307/2680234	41	12	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84138	10.1371/journal.pone.0084138	http://dx.doi.org/10.1371/journal.pone.0084138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367636	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300130
J	Gese, EM; Dowd, JLB; Aubry, LM				Gese, Eric M.; Dowd, Jennifer L. B.; Aubry, Lise M.			The Influence of Snowmobile Trails on Coyote Movements during Winter in High-Elevation Landscapes	PLOS ONE			English	Article							SEASONAL-VARIATION; NATIONAL-PARK; LYNX; BEHAVIOR; SNOW; DEER	Competition between sympatric carnivores has long been of interest to ecologists. Increased understanding of these interactions can be useful for conservation planning. Increased snowmobile traffic on public lands and in habitats used by Canada lynx (Lynx canadensis) remains controversial due to the concern of coyote (Canis latrans) use of snowmobile trails and potential competition with lynx. Determining the variables influencing coyote use of snowmobile trails has been a priority for managers attempting to conserve lynx and their critical habitat. During 2 winters in northwest Wyoming, we backtracked coyotes for 265 km to determine how varying snow characteristics influenced coyote movements; 278 km of random backtracking was conducted simultaneously for comparison. Despite deep snow (>1 m deep), radio-collared coyotes persisted at high elevations (2,500 m) year-round. All coyotes used snowmobile trails for some portion of their travel. Coyotes used snowmobile trails for 35% of their travel distance (random: 13%) for a mean distance of 149 m (random: 59 m). Coyote use of snowmobile trails increased as snow depth and penetrability off trails increased. Essentially, snow characteristics were most influential on how much time coyotes spent on snowmobile trails. In the early months of winter, snow depth was low, yet the snow column remained dry and the coyotes traveled off trails. As winter progressed and snow depth increased and snow penetrability increased, coyotes spent more travel distance on snowmobile trails. As spring approached, the snow depth remained high but penetrability decreased, hence coyotes traveled less on snowmobile trails because the snow column off trail was more supportive. Additionally, coyotes traveled closer to snowmobile trails than randomly expected and selected shallower snow when traveling off trails. Coyotes also preferred using snowmobile trails to access ungulate kills. Snow compaction from winter recreation influenced coyote movements within an area containing lynx and designated lynx habitat.	[Gese, Eric M.] Utah State Univ, USDA, Wildlife Serv, Natl Wildlife Res Ctr,Dept Wildland Resources, Logan, UT 84322 USA; [Dowd, Jennifer L. B.; Aubry, Lise M.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA	United States Department of Agriculture (USDA); Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Gese, EM (corresponding author), Utah State Univ, USDA, Wildlife Serv, Natl Wildlife Res Ctr,Dept Wildland Resources, Logan, UT 84322 USA.	eric.gese@usu.edu	Gese, Eric M/B-4578-2011	Aubry, Lise/0000-0003-3318-7329	United States Department of Agriculture, Wildlife Services; National Wildlife Research Center; United States Forest Service; Bridger-Teton National Forest; Endeavor Wildlife Research Foundation	United States Department of Agriculture, Wildlife Services; National Wildlife Research Center(United States Department of Agriculture (USDA)); United States Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Bridger-Teton National Forest; Endeavor Wildlife Research Foundation	The research was supported by funding from the United States Department of Agriculture, Wildlife Services, National Wildlife Research Center; the United States Forest Service, Bridger-Teton National Forest; and Endeavor Wildlife Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood TC, 2008, ANIM BEHAV, V75, P753, DOI 10.1016/j.anbehav.2007.08.024; Aubry Keith B., 2000, P373; Berry KJ, 2001, SPRINGER SERIES STAT; Bunnell KD, 2006, WILDLIFE SOC B, V34, P828, DOI 10.2193/0091-7648(2006)34[828:PIOCAS]2.0.CO;2; Burnham KP, 2002, MODELING SELECTION M; Buskirk Steven W., 2000, P83; Crete M, 2003, CAN J ZOOL, V81, P1808, DOI 10.1139/Z03-182; DeCesare NJ, 2005, WILDLIFE SOC B, V33, P935, DOI 10.2193/0091-7648(2005)33[935:EOFCOG]2.0.CO;2; Dowd JLB, 2012, NORTHWEST SCI, V86, P289, DOI 10.3955/046.086.0405; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; GESE EM, 1995, AM MIDL NAT, V133, P36, DOI 10.2307/2426345; GESE EM, 1987, WILDLIFE SOC B, V15, P444; KOEHLER GM, 1991, J MAMMAL, V72, P391, DOI 10.2307/1382112; Kolbe JA, 2007, J WILDLIFE MANAGE, V71, P1409, DOI 10.2193/2005-682; Lingle S, 2000, CAN J ZOOL, V78, P85, DOI 10.1139/cjz-78-1-85; McKelvey Kevin S., 2000, P307; MURRAY DL, 1995, ANIM BEHAV, V50, P1203, DOI 10.1016/0003-3472(95)80037-9; MURRAY DL, 1991, OECOLOGIA, V88, P463, DOI 10.1007/BF00317707; Natural Resources Conservation Service, 2008, SNOTEL DAT NETW; Neter J., 1996, APPL LINEAR STAT MOD; PAQUET PC, 1992, J MAMMAL, V73, P337, DOI 10.2307/1382067; R Core Team, 2018, R LANG ENV STAT COMP; RUEDIGER B, 2000, CANADA LYNX CONSERVA; RUGGIERO LF, 2000, ECOLOGY CONSERVATION; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stevens MHH, 2009, MULTIRESPONSE PERMUT; *US DEP INT FISH W, 2000, FED REGISTER, V65, P16052; US Department of Agriculture, 2007, NO ROCK LYNX MAN DIR; Wyoming Department of State Parks and Cultural Services, 2008, WYOM STAT GOV ANN RE	29	9	10	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82862	10.1371/journal.pone.0082862	http://dx.doi.org/10.1371/journal.pone.0082862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367565	Green Submitted, Green Published, gold			2022-12-27	WOS:000328740300078
J	Nam, YD; Kim, HJ; Seo, JG; Kang, SW; Bae, JW				Nam, Young-Do; Kim, Hak Jae; Seo, Jae-Gu; Kang, Seung Wan; Bae, Jin-Woo			Impact of Pelvic Radiotherapy on Gut Microbiota of Gynecological Cancer Patients Revealed by Massive Pyrosequencing	PLOS ONE			English	Article							COLORECTAL-CANCER; RADIATION; PREDISPOSE; DIVERSITY; RESPONSES; STRESS; HEALTH; INJURY; RISK	Although pelvic irradiation is effective for the treatment of various cancer types, many patients who receive radiotherapy experience serious complications. Gut microbial dysbiosis was hypothesized to be related to the occurrence of radiation-induced complications in cancer patients. Given the lack of clinical or experimental data on the impact of radiation on gut microbiota, a prospective observational study of gut microbiota was performed in gynecological cancer patients receiving pelvic radiotherapy. In the current study, the overall composition and alteration of gut microbiota in cancer patients receiving radiation were investigated by 454 pyrosequencing. Gut microbial composition showed significant differences (P < 0.001) between cancer patients and healthy individuals. The numbers of species-level taxa were severely reduced after radiotherapy (P < 0.045), and the abundance of each community largely changed. In particular, the phyla Firmicutes and Fusobacterium were significantly decreased by 10% and increased by 3% after radiation therapy, respectively. In addition, overall gut microbial composition was gradually remolded after the full treatment course of pelvic radiotherapy. In this set of cancer patients, dysbiosis of the gut microbiota was linked to health status, and the gut microbiota was influenced by pelvic radiotherapy. Although further studies are needed to elucidate the relationship between dysbiosis and complications induced by pelvic radiotherapy, the current study may offer insights into the treatment of cancer patients suffering from complications after radiation therapy.	[Nam, Young-Do; Bae, Jin-Woo] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul, South Korea; [Nam, Young-Do; Bae, Jin-Woo] Kyung Hee Univ, Dept Biol, Seoul, South Korea; [Nam, Young-Do] Korea Food Res Inst, Fermentat & Funct Res Grp, Sungnam, South Korea; [Kim, Hak Jae] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul 110744, South Korea; [Seo, Jae-Gu] Cell Biotech Co Ltd, Seoul, South Korea; [Kang, Seung Wan] Seoul Natl Univ, Coll Nursing, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Korea Food Research Institute (KFRI); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kang, SW (corresponding author), Seoul Natl Univ, Coll Nursing, Seoul, South Korea.	drdemian@snu.ac.kr; baejw@khu.ac.kr	Bae, Jin-Woo/S-1955-2017	Bae, Jin-Woo/0000-0001-6433-5270; Nam, Young-Do/0000-0002-2660-3569	Mid-Career Researcher Program through the National Research Foundation of Korea (NRF) [2011-0028854]; Ministry of Education, Science, and Technology (MEST); SNUH CRI grant [0620122120]	Mid-Career Researcher Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); SNUH CRI grant	This work was supported by a grant from the Mid-Career Researcher Program (2011-0028854 to J.-W.B.) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (MEST); SNUH CRI grant (0620122120), and nonprofit research donation for integrative medicine from SK Holdings and the late Chairman Jong-Hyun Choi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasakoor F, 2006, COLORECTAL DIS, V8, P2, DOI 10.1111/j.1463-1318.2005.00851.x; Alonso C, 2008, GASTROENTEROLOGY, V135, P163, DOI 10.1053/j.gastro.2008.03.036; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Beg AA, 2004, NAT IMMUNOL, V5, P14, DOI 10.1038/ni0104-14; Bismar Mike M, 2002, Curr Gastroenterol Rep, V4, P361, DOI 10.1007/s11894-002-0005-3; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Crawford PA, 2005, P NATL ACAD SCI USA, V102, P13254, DOI 10.1073/pnas.0504830102; DELONG EF, 1989, SCIENCE, V243, P1360, DOI 10.1126/science.2466341; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Giralt J, 2008, INT J RADIAT ONCOL, V71, P1213, DOI 10.1016/j.ijrobp.2007.11.009; Gotelli NJ, 2002, NATURE, V419, P575, DOI 10.1038/419575a; Guschin DY, 1997, APPL ENVIRON MICROB, V63, P2397, DOI 10.1128/AEM.63.6.2397-2402.1997; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Homann N, 2000, INT J CANCER, V86, P169, DOI 10.1002/(SICI)1097-0215(20000415)86:2&lt;169::AID-IJC4&gt;3.0.CO;2-3; HUSEBYE E, 1995, GASTROENTEROLOGY, V109, P1078, DOI 10.1016/0016-5085(95)90565-0; Huycke MM, 2004, EXP BIOL MED, V229, P586, DOI 10.1177/153537020422900702; Johnson Louis Banka, 2004, BMC Surg, V4, P10, DOI 10.1186/1471-2482-4-10; Manichanh C, 2008, AM J GASTROENTEROL, V103, P1754, DOI 10.1111/j.1572-0241.2008.01868.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Matsumoto M, 2007, MICROBIOL IMMUNOL, V51, P25, DOI 10.1111/j.1348-0421.2007.tb03887.x; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nam YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022109; O'Keefe SJD, 2008, CURR OPIN GASTROEN, V24, P51, DOI 10.1097/MOG.0b013e3282f323f3; PACE NR, 1985, ASM NEWS, V51, P4; Packey CD, 2010, CURR OPIN GASTROEN, V26, P88, DOI 10.1097/MOG.0b013e3283361927; Palmer C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj007; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; SHIN NR, 2013, GUT, P4561; Sonis SL, 2002, CRIT REV ORAL BIOL M, V13, P380, DOI 10.1177/154411130201300502; Tong JL, 2008, YONSEI MED J, V49, P792, DOI 10.3349/ymj.2008.49.5.792; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	44	113	121	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82659	10.1371/journal.pone.0082659	http://dx.doi.org/10.1371/journal.pone.0082659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367534	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300050
J	Toge, Y; Nishimura, Y; Basford, JR; Nogawa, T; Yamanaka, M; Nakamura, T; Yoshida, M; Nagano, A; Tajima, F				Toge, Yasushi; Nishimura, Yukihide; Basford, Jeffrey R.; Nogawa, Takako; Yamanaka, Midori; Nakamura, Takeshi; Yoshida, Munehito; Nagano, Akira; Tajima, Fumihiro			Comparison of the Effects of Flexion and Extension of the Thumb and Fingers on the Position and Cross-Sectional Area of the Median Nerve	PLOS ONE			English	Article							CARPAL-TUNNEL-SYNDROME; PRESSURE; EXCURSION; MOVEMENT; MOTION; STRAIN	Objective: To assess the separate effects of thumb and finger extension/flexion on median nerve position and cross-sectional area. Methods: Ultrasonography was used to assess median nerve transverse position and cross-sectional area within the carpal tunnel at rest and its movement during volitional flexion of the individual digits of the hand. Both wrists of 165 normal subjects (11 men, 4 women, mean age, 28.6, range, 22 to 38) were studied. Results: Thumb flexion resulted in transverse movement of the median nerve in radial direction (1.2 +/- 0.6 mm), whereas flexion of the fingers produced transverse movement in ulnar direction, which was most pronounced during flexion of the index and middle fingers (3.2 +/- 0.9 and 3.1 +/- 1.0 mm, respectively). Lesser but still statistically significant movements were noted with flexion of the ring finger (2.0 +/- 0.8 mm) and little finger (1.2 +/- 0.5 mm). Flexion of the thumb or individual fingers did not change median nerve cross-sectional area (8.5 +/- 1.1 mm(2)). Conclusions: Volitional flexion of the thumb and individual fingers, particularly the index and middle fingers, produced significant transverse movement of the median nerve within the carpal tunnel but did not alter the cross-sectional area of the nerve. The importance of these findings on the understanding of the pathogenesis of the carpal tunnel syndrome and its treatment remains to be investigated.	[Toge, Yasushi; Nishimura, Yukihide; Nogawa, Takako; Yamanaka, Midori; Nakamura, Takeshi; Tajima, Fumihiro] Wakayama Med Univ, Dept Rehabil Med, Wakayama, Japan; [Yoshida, Munehito] Wakayama Med Univ, Dept Orthoped Surg, Wakayama, Japan; [Nagano, Akira] Hamamatsu Univ Sch Med, Dept Orthoped Surg, Hamamatsu, Shizuoka 4313192, Japan; [Basford, Jeffrey R.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA	Wakayama Medical University; Wakayama Medical University; Hamamatsu University School of Medicine; Mayo Clinic	Nishimura, Y (corresponding author), Wakayama Med Univ, Dept Rehabil Med, Wakayama, Japan.	yuki-n@wakayama-med.ac.jp		Nishimura, Yukihide/0000-0002-5365-1347				Altinok T, 2004, CLIN RADIOL, V59, P916, DOI 10.1016/j.crad.2004.03.019; Dilley A, 2001, ULTRASOUND MED BIOL, V27, P1211, DOI 10.1016/S0301-5629(01)00413-6; DUMITRU D, 2001, ELECTRODIAGNOSTIC ME, P1043; GELBERMAN RH, 1981, J BONE JOINT SURG AM, V63, P380, DOI 10.2106/00004623-198163030-00009; Gerritsen AAM, 2002, JAMA-J AM MED ASSOC, V288, P1245, DOI 10.1001/jama.288.10.1245; Greening J, 2001, J HAND SURG-BRIT EUR, V26, P401, DOI 10.1054/jhsb.2001.0582; Hough AD, 2000, J HAND SURG-BRIT EUR, V25B, P585, DOI 10.1054/jhsb.2000.0453; Lam N, 1998, AUST NZ J SURG, V68, P190, DOI 10.1111/j.1445-2197.1998.tb04743.x; LUCHETTI R, 1994, J HAND SURG-BRIT EUR, V19B, P35, DOI 10.1016/0266-7681(94)90045-0; LUCHETTI R, 1989, ACTA ORTHOP SCAND, V60, P397, DOI 10.3109/17453678909149305; MCLELLAN DL, 1976, J NEUROL NEUROSUR PS, V39, P566, DOI 10.1136/jnnp.39.6.566; Miendany YM, 2004, RHEUMATOLOGY, V43, P887; NAKAMICHI K, 1992, J HAND SURG-BRIT EUR, V17B, P213, DOI 10.1016/0266-7681(92)90092-G; NAKAMICHI K, 1995, J HAND SURG-BRIT EUR, V20B, P460, DOI 10.1016/S0266-7681(05)80153-6; O'Neil BA, 2001, CAN FAM PHYSICIAN, V47, P311; REMPEL D, 1994, J HAND SURG-AM, V19A, P106, DOI 10.1016/0363-5023(94)90231-3; SZABO RM, 1994, J HAND SURG-AM, V19A, P901, DOI 10.1016/0363-5023(94)90087-6; WILGIS EFS, 1986, HAND CLIN, V2, P761; Wright TW, 1996, J BONE JOINT SURG AM, V78A, P1897, DOI 10.2106/00004623-199612000-00013; Yesildag A, 2004, CLIN RADIOL, V59, P910, DOI 10.1016/j.crad.2004.03.020	20	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83565	10.1371/journal.pone.0083565	http://dx.doi.org/10.1371/journal.pone.0083565			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367601	Green Submitted, Green Published, gold			2022-12-27	WOS:000328740300110
J	Anbeek, P; Isgum, I; van Kooiji, BJM; Moi, CP; Kersbergen, KJ; Groenendaal, F; Viergever, MA; de Vries, LS; Benders, MJNL				Anbeek, Petronella; Isgum, Ivana; van Kooiji, Britt J. M.; Moi, Christian P.; Kersbergen, Karina J.; Groenendaal, Floris; Viergever, Max A.; de Vries, Linda S.; Benders, Manon J. N. L.			Automatic Segmentation of Eight Tissue Classes in Neonatal Brain MRI	PLOS ONE			English	Article							TERM-EQUIVALENT AGE; PRETERM INFANTS; PREMATURE-INFANTS; BORN; CLASSIFICATION; IMAGES; CORPUS	Purpose: Volumetric measurements of neonatal brain tissues may be used as a biomarker for later neurodevelopmental outcome. We propose an automatic method for probabilistic brain segmentation in neonatal MRIs. Materials and Methods: In an IRB-approved study axial T1- and T2-weighted MR images were acquired at term-equivalent age for a preterm cohort of 108 neonates. A method for automatic probabilistic segmentation of the images into eight cerebral tissue classes was developed: cortical and central grey matter, unmyelinated and myelinated white matter, cerebrospinal fluid in the ventricles and in the extra cerebral space, brainstem and cerebellum. Segmentation is based on supervised pixel classification using intensity values and spatial positions of the image voxels. The method was trained and evaluated using leave-one-out experiments on seven images, for which an expert had set a reference standard manually. Subsequently, the method was applied to the remaining 101 scans, and the resulting segmentations were evaluated visually by three experts. Finally, volumes of the eight segmented tissue classes were determined for each patient. Results: The Dice similarity coefficients of the segmented tissue classes, except myelinated white matter, ranged from 0.75 to 0.92. Myelinated white matter was difficult to segment and the achieved Dice coefficient was 0.47. Visual analysis of the results demonstrated accurate segmentations of the eight tissue classes. The probabilistic segmentation method produced volumes that compared favorably with the reference standard. Conclusion: The proposed method provides accurate segmentation of neonatal brain MR images into all given tissue classes, except myelinated white matter. This is the one of the first methods that distinguishes cerebrospinal fluid in the ventricles from cerebrospinal fluid in the extracerebral space. This method might be helpful in predicting neurodevelopmental outcome and useful for evaluating neuroprotective clinical trials in neonates.	[Anbeek, Petronella; van Kooiji, Britt J. M.; Kersbergen, Karina J.; Groenendaal, Floris; de Vries, Linda S.; Benders, Manon J. N. L.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands; [Anbeek, Petronella; Isgum, Ivana; Moi, Christian P.; Viergever, Max A.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center	Benders, MJNL (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands.	m.benders@umcutrecht.nl	de Vries, Linda S/AAB-6454-2021; Isgum, Ivana/H-8659-2014; Viergever, Max A/J-1215-2014; Groenendaal, Floris/P-6872-2019	Isgum, Ivana/0000-0003-1869-5034; Groenendaal, Floris/0000-0002-9284-1637	International Pediatric Research Foundation; The Netherlands Organisation for Health Research and Development [94527022]	International Pediatric Research Foundation; The Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This work was supported by the Young Investigator Exchange Program Fellowship of the International Pediatric Research Foundation and The Netherlands Organisation for Health Research and Development [project 94527022]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allin M, 2001, BRAIN, V124, P60, DOI 10.1093/brain/124.1.60; Anbeek P, 2005, PROBABILISTIC SEGMEN; Anbeek P, 2008, PEDIATR RES, V63, P158, DOI 10.1203/PDR.0b013e31815ed071; Bayley N., 2019, BAYLEY SCALES INFANT; Cardoso MJ, 2013, NEUROIMAGE, V65, P97, DOI 10.1016/j.neuroimage.2012.08.009; De Bresser J, 2011, MRI BASED QUANTIFICA; Duda R.O., 2006, PATTERN CLASSIFICATI; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; Gousias IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059990; Gui L, 2012, MED IMAGE ANAL, V16, P1565, DOI 10.1016/j.media.2012.07.006; Hagmann CF, 2009, RADIOLOGY, V252, P209, DOI 10.1148/radiol.2522080589; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kuklisova-Murgasova M, 2011, NEUROIMAGE, V54, P2750, DOI 10.1016/j.neuroimage.2010.10.019; Likar B, 2001, IEEE T MED IMAGING, V20, P1398, DOI 10.1109/42.974934; Liu W, 2011, LECT NOTES COMPUTER, P345; Martinussen M, 2009, J PEDIATR-US, V155, P848, DOI 10.1016/j.jpeds.2009.06.015; Maunu J, 2011, DEV MED CHILD NEUROL, V53, P48, DOI 10.1111/j.1469-8749.2010.03785.x; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; Mewes AUJ, 2006, PEDIATRICS, V118, P23, DOI 10.1542/peds.2005-2675; Nishida M, 2006, NEUROIMAGE, V32, P1041, DOI 10.1016/j.neuroimage.2006.05.020; Nosarti C, 2008, BRAIN, V131, P205, DOI 10.1093/brain/awm282; Parvin H., 2008, P WORLD C ENG COMP S, P22; Peterson BS, 2003, PEDIATRICS, V111, P939, DOI 10.1542/peds.111.5.939; Prastawa M, 2005, MED IMAGE ANAL, V9, P457, DOI 10.1016/j.media.2005.05.007; Sun YM, 2009, INT J PATTERN RECOGN, V23, P687, DOI 10.1142/S0218001409007326; Tan SB, 2005, EXPERT SYST APPL, V28, P667, DOI 10.1016/j.eswa.2004.12.023; Thompson DK, 2007, BRAIN, V130, P667, DOI 10.1093/brain/awl277; Tolsa CB, 2004, PEDIATR RES, V56, P132, DOI 10.1203/01.PDR.0000128983.54614.7E; van Kooij BJM, 2010, NEONATOLOGY, V97, P235, DOI 10.1159/000253754; Van Kooij BJM, 2012, DEV MED CHILD NEUROL, V54, P260, DOI 10.1111/j.1469-8749.2011.04168.x; van Pul C, 2012, AM J NEURORADIOL, V33, P678, DOI 10.3174/ajnr.A2859; Warfield SK, 2000, MED IMAGE ANAL, V4, P43, DOI 10.1016/S1361-8415(00)00003-7; Weisenfeld NI, 2009, NEUROIMAGE, V47, P564, DOI 10.1016/j.neuroimage.2009.04.068; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Xue H, 2007, NEUROIMAGE, V38, P461, DOI 10.1016/j.neuroimage.2007.07.030; Yu XT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013874; Zacharia A, 2006, AM J NEURORADIOL, V27, P972	38	48	48	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e81895	10.1371/journal.pone.0081895	http://dx.doi.org/10.1371/journal.pone.0081895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358132	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700003
J	Jimenez-Trigos, E; Vicente, JS; Marco-Jimenez, F				Jimenez-Trigos, Estrella; Vicente, Jose S.; Marco-Jimenez, Francisco			Live Birth from Slow-Frozen Rabbit Oocytes after In Vivo Fertilisation	PLOS ONE			English	Article							INTRACYTOPLASMIC SPERM INJECTION; MESSENGER-RNA EXPRESSION; DIFFERENT CULTURE-SYSTEMS; THAWED BOVINE OOCYTES; EMBRYO CRYOPRESERVATION; MOUSE OOCYTES; VITRO; SURVIVAL; VITRIFICATION; OVIDUCT	In vivo fertilisation techniques such as intraoviductal oocyte transfer have been considered as alternatives to bypass the inadequacy of conventional in vitro fertilisation in rabbit. There is only one study in the literature, published in 1989, that reports live offspring from cryopreserved rabbit oocytes. The aim of the present study was to establish the in vivo fertilisation procedure to generate live offspring with frozen oocytes. First, the effect of two recipient models (i) ovariectomised or (ii) oviduct ligated immediately after transfer on the ability of fresh oocytes to fertilise were compared. Second, generation of live offspring from slow-frozen oocytes was carried out using the ligated oviduct recipient model. Throughout the experiment, recipients were artificially inseminated 9 hours prior to oocyte transfer. In the first experiment, two days after unilateral transfer of fresh oocytes, oviducts and uterine horns were flushed to assess embryo recovery rates. The embryo recovery rates were low compared to control in both ovariectomised and ligated oviduct groups. However, ligated oviduct recipient showed significantly (P < 0.05) higher embryo recovery rates compared to ovariectomised and control-transferred. In the second experiment, using bilateral oviduct ligation model, all females that received slow-frozen oocytes became pregnant and delivered a total of 4 live young naturally. Thus, in vivo fertilisation is an effective technique to generate live offspring using slow-frozen oocytes in rabbits.	[Jimenez-Trigos, Estrella; Vicente, Jose S.; Marco-Jimenez, Francisco] Univ Politecn Valencia, Inst Sci & Anim Technol, Lab Biotecnol Reprod, E-46071 Valencia, Spain	Universitat Politecnica de Valencia	Marco-Jimenez, F (corresponding author), Univ Politecn Valencia, Inst Sci & Anim Technol, Lab Biotecnol Reprod, E-46071 Valencia, Spain.	fmarco@dca.upv.es	Trigos, M Estrella Jiménez/M-2254-2017; Jiménez, Francisco Marco/I-7126-2012; Vicente, Jose/F-7738-2017	Jiménez, Francisco Marco/0000-0002-5226-4118; Vicente, Jose/0000-0003-0481-3802; Jimenez Trigos/0000-0002-0320-4813	Spanish Research Project [AGL2011-30170-C02-01 (CICYT)]; Generalitat Valenciana Research Programme [Prometeo 2009/125]; Education Ministry of the Valencian Regional Government [ACIF/2010/262]	Spanish Research Project(Spanish Government); Generalitat Valenciana Research Programme(Center for Forestry Research & Experimentation (CIEF)); Education Ministry of the Valencian Regional Government	This work was supported by the Spanish Research Project AGL2011-30170-C02-01 (CICYT) and by funds from the Generalitat Valenciana Research Programme (Prometeo 2009/125). Estrella Jimenez was supported by a research grant from the Education Ministry of the Valencian Regional Government (programme VALi+d (ACIF/2010/262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHASANI S, 1989, HUM REPROD, V4, P77; Aono N, 2005, FERTIL STERIL, V84, P1078, DOI 10.1016/j.fertnstert.2005.03.077; APELO CL, 1989, JPN J VET RES, V37, P49; Bavister BD, 1995, HUM REPROD UPDATE, V1, P91, DOI 10.1093/humupd/1.2.91; BEDFORD JM, 1962, NATURE, V193, P898, DOI 10.1038/193898a0; Besenfelder U, 2010, THERIOGENOLOGY, V73, P768, DOI 10.1016/j.theriogenology.2009.07.003; BESENFELDER U, 1993, J REPROD FERTIL, V99, P53, DOI 10.1530/jrf.0.0990053; BOSMIKICH A, 1995, BIOL REPROD, V53, P780, DOI 10.1095/biolreprod53.4.780; BRACKETT BG, 1968, FERTIL STERIL, V19, P144; Cai XY, 2005, HUM REPROD, V20, P1969, DOI 10.1093/humrep/deh805; Carnevale EM, 2005, THERIOGENOLOGY, V64, P519, DOI 10.1016/j.theriogenology.2005.05.008; Chang M C, 1970, Nature, V226, P1262, DOI 10.1038/2261262a0; CHEN C, 1986, LANCET, V1, P884, DOI 10.1016/S0140-6736(86)90989-X; Cortell C, 2010, REPROD DOMEST ANIM, V45, P155, DOI 10.1111/j.1439-0531.2008.01294.x; Coticchio G, 2004, EUR J OBSTET GYN R B, V115, pS2, DOI 10.1016/j.ejogrb.2004.01.006; Curry MR, 2000, CRYOBIOLOGY, V41, P167, DOI 10.1006/cryo.2000.2277; Deleuze S, 2009, THERIOGENOLOGY, V72, P203, DOI 10.1016/j.theriogenology.2009.02.001; Deng MQ, 2001, MOL REPROD DEV, V59, P38, DOI 10.1002/mrd.1005; DIEDRICH K, 1988, ANN NY ACAD SCI, V541, P562, DOI 10.1111/j.1749-6632.1988.tb22292.x; ELLINGTON JE, 1991, CORNELL VET, V81, P313; Fadini R, 2009, REPROD BIOMED ONLINE, V19, P171, DOI 10.1016/S1472-6483(10)60069-7; Fatehi AN, 2002, THERIOGENOLOGY, V57, P1347, DOI 10.1016/S0093-691X(01)00717-8; Fischer B, 2012, REPRODUCTION, V144, P1, DOI 10.1530/REP-12-0091; Fleming TP, 2004, BIOL REPROD, V71, P1046, DOI 10.1095/biolreprod.104.030957; FUKU E, 1992, CRYOBIOLOGY, V29, P485, DOI 10.1016/0011-2240(92)90051-3; Garcia ML, 2002, LIVEST PROD SCI, V74, P45, DOI 10.1016/S0301-6226(01)00280-9; Garcia ML, 2000, 7 WORLD RABB C VAL S, VA, P139; Garcia-Ximenez F, 2002, THERIOGENOLOGY, V57, P1319, DOI 10.1016/S0093-691X(01)00718-X; Gomez MC, 2008, REPROD FERT DEVELOP, V20, P118, DOI 10.1071/RDv20n1Ab74; Guidobaldi HA, 2012, REPRODUCTION, V143, P587, DOI 10.1530/REP-11-0478; Heape W, 1891, P R SOC LONDON, V48, P457; HOCHI S, 1994, THERIOGENOLOGY, V42, P483, DOI 10.1016/0093-691X(94)90686-D; Jimenez-Trigos E, 2013, CRYOBIOLOGY, V67, P106, DOI 10.1016/j.cryobiol.2013.05.006; Jimenez-Trigos E, 2013, REPROD DOMEST ANIM, V48, P15, DOI 10.1111/j.1439-0531.2012.02018.x; Jimenez-Trigos E, 2012, REPROD DOMEST ANIM, V47, P472, DOI 10.1111/j.1439-0531.2011.01906.x; KEEFER CL, 1989, GAMETE RES, V22, P59, DOI 10.1002/mrd.1120220107; KILLIAN GJ, 1989, J REPROD FERTIL, V86, P419, DOI 10.1530/jrf.0.0860419; Kubota C, 1998, MOL REPROD DEV, V51, P281, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;281::AID-MRD7&gt;3.0.CO;2-L; Lavara R, 2011, THERIOGENOLOGY, V76, P652, DOI 10.1016/j.theriogenology.2011.03.018; Ledda S, 2007, REPROD FERT DEVELOP, V19, P13, DOI 10.1071/RD06126; Lee HJ, 2010, REPROD BIOMED ONLINE, V20, P201, DOI 10.1016/j.rbmo.2009.11.012; Li GP, 2001, MOL REPROD DEV, V58, P180, DOI 10.1002/1098-2795(200102)58:2&lt;180::AID-MRD7&gt;3.0.CO;2-7; Marco-Jimenez F, 2010, REPROD DOMEST ANIM, V45, pE118, DOI 10.1111/j.1439-0531.2009.01532.x; Mehaisen GMK, 2004, REPROD DOMEST ANIM, V39, P347, DOI 10.1111/j.1439-0531.2004.00526.x; Mullen SF, 2007, ADV FUNDAMENTAL CRYO; NAKAGATA N, 1992, EXP ANIM TOKYO, V41, P443, DOI 10.1538/expanim1978.41.4_443; Naturil-Alfonso C, 2011, ANIM REPROD SCI, V127, P222, DOI 10.1016/j.anireprosci.2011.08.005; Nottola SA, 2008, REPROD BIOMED ONLINE, V17, P368, DOI 10.1016/S1472-6483(10)60220-9; Noyes N, 2010, J ASSIST REPROD GEN, V27, P69, DOI 10.1007/s10815-009-9382-y; OZIL JP, 1990, DEVELOPMENT, V109, P117; Paynter SJ, 1999, HUM REPROD, V14, P2338, DOI 10.1093/humrep/14.9.2338; Paynter SJ, 2001, FERTIL STERIL, V75, P532, DOI 10.1016/S0015-0282(00)01757-X; Pereira RM, 2008, CELL TISSUE BANK, V9, P267, DOI 10.1007/s10561-008-9075-2; Purpera MN, 2009, MOL REPROD DEV, V76, P783, DOI 10.1002/mrd.21028; Rizos D, 2002, BIOL REPROD, V66, P589, DOI 10.1095/biolreprod66.3.589; RYAN JP, 1988, J REPROD FERTIL, V84, P171, DOI 10.1530/jrf.0.0840171; Saenz-de-Juano MD, 2013, ZYGOTE, V21, P103, DOI 10.1017/S0967199411000414; Salvetti P, 2010, THERIOGENOLOGY, V74, P847, DOI 10.1016/j.theriogenology.2010.04.009; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; SIEBZEHNRUEBL ER, 1989, HUM REPROD, V4, P312, DOI 10.1093/oxfordjournals.humrep.a136895; STONE SL, 1975, GYNECOL OBSTET INVES, V6, P234, DOI 10.1159/000301520; Sultan KM, 1996, J REPROD FERTIL, V108, P179, DOI 10.1530/jrf.0.1080179; Suzuki T, 1996, CRYOBIOLOGY, V33, P515, DOI 10.1006/cryo.1996.0055; Vicente JS, 2011, THERIOGENOLOGY, V76, P1120, DOI 10.1016/j.theriogenology.2011.05.020; Vieira AD, 2002, CRYOBIOLOGY, V45, P91, DOI 10.1016/S0011-2240(02)00109-8; VINCENT C, 1989, J REPROD FERTIL, V87, P809, DOI 10.1530/jrf.0.0870809; ViudesdeCastro MP, 1997, ANIM REPROD SCI, V46, P313, DOI 10.1016/S0378-4320(96)01628-4; Wang J, 2010, ZYGOTE, V18, P27, DOI 10.1017/S0967199409990098; WHITTINGHAM DG, 1971, NATURE, V233, P125, DOI 10.1038/233125a0; WHITTINGHAM DG, 1977, J REPROD FERTIL, V49, P89, DOI 10.1530/jrf.0.0490089; YANAGIMACHI R, 1969, J REPROD FERTIL, V18, P275, DOI 10.1530/jrf.0.0180275; Zheng YL, 2004, ZYGOTE, V12, P75, DOI 10.1017/S0967199404002643	72	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83399	10.1371/journal.pone.0083399	http://dx.doi.org/10.1371/journal.pone.0083399			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358281	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700056
J	Zhang, RZ; Zhang, BT; Xu, Y; Li, YH; Li, M; Liang, HB; Xiao, R				Zhang, Rongzhen; Zhang, Botao; Xu, Yan; Li, Yaohui; Li, Ming; Liang, Hongbo; Xiao, Rong			Efficicent (R)-Phenylethanol Production with Enantioselectivity-Alerted (S)-Carbonyl Reductase II and NADPH Regeneration	PLOS ONE			English	Article							GLUCOSE-DEHYDROGENASE; CARBONYL REDUCTASE; ESCHERICHIA-COLI; TRANSLATION INITIATION; COFACTOR REGENERATION; CANDIDA-PARAPSILOSIS; EXPRESSION; KETONES; CELLS; (S)-1-PHENYL-1,2-ETHANEDIOL	The NADPH-dependent (S)-carbonyl reductaseII from Candida parapsilosis catalyzes acetophenone to chiral phenylethanol in a very low yield of 3.2%. Site-directed mutagenesis was used to design two mutants Ala220Asp and Glu228Ser, inside or adjacent to the substrate-binding pocket. Both mutations caused a significant enantioselectivity shift toward (R)-phenylethanol in the reduction of acetophenone. The variant E228S produced (R)-phenylethanol with an optical purity above 99%, in 80.2% yield. The E228S mutation resulted in a 4.6-fold decrease in the K-M value, but nearly 5-fold and 21-fold increases in the k(cat) and k(cat)/K-M values with respect to the wild type. For NADPH regeneration, Bacillus sp. YX-1 glucose dehydrogenase was introduced into the (R)-phenylethanol pathway. A coexpression system containing E228S and glucose dehydrogenase was constructed. The system was optimized by altering the coding gene order on the plasmid and using the Shine-Dalgarno sequence and the aligned spacing sequence as a linker between them. The presence of glucose dehydrogenase increased the NADPH concentration slightly and decreased NADP(+) pool 2- to 4-fold; the NADPH/NADP(+) ratio was improved 2- to 5-fold. The recombinant Escherichia coli/pET-MS-SD-AS-G, with E228S located upstream and glucose dehydrogenase downstream, showed excellent performance, giving (R)-phenylethanol of an optical purity of 99.5 % in 92.2% yield in 12 h in the absence of an external cofactor. When 0.06 mM NADP(+) was added at the beginning of the reaction, the reaction duration was reduced to 1 h. Optimization of the coexpression system stimulated an over 30-fold increase in the yield of (R)phenylethanol, and simultaneously reduced the reaction time 48-fold compared with the wild-type enzyme. This report describes possible mechanisms for alteration of the enantiopreferences of carbonyl reductases by site mutation, and cofactor rebalancing pathways for efficient chiral alcohols production.	[Zhang, Rongzhen; Zhang, Botao; Xu, Yan; Li, Yaohui; Li, Ming; Liang, Hongbo] Jiangnan Univ, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China; [Zhang, Rongzhen; Zhang, Botao; Xu, Yan; Li, Yaohui; Li, Ming; Liang, Hongbo] Jiangnan Univ, Sch Biotechnol, Wuxi, Peoples R China; [Zhang, Rongzhen; Xu, Yan; Li, Yaohui; Li, Ming; Liang, Hongbo] Jiangnan Univ, Natl Key Lab Food Sci, Wuxi, Peoples R China; [Zhang, Botao] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Xiao, Rong] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA	Jiangnan University; Jiangnan University; Jiangnan University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Rutgers State University New Brunswick	Xu, Y (corresponding author), Jiangnan Univ, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China.	yxu@jiangnan.edu.cn			National Key Basic Research and Development Program of China (973 Program) [2011CB710800]; National Science Foundation of China [31070059, 31370100]; Programme of Introducing Talents of Discipline to Universities [111-2-06]; Jiangsu Province Basic Research Program (Natural Science Foundation) [BK20131101]	National Key Basic Research and Development Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Programme of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); Jiangsu Province Basic Research Program (Natural Science Foundation)	This project was supported by the National Key Basic Research and Development Program of China (973 Program 2011CB710800), the National Science Foundation of China (31070059 and 31370100), the Programme of Introducing Talents of Discipline to Universities (No. 111-2-06), and Jiangsu Province Basic Research Program (Natural Science Foundation BK20131101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Bergmeyer H, 1985, METHOD ENZYMAT AN, V5, P15; Blaser H.-U., 2010, ASYMMETRIC CATALYSIS, Vsecond; Blazyk JL, 2004, J BIOL CHEM, V279, P5630, DOI 10.1074/jbc.M308940200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cedrone F, 2000, CURR OPIN STRUC BIOL, V10, P405, DOI 10.1016/S0959-440X(00)00106-8; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; Chen XJ, 2011, AFR J MICROBIOL RES, V5, P5882, DOI 10.5897/AJMR11.831; de Felipe FL, 1998, J BACTERIOL, V180, P3804; Endo T, 2001, ADV SYNTH CATAL, V343, P521, DOI 10.1002/1615-4169(200108)343:6/7<521::AID-ADSC521>3.0.CO;2-5; Faber K., 2018, BIOTRANSFORMATIONS O; Faber K., 2002, ANGEW CHEM, V114, P1056, DOI [10.1002/1521-3757(20020315)114:6, DOI 10.1002/1521-3757(20020315)114:6]; Flanagan JU, 2004, BIOCHEM J, V380, P353, DOI 10.1042/BJ20040062; Groger H, 2004, TETRAHEDRON, V60, P633, DOI 10.1016/j.tet.2003.11.066; Groger H, 2006, ANGEW CHEM INT EDIT, V45, P5677, DOI 10.1002/anie.200503394; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUMMEL W, 1989, EUR J BIOCHEM, V184, P1, DOI 10.1111/j.1432-1033.1989.tb14983.x; Itoh N, 2004, APPL MICROBIOL BIOT, V66, P53, DOI 10.1007/s00253-004-1702-7; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Kataoka M, 1999, APPL MICROBIOL BIOT, V51, P486, DOI 10.1007/s002530051421; Kizaki N, 2001, APPL MICROBIOL BIOT, V55, P590, DOI 10.1007/s002530100599; Koshland DE, 1998, NAT MED, V4, P1112, DOI 10.1038/2605; Kosjek B, 2008, ORG PROCESS RES DEV, V12, P584, DOI 10.1021/op700255b; Kroutil W, 2004, CURR OPIN CHEM BIOL, V8, P120, DOI 10.1016/j.cbpa.2004.02.005; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Masuda K, 2005, CHIRALITY, V17, P37, DOI 10.1002/chir.20092; Morley KL, 2005, TRENDS BIOTECHNOL, V23, P231, DOI 10.1016/j.tibtech.2005.03.005; Nie Y, 2007, APPL ENVIRON MICROB, V73, P3759, DOI 10.1128/AEM.02185-06; Nissen TL, 2001, YEAST, V18, P19, DOI 10.1002/1097-0061(200101)18:1<19::AID-YEA650>3.3.CO;2-X; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Pfrunder H, 2004, ANGEW CHEM, V116, P4629, DOI [DOI 10.1002/ANGE.200460241, 10.1002/ange.200460241]; RINGQUIST S, 1992, MOL MICROBIOL, V6, P1219, DOI 10.1111/j.1365-2958.1992.tb01561.x; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Schoemaker HE, 2003, SCIENCE, V299, P1694, DOI 10.1126/science.1079237; Schroer K, 2009, BIOTECHNOL BIOENG, V104, P251, DOI 10.1002/bit.22390; Tishkov VI, 1999, BIOTECHNOL BIOENG, V64, P187, DOI 10.1002/(SICI)1097-0290(19990720)64:2<187::AID-BIT7>3.0.CO;2-0; van der Donk WA, 2003, CURR OPIN BIOTECH, V14, P421, DOI 10.1016/S0958-1669(03)00094-6; Wandrey C, 2004, CHEM REC, V4, P254, DOI 10.1002/tcr.20016; Wichmann R, 2005, ADV BIOCHEM ENG BIOT, V92, P225, DOI 10.1007/b98911; Xiao ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008860; Ye Q, 2010, BIORESOURCE TECHNOL, V101, P6761, DOI 10.1016/j.biortech.2010.03.099; Zhang RZ, 2008, PROTEIN SCI, V17, P1412, DOI 10.1110/ps.035089.108; Zhang RZ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-167; Zhang RZ, 2011, BIORESOURCE TECHNOL, V102, P483, DOI 10.1016/j.biortech.2010.08.060; Zhang Rongzhen, 2009, Weishengwu Xuebao, V49, P204; Zhang YP, 2009, METAB ENG, V11, P101, DOI 10.1016/j.ymben.2008.11.001	47	14	17	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83586	10.1371/journal.pone.0083586	http://dx.doi.org/10.1371/journal.pone.0083586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358299	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700063
J	Dasgupta, SK; Le, A; Haudek, SB; Entman, ML; Rumbaut, RE; Thiagarajan, P				Dasgupta, Swapan K.; Anhquyen Le; Haudek, Sandra B.; Entman, Mark L.; Rumbaut, Rolando E.; Thiagarajan, Perumal			Rho Associated Coiled-Coil Kinase-1 Regulates Collagen-Induced Phosphatidylserine Exposure in Platelets	PLOS ONE			English	Article							BCL-X(L)-INHIBITORY BH3 MIMETICS; ACTIN STRESS FIBERS; PROTEIN-KINASE; SHAPE CHANGE; PROCOAGULANT RESPONSE; SIGNALING PATHWAYS; ROCK-II; PHOSPHORYLATION; BINDING; CYTOSKELETON	Background: The transbilayer movement of phosphatidylserine mediates the platelet procoagulant activity during collagen stimulation. The Rho-associated coiled-coil kinase (ROCK) inhibitor Y-27632 inhibits senescence induced but not activation induced phosphatidylserine exposure. To investigate further the specific mechanisms, we now utilized mice with genetic deletion of the ROCK1 isoform. Methods and Results: ROCK1-deficient mouse platelets expose significantly more phosphatidylserine and generate more thrombin upon activation with collagen compared to wild-type platelets. There were no significant defects in platelet shape change, aggregation, or calcium response compared to wild-type platelets. Collagen-stimulated ROCK1-deficient platelets also displayed decreased phosphorylation levels of Lim Kinase-1 and cofilin-1. However, there was no reduction in phosphorylation levels of myosin phosphatase subunit-1 (MYPT1) or myosin light chain (MLC). In an in vivo light/dye-induced endothelial injury/thrombosis model, ROCK1-deficient mice presented a shorter occlusion time in cremasteric venules when compared to wild-type littermates (3.16 +/- 1.33 min versus 6.6 +/- 2.6 min; p = 0.01). Conclusions: These studies define ROCK1 as a new regulator for collagen-induced phosphatidylserine exposure in platelets with functional consequences on thrombosis. This effect was downstream of calcium signaling and was mediated by Lim Kinase-1 / cofilin-1-induced cytoskeletal changes.	[Dasgupta, Swapan K.; Anhquyen Le; Rumbaut, Rolando E.; Thiagarajan, Perumal] Baylor Coll Med, Michael E DeBakey Vet Affairs Med Ctr, Ctr Translat Res Inflammatory Dis, Houston, TX 77030 USA; [Dasgupta, Swapan K.; Anhquyen Le; Thiagarajan, Perumal] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Haudek, Sandra B.; Entman, Mark L.; Rumbaut, Rolando E.; Thiagarajan, Perumal] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Rumbaut, Rolando E.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Dasgupta, SK (corresponding author), Baylor Coll Med, Michael E DeBakey Vet Affairs Med Ctr, Ctr Translat Res Inflammatory Dis, Houston, TX 77030 USA.	swapand@bcm.edu		Rumbaut, Rolando/0000-0002-8486-1013; Thiagarajan, Perumal/0000-0003-2186-7036	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; National Institutes of Health [HL116524, HL089792]; National Blood Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116524, R01HL089792] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000550, I01BX000502] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Blood Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by grants from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development (to PT and RR), grants from National Institutes of Health (HL116524 to RR and PT; HL089792 to MLE and SBH) and by a grant from the National Blood Foundation (to SKD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bender M, 2010, BLOOD, V116, P1767, DOI 10.1182/blood-2010-03-274340; Bergmeier W, 2009, BLOOD, V113, P675, DOI 10.1182/blood-2008-08-174516; Dasgupta SK, 2006, TRANSL RES, V148, P19, DOI 10.1016/j.lab.2006.03.006; Dasgupta SK, 2010, TRANSFUSION, V50, P2167, DOI 10.1111/j.1537-2995.2010.02676.x; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Freikman I, 2012, J MEMBRANE BIOL, V245, P779, DOI 10.1007/s00232-012-9478-7; Garg S, 2009, J STRUCT BIOL, V168, P11, DOI 10.1016/j.jsb.2009.04.001; Getz TM, 2010, J THROMB HAEMOST, V8, P2283, DOI 10.1111/j.1538-7836.2010.04000.x; Gilio K, 2010, J BIOL CHEM, V285, P23629, DOI 10.1074/jbc.M110.108696; Haudek SB, 2009, CARDIOVASC RES, V83, P511, DOI 10.1093/cvr/cvp135; Jeremy KP, 2009, HAEMATOL-HEMATOL J, V94, P1354, DOI 10.3324/haematol.2009.006585; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; Kunzelmann-Marche C, 2001, J BIOL CHEM, V276, P5134, DOI 10.1074/jbc.M007924200; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Lock FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008190; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Manno S, 2002, P NATL ACAD SCI USA, V99, P1943, DOI 10.1073/pnas.042688399; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; McCullough BR, 2008, J MOL BIOL, V381, P550, DOI 10.1016/j.jmb.2008.05.055; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Munnix ICA, 2009, THROMB HAEMOSTASIS, V102, P1149, DOI 10.1160/TH09-05-0289; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Patel KN, 2008, ARTERIOSCL THROM VAS, V28, P2225, DOI 10.1161/ATVBAHA.108.175679; Paul BZS, 1999, J BIOL CHEM, V274, P28293, DOI 10.1074/jbc.274.40.28293; Rennebaum S, 2012, PROTEINS, V80, P1998, DOI 10.1002/prot.24088; Schoenwaelder SM, 2012, BLOOD, V119, P1320, DOI 10.1182/blood-2011-10-387399; Schoenwaelder SM, 2011, BLOOD, V118, P1663, DOI 10.1182/blood-2011-04-347849; Siljander P, 2001, ARTERIOSCL THROM VAS, V21, P618, DOI 10.1161/01.ATV.21.4.618; Stalker Timothy J, 2012, Handb Exp Pharmacol, P59, DOI 10.1007/978-3-642-29423-5_3; STOUT AL, 1994, BIOPHYS J, V67, P1324, DOI 10.1016/S0006-3495(94)80604-6; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Suzuki Y, 1999, BLOOD, V93, P3408, DOI 10.1182/blood.V93.10.3408.410k37_3408_3417; THIAGARAJAN P, 1990, J BIOL CHEM, V265, P17420; THIAGARAJAN P, 1991, J BIOL CHEM, V266, P24302; Thumkeo D, 2005, GENES CELLS, V10, P825, DOI 10.1111/j.1365-2443.2005.00882.x; WEISS HJ, 1994, SEMIN HEMATOL, V31, P312; Wilde JI, 2000, PLATELETS, V11, P286; WILLIAMSON P, 1985, J CELL PHYSIOL, V123, P209, DOI 10.1002/jcp.1041230209; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Zhang YM, 2006, FASEB J, V20, P916, DOI 10.1096/fj.05-5129com	46	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84649	10.1371/journal.pone.0084649	http://dx.doi.org/10.1371/journal.pone.0084649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358370	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700164
J	Flatten, I; Skarstad, K				Flatten, Ingvild; Skarstad, Kirsten			The Fis Protein Has a Stimulating Role in Initiation of Replication in Escherichia coli In Vivo	PLOS ONE			English	Article							DNA-REPLICATION; CHROMOSOME-REPLICATION; DIVISION CYCLE; FLOW-CYTOMETRY; ORIGIN; BINDING; MECHANISM; EXPRESSION; COMPLEXES; INVERSION	The Fis protein is a nucleoid associated protein that has previously been reported to act negatively in initiation of replication in Escherichia coli. In this work we have examined the influence of this protein on the initiation of replication under different growth conditions using flow cytometry. The Fis protein was found to be increasingly important with increasing growth rate. During multi-fork replication severe under-initiation occurred in cells lacking the Fis protein; the cells initiated at an elevated mass, had fewer origins per cell and the origins were not initiated in synchrony. These results suggest a positive role for the Fis protein in the initiation of replication.	[Flatten, Ingvild; Skarstad, Kirsten] Oslo Univ Hosp, Dept Cell Biol, Inst Canc Res, Norwegian Radiumhosp, Oslo, Norway	University of Oslo	Skarstad, K (corresponding author), Oslo Univ Hosp, Dept Cell Biol, Inst Canc Res, Norwegian Radiumhosp, Oslo, Norway.	Kirsten.Skarstad@rr-research.no		Flatten, Ingvild/0000-0002-4213-1135	Norwegian Research Council FUGE program; CAMST platform; FRIBIO program	Norwegian Research Council FUGE program(Research Council of Norway); CAMST platform; FRIBIO program	This work was supported by The Norwegian Research Council FUGE program and CAMST platform and the FRIBIO program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAI T, 1992, MOL GEN GENET, V231, P169, DOI 10.1007/BF00279788; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; BALL CA, 1992, J BACTERIOL, V174, P8043, DOI 10.1128/JB.174.24.8043-8056.1992; BATES DB, 1995, NUCLEIC ACIDS RES, V23, P3119, DOI 10.1093/nar/23.16.3119; BOYE E, 1991, RES MICROBIOL, V142, P131, DOI 10.1016/0923-2508(91)90020-B; Boye E, 1996, P NATL ACAD SCI USA, V93, P12206, DOI 10.1073/pnas.93.22.12206; Boye E, 1992, DNA REPLICATION CELL, P15; Bradley MD, 2007, MICROBIOL-SGM, V153, P2922, DOI 10.1099/mic.0.2007/008565-0; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Bremer H, 1996, ESCHERICHIA COLI SAL; Browning DF, 2010, CURR OPIN MICROBIOL, V13, P773, DOI 10.1016/j.mib.2010.09.013; CASSLER MR, 1995, EMBO J, V14, P5833, DOI 10.1002/j.1460-2075.1995.tb00271.x; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; FILUTOWICZ M, 1992, J BACTERIOL, V174, P398, DOI 10.1128/jb.174.2.398-407.1992; FINKEL SE, 1992, MOL MICROBIOL, V6, P3257, DOI 10.1111/j.1365-2958.1992.tb02193.x; Flatten I, 2009, MOL MICROBIOL, V71, P1018, DOI 10.1111/j.1365-2958.2008.06585.x; Froelich JM, 1996, J BACTERIOL, V178, P6006, DOI 10.1128/jb.178.20.6006-6012.1996; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; GILLE H, 1991, NUCLEIC ACIDS RES, V19, P4167, DOI 10.1093/nar/19.15.4167; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; HELMSTETTER CE, 1996, ESCHERICHIA COLI SAL, P1627; HIASA H, 1994, J BIOL CHEM, V269, P24999; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; KOCH C, 1988, P NATL ACAD SCI USA, V85, P4237, DOI 10.1073/pnas.85.12.4237; Leonard AC, 2005, MOL MICROBIOL, V55, P978, DOI 10.1111/j.1365-2958.2004.04467.x; Leonard AC, 2010, CURR OPIN MICROBIOL, V13, P766, DOI 10.1016/j.mib.2010.10.001; Margulies C, 1998, NUCLEIC ACIDS RES, V26, P5170, DOI 10.1093/nar/26.22.5170; McGarry KC, 2004, P NATL ACAD SCI USA, V101, P2811, DOI 10.1073/pnas.0400340101; Morigen, 2003, MOL MICROBIOL, V50, P349, DOI 10.1046/j.1365-2958.2003.03695.x; Morigen, 2009, GENES CELLS, V14, P643, DOI 10.1111/j.1365-2443.2009.01298.x; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Ozaki S, 2009, PLASMID, V62, P71, DOI 10.1016/j.plasmid.2009.06.003; Riber L, 2009, MOL MICROBIOL, V71, P107, DOI 10.1111/j.1365-2958.2008.06516.x; ROTH A, 1994, BIOCHIMIE, V76, P917, DOI 10.1016/0300-9084(94)90016-7; Ryan VT, 2004, MOL MICROBIOL, V51, P1347, DOI 10.1046/j.1365-2958.2003.03906.x; Skarstad K, 1995, METHOD ENZYMOL, V262, P604; SKARSTAD K, 1986, EMBO J, V5, P1711, DOI 10.1002/j.1460-2075.1986.tb04415.x; SKARSTAD K, 1990, EMBO J, V9, P2341, DOI 10.1002/j.1460-2075.1990.tb07406.x; Skarstad K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012922; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; Stokke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030981; Torheim NK, 2000, MOL MICROBIOL, V37, P629, DOI 10.1046/j.1365-2958.2000.02031.x; Waldminghaus T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-414; Weigel C, 2001, MOL MICROBIOL, V40, P498, DOI 10.1046/j.1365-2958.2001.02409.x; Wold S, 1996, NUCLEIC ACIDS RES, V24, P3527, DOI 10.1093/nar/24.18.3527	46	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83562	10.1371/journal.pone.0083562	http://dx.doi.org/10.1371/journal.pone.0083562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358293	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700131
J	Kedem, A; Haas, J; Geva, LL; Yerushalmi, G; Gilboa, Y; Kanety, H; Hanochi, M; Maman, E; Hourvitz, A				Kedem, Alon; Haas, Jigal; Geva, Liat Lerner; Yerushalmi, Gil; Gilboa, Yinon; Kanety, Hanna; Hanochi, Mirit; Maman, Ettie; Hourvitz, Ariel			Ongoing Pregnancy Rates in Women with Low and Extremely Low AMH Levels. A Multivariate Analysis of 769 Cycles	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; IN-VITRO FERTILIZATION; ANTRAL FOLLICLE COUNT; ANTIMULLERIAN HORMONE; OVARIAN RESPONSE; LIVE-BIRTH; ASSISTED REPRODUCTION; MENSTRUAL-CYCLE; PREDICTION; IVF	Background: The ideal test for ovarian reserve should permit the identification of women who have no real chance of pregnancy with IVF treatments consequent upon an extremely reduced ovarian reserve. The aim of the current study was to evaluate pregnancy rates in patients with low AMH levels (0.2-1 ng/ml) and extremely low AMH levels (< 0.2 ng/ml) and to determine the cumulative pregnancy rates following consecutive IVF treatments. Methods: We conducted an historical cohort analysis at a tertiary medical center. Serum AMH levels were measured at initial clinic visit and prior to all following treatment cycles in 181 women (769 cycles) with an initial AMH level <= 1 ng/ml, undergoing IVF-ICSI. Main outcome measures were laboratory outcomes and pregnancy rates. Results: Seventy patients undergoing 249 cycles had extremely low AMH levels (<= 0.2 ng/ml), whereas 111 patients undergoing 520 cycles had low AMH levels (0.21-1.0 ng/ml). Number of oocytes retrieved per cycle, fertilized oocytes and number of transferred embryos were significantly lower in the extremely low AMH levels group compared to the low AMH levels (P < 0.003). Crude ongoing pregnancy rates were 4.4% for both groups of patients. Among 48 cycles of women aged >= 42 with AMH levels of <= 0.2 ng/ml no pregnancies were observed. But, in patients with AMH levels of 0.2-1.0 ng/ml, 3 ongoing pregnancies out of 192 cycles (1.6%) were observed. However, in a multivariate regression analysis adjusted for age and cycle characteristics, no significant differences in ongoing pregnancy rates per cycle between the two groups were evident. Cumulative pregnancy rates of 20% were observed following five cycles, for both groups of patients. Conclusions: Patients with extremely low AMH measurements have reasonable and similar pregnancy rates as patients with low AMH. Therefore, AMH should not be used as the criterion to exclude couples from performing additional IVF treatments.	[Kedem, Alon; Haas, Jigal; Yerushalmi, Gil; Gilboa, Yinon; Maman, Ettie; Hourvitz, Ariel] Chaim Sheba Med Ctr, Dept Obstet & Gynecol, IVF Unit, IL-52621 Tel Hashomer, Israel; [Kedem, Alon; Haas, Jigal; Geva, Liat Lerner; Yerushalmi, Gil; Gilboa, Yinon; Kanety, Hanna; Hanochi, Mirit; Maman, Ettie; Hourvitz, Ariel] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Geva, Liat Lerner] Gertner Inst Epidemiol & Hlth Policy Res Ltd, Women & Childrens Hlth Res Unit, Tel Hashomer, Israel; [Kanety, Hanna; Hanochi, Mirit] Chaim Sheba Med Ctr, Inst Endocrinol, IL-52621 Tel Hashomer, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center	Kedem, A (corresponding author), Chaim Sheba Med Ctr, Dept Obstet & Gynecol, IVF Unit, IL-52621 Tel Hashomer, Israel.	kedem2001@gmail.com						Arce JC, 2013, FERTIL STERIL, V99, P1644, DOI 10.1016/j.fertnstert.2012.12.048; Barad DH, 2009, FERTIL STERIL, V91, P1553, DOI 10.1016/j.fertnstert.2008.09.069; Bhide P, 2013, REPROD BIOMED ONLINE, V26, P247, DOI 10.1016/j.rbmo.2012.11.018; Brodin T, 2013, J CLIN ENDOCR METAB, V98, P1107, DOI 10.1210/jc.2012-3676; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Broer SL, 2009, FERTIL STERIL, V91, P705, DOI 10.1016/j.fertnstert.2007.12.013; Kedem A, 2013, J ASSIST REPROD GENE; La Marca A, 2007, HUM REPROD, V22, P766, DOI 10.1093/humrep/del421; Lande Y, 2011, FERTIL STERIL, V95, P568, DOI 10.1016/j.fertnstert.2010.06.005; Lee TH, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-100; Li HWR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061095; Nakhuda GS, 2006, FERTIL STERIL, V85, P1541, DOI 10.1016/j.fertnstert.2005.10.052; Nardo LG, 2007, GYNECOL ENDOCRINOL, V23, P486, DOI 10.1080/09513590701532815; Nelson SM, 2011, REPROD BIOMED ONLINE, V23, P411, DOI 10.1016/j.rbmo.2011.06.011; Nelson SM, 2007, HUM REPROD, V22, P2414, DOI 10.1093/humrep/dem204; Nelson SM, 2013, FERTIL STERIL, V99, P963, DOI 10.1016/j.fertnstert.2012.11.051; Nelson SM, 2009, HUM REPROD, V24, P867, DOI 10.1093/humrep/den480; Patrelli TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044571; Singer T, 2009, FERTIL STERIL, V91, P2616, DOI 10.1016/j.fertnstert.2008.03.034; Smeenk JMJ, 2007, FERTIL STERIL, V87, P223, DOI 10.1016/j.fertnstert.2006.06.019; Streuli I, 2008, FERTIL STERIL, V90, P395, DOI 10.1016/j.fertnstert.2007.06.023; Tokura Y, 2013, J ASSIST REPROD GENE; Wang JG, 2010, REPROD BIOMED ONLINE, V21, P757, DOI 10.1016/j.rbmo.2010.06.041; Weghofer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034290; Weghofer A, 2011, HUM REPROD, V26, P1905, DOI 10.1093/humrep/der134	25	27	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81629	10.1371/journal.pone.0081629	http://dx.doi.org/10.1371/journal.pone.0081629			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24363812	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700015
J	de Quiros, YB; Seewald, JS; Sylva, SP; Greer, B; Niemeyer, M; Bogomolni, AL; Moore, MJ				de Quiros, Yara Bernaldo; Seewald, Jeffrey S.; Sylva, Sean P.; Greer, Bill; Niemeyer, Misty; Bogomolni, Andrea L.; Moore, Michael J.			Compositional Discrimination of Decompression and Decomposition Gas Bubbles in Bycaught Seals and Dolphins	PLOS ONE			English	Article							CETACEANS; EMBOLISM; LESIONS	Gas bubbles in marine mammals entangled and drowned in gillnets have been previously described by computed tomography, gross examination and histopathology. The absence of bacteria or autolytic changes in the tissues of those animals suggested that the gas was produced peri- or post-mortem by a fast decompression, probably by quickly hauling animals entangled in the net at depth to the surface. Gas composition analysis and gas scoring are two new diagnostic tools available to distinguish gas embolisms from putrefaction gases. With this goal, these methods have been successfully applied to pathological studies of marine mammals. In this study, we characterized the flux and composition of the gas bubbles from bycaught marine mammals in anchored sink gillnets and bottom otter trawls. We compared these data with marine mammals stranded on Cape Cod, MA, USA. Fresh animals or with moderate decomposition (decomposition scores of 2 and 3) were prioritized. Results showed that bycaught animals presented with significantly higher gas scores than stranded animals. Gas composition analyses indicate that gas was formed by decompression, confirming the decompression hypothesis.	[de Quiros, Yara Bernaldo; Bogomolni, Andrea L.; Moore, Michael J.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Seewald, Jeffrey S.; Sylva, Sean P.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Greer, Bill] Integrated Stat, Woods Hole, MA USA; [Greer, Bill] NOAA NMFS Northeast Fisheries, Woods Hole, MA USA; [Niemeyer, Misty] Int Fund Anim Welf, Yarmouth Port, MA USA; [Bogomolni, Andrea L.] Univ Connecticut, Dept Pathobiol & Vet Sci, Storrs, CT USA	Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution; University of Connecticut	de Quiros, YB (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	ybernaldodequiros@whoi.edu	Sylva, Sean/D-4400-2014; Moore, Michael/E-1707-2015; de Quirós, Yara Bernaldo/A-3628-2015	Sylva, Sean/0000-0002-4727-440X; Moore, Michael/0000-0003-3074-6631; de Quirós, Yara Bernaldo/0000-0002-2611-0406	Woods Hole Oceanographic Institution Marine Mammal Center; Wick and Sloan Simmons	Woods Hole Oceanographic Institution Marine Mammal Center; Wick and Sloan Simmons	This study was funded by the Woods Hole Oceanographic Institution Marine Mammal Center, and Wick and Sloan Simmons. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong HG, 1939, ANAL GAS EMBOLI ENG; Bernaldo de Quiros Y, 2011, THESIS U PALMAS GRAN; de Quiros YB, 2013, INT J LEGAL MED, V127, P437, DOI 10.1007/s00414-012-0783-6; de Quiros YB, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00177; Bernaldo de QuiruEs, 2012, PROTOCOL EXCHANGE, DOI 10.1038/protex.2012.002; Bert P., 1878, PRESSION BAROMETRIQU; BROWN CD, 1978, J FORENSIC SCI, V23, P511; Cole AJ, 2006, J CLIN PATHOL, V59, P489, DOI 10.1136/jcp.2005.031708; Cowan D, 1979, DIS FACTORS STENELLA; de Quiros YB, 2011, SCI REP-UK, V1, DOI 10.1038/srep00193; Dennison S, 2012, P ROY SOC B-BIOL SCI, V279, P1396, DOI 10.1098/rspb.2011.1754; EGGLETON P, 1945, J PHYSIOL-LONDON, V104, P129, DOI 10.1113/jphysiol.1945.sp004111; Fernandez A, 2005, VET PATHOL, V42, P446, DOI 10.1354/vp.42-4-446; Fernandez A, 2012, J MARINE SCI RES DEV, V2; Francis T. J. R., 2003, BENNETT ELLIOTTS PHY, P530; HARRIS M, 1945, J GEN PHYSIOL, V28, P225, DOI 10.1085/jgp.28.3.225; Heimesaat MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040758; Hutter CDD, 2000, MED HYPOTHESES, V54, P585, DOI 10.1054/mehy.1999.0901; ISHIYAMA A, 1983, Bulletin of Tokyo Medical and Dental University, V30, P25; Ishiyama A, 1981, 6 M PAN DIV PHYS TEC, P201; Jackowski C, 2005, FORENSIC SCI INT, V149, P11, DOI 10.1016/j.forsciint.2004.05.019; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; Jepson PD, 2005, VET PATHOL, V42, P291, DOI 10.1354/vp.42-3-291; King J. M., 1989, NECROPSY BOOK; Knight B., 1996, FORENSIC PATHOLOGY, V2nd ed.; Kuiken T, 1991, NEWSLETTER; Lawrence C., 1997, SPUMS J, V27, P228; LEVER MJ, 1966, J PHYSIOL-LONDON, V184, P964, DOI 10.1113/jphysiol.1966.sp007960; LILLO RS, 1992, UNDERSEA BIOMED RES, V19, P375; Lorber B, 2000, PRINCIPLES PRACTICE; Moore MJ, 2009, VET PATHOL, V46, P536, DOI 10.1354/vp.08-VP-0065-M-FL; Moore MJ, 2004, SCIENCE, V306, P2215, DOI 10.1126/science.1105452; Pierucci G, 1968, Zacchia, V4, P347; ROMMEL SA, 1994, J COMP PHYSIOL B, V164, P130, DOI 10.1007/BF00301654; SHIM SS, 1967, CAN MED ASSOC J, V97, P1263	35	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e83994	10.1371/journal.pone.0083994	http://dx.doi.org/10.1371/journal.pone.0083994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367623	gold, Green Submitted, Green Published			2022-12-27	WOS:000328741900027
J	Dickson, BG; Roemer, GW; McRae, BH; Rundall, JM				Dickson, Brett G.; Roemer, Gary W.; McRae, Brad H.; Rundall, Jill M.			Models of Regional Habitat Quality and Connectivity for Pumas (Puma concolor) in the Southwestern United States	PLOS ONE			English	Article							SOUTHERN CALIFORNIA; GENETIC-STRUCTURE; COUGAR; CONSERVATION; POPULATIONS; VEGETATION; MOVEMENT; RANGE; CARNIVORES; DISPERSAL	The impact of landscape changes on the quality and connectivity of habitats for multiple wildlife species is of global conservation concern. In the southwestern United States, pumas (Puma concolor) are a well distributed and wide-ranging large carnivore that are sensitive to loss of habitat and to the disruption of pathways that connect their populations. We used an expert-based approach to define and derive variables hypothesized to influence the quality, location, and permeability of habitat for pumas within an area encompassing the entire states of Arizona and New Mexico. Survey results indicated that the presence of woodland and forest cover types, rugged terrain, and canyon bottom and ridgeline topography were expected to be important predictors of both high quality habitat and heightened permeability. As road density, distance to water, or human population density increased, the quality and permeability of habitats were predicted to decline. Using these results, we identified 67 high quality patches across the study area, and applied concepts from electronic circuit theory to estimate regional patterns of connectivity among these patches. Maps of current flow among individual pairs of patches highlighted possible pinch points along two major interstate highways. Current flow summed across all pairs of patches highlighted areas important for keeping the entire network connected, regardless of patch size. Cumulative current flow was highest in Arizona north of the Colorado River and around Grand Canyon National Park, and in the Sky Islands region owing to the many small habitat patches present. Our outputs present a first approximation of habitat quality and connectivity for dispersing pumas in the southwestern United States. Map results can be used to help target finer-scaled analyses in support of planning efforts concerned with the maintenance of puma metapopulation structure, as well as the protection of landscape features that facilitate the dispersal process.	[Dickson, Brett G.] Conservat Sci Partners Inc, Truckee, CA USA; [Dickson, Brett G.; Rundall, Jill M.] No Arizona Univ, Sch Earth Sci & Environm Sustainabil, Lab Landscape Ecol & Conservat Biol, Flagstaff, AZ 86011 USA; [Roemer, Gary W.] New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA; [McRae, Brad H.] Nature Conservancy, Seattle, WA USA	Northern Arizona University; New Mexico State University; Nature Conservancy	Dickson, BG (corresponding author), Conservat Sci Partners Inc, Truckee, CA USA.	brett@csp-inc.org			Wilburforce Foundation; Grand Canyon Trust; New Mexico State University Agricultural Experiment Station	Wilburforce Foundation; Grand Canyon Trust; New Mexico State University Agricultural Experiment Station	Funding for this work was provided by the Wilburforce Foundation, the Grand Canyon Trust, and the New Mexico State University Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beier P, 2011, CONSERV BIOL, V25, P879, DOI 10.1111/j.1523-1739.2011.01716.x; Beier Paul, 2010, P141; Bunn AG, 2000, J ENVIRON MANAGE, V59, P265, DOI 10.1006/jema.2000.0373; Burdett CL, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00005.1; Carroll C, 2001, ECOL APPL, V11, P961, DOI 10.1890/1051-0761(2001)011[0961:CAFSFC]2.0.CO;2; Carroll C, 2012, CONSERV BIOL, V26, P78, DOI 10.1111/j.1523-1739.2011.01753.x; Clevenger AP, 2002, CONSERV BIOL, V16, P503, DOI 10.1046/j.1523-1739.2002.00328.x; Cooley HS, 2009, ECOLOGY, V90, P2913, DOI 10.1890/08-1805.1; Crooks K. R., 2006, CONNECTIVITY CONSERV; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Dickson BG, 2007, J ZOOL, V271, P270, DOI 10.1111/j.1469-7998.2006.00215.x; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Dickson BG, 2002, J WILDLIFE MANAGE, V66, P1235, DOI 10.2307/3802956; Ernest HB, 2003, CONSERV GENET, V4, P353, DOI 10.1023/A:1024069014911; Flesch AD, 2010, CONSERV BIOL, V24, P171, DOI 10.1111/j.1523-1739.2009.01277.x; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Johnson CJ, 2012, EXPERT KNOWLEDGE AND ITS APPLICATION IN LANDSCAPE ECOLOGY, P153, DOI 10.1007/978-1-4614-1034-8_8; Kalies EL, 2010, FOREST ECOL MANAG, V259, P333, DOI 10.1016/j.foreco.2009.10.024; Kertson BN, 2011, ECOL APPL, V21, P2866, DOI 10.1890/11-0947.1; Kunkel KE, 2013, ANIM CONSERV, V16, P32, DOI 10.1111/j.1469-1795.2012.00568.x; LaPoint S, 2013, LANDSCAPE ECOL, V28, P1615, DOI 10.1007/s10980-013-9910-0; Lawler JJ, 2013, ECOL LETT, V16, P1014, DOI 10.1111/ele.12132; Logan K.A., 2001, DESERT PUMA EVOLUTIO; Lovich JE, 2011, BIOSCIENCE, V61, P982, DOI 10.1525/bio.2011.61.12.8; Loxterman JL, 2011, CONSERV GENET, V12, P1049, DOI 10.1007/s10592-011-0208-y; Malczewski J., 2000, T GIS, V4, P5, DOI [10.1111/1467-9671.00035, DOI 10.1111/1467-9671.00035]; McKenzie D, 2004, CONSERV BIOL, V18, P890, DOI 10.1111/j.1523-1739.2004.00492.x; McKinney T, 2009, SOUTHWEST NAT, V54, P151, DOI 10.1894/CLG-14.1; Mcrae BH, 2005, MOL ECOL, V14, P1965, DOI 10.1111/j.1365-294X.2005.02571.x; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Nicholson KL, 2009, THESIS U ARIZONA TUC; Noon Barry R., 2008, P51; Pearce JL, 2001, J APPL ECOL, V38, P412, DOI 10.1046/j.1365-2664.2001.00608.x; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Rollins MG, 2009, INT J WILDLAND FIRE, V18, P235, DOI 10.1071/WF08088; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Stoner DC, 2008, J WILDLIFE MANAGE, V72, P933, DOI 10.2193/2007-219; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Thompson DJ, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00028.1; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Williams AP, 2010, P NATL ACAD SCI USA, V107, P21289, DOI 10.1073/pnas.0914211107; Wilmers CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060590; Zollner PA, 1999, OIKOS, V84, P164, DOI 10.2307/3546878	45	58	61	1	149	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81898	10.1371/journal.pone.0081898	http://dx.doi.org/10.1371/journal.pone.0081898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367495	Green Submitted, Green Published, gold			2022-12-27	WOS:000328740300014
J	Peng, H; Yang, M; Chen, ZY; Chen, P; Guan, CX; Xiang, XD; Cai, S; Chen, Y; Fang, X				Peng, Hong; Yang, Min; Chen, Zhi-yong; Chen, Ping; Guan, Cha-xiang; Xiang, Xu-dong; Cai, Shan; Chen, Yan; Fang, Xiang			Expression and Methylation of Mitochondrial Transcription Factor A in Chronic Obstructive Pulmonary Disease Patients with Lung Cancer	PLOS ONE			English	Article							SEPTAL CELL APOPTOSIS; DNA METHYLATION; CIGARETTE-SMOKE; PROMOTER METHYLATION; N-ACETYLCYSTEINE; FACTOR-I; GENE; EPIGENETICS; DEATH; HYPERMETHYLATION	Background: Apoptosis plays a central role in the pathogenesis of chronic obstructive pulmonary disease (COPD), and this process can be regulated by mitochondrial transcription factor A (mtTFA). Epigenetics is involved in the regulation and modification of the genes involved in lung cancer and COPD. In this study, we determined the expression of mtTFA and its methylation levels in the COPD patients with lung cancer. Methods: Twenty-one squamous cell lung cancer patients, 11 with COPD and 10 without COPD, undergoing pneumonectomy were enrolled. The apoptotic index (AI) of pulmonary vascular endothelial cells was analyzed by transferase-mediated deoxyuridine triphosphate-biotin nick end labeling assay. The expression of mtTFA mRNA and protein was measured using PCR, immunohistochemistry and Western-blot. Methylation of the mtTFA promoter was detected using bisulfite sequencing PCR. Results: Compared to the non-COPD group, the AI was higher, and expression of mtTFA mRNA and protein was lower in the COPD group (P < 0.001). Expression of the mtTFA protein was positively correlated with FEV1/Pre (r = 0.892, P < 0.001), and negatively correlated with AI (r = -20.749, P < 0.001) and smoke index (r = 20.763, P < 0.001). Percentage of mtTFA promoter methylation in the COPD patients was significantly higher compared to the non-COPD patients (P < 0.05). Conclusion: These results suggest that the expression of mtTFA mRNA and protein is down-regulated in the lung tissue from the COPD patients with squamous cell lung cancer, and the level of mtTFA protein is related to apoptosis of pulmonary vascular endothelial cells. Aberrant mtTFA methylation may also play an important role in the pathogenesis of COPD.	[Peng, Hong; Yang, Min; Chen, Ping; Xiang, Xu-dong; Cai, Shan; Chen, Yan] Cent S Univ, Dept Resp Med, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Yang, Min] Cent S Univ, Human Key Lab Med Epigen, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Chen, Zhi-yong] Cent S Univ, Dept Urol, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Guan, Cha-xiang] Cent S Univ, Physiol Res Ctr, Xiangya Med Sch, Changsha, Hunan, Peoples R China; [Fang, Xiang] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA	Central South University; Central South University; Central South University; Central South University; University of Texas System; University of Texas Medical Branch Galveston	Chen, P (corresponding author), Cent S Univ, Dept Resp Med, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.	pingchen0731@sina.com		Guan, Cha-Xiang/0000-0002-8505-8724; Peng, Hong/0000-0003-3235-3348; Chen, Ping/0000-0001-6707-8636	National Natural Science Foundation of China [30800503, 30770931, 81070039]; National Natural Science Foundation of Hunan Province [09JJ3036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province)	The study was supported by the National Natural Science Foundation of China (No. 30800503, No. 30770931 and No. 81070039) and the National Natural Science Foundation of Hunan Province (No. 09JJ3036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2007, CURR OPIN IMMUNOL, V19, P694, DOI 10.1016/j.coi.2007.07.016; Barnes Peter J, 2009, Proc Am Thorac Soc, V6, P693, DOI 10.1513/pats.200907-071DP; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Baryshnikova E, 2008, CLIN CANCER RES, V14, P1913, DOI 10.1158/1078-0432.CCR-07-1741; Belinsky SA, 1996, P NATL ACAD SCI USA, V93, P4045, DOI 10.1073/pnas.93.9.4045; Bowman RV, 2006, RESPIROLOGY, V11, P355, DOI 10.1111/j.1440-1843.2006.00859.x; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Cai S, 2009, RESPIROLOGY, V14, P354, DOI 10.1111/j.1440-1843.2009.01511.x; CAPLIN M, 1975, BRIT MED J, V3, P678, DOI 10.1136/bmj.3.5985.678; Chen Y, 2009, AM J PHYSIOL-LUNG C, V296, pL648, DOI 10.1152/ajplung.90270.2008; Choi YS, 2004, BIOCHEM BIOPH RES CO, V314, P118, DOI 10.1016/j.bbrc.2003.12.065; CLAYTON DA, 1992, INT REV CYTOL, V141, P217, DOI 10.1016/S0074-7696(08)62067-7; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Georgiou E, 2007, EUR J CANCER PREV, V16, P396, DOI 10.1097/01.cej.0000236260.26265.d6; Giordano RJ, 2008, J BIOL CHEM, V283, P29447, DOI 10.1074/jbc.M804595200; Hillemacher T, 2008, EUR NEUROPSYCHOPHARM, V18, P295, DOI 10.1016/j.euroneuro.2007.12.005; Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835; Kagan Jacob, 2007, Cancer Res, V67, P4545, DOI 10.1158/0008-5472.CAN-06-2888; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Kikuchi S, 2006, CANCER-AM CANCER SOC, V106, P1751, DOI 10.1002/cncr.21800; Lange NE, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001231; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Liu H, 2007, ONCOGENE, V26, P5900, DOI 10.1038/sj.onc.1210400; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Miyanaga A, 2008, MOL CANCER THER, V7, P1923, DOI 10.1158/1535-7163.MCT-07-2140; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pulling LC, 2004, CANCER RES, V64, P3844, DOI 10.1158/0008-5472.CAN-03-2119; Punturieri A, 2009, JNCI-J NATL CANCER I, V101, P554, DOI 10.1093/jnci/djp023; Qiu WL, 2012, AM J RESP CRIT CARE, V185, P373, DOI 10.1164/rccm.201108-1382OC; Remels AH, 2007, EUR RESPIR J, V30, P245, DOI 10.1183/09031936.00144106; SAETTA M, 1985, AM REV RESPIR DIS, V131, P764; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; Shivapurkar N, 2007, CANCER LETT, V247, P56, DOI 10.1016/j.canlet.2006.03.020; Soria JC, 2002, CANCER RES, V62, P351; Szyf M, 2009, ANNU REV PHARMACOL, V49, P243, DOI 10.1146/annurev-pharmtox-061008-103102; Taraseviciene-Stewart L, 2005, AM J RESP CRIT CARE, V171, P734, DOI 10.1164/rccm.200409-1275OC; Terry MB, 2008, CANCER EPIDEM BIOMAR, V17, P2306, DOI 10.1158/1055-9965.EPI-08-0312; Vertino PM, 1996, MOL CELL BIOL, V16, P4555, DOI 10.1128/mcb.16.8.4555; Wan ES, 2012, HUM MOL GENET, V21, P3073, DOI 10.1093/hmg/dds135; Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798; Xu L, 2004, CHINESE MED J-PEKING, V117, P1611; Zhang C, 2008, CHINESE MED J-PEKING, V121, P597, DOI 10.1097/00029330-200804010-00005	45	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82739	10.1371/journal.pone.0082739	http://dx.doi.org/10.1371/journal.pone.0082739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367550	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300063
J	Utsumi, F; Kajiyama, H; Nakamura, K; Tanaka, H; Mizuno, M; Ishikawa, K; Kondo, H; Kano, H; Hori, M; Kikkawa, F				Utsumi, Fumi; Kajiyama, Hiroaki; Nakamura, Kae; Tanaka, Hiromasa; Mizuno, Masaaki; Ishikawa, Kenji; Kondo, Hiroki; Kano, Hiroyuki; Hori, Masaru; Kikkawa, Fumitaka			Effect of Indirect Nonequilibrium Atmospheric Pressure Plasma on Anti-Proliferative Activity against Chronic Chemo-Resistant Ovarian Cancer Cells In Vitro and In Vivo	PLOS ONE			English	Article							DIELECTRIC BARRIER DISCHARGE; EPITHELIAL OVARIAN; ENHANCED CHEMOSENSITIVITY; HYDROGEN-PEROXIDE; NONTHERMAL PLASMA; PACLITAXEL; APOPTOSIS	Purpose: Nonequilibrium atmospheric pressure plasma (NEAPP) therapy has recently been focused on as a novel medical practice. Using cells with acquired paclitaxel/cisplatin resistance, we elucidated effects of indirect NEAPP-activated medium (NEAPP-AM) exposure on cell viability and tumor growth in vitro and in vivo. Methods: Using chronic paclitaxel/cisplatin-resistant ovarian cancer cells, we applied indirect NEAPP-exposed medium to cells and xenografted tumors in a mouse model. Furthermore, we examined the role of reactive oxygen species (ROS) or their scavengers in the above-mentioned EOC cells. Results: We assessed the viability of NOS2 and NOS3 cells exposed to NEAPP-AM, which was prepared beforehand by irradiation with NEAPP for the indicated time. In NOS2 cells, viability decreased by approximately 30% after NEAPP-AM 120-sec treatment (P<0.01). The growth-inhibitory effects of NEAPP-AM were completely inhibited by N-acetyl cysteine treatment, while L-buthionine-[S, R]-sulfoximine, an inhibitor of the ROS scavenger used with NEAPP-AM, decreased cell viability by 85% after NEAPP-AM 60-sec treatment(P<0.05) and by 52% after 120 sec, compared to the control (P<0.01). In the murine subcutaneous tumor-formation model, NEAPP-AM injection resulted in an average inhibition of the NOS2 cell-inoculated tumor by 66% (P<0.05) and NOS2TR cell-inoculated tumor by 52% (P<0.05), as compared with the control. Conclusion: We demonstrated that plasma-activated medium also had an anti-tumor effect on chemo-resistant cells in vitro and in vivo. Indirect plasma therapy is a promising treatment option for EOC and may contribute to a better patient prognosis in the future.	[Utsumi, Fumi; Kajiyama, Hiroaki; Nakamura, Kae; Kikkawa, Fumitaka] Nagoya Univ, Grad Sch Med, Dept Obstet & Gynecol, Showa Ku, Nagoya, Aichi 4648601, Japan; [Tanaka, Hiromasa; Ishikawa, Kenji; Kondo, Hiroki; Hori, Masaru] Nagoya Univ, Grad Sch Engn, Dept Elect Engn & Comp Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Mizuno, Masaaki] Nagoya Univ, Grad Sch Med, Ctr Adv Med & Clin Res, Showa Ku, Nagoya, Aichi 4648601, Japan; [Kano, Hiroyuki] NU Ecoengn Co Ltd, Miyoshi, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University	Kajiyama, H (corresponding author), Nagoya Univ, Grad Sch Med, Dept Obstet & Gynecol, Showa Ku, Nagoya, Aichi 4648601, Japan.	kajiyama@med.nagoya-u.ac.jp	Ishikawa, Kenji/I-6758-2014; Tanaka, Hiromasa/AAE-3764-2019; KIKKAWA, Fumitaka/I-7341-2014; Kondo, Hiroki/I-6759-2014; UTSUMI, Fumi/I-6388-2015	Ishikawa, Kenji/0000-0002-8288-6620; Kondo, Hiroki/0000-0002-8336-3995; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [24108008]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas, Grant No. 24108008 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjunan KP, 2011, PLASMA PROCESS POLYM, V8, P1154, DOI 10.1002/ppap.201100078; Arjunan KP, 2012, J R SOC INTERFACE, V9, P147, DOI 10.1098/rsif.2011.0220; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Barros GP, 2012, INT J GEOPHYS, V2012, DOI [10.1155/2012/459497, 10.5402/2012/137289]; Brulle L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052653; Brun P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033245; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Cotgreave I, 1997, ADV PHARMACOL, V38, P206; FRIDMAN A, 2008, PLASMA CHEM; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Fridman G, 2006, PLASMA CHEM PLASMA P, V26, P425, DOI 10.1007/s11090-006-9024-4; Iseki S, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3694928; Iwasaki M, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2885084; Jia FD, 2011, APPL PHYS EXPRESS, V4; Kajiyama H, 2002, CANCER RES, V62, P2753; Kajiyama H, 2007, INT J ONCOL, V31, P277; Kajiyama H, 2010, CANCER SCI, V101, P347, DOI 10.1111/j.1349-7006.2009.01378.x; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kalghatgi S, 2010, ANN BIOMED ENG, V38, P748, DOI 10.1007/s10439-009-9868-x; Kim CH, 2010, J BIOTECHNOL, V150, P530, DOI 10.1016/j.jbiotec.2010.10.003; Lee J, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.06GF01; Maeda O, 2012, INT J CANCER, V130, P113, DOI 10.1002/ijc.25983; Miyahara T, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/45001; Morfill GE, 2009, NEW J PHYS, V11; Naitali M, 2010, APPL ENVIRON MICROB, V76, P7662, DOI 10.1128/AEM.01615-10; Oehmigen K, 2010, PLASMA PROCESS POLYM, V7, P250, DOI 10.1002/ppap.200900077; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Sato T, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/37/372001; Sensenig R, 2011, ANN BIOMED ENG, V39, P674, DOI 10.1007/s10439-010-0197-x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sun H, 2011, CANCER LETT, V310, P118, DOI 10.1016/j.canlet.2011.06.010; Tanaka H, 2011, PLASMA MED, V1, P265, DOI DOI 10.1615/PLASMAMED.2012006275; Teoh D, 2012, INT J GYNECOL CANCER, V22, P348, DOI 10.1097/IGC.0b013e31823c6efd; Usha L, 2011, GYNECOL ONCOL, V121, P455, DOI 10.1016/j.ygyno.2011.02.013; Vandamme M, 2010, PLASMA PROCESS POLYM, V7, P264, DOI 10.1002/ppap.200900080; Wang QO, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-159; Yamashita M, 2007, INT J CANCER, V120, P2243, DOI 10.1002/ijc.22528; Yamazaki H, 2011, DENT MATER J, V30, P384, DOI 10.4012/dmj.2010-190; Yousfi M, 2013, FUNDAMENTAL CLIN PHA	39	274	278	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81576	10.1371/journal.pone.0081576	http://dx.doi.org/10.1371/journal.pone.0081576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367486	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300007
J	de Goeij, M; van Eijk, LT; Vanelderen, P; Wilder-Smith, OH; Vissers, KC; van der Hoeven, JG; Kox, M; Scheffer, GJ; Pickkers, P				de Goeij, Moniek; van Eijk, Lucas T.; Vanelderen, Pascal; Wilder-Smith, Oliver H.; Vissers, Kris C.; van der Hoeven, Johannes G.; Kox, Matthijs; Scheffer, Gert Jan; Pickkers, Peter			Systemic Inflammation Decreases Pain Threshold in Humans In Vivo	PLOS ONE			English	Article							TO-BRAIN COMMUNICATION; MELANOCYTE-STIMULATING HORMONE; TUMOR-NECROSIS-FACTOR; NERVE GROWTH-FACTOR; MECHANICAL ALLODYNIA; INDUCED HYPERALGESIA; HUMAN ENDOTOXEMIA; CYTOKINE; INTERLEUKIN-10; BEHAVIOR	Background: Hyperalgesia is a well recognized hallmark of disease. Pro-inflammatory cytokines have been suggested to be mainly responsible, but human data are scarce. Changes in pain threshold during systemic inflammation evoked by human endotoxemia, were evaluated with three quantitative sensory testing methods. Methods and Results: Pressure pain thresholds, electrical pain thresholds and tolerance to the cold pressor test were measured before and 2 hours after the intravenous administration of 2 ng/kg purified E. coli endotoxin in 27 healthy volunteers. Another 20 subjects not exposed to endotoxemia served as controls. Endotoxemia led to a rise in body temperature and inflammatory symptom scores and a rise in plasma TNF-alpha, IL-6, IL-10 and IL-1RA. During endotoxemia, pressure pain thresholds and electrical pain thresholds were reduced with 20 +/- 4 % and 13 +/- 3 %, respectively. In controls only a minor decrease in pressure pain thresholds (7 +/- 3 %) and no change in electrical pain thresholds occurred. Endotoxin-treated subjects experienced more pain during the cold pressor test, and fewer subjects were able to complete the cold pressor test measurement, while in controls the cold pressor test results were not altered. Peak levels and area under curves of each individual cytokine did not correlate to a change in pain threshold measured by one of the applied quantitative sensory testing techniques. Conclusions and Significance: In conclusion, this study shows that systemic inflammation elicited by the administration of endotoxin to humans, results in lowering of the pain threshold measured by 3 quantitative sensory testing techniques. The current work provides additional evidence that systemic inflammation is accompanied by changes in pain perception.	[de Goeij, Moniek; Vanelderen, Pascal; Wilder-Smith, Oliver H.; Vissers, Kris C.; Kox, Matthijs; Scheffer, Gert Jan] RUNMC, Dept Anesthesiol Pain & Palliat Med, Nijmegen, Netherlands; [van Eijk, Lucas T.; van der Hoeven, Johannes G.; Kox, Matthijs; Pickkers, Peter] RUNMC, Dept Intens Care Med, Nijmegen, Netherlands; [van Eijk, Lucas T.; van der Hoeven, Johannes G.; Kox, Matthijs; Pickkers, Peter] Nijmegen Inst Infect Inflammat & Immun RUNMC, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Pickkers, P (corresponding author), RUNMC, Dept Intens Care Med, Nijmegen, Netherlands.	p.pickkers@ic.umcn.nl	Wilder-Smith, Oliver H.G./E-7541-2012; Pickkers, P./H-8080-2014; Vissers, Kris/H-8110-2014; Kox, Matthijs/L-4454-2015; van der Hoeven, J.G./H-8048-2014; van Eijk, Lucas T/H-4036-2016; Vissers, Kris C.P./D-3569-2009; Scheffer, G.J./H-8086-2014	Wilder-Smith, Oliver H.G./0000-0003-4390-2381; Pickkers, P./0000-0002-1104-4303; Vissers, Kris/0000-0002-2919-6356; Vissers, Kris C.P./0000-0002-2919-6356; 	Organisation for Health Research and Development (ZonMw), The Hague, Netherlands	Organisation for Health Research and Development (ZonMw), The Hague, Netherlands	LvE is a recipient of a grant from the Organisation for Health Research and Development (ZonMw), The Hague, Netherlands(http://www.zonmw.nl/nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Bahador M, 2007, J ENDOTOXIN RES, V13, P251, DOI 10.1177/0968051907085986; Benson S, 2012, PAIN, V153, P794, DOI 10.1016/j.pain.2011.12.001; Chacur M, 2004, PAIN, V108, P180, DOI 10.1016/j.pain.2003.12.023; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Diogenes A, 2011, DENT RES, V90, P759, DOI [10.1177/0022034511400225, DOI 10.1177/0022034511400225.PUBMED:21393555]; Dorresteijn MJ, 2005, J ENDOTOXIN RES, V11, P287, DOI 10.1179/096805105X58715; FOLLENFANT RL, 1989, BRIT J PHARMACOL, V98, P41, DOI 10.1111/j.1476-5381.1989.tb16860.x; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Laughlin TM, 2000, PAIN, V84, P159, DOI 10.1016/S0304-3959(99)00195-5; Ledeboer A, 2007, BRAIN BEHAV IMMUN, V21, P686, DOI 10.1016/j.bbi.2006.10.012; LEVINE FM, 1991, PAIN, V44, P69, DOI 10.1016/0304-3959(91)90149-R; Maier SF, 1998, PSYCHOL REV, V105, P83, DOI 10.1037/0033-295X.105.1.83; Maier SF, 1998, ANN NY ACAD SCI, V840, P289, DOI 10.1111/j.1749-6632.1998.tb09569.x; Milligan ED, 2005, EUR J NEUROSCI, V21, P2136, DOI 10.1111/j.1460-9568.2005.04057.x; Milligan ED, 2006, PAIN, V126, P294, DOI 10.1016/j.pain.2006.07.009; Ozaktay AC, 2006, EUR SPINE J, V15, P1529, DOI 10.1007/s00586-005-0058-8; Oka T, 1996, BRAIN RES, V736, P237, DOI 10.1016/S0006-8993(96)00705-6; POOLE S, 1992, BRIT J PHARMACOL, V106, P489, DOI 10.1111/j.1476-5381.1992.tb14361.x; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Uceyler N, 2007, NEUROLOGY, V69, P42, DOI 10.1212/01.wnl.0000265062.92340.a5; van Eijk LTGJ, 2005, CRIT CARE, V9, pR157, DOI 10.1186/cc3050; Walk D, 2009, CLIN J PAIN, V25, P632, DOI 10.1097/AJP.0b013e3181a68c64; WATKINS LR, 1995, LIFE SCI, V57, P1011, DOI 10.1016/0024-3205(95)02047-M; Wieseler-Frank J, 2005, BRAIN BEHAV IMMUN, V19, P104, DOI 10.1016/j.bbi.2004.08.004; Woolf CJ, 1997, BRIT J PHARMACOL, V121, P417, DOI 10.1038/sj.bjp.0701148	27	61	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84159	10.1371/journal.pone.0084159	http://dx.doi.org/10.1371/journal.pone.0084159			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358337	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700082
J	Garcia, Y; Callaway, RM; Diaconu, A; Montesinos, D				Garcia, Yedra; Callaway, Ragan M.; Diaconu, Alecu; Montesinos, Daniel			Invasive and Non-Invasive Congeners Show Similar Trait Shifts between Their Same Native and Non-Native Ranges	PLOS ONE			English	Article							STARTHISTLE CENTAUREA-SOLSTITIALIS; ALIEN PLANTS; SEED SIZE; GROWTH; EVOLUTION; IMPACTS; DETERMINANTS; METAANALYSIS; POPULATIONS; RESISTANCE	Differences in morphological or ecological traits expressed by exotic species between their native and non-native ranges are often interpreted as evidence for adaptation to new conditions in the non-native ranges. In turn this adaptation is often hypothesized to contribute to the successful invasion of these species. There is good evidence for rapid evolution by many exotic invasives, but the extent to which these evolutionary changes actually drive invasiveness is unclear. One approach to resolving the relationship between adaptive responses and successful invasion is to compare traits between populations from the native and non-native ranges for both exotic invaders and congeners that are exotic but not invasive. We compared a suite of morphological traits that are commonly tested in the literature in the context of invasion for three very closely related species of Centaurea, all of which are sympatric in the same native and non-native ranges in Europe and North America. Of these, C. solstitialis is highly invasive whereas C. calcitrapa and C. sulphurea are not. For all three species, plants from non-native populations showed similar shifts in key traits that have been identified in other studies as important putative adaptive responses to post-introduction invasion. For example, for all three species plants from populations in non-native ranges were (i) larger and (ii) produced seeds that germinated at higher rates. In fact, the non-invasive C. calcitrapa showed the strongest trait shift between ranges. Centaurea solstitialis was the only species for which plants from the non-native range increased allocation to defensive spines, and allocated proportionally less resources to reproduction, patterns contrary to what would be predicted by theory and other empirical studies to enhance invasion. Our results suggest caution when interpreting the commonly observed increase in size and reproductive capacity as factors that cause exotics to become invaders.	[Garcia, Yedra; Montesinos, Daniel] Univ Coimbra, Ctr Funct Ecol, Coimbra, Portugal; [Callaway, Ragan M.; Montesinos, Daniel] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Diaconu, Alecu] Inst Biol Res Iasi, Biol Control Lab, Iasi, Romania; [Montesinos, Daniel] UV, CSIC, Ctr Invest Desertificac CIDE, GV, Valencia, Spain	Universidade de Coimbra; University of Montana System; University of Montana; National Research Institute for Biological Sciences; Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia; CSIC-GV-UV - Centro de Investigaciones sobre Desertificacion (CIDE)	Garcia, Y (corresponding author), Univ Coimbra, Ctr Funct Ecol, Coimbra, Portugal.	yedragg@gmail.com	DIACONU, Alecu/A-9299-2011; Garcia, Yedra/M-2167-2019; Montesinos, Daniel/A-9070-2012	Garcia, Yedra/0000-0003-3373-1355; Montesinos, Daniel/0000-0003-2893-0878	NSF-DEB [0614406]; NSF EPSCoR; Spanish Micinn [2008-0662]; Portuguese FCT [SFRH/BPD/72595/2010]; Marie Curie Career Integration Grant; Office of Integrative Activities [1443108] Funding Source: National Science Foundation	NSF-DEB(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NSF EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD)); Spanish Micinn(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Portuguese FCT(Portuguese Foundation for Science and Technology); Marie Curie Career Integration Grant; Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	RMC was funded by NSF-DEB 0614406 and thanks NSF EPSCoR; DM was funded by the Spanish Micinn (2008-0662), by the Portuguese FCT (SFRH/BPD/72595/2010), and by a Marie Curie Career Integration Grant (FP7-321909); YG was funded by DM's MC-CIG (FP7-321909). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker H. G., 1965, The genetics of colonizing species., P147; Barbe GD, 1989, NOXIOUS WEEDS CALIFO; Bastlova-Hanzelyova D, 2001, PLANT INVASIONS: SPECIES ECOLOGY AND ECOSYSTEM MANAGEMENT, P33; Bennett JR, 2013, BIOL INVASIONS, V15, P707, DOI 10.1007/s10530-012-0320-z; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Buckley YM, 2003, ECOLOGY, V84, P1434, DOI 10.1890/0012-9658(2003)084[1434:AIBAGS]2.0.CO;2; Burns JH, 2004, DIVERS DISTRIB, V10, P387, DOI 10.1111/j.1366-9516.2004.00105.x; Cadotte MW, 2006, ECOSCIENCE, V13, P388, DOI 10.2980/i1195-6860-13-3-388.1; Callaway RM, 2011, ECOLOGY, V92, P2208, DOI 10.1890/11-0518.1; Castro SA, 2005, DIVERS DISTRIB, V11, P183, DOI 10.1111/j.1366-9516.2005.00145.x; Cronk QCB, 1995, PLANT INVADERS THREA; Crooks Jeffrey A., 1999, Population and Community Biology Series, V24, P103; Daehler CC, 1997, OECOLOGIA, V110, P99, DOI 10.1007/s004420050138; Daehler CC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004462; DiTomaso JM, 2000, WEED SCI, V48, P255, DOI 10.1614/0043-1745(2000)048[0255:IWIRSI]2.0.CO;2; Dlugosch KM, 2013, G3-GENES GENOM GENET, V3, P359, DOI 10.1534/g3.112.003871; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Elton C. S., 1958, ECOLOGY INVASIONS AN; Essl F, 2011, P NATL ACAD SCI USA, V108, P203, DOI 10.1073/pnas.1011728108; Garcia-Jacas N, 2006, ANN BOT-LONDON, V98, P741, DOI 10.1093/aob/mcl157; Gerlach JD, 2003, ECOL APPL, V13, P167, DOI 10.1890/1051-0761(2003)013[0167:TLHCOI]2.0.CO;2; Gerlach JD, 1997, P CALIF WEED SCI SOC, V49, P136; Graebner RC, 2012, PLANT ECOL, V213, P545, DOI 10.1007/s11258-012-0020-x; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; Hierro JL, 2009, OIKOS, V118, P529, DOI [10.1111/j.1600-0706.2009.17283.x, 10.1111/j.1600-0706.2008.17283.x]; HOBBS RJ, 1995, CONSERV BIOL, V9, P761, DOI 10.1046/j.1523-1739.1995.09040761.x; Jakobs G, 2004, DIVERS DISTRIB, V10, P11, DOI 10.1111/j.1472-4642.2004.00052.x; Kelly M, 1996, P CAL EX PEST PLANT, P61; Knapp S, 2012, ECOL LETT, V15, P696, DOI 10.1111/j.1461-0248.2012.01787.x; Kudoh H, 2007, ECOL RES, V22, P869, DOI 10.1007/s11284-007-0417-5; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lambrinos JG, 2002, ECOLOGY, V83, P518, DOI 10.1890/0012-9658(2002)083[0518:TVISOC]2.0.CO;2; Leger EA, 2003, ECOL LETT, V6, P257, DOI 10.1046/j.1461-0248.2003.00423.x; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Maddox DM, 1996, CAN J BOT, V74, P262, DOI 10.1139/b96-031; MADDOX DM, 1985, WEED SCI, V33, P315, DOI 10.1017/S0043174500082357; Maron JL, 2004, ECOLOGY, V85, P3243, DOI 10.1890/04-0297; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Milbau A, 2008, CONSERV BIOL, V22, P308, DOI 10.1111/j.1523-1739.2007.00877.x; Montesinos D, 2012, AM NAT, V180, P529, DOI 10.1086/667585; Muth NZ, 2006, AM J BOT, V93, P188, DOI 10.3732/ajb.93.2.188; Nijs I, 2004, WEED TECHNOL, V18, P1240, DOI 10.1614/0890-037X(2004)018[1240:NMFAAP]2.0.CO;2; Penuelas J, 2010, GLOBAL CHANGE BIOL, V16, P2171, DOI 10.1111/j.1365-2486.2009.02054.x; Pitcairn MJ, 2002, WEED TECHNOL, V16, P452, DOI 10.1614/0890-037X(2002)016[0452:PSCCSG]2.0.CO;2; Pysek P, 2003, OECOLOGIA, V135, P122, DOI 10.1007/s00442-002-1170-7; Pysek Petr, 2007, V193, P97; R Core Team, 2012, R LANG ENV STAT COMP; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Ridenour WM, 2008, ECOL MONOGR, V78, P369, DOI 10.1890/06-1926.1; ROBBINS W. W., 1940, CALIFORNIA AGRIC EXP STA BULL, V637, P1; Seabloom EW, 2006, ECOL APPL, V16, P1338, DOI 10.1890/1051-0761(2006)016[1338:HIPIAI]2.0.CO;2; Siemann E, 2001, ECOL LETT, V4, P514, DOI 10.1046/j.1461-0248.2001.00274.x; Sun M, 1997, CAN J BOT, V75, P1470, DOI 10.1139/b97-861; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; Thebaud C, 1996, ECOLOGY, V77, P791, DOI 10.2307/2265502; Thomsen CD, 1993, CALIF AGR, V47, P36; van Kleunen M, 2010, ECOL LETT, V13, P947, DOI 10.1111/j.1461-0248.2010.01503.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Widmer TL, 2007, WEED SCI, V55, P465, DOI 10.1614/WS-06-211R.1; Williamson MH, 1996, BIOL CONSERV, V78, P163, DOI 10.1016/0006-3207(96)00025-0; Willis AJ, 1999, OECOLOGIA, V120, P632, DOI 10.1007/s004420050899	66	19	20	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82281	10.1371/journal.pone.0082281	http://dx.doi.org/10.1371/journal.pone.0082281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358163	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700009
J	Hammar, L; Andersson, S; Eggertsen, L; Haglund, J; Gullstrom, M; Ehnberg, J; Molander, S				Hammar, Linus; Andersson, Sandra; Eggertsen, Linda; Haglund, Johan; Gullstrom, Martin; Ehnberg, Jimmy; Molander, Sverker			Hydrokinetic Turbine Effects on Fish Swimming Behaviour	PLOS ONE			English	Article							RENEWABLE ENERGY; GENERATING ELECTRICITY; REEF FISHES; CONNECTIVITY; ECOLOGY; PREDATORS; PROSPECTS; TURBIDITY; TESTS; VIDEO	Hydrokinetic turbines, targeting the kinetic energy of fast-flowing currents, are under development with some turbines already deployed at ocean sites around the world. It remains virtually unknown as to how these technologies affect fish, and rotor collisions have been postulated as a major concern. In this study the effects of a vertical axis hydrokinetic rotor with rotational speeds up to 70 rpm were tested on the swimming patterns of naturally occurring fish in a subtropical tidal channel. Fish movements were recorded with and without the rotor in place. Results showed that no fish collided with the rotor and only a few specimens passed through rotor blades. Overall, fish reduced their movements through the area when the rotor was present. This deterrent effect on fish increased with current speed. Fish that passed the rotor avoided the near-field, about 0.3 m from the rotor for benthic reef fish. Large predatory fish were particularly cautious of the rotor and never moved closer than 1.7 m in current speeds above 0.6 ms(-1). The effects of the rotor differed among taxa and feeding guilds and it is suggested that fish boldness and body shape influenced responses. In conclusion, the tested hydrokinetic turbine rotor proved non-hazardous to fish during the investigated conditions. However, the results indicate that arrays comprising multiple turbines may restrict fish movements, particularly for large species, with possible effects on habitat connectivity if migration routes are exploited. Arrays of the investigated turbine type and comparable systems should therefore be designed with gaps of several metres width to allow large fish to pass through. In combination with further research the insights from this study can be used for guiding the design of hydrokinetic turbine arrays where needed, so preventing ecological impacts.	[Hammar, Linus; Ehnberg, Jimmy; Molander, Sverker] Chalmers Univ Technol, Environm & Energy Dept, S-41296 Gothenburg, Sweden; [Andersson, Sandra] Marine Monitoring AB, Lysekil, Sweden; [Eggertsen, Linda; Haglund, Johan; Gullstrom, Martin] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden	Chalmers University of Technology; Stockholm University	Hammar, L (corresponding author), Chalmers Univ Technol, Environm & Energy Dept, S-41296 Gothenburg, Sweden.	linus.hammar@chalmers.se	Molander, Sverker/E-1462-2012	Molander, Sverker/0000-0002-9081-8847	Chalmersska Research Foundation [Dnr CS2010/53]; Aforsk foundation; Swedish International Development Cooperation Agency (Sida) [SWE-2010-194]	Chalmersska Research Foundation; Aforsk foundation; Swedish International Development Cooperation Agency (Sida)	The study recieved financial support from the Chalmersska Research Foundation (Dnr CS2010/53), the Aforsk foundation (http://www.aforsk.se/in-english.php), and Swedish International Development Cooperation Agency (Sida) (SWE-2010-194, http://www.sida.se/English/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able KW, 2005, ESTUAR COAST SHELF S, V64, P5, DOI 10.1016/j.ecss.2005.02.002; Bahaj AS, 2011, RENEW SUST ENERG REV, V15, P3399, DOI 10.1016/j.rser.2011.04.032; Battey, 2013, ENV EFFECTS MARINE E; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkstrom C, 2012, ESTUAR COAST SHELF S, V107, P1, DOI 10.1016/j.ecss.2012.03.020; Boehlert GW, 2010, OCEANOGRAPHY, V23, P68, DOI 10.5670/oceanog.2010.46; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Broadhurst M, 2011, 9 EUR WAV TID EN C S; Bshary R, 2002, BEHAV ECOL SOCIOBIOL, V52, P365, DOI 10.1007/s00265-002-0527-6; Cada G.F., 1997, DEV BIOL CRITERIA DE; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Dirnwoeber M, 2012, REMOTE SENS-BASEL, V4, P3346, DOI 10.3390/rs4113346; Domenici P, 2002, MAR FRESHW BEHAV PHY, V35, P87, DOI 10.1080/10236240290025635; Douglas R.H., 1990, P373; EPRI, 2011, EV FISH INJ MORT ASS; Esteban M, 2012, APPL ENERG, V90, P128, DOI 10.1016/j.apenergy.2011.06.011; Frid C, 2012, ENVIRON IMPACT ASSES, V32, P133, DOI 10.1016/j.eiar.2011.06.002; Froese R, 2013, FISHBASE; Gill AB, 2005, J APPL ECOL, V42, P605, DOI 10.1111/j.1365-2664.2005.01060.x; Gorlov A, 2001, TIDAL ENERGY; Grabbe M, 2009, RENEW SUST ENERG REV, V13, P1898, DOI 10.1016/j.rser.2009.01.026; Hammar L, 2012, 1 ASIAN WAVE TIDAL C, P8; Hammar L, 2012, RENEW ENERG, V44, P414, DOI 10.1016/j.renene.2012.02.010; HAMMER C, 1995, COMP BIOCHEM PHYS A, V112, P1, DOI 10.1016/0300-9629(95)00060-K; Harvey E, 2002, FISH RES, V57, P255, DOI 10.1016/S0165-7836(01)00356-3; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Inger R, 2009, J APPL ECOL, V46, P1145, DOI 10.1111/j.1365-2664.2009.01697.x; Jeffrey H, TECHNOL FOR IN PRESS; Kennish M.J., 1992, ECOLOGY ESTUARIES AN; Khan MJ, 2008, RENEW SUST ENERG REV, V12, P2177, DOI 10.1016/j.rser.2007.04.016; Khan MJ, 2009, APPL ENERG, V86, P1823, DOI 10.1016/j.apenergy.2009.02.017; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Langhamer O, 2012, SCI WORLD J, DOI 10.1100/2012/386713; Laroche J, 1997, J FISH BIOL, V51, P3, DOI 10.1111/j.1095-8649.1997.tb02509.x; Lewis A., 2011, IPCC SPECIAL REPORT; Liao JC, 2007, PHILOS T R SOC B, V362, P1973, DOI 10.1098/rstb.2007.2082; Lindsey CC, 1978, FISH PHYSIOL, VVII, DOI DOI 10.1016/S1546-5098(08)60163-6; Mavume AF, 2000, THROUGHFLOW PONTA TE; Meager JJ, 2006, J EXP BIOL, V209, P4174, DOI 10.1242/jeb.02489; Miner JG, 1996, T AM FISH SOC, V125, P97, DOI 10.1577/1548-8659(1996)125<0097:DOPAHC>2.3.CO;2; Mumby PJ, 2006, BIOL CONSERV, V128, P215, DOI 10.1016/j.biocon.2005.09.042; Mumby PJ, 2002, MAR POLLUT BULL, V44, P85, DOI 10.1016/S0025-326X(01)00097-2; Muntz W.R.A., 1990, P491; Normandeau Associates, 2009, EST SURV INJ FISH PA; Pelc R, 2002, MAR POLICY, V26, P471, DOI 10.1016/S0308-597X(02)00045-3; Quinn G, 2002, EXPT DES DATA ANAL B, P339; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Robinson CJ, 2007, J FISH BIOL, V71, P200, DOI 10.1111/j.1095-8649.2007.01484.x; Rourke FO, 2010, APPL ENERG, V87, P398, DOI 10.1016/j.apenergy.2009.08.014; Schilt CR, 2007, APPL ANIM BEHAV SCI, V104, P295, DOI 10.1016/j.applanim.2006.09.004; Schweizer PE, 2011, ESTIMATION RISKS COL; SMITH J. L. B., 1938, TRANS ROY SOC S AFRICA, V26, P225; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Stoner AW, 2004, J FISH BIOL, V65, P1445, DOI 10.1111/j.0022-1112.2004.00593.x; Toms CN., 2010, INT J COMPPSYCHOL, V23, P1, DOI DOI 10.1002/CPMO.17; Verdant Power, 2010, FIN KIN HYDR PIL LIC; Viehman HA, 2012, FISH TIDALLY DYNAMIC; WARE DM, 1978, J FISH RES BOARD CAN, V35, P220, DOI 10.1139/f78-036; Watson DL, 2007, MAR FRESHW BEHAV PHY, V40, P85, DOI 10.1080/10236240701393263; WEBB PW, 1994, MECHANICS AND PHYSIOLOGY OF ANIMAL SWIMMING, P45; Wilson B., 2007, REPORT SCOTTISH EXEC	63	37	37	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84141	10.1371/journal.pone.0084141	http://dx.doi.org/10.1371/journal.pone.0084141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358334	gold, Green Published			2022-12-27	WOS:000328737700081
J	Jenks, KR; Lucas, MM; Duffy, BA; Robbins, AA; Gimi, B; Barry, JM; Scott, RC				Jenks, Kyle R.; Lucas, Marcella M.; Duffy, Ben A.; Robbins, Ashlee A.; Gimi, Barjor; Barry, Jeremy M.; Scott, Rod C.			Enrichment and Training Improve Cognition in Rats with Cortical Malformations	PLOS ONE			English	Article							ENVIRONMENTAL ENRICHMENT; METHYLAZOXYMETHANOL ACETATE; EPILEPSY; CHILDHOOD; CHILDREN; SEIZURE; DISRUPTION; BEHAVIOR; NEURONS; MODEL	Children with malformations of cortical development (MCD) frequently have associated cognitive impairments which reduce quality of life. We hypothesized that cognitive deficits associated with MCD can be improved with environmental manipulation or additional training. The E17 methylazoxymethanol acetate (MAM) exposure model bears many anatomical hallmarks seen in human MCDs as well as similar behavioral and cognitive deficits. We divided control and MAM exposed Sprague-Dawley rats into enriched and non-enriched groups and tested performance in the Morris water maze. Another group similarly divided underwent sociability testing and also underwent Magnetic Resonance Imaging (MRI) scans pre and post enrichment. A third group of control and MAM rats without enrichment were trained until they reached criterion on the place avoidance task. MAM rats had impaired performance on spatial tasks and enrichment improved performance of both control and MAM animals. Although MAM rats did not have a deficit in sociability they showed similar improvement with enrichment as controls. MRI revealed a whole brain volume decrease with MAM exposure, and an increase in both MAM and control enriched volumes in comparison to non-enriched animals. In the place avoidance task, MAM rats required approximately 3 times as long to reach criterion as control animals, but with additional training were able to reach control performance. Environmental manipulation and additional training can improve cognition in a rodent MCD model. We therefore suggest that patients with MCD may benefit from appropriate alterations in educational strategies, social interaction and environment. These factors should be considered in therapeutic strategies.	[Jenks, Kyle R.; Lucas, Marcella M.; Robbins, Ashlee A.; Barry, Jeremy M.; Scott, Rod C.] Geisel Sch Med Dartmouth, Dept Neurol, Lebanon, NH USA; [Duffy, Ben A.] UCL, Div Med, Ctr Adv Biomed Imaging, London, England; [Gimi, Barjor] Geisel Sch Med Dartmouth, Dept Radiol, Lebanon, NH USA; [Scott, Rod C.] UCL, Inst Child Hlth, London, England	Dartmouth College; University of London; University College London; Dartmouth College; University of London; University College London	Scott, RC (corresponding author), Geisel Sch Med Dartmouth, Dept Neurol, Lebanon, NH USA.	Rodney.Scott@med.uvm.edu		Scott, Rod/0000-0002-8944-928X	National Institute of Health (NIH) [R01NS075249, 1S10RR25048]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075249] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the National Institute of Health (NIH) grants R01NS075249 and 1S10RR25048. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauquis J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013993; Bindu B, 2007, NEUROSCIENCE, V144, P412, DOI 10.1016/j.neuroscience.2006.09.057; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; Chevassus-au-Louis N, 1998, BRAIN RES, V812, P252, DOI 10.1016/S0006-8993(98)00932-9; Espie CA, 2003, J NEUROL NEUROSUR PS, V74, P1485, DOI 10.1136/jnnp.74.11.1485; Fastenau PS, 2004, EPILEPSIA, V45, P1261, DOI 10.1111/j.0013-9580.2004.15204.x; Fausto D, 2006, NEUROTOXICOL TERATOL, V29, P273; Featherstone RE, 2007, NEUROPSYCHOPHARMACOL, V32, P483, DOI 10.1038/sj.npp.1301223; Flagstad P, 2005, NEUROPSYCHOPHARMACOL, V30, P250, DOI 10.1038/sj.npp.1300625; Guerrini R, 2006, EXP BRAIN RES, V173, P322, DOI 10.1007/s00221-006-0501-z; HOLDSWORTH L, 1974, DEV MED CHILD NEUROL, V16, P746; Jennekens-Schinkel A, 2005, EPILEPSIA, V46, P599, DOI 10.1111/j.0013-9580.2005.64204_1.x; KUZNIECKY R, 1994, J CHILD NEUROL, V9, P420, DOI 10.1177/088307389400900418; Kuzniecky RI, 2001, BRAIN DEV-JPN, V23, P2, DOI 10.1016/S0387-7604(00)00195-9; Kwong KL, 2000, ACTA PAEDIATR, V89, P593, DOI 10.1080/080352500750027916; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Lodge DJ, 2009, J NEUROSCI, V29, P2344, DOI 10.1523/JNEUROSCI.5419-08.2009; Lucas MM, 2011, BRAIN, V134, P1684, DOI 10.1093/brain/awr087; Moore H, 2006, BIOL PSYCHIAT, V60, P253, DOI 10.1016/j.biopsych.2006.01.003; Moy SS, 2013, NEUROTOXICOL TERATOL, V36, P36, DOI 10.1016/j.ntt.2012.07.007; Oostrom KJ, 2005, BRAIN, V128, P1546, DOI 10.1093/brain/awh494; Ourselin S, 2001, IMAGE VISION COMPUT, V19, P25, DOI 10.1016/S0262-8856(00)00052-4; Pang T, 2008, NEUROLOGIST, V14, P181, DOI 10.1097/NRL.0b013e31816606b9; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; PIVEN J, 1990, AM J PSYCHIAT, V147, P734; Popp SS, 2011, NEUROSCIENCE, V192, P537, DOI 10.1016/j.neuroscience.2011.06.086; Ryan BL, 2003, SEIZURE-EUR J EPILEP, V12, P359, DOI 10.1016/S1059-1311(02)00325-4; Schrijver NCA, 2004, BEHAV BRAIN RES, V152, P307, DOI 10.1016/j.bbr.2003.10.016; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Woo CC, 2013, BEHAV NEUROSCI, V127, P487, DOI 10.1037/a0033010; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	33	25	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84492	10.1371/journal.pone.0084492	http://dx.doi.org/10.1371/journal.pone.0084492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358362	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700097
J	Otsuki, N; Nakatsu, Y; Kubota, T; Sekizuka, T; Seki, F; Sakai, K; Kuroda, M; Yamaguchi, R; Takeda, M				Otsuki, Noriyuki; Nakatsu, Yuichiro; Kubota, Toru; Sekizuka, Tsuyoshi; Seki, Fumio; Sakai, Kouji; Kuroda, Makoto; Yamaguchi, Ryoji; Takeda, Makoto			The V Protein of Canine Distemper Virus Is Required for Virus Replication in Human Epithelial Cells	PLOS ONE			English	Article							UPPER RESPIRATORY-TRACT; MEASLES-VIRUS; C-PROTEIN; RIG-I; SLAM CD150; ANTIVIRAL RESPONSES; INTERFERON RESPONSE; CELLULAR RECEPTOR; RHESUS-MONKEYS; RNA HELICASE	Canine distemper virus (CDV) becomes able to use human receptors through a single amino acid substitution in the H protein. In addition, CDV strains possessing an intact C protein replicate well in human epithelial H358 cells. The present study showed that CDV strain 007Lm, which was isolated from lymph node tissue of a dog with distemper, failed to replicate in H358 cells, although it possessed an intact C protein. Sequence analyses suggested that a cysteine-to-tyrosine substitution at position 267 of the V protein caused this growth defect. Analyses using H358 cells constitutively expressing the CDV V protein showed that the V protein with a cysteine, but not that with a tyrosine, at this position effectively blocked the interferon-stimulated signal transduction pathway, and supported virus replication of 007Lm in H358 cells. Thus, the V protein as well as the C protein appears to be functional and essential for CDV replication in human epithelial cells.	[Otsuki, Noriyuki; Nakatsu, Yuichiro; Kubota, Toru; Seki, Fumio; Sakai, Kouji; Takeda, Makoto] Natl Inst Infect Dis, Dept Virol 3, Tokyo, Japan; [Sekizuka, Tsuyoshi; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Lab Bacterial Gen, Shinjyuku Ku, Tokyo, Japan; [Yamaguchi, Ryoji] Miyazaki Univ, Fac Agr, Miyazaki 88921, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); University of Miyazaki	Otsuki, N (corresponding author), Natl Inst Infect Dis, Dept Virol 3, Tokyo, Japan.	otsuki@nih.go.jp	SAKAI, KOUJI/J-4436-2018; Takeda, Makoto/J-2550-2018	Takeda, Makoto/0000-0002-8194-7727; Seki, Fumio/0000-0002-6144-468X; Sekizuka, Tsuyoshi/0000-0002-1302-5472	Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare of Japan; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported, in part, by grants from the Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labour and Welfare of Japan, and a grant from The Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; APPEL MJG, 1994, J VET DIAGN INVEST, V6, P277, DOI 10.1177/104063879400600301; APPEL MJG, 1969, AM J VET RES, V30, P1167; BEAUVERGER P, 1993, J GEN VIROL, V74, P2357, DOI 10.1099/0022-1317-74-11-2357; BEAUVERGER P, 1994, VIROLOGY, V203, P172, DOI 10.1006/viro.1994.1470; Bieringer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057488; Caignard G, 2007, VIROLOGY, V368, P351, DOI 10.1016/j.virol.2007.06.037; Childs K, 2007, VIROLOGY, V359, P190, DOI 10.1016/j.virol.2006.09.023; Chinnakannan SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057063; de Swart RL, 2012, CURR OPIN VIROL, V2, P330, DOI 10.1016/j.coviro.2012.02.010; Devaux P, 2007, VIROLOGY, V360, P72, DOI 10.1016/j.virol.2006.09.049; Garcia-Sastre A, 2002, MICROBES INFECT, V4, P647, DOI 10.1016/S1286-4579(02)01583-6; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hirama K, 2004, J VET MED SCI, V66, P1575, DOI 10.1292/jvms.66.1575; Hur K, 1999, J COMP PATHOL, V121, P295, DOI 10.1053/jcpa.1999.0322; Ikegame S, 2010, J VIROL, V84, P372, DOI 10.1128/JVI.01690-09; Ito M, 2013, J VIROL; Iwasaki M, 2011, P NATL ACAD SCI USA, V108, P15384, DOI 10.1073/pnas.1107382108; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; KOTANI T, 1989, JPN J VET SCI, V51, P1263; Lan NT, 2006, VET MICROBIOL, V115, P32, DOI 10.1016/j.vetmic.2006.01.010; Lan NT, 2009, J VET MED SCI, V71, P155, DOI 10.1292/jvms.71.155; Lan NT, 2005, VET MICROBIOL, V110, P197, DOI 10.1016/j.vetmic.2005.07.016; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Ludlow M, 2013, J GEN VIROL, V94, P1933, DOI 10.1099/vir.0.054650-0; Ludlow M, 2013, J VIROL, V87, P4033, DOI 10.1128/JVI.03258-12; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Nakatsu Y, 2008, J VIROL, V82, P8296, DOI 10.1128/JVI.00108-08; Nakatsu Y, 2006, J VIROL, V80, P11861, DOI 10.1128/JVI.00751-06; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Ohno S, 2004, J GEN VIROL, V85, P2991, DOI 10.1099/vir.0.80308-0; Ohno S, 2003, J GEN VIROL, V84, P2381, DOI 10.1099/vir.0.19248-0; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; OSTERHAUS ADME, 1988, NATURE, V335, P403, DOI 10.1038/335403a0; Otsuki N, 2013, VIROLOGY; Perpinan D, 2008, VET REC, V163, P248; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Pratakpiriya W, 2012, J VIROL; Qiu W, 2011, EMERG INFECT DIS, V17, P1541, DOI 10.3201/eid1708.101153; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Rothlisberger A, 2010, J VIROL, V84, P6328, DOI 10.1128/JVI.01878-09; ROSCOE DE, 1993, J WILDLIFE DIS, V29, P390, DOI 10.7589/0090-3558-29.3.390; Sakai K, 2013, J VIROL; Seki F, 2003, J VIROL, V77, P9943, DOI 10.1128/JVI.77.18.9943-9950.2003; Shaffer JA, 2003, VIROLOGY, V315, P389, DOI 10.1016/S0042-6822(03)00537-3; STEPHENSON JR, 1979, P NATL ACAD SCI USA, V76, P6601, DOI 10.1073/pnas.76.12.6601; Sun ZZ, 2010, VET MICROBIOL, V141, P374, DOI 10.1016/j.vetmic.2009.09.024; Takeda M, 2007, J VIROL, V81, P12091, DOI 10.1128/JVI.01264-07; Takeda M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00279; Takeuchi K, 2005, J VIROL, V79, P7838, DOI 10.1128/JVI.79.12.7838-7844.2005; Takeuchi K, 2003, FEBS LETT, V545, P177, DOI 10.1016/S0014-5793(03)00528-3; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; THOMAS SM, 1988, CELL, V54, P891, DOI 10.1016/S0092-8674(88)91285-8; von Messling V, 2006, J VIROL, V80, P6084, DOI 10.1128/JVI.00357-06; Wang L- F, 2012, VIRUS TAXONOMY, P672; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	61	13	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82343	10.1371/journal.pone.0082343	http://dx.doi.org/10.1371/journal.pone.0082343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358174	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700012
J	Bowser, AK; Diamond, AW; Addison, JA				Bowser, A. Kirsten; Diamond, Antony W.; Addison, Jason A.			From Puffins to Plankton: A DNA-Based Analysis of a Seabird Food Chain in the Northern Gulf of Maine	PLOS ONE			English	Article							PREY DNA; DIET; CONSUMPTION; ECOSYSTEM; SAMPLES; FISH; FISHERIES; SELECTION; PREDATOR; PRIMERS	The predator-prey interactions within food chains are used to both characterize and understand ecosystems. Conventional methods of constructing food chains from visual identification of prey in predator diet can suffer from poor taxonomic resolution, misidentification, and bias against small or completely digestible prey. Next-generation sequencing (NGS) technology has become a powerful tool for diet reconstruction through barcoding of DNA in stomach content or fecal samples. Here we use multi-locus (16S and CO1) next-generation sequencing of DNA barcodes on the feces of Atlantic puffin (Fratercula arctica) chicks (n=65) and adults (n=64) and the stomach contents of their main prey, Atlantic herring (Clupea harengus, n=44) to investigate a previously studied food chain. We compared conventional and molecular-derived chick diet, tested the similarity between the diets of puffin adults and chicks, and determined whether herring prey can be detected in puffin diet samples. There was high variability in the coverage of prey groups between 16S and CO1 markers. We identified more unique prey with our 16S compared to CO1 barcoding markers (51 and 39 taxa respectively) with only 12 taxa identified by both genes. We found no significant difference between the 16S-identified diets of puffin adults (n=17) and chicks (n=41). Our molecular method is more taxonomically resolved and detected chick prey at higher frequencies than conventional field observations. Many likely planktonic prey of herring were detected in feces from puffin adults and chicks, highlighting the impact secondary consumption may have on the interpretation of molecular dietary analysis. This study represents the first simultaneous molecular investigation into the diet of multiple components of a food chain and highlights the utility of a multi-locus approach to diet reconstruction that is broadly applicable to food web analysis.	[Bowser, A. Kirsten; Diamond, Antony W.; Addison, Jason A.] Univ New Brunswick, Dept Biol, Fredericton, NB E3B 6E1, Canada; [Bowser, A. Kirsten; Diamond, Antony W.] Univ New Brunswick, Atlantic Lab Avian Res, Fredericton, NB, Canada	University of New Brunswick; University of New Brunswick	Bowser, AK (corresponding author), Univ New Brunswick, Dept Biol, Fredericton, NB E3B 6E1, Canada.	akbowser@gmail.com			NSERC; Environment Canada; Canadian Wildlife Service (Atlantic Region); University of New Brunswick; New Brunswick Innovation Foundation; Canada Foundation for Innovation	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Environment Canada(CGIAR); Canadian Wildlife Service (Atlantic Region); University of New Brunswick; New Brunswick Innovation Foundation; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was funded by NSERC, Environment Canada, Canadian Wildlife Service (Atlantic Region), University of New Brunswick, New Brunswick Innovation Foundation, and Canada Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso H, 2012, MAR BIOL, V159, P1197, DOI 10.1007/s00227-012-1900-2; BAIRD PH, 1991, CONDOR, V93, P503, DOI 10.2307/1368182; Barnett A, 2010, J EXP MAR BIOL ECOL, V393, P188, DOI 10.1016/j.jembe.2010.07.022; Barrett RT, 2007, ICES J MAR SCI, V64, P1675, DOI 10.1093/icesjms/fsm152; Battle H. I., 1936, Journal of the Biological Board of Canada, V2, P401; Berry D, 2011, APPL ENVIRON MICROB, V77, P7846, DOI 10.1128/AEM.05220-11; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; BOND AL, 2007, THESIS U NEW BRUNSWI; Bowman R.E., 2000, NMFSNE155 NOAA, pNMFS; Braley M, 2010, MOL ECOL RESOUR, V10, P466, DOI 10.1111/j.1755-0998.2009.02767.x; Brown DS, 2012, MOL ECOL RESOUR, V12, P259, DOI 10.1111/j.1755-0998.2011.03098.x; Bugge J, 2011, J ORNITHOL, V152, P253, DOI 10.1007/s10336-010-0578-9; Casper RM, 2007, MAR BIOL, V152, P815, DOI 10.1007/s00227-007-0732-y; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Cury PM, 2008, TRENDS ECOL EVOL, V23, P338, DOI 10.1016/j.tree.2008.02.005; Davoren GK, 1999, ANIM BEHAV, V58, P853, DOI 10.1006/anbe.1999.1209; Deagle BE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000831; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; Diamond AW, 2003, ENVIRON MONIT ASSESS, V88, P153, DOI 10.1023/A:1025560805788; Diamond AW, 2013, SEABIRD RES MONITORI; Drolet D, 2012, MAR ECOL PROG SER, V449, P197, DOI 10.3354/meps09495; Garcia SM, 2005, ICES J MAR SCI, V62, P311, DOI 10.1016/j.icesjms.2004.12.003; Gorley C.K., 2006, GETTING STARTED PRIM; GRAHAME J, 1977, MAR BIOL, V40, P217, DOI 10.1007/BF00390877; Grosberg RK, 1996, CHARACTERIZATION GEN, P67; Hibert F, 2013, PLOS ONE, V8, P11; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; ILES TD, 1982, SCIENCE, V215, P627, DOI 10.1126/science.215.4533.627; Johnson CL, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016491, 10.1371/journal.pone.0021046, 10.1371/journal.pone.0019210]; Jones M, 2011, UNITS PLOS ONE, V6, DOI [10.1371/journal.pone.0019259, DOI 10.1371/J0URNAL.P0NE.0019259]; Kohn MH, 1997, TRENDS ECOL EVOL, V12, P223, DOI 10.1016/S0169-5347(97)01050-1; KULKA DW, 1982, CAN J FISH AQUAT SCI, V39, P326, DOI 10.1139/f82-045; LEE WY, 1979, ESTUARIES, V2, P228, DOI 10.2307/1351569; LEGARE JEH, 1960, J FISH RES BOARD CAN, V17, P409, DOI 10.1139/f60-030; Lowther P, 2002, ATLANTIC PUFFIN FRAT; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Murray DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025776; Overholtz WJ, 2007, ICES J MAR SCI, V64, P83, DOI 10.1093/icesjms/fsl009; Overholtz WJ, 2000, ICES J MAR SCI, V57, P1147, DOI 10.1006/jmsc.2000.0802; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pollupuu M, 2010, J PLANKTON RES; Puritz JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034241; Quinlan AR, 2008, NAT METHODS, V5, P179, DOI 10.1038/NMETH.1172; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Razgour O, 2011, ECOL EVOL, V1, P15, DOI [10.1002/ece3.2, DOI 10.1002/ECE3.2.PUBMED:22393479]; Read AJ, 2003, CONSERV ECOL, V7; Scaps P, 2002, HYDROBIOLOGIA, V470, P203, DOI 10.1023/A:1015681605656; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; SHERMAN K, 1971, T AM FISH SOC, V100, P121, DOI 10.1577/1548-8659(1971)100<121:SVITFO>2.0.CO;2; SHERMAN K, 1971, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V160, P121; Stuglik MT, 2011, MOL ECOL RESOUR, V11, P739, DOI 10.1111/j.1755-0998.2011.02997.x; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; Wilson LJ, 2004, ARDEA, V92, P197; Ydenberg RC, 1994, ECOSCIENCE, V1, P1	59	60	63	1	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83152	10.1371/journal.pone.0083152	http://dx.doi.org/10.1371/journal.pone.0083152			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358258	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700107
J	Moshabela, M; Gitomer, S; Qhibi, B; Schneider, H				Moshabela, Mosa; Gitomer, Shira; Qhibi, Bongiwe; Schneider, Helen			Development of Non-Profit Organisations Providing Health and Social Services in Rural South Africa: A Three-Year Longitudinal Study	PLOS ONE			English	Article							HOME-BASED CARE; COMMUNITY/HOME-BASED CARE; HIV; PROGRAM; CHALLENGES; HIV/AIDS; WORKERS; ERA	Introduction: In an effort to increase understanding of formation of the community and home-based care economy in South Africa, we investigated the origin and development of non-profit organisations (NPOs) providing home-and community-based care for health and social services in a remote rural area of South Africa. Methods: Over a three-year period (2010-12), we identified and tracked all NPOs providing health care and social services in Bushbuckridge sub-district through the use of local government records, snowballing techniques, and attendance at NPO networking meetings-recording both existing and new NPOs. NPO founders and managers were interviewed in face-to-face in-depth interviews, and their organisational records were reviewed. Results: Forty-seven NPOs were formed prior to the study period, and 14 during the study period - six in 2010, six in 2011 and two in 2012, while four ceased operation, representing a 22% growth in the number of NPOs during the study period. Histories of NPOs showed a steady rise in the NPO formation over a 20-year period, from one (1991-1995) to 12 (1996-2000), 16 (2001-2005) and 24 (2006-2010) new organisations formed in each period. Furthermore, the histories of formation revealed three predominant milestones - loose association, formal formation and finally registration. Just over one quarter (28%) of NPOs emerged from a long-standing community based programme of 'care groups' of women. Founders of NPOs were mostly women (62%), with either a religious motivation or a nursing background, but occasionally had an entrepreneurial profile. Conclusion: We observed rapid growth of the NPO sector providing community based health and social services. Women dominated the rural NPO sector, which is being seen as creating occupation and employment opportunities. The implications of this growth in the NPO sector providing community based health and social services needs to be further explored and suggests the need for greater coordination and possibly regulation.	[Moshabela, Mosa] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Moshabela, Mosa; Qhibi, Bongiwe] Univ Witwatersrand, Acornhoek, South Africa; [Gitomer, Shira] Wayne, Geneva Global, Philadelphia, PA USA; [Schneider, Helen] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa	University of Witwatersrand; University of Witwatersrand; University of the Western Cape	Moshabela, M (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.	mosa@agincourt.co.za	Moshabela, Mosa/AAK-4418-2021	Moshabela, Mosa/0000-0002-9438-7095; Schneider, Helen/0000-0002-0418-1828	AVERTing HIV; AIDS (AVERT); South Africa Netherlands research Programme on Alternatives in Development (SANPAD)	AVERTing HIV; AIDS (AVERT); South Africa Netherlands research Programme on Alternatives in Development (SANPAD)	Funders of the Care in the Home Study were AVERTing HIV and AIDS (AVERT) and the South Africa Netherlands research Programme on Alternatives in Development (SANPAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akintola O, 2008, J ADV NURS, V63, P357, DOI 10.1111/j.1365-2648.2008.04704.x; Akintola Olagoke, 2006, Afr J AIDS Res, V5, P237, DOI 10.2989/16085900609490385; BRATTON M, 1989, WORLD DEV, V17, P569, DOI 10.1016/0305-750X(89)90263-5; Busgeeth K, 2010, COCHRANE DB SYST REV, V1; Coston JM, 1998, NONPROF VOLUNT SEC Q, V27, P358, DOI 10.1177/0899764098273006; Daniels K, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-8; Glenton C, 2010, SOC SCI MED, V70, P1920, DOI 10.1016/j.socscimed.2010.02.034; Johnson BA, 2004, J NATL MED ASSOC, V96, P496; Krebs DW, 2008, AIDS CARE, V20, P311, DOI 10.1080/09540120701594776; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; Morrell R, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-17; Ncama BP, 2007, INT NURS REV, V54, P391, DOI 10.1111/j.1466-7657.2007.00560.x; Ncama BP, 2005, J ASSOC NURSE AIDS C, V16, P33, DOI 10.1016/j.jana.2005.03.006; Nxumalo N, 2013, GLOB HLTH ACTION, V6; Ogden J, 2006, HEALTH POLICY PLANN, V21, P333, DOI 10.1093/heapol/czl025; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Schneider H, 2010, AIDS CARE, V22, P60, DOI 10.1080/09540120903483042; Schneider H, 2008, HEALTH POLICY PLANN, V23, P179, DOI 10.1093/heapol/czn006; Shaibli S, 2006, J TRANSCULT NURS, V17, P89, DOI 10.1177/1043659605281974; Tillekeratne LG, 2009, ANN TROP MED PARASIT, V103, P263, DOI 10.1179/136485909X398203; van Ginneken N, 2010, SOC SCI MED, V71, P1110, DOI 10.1016/j.socscimed.2010.06.009; van Pletzen E, 2013, HLTH POLICY PLAN; Wilson MG, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-36; Wouters E, 2009, SOC SCI MED, V69, P1177, DOI 10.1016/j.socscimed.2009.07.034; Wringe A, 2010, HEALTH POLICY PLANN, V25, P352, DOI 10.1093/heapol/czq005	25	8	8	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83861	10.1371/journal.pone.0083861	http://dx.doi.org/10.1371/journal.pone.0083861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GD	24358314	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700140
J	Zauberman, A; Flashner, Y; Levy, Y; Vagima, Y; Tidhar, A; Cohen, O; Bar-Haim, E; Gur, D; Aftalion, M; Halperin, G; Shafferman, A; Mamroud, E				Zauberman, Ayelet; Flashner, Yehuda; Levy, Yinon; Vagima, Yaron; Tidhar, Avital; Cohen, Ofer; Bar-Haim, Erez; Gur, David; Aftalion, Moshe; Halperin, Gideon; Shafferman, Avigdor; Mamroud, Emanuelle			Yopp-Expressing Variant of Y. pestis Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SMALL-MOLECULE INHIBITORS; PNEUMONIC PLAGUE; GAMMA-INTERFERON; ENTEROCOLITICA INFECTION; III SECRETION; MACROPHAGES; RESISTANCE; VACCINE; FRANCISELLA	Plague, initiated by Yersinia pestis infection, is a rapidly progressing disease with a high mortality rate if not quickly treated. The existence of antibiotic- resistant Y. pestis strains emphasizes the need for the development of novel countermeasures against plague. We previously reported the generation of a recombinant Y. pestis strain (Kim53 Delta J+ P) that over-expresses Y. enterocolitica YopP. When this strain was administered subcutaneously to mice, it elicited a fast and effective protective immune response in models of bubonic, pneumonic and septicemic plague. In the present study, we further characterized the immune response induced by the Kim53 Delta J+ P recombinant strain. Using a panel of mouse strains defective in specific immune functions, we observed the induction of a prompt protective innate immune response that was interferon- c dependent. Moreover, inoculation of mice with Y. pestis Kim53 Delta J+ P elicited a rapid protective response against secondary infection by other bacterial pathogens, including the enteropathogen Y. enterocolitica and the respiratory pathogen Francisella tularensis. Thus, the development of new therapies to enhance the innate immune response may provide an initial critical delay in disease progression following the exposure to highly virulent bacterial pathogens, extending the time window for successful treatment.	[Zauberman, Ayelet; Flashner, Yehuda; Levy, Yinon; Vagima, Yaron; Tidhar, Avital; Cohen, Ofer; Bar-Haim, Erez; Gur, David; Aftalion, Moshe; Halperin, Gideon; Shafferman, Avigdor; Mamroud, Emanuelle] Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel		Mamroud, E (corresponding author), Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel.	emmym@iibr.gov.il	Bar-Haim, Erez/AAA-6444-2020	Bar-Haim, Erez/0000-0003-3435-8599	Israel Institute for Biological Research funds [SB/5112-50]	Israel Institute for Biological Research funds	This work was supported by the Israel Institute for Biological Research funds, grand number SB/5112-50. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; AUTENRIETH IB, 1992, MED MICROBIOL IMMUN, V181, P333; Bar-Haim E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000211; BENGURION R, 1981, PLASMID, V5, P183, DOI 10.1016/0147-619X(81)90019-6; Ber R, 2003, APPL ENVIRON MICROB, V69, P5787, DOI 10.1128/AEM.69.10.5787-5792.2003; BHARDWAJ N, 1986, J IMMUNOL, V137, P2662; BOHN E, 1994, INFECT IMMUN, V62, P3027, DOI 10.1128/IAI.62.7.3027-3032.1994; Brodsky IE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000067; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; Butler T, 1983, PLAGUE OTHER YERSIAN; Dawicki W, 2007, CURR OPIN IMMUNOL, V19, P31, DOI 10.1016/j.coi.2006.11.006; Dentovskaya SV, 2013, MOL GENET MICROBIOL+, V28, P87, DOI 10.3103/S089141681303004X; Edwards JA, 2010, MICROBIOL-SGM, V156, P327, DOI 10.1099/mic.0.031716-0; Elkins KL, 1998, INFECT IMMUN, V66, P3467, DOI 10.1128/IAI.66.7.3467-3469.1998; Elkins KL, 1999, J IMMUNOL, V162, P2291; Elkins KL, 1996, INFECT IMMUN, V64, P3288, DOI 10.1128/IAI.64.8.3288-3293.1996; Elvin SJ, 2004, MICROB PATHOGENESIS, V37, P177, DOI 10.1016/j.micpath.2004.06.009; Eriksson J, 2012, ADV EXP MED BIOL, V954, P357, DOI 10.1007/978-1-4614-3561-7_43; Feodorova VA, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.34; Galimand M, 2006, ANTIMICROB AGENTS CH, V50, P3233, DOI 10.1128/AAC.00306-06; Garrity-Ryan LK, 2010, INFECT IMMUN, V78, P4683, DOI 10.1128/IAI.01305-09; Handley SA, 2006, P NATL ACAD SCI USA, V103, P9268, DOI 10.1073/pnas.0510414103; HENDERSON D. W., 1964, SYMP SOC GEN MICROBIOL, V14, P241; Herbst S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019105; KILLAR LM, 1985, INFECT IMMUN, V47, P605, DOI 10.1128/IAI.47.3.605-612.1985; Kool JL, 2005, CLIN INFECT DIS, V40, P1166, DOI 10.1086/428617; Kummer LW, 2008, VACCINE, V26, P6901, DOI 10.1016/j.vaccine.2008.09.063; Lin JS, 2011, J IMMUNOL, V187, P897, DOI 10.4049/jimmunol.1100174; Lin JS, 2010, VACCINE, V29, P357, DOI 10.1016/j.vaccine.2010.08.099; Lindgren H, 2005, MICROBES INFECT, V7, P467, DOI 10.1016/j.micinf.2004.11.020; MACKANESS GB, 1964, J EXP MED, V120, P105, DOI 10.1084/jem.120.1.105; Mamroud E, 2003, ADV EXP MED BIOL, V529, P425; Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385; NAKAJIMA R, 1993, INFECT IMMUN, V61, P23, DOI 10.1128/IAI.61.1.23-31.1993; Pan N, 2007, ADV EXP MED BIOL, V603, P367; Parent MA, 2006, INFECT IMMUN, V74, P3381, DOI 10.1128/IAI.00185-06; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Pujol C, 2005, P NATL ACAD SCI USA, V102, P12909, DOI 10.1073/pnas.0502849102; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; Rosenzweig JA, 2011, APPL MICROBIOL BIOT, V91, P265, DOI 10.1007/s00253-011-3380-6; Ruckdeschel K, 1997, J BIOL CHEM, V272, P15920, DOI 10.1074/jbc.272.25.15920; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Smiley ST, 2008, EXPERT REV VACCINES, V7, P209, DOI 10.1586/14760584.7.2.209; Swietnicki W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019716; Tidhar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007023; Urb M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002619; Wang XY, 2013, EXPERT REV VACCINES, V12, P677, DOI [10.1586/erv.13.42, 10.1586/ERV.13.42]; Williamson ED, 2013, CLIN EXP IMMUNOL, V172, P1, DOI 10.1111/cei.12044; Zauberman A, 2006, INFECT IMMUN, V74, P3239, DOI 10.1128/IAI.00097-06; Zauberman A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005938; Zhang Y, 2005, J IMMUNOL, V174, P7939, DOI 10.4049/jimmunol.174.12.7939; Zhang Y, 2010, INFECT IMMUN, V78, P2329, DOI 10.1128/IAI.00094-10	52	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83560	10.1371/journal.pone.0083560	http://dx.doi.org/10.1371/journal.pone.0083560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358292	gold, Green Submitted, Green Published			2022-12-27	WOS:000328735700130
J	Sundblad, BM; Jansson, SA; Nystrom, L; Arvidsson, P; Lundback, B; Larsson, K				Sundblad, Britt-Marie; Jansson, Sven-Arne; Nystrom, Lennarth; Arvidsson, Peter; Lundback, Bo; Larsson, Kjell			Chronic Obstructive Pulmonary Disease (COPD) During the Two Last Years of Life - A Retrospective Study of Decedents	PLOS ONE			English	Article							SEX-DIFFERENCES; LUNG-DISEASE; GENDER-DIFFERENCE; SMOKING-HABITS; GLOBAL BURDEN; MORTALITY; SURVIVAL; HOSPITALIZATION; WOMEN; RISK	Background: Little is known about the management of patients suffering from chronic obstructive pulmonary disease (COPD) during the last years of life. The aim of the study was to describe how management of COPD is performed in Sweden during the last two years of life. Methods: From the nationwide Cause of Death register all individuals with COPD as the underlying cause of death during two years were identified in one sparsely and one densely populated area of Sweden. Data were collected from medical records using a pre-defined protocol, especially developed for this purpose. Results: Of 822 individuals with COPD as underlying cause of death, medical records from 729 were available. The COPD diagnosis was based on lung function measurements in approximately half of the patients and median age at COPD diagnosis was 74 years (range 34-95). Women died at younger age, median 78 years (range 52-96) than did men (80 years (51-99)). The median survival time from diagnosis to death was 6 years in men and women in both areas. Among women and men 8.3% and 4.3% were never smokers, respectively. The structure of COPD management differed between the two areas, with utilization of physiotherapists, dieticians and working therapists being more used in the northern area, likely because of differences in accessibility to care institutions. Conclusions: In Sweden COPD is mostly diagnosed late in life and often not verified by lung function measurements. Opposite to the general population, women with COPD die at a lower age than men.	[Sundblad, Britt-Marie; Jansson, Sven-Arne; Larsson, Kjell] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Lundback, Bo] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Krefting Res Ctr, Gothenburg, Sweden; [Nystrom, Lennarth] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Arvidsson, Peter] GlaxoSmithKline Sweden, Astma COPD, Stockholm, Sweden	Karolinska Institutet; University of Gothenburg; Umea University; GlaxoSmithKline	Sundblad, BM (corresponding author), Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.	britt-marie.sundblad@ki.se		Sundblad, Britt-Marie/0000-0002-9939-418X	GlaxoSmithKline, Sweden	GlaxoSmithKline, Sweden(GlaxoSmithKline)	The study was supported from GlaxoSmithKline, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Celli B, 2011, AM J RESP CRIT CARE, V183, P317, DOI 10.1164/rccm.201004-0665OC; Cleland JGF, 2000, EUR J HEART FAIL, V2, P123, DOI 10.1016/S1388-9842(00)00081-7; Crockett AJ, 2001, INTERN MED J, V31, P448, DOI 10.1046/j.1445-5994.2001.00103.x; de Torres JP, 2009, EUR RESPIR J, V33, P528, DOI 10.1183/09031936.00096108; Ekstrom M, 2010, CHEST, V137, P31, DOI 10.1378/chest.09-0636; Gold DR, 1996, NEW ENGL J MED, V335, P931, DOI 10.1056/NEJM199609263351304; Gonzalez AV, 2011, THORAX, V66, P38, DOI 10.1136/thx.2010.141978; Hagstad S, 2012, RESP MED, V106, P980, DOI 10.1016/j.rmed.2012.03.010; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Lacasse Y, 1996, LANCET, V348, P1115, DOI 10.1016/S0140-6736(96)04201-8; Lindberg A, 2006, RESP MED, V100, P264, DOI 10.1016/j.rmed.2005.04.029; Lindberg A, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-1; Linstrom M, 2002, INT J TUBERC LUNG D, V6, P76; Lundback B, 2003, RESP MED, V97, P115, DOI 10.1053/rmed.2003.1446; Machado MCL, 2006, AM J RESP CRIT CARE, V174, P524, DOI 10.1164/rccm.200507-1057OC; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Prescott E, 1997, EUR RESPIR J, V10, P822; Prescott E, 1998, J EPIDEMIOL COMMUN H, V52, P131, DOI 10.1136/jech.52.2.131; Silverman EK, 2000, AM J RESP CRIT CARE, V162, P2152, DOI 10.1164/ajrccm.162.6.2003112; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Sundblad BM, 2008, CLIN RESPIR J, V2, P11, DOI 10.1111/j.1752-699X.2007.00020.x; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; XU X, 1994, EUR RESPIR J, V7, P477, DOI 10.1183/09031936.94.07030477; XU X, 1994, EUR RESPIR J, V7, P1056	25	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84110	10.1371/journal.pone.0084110	http://dx.doi.org/10.1371/journal.pone.0084110			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367631	Green Published, gold, Green Submitted			2022-12-27	WOS:000328741900032
J	Wang, W; He, M; Zhou, MW; Zhang, XL				Wang, Wei; He, Miao; Zhou, Minwen; Zhang, Xiulan			Selective Laser Trabeculoplasty versus Argon Laser Trabeculoplasty in Patients with Open-Angle Glaucoma: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE REDUCTION; LONG-TERM OUTCOMES; EFFICACY	Objective: To examine possible differences in clinical outcomes between selective laser trabeculoplasty (SLT) and argon laser trabeculoplasty (ALT) in open-angle glaucoma at different times post-treatment. Methods: Randomized controlled trials (RCTs) comparing SLT versus ALT were searched through August 2013. The main outcome measure was IOP, and secondary outcomes included the number of glaucoma medications, the success rate, and adverse events. Results: Six RCTs, involving 482 eyes treated with laser trabeculoplasty, were included in the meta-analysis. For all patients (including first and previous laser trabeculoplasy), no significant difference in IOP lowering was observed between SLT and ALT at one hour (P = 0.40), one week (P = 0.72), one month (P = 0.37), six months (P = 0.08), one year (P = 0.34), two years (P = 0.58), three years (P = 0.34), four years (P = 0.47), and five years (P = 0.50). A statistically significant difference in favor of SLT was found when comparing the IOP reduction at three months after intervention (weighted mean difference (WMD): 1.19 mmHg [0.41; 1.97]; I2= 0%; P = 0.003). For patients who were naive to laser, there was no significant difference of reduction in IOP comparing SLT with ALT at any time point. In patients' previous LT, no statistically significant difference in IOP reduction was found at six months (WMD: 1.92 mmHg [-0.91; 4.74]; I2 = 77.3%; P = 0.18). There was no significant difference in the reduction in the number of glaucoma medications, the success rate, or adverse event rates between the two treatments. Conclusions: SLT has equivalent efficacy to ALT with a similar constellation of side effects. In the case of retreatment, SLT appears to be similar to ALT in IOP lowering at six months.	[Wang, Wei; He, Miao; Zhou, Minwen; Zhang, Xiulan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, XL (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhangxl2@mail.sysu.edu.cn			National Natural Science Foundation of China [81371008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (81371008), No additional external funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ED, 2011, CLIN OPHTHALMOL, V5, P933, DOI 10.2147/OPTH.S21759; Ayala M, 2011, OPEN OPHTHALMOL J, V5, P32, DOI 10.2174/1874364101105010032; Best UP, 2007, KLIN MONATSBL AUGENH, V224, P173, DOI 10.1055/s-2007-963014; Birt CM, 2007, CAN J OPHTHALMOL, V42, P715, DOI 10.3129/i07-131; Bovell AM, 2011, CAN J OPHTHALMOL, V46, P408, DOI 10.1016/j.jcjo.2011.07.016; Damji KF, 2006, BRIT J OPHTHALMOL, V90, P1490, DOI 10.1136/bjo.2006.098855; DAMJI KE, 2008, ALTERNATIVES SURVEY, V53, P646, DOI DOI 10.1016/J.SURV0PHTHAL.2008.09.001; Damji KF, 1999, BRIT J OPHTHALMOL, V83, P718, DOI 10.1136/bjo.83.6.718; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FELLMAN RL, 2007, COMMENTARY EVIDENCE, V8, P112; Girkin CA, 2007, AM J OPHTHALMOL, V144, P120, DOI 10.1016/j.ajo.2007.04.012; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hodge WG, 2005, BRIT J OPHTHALMOL, V89, P1157, DOI 10.1136/bjo.2004.062414; Hollo G, 1996, ACTA OPHTHALMOL SCAN, V74, P126; Juzych MS, 2004, OPHTHALMOLOGY, V111, P1853, DOI 10.1016/j.ophtha.2004.04.030; Kent SS, 2013, J GLAUCOMA; Liu YW, 2012, J GLAUCOMA, V21, P112, DOI 10.1097/IJG.0b013e318202791c; Mao AJ, 2008, J GLAUCOMA, V17, P449, DOI 10.1097/IJG.0b013e31815f52cb; Martinez-de-la-Casa JM, 2004, EYE, V18, P498, DOI 10.1038/sj.eye.6700695; Meyer JJ, 2012, CURR OPIN OPHTHALMOL, V23, P111, DOI 10.1097/ICU.0b013e32834f1887; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; PANARELLI JF, 2013, J GLAUCOMA, P32410; Pham H, 2008, SURV OPHTHALMOL, V53, P641, DOI 10.1016/j.survophthal.2008.08.020; Popiela G, 2000, Klin Oczna, V102, P129; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Realini T, 2013, JAMA OPHTHALMOL, V131, P321, DOI 10.1001/jamaophthalmol.2013.1706; Rolim DMC, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003919.pub2; Rosenfeld E, 2012, CLIN OPHTHALMOL, V6, P1935, DOI 10.2147/OPTH.S34193; Russo V, 2009, EUR J OPHTHALMOL, V19, P429, DOI 10.1177/112067210901900317; Samples JR, 2011, OPHTHALMOLOGY, V118, P2296, DOI 10.1016/j.ophtha.2011.04.037; Shi JM, 2012, INT J OPHTHALMOL-CHI, V5, P742, DOI 10.3980/j.issn.2222-3959.2012.06.17; Terrin N, 2005, J CLIN EPIDEMIOL, V58, P894, DOI 10.1016/j.jclinepi.2005.01.006; Van de Veire S, 2006, Bull Soc Belge Ophtalmol, P5; Wang H, 2013, CAN J OPHTHALMOL, V48, P186, DOI 10.1016/j.jcjo.2013.01.001	36	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84270	10.1371/journal.pone.0084270	http://dx.doi.org/10.1371/journal.pone.0084270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367649	gold, Green Submitted, Green Published			2022-12-27	WOS:000328741900042
J	van't Hoog, AH; Cobelens, F; Vassall, A; van Kampen, S; Dorman, SE; Alland, D; Ellner, J				van't Hoog, Anna H.; Cobelens, Frank; Vassall, Anna; van Kampen, Sanne; Dorman, Susan E.; Alland, David; Ellner, Jerrold			Optimal Triage Test Characteristics to Improve the Cost-Effectiveness of the Xpert MTB/RIF Assay for TB Diagnosis: A Decision Analysis	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; MALARIA CONTROL; RESISTANCE; DURATION; COUGH	Background: High costs are a limitation to scaling up the Xpert MTB/RIF assay (Xpert) for the diagnosis of tuberculosis in resource-constrained settings. A triaging strategy in which a sensitive but not necessarily highly specific rapid test is used to select patients for Xpert may result in a more affordable diagnostic algorithm. To inform the selection and development of particular diagnostics as a triage test we explored combinations of sensitivity, specificity and cost at which a hypothetical triage test will improve affordability of the Xpert assay. Methods: In a decision analytical model parameterized for Uganda, India and South Africa, we compared a diagnostic algorithm in which a cohort of patients with presumptive TB received Xpert to a triage algorithm whereby only those with a positive triage test were tested by Xpert. Findings: A triage test with sensitivity equal to Xpert, 75% specificity, and costs of US$5 per patient tested reduced total diagnostic costs by 42% in the Uganda setting, and by 34% and 39% respectively in the India and South Africa settings. When exploring triage algorithms with lower sensitivity, the use of an example triage test with 95% sensitivity relative to Xpert, 75% specificity and test costs $5 resulted in similar cost reduction, and was cost-effective by the WHO willingness-to-pay threshold compared to Xpert for all in Uganda, but not in India and South Africa. The gain in affordability of the examined triage algorithms increased with decreasing prevalence of tuberculosis among the cohort. Conclusions: A triage test strategy could potentially improve the affordability of Xpert for TB diagnosis, particularly in low-income countries and with enhanced case-finding. Tests and markers with lower accuracy than desired of a diagnostic test may fall within the ranges of sensitivity, specificity and cost required for triage tests and be developed as such.	[van't Hoog, Anna H.; Cobelens, Frank] AIGHD, Amsterdam, Netherlands; [van't Hoog, Anna H.; Cobelens, Frank] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Vassall, Anna] London Sch Hyg & Trop Med, Social & Math Epidemiol Grp SAME, Dept Global Hlth & Dev, London WC1, England; [van Kampen, Sanne] KNCV TB Fdn, The Hague, Netherlands; [Dorman, Susan E.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Alland, David] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA; [Ellner, Jerrold] Boston Univ, Sch Med, Boston, MA 02118 USA; [Ellner, Jerrold] Boston Med Ctr, Boston, MA 02118 USA	University of Amsterdam; Academic Medical Center Amsterdam; University of London; London School of Hygiene & Tropical Medicine; KNCV Tuberculosis Foundation; Johns Hopkins University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Boston University; Boston Medical Center	van't Hoog, AH (corresponding author), AIGHD, Amsterdam, Netherlands.	a.h.vanthoog@aighd.org		Vassall, Anna/0000-0002-2911-1375; van Kampen, Sanne/0000-0002-1519-5248; Cobelens, Frank/0000-0002-4367-1133	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900050C]	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200900050C., "The Tuberculosis Clinical Diagnostics Research Consortium''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Batwala V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-372; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Hayen A, 2010, J CLIN EPIDEMIOL, V63, P883, DOI 10.1016/j.jclinepi.2009.08.024; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hogeweg L, 2010, LECT NOTES COMPUT SC, V6363, P650; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Ling DI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001536; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Mabaera B, 2007, INT J TUBERC LUNG D, V11, P959; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ngadaya ES, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-112; Otero L, 2010, TROP MED INT HEALTH, V15, P1475, DOI 10.1111/j.1365-3156.2010.02645.x; Pantoja A, 2013, EUR RESPIR J, V42, P708, DOI 10.1183/09031936.00147912; Schackman BR, 2007, PLOS MED, V4, P937, DOI 10.1371/journal.pmed.0040183; Schnippel K, 2013, TROP MED INT HEALTH, V18, P109, DOI 10.1111/tmi.12018; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; Stop TB Department, 2012, BUY DOWN AGR RED COS; Stothard JR, 2009, T ROY SOC TROP MED H, V103, P325, DOI 10.1016/j.trstmh.2008.12.012; The World Bank, 2012, DAT GDP PER CAP CURR; van't Hoog AH, 2011, INT J TUBERC LUNG D, V15, P1308, DOI 10.5588/ijtld.11.0004; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Weyer K, 2013, EUR RESP J, V42; Weyer K, 2011, J INFECT DIS, V204, pS1196, DOI 10.1093/infdis/jir452; White MT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-337; WHO, 2011, POL STAT AUT REAL TI; World Health Organization, 2013, WHO MON XPERT MTB RI; World Health Organization, 2012, CHOOSING INT AR COST	31	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82786	10.1371/journal.pone.0082786	http://dx.doi.org/10.1371/journal.pone.0082786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367555	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000328740300069
J	Frerichs, LM; Araz, OM; Huang, TTK				Frerichs, Leah M.; Araz, Ozgur M.; Huang, Terry T. -K.			Modeling Social Transmission Dynamics of Unhealthy Behaviors for Evaluating Prevention and Treatment Interventions on Childhood Obesity	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; PUBLIC-HEALTH; US CHILDREN; SYSTEM DYNAMICS; WEIGHT; ADOLESCENTS; PREVALENCE; TRENDS; OVERWEIGHT; ADULTS	Research evidence indicates that obesity has spread through social networks, but lever points for interventions based on overlapping networks are not well studied. The objective of our research was to construct and parameterize a system dynamics model of the social transmission of behaviors through adult and youth influence in order to explore hypotheses and identify plausible lever points for future childhood obesity intervention research. Our objectives were: (1) to assess the sensitivity of childhood overweight and obesity prevalence to peer and adult social transmission rates, and (2) to test the effect of combinations of prevention and treatment interventions on the prevalence of childhood overweight and obesity. To address the first objective, we conducted two-way sensitivity analyses of adult-to-child and child-to-child social transmission in relation to childhood overweight and obesity prevalence. For the second objective, alternative combinations of prevention and treatment interventions were tested by varying model parameters of social transmission and weight loss behavior rates. Our results indicated child overweight and obesity prevalence might be slightly more sensitive to the same relative change in the adult-to-child compared to the child-to-child social transmission rate. In our simulations, alternatives with treatment alone, compared to prevention alone, reduced the prevalence of childhood overweight and obesity more after 10 years (1.2-1.8% and 0.2-1.0% greater reduction when targeted at children and adults respectively). Also, as the impact of adult interventions on children was increased, the rank of six alternatives that included adults became better (i.e., resulting in lower 10 year childhood overweight and obesity prevalence) than alternatives that only involved children. The findings imply that social transmission dynamics should be considered when designing both prevention and treatment intervention approaches. Finally, targeting adults may be more efficient, and research should strengthen and expand adult-focused interventions that have a high residual impact on children.	[Frerichs, Leah M.; Araz, Ozgur M.; Huang, Terry T. -K.] Univ Nebraska Med Ctr, Coll Publ Hlth, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Frerichs, LM (corresponding author), Univ Nebraska Med Ctr, Coll Publ Hlth, Omaha, NE 68198 USA.	leah.frerichs@unmc.edu	Araz, Ozgur/AAC-5266-2020	Huang, Terry/0000-0001-5544-5187				Abdel-Hamid TK, 2002, SYST DYNAM REV, V18, P431, DOI 10.1002/sdr.240; Ali MM, 2012, APPL ECON, V44, P2969, DOI 10.1080/00036846.2011.568408; Ali MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021179; [Anonymous], 1998, OBES RES, V6, p51S; [Anonymous], P 29 INT C SYST DYN; Bahr DB, 2009, OBESITY, V17, P723, DOI 10.1038/oby.2008.615; BARLAS Y, 1989, EUR J OPER RES, V42, P59, DOI 10.1016/0377-2217(89)90059-3; Birch LL, 2009, INT J OBESITY, V33, pS74, DOI 10.1038/ijo.2009.22; Boutelle KN, 2011, OBESITY, V19, P574, DOI 10.1038/oby.2010.238; Brownell KD, 2010, HEALTH AFFAIR, V29, P379, DOI 10.1377/hlthaff.2009.0739; *CDCP NCHS, 2009, NAT HLTH NUTR EX SUR; Chow CC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000045; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Davison KK, 2012, HEALTH PROMOT PRACT, V13, P454, DOI 10.1177/1524839910377966; de la Haye K, 2010, SOC NETWORKS, V32, P161, DOI 10.1016/j.socnet.2009.09.001; Division of Nutrition Physical Activity and Obesity National Center for Chronic Disease Prevention and Health Promotion, 2011, LOS WEIGHT; Evangelista A.M., 2004, US FAST FOOD NATION; Feunekes GIJ, 1998, PREV MED, V27, P645, DOI 10.1006/pmed.1998.0341; Flatt JP, 2004, OBES RES, V12, P2013, DOI 10.1038/oby.2004.252; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; FORRESTER JW, 1994, SYST DYNAM REV, V10, P245, DOI 10.1002/sdr.4260100211; Fortin B, 2011, CIRANO SCI PUBLICATI; Franzini L, 2009, AM J PUBLIC HEALTH, V99, P271, DOI 10.2105/AJPH.2007.128702; Gable S, 2000, FAM RELAT, V49, P293, DOI 10.1111/j.1741-3729.2000.00293.x; Goetzel RZ, 2009, HEALTH AFFAIR, V28, P37, DOI 10.1377/hlthaff.28.1.37; Golan M, 1998, AM J CLIN NUTR, V67, P1130, DOI 10.1093/ajcn/67.6.1130; Golan M, 2004, NUTR REV, V62, P39, DOI 10.1111/j.1753-4887.2004.tb00005.x; Goldbeter A, 2006, J BIOSCIENCES, V31, P129, DOI 10.1007/BF02705242; Golley RK, 2007, PEDIATRICS, V119, P517, DOI 10.1542/peds.2006-1746; Gonzalez-Parra G, 2010, MATH POPUL STUD, V17, P1, DOI 10.1080/07481180903467218; Gustafson SL, 2006, SPORTS MED, V36, P79, DOI 10.2165/00007256-200636010-00006; Hall KD, 2006, AM J PHYSIOL-ENDOC M, V291, pE23, DOI 10.1152/ajpendo.00523.2005; Hammond RA, 2010, CURR OPIN ENDOCRINOL, V17, P467, DOI 10.1097/MED.0b013e32833d4687; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Homer J, 2006, P 24 INT SYST DYN C; Huang TT, 2009, PREV CHRONIC DIS, V6; IOM, 2012, ACC PROGR OB PREV SO; Jodar L, 2008, COMPUT MATH APPL, V56, P679, DOI 10.1016/j.camwa.2008.01.011; Kapka, 2011, 1105159EF1 AG HEALTH; Karanfil O, 2011, MULTISCALE PARADIGM; Kirk SFL, 2010, OBES REV, V11, P109, DOI 10.1111/j.1467-789X.2009.00611.x; Koehly LM, 2009, PREV CHRONIC DIS, V6; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; McDermott R, 2008, PUBLIC HLTH B SA, V6, P14; Ogden C., 2010, PREVALENCE OBESITY C, P201; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Rappange DR, 2010, J PUBLIC HEALTH-UK, V32, P440, DOI 10.1093/pubmed/fdp079; Rasmussen M, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-22; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Rein AS, 2012, J PUBLIC HEALTH MAN, V18, P299, DOI 10.1097/PHH.0b013e31825d25dd; Renna F, 2008, ECON HUM BIOL, V6, P377, DOI 10.1016/j.ehb.2008.06.005; Salvy SJ, 2012, PHYSIOL BEHAV, V106, P369, DOI 10.1016/j.physbeh.2012.03.022; Santonja FJ, 2012, EVAL PROGRAM PLANN, V35, P34, DOI 10.1016/j.evalprogplan.2011.06.004; Steinbeck K S, 2001, Obes Rev, V2, P117, DOI 10.1046/j.1467-789x.2001.00033.x; van der Horst K, 2007, HEALTH EDUC RES, V22, P203, DOI 10.1093/her/cyl069; Vasan RS, 2005, ANN INTERN MED, V143, P473, DOI 10.7326/0003-4819-143-7-200510040-00005; Wagner A, 2004, DIABETES METAB, V30, P359, DOI 10.1016/S1262-3636(07)70129-5; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Waters E, 2009, B WORLD HEALTH ORGAN, V87, P164, DOI 10.2471/BLT.09.064022; Whitlock EP, 2010, PEDIATRICS, V125, pE396, DOI 10.1542/peds.2009-1955; Williamson DA, 2010, OBESITY, V19, P667; Wolf AM, 1998, OBES RES, V6, P97, DOI 10.1002/j.1550-8528.1998.tb00322.x; Wrotniak BH, 2004, ARCH PEDIAT ADOL MED, V158, P342, DOI 10.1001/archpedi.158.4.342	64	23	24	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82887	10.1371/journal.pone.0082887	http://dx.doi.org/10.1371/journal.pone.0082887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GT	24358234	gold, Green Published, Green Submitted			2022-12-27	WOS:000328737700037
J	Hausmann, A; Godfray, HCJ; Huemer, P; Mutanen, M; Rougerie, R; van Nieukerken, EJ; Ratnasingham, S; Hebert, PDN				Hausmann, Axel; Godfray, H. Charles J.; Huemer, Peter; Mutanen, Marko; Rougerie, Rodolphe; van Nieukerken, Erik J.; Ratnasingham, Sujeevan; Hebert, Paul D. N.			Genetic Patterns in European Geometrid Moths Revealed by the Barcode Index Number (BIN) System	PLOS ONE			English	Article							DNA TAXONOMY; SPECIES DELIMITATION; PHYLOGENY; SCALE	Background: The geometrid moths of Europe are one of the best investigated insect groups in traditional taxonomy making them an ideal model group to test the accuracy of the Barcode Index Number (BIN) system of BOLD (Barcode of Life Datasystems), a method that supports automated, rapid species delineation and identification. Methodology/Principal Findings: This study provides a DNA barcode library for 219 of the 249 European geometrid moth species (88%) in five selected subfamilies. The data set includes COI sequences for 2130 specimens. Most species (93%) were found to possess diagnostic barcode sequences at the European level while only three species pairs (3%) were genetically indistinguishable in areas of sympatry. As a consequence, 97% of the European species we examined were unequivocally discriminated by barcodes within their natural areas of distribution. We found a 1: 1 correspondence between BINs and traditionally recognized species for 67% of these species. Another 17% of the species (15 pairs, three triads) shared BINs, while specimens from the remaining species (18%) were divided among two or more BINs. Five of these species are mixtures, both sharing and splitting BINs. For 82% of the species with two or more BINs, the genetic splits involved allopatric populations, many of which have previously been hypothesized to represent distinct species or subspecies. Conclusions/Significance: This study confirms the effectiveness of DNA barcoding as a tool for species identification and illustrates the potential of the BIN system to characterize formal genetic units independently of an existing classification. This suggests the system can be used to efficiently assess the biodiversity of large, poorly known assemblages of organisms. For the moths examined in this study, cases of discordance between traditionally recognized species and BINs arose from several causes including overlooked species, synonymy, and cases where DNA barcodes revealed regional variation of uncertain taxonomic significance.	[Hausmann, Axel] Bavarian State Collect Zool, Dept Entomol, Munich, Germany; [Hausmann, Axel] Bavarian Nat Hist Collect, Munich, Germany; [Godfray, H. Charles J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Huemer, Peter] Tiroler Landesmuseen Betriebsgesell, Nat Wissensch Sammlungen, Innsbruck, Austria; [Mutanen, Marko] Univ Oulu, Zool Museum, Dept Biol, Oulu, Finland; [Rougerie, Rodolphe] Univ Rouen, Ecol Lab, Mont St Aignan, France; [Rougerie, Rodolphe] Unite Rech Zool Forestiere, Orleans, France; [van Nieukerken, Erik J.] Naturalis Biodivers Ctr, Leiden, Netherlands; [Ratnasingham, Sujeevan; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	University of Oxford; University of Oulu; Universite de Rouen Normandie; Naturalis Biodiversity Center; University of Guelph	Hausmann, A (corresponding author), Bavarian State Collect Zool, Dept Entomol, Munich, Germany.	axel.hausmann@zsm.mwn.de	Hebert, Paul DN/C-4161-2013; CHARLES, Hubert/B-9392-2011; Ratnasingham, Sujeevan/G-9103-2014; Rougerie, Rodolphe/D-2930-2009; van Nieukerken, Erik/B-4512-2012	Hebert, Paul DN/0000-0002-3081-6700; CHARLES, Hubert/0000-0002-0809-4705; Rougerie, Rodolphe/0000-0003-0937-2815; van Nieukerken, Erik/0000-0002-5721-1840	components of the "Barcoding Fauna Bavarica" project by the Bavarian Ministry of Science, Research and Art (Bayerisches Staatsministerium fur Wissenschaft, Forschung und Kunst, Munich, Germany); "German Barcode of Life" project by the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) [01 LI 1101 B]; project on Barcoding Lepidoptera of Finland by the Finnish Cultural Foundation; Kone Foundation	components of the "Barcoding Fauna Bavarica" project by the Bavarian Ministry of Science, Research and Art (Bayerisches Staatsministerium fur Wissenschaft, Forschung und Kunst, Munich, Germany); "German Barcode of Life" project by the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); project on Barcoding Lepidoptera of Finland by the Finnish Cultural Foundation; Kone Foundation	This study represents a contribution to WG1.9 of the International Barcode of Life Project. Sequence analysis was supported by Genome Canada through the Ontario Genomics Institute, while informatics support was provided through a grant from the Ontario Ministry of Research and Innovation. The collection and processing of specimens were funded as components of the "Barcoding Fauna Bavarica" project by the Bavarian Ministry of Science, Research and Art (Bayerisches Staatsministerium fur Wissenschaft, Forschung und Kunst, Munich, Germany), the "German Barcode of Life" project by the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung; 01 LI 1101 B), the project on Barcoding Lepidoptera of Finland by the Finnish Cultural Foundation, Kone Foundation and the project on Barcoding Lepidoptera of northern France by the Conseil Regional de Haute-Normandie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; DeWaard Jeremy R., 2008, V410, P275; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Eberhard W.G., 1985, SEXUAL SELECTION ANI; Eberhard W, 2010, GENETICA, V138, P5, DOI 10.1007/s10709-009-9358-y; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Grill A, 2007, J EVOLUTION BIOL, V20, P1255, DOI 10.1111/j.1420-9101.2007.01358.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hausmann A., 2001, GEOMETRID MOTHS EURO, V1, P1, DOI DOI 10.1007/978-1-4757-3423-2_; Hausmann Axel, 2011, Mitteilungen Muenchener Entomologischen Gesellschaft, V101, P73; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hausmann Axel, 2004, V2, P7; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huemer P, 2012, BARCODE B, V3, P4; Huemer P, 2012, ZOOTAXA, P1; Hundsdoerfer AK, 2009, MOL PHYLOGENET EVOL, V52, P852, DOI 10.1016/j.ympev.2009.05.023; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Karsholt O, 2012, FAUNA EUROPAEA LEPID; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; Monaghan MT, 2006, P ROY SOC B-BIOL SCI, V273, P887, DOI 10.1098/rspb.2005.3391; Mutanen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047214; Nyst R.H., 1993, Entomologica Gallica, V4, P159; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; PFRENDER ME, 2010, Q REV BIOL, V85, P319, DOI DOI 10.1086/655118.PUBMED:20919633; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ratnasingham S., 2013, BOLD BARCODE LIFE DA; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Scoble M. J., 1999, GEOMETRID MOTHS WORL, V1; SHAPIRO AM, 1989, ANNU REV ENTOMOL, V34, P231, DOI 10.1146/annurev.en.34.010189.001311; Smith MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036514; Teletchea F, 2010, MITOCHONDR DNA, V21, P206, DOI 10.3109/19401736.2010.532212; Usami T, 2006, BIOL J LINN SOC, V87, P145, DOI 10.1111/j.1095-8312.2006.00562.x; van Nieukerken EJ, 2012, CONTRIB ZOOL, V81, P1; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Whittaker RJ, 1998, ECOLOGY EVOLUTION CO; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x; Zerche Lothar, 1996, Beitraege zur Entomologie, V46, P277	44	118	123	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84518	10.1371/journal.pone.0084518	http://dx.doi.org/10.1371/journal.pone.0084518			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358363	gold, Green Published, Green Submitted			2022-12-27	WOS:000328737700098
J	Martinez-Cabrera, HI; Peres-Neto, PR				Martinez-Cabrera, Hugo I.; Peres-Neto, Pedro R.			Shifts in Climate Foster Exceptional Opportunities for Species Radiation: The Case of South African Geraniums	PLOS ONE			English	Article							DIVERSITY PATTERNS; PHYLOGENETIC RELATEDNESS; DIVERSIFICATION RATES; NICHE CONSERVATISM; EVOLUTION; DIVERGENCE; RICHNESS; EXPLAIN; MODELS; CLADES	Climate change is often assumed to be a major driver of biodiversity loss. However, it can also set the stage for novel diversification in lineages with the evolutionary ability to colonize new environments. Here we tested if the extraordinary evolutionary success of the genus Pelargonium was related to the ability of its species to capitalize on the climate niche variation produced by the historical changes in southern Africa. We evaluated the relationship between rates of climate niche evolution and diversification rates in the main Pelargonium lineages and disentangled the roles of deep and recent historical events in the modification of species niches. Pelargonium clades exhibiting higher ecological differentiation along summer precipitation (SPP) gradients also experienced higher diversification rates. Faster rates of niche differentiation in spatially structured variables, along with lower levels of niche overlap among closely related species, suggest recent modification in species niches (e.g. dispersal or range shift) and niche lability. We suggest that highly structured SPP gradients established during the aridification process within southern Africa, in concert with niche lability and low niche overlap, contributed to species divergence. These factors are likely to be responsible for the extensive diversification of other lineages in this diversity hot spot.	[Martinez-Cabrera, Hugo I.; Peres-Neto, Pedro R.] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; [Peres-Neto, Pedro R.] Univ Quebec, Canada Res Chair Spatial Modelling & Biodivers, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal	Martinez-Cabrera, HI (corresponding author), Univ Quebec, Dept Sci Biol, CP 8888, Montreal, PQ H3C 3P8, Canada.	huismaca@yahoo.com.mx		Peres Neto, Pedro/0000-0002-5629-8067	CONACYT; FQRNT; NSERC; CRC; "Plan Vert'' of the Government of Quebec [554010-107]; NSF-IRE [OISE-0623341]; NSF Dimensions of Biodiversity [1046328]; Division Of Environmental Biology [1046328] Funding Source: National Science Foundation	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); FQRNT(FQRNT); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); "Plan Vert'' of the Government of Quebec; NSF-IRE; NSF Dimensions of Biodiversity(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	CONACYT and FQRNT provided postdoctoral support to HIM-C. PRP-N was supported by NSERC and CRC grants. Funding was partially provided by the "Plan Vert'' of the Government of Quebec via a grant by the Ouranos consortium (project 554010-107). Species field locations were determined during research that was funded by NSF-IRE (OISE-0623341) and NSF Dimensions of Biodiversity (1046328) to C. Schlichting, C. Jones, K. Holsinger and J. Silander (University of Connecticut). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly D, 2009, P NATL ACAD SCI USA, V106, P19699, DOI 10.1073/pnas.0901635106; Adams DC, 2009, P ROY SOC B-BIOL SCI, V276, P2729, DOI 10.1098/rspb.2009.0543; Bakker FT, 2005, REGNUM VEG, V143, P75; Bakker FT, 2004, TAXON, V53, P17, DOI 10.2307/4135485; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; COETZEE J A, 1983, Bothalia, V14, P345; Cooper N, 2011, P ROY SOC B-BIOL SCI, V278, P2384, DOI 10.1098/rspb.2010.2207; Cowling R. M., 1997, P99; Freckleton RP, 2009, P ROY SOC B-BIOL SCI, V276, P21, DOI 10.1098/rspb.2008.0905; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HOLT RD, 1990, TRENDS ECOL EVOL, V5, P311, DOI 10.1016/0169-5347(90)90088-U; Jones C. S., 1996, Aliso, V14, P281; Jones CS, 2013, AM J BOT, V100, P1306, DOI 10.3732/ajb.1200526; Jones CS, 2009, EVOLUTION, V63, P479, DOI 10.1111/j.1558-5646.2008.00552.x; Kozak KH, 2010, ECOL LETT, V13, P1378, DOI 10.1111/j.1461-0248.2010.01530.x; Kozak KH, 2006, P ROY SOC B-BIOL SCI, V273, P539, DOI 10.1098/rspb.2005.3326; Linder HP, 2003, BIOL REV, V78, P597, DOI 10.1017/S1464793103006171; LINDER HP, 1991, J BIOGEOGR, V18, P509, DOI 10.2307/2845687; Losos JB, 2002, AM NAT, V160, P147, DOI 10.1086/341557; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Martinez-Cabrera HI, 2010, INFLUENCE CLIMATE FU; Martinez-Cabrera HI, 2012, AM J BOT, V99, P954, DOI 10.3732/ajb.1100600; Morris JW, 1978, PRECIS NATL HERBARIU; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peres-Neto PR, 2012, ECOLOGY, V93, pS14, DOI 10.1890/11-0494.1; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2006, EVOLUTION, V60, P1152; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; Ricklefs RE, 2007, J EVOLUTION BIOL, V20, P1751, DOI 10.1111/j.1420-9101.2007.01388.x; Roncal J, 2011, BIOTROPICA, V43, P324, DOI 10.1111/j.1744-7429.2010.00696.x; Rutherford MC, 2003, S AFR J BOT, V69, P99, DOI 10.1016/S0254-6299(15)30364-1; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; SCHULZE RE, 2007, S AFRICAN ATLAS CLIM; SIESSER WG, 1980, SCIENCE, V208, P283, DOI 10.1126/science.208.4441.283; Slingsby JA, 2006, AM NAT, V168, P14, DOI 10.1086/505158; Thuiller W, 2006, ECOGRAPHY, V29, P733, DOI 10.1111/j.0906-7590.2006.04674.x; Verboom GA, 2009, MOL PHYLOGENET EVOL, V51, P44, DOI 10.1016/j.ympev.2008.01.037; Verboom GA, 2004, AM J BOT, V91, P1364, DOI 10.3732/ajb.91.9.1364; WALKER TD, 1984, AM NAT, V124, P887, DOI 10.1086/284322; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JJ, 2011, ECOL LETT, V14, P643, DOI 10.1111/j.1461-0248.2011.01625.x; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	50	9	10	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83087	10.1371/journal.pone.0083087	http://dx.doi.org/10.1371/journal.pone.0083087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358250	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700046
J	McCarroll, MN; Nechiporuk, AV				McCarroll, Matthew N.; Nechiporuk, Alex V.			Fgf3 and Fgf10a Work in Concert to Promote Maturation of the Epibranchial Placodes in Zebrafish	PLOS ONE			English	Article							NEURAL CREST CELLS; INNER-EAR; OTIC PLACODE; INDUCTION; SPECIFICATION; FOXI1; FATE; GENE; DOWNSTREAM; ECTODERM	Essential cellular components of the paired sensory organs of the vertebrate head are derived from transient thickenings of embryonic ectoderm known as cranial placodes. The epibranchial (EB) placodes give rise to sensory neurons of the EB ganglia that are responsible for relaying visceral sensations form the periphery to the central nervous system. Development of EB placodes and subsequent formation of EB ganglia is a multistep process regulated by various extrinsic factors, including fibroblast growth factors (Fgfs). We discovered that two Fgf ligands, Fgf3 and Fgf10a, cooperate to promote EB placode development. Whereas EB placodes are induced in the absence of Fgf3 and Fgf10a, they fail to express placode specific markers Pax2a and Sox3. Expression analysis and mosaic rescue experiments demonstrate that Fgf3 signal is derived from the endoderm, whereas Fgf10a is emitted from the lateral line system and the otic placode. Further analyses revealed that Fgf3 and Fgf10a activities are not required for cell proliferation or survival, but are required for placodal cells to undergo neurogenesis. Based on these data, we conclude that a combined loss of these Fgf factors results in a failure of the EB placode precursors to initiate a transcriptional program needed for maturation and subsequent neurogenesis. These findings highlight the importance and complexity of reiterated Fgf signaling during cranial placode formation and subsequent sensory organ development.	[McCarroll, Matthew N.; Nechiporuk, Alex V.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA	Oregon Health & Science University	Nechiporuk, AV (corresponding author), Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA.	nechipor@ohsu.edu			NICHD [HD055303]; OHSU Brain Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R00HD055303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OHSU Brain Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NICHD HD055303 to AVN; OHSU Brain Institute Predoctoral Fellowship to MNM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahrens K, 2005, DEV BIOL, V288, P40, DOI 10.1016/j.ydbio.2005.07.022; Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; BANCROFT M, 1977, ANAT EMBRYOL, V151, P97, DOI 10.1007/BF00315302; Begbie J, 1999, DEVELOPMENT, V126, P895; Brugmann SA, 2004, DEVELOPMENT, V131, P5871, DOI 10.1242/dev.01516; Crump JG, 2004, DEVELOPMENT, V131, P5703, DOI 10.1242/dev.01444; Culbertson MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024443; DAMICOMARTEL A, 1983, AM J ANAT, V166, P445, DOI 10.1002/aja.1001660406; Dauger S, 2003, DEVELOPMENT, V130, P6635, DOI 10.1242/dev.00866; Drerup CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003303; Freter S, 2008, DEVELOPMENT, V135, P3415, DOI 10.1242/dev.026674; Freter S, 2013, DEVELOPMENT, V140, P3595, DOI 10.1242/dev.091033; Grandel H, 2000, DEVELOPMENT, V127, P4169; Hammond KL, 2011, DEVELOPMENT, V138, P3977, DOI 10.1242/dev.066639; Hammond KL, 2003, DEVELOPMENT, V130, P1403, DOI 10.1242/dev.00360; Hans S, 2004, DEVELOPMENT, V131, P5091, DOI 10.1242/dev.01346; Hans S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-5; Hans S, 2013, DEVELOPMENT, V140, P1936, DOI 10.1242/dev.087718; Herzog W, 2004, DEVELOPMENT, V131, P3681, DOI 10.1242/dev.01235; Kiefer P, 1996, GENE, V168, P211, DOI 10.1016/0378-1119(95)00736-9; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kozlowski DJ, 1997, BIOCHEM CELL BIOL, V75, P551, DOI 10.1139/bcb-75-5-551; Kucenas S, 2008, NAT NEUROSCI, V11, P143, DOI 10.1038/nn2025; Ladher RK, 2010, DEVELOPMENT, V137, P1777, DOI 10.1242/dev.040055; Lee SA, 2003, DEVELOPMENT, V130, P2669, DOI 10.1242/dev.00502; Leger S, 2002, MECH DEVELOP, V119, P91, DOI 10.1016/S0925-4773(02)00343-X; Litsiou A, 2005, DEVELOPMENT, V132, P4051, DOI 10.1242/dev.01964; Maroon H, 2002, DEVELOPMENT, V129, P2099; MCCARROLL MN, 2012, GRADED LEVELS PAX2A, DOI DOI 10.1242/DEV.076075; Nechiporuk A, 2005, DEVELOPMENT, V132, P3717, DOI 10.1242/dev.01876; Nechiporuk A, 2008, SCIENCE, V320, P1774, DOI 10.1126/science.1156547; Nechiporuk A, 2007, DEVELOPMENT, V134, P611, DOI 10.1242/dev.02749; Nikaido M, 2007, DEV DYNAM, V236, P564, DOI 10.1002/dvdy.21050; Norton WHJ, 2005, DEVELOPMENT, V132, P4963, DOI 10.1242/dev.02084; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Padanad MS, 2011, DEV BIOL, V351, P90, DOI 10.1016/j.ydbio.2010.12.036; Phillips BT, 2001, DEV BIOL, V235, P351, DOI 10.1006/dbio.2001.0297; Picker A, 2002, DEVELOPMENT, V129, P3227; Sahly I, 1999, DEV GENES EVOL, V209, P399, DOI 10.1007/s004270050270; Sakaguchi T, 2001, MECH DEVELOP, V107, P25, DOI 10.1016/S0925-4773(01)00453-1; Schlosser G, 2000, J COMP NEUROL, V418, P121; Schlosser G, 2005, J EXP ZOOL PART B, V304B, P347, DOI 10.1002/jez.b.21055; Streit A, 2004, DEV BIOL, V276, P1, DOI 10.1016/j.ydbio.2004.08.037; Sun SK, 2007, DEV BIOL, V303, P675, DOI 10.1016/j.ydbio.2006.12.008; Theveneau E, 2013, NAT CELL BIOL, V15, P763, DOI 10.1038/ncb2772; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wright TJ, 2003, DEVELOPMENT, V130, P3379, DOI 10.1242/dev.00555; Zelarayan LC, 2007, DEV BIOL, V308, P379, DOI 10.1016/j.ydbio.2007.05.033	49	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e85087	10.1371/journal.pone.0085087	http://dx.doi.org/10.1371/journal.pone.0085087			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358375	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700109
J	Otali, D; He, QH; Grizzle, WE				Otali, Dennis; He, Qinghua; Grizzle, William E.			The Effect of Antigen Retrieval on Cells Fixed in 10% Neutral Buffered Formalin Followed by Transfer to 70% Ethanol	PLOS ONE			English	Article							FIXATION	Fixation in 10% neutral buffered formalin prior to transfer to 70% ethanol for one week has been shown to adequately preserve immunorecognition of PCNA, cytokeratins AE1/AE3 and EGFr. This study investigated whether 12 hrs fixation in 10% NBF plus transfer to 70% ethanol for 4 weeks would similarly preserve immunorecognition to an extent where antigen retrieval (AR) used to reverse the masking effects of fixation on some antigens would not be necessary. Two cell lines, DU145 and SKOV3 were grown on coverslips and fixed either for 684 hrs in 10% NBF or for 12 hrs in 10% NBF which was then replaced with 70% ethanol for 672 hrs. The second experiment had the same design except an additional set of cells were subjected to heat-induced AR concomitantly. PCNA, cytokeratins AE1/AE3, and EGFr (membrane and cytoplasmic) were used to evaluate the effects of immunorecognition. Fixation in 10% NBF for 12 hrs plus transfer to 70% ethanol for 672 hrs did not preserve immunorecognition of PCNA adequately in either cell lines. Cytokeratins immunoreactivity was preserved by transfer to 70% ethanol. Cytoplasmic EGFr antigens were not adversely affected by 10% NBF fixation in either cell line and transfer to 70% ethanol had limited effects. With AR, there was little recovery of PCNA immunorecognition on cells fixed in only 10% NBF, but almost complete recovery for cells transferred to 70% ethanol. For cytokeratins there was complete recovery of immunorecognition either with only 10% NBF or 12 hrs plus transfer to 70% ethanol. For EGFr, AR resulted in complete loss of immunorecognition following either treatment. This study indicated that 12 hrs of fixation in 10% NBF plus transfer to 70% ethanol for 4 weeks with AR resulted in recovery of immunorecognition for PCNA and cytokeratins, but standard methods of AR caused loss of immunorecognition of EGFr.	[Otali, Dennis; Grizzle, William E.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Otali, Dennis] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [He, Qinghua] Tuskegee Univ, Dept Chem Engn, Tuskegee, AL 36088 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Tuskegee University	Grizzle, WE (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	wgrizzle@uab.edu			Susan G. Komen Breast Cancer Foundation [BCTR0600484]; Cooperative Human Tissue Network [5U01CA44968]; UAB Pancreatic [2P50CA101955]; Breast [5P50CA089019]; SPORES; DOD [W81XWH-10-1-0543]; UAB Comprehensive Cancer Center Core Support Grant [P30CA13148]; U54 MSM/TU/UAB Comprehensive Cancer Center Partnership [2U54CA118948, 2U54CA118623]; NATIONAL CANCER INSTITUTE [P30CA013148, P50CA089019, P50CA101955, U01CA044968, U54CA118623, U54CA118948] Funding Source: NIH RePORTER	Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Cooperative Human Tissue Network; UAB Pancreatic; Breast; SPORES; DOD(United States Department of Defense); UAB Comprehensive Cancer Center Core Support Grant; U54 MSM/TU/UAB Comprehensive Cancer Center Partnership; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported in part by the following grants: the Susan G. Komen Breast Cancer Foundation (BCTR0600484), the Cooperative Human Tissue Network (5U01CA44968), the UAB Pancreatic (2P50CA101955) and Breast (5P50CA089019) SPORES, the DOD Grant (W81XWH-10-1-0543), the UAB Comprehensive Cancer Center Core Support Grant (P30CA13148) and the U54 MSM/TU/UAB Comprehensive Cancer Center Partnership (2U54CA118948, 2U54CA118623). Mr. Cecil Stockard, who is deceased, also aided in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold MM, 1996, BIOTECH HISTOCHEM, V71, P224, DOI 10.3109/10520299609117164; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; FRAENKELCONRAT H, 1948, J BIOL CHEM, V174, P827; Grizzle EW, 2008, THEORY PRACTICE HIST, P53; Grizzle EW, 1998, IMMUNOHISTOCHEMICAL; Grizzle WE, 2001, J HISTOTECHNOL, V24, P213; Lillie R.D, 1948, HISTOPATHOLOGIC TECH; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Otali D, 2009, BIOTECH HISTOCHEM, V84, P223, DOI 10.1080/10520290903039094; Otali D, 2012, BIOTECH HIS IN PRESS; Poczatek RB, 1999, J UROLOGY, V162, P1462, DOI 10.1016/S0022-5347(05)68341-3; Shi SR, 2011, J HISTOCHEM CYTOCHEM, V59, P13, DOI 10.1369/jhc.2010.957191; [No title captured]	13	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82405	10.1371/journal.pone.0082405	http://dx.doi.org/10.1371/journal.pone.0082405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358179	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700014
J	Zhu, ZX; Liu, YX; Zhang, CQ; Yuan, ZS; Zhang, Q; Tang, F; Lin, HY; Zhang, YY; Liu, LJ; Xue, FZ				Zhu, Zhenxin; Liu, Yanxun; Zhang, Chengqi; Yuan, Zhongshang; Zhang, Qian; Tang, Fang; Lin, Haiyan; Zhang, Yongyuan; Liu, Longjian; Xue, Fuzhong			Identification of Cardiovascular Risk Components in Urban Chinese with Metabolic Syndrome and Application to Coronary Heart Disease Prediction: A Longitudinal Study	PLOS ONE			English	Article							BLOOD-CELL COUNT; INSULIN-RESISTANCE SYNDROME; GAMMA-GLUTAMYL-TRANSFERASE; FATTY LIVER-DISEASE; SERUM URIC-ACID; FOLLOW-UP; 10-YEAR RISK; STROKE; ASSOCIATION; MORTALITY	Background: Metabolic syndrome (MetS) is proposed as a predictor for cardiovascular disease (CVD). It involves the mechanisms of insulin resistance, obesity, inflammation process of atherosclerosis, and their complex relationship in the metabolic network. Therefore, more cardiovascular risk-related biomarkers within this network should be considered as components of MetS in order to improve the prediction of CVD. Methods: Factor analysis was performed in 5311 (4574 males and 737 females) Han Chinese subjects with MetS to extract CVD-related factors with specific clinical significance from 16 biomarkers tested in routine health check-up. Logistic regression model, based on an extreme case-control design with 445 coronary heart disease (CHD) patients and 890 controls, was performed to evaluate the extracted factors used to identify CHD. Then, Cox model, based on a cohort design with 1923 subjects followed up for 5 years, was conducted to validate their predictive effects. Finally, a synthetic predictor (SP) was created by weighting each factor with their risks for CHD to develop a risk matrix to predicting CHD. Results: Eight factors were obtained from both males and females with a similar pattern. The AUC to classify CHD under the extreme case-control suggested that SP might serve as a useful tool in identifying CHD with 0.994 (95% CI 0.984-0.998) for males and 0.998 (95% CI 0.982-1.000) for females respectively. In the cohort study, the AUC to predict CHD was 0.871 (95% CI 0.851-0.889) for males and 0.899 (95% CI 0.873-0.921) for females, highlighting that SP was a powerful predictor for CHD. The SP-based 5-year CHD risk matrix provided as convenient tool for CHD risk appraisal. Conclusions: Eight factors were extracted from sixteen biomarkers in subjects with MetS and the SP adds to new insights into studies of prediction of CHD risk using data from routine health check-up.	[Zhu, Zhenxin; Liu, Yanxun; Yuan, Zhongshang; Zhang, Qian; Zhang, Yongyuan; Xue, Fuzhong] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Jinan 250100, Shandong, Peoples R China; [Zhang, Chengqi; Tang, Fang] Shandong Prov QianFoShan Hosp, Hlth Management Ctr, Jinan, Shandong, Peoples R China; [Lin, Haiyan] Shandong Univ, Prov Hosp, Ctr Hlth Management, Jinan 250100, Shandong, Peoples R China; [Liu, Longjian] Drexel Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Drexel University	Xue, FZ (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Jinan 250100, Shandong, Peoples R China.	xuefzh@sdu.edu.cn	Yuan, Zhongshang/GVT-8351-2022; Xue, Fuzhong/AAG-4808-2020; zhang, chi/GRX-3610-2022; Liu, Longjian/Q-4774-2018	Xue, Fuzhong/0000-0003-0378-7956	National Natural Science Foundation of China [81273177]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by grant 81273177 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Borges RL, 2010, CURR HYPERTENS REP, V12, P113, DOI 10.1007/s11906-010-0098-2; CDS (Chinese Diabetes Society), 2004, CHIN J DIABETES, P156, DOI DOI 10.1002/IJG0.12802; Chen W, 2010, DIABETES CARE, V33, P2474, DOI 10.2337/dc10-0619; Cheung BMY, 2011, CLIN CHIM ACTA, V412, P1326, DOI 10.1016/j.cca.2011.03.030; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cui RZ, 2007, ATHEROSCLEROSIS, V194, P415, DOI 10.1016/j.atherosclerosis.2006.08.022; Cui RZ, 2012, ATHEROSCLEROSIS, V221, P565, DOI 10.1016/j.atherosclerosis.2012.01.013; Deedwania PC, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000110642.73995.BF; EDWARDS KL, 1994, ARTERIOSCLER THROMB, V14, P1940, DOI 10.1161/01.ATV.14.12.1940; Elkind MSV, 2010, ARCH NEUROL-CHICAGO, V67, P33, DOI 10.1001/archneurol.2009.271; Ferrario M, 2005, INT J EPIDEMIOL, V34, P413, DOI 10.1093/ije/dyh405; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Goodman E, 2005, CIRCULATION, V111, P1970, DOI 10.1161/01.CIR.0000161957.34198.2B; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hamaguchi M, 2012, WORLD J GASTROENTERO, V18, P1508, DOI 10.3748/wjg.v18.i13.1508; Hanson RL, 2002, DIABETES, V51, P3120, DOI 10.2337/diabetes.51.10.3120; Jimba S, 2009, METAB SYNDR RELAT D, V7, P411, DOI 10.1089/met.2008.0082; Kwon CH, 2011, METABOLISM, V60, P1136, DOI 10.1016/j.metabol.2010.12.007; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lao XQ, 2008, ATHEROSCLEROSIS, V201, P418, DOI 10.1016/j.atherosclerosis.2007.12.053; Lee CD, 2001, AM J EPIDEMIOL, V154, P758, DOI 10.1093/aje/154.8.758; Lehto S, 2000, DIABETOLOGIA, V43, P148, DOI 10.1007/s001250050023; Lehto S, 1998, STROKE, V29, P635, DOI 10.1161/01.STR.29.3.635; Lemieux I, 2001, ARCH INTERN MED, V161, P2685, DOI 10.1001/archinte.161.22.2685; Lempiainen P, 1999, CIRCULATION, V100, P123, DOI 10.1161/01.CIR.100.2.123; Liese AD, 1999, EPIDEMIOLOGY, V10, P391, DOI 10.1097/00001648-199907000-00009; Lin YC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-747; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Meng WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049875; Nebeck K, 2012, DIABETES METAB SYND, V6, P22, DOI 10.1016/j.dsx.2012.05.009; Normann J, 2012, AM HEART J, V164, P698, DOI 10.1016/j.ahj.2012.08.003; Odagiri K, 2011, INTERNAL MED, V50, P2491, DOI 10.2169/internalmedicine.50.5877; Onat A, 2013, J INVEST MED, V61, P27, DOI 10.2310/JIM.0b013e318276de59; Onat A, 2012, OBESITY, V20, P842, DOI 10.1038/oby.2011.136; Povel CM, 2013, DIABETES CARE, V36, P362, DOI 10.2337/dc11-2546; Pyorala M, 2000, ARTERIOSCL THROM VAS, V20, P538, DOI 10.1161/01.ATV.20.2.538; Nguyen QM, 2011, DIABETES CARE, V34, P2603, DOI 10.2337/dc11-0919; REAVEN GM, 1993, ANNU REV MED, V44, P121, DOI 10.1146/annurev.me.44.020193.001005; Rose G A, 1968, Monogr Ser World Health Organ, V56, P1; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; Scott R, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-102; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Steuenson JE, 2012, METABOLISM, V61, P1582, DOI 10.1016/j.metabol.2012.04.010; Sui XM, 2008, METABOLISM, V57, P845, DOI 10.1016/j.metabol.2008.01.030; Suzuki K, 2011, CEREBROVASC DIS, V31, P100, DOI 10.1159/000321506; Hong TK, 2012, PREV MED, V55, P409, DOI 10.1016/j.ypmed.2012.09.002; Treeprasertsuk S, 2012, LIVER INT, V32, P945, DOI 10.1111/j.1478-3231.2011.02753.x; Treeprasertsuk S, 2011, DIGEST DIS SCI, V56, P35, DOI 10.1007/s10620-010-1241-2; Tsai CH, 2011, ENDOCRINE, V40, P256, DOI 10.1007/s12020-011-9466-1; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wu YF, 2006, CIRCULATION, V114, P2217, DOI 10.1161/CIRCULATIONAHA.105.607499; Xu Y, 2011, J DIABETES, V3, P38, DOI 10.1111/j.1753-0407.2010.00111.x; Zhang Q, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-419	55	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84204	10.1371/journal.pone.0084204	http://dx.doi.org/10.1371/journal.pone.0084204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358344	Green Submitted, gold, Green Published			2022-12-27	WOS:000328737700086
J	Kelkka, T; Pizzolla, A; Laurila, JP; Friman, T; Gustafsson, R; Kallberg, E; Olsson, O; Leanderson, T; Rubin, K; Salmi, M; Jalkanen, S; Holmdahl, R				Kelkka, Tiina; Pizzolla, Angela; Laurila, Juha Petteri; Friman, Tomas; Gustafsson, Renata; Kallberg, Eva; Olsson, Olof; Leanderson, Tomas; Rubin, Kristofer; Salmi, Marko; Jalkanen, Sirpa; Holmdahl, Rikard			Mice Lacking NCF1 Exhibit Reduced Growth of Implanted Melanoma and Carcinoma Tumors	PLOS ONE			English	Article							OXIDATIVE STRESS; CELLS; ARTHRITIS; GENE; MACROPHAGES; EXPRESSION; CANCER; INHIBITION; BURST; ROS	The NADPH oxidase 2 (NOX2) complex is a professional producer of reactive oxygen species (ROS) and is mainly expressed in phagocytes. While the activity of the NOX2 complex is essential for immunity against pathogens and protection against autoimmunity, its role in the development of malignant tumors remains unclear. We compared wild type and Ncf1(m1J) mutated mice, which lack functional NOX2 complex, in four different tumor models. Ncf1(m1J) mutated mice developed significantly smaller tumors in two melanoma models in which B16 melanoma cells expressing a hematopoietic growth factor FLT3L or luciferase reporter were used. Ncf1(m1J) mutated mice developed significantly fewer Lewis Lung Carcinoma (LLC) tumors, but the tumors that did develop, grew at a pace that was similar to the wild type mice. In the spontaneously arising prostate carcinoma model (TRAMP), tumor growth was not affected. The lack of ROS-mediated protection against tumor growth was associated with increased production of immunity-associated cytokines. A significant increase in Th2 associated cytokines was observed in the LLC model. Our present data show that ROS regulate rejection of the antigenic B16-luc and LLC tumors, whereas the data do not support a role for ROS in growth of intrinsically generated tumors.	[Kelkka, Tiina; Laurila, Juha Petteri; Salmi, Marko; Jalkanen, Sirpa; Holmdahl, Rikard] Medicity Res Lab, Turku, Finland; [Kelkka, Tiina] Turku Doctoral Programme Biomed Sci, Turku, Finland; [Pizzolla, Angela; Holmdahl, Rikard] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Friman, Tomas; Gustafsson, Renata; Olsson, Olof; Rubin, Kristofer] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Leanderson, Tomas] Lund Univ, Immunol Grp, Biomed Ctr, Lund, Sweden	University of Turku; Karolinska Institutet; Uppsala University; Lund University	Holmdahl, R (corresponding author), Medicity Res Lab, Turku, Finland.	rikard.holmdahl@ki.se	Rubin, Kristofer/AAC-1810-2020; Holmdahl, Rikard/AAI-7682-2020; Kelkka, Tiina/ABI-2952-2022; Pizzolla, Angela/AAN-1566-2021	Rubin, Kristofer/0000-0003-2789-6276; Kelkka, Tiina/0000-0003-1085-6382; Pizzolla, Angela/0000-0003-2024-4144; Olsson, P. Olof/0000-0002-1048-0832	Swedish Strategic Science Foundation; Knut and Alice Wallenberg foundation; Swedish Research Council; Swedish Rheumatism Association; Swedish Cancer Society; The Alfred stelunds Stiftelse (Sweden); Juselius Foundation; Finnish Academy; Finnish Cancer Foundation; Svenska Kulturfonden in Finland; EU Masterswitch [HEALTH-F2-2008-223404]; Neurinox; BeTheCure	Swedish Strategic Science Foundation; Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; Swedish Cancer Society(Swedish Cancer Society); The Alfred stelunds Stiftelse (Sweden); Juselius Foundation; Finnish Academy(Academy of Finland); Finnish Cancer Foundation; Svenska Kulturfonden in Finland; EU Masterswitch; Neurinox; BeTheCure	This study was supported by grants from the Swedish Strategic Science Foundation, Knut and Alice Wallenberg foundation, Swedish Research Council, Swedish Rheumatism Association, Swedish Cancer Society, The Alfred stelunds Stiftelse (Sweden), Juselius Foundation, Finnish Academy, the Finnish Cancer Foundation, Svenska Kulturfonden in Finland, EU Masterswitch (Grant No. HEALTH-F2-2008-223404), Neurinox and BeTheCure grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Antony S, 2013, FREE RADICAL BIO MED, V65, P497, DOI 10.1016/j.freeradbiomed.2013.07.005; BERTRAM JS, 1980, CANCER LETT, V11, P63, DOI 10.1016/0304-3835(80)90130-5; Fitzgerald JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030712; Friman T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034082; Fukuyama M, 2005, CANCER LETT, V221, P97, DOI 10.1016/j.canlet.2004.08.031; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Hagenow K, 2009, J IMMUNOL, V183, P874, DOI 10.4049/jimmunol.0900966; Hellstrand K, 2000, MED ONCOL, V17, P258, DOI 10.1007/BF02782190; Hole PS, 2013, BLOOD, V122, P3322, DOI 10.1182/blood-2013-04-491944; Holland SM, 2010, CLIN REV ALLERG IMMU, V38, P3, DOI 10.1007/s12016-009-8136-z; Holmdahl R, 2013, ANTIOXID REDOX SIGN, V18, P1463, DOI 10.1089/ars.2012.4734; Hultqvist M, 2004, P NATL ACAD SCI USA, V101, P12646, DOI 10.1073/pnas.0403831101; Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luxen S, 2008, CANCER RES, V68, P1037, DOI 10.1158/0008-5472.CAN-07-5782; Mach N, 2000, CANCER RES, V60, P3239; Maraldi T, 2009, FREE RADICAL RES, V43, P1111, DOI 10.1080/10715760903186132; Marttila-Ichihara F, 2009, CANCER RES, V69, P7875, DOI 10.1158/0008-5472.CAN-09-1205; Marttila-Ichihara F, 2008, BLOOD, V112, P64, DOI 10.1182/blood-2007-10-118984; Meitzler JL, 2013, ANTIOX REDOX SIGNAL; Mellqvist UH, 2000, BLOOD, V96, P1961, DOI 10.1182/blood.V96.5.1961.h8001961_1961_1968; Nagaraj S, 2010, J IMMUNOL, V184, P3106, DOI 10.4049/jimmunol.0902661; Olofsson P, 2003, NAT GENET, V33, P25, DOI 10.1038/ng1058; Olsson LM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2299; Olsson LM, 2012, ANTIOXID REDOX SIGN, V16, P71, DOI 10.1089/ars.2011.4013; Salnikov AV, 2005, LAB INVEST, V85, P512, DOI 10.1038/labinvest.3700252; Tiffen JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-299; Zhang Y, 2013, CELL RES, V23, P898, DOI 10.1038/cr.2013.75	29	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84148	10.1371/journal.pone.0084148	http://dx.doi.org/10.1371/journal.pone.0084148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358335	Green Published, gold			2022-12-27	WOS:000328735700152
J	Li, L; Khush, K; Hsieh, SC; Ying, LH; Luikart, H; Sigdel, T; Roedder, S; Yang, A; Valantine, H; Sarwal, MM				Li, Li; Khush, Kiran; Hsieh, Szu-Chuan; Ying, Lihua; Luikart, Helen; Sigdel, Tara; Roedder, Silke; Yang, Andrew; Valantine, Hannah; Sarwal, Minnie M.			Identification of Common Blood Gene Signatures for the Diagnosis of Renal and Cardiac Acute Allograft Rejection	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; ACUTE CELLULAR REJECTION; WORKING FORMULATION; ENDOMYOCARDIAL BIOPSIES; INTERNATIONAL SOCIETY; STEROID AVOIDANCE; RANDOMIZED-TRIAL; HEART; INTRAGRAFT; CYTOKINE	To test, whether 10 genes, diagnostic of renal allograft rejection in blood, are able to diagnose and predict cardiac allograft rejection, we analyzed 250 blood samples from heart transplant recipients with and without acute rejection (AR) and with cytomegalovirus (CMV) infection by QPCR. A QPCR-based logistic regression model was built on 5 of these 10 genes (AR threshold composite score>37% = AR) and tested for AR prediction in an independent set of 109 samples, where it correctly diagnosed AR with 89% accuracy, with no misclassifications for AR ISHLT grade 1b. CMV infection did not confound the AR score. The genes correctly diagnosed AR in a blood sample within 6 months prior to biopsy diagnosis with 80% sensitivity and untreated grade 1b AR episodes had persistently elevated scores until 6 months after biopsy diagnosis. The gene score was also correlated with presence or absence of cardiac allograft vasculopathy (CAV) irrespective of rejection grade. In conclusion, there is a common transcriptional axis of immunological trafficking in peripheral blood in both renal and cardiac organ transplant rejection, across a diverse recipient age range. A common gene signature, initially identified in the setting of renal transplant rejection, can be utilized serially after cardiac transplantation, to diagnose and predict biopsy confirmed acute heart transplant rejection.	[Li, Li; Hsieh, Szu-Chuan; Ying, Lihua; Sigdel, Tara; Roedder, Silke; Sarwal, Minnie M.] Stanford Univ, Dept Pediat, Palo Alto, CA 94304 USA; [Khush, Kiran; Luikart, Helen; Yang, Andrew; Valantine, Hannah] Stanford Univ, Div Cardiovasc Med, Dept Med, Palo Alto, CA 94304 USA; [Hsieh, Szu-Chuan; Sigdel, Tara; Roedder, Silke; Sarwal, Minnie M.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA	Stanford University; Stanford University; California Pacific Medical Center; California Pacific Medical Center Research Institute	Valantine, H (corresponding author), Stanford Univ, Div Cardiovasc Med, Dept Med, Palo Alto, CA 94304 USA.	hvalantine@stanford.edu; msarwal@psg.ucsf.edu	Sigdel, Tara/AAV-5886-2020	Sigdel, Tara/0000-0001-8448-0328; Li, Li/0000-0001-6746-4297; Khush, Kiran/0000-0001-9697-5926				Alpert S, 1995, TRANSPLANTATION, V60, P1478, DOI 10.1097/00007890-199560120-00019; BAAN CC, 1994, CLIN EXP IMMUNOL, V97, P293; BARALDIJUNKINS C, 1993, J HEART LUNG TRANSPL, V12, P63; Bernstein D, 2007, J HEART LUNG TRANSPL, V26, P1270, DOI 10.1016/j.healun.2007.09.017; Billingham M E, 1990, J Heart Transplant, V9, P587; Bromberg JS, 2012, AM J TRANSPLANT, V12, P2573, DOI 10.1111/j.1600-6143.2012.04250.x; Chen R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000940; de Groot-Kruseman HA, 2002, HEART, V87, P363, DOI 10.1136/heart.87.4.363; DECKERS JW, 1992, J AM COLL CARDIOL, V19, P43, DOI 10.1016/0735-1097(92)90049-S; Delgado DH, 2002, CLIN TRANSPLANT, V16, P217, DOI 10.1034/j.1399-0012.2002.01132.x; Deng MC, 2006, AM J TRANSPLANT, V6, P150, DOI 10.1111/j.1600-6143.2005.01175.x; Evans RW, 2005, AM J TRANSPLANT, V5, P1553, DOI 10.1111/j.1600-6143.2005.00869.x; Ferreira JA, 2007, INT J BIOSTAT, V3; FISHBEIN MC, 1994, J HEART LUNG TRANSPL, V13, P1051; Holweg CTJ, 2011, CIRCULATION, V123, P2236, DOI 10.1161/CIRCULATIONAHA.109.913921; Hornick P, 1997, CIRCULATION, V96, P148; Horwitz PA, 2004, CIRCULATION, V110, P3815, DOI 10.1161/01.CIR.0000150539.72783.BF; Khatri P, 2009, CURR OPIN ORGAN TRAN, V14, P34, DOI 10.1097/MOT.0b013e32831e13d0; Kienzl K, 2009, TRANSPLANTATION, V88, P553, DOI 10.1097/TP.0b013e3181b119b1; Kimball PM, 1996, TRANSPLANTATION, V61, P909, DOI 10.1097/00007890-199603270-00012; Lagoo AS, 1996, J HEART LUNG TRANSPL, V15, P206; Laguens RP, 1996, J HEART LUNG TRANSPL, V15, P911; Li L, 2012, AM J TRANSPLANT, V12, P2710, DOI 10.1111/j.1600-6143.2012.04253.x; Mehra MR, 2006, NAT CLIN PRACT CARD, V3, P136, DOI 10.1038/ncpcardio0457; Morgun A, 2001, TRANSPLANT P, V33, P1610, DOI 10.1016/S0041-1345(00)02613-0; Naesens M, 2012, AM J TRANSPLANT, V12, P2730, DOI 10.1111/j.1600-6143.2012.04144.x; Navia JL, 2005, J HEART VALVE DIS, V14, P264; NIELSEN H, 1993, J HEART LUNG TRANSPL, V12, P239; Pham MX, 2010, NEW ENGL J MED, V362, P1890, DOI 10.1056/NEJMoa0912965; Purvesh Khatri SR, 2013, JEM; Raichlin E, 2009, J HEART LUNG TRANSPL, V28, P320, DOI 10.1016/j.healun.2009.01.006; RUSSELL ME, 1993, TRANSPLANTATION, V56, P1599; SAHAI H, 1995, COMPUT BIOL MED, V25, P35, DOI 10.1016/0010-4825(95)98883-F; Sarwal M, 2003, NEW ENGL J MED, V349, P125, DOI 10.1056/NEJMoa035588; Sarwal MM, 2012, AM J TRANSPLANT, V12, P2719, DOI 10.1111/j.1600-6143.2012.04145.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Shulzhenko N, 2001, TRANSPLANTATION, V72, P1705, DOI 10.1097/00007890-200111270-00025; Shulzhenko N, 2001, BRAZ J MED BIOL RES, V34, P779, DOI 10.1590/S0100-879X2001000600013; Shulzhenko N, 2001, HUM IMMUNOL, V62, P342, DOI 10.1016/S0198-8859(01)00211-7; SOLEZ K, 1993, KIDNEY INT, V44, P411, DOI 10.1038/ki.1993.259; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Stewart S, 2007, J HEART LUNG TRANSPL, V26, P1229, DOI 10.1016/j.healun.2007.10.017; STGOAR FG, 1992, CIRCULATION, V85, P979, DOI 10.1161/01.CIR.85.3.979; Stoica SC, 2006, J HEART LUNG TRANSPL, V25, P420, DOI 10.1016/j.healun.2005.11.449; Taylor DO, 2009, J HEART LUNG TRANSPL, V28, P1007, DOI 10.1016/j.healun.2009.08.014; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Emmerik N, 1994, Transpl Int, V7 Suppl 1, pS623; Wang E, 2008, TRENDS IMMUNOL, V29, P256, DOI 10.1016/j.it.2008.03.002; Winters GL, 1996, J HEART LUNG TRANSPL, V15, P728; Wong BW, 2005, CARDIOVASC PATHOL, V14, P176, DOI 10.1016/j.carpath.2005.05.001; Wu T, 2003, TRANSPLANTATION, V75, P1241, DOI 10.1097/01.TP.0000062840.49159.2F; Yamani MH, 2007, J HEART LUNG TRANSPL, V26, P403, DOI 10.1016/j.healun.2006.12.011; YEOH TK, 1992, CIRCULATION, V86, P267	54	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82153	10.1371/journal.pone.0082153	http://dx.doi.org/10.1371/journal.pone.0082153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358149	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700038
J	Tocco, C; Probo, M; Lonati, M; Lombardi, G; Negro, M; Nervo, B; Rolando, A; Palestrini, C				Tocco, Claudia; Probo, Massimiliano; Lonati, Michele; Lombardi, Giampiero; Negro, Matteo; Nervo, Beatrice; Rolando, Antonio; Palestrini, Claudia			Pastoral Practices to Reverse Shrub Encroachment of Sub-Alpine Grasslands: Dung Beetles (Coleoptera, Scarabaeoidea) Respond More Quickly Than Vegetation	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; CATTLE; BIODIVERSITY; RESTORATION; CONSEQUENCES; CONSERVATION; ASSEMBLAGES; ABANDONMENT; HEATHLAND; DYNAMICS	In recent decades, pastoral abandonment has produced profound ecological changes in the Alps. In particular, the reduction in grazing has led to extensive shrub encroachment of semi-natural grasslands, which may represent a threat to open habitat biodiversity. To reverse shrub encroachment, we assessed short-term effects of two different pastoral practices on vegetation and dung beetles (Coleoptera, Scarabaeoidea). Strategic placement of mineral mix supplements (MMS) and arrangement of temporary night camp areas (TNCA) for cattle were carried out during summer 2011 in the Val Troncea Natural Park, north-western Italian Alps. In 2012, one year after treatment, a reduction in shrub cover and an increase in bare ground cover around MMS sites was detected. A more intense effect was detected within TNCA through increases in forage pastoral value, and in the cover and height of the herbaceous layer. Immediately after treatment, changes in dung beetle diversity (total abundance, species richness, Shannon diversity, taxonomic and functional diversity) showed a limited disturbance effect caused by high cattle density. In contrast, dung beetle diversity significantly increased one year later both at MMS and TNCA sites, with a stronger effect within TNCA. Multivariate Regression Trees and associated Indicator Value analyses showed that some ecologically relevant dung beetle species preferred areas deprived of shrub vegetation. Our main conclusions are: i) TNCA are more effective than MMS in terms of changes to vegetation and dung beetles, ii) dung beetles respond more quickly than vegetation to pastoral practices, and iii) the main driver of the rapid response by dung beetles is the removal of shrubs. The resulting increase in dung beetle abundance and diversity, which are largely responsible for grassland ecosystem functioning, may have a positive effect on meso-eutrophic grassland restoration. Shrub encroachment in the Alps may therefore be reversed, and restoration of grassland enhanced, by using appropriate pastoral practices.	[Tocco, Claudia; Negro, Matteo; Nervo, Beatrice; Rolando, Antonio; Palestrini, Claudia] Univ Torino, Dept Life Sci & Syst Biol, Turin, Italy; [Probo, Massimiliano; Lonati, Michele; Lombardi, Giampiero] Univ Turin, Dept Agr Forest & Food Sci, Turin, Italy	University of Turin; University of Turin	Tocco, C (corresponding author), Univ Torino, Dept Life Sci & Syst Biol, Turin, Italy.	claudia.tocco@unito.it	Lombardi, Giampiero/G-3714-2012	Lombardi, Giampiero/0000-0003-3787-2374; Probo, Massimiliano/0000-0002-0017-7557; ROLANDO, Antonio/0000-0002-3432-1780				Ascoli D, 2009, INT J WILDLAND FIRE, V18, P727, DOI 10.1071/WF07114; Bailey DW, 2007, RANGELAND ECOL MANAG, V60, P54, DOI 10.2111/05-138R1.1; Bang HS, 2005, APPL SOIL ECOL, V29, P165, DOI 10.1016/j.apsoil.2004.11.001; Barbaro L, 2001, BIODIVERS CONSERV, V10, P119, DOI 10.1023/A:1016629507196; Barragan F, 2011, PLOS ONE, V6; Beynon SA, 2012, J APPL ECOL, V49, P1365, DOI 10.1111/j.1365-2664.2012.02210.x; Bokdam J, 2000, J APPL ECOL, V37, P415, DOI 10.1046/j.1365-2664.2000.00507.x; Borghesio L, 1999, PEDOBIOLOGIA, V43, P97; Braga RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057786; Cavallero A., 2007, TIPI PASTORALI ALPI; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; Dellacasa G., 2006, FAUNA ITALIA; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dzwonko Z, 2007, J VEG SCI, V18, P203, DOI 10.1111/j.1654-1103.2007.tb02531.x; Elzein TM, 2011, ALPINE BOT, V121, P129, DOI 10.1007/s00035-011-0095-3; Falcucci A, 2007, LANDSCAPE ECOL, V22, P617, DOI 10.1007/s10980-006-9056-4; Finn JA, 2003, ECOL ENTOMOL, V28, P1, DOI 10.1046/j.1365-2311.2002.00487.x; Gallet S, 2001, BIOL CONSERV, V97, P189, DOI 10.1016/S0006-3207(00)00111-7; Gusewell S, 2005, PLANT SOIL, V268, P135, DOI 10.1007/s11104-004-0304-6; Jay-Robert P, 2008, ANN ENTOMOL SOC AM, V101, P58, DOI 10.1603/0013-8746(2008)101[58:SATVOM]2.0.CO;2; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kohler F, 2004, J VEG SCI, V15, P143, DOI 10.1111/j.1654-1103.2004.tb02249.x; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Laiolo P, 2004, J APPL ECOL, V41, P294, DOI 10.1111/j.0021-8901.2004.00893.x; LANDOLT E., 1977, OKOLOGISCHE ZEIGERWE; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Lyet A, 2009, ANIM CONSERV, V12, P238, DOI 10.1111/j.1469-1795.2009.00245.x; Macagno ALM, 2009, BIODIVERS CONSERV, V18, P3309, DOI 10.1007/s10531-009-9643-1; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; Mitlacher K, 2002, APPL VEG SCI, V5, P63, DOI 10.1111/j.1654-109X.2002.tb00536.x; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Negro M, 2011, ENVIRON ENTOMOL, V40, P1081, DOI 10.1603/EN11105; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Numa C, 2012, INSECT CONSERV DIVER, V5, P106, DOI 10.1111/j.1752-4598.2011.00137.x; Obrist MK, 2011, FOREST ECOL MANAG, V261, P789, DOI 10.1016/j.foreco.2010.12.010; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Probo M, 2013, RANGELAND J, V35, P85, DOI 10.1071/RJ12108; R Development Core Team, 2005, R LANG ENV STAT COMP; Rolando A, 2013, INSECT CONSERV DIVER, V6, P212, DOI 10.1111/j.1752-4598.2012.00204.x; Rosenlew H, 2008, OIKOS, V117, P1659, DOI 10.1111/j.1600-0706.2008.16904.x; Scrucca L., 2004, R NEWS, V4, P11; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Stewart KEJ, 2001, J APPL ECOL, V38, P1148, DOI 10.1046/j.1365-2664.2001.00658.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tocco C, 2013, J INSECT CONSERV, V17, P207, DOI 10.1007/s10841-012-9498-8; Torok P, 2011, BIODIVERS CONSERV, V20, P2311, DOI 10.1007/s10531-011-9992-4; Zuur Alain F., 2009, P1	51	38	38	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83344	10.1371/journal.pone.0083344	http://dx.doi.org/10.1371/journal.pone.0083344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358277	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700120
J	Wang, R; Alen, M; Yu, ZS; Wiklund, P; Cheng, SM; Tormakangas, T; Chen, PJ; Cheng, SL				Wang, Ru; Alen, Markku; Yu, Zhusheng; Wiklund, Petri; Cheng, Shu Mei; Tormakangas, Timo; Chen, Peijie; Cheng, Sulin			Does Serum 25-Hydroxyvitamin D Influence Muscle Development during Puberty in Girls? - A 7-Year Longitudinal Study	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; HUMAN SKELETAL-MUSCLE; BONE-MINERAL DENSITY; PARATHYROID-HORMONE; PHYSICAL PERFORMANCE; D SUPPLEMENTATION; GRIP STRENGTH; D DEFICIENCY; FAT MASS; CHILDREN	Vitamin D is well known for its regulatory role in calcium and phosphate homeostasis, but its role in muscle mass and strength during growth remains inconclusive. We explored the association of serum 25-hydroxyvitamin D (25(OH)D) with muscle development in girls from 11 to 18-years old. Whole body lean tissue mass (LMWB), appendicular lean mass (aLM), muscle cross-sectional area at the lower leg (mCSA), maximal voluntary contraction of elbow flexors (MVCelbow) and knee extensors (MVCknee) were assessed in 217 girls aged 10-13 years (at baseline), 215 in 2-year and 226 in 7.5-year follow-up. Serum concentration of 25(OH)D and intact parathyroid hormone (PTH) were analyzed retrospectively and girls were categorized according to their 25(OH)D levels (consistently insufficient 25(OH)D G(LL) <50 nmol/l and consistently sufficient G(HH) >50 nmol/l from baseline to 7-year follow-up). We found that 25(OH)D level declined until menarche (p<0.05) while LMWB, aLM, mCSA, MVCelbow and MVCknee continued to increase (p<0.001 for all) post menarche. At pre-menarche, the G(LL) (n = 34) had higher LMWB and aLM than the G(HH) (n = 21, p<0.05), while post-menarche the G(HH) (n = 15) had a greater catch-up gain in LMWB (p = 0.004), aLM (p = 0.001) and mCSA (p = 0.027) compared to the G(LL) (n = 65) over the first 2-year period. At the age of 18, no differences in muscle mass/strength between the low (n = 151) and high (n = 77) levels of 25(OH)D groups were found. This finding was independent of vitamin D receptor genotype and other confounders. In conclusion, our results showed that levels of 25(OH)D have no significant negative influence on the development of muscle mass and strength during pubertal growth both with longitudinal and cross-sectional comparison. On the contrary, our results suggest that the temporary negative association between 25(OH)D and muscle mass arises as a consequence of fast growth prior to menarche, and this negative association is diminished through catch-up growth after menarche.	[Wang, Ru; Yu, Zhusheng; Chen, Peijie; Cheng, Sulin] Shanghai Univ Sport, Key Lab Exercise & Hlth Sci, Minist Educ, Shanghai, Peoples R China; [Wang, Ru; Yu, Zhusheng; Wiklund, Petri; Cheng, Shu Mei; Tormakangas, Timo; Chen, Peijie; Cheng, Sulin] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland; [Alen, Markku; Wiklund, Petri] Oulu Univ Hosp, Dept Rehabil Med, Oulu, Finland; [Alen, Markku] Univ Oulu, Inst Hlth Sci, Oulu, Finland	Shanghai University of Sport; University of Jyvaskyla; University of Oulu; University of Oulu	Chen, PJ (corresponding author), Shanghai Univ Sport, Key Lab Exercise & Hlth Sci, Minist Educ, Shanghai, Peoples R China.	chenpeijie@sus.edu.cn; sulin.cheng@jyu.fi		Tormakangas, Timo/0000-0001-7268-5297	Academy of Finland; SKID-KID program [135038]; Shanghai Sport University; Shanghai Key Lab of Human Sport Competence Development and Maintenance [11DZ2261100]	Academy of Finland(Academy of Finland); SKID-KID program; Shanghai Sport University; Shanghai Key Lab of Human Sport Competence Development and Maintenance	This study was financially supported by the Academy of Finland, SKID-KID program, project # 135038 and by Shanghai Sport University, the Shanghai overseas distinguish professor award program 2012 and the Shanghai Key Lab of Human Sport Competence Development and Maintenance (No. 11DZ2261100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams SA, 2005, J CLIN ENDOCR METAB, V90, P5576, DOI 10.1210/jc.2005-1021; Annweiler C, 2009, J NUTR HEALTH AGING, V13, P893, DOI 10.1007/s12603-009-0248-x; Au LE, 2012, PUBLIC HEALTH NUTR, V15, P2047, DOI 10.1017/S1368980012003217; BACZYNSKI R, 1985, KIDNEY INT, V28, P722, DOI 10.1038/ki.1985.190; BEGUM N, 1992, J BIOL CHEM, V267, P5959; Bischoff HA, 2001, HISTOCHEM J, V33, P19, DOI 10.1023/A:1017535728844; Bischoff-Ferrari HA, 2004, J BONE MINER RES, V19, P265, DOI 10.1359/jbmr.2004.19.2.265; Ceglia L, 2013, CALCIFIED TISSUE INT, V92, P151, DOI 10.1007/s00223-012-9645-y; Cheng SL, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-5; Dahifar H, 2006, J MED INVESTIG, V53, P204, DOI 10.2152/jmi.53.204; Dong YB, 2010, PEDIATRICS, V125, P1104, DOI 10.1542/peds.2009-2055; Dupuy C, 2013, J NUTR HEALTH AGING, V17, P119, DOI 10.1007/s12603-012-0089-x; El-Hajj Fuleihan G, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.4.e53; El-Hajj Fuleihan G, 2006, J CLIN ENDOCR METAB, V91, P405, DOI 10.1210/jc.2005-1436; GARBER AJ, 1983, J CLIN INVEST, V71, P1806, DOI 10.1172/JCI110936; Geusens P, 1997, J BONE MINER RES, V12, P2082, DOI 10.1359/jbmr.1997.12.12.2082; Gilsanz V, 2010, J CLIN ENDOCR METAB, V95, P1595, DOI 10.1210/jc.2009-2309; Goswami R, 2012, J CLIN ENDOCR METAB, V97, P4709, DOI 10.1210/jc.2012-2340; Grundberg E, 2004, EUR J ENDOCRINOL, V150, P323, DOI 10.1530/eje.0.1500323; Hamilton B, 2010, SCAND J MED SCI SPOR, V20, P182, DOI 10.1111/j.1600-0838.2009.01016.x; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Houston DK, 2007, J GERONTOL A-BIOL, V62, P440, DOI 10.1093/gerona/62.4.440; KROGER H, 1995, LANCET, V345, P1238, DOI 10.1016/S0140-6736(95)92019-6; Kuh D, 2006, J GERONTOL A-BIOL, V61, P702, DOI 10.1093/gerona/61.7.702; Kumar J, 2009, PEDIATRICS, V124, pE362, DOI 10.1542/peds.2009-0051; Lehtonen-Veromaa M, 1999, EUR J CLIN NUTR, V53, P746, DOI 10.1038/sj.ejcn.1600844; Libuda L, 2011, BRIT J NUTR, V105, P428, DOI 10.1017/S0007114510003508; Lyytikainen A, 2005, PUBLIC HEALTH NUTR, V8, P284, DOI 10.1079/PHN2004703; Marwaha RK, 2005, AM J CLIN NUTR, V82, P477, DOI 10.1093/ajcn/82.2.477; McCarty MF, 2002, AM J CLIN NUTR, V76, P1454, DOI 10.1093/ajcn/76.6.1454; McGrath JJ, 2001, MED J AUSTRALIA, V174, P150, DOI 10.5694/j.1326-5377.2001.tb143195.x; Pekkinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040090; Sayer AA, 2004, J GERONTOL A-BIOL, V59, P930, DOI 10.1093/gerona/59.9.M930; SEDRANI SH, 1984, ANN NUTR METAB, V28, P181, DOI 10.1159/000176801; Stein MS, 1999, J AM GERIATR SOC, V47, P1195, DOI 10.1111/j.1532-5415.1999.tb05199.x; Tylavsky FA, 2007, J AM COLL NUTR, V26, P462, DOI 10.1080/07315724.2007.10719637; Venning G, 2005, BRIT MED J, V330, P524, DOI 10.1136/bmj.330.7490.524; Volgyi E, 2011, J APPL PHYSIOL, V110, P1211, DOI 10.1152/japplphysiol.00996.2010; Wang YJ, 2011, ENDOCRINOLOGY, V152, P354, DOI 10.1210/en.2010-1109; Ward KA, 2010, J CLIN ENDOCR METAB, V95, P4643, DOI 10.1210/jc.2009-2725; Ward KA, 2009, J CLIN ENDOCR METAB, V94, P559, DOI 10.1210/jc.2008-1284; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Willis CM, 2007, AM J CLIN NUTR, V85, P124, DOI 10.1093/ajcn/85.1.124; Windelinckx A, 2007, OSTEOPOROSIS INT, V18, P1235, DOI 10.1007/s00198-007-0374-4; Winzenberg T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7254; Xu LT, 2009, J BONE MINER RES, V24, P1693, DOI [10.1359/JBMR.090405, 10.1359/jbmr.090405]	46	3	3	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82124	10.1371/journal.pone.0082124	http://dx.doi.org/10.1371/journal.pone.0082124			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358145	Green Submitted, gold, Green Published			2022-12-27	WOS:000328735700035
J	Chiang, WC; Lai, CF; Su, CT; Peng, WH; Wu, CF; Chang, FC; Chen, YT; Lin, SL; Chen, YM; Wu, KD; Lu, KS; Tsai, TJ				Chiang, Wen Chih; Lai, Chun Fu; Su, Chi Ting; Peng, Wei Hao; Wu, Ching Fang; Chang, Fan Chi; Chen, Yi Ting; Lin, Shuei Liong; Chen, Yung Ming; Wu, Kwan Dun; Lu, Kuo Shyan; Tsai, Tun Jun			Angiopoietins Modulate Endothelial Adaptation, Glomerular and Podocyte Hypertrophy after Uninephrectomy	PLOS ONE			English	Article							BASEMENT-MEMBRANE COMPONENTS; RECEPTOR TYROSINE KINASE; GROWTH-FACTOR; IN-VIVO; CELL SURVIVAL; TIE2 RECEPTOR; VEGF; ANGIOGENESIS; MODEL; EXPRESSION	Glomerular capillary remodeling is an essential process in the development of glomerular hypertrophy. Angiopoietins, which are important regulators in angiogenesis, plays a role in the development of glomerulus during embryogenesis. Here, we evaluated the influence of angiopoietin on glomerular components and hypertrophy after uninephrectomy in adult male BALB/c mice. The actions of angiopoietin 1 or 2 were systemically antagonized by the subcutaneous administration of antagonists. We observed that the angiopoietin system was activated after uninephrectomy, and that the blockade of angiopoietin 1 or 2 decreased the activation of the angiopoietin receptor-tyrosine kinase with Ig and EGF homology domains-2-and attenuated the development of glomerular and podocyte hypertrophy. The increase in endothelial density staining (anti-CD31) following uninephrectomy was also reversed by angiopoietin 1 or 2 blockades. Glomerular basement thickness and foot process width were observed to decrease in the angiopoietin blockade groups. These changes were associated with the down regulation of the expression of genes for the glomerular matrix and basement membrane, including collagen type IV alpha 1, collagen type IV alpha 2, collagen type IV alpha 5, and laminin alpha 5. Thus, angiopoietin 1 or 2 may play an important role in the development of glomerular hypertrophy after uninephrectomy. A blockade of the angiopoietin system not only influenced the endothelium but also the podocyte, leading to diminished gene expression and morphological changes after uninephrectomy.	[Chiang, Wen Chih; Lai, Chun Fu; Wu, Ching Fang; Lin, Shuei Liong; Chen, Yung Ming; Wu, Kwan Dun; Tsai, Tun Jun] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Su, Chi Ting] Natl Taiwan Univ Hosp Yunlin Branch, Dept Internal Med, Taipei, Yunlin Branch, Taiwan; [Peng, Wei Hao; Lu, Kuo Shyan] Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, Taipei 10764, Taiwan; [Chang, Fan Chi] Natl Taiwan Univ Hosp Zhudong Branch, Dept Internal Med, Zhudong, Hsinchu County, Taiwan; [Chen, Yi Ting] E Da Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Lin, Shuei Liong] Natl Taiwan Univ, Grad Inst Physiol, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; E-Da Hospital; National Taiwan University	Tsai, TJ (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	tjtsai@ntuh.gov.tw	Chen, Yi/HIR-2608-2022; Lin, Shuei-Liong/AGR-2002-2022; Chang, Fan-Chi/GOK-2657-2022	Lin, Shuei-Liong/0000-0002-1041-5571; peng, wei hao/0000-0002-7524-1218; TSAI, TUN-JUN/0000-0002-1666-8940; WU, KWAN-DUN/0000-0002-3339-1509; Su, Chi-Ting/0000-0002-2926-3950; LAI, CHUN-FU/0000-0003-2109-1522; CHEN, YUNG-MING/0000-0002-9241-1258; Chiang, Wen Chih/0000-0002-8844-0988	National Health Research Institute Taiwan [PS9505, NHRI-EX101-10125SC]; National Taiwan University Hospital [100N01]; Ta-Tung Kidney Foundation; Mrs. Hsiu-Chin Lee Kidney Research Foundation	National Health Research Institute Taiwan(National Health Research Institutes - Taiwan); National Taiwan University Hospital(National Taiwan University); Ta-Tung Kidney Foundation; Mrs. Hsiu-Chin Lee Kidney Research Foundation	This study was supported by grant from the National Health Research Institute Taiwan (PS9505, NHRI-EX101-10125SC), grant from National Taiwan University Hospital (100N01), Ta-Tung Kidney Foundation, Mrs. Hsiu-Chin Lee Kidney Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2009, J AM SOC NEPHROL, V20, P1471, DOI 10.1681/ASN.2008101086; [Anonymous], 1979, STEREOLOGICAL METHOD; Bogdanovic E, 2006, J CELL SCI, V119, P3551, DOI 10.1242/jcs.03077; Campean V, 2008, AM J PHYSIOL-RENAL, V294, pF1174, DOI 10.1152/ajprenal.00320.2007; Coxon A, 2010, MOL CANCER THER, V9, P2641, DOI 10.1158/1535-7163.MCT-10-0213; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Falcon BL, 2009, AM J PATHOL, V175, P2159, DOI 10.2353/ajpath.2009.090391; Flyvbjerg A, 2002, AM J PHYSIOL-ENDOC M, V283, pE362, DOI 10.1152/ajpendo.00007.2002; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Henao DE, 2010, HYPERTENS PREGNANCY, V29, P10, DOI 10.3109/10641950802631036; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Holash J, 1999, ONCOGENE, V18, P5356, DOI 10.1038/sj.onc.1203035; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Kim I, 2000, ONCOGENE, V19, P4549, DOI 10.1038/sj.onc.1203800; Kim KE, 2007, ARTERIOSCL THROM VAS, V27, P564, DOI 10.1161/01.ATV.0000256458.82320.be; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; MARCUSSEN N, 1994, LAB INVEST, V70, P868; Miner JH, 1998, CURR OPIN NEPHROL HY, V7, P13; Miner JH, 1999, KIDNEY INT, V56, P2016, DOI 10.1046/j.1523-1755.1999.00785.x; Morisada T, 2006, ENDOTHELIUM-J ENDOTH, V13, P71, DOI 10.1080/10623320600697989; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; NYENGAARD JR, 1993, KIDNEY INT, V43, P1049, DOI 10.1038/ki.1993.147; NYENGAARD JR, 1993, DIABETOLOGIA, V36, P189, DOI 10.1007/BF00399948; Reinhardt C, 2012, NATURE, V483, P627, DOI 10.1038/nature10893; Schrijvers BF, 2006, NEPHROL DIAL TRANSPL, V21, P324, DOI 10.1093/ndt/gfi217; Schrijvers BF, 2005, NEPHRON EXP NEPHROL, V101, pE9, DOI 10.1159/000086034; Schrijvers BF, 2002, KIDNEY INT, V61, P1600, DOI 10.1046/j.1523-1755.2002.00310.x; St John PL, 2001, KIDNEY INT, V60, P1037, DOI 10.1046/j.1523-1755.2001.0600031037.x; Sugimoto H, 2003, J BIOL CHEM, V278, P12605, DOI 10.1074/jbc.C300012200; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Teichert-Kuliszewska K, 2001, CARDIOVASC RES, V49, P659, DOI 10.1016/S0008-6363(00)00231-5; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Tressel SL, 2008, ARTERIOSCL THROM VAS, V28, P1989, DOI 10.1161/ATVBAHA.108.175463; Woolf AS, 2001, PEDIATR NEPHROL, V16, P177, DOI 10.1007/s004670000509; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08; Yuan HT, 1999, J AM SOC NEPHROL, V10, P1722	40	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82592	10.1371/journal.pone.0082592	http://dx.doi.org/10.1371/journal.pone.0082592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367525	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300041
J	Lee, JJ; Sohn, Y; Fowler, JH				Lee, Jooa Julia; Sohn, Yunkyu; Fowler, James H.			Emotion Regulation as the Foundation of Political Attitudes: Does Reappraisal Decrease Support for Conservative Policies?	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; DISGUST SENSITIVITY; TERROR MANAGEMENT; ORIENTATIONS; GENES; NEED	Cognitive scientists, behavior geneticists, and political scientists have identified several ways in which emotions influence political attitudes, and psychologists have shown that emotion regulation can have an important causal effect on physiology, cognition, and subjective experience. However, no work to date explores the possibility that emotion regulation may shape political ideology and attitudes toward policies. Here, we conduct four studies that investigate the role of a particular emotion regulation strategy - reappraisal in particular. Two observational studies show that individual differences in emotion regulation styles predict variation in political orientations and support for conservative policies. In the third study, we experimentally induce disgust as the target emotion to be regulated and show that use of reappraisal reduces the experience of disgust, thereby decreasing moral concerns associated with conservatism. In the final experimental study, we show that use of reappraisal successfully attenuates the relationship between trait-level disgust sensitivity and support for conservative policies. Our findings provide the first evidence of a critical link between emotion regulation and political attitudes.	[Lee, Jooa Julia] Harvard Univ, Harvard Kennedy Sch, Cambridge, MA 02138 USA; [Sohn, Yunkyu; Fowler, James H.] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA; [Fowler, James H.] Univ Calif San Diego, Div Med Genet, La Jolla, CA 92093 USA	Harvard University; University of California System; University of California San Diego; University of California System; University of California San Diego	Lee, JJ (corresponding author), Harvard Univ, Harvard Kennedy Sch, Cambridge, MA 02138 USA.	jooajulialee@fas.harvard.edu	Fowler, James H/C-2750-2008; Cunningham, Julia J. Lee/AAK-6843-2020	Fowler, James H/0000-0001-7795-1638; Cunningham, Julia J. Lee/0000-0002-6650-7088	Center for American Political Studies (CAPS), Harvard University	Center for American Political Studies (CAPS), Harvard University	This research was supported by the Graduate Seed Grant from the Center for American Political Studies (CAPS), Harvard University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford JR, 2005, AM POLIT SCI REV, V99, P153, DOI 10.1017/S0003055405051579; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Braams BR, 2012, J BEHAV THER EXP PSY, V43, P1014, DOI 10.1016/j.jbtep.2012.04.001; Bradley M. M., 2000, HDB PSYCHOPHYSIOLOGY; Dasgupta N, 2009, EMOTION, V9, P585, DOI 10.1037/a0015961; Dechesne M, 2000, J PERS SOC PSYCHOL, V79, P923, DOI 10.1037//0022-3514.79.6.923; Eaves LJ, 2008, BEHAV GENET, V38, P247, DOI 10.1007/s10519-008-9205-4; Eskine KJ, 2011, PSYCHOL SCI, V22, P295, DOI 10.1177/0956797611398497; Feinberg M, 2012, PSYCHOL SCI, V23, P788, DOI 10.1177/0956797611434747; Fowler JH, 2008, J POLIT, V70, P579, DOI 10.1017/S0022381608080638; Fowler JH, 2008, AM POLIT SCI REV, V102, P233, DOI 10.1017/S0003055408080209; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; GREENBERG J, 1992, J PERS SOC PSYCHOL, V63, P212, DOI 10.1037/0022-3514.63.2.212; GREENBERG J, 1990, J SOC CLIN PSYCHOL, V9, P202, DOI 10.1521/jscp.1990.9.2.202; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; HAIDT J, 1994, PERS INDIV DIFFER, V16, P701, DOI 10.1016/0191-8869(94)90212-7; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Halperin E, 2013, PSYCHOL SCI, V24, P106, DOI 10.1177/0956797612452572; Halperin E, 2011, COGNITION EMOTION, V25, P1228, DOI 10.1080/02699931.2010.536081; HAMM AO, 2003, HDB AFFECTIVE SCI; Hannagan RJ, 2008, PERSPECT POLIT, V6, P329, DOI 10.1017/S153759270808064X; Hatemi PK, 2013, AM J POLIT SCI, V57, P279, DOI 10.1111/ajps.12016; Inbar Y, 2012, SOC PSYCHOL PERS SCI, V3, P537, DOI 10.1177/1948550611429024; Inbar Y, 2009, COGNITION EMOTION, V23, P714, DOI 10.1080/02699930802110007; Inbar Y, 2009, EMOTION, V9, P435, DOI 10.1037/a0015960; Kanai R, 2011, CURR BIOL, V21, P677, DOI 10.1016/j.cub.2011.03.017; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Lang J.P., 1999, A4 U FLOR CTR RES PS; LEVENSON RW, 1990, PSYCHOPHYSIOLOGY, V27, P363, DOI 10.1111/j.1469-8986.1990.tb02330.x; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; Rozin P, 1999, J RES PERS, V33, P330, DOI 10.1006/jrpe.1999.2251; Saguy T, 2013, J CONFLICT RESOLUT; Schnall S, 2008, PERS SOC PSYCHOL B, V34, P1096, DOI 10.1177/0146167208317771; Schnall S, 2008, PSYCHOL SCI, V19, P1219, DOI 10.1111/j.1467-9280.2008.02227.x; Schreiber D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052970; Sherman GD, 2012, PSYCHOL SCI, V23, P1506, DOI 10.1177/0956797612445318; Shiota MN, 2009, PSYCHOL AGING, V24, P890, DOI 10.1037/a0017896; Smith KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025552; Smith KB, 2011, POLIT PSYCHOL, V32, P369, DOI 10.1111/j.1467-9221.2010.00821.x; Tomkins S. S., 1963, STUDY LIVES, P388, DOI [DOI 10.1037/12238-017, 10.1037/12238-017]; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Williams S., 1984, POLIT PSYCHOL, V5, P573, DOI [10.2307/3791228, DOI 10.2307/3791228, https://doi.org/10.2307/3791228]; WILSON GD, 1973, SOC BEHAV PERSONAL, V1, P115, DOI 10.2224/sbp.1973.1.2.115; WILSON GD, 1968, BRIT J SOC CLIN PSYC, V7, P264	47	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83143	10.1371/journal.pone.0083143	http://dx.doi.org/10.1371/journal.pone.0083143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367583	Green Published, gold			2022-12-27	WOS:000328740300094
J	Molero-Luis, M; Fernandez-Urena, S; Jordan, I; Serrano, M; Ormazabal, A; Garcia-Cazorla, A; Artuch, R				Molero-Luis, Marta; Fernandez-Urena, Sergio; Jordan, Iolanda; Serrano, Mercedes; Ormazabal, Aida; Garcia-Cazorla, Angels; Artuch, Rafael		Neopterin Working Grp	Cerebrospinal Fluid Neopterin Analysis in Neuropediatric Patients: Establishment of a New Cut Off-Value for the Identification of Inflammatory-Immune Mediated Processes	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; NEUROLOGICAL DISORDERS; INTERFERON-GAMMA; PTERINS; CHILDREN; ACTIVATION; BIOPTERIN; INFECTIONS; SEROTONIN	Objective: A high level of cerebrospinal fluid (CSF) neopterin is a marker of central nervous system inflammatory-immune mediated processes. We aimed to assess data from 606 neuropediatric patients, describing the clinical and biochemical features of those neurological disorders presenting CSF neopterin values above a new cut-off value that was defined in our laboratory. Methods: To establish the new CSF neopterin cut-off value, we studied two groups of patients: Group 1 comprised 68 patients with meningoencephalitis, and Group 2 comprised 52 children with a confirmed peripheral infection and no central nervous system involvement. We studied 606 CSF samples from neuropediatric patients who were classified into 3 groups: genetic diagnosis (A), acquired/unknown etiologic neurologic diseases (B) and inflammatory-immune mediated processes (C). Results: The CSF neopterin cut-off value was 61 nmol/L. Out of 606 cases, 56 presented a CSF neopterin level above this value. Group C had significantly higher CSF neopterin, protein and leukocyte values than the other groups. Sixteen of twenty-three patients in this group had a CSF neopterin level above the cut-off, whereas three and seven patients presented increased leukocyte and protein values, respectively. A significant association was found among CSF neopterin, proteins and leukocytes in the 606 patients. White matter disturbances were associated with high CSF neopterin concentrations. Conclusions: Although children with inflammatory-immune mediated processes presented higher CSF neopterin values, patients with other neurological disorders also showed increased CSF neopterin concentrations. These results stress the importance of CSF neopterin analysis for the identification of inflammatory-immune mediated processes.	[Molero-Luis, Marta; Serrano, Mercedes; Ormazabal, Aida; Garcia-Cazorla, Angels; Artuch, Rafael] Inst Salud Carlos III, Dept Clin Biochem, Univ Hosp St Joan de Deu, Barcelona, Spain; [Molero-Luis, Marta; Serrano, Mercedes; Ormazabal, Aida; Garcia-Cazorla, Angels; Artuch, Rafael] Inst Salud Carlos III, Neuropediatrc Dept, Univ Hosp St Joan de Deu, Barcelona, Spain; [Molero-Luis, Marta; Serrano, Mercedes; Ormazabal, Aida; Garcia-Cazorla, Angels; Artuch, Rafael] Inst Salud Carlos III, Ctr Biomed Res Rare Dis CIBER ER, Barcelona, Spain; [Fernandez-Urena, Sergio; Jordan, Iolanda] Univ Hosp St Joan de Deu, Intens Pediat Care Unit Serv, Barcelona, Spain; [Neopterin Working Grp] Univ Hosp St Joan de Deu, Dept Mol Microbiol, Microbiol Serv, Barcelona, Spain	Instituto de Salud Carlos III; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Molero-Luis, M (corresponding author), Inst Salud Carlos III, Dept Clin Biochem, Univ Hosp St Joan de Deu, Barcelona, Spain.	mmolerol@hsjdbcn.org	Muñoz-Almagro, Carmen/N-7248-2015; Munoz-Almagro, Carmen/B-4308-2015	Muñoz-Almagro, Carmen/0000-0001-5586-404X; Munoz-Almagro, Carmen/0000-0001-5586-404X; Serrano, Mercedes/0000-0002-2056-2428; Artuch, Rafael/0000-0002-3422-9685; Molero, Marta/0000-0002-6839-1963	Centre for Biomedical Research on Rare Diseases (CIBER-ER, ISCIII); CIBER-ER; ISCIII; program Rio Hortega (ISCIII); Jose Luis Castano Foundation	Centre for Biomedical Research on Rare Diseases (CIBER-ER, ISCIII); CIBER-ER; ISCIII(Instituto de Salud Carlos III); program Rio Hortega (ISCIII); Jose Luis Castano Foundation	This research was supported by Centre for Biomedical Research on Rare Diseases (CIBER-ER, ISCIII). Dr. Mercedes Serrano and Mercedes Casado were supported by a CIBER-ER contract. Dr. Rafael Artuch is supported by the "programa de intensificacion de la actividad investigadora'' from ISCIII. Marta Molero was supported by program Rio Hortega (ISCIII) and Jose Luis Castano Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2012.03696.x; Azumagawa K, 2003, BRAIN DEV-JPN, V25, P200, DOI 10.1016/S0387-7604(02)00217-6; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Blau N, 2003, NEUROLOGY, V61, P642, DOI 10.1212/01.WNL.0000082726.08631.E7; Blau N., 2003, PHYS GUIDE LAB DIAGN, P89; Dale RC, 2009, DEV MED CHILD NEUROL, V51, P317, DOI 10.1111/j.1469-8749.2008.03225.x; De Grandis E, 2010, J INHERIT METAB DIS, V33, P803, DOI 10.1007/s10545-010-9200-9; Duarte S, 2008, BRAIN DEV-JPN, V30, P106, DOI 10.1016/j.braindev.2007.06.009; FREDRIKSON S, 1987, CLIN EXP IMMUNOL, V67, P76; FURUKAWA Y, 1992, J NEUROL SCI, V111, P65, DOI 10.1016/0022-510X(92)90113-Y; Ghanem E, 2008, J ARTHROPLASTY, V23, P182, DOI 10.1016/j.arth.2007.08.016; Hagberg L, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-15; Herlenius E, 2004, EXP NEUROL, V190, pS8, DOI 10.1016/j.expneurol.2004.03.027; Hoffmann G, 2003, INFLAMM RES, V52, P313, DOI 10.1007/s00011-003-1181-9; HUBER C, 1984, J EXP MED, V160, P310, DOI 10.1084/jem.160.1.310; HYLAND K, 1993, PEDIATR RES, V34, P10, DOI 10.1203/00006450-199307000-00003; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Kawakami Yasuhiko, 1996, No To Hattatsu, V28, P23; Millner MM, 1998, CLIN CHEM, V44, P161; Molero-Luis M, 2013, DEV MED CHILD NEUROL, V55, P559, DOI 10.1111/dmcn.12116; Ormazabal A, 2005, J NEUROSCI METH, V142, P153, DOI 10.1016/j.jneumeth.2004.08.007; Pranzatelli MR, 2004, J CHILD NEUROL, V19, P919, DOI 10.1177/08830738040190120201; Sawada Y, 1999, BRAIN DEV-JPN, V21, P264, DOI 10.1016/S0387-7604(99)00021-2; SCHOEDON G, 1986, J INTERFERON RES, V6, P697, DOI 10.1089/jir.1986.6.697; Serrano M, 2009, PEDIATR NEUROL, V41, P448, DOI 10.1016/j.pediatrneurol.2009.06.008; Speth C, 2000, IMMUNOBIOLOGY, V202, P460, DOI 10.1016/S0171-2985(00)80104-7; WACHTER H, 1989, ADV CLIN CHEM, V27, P81, DOI 10.1016/S0065-2423(08)60182-1	27	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83237	10.1371/journal.pone.0083237	http://dx.doi.org/10.1371/journal.pone.0083237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367586	Green Published, gold			2022-12-27	WOS:000328740300097
J	Noreen, AME; Webb, EL				Noreen, Annika M. E.; Webb, Edward L.			High Genetic Diversity in a Potentially Vulnerable Tropical Tree Species Despite Extreme Habitat Loss	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; KOOMPASSIA-MALACCENSIS; MICROSATELLITE MARKERS; FLOW; EXTINCTION; FRAGMENTATION; FOREST; SINGAPORE; SUSCEPTIBILITY; CONSERVATION	Over the last 150 years, Singapore's primary forest has been reduced to less than 0.2% of its previous area, resulting in extinctions of native flora and fauna. Remaining species may be threatened by genetic erosion and inbreeding. We surveyed >95% of the remaining primary forest in Singapore and used eight highly polymorphic microsatellite loci to assess genetic diversity indices of 179 adults (>30 cm stem diameter), 193 saplings (>1 yr), and 1,822 seedlings (<1 yr) of the canopy tree Koompassia malaccensis (Fabaceae). We tested hypotheses relevant to the genetic consequences of habitat loss: (1) that the K. malaccensis population in Singapore experienced a genetic bottleneck and a reduction in effective population size, and (2) K. malaccensis recruits would exhibit genetic erosion and inbreeding compared to adults. Contrary to expectations, we detected neither a population bottleneck nor a reduction in effective population size, and high genetic diversity in all age classes. Genetic diversity indices among age classes were not significantly different: we detected overall high expected heterozygosity (H-e = 0.843-0.854), high allelic richness (R = 16.7-19.5), low inbreeding co-efficients (F-IS = 0.013-0.076), and a large proportion (30.1%) of rare alleles (i.e. frequency <1%). However, spatial genetic structure (SGS) analyses showed significant differences between the adults and the recruits. We detected significantly greater SGS intensity, as well as higher relatedness in the 0-10 m distance class, for seedlings and saplings compared to the adults. Demographic factors for this population (i.e. <200 adult trees) are a cause for concern, as rare alleles could be lost due to stochastic factors. The high outcrossing rate (t(m) = 0.961), calculated from seedlings, may be instrumental in maintaining genetic diversity and suggests that pollination by highly mobile bee species in the genus Apis may provide resilience to acute habitat loss.	[Noreen, Annika M. E.; Webb, Edward L.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Webb, EL (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	ted.webb@nus.edu.sg	Webb, Edward L/E-8343-2011	Webb, Edward L/0000-0001-5554-9955; Noreen, Annika/0000-0002-7695-5095	Singapore Ministry of Education [R154-000-400-133]; Lee Hiok Kwee Endowment [R-154-000-480-720]	Singapore Ministry of Education(Ministry of Education, Singapore); Lee Hiok Kwee Endowment	The study was supported by the Singapore Ministry of Education (grant R154-000-400-133) and the Lee Hiok Kwee Endowment to the Department of Biological Sciences, NUS (grant R-154-000-480-720). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; [Anonymous], 2009, CHECKLIST TOTAL VASC; Bijlsma R, 2000, J EVOLUTION BIOL, V13, P502, DOI 10.1046/j.1420-9101.2000.00177.x; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Corlett RT, 2011, HONEYBEES OF ASIA, P215, DOI 10.1007/978-3-642-16422-4_10; Corlett Richard T., 1997, Gardens' Bulletin (Singapore), V49, P147; CORLETT RT, 1990, J TROP ECOL, V6, P55, DOI 10.1017/S0266467400004028; CORLETT RT, 1992, J BIOGEOGR, V19, P411, DOI 10.2307/2845569; Corlett RT, 2001, J TROP ECOL, V17, P155, DOI 10.1017/S0266467401001109; Cornuet JM, 1996, GENETICS, V144, P2001; Doyle J. J., 1987, PHYTOCHEM B, P11; Dutta A, 2001, BIODIVERSITY ECOSYST, P173; Fenster CB, 2003, EVOLUTION, V57, P995, DOI 10.1111/j.0014-3820.2003.tb00311.x; Finger A, 2012, MOL ECOL, V21, P2369, DOI 10.1111/j.1365-294X.2012.05543.x; Fiumera AC, 2000, CONSERV BIOL, V14, P886, DOI 10.1046/j.1523-1739.2000.97337.x; Flather CH, 2011, TRENDS ECOL EVOL, V26, P307, DOI 10.1016/j.tree.2011.03.001; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gibson L, 2013, SCIENCE, V341, P1508, DOI 10.1126/science.1240495; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Goudet J, 2001, FSTAT VERS 2 9 3 PRO; Hamrick JL, 2012, HEREDITY, V109, P330, DOI 10.1038/hdy.2012.47; Harata T, 2012, BIOTROPICA, V44, P586, DOI 10.1111/j.1744-7429.2011.00836.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hauser L, 2002, P NATL ACAD SCI USA, V99, P11742, DOI 10.1073/pnas.172242899; Honnay O, 2007, CONSERV BIOL, V21, P823, DOI 10.1111/j.1523-1739.2006.00646.x; IUCN (International Union for Conservation of Nature), 2012, RED LIST THREAT SPEC; Jamieson IG, 2012, TRENDS ECOL EVOL, V27, P578, DOI 10.1016/j.tree.2012.07.001; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kim Su Lee, 2007, Sains Malaysiana, V36, P233; Kramer AT, 2008, CONSERV BIOL, V22, P878, DOI 10.1111/j.1523-1739.2008.00944.x; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Lasso E, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.40; Lee CT, 2006, MOL ECOL NOTES, V6, P1198, DOI 10.1111/j.1471-8286.2006.01490.x; Lee CT, 2011, J TROP FOR SCI, V23, P410; Lee C. T., 2008, Pertanika Journal of Tropical Agricultural Science, V31, P127; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lowe AJ, 2005, HEREDITY, V95, P255, DOI 10.1038/sj.hdy.6800725; McGreevy TJ, 2011, ZOO BIOL, V30, P636, DOI 10.1002/zoo.20362; Menges ES, 2000, TRENDS ECOL EVOL, V15, P51, DOI 10.1016/S0169-5347(99)01763-2; Michalski SG, 2007, MOL ECOL, V16, P4715, DOI 10.1111/j.1365-294X.2007.03547.x; Newman D, 2001, CONSERV BIOL, V15, P1054, DOI 10.1046/j.1523-1739.2001.0150041054.x; Nuismer SL, 2012, J EVOLUTION BIOL, V25, P2665, DOI 10.1111/jeb.12002; OOSTERMEIJER JGB, 1994, OECOLOGIA, V97, P289, DOI 10.1007/BF00317317; Palomares F, 2012, CONSERV BIOL, V26, P689, DOI 10.1111/j.1523-1739.2012.01870.x; Pastor T, 2004, J HERED, V95, P291, DOI 10.1093/jhered/esh055; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; R Core Team, 2012, R LANG ENV STAT COMP; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Rosas F, 2011, BIOL CONSERV, V144, P3082, DOI 10.1016/j.biocon.2011.10.003; Sebbenn AM, 2011, HEREDITY, V106, P134, DOI 10.1038/hdy.2010.33; Shono K, 2007, J TROP FOR SCI, V19, P25; Thuillet AC, 2002, MOL BIOL EVOL, V19, P122, DOI 10.1093/oxfordjournals.molbev.a003977; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Traill LW, 2007, BIOL CONSERV, V139, P159, DOI 10.1016/j.biocon.2007.06.011; Traill LW, 2010, BIOL CONSERV, V143, P28, DOI 10.1016/j.biocon.2009.09.001; TURNER IM, 1994, CONSERV BIOL, V8, P705, DOI 10.1046/j.1523-1739.1994.08030705.x; Vali U, 2008, MOL ECOL, V17, P3808, DOI 10.1111/j.1365-294X.2008.03876.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; van Treuren R., 1991, HEREDITY, V48, P996; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Vieira FD, 2012, TREE GENET GENOMES, V8, P1191, DOI 10.1007/s11295-012-0506-7; Vranckx G, 2012, CONSERV BIOL, V26, P228, DOI 10.1111/j.1523-1739.2011.01778.x; Wang R, 2011, MOL ECOL, V20, P4421, DOI 10.1111/j.1365-294X.2011.05293.x; Willi Y, 2009, J EVOLUTION BIOL, V22, P124, DOI 10.1111/j.1420-9101.2008.01631.x; Yee A. T. K., 2011, Gardens' Bulletin (Singapore), V63, P205	68	16	18	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82632	10.1371/journal.pone.0082632	http://dx.doi.org/10.1371/journal.pone.0082632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367531	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300047
J	Luu, AN; Anez-Bustillos, L; Aran, S; Arroyo, FJA; Entezari, V; Rosso, C; Snyder, BD; Nazarian, A				Luu, Andrew N.; Anez-Bustillos, Lorenzo; Aran, Shima; Arroyo, Francisco J. Araiza; Entezari, Vahid; Rosso, Claudio; Snyder, Brian D.; Nazarian, Ara			Microstructural, Densitometric and Metabolic Variations in Bones from Rats with Normal or Altered Skeletal States	PLOS ONE			English	Article							QUANTITATIVE COMPUTED-TOMOGRAPHY; POSITRON-EMISSION-TOMOGRAPHY; VITAMIN-D DEFICIENCY; MINERAL DENSITY; OVARIECTOMIZED RATS; CANCELLOUS BONE; FEMORAL-NECK; IN-VIVO; VERTEBRAL FRACTURES; TEMPORAL CHANGES	Background: High resolution mu CT, and combined mu PET/CT have emerged as non-invasive techniques to enhance or even replace dual energy X-ray absorptiometry (DXA) as the current preferred approach for fragility fracture risk assessment. The aim of this study was to assess the ability of mu PET/CT imaging to differentiate changes in rat bone tissue density and microstructure induced by metabolic bone diseases more accurately than current available methods. Methods: Thirty three rats were divided into three groups of control, ovariectomy and vitamin-D deficiency. At the conclusion of the study, animals were subjected to glucose ((18)FDG) and sodium fluoride ((NaF)-F-18) PET/CT scanning. Then, specimens were subjected to mu CT imaging and tensile mechanical testing. Results: Compared to control, those allocated to ovariectomy and vitamin D deficiency groups showed 4% and 22% (significant) increase in (18)FDG uptake values, respectively. DXA-based bone mineral density was higher in the vitamin D deficiency group when compared to the other groups (cortical bone), yet mu CT-based apparent and mineral density results were not different between groups. DXA-based bone mineral density was lower in the ovariectomy group when compared to the other groups (cancellous bone); yet mu CT-based mineral density results were not different between groups, and the mu CT-based apparent density results were lower in the ovariectomy group compared to the other groups. Conclusion: PET and micro-CT provide an accurate three-dimensional measurement of the changes in bone tissue mineral density, as well as microstructure for cortical and cancellous bone and metabolic activity. As osteomalacia is characterized by impaired bone mineralization, the use of densitometric analyses may lead to misinterpretation of the condition as osteoporosis. In contrast, mu CT alone and in combination with the PET component certainly provides an accurate three-dimensional measurement of the changes in both bone tissue mineral density, as well as microstructure for cortical and cancellous bone and metabolic activity.	[Luu, Andrew N.; Anez-Bustillos, Lorenzo; Aran, Shima; Arroyo, Francisco J. Araiza; Entezari, Vahid; Rosso, Claudio; Snyder, Brian D.; Nazarian, Ara] Beth Israel Deaconess Med Ctr, Ctr Adv Orthopaed Studies, Boston, MA 02215 USA; [Luu, Andrew N.; Anez-Bustillos, Lorenzo; Aran, Shima; Arroyo, Francisco J. Araiza; Entezari, Vahid; Rosso, Claudio; Snyder, Brian D.; Nazarian, Ara] Harvard Univ, Sch Med, Boston, MA USA; [Snyder, Brian D.] Harvard Univ, Dept Orthopaed Surg, Sch Med, Boston Childrens Hosp, Boston, MA USA; [Luu, Andrew N.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Rosso, Claudio] Univ Basel Hosp, Dept Orthopaed Surg, CH-4031 Basel, Switzerland; [Rosso, Claudio] Univ Basel, Basel, Switzerland	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Tufts University; University of Basel; University of Basel	Nazarian, A (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Adv Orthopaed Studies, Boston, MA 02215 USA.	anazaria@bidmc.harvard.edu	entezari, vahid/B-5459-2013		NIH LRP [L30 AR056606]; Boston Children's Hospital Orthopedic Surgery Foundation	NIH LRP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Children's Hospital Orthopedic Surgery Foundation	The authors would like to acknowledge the NIH LRP program for providing financial support to AN (L30 AR056606) for the duration of this study. The authors would also like to acknowledge the Boston Children's Hospital Orthopedic Surgery Foundation for providing support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi JD, 2010, MAYO CLIN PROC, V85, P806, DOI 10.4065/mcp.2010.0082; Akhter MP, 2007, BONE, V41, P111, DOI 10.1016/j.bone.2007.03.019; Bauer DC, 2004, J BONE MINER RES, V19, P1250, DOI 10.1359/JBMR.040512; Bhambri R, 2006, J CLIN DENSITOM, V9, P120, DOI 10.1016/j.jocd.2005.11.001; Bischoff-Ferrari HA, 2004, AM J MED, V116, P634, DOI 10.1016/j.amjmed.2003.12.029; BLAU M, 1962, J NUCL MED, V3, P332; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Consensus development conference, 1993, AM J MED, V94, P646, DOI DOI 10.1016/0002-9343(93)90218-E.PUBMED:8506892; Cummings SR, 2002, AM J MED, V112, P281, DOI 10.1016/S0002-9343(01)01124-X; DEMPSTER DW, 1995, BONE, V16, P157, DOI 10.1016/S8756-3282(94)00024-7; Dougherty G, 1996, MED ENG PHYS, V18, P557, DOI 10.1016/1350-4533(96)00011-2; FRASER DR, 1995, LANCET, V345, P104, DOI 10.1016/S0140-6736(95)90067-5; FROST HM, 1992, BONE MINER, V18, P227, DOI 10.1016/0169-6009(92)90809-R; Genant HK, 1996, J BONE MINER RES, V11, P707; Grampp S, 1997, J BONE MINER RES, V12, P697, DOI 10.1359/jbmr.1997.12.5.697; GURKAN L, 1986, ACTA ORTHOP SCAND, V57, P67; Hashefi M, 2011, ANN NY ACAD SCI, V1228, P167, DOI 10.1111/j.1749-6632.2011.06082.x; Haugeberg G, 2008, BEST PRACT RES CL RH, V22, P1127, DOI 10.1016/j.berh.2008.09.016; Heaney RP, 2003, BONE, V33, P457, DOI 10.1016/S8756-3282(03)00236-9; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; HILDEBRAND T, 1997, METHODS, V1, P15; Holick MF, 2005, J CLIN ENDOCR METAB, V90, P3215, DOI 10.1210/jc.2004-2364; HORDON LD, 1990, BONE MINER, V11, P247, DOI 10.1016/0169-6009(90)90063-L; Kaastad TS, 2001, CALCIFIED TISSUE INT, V69, P102, DOI 10.1007/s00223-001-0009-2; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Kato K, 2003, ANN NUCL MED, V17, P41, DOI 10.1007/BF02988257; Kim CH, 2007, J BIOMECH ENG-T ASME, V129, P481, DOI 10.1115/1.2746368; Krupski W, 2007, B VET I PULAWY, V51, P621; Laib A, 2001, OSTEOPOROSIS INT, V12, P936, DOI 10.1007/s001980170022; Li JL, 2005, BONE, V37, P819, DOI 10.1016/j.bone.2005.06.022; Li M, 1997, BONE, V20, P55, DOI 10.1016/S8756-3282(96)00317-1; Li Y, 2012, BONE, V50, P128, DOI 10.1016/j.bone.2011.09.053; Li ZC, 2011, J NUCL MED, V52, P769, DOI 10.2967/jnumed.110.085456; Lim R, 2007, J PEDIATR ORTHOPED, V27, P277, DOI 10.1097/BPO.0b013e31803409ba; Lochmuller EM, 2002, BONE, V31, P77, DOI 10.1016/S8756-3282(02)00792-5; MacNeil JA, 2007, MED ENG PHYS, V29, P1096, DOI 10.1016/j.medengphy.2006.11.002; Melhus G, 2007, ACTA ORTHOP, V78, P393, DOI 10.1080/17453670710013988; Melton LJ, 1997, J BONE MINER RES, V12, P16, DOI 10.1359/jbmr.1997.12.1.16; MOSEKILDE L, 1995, BONE, V17, pS343, DOI 10.1016/8756-3282(95)00312-2; Nazarian A, 2009, OSTEOPOROSIS INT, V20, P123, DOI 10.1007/s00198-008-0632-0; Nazarian A, 2011, J BIOMECH, V44, P2482, DOI 10.1016/j.jbiomech.2011.06.016; OOMS ME, 1995, J BONE MINER RES, V10, P1177; Perez-Casanova JC, 2008, FISH SHELLFISH IMMUN, V24, P600, DOI 10.1016/j.fsi.2008.01.012; RIGGS BL, 1995, BONE, V17, pS505, DOI 10.1016/8756-3282(95)00258-4; Riggs BL, 2002, J BONE MINER RES, V17, P11, DOI 10.1359/jbmr.2002.17.1.11; Schmitz A, 2002, OSTEOPOROSIS INT, V13, P755, DOI 10.1007/s001980200103; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Sekhon K, 2009, BONE, V45, P473, DOI 10.1016/j.bone.2009.05.023; SHEN V, 1993, J CLIN INVEST, V91, P2479, DOI 10.1172/JCI116483; Silva MJ, 2006, BONE, V39, P229, DOI 10.1016/j.bone.2006.01.149; SOKOLOFF L, 1978, AM J SURG PATHOL, V2, P21, DOI 10.1097/00000478-197803000-00003; Tatara MR, 2006, MED WETER, V62, P266; Turner CH, 2002, OSTEOPOROSIS INT, V13, P97, DOI 10.1007/s001980200000; Uchida K, 2009, J NUCL MED, V50, P1808, DOI 10.2967/jnumed.109.062570; Wang P, 2008, NAN FANG YI KE DA XU, V28, P76; Weatherall M, 2000, NEW ZEAL MED J, V113, P137; WRONSKI TJ, 1989, CALCIFIED TISSUE INT, V45, P360, DOI 10.1007/BF02556007	59	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82709	10.1371/journal.pone.0082709	http://dx.doi.org/10.1371/journal.pone.0082709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358219	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700027
J	Schugr, GR; Blevins, KE; Cox, B; Gray, K; Mushrif-Tripathy, V				Schugr, Gwen Robbins; Blevins, K. Elaine; Cox, Brett; Gray, Kelsey; Mushrif-Tripathy, V.			Infection, Disease, and Biosocial Processes at the End of the Indus Civilization	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSIS; CLIMATE-CHANGE; HOLOCENE CLIMATE; AGRICULTURAL INTENSIFICATION; MYCOBACTERIUM-TUBERCULOSIS; CULTURAL-EVOLUTION; SOUTH-ASIA; ANCIENT; VALLEY; PAKISTAN	In the third millennium B. C., the Indus Civilization flourished in northwest India and Pakistan. The late mature phase (2200-1900 B. C.) was characterized by long-distance exchange networks, planned urban settlements, sanitation facilities, standardized weights and measures, and a sphere of influence over 1,000,000 square kilometers of territory. Recent paleoclimate reconstructions from the Beas River Valley demonstrate hydro-climatic stress due to a weakened monsoon system may have impacted urban centers like Harappa by the end of the third millennium B. C. the impact of environmental change was compounded by concurrent disruptions to the regional interaction sphere. Climate, economic, and social changes contributed to the disintegration of this civilization after 1900 B. C. We assess evidence for paleopathology to infer the biological consequences of climate change and socio-economic disruption in the post-urban period at Harappa, one of the largest urban centers in the Indus Civilization. Bioarchaeological evidence demonstrates the prevalence of infection and infectious disease increased through time. Furthermore, the risk for infection and disease was uneven among burial communities. Corresponding mortuary differences suggest that socially and economically marginalized communities were most vulnerable in the context of climate uncertainty at Harappa. Combined with prior evidence for increasing levels of interpersonal violence, our data support a growing pathology of power at Harappa after 2000 B. C. Observations of the intersection between climate change and social processes in proto-historic cities offer valuable lessons about vulnerability, insecurity, and the long-term consequences of short-term strategies for coping with climate change.	[Schugr, Gwen Robbins; Blevins, K. Elaine; Cox, Brett] Appalachian State Univ, Dept Anthropol, Boone, NC 28608 USA; [Gray, Kelsey] UCL, Inst Archaeol, London, England; [Mushrif-Tripathy, V.] Deccan Coll Postgrad Res Inst, Dept Archaeol, Pune, Maharashtra, India	University of North Carolina; Appalachian State University; University of London; University College London	Schugr, GR (corresponding author), Appalachian State Univ, Dept Anthropol, Boone, NC 28608 USA.	Robbinsgm@appstate.edu	SCHUG, GWEN ROBBINS/AAN-8980-2020	SCHUG, GWEN ROBBINS/0000-0002-3928-9230; Mushrif-Tripathy, Veena/0000-0002-4749-1316	Fulbright-Nehru Senior Research Fellowship	Fulbright-Nehru Senior Research Fellowship	This research was funded by a Fulbright-Nehru Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Adger WN, 2009, CLIMATIC CHANGE, V93, P335, DOI 10.1007/s10584-008-9520-z; Agarwal S. C., 2011, SOCIAL BIOARCHAEOLOG; Andersen J.G., 1992, INT J OSTEOARCHAEOL, V2, P121, DOI [10.1002/oa.1390020204, DOI 10.1002/OA.1390020204]; [Anonymous], 1992, E ANTHR; Auferheide AC, 1998, CAMBRIDGE ENCY HUMAN; Barnes I, 2011, EVOLUTION, V65, P842, DOI 10.1111/j.1558-5646.2010.01132.x; Barnett J, 2003, GLOBAL ENVIRON CHANG, V13, P7, DOI 10.1016/S0959-3780(02)00080-8; Barnett J, 2007, POLIT GEOGR, V26, P639, DOI 10.1016/j.polgeo.2007.03.003; BERNHARD W, 1998, 2 PREVIOUSLY UNDESCR, V49, P21; Brooks N, 2009, DEV POLICY REV, V27, P741, DOI 10.1111/j.1467-7679.2009.00468.x; BRYSON RA, 1981, QUATERNARY RES, V16, P135, DOI 10.1016/0033-5894(81)90041-7; Buikstra J.E, 2006, BIOARCHAEOLOGY CONTE; Buikstra J. E., 1994, P SEM FIELD MUS NAT, V68; CARATINI C, 1991, CURR SCI INDIA, V61, P669; CARATINI C, 1994, PALAEOGEOGR PALAEOCL, V109, P371, DOI 10.1016/0031-0182(94)90186-4; Change IPOC, 2007, CLIMATE CHANGE 2007; Cork E, 2005, ANTIQUITY, V79, P411, DOI 10.1017/S0003598X0011419X; Costanza R, 2007, AMBIO, V36, P522, DOI 10.1579/0044-7447(2007)36[522:SOCWCW]2.0.CO;2; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Cullen HM, 2002, CLIMATIC CHANGE, V55, P315, DOI 10.1023/A:1020518305517; Cullen HM, 2000, INT J CLIMATOL, V20, P853, DOI 10.1002/1097-0088(20000630)20:8&lt;853::AID-JOC497&gt;3.0.CO;2-M; Dales G., 1991, HARAPPA EXCAVATIONS, P185; DALES GF, 1968, AM ANTHROPOL, V70, P957, DOI 10.1525/aa.1968.70.5.02a00130; Dales GF, 1962, IRRIGATION DESERT LA; Dales GF., 1965, EXPEDITION, V7, P10; deMenocal PB, 2001, SCIENCE, V292, P667, DOI 10.1126/science.1059827; Diamond J., 2011, COLLAPSE SOC CHOOSE; Diamond Jared, 1998, GUNS GERMS STEEL SHO; Dutta PC, 1975, HARAPPANS BIOANTHROP; EMBER CR, 1992, J CONFLICT RESOLUT, V36, P242, DOI 10.1177/0022002792036002002; Enzel Y, 1999, SCIENCE, V284, P125, DOI 10.1126/science.284.5411.125; Farmer P, 1999, AM J PUBLIC HEALTH, V89, P1486, DOI 10.2105/AJPH.89.10.1486; Farmer P, 1997, SOC SCI MED, V44, P347, DOI 10.1016/S0277-9536(96)00143-8; Farmer P, 2004, CURR ANTHROPOL, V45, P305, DOI 10.1086/382250; Farmer P.E, 2001, INFECT INEQUALITIES; Farooqui A, 2013, J ARCHAEOL SCI, V40, P2631, DOI 10.1016/j.jas.2013.02.005; Feinman Gary M., 1998, ARCHAIC STATES, P261; Fiorentino G, 2008, PALAEOGEOGR PALAEOCL, V266, P51, DOI 10.1016/j.palaeo.2008.03.034; Frahm E, 2013, J ARCHAEOL SCI, V40, P1866, DOI 10.1016/j.jas.2012.11.026; GALTUNG J, 1969, J PEACE RES, P167; Giosan L, 2012, P NATL ACAD SCI USA, V109, pE1688, DOI 10.1073/pnas.1112743109; Gleditsch N.P., 2007, CLIMATE CHANGE CONFL; Gleditsch NP, 2012, J PEACE RES, V49, P3, DOI 10.1177/0022343311431288; Good IL, 2009, ARCHAEOMETRY, V51, P457, DOI 10.1111/j.1475-4754.2008.00454.x; Gupta P, 1962, HUMAN SKELETAL REMAI, P74; Gupta SP, 1982, LATE HARAPPAN STUDY, P51; Hassan FA, 1997, WORLD ARCHAEOL, V29, P51, DOI 10.1080/00438243.1997.9980363; Hemphill BE, 1991, S ASIAN ARCHAEOL, P11; Hershkovitz I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003426; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110; Joyce RA, 2005, ANNU REV ANTHROPOL, V34, P139, DOI 10.1146/annurev.anthro.33.070203.143729; Judd M, 2004, INT J OSTEOARCHAEOL, V14, P34, DOI 10.1002/oa.711; Judkins G, 2008, GEOGR J, V174, P17, DOI 10.1111/j.1475-4959.2008.00265.x; Kellner C.M., 2002, THESIS U CALIFORNIA; Kennedy, 1992, E ANTHR, V45, P55; Kennedy K A, 1993, Anthropol Anz, V51, P1; Kennedy K.A.R., 2002, INDIAN ARCHAEOLOGY R, V2, P293; Kennedy K. A. R., 2000, GOD APES FOSSIL MEN; Kennedy KAR, 1976, ECOLOGICAL BACKGROUN, V4, P166; Kennedy KAR, 1982, S ASIA OCCASIONAL PA, V8, P211; Kennedy KAR, 1984, FRONTIERS INDUS CIVI, P545; Kennedy KAR, 1982, SKULLS ARYANS FLOWIN, P289; Kenoyer J. M., 1997, LAHORE MUS B, V9, P1; Kenoyer J.M, 1998, ANCIENT CITIES INDUS; Kenoyer J. M., 1991, PALEORIENT, V17, P79, DOI DOI 10.3406/PALE0.1991.4553; Kenoyer J.M., 2008, ANCIENT CITY NEW PER, P183; Kenoyer JM, 2013, J ARCHAEOL SCI, V40, P2286, DOI 10.1016/j.jas.2012.12.040; Kenoyer JK, 1994, S ASIAN ARCHAEOLOGY, P451; KENOYER JM, 1991, J WORLD PREHIST, V5, P331, DOI 10.1007/BF00978474; Kenoyer JM, 1997, WORLD ARCHAEOL, V29, P262, DOI 10.1080/00438243.1997.9980377; Kenoyer JM, 2005, S ASIAN ARCHAEOLOGY; Kenoyer JM, 1997, ARCHAEOLOGY CITY STA, P51; Klaus H, 2013, BIOARCHAEOLOGY VIOLE, P291; Kleinman A, 1997, SOCIAL SUFFERING; KNUDSON KJ, 2008, SOCIAL IDENTITIES J, V16, P397; Kumar KR, 2006, CURR SCI INDIA, V90, P334; Lahiri N, 2000, DECLINE FALL INDUS C, P410; LAL BB, 1968, AM ANTHROPOL, V70, P857, DOI 10.1525/aa.1968.70.5.02a00030; Lambert PM, 1997, TROUBLED TIMES VIOLE, P376; Leichenko R. M., 2002, Mitigation and Adaptation Strategies for Global Change, V7, P1, DOI 10.1023/A:1015860421954; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P47, DOI 10.1002/ajpa.1330680105; LOVELL NC, 1994, AM J PHYS ANTHROPOL, V93, P149, DOI 10.1002/ajpa.1330930202; Lovell NC, 1997, INT J OSTEOARCHAEOL, V7, P115, DOI 10.1002/(SICI)1099-1212(199703)7:2<115::AID-OA323>3.0.CO;2-H; Lovell NC, 1989, SOC DIS PREHISTORIC; Lukacs J. R., 1994, WISCONSIN ARCHAEOLOG, V3, P143; Lukacs JR, 2007, VERTEBR PALEOBIOL PA, P271, DOI 10.1007/1-4020-5562-5_12; LUKACS JR, 1992, AM J PHYS ANTHROPOL, V87, P133, DOI 10.1002/ajpa.1330870202; Madella M, 2006, QUATERNARY SCI REV, V25, P1283, DOI 10.1016/j.quascirev.2005.10.012; MANCHESTER K, 1984, MED HIST, V28, P162, DOI 10.1017/S0025727300035705; Masi A, 2013, PLANT BIOLOGY, V15, P83, DOI 10.1111/j.1438-8677.2012.00669.x; Matos V, 2006, AM J PHYS ANTHROPOL, V130, P190, DOI 10.1002/ajpa.20309; Matthew R.A., 2001, GLOBAL ENVIRON POLIT, V1, P48, DOI [DOI 10.1162/152638001750336596, 10.1162/152638001750336596]; Mayewski PA, 2004, QUATERNARY RES, V62, P243, DOI 10.1016/j.yqres.2004.07.001; McAnany PA, 2010, QUESTIONING COLLAPSE; McAnany Patricia Ann, 2010, QUESTIONING COLLAPSE, P1; McIntosh J., 2008, MCINTOSH; McIntosh R., 2000, WAY WIND BLOWS CLIMA; Meadow R. H., 1991, HARAPPA EXCAVATIONS; Meskell L, 2004, J SOC ARCHAEOL, P121; Meskell L. M., 2000, READING BODY REPRESE, P13; Migowski C, 2006, QUATERNARY RES, V66, P421, DOI 10.1016/j.yqres.2006.06.010; Minnegal M, 2000, HUM ECOL, V28, P493, DOI 10.1023/A:1026483630039; Misra VN, 1984, CLIMATE FACTOR RISE, V1984, P461; Moller-Christensen V., 1961, BONE CHANGES LEPROSY; Moller-Christensen V., 1978, LEPROSY CHANGES SKUL; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; MOORREES CF, 1963, AM J PHYS ANTHROPOL, V21, P205, DOI 10.1002/ajpa.1330210212; MOORREES COENRAAD F.A., 1963, JOUR DENT RES, V42, P1490, DOI 10.1177/00220345630420062701; Mughal M. R., 1990, LAHORE MUSEUM B, V3, P1; Mughal MR, 1989, S ASIAN ARCHAEOL, P213; Myers N., 1995, ENV EXODUS EMERGENT; Nordas R, 2007, POLIT GEOGR, V26, P627, DOI 10.1016/j.polgeo.2007.06.003; O'Brien K, 2004, GLOBAL ENVIRON CHANG, V14, P303, DOI 10.1016/j.gloenvcha.2004.01.001; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Parry M. L., 2007, CONTRIBUTION WORKING, P976; Phadtare NR, 2000, QUATERNARY RES, V53, P122, DOI 10.1006/qres.1999.2108; Pinhasi R, 2006, SCIENCE, V312, P846; POSSEHL GL, 1990, ANNU REV ANTHROPOL, V19, P261, DOI 10.1146/annurev.an.19.100190.001401; Possehl GL, 1997, J WORLD PREHIST, V11, P425, DOI 10.1007/BF02220556; Possehl GL, 2000, ENV DISASTER ARCHAEO, V7; Possehl GL, 2002, INDUS CIVILIZATION C, P276; Prasad S, 2006, QUATERNARY RES, V66, P442, DOI 10.1016/j.yqres.2006.05.008; Raikes R. L., 1986, MAN ENV, V10, P33; RAIKES RL, 1961, AM ANTHROPOL, V63, P265, DOI 10.1525/aa.1961.63.2.02a00020; RAIKES RL, 1964, AM ANTHROPOL, V66, P284, DOI 10.1525/aa.1964.66.2.02a00040; Raleigh C, 2007, POLIT GEOGR, V26, P674, DOI 10.1016/j.polgeo.2007.06.005; Rao SR., 1965, EXPEDITION, V7, P30; Ratnagar S., 1981, ENCOUNTERS WESTERLY; Resnick D., 2002, DIAGNOSIS BONE JOINT, V3, P2510; Resnick D., 2002, DIAGNOSIS BONE JOINT; RISSMAN P, 1988, WORLD ARCHAEOL, V20, P209, DOI 10.1080/00438243.1988.9980068; Robbins G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005669; Robbins Schug G., 2011, BIOARCHAEOLOGY CLIMA; Roberts C., 2007, ARCHAEOLOGY DIS; Roberts C., 2011, SOCIAL BIOARCHAEOLOG, P252; Roberts Charlotte, 2005, ARCHAEOLOGY DIS; ROGERS J, 1989, J ARCHAEOL SCI, V16, P611, DOI 10.1016/0305-4403(89)90026-5; Rosen A.M., 2007, CIVILIZING CLIMATE S; Salehyan I, 2008, J PEACE RES, V45, P315, DOI 10.1177/0022343308088812; Scheuer J. L., 2000, DEV JUVENILE OSTEOLO; Schug GR, 2012, INT J PALEOPATHOL, V2, P136, DOI 10.1016/j.ijpp.2012.09.012; Schuldenrein J, 2004, J ARCHAEOL SCI, V31, P777, DOI 10.1016/j.jas.2003.10.015; Shaffer JG, 2005, INDOARYAN CONTROVERS, P522; Sharma A, 1999, DEPARTED HARAPPANS K, P121; Shinde V, 1991, S ASIAN STUD, V7, P91, DOI [10.1080/02666030.1991.9628427, DOI 10.1080/02666030.1991.9628427]; Shinde V, 1985, B DECCAN COLL RES I, V44, P173; Singh P, 2004, HYDROL PROCESS, V18, P2363, DOI 10.1002/hyp.1468; Staubwasser M, 2006, QUATERNARY RES, V66, P372, DOI 10.1016/j.yqres.2006.09.001; Taylor GM, 2009, J ARCHAEOL SCI, V36, P2408, DOI 10.1016/j.jas.2009.06.026; Torres-Rouff C, 2006, AM J PHYS ANTHROPOL, V130, P60, DOI 10.1002/ajpa.20315; Vats M.S, 1940, EXCAVATIONS HARAPPA; von Rad U, 1999, QUATERNARY RES, V51, P39, DOI 10.1006/qres.1998.2016; Walker PL, 2001, ANNU REV ANTHROPOL, V30, P573, DOI 10.1146/annurev.anthro.30.1.573; WALKER PL, 1989, AM J PHYS ANTHROPOL, V80, P313, DOI 10.1002/ajpa.1330800305; Weston DA, 2008, AM J PHYS ANTHROPOL, V137, P48, DOI 10.1002/ajpa.20839; Wheeler Robert Eric Mortimer, 1946, ANCIENT INDIA, V2, P58; Wossink A., 2009, CHALLENGING CLIMATE; Wright H.E., 1993, GLOBAL CLIMATES LAST; Wright R.P, 2010, ANCIENT INDUS URBANI; Wright RP, 2008, ANTIQUITY, V82, P37, DOI 10.1017/S0003598X00096423; Wright RP, 2012, ARCHAEOL ANTHROP SCI, V4, P137, DOI 10.1007/s12520-012-0088-1; Zhang DD, 2007, P NATL ACAD SCI USA, V104, P19214, DOI 10.1073/pnas.0703073104; Zhang DD, 2011, P NATL ACAD SCI USA, V108, P17296, DOI 10.1073/pnas.1104268108; Zink A, 2001, J MED MICROBIOL, V50, P355, DOI 10.1099/0022-1317-50-4-355	166	34	34	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84814	10.1371/journal.pone.0084814	http://dx.doi.org/10.1371/journal.pone.0084814			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	276GT	24358372	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700106
J	Sheng, L; Liu, Y; Jiang, L; Chen, Z; Zhou, YJ; Cho, KW; Rui, LY				Sheng, Liang; Liu, Yan; Jiang, Lin; Chen, Zheng; Zhou, Yingjiang; Cho, Kae Won; Rui, Liangyou			Hepatic SH2B1 and SH2B2 Regulate Liver Lipid Metabolism and VLDL Secretion in Mice	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ADAPTER PROTEIN; INSULIN-RECEPTOR; NEURONAL SH2B1; BODY-WEIGHT; SH2-B; KINASE; IDENTIFICATION; SENSITIVITY; ACTIVATION	SH2B1 is an SH2 and PH domain-containing adaptor protein. Genetic deletion of SH2B1 results in obesity, type 2 diabetes, and fatty liver diseases in mice. Mutations in SH2B1 are linked to obesity in humans. SH2B1 in the brain controls energy balance and body weight at least in part by enhancing leptin sensitivity in the hypothalamus. SH2B1 in peripheral tissues also regulates glucose and lipid metabolism, presumably by enhancing insulin sensitivity in peripheral metabolically-active tissues. However, the function of SH2B1 in individual peripheral tissues is unknown. Here we generated and metabolically characterized hepatocyte-specific SH2B1 knockout (HKO) mice. Blood glucose and plasma insulin levels, glucose tolerance, and insulin tolerance were similar between HKO, albumin-Cre, and SH2B1(f/f) mice fed either a normal chow diet or a high fat diet (HFD). Adult-onset deletion of SH2B1 in the liver either alone or in combination with whole body SH2B2 knockout also did not exacerbate HFD-induced insulin resistance and glucose intolerance. Adult-onset, but not embryonic, deletion of SH2B1 in the liver attenuated HFD-induced hepatic steatosis. In agreement, adult-onset deletion of hepatic SH2B1 decreased the expression of diacylglycerol acyltransferase-2 (DGAT2) and increased the expression of adipose triglyceride lipase (ATGL). Furthermore, deletion of liver SH2B1 in SH2B2 null mice attenuated very low-density lipoprotein (VLDL) secretion. These data indicate that hepatic SH2B1 is not required for the maintenance of normal insulin sensitivity and glucose metabolism; however, it regulates liver triacylglycerol synthesis, lipolysis, and VLDL secretion.	[Sheng, Liang; Liu, Yan; Jiang, Lin; Chen, Zheng; Zhou, Yingjiang; Cho, Kae Won; Rui, Liangyou] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Rui, LY (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	ruily@umich.edu	chen, zheng/J-4600-2014; Liu, Yan/J-7597-2019	chen, zheng/0000-0003-2161-6106; Liu, Yan/0000-0002-3961-9172	National Institutes of Health (NIH) [DK 065122, DK091591, DK094014]; Michigan Diabetes Research and Training Center; NIH [5P60 DK20572, 5 P30 CA46592, P30AG013283, DK34933]; University of Michigan's Cancer Center; University of Michigan Nathan Shock Center; University of Michigan Gut Peptide Research Center; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK094014, P30DK034933, P60DK020572, R01DK091591, R01DK065122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Diabetes Research and Training Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan's Cancer Center(University of Michigan System); University of Michigan Nathan Shock Center; University of Michigan Gut Peptide Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health (NIH) grants DK 065122, DK091591, and DK094014. This work utilized cores supported by the Michigan Diabetes Research and Training Center (funded by NIH 5P60 DK20572), the University of Michigan's Cancer Center (funded by NIH 5 P30 CA46592), the University of Michigan Nathan Shock Center (funded by NIH P30AG013283), and the University of Michigan Gut Peptide Research Center (funded by NIH DK34933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2003, BIOCHEM J, V371, P405, DOI 10.1042/BJ20021589; Bachmann-Gagescu R, 2010, GENET MED, V12, P641, DOI 10.1097/GIM.0b013e3181ef4286; Chen Z, 2013, DIABETES; Cole LK, 2012, BBA-MOL CELL BIOL L, V1821, P754, DOI 10.1016/j.bbalip.2011.09.009; Doche ME, 2012, J CLIN INVEST, V122, P4732, DOI 10.1172/JCI62696; Duan CJ, 2004, J BIOL CHEM, V279, P43684, DOI 10.1074/jbc.M408495200; Duan CJ, 2004, MOL CELL BIOL, V24, P7435, DOI 10.1128/MCB.24.17.7435-7443.2004; Herrington J, 2000, J BIOL CHEM, V275, P13126, DOI 10.1074/jbc.275.17.13126; Javadi M, 2012, J BIOL CHEM, V287, P26223, DOI 10.1074/jbc.M112.382721; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Kong M, 2002, J BIOL CHEM, V277, P15962, DOI 10.1074/jbc.M102777200; Kong XN, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00069; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; Lewis JR, 2010, DIGEST DIS SCI, V55, P560, DOI 10.1007/s10620-009-1081-0; Li M, 2006, ENDOCRINOLOGY, V147, P2163, DOI 10.1210/en.2005-1313; Li ZQ, 2007, MOL ENDOCRINOL, V21, P2270, DOI 10.1210/me.2007-0111; Liu MX, 2012, BBA-MOL CELL BIOL L, V1821, P770, DOI 10.1016/j.bbalip.2011.09.020; Matsuda Satoru, 2013, ISRN Endocrinol, V2013, P472432, DOI 10.1155/2013/472432; Maures TJ, 2007, TRENDS ENDOCRIN MET, V18, P38, DOI 10.1016/j.tem.2006.11.007; Mendez-Sanchez N, 2007, LIVER INT, V27, P423, DOI 10.1111/j.1478-3231.2007.01483.x; Minami A, 2003, DIABETES, V52, P2657, DOI 10.2337/diabetes.52.11.2657; Morris DL, 2010, ENDOCRINOLOGY, V151, P3643, DOI 10.1210/en.2010-0254; Morris DL, 2009, DIABETES, V58, P2039, DOI 10.2337/db08-1388; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Ren DC, 2005, CELL METAB, V2, P95, DOI 10.1016/j.cmet.2005.07.004; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Rider L, 2011, MOL ENDOCRINOL, V25, P1231, DOI 10.1210/me.2011-0056; Rui LY, 1999, J BIOL CHEM, V274, P10590, DOI 10.1074/jbc.274.15.10590; Rui LY, 1998, J BIOL CHEM, V273, P21239, DOI 10.1074/jbc.273.33.21239; Rui LY, 1999, P NATL ACAD SCI USA, V96, P7172, DOI 10.1073/pnas.96.13.7172; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; Sheng L, 2013, AM J PHYSIOL-ENDOC M, V305, pE1115, DOI 10.1152/ajpendo.00401.2013; Sheng L, 2012, NAT MED, V18, P943, DOI 10.1038/nm.2756; Song W, 2010, CELL METAB, V11, P427, DOI 10.1016/j.cmet.2010.04.002; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883; Werz C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000596; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Xiao CT, 2011, AM J PHYSIOL-ENDOC M, V301, pE429, DOI 10.1152/ajpendo.00178.2011; Zhang MC, 2008, J CELL BIOCHEM, V103, P162, DOI 10.1002/jcb.21397	42	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83269	10.1371/journal.pone.0083269	http://dx.doi.org/10.1371/journal.pone.0083269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358267	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700054
J	Tangen, SE; Tsinajinnie, D; Nunez, M; Shaibi, GQ; Mandarino, LJ; Coletta, DK				Tangen, Samantha E.; Tsinajinnie, Darwin; Nunez, Martha; Shaibi, Gabriel Q.; Mandarino, Lawrence J.; Coletta, Dawn K.			Whole Blood Gene Expression Profiles in Insulin Resistant Latinos with the Metabolic Syndrome	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; GLYCOGEN-SYNTHASE; MESSENGER-RNA; HEXOKINASE-II; US POPULATION; BETA-CELL; PROTEIN; PREVALENCE; DISEASE	Although insulin resistance in skeletal muscle is well-characterized, the role of circulating whole blood in the metabolic syndrome phenotype is not well understood. We set out to test the hypothesis that genes involved in inflammation, insulin signaling and mitochondrial function would be altered in expression in the whole blood of individuals with metabolic syndrome. We further wanted to examine whether similar relationships that we have found previously in skeletal muscle exist in peripheral whole blood cells. All subjects (n=184) were Latino descent from the Arizona Insulin Resistance registry. Subjects were classified based on the metabolic syndrome phenotype according to the National Cholesterol Education Program's Adult Treatment Panel III. Of the 184 Latino subjects in the study, 74 were classified with the metabolic syndrome and 110 were without. Whole blood gene expression profiling was performed using the Agilent 4x44K Whole Human Genome Microarray. Whole blood microarray analysis identified 1,432 probes that were altered in expression >= 1.2 fold and P<0.05 after Benjamini-Hochberg in the metabolic syndrome subjects. KEGG pathway analysis revealed significant enrichment for pathways including ribosome, oxidative phosphorylation and MAPK signaling (all Benjamini-Hochberg P<0.05). Whole blood mRNA expression changes observed in the microarray data were confirmed by quantitative RT-PCR. Transcription factor binding motif enrichment analysis revealed E2F1, ELK1, NF-kappaB, STAT1 and STAT3 significantly enriched after Bonferroni correction (all P<0.05). The results of the present study demonstrate that whole blood is a useful tissue for studying the metabolic syndrome and its underlying insulin resistance although the relationship between blood and skeletal muscle differs.	[Tangen, Samantha E.; Tsinajinnie, Darwin; Nunez, Martha; Mandarino, Lawrence J.; Coletta, Dawn K.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Shaibi, Gabriel Q.] Arizona State Univ, Coll Nursing & Hlth Innovat, Tempe, AZ USA; [Shaibi, Gabriel Q.; Mandarino, Lawrence J.; Coletta, Dawn K.] Mayo Clin Arizona, Scottsdale, AZ USA; [Coletta, Dawn K.] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Mayo Clinic; Mayo Clinic Phoenix; University of Arizona	Coletta, DK (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	dawn.coletta@asu.edu	Coletta, Dawn/G-6382-2016; Day, Samantha/K-4569-2019	Shaibi, Gabriel/0000-0002-6890-2903; Coletta, Dawn/0000-0001-5819-5152; Day, Samantha/0000-0002-9818-0972	NIDDK NIH HHS [R01 DK094013] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Accardi G, 2012, REJUV RES, V15, P217, DOI 10.1089/rej.2011.1289; Adlerova L, 2008, VET MED-CZECH, V53, P457, DOI 10.17221/1978-VETMED; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Bonadonna RC, 1996, DIABETES, V45, P915, DOI 10.2337/diabetes.45.7.915; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Christian P, 2013, BBA-MOL CELL BIOL L, V1831, P819, DOI 10.1016/j.bbalip.2012.12.009; Cole AR, 2007, NEUROSCI BIOBEHAV R, V31, P1046, DOI 10.1016/j.neubiorev.2007.04.004; Coletta DK, 2008, AM J PHYSIOL-ENDOC M, V294, pE910, DOI 10.1152/ajpendo.00607.2007; Coletta DK, 2011, AM J PHYSIOL-ENDOC M, V301, pE749, DOI 10.1152/ajpendo.00363.2011; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Feitosa MF, 2013, ATHEROSCLEROSIS, V227, P420, DOI 10.1016/j.atherosclerosis.2013.01.013; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Ford ES, 2010, J DIABETES, V2, P180, DOI 10.1111/j.1753-0407.2010.00078.x; Gehart H, 2010, EMBO REP, V11, P834, DOI 10.1038/embor.2010.160; Ghosh S, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-56; Hoppe S, 2009, P NATL ACAD SCI USA, V106, P17781, DOI 10.1073/pnas.0909873106; Kashyap Sangeeta R, 2007, Diab Vasc Dis Res, V4, P13, DOI 10.3132/dvdr.2007.001; KELLEY DE, 1990, J CLIN INVEST, V86, P1999, DOI 10.1172/JCI114935; Kim JY, 2012, DIABETES CARE, V35, P1925, DOI 10.2337/dc11-2476; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Liu CL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3707; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magkos F, 2010, NUTRITION, V26, P686, DOI 10.1016/j.nut.2009.10.013; MANDARINO LJ, 1995, AM J PHYSIOL-ENDOC M, V269, pE701; Manoel-Caetano FS, 2012, GENE, V511, P151, DOI 10.1016/j.gene.2012.09.090; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Min JL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-96; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muniyappa R, 2013, REV ENDOCR METAB DIS, V14, P5, DOI 10.1007/s11154-012-9229-1; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pendergrass M, 1998, DIABETES, V47, P387, DOI 10.2337/diabetes.47.3.387; Perl Andras, 2012, Methods Mol Biol, V900, P61, DOI 10.1007/978-1-60761-720-4_4; Power ML, 2008, BRIT J NUTR, V99, P931, DOI 10.1017/S0007114507853347; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Richardson DK, 2005, J BIOL CHEM, V280, P10290, DOI 10.1074/jbc.M408985200; Robbins RD, 2010, J BIOL CHEM, V285, P39943, DOI 10.1074/jbc.M110.170142; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; VESTERGAARD H, 1993, J CLIN INVEST, V91, P2342, DOI 10.1172/JCI116466; Williams CM, 2004, P NUTR SOC, V63, P153, DOI 10.1079/PNS2003314; Yamaoka M, 2013, BIOCHEM BIOPH RES CO, V433, P450, DOI 10.1016/j.bbrc.2013.02.096; Yamaoka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047377; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464	49	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84002	10.1371/journal.pone.0084002	http://dx.doi.org/10.1371/journal.pone.0084002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358323	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700076
J	Tng, DYP; Jordan, GJ; Bowman, DMJS				Tng, David Y. P.; Jordan, Greg J.; Bowman, David M. J. S.			Plant Traits Demonstrate That Temperate and Tropical Giant Eucalypt Forests Are Ecologically Convergent with Rainforest Not Savanna	PLOS ONE			English	Article							ALTERNATIVE STABLE STATES; CARBON-ISOTOPE DISCRIMINATION; DOMINATED WOODLAND SAVANNA; NORTH-EASTERN AUSTRALIA; FUNCTIONAL TRAITS; LEAF SIZE; ECONOMICS SPECTRUM; REGIME SHIFTS; IRON RANGE; DRY FOREST	Ecological theory differentiates rainforest and open vegetation in many regions as functionally divergent alternative stable states with transitional (ecotonal) vegetation between the two forming transient unstable states. This transitional vegetation is of considerable significance, not only as a test case for theories of vegetation dynamics, but also because this type of vegetation is of major economic importance, and is home to a suite of species of conservation significance, including the world's tallest flowering plants. We therefore created predictions of patterns in plant functional traits that would test the alternative stable states model of these systems. We measured functional traits of 128 trees and shrubs across tropical and temperate rainforest - open vegetation transitions in Australia, with giant eucalypt forests situated between these vegetation types. We analysed a set of functional traits: leaf carbon isotopes, leaf area, leaf mass per area, leaf slenderness, wood density, maximum height and bark thickness, using univariate and multivariate methods. For most traits, giant eucalypt forest was similar to rainforest, while rainforest, particularly tropical rainforest, was significantly different from the open vegetation. In multivariate analyses, tropical and temperate rainforest diverged functionally, and both segregated from open vegetation. Furthermore, the giant eucalypt forests overlapped in function with their respective rainforests. The two types of giant eucalypt forests also exhibited greater overall functional similarity to each other than to any of the open vegetation types. We conclude that tropical and temperate giant eucalypt forests are ecologically and functionally convergent. The lack of clear functional differentiation from rainforest suggests that giant eucalypt forests are unstable states within the basin of attraction of rainforest. Our results have important implications for giant eucalypt forest management.	[Tng, David Y. P.; Jordan, Greg J.; Bowman, David M. J. S.] Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia	University of Tasmania	Tng, DYP (corresponding author), Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia.	david.tng@utas.edu.au	Jordan, Gregory/B-3932-2013; Tng, David/J-3156-2015; Bowman, David/A-2930-2011	Jordan, Gregory/0000-0002-6033-2766; Tng, David/0000-0001-5135-0922; Bowman, David/0000-0001-8075-124X	Wet Tropics Management Authority [B002055]; ARC [DP0878177]	Wet Tropics Management Authority; ARC(Australian Research Council)	Part of this research was also carried out under a student grant B002055 from the Wet Tropics Management Authority (http://www.wettropics.gov.au/) awarded to DYPT and an ARC (http://www.arc.gov.au/ncgp/) Discovery Grant (DP0878177) given to DMJSB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P., 1992, AUSTR RAINFORESTS; Beckage B, 2009, AM NAT, V174, P805, DOI 10.1086/648458; Beckage B, 2008, COMPLEX SYST, V18, P159; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.2307/3868190; Boland DJ, 2006, FOREST TREES AUSTR; Bonal D, 2007, ANN FOREST SCI, V64, P169, DOI 10.1051/forest:2006101; Bowman, 2000, AUSTR GEOGRAPHICAL S, V38, P327, DOI DOI 10.1111/1467-8470.00120; Bowman D.M., 2000, AUSTR RAINFORESTS IS; Bowman DMJS, 2013, FRONT ECOL ENVIRON, V11, P66, DOI 10.1890/13.WB.005; Brando PM, 2012, GLOBAL CHANGE BIOL, V18, P630, DOI 10.1111/j.1365-2486.2011.02533.x; Bucci SJ, 2004, TREE PHYSIOL, V24, P891, DOI 10.1093/treephys/24.8.891; Campbell N. A., 1984, AUSTR J STAT, V26, P86, DOI DOI 10.1111/J.1467-842X.1984.TB01271.X; Carpenter R. J., 1994, AUSTR VEGETATION HIS, P276; Chapin FS, 2003, ANN BOT-LONDON, V91, P455, DOI 10.1093/aob/mcg041; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cremer K. W., 1960, Australian Forestry, V24, P120; Crowley BE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044538; Curtis W., 1975, STUDENTS FLORA TASMA, V1; CURTIS WM, 1967, STUDENTS FLORA TAS 3; CURTIS WM, 1963, STUDENTS FLORA TAS 2; Dantas VD, 2013, ECOLOGY, V94, P2454, DOI 10.1890/12-1629.1; DARLINGTON RB, 1973, REV EDUC RES, V43, P433, DOI 10.3102/00346543043004433; Diaz-Sierra R, 2010, THEOR POPUL BIOL, V77, P131, DOI 10.1016/j.tpb.2009.12.001; Falster DS, 2005, J ECOL, V93, P521, DOI 10.1111/j.0022-0477.2005.00992.x; Farquhar G.D., 1989, STABLE ISOTOPES ECOL, V68, P21, DOI [10.1007/978-1-4612-3498-2_2, DOI 10.1007/978-1-4612-3498-2_2]; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; FRANCIS WD, 1951, AUSTR RAIN FOREST TR; Fukami T, 2006, OIKOS, V113, P353, DOI 10.1111/j.2006.0030-1299.14563.x; GIVNISH TJ, 1987, NEW PHYTOL, V106, P131, DOI 10.1111/j.1469-8137.1987.tb04687.x; Goosem S., 1999, CONSERVATION STATUS; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; Harrington Graham N., 2000, Proceedings of the Royal Society of Queensland, V109, P59; Harris S., 2005, FOREST FJAELDMARK DE; Helsen K, 2012, OIKOS, V121, P2121, DOI 10.1111/j.1600-0706.2012.20499.x; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Hoffmann WA, 2005, FUNCT ECOL, V19, P932, DOI 10.1111/j.1365-2435.2005.01045.x; Hoffmann WA, 2012, ECOL LETT, V15, P759, DOI 10.1111/j.1461-0248.2012.01789.x; HUC R, 1994, OECOLOGIA, V99, P297, DOI 10.1007/BF00627742; Hutyra LR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024981; Ibanez T, 2013, AUST J BOT, V61, P128, DOI 10.1071/BT12255; Jarman SJ, 1991, 3 NRCP FOR COMM; Kark S, 2006, ISR J ECOL EVOL, V52, P29, DOI 10.1560/IJEE.52.1.29; Keith H, 2010, GLOBAL CHANGE BIOL, V16, P2971, DOI 10.1111/j.1365-2486.2009.02146.x; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; Kirkpatrick JB, 1988, WET EUCALYPT FORESTS, P156; Konar B, 2003, ECOLOGY, V84, P174, DOI 10.1890/0012-9658(2003)084[0174:TSOBRB]2.0.CO;2; Lawes MJ, 2013, J ECOL, V101, P517, DOI 10.1111/1365-2745.12035; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; LEWONTIN RC, 1969, BROOKHAVEN SYM BIOL, P13; Lusk CH, 2013, ANN BOT-LONDON, V111, P479, DOI 10.1093/aob/mcs289; Mayer AL, 2011, SCIENCE, V334, P188, DOI 10.1126/science.1213908; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Meinzer FC, 2003, OECOLOGIA, V134, P1, DOI 10.1007/s00442-002-1088-0; Milla R, 2007, P ROY SOC B-BIOL SCI, V274, P2109, DOI 10.1098/rspb.2007.0417; Murphy BP, 2012, ECOL LETT, V15, P748, DOI 10.1111/j.1461-0248.2012.01771.x; Musselwhite G, 2005, FOREST POLICY ECON, V7, P579, DOI 10.1016/j.forpol.2003.11.001; Nicholas AMM, 2011, J ARID ENVIRON, V75, P1090, DOI 10.1016/j.jaridenv.2011.06.016; Nicotra AB, 2011, FUNCT PLANT BIOL, V38, P535, DOI 10.1071/FP11057; Odion DC, 2010, J ECOL, V98, P96, DOI 10.1111/j.1365-2745.2009.01597.x; Orchard KA, 2010, FUNCT PLANT BIOL, V37, P1050, DOI 10.1071/FP09306; PARKHURST DF, 1972, J ECOL, V60, P505, DOI 10.2307/2258359; Pinard MA, 1997, J TROP ECOL, V13, P727, DOI 10.1017/S0266467400010890; Pineda-Garcia F, 2011, PLANT CELL ENVIRON, V34, P1536, DOI 10.1111/j.1365-3040.2011.02351.x; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; RISSER PG, 1995, BIOSCIENCE, V45, P318, DOI 10.2307/1312492; Romero C, 2008, CAN J FOREST RES, V38, P611, DOI 10.1139/X07-205; Royer DL, 2005, AM J BOT, V92, P1141, DOI 10.3732/ajb.92.7.1141; Russell-Smith J, 2004, J BIOGEOGR, V31, P1305, DOI 10.1111/j.1365-2699.2004.01070.x; Russell-Smith J, 2004, J BIOGEOGR, V31, P1293, DOI 10.1111/j.1365-2699.2004.01069.x; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Schimper AFW., 1903, PLANT GEOGRAPHY PHYS; SMITH JMB, 1983, AUST J ECOL, V8, P55, DOI 10.1111/j.1442-9993.1983.tb01518.x; Smith TB, 1997, SCIENCE, V276, P1855, DOI 10.1126/science.276.5320.1855; Sniderman JMK, 2011, J BIOGEOGR, V38, P1445, DOI 10.1111/j.1365-2699.2011.02519.x; Specht R.L., 1981, VEGETATION CLASSIFIC, P10; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Tng DYP, 2012, NEW PHYTOL, V196, P1001, DOI 10.1111/j.1469-8137.2012.04359.x; Tng DYP, 2012, ECOL EVOL, V2, P34, DOI 10.1002/ece3.70; Tracey JG, 1982, VEGETATION HUMID TRO; UNWIN GL, 1989, AUST J BOT, V37, P413, DOI 10.1071/BT9890413; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Warman L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060789; Warman L, 2009, LANDSCAPE ECOL, V24, P1, DOI 10.1007/s10980-008-9285-9; WEBB LJ, 1959, J ECOL, V47, P551, DOI 10.2307/2257290; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Wood SW, 2012, LANDSCAPE ECOL, V27, P13, DOI 10.1007/s10980-011-9677-0; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P411, DOI 10.1111/j.1466-822x.2005.00172.x; Xiang S, 2013, FUNCT ECOL, V27, P522, DOI 10.1111/1365-2435.12047	91	24	27	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84378	10.1371/journal.pone.0084378	http://dx.doi.org/10.1371/journal.pone.0084378			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358359	gold, Green Published			2022-12-27	WOS:000328737700095
J	Alessi-Severini, S; Le Dorze, JA; Nguyen, D; Honcharik, P; Eleff, M				Alessi-Severini, Silvia; Le Dorze, Josee-Anne; Nguyen, David; Honcharik, Patricia; Eleff, Michael			Clozapine Prescribing in a Canadian Outpatient Population	PLOS ONE			English	Article							SCHIZOPHRENIA; DISCONTINUATION; ANTIPSYCHOTICS	Objective: Description of demographics of an outpatient population of clozapine users. Methods: Retrospective chart review study of an urban population diagnosed with schizophrenia. Assessment of therapeutic histories in relation to clinical practice guidelines. Results: Seventy-seven of the 467 patients were on clozapine therapy. Average patients' age was 39.4 +/- 11.8 years) and 68% were males. The majority of patients (68%) had tried 3 or more antipsychotics before switching to clozapine, 21% had tried two and 11% had tried one. Median length of therapy prior to clozapine initiation was 8.9 years in males and 7.7 years in females. Conclusion: Until 2010, the use of clozapine was often delayed and more than 2 antipsychotic medications were tried for relatively long periods of time before patients were switched to this effective agent.	[Alessi-Severini, Silvia; Le Dorze, Josee-Anne; Nguyen, David; Honcharik, Patricia] Univ Manitoba, Fac Pharm, Winnipeg, MB R3T 2N2, Canada; [Honcharik, Patricia] Hlth Sci Ctr, Dept Pharmaceut Serv, Winnipeg, MB, Canada; [Eleff, Michael] Univ Manitoba, Fac Med, Dept Psychiat, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba	Alessi-Severini, S (corresponding author), Univ Manitoba, Fac Pharm, Winnipeg, MB R3T 2N2, Canada.	Silvia.Alessi-Severini@ad.umanitoba.ca		Alessi-Severini, Silvia/0000-0002-6543-7719	Faculty of Pharmacy, University of Manitoba	Faculty of Pharmacy, University of Manitoba	JAL and DN were supported by institutional summer studentship awards from the Faculty of Pharmacy, University of Manitoba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asenjo Lobos C, 2010, COCHRANE DB SYST REV, V12, P1; Barnes TRE, 2011, J PSYCHOPHARMACOL, V25, P567, DOI 10.1177/0269881110391123; Canadian Psychiatric Association, 2005, CAN J PSYCHIAT S1, V50, p7S; Ciudad A, 2008, EUR PSYCHIAT, V23, P1, DOI 10.1016/j.eurpsy.2007.09.008; Essali A, 2009, COCHRANE DB SYST REV, V1, P1; Kreyenbuhl J, 2010, SCHIZOPHRENIA BULL, V36, P94, DOI 10.1093/schbul/sbp130; Mcilwain ME, 2011, NEUROPSYCH DIS TREAT, V7, P135, DOI 10.2147/NDT.S12769; Meltzer HY, 2003, ARCH GEN PSYCHIAT, V60, P82, DOI 10.1001/archpsyc.60.1.82; Mortimer Ann M, 2010, Clin Schizophr Relat Psychoses, V4, P49, DOI 10.3371/CSRP.4.1.4; National Institute of Health and Clinical Excellence, 2009, COR INT TREATM MAN S; Porcelli S, 2012, EUR NEUROPSYCHOPHARM, V22, P165, DOI 10.1016/j.euroneuro.2011.08.005; Taylor DM, 2003, J CLIN PSYCHIAT, V64, P30, DOI 10.4088/JCP.v64n0107; Taylor M, 2008, J CLIN PSYCHIAT, V69, P240, DOI 10.4088/JCP.v69n0210; Werneck AP, 2011, PSYCHIAT RES, V188, P315, DOI 10.1016/j.psychres.2011.04.004; Wheeler AJ, 2008, ANN PHARMACOTHER, V42, P852, DOI 10.1345/aph.1K662	15	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83539	10.1371/journal.pone.0083539	http://dx.doi.org/10.1371/journal.pone.0083539			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358290	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700129
J	Koens, L; Qin, YJ; Leung, WY; Corver, WE; Jansen, PM; Willemze, R; Vermeer, MH; Tensen, CP				Koens, Lianne; Qin, Yongjun; Leung, Wai Y.; Corver, Willem E.; Jansen, Patty M.; Willemze, Rein; Vermeer, Maarten H.; Tensen, Cornelis P.			MicroRNA Profiling of Primary Cutaneous Large B-Cell Lymphomas	PLOS ONE			English	Article							WHO-EORTC CLASSIFICATION; PROGNOSTIC MARKERS; ANALYSIS REVEALS; GERMINAL CENTER; EXPRESSION; CANCER; DIFFERENTIATION; MIR-155; GENES; RNA	Aberrant expression of microRNAs is widely accepted to be pathogenetically involved in nodal diffuse large B-cell lymphomas (DLBCLs). However, the microRNAs profiles of primary cutaneous large B-cell lymphomas (PCLBCLs) are not yet described. Its two main subtypes, i.e., primary cutaneous diffuse large B-cell lymphoma, leg type (PCLBCL-LT) and primary cutaneous follicle center lymphoma (PCFCL) are characterized by an activated B-cell (ABC)-genotype and a germinal center B-cell (GCB)-genotype, respectively. We performed high-throughput sequencing analysis on frozen tumor biopsies from 19 cases of PCFCL and PCLBCL-LT to establish microRNA profiles. Cluster analysis of the complete microRNome could not distinguish between the two subtypes, but 16 single microRNAs were found to be differentially expressed. Single microRNA RT-qPCR was conducted on formalin-fixed paraffin-embedded tumor biopsies of 20 additional cases, confirming higher expression of miR-9-5p, miR-31-5p, miR-129-2-3p and miR-214-3p in PCFCL as compared to PCLBCL-LT. MicroRNAs previously described to be higher expressed in ABC-type as compared to GCB-type nodal DLBCL were not differentially expressed between PCFCL and PCLBCL-LT. In conclusion, PCFCL and PCLBCL-LT differ in their microRNA profiles. In contrast to their gene expression profile, they only show slight resemblance with the microRNA profiles found in GCB- and ABC-type nodal DLBCL.	[Koens, Lianne; Corver, Willem E.; Jansen, Patty M.] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Qin, Yongjun; Leung, Wai Y.; Willemze, Rein; Vermeer, Maarten H.; Tensen, Cornelis P.] Leiden Univ, Med Ctr, Dept Dermatol, Leiden, Netherlands; [Qin, Yongjun] Shanxi Acad Agr Sci, Ctr Biotechnol, Taiynan, Peoples R China	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Shanxi Agricultural University	Koens, L (corresponding author), Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands.	l.koens@lumc.nl	Vermeer, Maarten/AAO-5381-2021; Corver, Willem/T-6576-2018	Vermeer, Maarten/0000-0002-5872-4613; Tensen, Cornelis/0000-0002-5325-1888; Corver, Willem/0000-0001-8313-3658				Alencar AJ, 2011, CLIN CANCER RES, V17, P4125, DOI 10.1158/1078-0432.CCR-11-0224; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Choi WWL, 2009, CLIN CANCER RES, V15, P5494, DOI 10.1158/1078-0432.CCR-09-0113; Culpin RE, 2010, INT J ONCOL, V37, P367, DOI 10.3892/ijo_00000685; Dagan LN, 2012, BLOOD, V119, P513, DOI 10.1182/blood-2011-08-370536; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Derfoul A, 2011, CARCINOGENESIS, V32, P1607, DOI 10.1093/carcin/bgr184; Dijkman R, 2006, J CLIN ONCOL, V24, P296, DOI 10.1200/JCO.2005.02.0842; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Fischer L, 2011, NEURO-ONCOLOGY, V13, P1090, DOI 10.1093/neuonc/nor107; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Garzon R, 2008, CURR OPIN HEMATOL, V15, P352, DOI 10.1097/MOH.0b013e328303e15d; Guo LM, 2009, FEBS J, V276, P5537, DOI 10.1111/j.1742-4658.2009.07237.x; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hoefnagel JJ, 2005, BLOOD, V105, P3671, DOI 10.1182/blood-2004-04-1594; Huang X, 2012, AM J PATHOL, V181, P26, DOI 10.1016/j.ajpath.2012.03.013; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Jima DD, 2010, BLOOD, V116, pE118, DOI 10.1182/blood-2010-05-285403; Jindra PT, 2010, J IMMUNOL, V185, P990, DOI 10.4049/jimmunol.1000793; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Lawrie CH, 2007, INT J CANCER, V121, P1156, DOI 10.1002/ijc.22800; Lawrie CH, 2009, J CELL MOL MED, V13, P1248, DOI 10.1111/j.1582-4934.2008.00628.x; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Monsalvez V, 2013, MODERN PATHOL, V26, P171, DOI 10.1038/modpathol.2012.149; Montes-Moreno S, 2011, BLOOD, V118, P1034, DOI 10.1182/blood-2010-11-321554; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Qin YJ, 2012, J INVEST DERMATOL, V132, P1520, DOI 10.1038/jid.2011.481; Rai D, 2008, CANCER GENET CYTOGEN, V181, P8, DOI 10.1016/j.cancergencyto.2007.10.008; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roehle A, 2008, BRIT J HAEMATOL, V142, P732, DOI 10.1111/j.1365-2141.2008.07237.x; Senff NJ, 2008, BLOOD, V112, P1600, DOI 10.1182/blood-2008-04-152850; Senff NJ, 2007, J CLIN ONCOL, V25, P1581, DOI 10.1200/JCO.2006.09.6396; Senff NJ, 2009, J INVEST DERMATOL, V129, P1149, DOI 10.1038/jid.2008.357; Smith E, 2004, J LEUKOCYTE BIOL, V75, P973, DOI 10.1189/jlb.1103554; Swerdlow SH, 2008, WHO CLASSIFICATION T; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vergier B, 2008, WHO CLASSIFICATION T, P242; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015; Zhang J, 2009, BLOOD, V113, P4586, DOI 10.1182/blood-2008-09-178186; Zhong H, 2012, EXP THER MED, V3, P763, DOI 10.3892/etm.2012.502	49	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82471	10.1371/journal.pone.0082471	http://dx.doi.org/10.1371/journal.pone.0082471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358187	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700068
J	Yang, T; Lu, MJ; Sun, HS; Tang, Y; Pan, SW; Zhao, SH				Yang, Tao; Lu, Min-Jie; Sun, Han-Song; Tang, Yue; Pan, Shi-Wei; Zhao, Shi-Hua			Myocardial Scar Identified by Magnetic Resonance Imaging Can Predict Left Ventricular Functional Improvement after Coronary Artery Bypass Grafting	PLOS ONE			English	Article							LATE GADOLINIUM ENHANCEMENT; ISCHEMIC CARDIOMYOPATHY; HEART-FAILURE; SURGICAL REVASCULARIZATION; PROGNOSTIC-SIGNIFICANCE; DELAYED-ENHANCEMENT; INFARCT SIZE; VIABILITY; DYSFUNCTION; RECOVERY	Background: Previous studies have shown that viable myocardium predicts recovery of left ventricular (LV) dysfunction after revascularization. Our aim was to evaluate the prognostic value of myocardial scar assessed by late gadolinium-enhanced cardiovascular magnetic resonance imaging (LGE-CMR) on functional recovery in patients undergoing coronary artery bypass grafting (CABG). Methods: From November 2009 to September 2012, 63 patients with reduced left ventricular ejection fraction (LVEF) referred for first-time isolated CABG were prospectively enrolled, 52 were included in final analysis. LV functional parameters and scar tissue were assessed by LGE-CMR at baseline and 6 months after surgery. Patency of grafts was evaluated by computed tomography angiography (CTA) 6 months post-CABG. Predictors for global functional recovery were analyzed. Results: The baseline LVEF was 32.7 +/- 9.2%, which improved to 41.6 +/- 11.0% 6 months later and 32/52 patients improved LVEF by >= 5%. Multivariate logistic regression analysis showed that the most significant negative predictor for global functional recovery was the number of scar segments (Odds ratio 2.864, 95% Confidence Interval 1.172-6.996, p = 0.021). Receiver-Operator-Characteristic (ROC) analysis demonstrated that <= 4 scar segments predicted global functional recovery with a sensitivity and specificity of 85.0% and 87.5%, respectively (AUC = 0.91, p<0.001). Comparison of ROC curves also indicated that scar tissue was superior to viable myocardium in predicting cardiac functional recovery (p<0.001). Conclusions: Our findings indicated that scar tissue on LGE-CMR is an independent negative predictor of cardiac functional recovery in patients with impaired LV function undergoing CABG. These observations may be helpful for clinicians and cardiovascular surgeons to determine which patients are most likely to benefit from surgical revascularization.	[Yang, Tao; Sun, Han-Song; Tang, Yue; Pan, Shi-Wei] Peking Union Med Coll, Dept Cardiovasc Surg, State Key Lab Cardiovasc Dis, Fu Wai Hosp, Beijing 100021, Peoples R China; [Yang, Tao; Lu, Min-Jie; Sun, Han-Song; Tang, Yue; Pan, Shi-Wei; Zhao, Shi-Hua] Peking Union Med Coll, Cardiovasc Inst, Natl Ctr Cardiovasc Dis, Beijing 100021, Peoples R China; [Yang, Tao; Lu, Min-Jie; Sun, Han-Song; Tang, Yue; Pan, Shi-Wei; Zhao, Shi-Hua] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Lu, Min-Jie; Zhao, Shi-Hua] Peking Union Med Coll, Dept Radiol, State Key Lab Cardiovasc Dis, Fu Wai Hosp, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College	Sun, HS (corresponding author), Peking Union Med Coll, Dept Cardiovasc Surg, State Key Lab Cardiovasc Dis, Fu Wai Hosp, Beijing 100021, Peoples R China.	drsunhs@sina.com; cjr.zhaoshihua@vip.163.com	Zhao, Shihua/A-7553-2019; Lu, Minjie/AAF-5091-2020	Zhao, Shihua/0000-0003-1339-7476; Lu, Minjie/0000-0001-8696-318X	National Natural Science Foundation of China [81130029, 81000604, 81370036, 81071199]; Research Foundation of Capital Medical Development [2009-1004]; Peking Union Medical College (PUMC) Youth Fund; Fundamental Research Funds for the Central Universities [3332013105]; Talent Research Star of Fu Wai Hospital [2012-FWXX01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of Capital Medical Development; Peking Union Medical College (PUMC) Youth Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Talent Research Star of Fu Wai Hospital	The study was financially supported by the research grant of the National Natural Science Foundation of China (81130029, 81000604, 81370036 and 81071199), Research Foundation of Capital Medical Development (2009-1004), Peking Union Medical College (PUMC) Youth Fund and the Fundamental Research Funds for the Central Universities (3332013105), and Talent Research Star of Fu Wai Hospital (2012-FWXX01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERMAN EL, 1983, CIRCULATION, V68, P785, DOI 10.1161/01.CIR.68.4.785; Bax J.J., 2004, CIRCULATION, V110, pIi103; Bax JJ, 1997, J AM COLL CARDIOL, V30, P1451, DOI 10.1016/S0735-1097(97)00352-5; Bello D, 2011, MAGN RESON IMAGING, V29, P50, DOI 10.1016/j.mri.2010.03.031; Bingham SE, 2011, CIRCULATION, V123, P1509, DOI 10.1161/CIRCULATIONAHA.109.907659; Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358; Camici PG, 2008, CIRCULATION, V117, P103, DOI 10.1161/CIRCULATIONAHA.107.702993; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Cohn PF, 2003, CIRCULATION, V108, P1263, DOI 10.1161/01.CIR.0000088001.59265.EE; Gerber BL, 2012, J AM COLL CARDIOL, V59, P825, DOI 10.1016/j.jacc.2011.09.073; Gerber BL, 2010, JACC-CARDIOVASC IMAG, V3, P720, DOI 10.1016/j.jcmg.2010.03.008; Hombach V, 2005, EUR HEART J, V26, P549, DOI 10.1093/eurheartj/ehi147; Hundley WG, 2010, CIRCULATION, V121, P2462, DOI 10.1161/CIR.0b013e3181d44a8f; Kelle S, 2009, J AM COLL CARDIOL, V54, P1770, DOI 10.1016/j.jacc.2009.07.027; Kim HW, 2009, J AM COLL CARDIOL, V55, P1, DOI 10.1016/j.jacc.2009.06.059; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Krittayaphong R, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-41; Kwon DH, 2009, JACC-CARDIOVASC IMAG, V2, P34, DOI 10.1016/j.jcmg.2008.09.010; McCrohon A, 2003, CIRCULATION, V108, P54, DOI 10.1161/01.CIR.0000078641.19365.4C; Panza JA, 2013, J AM COLL CARDIOL, V61, P1860, DOI 10.1016/j.jacc.2013.02.014; Pegg TJ, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-56; Rizzello V, 2004, CIRCULATION, V110, P2383, DOI 10.1161/01.CIR.0000145115.29952.14; Sawada SG, 2010, AM J CARDIOL, V106, P187, DOI 10.1016/j.amjcard.2010.03.014; Schinkel AFL, 2004, J THORAC CARDIOV SUR, V127, P385, DOI 10.1016/j.jtcvs.2003.08.005; Schinkel AFL, 2007, J NUCL MED, V48, P1135, DOI 10.2967/jnumed.106.038851; Selvanayagam JB, 2004, CIRCULATION, V110, P1535, DOI 10.1161/01.CIR.0000142045.22628.74; Senior R, 2001, AM J CARDIOL, V88, P624, DOI 10.1016/S0002-9149(01)01803-3; Slart RHJA, 2006, J NUCL CARDIOL, V13, P210, DOI 10.1016/j.nuclcard.2006.01.015; Wu YW, 2005, J NUCL CARDIOL, V12, P451, DOI 10.1016/j.nuclcard.2005.04.007	29	14	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81991	10.1371/journal.pone.0081991	http://dx.doi.org/10.1371/journal.pone.0081991			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358136	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700030
J	Antonysamy, S; Condon, B; Druzina, Z; Bonanno, JB; Gheyi, T; Zhang, F; MacEwan, I; Zhang, A; Ashok, S; Rodgers, L; Russell, M; Luz, JG				Antonysamy, Stephen; Condon, Bradley; Druzina, Zhanna; Bonanno, Jeffrey B.; Gheyi, Tarun; Zhang, Feiyu; MacEwan, Iain; Zhang, Aiping; Ashok, Sheela; Rodgers, Logan; Russell, Marijane; Luz, John Gately			Structural Context of Disease-Associated Mutations and Putative Mechanism of Autoinhibition Revealed by X-Ray Crystallographic Analysis of the EZH2-SET Domain	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; H3 LYSINE-27 METHYLATION; CAUSE WEAVER SYNDROME; STEM-LIKE CELLS; SOMATIC MUTATIONS; MYELODYSPLASTIC SYNDROMES; CANCER CELLS; GENE EZH2; LYMPHOMA; COMPLEX	The enhancer-of-zeste homolog 2 (EZH2) gene product is an 87 kDa polycomb group (PcG) protein containing a Cterminal methyltransferase SET domain. EZH2, along with binding partners, i. e., EED and SUZ12, upon which it is dependent for activity forms the core of the polycomb repressive complex 2 (PRC2). PRC2 regulates gene silencing by catalyzing the methylation of histone H3 at lysine 27. Both overexpression and mutation of EZH2 are associated with the incidence and aggressiveness of various cancers. The novel crystal structure of the SET domain was determined in order to understand disease-associated EZH2 mutations and derive an explanation for its inactivity independent of complex formation. The 2.00 angstrom crystal structure reveals that, in its uncomplexed form, the EZH2 Cterminus folds back into the active site blocking engagement with substrate. Furthermore, the S-adenosyl-Lmethionine (SAM) binding pocket observed in the crystal structure of homologous SET domains is notably absent. This suggests that a conformational change in the EZH2 SET domain, dependent upon complex formation, must take place for cofactor and substrate binding activities to be recapitulated. In addition, the data provide a structural context for clinically significant mutations found in the EZH2 SET domain.	[Antonysamy, Stephen; Condon, Bradley; Druzina, Zhanna; Gheyi, Tarun; Zhang, Feiyu; Zhang, Aiping; Ashok, Sheela; Rodgers, Logan; Russell, Marijane; Luz, John Gately] Lilly Biotechnol Ctr San Diego, San Diego, CA USA; [Bonanno, Jeffrey B.] Albert Einstein Coll Med Univ, Dept Biochem, Bronx, NY USA; [MacEwan, Iain] Loma Linda Univ, Med Ctr, Dept Radiol, Loma Linda, CA USA	Loma Linda University	Luz, JG (corresponding author), Lilly Biotechnol Ctr San Diego, San Diego, CA USA.	luz_john@lilly.com			Eli Lily and Company; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	Eli Lily and Company; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	The funders of this study were Eli Lily and Company and the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Eli Lilly and Company is a pharmaceutical company focused on discovering medicines to treat human disease. The LRL-CAT synchrotron beamline at the Advanced Photon Source in Chicago is in part funded by the aforementioned grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An S, 2011, J BIOL CHEM, V286, P8369, DOI 10.1074/jbc.M110.203380; Bodor C, 2011, LEUKEMIA, V25, P726, DOI 10.1038/leu.2010.311; Brecqueville M, 2013, HAEMATOLOGICA; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cardoso C, 1998, HUM MOL GENET, V7, P679, DOI 10.1093/hmg/7.4.679; Del Rizzo PA, 2010, J BIOL CHEM, V285, P31849, DOI 10.1074/jbc.M110.114587; Denisenko O, 1998, MOL CELL BIOL, V18, P5634, DOI 10.1128/MCB.18.10.5634; DIFFLEY JFX, 1989, SCIENCE, V246, P1034, DOI 10.1126/science.2511628; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst T, 2012, LEUKEMIA, V26, P1701, DOI 10.1038/leu.2012.16; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Gibson WT, 2012, AM J HUM GENET, V90, P110, DOI 10.1016/j.ajhg.2011.11.018; Grossmann V, 2011, LEUKEMIA, V25, P877, DOI 10.1038/leu.2011.10; Guglielmelli P, 2011, BLOOD, V118, P5227, DOI 10.1182/blood-2011-06-363424; He LR, 2010, INT J CANCER, V127, P138, DOI 10.1002/ijc.25031; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Lee JM, 2012, MOL CELL, V48, P572, DOI 10.1016/j.molcel.2012.09.004; Li H, 2010, MOL CANCER RES, V8, P1610, DOI 10.1158/1541-7786.MCR-10-0398; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Makishima H, 2010, LEUKEMIA, V24, P1799, DOI 10.1038/leu.2010.167; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nikolaev SI, 2013, BLOOD, V122, P554, DOI 10.1182/blood-2013-03-491936; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Orzan F, 2011, NEUROPATH APPL NEURO, V37, P381, DOI 10.1111/j.1365-2990.2010.01132.x; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Qiao Q, 2011, J BIOL CHEM, V286, P8361, DOI 10.1074/jbc.M110.204115; Rao ZY, 2010, CARCINOGENESIS, V31, P1576, DOI 10.1093/carcin/bgq150; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sewalt RGAB, 1998, MOL CELL BIOL, V18, P3586, DOI 10.1128/MCB.18.6.3586; SIMON J, 1993, DEV BIOL, V158, P131, DOI 10.1006/dbio.1993.1174; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Tatton-Brown K, 2011, ONCOTARGET, V2, P1127, DOI 10.18632/oncotarget.385; Tong ZT, 2012, ONCOGENE, V31, P583, DOI 10.1038/onc.2011.254; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; Wang JY, 2013, LEUKEMIA RES, V37, P305, DOI 10.1016/j.leukres.2012.10.004; Wang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061341; WEDEEN C, 1986, CELL, V44, P739, DOI 10.1016/0092-8674(86)90840-8; Wei YK, 2008, MOL CARCINOGEN, V47, P701, DOI 10.1002/mc.20413; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	57	63	66	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84147	10.1371/journal.pone.0084147	http://dx.doi.org/10.1371/journal.pone.0084147			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367637	Green Published, gold, Green Submitted			2022-12-27	WOS:000328741900034
J	Dickie, DA; Job, DE; Gonzalez, DR; Shenkin, SD; Ahearn, TS; Murray, AD; Wardlaw, JM				Dickie, David Alexander; Job, Dominic E.; Gonzalez, David Rodriguez; Shenkin, Susan D.; Ahearn, Trevor S.; Murray, Alison D.; Wardlaw, Joanna M.			Variance in Brain Volume with Advancing Age: Implications for Defining the Limits of Normality	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; WHITE-MATTER; OLDER-ADULTS; MR-IMAGES; REGISTRATION; ATROPHY	Background: Statistical models of normal ageing brain tissue volumes may support earlier diagnosis of increasingly common, yet still fatal, neurodegenerative diseases. For example, the statistically defined distribution of normal ageing brain tissue volumes may be used as a reference to assess patient volumes. To date, such models were often derived from mean values which were assumed to represent the distributions and boundaries, i. e. percentile ranks, of brain tissue volume. Since it was previously unknown, the objective of the present study was to determine if this assumption was robust, i. e. whether regression models derived from mean values accurately represented the distributions and boundaries of brain tissue volume at older ages. Materials and Methods: We acquired T1-w magnetic resonance (MR) brain images of 227 normal and 219 Alzheimer's disease (AD) subjects (aged 55-89 years) from publicly available databanks. Using nonlinear regression within both samples, we compared mean and percentile rank estimates of whole brain tissue volume by age. Results: In both the normal and AD sample, mean regression estimates of brain tissue volume often did not accurately represent percentile rank estimates (errors=-74% to 75%). In the normal sample, mean estimates generally underestimated differences in brain volume at percentile ranks below the mean. Conversely, in the AD sample, mean estimates generally underestimated differences in brain volume at percentile ranks above the mean. Differences between ages at the 5th percentile rank of normal subjects were similar to 39% greater than mean differences in the AD subjects. Conclusions: While more data are required to make true population inferences, our results indicate that mean regression estimates may not accurately represent the distributions of ageing brain tissue volumes. This suggests that percentile rank estimates will be required to robustly define the limits of brain tissue volume in normal ageing and neurodegenerative disease.	[Dickie, David Alexander; Job, Dominic E.; Gonzalez, David Rodriguez; Wardlaw, Joanna M.] Univ Edinburgh, Western Gen Hosp, BRIC, Edinburgh, Midlothian, Scotland; [Shenkin, Susan D.] Univ Edinburgh, Royal Infirm Edinburgh, Geriatr Med Unit, Edinburgh, Midlothian, Scotland; [Ahearn, Trevor S.; Murray, Alison D.] Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Aberdeen, Scotland; [Dickie, David Alexander; Job, Dominic E.; Gonzalez, David Rodriguez; Shenkin, Susan D.; Ahearn, Trevor S.; Murray, Alison D.; Wardlaw, Joanna M.] Platform Sci Excellence SINAPSE Collaborat, Scottish Imaging Network, Edinburgh, Midlothian, Scotland	University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; University of Aberdeen; University of Edinburgh	Job, DE (corresponding author), Univ Edinburgh, Western Gen Hosp, BRIC, Edinburgh, Midlothian, Scotland.	Dominic.Job@ed.ac.uk	Rodriguez Gonzalez, David/AAA-1966-2019; Hernandez, María/GYU-3543-2022; Shenkin, Susan/GWZ-3174-2022; Wardlaw, Joanna M/Y-3456-2019; Murray, Alison/H-6250-2017	Rodriguez Gonzalez, David/0000-0002-9160-5106; Wardlaw, Joanna M/0000-0002-9812-6642; Murray, Alison/0000-0003-4915-4847; Dickie, David Alexander/0000-0002-9443-8403; Shenkin, Susan/0000-0001-7375-4776; Job, Dominic/0000-0002-7829-7217	Alzheimer's Disease Neuroimaging Initiative (ADNI); National Institutes of Health (NIH) [U01 AG024904]; NIH [P30 AG010129, K01 AG030514]; Open Access Series of Imaging Studies (OASIS) [P50 AG05681, P01 AG03991, R01 AG021910, P20 MH071616, U24 RR021382]; MRC [G1001245, G0701120] Funding Source: UKRI; Medical Research Council [MR/K026992/1, G0701120, G1001245] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH071616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG003991, K01AG030514, P30AG010129, P50AG005681, U01AG024904, R01AG021910] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Open Access Series of Imaging Studies (OASIS); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Alzheimer's Disease Neuroimaging Initiative (ADNI - PI Michael W. Weiner, MD); data were acquired through the National Institutes of Health (NIH) Grant U01 AG024904, National Institute on Aging, National Institute of Biomedical Imaging and Bioengineering, Abbott, Alzheimer's Association, Alzheimer's Drug Discovery Foundation, Amorfix Life Sciences Ltd., AstraZeneca, Bayer HealthCare, BioClinica, Inc., Biogen Idec Inc., Bristol- Myers Squibb Company, Eisai Inc., Elan Pharmaceuticals Inc., Eli Lilly and Company, F. Hoffmann- La Roche Ltd., and its affiliated company Genentech, Inc., GE Healthcare, Innogenetics, N.V., IXICO Ltd., Janssen Alzheimer Immunotherapy Research & Development, LLC., Johnson & Johnson Pharmaceutical Research & Development LLC., Medpace, Inc., Merck & Co., Inc., Meso Scale Diagnostics, LLC., Novartis Pharmaceuticals Corporation, Pfizer Inc., Servier, Synarc Inc., Takeda Pharmaceutical Company, Canadian Institutes of Health Research, Foundation for the National Institutes of Health (www.fnih.org), Northern California Institute for Research and Education, Alzheimer's Disease Cooperative Study at the University of California, San Diego, Laboratory for Neuro Imaging at the University of California, Los Angeles, and NIH grants P30 AG010129 and K01 AG030514. The Open Access Series of Imaging Studies (OASIS) data were acquired through grants: P50 AG05681, P01 AG03991, R01 AG021910, P20 MH071616, U24 RR021382. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JS, 2005, NEUROBIOL AGING, V26, P1245, DOI 10.1016/j.neurobiolaging.2005.05.023; Aribisala BS, 2012, EUR RADIOL, DOI [10.1007/s00330-00012-02677-x, DOI 10.1007/S00330-00012-02677-X]; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; DeCarli C, 2005, NEUROBIOL AGING, V26, P491, DOI 10.1016/j.neurobiolaging.2004.05.004; Dickie DA, 2012, EUR RADIOL, V22, P1385, DOI 10.1007/s00330-012-2392-7; Ellis KA, 2010, ALZHEIMERS DEMENT, V6, P291, DOI 10.1016/j.jalz.2010.03.009; ELVEBACK LR, 1970, J AMER MED ASSOC, V211, P69, DOI 10.1001/jama.211.1.69; Farrell C, 2009, EUR RADIOL, V19, P177, DOI 10.1007/s00330-008-1119-2; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; Fox NC, 2001, LANCET, V358, P201, DOI 10.1016/S0140-6736(01)05408-3; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; GUR RC, 1991, P NATL ACAD SCI USA, V88, P2845, DOI 10.1073/pnas.88.7.2845; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Kruggel F, 2006, NEUROIMAGE, V30, P1, DOI 10.1016/j.neuroimage.2005.09.063; Malone IB, 2013, NEUROIMAGE, V70, P33, DOI 10.1016/j.neuroimage.2012.12.044; MANOLIO TA, 1994, STROKE, V25, P318, DOI 10.1161/01.STR.25.2.318; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; McEvoy LK, 2009, RADIOLOGY, V251, P195, DOI 10.1148/radiol.2511080924; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Resnick SM, 2003, J NEUROSCI, V23, P3295; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SELKOE DJ, 2013, ANN NEUROL IN PRESS, P1012; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Ziegler G, 2012, HUM BRAIN MAPP, V33, P2377, DOI 10.1002/hbm.21374	36	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84093	10.1371/journal.pone.0084093	http://dx.doi.org/10.1371/journal.pone.0084093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367629	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000328741900030
J	Frade, AF; Teixeira, PC; Ianni, BM; Pissetti, CW; Saba, B; Wang, LHT; Kuramoto, A; Nogueira, LG; Buck, P; Dias, F; Giniaux, H; Llored, A; Alves, S; Schmidt, A; Donadi, E; Marin-Neto, JA; Hirata, M; Sampaio, M; Fragata, A; Bocchi, EA; Stolf, AN; Fiorelli, AI; Santos, RHB; Rodrigues, V; Pereira, AC; Kalil, J; Cunha-Neto, E; Chevillard, C				Frade, Amanda Farage; Teixeira, Priscila Camilo; Ianni, Barbara Maria; Pissetti, Cristina Wide; Saba, Bruno; Tzu Wang, Lin Hui; Kuramoto, Andreia; Nogueira, Luciana Gabriel; Buck, Paula; Dias, Fabricio; Giniaux, Helene; Llored, Agnes; Alves, Sthefanny; Schmidt, Andre; Donadi, Eduardo; Marin-Neto, Jose Antonio; Hirata, Mario; Sampaio, Marcelo; Fragata, Abilio; Bocchi, Edimar Alcides; Stolf, Antonio Noedir; Fiorelli, Alfredo Inacio; Barros Santos, Ronaldo Honorato; Rodrigues, Virmondes; Pereira, Alexandre Costa; Kalil, Jorge; Cunha-Neto, Edecio; Chevillard, Christophe			Polymorphism in the Alpha Cardiac Muscle Actin 1 Gene Is Associated to Susceptibility to Chronic Inflammatory Cardiomyopathy	PLOS ONE			English	Article							CHRONIC CHAGAS-DISEASE; NECROSIS-FACTOR-ALPHA; MYOSIN HEAVY-CHAIN; HEART-FAILURE; DILATED CARDIOMYOPATHY; EXPRESSION; MYOCARDITIS; CHEMOKINES; INFECTION; CYTOKINES	Aims: Chagas disease, caused by the protozoan Trypanosoma cruzi is endemic in Latin America, and may lead to a life-threatening inflammatory dilated, chronic Chagas cardiomyopathy (CCC). One third of T. cruzi-infected individuals progress to CCC while the others remain asymptomatic (ASY). A possible genetic component to disease progression was suggested by familial aggregation of cases and the association of markers of innate and adaptive immunity genes with CCC development. Since mutations in multiple sarcomeric genes, including alpha-cardiac actin (ACTC1) have been involved in hereditary dilated cardiomyopathy, we investigated the involvement of the ACTC1 gene in CCC pathogenesis. Methods and Results: We conducted a proteomic and genetic study on a Brazilian study population. The genetic study was done on a main cohort including 118 seropositive asymptomatic subjects and 315 cases and the replication was done on 36 asymptomatic and 102 CCC cases. ACTC1 protein and mRNA levels were lower in myocardial tissue from patients with end-stage CCC than those found in hearts from organ donors. Genotyping a case-control cohort of CCC and ASY subjects for all informative single nucleotide polymorphism (SNP) in the ACTC1 gene identified rs640249 SNP, located at the 5' region, as associated to CCC. Associations are borderline after correction for multiple testing. Correlation and haplotype analysis led to the identification of a susceptibility haplotype. Functional assays have shown that the rs640249A/C polymorphism affects the binding of transcriptional factors in the promoter regions of the ACTC1 gene. Confirmation of the detected association on a larger independent replication cohort will be useful. Conclusions: Genetic variations at the ACTC1 gene may contribute to progression to chronic Chagas Cardiomyopathy among T. cruzi-infected patients, possibly by modulating transcription factor binding to ACTC1 promoter regions.	[Frade, Amanda Farage; Teixeira, Priscila Camilo; Ianni, Barbara Maria; Kuramoto, Andreia; Nogueira, Luciana Gabriel; Buck, Paula; Alves, Sthefanny; Fiorelli, Alfredo Inacio; Barros Santos, Ronaldo Honorato; Pereira, Alexandre Costa; Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil; [Frade, Amanda Farage; Teixeira, Priscila Camilo; Kuramoto, Andreia; Nogueira, Luciana Gabriel; Kalil, Jorge; Cunha-Neto, Edecio] Inst Nacl Ciencias & Tecnol, Inst Invest Immunol 3, Sao Paulo, Brazil; [Pissetti, Cristina Wide] Univ Fed Triangulo Mineiro, Immunol Lab, Uberaba, MG, Brazil; [Saba, Bruno; Tzu Wang, Lin Hui; Hirata, Mario; Sampaio, Marcelo; Fragata, Abilio] Inst Cardiol Dante Pazzanese, Sao Paulo, Brazil; [Dias, Fabricio; Schmidt, Andre; Donadi, Eduardo; Marin-Neto, Jose Antonio] Univ Sao Paulo, Sch Med Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil; [Frade, Amanda Farage; Giniaux, Helene; Llored, Agnes; Chevillard, Christophe] Aix Marseille Univ, Marseille, France; [Bocchi, Edimar Alcides; Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal do Triangulo Mineiro; Instituto Dante Pazzanese de Cardiologia; Universidade de Sao Paulo; UDICE-French Research Universities; Aix-Marseille Universite; Universidade de Sao Paulo	Chevillard, C (corresponding author), Aix Marseille Univ, Marseille, France.	christophe.chevillard@univ-amu.fr	Pereira, Alexandre/HHN-1038-2022; Chevillard, Christophe/A-7087-2015; Ianni, Barbara Maria/C-7689-2012; KALIL, JORGE/C-8029-2012; Marin-Neto, Jose Antonio/F-6099-2012; Barbosa, Luciana Gabriel Nogueira/AAH-3061-2021; Schmidt, André/G-1569-2011; Hirata, Mario Hiroyuki/C-9718-2013; Frade Barros, Amanda Farage/O-3322-2017; donadi, eduardo A/H-7080-2013; Cunha-Neto, Edecio/B-4157-2009; Buck, Paula C/F-8781-2012	Chevillard, Christophe/0000-0002-5269-8813; Ianni, Barbara Maria/0000-0002-1588-5492; KALIL, JORGE/0000-0001-8415-4274; Barbosa, Luciana Gabriel Nogueira/0000-0003-1396-2949; Schmidt, André/0000-0002-1090-8165; Hirata, Mario Hiroyuki/0000-0002-9521-7979; Frade Barros, Amanda Farage/0000-0002-9004-8811; donadi, eduardo A/0000-0002-9457-9601; Cunha-Neto, Edecio/0000-0002-3699-3345; Buck, Paula C/0000-0002-1411-4485; Marin-Neto, Jose Antonio/0000-0002-8651-8833; Camillo Teixeira, Priscila/0000-0002-9698-4563; Lin-Wang, Hui Tzu/0000-0002-7027-7748; Rodrigues Jr, Virmondes/0000-0001-8706-4223	Institut National de la Sante et de la Recherche Medicale (INSERM), Aix-Marseille University (Direction des Relations Internationales); USP-COFECUB program; ARCUS II PACA Brasil program; CNPq (the Brazilian National Research Council); FAPESP (Sao Paulo State Research Funding Agency-Brazil); French ANR agency; Brazilian FAPESP agency	Institut National de la Sante et de la Recherche Medicale (INSERM), Aix-Marseille University (Direction des Relations Internationales); USP-COFECUB program; ARCUS II PACA Brasil program; CNPq (the Brazilian National Research Council)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP (Sao Paulo State Research Funding Agency-Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); French ANR agency(French National Research Agency (ANR)); Brazilian FAPESP agency(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), Aix-Marseille University (Direction des Relations Internationales), the USP-COFECUB program, the ARCUS II PACA Brasil program, CNPq (the Brazilian National Research Council), and FAPESP (Sao Paulo State Research Funding Agency-Brazil). ECN and CC received support from an international program funded by the French ANR agency and the Brazilian FAPESP agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel LCJ, 2001, J AUTOIMMUN, V17, P99, DOI 10.1006/jaut.2001.0523; Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Barretto A C, 1993, Arq Bras Cardiol, V60, P225; BARRETTO ACP, 1986, AM HEART J, V111, P307, DOI 10.1016/0002-8703(86)90144-4; Basquiera AL, 2003, HEART, V89, P1186, DOI 10.1136/heart.89.10.1186; BEALL CJ, 1989, GENE DEV, V3, P131, DOI 10.1101/gad.3.2.131; Bestetti RB, 1997, INT J CARDIOL, V60, P187, DOI 10.1016/S0167-5273(97)00083-1; Bilate AMB, 2003, MICROBES INFECT, V5, P1116, DOI 10.1016/j.micinf.2003.07.001; Bilate AM, 2008, J INFECT DIS, V198, P614, DOI 10.1086/590347; Coura JR, 2007, MEM I OSWALDO CRUZ, V102, P113, DOI 10.1590/S0074-02762007000900018; Cunha-Neto E, 2005, AM J PATHOL, V167, P305, DOI 10.1016/S0002-9440(10)62976-8; Cunha-Neto E, 2009, MEM I OSWALDO CRUZ, V104, P252, DOI 10.1590/S0074-02762009000900032; Dellefave L, 2010, CURR OPIN CARDIOL, V25, P198, DOI 10.1097/HCO.0b013e328337ba52; Fae KC, 2000, MICROBES INFECT, V2, P745, DOI 10.1016/S1286-4579(00)00501-3; Foo RSY, 2005, J CLIN INVEST, V115, P565, DOI 10.1172/JCI200524569; Gregorio CC, 1997, CELL STRUCT FUNCT, V22, P191, DOI 10.1247/csf.22.191; HIGUCHI MD, 1987, CLIN CARDIOL, V10, P665; Isnard A, 2011, GENES IMMUN, V12, P31, DOI 10.1038/gene.2010.43; Januzzi JL, 2013, J AM COLL CARDIOL, V61, P1507, DOI 10.1016/j.jacc.2013.01.039; Jiang HK, 2010, CIRC J, V74, P2410, DOI 10.1253/circj.CJ-10-0234; Jorge MT, 2003, ANN TROP MED PARASIT, V97, P139, DOI 10.1179/000349803235001561; Kirchhoff LV, 2004, FRONT BIOSCI-LANDMRK, V9, P706, DOI 10.2741/1255; Knoll R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/569628; Kruger M, 2009, J MOL CELL CARDIOL, V46, P490, DOI 10.1016/j.yjmcc.2009.01.004; Kubota T, 2000, CIRCULATION, V101, P2518, DOI 10.1161/01.CIR.101.21.2518; LARANJA FS, 1956, CIRCULATION, V14, P1035, DOI 10.1161/01.CIR.14.6.1035; LU MH, 1992, J CELL BIOL, V117, P1007, DOI 10.1083/jcb.117.5.1007; MADY C, 1994, CIRCULATION, V90, P3098, DOI 10.1161/01.CIR.90.6.3098; MARTIN UO, 1987, MEDICINA-BUENOS AIRE, V47, P159; Mocelin AO, 2005, EUR J HEART FAIL, V7, P869, DOI 10.1016/j.ejheart.2004.10.014; Nogueira LG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001867; Nyholt DR, 2005, HUM HERED, V60, P61, DOI 10.1159/000087919; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Pulkki KJ, 1997, ANN MED, V29, P339, DOI 10.3109/07853899708999358; Ramasawmy R, 2006, CLIN INFECT DIS, V43, P305, DOI 10.1086/505395; Reddy VS, 2008, J CELL PHYSIOL, V215, P697, DOI 10.1002/jcp.21348; Reifenberg K, 2007, AM J PATHOL, V171, P463, DOI 10.2353/ajpath.2007.060906; Ribeirao M, 2000, PARASITE IMMUNOL, V22, P49, DOI 10.1046/j.1365-3024.2000.00260.x; Riol-Blanco L, 2005, J IMMUNOL, V174, P4070, DOI 10.4049/jimmunol.174.7.4070; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Salvatella R, 2007, MEM I OSWALDO CRUZ, V102, P39, DOI 10.1590/S0074-02762007005000105; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schofield CJ, 2006, TRENDS PARASITOL, V22, P583, DOI 10.1016/j.pt.2006.09.011; Talvani A, 2004, CLIN INFECT DIS, V38, P943, DOI 10.1086/381892; Teixeira MM, 2002, TRENDS PARASITOL, V18, P262, DOI 10.1016/S1471-4922(02)02283-3; Teixeira PC, 2012, WORLD J CLIN INFECT, V2, P39, DOI DOI 10.5495/WJCID.V2.I3.39; Teixeira PC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001205; Tostes S, 2005, INT J CARDIOL, V99, P233, DOI 10.1016/j.ijcard.2004.01.026; van Veldhuisen DJ, 2013, J AM COLL CARDIOL, V61, P1498, DOI 10.1016/j.jacc.2012.12.044; ZICKER F, 1990, AM J TROP MED HYG, V43, P498, DOI 10.4269/ajtmh.1990.43.498	52	23	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e83446	10.1371/journal.pone.0083446	http://dx.doi.org/10.1371/journal.pone.0083446			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367596	Green Submitted, Green Published, gold			2022-12-27	WOS:000328741900018
J	Que, YA; Hazan, R; Strobel, B; Maura, D; He, JX; Kesarwani, M; Panopoulos, P; Tsurumi, A; Giddey, M; Wilhelmy, J; Mindrinos, MN; Rahme, LG				Que, Yok-Ai; Hazan, Ronen; Strobel, Benjamin; Maura, Damien; He, Jianxin; Kesarwani, Meenu; Panopoulos, Panagiotis; Tsurumi, Amy; Giddey, Marlyse; Wilhelmy, Julie; Mindrinos, Michael N.; Rahme, Laurence G.			A Quorum Sensing Small Volatile Molecule Promotes Antibiotic Tolerance in Bacteria	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; PERSISTER CELLS; MULTIDRUG TOLERANCE; GENE; MECHANISM; MVFR; 2-AMINOACETOPHENONE; IDENTIFICATION; LEISHMANIASIS; INFECTIONS	Bacteria can be refractory to antibiotics due to a sub-population of dormant cells, called persisters that are highly tolerant to antibiotic exposure. The low frequency and transience of the antibiotic tolerant "persister" trait has complicated elucidation of the mechanism that controls antibiotic tolerance. In this study, we show that 2' Aminoacetophenone (2-AA), a poorly studied but diagnostically important small, volatile molecule produced by the recalcitrant gram-negative human pathogen Pseudomonas aeruginosa, promotes antibiotic tolerance in response to quorum-sensing (QS) signaling. Our results show that 2-AA mediated persister cell accumulation occurs via alteration of the expression of genes involved in the translational capacity of the cell, including almost all ribosomal protein genes and other translation-related factors. That 2-AA promotes persisters formation also in other emerging multi-drug resistant pathogens, including the non 2-AA producer Acinetobacter baumannii implies that 2-AA may play an important role in the ability of gram-negative bacteria to tolerate antibiotic treatments in polymicrobial infections. Given that the synthesis, excretion and uptake of QS small molecules is a common hallmark of prokaryotes, together with the fact that the translational machinery is highly conserved, we posit that modulation of the translational capacity of the cell via QS molecules, may be a general, widely distributed mechanism that promotes antibiotic tolerance among prokaryotes.	[Que, Yok-Ai; Hazan, Ronen; Strobel, Benjamin; Maura, Damien; He, Jianxin; Kesarwani, Meenu; Panopoulos, Panagiotis; Tsurumi, Amy; Rahme, Laurence G.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Que, Yok-Ai; Hazan, Ronen; Strobel, Benjamin; Maura, Damien; He, Jianxin; Kesarwani, Meenu; Panopoulos, Panagiotis; Tsurumi, Amy; Rahme, Laurence G.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Que, Yok-Ai; Hazan, Ronen; Strobel, Benjamin; Maura, Damien; He, Jianxin; Kesarwani, Meenu; Panopoulos, Panagiotis; Tsurumi, Amy; Rahme, Laurence G.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Que, Yok-Ai; Hazan, Ronen; Strobel, Benjamin; Maura, Damien; He, Jianxin; Kesarwani, Meenu; Panopoulos, Panagiotis; Tsurumi, Amy; Rahme, Laurence G.] Shriners Hosp Children, Boston, MA USA; [Wilhelmy, Julie; Mindrinos, Michael N.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Hazan, Ronen] Hebrew Univ Jerusalem, Inst Dent Sci, Jerusalem, Israel; [Hazan, Ronen] Hebrew Univ Jerusalem, Sch Dent Med, Jerusalem, Israel; [Giddey, Marlyse] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Stanford University; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Lausanne	Rahme, LG (corresponding author), Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA.	rahme@molbio.mgh.harvard.edu	Tsurumi, Amy/AAJ-7857-2020; Hazan, Ronen/ABI-1067-2020; Que, Yok Ai/AAE-5474-2020; Hazan, Ronen/R-8384-2016	Tsurumi, Amy/0000-0001-7678-169X; Hazan, Ronen/0000-0001-9967-730X; Que, Yok Ai/0000-0001-9443-6101; Hazan, Ronen/0000-0001-9967-730X; Strobel, Benjamin/0000-0002-8687-3499	NIH [AI105902, R56AI063433]; Swiss National Science Foundation/Swiss Medical Association (FMH) [PASMP3-123226]; SICPA Foundation; Shriners' Hospitals Research Fellowship [8494];  [8770]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105902, R56AI063433, R33AI105902] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation/Swiss Medical Association (FMH)(Swiss National Science Foundation (SNSF)); SICPA Foundation; Shriners' Hospitals Research Fellowship; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Shriners' research grant #8770, and NIH grants AI105902 and R56AI063433 to LGR. YAQ was supported by a Swiss National Science Foundation/Swiss Medical Association (FMH) grant #PASMP3-123226 and a grant from the SICPA Foundation. RH was supported by Shriners' Hospitals Research Fellowship #8494. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Baldwin T, 2007, PARASITE IMMUNOL, V29, P501, DOI 10.1111/j.1365-3024.2007.00969.x; Bandyopadhaya A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003024; Bigger JW, 1944, LANCET, V2, P497; Bolstad B, 2005, BIOINFORMATICS COMPU; Braeken K, 2006, TRENDS MICROBIOL, V14, P45, DOI 10.1016/j.tim.2005.11.006; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Cao H, 2001, P NATL ACAD SCI USA, V98, P14613, DOI 10.1073/pnas.251465298; COX CD, 1979, J CLIN MICROBIOL, V9, P479; Deziel E, 2005, MOL MICROBIOL, V55, P998, DOI 10.1111/j.1365-2958.2004.04448.x; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760; Elso CM, 2004, GENES IMMUN, V5, P93, DOI 10.1038/sj.gene.6364042; Fauvart M, 2011, J MED MICROBIOL, V60, P699, DOI 10.1099/jmm.0.030932-0; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Gefen O, 2009, FEMS MICROBIOL REV, V33, P704, DOI 10.1111/j.1574-6976.2008.00156.x; Grant SS, 2012, P NATL ACAD SCI USA, V109, P12147, DOI 10.1073/pnas.1203735109; Guido NJ, 2007, BIOPHYS J, V93, pL55, DOI 10.1529/biophysj.107.118687; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hazan R, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-259; Hazan R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000810; Heeb S, 2011, FEMS MICROBIOL REV, V35, P247, DOI 10.1111/j.1574-6976.2010.00247.x; Kayama S, 2009, FEMS MICROBIOL LETT, V298, P184, DOI 10.1111/j.1574-6968.2009.01717.x; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kesarwani M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002192; LaFleur MD, 2010, ANTIMICROB AGENTS CH, V54, P39, DOI 10.1128/AAC.00860-09; Lepine F, 2004, J AM SOC MASS SPECTR, V15, P862; Lewis Kim, 2012, Handb Exp Pharmacol, P121, DOI 10.1007/978-3-642-28951-4_8; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; MANN S, 1966, ARCH MIKROBIOL, V54, P184, DOI 10.1007/BF00408715; Miller JH, 1972, DETERMINATION VIABLE, P31; Moker N, 2010, J BACTERIOL, V192, P1946, DOI 10.1128/JB.01231-09; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Que YA, 1998, J INFECT DIS, V177, P146, DOI 10.1086/513805; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Rezaei E, 2011, BURNS, V37, P805, DOI 10.1016/j.burns.2011.01.019; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; SAHM DF, 1991, MANUAL CLIN MICROBIO, P1109; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Scott-Thomas AJ, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-56; Tozawa Y, 2011, PLANT BIOLOGY, V13, P699, DOI 10.1111/j.1438-8677.2011.00484.x; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; Tzika AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074528; Vega NM, 2012, NAT CHEM BIOL, V8, P431, DOI [10.1038/NCHEMBIO.915, 10.1038/nchembio.915]; Wada A, 1998, GENES CELLS, V3, P203, DOI 10.1046/j.1365-2443.1998.00187.x; Wade DS, 2005, J BACTERIOL, V187, P4372, DOI 10.1128/JB.187.13.4372-4380.2005; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Xiao GP, 2006, MOL MICROBIOL, V62, P1689, DOI 10.1111/j.1365-2958.2006.05462.x; Xiao GP, 2006, MICROBIOL-SGM, V152, P1679, DOI 10.1099/mic.0.28605-0; Yoshida H, 2004, GENES CELLS, V9, P271, DOI 10.1111/j.1356-9597.2004.00723.x	55	93	97	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e80140	10.1371/journal.pone.0080140	http://dx.doi.org/10.1371/journal.pone.0080140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367477	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900001
J	Baumuratova, T; Dobre, S; Bastogne, T; Sauter, T				Baumuratova, Tatiana; Dobre, Simona; Bastogne, Thierry; Sauter, Thomas			Switch of Sensitivity Dynamics Revealed with DyGloSA Toolbox for Dynamical Global Sensitivity Analysis as an Early Warning for System's Critical Transition	PLOS ONE			English	Article							PARAMETER SENSITIVITY; EPILEPTIC SEIZURES; COMPLEX-SYSTEMS; SLOWING-DOWN; MODEL; SIGNALS; SHIFTS; NETWORK; BIOLOGY; TIME	Systems with bifurcations may experience abrupt irreversible and often unwanted shifts in their performance, called critical transitions. For many systems like climate, economy, ecosystems it is highly desirable to identify indicators serving as early warnings of such regime shifts. Several statistical measures were recently proposed as early warnings of critical transitions including increased variance, autocorrelation and skewness of experimental or model-generated data. The lack of automatized tool for model-based prediction of critical transitions led to designing DyGloSA - a MATLAB toolbox for dynamical global parameter sensitivity analysis (GPSA) of ordinary differential equations models. We suggest that the switch in dynamics of parameter sensitivities revealed by our toolbox is an early warning that a system is approaching a critical transition. We illustrate the efficiency of our toolbox by analyzing several models with bifurcations and predicting the time periods when systems can still avoid going to a critical transition by manipulating certain parameter values, which is not detectable with the existing SA techniques. DyGloSA is based on the SBToolbox2 and contains functions, which compute dynamically the global sensitivity indices of the system by applying four main GPSA methods: eFAST, Sobol's ANOVA, PRCC and WALS. It includes parallelized versions of the functions enabling significant reduction of the computational time (up to 12 times). DyGloSA is freely available as a set of MATLAB scripts at http://bio.uni.lu/systems_biology/software/dyglosa. It requires installation of MATLAB (versions R2008b or later) and the Systems Biology Toolbox2 available at www.sbtoolbox2. org.DyGloSA can be run on Windows and Linux systems, -32 and -64 bits.	[Baumuratova, Tatiana; Sauter, Thomas] Univ Luxembourg, Syst Biol Grp, Life Sci Res Unit, Luxembourg, Luxembourg; [Baumuratova, Tatiana] Russian Acad Sci, Inst Math Problems Biol, Pushchino 142292, Moscow Region, Russia; [Dobre, Simona] French German Res Inst St Louis, ISL, St Louis, France; [Bastogne, Thierry] Univ Lorraine, CRAN, UMR 7039, Vandoeuvre Les Nancy, France; [Bastogne, Thierry] CNRS, CRAN, UMR 7039, Vandoeuvre Les Nancy, France; [Bastogne, Thierry] BIGS, INRIA, Vandoeuvre Les Nancy, France	University of Luxembourg; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Inria	Baumuratova, T (corresponding author), Univ Luxembourg, Syst Biol Grp, Life Sci Res Unit, Luxembourg, Luxembourg.	tatiana.baumuratova@uni.lu		Sauter, Thomas/0000-0001-8225-2954	University of Luxembourg	University of Luxembourg	The work was supported by the University of Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Boettiger C, 2012, J ROYAL SOC INTERFAC; Brock WA, 2004, TIPPING POINTS ABRUP; Carpenter SR, 2011, ECOLOGY, V92, P2196, DOI 10.1890/11-0716.1; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Chen LN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00342; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; Ditlevsen PD, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044486; Dobre S, 2012, AUTOMATICA, V48, P2740, DOI 10.1016/j.automatica.2012.05.004; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Fomekong-Nanfack Y, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-94; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Held H, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020972; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Kambhu J., 2007, NEW DIRECTIONS UNDER; Kleinen T, 2003, OCEAN DYNAM, V53, P53, DOI DOI 10.1007/S10236-002-0023-6; Kontoravdi C, 2005, BIOTECHNOL PROGR, V21, P1128, DOI 10.1021/bp050028k; Lade SJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002360; Lebedeva G, 2012, EUR J PHARM SCI, V46, P244, DOI 10.1016/j.ejps.2011.10.026; Lenton TM, 2012, PHILOS T R SOC A, V370, P1185, DOI 10.1098/rsta.2011.0304; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Letellier C, 2002, CHAOS SOLITON FRACT, V13, P95, DOI 10.1016/S0960-0779(00)00239-3; Litt B, 2001, NEURON, V30, P51, DOI 10.1016/S0896-6273(01)00262-8; Livina VN, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028672; Maeda S, 2008, CANCER SCI, V99, P836, DOI 10.1111/j.1349-7006.2008.00763.x; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; McSharry PE, 2003, NAT MED, V9, P241, DOI 10.1038/nm0303-241; Rodriguez-Fernandez M, 2010, BIOINFORMATICS, V26, P1675, DOI 10.1093/bioinformatics/btq242; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Saltelli A., 2008, GLOBAL SENSITIVITY A; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2010, NATURE, V467, P411, DOI 10.1038/467411a; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; SHIN SY, 2008, VENTRICULAR MYOCYTES, V110, P25, DOI DOI 10.1007/10; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; Valeyev NV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001024; van Voorn GAK, 2010, MATH BIOSCI, V226, P120, DOI 10.1016/j.mbs.2010.04.005; Venegas J, 2005, NATURE, P434; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470; Zheng Y, 2006, IEE P SYST BIOL, V153, P201, DOI 10.1049/ip-syb:20050088	48	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82973	10.1371/journal.pone.0082973	http://dx.doi.org/10.1371/journal.pone.0082973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367574	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300085
J	Li, SF; Tian, L; Han, Z; Wang, J				Li, Shufeng; Tian, Liang; Han, Zhao; Wang, Jing			Impact of Postmaneuver Sleep Position on Recurrence of Benign Paroxysmal Positional Vertigo	PLOS ONE			English	Article							HEAD-LYING SIDE; POSTURAL RESTRICTIONS; MANEUVER; POSTERIOR; NO	Background: The necessity of postural restriction to patients suffering from benign paroxysmal positional vertigo is controversial. Objective: To investigate the impact of the sleep position after the repositioning maneuver on BPPV recurrence. Methods: 150 unilateral BPPV patients who were treated by repositioning maneuver were distributed into two groups. The patients in group A were instructed to sleep in a semi-sitting position at an angle of approximately 30 degrees and refrain from sleeping on their BPPV affected side for one week. The patients in group B were told to sleep in any preferred position. The comparison of recurrence rates according to different actual sleep positions in one week and one month was performed. Results: There was a statistically significant correlation between the sleeping side and the side affected by BPPV. Without instructions on postural restriction, most patients (82.9%, 73/88) avoided sleeping on their affected side. The patients sleeping on their affected side had a higher recurrence rate (35.3%) than ones sleeping in other positions in the first week after the repositioning maneuver (p<0.05, Chi-square test and Fisher's exact test). The patients sleeping randomly in following 3 weeks had a lower recurrence rate than ones sleeping in other position (p<0.05, Fisher's exact test). Conclusions: BPPV patients had a poor compliance to postural instructions. The habitual sleep side was associated with the side affected by BPPV. The patients sleeping on their affected side had a higher recurrence rate than those sleeping in other positions in first week after the repositioning maneuver.	[Li, Shufeng; Tian, Liang; Han, Zhao; Wang, Jing] Fudan Univ, Dept Otolaryngol Head & Neck Surg, EYE & ENT Hosp, Shanghai 200433, Peoples R China	Fudan University	Li, SF (corresponding author), Fudan Univ, Dept Otolaryngol Head & Neck Surg, EYE & ENT Hosp, Shanghai 200433, Peoples R China.	lisf@fudan.edu.cn		Li, Shufeng/0000-0001-5403-5717	National Natural Science Foundation of China (NSFC) [81171482]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (NSFC, number 81171482). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharyya N, 2008, OTOLARYNG HEAD NECK, V139, pS47, DOI 10.1016/j.otohns.2008.08.022; Cakir BO, 2006, J LARYNGOL OTOL, V120, P534, DOI 10.1017/S002221510600082X; Cakir BO, 2006, ARCH OTOLARYNGOL, V132, P501, DOI 10.1001/archotol.132.5.501; Casqueiro JC, 2008, OTOL NEUROTOL, V29, P706, DOI 10.1097/MAO.0b013e31817d01e8; DEKONINCK J, 1992, SLEEP, V15, P143, DOI 10.1093/sleep/15.2.143; EPLEY JM, 1992, OTOLARYNG HEAD NECK, V107, P399, DOI 10.1177/019459989210700310; Fyrmpas G, 2009, AURIS NASUS LARYNX, V36, P637, DOI 10.1016/j.anl.2009.04.004; Gananca Fernando Freitas, 2005, Braz J Otorhinolaryngol, V71, P764; Gordon CR, 2004, ARCH NEUROL-CHICAGO, V61, P1590, DOI 10.1001/archneur.61.10.1590; GYO K, 1988, LARYNGOSCOPE, V98, P332; HALL SF, 1979, J OTOLARYNGOL, V8, P151; HARVEY SA, 1994, LARYNGOSCOPE, V104, P1206; HERDMAN SJ, 1993, ARCH OTOLARYNGOL, V119, P450; Korres SG, 2008, J LARYNGOL OTOL, V122, P1295, DOI 10.1017/S0022215108002168; Lempert T, 1996, LARYNGOSCOPE, V106, P476, DOI 10.1097/00005537-199604000-00015; Leung RST, 2003, J AM COLL CARDIOL, V41, P227, DOI 10.1016/S0735-1097(02)02717-1; Lopez-Escamez JA, 2002, AM J OTOLARYNG, V23, P263, DOI 10.1053/ajot.2002.124199; Macias JD, 2000, LARYNGOSCOPE, V110, P1921, DOI 10.1097/00005537-200011000-00029; Magliulo G, 2005, EUR ARCH OTO-RHINO-L, V262, P627, DOI 10.1007/s00405-004-0784-2; Marciano E, 2002, EUR ARCH OTO-RHINO-L, V259, P262, DOI 10.1007/s00405-001-0445-7; Massoud EAS, 1996, J OTOLARYNGOL, V25, P121; Moon SJ, 2005, EUR ARCH OTO-RHINO-L, V262, P408, DOI 10.1007/s00405-004-0836-7; Mostafa BE, 2013, EUR ARCH OTO-RHINO-L, V270, P849, DOI 10.1007/s00405-012-2046-z; Nuti D, 2000, OTOLARYNG HEAD NECK, V122, P440, DOI 10.1016/S0194-5998(00)70070-2; Otsuka K, 2010, ACTA OTO-LARYNGOL, V130, P804, DOI 10.3109/00016480903456318; Papacharalampous George X, 2012, Int J Otolaryngol, V2012, P932847, DOI 10.1155/2012/932847; Prokopakis EP, 2005, LARYNGOSCOPE, V115, P1667, DOI 10.1097/01.mlg.0000175062.36144.b9; Richard-Vitton T, 2011, Rev Laryngol Otol Rhinol (Bord), V132, P75; Roberts Richard A, 2005, J Am Acad Audiol, V16, P357, DOI 10.3766/jaaa.16.6.4; Sakaida M, 2003, NEUROLOGY, V60, P1532, DOI 10.1212/01.WNL.0000061477.03862.4D; Sato G, 2012, ACTA OTO-LARYNGOL, V132, P614, DOI 10.3109/00016489.2012.655860; SCHUKNECHT H F, 1962, Trans Am Acad Ophthalmol Otolaryngol, V66, P319; SCHUKNECHT HF, 1969, ARCH OTOLARYNGOL, V90, P765; Semont A, 1988, Adv Otorhinolaryngol, V42, P290; Shim DB, 2012, LARYNGOSCOPE, V122, P873, DOI 10.1002/lary.23180; Simoceli Lucinda, 2005, Braz J Otorhinolaryngol, V71, P55; Soto-Varela A, 2012, J LARYNGOL OTOL, V128, P363, DOI 10.1017/S0022215111003495; Sridbar S, 2005, J OTOLARYNGOL, V34, P41, DOI 10.2310/7070.2005.00041; Vannucchi P, 1997, J VESTIBUL RES-EQUIL, V7, P1; Wolf JS, 1999, LARYNGOSCOPE, V109, P900, DOI 10.1097/00005537-199906000-00011; Zucca G, 1998, J VESTIBUL RES-EQUIL, V8, P325	41	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83566	10.1371/journal.pone.0083566	http://dx.doi.org/10.1371/journal.pone.0083566			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367602	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300111
J	McKay, BS; Congrove, NR; Johnson, AA; Dismuke, WM; Bowen, TJ; Stamer, WD				McKay, Brian S.; Congrove, Nicole R.; Johnson, Adiv A.; Dismuke, W. Michael; Bowen, Trent J.; Stamer, W. Daniel			A Role for Myocilin in Receptor-Mediated Endocytosis	PLOS ONE			English	Article							MULTIVESICULAR BODY; CHEMICAL CHAPERONE; RETICULUM STRESS; EXOSOME RELEASE; MOUSE MODEL; GLAUCOMA; PROTEIN; MUTATIONS; BETA; GENE	Myocilin is a broadly expressed protein that when mutated uniquely causes glaucoma. While no function has been ascribed to explain focal disease, some properties of myocilin are known. Myocilin is a cytoplasmic protein that also localizes to vesicles specifically as part of a large membrane-associated complex with properties similar to the SNARE machinery that function in vesicle fusion. Its role in vesicle dynamics has not been detailed, however myocilin intersects with the endocytic compartment at the level of the multivesicular body. Since internalized GPCRs are sorted in the multivesicular body, we investigated whether myocilin functions in ligand-dependent GPR143 endocytosis. Using recombinant systems we found that the kinetics of myocilin recruitment to biotinylated membrane proteins was similar to that of arrestin-3. We also co-localized myocilin with GPR143 and Arrestin-2 by confocal microscopy. However, wild-type myocilin differed significantly in its association kinetics and co-localization with internalized proteins from mutant myocilin (P370L or T377M). Moreover, we found that myocilin bound to the cytoplasmic tail of GPR143, an interaction mediated by its amino terminal helix-turn-helix domain. Hydrodynamic analyses show that the myocilin-GPR143 protein complex is >158 kD and stable in 500 mM KCl, but not 0.1% SDS. Collectively, data indicate that myocilin is recruited to the membrane compartment, interacting with GPCR proteins during ligand-mediated endocytosis and that GPCR signaling underlies pathology in myocilin glaucoma.	[McKay, Brian S.; Congrove, Nicole R.; Johnson, Adiv A.; Bowen, Trent J.] Univ Arizona, Dept Ophthalmol & Vis Sci, Tucson, AZ 85719 USA; [McKay, Brian S.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA; [Dismuke, W. Michael; Stamer, W. Daniel] Duke Univ, Dept Ophthalmol, Durham, NC USA; [Stamer, W. Daniel] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	University of Arizona; University of Arizona; Duke University; Duke University	McKay, BS (corresponding author), Univ Arizona, Dept Ophthalmol & Vis Sci, Tucson, AZ 85719 USA.	bsmckay@eyes.arizona.edu		McKay, Brian/0000-0002-2893-3959	Research to Prevent Blindness	Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was funded by an unrestricted grant from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham RR, 1998, INVEST OPHTH VIS SCI, V39, P2288; Alward WLM, 2003, AM J OPHTHALMOL, V136, P904, DOI 10.1016/S0002-9394(03)00577-4; Anborgh PH, 2005, J BIOL CHEM, V280, P34840, DOI 10.1074/jbc.M504508200; Blanc L, 2005, BLOOD CELL MOL DIS, V35, P21, DOI 10.1016/j.bcmd.2005.04.008; Cartier A, 2011, J CELL SCI, V124, P3292, DOI 10.1242/jcs.085795; Cattaneo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017206; Cullis DN, 2002, J BIOL CHEM, V277, P49158, DOI 10.1074/jbc.M206316200; Da Q, 2011, J IMMUNOL, V186, P3023, DOI 10.4049/jimmunol.1000262; Denzer K, 2000, J CELL SCI, V113, P3365; Dhami GK, 2006, PHARMACOL THERAPEUT, V111, P260, DOI 10.1016/j.pharmthera.2005.01.008; Dismuke WM, 2012, BIOCHEMISTRY-US, V51, P3606, DOI 10.1021/bi300073r; Fingert JH, 1998, GENOME RES, V8, P377, DOI 10.1101/gr.8.4.377; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Gould DB, 2006, MOL CELL BIOL, V26, P8427, DOI 10.1128/MCB.01127-06; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Hardy KM, 2005, J BIOL CHEM, V280, P28917, DOI 10.1074/jbc.M504803200; Hauser MA, 2006, INVEST OPHTH VIS SCI, V47, P2542, DOI 10.1167/iovs.05-1476; He Y, 2009, MOL VIS, V15, P815; Hoffman EA, 2009, INVEST OPHTH VIS SCI, V50, P1313, DOI 10.1167/iovs.08-2326; Huang W, 2000, Ophthalmic Genet, V21, P155, DOI 10.1076/1381-6810(200009)21:3;1-Z;FT155; Joe MK, 2012, J BIOL CHEM, V287, P13216, DOI 10.1074/jbc.M111.224063; Karali A, 2000, INVEST OPHTH VIS SCI, V41, P729; Kennan AM, 1998, J MED GENET, V35, P957, DOI 10.1136/jmg.35.11.957; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Kubota R, 1997, GENOMICS, V41, P360, DOI 10.1006/geno.1997.4682; Kubota R, 1998, BIOCHEM BIOPH RES CO, V242, P396, DOI 10.1006/bbrc.1997.7972; Kwon HS, 2011, J CELL PHYSIOL, V226, P3392, DOI 10.1002/jcp.22701; Lefkowitz RJ, 2013, PROG MOL BIOL TRANSL, V118, P3, DOI 10.1016/B978-0-12-394440-5.00001-2; Lindsay AJ, 2002, J BIOL CHEM, V277, P27193, DOI 10.1074/jbc.M200757200; Lopez VM, 2008, PLOS BIOL, V6, P1861, DOI 10.1371/journal.pbio.0060236; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Mertts M, 1999, LAB INVEST, V79, P1237; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Noda S, 2000, BIOCHEM BIOPH RES CO, V276, P1129, DOI 10.1006/bbrc.2000.3591; Perkumas KM, 2007, EXP EYE RES, V84, P209, DOI 10.1016/j.exer.2006.09.020; Peters DM, 2005, EXP CELL RES, V303, P218, DOI 10.1016/j.yexcr.2004.09.026; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Resch ZT, 2010, EXP EYE RES, V91, P901, DOI 10.1016/j.exer.2010.09.017; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Schiaffino MV, 1999, NAT GENET, V23, P108, DOI 10.1038/12715; Schilders G, 2008, METHOD ENZYMOL, V448, P211, DOI 10.1016/S0076-6879(08)02611-6; Seo S, 2013, CURR EYE RES, V38, P310, DOI 10.3109/02713683.2012.754047; SHEN J, 1992, AM J PHYSIOL, V262, pC384, DOI 10.1152/ajpcell.1992.262.2.C384; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Shi L, 2012, SCIENCE, V335, P1355, DOI 10.1126/science.1214984; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Stamer WD, 2006, EXP EYE RES, V83, P1386, DOI 10.1016/j.exer.2006.07.018; Stamer WD, 1998, INVEST OPHTH VIS SCI, V39, P1804; Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014; Taniguchi F, 1999, JPN J OPHTHALMOL, V43, P80, DOI 10.1016/S0021-5155(98)00074-4; Ueda J, 2002, INVEST OPHTH VIS SCI, V43, P1068; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; van Zuylen WJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002747; Wang L, 2007, MOL VIS, V13, P618; Weidberg H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002355; Wentz-Hunter K, 2004, EXP CELL RES, V297, P39, DOI 10.1016/j.yexcr.2004.02.024; Wentz-Hunter K, 2004, J CELL PHYSIOL, V200, P45, DOI 10.1002/jcp.10478; Wiggs JL, 1998, AM J HUM GENET, V63, P1549, DOI 10.1086/302098; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; WILSON DW, 1992, J CELL BIOL, V117, P531, DOI 10.1083/jcb.117.3.531; Yam GHT, 2007, INVEST OPHTH VIS SCI, V48, P1683, DOI 10.1167/iovs.06-0943; Zode GS, 2012, INVEST OPHTH VIS SCI, V53, P1557, DOI 10.1167/iovs.11-8837; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	67	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82301	10.1371/journal.pone.0082301	http://dx.doi.org/10.1371/journal.pone.0082301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367514	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300030
J	Niederkrotenthaler, T; Parker, EM; Ovalle, F; Noe, RE; Bell, J; Xu, LK; Morrison, MA; Mertzlufft, CE; Sugerman, DE				Niederkrotenthaler, Thomas; Parker, Erin M.; Ovalle, Fernando; Noe, Rebecca E.; Bell, Jeneita; Xu, Likang; Morrison, Melissa A.; Mertzlufft, Caitlin E.; Sugerman, David E.			Injuries and Post-Traumatic Stress following Historic Tornados: Alabama, April 2011	PLOS ONE			English	Article							RISK-FACTORS; DISASTER PREPAREDNESS; NATURAL DISASTER; DISORDER; OKLAHOMA; DEATH; BANGLADESH; ILLINOIS; GEORGIA; SYSTEM	Objectives: We analyzed tornado-related injuries seen at hospitals and risk factors for tornado injury, and screened for post-traumatic stress following a statewide tornado-emergency in Alabama in April 2011. Methods: We conducted a chart abstraction of 1,398 patients at 39 hospitals, mapped injured cases, and conducted a case-control telephone survey of 98 injured cases along with 200 uninjured controls. Results: Most (n = 1,111, 79.5%) injuries treated were non-life threatening (Injury Severity Score <= 15). Severe injuries often affected head (72.9%) and chest regions (86.4%). Mobile home residents showed the highest odds of injury (OR, 6.98; 95% CI: 2.10-23.20). No severe injuries occurred in tornado shelters. Within permanent homes, the odds of injury were decreased for basements (OR, 0.13; 95% CI: 0.04-0.40), bathrooms (OR, 0.22; 95% CI: 0.06-0.78), hallways (OR, 0.31; 95% CI: 0.11-0.90) and closets (OR, 0.25; 95% CI: 0.07-0.80). Exposure to warnings via the Internet (aOR, 0.20; 95% CI: 0.09-0.49), television (aOR, 0.45; 95% CI: 0.24-0.83), and sirens (aOR, 0.50; 95% CI: 0.30-0.85) decreased the odds of injury, and residents frequently exposed to tornado sirens had lower odds of injury. The prevalence of PTSD in respondents was 22.1% and screening positive for PTSD symptoms was associated with tornado-related loss events. Conclusions: Primary prevention, particularly improved shelter access, and media warnings, seem essential to prevent severe tornado-injury. Small rooms such as bathrooms may provide some protection within permanent homes when no underground shelter is available.	[Niederkrotenthaler, Thomas; Parker, Erin M.; Ovalle, Fernando; Bell, Jeneita; Sugerman, David E.] Ctr Dis Control & Prevent CDC, Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, Atlanta, GA USA; [Niederkrotenthaler, Thomas; Parker, Erin M.] Ctr Dis Control & Prevent CDC, Sci Educ & Profess Dev Program Off, Div Appl Sci, Epidem Intelligence Serv, Atlanta, GA USA; [Noe, Rebecca E.] Ctr Dis Control & Prevent CDC, Natl Ctr Environm Hlth, Div Environm Hazards & Hlth Effects, Atlanta, GA USA; [Xu, Likang] Ctr Dis Control & Prevent CDC, Natl Ctr Injury Prevent & Control, Div Anal Res & Practice Integrat, Atlanta, GA USA; [Morrison, Melissa A.] Ctr Dis Control & Prevent CDC, Off Publ Hlth Preparedness & Response, Atlanta, GA USA; [Morrison, Melissa A.] Alabama Dept Publ Hlth, Montgomery, AL 36102 USA; [Mertzlufft, Caitlin E.] ATSDR, Div Toxicol & Human Hlth Sci, Geospatial Res Anal & Serv Program, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Niederkrotenthaler, T (corresponding author), Med Univ Vienna, Dept Gen Practice & Family Med, Ctr Publ Hlth, Vienna, Austria.	thomas.niederkrotenthaler@meduniwien.ac.at	Ovalle, Fernando/Q-6647-2019	Ovalle, Fernando/0000-0002-6711-071X; Niederkrotenthaler, Thomas/0000-0001-9550-628X				[Anonymous], 2009, STAND DEF FIN DISP C; Balluz L, 2000, DISASTERS, V24, P71, DOI 10.1111/1467-7717.00132; Bisson J, 2009, PSYCHOL TREATMENT PO; Bohonos JJ, 1999, J EMERG MED, V17, P67, DOI 10.1016/S0736-4679(98)00125-5; BRENNER SA, 1995, INT J EPIDEMIOL, V24, P144, DOI 10.1093/ije/24.1.144; BRENNER SA, 1992, AM J PUBLIC HEALTH, V82, P1296, DOI 10.2105/AJPH.82.9.1296-a; Breslau N, 1999, AM J PSYCHIAT, V156, P908, DOI 10.1176/ajp.156.6.908; Caldera T, 2001, SOC PSYCH PSYCH EPID, V36, P108, DOI 10.1007/s001270050298; CARTER AO, 1989, AM J EPIDEMIOL, V130, P1209, DOI 10.1093/oxfordjournals.aje.a115449; Casey-Lockyer Mary, 2012, Morbidity and Mortality Weekly Report, V61, P529; Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P412; Chaudhuri A, 2005, TELECOMMUN POLICY, V29, P731, DOI 10.1016/j.telpol.2005.07.001; Chern JJ, 2011, J NEUROSURG-PEDIATR, V8, P588, DOI 10.3171/2011.9.PEDS11207; Choudhury WA, 2006, INT REV PSYCHIATR, V18, P529, DOI 10.1080/09540260601037896; Comstock RD, 2005, DISASTERS, V29, P277, DOI 10.1111/j.0361-3666.2005.00291.x; Cook L.J., 2009, MOTORCYCLE HELMET US; Daley WR, 2005, AM J EPIDEMIOL, V161, P1144, DOI 10.1093/aje/kwi142; DUCLOS PJ, 1989, INT J EPIDEMIOL, V18, P213, DOI 10.1093/ije/18.1.213; EIDSON M, 1990, INT J EPIDEMIOL, V19, P1051, DOI 10.1093/ije/19.4.1051; Federal Emergency Management Agency, 2012, P908 FEMA; Friedman M. J., 2007, HDB PTSD SCI PRACTIC, V3rd; GLASS RI, 1980, SCIENCE, V207, P734, DOI 10.1126/science.207.4432.734; Gregg M, 2008, FIELD EPIDEMIOLOGY, V3rd; Hammer B, 2002, WEATHER FORECAST, V17, P577, DOI 10.1175/1520-0434(2002)017<0577:RTWDTM>2.0.CO;2; Hartmann EH, 2012, AM SURGEON, V78, P770; Liu S, 1996, AM J PUBLIC HEALTH, V86, P87, DOI 10.2105/AJPH.86.1.87; MacKenzie E, 1997, ICDMAP 90 USERS GUID; MADAKASIRA S, 1987, J NERV MENT DIS, V175, P286, DOI 10.1097/00005053-198705000-00008; MANDELBAUM I, 1966, J TRAUM, V6, P353, DOI 10.1097/00005373-196605000-00005; May AK, 2000, J TRAUMA, V48, P666, DOI 10.1097/00005373-200004000-00014; May Beth M., 2002, Journal of the American Osteopathic Association, V102, P225; Middleton KL, 2002, INT J STRESS MANAGE, V9, P229, DOI 10.1023/A:1015571816227; Millie M, 2000, AM SURGEON, V66, P223; National Oceanic and Atmospheric Administration, 2009, SERV ASS MOTH DAY WE; National Oceanic and Atmospheric Administration, 2011, SERV ASS HIST TORN A; Peitzmann A.B., 2008, TRAUMA MANUAL TRAUMA; Penick E C, 1976, J Community Psychol, V4, P64, DOI 10.1002/1520-6629(197601)4:1<64::AID-JCOP2290040103>3.0.CO;2-0; Polusny MA, 2008, J TRAUMA STRESS, V21, P75, DOI 10.1002/jts.20281; PTSD, COCHRANE DATABASE SY; SCHMIDLIN TW, 1995, DISASTERS, V19, P170, DOI 10.1111/j.1467-7717.1995.tb00367.x; Sorensen JH, 2006, HDB DISASTER RES; Sugimoto JD, 2011, DISASTERS, V35, P329, DOI 10.1111/j.1467-7717.2010.01214.x; Trickey D, 2012, CLIN PSYCHOL REV, V32, P122, DOI 10.1016/j.cpr.2011.12.001; Wind Science and Engineering Center, REC ENH FUJ SCAL EF	44	17	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83038	10.1371/journal.pone.0083038	http://dx.doi.org/10.1371/journal.pone.0083038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367581	gold, Green Published			2022-12-27	WOS:000328740300092
J	Snoek, JA; van Berkel, S; van Meeteren, N; Backx, FJG; Daanen, HAM				Snoek, Johan A.; van Berkel, Sietske; van Meeteren, Nico; Backx, Frank J. G.; Daanen, Hein A. M.			Effect of Aerobic Training on Heart Rate Recovery in Patients with Established Heart Disease; a Systematic Review	PLOS ONE			English	Review							ACUTE MYOCARDIAL-INFARCTION; CARDIAC REHABILITATION; EXERCISE INTOLERANCE; SECONDARY PREVENTION; FAILURE MECHANISMS; ASSOCIATION; TRIALS; IMPACT	Background: Although a delayed decrease in heart rate during the first minute after graded exercise has been identified as a powerful predictor of overall mortality in cardiac patients, the potential to influence this risk factor by aerobic training remains to be proven. Objective: The aim was to study the relationship between aerobic training and Heart Rate Recovery (HRR) in patients with established heart disease. Methods: (Quasi) randomized clinical trials on aerobic exercise training in adults with established heart disease were identified through electronic database and reference screening. Two reviewers extracted data and assessed the risk of bias and therapeutic validity. Methodological validity was evaluated using an adapted version of the Cochrane Collaboration's tool for assessing risk of bias and the therapeutic validity of the interventions was assessed with a nine-itemed, expert-based rating scale (CONTENT). Scores range from 0 to 9 (score >= 6 reflecting therapeutic validity). Results: Of the 384 articles retrieved, 8 studies (449 patients) were included. Three of the included studies demonstrated adequate therapeutic validity and five demonstrated low risk of bias. Two studies showed both adequate therapeutic validity and a low risk of bias. For cardiac patients aerobic exercise training was associated with more improvement in HRR compared to usual care. Conclusion: The present systematic review shows a level 1A evidence that aerobic training increases HRR in patients with established heart disease.	[Snoek, Johan A.; van Berkel, Sietske] Isala, Sports Med Dept, Zwolle, Netherlands; [van Meeteren, Nico; Daanen, Hein A. M.] TNO Hlth Living, Leiden, Netherlands; [van Meeteren, Nico] Ctr Care Technol Res, Maastricht, Netherlands; [Backx, Frank J. G.] UMC Utrecht, Rehabil Nursing Sci & Sports Dept, Utrecht, Netherlands; [Daanen, Hein A. M.] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Daanen, Hein A. M.] Vrije Univ Amsterdam, Fac Human Movement Sci, Amsterdam, Netherlands	Netherlands Organization Applied Science Research; Maastricht University; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Snoek, JA (corresponding author), Isala, Sports Med Dept, Zwolle, Netherlands.	j.a.snoek@isala.nl	Daanen, Hein/AAF-6496-2020; van Berkel, Sietske/Y-6277-2018	Daanen, Hein/0000-0002-7459-0678; van Berkel, Sietske/0000-0001-7275-0677				Borresen J, 2007, EUR J APPL PHYSIOL, V101, P503, DOI 10.1007/s00421-007-0516-6; Buchheit M, 2010, EUR J APPL PHYSIOL, V109, P869, DOI 10.1007/s00421-010-1422-x; Chen YF, 1997, AM J PHYSIOL-HEART C, V272, pH1412, DOI 10.1152/ajpheart.1997.272.3.H1412; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Daanen HAM, 2012, INT J SPORT PHYSIOL, V7, P251, DOI 10.1123/ijspp.7.3.251; Giallauria F, 2011, J CARD FAIL, V17, P108, DOI 10.1016/j.cardfail.2010.09.001; Goldsmith RL, 2000, CORONARY ARTERY DIS, V11, P129, DOI 10.1097/00019501-200003000-00007; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; Hoogeboom TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038031; Jolly MA, 2011, CIRCULATION, V124, P1520, DOI 10.1161/CIRCULATIONAHA.110.005009; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Legramante JM, 2007, AM J PHYSIOL-HEART C, V292, pH510, DOI 10.1152/ajpheart.00748.2006; Leon AS, 2005, CIRCULATION, V111, P369, DOI 10.1161/01.CIR.0000151788.08740.5C; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Maeder MT, 2009, EUR J APPL PHYSIOL, V105, P247, DOI 10.1007/s00421-008-0896-2; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moholdt T, 2012, CLIN REHABIL, V26, P33, DOI 10.1177/0269215511405229; Myers J, 2007, AM HEART J, V153, P1056, DOI 10.1016/j.ahj.2007.02.038; OCONNOR GT, 1989, CIRCULATION, V80, P234, DOI 10.1161/01.CIR.80.2.234; OLDRIDGE NB, 1988, JAMA-J AM MED ASSOC, V260, P945, DOI 10.1001/jama.260.7.945; Piepoli MF, 2010, EUR J CARDIOV PREV R, V17, P637, DOI 10.1097/HJR.0b013e3283361dc5; Piepoli MF, 2010, EUR J CARDIOV PREV R, V17, P643, DOI 10.1097/HJR.0b013e32833f3aa5; Piepoli MF, 2010, EUR J CARDIOV PREV R, V17, P1, DOI 10.1097/HJR.0b013e3283313592; Ribeiro F, 2012, REV PORT CARDIOL, V31, P135, DOI 10.1016/j.repc.2011.12.009; Shetler K, 2001, J AM COLL CARDIOL, V38, P1980, DOI 10.1016/S0735-1097(01)01652-7; Tsai SW, 2005, CLIN REHABIL, V19, P843, DOI 10.1191/0269215505cr915oa; van Rijn RM, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5688; van Tulder MW, 2009, SPINE, V34, P1685, DOI 10.1097/BRS.0b013e3181ab6a78; Wu SK, 2006, AM J PHYS MED REHAB, V85, P711, DOI 10.1097/01.phm.0000228597.64057.66; Zheng H, 2008, J REHABIL MED, V40, P776, DOI 10.2340/16501977-0254	30	20	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83907	10.1371/journal.pone.0083907	http://dx.doi.org/10.1371/journal.pone.0083907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367618	Green Submitted, Green Published, gold			2022-12-27	WOS:000328740300120
J	Huang, XC; Rong, J; Liu, Y; Zhang, MH; Wan, Y; Ouyang, S; Zhou, CH; Wu, XP				Huang, Xiao-Chen; Rong, Jun; Liu, Yong; Zhang, Ming-Hua; Wan, Yuan; Ouyang, Shan; Zhou, Chun-Hua; Wu, Xiao-Ping			The Complete Maternally and Paternally Inherited Mitochondrial Genomes of the Endangered Freshwater Mussel Solenaia carinatus (Bivalvia: Unionidae) and Implications for Unionidae Taxonomy	PLOS ONE			English	Article							DOUBLY UNIPARENTAL INHERITANCE; MOLECULAR PHYLOGENETIC ANALYSIS; SUBUNIT-II PROTEIN; MYTILUS-GALLOPROVINCIALIS; FUNCTIONAL-ROLE; DNA; EVOLUTION; GENE; UNIONOIDA; MOLLUSCA	Doubly uniparental inheritance (DUI) is an exception to the typical maternal inheritance of mitochondrial (mt) DNA in Metazoa, and found only in some bivalves. In species with DUI, there are two highly divergent gender-associated mt genomes: maternal (F) and paternal (M), which transmit independently and show different tissue localization. Solenaia carinatus is an endangered freshwater mussel species exclusive to Poyang Lake basin, China. Anthropogenic events in the watershed greatly threaten the survival of this species. Nevertheless, the taxonomy of S. carinatus based on shell morphology is confusing, and the subfamilial placement of the genus Solenaia remains unclear. In order to clarify the taxonomic status and discuss the phylogenetic implications of family Unionidae, the entire F and M mt genomes of S. carinatus were sequenced and compared with the mt genomes of diverse freshwater mussel species. The complete F and M mt genomes of S. carinatus are 16716 bp and 17102 bp in size, respectively. The F and M mt genomes of S. carinatus diverge by about 40% in nucleotide sequence and 48% in amino acid sequence. Compared to F counterparts, the M genome shows a more compact structure. Different gene arrangements are found in these two gender-associated mt genomes. Among these, the F genome cox2-rrnS gene order is considered to be a genome-level synapomorphy for female lineage of the subfamily Gonideinae. From maternal and paternal mtDNA perspectives, the phylogenetic analyses of Unionoida indicate that S. carinatus belongs to Gonideinae. The F and M clades in freshwater mussels are reciprocal monophyly. The phylogenetic trees advocate the classification of sampled Unionidae species into four subfamilies: Gonideinae, Ambleminae, Anodontinae, and Unioninae, which is supported by the morphological characteristics of glochidia.	[Huang, Xiao-Chen; Rong, Jun; Wan, Yuan; Zhou, Chun-Hua; Wu, Xiao-Ping] Nanchang Univ, Inst Life Sci, Ctr Watershed Ecol, Nanchang, Peoples R China; [Huang, Xiao-Chen; Liu, Yong; Zhang, Ming-Hua; Wan, Yuan; Ouyang, Shan; Zhou, Chun-Hua; Wu, Xiao-Ping] Nanchang Univ, Sch Life Sci & Food Engn, Nanchang, Peoples R China	Nanchang University; Nanchang University	Zhou, CH (corresponding author), Nanchang Univ, Inst Life Sci, Ctr Watershed Ecol, Nanchang, Peoples R China.	zhouchunhuajx@hotmail.com; xpwu@ncu.edu.cn	Rong, Jun/B-6037-2008	Rong, Jun/0000-0003-1408-2898; Huang, Xiao-Chen/0000-0002-0242-3571	National Natural Science Foundation of China [31260515]; Leading talent training plan of the GanPo Outstanding Talents 555 Project [18000041]; Youth Science Foundation of Jiangxi province education department [GJJ13025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Leading talent training plan of the GanPo Outstanding Talents 555 Project; Youth Science Foundation of Jiangxi province education department	This work is supported by grants from the National Natural Science Foundation of China (No. 31260515), Leading talent training plan of the GanPo Outstanding Talents 555 Project (18000041), and the Youth Science Foundation of Jiangxi province education department (GJJ13025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Akasaki T, 2006, MOL PHYLOGENET EVOL, V38, P648, DOI 10.1016/j.ympev.2005.10.018; BERNT M, 2012, MITOS IMPROVED NOVO, P42937; Boore JL, 2006, TRENDS ECOL EVOL, V21, P439, DOI 10.1016/j.tree.2006.05.009; Bouchet P, 2010, MALACOLOGIA, V52, P4; Breton S, 2006, GENETICS, V172, P1107, DOI 10.1534/genetics.105.047159; Breton S, 2007, TRENDS GENET, V23, P465, DOI 10.1016/j.tig.2007.05.011; Breton S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019365; Breton S, 2011, MOL BIOL EVOL, V28, P1645, DOI 10.1093/molbev/msq345; Breton S, 2009, GENETICS, V183, P1575, DOI 10.1534/genetics.109.110700; Brown W.M., 1985, MOL EVOLUTIONARY GEN, P399; Campbell DC, 2005, INVERTEBR BIOL, V124, P131, DOI 10.1111/j.1744-7410.2005.00015.x; Chakrabarti R, 2007, FEBS LETT, V581, P5213, DOI 10.1016/j.febslet.2007.10.006; Chapman EG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-165; Chen HX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-139; [陈玲 Chen Ling], 2012, [生态学报, Acta Ecologica Sinica], V32, P2420; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Curole JP, 2002, MOL BIOL EVOL, V19, P1323, DOI 10.1093/oxfordjournals.molbev.a004193; Curole JP, 2005, J MOL EVOL, V61, P381, DOI 10.1007/s00239-004-0192-7; Deein Gridsada, 2008, Natural History Journal of Chulalongkorn University, V8, P61; Doucet-Beaupre H, 2012, MOL PHYLOGENET EVOL, V63, P430, DOI 10.1016/j.ympev.2012.01.017; Doucet-Beaupre H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-50; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FICKETT JW, 1982, NUCLEIC ACIDS RES, V10, P5303, DOI 10.1093/nar/10.17.5303; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Garrido-Ramos MA, 1998, GENOME, V41, P818, DOI 10.1139/gen-41-6-818; Geist J, 2010, HYDROBIOLOGIA, V644, P69, DOI 10.1007/s10750-010-0190-2; Ghiselli F, 2013, GENOME BIOL EVOL, V5, P1535, DOI 10.1093/gbe/evt112; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Graf DL, 2007, J MOLLUS STUD, V73, P291, DOI 10.1093/mollus/eym029; Graf DL, 2006, ZOOL J LINN SOC-LOND, V148, P343, DOI 10.1111/j.1096-3642.2006.00259.x; Graf DL, 2002, J MOLLUS STUD, V68, P65, DOI 10.1093/mollus/68.1.65; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAAS F, 1969, SUPERFAMILIA UNIONAC, V88, P1; Heude R. P., 1875, CONCHYLIOLOGIE FLUVI; Howard JK, 2006, FRESHWATER BIOL, V51, P460, DOI 10.1111/j.1365-2427.2005.01507.x; Huang YY, 2002, J MOLLUS STUD, V68, P359, DOI 10.1093/mollus/68.4.359; Jiang Wen-Ping, 2010, Yichuan, V32, P153, DOI 10.3724/SP.J.1005.2010.00153; KAT PW, 1984, BIOL REV, V59, P189, DOI 10.1111/j.1469-185X.1984.tb00407.x; Kolpakov R, 2003, NUCLEIC ACIDS RES, V31, P3672, DOI 10.1093/nar/gkg617; Krebs RA, 2013, BIOL J LINN SOC, V109, P229, DOI 10.1111/bij.12025; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lavrov DV, 2005, SYST BIOL, V54, P651, DOI 10.1080/10635150500221044; Lefevre G, 1910, J EXP ZOOL, V9, P79, DOI 10.1002/jez.1400090105; LIU Y-Y, 1991, Acta Zootaxonomica Sinica, V16, P122; Liu YY, 1979, EC FAUNA CHINA FRESH, P116; Lydeard C, 2004, BIOSCIENCE, V54, P321, DOI 10.1641/0006-3568(2004)054[0321:TGDONM]2.0.CO;2; Maddison WP, 2009, MESQUITE MODULAR SYS; Milani L, 2013, GENOME BIOL EVOL, V5, P1408, DOI 10.1093/gbe/evt101; Mizi A, 2005, MOL BIOL EVOL, V22, P952, DOI 10.1093/molbev/msi079; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nylander JAA., 2004, BIOINFORMATICS; Obata M, 2006, DEV GROWTH DIFFER, V48, P253, DOI [10.1111/j.1440-169x.2006.00863.x, 10.1111/j.1440-169X.2006.00863.x]; Obata M, 2007, DEV GROWTH DIFFER, V49, P335, DOI [10.1111/j.1440-169X.2007.00930.x, 10.1111/j.1440-169x.2007.00930.x]; Ouyang JX, 2011, J CONCHOL, V40, P543; Passamonti M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-442; Passamonti M, 2009, DNA CELL BIOL, V28, P79, DOI 10.1089/dna.2008.0807; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Prozorova L.A., 2005, Byulleten' Dal'nevostochnogo Malakologicheskogo Obshchestva, V9, P46; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SAVAZZI E, 1992, LETHAIA, V25, P195, DOI 10.1111/j.1502-3931.1992.tb01384.x; Serb JM, 2003, MOL PHYLOGENET EVOL, V28, P1, DOI 10.1016/S1055-7903(03)00026-5; Serb JM, 2003, MOL BIOL EVOL, V20, P1854, DOI 10.1093/molbev/msg218; Shu Feng-Yue, 2009, Acta Hydrobiologica Sinica, V33, P1051, DOI 10.3724/SP.J.0000.2009.61051; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simpson C.T., 1914, DESCRIPTIVE CATALOGU; SKIBINSKI DOF, 1994, NATURE, V368, P817, DOI 10.1038/368817b0; Soroka M, 2010, J APPL GENET, V51, P469, DOI 10.1007/BF03208876; Soroka Marianna, 2010, Folia Malacologica, V18, P189, DOI 10.2478/v10125-010-0016-x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stewart DT, 1996, GENETICS, V143, P1349; STOGER I, 2012, MOL PHYLOGE IN PRESS, P42937; Strayer DL, 2008, FRESHW ECOL SER, V1, P1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tchang S, 1965, ACTA ZOOL SINICA, V17, P309; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Vaughn CC, 2001, FRESHWATER BIOL, V46, P1431, DOI 10.1046/j.1365-2427.2001.00771.x; Venetis C, 2006, P R SOC B, V273, P2483, DOI 10.1098/rspb.2006.3607; Walker JM, 2007, MOL ECOL NOTES, V7, P489, DOI 10.1111/j.1471-8286.2006.01630.x; Whelan NV, 2011, MOL PHYLOGENET EVOL, V61, P504, DOI 10.1016/j.ympev.2011.07.016; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wu Xiaoping, 2000, Hupo Kexue, V12, P111; Wu Xiaoping, 1999, Acta Hydrobiologica Sinica, V23, P139; Xiong LF, 2012, CHIN J OCEANOL LIMN, V30, P124, DOI 10.1007/s00343-012-1070-6; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YEAGER MM, 1994, J N AM BENTHOL SOC, V13, P217, DOI 10.2307/1467240; Yuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032353; ZOUROS E, 1994, NATURE, V368, P818, DOI 10.1038/368818a0	90	50	53	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84352	10.1371/journal.pone.0084352	http://dx.doi.org/10.1371/journal.pone.0084352			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358356	Green Submitted, Green Published, gold			2022-12-27	WOS:000328737700092
J	Liao, YC; Lin, HH; Lin, CH; Chung, WB				Liao, Yu-Chieh; Lin, Hsin-Hung; Lin, Chieh-Hua; Chung, Wen-Bin			Identification of Cytotoxic T Lymphocyte Epitopes on Swine Viruses: Multi-Epitope Design for Universal T Cell Vaccine	PLOS ONE			English	Article							BINDING PREDICTION; PROTEIN; CD8(+); IMMUNOGENICITY; COMPLEX; GENOTYPE; UTILITY	Classical swine fever (CSF), foot-and-mouth disease (FMD) and porcine reproductive and respiratory syndrome (PRRS) are the primary diseases affecting the pig industry globally. Vaccine induced CD8(+) T cell-mediated immune response might be long-lived and cross-serotype and thus deserve further attention. Although large panels of synthetic overlapping peptides spanning the entire length of the polyproteins of a virus facilitate the detection of cytotoxic T lymphocyte (CTL) epitopes, it is an exceedingly costly and cumbersome approach. Alternatively, computational predictions have been proven to be of satisfactory accuracy and are easily performed. Such a method enables the systematic identification of genome-wide CTL epitopes by incorporating epitope prediction tools in analyzing large numbers of viral sequences. In this study, we have implemented an integrated bioinformatics pipeline for the identification of CTL epitopes of swine viruses including the CSF virus (CSFV), FMD virus (FMDV) and PRRS virus (PRRSV) and assembled these epitopes on a web resource to facilitate vaccine design. Identification of epitopes for cross protections to different subtypes of virus are also reported in this study and may be useful for the development of a universal vaccine against such viral infections among the swine population. The CTL epitopes identified in this study have been evaluated in silico and possibly provide more and wider protection in compared to traditional single-reference vaccine design. The web resource is free and open to all users through http://sb.nhri.org.tw/ICES.	[Liao, Yu-Chieh; Lin, Hsin-Hung; Lin, Chieh-Hua] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Miaoli, Taiwan; [Lin, Chieh-Hua] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Chung, Wen-Bin] Natl Pingtung Univ Sci & Technol, Dept Vet Med, Pingtung, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; National Pingtung University Science & Technology	Liao, YC (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Miaoli, Taiwan.	jade@nhri.org.tw	Liao, Yu-Chieh/L-5113-2019; Liao, Yu-Chieh/E-5031-2011	Liao, Yu-Chieh/0000-0002-4360-7932; 	National Health Research Institutes, Taiwan [PH-101-PP-45]; National Science Council, Taiwan [NSC101-2319-B-400-001, NSC101-2313-B-020-017-MY3]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by intramural funding from the National Health Research Institutes, Taiwan (PH-101-PP-45 to YCLiao). The computational facilities for this work were partly supported by the National Science Council, Taiwan (NSC101-2319-B-400-001 to YC Liao and NSC101-2313-B-020-017-MY3 to WB Chung). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armengol E, 2002, J GEN VIROL, V83, P551, DOI 10.1099/0022-1317-83-3-551; Barfoed AM, 2006, ANTIVIR RES, V72, P178, DOI 10.1016/j.antiviral.2006.07.002; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Ceppi M, 2005, J GEN VIROL, V86, P2525, DOI 10.1099/vir.0.80907-0; Chaves FA, 2012, J IMMUNOL, V188, P4235, DOI 10.4049/jimmunol.1103640; Chen WH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-199; Diaz I, 2009, VACCINE, V27, P5603, DOI 10.1016/j.vaccine.2009.07.029; Gao FS, 2006, VET IMMUNOL IMMUNOP, V113, P328, DOI 10.1016/j.vetimm.2006.06.002; Gilbert SC, 2012, IMMUNOLOGY, V135, P19, DOI 10.1111/j.1365-2567.2011.03517.x; Goodman AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025938; Graham SP, 2012, VACCINE, V30, P2742, DOI 10.1016/j.vaccine.2012.02.029; Guo KK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-236; Guzman E, 2010, J VIROL, V84, P12375, DOI 10.1128/JVI.01545-10; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Ichihashi T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024626; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; Lillie PJ, 2012, CLIN INFECT DIS, V55, P19, DOI 10.1093/cid/cis327; Martin W, 2003, METHODS, V29, P289, DOI 10.1016/S1046-2023(02)00351-1; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Pan XC, 2011, ACTA CRYSTALLOGR F, V67, P568, DOI 10.1107/S174430911100741X; Patch JR, 2011, CLIN VACCINE IMMUNOL, V18, P280, DOI 10.1128/CVI.00417-10; PAULY T, 1995, J GEN VIROL, V76, P3039, DOI 10.1099/0022-1317-76-12-3039; Pedersen LE, 2011, IMMUNOGENETICS, V63, P821, DOI 10.1007/s00251-011-0555-3; Pedersen LE, 2012, ANIM GENET; Powell TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062778; Rock MT, 2011, J IMMUNOL METHODS, V374, P13, DOI 10.1016/j.jim.2011.08.004; Sanchez-Burgos G, 2010, VIRUS RES, V153, P113, DOI 10.1016/j.virusres.2010.07.014; Somvanshi P, 2009, INDIAN J BIOTECHNOL, V8, P193; Stranzl T, 2010, IMMUNOGENETICS, V62, P357, DOI 10.1007/s00251-010-0441-4; Vanhee M, 2011, VACCINE, V29, P4794, DOI 10.1016/j.vaccine.2011.04.071; Vashisht K, 2008, VACCINE, V26, P4747, DOI 10.1016/j.vaccine.2008.06.047; Xu YG, 2011, CLIN VACCINE IMMUNOL, V18, P1979, DOI 10.1128/CVI.05204-11; Zhang LM, 2012, BRIEF BIOINFORM, V13, P350, DOI 10.1093/bib/bbr060	34	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84443	10.1371/journal.pone.0084443	http://dx.doi.org/10.1371/journal.pone.0084443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358361	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700096
J	Shen, H; Yamashita, A; Nakakoshi, M; Yokoe, H; Sudo, M; Kasai, H; Tanaka, T; Fujimoto, Y; Ikeda, M; Kato, N; Sakamoto, N; Shindo, H; Maekawa, S; Enomoto, N; Tsubuki, M; Moriishi, K				Shen, Hui; Yamashita, Atsuya; Nakakoshi, Masamichi; Yokoe, Hiromasa; Sudo, Masashi; Kasai, Hirotake; Tanaka, Tomohisa; Fujimoto, Yuusuke; Ikeda, Masanori; Kato, Nobuyuki; Sakamoto, Naoya; Shindo, Hiroko; Maekawa, Shinya; Enomoto, Nobuyuki; Tsubuki, Masayoshi; Moriishi, Kohji			Inhibitory Effects of Caffeic Acid Phenethyl Ester Derivatives on Replication of Hepatitis C Virus	PLOS ONE			English	Article							IN-VITRO; ANALOGS; CAPE; SUPPRESSION; ACTIVATION; EXPRESSION; CULTURE; GENOME; POTENT	Caffeic acid phenethyl ester (CAPE) has been reported as a multifunctional compound. In this report, we tested the effect of CAPE and its derivatives on hepatitis C virus (HCV) replication in order to develop an effective anti-HCV compound. CAPE and CAPE derivatives exhibited anti-HCV activity against an HCV replicon cell line of genotype 1b with EC50 values in a range from 1.0 to 109.6 mu M. Analyses of chemical structure and antiviral activity suggested that the length of the n-alkyl side chain and catechol moiety are responsible for the anti-HCV activity of these compounds. Caffeic acid n-octyl ester exhibited the highest anti-HCV activity among the tested derivatives with an EC50 value of 1.0 mu M and an SI value of 63.1 by using the replicon cell line derived from genotype 1b strain Con1. Treatment with caffeic acid n-octyl ester inhibited HCV replication of genotype 2a at a similar level to that of genotype 1b irrespectively of interferon signaling. Caffeic acid n-octyl ester could synergistically enhance the anti-HCV activities of interferon-alpha 2b, daclatasvir, and VX-222, but neither telaprevir nor danoprevir. These results suggest that caffeic acid n-octyl ester is a potential candidate for novel anti-HCV chemotherapy drugs.	[Shen, Hui; Yamashita, Atsuya; Kasai, Hirotake; Tanaka, Tomohisa; Fujimoto, Yuusuke; Moriishi, Kohji] Univ Yamanashi, Grad Sch Med & Engn, Dept Microbiol, Div Med, Yamanashi, Japan; [Nakakoshi, Masamichi] Toho Univ, Fac Pharmaceut Sci, Chiba 2748510, Japan; [Yokoe, Hiromasa; Sudo, Masashi; Tsubuki, Masayoshi] Hoshi Univ, Inst Med Chem, Tokyo 142, Japan; [Ikeda, Masanori; Kato, Nobuyuki] Okayama Univ, Grad Sch Med Dent, Dept Tumor Virol, Okayama 7008530, Japan; [Sakamoto, Naoya] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan; [Shindo, Hiroko; Maekawa, Shinya; Enomoto, Nobuyuki] Univ Yamanashi, Fac Med, Dept Internal Med 1, Yamanashi, Japan	University of Yamanashi; Toho University; Hoshi University; Okayama University; Hokkaido University; University of Yamanashi	Tsubuki, M (corresponding author), Hoshi Univ, Inst Med Chem, Ebara 2-4-41, Tokyo 142, Japan.	tsubuki@hoshi.ac.jp; kmoriishi@yamanashi.ac.jp	Maekawa, Shinya/AAF-1349-2019; Moriishi, Kohji/I-4173-2019; Yokoe, Hiromasa/ABC-8412-2020; Kasai, Hirotake/L-9668-2017	Moriishi, Kohji/0000-0002-9542-5188; Yokoe, Hiromasa/0000-0002-3326-7938; Kasai, Hirotake/0000-0002-5808-0803	Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [24659204] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Ministry of Health, Labor, and Welfare and from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed-Belkacem A, 2010, GASTROENTEROLOGY, V138, P1112, DOI 10.1053/j.gastro.2009.11.053; Bachmetov L, 2012, J VIRAL HEPATITIS, V19, pE81, DOI 10.1111/j.1365-2893.2011.01507.x; Baldo V, 2008, CURR PHARM DESIGN, V14, P1646, DOI 10.2174/138161208784746770; Boudreau LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031833; Bourne GT, 2001, J ORG CHEM, V66, P7706, DOI 10.1021/jo010580y; Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803; Chen MH, 2012, INT J MOL MED, V30, P1021, DOI 10.3892/ijmm.2012.1096; CHIAO C, 1995, CANCER RES, V55, P3576; FESEN MR, 1993, P NATL ACAD SCI USA, V90, P2399, DOI 10.1073/pnas.90.6.2399; Frese M, 2003, J GEN VIROL, V84, P1253, DOI 10.1099/vir.0.18997-0; Fujimoto Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048685; HIJIKATA M, 1991, P NATL ACAD SCI USA, V88, P5547, DOI 10.1073/pnas.88.13.5547; Ho CC, 2005, J ANTIMICROB CHEMOTH, V56, P372, DOI 10.1093/jac/dki244; Hofmann WP, 2011, NAT REV GASTRO HEPAT, V8, P257, DOI 10.1038/nrgastro.2011.49; Ikeda M, 2005, BIOCHEM BIOPH RES CO, V329, P1350, DOI 10.1016/j.bbrc.2005.02.138; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jin H, 2008, HEPATOL RES, V38, P909, DOI 10.1111/j.1872-034X.2008.00352.x; Kieffer TL, 2010, J ANTIMICROB CHEMOTH, V65, P202, DOI 10.1093/jac/dkp388; Kusano-Kitazume A, 2012, ANTIMICROB AGENTS CH, V56, P1315, DOI 10.1128/AAC.05764-11; Lee JC, 2011, J VIRAL HEPATITIS, V18, pE315, DOI 10.1111/j.1365-2893.2010.01424.x; Lee JC, 2011, ANTIVIR RES, V89, P35, DOI 10.1016/j.antiviral.2010.11.003; Lee KW, 2004, ANN NY ACAD SCI, V1030, P501, DOI 10.1196/annals.1329.062; Lee YJ, 2000, CANCER LETT, V153, P51, DOI 10.1016/S0304-3835(00)00389-X; Lee Y, 2010, EUR J PHARMACOL, V643, P21, DOI 10.1016/j.ejphar.2010.06.016; Li Y, 2003, AM J PATHOL, V163, P1167, DOI 10.1016/S0002-9440(10)63476-1; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Moriishi K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00054; Nagaoka T, 2002, BIOORGAN MED CHEM, V10, P3351, DOI 10.1016/S0968-0896(02)00138-4; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Nishimura-Sakurai Y, 2010, J GASTROENTEROL, V45, P523, DOI 10.1007/s00535-009-0162-3; Okamoto T, 2008, J VIROL, V82, P3480, DOI 10.1128/JVI.02253-07; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Takeshita M, 2009, J BIOL CHEM, V284, P21165, DOI 10.1074/jbc.M109.004945; Toyoda T, 2009, INT J CANCER, V125, P1786, DOI 10.1002/ijc.24586; Uwai K, 2008, BIOORGAN MED CHEM, V16, P7795, DOI 10.1016/j.bmc.2008.07.006; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yamashita A, 2012, MAR DRUGS, V10, P744, DOI 10.3390/md10040744; Yokota T, 2003, EMBO REP, V4, P602, DOI 10.1038/sj.embor.embor840; Zhang ZZ, 2010, J NAT PROD, V73, P252, DOI 10.1021/np900519d	41	29	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82299	10.1371/journal.pone.0082299	http://dx.doi.org/10.1371/journal.pone.0082299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358168	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700010
J	Suemizu, H; Kawai, K; Higuchi, Y; Hashimoto, H; Ogura, T; Itoh, T; Sasaki, E; Nakamura, M				Suemizu, Hiroshi; Kawai, Kenji; Higuchi, Yuichiro; Hashimoto, Haruo; Ogura, Tomoyuki; Itoh, Toshio; Sasaki, Erika; Nakamura, Masato			A Versatile Technique for the In Vivo Imaging of Human Tumor Xenografts Using Near-Infrared Fluorochrome-Conjugated Macromolecule Probes	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; NOG MICE; ORTHOTOPIC MODELS; LIVER METASTASIS; CANCER; PROTEINS; THERAPEUTICS; ENGRAFTMENT; EXPRESSION; ADVANTAGES	Here, we present a versatile method for detecting human tumor xenografts in vivo, based on the enhanced permeability and retention (EPR) effect, using near-infrared (NIR) fluorochrome-conjugated macromolecule probes. Bovine serum albumin (BSA) and two immunoglobulins-an anti-human leukocyte antigen (HLA) monoclonal antibody and isotype control IgG(2a)-were labeled with XenoLight CF770 fluorochrome and used as NIR-conjugated macromolecule probes to study whole-body imaging in a variety of xenotransplantation mouse models. NIR fluorescent signals were observed in subcutaneously transplanted BxPC-3 (human pancreatic cancer) cells and HCT 116 (colorectal cancer) cells within 24 h of NIR-macromolecule probe injection, but the signal from the fluorochrome itself or from the NIR-conjugated small molecule (glycine) injection was not observed. The accuracy of tumor targeting was confirmed by the localization of the NIR-conjugated immunoglobulin within the T-HCT 116 xenograft (in which the orange-red fluorescent protein tdTomato was stably expressed by HCT 116 cells) in the subcutaneous transplantation model. However, there was no significant difference in the NIR signal intensity of the region of interest between the anti-HLA antibody group and the isotype control group in the subcutaneous transplantation model. Therefore, the antibody accumulation within the tumor in vivo is based on the EPR effect. The liver metastasis generated by an intrasplenic injection of T-HCT 116 cells was clearly visualized by the NIR-conjugated anti-HLA probe but not by the orange-red fluorescent signal derived from the tdTomato reporter. This result demonstrated the superiority of the NIR probes over the tdTomato reporter protein at enhancing tissue penetration. In another xenograft model, patient-derived xenografts (PDX) of LC11-JCK (human non-small cell lung cancer) were successfully visualized using the NIR-conjugated macromolecule probe without any genetic modification. These results suggested that NIR-conjugated macromolecule, preferably, anti-HLA antibody probe is a valuable tool for the detection of human tumors in experimental metastasis models using whole-body imaging.	[Suemizu, Hiroshi; Higuchi, Yuichiro; Hashimoto, Haruo] Cent Inst Expt Anim, Biomed Res Dept, Kawasaki, Kanagawa, Japan; [Kawai, Kenji; Nakamura, Masato] Cent Inst Expt Anim, Dept Pathol Res, Kawasaki, Kanagawa, Japan; [Ogura, Tomoyuki] Cent Inst Expt Anim, Anim Resource Dept, Kawasaki, Kanagawa, Japan; [Itoh, Toshio] Cent Inst Expt Anim, Marmoset Res Dept, Kawasaki, Kanagawa, Japan; [Sasaki, Erika] Cent Inst Expt Anim, Dept Appl Dev Biol, Kawasaki, Kanagawa, Japan; [Nakamura, Masato] Tokai Univ, Sch Med, Dept Pathol & Regenerat Med, Isehara, Kanagawa 25911, Japan	Tokai University	Suemizu, H (corresponding author), Cent Inst Expt Anim, Biomed Res Dept, Kawasaki, Kanagawa, Japan.	suemizu@ciea.or.jp		Suemizu, Hiroshi/0000-0002-3706-2454	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [21240042]; MEXT of Japan	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	A part of this work was supported by a Grant-in-Aid for Scientific Research (21240042) to HS from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan: the Project for the Realization of Regenerative Medicine from MEXT of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MOUSE NEWS LETT; Bibby MC, 2004, EUR J CANCER, V40, P852, DOI 10.1016/j.ejca.2003.11.021; Bouvet M, 2000, CLIN EXP METASTAS, V18, P213, DOI 10.1023/A:1006767405609; Chang CJ, 2004, J IMMUNOL, V173, P6025, DOI 10.4049/jimmunol.173.10.6025; Concha A, 1991, Semin Cancer Biol, V2, P47; Deliolanis NC, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2967184; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; GIAVAZZI R, 1986, CANCER RES, V46, P1928; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Greish K, 2003, CLIN PHARMACOKINET, V42, P1089, DOI 10.2165/00003088-200342130-00002; Hamada K, 2008, INT J ONCOL, V32, P153; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Keereweer S, 2012, J SURG ONCOL, V105, P714, DOI 10.1002/jso.22102; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Luo SL, 2011, BIOMATERIALS, V32, P7127, DOI 10.1016/j.biomaterials.2011.06.024; Machida K, 2009, J TOXICOL SCI, V34, P123, DOI 10.2131/jts.34.123; Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Mizukami Y, 2008, BRIT J CANCER, V99, P1462, DOI 10.1038/sj.bjc.6604715; Moro M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/568567; Oshika Y, 1998, EUR J CANCER, V34, P1958, DOI 10.1016/S0959-8049(98)00236-6; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Suemizu H, 2007, INT J ONCOL, V31, P741; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Troy Tamara, 2004, Mol Imaging, V3, P9, DOI 10.1162/153535004773861688; Vora AR, 1997, BRIT J CANCER, V76, P836, DOI 10.1038/bjc.1997.472; Zhang Xuan, 2012, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1227s60	29	5	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82708	10.1371/journal.pone.0082708	http://dx.doi.org/10.1371/journal.pone.0082708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358218	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700026
J	Twomey, KB; Alston, M; An, SQ; O'Connell, OJ; McCarthy, Y; Swarbreck, D; Febrer, M; Dow, JM; Plant, BJ; Ryan, RP				Twomey, Kate B.; Alston, Mark; An, Shi-Qi; O'Connell, Oisin J.; McCarthy, Yvonne; Swarbreck, David; Febrer, Melanie; Dow, J. Maxwell; Plant, Barry J.; Ryan, Robert P.			Microbiota and Metabolite Profiling Reveal Specific Alterations in Bacterial Community Structure and Environment in the Cystic Fibrosis Airway during Exacerbation	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; PSEUDOMONAS-AERUGINOSA; LUNG INFECTIONS; SPUTUM; PATHOGENESIS; BIOMARKERS; TOLERANCE; DIVERSITY	Chronic polymicrobial infections of the lung are the foremost cause of morbidity and mortality in cystic fibrosis (CF) patients. The composition of the microbial flora of the airway alters considerably during infection, particularly during patient exacerbation. An understanding of which organisms are growing, their environment and their behaviour in the airway is of importance for designing antibiotic treatment regimes and for patient prognosis. To this end, we have analysed sputum samples taken from separate cohorts of CF and non-CF subjects for metabolites and in parallel, and we have examined both isolated DNA and RNA for the presence of 16S rRNA genes and transcripts by high-throughput sequencing of amplicon or cDNA libraries. This analysis revealed that although the population size of all dominant orders of bacteria as measured by DNA-and RNA-based methods are similar, greater discrepancies are seen with less prevalent organisms, some of which we associated with CF for the first time. Additionally, we identified a strong relationship between the abundance of specific anaerobes and fluctuations in several metabolites including lactate and putrescine during patient exacerbation. This study has hence identified organisms whose occurrence within the CF microbiome has been hitherto unreported and has revealed potential metabolic biomarkers for exacerbation.	[Twomey, Kate B.; McCarthy, Yvonne; Dow, J. Maxwell; Ryan, Robert P.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Biosci Inst, Cork, Ireland; [Alston, Mark; Swarbreck, David; Febrer, Melanie] Genome Anal Ctr, Norwich, Norfolk, England; [An, Shi-Qi; Ryan, Robert P.] Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee, Scotland; [O'Connell, Oisin J.; Plant, Barry J.] Natl Univ Ireland Univ Coll Cork, Cork Univ Hosp, Dept Resp Med, Cork Adult Cyst Fibrosis Ctr, Cork, Ireland; [Febrer, Melanie] Univ Dundee, Coll Life Sci, Div Mol Med, Genom Sequencing Unit, Dundee, Scotland	University College Cork; The Genome Analysis Centre (TGAC); University of Dundee; University College Cork; University of Dundee	Ryan, RP (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Biosci Inst, Cork, Ireland.	rpryan@dundee.ac.uk		Alston, Mark/0000-0002-1645-3982; Dow, Max/0000-0001-8245-2294; Swarbreck, David/0000-0002-5453-1013; Ryan, Rober/0000-0002-7353-0913; An, Shi-qi/0000-0002-2593-9642	Wellcome Trust [100204] Funding Source: Medline; BBSRC [BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bai GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036934; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Eschbach M, 2004, J BACTERIOL, V186, P4596, DOI 10.1128/JB.186.14.4596-4604.2004; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Galperin MY, 2008, ENVIRON MICROBIOL, V10, P3187, DOI 10.1111/j.1462-2920.2008.01811.x; Grasemann H, 2012, CURR PHARM DESIGN, V18, P726, DOI 10.2174/138161212799315911; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hoffman LR, 2013, CHEST, V143, P207, DOI 10.1378/chest.12-1639; Hoffman LR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000712; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Johnson L, 2012, J BACTERIOL, V194, P813, DOI 10.1128/JB.05230-11; Kang SH, 2013, J APPL MICROBIOL, V115, P644, DOI 10.1111/jam.12270; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Macy JM, 1996, INT J SYST BACTERIOL, V46, P1153, DOI 10.1099/00207713-46-4-1153; Oksanen J, 2009, ORDINATION ANAL DISS; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Pamp SJ, 2008, MOL MICROBIOL, V68, P223, DOI 10.1111/j.1365-2958.2008.06152.x; Petrova OE, 2012, MOL MICROBIOL, V86, P819, DOI 10.1111/mmi.12018; Rabin HR, 2012, CURR OPIN PULM MED, V18, P622, DOI 10.1097/MCP.0b013e328358d49a; Rauschenbach I, 2011, INT J SYST EVOL MICR, V61, P654, DOI 10.1099/ijs.0.022392-0; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2010, EXPERT REV MOL DIAGN, V10, P187, DOI 10.1586/ERM.09.81; Rogers GB, 2009, J MED MICROBIOL, V58, P1401, DOI 10.1099/jmm.0.013334-0; Ryan RP, 2008, MOL MICROBIOL, V68, P75, DOI 10.1111/j.1365-2958.2008.06132.x; Ryan RP, 2011, TRENDS MICROBIOL, V19, P145, DOI 10.1016/j.tim.2010.12.003; Sibley CD, 2009, CURR OPIN INVEST DR, V10, P787; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; Stressmann FA, 2011, J CYST FIBROS, V10, P357, DOI 10.1016/j.jcf.2011.05.002; Tunney MM, 2011, THORAX, V66, P579, DOI 10.1136/thx.2010.137281; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Twomey KB, 2012, ISME J, V6, P939, DOI 10.1038/ismej.2011.167; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Wetmore DR, 2010, J BIOL CHEM, V285, P30516, DOI 10.1074/jbc.M110.140806; Wolak JE, 2009, BIOMARKERS, V14, P55, DOI 10.1080/13547500802688194; Wold S., 1994, METHODS PRINCIPLES M; Wold S., 1993, 3D QSAR DRUG DESIGN, P523, DOI DOI 10.1007/0-306-46858-1; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Yang J, 2012, FREE RADICAL BIO MED, V53, P160, DOI 10.1016/j.freeradbiomed.2012.05.001; Zink KG, 2004, ANAL BIOANAL CHEM, V380, P798, DOI 10.1007/s00216-004-2828-2	43	50	50	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82432	10.1371/journal.pone.0082432	http://dx.doi.org/10.1371/journal.pone.0082432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358183	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000328737700016
J	Chung, SJ; Kwon, H; Lee, DK; Hong, JY; Sunwoo, MK; Sohn, YH; Lee, JM; Lee, PH				Chung, Seok Jong; Kwon, Hunki; Lee, Dong-Kyun; Hong, Jin Yong; Sunwoo, Mun-Kyung; Sohn, Young H.; Lee, Jong-Min; Lee, Phil Hyu			Neuroanatomical Heterogeneity of Essential Tremor According to Propranolol Response	PLOS ONE			English	Article							BETA-ADRENORECEPTOR MECHANISMS; AUTOMATED 3-D EXTRACTION; VOXEL-BASED MORPHOMETRY; LOCUS-COERULEUS; CEREBELLAR DYSFUNCTION; SPATIAL STATISTICS; ALZHEIMERS-DISEASE; CORTICAL THICKNESS; CEREBRAL-CORTEX; DOUBLE-BLIND	Background: Recent studies have suggested that essential tremor (ET) is a more complex and heterogeneous clinical entity than initially thought. In the present study, we assessed the pattern of cortical thickness and diffusion tensor white matter (WM) changes in patients with ET according to the response to propranolol to explore the pathogenesis underlying the clinical heterogeneity of ET. Methods: A total of 32 patients with drug naive ET were recruited prospectively from the Movement Disorders outpatient clinic. The patients were divided into a propranolol-responder group (n = 18) and a non-responder group (n = 14). We analyzed the pattern of cortical thickness and diffusion tensor WM changes between these two groups and performed correlation analysis between imaging and clinical parameters. Results: There were no significant differences in demographic characteristics, general cognition, or results of detailed neuropsychological tests between the groups. The non-responder group showed more severe cortical atrophy in the left orbitofrontal cortex and right temporal cortex relative to responders. However, the responders exhibited significantly lower fractional anisotropy values in the bilateral frontal, corpus callosal, and right parietotemporal WM compared with the non-responder group. There were no significant clusters where the cortical thickness or WM alterations were significantly correlated with initial tremor severity or disease duration. Conclusions: The present data suggest that patients with ET have heterogeneous cortical thinning and WM alteration with respect to responsiveness to propranolol, suggesting that propranolol responsiveness may be a predictive factor to determine ET subtypes in terms of neuroanatomical heterogeneity.	[Chung, Seok Jong; Sunwoo, Mun-Kyung; Sohn, Young H.; Lee, Phil Hyu] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Kwon, Hunki; Lee, Dong-Kyun; Lee, Jong-Min] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea; [Hong, Jin Yong] Yonsei Univ, Wonju Coll Med, Dept Neurol, Wonju, South Korea	Yonsei University; Yonsei University Health System; Hanyang University; Yonsei University	Lee, PH (corresponding author), Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea.	phisland@chol.net		Sohn, Young H./0000-0001-6533-2610; Hong, Jin Yong/0000-0002-2476-3737; Chung, Seok Jong/0000-0001-6086-3199; Lee, Phil Hyu/0000-0001-9931-8462	Korea Healthcare technology RD Project; Ministry for Health, Welfare and Family Affairs, Republic of Korea [A091159]	Korea Healthcare technology RD Project; Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A091159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2010, J KOREAN MED SCI, V25, P1071, DOI 10.3346/jkms.2010.25.7.1071; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Axelrad JE, 2008, ARCH NEUROL-CHICAGO, V65, P101, DOI 10.1001/archneurol.2007.8; Baker MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049088; Benito-Leon J, 2006, NEUROLOGY, V66, P69, DOI 10.1212/01.wnl.0000192393.05850.ec; Benito-Leon J, 2009, J NEUROL SCI, V287, P138, DOI 10.1016/j.jns.2009.08.037; CALZETTI S, 1981, J NEUROL NEUROSUR PS, V44, P814, DOI 10.1136/jnnp.44.9.814; Cerasa A, 2009, AM J NEURORADIOL, V30, P1240, DOI 10.3174/ajnr.A1544; CLEEVES L, 1984, J NEUROL NEUROSUR PS, V47, P976, DOI 10.1136/jnnp.47.9.976; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563; DAVIS CH, 1951, ARCH INTERN MED, V87, P808, DOI 10.1001/archinte.1951.03810060035004; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; Elble RJ, 2002, MOVEMENT DISORD, V17, P633, DOI 10.1002/mds.10222; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Helmchen C, 2003, BRAIN, V126, P1319, DOI 10.1093/brain/awg132; HOFFER BJ, 1973, J PHARMACOL EXP THER, V184, P553; Hoshi E, 2005, NAT NEUROSCI, V8, P1491, DOI 10.1038/nn1544; Ichinohe N, 2000, BRAIN RES, V880, P191, DOI 10.1016/S0006-8993(00)02744-X; JEFFERSON D, 1979, J NEUROL NEUROSUR PS, V42, P904, DOI 10.1136/jnnp.42.10.904; JENKINS IH, 1993, ANN NEUROL, V34, P82, DOI 10.1002/ana.410340115; Kang Y., 1997, J KOREAN NEUROL ASS, V15, P300; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Klein JC, 2011, HUM BRAIN MAPP, V32, P896, DOI 10.1002/hbm.21077; Kolasiewicz W, 2011, CEREBELLUM, V10, P267, DOI 10.1007/s12311-011-0250-9; KOLLER WC, 1989, NEUROLOGY, V39, P1587, DOI 10.1212/WNL.39.12.1587; KOLLER WC, 1986, ARCH NEUROL-CHICAGO, V43, P42, DOI 10.1001/archneur.1986.00520010038018; Koster B, 2002, J NEUROL NEUROSUR PS, V73, P400, DOI 10.1136/jnnp.73.4.400; Lee JE, 2010, J NEUROL NEUROSUR PS, V81, P320, DOI 10.1136/jnnp.2009.184747; Lee KS, 2003, PARKINSONISM RELAT D, V9, P341, DOI 10.1016/S1353-8020(03)00029-4; LEIGH PN, 1983, J NEUROL NEUROSUR PS, V46, P710, DOI 10.1136/jnnp.46.8.710; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Liu J, 2011, J NEUROIMAGING, V21, P370, DOI 10.1111/j.1552-6569.2010.00535.x; Louis ED, 2002, NEUROLOGY, V59, P1631, DOI 10.1212/01.WNL.0000033798.85208.F2; Louis ED, 2007, BRAIN, V130, P3297, DOI 10.1093/brain/awm266; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Morita S, 2005, PARKINSONISM RELAT D, V11, P101, DOI 10.1016/j.parkreldis.2004.09.004; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; NICHOLAS AP, 1993, NEUROSCIENCE, V56, P1023, DOI 10.1016/0306-4522(93)90148-9; Nicoletti G, 2010, NEUROLOGY, V74, P988, DOI 10.1212/WNL.0b013e3181d5a460; Quattrone A, 2008, AM J NEURORADIOL, V29, P1692, DOI 10.3174/ajnr.A1190; Saini J, 2012, PARKINSONISM RELAT D, V18, P477, DOI 10.1016/j.parkreldis.2012.01.006; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; Shill HA, 2008, NEUROLOGY, V70, P1452, DOI 10.1212/01.wnl.0000310425.76205.02; Shin DH, 2008, AM J NEURORADIOL, V29, P151, DOI 10.3174/ajnr.A0744; Singh V, 2006, BRAIN, V129, P2885, DOI 10.1093/brain/awl256; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stacy MA, 2007, MOVEMENT DISORD, V22, P833, DOI 10.1002/mds.21412; Suemaru K, 1997, N-S ARCH PHARMACOL, V355, P571, DOI 10.1007/PL00004985; Troster AI, 2002, EUR J NEUROL, V9, P143; Voogd J, 1998, TRENDS COGN SCI, V2, P307, DOI 10.1016/S1364-6613(98)01210-8; Worsley KJ, 2004, NEUROIMAGE, V23, pS189, DOI 10.1016/j.neuroimage.2004.07.026; YAMAZAKI M, 1979, PHARMACOL BIOCHEM BE, V10, P421, DOI 10.1016/0091-3057(79)90207-7; YOUNG RR, 1975, NEW ENGL J MED, V293, P950, DOI 10.1056/NEJM197511062931902; Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283	60	10	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84054	10.1371/journal.pone.0084054	http://dx.doi.org/10.1371/journal.pone.0084054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358327	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700149
J	Diez-del-Molino, D; Carmona-Catot, G; Araguas, RM; Vidal, O; Sanz, N; Garcia-Berthou, E; Garcia-Marin, JL				Diez-del-Molino, David; Carmona-Catot, Gerard; Araguas, Rosa-Maria; Vidal, Oriol; Sanz, Nuria; Garcia-Berthou, Emili; Garcia-Marin, Jose-Luis			Gene Flow and Maintenance of Genetic Diversity in Invasive Mosquitofish (Gambusia holbrooki)	PLOS ONE			English	Article							INTRODUCED EASTERN MOSQUITOFISH; GUPPIES POECILIA-RETICULATA; LIFE-HISTORY TRAITS; FRESH-WATER FISH; COMPUTER-PROGRAM; POPULATIONS; SUCCESS; BIOLOGY; SOFTWARE; DIFFERENTIATION	Genetic analyses contribute to studies of biological invasions by mapping the origin and dispersal patterns of invasive species occupying new territories. Using microsatellite loci, we assessed the genetic diversity and spatial population structure of mosquitofish (Gambusia holbrooki) that had invaded Spanish watersheds, along with the American locations close to the suspected potential source populations. Mosquitofish populations from the Spanish streams that were studied had similar levels of genetic diversity to the American samples; therefore, these populations did not appear to have undergone substantial losses of genetic diversity during the invasion process. Population structure analyses indicated that the Spanish populations fell into four main clusters, which were primarily associated with hydrography. Dispersal patterns indicated that local populations were highly connected upstream and downstream through active dispersal, with an average of 21.5% fish from other locations in each population. After initially introducing fish to one location in a given basin, such dispersal potential might contribute to the spread and colonization of suitable habitats throughout the entire river basin. The two-dimension isolation-by-distance pattern here obtained, indicated that the human-mediated translocation of mosquitofish among the three study basins is a regular occurrence. Overall, both phenomena, high natural dispersal and human translocation, favor gene flow among river basins and the retention of high genetic diversity, which might help retain the invasive potential of mosquitofish populations.	[Diez-del-Molino, David; Araguas, Rosa-Maria; Vidal, Oriol; Sanz, Nuria; Garcia-Marin, Jose-Luis] Univ Girona, Dept Biol, Lab Ictiol Genet, Girona, Spain; [Carmona-Catot, Gerard; Garcia-Berthou, Emili] Univ Girona, Dept Biol, Inst Ecol Aquat, Girona, Spain	Universitat de Girona; Universitat de Girona	Diez-del-Molino, D (corresponding author), Univ Girona, Dept Biol, Lab Ictiol Genet, Girona, Spain.	david.diez@udg.edu	Diez-del-Molino, David/ABC-3313-2020; Sanz, Nuria/L-3074-2014; Araguas, Rosa M./L-3073-2014; Vidal, Oriol/C-8973-2009; García-Berthou, Emili/A-5392-2008; Garcia-Marin, Jose-Luis/B-9597-2009	Diez-del-Molino, David/0000-0002-9701-5940; Sanz, Nuria/0000-0001-5274-1917; Araguas, Rosa M./0000-0001-6306-2282; Vidal, Oriol/0000-0002-8197-1567; García-Berthou, Emili/0000-0001-8412-741X; Garcia-Marin, Jose-Luis/0000-0001-9976-5211	Spanish Ministry of Economy and Competitiveness (MINECO); University of Girona (UdG)	Spanish Ministry of Economy and Competitiveness (MINECO); University of Girona (UdG)	Financial support from the Spanish Ministry of Economy and Competitiveness (MINECO) and the University of Girona (UdG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz C, 2008, OECOLOGIA, V155, P205, DOI 10.1007/s00442-007-0899-4; Alemadi SD, 2008, BIOL INVASIONS, V10, P59, DOI 10.1007/s10530-007-9109-x; Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; Araguas RM, 2007, ECOL FRESHW FISH, V16, P257, DOI 10.1111/j.1600-0633.2006.00217.x; Araguas RM, 2012, FRESHWATER BIOL, V57, P143, DOI 10.1111/j.1365-2427.2011.02705.x; Ayres RM, 2010, BIOL INVASIONS, V12, P3727, DOI 10.1007/s10530-010-9766-z; Barson NJ, 2009, J EVOLUTION BIOL, V22, P485, DOI 10.1111/j.1420-9101.2008.01675.x; Blanchet S, 2012, FISHERIES MANAG ECOL, V19, P120, DOI 10.1111/j.1365-2400.2011.00832.x; Boix D, 2008, HYDROBIOLOGIA, V597, P53, DOI 10.1007/s10750-007-9221-z; Carmona-Catot G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054734; Carmona-Catot G, 2011, DIVERS DISTRIB, V17, P214, DOI 10.1111/j.1472-4642.2011.00743.x; Chapman P, 2006, ECOL FRESHW FISH, V15, P357, DOI 10.1111/j.1600-0633.2006.00145.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Clavero M, 2009, ECOL FRESHW FISH, V18, P550, DOI 10.1111/j.1600-0633.2009.00369.x; CONGDON BC, 1995, COPEIA, P162, DOI 10.2307/1446811; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Courtenay W.R. Jr, 1989, P319; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Echelle A, 1989, ECOLOGY EVOLUTION LI, V1991, P217; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fernandez-Astasio B, 2002, THESIS U COMPLUTENSE; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Frankham R, 2010, BIOL CONSERV, V143, P1919, DOI 10.1016/j.biocon.2010.05.011; Garcia-Berthou E, 2000, ARCH HYDROBIOL, V149, P271; Garcia-Berthou E, 2005, CAN J FISH AQUAT SCI, V62, P453, DOI 10.1139/F05-017; GARCIAMARIN JL, 1991, AQUACULTURE, V95, P235, DOI 10.1016/0044-8486(91)90090-T; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Gozlan RE, 2010, J FISH BIOL, V76, P751, DOI 10.1111/j.1095-8649.2010.02566.x; Grapputo A, 2006, ITAL J ZOOL, V73, P67, DOI 10.1080/11250000500502111; Hanfling B, 2007, J FISH BIOL, V71, P115, DOI 10.1111/j.1095-8649.2007.01685.x; Hardie DC, 2010, ENVIRON REV, V18, P1, DOI 10.1139/A09-014; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HERNANDEZMARTICH JD, 1990, COPEIA, P619; HernandezMartich JD, 1997, HEREDITY, V79, P295, DOI 10.1038/hdy.1997.157; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Keller SR, 2010, J EVOLUTION BIOL, V23, P1720, DOI 10.1111/j.1420-9101.2010.02037.x; KENNEDY PK, 1986, COPEIA, P937, DOI 10.2307/1445290; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; KRUMHOLZ LA, 1948, ECOL MONOGR, V18, P1, DOI 10.2307/1948627; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; LEBERG PL, 1992, EVOLUTION, V46, P477, DOI 10.1111/j.1558-5646.1992.tb02053.x; Lee CE, 2008, EVOL APPL, V1, P427, DOI 10.1111/j.1752-4571.2008.00039.x; Levine JM, 2008, CURR BIOL, V18, pR57, DOI 10.1016/j.cub.2007.11.030; Lindholm AK, 2005, MOL ECOL, V14, P3671, DOI 10.1111/j.1365-294X.2005.02697.x; Lintermans M, 2004, NEW ZEAL J MAR FRESH, V38, P481, DOI 10.1080/00288330.2004.9517255; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Lowe S., 2000, ENCY BIOL INVASIONS; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; MCCLENAGHAN LR, 1985, EVOLUTION, V39, P451, DOI [10.1111/j.1558-5646.1985.tb05681.x, 10.2307/2408377]; McElroy TC, 2011, J HERED, V102, P678, DOI 10.1093/jhered/esr088; Najera L, 1944, B REAL SOC ESP HIST, V42, P51; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Pyke GH, 2008, ANNU REV ECOL EVOL S, V39, P171, DOI 10.1146/annurev.ecolsys.39.110707.173451; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Ribeiro F, 2008, BIOL INVASIONS, V10, P89, DOI 10.1007/s10530-007-9112-2; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rincon PA, 2002, J FISH BIOL, V61, P1560, DOI 10.1006/jfbi.2002.2175; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Rousset F, 1997, GENETICS, V145, P1219; Sanz N, 2013, BIOL INVASIONS, V15, P2333, DOI 10.1007/s10530-013-0456-5; SCRIBNER KT, 1993, MOL ECOL, V2, P139, DOI 10.1111/j.1365-294X.1993.tb00103.x; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Smith M.H., 1989, P235; SMITH MW, 1983, COPEIA, P182; Spencer CC, 2000, MOL ECOL, V9, P1517, DOI 10.1046/j.1365-294x.2000.01031.x; Stepien CA, 2005, RISK ANAL, V25, P1043, DOI 10.1111/j.1539-6924.2005.00655.x; Suarez AV, 2008, MOL ECOL, V17, P351, DOI 10.1111/j.1365-294X.2007.03456.x; Trigo RM, 2004, INT J CLIMATOL, V24, P925, DOI 10.1002/joc.1048; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vidal O, 2012, ECOL FRESHW FISH, V21, P100, DOI 10.1111/j.1600-0633.2011.00527.x; Vidal O, 2010, BIOL INVASIONS, V12, P841, DOI 10.1007/s10530-009-9505-5; Wilson GA, 2003, GENETICS, V163, P1177; Zane L, 1999, J EVOLUTION BIOL, V12, P61, DOI 10.1046/j.1420-9101.1999.00006.x	78	26	27	4	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82501	10.1371/journal.pone.0082501	http://dx.doi.org/10.1371/journal.pone.0082501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358194	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700073
J	Hart, SN; Sarangi, V; Moore, R; Baheti, S; Bhavsar, JD; Couch, FJ; Kocher, JPA				Hart, Steven N.; Sarangi, Vivekananda; Moore, Raymond; Baheti, Saurabh; Bhavsar, Jaysheel D.; Couch, Fergus J.; Kocher, Jean-Pierre A.			SoftSearch: Integration of Multiple Sequence Features to Identify Breakpoints of Structural Variations	PLOS ONE			English	Article							LARGE GENOMIC DELETIONS; BRCA1; REARRANGEMENTS; MUTATIONS; FAMILIES; GENE	Background: Structural variation (SV) represents a significant, yet poorly understood contribution to an individual's genetic makeup. Advanced next-generation sequencing technologies are widely used to discover such variations, but there is no single detection tool that is considered a community standard. In an attempt to fulfil this need, we developed an algorithm, SoftSearch, for discovering structural variant breakpoints in Illumina paired-end next-generation sequencing data. SoftSearch combines multiple strategies for detecting SV including split-read, discordant read-pair, and unmated pairs. Co-localized split-reads and discordant read pairs are used to refine the breakpoints. Results: We developed and validated SoftSearch using real and synthetic datasets. SoftSearch's key features are 1) not requiring secondary (or exhaustive primary) alignment, 2) portability into established sequencing workflows, and 3) is applicable to any DNA-sequencing experiment (e. g. whole genome, exome, custom capture, etc.). SoftSearch identifies breakpoints from a small number of soft-clipped bases from split reads and a few discordant read-pairs which on their own would not be sufficient to make an SV call. Conclusions: We show that SoftSearch can identify more true SVs by combining multiple sequence features. SoftSearch was able to call clinically relevant SVs in the BRCA2 gene not reported by other tools while offering significantly improved overall performance.	[Hart, Steven N.; Sarangi, Vivekananda; Moore, Raymond; Baheti, Saurabh; Bhavsar, Jaysheel D.; Kocher, Jean-Pierre A.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Div Expt Pathol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Kocher, JPA (corresponding author), Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA.	kocher.jeanpierre@mayo.edu	Hart, Steven/AAI-4761-2021	Hart, Steven/0000-0001-7714-2734; Moore, Raymond/0000-0003-4196-1804				Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Agata S, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.032789; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Hogervorst FBL, 2003, CANCER RES, V63, P1449; Jiang Y, 2012, BIOINFORMATICS; Karakoc E, 2012, NAT METHODS, V9, P176, DOI [10.1038/NMETH.1810, 10.1038/nmeth.1810]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Montagna M, 2003, HUM MOL GENET, V12, P1055, DOI 10.1093/hmg/ddg120; Palma MD, 2008, CANCER RES, V68, P7006, DOI 10.1158/0008-5472.CAN-08-0599; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Woodward AM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.027961; Xi RB, 2010, BRIEF FUNCT GENOMICS, V9, P405, DOI 10.1093/bfgp/elq025; Zhang J, 2011, BIOINFORMATICS, V27, P3228, DOI 10.1093/bioinformatics/btr563	18	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83356	10.1371/journal.pone.0083356	http://dx.doi.org/10.1371/journal.pone.0083356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358278	Green Submitted, gold, Green Published			2022-12-27	WOS:000328735700121
J	Islas, AA; Sanchez-Solano, A; Scior, T; Millan-PerezPena, L; Salinas-Stefanon, EM				Islas, Angel A.; Sanchez-Solano, Alfredo; Scior, Thomas; Millan-PerezPena, Lourdes; Salinas-Stefanon, Eduardo M.			Identification of Nav beta 1 Residues Involved in the Modulation of the Sodium Channel Nav1.4	PLOS ONE			English	Article							BETA(1) SUBUNIT; BETA-1 SUBUNIT; GENERALIZED EPILEPSY; DISULFIDE BOND; BETA-1-SUBUNIT; INACTIVATION; EXPRESSION; MUSCLE; DOMAIN; SERVER	Voltage-gated sodium channels (VGSCs) are heteromeric protein complexes that initiate action potentials in excitable cells. The voltage-gated sodium channel accessory subunit, Nav beta 1, allosterically modulates the alpha subunit pore structure upon binding. To date, the molecular determinants of the interface remain unknown. We made use of sequence, knowledge and structure-based methods to identify residues critical to the association of the alpha and beta 1 Nav1.4 subunits. The Nav beta 1 point mutant C43A disrupted the modulation of voltage dependence of activation and inactivation and delayed the peak current decay, the recovery from inactivation, and induced a use-dependent decay upon depolarisation at 1 Hz. The Nav beta 1 mutant R89A selectively delayed channel inactivation and recovery from inactivation and had no effect on voltage dependence or repetitive depolarisations. Nav beta 1 mutants Y32A and G33M selectively modified the half voltage of inactivation without altering the kinetics. Despite low sequence identity, highly conserved structural elements were identified. Our models	[Islas, Angel A.; Sanchez-Solano, Alfredo; Salinas-Stefanon, Eduardo M.] Univ Autonoma Puebla, Lab Biofis, Inst Fisiol, Puebla 72570, Mexico; [Scior, Thomas] Univ Autonoma Puebla, Fac Ciencias Quim, Puebla 72570, Mexico; [Millan-PerezPena, Lourdes] Univ Autonoma Puebla, Ctr Quim, Inst Ciencias, Puebla 72570, Mexico	Benemerita Universidad Autonoma de Puebla; Benemerita Universidad Autonoma de Puebla; Benemerita Universidad Autonoma de Puebla	Salinas-Stefanon, EM (corresponding author), Univ Autonoma Puebla, Lab Biofis, Inst Fisiol, Puebla 72570, Mexico.	eduardo.salinas@correo.buap.mx	Thomas, alias Tom Scior/AAM-9189-2020	Thomas, alias Tom Scior/0000-0003-2196-2682; , ALFREDO/0000-0002-8218-256X; Islas, Angel A/0000-0002-6322-1295; Sanchez-Solano, Alfredo/0000-0002-4323-7361	Conacyt [48294]; UAP-VIEP [SAL08-G]; PIFI;  [239388];  [226507]	Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UAP-VIEP; PIFI; ; 	This paper was supported by a grant from Conacyt # 48294, UAP-VIEP # SAL08-G and PIFI to EMSS. This work was submitted in partial fulfilment of the requirements for the PhD degree of Angel Islas. Scholarship to AI Conacyt # 239388, AS Conacyt # 226507. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri R, 2012, BIOCHEM BIOPH RES CO, V420, P364, DOI 10.1016/j.bbrc.2012.02.163; BENNETT PB, 1993, FEBS LETT, V326, P21, DOI 10.1016/0014-5793(93)81752-L; Brackenbury WJ, 2008, EXPERT OPIN THER TAR, V12, P1191, DOI 10.1517/14728222.12.9.1191 ; Brackenbury WJ, 2011, FRONT PHARM, V28, P2; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Chen CF, 1995, PFLUG ARCH EUR J PHY, V431, P186, DOI 10.1007/BF00410190; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; Makita N, 1996, J NEUROSCI, V16, P7117; McCormick KA, 1999, J BIOL CHEM, V274, P32638, DOI 10.1074/jbc.274.46.32638; Meadows LS, 2002, J NEUROSCI, V22, P10699; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Moran O, 2000, FEBS LETT, V473, P132, DOI 10.1016/S0014-5793(00)01518-0; Nguyen HM, 2012, P NATL ACAD SCI USA, V109, P18577, DOI 10.1073/pnas.1209142109; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; O'Reilly AO, 2008, MOL MEMBR BIOL, V25, P670, DOI 10.1080/09687680802508754; Ofran Y, 2007, PLOS COMPUT BIOL, V3, P1169, DOI 10.1371/journal.pcbi.0030119; Orta-Salazar G, 2004, THESIS; Patino GA, 2010, NEUROSCI LETT, V486, P53, DOI 10.1016/j.neulet.2010.06.050; PATTON DE, 1994, J BIOL CHEM, V269, P17649; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Qu YS, 1999, J BIOL CHEM, V274, P32647, DOI 10.1074/jbc.274.46.32647; Scior T, 2007, DRUG DESIGN RES PERS, P675; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Snider C, 2009, PROTEIN SCI, V18, P2624, DOI 10.1002/pro.256; Valencia A, 2006, METHOD BIOCHEM ANAL, V44, P411; Watanabe H, 2008, J CLIN INVEST, V118, P2260, DOI [10.1172/JC133891, 10.1172/JCI33891]; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999; Xu R, 2007, NEUROSCIENCE, V148, P164, DOI 10.1016/j.neuroscience.2007.05.038; Yereddi NR, 2013, FASEB J, V27, P568, DOI 10.1096/fj.12-209445; Yu EJ, 2005, BIOCHEM J, V392, P519, DOI 10.1042/BJ20050518; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zimmer T, 2002, J GEN PHYSIOL, V120, P887, DOI 10.1085/jgp.20028703	39	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81995	10.1371/journal.pone.0081995	http://dx.doi.org/10.1371/journal.pone.0081995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358138	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700031
J	Li, Y; Liu, H; Sato, Y				Li, Ying; Liu, Hua; Sato, Yasuto			The Association between the Serum C-Peptide Level and Bone Mineral Density	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; INSULIN-SECRETION; BODY-COMPOSITION; OSTEOPOROTIC FRACTURES; FAT MASS; WOMEN; CLEARANCE; TURNOVER; CELLS; AGE	Objective: Although serum C-peptide was previously considered biologically inactive, a growing number of recent studies have shown that it is an active peptide with important physiologic functions. The present study aimed to investigate the association of serum C-peptide level with bone mineral density (BMD) in residents of the United States. Methods: The study included 6,625 participants aged 12-85 years. Total and regional BMD were measured using dual-energy X-ray absorptiometry. Stratified multiple linear regression analysis was performed to determine the association of the serum C-peptide level with BMD. Three regression models were produced for each stratum. All models were adjusted for ethnicity, height, weight, education level, physical activity, smoking status, alcohol use, triglycerides and creatinine level, and models 2 and 3 were further adjusted for the fasting plasma glucose (FPG) and alkaline phosphatase (ALP) levels, respectively. Results: Sex-specific results showed a significant association between the serum C-peptide level and total BMD in both sexes. Stratified analyses based on age and body mass index showed that serum C-peptide levels were significantly negatively associated with most regional BMD, and most of these associations remained significant after stratification based on the serum insulin level. Conclusion: The serum C-peptide level was significantly negatively associated with the total and most regional BMD. These findings suggest that serum C-peptide may have biological activity associated with bone metabolism and therefore serum C-peptide control is advisable in order to reduce the risk of low bone mineral density.	[Li, Ying] Zhejiang Univ, Dept Social Med, Sch Publ Hlth, Hangzhou, Zhejiang, Peoples R China; [Liu, Hua] Zhejiang Univ, Sch Basic Med Sci, Hangzhou, Zhejiang, Peoples R China; [Sato, Yasuto] Tokyo Womens Med Univ, Dept Hyg & Publ Hlth 2, Tokyo, Japan	Zhejiang University; Zhejiang University; Tokyo Women's Medical University	Li, Y (corresponding author), Zhejiang Univ, Dept Social Med, Sch Publ Hlth, Hangzhou, Zhejiang, Peoples R China.	ying_li@zju.edu.cn		Liu, Hua/0000-0001-7729-1246				Abrahamsen B, 2000, DIABETIC MED, V17, P124, DOI 10.1046/j.1464-5491.2000.00234.x; Adams CS, 2001, J BIOL CHEM, V276, P20316, DOI 10.1074/jbc.M006492200; Basu R, 2003, DIABETES, V52, P1738, DOI 10.2337/diabetes.52.7.1738; Basu R, 2006, DIABETES, V55, P2001, DOI 10.2337/db05-1692; BOUILLON R, 1991, CALCIFIED TISSUE INT, V49, P155, DOI 10.1007/BF02556109; Centers for Disease Control and Prevention, NHANES AN REP GUID N; Centers for Disease Control and Prevention, LAB PROC MAN C PEPT; COOPER C, 1993, AM J EPIDEMIOL, V137, P1001, DOI 10.1093/oxfordjournals.aje.a116756; DUMOUCHEL WH, 1983, J AM STAT ASSOC, V78, P535, DOI 10.2307/2288115; Espallargues M, 2001, OSTEOPOROSIS INT, V12, P811, DOI 10.1007/s001980170031; FINK RI, 1985, DIABETES, V34, P275, DOI 10.2337/diabetes.34.3.275; Fukunaga Y, 1997, ARCH INTERN MED, V157, P2668; GALLACHER SJ, 1993, DIABETIC MED, V10, P129, DOI 10.1111/j.1464-5491.1993.tb00029.x; Gnudi S, 2007, J BONE MINER METAB, V25, P326, DOI 10.1007/s00774-007-0758-8; GUMBINER B, 1989, DIABETES, V38, P1549, DOI 10.2337/diabetes.38.12.1549; HAKEDA Y, 1991, Acta Anatomica Nipponica, V66, P215; HOOGWERF BJ, 1983, J CLIN ENDOCR METAB, V56, P60, DOI 10.1210/jcem-56-1-60; Hsu CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055625; Hsu YH, 2006, AM J CLIN NUTR, V83, P146; KAO CH, 1993, NUCL MED COMMUN, V14, P373, DOI 10.1097/00006231-199305000-00005; Kelsey J L, 1989, Public Health Rep, V104 Suppl, P14; LINDSAY R, 1992, J BONE MINER RES, V7, P55; Ma LL, 2012, EUR J EPIDEMIOL, V27, P319, DOI 10.1007/s10654-012-9674-x; Marx N, 2013, DIABETES CARE, V36, P708, DOI 10.2337/dc12-1211; National Center for Health Statistics. Centers for Disease Control and Prevention, 2004, NAT HLTH NUTR EX SUR; Okazaki R, 1997, J CLIN ENDOCR METAB, V82, P2915, DOI 10.1210/jc.82.9.2915; PACINI G, 1990, J AM GERIATR SOC, V38, P1283, DOI 10.1111/j.1532-5415.1990.tb03449.x; Petrone A, 2005, DIABETES-METAB RES, V21, P271, DOI 10.1002/dmrr.549; Pinkney J., 2001, BR J DIABETES VASC D, V1, P103; RAPOPORT RM, 1985, EUR J PHARMACOL, V110, P203, DOI 10.1016/0014-2999(85)90212-2; Romanello M, 2001, BIOCHEM BIOPH RES CO, V289, P1275, DOI 10.1006/bbrc.2001.6124; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Shafqat J, 2002, CELL MOL LIFE SCI, V59, P1185, DOI 10.1007/s00018-002-8496-5; Terada M, 1998, BONE, V22, P17, DOI 10.1016/S8756-3282(97)00220-2; Thrailkill KM, 2005, AM J PHYSIOL-ENDOC M, V289, pE735, DOI 10.1152/ajpendo.00159.2005; VANCAUTER E, 1992, DIABETES, V41, P368, DOI 10.2337/diabetes.41.3.368; VANDAELE PLA, 1995, ANN INTERN MED, V122, P409, DOI 10.7326/0003-4819-122-6-199503150-00002; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; Yamaguchi T, 2009, BONE, V45, P174, DOI 10.1016/j.bone.2009.05.003; Yoon HJ, 2012, DIABETES METAB J, V36, P379, DOI 10.4093/dmj.2012.36.5.379; Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572; Zhou YJ, 2010, DIABETES RES CLIN PR, V90, P261, DOI 10.1016/j.diabres.2010.09.013	42	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83107	10.1371/journal.pone.0083107	http://dx.doi.org/10.1371/journal.pone.0083107			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358252	Green Submitted, gold, Green Published			2022-12-27	WOS:000328735700103
J	Painter, JA; Graviss, EA; Hai, HH; Nhung, DTC; Nga, TTT; Ha, NP; Wall, K; Loan, LTH; Parker, M; Manangan, L; O'Brien, R; Maloney, SA; Hoekstra, RM; Reves, R				Painter, John A.; Graviss, Edward A.; Hoang Hoa Hai; Duong Thi Cam Nhung; Tran Thi Thanh Nga; Ha, Ngan P.; Wall, Kirsten; Le Thien Huong Loan; Parker, Matt; Manangan, Lilia; O'Brien, Rick; Maloney, Susan A.; Hoekstra, R. M.; Reves, Randall			Tuberculosis Screening by Tuberculosis Skin Test or QuantiFERON (R)-TB Gold In-Tube Assay among an Immigrant Population with a High Prevalence of Tuberculosis and BCG Vaccination	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; FOREIGN-BORN PERSONS; UNITED-STATES; DIAGNOSIS; INFECTION	Rationale: Each year 1 million persons acquire permanent U. S. residency visas after tuberculosis (TB) screening. Most applicants undergo a 2-stage screening with tuberculin skin test (TST) followed by CXR only if TST-positive at > 5 mm. Due to cross reaction with bacillus Calmette-Guerin (BCG), TST may yield false positive results in BCG-vaccinated persons. Interferon gamma release assays exclude antigens found in BCG. In Vietnam, like most high TB-prevalence countries, there is universal BCG vaccination at birth. Objectives: 1. Compare the sensitivity of QuantiFERON (R)-TB Gold In-Tube Assay (QFT) and TST for culture-positive pulmonary TB. 2. Compare the age-specific and overall prevalence of positive TST and QFT among applicants with normal and abnormal CXR. Methods: We obtained TST and QFT results on 996 applicants with abnormal CXR, of whom 132 had TB, and 479 with normal CXR. Results: The sensitivity for tuberculosis was 86.4% for QFT; 89.4%, 81.1%, and 52.3% for TST at 5, 10, and 15 mm. The estimated prevalence of positive results at age 15-19 years was 22% and 42% for QFT and TST at 10 mm, respectively. The prevalence increased thereafter by 0.7% year of age for TST and 2.1% for QFT, the latter being more consistent with the increase in TB among applicants. Conclusions: During 2-stage screening, QFT is as sensitive as TST in detecting TB with fewer requiring CXR and being diagnosed with LTBI. These data support the use of QFT over TST in this population.	[Painter, John A.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Graviss, Edward A.; Ha, Ngan P.] Methodist Hosp Res Inst, Houston, TX USA; [Hoang Hoa Hai; Duong Thi Cam Nhung; Tran Thi Thanh Nga; Le Thien Huong Loan] Cho Ray Hosp, Visa Med Unit, Ho Chi Minh City, Vietnam; [Wall, Kirsten; Parker, Matt; Reves, Randall] Denver Hlth & Hosp Author, Denver, CO USA; [Manangan, Lilia] Ctr Dis Control & Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USA; [O'Brien, Rick] Fdn Innovat New Diagnost, Geneva, Switzerland; [Maloney, Susan A.] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA; [Hoekstra, R. M.] Ctr Dis Control & Prevent, Biostat & Informat Management Off, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; Denver Health Medical Center; Centers for Disease Control & Prevention - USA; Foundation For Innovative New Diagnostics; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Painter, JA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.	jpainter@cdc.gov	Hải, Hoàng/GXA-2392-2022	Hoekstra, Robert Michael/0000-0002-0340-8015	Tuberculosis Epidemiologic Studies Consortium (TBESC) of the United States Centers for the Disease Control and Prevention	Tuberculosis Epidemiologic Studies Consortium (TBESC) of the United States Centers for the Disease Control and Prevention	Funding for the study was achieved through the Tuberculosis Epidemiologic Studies Consortium (TBESC) of the United States Centers for the Disease Control and Prevention. QuantiFERON (R)-TB Gold In-Tube Assay kits were provided by the Foundation for Innovative New Diagnostics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Baron E.J., 1999, MANUAL CLIN MICROBIO, V7th; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; BLUM RN, 1993, CHEST, V103, P1670, DOI 10.1378/chest.103.6.1670; Cain KP, 2007, AM J RESP CRIT CARE, V175, P75, DOI 10.1164/rccm.200608-1178OC; *CDCP, 2008, TECHN INSTR MED EX A; *CDCP, 2009, TECHN INSTR MED EX A; *CDCP, 2007, CDC IMM REQ TECHN IN; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P333; Czajkowski M, 2008, STAT MED, V27, P1508, DOI 10.1002/sim.3017; Dai Y, 2012, EUR J CLIN MICROBIOL, V31, P3127, DOI 10.1007/s10096-012-1674-y; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Hill AN, 2012, EPIDEMIOL INFECT, V140, P1862, DOI 10.1017/S095026881100286X; Jacobs S, 2011, PEDIATR INFECT DIS J, V30, P754, DOI 10.1097/INF.0b013e31821b8f54; Kent PT, 1985, GUIDE LEVEL 3 LAB; Liu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032158; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Maloney SA, 2006, ARCH INTERN MED, V166, P234, DOI 10.1001/archinte.166.2.234; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Menzies D, 2008, INT J TUBERC LUNG D, V12, P498; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; MONGER RY, 2012, ANN FLOW REPORT; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; REISNER BS, 1994, J CLIN MICROBIOL, V32, P2995, DOI 10.1128/JCM.32.12.2995-2998.1994; Reves RR, 2012, AM J RESP CRIT CARE, V186, pI, DOI 10.1164/rccm.201206-1039ED; Somoskovi A, 2000, J CLIN MICROBIOL, V38, P2395; Stout JE, 2008, AM J RESP CRIT CARE, V177, P1055, DOI 10.1164/rccm.200802-251ED; Team R. D. C, 2011, R LANG ENV STAT COMP; van Pinxteren LAH, 2000, CLIN DIAGN LAB IMMUN, V7, P155, DOI 10.1128/CDLI.7.2.155-160.2000; *WHO, 2010, GLOB TUB CONTR 2011; Wickaham H., 2009, GGPLOT2 ELEGANT GRAP; Winje BA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-140; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012; 2011, J AM COLL HLTH, V59, P670	37	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82727	10.1371/journal.pone.0082727	http://dx.doi.org/10.1371/journal.pone.0082727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367546	gold, Green Published, Green Submitted			2022-12-27	WOS:000328741900012
J	Stewart, ZP; Oxborough, RM; Tungu, PK; Kirby, MJ; Rowland, MW; Irish, SR				Stewart, Zachary P.; Oxborough, Richard M.; Tungu, Patrick K.; Kirby, Matthew J.; Rowland, Mark W.; Irish, Seth R.			Indoor Application of Attractive Toxic Sugar Bait (ATSB) in Combination with Mosquito Nets for Control of Pyrethroid-Resistant Mosquitoes	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; ANOPHELES-GAMBIAE; CULEX-QUINQUEFASCIATUS; ALTERNATIVE INSECTICIDES; MALARIA VECTORS; POPULATIONS; CHLORFENAPYR; ARABIENSIS; EFFICACY; DIPTERA	Background: Attractive toxic sugar bait (ATSB) sprayed onto vegetation has been successful in controlling Anopheles mosquitoes outdoors. Indoor application of ATSB has yet to be explored. The purpose of this study was to determine whether ATSB stations positioned indoors have the potential to kill host-seeking mosquitoes and constitute a new approach to control of mosquito-borne diseases. Methods: Insecticides were mixed with dyed sugar solution and tested as toxic baits against Anopheles arabiensis, An. Gambiae s. s. and Culex quinquefasciatus in feeding bioassay tests to identify suitable attractant-insecticide combinations. The most promising ATSB candidates were then trialed in experimental huts in Moshi, Tanzania. ATSB stations were hung in huts next to untreated mosquito nets occupied by human volunteers. The proportions of mosquitoes killed in huts with ATSB treatments relative to huts with non-insecticide control treatments huts were recorded, noting evidence of dye in mosquito abdomens. Results: In feeding bioassays, chlorfenapyr 0.5% v/v, boric acid 2% w/v, and tolfenpyrad 1% v/v, mixed in a guava juice-based bait, each killed more than 90% of pyrethroid-susceptible An. Gambiae s. s. and pyrethroid-resistant An. arabiensis and Cx. quinquefasciatus. In the hut trial, mortality rates of the three ATSB treatments ranged from 41-48% against An. arabiensis and 36-43% against Cx. quinquefasciatus and all were significantly greater than the control mortalities: 18% for An. arabiensis, 7% for Cx. quinquefasciatus (p< 0.05). Mortality rates with ATSB were comparable to those with long lasting insecticidal nets previously tested against the same species in this area. Conclusions: Indoor ATSB shows promise as a supplement to mosquito nets for controlling mosquitoes. Indoor ATSB constitute a novel application method for insecticide classes that act as stomach poisons and have not hitherto been exploited for mosquito control. Combined with LLIN, indoor use of ATSB has the potential to serve as a strategy for managing insecticide resistance.	[Stewart, Zachary P.; Oxborough, Richard M.; Kirby, Matthew J.; Rowland, Mark W.; Irish, Seth R.] Univ London London Sch Hyg & Trop Med, Fac Infect Trop Dis, London WC1E 7HT, England; [Stewart, Zachary P.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA; [Oxborough, Richard M.; Tungu, Patrick K.; Kirby, Matthew J.; Rowland, Mark W.; Irish, Seth R.] Pan African Malaria Vector Res Consortium PAMVERC, Moshi, Tanzania; [Oxborough, Richard M.] Tumaini Univ, Kilimanjaro Christian Med Univ Coll KCMUCo, Dept Parasitol & Entomol, Moshi, Tanzania; [Tungu, Patrick K.] Natl Inst Med Res, Amani Med Res Ctr, Muheza, Tanzania; [Kirby, Matthew J.] Malaria Consortium, London, England	University of London; London School of Hygiene & Tropical Medicine; University of Nebraska System; University of Nebraska Lincoln; National Institute of Medical Research	Irish, SR (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect Trop Dis, Keppel St, London WC1E 7HT, England.	seth.irish@lshtm.ac.uk		Stewart, Zachary/0000-0003-4058-8526	London School of Hygiene; Tropical Medicine; Helena Vrbova; Gordon Smith Scholarships	London School of Hygiene; Tropical Medicine; Helena Vrbova; Gordon Smith Scholarships	This work was supported by the London School of Hygiene and Tropical Medicine and Helena Vrbova and Gordon Smith Scholarships. The funders played no role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, PESTICIDES THEIR APP; [Anonymous], 2011, TECHN BAS ACT INS RE; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Beier JC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-31; Chandre F, 1998, MED VET ENTOMOL, V12, P359, DOI 10.1046/j.1365-2915.1998.00120.x; Curtis CF, 1998, PHILOS T ROY SOC B, V353, P1769, DOI 10.1098/rstb.1998.0329; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; EBELING W, 1966, J ECON ENTOMOL, V59, P1374, DOI 10.1093/jee/59.6.1374; Gatton ML, 2013, EVOLUTION, V67, P1218, DOI 10.1111/evo.12063; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Jones CM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-78; Kitau J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031481; Manda H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-113; Matowo J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-193; Mosha FW, 2008, ANN TROP MED PARASIT, V102, P367, DOI 10.1179/136485908X278829; Muller GC, 2010, J MED ENTOMOL, V47, P63, DOI 10.1603/033.047.0108; Muller GC, 2008, J AM MOSQUITO CONTR, V24, P147, DOI 10.2987/8756-971X(2008)24[147:DOASAA]2.0.CO;2; Muller GC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-210; N'Guessan R, 2007, ACTA TROP, V102, P69, DOI 10.1016/j.actatropica.2007.03.003; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Ngufor C, 2011, MALARIA J, V16, P10; Raghavendra K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-16; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Rowland M, 2012, OUTLOOK PEST MANAG, V23, P150, DOI [DOI 10.1564/23AUG01, 10.1564/23aug01]; Rowland M, 2009, ACS SYM SER, V1014, P13, DOI 10.1021/bk-2009-1014.ch002; Seyoum A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-101; Stone CM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-3; WHO, 2012, WORLD MALARIA REPORT 2012, P1; World Health Organization, 2012, WHO GLOB MAL PROGR G; Xue RD, 2003, J ECON ENTOMOL, V96, P1559, DOI 10.1603/0022-0493-96.5.1559; Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6	31	55	56	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84168	10.1371/journal.pone.0084168	http://dx.doi.org/10.1371/journal.pone.0084168			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367638	Green Accepted, Green Published, gold			2022-12-27	WOS:000328741900035
J	Brassey, CA; Holdaway, RN; Packham, AG; Anne, J; Manning, PL; Sellers, WI				Brassey, Charlotte A.; Holdaway, Richard N.; Packham, Abigail G.; Anne, Jennifer; Manning, Philip L.; Sellers, William I.			More than One Way of Being a Moa: Differences in Leg Bone Robustness Map Divergent Evolutionary Trajectories in Dinornithidae and Emeidae (Dinornithiformes)	PLOS ONE			English	Article							NEW-ZEALAND; AVES DINORNITHIFORMES; MECHANICAL-PROPERTIES; LIMB POSTURE; GROWTH; REVEAL; MASS; ALLOMETRY; STRUTHIO; KINETICS	The extinct moa of New Zealand included three families (Megalapterygidae; Dinornithidae; Emeidae) of flightless palaeognath bird, ranging in mass from < 15 kg to > 200 kg. They are perceived to have evolved extremely robust leg bones, yet current estimates of body mass have very wide confidence intervals. Without reliable estimators of mass, the extent to which dinornithid and emeid hindlimbs were more robust than modern species remains unclear. Using the convex hull volumetric-based method on CT-scanned skeletons, we estimate the mass of a female Dinornis robustus (Dinornithidae) at 196 kg (range 155-245 kg) and of a female Pachyornis australis (Emeidae) as 50 kg (range 33-68 kg). Finite element analysis of CT-scanned femora and tibiotarsi of two moa and six species of modern palaeognath showed that P. australis experienced the lowest values for stress under all loading conditions, confirming it to be highly robust. In contrast, stress values in the femur of D. robustus were similar to those of modern flightless birds, whereas the tibiotarsus experienced the highest level of stress of any palaeognath. We consider that these two families of Dinornithiformes diverged in their biomechanical responses to selection for robustness and mobility, and exaggerated hindlimb strength was not the only successful evolutionary pathway.	[Brassey, Charlotte A.; Packham, Abigail G.; Sellers, William I.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Holdaway, Richard N.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Anne, Jennifer; Manning, Philip L.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England	University of Manchester; University of Canterbury; University of Manchester	Brassey, CA (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	charlotte.brassey-2@postgrad.manchester.ac.uk	Sellers, William Irvin/Q-3843-2019; Brassey, Charlotte A/R-2029-2017; Manning, Phillip/F-9966-2011	Sellers, William Irvin/0000-0002-2913-5406; Brassey, Charlotte A/0000-0002-6552-541X; Manning, Phillip/0000-0002-7161-6246	Natural Environment Research Council Doctoral Training Grant [NE/1528134/1]; Engineering and Physical Sciences Research Council [EP/F007906, EP/I02249X]	Natural Environment Research Council Doctoral Training Grant(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by a Natural Environment Research Council Doctoral Training Grant (NE/1528134/1). The Henry Moseley X-Ray Imaging Facility (University of Manchester) is supported by the Engineering and Physical Sciences Research Council under nos. EP/F007906 and EP/I02249X. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.M., 1989, DYNAMICS DINOSAURS O; ALEXANDER RM, 1983, J ZOOL, V201, P363; ALEXANDER RM, 1983, J ZOOL, V200, P215; ALEXANDER RM, 1985, ACTA BIOTHEOR, V34, P165, DOI 10.1007/BF00046782; Allen V, 2009, ANAT REC, V292, P1442, DOI 10.1002/ar.20973; Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Allentoft ME, 2012, ANN ANAT, V194, P36, DOI 10.1016/j.aanat.2011.04.002; Bourdon E, 2009, BIOL LETTERS, V5, P639, DOI 10.1098/rsbl.2009.0310; Brassey CA, 2013, ANAT REC, V296, P395, DOI 10.1002/ar.22658; Brassey CA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0823; Bunce M, 2009, P NATL ACAD SCI USA, V106, P20646, DOI 10.1073/pnas.0906660106; BURROWS C J, 1981, Records of the Canterbury Museum, V9, P309; CRACRAFT J, 1976, Paleobiology, V2, P166; Cubo J, 1997, NETH J ZOOL, V47, P209, DOI 10.1163/156854297X00175; Cubo J, 2000, EUR J MORPHOL, V38, P112, DOI 10.1076/0924-3860(200004)38:2;1-F;FT112; Currey JD, 1999, J EXP BIOL, V202, P2495; CURREY JD, 1985, J ZOOL, V206, P453; Currey JD., 2006, BONES STRUCTURE MECH; Currey JD, 2007, J R SOC INTERFACE, V4, P127, DOI 10.1098/rsif.2006.0166; Dickison M, 2009, THESIS DUKE U; GARLAND T, 1994, PHYSIOL ZOOL, V67, P797, DOI 10.1086/physzool.67.4.30163866; GATESY SM, 1991, J ZOOL, V224, P127, DOI 10.1111/j.1469-7998.1991.tb04794.x; GATESY SM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P219; Goonewardene LA, 2003, J APPL POULTRY RES, V12, P27, DOI 10.1093/japr/12.1.27; HAZLEHURST GA, 1992, PALEOBIOLOGY, V18, P447, DOI 10.1017/S009483730001099X; Holdaway RN, 2000, SCIENCE, V287, P2250, DOI 10.1126/science.287.5461.2250; Hutchinson JR, 2007, J THEOR BIOL, V246, P660, DOI 10.1016/j.jtbi.2007.01.023; Hutchinson JR, 2004, J MORPHOL, V262, P441, DOI 10.1002/jmor.10240; Main RP, 2007, J EXP BIOL, V210, P2676, DOI 10.1242/jeb.004580; NOBLE JC, 1991, REV CHIL HIST NAT, V64, P85; Panagiotopoulou O, 2012, J R SOC INTERFACE, V9, P351, DOI 10.1098/rsif.2011.0323; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Picasso MBJ, 2012, J ZOOL, V286, P303, DOI 10.1111/j.1469-7998.2011.00880.x; PRANGE HD, 1979, AM NAT, V113, P103, DOI 10.1086/283367; R Core Team, 2021, R LANGUAGE ENV STAT; Ramos A, 2006, MED ENG PHYS, V28, P916, DOI 10.1016/j.medengphy.2005.12.006; Rawlence NJ, 2012, QUATERNARY SCI REV, V50, P141, DOI 10.1016/j.quascirev.2012.07.004; Reid B., 1987, International Zoo Yearbook, V26, P189; RUBIN CT, 1984, J THEOR BIOL, V107, P321, DOI 10.1016/S0022-5193(84)80031-4; Sellers WI, 2012, BIOL LETTERS, V8, P842, DOI 10.1098/rsbl.2012.0263; Smith NC, 2010, J EXP BIOL, V213, P1347, DOI 10.1242/jeb.020271; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Tennyson AJD, 2010, REC AUST MUS, V62, P105, DOI 10.3853/j.0067-1975.62.2010.1546; Tumarkin-Deratzian AR, 2006, ZOOL J LINN SOC-LOND, V148, P133, DOI 10.1111/j.1096-3642.2006.00232.x; Turvey ST, 2005, NATURE, V435, P940, DOI 10.1038/nature03635; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Welty J.C., 1988, LIFE BIRDS, V4th edn; Wood JR, 2013, P NATL ACAD SCI USA, V110, P16910, DOI 10.1073/pnas.1307700110; Worthy TH, 2012, NEW ZEAL J ZOOL, V39, P87, DOI 10.1080/03014223.2012.665060; Worthy T. H., 2002, LOST WORLD MOA PREHI; WORTHY TH, 1991, J ROY SOC NEW ZEAL, V21, P101; Worthy TH, 2013, P 8 M SOC AV PAL EV	53	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82668	10.1371/journal.pone.0082668	http://dx.doi.org/10.1371/journal.pone.0082668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367537	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000328740300053
J	Gonzalez-Cabrera, J; Davies, TGE; Field, LM; Kennedy, PJ; Williamson, MS				Gonzalez-Cabrera, Joel; Davies, T. G. Emyr; Field, Linda M.; Kennedy, Peter J.; Williamson, Martin S.			An Amino Acid Substitution (L925V) Associated with Resistance to Pyrethroids in Varroa destructor	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; FLUVALINATE-RESISTANCE; MITE; MUTATIONS; JACOBSONI; IDENTIFICATION; SENSITIVITY	The Varroa mite, Varroa destructor, is an important pest of honeybees and has played a prominent role in the decline in bee colony numbers over recent years. Although pyrethroids such as tau-fluvalinate and flumethrin can be highly effective in removing the mites from hives, their intensive use has led to many reports of resistance. To investigate the mechanism of resistance in UK Varroa samples, the transmembrane domain regions of the V. destructor voltage-gated sodium channel (the main target site for pyrethroids) were PCR amplified and sequenced from pyrethroid treated/untreated mites collected at several locations in Central/Southern England. A novel amino acid substitution, L925V, was identified that maps to a known hot spot for resistance within the domain IIS5 helix of the channel protein; a region that has also been proposed to form part of the pyrethroid binding site. Using a high throughput diagnostic assay capable of detecting the mutation in individual mites, the L925V substitution was found to correlate well with resistance, being present in all mites that had survived tau-fluvalinate treatment but in only 8 % of control, untreated samples. The potential for using this assay to detect and manage resistance in Varroa-infected hives is discussed.	[Gonzalez-Cabrera, Joel; Davies, T. G. Emyr; Field, Linda M.; Kennedy, Peter J.; Williamson, Martin S.] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Gonzalez-Cabrera, J (corresponding author), Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England.	joel.gonzalez@rothamsted.ac.uk	Davies, Thomas G. Emyr/C-2795-2017; Gonzalez-Cabrera, Joel/B-2279-2013	Davies, Thomas G. Emyr/0000-0002-9452-2947; Gonzalez-Cabrera, Joel/0000-0002-8338-370X; Field, Linda/0000-0002-3328-2513	Marie Curie Intra European Fellowship; Biotechnology and Biological Sciences Research Council of the United Kingdom; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005193] Funding Source: researchfish; BBSRC [BBS/E/C/00005193] Funding Source: UKRI	Marie Curie Intra European Fellowship(European Commission); Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Joel Gonzalez-Cabrera-Cabrera was supported by a Marie Curie Intra European Fellowship within the 7th European Community Framework. http://ec.europa.eu/research/mariecurieactions/index_en.htm. Rothamsted Research is supported by the Biotechnology and Biological Sciences Research Council of the United Kingdom. http://bbsrc.ac.uk/home/home.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina I, 1997, NUCLEIC ACIDS RES, V25, P2657, DOI 10.1093/nar/25.13.2657; Bak B, 2012, MED WETER, V68, P603; Baxter JR, 2000, AM BEE J, V140, P898; Bell J., 1999, AM BEE J, V139, P308; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Cornman SR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-602; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; Dietemann V, 2013, COLOSS BEEBOOK, V2; Elzen PJ, 1998, AM BEE J, V138, P674; Gracia-Salinas MJ, 2006, J APICULT RES, V45, P101, DOI 10.1080/00218839.2006.11101326; Green MR, 2012, MOL CLONING LAB MANU, V1; Gregorc A, 2012, J APIC SCI, V56, P61, DOI 10.2478/v10289-012-0024-8; Karatolos N, 2012, PEST MANAG SCI, V68, P834, DOI 10.1002/ps.2334; Kliot A, 2012, PEST MANAG SCI, V68, P1431, DOI 10.1002/ps.3395; Liu ZQ, 2006, INSECT BIOCHEM MOLEC, V36, P885, DOI 10.1016/j.ibmb.2006.08.006; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Martin S, 1998, APIDOLOGIE, V29, P369, DOI 10.1051/apido:19980407; MILANI N, 1995, APIDOLOGIE, V26, P415, DOI 10.1051/apido:19950507; Morgan JAT, 2009, INT J PARASITOL, V39, P775, DOI 10.1016/j.ijpara.2008.12.006; Mozes-Koch R, 2000, EXP APPL ACAROL, V24, P35, DOI 10.1023/A:1006379114942; O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925; O'Reilly AO, 2014, PEST MANAG SCI, V70, P369, DOI 10.1002/ps.3561; Rinkevich FD, 2013, PESTIC BIOCHEM PHYS, V106, P93, DOI 10.1016/j.pestbp.2013.02.007; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Sammataro D, 2005, INT J ACAROL, V31, P67, DOI 10.1080/01647950508684419; SODERLUND DM, 1989, ANNU REV ENTOMOL, V34, P77, DOI 10.1146/annurev.en.34.010189.000453; Soderlund DM, 2001, NEUROTOXICOLOGY, V22, P755, DOI 10.1016/S0161-813X(01)00065-1; Stanton JM, 1998, AUSTRALAS PLANT PATH, V27, P112, DOI 10.1071/AP98014; Thompson HM, 2002, APIDOLOGIE, V33, P357, DOI 10.1051/apido:2002027; Wang RW, 2003, INSECT BIOCHEM MOLEC, V33, P733, DOI 10.1016/S0965-1748(03)00068-7; Wang RW, 2002, J APICULT RES, V41, P17, DOI 10.1080/00218839.2002.11101064; Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204; Yoon KS, 2008, J MED ENTOMOL, V45, P1092, DOI 10.1603/0022-2585(2008)45[1092:BAMAOD]2.0.CO;2; 김원태, 2009, Journal of Apiculture, V24, P159	34	55	56	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82941	10.1371/journal.pone.0082941	http://dx.doi.org/10.1371/journal.pone.0082941			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367572	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300083
J	Gyorffy, B; Surowiak, P; Budczies, J; Lanczky, A				Gyorffy, Balazs; Surowiak, Pawel; Budczies, Jan; Lanczky, Andras			Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; GENE-EXPRESSION; SQUAMOUS-CELL; STAGE-I; MARKER; ADENOCARCINOMA; METAANALYSIS; PREDICTION; RECEPTOR; OSTEOPONTIN	In the last decade, optimized treatment for non-small cell lung cancer had lead to improved prognosis, but the overall survival is still very short. To further understand the molecular basis of the disease we have to identify biomarkers related to survival. Here we present the development of an online tool suitable for the real-time meta-analysis of published lung cancer microarray datasets to identify biomarkers related to survival. We searched the caBIG, GEO and TCGA repositories to identify samples with published gene expression data and survival information. Univariate and multivariate Cox regression analysis, Kaplan-Meier survival plot with hazard ratio and logrank P value are calculated and plotted in R. The complete analysis tool can be accessed online at: www.kmplot.com/lung. All together 1,715 samples of ten independent datasets were integrated into the system. As a demonstration, we used the tool to validate 21 previously published survival associated biomarkers. Of these, survival was best predicted by CDK1 (p<1E-16), CD24 (p<1E-16) and CADM1 (p = 7E-12) in adenocarcinomas and by CCNE1 (p = 2.3E-09) and VEGF (p = 3.3E-10) in all NSCLC patients. Additional genes significantly correlated to survival include RAD51, CDKN2A, OPN, EZH2, ANXA3, ADAM28 and ERCC1. In summary, we established an integrated database and an online tool capable of uni- and multivariate analysis for in silico validation of new biomarker candidates in non-small cell lung cancer.	[Gyorffy, Balazs; Lanczky, Andras] Hungarian Acad Sci, Res Lab Pediat & Nephrol, Budapest, Hungary; [Surowiak, Pawel] Wroclaw Med Univ, Dept Histol & Embryol, Wroclaw, Poland; [Budczies, Jan] Charite, Inst Pathol, D-13353 Berlin, Germany	Hungarian Academy of Sciences; Wroclaw Medical University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Gyorffy, B (corresponding author), Hungarian Acad Sci, Res Lab Pediat & Nephrol, Budapest, Hungary.	zsalab2@yahoo.com	Gyorffy, Balazs/AAA-9135-2021; Budczies, Jan/AAG-8122-2020	Gyorffy, Balazs/0000-0002-5772-3766; Surowiak, Pawel/0000-0002-4241-5197	OTKA [PD 83154]; EU Health [259303, 2010.2.4.1.-8]; KTIA [U_BONUS_12-1-2013-0003]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); EU Health; KTIA	The authors work was supported by the OTKA PD 83154 grant, by the Predict project (grant no. 259303 of the EU Health. 2010.2.4.1.-8 call) and by the KTIA U_BONUS_12-1-2013-0003 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1996, CANCER RES, V56, P1751; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; BOTLING J, 2012, CLIN CANC RES; Boyle P, 1996, INT J CANCER, V67, P63, DOI 10.1002/(SICI)1097-0215(19960703)67:1<63::AID-IJC12>3.0.CO;2-D; Brabender J, 2001, CLIN CANCER RES, V7, P1850; Chambers AF, 1996, LUNG CANCER-J IASLC, V15, P311, DOI 10.1016/0169-5002(95)00595-1; Chen YB, 2011, CHINESE MED J-PEKING, V124, P3238, DOI 10.3760/cma.j.issn.0366-6999.2011.20.006; Dawood S, 2010, J CLIN ONCOL, V28, P92, DOI 10.1200/JCO.2008.19.9844; Ferreira CG, 2001, CLIN CANCER RES, V7, P2468; FORD CHJ, 1981, BRIT J CANCER, V44, P145, DOI 10.1038/bjc.1981.164; Guo L, 2006, CLIN CANCER RES, V12, P3344, DOI 10.1158/1078-0432.CCR-05-2336; Gyorffy B, 2012, BREAST CANCER RES TR, V132, P1025, DOI 10.1007/s10549-011-1676-y; Gyorffy B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005645; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hayes DN, 2006, J CLIN ONCOL, V24, P5079, DOI 10.1200/JCO.2005.05.1748; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Huang LN, 2012, CLIN CHIM ACTA, V413, P663, DOI 10.1016/j.cca.2011.12.020; Huqun, 2012, CANCER-AM CANCER SOC, V118, P1599, DOI 10.1002/cncr.26441; Jin ML, 2001, LUNG CANCER-J IASLC, V34, P207, DOI 10.1016/S0169-5002(01)00225-2; Kuroda H, 2010, INT J CANCER, V127, P1844, DOI 10.1002/ijc.25212; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Lee HJ, 2010, J THORAC ONCOL, V5, P649, DOI 10.1097/JTO.0b013e3181d5e554; Liu YF, 2009, J PATHOL, V217, P54, DOI 10.1002/path.2429; Lu C, 2004, J CLIN ONCOL, V22, P4575, DOI 10.1200/JCO.2004.01.091; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Peng WJ, 2012, CLIN CHIM ACTA, V413, P1121, DOI 10.1016/j.cca.2012.03.012; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Qiao GB, 2005, BRIT J CANCER, V93, P137, DOI 10.1038/sj.bjc.6602665; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Schneider S, 2004, CLIN CANCER RES, V10, P1588, DOI 10.1158/1078-0432.CCR-0565-3; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simon GR, 2005, CHEST, V127, P978, DOI 10.1378/chest.127.3.978; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Tanaka S, 2012, PATHOBIOLOGY, V79, P24, DOI 10.1159/000331230; Trikalinos TA, 2008, ADV GENET, V60, P311, DOI 10.1016/S0065-2660(07)00413-0; Tsuna M, 2009, ANTICANCER RES, V29, P2547; Wakelee HA, 2007, J CLIN ONCOL, V25, P472, DOI 10.1200/JCO.2006.07.2983; Xi LQ, 2005, CLIN CANCER RES, V11, P4128, DOI 10.1158/1078-0432.CCR-04-2525; Xie Y, 2011, CLIN CANCER RES, V17, P5705, DOI 10.1158/1078-0432.CCR-11-0196; Yamauchi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043923; Zhan P, 2009, J THORAC ONCOL, V4, P1094, DOI 10.1097/JTO.0b013e3181a97e31; Zhang LQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034100; Zhang LQ, 2012, CLIN LUNG CANCER, V13, P188, DOI 10.1016/j.cllc.2011.10.003; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	48	1220	1241	7	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82241	10.1371/journal.pone.0082241	http://dx.doi.org/10.1371/journal.pone.0082241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367507	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000328740300023
J	Hasan, MR; Sharma, R; Saraya, A; Chattopadhyay, TK; DattaGupta, S; Walfish, PG; Chauhan, SS; Ralhan, R				Hasan, Md Raghibul; Sharma, Rinu; Saraya, Anoop; Chattopadhyay, Tushar K.; DattaGupta, Siddartha; Walfish, Paul G.; Chauhan, Shyam S.; Ralhan, Ranju			Slug Is a Predictor of Poor Prognosis in Esophageal Squamous Cell Carcinoma Patients	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; TRANSCRIPTION FACTORS; LUNG ADENOCARCINOMA; BREAST-CANCER; EXPRESSION; MARKERS; EPIDEMIOLOGY; SNAIL; PROGRESSION	Background: Slug, a regulator of epithelial mesenchymal transition, was identified to be differentially expressed in esophageal squamous cell carcinoma (ESCC) using cDNA microarrays by our laboratory. This study aimed to determine the clinical significance of Slug overexpression in ESCC and determine its correlation with clinicopathological parameters and disease prognosis for ESCC patients. Methods: Immunohistochemical analysis of Slug expression was carried out in archived tissue sections from 91 ESCCs, 61 dysplastic and 47 histologically normal esophageal tissues. Slug immunopositivity in epithelial cells was correlated with clinicopathological parameters and disease prognosis over up to 7.5 years for ESCC patients. Results: Increased expression of Slug was observed in esophageal dysplasia [cytoplasmic, 24/61 (39.3%) cases, p = 0.001, odd's ratio (OR) = 4.7; nuclear, 11/61 (18%) cases, p < 0.001, OR = 1.36] in comparison with normal esophageal tissues. The Slug expression was further increased in ESCCs [cytoplasmic, 64/91 (70.3%) p < 0.001, OR = 10.0; nuclear, 27/91 (29.7%) p < 0.001, OR = 1.42]. Kaplan Meier survival analysis showed significant association of nuclear Slug accumulation with reduced disease free survival of ESCC patients (median disease free survival (DFS) = 6 months, as compared to those that did not show overexpression, DFS = 18 months; p = 0.006). In multivariate Cox regression analysis nuclear Slug expression [p=0.005, Hazard's ratio (HR) = 2.269, 95% CI = 1.289 -3.996] emerged as the most significant independent predictor of poor prognosis for ESCC patients. Conclusions: Alterations in Slug expression occur in early stages of development of ESCC and are sustained during disease progression. Slug may serve as a diagnostic biomarker and as a predictor of poor disease prognosis to identify ESCC patients that are likely to show recurrence of the disease.	[Hasan, Md Raghibul; Chauhan, Shyam S.; Ralhan, Ranju] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Sharma, Rinu] Guru Gobind Singh Indraprastha Univ, Sch Biotechnol, Delhi, India; [Saraya, Anoop] All India Inst Med Sci, Dept Gastroenterol, New Delhi, India; [Chattopadhyay, Tushar K.] All India Inst Med Sci, Dept Gastrointestinal Surg, New Delhi, India; [DattaGupta, Siddartha] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India; [Walfish, Paul G.; Ralhan, Ranju] Mt Sinai Hosp, Dept Med, Div Endocrine, Toronto, ON M5G 1X5, Canada; [Walfish, Paul G.; Ralhan, Ranju] Univ Toronto, Toronto, ON, Canada; [Walfish, Paul G.; Ralhan, Ranju] Mt Sinai Hosp, Dept Pathol & Lab Med, Alex & Simona Shnaider Res Lab Mol Oncol, Toronto, ON M5G 1X5, Canada; [Walfish, Paul G.; Ralhan, Ranju] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Walfish, Paul G.; Ralhan, Ranju] Mt Sinai Hosp, Dept Otolaryngol Head & Neck Surg, Joseph & Mildred Sonshine Family Ctr Head & Neck, Toronto, ON M5G 1X5, Canada; [Walfish, Paul G.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada	All India Institute of Medical Sciences (AIIMS) New Delhi; GGS Indraprastha University; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Chauhan, SS (corresponding author), All India Inst Med Sci, Dept Biochem, New Delhi 110029, India.	s_s_chauhan@hotmail.com; rralhan@mtsinai.on.ca			Senior Research Fellowship from Department of Biotechnology, India; Canadian Institutes of Health Research for Chair in Advanced Cancer Diagnostics	Senior Research Fellowship from Department of Biotechnology, India; Canadian Institutes of Health Research for Chair in Advanced Cancer Diagnostics(Canadian Institutes of Health Research (CIHR))	MRH is the recipient of Senior Research Fellowship from Department of Biotechnology, India. The financial support of this work from the Canadian Institutes of Health Research for Chair in Advanced Cancer Diagnostics (RR) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CC, 2009, FRONT BIOSCI-LANDMRK, V14, P3041, DOI 10.2741/3433; Behnsawy HM, 2013, BJU INT, V111, P30, DOI 10.1111/j.1464-410X.2012.11551.x; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Cates JMM, 2009, PANCREAS, V38, pE1, DOI 10.1097/MPA.0b013e3181878b7f; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Giarnieri E, 2013, J CELL PHYSIOL, V228, P1720, DOI 10.1002/jcp.24300; Hajra KM, 2002, CANCER RES, V62, P1613; Hugo HJ, 2011, CELLS TISSUES ORGANS, V193, P23, DOI 10.1159/000320174; Jethwa P, 2008, WORLD J GASTROENTERO, V14, P1044, DOI 10.3748/wjg.14.1044; Kausar T, 2011, CANCER INVEST, V29, P42, DOI 10.3109/07357907.2010.512597; Kumar A, 2007, INT J CANCER, V120, P230, DOI 10.1002/ijc.22246; Lee JM, 2011, ANN SURG, V253, P918, DOI 10.1097/SLA.0b013e318216f374; Lee JM, 2011, ANN SURG ONCOL, V18, P2066, DOI 10.1245/s10434-011-1559-9; Liu MN, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-142; Markiewicz A, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-226; Matta A, 2009, INT J CANCER, V125, P1398, DOI 10.1002/ijc.24517; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Prasad CP, 2008, LIFE SCI, V83, P318, DOI 10.1016/j.lfs.2008.06.019; Ryan AM, 2011, CANCER EPIDEMIOL, V35, P309, DOI 10.1016/j.canep.2011.03.001; Shih JY, 2005, CLIN CANCER RES, V11, P8070, DOI 10.1158/1078-0432.CCR-05-0687; Shioiri M, 2006, BRIT J CANCER, V94, P1816, DOI 10.1038/sj.bjc.6603193; Smith A, 2013, ORAL ONCOL, V49, P287, DOI 10.1016/j.oraloncology.2012.10.009; Tanaka Y, 2013, CANCER BIOL THER, V14, P13, DOI 10.4161/cbt.22625; Tang P, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-60; Tomizawa Y, 2012, ONCOL LETT, V3, P1059, DOI 10.3892/ol.2012.632; Uchikado Y, 2005, CLIN CANCER RES, V11, P1174; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Wheeler JB, 2012, SURG CLIN N AM, V92, P1077, DOI 10.1016/j.suc.2012.07.008; Worni M, 2012, J AM COLL SURGEONS, V215, P643, DOI 10.1016/j.jamcollsurg.2012.07.006; Ye Y, 2008, BIOCHEM J, V416, P179, DOI 10.1042/BJ20080328; Yu QC, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-119; Zhang KJ, 2012, LAB INVEST, V92, P1801, DOI 10.1038/labinvest.2012.138	33	27	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82846	10.1371/journal.pone.0082846	http://dx.doi.org/10.1371/journal.pone.0082846			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367561	Green Submitted, Green Published, gold			2022-12-27	WOS:000328740300074
J	Dubus, G; Bresin, R				Dubus, Gael; Bresin, Roberto			A Systematic Review of Mapping Strategies for the Sonification of Physical Quantities	PLOS ONE			English	Article							CONCEPTUAL DATA DIMENSIONS; AUDIO-BIOFEEDBACK; IMAGE SCENES; SOUND; INTERFACE; INFORMATION; FEEDBACK; EEG; PERCEPTION; NAVIGATION	The field of sonification has progressed greatly over the past twenty years and currently constitutes an established area of research. This article aims at exploiting and organizing the knowledge accumulated in previous experimental studies to build a foundation for future sonification works. A systematic review of these studies may reveal trends in sonification design, and therefore support the development of design guidelines. To this end, we have reviewed and analyzed 179 scientific publications related to sonification of physical quantities. Using a bottom-up approach, we set up a list of conceptual dimensions belonging to both physical and auditory domains. Mappings used in the reviewed works were identified, forming a database of 495 entries. Frequency of use was analyzed among these conceptual dimensions as well as higher-level categories. Results confirm two hypotheses formulated in a preliminary study: pitch is by far the most used auditory dimension in sonification applications, and spatial auditory dimensions are almost exclusively used to sonify kinematic quantities. To detect successful as well as unsuccessful sonification strategies, assessment of mapping efficiency conducted in the reviewed works was considered. Results show that a proper evaluation of sonification mappings is performed only in a marginal proportion of publications. Additional aspects of the publication database were investigated: historical distribution of sonification works is presented, projects are classified according to their primary function, and the sonic material used in the auditory display is discussed. Finally, a mapping-based approach for characterizing sonification is proposed.	[Dubus, Gael; Bresin, Roberto] KTH Royal Inst Technol, Sch Comp Sci & Commun, Dept Speech Mus & Hearing, Stockholm, Sweden	Royal Institute of Technology	Dubus, G (corresponding author), KTH Royal Inst Technol, Sch Comp Sci & Commun, Dept Speech Mus & Hearing, Stockholm, Sweden.	dubus@kth.se	Dubus, Gaël/Y-7234-2019; Bresin, Roberto/J-4240-2012; Bresin, Roberto/I-3458-2019	Bresin, Roberto/0000-0002-3086-0322; Bresin, Roberto/0000-0002-3086-0322; Dubus, Gael/0000-0002-8830-963X	Swedish Research Council [2010-4654]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council, Grant Nr. 2010-4654. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhitya S, 2011, P 17 INT C AUD DISPL; Adhitya S., 2012, P 9 SOUND MUS COMP C, P171; Ahmad A, 2010, OPT EXPRESS, V18, P9934, DOI 10.1364/OE.18.009934; Alexander RL, 2010, P 16 INT C AUD DISPL, P39; Anderson J, 2000, P 5 AUSTR AV PSYCH S; [Anonymous], 2007, P INT COMM AUD DISPL; [Anonymous], 1998, GREEK ROMAN TECHNOLO; [Anonymous], 2010, P INT SON WORKSH ISO; Anselmetti D, 2004, P 1 INT WORKSH INT S; Arfib D, 2002, ORGANISED SOUND, V7, P135; Baier G, 2007, P 13 INT C AUD DISPL, P491; Baier G, 2004, P 10 INT C AUD DISPL; Baier G., 2006, P 12 INT C AUD DISPL, P148; Baier G, 2007, CLIN NEUROPHYSIOL, V118, P1377, DOI 10.1016/j.clinph.2007.01.025; Barrass S., 2011, SONIFICATION HDB, P145; Barrass S., 2010, P ISON 2010 3 INT SO, P23; Barrass S., 2000, PROC INT C AUDITORY, P72; Bearman NE, 2011, P 17 INT C AUD DISPL; Bearman NE, 2012, P 18 INT C AUD DISPL, P231; Bearman N, 2012, COMPUT GEOSCI-UK, V46, P157, DOI 10.1016/j.cageo.2011.12.001; Bearman N, 2010, CARTOGR J, V47, P308, DOI 10.1179/000870410X12911302296833; Beilharz K, 2005, Computer Aided Architectural Design Futures 2005, Proceedings, P361, DOI 10.1007/1-4020-3698-1_34; Beilharz K, 2005, P 2 AUSTR C INT ENT, P11; Beilharz K, 2004, INTERACTION SYSTEMS, P75; Beilharz K, 2005, P 11 INT C AUD DISPL, P105; Birbaumer N, 2004, P 10 INT C AUD DISPL, P158; Bologna G, 2005, LECT NOTES COMPUT SC, V3561, P327; Bologna G, 2008, IEEE IJCNN, P1621, DOI 10.1109/IJCNN.2008.4634014; Bologna G, 2009, NEUROCOMPUTING, V72, P839, DOI 10.1016/j.neucom.2008.06.020; Bologna G, 2007, EURASIP J IMAGE VIDE, V2007; Bologna G, 2007, LECT NOTES COMPUT SC, V4528, P81; Bologna G, 2011, NEUROCOMPUTING, V74, P1182, DOI 10.1016/j.neucom.2010.07.022; Bologna G, 2009, LECT NOTES COMPUT SC, V5602, P235, DOI 10.1007/978-3-642-02267-8_26; Brazil E., 2011, SONIFICATION HDB, P325; Brown E, 2012, SIGNIFICANCE, V9, P14, DOI DOI 10.1111/J.1740-9713.2012.00601.X; Brunelli D, 2006, FOURTH ANNUAL IEEE INTERNATIONAL CONFERENCE ON PERVASIVE COMPUTING AND COMMUNICATIONS WORKSHOPS, PROCEEDINGS, P527, DOI 10.1109/PERCOMW.2006.27; Chen Y., 2006, P 14 ACM INT C MULT, P763, DOI [DOI 10.1145/1180639.1180804, 10.1145/1180639, DOI 10.1145/1180639]; Chiari L, 2005, IEEE T BIO-MED ENG, V52, P2108, DOI 10.1109/TBME.2005.857673; Childs E., 2003, P 2003 INT C AUD DIS, P192; d'Arsonval JA, 1878, CR HEBD ACAD SCI, V86, P832; Deville B, 2009, LECT NOTES COMPUT SC, V5440, P251, DOI 10.1007/978-3-642-00437-7_10; Diennet J, 2007, P MUTAMORPHOSIS CHAL; Diennet J, 2004, STRUCTURE SPECTACLES; Dombois F., 2011, SONIFICATION HDB, P301; Dozza M, 2005, ARCH PHYS MED REHAB, V86, P1401, DOI 10.1016/j.apmr.2004.12.036; Dozza Marco, 2005, J Neuroeng Rehabil, V2, P13, DOI 10.1186/1743-0003-2-13; Dubus G., 2011, 17 INT C AUD DISPL I; Effenberg A. O, 2001, P 6 ANN C EUR COLL S, P122; Effenberg AO, 2005, IEEE MULTIMEDIA, V12, P53, DOI 10.1109/MMUL.2005.31; Effenberg AO, 2007, P 2 INT WORKSH INT S; Effenberg AO, 2003, P 8 ANN C EUR COLL S, P196; Effenberg AO, 1999, MOTORIK, V22, P150; El-Shimy D, 2012, J MULTIMODAL USER IN, V5, P131, DOI 10.1007/s12193-011-0065-5; Eriksson M, 2011, J SPORT SCI, V29, P253, DOI 10.1080/02640414.2010.523088; Eslambolchilar P, 2004, P 1 INT WORKSH INT S; Filatriau JJ, 2008, P 14 INT C AUD DISPL; Frohlich B., 1999, Proceedings Visualization '99 (Cat. No.99CB37067), P169, DOI 10.1109/VISUAL.1999.809884; GAIZAUSKAS BR, 1974, J ROY ASTRON SOC CAN, V68, P146; Garcia-Ruiz MA, 2006, INTERACT COMPUT, V18, P853, DOI 10.1016/j.intcom.2005.12.001; Garrison D. R., 2006, INTERNET HIGH EDUC, V9, P1, DOI [10.1016/j.iheduc.2005.11.001, DOI 10.1016/J.IHEDUC.2005.11.001]; Gaver W. W., 1986, HUMAN COMPUTER INTER, V2, p[2, 167], DOI DOI 10.1207/S15327051HCI0202_3; GAVER WW, 1993, ECOL PSYCHOL, V5, P1, DOI 10.1207/s15326969eco0501_1; Giansanti D, 2009, MED ENG PHYS, V31, P48, DOI 10.1016/j.medengphy.2008.04.004; Gibet S, 2010, MUSICAL GESTURES, P212; Gill T, 2004, P 2004 ANN C COMP HU; Gobin P, 2004, LECT NOTES COMPUT SC, V2771, P225; Godbout A., 2010, P 16 INT C AUD DISPL, P23; GOMEZ JD, 2010, P 12 INT ACM SIGACCE, P245; Grond F, 2008, P 14 INT C AUD DISPL; Grond F., 2011, SONIFICATION HDB, P363, DOI DOI 10.1080/13658816.2017.1420192; Grond F, 2012, AI SOC, V27, P213, DOI 10.1007/s00146-011-0341-7; Harada S, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P2779; Harding C, 2002, COMPUT GRAPH-UK, V26, P259, DOI 10.1016/S0097-8493(02)00057-2; Harding C, 2000, LECT NOTES COMPUT SC, V1948, P615; Henkelmann Christoph, 2007, CG20074 U BONN; Hermann T, 2005, IEEE MULTIMEDIA, V12, P20, DOI 10.1109/MMUL.2005.26; Hermann T, 2004, P IEEE, V92, P730, DOI 10.1109/JPROC.2004.825904; Hermann T, 2004, IEEE INFOR VIS, P871, DOI 10.1109/IV.2004.1320243; Hermann T, 2002, P 8 INT C AUD DISPL, P37; Hermann T, 2011, SONIFICATION HDB, P1; Hermann T., 1999, ADV INTELLIGENT COMP, P189; Hermann T, 2010, SONIFICATION DEFINIT; Hermann T, 2002, P INT C AUD DISPL IC, P82; Hermann T., 2006, P 12 INT C AUD DISPL, P158; Hermann T., 2012, P 18 INT C AUD DISPL, P60; Hermann T, 2004, P 10 INT C AUD DISPL; Hermann T, 2008, P 14 INT C AUD DISPL; Hermann T, 2009, TECHNICAL REPORT; Hermann T, 2010, P 16 INT C AUD DISPL, P301; Hermann T., 2011, SONIFICATION HDB, P399; Hermann T., 2000, P INT C AUD DISPL, P81; Hermann Thomas, 2011, SONIFICATION HDB; Hinterberger T, 2005, IEEE MULTIMEDIA, V12, P70, DOI 10.1109/MMUL.2005.36; Hinterberger T, 2004, EXP BRAIN RES, V154, P521, DOI 10.1007/s00221-003-1690-3; Hinterberger T, 2003, I IEEE EMBS C NEUR E, P603, DOI 10.1109/CNE.2003.1196900; Hinterberger T., 2007, P 2 INT WORKSH INT S; Huang H, 2005, P ANN INT IEEE EMBS, P2547; Huang H, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-11; Hughes DE, 1881, P ROY SOC LONDON, V32, P213; Jacobson RD, 2007, P 13 INT C AUD DISPL, P530; Jeon M., 2012, P 18 INT C AUDITORY, P246; Jie Xu, 2010, 2010 IEEE International Conference on Industrial Engineering & Engineering Management (IE&EM 2010), P2435, DOI 10.1109/IEEM.2010.5674377; Jones D, 2008, LECT NOTES COMPUT SC, V4974, P423; Jovanov E, 1999, IEEE Trans Inf Technol Biomed, V3, P109, DOI 10.1109/4233.767086; Jovanov E, 1999, IEEE ENG MED BIOL, V18, P50, DOI 10.1109/51.740964; Jovanov E, 1999, FUTURE GENER COMP SY, V15, P255, DOI 10.1016/S0167-739X(98)00068-5; Jovanov E, 1999, LECT NOTES COMPUT SC, V1593, P964; Joy J, 2012, AI SOC, V27, P233, DOI 10.1007/s00146-011-0343-5; Junior EA, 1996, P 3 INT C AUD DISPL, P9; Kay L., 1974, Radio and Electronic Engineer, V44, P605, DOI 10.1049/ree.1974.0148; KAY L, 1984, IEE PROC-A, V131, P559, DOI 10.1049/ip-a-1.1984.0071; Kay L, 1968, US Patent, Patent No. 3366922; Kay L., 1964, ULTRASONICS, V2, P53, DOI 10.1016/0041-624X(64)90382-8; Kay L, 1966, J ACOUST SOC AM, V40, P1564; Kay L, 1962, J BR I RADIO ENG, V24, P309; Kay L, 1964, GB Patent, Patent No. 978742; Kazakevich M, 2006, P 5 IEEE INT WORKSH, P15; Kleimann-Weiner J., 2006, P 12 INT C AUD DISPL, P278; Kopecek I, 2008, THIRD 2008 INTERNATIONAL CONFERENCE ON CONVERGENCE AND HYBRID INFORMATION TECHNOLOGY, VOL 2, PROCEEDINGS, P722, DOI 10.1109/ICCIT.2008.152; Kovaric AF, 1917, PHYS REV, V9, P567; Kramer G, 1999, TECHNICAL REPORT; Kramer G., 1994, AUDITORY DISPLAY SON; Krishnan S, 2001, J ACOUST SOC AM, V110, P3292, DOI 10.1121/1.1413995; Krishnan S, 2000, P ANN INT IEEE EMBS, V22, P1995, DOI 10.1109/IEMBS.2000.900486; Kronland-Martinet R, 2008, EURASIP J AUDIO SPEE, DOI 10.1155/2008/849696; Kronland-Martinet R, 2000, TECHNICAL REPORT; Kronland-Martinet R, 2012, AI SOC, V27, P307, DOI 10.1007/s00146-011-0353-3; Larkin O., 2008, P 14 INT C AUD DISPL; Mansur D L, 1985, J Med Syst, V9, P163, DOI 10.1007/BF00996201; Maria R, 2006, P ACOUSTICS 2006 CHR, P383; Martins ACG, 2001, J ELECTRON IMAGING, V10, P690, DOI 10.1117/1.1382811; Martins ACG, 1997, P 4 INT C AUD DISPL, P129; Mattes K, 2012, P 18 INT C AUD DISPL, P83; McGookin D, 2011, SONIFICATION HDB, P339; McMullen SC, 2010, P 28 ACM C HUM FACT, P3001; Meinicke P., 2004, Intelligent Data Analysis, V8, P97; Milios E, 2003, IEEE T NEUR SYS REH, V11, P416, DOI 10.1109/TNSRE.2003.819645; Monache Stefano Delle, 2010, P 5 AUD MOSTL C C IN, P1; MUNEMORI J, 1991, INFORM SOFTWARE TECH, V33, P259, DOI 10.1016/0950-5849(91)90150-A; Munemori J, 2012, P ACM 2012 C COMP SU, P147; Murgia M., 2012, REV PSYCHOL, V19, P13; Nasir T, 2009, 2009 IEEE INTERNATIONAL WORKSHOP ON HAPTIC AUDIO VISUAL ENVIRONMENT AND GAMES, P141, DOI 10.1109/HAVE.2009.5356116; Ng K, 2007, ICMI'07: PROCEEDINGS OF THE NINTH INTERNATIONAL CONFERENCE ON MULTIMODAL INTERFACES, P339; Noirhomme-Fraiture M, 2008, LECT NOTES COMPUT SC, V4404, P236, DOI 10.1007/978-3-540-71080-6_15; O'Neill C, 2008, FOURTH INTERNATIONAL CONFERENCE ON AUTOMATED SOLUTIONS FOR CROSS MEDIA CONTENT AND MULTI-CHANNEL DISTRIBUTION, PROCEEDINGS, P25, DOI 10.1109/AXMEDIS.2008.42; Palomaki H, 2006, P 12 INT C AUD DISPL, P99; Patel AD, 2008, MUSIC LANGUAGE BRAIN, P7; Pauletto S., 2006, PROC 12 INT C AUDIT, P152; Pauletto S, 2004, P 1 INT WORKSH INT S; Pauletto S, 2004, P 10 INT C AUD DISPL; Pauletto S, 2009, INT J HUM-COMPUT ST, V67, P923, DOI 10.1016/j.ijhcs.2009.05.006; Pendse Anandi, 2008, P 10 INT ACM SIGACCE, P297, DOI 10.1002/acp.1291; Pirhonen A., 2007, P 13 INT C AUD DISPL, P319; Pirhonen A, 2008, P 14 INT C AUD DISPL; POLLACK I, 1954, J ACOUST SOC AM, V26, P155, DOI 10.1121/1.1907300; Polzer BO, 2008, KATALOG WIEN MODERN, P25; Pun T, 2011, P 17 INT C AUD DISPL; Pun T, 2010, P 16 INT C AUD DISPL, P9; Pun T, 2008, P 14 INT C AUD DISPL; Rangayyan RM, 1996, P SOC PHOTO-OPT INS, V2656, P283, DOI 10.1117/12.234688; Rasch R., 1999, PSYCHOL MUSIC, V2, P89; REUTER LH, 1990, PROCEEDINGS OF THE FIRST IEEE CONFERENCE ON VISUALIZATION - VISUALIZATION 90, P401; Ritter HJ, 2005, ACM T APPL PERCEPT, V2, P550; Russell WJ, 2003, P 2003 ANN C COMP HU, P128; Sanderson P., 2004, Cognition, Technology & Work, V6, P172, DOI 10.1007/s10111-004-0159-x; Sanderson PM, 2008, ANESTH ANALG, V106, P1787, DOI 10.1213/ane.0b013e31817325cb; Sanderson PM, 2005, ANAESTHESIA, V60, P1073, DOI 10.1111/j.1365-2044.2005.04377.x; Sanderson PM, 2004, P 2004 ANN C COMP HU; Sanderson PM, 2001, P HUM FACT ERG SOC 4, P1293; Sanderson PM, 2003, P 47 ANN M HUM FACT, P1574; Sanderson PM, 2002, P JOINT ESA CHISIG C; Sanderson PM, 2006, US Patent, Patent No. 7070570; Sands Philippe, 2003, P 39 ANN C ERG SOC A, P48; Sarkar R., 2012, Proceedings of the 2012 1st International Conference on Recent Advances in Information Technology (RAIT 2012), P86, DOI 10.1109/RAIT.2012.6194485; Saue S, 2000, P 6 INT C AUD DISPL, P105; Saue S, 1997, P 4 INT C AUD DISPL, P47; Scaletti C, 1994, SFI STUD SCI COMPL P, P223; Schaffert N, 2009, P 2 INT C MUS COMM S, P83; Schaffert N., 2010, HUMAN INTERACTION AU, P31; Schaffert N, 2009, P 15 INT C AUD DISPL, P72; Schaffert N, 2008, 8 WORLD C PERF AN SP, P210; Schaffert N, 2011, P 17 INT C AUD DISPL; Schaffert N, 2011, J HUM SPORT EXERC, V6, P392, DOI 10.4100/jhse.2011.62.20; Schaffert N, 2012, J AUDIO ENG SOC, V60, P551; Schaffert N, 2010, LECT NOTES COMPUT SC, V5954, P143; Schaffert Nina, 2011, P 6 AUD MOSTL C AM 1, P122, DOI DOI 10.1145/2095667.2095685; Scheef L, 2009, BRAIN RES, V1252, P94, DOI 10.1016/j.brainres.2008.10.067; Sethares WA, 2007, RHYTHM TRANSFORMS, P6; Sigrist R, 2013, PSYCHON B REV, V20, P21, DOI 10.3758/s13423-012-0333-8; SPEETH SD, 1961, J ACOUST SOC AM, V33, P909, DOI 10.1121/1.1908843; Stergiopoulos S, 1999, J ACOUST SOC AM, V105, P980; Stevens SS, 1941, AM J PSYCHOL, V53, P329; Sturm BL, 2000, P 6 INT C AUD DISPL, P87; Supper A., 2012, OXFORD HDB SOUND STU, P249; Takahashi Y, 2011, P 8 SOUND MUS COMP C, P77; Taylor R, 2007, LECT NOTES COMPUT SC, V4569, P182; Thompson J, 2009, INT J HUM-COMPUT ST, V67, P934, DOI 10.1016/j.ijhcs.2009.05.005; Valenti R., 2010, P 18 ACM INT C MULTI, P1363; Vallee C, 2002, LEONARDO, V35, P129, DOI 10.1162/00240940252940478; Vallee C, 2000, TECHNICAL REPORT; Varni G, 2012, J MULTIMODAL USER IN, V5, P157, DOI 10.1007/s12193-011-0079-z; Vickers P., 2006, P 12 INT C AUD DISPL, P210; Vogt K, 2010, THESIS U MUSIC PERFO; Vogt K, 2011, P 17 INT C AUD DISPL; Walker B, 2011, SONIFICATION HDB, P9; Walker B. N., 2010, ACM T ACCESSIBLE COP, V2, DOI DOI 10.1145/1714458.1714459; Walker B.N., 2001, P 7 INT C AUDITORY D, P90; Walker B. N., 2000, P INT C AUD DISPL AT, P99; Walker B. N., 2006, P 12 INT C AUD DISPL, P238; Walker B.N., 2005, ACM T APPL PERCEPT, V2, P407, DOI [10.1145/1101530.1101534, DOI 10.1145/1101530.1101534]; Walker BN, 2002, J EXP PSYCHOL-APPL, V8, P211, DOI 10.1037/1076-898X/8.4.211; Walker BN, 2007, P INT COMP MUS C ICM, P268; Walker BN, 2004, P 10 INT C AUD DISPL; Walker BN, 2000, THESIS RICE U HOUSTO; Walker BN, 2001, P 7 INT C AUD DISPL, P281; Walker BN, 2007, APPL COGNITIVE PSYCH, V21, P579, DOI 10.1002/acp.1291; Walker BN, 2013, HUM FACTORS, V55, P157, DOI 10.1177/0018720812450587; Walker Bruce N., 1996, P 3 INT C AUD DISPL P 3 INT C AUD DISPL, P71; Watson M, 2004, HUM FACTORS, V46, P497, DOI 10.1518/hfes.46.3.497.50401; Watson M., 2000, Australian Journal of Information Systems, V7, P109; Watson M, 2004, INTERACT COMPUT, V16, P271, DOI 10.1016/j.intcom.2003.12.002; Watson M, 1998, OZCHI 98 - 1998 AUSTRALASIAN COMPUTER HUMAN INTERACTION CONFERENCE, PROCEEDINGS, P228, DOI 10.1109/OZCHI.1998.732219; Watson M., 2006, P 12 INTERNATION C A, P59; Watson MO, 2007, HUM FACTORS, V49, P331, DOI 10.1518/001872007X312531; Watson MO, 2006, WO Patent, Patent No. [2006/079148, 2006079148]; Wilde D., 2008, INT J PERFORMING ART, V4, P7; Wilde D, 2012, P 30 ACM C HUM FACT, P111; Wilde Danielle, 2011, INT J DISABILITY HUM, DOI [10.1515/IJDHD.2011.004, DOI 10.1515/IJDHD.2011.004]; Wilde Danielle, 2008, P 20 AUSTR C COMP HU, P259, DOI DOI 10.1145/1517744.1517771; Williamson J, 2010, HUM-COMPUT INT-SPRIN, P233, DOI 10.1007/978-1-84882-733-2_12; Winton R, 2012, P 18 INT C AUD DISPL, P218; Worrall D, 2009, THESIS U CANBERRA CA; YEUNG ES, 1980, ANAL CHEM, V52, P1120, DOI 10.1021/ac50057a028; Zhao H, 2004, P 10 INT C AUD DISPL; Zhao H, 2005, P 23 ACM C HUM FACT, P1134; Zhao H, 2008, ACM T COMPUT-HUM INT, V15, DOI 10.1145/1352782.1352786; Zhao HX, 2005, IEEE MULTIMEDIA, V12, P26, DOI 10.1109/MMUL.2005.28	237	108	108	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82491	10.1371/journal.pone.0082491	http://dx.doi.org/10.1371/journal.pone.0082491			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358192	Green Submitted, gold, Green Published			2022-12-27	WOS:000328737700019
J	Rivera-Ordaz, A; Bracher, S; Sarrach, S; Li, Z; Shi, L; Quick, M; Hilger, D; Haas, R; Jung, H				Rivera-Ordaz, Araceli; Bracher, Susanne; Sarrach, Sannia; Li, Zheng; Shi, Lei; Quick, Matthias; Hilger, Daniel; Haas, Rainer; Jung, Heinrich			The Sodium/Proline Transporter PutP of Helicobacter pylori	PLOS ONE			English	Article							ESCHERICHIA-COLI; NA+/PROLINE TRANSPORTER; TRANSMEMBRANE SEGMENT; CRYSTAL-STRUCTURE; SYMPORTER FAMILY; GASTRIC-CANCER; PROLINE UPTAKE; NA+; BINDING; PROTEIN	Helicobacter pylori is cause of chronic gastritis, duodenal ulcer and gastric carcinoma in humans. L-proline is a preferred energy source of the microaerophilic bacterium. Previous analyses revealed that HpputP and HpputA, the genes that are predicted to play a central role in proline metabolism as they encode for the proline transporter and proline dehydrogenase, respectively, are essential for stomach colonization. Here, the molecular basis of proline transport in H. pylori by HpPutP was investigated experimentally for the first time. Measuring radiolabeled substrate transport in H. pylori and E. coli heterologously expressing HpputP as well as in proteoliposomes reconstituted with HpPutP, we demonstrate that the observed proline transport in H. pylori is mediated by HpPutP. HpPutP is specific and exhibits a high affinity for L-proline. Notably, L-proline transport is exclusively dependent on Na+ as coupling ion, i.e., Na+/L-proline symport, reminiscent to the properties of PutP of E. coli even though H. pylori lives in a more acidic environment. Homology model-based structural comparisons and substitution analyses identified amino acids crucial for function. HpPutP-catalyzed proline uptake was efficiently inhibited by the known proline analogs 3,4-dehydro-D, L-proline and L-azetidine-2-carboxylic acid.	[Rivera-Ordaz, Araceli; Bracher, Susanne; Sarrach, Sannia; Hilger, Daniel; Jung, Heinrich] Univ Munich, Dept Biol 1, Martinsried, Germany; [Li, Zheng; Shi, Lei] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA; [Shi, Lei] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY USA; [Quick, Matthias] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Quick, Matthias] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Haas, Rainer] Univ Munich, Max von Pettenkofer Inst Hyg & Med Microbiol, Munich, Germany	University of Munich; Cornell University; Cornell University; Columbia University; Columbia University; University of Munich	Jung, H (corresponding author), Univ Munich, Dept Biol 1, Martinsried, Germany.	hjung@lmu.de	Hilger, Daniel/C-7297-2019; Shi, Lei/AAV-1321-2020; Jung, Heinrich/K-3790-2014; Ordaz, Araceli Rivera/AAB-9260-2019	Hilger, Daniel/0000-0001-5179-1357; Shi, Lei/0000-0002-4137-096X; Jung, Heinrich/0000-0002-5450-3063; 	Deutsche Forschungsgemeinschaft [JU333/3-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was funded by the Deutsche Forschungsgemeinschaft grant JU333/3-3 to HJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Aslan M, 2007, CLIN BIOCHEM, V40, P37, DOI 10.1016/j.clinbiochem.2006.08.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN CC, 1985, J MEMBRANE BIOL, V84, P157, DOI 10.1007/BF01872213; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; Dailidiene D, 2006, APPL ENVIRON MICROB, V72, P5908, DOI 10.1128/AEM.01135-06; De la Vieja A, 2007, J BIOL CHEM, V282, P25290, DOI 10.1074/jbc.M700147200; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; Guan L, 2007, NAT PROTOC, V2, P2012, DOI 10.1038/nprot.2007.275; HAAS R, 1993, MOL MICROBIOL, V8, P753, DOI 10.1111/j.1365-2958.1993.tb01618.x; Hilger D, 2008, J BIOL CHEM, V283, P4921, DOI 10.1074/jbc.M706741200; Hofreuter D, 2002, J BACTERIOL, V184, P2755, DOI 10.1128/JB.184.10.2755-2766.2002; HOLLOWAY PW, 1973, ANAL BIOCHEM, V53, P304, DOI 10.1016/0003-2697(73)90436-3; Jung H, 1998, BBA-BIOENERGETICS, V1365, P60, DOI 10.1016/S0005-2728(98)00044-9; Jung H, 1998, BIOCHEMISTRY-US, V37, P11083, DOI 10.1021/bi980684b; Jung H, 2002, FEBS LETT, V529, P73, DOI 10.1016/S0014-5793(02)03184-8; Jung H, 2001, MICROBIAL TRANSPORT, P47; Kavermann H, 2003, J EXP MED, V197, P813, DOI 10.1084/jem.20021531; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Krishnan N, 2006, J BACTERIOL, V188, P1227, DOI 10.1128/JB.188.4.1227-1235.2006; Liao MK, 2001, AMINO ACIDS, V21, P161, DOI 10.1007/s007260170023; Marais A, 1999, MICROBIOL MOL BIOL R, V63, P642, DOI 10.1128/MMBR.63.3.642-674.1999; MARSHALL BJ, 1984, LANCET, V1, P1311; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mazier S, 2011, J BIOL CHEM, V286, P29347, DOI 10.1074/jbc.M111.263327; McNamara D, 2008, DIGEST LIVER DIS, V40, P504, DOI 10.1016/j.dld.2008.02.031; Nagata K, 2003, MICROBIOL-SGM, V149, P2023, DOI 10.1099/mic.0.26203-0; Nakajima K, 2008, BIOMED RES-TOKYO, V29, P9, DOI 10.2220/biomedres.29.9; Olkhova E, 2011, J MOL BIOL, V406, P59, DOI 10.1016/j.jmb.2010.11.045; Petzold K, 2009, J AM CHEM SOC, V131, P14150, DOI 10.1021/ja905282h; Pirch T, 2002, J BIOL CHEM, V277, P8790, DOI 10.1074/jbc.M111008200; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; POWELL JJ, 1992, GUT, V33, P1617, DOI 10.1136/gut.33.12.1617; Quick M, 1996, EUR J BIOCHEM, V239, P732, DOI 10.1111/j.1432-1033.1996.0732u.x; Quick M, 1997, BIOCHEMISTRY-US, V36, P4631, DOI 10.1021/bi963063w; Racher KI, 1999, BIOCHEMISTRY-US, V38, P1676, DOI 10.1021/bi981279n; Rohrer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045623; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Shimomura H, 2012, J BACTERIOL, V194, P2658, DOI 10.1128/JB.00105-12; STALMACH ME, 1983, J BACTERIOL, V156, P481, DOI 10.1128/JB.156.2.481-486.1983; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; van Amsterdam K, 2004, HELICOBACTER, V9, P614, DOI 10.1111/j.1083-4389.2004.00272.x; Wood JM, 2007, METHOD ENZYMOL, V428, P77, DOI 10.1016/S0076-6879(07)28005-X; WOOD JM, 1979, CAN J BIOCHEM CELL B, V57, P1191, DOI 10.1139/o79-155; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	50	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83576	10.1371/journal.pone.0083576	http://dx.doi.org/10.1371/journal.pone.0083576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358297	gold, Green Published, Green Submitted			2022-12-27	WOS:000328737700062
J	Yeheskely-Hayon, D; Kotler, A; Stark, M; Hashimshony, T; Sagee, S; Kassir, Y				Yeheskely-Hayon, Daniella; Kotler, Anat; Stark, Michal; Hashimshony, Tamar; Sagee, Shira; Kassir, Yona			The Roles of the Catalytic and Noncatalytic Activities of Rpd3L and Rpd3S in the Regulation of Gene Transcription in Yeast	PLOS ONE			English	Article							MEIOTIC RECOMBINATION CHECKPOINT; HISTONE DEACETYLASE COMPLEX; MEIOSIS-SPECIFIC GENES; BIDIRECTIONAL PROMOTERS; NEGATIVE REGULATOR; POSITIVE REGULATOR; SPORE FORMATION; ACETYLATION; EXPRESSION; REPRESSION	In budding yeasts, the histone deacetylase Rpd3 resides in two different complexes called Rpd3L (large) and Rpd3S (small) that exert opposing effects on the transcription of meiosis-specific genes. By introducing mutations that disrupt the integrity and function of either Rpd3L or Rpd3S, we show here that Rpd3 function is determined by its association with either of these complexes. Specifically, the catalytic activity of Rpd3S activates the transcription of the two major positive regulators of meiosis, IME1 and IME2, under all growth conditions and activates the transcription of NDT80 only during vegetative growth. In contrast, the effects of Rpd3L depends on nutrients; it represses or activates transcription in the presence or absence of a nitrogen source, respectively. Further, we show that transcriptional activation does not correlate with histone H4 deacetylation, suggesting an effect on a nonhistone protein. Comparison of rpd3-null and catalytic-site point mutants revealed an inhibitory activity that is independent of either the catalytic activity of Rpd3 or the integrity of Rpd3L and Rpd3S.	[Yeheskely-Hayon, Daniella; Kotler, Anat; Stark, Michal; Hashimshony, Tamar; Sagee, Shira; Kassir, Yona] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Kassir, Y (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	ykassir@tx.technion.ac.il	Stark, Michal/AAH-1763-2022; Stark, Michal/AFL-9651-2022	Stark, Michal/0000-0002-4712-7696; Stark, Michal/0000-0002-4712-7696	ISF - Israel Science Foundation	ISF - Israel Science Foundation(Israel Science Foundation)	ISF - Israel Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; ANDERSON SF, 1995, PROTEIN SCI, V4, P1832, DOI 10.1002/pro.5560040918; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Biswas D, 2008, MOL CELL BIOL, V28, P4445, DOI 10.1128/MCB.00164-08; BOWDISH KS, 1993, MOL CELL BIOL, V13, P2172, DOI 10.1128/MCB.13.4.2172; Burgess SM, 1999, P NATL ACAD SCI USA, V96, P6835, DOI 10.1073/pnas.96.12.6835; Carrozza MJ, 2005, BBA-GENE STRUCT EXPR, V1731, P77, DOI 10.1016/j.bbaexp.2005.09.005; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chen XF, 2012, CURR BIOL, V22, P56, DOI 10.1016/j.cub.2011.11.042; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Collart MA, 2001, CURRENT PROTOCOLS MO, V12; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Duffy SK, 2012, CELL, V149, P936, DOI 10.1016/j.cell.2012.02.064; Foiani M, 1996, MOL GEN GENET, V253, P278, DOI 10.1007/s004380050323; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Gray SG, 2001, EXP CELL RES, V262, P75, DOI 10.1006/excr.2000.5080; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gurevich V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011005; Hepworth SR, 1998, MOL CELL BIOL, V18, P5750, DOI 10.1128/MCB.18.10.5750; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Kadosh D, 1998, MOL CELL BIOL, V18, P5121, DOI 10.1128/MCB.18.9.5121; Kadosh D, 1998, GENE DEV, V12, P797, DOI 10.1101/gad.12.6.797; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kahana S, 2010, GENETICS, V186, P829, DOI 10.1534/genetics.110.122200; KASSIR Y, 1991, METHOD ENZYMOL, V194, P94; Kassir Y, 2003, INT REV CYTOL, V224, P111, DOI 10.1016/S0074-7696(05)24004-4; KASSIR Y, 1988, CELL, V52, P853, DOI 10.1016/0092-8674(88)90427-8; Kasten MM, 1997, MOL CELL BIOL, V17, P4852, DOI 10.1128/MCB.17.8.4852; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim GW, 2011, TRENDS BIOCHEM SCI, V36, P211, DOI 10.1016/j.tibs.2010.10.001; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; Kremer SB, 2009, J BIOL CHEM, V284, P32914, DOI 10.1074/jbc.M109.058610; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lechner T, 2000, J BIOL CHEM, V275, P40961, DOI 10.1074/jbc.M005730200; Mallory MJ, 2007, MOL CELL, V27, P951, DOI 10.1016/j.molcel.2007.08.019; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Nusinzon Inna, 2005, Sci STKE, V2005, pre11, DOI 10.1126/stke.2962005re11; Pak J, 2002, MOL CELL BIOL, V22, P6430, DOI 10.1128/MCB.22.18.6430-6440.2002; Pak J, 2002, MOL CELL BIOL, V22, P6417, DOI 10.1128/MCB.22.18.6417-6429.2002; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; Pnueli L, 2004, MOL CELL BIOL, V24, P5197, DOI 10.1128/MCB.24.12.5197-5208.2004; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; ROSE M, 1983, METHOD ENZYMOL, V101, P167; Rose MD., 1990, METHODS YEAST GENETI; Rubinstein A, 2007, P NATL ACAD SCI USA, V104, P6241, DOI 10.1073/pnas.0611168104; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Sagee S, 1998, MOL CELL BIOL, V18, P1985, DOI 10.1128/MCB.18.4.1985; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Shenhar G, 2001, MOL CELL BIOL, V21, P1603, DOI 10.1128/MCB.21.5.1603-1612.2001; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; SMITH HE, 1989, MOL CELL BIOL, V9, P2142, DOI 10.1128/MCB.9.5.2142; STRICH R, 1994, GENE DEV, V8, P796, DOI 10.1101/gad.8.7.796; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Takahata S, 2009, EMBO J, V28, P3378, DOI 10.1038/emboj.2009.270; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; van Werven FJ, 2012, CELL, V150, P1170, DOI 10.1016/j.cell.2012.06.049; VERSHON AK, 1992, MOL CELL BIOL, V12, P3706, DOI 10.1128/MCB.12.9.3706; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yassour M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r87; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	66	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e85088	10.1371/journal.pone.0085088	http://dx.doi.org/10.1371/journal.pone.0085088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358376	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700110
J	Chow, MJ; Choi, M; Yun, SH; Zhang, YH				Chow, Ming-Jay; Choi, Myunghwan; Yun, Seok Hyun; Zhang, Yanhang			The Effect of Static Stretch on Elastin Degradation in Arteries	PLOS ONE			English	Article							VASCULAR EXTRACELLULAR-MATRIX; BINDING-SITE AVAILABILITY; MECHANICAL-PROPERTIES; COLLAGEN; PROTEOGLYCANS; DIGESTION; STRESS; TISSUE; ORGANIZATION; AORTA	Previously we have shown that gradual changes in the structure of elastin during an elastase treatment can lead to important transition stages in the mechanical behavior of arteries [1]. However, in vivo arteries are constantly being loaded due to systolic and diastolic pressures and so understanding the effects of loading on the enzymatic degradation of elastin in arteries is important. With biaxial tensile testing, we measured the mechanical behavior of porcine thoracic aortas digested with a mild solution of purified elastase (5 U/mL) in the presence of a static stretch. Arterial mechanical properties and biochemical composition were analyzed to assess the effects of mechanical stretch on elastin degradation. As elastin is being removed, the dimensions of the artery increase by more than 20% in both the longitude and circumference directions. Elastin assays indicate a faster rate of degradation when stretch was present during the digestion. A simple exponential decay fitting confirms the time constant for digestion with stretch (0.11 +/- 0.04 h(-1)) is almost twice that of digestion without stretch (0.069 +/- 0.028 h(-1)). The transition from J-shaped to S-shaped stress vs. strain behavior in the longitudinal direction generally occurs when elastin content is reduced by about 60%. Multiphoton image analysis confirms the removal/fragmentation of elastin and also shows that the collagen fibers are closely intertwined with the elastin lamellae in the medial layer. After removal of elastin, the collagen fibers are no longer constrained and become disordered. Release of amorphous elastin during the fragmentation of the lamellae layers is observed and provides insights into the process of elastin degradation. Overall this study reveals several interesting microstructural changes in the extracellular matrix that could explain the resulting mechanical behavior of arteries with elastin degradation.	[Chow, Ming-Jay; Zhang, Yanhang] Boston Univ, Dept Mech Engn, Boston, MA 02215 USA; [Zhang, Yanhang] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Choi, Myunghwan; Yun, Seok Hyun] Harvard Univ, Wellman Ctr Photomed, Cambridge, MA 02138 USA; [Choi, Myunghwan; Yun, Seok Hyun] Massachusetts Gen Hosp, Cambridge, MA USA; [Choi, Myunghwan] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol WCU, Taejon 305701, South Korea	Boston University; Boston University; Harvard University; Harvard University; Massachusetts General Hospital; Korea Advanced Institute of Science & Technology (KAIST)	Zhang, YH (corresponding author), Boston Univ, Dept Mech Engn, Boston, MA 02215 USA.	yanhang@bu.edu		Choi, Myunghwan (Mark)/0000-0002-4235-7003	NIH [HL098028]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015903] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by a grant from the NIH (HL098028) that was provided to Dr. Zhang. The imaging work was made possible through access to Dr. Yun's lab at Wellman Center for Photomedicine, P41EB015903. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhole AP, 2009, PHILOS T R SOC A, V367, P3339, DOI 10.1098/rsta.2009.0093; Carmo M, 2002, EUR J VASC ENDOVASC, V23, P543, DOI 10.1053/ejvs.2002.1620; Cavalcante FSA, 2005, J APPL PHYSIOL, V98, P672, DOI 10.1152/japplphysiol.00619.2004; Chow MJ, 2013, BIOMECH MODEL MECHAN, V12, P361, DOI 10.1007/s10237-012-0404-9; Collins MJ, 2012, J BIOMECH, V45, P660, DOI 10.1016/j.jbiomech.2011.12.013; Dahl SLM, 2007, ANN BIOMED ENG, V35, P348, DOI 10.1007/s10439-006-9226-1; DOBRIN PB, 1984, AM J PHYSIOL, V247, pH124, DOI 10.1152/ajpheart.1984.247.1.H124; DOBRIN PB, 1978, PHYSIOL REV, V58, P397, DOI 10.1152/physrev.1978.58.2.397; Faury G, 2003, J CLIN INVEST, V112, P1419, DOI 10.1172/JCI200319028; Ferruzzi J, 2011, CARDIOVASC RES, V92, P287, DOI 10.1093/cvr/cvr195; Fonck E, 2007, AM J PHYSIOL-HEART C, V292, pH2754, DOI 10.1152/ajpheart.01108.2006; Gandley RE, 1997, AM J PHYSIOL-HEART C, V273, pH952, DOI 10.1152/ajpheart.1997.273.2.H952; Geest JPV, 2006, J BIOMECH, V39, P1324, DOI 10.1016/j.jbiomech.2005.03.003; Guo DC, 2011, CIRC-CARDIOVASC GENE, V4, P36, DOI 10.1161/CIRCGENETICS.110.958066; Hariton I, 2007, BIOMECH MODEL MECHAN, V6, P163, DOI [10.1007/s10237-006-0049-7, 10.1007/s10237-006-0019-0]; Hellenthal FAMVI, 2009, CARDIOVASC PATHOL, V18, P286, DOI 10.1016/j.carpath.2008.06.014; Holzapfel G., 2000, NONLINEAR SOLID MECH; Humphrey JD, 2009, J BIOMECH, V42, P1, DOI 10.1016/j.jbiomech.2008.11.011; Jesudason R, 2007, J APPL PHYSIOL, V103, P803, DOI 10.1152/japplphysiol.00057.2007; Jesudason R, 2010, BIOPHYS J, V99, P3076, DOI 10.1016/j.bpj.2010.09.018; Kallmes DF, 2002, AM J NEURORADIOL, V23, P295; Kelleher CM, 2004, CURR TOP DEV BIOL, V62, P153; Kim J, 2011, J BIOMECH, DOI [10.1016/j.jbiomech.2011.04.022, DOI 10.1016/J.JBI0MECH.2011.04.022]; LAKATTA EG, 1987, J AM COLL CARDIOL, V10, pA42, DOI 10.1016/S0735-1097(87)80447-3; Lee RT, 2001, J BIOL CHEM, V276, P13847, DOI 10.1074/jbc.M010556200; Lillie MA, 2010, J BIOMECH, V43, P2070, DOI 10.1016/j.jbiomech.2010.04.014; Lu QJ, 2004, BIOMATERIALS, V25, P5227, DOI 10.1016/j.biomaterials.2003.12.019; Martinez-Lemus LA, 2009, PHYSIOLOGY, V24, P45, DOI 10.1152/physiol.00029.2008; Matsumoto T., 2009, JBSE, V4, P518, DOI [10.1299/jbse.4.518, DOI 10.1299/JBSE.4.518]; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Miskolczi L, 1998, NEUROSURGERY, V43, P595, DOI 10.1097/00006123-199809000-00110; Negrini D, 1998, AM J PHYSIOL-LUNG C, V274, pL203, DOI 10.1152/ajplung.1998.274.2.L203; Pistea A, 2005, AM J PHYSIOL-HEART C, V289, pH2632, DOI 10.1152/ajpheart.00205.2005; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Satta J, 1998, EUR J VASC ENDOVASC, V15, P313, DOI 10.1016/S1078-5884(98)80034-8; Suki B, 2012, PULM PHARMACOL THER, V25, P268, DOI 10.1016/j.pupt.2011.04.027; Tanaka A, 2009, J VASC SURG, V50, P1423, DOI 10.1016/j.jvs.2009.08.062; Taylor CA, 2009, COMPUT METHOD APPL M, V198, P3514, DOI 10.1016/j.cma.2009.02.004; Valdez-Jasso D, 2011, ANN BIOMED ENG, V39, P1438, DOI 10.1007/s10439-010-0236-7; VANDELEST CHA, 1995, EUR RESPIR J, V8, P238, DOI 10.1183/09031936.95.08020238; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; WALKERCAPRIOGLIO HM, 1991, CELL TISSUE RES, V264, P63, DOI 10.1007/BF00305723; Zeinali-Davarani S, 2013, ANN BIOMED ENG, V41, P1528, DOI 10.1007/s10439-012-0733-y	43	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81951	10.1371/journal.pone.0081951	http://dx.doi.org/10.1371/journal.pone.0081951			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358135	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700029
J	Dong, GF; Wang, CZ; Wu, YH; Cong, JB; Cheng, L; Wang, MQ; Zhao, PK; Tang, L; Zhang, CG; Wu, K				Dong, Guofu; Wang, Changzhen; Wu, Yonghong; Cong, Jianbo; Cheng, Li; Wang, Mingqun; Zhao, Pengkai; Tang, Li; Zhang, Chenggang; Wu, Ke			Tat Peptide-Mediated Soluble Expression of the Membrane Protein LSECtin-CRD in Escherichia coli	PLOS ONE			English	Article							C-TYPE LECTIN; DC-SIGN; FAMILY-MEMBER; BINDING; TRANSDUCTION; GLYCOPROTEIN; MECHANISM; FUSION; CELLS	The human liver and lymph node sinusoidal endothelial cell C-type lectin (hLSECtin), a type II integral membrane protein, containing a Ca2+-dependent carbohydrate recognition domain (CRD), has a well-established biological activity, yet its three-dimensional structure is unknown due to low expression yields and aggregation into inclusion bodies. Previous study has demonstrated that the HIV-1 virus-encoded Tat peptide ('YGRKKRRQRRR') can increase the yields and the solubility of heterologous proteins. However, whether the Tat peptide could promote the high-yield and soluble expression of membrane proteins in Escherichia coli is not known. Therefore, the prokaryotic expression vector pET28b-Tat-hLSECtin-CRD (using pET28b and pET28b-hLSECtin-CRD as controls) was constructed, and transformed into E. coli BL21 (DE3) cells and induced with isopropyl-beta-d-thiogalactoside (IPTG) followed with identifying by SDS-PAGE and Western blot. Subsequently, the bacterial subcellular structure, in which overexpressed the heterologous proteins Tat-hLSECtin-CRD and Tat-free hLSECtin-CRD, was analyzed by transmission electron microscope (TEM) respectively, and the mannose-binding activity of Tat-hLSECtin-CRD was also determined. Expectedly, the solubility of Tat-LSECtin-CRD significantly increased compared to Tat-free LSECtin-CRD (**p < 0.01) with prolonged time, and the Tat-LSECtin-CRD had a significant mannose-binding activity. The subcellular structure analysis indicated that the bacterial cells overexpressed Tat-hLSECtin-CRD exhibited denser region compared with controls, while dot denser region aggregated in the two ends of bacterial cells overexpressed Tat-free hLSECtin-CRD. This study provided a novel method for improving the soluble expression of membrane proteins in prokaryotic systems by fusion with the Tat peptide, which may be potentially expanded to the expression of other membrane proteins.	[Dong, Guofu; Wang, Changzhen; Cong, Jianbo; Cheng, Li; Wang, Mingqun; Zhao, Pengkai; Wu, Ke] Beijing Inst Radiat Med, Beijing, Peoples R China; [Wu, Yonghong; Zhang, Chenggang] Cognit & Mental Hlth Res Ctr PLA, Beijing Inst Radiat Med, State Key Lab Prote, Beijing, Peoples R China; [Tang, Li] Chinese Human Genome Ctr, Beijing Inst Radiat Med, Dept Genom & Prote, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China	Tang, L (corresponding author), Chinese Human Genome Ctr, Beijing Inst Radiat Med, Dept Genom & Prote, Beijing, Peoples R China.	tangli08@yahoo.com.cn; zcgweb@126.com; wuke315@126.com	Zhang, Chenggang/B-1480-2009	Zhang, Chenggang/0000-0002-4521-3304	National Science Funds of China [31170714, 30970693]; Beijing Municipal Natural Science Foundation [7132134]	National Science Funds of China; Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by grants from the National Science Funds of China (Nos. 31170714 and 30970693), and Beijing Municipal Natural Science Foundation (No. 7132134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bowden TA, 2008, J VIROL, V82, P11628, DOI 10.1128/JVI.01344-08; Dominguez-Soto A, 2007, BLOOD, V109, P5337, DOI 10.1182/blood-2006-09-048058; Dominguez-Soto A, 2009, HEPATOLOGY, V49, P287, DOI 10.1002/hep.22678; Drew D, 2003, BBA-BIOMEMBRANES, V1610, P3, DOI 10.1016/S0005-2736(02)00707-1; East L, 2002, J BIOL CHEM, V277, P50469, DOI 10.1074/jbc.M208985200; Fagerberg L, 2010, PROTEOMICS, V10, P1141, DOI 10.1002/pmic.200900258; Farrokhi Naser, 2009, V513, P175, DOI 10.1007/978-1-59745-427-8_10; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Feinberg H, 2000, J BIOL CHEM, V275, P35176, DOI 10.1074/jbc.M005557200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Glatz JFC, 2001, J MOL NEUROSCI, V16, P123, DOI 10.1385/JMN:16:2-3:123; Gramberg T, 2005, VIROLOGY, V340, P224, DOI 10.1016/j.virol.2005.06.026; Gramberg T, 2008, VIROLOGY, V373, P189, DOI 10.1016/j.virol.2007.11.001; Granseth E, 2007, MOL MEMBR BIOL, V24, P329, DOI 10.1080/09687680701413882; Heinke F, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/790281; Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081; Huang YW, 2009, DEV COMP IMMUNOL, V33, P747, DOI 10.1016/j.dci.2008.12.007; Jimonet P, 2004, CURR OPIN DRUG DISC, V7, P325; Katzen F, 2005, TRENDS BIOTECHNOL, V23, P150, DOI 10.1016/j.tibtech.2005.01.003; Katzen F, 2009, TRENDS BIOTECHNOL, V27, P455, DOI 10.1016/j.tibtech.2009.05.005; Kim RB, 2006, MOL PHARMACEUT, V3, P26, DOI 10.1021/mp050084o; Kusumi A, 2012, SEMIN CELL DEV BIOL, V23, P126, DOI 10.1016/j.semcdb.2012.01.018; Lacapere JJ, 2007, TRENDS BIOCHEM SCI, V32, P259, DOI 10.1016/j.tibs.2007.04.001; Le YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018489; Li Y, 2009, MOL CELL BIOCHEM, V327, P183, DOI 10.1007/s11010-009-0056-y; Liu WL, 2004, J BIOL CHEM, V279, P18748, DOI 10.1074/jbc.M311227200; Lopez PHH, 2009, CURR OPIN STRUC BIOL, V19, P549, DOI 10.1016/j.sbi.2009.06.001; Luoma JI, 2008, MOL CELL ENDOCRINOL, V290, P8, DOI 10.1016/j.mce.2008.04.005; Mazzuchelli-De-Souza J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/421398; Merkulova M, 2010, PROTEIN SCI, V19, P1850, DOI 10.1002/pro.470; Midgett CR, 2007, J STRUCT BIOL, V160, P265, DOI 10.1016/j.jsb.2007.07.001; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Powlesland AS, 2008, J BIOL CHEM, V283, P593, DOI 10.1074/jbc.M706292200; Rigaud JL, 2002, BRAZ J MED BIOL RES, V35, P753, DOI 10.1590/S0100-879X2002000700001; Sanchez L, 1999, J BIOTECHNOL, V72, P13, DOI 10.1016/S0168-1656(99)00036-X; Tang L, 2010, EUR J IMMUNOL, V40, P1185, DOI 10.1002/eji.200939936; Tang L, 2009, GASTROENTEROLOGY, V137, P1498, DOI 10.1053/j.gastro.2009.07.051; Tate CG, 2003, BBA-BIOMEMBRANES, V1610, P141, DOI 10.1016/S0005-2736(02)00719-8; Wadia JS, 2003, CURR PROTEIN PEPT SC, V4, P97, DOI 10.2174/1389203033487289; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Wang CZ, 2012, APPL BIOCHEM BIOTECH, V167, P2295, DOI 10.1007/s12010-012-9766-9; White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]; Wu W, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-9; Wu YH, 2010, AMINO ACIDS, V39, P811, DOI 10.1007/s00726-010-0534-2; Yabe R, 2010, FEBS J, V277, P4010, DOI 10.1111/j.1742-4658.2010.07792.x; Zhao DY, 2013, IMMUNOBIOLOGY, V218, P602, DOI 10.1016/j.imbio.2012.07.017	48	3	4	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83579	10.1371/journal.pone.0083579	http://dx.doi.org/10.1371/journal.pone.0083579			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358298	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700134
J	Fajardo, VA; Bombardier, E; Vigna, C; Devji, T; Bloemberg, D; Gamu, D; Gramolini, AO; Quadrilatero, J; Tupling, AR				Fajardo, Val A.; Bombardier, Eric; Vigna, Chris; Devji, Tahira; Bloemberg, Darin; Gamu, Daniel; Gramolini, Anthony O.; Quadrilatero, Joe; Tupling, A. Russell			Co-Expression of SERCA Isoforms, Phospholamban and Sarcolipin in Human Skeletal Muscle Fibers	PLOS ONE			English	Article							RETICULUM CA2+ ATPASE; SLOW-TWITCH MUSCLE; SARCOPLASMIC-RETICULUM; PROTEIN EXPRESSION; GENE; TRANSPORT; ABLATION; MYOSIN; CA2+-ATPASES; ADAPTATIONS	Sarcolipin (SLN) and phospholamban (PLN) inhibit the activity of sarco(endo) plasmic reticulum Ca2+- ATPases (SERCAs) by reducing their apparent affinity for Ca2+. A ternary complex between SLN, PLN, and SERCAs results in super- inhibition of SERCA activity. Analysis of skeletal muscle homogenate has limited our current understanding of whether SLN and PLN regulate SERCA1a, SERCA2a, or both in skeletal muscle and whether SLN and PLN are coexpressed in skeletal muscle fibers. Biopsies from human vastus lateralis were analyzed through single fiber Western blotting and immunohisto/fluorescence staining to circumvent this limitation. With a newly generated SLN antibody, we report for the first time that SLN protein is present in human skeletal muscle. Addition of the SLN antibody (50 mu g) to vastus lateralis homogenates increased the apparent Ca2+ affinity of SERCA (KCa, pCa units) (- Ab, 5.85 +/- 0.02 vs. +Ab, 5.95 +/- 0.02) and maximal SERCA activity (mu mol/g protein/min) (K-ca, Ab, 122 +/- 6.4 vs. + Ab, 159 +/- 11) demonstrating a functional interaction between SLN and SERCAs in human vastus lateralis. Specifically, our results suggest that although SLN and PLN may preferentially regulate SERCA1a, and SERCA2a, respectively, physiologically they both may regulate either SERCA isoform. Furthermore, we show that SLN and PLN co- immunoprecipitate in human vastus lateralis homogenate and are simultaneously expressed in 81% of the fibers analyzed with Western blotting which implies that super- inhibition of SERCA may exist in human skeletal muscle. Finally, we demonstrate unequivocally that mouse soleus contains PLN protein suggesting that super- inhibition of SERCA may also be important physiologically in rodent skeletal muscle.	[Fajardo, Val A.; Bombardier, Eric; Vigna, Chris; Devji, Tahira; Bloemberg, Darin; Gamu, Daniel; Quadrilatero, Joe; Tupling, A. Russell] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada; [Gramolini, Anthony O.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Waterloo; University of Toronto	Tupling, AR (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada.	rtupling@uwaterloo.ca		Tupling, A. Russell/0000-0002-3895-6767	Natural Sciences and Engineering Research Council of Canada [RGPIN 311922]; Canadian Institutes of Health Research [MOP 106566]; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada [RGPIN 311922) and the Canadian Institutes of Health Research (MOP 106566) to AR Tupling. VAF was supported by a doctoral award from the Canadian Institutes of Health Research. EB and CV were supported by post-graduate scholarship doctoral awards from the Natural Sciences and Engineering Research Council of Canada. A O Gramolini is a New Investigator of HSF Canada and holds a Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahi M, 2002, J BIOL CHEM, V277, P26725, DOI 10.1074/jbc.C200269200; Autry JM, 2011, J BIOL CHEM, V286, P31697, DOI 10.1074/jbc.M111.246843; Babu GJ, 2007, J MOL CELL CARDIOL, V43, P215, DOI 10.1016/j.yjmcc.2007.05.009; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; BERGSTROM J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Bombardier E, 2013, FASEB J, V27, P3871, DOI 10.1096/fj.13-230631; Bombardier E, 2013, FEBS LETT, V587, P1687, DOI 10.1016/j.febslet.2013.04.019; BRIGGS FN, 1992, J BIOL CHEM, V267, P26056; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Damiani E, 2000, BBA-BIOMEMBRANES, V1464, P231, DOI 10.1016/S0005-2736(00)00153-X; Duhamel TA, 2007, J APPL PHYSIOL, V103, P1986, DOI 10.1152/japplphysiol.01440.2006; East JM, 2000, MOL MEMBR BIOL, V17, P189, DOI 10.1080/09687680010009646; ESSEN B, 1975, ACTA PHYSIOL SCAND, V95, P153, DOI 10.1111/j.1748-1716.1975.tb10038.x; Fajardo VA, 2013, LIPIDS, V48, P421, DOI 10.1007/s11745-013-3770-x; Fu MH, 2009, AM J PHYSIOL-HEART C, V296, pH1175, DOI 10.1152/ajpheart.01276.2008; Gorski PA, 2013, J BIOL CHEM, V288, P8456, DOI 10.1074/jbc.M112.446161; Hamalainen N, 2001, J MUSCLE RES CELL M, V22, P453, DOI 10.1023/A:1014543507149; Holloway GP, 2005, J APPL PHYSIOL, V99, P836, DOI 10.1152/japplphysiol.01407.2004; Kargacin ME, 1998, BIOCHEM J, V331, P245, DOI 10.1042/bj3310245; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Liu YW, 1997, AM J PHYSIOL-CELL PH, V273, pC1915, DOI 10.1152/ajpcell.1997.273.6.C1915; Lucas CA, 2000, BIOCHEM BIOPH RES CO, V272, P303, DOI 10.1006/bbrc.2000.2768; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; MacLennan DH, 2003, ANN NY ACAD SCI, V986, P472, DOI 10.1111/j.1749-6632.2003.tb07231.x; MACLENNAN DH, 1990, BIOPHYS J, V58, P1355, DOI 10.1016/S0006-3495(90)82482-6; MacLennan DH, 1972, COLD SPRING HARB SYM, V37, P469; McMillan EM, 2011, AM J PHYSIOL-REG I, V300, pR531, DOI 10.1152/ajpregu.00488.2010; Morita T, 2008, BIOCHEM BIOPH RES CO, V369, P188, DOI 10.1016/j.bbrc.2007.11.098; Murphy RM, 2011, J APPL PHYSIOL, V110, P820, DOI 10.1152/japplphysiol.01082.2010; Murphy RM, 2009, J PHYSIOL-LONDON, V587, P443, DOI 10.1113/jphysiol.2008.163162; Nef HM, 2009, EUR HEART J, V30, P2155, DOI 10.1093/eurheartj/ehp240; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Odermatt A, 1996, NAT GENET, V14, P191, DOI 10.1038/ng1096-191; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Pan Y, 2003, J BIOL CHEM, V278, P13367, DOI 10.1074/jbc.M213228200; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Rose AJ, 2006, J PHYSIOL-LONDON, V574, P889, DOI 10.1113/jphysiol.2006.111757; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; Salanova M, 2009, HISTOCHEM CELL BIOL, V132, P383, DOI 10.1007/s00418-009-0624-y; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; Slack JP, 1997, AM J PHYSIOL-CELL PH, V273, pC1, DOI 10.1152/ajpcell.1997.273.1.C1; Talmadge RJ, 2002, J APPL PHYSIOL, V92, P147, DOI 10.1152/japplphysiol.000247.2001; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Tupling AR, 2007, J APPL PHYSIOL, V103, P2105, DOI 10.1152/japplphysiol.00771.2007; Tupling AR, 2011, AM J PHYSIOL-CELL PH, V301, pC841, DOI 10.1152/ajpcell.00409.2010; Tupling AR, 2004, CAN J APPL PHYSIOL, V29, P308, DOI 10.1139/h04-021; Vangheluwe P, 2005, BIOCHEM J, V389, P151, DOI 10.1042/BJ20050068; Zubrzycka-Gaarn E, 1984, Prog Clin Biol Res, V168, P19	50	56	57	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84304	10.1371/journal.pone.0084304	http://dx.doi.org/10.1371/journal.pone.0084304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358354	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700162
J	Hou, JM; Song, LH; Zhang, W; Wu, WJ; Wang, J; Zhou, DQ; Qu, W; Guo, JW; Gu, SS; He, M; Xie, B; Li, HT				Hou, Jingming; Song, Lingheng; Zhang, Wei; Wu, Wenjing; Wang, Jian; Zhou, Daiquan; Qu, Wei; Guo, Junwei; Gu, Shanshan; He, Mei; Xie, Bing; Li, Haitao			Morphologic and Functional Connectivity Alterations of Corticostriatal and Default Mode Network in Treatment-Naive Patients with Obsessive-Compulsive Disorder	PLOS ONE			English	Article							GLUCOSE METABOLIC-RATE; CEREBRAL BLOOD-FLOW; RESTING-STATE; ORBITOFRONTAL CORTEX; UNMEDICATED PATIENTS; BEHAVIOR-THERAPY; MATTER CHANGES; GLOBAL SIGNAL; BRAIN; METAANALYSIS	Background: Previous studies have demonstrated that structural deficits and functional connectivity imbalances might underlie the pathophysiology of obsessive-compulsive disorder (OCD). The purpose of the present study was to investigate gray matter deficits and abnormal resting-state networks in patients with OCD and further investigate the association between the anatomic and functional alterations and clinical symptoms. Methods: Participants were 33 treatment-nave OCD patients and 33 matched healthy controls. Voxel-based morphometry was used to investigate the regions with gray matter abnormalities and resting-state functional connectivity analysis was further conducted between each gray matter abnormal region and the remaining voxels in the brain. Results: Compared with healthy controls, patients with OCD showed significantly increased gray matter volume in the left caudate, left thalamus, and posterior cingulate cortex, as well as decreased gray matter volume in the bilateral medial orbitofrontal cortex, left anterior cingulate cortex, and left inferior frontal gyrus. By using the above morphologic deficits areas as seed regions, functional connectivity analysis found abnormal functional integration in the cortical-striatum-thalamic-cortical (CSTC) circuits and default mode network. Subsequent correlation analyses revealed that morphologic deficits in the left thalamus and increased functional connectivity within the CSTC circuits positively correlated with the total Y-BOCS score. Conclusion: This study provides evidence that morphologic and functional alterations are seen in CSTC circuits and default mode network in treatment-nave OCD patients. The association between symptom severity and the CSTC circuits suggests that anatomic and functional alterations in CSTC circuits are especially important in the pathophysiology of OCD.	[Hou, Jingming; Song, Lingheng; Zhang, Wei; Wu, Wenjing; Wang, Jian; Zhou, Daiquan; Xie, Bing; Li, Haitao] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [Qu, Wei; Guo, Junwei; Gu, Shanshan; He, Mei] Third Mil Med Univ, Southwest Hosp, Dept Clin Psychol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Xie, B (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China.	xiebing6@gmail.com; liihaitao@163.com	guo, junwei/GSI-5525-2022	Hou, Jing-ming/0000-0002-8964-0359; Hou, Jingming/0000-0002-4991-7587	National Nature Science Foundation of China [81171283]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Nature Science Foundation of China (grant no. 81171283). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmari SE, 2013, SCIENCE, V340, P1234, DOI 10.1126/science.1234733; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Aouizerate B, 2004, PROG NEUROBIOL, V72, P195, DOI 10.1016/j.pneurobio.2004.02.004; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BAXTER LR, 1992, ARCH GEN PSYCHIAT, V49, P681; Beucke JC, 2013, JAMA PSYCHIAT, V70, P619, DOI 10.1001/jamapsychiatry.2013.173; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Brody AL, 1998, PSYCHIAT RES-NEUROIM, V84, P1, DOI 10.1016/S0925-4927(98)00041-9; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Cavallaro R, 2003, BIOL PSYCHIAT, V54, P437, DOI 10.1016/S0006-3223(02)01814-0; Chamberlain SR, 2008, SCIENCE, V321, P421, DOI 10.1126/science.1154433; Chamberlain SR, 2005, NEUROSCI BIOBEHAV R, V29, P399, DOI 10.1016/j.neubiorev.2004.11.006; Chang C, 2009, NEUROIMAGE, V47, P1448, DOI 10.1016/j.neuroimage.2009.05.012; Cheng YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067478; Deckersbach T, 2006, J NEUROIMAGING, V16, P1, DOI 10.1177/1051228405001474; Deckersbach T, 2002, AM J PSYCHIAT, V159, P1780, DOI 10.1176/appi.ajp.159.10.1780; Del Casale A, 2011, NEUROPSYCHOBIOLOGY, V64, P61, DOI 10.1159/000325223; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Evans DW, 2004, BRAIN COGNITION, V55, P220, DOI 10.1016/s0278-2626(03)00274-4; Exner C, 2012, PSYCHIAT RES-NEUROIM, V202, P74, DOI 10.1016/j.pscychresns.2011.10.007; Figee M, 2013, NAT NEUROSCI, V16, P386, DOI 10.1038/nn.3344; Figee M, 2011, BIOL PSYCHIAT, V69, P867, DOI 10.1016/j.biopsych.2010.12.003; Fitzgerald KD, 2010, BIOL PSYCHIAT, V68, P1039, DOI 10.1016/j.biopsych.2010.08.018; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1012; Gotts SJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00356; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Gu BM, 2008, BRAIN, V131, P155, DOI 10.1093/brain/awm277; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Harrison BJ, 2013, BIOL PSYCHIAT, V73, P321, DOI 10.1016/j.biopsych.2012.10.006; Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hoexter MQ, 2012, NEUROPSYCHOPHARMACOL, V37, P734, DOI 10.1038/npp.2011.250; Horwath E, 2000, PSYCHIAT CLIN N AM, V23, P493, DOI 10.1016/S0193-953X(05)70176-3; Hou JM, 2012, J AFFECT DISORDERS, V138, P313, DOI 10.1016/j.jad.2012.01.022; Jang JH, 2010, NEUROSCI LETT, V474, P158, DOI 10.1016/j.neulet.2010.03.031; Jung WH, 2011, ACTA PSYCHIAT SCAND, V123, P376, DOI 10.1111/j.1600-0447.2010.01659.x; Kwon JS, 2003, PSYCHIAT RES-NEUROIM, V122, P37, DOI 10.1016/S0925-4927(02)00104-X; MACHLIN SR, 1991, AM J PSYCHIAT, V148, P1240; Maltby N, 2005, NEUROIMAGE, V24, P495, DOI 10.1016/j.neuroimage.2004.08.041; Marsh R, 2009, AM J PSYCHIAT, V166, P664, DOI 10.1176/appi.ajp.2009.08091354; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Murray EA, 2007, J NEUROSCI, V27, P8166, DOI 10.1523/JNEUROSCI.1556-07.2007; Nabeyama M, 2008, PSYCHIAT RES-NEUROIM, V163, P236, DOI 10.1016/j.pscychresns.2007.11.001; O'Doherty JP, 2007, ANN NY ACAD SCI, V1121, P254, DOI 10.1196/annals.1401.036; Radua J, 2009, BRIT J PSYCHIAT, V195, P393, DOI 10.1192/bjp.bp.108.055046; Rauch SL, 1997, J NEUROPSYCH CLIN N, V9, P568; Rauch SL, 2001, BIOL PSYCHIAT, V50, P659, DOI 10.1016/S0006-3223(01)01188-X; Remijnse PL, 2006, ARCH GEN PSYCHIAT, V63, P1225, DOI 10.1001/archpsyc.63.11.1225; Rotge JY, 2008, J PSYCHIATR NEUROSCI, V33, P405; Rotge Jean-Yves, 2010, Biol Psychiatry, V67, pe37, DOI 10.1016/j.biopsych.2009.10.007; Rotge JY, 2009, BIOL PSYCHIAT, V65, P75, DOI 10.1016/j.biopsych.2008.06.019; RUBIN RT, 1992, ARCH GEN PSYCHIAT, V49, P695; Sakai Y, 2011, EUR PSYCHIAT, V26, P463, DOI 10.1016/j.eurpsy.2010.09.005; Saxena S, 2001, Semin Clin Neuropsychiatry, V6, P82, DOI 10.1053/scnp.2001.21833; Saxena S, 1999, NEUROPSYCHOPHARMACOL, V21, P683, DOI 10.1016/S0893-133X(99)00082-2; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Schwartz JM, 1996, ARCH GEN PSYCHIAT, V53, P109; Stern ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036356; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; SWEDO SE, 1989, ARCH GEN PSYCHIAT, V46, P518; Togao O, 2010, PSYCHIAT RES-NEUROIM, V184, P29, DOI 10.1016/j.pscychresns.2010.06.011; Ursu S, 2003, PSYCHOL SCI, V14, P347, DOI 10.1111/1467-9280.24411; Valente AA, 2005, BIOL PSYCHIAT, V58, P479, DOI 10.1016/j.biopsych.2005.04.021; van den Heuvel OA, 2005, ARCH GEN PSYCHIAT, V62, P301, DOI 10.1001/archpsyc.62.3.301; van den Heuvel OA, 2010, J NEUROL SCI, V289, P55, DOI 10.1016/j.jns.2009.08.043; van den Heuvel OA, 2009, BRAIN, V132, P853, DOI 10.1093/brain/awn267; van der Wee NJA, 2003, NEUROIMAGE, V20, P2271, DOI 10.1016/j.neuroimage.2003.05.001; WANG L, 2013, HUM BRAIN MAPP, P8420; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Whiteside SP, 2004, PSYCHIAT RES-NEUROIM, V132, P69, DOI 10.1016/j.pscychresns.2004.07.001; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang T, 2010, NEUROREPORT, V21, P786, DOI 10.1097/WNR.0b013e32833cadf0; ZALD DH, 2012, CORTEX CEREB CORTEX, P13934; Zarei M, 2011, BIOL PSYCHIAT, V70, P1083, DOI 10.1016/j.biopsych.2011.06.032; Zhang TJ, 2011, J PSYCHIATR NEUROSCI, V36, P23, DOI 10.1503/jpn.100006	84	41	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83931	10.1371/journal.pone.0083931	http://dx.doi.org/10.1371/journal.pone.0083931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358320	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700145
J	Nishizawa, M; Hattori, J; Shiino, T; Matano, T; Heneine, W; Johnson, JA; Sugiura, W				Nishizawa, Masako; Hattori, Junko; Shiino, Teiichiro; Matano, Tetsuro; Heneine, Walid; Johnson, Jeffrey A.; Sugiura, Wataru			Highly-Sensitive Allele-Specific PCR Testing Identifies a Greater Prevalence of Transmitted HIV Drug Resistance in Japan	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TREATMENT-NAIVE; REVERSE-TRANSCRIPTASE; IN-VIVO; MUTATIONS; FITNESS; NEVIRAPINE; POPULATIONS; THERAPY; IMPACT	Background: The transmission of drug-resistant HIV in newly identified infected populations has become an underlying epidemic which can be better assessed with sensitive resistance testing. Since minority drug resistant variants cannot be detected by bulk sequencing, methods with improved sensitivity are required. Thus, the goal of this study was to evaluate if transmitted drug resistance mutations at minority levels in Japanese patients could be identified using highly sensitive allele-specific PCR (AS-PCR). Materials and Methods: Samples were taken from newly diagnosed HIV/AIDS cases at the National Nagoya Hospital from January 2008 to December 2009. All samples were bulk sequenced for HIV protease and reverse transcriptase. To detect minority populations with drug resistance, we used AS-PCR with mutation-specific primers designed for seven reverse transcriptase inhibitor resistance mutations, M41L, K65R, K70R, K103N, Y181C, M184V, and T215F/Y, and for three protease inhibitor resistance mutations, M46I/L and L90M. Results: We studied 149 newly identified HIV cases. Bulk sequencing detected 8 cases with NRTI resistance mutations (one with A62V, one D67E, one T215D, one T215E, two with T215L and two T215S) and 15 with PI resistance mutations (one with N88D and 14 with M46I). Results obtained by AS-PCR and bulk sequencing demonstrated good concordance but the AS-PCR enabled the detection of seven additional drug-resistant cases (one M41L, two with K65R, two with K70R, and one M184V) in the RT region. Additionally, AS-PCR assays identified 15 additional cases with M46I, five with M46L and four cases with L90M in the protease region. Conclusions: Using AS-PCR substantially increased the detection of transmitted drug resistance in this population from 15.4% to 26.8%, further supporting the benefit of sensitive testing among drug-naive populations. Since the clinical impact of minority drug-resistant populations is not fully comprehended for all mutations, follow-up studies are needed to understand their significance for treatment.	[Nishizawa, Masako; Shiino, Teiichiro; Matano, Tetsuro; Sugiura, Wataru] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Hattori, Junko; Sugiura, Wataru] Nagoya Med Ctr, Natl Hosp Org, Clin Res Ctr, Nagoya, Aichi, Japan; [Heneine, Walid; Johnson, Jeffrey A.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA; [Sugiura, Wataru] Nagoya Univ, Grad Sch Med, Dept AIDS Res, Nagoya, Aichi 4648601, Japan	National Institute of Infectious Diseases (NIID); Nagoya Medical Center; Centers for Disease Control & Prevention - USA; Nagoya University	Sugiura, W (corresponding author), Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan.	wsugiura@nnh.hosp.go.jp			Ministry of Health, Labour, and Welfare of Japan [H22-AIDS-004]	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for AIDS research from the Ministry of Health, Labour, and Welfare of Japan [H22-AIDS-004]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidor B, 2013, J CLIN MICROBIOL, V51, P880, DOI 10.1128/JCM.02652-12; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Boltz VF, 2010, J VIROL METHODS, V164, P122, DOI 10.1016/j.jviromet.2009.11.025; Borroto-Esoda Katyna, 2007, Antiviral Chemistry & Chemotherapy, V18, P297; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Collins JA, 2004, J VIROL, V78, P603, DOI 10.1128/JVI.78.2.603-611.2004; Cong ME, 2007, J VIROL, V81, P3037, DOI 10.1128/JVI.02712-06; Delobel P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021655; Dudley DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036494; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Geretti AM, 2009, JAIDS-J ACQ IMM DEF, V52, P569, DOI 10.1097/QAI.0b013e3181ba11e8; Ghosn J, 2006, AIDS, V20, P159, DOI 10.1097/01.aids.0000199820.47703.a0; Goodman DD, 2011, AIDS, V25, P325, DOI 10.1097/QAD.0b013e3283427dcb; Goudsmit J, 1996, J VIROL, V70, P5662, DOI 10.1128/JVI.70.8.5662-5664.1996; Gunthard HF, 1998, AIDS RES HUM RETROV, V14, P869, DOI 10.1089/aid.1998.14.869; Halvas EK, 2006, J CLIN MICROBIOL, V44, P2612, DOI 10.1128/JCM.00449-06; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Hance AJ, 2001, J VIROL, V75, P6410, DOI 10.1128/JVI.75.14.6410-6417.2001; Hattori J, 2010, ANTIVIR RES, V88, P72, DOI 10.1016/j.antiviral.2010.07.008; Johnson JA, 2005, J INFECT DIS, V192, P16, DOI 10.1086/430741; Johnson JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000638; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; LEITNER T, 1993, BIOTECHNIQUES, V15, P120; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Ly John K., 2007, Antiviral Chemistry & Chemotherapy, V18, P307; Martinez-Picado J, 1999, J VIROL, V73, P3744, DOI 10.1128/JVI.73.5.3744-3752.1999; Martinez-Picado J, 2000, VIROLOGY, V275, P318, DOI 10.1006/viro.2000.0527; Martinez-Picado J, 2008, VIRUS RES, V134, P104, DOI 10.1016/j.virusres.2007.12.021; Messiaen P, 2012, VIROLOGY, V426, P7, DOI 10.1016/j.virol.2012.01.002; Metzner KJ, 2011, J CLIN VIROL, V50, P156, DOI 10.1016/j.jcv.2010.10.001; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Schuurman R, 2002, AIDS RES HUM RETROV, V18, P243, DOI 10.1089/088922202753472801; Shi CJ, 2004, NAT METHODS, V1, P141, DOI 10.1038/NMETH713; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Sturmer M, 2002, J CLIN VIROL, V25, pS65; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Maarseveen NM, 2007, J INFECT DIS, V195, P399, DOI 10.1086/510533; Villahermosa ML, 2001, J HUMAN VIROL, V4, P238; Wainberg MA, 2004, JAIDS-J ACQ IMM DEF, V37, pS36, DOI 10.1097/01.qai.0000137005.63376.6e; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9	44	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83150	10.1371/journal.pone.0083150	http://dx.doi.org/10.1371/journal.pone.0083150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358257	Green Submitted, Green Published, gold			2022-12-27	WOS:000328735700106
J	Ozerov, M; Vasemagi, A; Wennevik, V; Diaz-Fernandez, R; Kent, M; Gilbey, J; Prusov, S; Niemela, E; Vaha, JP				Ozerov, Mikhail; Vasemagi, Anti; Wennevik, Vidar; Diaz-Fernandez, Rogelio; Kent, Matthew; Gilbey, John; Prusov, Sergey; Niemela, Eero; Vaha, Juha-Pekka			Finding Markers That Make a Difference: DNA Pooling and SNP-Arrays Identify Population Informative Markers for Genetic Stock Identification	PLOS ONE			English	Article							SALMO-SALAR POPULATIONS; ATLANTIC SALMON; MICROSATELLITE DATA; ALLELE FREQUENCIES; LOCI; WILD; POLYMORPHISM; IMMIGRATION; ACCURACY; SEA	Genetic stock identification (GSI) using molecular markers is an important tool for management of migratory species. Here, we tested a cost-effective alternative to individual genotyping, known as allelotyping, for identification of highly informative SNPs for accurate genetic stock identification. We estimated allele frequencies of 2880 SNPs from DNA pools of 23 Atlantic salmon populations using Illumina SNP-chip. We evaluated the performance of four common strategies (global F-ST, pairwise F-ST, Delta and outlier approach) for selection of the most informative set of SNPs and tested their effectiveness for GSI compared to random sets of SNP and microsatellite markers. For the majority of cases, SNPs selected using the outlier approach performed best followed by pairwise F-ST and Delta methods. Overall, the selection procedure reduced the number of SNPs required for accurate GSI by up to 53% compared with randomly chosen SNPs. However, GSI accuracy was more affected by populations in the ascertainment group rather than the ranking method itself. We demonstrated for the first time the compatibility of different large-scale SNP datasets by compiling the largest population genetic dataset for Atlantic salmon to date. Finally, we showed an excellent performance of our top SNPs on an independent set of populations covering the main European distribution range of Atlantic salmon. Taken together, we demonstrate how combination of DNA pooling and SNP arrays can be applied for conservation and management of salmonids as well as other species.	[Ozerov, Mikhail; Diaz-Fernandez, Rogelio; Vaha, Juha-Pekka] Univ Turku, Kevo Subarct Res Inst, Turku, Finland; [Vasemagi, Anti] Univ Turku, Dept Biol, Div Genet & Physiol, SF-20500 Turku, Finland; [Wennevik, Vidar] Inst Marine Res, Res Grp Populat Genet & Ecol, N-5024 Bergen, Norway; [Kent, Matthew] Norwegian Univ Life Sci, Ctr Integrat Genet CIGENE, Dept Anim & Aquacultural Sci, As, Norway; [Gilbey, John] Marine Scotland, Freshwater Lab, Faskally, Pitlochry, Scotland; [Prusov, Sergey] Knipovitch Polar Res Inst Marine Fisheries & Ocea, Freshwater Resources Lab, Murmansk, Russia; [Niemela, Eero] Finnish Game & Fisheries Res Inst, Oulu, Finland; [Vasemagi, Anti] Estonian Univ Life Sci, Inst Vet Med & Anim Sci, Dept Aquaculture, Tartu, Estonia	University of Turku; University of Turku; Institute of Marine Research - Norway; Norwegian University of Life Sciences; Natural Resources Institute Finland (Luke); Estonian University of Life Sciences	Vaha, JP (corresponding author), Univ Turku, Kevo Subarct Res Inst, Turku, Finland.	juha-pekka.vaha@utu.fi	Vähä, Juha-Pekka/N-1255-2014; Ozerov, Mikhail/B-6665-2013; Prusov, Sergey/AAR-8621-2020; Vasemägi, Anti/B-1964-2018	Ozerov, Mikhail/0000-0002-1817-7707; Vasemagi, Anti/0000-0002-2184-5534	European Union; Kolarctic ENPI CBC project [KO197]; Academy of Finland; Norwegian Directorate of Nature Management; Norwegian Research Council; Estonian Ministry of Education and Research [IUT8-2]; Estonian Science Foundation [6802, 8215]	European Union(European Commission); Kolarctic ENPI CBC project; Academy of Finland(Academy of Finland); Norwegian Directorate of Nature Management; Norwegian Research Council(Research Council of NorwayEuropean Commission); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation	This study was funded by the European Union, Kolarctic ENPI CBC project KO197 "Trilateral cooperation in our common resource; the Atlantic salmon in the Barents Region" (M.O., R. D. F., E.N. and S. P.), Academy of Finland (J.-P.V.), Norwegian Directorate of Nature Management (V. W.), Norwegian Research Council (V. W.), Estonian Ministry of Education and Research (Institutional Research Funding project IUT8-2 to A. V.) and Estonian Science Foundation (grant numbers 6802, 8215 to A. V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-44; Anderson EC, 2010, MOL ECOL RESOUR, V10, P701, DOI 10.1111/j.1755-0998.2010.02846.x; Beacham TD, 2011, CAN J FISH AQUAT SCI, V68, P550, DOI 10.1139/F10-167; Bourret V, 2013, MOL ECOL, V22, P532, DOI 10.1111/mec.12003; Chiang CWK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000866; Earp MA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-81; Ellis JS, 2011, GENETICA, V139, P353, DOI 10.1007/s10709-011-9554-4; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Frantz AC, 2006, MOL ECOL, V15, P3191, DOI 10.1111/j.1365-294X.2006.03022.x; Freamo H, 2011, MOL ECOL RESOUR, V11, P254, DOI 10.1111/j.1755-0998.2010.02952.x; Gautier M, 2013, MOL ECOL, V22, P3766, DOI 10.1111/mec.12360; Glover KA, 2008, ICES J MAR SCI, V65, P912, DOI 10.1093/icesjms/fsn056; Glover KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043129; Glover KA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-2; Griffiths AM, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-31; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Hess JE, 2011, MOL ECOL RESOUR, V11, P137, DOI 10.1111/j.1755-0998.2010.02958.x; Huang Y, 2010, GENET EPIDEMIOL, V34, P603, DOI 10.1002/gepi.20517; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Janicki P, 2009, INTERNET J GENOM PRO, V5; Kalinowsi ST, 2007, ONCOR COMPUTER PROGR; Karlsson S, 2011, MOL ECOL RESOUR, V11, P247, DOI 10.1111/j.1755-0998.2010.02959.x; Kersbergen P, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-69; Kidd Judith R, 2011, Investig Genet, V2, P1, DOI 10.1186/2041-2223-2-1; Koljonen ML, 2006, ICES J MAR SCI, V63, P1274, DOI 10.1016/j.icesjms.2006.04.010; Lao O, 2006, AM J HUM GENET, V78, P680, DOI 10.1086/501531; Lien S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-615; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Moran P, 2006, ECOL FRESHW FISH, V15, P597, DOI 10.1111/j.1600-0633.2006.00201.x; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nielsen EE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1845; Ozerov M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-12; Primmer CR, 2000, P ROY SOC B-BIOL SCI, V267, P1699; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Rengmark AH, 2006, AQUACULTURE, V253, P229, DOI 10.1016/j.aquaculture.2005.09.022; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Russello MA, 2012, EVOL APPL, V5, P39, DOI 10.1111/j.1752-4571.2011.00206.x; Ryynanen HJ, 2007, J HERED, V98, P692, DOI 10.1093/jhered/esm093; Shriver MD, 1997, AM J HUM GENET, V60, P957; Smith CT, 2008, T AM FISH SOC, V137, P751, DOI 10.1577/T07-104.1; Storer CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049018; Tonteri A, 2009, CAN J FISH AQUAT SCI, V66, P717, DOI 10.1139/F09-010; Vaha JP, 2011, EVOL APPL, V4, P39, DOI 10.1111/j.1752-4571.2010.00131.x; Vasemagi A, 2005, HEREDITY, V95, P76, DOI 10.1038/sj.hdy.6800693; Wilkinson S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-45; WRIGHT S, 1951, ANN EUGENIC, V15, P323	46	32	33	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82434	10.1371/journal.pone.0082434	http://dx.doi.org/10.1371/journal.pone.0082434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358184	Green Submitted, gold, Green Published			2022-12-27	WOS:000328735700066
J	Fang, XL; Zhao, YY; Ma, QB; Huang, Y; Wang, P; Zhang, J; Nian, H; Yang, CY				Fang, Xiaolong; Zhao, Yunyun; Ma, Qibin; Huang, Yian; Wang, Peng; Zhang, Jie; Nian, Hai; Yang, Cunyi			Identification and Comparative Analysis of Cadmium Tolerance-Associated miRNAs and Their Targets in Two Soybean Genotypes	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; AUXIN-RESPONSE; SMALL RNAS; OXIDATIVE STRESS; COMPUTATIONAL IDENTIFICATION; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; COPPER HOMEOSTASIS; CELL-PROLIFERATION; GENE-EXPRESSION	MicroRNAs (miRNAs) play crucial roles in regulating the expression of various stress responses genes in plants. To investigate soybean (Glycine max) miRNAs involved in the response to cadmium (Cd), microarrays containing 953 unique miRNA probes were employed to identify differences in the expression patterns of the miRNAs between different genotypes, Huaxia3 (HX3, Cd-tolerant) and Zhonghuang24 (ZH24, Cd-sensitive). Twenty six Cd-responsive miRNAs were identified in total. Among them, nine were detected in both cultivars, while five were expressed only in HX3 and 12 were only in ZH24. The expression of 16 miRNAs was tested by qRT-PCR and most of the identified miRNAs were found to have similar expression patterns with microarray. Three hundred and seventy six target genes were identified for 204 miRNAs from a mixture degradome library, which was constructed from the root of HX3 and ZH24 with or without Cd treatment. Fifty five genes were identified to be cleaved by 14 Cd-responsive miRNAs. Gene ontology (GO) annotations showed that these target transcripts are implicated in a broad range of biological processes. In addition, the expression patterns of ten target genes were validated by qRT-PCR. The characterization of the miRNAs and the associated target genes in response to Cd exposure provides a framework for understanding the molecular mechanism of heavy metal tolerance in plants.	[Fang, Xiaolong; Zhao, Yunyun; Ma, Qibin; Huang, Yian; Wang, Peng; Zhang, Jie; Nian, Hai; Yang, Cunyi] South China Agr Univ, Coll Agr, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Nian, H (corresponding author), South China Agr Univ, Coll Agr, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China.	hnian@scau.edu.cn; ycy@scau.edu.cn	Fang, Andy/GLU-9004-2022; ma, qibin/HDO-2133-2022		National Natural Science Foundation of China [31271745]; National High-tech RAMP;D Program of China [2011BAD35B06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech RAMP;D Program of China	This work was funded by National Natural Science Foundation of China (31271745), and National High-tech R&D Program of China (2011BAD35B06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, RNA, V15, P2112, DOI 10.1261/rna.1774909; AKIYOSHI DE, 1984, P NATL ACAD SCI-BIOL, V81, P5994, DOI 10.1073/pnas.81.19.5994; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Barrera-Figueroa BE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-127; BARRY GF, 1984, P NATL ACAD SCI-BIOL, V81, P4776, DOI 10.1073/pnas.81.15.4776; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benitez ER, 2012, J HERED, V103, P278, DOI 10.1093/jhered/esr123; Benitez ER, 2010, CROP SCI, V50, P1728, DOI 10.2135/cropsci2009.11.0664; Berthet S, 2011, PLANT CELL, V23, P1124, DOI 10.1105/tpc.110.082792; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Chaudhuri K, 2007, DNA CELL BIOL, V26, P321, DOI 10.1089/dna.2006.0549; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen L, 2012, PLANTA, V235, P375, DOI 10.1007/s00425-011-1514-9; Chen ZH, 2011, PLANT MOL BIOL, V77, P619, DOI 10.1007/s11103-011-9838-1; Chmielnicka J, 1996, ECOTOX ENVIRON SAFE, V35, P277, DOI 10.1006/eesa.1996.0111; Clemens S, 2012, TRENDS PLANT SCI; Ding YF, 2009, BIOCHEM BIOPH RES CO, V386, P6, DOI 10.1016/j.bbrc.2009.05.137; Ding YF, 2011, J EXP BOT, V62, P3563, DOI 10.1093/jxb/err046; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Elobeid M, 2012, J EXP BOT, V63, P1413, DOI 10.1093/jxb/err384; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Finger-Teixeira A, 2010, ECOTOX ENVIRON SAFE, V73, P1959, DOI 10.1016/j.ecoenv.2010.08.021; Franke R, 2002, PLANT J, V30, P47, DOI 10.1046/j.1365-313X.2002.01267.x; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; Horiguchi G, 2005, PLANT J, V43, P68, DOI 10.1111/j.1365-313X.2005.02429.x; Huang SQ, 2010, PLANT BIOTECHNOL J, V8, P887, DOI 10.1111/j.1467-7652.2010.00517.x; Huang SQ, 2009, J INORG BIOCHEM, V103, P282, DOI 10.1016/j.jinorgbio.2008.10.019; Jegadeesan S, 2010, THEOR APPL GENET, V121, P283, DOI 10.1007/s00122-010-1309-6; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kim JH, 2004, P NATL ACAD SCI USA, V101, P13374, DOI 10.1073/pnas.0405450101; Kim JH, 2003, PLANT J, V36, P94, DOI 10.1046/j.1365-313X.2003.01862.x; Kropat J, 2005, P NATL ACAD SCI USA, V102, P18730, DOI 10.1073/pnas.0507693102; Kuderova A, 2008, PLANT CELL PHYSIOL, V49, P570, DOI 10.1093/pcp/pcn029; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Li HY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-170; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039650; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Lin YF, 2012, CELL MOL LIFE SCI, V69, P3187, DOI 10.1007/s00018-012-1089-z; Liu DM, 2009, PHYSIOL PLANTARUM, V136, P223, DOI 10.1111/j.1399-3054.2009.01229.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Marin E, 2010, PLANT CELL, V22, P1104, DOI 10.1105/tpc.109.072553; Marmiroli M, 2005, ENVIRON POLLUT, V134, P217, DOI 10.1016/j.envpol.2004.08.004; Marschner P, 2012, MARSCHNERS MINERAL N, Vxv; Mendoza-Soto AB, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00105; Merewitz EB, 2011, J EXP BOT, V62, P383, DOI 10.1093/jxb/erq285; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Miyadate H, 2011, NEW PHYTOL, V189, P190, DOI 10.1111/j.1469-8137.2010.03459.x; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; Nakai Y, 2013, PLANT J, V73, P761, DOI 10.1111/tpj.12069; Pineros MA, 2005, PLANT PHYSIOL, V137, P231, DOI 10.1104/pp.104.047357; Pinto AP, 2004, SCI TOTAL ENVIRON, V326, P239, DOI 10.1016/j.scitotenv.2004.01.004; Rea D, 2011, CNS NEUROL DISORD-DR, V10, P306, DOI 10.2174/187152711794653850; Rellan-Alvarez R, 2006, ANAL BIOCHEM, V356, P254, DOI 10.1016/j.ab.2006.05.032; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rodriguez RE, 2010, DEVELOPMENT, V137, P103, DOI 10.1242/dev.043067; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Schutzendubel A, 2001, PLANT PHYSIOL, V127, P887, DOI 10.1104/pp.010318; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Thomine S, 2000, P NATL ACAD SCI USA, V97, P4991, DOI 10.1073/pnas.97.9.4991; Turner M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-169; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang Y, 2012, MOL BIOL REP, V39, P1585, DOI 10.1007/s11033-011-0897-9; Xie FL, 2007, FEBS LETT, V581, P1464, DOI 10.1016/j.febslet.2007.02.074; Yadav SK, 2010, S AFR J BOT, V76, P167, DOI 10.1016/j.sajb.2009.10.007; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Yang YJ, 2007, PLANT SCI, V172, P632, DOI 10.1016/j.plantsci.2006.11.018; Zeng HQ, 2010, J PLANT PHYSIOL, V167, P1289, DOI 10.1016/j.jplph.2010.04.017; Zeng QY, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-182; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhang L, 2007, ENVIRON INT, V33, P108, DOI 10.1016/j.envint.2006.06.022; Zhou ZS, 2008, BIOCHEM BIOPH RES CO, V374, P538, DOI 10.1016/j.bbrc.2008.07.083; Zhou ZS, 2012, J EXP BOT, V63, P4597, DOI 10.1093/jxb/ers136; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x; Zhu Qi, 2007, V382, P287, DOI 10.1007/978-1-59745-304-2_19	88	51	57	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81471	10.1371/journal.pone.0081471	http://dx.doi.org/10.1371/journal.pone.0081471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24363811	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400019
J	Zhang, HJ; Liu, H; Jiang, GF				Zhang, Haijun; Liu, Hang; Jiang, Gaofeng			Genetic Polymorphisms of XRCC1 and Leukemia Risk: A Meta-Analysis of 19 Case-Control Studies	PLOS ONE			English	Article							DNA-REPAIR POLYMORPHISMS; BASE EXCISION-REPAIR; CANCER-RISK; GENOTYPE DISTRIBUTION; POLYMERASE BETA; SUSCEPTIBILITY; ASSOCIATION; P14ARF; BIAS; XPD	Objective: Three common X-ray repair cross-complementing groups 1 (XRCC1) polymorphisms, Arg399Gln, Arg194Trp, and Arg280His, have been reported to be implicated in the development of leukemia. However, previous results from different studies were inconsistent. Consequently, we performed a meta-analysis in order to accurately evaluate the association between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and leukemia risk. Methods: Through computerized searching of PubMed, ISI Web of Knowledge, Cochrane, EBSCO, and OpenGrey databases, and manually searching relevant references, a total of 19 studies with 3387 cases and 6168 controls for Arg399Gln (G > A) polymorphism, 12 studies with 2043 cases and 4550 controls for Arg194Trp (C > T), and 6 studies with 1445 cases and 1905 controls for Arg280His (G > A) were collected to perform meta-analysis and stratified analysis to explore the associations between these variants and leukemia susceptibility. Based on three genetic models, the codominant model, dominant model and recessive model, odds ratios (ORs) as well as their 95% confidence intervals (CIs) were used to evaluate the association strength between XRCC1 genotypes and leukemia risk. Results: With respect to overall leukemia susceptibility, no association was detected. In stratified analyses by tumor type, Arg399Gln was associated with higher acute lymphoblastic leukemia (ALL) risk (AA vs. GG, OR = 1.50, 95% CI: 1.11-2.02; AA+GA vs. GG, OR = 1.35, 95% CI: 1.02-1.78). Additionally, Arg399Gln, Arg194Trp, and Arg280His may influence the susceptibilities of some leukemia type and race populations. Conclusion: This meta-analysis indicates these three polymorphisms of XRCC1 do not associate with overall leukemia risks but could be associated with the risks for some specific subgroups.	[Zhang, Haijun] Cornell Univ, Dept Cell & Dev Biol, Weill Med Coll, New York, NY 10021 USA; [Liu, Hang] Columbia Univ, Sch Social Work, New York, NY USA; [Jiang, Gaofeng] Wuhan Univ Sci & Technol, Sch Publ Hlth, Coll Med, Wuhan, Hubei, Peoples R China	Cornell University; Columbia University; Wuhan University of Science & Technology	Zhang, HJ (corresponding author), Cornell Univ, Dept Cell & Dev Biol, Weill Med Coll, New York, NY 10021 USA.	haz2004@med.cornell.edu; gaofeng.jiang@yahoo.com			National Natural Science Foundation of China [81172462]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partly supported by the National Natural Science Foundation of China (No. 81172462). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abramenko I, 2012, J RADIAT RES, V53, P497, DOI 10.1269/jrr.11093; Annamaneni S, 2012, HEMATOLOGY; [Anonymous], 2010, R LANG ENV STAT COMP; Armijo-Olivo S, 2012, J EVAL CLIN PRACT, V18, P12, DOI 10.1111/j.1365-2753.2010.01516.x; Batar B, 2009, LEUKEMIA RES, V33, P759, DOI 10.1016/j.leukres.2008.11.005; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berwick M, 2000, JNCI-J NATL CANCER I, V92, P874, DOI 10.1093/jnci/92.11.874; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Canalle R, 2011, LEUKEMIA LYMPHOMA, V52, P1118, DOI 10.3109/10428194.2011.559672; Celkan T, 2008, LEUKEMIA LYMPHOMA, V49, P1638, DOI 10.1080/10428190802140063; Dai LP, 2012, MOL BIOL REP, V39, P9535, DOI 10.1007/s11033-012-1818-2; Deligezer U, 2007, ANTICANCER RES, V27, P2453; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dianov GL, 1999, J BIOL CHEM, V274, P13741, DOI 10.1074/jbc.274.20.13741; Duman N, 2012, GENET TEST MOL BIOMA, V16, P287, DOI 10.1089/gtmb.2011.0152; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Din M. S., 2012, Comparative Clinical Pathology, V21, P505, DOI 10.1007/s00580-010-1120-4; Ganster C, 2009, GENE CHROMOSOME CANC, V48, P760, DOI 10.1002/gcc.20680; Ginsberg G, 2011, MUTAT RES-REV MUTAT, V727, P1, DOI 10.1016/j.mrrev.2011.02.001; Howlader N, 2013, SEER CANC STAT REV 1; Hu ZB, 2005, CANCER EPIDEM BIOMAR, V14, P1810, DOI 10.1158/1055-9965.EPI-04-0793; Joseph T, 2005, CANCER LETT, V217, P17, DOI 10.1016/j.canlet.2004.06.055; Kim HN, 2012, LEUKEMIA LYMPHOMA, V53, P681, DOI 10.3109/10428194.2011.625576; Li WJ, 2009, CHEMOTHERAPY, V55, P335, DOI 10.1159/000230697; Matullo G, 2006, CARCINOGENESIS, V27, P997, DOI 10.1093/carcin/bgi280; Meza-Espinoza J P, 2009, Genet Mol Res, V8, P1451, DOI 10.4238/vol8-4gmr687; Ozcan A, 2011, AFR J BIOTECHNOL, V10, P8860; Pakakasama S, 2007, PEDIATR BLOOD CANCER, V48, P16, DOI 10.1002/pbc.20742; Seedhouse C, 2002, BLOOD, V100, P3761, DOI 10.1182/blood-2002-04-1152; Shi JY, 2011, INT J CANCER, V128, P233, DOI 10.1002/ijc.25318; Sorour A, 2013, GENET TEST MOL BIOMA, V17, P195, DOI 10.1089/gtmb.2012.0278; Stanczyk M, 2011, MOL BIOL REP, V38, P445, DOI 10.1007/s11033-010-0127-x; Thompson LH, 2000, MUTAT RES-DNA REPAIR, V459, P1, DOI 10.1016/S0921-8777(99)00058-0; Tumer TB, 2010, LEUKEMIA RES, V34, P1275, DOI 10.1016/j.leukres.2010.02.035; Wang D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013067; Zhang HJ, 2010, J CELL BIOCHEM, V109, P693, DOI 10.1002/jcb.22446; Zhang HJ, 2009, J CELL BIOCHEM, V106, P464, DOI 10.1002/jcb.22033; Zhang HJ, 2013, TUMOR BIOL, V34, P3003, DOI 10.1007/s13277-013-0865-1; Zhang HJ, 2011, ANTICANCER RES, V31, P3945; Zhang HJ, 2011, CANCER RES, V71, P3257, DOI 10.1158/0008-5472.CAN-10-2603; Zhang H, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00001	42	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80687	10.1371/journal.pone.0080687	http://dx.doi.org/10.1371/journal.pone.0080687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24363792	Green Published, gold, Green Submitted			2022-12-27	WOS:000327543500053
J	Lomtadze, N; Kupreishvili, L; Salakaia, A; Vashakidze, S; Sharvadze, L; Kempker, RR; Magee, MJ; del Rio, C; Blumberg, HM				Lomtadze, Nino; Kupreishvili, Lali; Salakaia, Archil; Vashakidze, Sergo; Sharvadze, Lali; Kempker, Russell R.; Magee, Matthew J.; del Rio, Carlos; Blumberg, Henry M.			Hepatitis C Virus Co-Infection Increases the Risk of Anti-Tuberculosis Drug-Induced Hepatotoxicity among Patients with Pulmonary Tuberculosis	PLOS ONE			English	Article							INFECTION; PREVALENCE; HIV	Background: The country of Georgia has a high prevalence of tuberculosis (TB) and hepatitis C virus (HCV) infection. Purpose: To determine whether HCV co-infection increases the risk of incident drug-induced hepatitis among patients on first-line anti-TB drug therapy. Methods: Prospective cohort study; HCV serology was obtained on all study subjects at the time of TB diagnosis; hepatic enzyme tests (serum alanine aminotransferase [ALT] activity) were obtained at baseline and monthly during treatment. Results: Among 326 study patients with culture-confirmed TB, 68 (21%) were HCV co-infected, 14 (4.3%) had chronic hepatitis B virus (HBV) infection (hepatitis B virus surface antigen positive [HBsAg+]), and 6 (1.8%) were HIV co-infected. Overall, 19% of TB patients developed mild to moderate incident hepatotoxicity. In multi-variable analysis, HCV co-infection (adjusted Hazards Ratio [aHR]=3.2, 95% CI=1.6-6.5) was found to be an independent risk factor for incident anti-TB drug-induced hepatotoxicity. Survival analysis showed that HCV co-infected patients developed hepatitis more quickly compared to HCV seronegative patients with TB. Conclusion: A high prevalence of HCV co-infection was found among patients with TB in Georgia. Drug-induced hepatotoxicity was significantly associated with HCV co-infection but severe drug-induced hepatotoxicity (WHO grade III or IV) was rare.	[Lomtadze, Nino; Kupreishvili, Lali; Salakaia, Archil; Vashakidze, Sergo] Natl Ctr TB & Lung Dis, Tbilisi, Georgia; [Sharvadze, Lali] Infect Dis AIDS & Clin Immunol Res Ctr, Tbilisi, Georgia; [Kempker, Russell R.; del Rio, Carlos; Blumberg, Henry M.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [del Rio, Carlos; Blumberg, Henry M.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Magee, Matthew J.; Blumberg, Henry M.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA	Emory University; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health	Blumberg, HM (corresponding author), Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.	henry.m.blumberg@emory.edu	Blumberg, Henry/W-2156-2019; Magee, Matthew/W-1169-2019; del Rio, Carlos/B-3763-2012	Blumberg, Henry/0000-0002-3110-2443; del Rio, Carlos/0000-0002-0153-3517	National Institutes of Health (NIH), Fogarty International Center (FIC) [D43TW007124, D43TW007124-06S1, D43TW001042]; National Institute of Allergy and Immunology (NIAID) [K23 AI103044]; National Center for Advancing Translational Sciences (NCATS)/Atlanta Clinical and Translational Science Institute [UL1TR000454]; U.S. Civilian and Research Development Foundation [GEB1-002725-TB-07]; Emory Global Health Institute; FOGARTY INTERNATIONAL CENTER [D43TW001042, D43TW007124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI103044] Funding Source: NIH RePORTER	National Institutes of Health (NIH), Fogarty International Center (FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Allergy and Immunology (NIAID); National Center for Advancing Translational Sciences (NCATS)/Atlanta Clinical and Translational Science Institute; U.S. Civilian and Research Development Foundation; Emory Global Health Institute; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health (NIH), Fogarty International Center (FIC) [D43TW007124, D43TW007124-06S1, and D43TW001042], National Institute of Allergy and Immunology (NIAID) [K23 AI103044], National Center for Advancing Translational Sciences (NCATS)/Atlanta Clinical and Translational Science Institute [UL1TR000454], the U.S. Civilian and Research Development Foundation (GEB1-002725-TB-07), and the Emory Global Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Butsashvili M, 2001, EUR J EPIDEMIOL, V17, P693, DOI 10.1023/A:1015566132757; Chien JY, 2010, INT J TUBERC LUNG D, V14, P616; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Jafari S, 2010, INT J INFECT DIS, V14, pE928, DOI 10.1016/j.ijid.2010.03.019; Jasmer RM, 2002, ANN INTERN MED, V137, P640, DOI 10.7326/0003-4819-137-8-200210150-00007; Karchava M, 2009, Georgian Med News, P51; Kwon YS, 2007, CHEST, V131, P803, DOI 10.1378/chest.06-2042; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lomtadze N, 2009, INT J TUBERC LUNG D, V13, P68; Park WB, 2010, J INFECTION, V61, P323, DOI 10.1016/j.jinf.2010.07.009; Parsons LM, 2011, CLIN MICROBIOL REV, V24, P314, DOI 10.1128/CMR.00059-10; Richards DC, 2006, INT J TUBERC LUNG D, V10, P396; Shapatava E, 2006, DRUG ALCOHOL DEPEN, V82, pS35, DOI 10.1016/S0376-8716(06)80006-2; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; Tuberculosis Coalition for Technical Assistance, 2009, INT STAND TUB CAR IS; Tukvadze N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031563; Ungo JR, 1998, AM J RESP CRIT CARE, V157, P1871, DOI 10.1164/ajrccm.157.6.9711039; Wang JY, 2011, J INFECTION, V62, P448, DOI 10.1016/j.jinf.2011.04.005; Weinstock DM, 2001, INT J TUBERC LUNG D, V5, P164; WHO, 2009, WHOHTMTB2009422; World Health Organization, 2013, WHOHTMTB201311; World Health Organization, 2010, WHOHTMTB20103; World Health Organization (WHO), 2010, GUIDELINES TREATMENT, V2nd; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC; Zaller N, 2004, EUR J EPIDEMIOL, V19, P547, DOI 10.1023/B:EJEP.0000032352.29173.78	29	39	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e83892	10.1371/journal.pone.0083892	http://dx.doi.org/10.1371/journal.pone.0083892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367617	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900025
J	Purmal, K; Alam, MK; Pohchi, A; Razak, NHA				Purmal, Kathiravan; Alam, Mohammad Khursheed; Pohchi, Abdullah; Razak, Noor Hayati Abdul			3D Mapping of Safe and Danger Zones in the Maxilla and Mandible for the Placement of Intermaxillary Fixation Screws	PLOS ONE			English	Article							CORTICAL-BONE THICKNESS; ALVEOLAR BONE	Intermaxillary (IMF) screws feature several advantages over other devices used for intermaxillary fixation, but using cone beam computed tomography (CBCT) scans to determine the safe and danger zones to place these devices for all patients can be expensive. This study aimed to determine the optimal interradicular and buccopalatal/buccolingual spaces for IMF screw placement in the maxilla and mandible. The CBCT volumetric data of 193 patients was used to generate transaxial slices between the second molar on the right to the second molar on the left in both arches. The mean interradicular and buccopalatal/buccolingual distances and standard deviation values were obtained at heights of 2, 5, 8 and 11 mm from the alveolar bone crest. An IMF screw with a diameter of 1.0 mm and length of 7 mm can be placed distal to the canines (2 -11 mm from the alveolar crest) and less than 8 mm between the molars in the maxilla. In the mandible, the safest position is distal to the first premolar (more than 5 mm) and distal to the second premolar (more than 2 mm). There was a significant difference (p< 0.05) between the right and left quadrants. The colour coding 3D template showed the safe and danger zones based on the mesiodistal, buccopalatal and buccolingual distances in the maxilla and mandible. The safest sites for IMF screw insertion in the maxilla were between the canines and first premolars and between the first and second molars. In the mandible, the safest sites were between the first and second premolars and between the second premolar and first molar. However, the IMF screw should not exceed 1.0 mm in diameter and 7 mm in length.	[Purmal, Kathiravan; Pohchi, Abdullah; Razak, Noor Hayati Abdul] Univ Sains Malaysia, Sch Dent Sci, Dept Oral & Maxillofacial Surg, Kota Baharu, Kelantan, Malaysia; [Alam, Mohammad Khursheed] Univ Sains Malaysia, Sch Dent Sci, Orthodont Unit, Kota Baharu, Kelantan, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Alam, MK (corresponding author), Univ Sains Malaysia, Sch Dent Sci, Orthodont Unit, Kota Baharu, Kelantan, Malaysia.	dralam@gmail.com	Alam, Mohammad Khursheed/D-3062-2012; Alam, Mohammad/GQR-2648-2022; alam, mohammed/GXH-3645-2022	Alam, Mohammad Khursheed/0000-0001-7131-1752; 	Short Term Grant [304/PPSG/61312043]; Universiti Sains Malaysia	Short Term Grant; Universiti Sains Malaysia(Universiti Sains Malaysia)	This study was supported by Short Term Grant (304/PPSG/61312043), Universiti Sains Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHUR G, 1989, J ORAL MAXIL SURG, V47, P1234, DOI 10.1016/0278-2391(89)90024-4; BISHARA SE, 1989, AM J ORTHOD DENTOFAC, V96, P416, DOI 10.1016/0889-5406(89)90326-0; Bittencourt Luiza Paiva, 2011, Rev. odonto ciênc., V26, P133, DOI 10.1590/S1980-65232011000200007; Carano Aldo, 2004, Prog Orthod, V5, P212; Coburn DG, 2002, BRIT J ORAL MAX SURG, V40, P241, DOI 10.1054/bjom.2001.0771; Coletti DP, 2007, J ORAL MAXIL SURG, V65, P1746, DOI 10.1016/j.joms.2007.04.022; Evans CA, 2013, OR SURG OR MED OR PA, V116, P238, DOI 10.1016/j.oooo.2013.06.002; Farnsworth D, 2011, AM J ORTHOD DENTOFAC, V139, P495, DOI 10.1016/j.ajodo.2009.03.057; HARRIS EF, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P121; Hernandez LC, 2008, CLIN ORAL IMPLAN RES, V19, P576, DOI 10.1111/j.1600-0501.2007.01507.x; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; Kim HJ, 2006, AM J ORTHOD DENTOFAC, V130, P177, DOI 10.1016/j.ajodo.2004.12.024; Kuroda T, 2006, AM J ORTHOD DENTOFAC, V129, P562, DOI 10.1016/j.ajodo.2004.12.020; LAVELLE CLB, 1972, AMER J ORTHODONTICS, V61, P29, DOI 10.1016/0002-9416(72)90173-X; Lee KJ, 2009, AM J ORTHOD DENTOFAC, V135, P486, DOI 10.1016/j.ajodo.2007.05.019; LINDHE J, 1984, TXB CLIN PERIODONTOL; Mah JK, 2010, J AM DENT ASSOC, V141, p7S, DOI 10.14219/jada.archive.2010.0361; Monnerat C, 2009, AM J ORTHOD DENTOFAC, V135, DOI [10.1016/j.ajodo.2008.12.003, 10.1016/j.ajodo.2008.06.024]; Park HS, 2008, AM J ORTHOD DENTOFAC, V133, P30, DOI 10.1016/j.ajodo.2006.01.044; PARK J, 2009, AM J ORTHOD DENTOFAC, V136; PARK J, 2009, AM J ORTHOD DENTOFAC, V136, P14; Poggio PM, 2006, ANGLE ORTHOD, V76, P191; Rai AJ, 2009, BRIT J ORAL MAX SURG, V47, P325, DOI 10.1016/j.bjoms.2008.12.009; Schneider AM, 2000, ANN PLAS SURG, V44, P154, DOI 10.1097/00000637-200044020-00005; Schnelle MA, 2004, ANGLE ORTHOD, V74, P832; Schroeder HE, 1997, PERIODONTOL 2000, V13, P91, DOI 10.1111/j.1600-0757.1997.tb00097.x; Silvestrini-Biavati A, 2011, ORTHOD CRANIOFAC RES, V14, P88, DOI 10.1111/j.1601-6343.2011.01512.x; Stirrups D R, 1993, Br J Orthod, V20, P359; Thongudomporn U, 2009, ORTHOD CRANIOFAC RES, V12, P1, DOI 10.1111/j.1601-6343.2008.01430.x; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511	30	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84202	10.1371/journal.pone.0084202	http://dx.doi.org/10.1371/journal.pone.0084202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367643	Green Submitted, Green Published, gold			2022-12-27	WOS:000328741900038
J	Molina, JA; Gimenez-Nadal, JI; Cuesta, JA; Gracia-Lazaro, C; Moreno, Y; Sanchez, A				Alberto Molina, J.; Ignacio Gimenez-Nadal, J.; Cuesta, Jose A.; Gracia-Lazaro, Carlos; Moreno, Yamir; Sanchez, Angel			Gender Differences in Cooperation: Experimental Evidence on High School Students	PLOS ONE			English	Article							PARENTS INVESTING LESS; PRISONERS-DILEMMA; CHILD-CARE; RATIONAL COOPERATION; PROMOTE COOPERATION; TIME; SEX; BEHAVIOR; ALLOCATION; EDUCATION	The emergence of cooperation among unrelated human subjects is a long-standing conundrum that has been amply studied both theoretically and experimentally. Within the question, a less explored issue relates to the gender dependence of cooperation, which can be traced back to Darwin, who stated that "women are less selfish but men are more competitive". Indeed, gender has been shown to be relevant in several game theoretical paradigms of social cooperativeness, including prisoner's dilemma, snowdrift and ultimatum/dictator games, but there is no consensus as to which gender is more cooperative. We here contribute to this literature by analyzing the role of gender in a repeated Prisoners' Dilemma played by Spanish high-school students in both a square lattice and a heterogeneous network. While the experiment was conducted to shed light on the influence of networks on the emergence of cooperation, we benefit from the availability of a large dataset of more 1200 participants. We applied different standard econometric techniques to this dataset, including Ordinary Least Squares and Linear Probability models including random effects. All our analyses indicate that being male is negatively associated with the level of cooperation, this association being statistically significant at standard levels. We also obtain a gender difference in the level of cooperation when we control for the unobserved heterogeneity of individuals, which indicates that the gender gap in cooperation favoring female students is present after netting out this effect from other socio-demographics factors not controlled for in the experiment, and from gender differences in risk, social and competitive preferences.	[Alberto Molina, J.; Ignacio Gimenez-Nadal, J.] Univ Zaragoza, Dept Anal Econ, Zaragoza, Spain; [Alberto Molina, J.] Inst Study Labor IZA, Bonn, Germany; [Cuesta, Jose A.; Gracia-Lazaro, Carlos; Moreno, Yamir; Sanchez, Angel] Univ Zaragoza, Inst Biocomp & Fis Sistemas Complejos, Zaragoza, Spain; [Cuesta, Jose A.; Sanchez, Angel] Univ Carlos III Madrid, Grp Interdisciplinar Sistemas Complejos, Dept Matemat, Leganes, Spain; [Moreno, Yamir] Inst Sci Interchange, Complex Networks & Syst Lagrange Lab, Turin, Italy	University of Zaragoza; IZA Institute Labor Economics; University of Zaragoza; Universidad Carlos III de Madrid	Gimenez-Nadal, JI (corresponding author), Univ Zaragoza, Dept Anal Econ, Zaragoza, Spain.	ngimenez@unizar.es	Cuesta, Jose A/Z-4696-2019; Cuesta, Jose A/A-7157-2008; Moreno, Yamir/A-1076-2009; Gimenez-Nadal, Jose Ignacio/H-4276-2015; Gracia-Lázaro, Carlos/K-9334-2014; Molina, Jose Alberto/H-1676-2015	Cuesta, Jose A/0000-0001-9890-9367; Moreno, Yamir/0000-0002-0895-1893; Gimenez-Nadal, Jose Ignacio/0000-0002-1610-5451; Gracia-Lázaro, Carlos/0000-0002-9769-8796; Molina, Jose Alberto/0000-0002-9437-4606	Spanish Ministry of Education and Science [ECO2012-34828]	Spanish Ministry of Education and Science(Spanish Government)	This paper has benefited from the funding from the Spanish Ministry of Education and Science (Projects ECO2012-34828, RESINEE and PRODIEVO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andaluz Funcia J., 2013, THEOR EC LETT, V3, P69; ANDREONI J, 1993, ECON J, V103, P570, DOI 10.2307/2234532; Andrighetto G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064941; Benko TP, 2009, BIOSYSTEMS, V97, P154, DOI 10.1016/j.biosystems.2009.05.011; Bianchi SM, 2000, DEMOGRAPHY, V37, P401, DOI 10.1353/dem.2000.0001; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; DAWES RM, 1977, J PERS SOC PSYCHOL, V35, P1, DOI 10.1037/0022-3514.35.1.1; DAWES RM, 1988, J ECON PERSPECT, V2, P187, DOI 10.1257/jep.2.3.187; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; FRANK RH, 1993, J ECON PERSPECT, V7, P159, DOI 10.1257/jep.7.2.159; Fudenberg D., 1991, GAME THEORY; Garcia-Mainar I, 2011, FEM ECON, V17, P119, DOI 10.1080/13545701.2010.542004; Gauthier AH, 2004, POPUL DEV REV, V30, P647, DOI 10.1111/j.1728-4457.2004.00036.x; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; Gracia-Lazaro C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00325; Grujic J, 2012, J THEOR BIOL, V300, P299, DOI 10.1016/j.jtbi.2012.02.003; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Guryan J, 2008, J ECON PERSPECT, V22, P23, DOI 10.1257/jep.22.3.23; Hallberg D, 2003, J POPUL ECON, V16, P205, DOI 10.1007/s001480200133; HILL CR, 1974, J HUM RESOUR, V9, P323, DOI 10.2307/144690; Gimenez-Nadal JI, 2013, J POPUL ECON, V26, P719, DOI 10.1007/s00148-012-0443-7; Jiang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064677; KAHN A, 1971, J PERS SOC PSYCHOL, V17, P267, DOI 10.1037/h0030597; Kalenkoski CM, 2009, J POPUL ECON, V22, P399, DOI 10.1007/s00148-008-0192-9; Kimmel J, 2007, J HUM RESOUR, V42, P643, DOI 10.3368/jhr.XLII.3.643; KREPS DM, 1982, J ECON THEORY, V27, P245, DOI 10.1016/0022-0531(82)90029-1; Kummerli R, 2007, P R SOC B, V274, P2965, DOI 10.1098/rspb.2007.0793; MACK D, 1971, PSYCHON SCI, V24, P280; MANSER M, 1980, INT ECON REV, V21, P31, DOI 10.2307/2526238; MCELROY MB, 1981, INT ECON REV, V22, P333, DOI 10.2307/2526280; ORBELL J, 1994, MOTIV EMOTION, V18, P109, DOI 10.1007/BF02249396; Ortmann A, 1999, J ECON BEHAV ORGAN, V39, P327, DOI 10.1016/S0167-2681(99)00038-4; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; RAPOPORT A, 1965, J PERS SOC PSYCHOL, V2, P831, DOI 10.1037/h0022678; Sayer LC, 2004, AM J SOCIOL, V110, P1, DOI 10.1086/386270; SIBLEY SA, 1968, PSYCHON SCI, V13, P123, DOI 10.3758/BF03342441; TEDESCHI JT, 1969, J SOC PSYCHOL, V79, P43, DOI 10.1080/00224545.1969.9922385; Wang J, 2012, P NATL ACAD SCI USA, V109, P14363, DOI 10.1073/pnas.1120867109; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; Zick CD, 1996, SOC SCI RES, V25, P260, DOI 10.1006/ssre.1996.0012	40	36	37	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83700	10.1371/journal.pone.0083700	http://dx.doi.org/10.1371/journal.pone.0083700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367608	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300115
J	Naumann, MS; Jantzen, C; Haas, AF; Iglesias-Prieto, R; Wild, C				Naumann, Malik S.; Jantzen, Carin; Haas, Andreas F.; Iglesias-Prieto, Roberto; Wild, Christian			Benthic Primary Production Budget of a Caribbean Reef Lagoon (Puerto Morelos, Mexico)	PLOS ONE			English	Article							CORAL-REEF; FRINGING-REEF; SURFACE-AREA; MARINE; CARBON; RESPIRATION; MORPHOLOGY; QUANTIFICATION; PHOTOSYNTHESIS; METABOLISM	High photosynthetic benthic primary production (P) represents a key ecosystem service provided by tropical coral reef systems. However, benthic P budgets of specific ecosystem compartments such as macrophyte-dominated reef lagoons are still scarce. To address this, we quantified individual and lagoon-wide net (P-n) and gross (P-g) primary production by all dominant functional groups of benthic primary producers in a typical macrophyte-dominated Caribbean reef lagoon near Puerto Morelos (Mexico) via measurement of O-2 fluxes in incubation experiments. The photosynthetically active 3D lagoon surface area was quantified using conversion factors to allow extrapolation to lagoon-wide P budgets. Findings revealed that lagoon 2D benthic cover was primarily composed of sand-associated microphytobenthos (40%), seagrasses (29%) and macroalgae (27%), while seagrasses dominated the lagoon 3D surface area (84%). Individual Pg was highest for macroalgae and scleractinian corals (87 and 86 mmol O-2 m(-2) specimen area d(-1), respectively), however seagrasses contributed highest (59%) to the lagoon-wide P-g. Macroalgae exhibited highest individual P-n rates, but seagrasses generated the largest fraction (51%) of lagoon-wide P-n. Individual R was highest for scleractinian corals and macroalgae, whereas seagrasses again provided the major lagoon-wide share (68%). These findings characterise the investigated lagoon as a net autotrophic coral reef ecosystem compartment revealing similar P compared to other macrophyte-dominated coastal environments such as seagrass meadows and macroalgae beds. Further, high lagoon-wide P (Pg: 488 and P-n: 181 mmol O-2 m(-2) lagoon area d(-1)) and overall P-g:R (1.6) indicate substantial benthic excess production within the Puerto Morelos reef lagoon and suggest the export of newly synthesised organic matter to surrounding ecosystems.	[Naumann, Malik S.; Jantzen, Carin; Haas, Andreas F.; Wild, Christian] Leibniz Ctr Trop Marine Ecol ZMT, Coral Reef Ecol Grp CORE, Bremen, Germany; [Iglesias-Prieto, Roberto] UNAM, Unidad Acad Puerto Morelos, Inst Ciencias Mar & Limnol, Cancun, Quintana Roo, Mexico; [Wild, Christian] Univ Bremen, Fac Biol & Chem, D-28359 Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico; University of Bremen	Naumann, MS (corresponding author), Leibniz Ctr Trop Marine Ecol ZMT, Coral Reef Ecol Grp CORE, Bremen, Germany.	mnaumann@uni-bremen.de	Naumann, Malik/A-3607-2011	Naumann, Malik/0000-0002-6870-291X	German Research Foundation (DFG) [Wi 2677/2-1, Wi 2677/6-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was funded by German Research Foundation (DFG) grant Wi 2677/2-1 and Wi 2677/6-1 to C.W., and Bleaching Work Group funding within the CRTR project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes D. J., 1983, PERSPECTIVES CORAL R, P209; BOUCHER G, 1990, MAR ECOL PROG SER, V64, P271, DOI 10.3354/meps064271; Bruno JF, 1998, J EXP MAR BIOL ECOL, V229, P187, DOI 10.1016/S0022-0981(98)00050-1; Bythell JC, 2011, J EXP MAR BIOL ECOL, V408, P88, DOI 10.1016/j.jembe.2011.07.028; CARPENTER RC, 1991, LIMNOL OCEANOGR, V36, P40, DOI 10.4319/lo.1991.36.1.0040; Clavier J, 1999, MAR ECOL PROG SER, V191, P79, DOI 10.3354/meps191079; COLLADOVIDES L, 1998, HIDROBIOLOGICA, V8, P133; Colombo-Pallotta MF, 2010, CORAL REEFS, V29, P899, DOI 10.1007/s00338-010-0638-x; Coronado C, 2007, CORAL REEFS, V26, P149, DOI 10.1007/s00338-006-0175-9; Cuet P, 2011, CORAL REEFS, V30, P45, DOI 10.1007/s00338-011-0744-4; DAHL AL, 1973, MAR BIOL, V23, P239, DOI 10.1007/BF00389331; Duarte CM, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003793; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Enriquez S, 2005, OECOLOGIA, V145, P235, DOI 10.1007/s00442-005-0111-7; Falter JL, 2011, CORAL REEFS, V30, P53, DOI 10.1007/s00338-010-0671-9; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; FOURQUREAN JW, 1991, MAR ECOL PROG SER, V69, P161, DOI 10.3354/meps069161; Gattuso JP, 1998, ANNU REV ECOL SYST, V29, P405, DOI 10.1146/annurev.ecolsys.29.1.405; Haas AF, 2010, MAR ECOL PROG SER, V409, P27, DOI 10.3354/meps08631; HATCHER BG, 1988, TRENDS ECOL EVOL, V3, P106, DOI 10.1016/0169-5347(88)90117-6; HATCHER BG, 1990, TRENDS ECOL EVOL, V5, P149, DOI 10.1016/0169-5347(90)90221-X; Heck KL, 2008, ECOSYSTEMS, V11, P1198, DOI 10.1007/s10021-008-9155-y; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jordan E., 1982, Proceedings of the International Coral Reef Symposium, P303; Kinsey D. W., 1977, Proceedings int Coral Reef Symp, V3, P383; Kinsey D.W., 1985, P 5 INT COR REEF S, V4, P505; Kirk J. T. O., 1983, LIGHT PHOTOSYNTHESIS; LESSER MP, 1994, J EXP MAR BIOL ECOL, V178, P153, DOI 10.1016/0022-0981(94)90034-5; Marba N, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P135; Mass T, 2010, P NATL ACAD SCI USA, V107, P2527, DOI 10.1073/pnas.0912348107; Mayer FW, 2010, MAR FRESHWATER RES, V61, P1006, DOI 10.1071/MF09250; McClanahan TR, 1998, ENVIRON CONSERV, V25, P122, DOI 10.1017/S0376892998000174; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Naumann MS, 2010, CORAL REEFS, V29, P649, DOI 10.1007/s00338-010-0612-7; Naumann MS, 2009, CORAL REEFS, V28, P109, DOI 10.1007/s00338-008-0459-3; Naumann MS, 2012, J MARINE SYST, V105, P20, DOI 10.1016/j.jmarsys.2012.05.007; Naumann MS, 2012, P 12 INT COR REEF S; ODUM HT, 1955, ECOL MONOGR, V25, P291, DOI 10.2307/1943285; ODUM HT, 1957, LIMNOL OCEANOGR, V2, P85, DOI 10.4319/lo.1957.2.2.0085; POLLARD PC, 1993, AUST J MAR FRESH RES, V44, P155; Richter C, 1999, MAR ECOL PROG SER, V188, P105, DOI 10.3354/meps188105; van Tussenbroek BI, 2007, J PHYCOL, V43, P69, DOI 10.1111/j.1529-8817.2006.00307.x; van Tussenbroek BI, 2011, HIDROBIOLOGICA, V21, P293; VANTUSSENBROEK BI, 1995, MAR BIOL, V122, P33, DOI 10.1007/BF00349275; WANDERS J B W, 1976, Aquatic Botany, V2, P327, DOI 10.1016/0304-3770(76)90030-9; Wild C, 2006, MAR FRESHWATER RES, V57, P415, DOI 10.1071/MF05205; Wild C, 2013, P NATL ACAD SCI USA, V110, P8767, DOI 10.1073/pnas.1306839110; Wild C, 2010, MAR ECOL PROG SER, V411, P61, DOI 10.3354/meps08653; Wild C, 2009, AQUAT BIOL, V6, P133, DOI 10.3354/ab00181; Wilkinson C, 2008, STATUS CORAL REEFS W; Wu EY, 1997, J APPL PHYSIOL, V82, P196, DOI 10.1152/jappl.1997.82.1.196	52	19	19	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82923	10.1371/journal.pone.0082923	http://dx.doi.org/10.1371/journal.pone.0082923			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367570	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300081
J	Prandi, S; Bromke, M; Hubner, S; Voigt, A; Boehm, U; Meyerhof, W; Behrens, M				Prandi, Simone; Bromke, Marta; Huebner, Sandra; Voigt, Anja; Boehm, Ulrich; Meyerhof, Wolfgang; Behrens, Maik			A Subset of Mouse Colonic Goblet Cells Expresses the Bitter Taste Receptor Tas2r131	PLOS ONE			English	Article							ENTEROENDOCRINE STC-1 CELLS; EPITHELIAL-CELLS; ALPHA-GUSTDUCIN; SECRETION; MICE; RAT; INTESTINE; PROTEIN; FAMILY; SWEET	The concept that gut nutrient sensing involves taste receptors has been fueled by recent reports associating the expression of taste receptors and taste-associated signaling molecules in the gut and in gut-derived cell lines with physiological responses induced by known taste stimuli. However, for bitter taste receptors (Tas2rs), direct evidence for their functional role in gut physiology is scarce and their cellular expression pattern remained unknown. We therefore investigated Tas2r expression in mice. RT-PCR experiments assessed the presence of mRNA for Tas2rs and taste signaling molecules in the gut. A gene-targeted mouse strain was established to visualize and identify cell types expressing the bitter receptor Tas2r131. Messenger RNA for various Tas2rs and taste signaling molecules were detected by RT-PCR in the gut. Using our knock-in mouse strain we demonstrate that a subset of colonic goblet cells express Tas2r131. Cells that express this receptor are absent in the upper gut and do not correspond to enteroendocrine and brush cells. Expression in colonic goblet cells is consistent with a role of Tas2rs in defense mechanisms against potentially harmful xenobiotics.	[Prandi, Simone; Bromke, Marta; Huebner, Sandra; Voigt, Anja; Meyerhof, Wolfgang; Behrens, Maik] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Genet, Nuthetal, Germany; [Voigt, Anja; Boehm, Ulrich] Univ Saarland, Sch Med, Dept Pharmacol & Toxicol, Homburg, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Saarland University	Behrens, M (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Genet, Nuthetal, Germany.	behrens@dife.de	Behrens, Maik/B-6753-2016	Behrens, Maik/0000-0003-2082-8860	German Ministry of Education and Research (BMBF) [0315669]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Ministry of Education and Research (BMBF, #0315669, to WM and MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Behrens M, 2000, EUR J NEUROSCI, V12, P1372, DOI 10.1046/j.1460-9568.2000.00032.x; Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; Behrens M, 2011, PHYSIOL BEHAV, V105, P4, DOI 10.1016/j.physbeh.2011.02.010; Bezencon C, 2007, CHEM SENSES, V32, P41, DOI 10.1093/chemse/bjl034; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Chen MC, 2006, AM J PHYSIOL-CELL PH, V291, pC726, DOI 10.1152/ajpcell.00003.2006; Dotson CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003974; Foster SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064579; Geraedts MCP, 2012, AM J PHYSIOL-ENDOC M, V303, pE464, DOI 10.1152/ajpendo.00163.2012; Glendinning JI, 2008, PHYSIOL BEHAV, V93, P757, DOI 10.1016/j.physbeh.2007.11.029; GOODWIN EC, 1992, J BIOL CHEM, V267, P16330; Hass N, 2007, HISTOCHEM CELL BIOL, V128, P457, DOI 10.1007/s00418-007-0325-3; Hass N, 2010, CELL TISSUE RES, V339, P493, DOI 10.1007/s00441-009-0907-6; Hofer D, 1996, P NATL ACAD SCI USA, V93, P6631, DOI 10.1073/pnas.93.13.6631; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Jeon TI, 2008, J CLIN INVEST, V118, P3693, DOI 10.1172/JCI36461; Kaji I, 2009, AM J PHYSIOL-GASTR L, V296, pG971, DOI 10.1152/ajpgi.90514.2008; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Meyerhof W, 2005, REV PHYSIOL BIOCH P, V154, P37, DOI 10.1007/s10254-005-0041-0; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Moran AW, 2010, BRIT J NUTR, V104, P637, DOI 10.1017/S0007114510000917; ROBINE S, 1985, P NATL ACAD SCI USA, V82, P8488, DOI 10.1073/pnas.82.24.8488; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rozengurt N, 2006, AM J PHYSIOL-GASTR L, V291, pG792, DOI 10.1152/ajpgi.00074.2006; Sainz E, 2007, BIOCHEM J, V403, P537, DOI 10.1042/BJ20061744; Sternini C, 2008, CURR OPIN ENDOCRINOL, V15, P73, DOI 10.1097/MED.0b013e3282f43a73; Sutherland K, 2007, AM J PHYSIOL-GASTR L, V292, pG1420, DOI 10.1152/ajpgi.00504.2006; THOMPSON WJ, 1991, PHARMACOL THERAPEUT, V51, P13, DOI 10.1016/0163-7258(91)90039-O; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wu SV, 2005, PHYSIOL GENOMICS, V22, P139, DOI 10.1152/physiolgenomics.00030.2005; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	39	47	47	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82820	10.1371/journal.pone.0082820	http://dx.doi.org/10.1371/journal.pone.0082820			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367558	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300072
J	Rosenkranz, SC; Geissen, M; Harter, K; Szalay, B; Ferrer, I; Vogel, J; Smith, S; Glatzel, M				Rosenkranz, Sina Catherine; Geissen, Markus; Haerter, Kristina; Szalay, Beata; Ferrer, Isidro; Vogel, Jana; Smith, Stephen; Glatzel, Markus			Amyloid-Precursor-Protein-Lowering Small Molecules for Disease Modifying Therapy of Alzheimer's Disease	PLOS ONE			English	Article							BETA; IDENTIFICATION; INHIBITOR; PROMOTER; MUTATION; BRAIN; PRION; GENE; APP	Alzheimer's disease (AD) is the most common form of dementia in the elderly with progressive cognitive decline and memory loss. According to the amyloid-hypothesis, AD is caused by generation and subsequent cerebral deposition of beta-amyloid (A beta). A beta is generated through sequential cleavage of the transmembrane Amyloid-Precursor-Protein (APP) by two endoproteinases termed beta-and gamma-secretase. Increased APP-expression caused by APP gene dosage effects is a risk factor for the development of AD. Here we carried out a large scale screen for novel compounds aimed at decreasing APP-expression. For this we developed a screening system employing a cell culture model of AD. A total of 10,000 substances selected for their ability of drug-likeness and chemical diversity were tested for their potential to decrease APP-expression resulting in reduced A beta-levels. Positive compounds were further evaluated for their effect at lower concentrations, absence of cytotoxicity and specificity. The six most promising compounds were characterized and structure function relationships were established. The novel compounds presented here provide valuable information for the development of causal therapies for AD.	[Rosenkranz, Sina Catherine; Geissen, Markus; Haerter, Kristina; Szalay, Beata; Vogel, Jana; Glatzel, Markus] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Rosenkranz, Sina Catherine] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Geissen, Markus] Univ Med Ctr Hamburg Eppendorf, Dept Vasc Med, Hamburg, Germany; [Ferrer, Isidro] Hosp Univ Bellvitge, Inst Neuropathol, Barcelona, Spain; [Smith, Stephen] European Screening Port GmbH, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Glatzel, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany.	m.glatzel@uke.de	Glatzel, Markus/G-3356-2011; Glatzel, Markus/V-8844-2019	Glatzel, Markus/0000-0002-7720-8817; Glatzel, Markus/0000-0002-7720-8817	DFG (Deutsche Forschungsgesellschaft) as part of their research training group 1459; University of Hamburg by their research training group, Inflammation and regeneration	DFG (Deutsche Forschungsgesellschaft) as part of their research training group 1459(German Research Foundation (DFG)); University of Hamburg by their research training group, Inflammation and regeneration	This work was funded by the DFG (Deutsche Forschungsgesellschaft) as part of their research training group 1459 and by the University of Hamburg by their research training group, Inflammation and regeneration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.dfg.de/http://www.uni-hamburg.de/	[Anonymous], Patent US, Patent No. 20100248365; Beyer K, 2004, MOL BRAIN RES, V131, P131, DOI 10.1016/j.molbrainres.2004.08.006; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Burns A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b158; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; DONNELLY RJ, 1990, CELL MOL NEUROBIOL, V10, P485, DOI 10.1007/BF00712843; Ertekin-Taner N, 2007, NEUROL CLIN, V25, P611, DOI 10.1016/j.ncl.2007.03.009; Estivill X, 2007, PLOS GENET, V3, P1787, DOI 10.1371/journal.pgen.0030190; Freshney R.I., 2010, CULTURE ANIMAL CELLS; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Geissen M, 2011, CHEMMEDCHEM, V6, P1928, DOI 10.1002/cmdc.201100119; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hopkins CR, 2011, ACS CHEM NEUROSCI, V2, P279, DOI 10.1021/cn2000469; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; JACOBSEN JS, 1991, NEUROBIOL AGING, V12, P585, DOI 10.1016/0197-4580(91)90090-7; Jellinger KA, 1998, J NEURAL TRANSM-SUPP, P77; Kim W, 2006, NY TIMES BK REV, P1; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; LAHIRI DK, 1991, MOL BRAIN RES, V9, P253, DOI 10.1016/0169-328X(91)90009-M; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; Lewis V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031754; Licastro F, 2007, NEUROBIOL AGING, V28, P1637, DOI 10.1016/j.neurobiolaging.2006.07.007; May PC, 2011, J NEUROSCI, V31, P16507, DOI 10.1523/JNEUROSCI.3647-11.2011; McNaughton D, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.10.010; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; NINOMIYA H, 1993, J CELL BIOL, V121, P879, DOI 10.1083/jcb.121.4.879; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; QUITSCHKE WW, 1992, J BIOL CHEM, V267, P17362; Rinderspacher A, 2009, BIOORG MED CHEM LETT, V19, P1715, DOI 10.1016/j.bmcl.2009.01.087; Saito Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022108; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; Sepulveda-Falla D, 2012, J ALZHEIMERS DIS, V32, P1, DOI 10.3233/JAD-2012-120907; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Troy CM, 2000, J NEUROSCI, V20, P1386; Utsuki T, 2006, J PHARMACOL EXP THER, V318, P855, DOI 10.1124/jpet.106.103309; Verbeek MM, 1997, BIOL CHEM, V378, P937; Wagner J, 2013, ACTA NEUROPATHOL, V125, P795, DOI 10.1007/s00401-013-1114-9; Wang H, 2008, J NEUROSCI, V28, P8677, DOI 10.1523/JNEUROSCI.2440-08.2008; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; YOUNKIN SG, 1995, ANN NEUROL, V37, P287, DOI 10.1002/ana.410370303	50	5	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82255	10.1371/journal.pone.0082255	http://dx.doi.org/10.1371/journal.pone.0082255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367508	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300024
J	Wang, J; Liu, KX; Ariani, F; Tao, LL; Zhang, J; Qu, JM				Wang, Jie; Liu, Kai-xiong; Ariani, Felinda; Tao, Li-li; Zhang, Jing; Qu, Jie-Ming			Probiotics for Preventing Ventilator-Associated Pneumonia: A Systematic Review and Meta-Analysis of High-Quality Randomized Controlled Trials	PLOS ONE			English	Review							EARLY ENTERAL NUTRITION; CRITICALLY-ILL PATIENTS; DOUBLE-BLIND; DIGESTIVE-TRACT; NOSOCOMIAL PNEUMONIA; SYNBIOTIC THERAPY; INTENSIVE-CARE; DECONTAMINATION; LACTOBACILLUS; MORTALITY	Background: Ventilator-associated pneumonia (VAP) is considered to be a worldwide issue along with the development of supportive ventilation. The preventing strategy is of great importance for its poor prognostic and difficulties in treatment. Probiotics have been advocated as one of the possible preventive measures. We conducted a systematic review and meta-analysis to explore the potential benefits of probiotics. Methods: The databases, Web of science, PubMed, Ovid and Cochrane lib were searched for randomized controlled trials (RCTs) publications that compared the effectiveness of probiotics with placebo in the prevention of VAP. The incidence of VAP was considered as the primary endpoint, mortality, length of stay in intensive care units (ICUs), etiology of the infections were considered as secondary endpoints. Results: A total of 844 patients from 5 trials were subjected to meta-analysis. Probiotics did not significantly decrease the incidence of VAP (RR 0.94, 95%CI 0.85-1.04, p=0.22), however, the administration of probiotics reduced the risk of VAP caused by Pseudomonas aeruginosa (P. aeruginosa) (RR 0.30, 95%CI 0.11-0.91, P=0.03). It failed to affect any other endpoints. Conclusion: Probiotic prophylaxis of ventilator-associated pneumonia remained inconclusive and it failed to improve the prognosis of general mechanically ventilated patients. It was noteworthy that infections caused by P. aeruginosa was reduced by administration of probiotics. In further, it is recommended that advanced studies should exploit transformation in pathogenic microorganisms owing to administration of probiotics as well as the specific population.	[Wang, Jie; Ariani, Felinda; Tao, Li-li; Qu, Jie-Ming] Fudan Univ, Dept Pulm Med, Huadong Hosp, Shanghai 200433, Peoples R China; [Liu, Kai-xiong] Fujian Med Univ, Dept Pulm Med, Affiliated Hosp 1, Fuzhou, Fujian Province, Peoples R China; [Zhang, Jing] Fudan Univ, Dept Pulm Med, Zhongshan Hosp, Shanghai 200433, Peoples R China	Fudan University; Fujian Medical University; Fudan University	Qu, JM (corresponding author), Fudan Univ, Dept Pulm Med, Huadong Hosp, Shanghai 200433, Peoples R China.	jmqu0906@163.com	Tao, Lili/AAU-7674-2021		National Basic Research Program (973 Program) in China [2013CB531400]; Shanghai Subject Chief Scientist Program [07XD14012]; Shanghai Leading Talent Projects [036]	National Basic Research Program (973 Program) in China(National Basic Research Program of China); Shanghai Subject Chief Scientist Program; Shanghai Leading Talent Projects	The manuscript was sponsored by the National Basic Research Program (973 Program) in China (2013CB531400), the Shanghai Subject Chief Scientist Program (07XD14012) and Shanghai Leading Talent Projects (No. 036, 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbeleHorn M, 1997, INTENS CARE MED, V23, P187, DOI 10.1007/s001340050314; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Barraud D, 2013, CHEST, V143, P646, DOI 10.1378/chest.12-1745; Barraud D, 2010, INTENS CARE MED, V36, P1540, DOI 10.1007/s00134-010-1927-0; Bergmans DCJJ, 2001, AM J RESP CRIT CARE, V164, P382, DOI 10.1164/ajrccm.164.3.2005003; Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Bonten M J, 2000, Semin Respir Infect, V15, P327; Bonten MJM, 2010, AM J RESP CRIT CARE, V182, P993, DOI 10.1164/rccm.201007-1033ED; Bregeon F, 2001, ANESTHESIOLOGY, V94, P554, DOI 10.1097/00000542-200104000-00005; Chifiriuc Mariana-Carmen, 2009, Roum Arch Microbiol Immunol, V68, P27; de Arruda ISF, 2004, CLIN SCI, V106, P287, DOI 10.1042/CS20030251; de Jonge E, 2003, LANCET, V362, P1011, DOI 10.1016/S0140-6736(03)14409-1; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Forestier C, 2008, CRIT CARE, V12, DOI 10.1186/cc6907; Fukushima Y, 2007, BRIT J NUTR, V98, P969, DOI 10.1017/S0007114507764723; Giamarellos-Bourboulis EJ, 2009, J TRAUMA, V67, P815, DOI 10.1097/TA.0b013e31819d979e; Gu WJ, 2013, JPEN-PARENTER ENTER, V37, P310, DOI 10.1177/0148607112463245; Gu WJ, 2012, CHEST, V142, P859, DOI 10.1378/chest.12-0679; Hayakawa M, 2012, DIGEST DIS SCI, V57, P2642, DOI 10.1007/s10620-012-2201-9; Heyland DK, 1999, AM J RESP CRIT CARE, V159, P1249, DOI 10.1164/ajrccm.159.4.9807050; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Klarin B, 2008, CRIT CARE, V12, DOI 10.1186/cc7109; Knight DJW, 2009, INTENS CARE MED, V35, P854, DOI 10.1007/s00134-008-1368-1; Kotzampassi K, 2006, WORLD J SURG, V30, P1848, DOI 10.1007/s00268-005-0653-1; Linssen CFM, 2008, ANN CLIN BIOCHEM, V45, P293, DOI 10.1258/acb.2007.007133; Liu KX, 2012, CRIT CARE, V16, DOI 10.1186/cc11398; MANTEL N, 1959, J NATL CANCER I, V22, P719; Morrow LE, 2005, CHEST, V128, p144S, DOI 10.1378/chest.128.4_MeetingAbstracts.144S; Morrow LE, 2010, AM J RESP CRIT CARE, V182, P1058, DOI 10.1164/rccm.200912-1853OC; Muszynski J, 2012, TRANSFUSION, V52, P794, DOI 10.1111/j.1537-2995.2011.03348.x; Oudhuis GJ, 2011, INTENS CARE MED, V37, P110, DOI 10.1007/s00134-010-2002-6; PUGIN J, 1991, JAMA-J AM MED ASSOC, V265, P2704, DOI 10.1001/jama.265.20.2704; Rayes N, 2002, TRANSPLANTATION, V74, P123, DOI 10.1097/00007890-200207150-00021; RELLO J, 1993, CHEST, V104, P1230, DOI 10.1378/chest.104.4.1230; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Siempos II, 2010, CRIT CARE MED, V38, P954, DOI 10.1097/CCM.0b013e3181c8fe4b; Spindler-Vesel A, 2007, JPEN-PARENTER ENTER, V31, P119, DOI 10.1177/0148607107031002119; Timmerman HM, 2007, CLIN NUTR, V26, P450, DOI 10.1016/j.clnu.2007.04.008; van Saene HKF, 1999, NEW ENGL J MED, V341, P293; Vanderpool C, 2008, INFLAMM BOWEL DIS, V14, P1585, DOI 10.1002/ibd.20525; Varma P, 2011, J MOL MICROB BIOTECH, V20, P137, DOI 10.1159/000328512; Williams MD, 2010, J CLIN GASTROENTEROL, V44, P631, DOI 10.1097/MCG.0b013e3181d47f5b	44	37	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83934	10.1371/journal.pone.0083934	http://dx.doi.org/10.1371/journal.pone.0083934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367620	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300122
J	Han, YM; Chen, A; Cao, JJ; Fung, K; Ho, F; Yan, BZ; Zhan, CLL; Liu, SX; Wei, C; An, ZS				Han, Yongming; Chen, Antony; Cao, Junji; Fung, Kochy; Ho, Fai; Yan, Beizhan; Zhan, Changlin; Liu, Suixin; Wei, Chong; An, Zhisheng			Thermal/Optical Methods for Elemental Carbon Quantification in Soils and Urban Dusts: Equivalence of Different Analysis Protocols	PLOS ONE			English	Article							THERMAL-OPTICAL METHOD; BLACK CARBON; REFLECTANCE METHOD; SOOT; TEMPERATURE; CHAR; TRANSMITTANCE; SPECIATION; SEDIMENTS; IMPROVE	Quantifying elemental carbon (EC) content in geological samples is challenging due to interferences of crustal, salt, and organic material. Thermal/optical analysis, combined with acid pretreatment, represents a feasible approach. However, the consistency of various thermal/optical analysis protocols for this type of samples has never been examined. In this study, urban street dust and soil samples from Baoji, China were pretreated with acids and analyzed with four thermal/optical protocols to investigate how analytical conditions and optical correction affect EC measurement. The EC values measured with reflectance correction (ECR) were found always higher and less sensitive to temperature program than the EC values measured with transmittance correction (ECT). A hightemperature method with extended heating times (STN120) showed the highest ECT/ECR ratio (0.86) while a lowtemperature protocol (IMPROVE-550), with heating time adjusted for sample loading, showed the lowest (0.53). STN ECT was higher than IMPROVE ECT, in contrast to results from aerosol samples. A higher peak inert-mode temperature and extended heating times can elevate ECT/ECR ratios for pretreated geological samples by promoting pyrolyzed organic carbon (PyOC) removal over EC under trace levels of oxygen. Considering that PyOC within filter increases ECR while decreases ECT from the actual EC levels, simultaneous ECR and ECT measurements would constrain the range of EC loading and provide information on method performance. Further testing with standard reference materials of common environmental matrices supports the findings. Char and soot fractions of EC can be further separated using the IMPROVE protocol. The char/soot ratio was lower in street dusts (2.2 on average) than in soils (5.2 on average), most likely reflecting motor vehicle emissions. The soot concentrations agreed with EC from CTO-375, a pure thermal method.	[Han, Yongming; Chen, Antony; Cao, Junji; Ho, Fai; Zhan, Changlin; Liu, Suixin; Wei, Chong; An, Zhisheng] Chinese Acad Sci, Inst Earth Environm, SKLLQG, Key Lab Aerosol Sci & Technol, Xian, Peoples R China; [Chen, Antony] Univ Nevada, Desert Res Inst, Reno, NV 89506 USA; [Fung, Kochy] AtmAA Inc, Calabasas, CA USA; [Ho, Fai] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China; [Han, Yongming; Yan, Beizhan] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA	Chinese Academy of Sciences; Institute of Earth Environment, CAS; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; University of Nevada Reno; Chinese University of Hong Kong; Columbia University	Han, YM (corresponding author), Chinese Acad Sci, Inst Earth Environm, SKLLQG, Key Lab Aerosol Sci & Technol, Xian, Peoples R China.	yongming@ieecas.cn	Wei, Chong/I-8822-2014; Junji, Cao/D-3259-2014; AN, Zhisheng/F-8834-2012; Han, Yongming/I-8824-2014; Ho, Kin Fai/E-6131-2011; Chen, Lung-Wen Antony/J-5792-2015	Wei, Chong/0000-0003-0632-4324; Junji, Cao/0000-0003-1000-7241; Ho, Kin Fai/0000-0001-7464-3437; Chen, Lung-Wen Antony/0000-0002-2311-7506; an, zhi sheng/0000-0002-9538-9826; han, yong ming/0000-0002-1282-1354	West Light Foundation of Chinese Academy of Sciences; NSF of China [41073102, 41273140, 40925009]; National Basic Research Program of China [2010CB833403, 2013CB955900]; Chinese Academy of Sciences [XDA05100402, KZZD-EW-04]; State Key Laboratory of Loess & Quaternary Geology [LQ0701]; Key Project of the National Research Program of China [2012BAH31B03]	West Light Foundation of Chinese Academy of Sciences(Chinese Academy of Sciences); NSF of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Loess & Quaternary Geology(Chinese Academy of Sciences); Key Project of the National Research Program of China	This study was supported by the West Light Foundation of Chinese Academy of Sciences, the NSF of China (41073102, 41273140, and 40925009), the National Basic Research Program of China (2010CB833403, 2013CB955900), the Chinese Academy of Sciences (XDA05100402, KZZD-EW-04), the State Key Laboratory of Loess & Quaternary Geology (LQ0701), and the Key Project of the National Research Program of China (2012BAH31B03). L.-W.A. Chen was partly supported by the Grant CHE1214163 from U. S. National Science Foundation and Grant KZZD-EW-TZ-03 from the Chinese Academy of Sciences/State Administration of Foreign Experts Affairs international partnership program for creative research teams. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi-Dey A, 2002, ENVIRON SCI TECHNOL, V36, P21, DOI 10.1021/es010953c; Birch ME, 1998, ANALYST, V123, P851; Cavalli F, 2010, ATMOS MEAS TECH, V3, P79, DOI 10.5194/amt-3-79-2010; Chen L-WA, 2012, MEAS TECH, V5, P2329; Chen LWA, 2004, J AEROSOL SCI, V35, P765, DOI 10.1016/j.jaerosci.2003.12.005; Cheng Y, 2012, ATMOS ENVIRON, V61, P453, DOI 10.1016/j.atmosenv.2012.07.066; Cheng Y, 2011, ENVIRON SCI TECHNOL, V45, P10117, DOI 10.1021/es202649g; Chow JC, 2001, AEROSOL SCI TECH, V34, P23, DOI 10.1080/02786820119073; CHOW JC, 1993, ATMOS ENVIRON A-GEN, V27, P1185, DOI 10.1016/0960-1686(93)90245-T; Chow JC, 2004, ENVIRON SCI TECHNOL, V38, P4414, DOI 10.1021/es034936u; Chow JC, 2007, J AIR WASTE MANAGE, V57, P1014, DOI 10.3155/1047-3289.57.9.1014; DUTTER R, 1981, J STAT COMPUT SIM, V13, P79, DOI 10.1080/00949658108810482; FUNG K, 1990, AEROSOL SCI TECH, V12, P122, DOI 10.1080/02786829008959332; Goldberg E. D., 1985, Black carbon in the environment. Properties and distribution; Gustafsson O, 1997, ACS SYM SER, V671, P365; Gustafsson O, 2001, GLOBAL BIOGEOCHEM CY, V15, P881, DOI 10.1029/2000GB001380; Gustafsson O, 1997, ENVIRON SCI TECHNOL, V31, P203, DOI 10.1021/es960317s; Hammes K, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002914; Han YM, 2008, ATMOS ENVIRON, V42, P2405, DOI 10.1016/j.atmosenv.2007.12.020; Han YM, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004197; Han YM, 2011, ENVIRON SCI TECHNOL, V45, P5287, DOI 10.1021/es103518c; Han YM, 2010, ATMOS CHEM PHYS, V10, P595, DOI 10.5194/acp-10-595-2010; Han YM, 2009, ATMOS ENVIRON, V43, P2464, DOI 10.1016/j.atmosenv.2009.01.040; Han YM, 2009, CHEMOSPHERE, V75, P92, DOI 10.1016/j.chemosphere.2008.11.044; Han YN, 2007, CHEMOSPHERE, V69, P526, DOI 10.1016/j.chemosphere.2007.03.035; Han YM, 2007, CHEMOSPHERE, V69, P569, DOI 10.1016/j.chemosphere.2007.03.024; Harvey OR, 2012, ENVIRON SCI TECHNOL, V46, P1415, DOI 10.1021/es2040398; Hitzenberger R, 2006, ENVIRON SCI TECHNOL, V40, P6377, DOI 10.1021/es051228v; Husain L, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009398; Janssen N. A. H., 2012, HLTH EFFECTS BLACK C; Lehmann J, 2007, FRONT ECOL ENVIRON, V5, P381, DOI 10.1890/1540-9295(2007)5[381:BITB]2.0.CO;2; Masiello CA, 2004, MAR CHEM, V92, P201, DOI 10.1016/j.marchem.2004.06.043; Nguyen TH, 2004, ORG GEOCHEM, V35, P217, DOI 10.1016/j.orggeochem.2003.09.005; NOVAKOV T, 1995, MIKROCHIM ACTA, V119, P157, DOI 10.1007/BF01244864; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Schauer JJ, 2003, ENVIRON SCI TECHNOL, V37, P993, DOI 10.1021/es020622f; Schmidt MWI, 2001, GLOBAL BIOGEOCHEM CY, V15, P163, DOI 10.1029/2000GB001284; Schmidt MWI, 2000, GLOBAL BIOGEOCHEM CY, V14, P777, DOI 10.1029/1999GB001208; Subramanian R, 2006, AEROSOL SCI TECH, V40, P763, DOI 10.1080/02786820600714403; Watson J.G., 2005, AEROSOL AIR QUAL RES, V5, P65, DOI DOI 10.4209/AAQR.2005.06.0006	40	3	3	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83462	10.1371/journal.pone.0083462	http://dx.doi.org/10.1371/journal.pone.0083462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358286	gold, Green Published, Green Submitted			2022-12-27	WOS:000328737700059
J	Mohan, S; Huff, E; Wish, J; Lilly, M; Chen, SC; McClellan, WM				Mohan, Sumit; Huff, Edwin; Wish, Jay; Lilly, Michael; Chen, Shu-Cheng; McClellan, William M.		Fistula First Breakthrough Initiat	Recovery of Renal Function among ESRD Patients in the US Medicare Program	PLOS ONE			English	Article							CHRONIC DIALYSIS; SURVIVAL	Background: Patients started on long term hemodialysis have typically had low rates of reported renal recovery with recent estimates ranging from 0.9-2.4% while higher rates of recovery have been reported in cohorts with higher percentages of patients with acute renal failure requiring dialysis. Study Design: Our analysis followed approximately 194,000 patients who were initiated on hemodialysis during a 2-year period (2008 & 2009) with CMS-2728 forms submitted to CMS by dialysis facilities, cross-referenced with patient record updates through the end of 2010, and tracked through December 2010 in the CMS SIMS registry. Results: We report a sustained renal recovery (i.e no return to ESRD during the available follow up period) rate among Medicare ESRD patients of >5% - much higher than previously reported. Recovery occurred primarily in the first 2 months post incident dialysis, and was more likely in cases with renal failure secondary to etiologies associated with acute kidney injury. Patients experiencing sustained recovery were markedly less likely than true long-term ESRD patients to have permanent vascular accesses in place at incident hemodialysis, while non-White patients, and patients with any prior nephrology care appeared to have significantly lower rates of renal recovery. We also found widespread geographic variation in the rates of renal recovery across the United States. Conclusions: Renal recovery rates in the US Medicare ESRD program are higher than previously reported and appear to have significant geographic variation. Patients with diagnoses associated with acute kidney injury who are initiated on long-term hemodialysis have significantly higher rates of renal recovery than the general ESRD population and lower rates of permanent access placement.	[Mohan, Sumit] Columbia Univ, Coll Phys & Surg, Dept Med, Div Nephrol, New York, NY 10027 USA; [Huff, Edwin] Boston Reg Off, Centers Medicare & Medicaid Serv, Div Qual Improvement, Boston, MA USA; [Wish, Jay] Case Western Reserve Univ, Dept Med, Div Nephrol, Cleveland, OH 44106 USA; [Lilly, Michael] Univ Maryland, Baltimore Sch Med, Dept Surg, Div Vasc Surg, Baltimore, MD 21201 USA; [Chen, Shu-Cheng] Minneapolis Med Res Fdn Inc, Chron Dis Res Grp, Minneapolis, MN USA; [McClellan, William M.] Emory Sch Med, Dept Med, Div Nephrol, Atlanta, GA USA	Columbia University; Case Western Reserve University; University System of Maryland; University of Maryland Baltimore; Minneapolis Medical Research Foundation; Emory University	Mohan, S (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, Div Nephrol, New York, NY 10027 USA.	sm2206@columbia.edu	Mohan, Sumit/I-5625-2019	Mohan, Sumit/0000-0002-5305-9685	 [HHSM-500-2010-NW002C]		This study was prepared in part by the IPRO EndStage Renal Disease Network of New York, the ESRD Organization for New York State, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U. S. Department of Health and Human Services. The contents presented do not necessarily reflect CMS policy. CMS Contract Number: HHSM-500-2010-NW002C	[Anonymous], 2012, ESRD MED EVIDENCE RE; Bagshaw SM, 2005, CRIT CARE, V9, pR700, DOI 10.1186/cc3879; Chan KE, 2011, CLIN J AM SOC NEPHRO, V6, P2642, DOI 10.2215/CJN.03680411; Chu JK, 2010, SEMIN DIALYSIS, V23, P606, DOI 10.1111/j.1525-139X.2010.00769.x; Goldstein A, 2003, PERITON DIALYSIS INT, V23, P151; Heung M, 2010, J AM SOC NEPHROL, V21, p717A; U S Renal Data System, 2011, USRDS 2011 ANN DAT R; Wright S, 2010, CLIN J AM SOC NEPHRO, V5, P1828, DOI 10.2215/CJN.06230909	8	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83447	10.1371/journal.pone.0083447	http://dx.doi.org/10.1371/journal.pone.0083447			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358285	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700058
J	Sommi, P; Necchi, V; Vitali, A; Montagna, D; De Luigi, A; Salmona, M; Ricci, V; Solcia, E				Sommi, Patrizia; Necchi, Vittorio; Vitali, Agostina; Montagna, Daniela; De Luigi, Ada; Salmona, Mario; Ricci, Vittorio; Solcia, Enrico			PaCS Is a Novel Cytoplasmic Structure Containing Functional Proteasome and Inducible by Cytokines/Trophic Factors	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR RECEPTOR; UBIQUITINATED PROTEINS; INHERITED THROMBOCYTOPENIA; MULTICATALYTIC PROTEINASE; MISFOLDED PROTEINS; VIRAL ONCOPROTEIN; BINDING PROTEIN; DENDRITIC CELLS; DEGRADATION	A variety of ubiquitinated protein-containing cytoplasmic structures has been reported, from aggresomes to aggresome-like induced structures/sequestosomes or particle-rich cytoplasmic structures (PaCSs) that we recently observed in some human diseases. Nevertheless, the morphological and cytochemical patterns of the different structures remain largely unknown thus jeopardizing their univocal identification. Here, we show that PaCSs resulted from proteasome and polyubiquitinated protein accumulation into well-demarcated, membrane-free, cytoskeleton-poor areas enriched in glycogen and glycosaminoglycans. A major requirement for PaCS detection by either electron or confocal microscopy was the addition of osmium to aldehyde fixatives. However, by analyzing living cells, we found that proteasome chymotrypsin-like activity concentrated in well-defined cytoplasmic structures identified as PaCSs by ultrastructural morphology and immunocytochemistry of the same cells. PaCSs differed ultrastructurally and cytochemically from sequestosomes which may coexist with PaCSs. In human dendritic or natural killer cells, PaCSs were induced in vitro by cytokines/trophic factors during differentiation/activation from blood progenitors. Our results provide evidence that PaCS is indeed a novel distinctive cytoplasmic structure which may play a critical role in the ubiquitin-proteasome system response to immune, infectious or proneoplastic stimuli.	[Sommi, Patrizia; Necchi, Vittorio; Vitali, Agostina; Ricci, Vittorio; Solcia, Enrico] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Sommi, Patrizia; Necchi, Vittorio; Vitali, Agostina; Montagna, Daniela; Ricci, Vittorio; Solcia, Enrico] Fdn IRCCS Policlin San Matteo, Pavia, Italy; [Sommi, Patrizia; Solcia, Enrico] Univ Pavia, Serv Anat Pathol, I-27100 Pavia, Italy; [Necchi, Vittorio] Univ Pavia, Ctr Grandi Strumenti, I-27100 Pavia, Italy; [Montagna, Daniela] Univ Pavia, Pediat Hematol Oncol Serv, I-27100 Pavia, Italy; [De Luigi, Ada; Salmona, Mario] IRCCS Ist Ric Farmacol Mario Negri, Milan, Italy	University of Pavia; IRCCS Fondazione San Matteo; University of Pavia; University of Pavia; University of Pavia; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Ricci, V (corresponding author), Univ Pavia, Dept Mol Med, Via Palestro 3, I-27100 Pavia, Italy.	vricci@unipv.it; solciae@smatteo.pv.it	De Luigi, Ada/ABF-7913-2020; salmona, mario/ABI-4066-2020; salmona, mario/AAA-7116-2020; Montagna, Daniela/AAK-9380-2020	De Luigi, Ada/0000-0001-7907-7139; salmona, mario/0000-0002-9098-9873; MONTAGNA, DANIELA/0000-0002-1533-579X	Italian Ministry of Health to Fondazione IRCCS Policlinico San Matteo [RF-20102310098]; Italian Ministry for University and Research [2009A37C8C_002]; Fondazione Cariplo [2009-2532, 2011-0485]	Italian Ministry of Health to Fondazione IRCCS Policlinico San Matteo; Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by grants from the Italian Ministry of Health to Fondazione IRCCS Policlinico San Matteo (Ricerca Finalizzata RF-20102310098), from the Italian Ministry for University and Research (Progetto di Ricerca di Interesse Nazionale 2009A37C8C_002 to VR) and from Fondazione Cariplo (grants n. 2009-2532 to ES and n. 2011-0485 to VR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso LG, 2004, BIOCHEMISTRY-US, V43, P3310, DOI 10.1021/bi036037o; Baba O, 1993, Kokubyo Gakkai Zasshi, V60, P264; Bao XF, 2004, J BIOL CHEM, V279, P9765, DOI 10.1074/jbc.M310877200; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; BAUMEISTER W, 1988, FEBS LETT, V241, P239, DOI 10.1016/0014-5793(88)81069-X; Bazzaro M, 2006, CANCER RES, V66, P3754, DOI 10.1158/0008-5472.CAN-05-2321; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boocock GRB, 2003, NAT GENET, V33, P97, DOI 10.1038/ng1062; Canadien V, 2005, J IMMUNOL, V174, P2471, DOI 10.4049/jimmunol.174.5.2471; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; Chen QH, 2005, CIRC RES, V97, P1018, DOI 10.1161/01.RES.0000189262.92896.0b; Cheng KW, 2012, EMBO MOL MED, V4, P125, DOI 10.1002/emmm.201100193; Chiozzi V, 2009, J PHYSIOL PHARMACOL, V60, P23; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Dantur K, 2009, INT J CANCER, V125, P1902, DOI 10.1002/ijc.24579; Denk H, 2006, J PATHOL, V208, P653, DOI 10.1002/path.1946; Dhungana S, 2009, MOL CELL PROTEOMICS, V8, P201, DOI 10.1074/mcp.M800286-MCP200; Fassbender M, 2008, MED MICROBIOL IMMUN, V197, P185, DOI 10.1007/s00430-008-0091-4; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Garyali P, 2009, HUM MOL GENET, V18, P688, DOI 10.1093/hmg/ddn398; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; GRAY CW, 1994, J MOL BIOL, V236, P7, DOI 10.1006/jmbi.1994.1113; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Herter S, 2005, J IMMUNOL, V175, P891, DOI 10.4049/jimmunol.175.2.891; Hipp MS, 2012, J CELL BIOL, V196, P573, DOI 10.1083/jcb.201110093; HIRSCH JG, 1968, J CELL BIOL, V38, P615, DOI 10.1083/jcb.38.3.615; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Keates S, 2007, J INFECT DIS, V196, P95, DOI 10.1086/518440; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kuboki Y, 2010, MODERN PATHOL, V23, P1127, DOI 10.1038/modpathol.2010.97; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lelouard H, 2004, J CELL BIOL, V164, P667, DOI 10.1083/jcb.200312073; Lelouard H, 2002, NATURE, V417, P177, DOI 10.1038/417177a; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Mani K, 2007, J BIOL CHEM, V282, P21934, DOI 10.1074/jbc.M701200200; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Mittal S, 2007, HUM MOL GENET, V16, P753, DOI 10.1093/hmg/ddm006; Montagna D, 2003, EXP HEMATOL, V31, P1031, DOI 10.1016/S0301-472X(03)00230-3; Nannmark U, 1996, EUR J CELL BIOL, V71, P402; Necchi V, 2013, THROMB HAEMOSTASIS, V109, P263, DOI 10.1160/TH12-07-0497; Necchi V, 2012, HAEMATOL-HEMATOL J, V97, P1057, DOI 10.3324/haematol.2011.048462; Necchi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021317; Necchi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009716; Nishimura A, 2006, MICROBES INFECT, V8, P984, DOI 10.1016/j.micinf.2005.10.015; Noris P, 2011, BLOOD, V117, P6673, DOI 10.1182/blood-2011-02-336537; OHKAWA K, 1977, CANCER-AM CANCER SOC, V40, P3019, DOI 10.1002/1097-0142(197712)40:6<3019::AID-CNCR2820400639>3.0.CO;2-M; OHKUBO I, 1991, BIOCHEM BIOPH RES CO, V174, P1133, DOI 10.1016/0006-291X(91)91538-N; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pearse AGE, 1985, ANAL TECHNOLOGY, V2; Pende D, 2009, BLOOD, V113, P3119, DOI 10.1182/blood-2008-06-164103; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; Pierre P, 2005, IMMUNOL REV, V207, P184, DOI 10.1111/j.0105-2896.2005.00300.x; Pippucci T, 2011, AM J HUM GENET, V88, P115, DOI 10.1016/j.ajhg.2010.12.006; Pitzer F, 1996, FEBS LETT, V394, P47, DOI 10.1016/0014-5793(96)00920-9; Puri R, 2011, FEBS J, V278, P3688, DOI 10.1111/j.1742-4658.2011.08287.x; Qureshi N, 2003, J IMMUNOL, V171, P1515, DOI 10.4049/jimmunol.171.3.1515; Ricci V, 2000, MOL BIOL CELL, V11, P3897, DOI 10.1091/mbc.11.11.3897; Riley BE, 2010, J CELL BIOL, V191, P537, DOI 10.1083/jcb.201005012; Rivett AJ, 1998, CURR OPIN IMMUNOL, V10, P110, DOI 10.1016/S0952-7915(98)80040-X; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Segundo C, 1999, BLOOD, V94, P1012, DOI 10.1182/blood.V94.3.1012.415k05_1012_1020; Shearer J, 2002, CAN J APPL PHYSIOL, V27, P179, DOI 10.1139/h02-012; Simonsen A, 2004, J CELL SCI, V117, P4239, DOI 10.1242/jcs.01287; Suber T, 2009, ARTHRITIS RHEUM-US, V60, P2216, DOI 10.1002/art.24715; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Urru SAM, 2010, J MED CHEM, V53, P7452, DOI 10.1021/jm100362x; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958; WASSERMAN K, 1994, J CELL BIOCHEM, V55, P133, DOI 10.1002/jcb.240550115; Wenger T, 2012, AUTOPHAGY, V8, P350, DOI [10.4161/auto.8.3.18806, 10.4161/auto.18806]; Willis MS, 2013, NEW ENGL J MED, V368, P455, DOI 10.1056/NEJMra1106180; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6	89	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82560	10.1371/journal.pone.0082560	http://dx.doi.org/10.1371/journal.pone.0082560			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358206	Green Published, gold, Green Submitted			2022-12-27	WOS:000328737700023
J	Chen, WB; Guo, W; Li, M; Shi, DB; Tian, Y; Li, ZL; Wang, JS; Fu, LY; Xiao, XS; Liu, QQ; Wang, SS; Huang, WL; Deng, WG				Chen, Wangbing; Guo, Wei; Li, Mei; Shi, Dingbo; Tian, Yun; Li, Zhenlin; Wang, Jingshu; Fu, Lingyi; Xiao, Xiangsheng; Liu, Quentin Qiang; Wang, Shusen; Huang, Wenlin; Deng, Wuguo			Upregulation of Cleavage and Polyadenylation Specific Factor 4 in Lung Adenocarcinoma and Its Critical Role for Cancer Cell Survival and Proliferation	PLOS ONE			English	Article							CHRONIC EOSINOPHILIC LEUKEMIA; HYPEREOSINOPHILIC SYNDROME; TUMOR SUPPRESSION; RNA; POLYMERASE; SUBUNIT; KINASE; CPSF; CHEMOTHERAPY; ACTIVATION	Cleavage and polyadenylation specific factor 4 (CPSF4), a member of CPSF complex, plays a key role in mRNA polyadenylation and mRNA 39 ends maturation. However, its possible role in lung cancer pathogenesis is unknown. In this study, we investigated the biological role and clinical significance of CPSF4 in lung cancer growth and survival and elucidated its underlying molecular mechanisms. We found that CPSF4 was highly expressed in lung adenocarcinoma cell lines and tumor tissue but was undetectable in 8 normal human tissues. We also found that CPSF4 overexpression was correlated with poor overall survival in patients with lung adenocarcinomas (P<0.001). Multivariate survival analyses revealed that higher CPSF4 expression was an independent prognostic factor for overall survival of the patients with lung adenocarcinomas. Suppression of CPSF4 by siRNA inhibited lung cancer cells proliferation, colony formation, and induced apoptosis. Mechanism studies revealed that these effects were achieved through simultaneous modulation of multiple signaling pathways. Knockdown of CPSF4 expression by siRNA markedly inhibited the phosphorylation of PI3K, AKT and ERK1/2 and JNK proteins. In contrast, the ectopic expression of CPSF4 had the opposite effects. Moreover, CPSF4 knockdown also induced the cleavage of caspase-3 and caspse-9 proteins. Collectively, these results demonstrate that CPSF4 plays a critical role in regulating lung cancer cell proliferation and survival and may be a potential prognostic biomarker and therapeutic target for lung adenocarcinoma.	[Chen, Wangbing; Li, Mei; Shi, Dingbo; Tian, Yun; Wang, Jingshu; Fu, Lingyi; Xiao, Xiangsheng; Liu, Quentin Qiang; Wang, Shusen; Huang, Wenlin; Deng, Wuguo] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Guo, Wei; Li, Zhenlin; Liu, Quentin Qiang] Dalian Med Univ Canc Ctr, Inst Canc Stem Cell, Dalian, Peoples R China; [Huang, Wenlin; Deng, Wuguo] Guangzhou Double Bioprod Inc, State Key Lab Targeted Drug Tumors Guangdong Prov, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Dalian Medical University	Wang, SS (corresponding author), Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	wangshs@sysucc.org.cn; dengwg@sysucc.org.cn	xiao, xiang/GWU-6035-2022	Chen, Wangbing/0000-0002-9469-1337	National Natural Science Foundation of China [81272195, 81071687, 81372133]; State "863 Program'' of China [SS2012AA020403]; State "973 Program'' of China [2014CB542005]; Doctoral Programs Foundation of Ministry of Education of China [20110171110077]; State Key Laboratory of Oncology in South China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State "863 Program'' of China(National High Technology Research and Development Program of China); State "973 Program'' of China(National Basic Research Program of China); Doctoral Programs Foundation of Ministry of Education of China(Ministry of Education, China); State Key Laboratory of Oncology in South China	This research was supported by funds from the National Natural Science Foundation of China (81272195, 81071687, 81071687, 81372133), the State "863 Program'' of China (SS2012AA020403), the State "973 Program'' of China (2014CB542005), the Doctoral Programs Foundation of Ministry of Education of China (20110171110077), and the State Key Laboratory of Oncology in South China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragaki M, 2011, CLIN CANCER RES, V17, P5889, DOI 10.1158/1078-0432.CCR-11-0240; Barabino SML, 1997, GENE DEV, V11, P1703, DOI 10.1101/gad.11.13.1703; Berger N, 2001, INT J PHARM, V223, P55, DOI 10.1016/S0378-5173(01)00721-9; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; Cools J, 2004, CURR OPIN HEMATOL, V11, P51, DOI 10.1097/00062752-200401000-00008; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895; Deng WG, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M610579200; Deng WG, 2007, CANCER RES, V67, P709, DOI 10.1158/0008-5472.CAN-06-3463; Gotlib J, 2004, BLOOD, V103, P2879, DOI 10.1182/blood-2003-06-1824; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Kaufmann I, 2004, EMBO J, V23, P616, DOI 10.1038/sj.emboj.7600070; Kiefer H, 2009, J BIOL CHEM, V284, P10694, DOI 10.1074/jbc.M807136200; Kleiman FE, 2001, CELL, V104, P743, DOI 10.1016/S0092-8674(02)07059-9; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Papadimitrakopoulou V, 2012, J THORAC ONCOL, V7, P1315, DOI 10.1097/JTO.0b013e31825493eb; Pupo E, 2005, J CONTROL RELEASE, V104, P379, DOI 10.1016/j.jconrel.2005.02.001; Reungwetwattana T, 2012, CLIN LUNG CANCER, V13, P252, DOI 10.1016/j.cllc.2011.09.004; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tabuse M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-60; Topalian SL, 2001, MOL CELL BIOL, V21, P5614, DOI 10.1128/MCB.21.16.5614-5623.2001; Travis WD, 2004, SEM RESP CRIT CARE M, V25, P475, DOI 10.1055/s-2004-836141; Ueda K, 2006, CANCER RES, V66, P9682, DOI 10.1158/0008-5472.CAN-06-1483; Wang GD, 2004, ONCOL REP, V12, P955; Xue MZ, 2012, CURR PHARM DESIGN, V18, P2901, DOI 10.2174/138161212800672723	29	21	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82728	10.1371/journal.pone.0082728	http://dx.doi.org/10.1371/journal.pone.0082728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358221	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700091
J	Ma, XT; Zhang, HT; Pan, QW; Zhao, YH; Chen, J; Zhao, B; Chen, YF				Ma, Xiaotang; Zhang, Huiting; Pan, Qunwen; Zhao, Yuhui; Chen, Ji; Zhao, Bin; Chen, Yanfang			Hypoxia/Aglycemia-Induced Endothelial Barrier Dysfunction and Tight Junction Protein Downregulation Can Be Ameliorated by Citicoline	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ACUTE ISCHEMIC-STROKE; CDP-CHOLINE; IN-VITRO; CELLS; EXPRESSION; HYPOXIA; NEUROPROTECTION; PERMEABILITY; INVOLVEMENT	This study explores the effect of citicoline on the permeability and expression of tight junction proteins (TJPs) in endothelial cells under hypoxia/aglycemia conditions. Hypoxia or oxygen and glucose deprivation (OGD) was utilized to induce endothelial barrier breakdown model on human umbilical vein endothelial cells (HUVECs) and mouse brain microvascular endothelial cells (bEnd.3s). The effect of citicoline on endothelial barrier breakdown models was determined at either low or high concentrations. FITC-Dextran flux was used to examine the endothelial permeability. The expression of TJPs was measured by immunofluorescence, Real-time PCR and Western Blot methods. Results showed that hypoxia or OGD increased the permeability of HUVECs accompanied with down-regulation of occludens-1 (ZO-1) and occludin at both mRNA and protein levels. Similarly in bEnd.3s, hypoxia increased the permeability and decreased the expression of ZO-1 and claudin-5. Citicoline treatment dose-dependently decreased the permeability in these two models, which paralleled with elevated expression of TJPs. The data demonstrate that citicoline restores the barrier function of endothelial cells compromised by hypoxia/aglycemia probably via up-regulating the expression of TJPs.	[Ma, Xiaotang; Zhang, Huiting; Pan, Qunwen; Chen, Ji; Zhao, Bin; Chen, Yanfang] Guangdong Med Coll, Affiliated Hosp, Inst Neurol, Guangdong Key Lab Age Related Cardiac & Cerebral, Zhanjiang, Peoples R China; [Zhao, Yuhui; Chen, Ji; Chen, Yanfang] Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA	Guangdong Medical University; University System of Ohio; Wright State University Dayton	Zhao, B (corresponding author), Guangdong Med Coll, Affiliated Hosp, Inst Neurol, Guangdong Key Lab Age Related Cardiac & Cerebral, Zhanjiang, Peoples R China.	zhaobine@163.net; yanfang.chen@wright.edu	pan, qunwen/Y-1522-2019	Bihl, Ji/0000-0003-2404-1782	National Nature Science Foundation of China [81271214, 81270195]; National Heart, Lung, and Blood Institute [HL-098637]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098637] Funding Source: NIH RePORTER	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funding from the National Nature Science Foundation of China (# 81271214, #81270195) and the National Heart, Lung, and Blood Institute (HL-098637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Al Ahmad A, 2012, MICROVASC RES, V84, P222, DOI 10.1016/j.mvr.2012.05.008; Arenth PM, 2011, PM&R, V3, pS123, DOI 10.1016/j.pmrj.2011.03.012; Bala K, 2012, MOL BIOSYST, V8, P2657, DOI 10.1039/c2mb25156f; Brown RC, 2005, BIOCHEM BIOPH RES CO, V327, P1114, DOI 10.1016/j.bbrc.2004.12.123; Cappellano Giuseppe, 2013, Am J Neurodegener Dis, V2, P89; Chen Z., 2013, PROG NEUROBIOL; Cho HJ, 2009, METHOD FIND EXP CLIN, V31, P171, DOI 10.1358/mf.2009.31.3.1364241; Coskun C, 2010, J PHARM PHARMACOL, V62, P497, DOI 10.1211/jpp.62.04.0013; Cotroneo AM, 2013, CLIN INTERV AGING, V8, P131, DOI 10.2147/CIA.S38420; Davalos A, 2012, LANCET, V380, P349, DOI 10.1016/S0140-6736(12)60813-7; Diederich K, 2012, STROKE, V43, P1931, DOI 10.1161/STROKEAHA.112.654806; Escudero-Esparza A, 2011, FRONT BIOSCI-LANDMRK, V16, P1069, DOI 10.2741/3736; Horiuchi T, 2009, PERITON DIALYSIS INT, V29, P217; Huang SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062164; Hurtado O, 2005, NEUROBIOL DIS, V18, P336, DOI 10.1016/j.nbd.2004.10.006; Ilcol YO, 2009, SHOCK, V32, P286, DOI 10.1097/SHK.0b013e3181971b02; Inamura A, 2013, NEUROCHEM RES, V38, P1641, DOI 10.1007/s11064-013-1066-4; Kohnke R, 2007, NUTR NEUROSCI, V10, P273, DOI 10.1080/10284150701745910; Koto T, 2007, AM J PATHOL, V170, P1389, DOI 10.2353/ajpath.2007.060693; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; Piehl C, 2010, CELL MOL LIFE SCI, V67, P2131, DOI 10.1007/s00018-010-0332-8; Rajadas J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058194; Rao AM, 1999, J NEUROSCI RES, V58, P697, DOI 10.1002/(SICI)1097-4547(19991201)58:5<697::AID-JNR11>3.3.CO;2-2; Sengillo JD, 2013, BRAIN PATHOL, V23, P303, DOI 10.1111/bpa.12004; Shakir Taner, 2013, Am J Neurodegener Dis, V2, P70; Strazielle N, 2013, MOL PHARMACEUT, V10, P1473, DOI 10.1021/mp300518e; Takizawa Y, 2013, EUR J DRUG METAB PHA; Tam SJ, 2010, ANNU REV NEUROSCI, V33, P379, DOI 10.1146/annurev-neuro-060909-152829; Wilcock DM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-84; Wuest DM, 2013, J NEUROSCI METH, V212, P211, DOI 10.1016/j.jneumeth.2012.10.016; Xia YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068891; Yu ASL, 2005, AM J PHYSIOL-CELL PH, V288, pC1231, DOI 10.1152/ajpcell.00581.2004; Zhang WM, 2007, PUBLIC HLTH SUPERVIS, V8, P1006; Zhu HY, 2012, J ETHNOPHARMACOL, V141, P714, DOI 10.1016/j.jep.2011.08.063	36	26	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82604	10.1371/journal.pone.0082604	http://dx.doi.org/10.1371/journal.pone.0082604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358213	Green Published, gold			2022-12-27	WOS:000328735700086
J	Negandhi, PH; Ghouri, N; Colhoun, HM; Fischbacher, CM; Lindsay, RS; McKnight, JA; Petrie, J; Philip, S; Sattar, N; Wild, SH				Negandhi, Preeti H.; Ghouri, Nazim; Colhoun, Helen M.; Fischbacher, Colin M.; Lindsay, Robert S.; McKnight, John A.; Petrie, John; Philip, Sam; Sattar, Naveed; Wild, Sarah H.		Scottish Diabet Res Network	Ethnic Differences in Glycaemic Control in People with Type 2 Diabetes Mellitus Living in Scotland	PLOS ONE			English	Article							INTERMEDIATE OUTCOMES; EUROPEAN PATIENTS; SOUTH ASIANS; POPULATION; RISK; BANGLADESHI; DISPARITIES; PREVALENCE; MORTALITY; PAKISTANI	Background and Aims: Previous studies have investigated the association between ethnicity and processes of care and intermediate outcomes of diabetes, but there are limited population-based studies available. The aim of this study was to use population-based data to investigate the relationships between ethnicity and glycaemic control in men and women with diabetes mellitus living in Scotland Methods: We used a 2008 extract from the population-based national electronic diabetes database of Scotland. The association between ethnicity with mean glycaemic control in type 2 diabetes mellitus was examined in a retrospective cohort study, including adjustment for a number of variables including age, sex, socioeconomic status, body mass index (BMI), prescribed treatment and duration of diabetes. Results: Complete data for analyses were available for 56,333 White Scottish adults, 2,535 Pakistanis, 857 Indians, 427 Chinese and 223 African-Caribbeans. All other ethnic groups had significantly (p<0.05) greater proportions of people with suboptimal glycaemic control (HbA1c >58 mmol/mol, 7.5%) compared to the White Scottish group, despite generally younger mean age and lower BMI. Fully adjusted odds ratios for suboptimal glycaemic control were significantly higher among Pakistanis and Indians (1.85, 95% CI: 1.68-2.04, and 1.62,95% CI: 1.38-1.89) respectively. Conclusions: Pakistanis and Indians with type 2 diabetes mellitus were more likely to have suboptimal glycaemic control than the white Scottish population. Further research on health services and self-management are needed to understand the association between ethnicity and glycaemic control to address ethnic disparities in glycaemic control.	[Negandhi, Preeti H.] Publ Hlth Fdn India, Indian Inst Publ Hlth, Gurgaon, Haryana, India; [Ghouri, Nazim; Lindsay, Robert S.; Petrie, John; Sattar, Naveed] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Colhoun, Helen M.] Univ Dundee, Biomed Res Inst, Dundee, Scotland; [Fischbacher, Colin M.] NHS Natl Serv Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland; [McKnight, John A.] Western Gen Hosp, Metab Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Philip, Sam] Aberdeen Royal Infirm, Dept Endocrinol & Diabet, Aberdeen, Scotland; [Wild, Sarah H.] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland	Public Health Foundation of India; University of Glasgow; University of Dundee; NHS National Services Scotland; University of Edinburgh; University of Aberdeen; University of Edinburgh	Ghouri, N (corresponding author), Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	nazim.ghouri@glasgow.ac.uk	Philip, Sam/AAE-3349-2021	Philip, Sam/0000-0001-6164-211X; Fischbacher, Colin/0000-0003-3090-1857; Lindsay, Robert/0000-0002-9868-5217; Ghouri, Noushima/0000-0002-8202-3913; , SDRN-NDS (Scottish Diabetes Research Network National Diabetes Research Dataset)/0000-0002-3365-3441; Colhoun, Helen/0000-0002-8345-3288	Pfizer; Roche; Boehringer Ingelheim; Astra Zeneca	Pfizer(Pfizer); Roche(Roche Holding); Boehringer Ingelheim(Boehringer Ingelheim); Astra Zeneca(AstraZeneca)	HMC received monies from Pfizer for attending symposia, a speaker's bureau, as a member of staff and for consultancy. HMC has received research funds from Pfizer, Roche, Eli-Lilly, Boehringer Ingelheim (BI) and Astra Zeneca. HMC has shares in Roche. JAM is the PI for drug studies for Novo Nordisk, Eli Lilly and BI (contracts relating to this work are through JAM's NHS employer R&D department). JAM received monies 2 years ago from BI for organising the ethics application for their study and attending the meeting relating to this. JAM has received support to attend meetings from the above companies as well as from Takeda. This does not alter the authors' adherence to all PLOS ONE policies on sharing materials.	Agyemang C, 2002, J HUM HYPERTENS, V16, P739, DOI 10.1038/sj.jhh.1001488; Ahmed US, 2010, DIABETIC MED, V27, P169, DOI 10.1111/j.1464-5491.2009.02904.x; [Anonymous], MAN DIAB; Bhopal R, 1999, BRIT MED J, V319, P215, DOI 10.1136/bmj.319.7204.215; Bhopal R, 1997, BRIT MED J, V314, P1751, DOI 10.1136/bmj.314.7096.1751; Choudhury SM, 2009, DIABETIC MED, V26, P636, DOI 10.1111/j.1464-5491.2009.02741.x; Fischbacher CM, 2009, J PUBLIC HEALTH-UK, V31, P239, DOI 10.1093/pubmed/fdp003; Hall LML, 2008, FUTURE LIPIDOL, V3, P411, DOI 10.2217/17460875.3.4.411; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; James GD, 2012, J ROY SOC MED, V105, P300, DOI 10.1258/jrsm.2012.110289; Gonzalez ELM, 2009, J EPIDEMIOL COMMUN H, V63, P332, DOI 10.1136/jech.2008.080382; McElduff P, 2005, DIABETIC MED, V22, P1226, DOI 10.1111/j.1464-5491.2005.01614.x; McKnight JA, 2008, DIABETIC MED, V25, P743, DOI 10.1111/j.1464-5491.2008.02453.x; Millett C, 2009, DIABETES CARE, V32, P404, DOI 10.2337/dc08-0912; Mir G, 2010, ETHNIC HEALTH, V15, P327, DOI 10.1080/13557851003624273; Mukhopadhyay B, 2006, DIABETIC MED, V23, P94, DOI 10.1111/j.1464-5491.2005.01735.x; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; Scottish Diabetes Survey Monitoring Group, 2012, SCOTT DIAB SURV 2010; Scottish Diabetes Survey Monitoring Group, 2013, SCOTT DIAB SURV 2011; Scottish Executive, 2012, AN ETHN 2001 CENS SU; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Smith GD, 2000, AM J PUBLIC HEALTH, V90, P1694, DOI 10.2105/AJPH.90.11.1694; Verma A, 2010, J PUBLIC HEALTH-UK, V32, P250, DOI 10.1093/pubmed/fdp114; Walker JJ, 2011, DIABETES CARE, V34, P1127, DOI 10.2337/dc10-1862; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zoppini G, 2008, DIABETES-METAB RES, V24, P624, DOI 10.1002/dmrr.897	26	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83292	10.1371/journal.pone.0083292	http://dx.doi.org/10.1371/journal.pone.0083292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358273	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000328735700116
J	Yusop, NBM; Mun, CY; Shariff, ZM; Huat, CB				Yusop, Nor Baizura Md; Mun, Chan Yoke; Shariff, Zalilah Mohd; Huat, Choo Beng			Factors Associated with Quality of Life among Hemodialysis Patients in Malaysia	PLOS ONE			English	Article							SUBJECTIVE GLOBAL ASSESSMENT; NUTRITIONAL-STATUS; KIDNEY-DISEASE; RENAL-FAILURE; BODY-FAT; MAINTENANCE HEMODIALYSIS; DIALYSIS ADEQUACY; DIABETIC-PATIENTS; DIETARY-INTAKE; MENTAL-HEALTH	Although hemodialysis treatment has greatly increased the life expectancy of end stage renal disease patients, low quality of life among hemodialysis patients is frequently reported. This cross-sectional study aimed to determine the relationship between medical history, hemodialysis treatment and nutritional status with the mental and physical components of quality of life in hemodialysis patients. Respondents (n=90) were recruited from Hospital Kuala Lumpur and dialysis centres of the National Kidney Foundation of Malaysia. Data obtained included socio-demography, medical history, hemodialysis treatment and nutritional status. Mental and physical quality of life were measured using the Mental Composite Summary (MCS) and Physical Composite Summary (PCS) of the Short-Form Health Survey 36-items, a generic core of the Kidney Disease Quality of Life Short Form. Two summary measures and total SF-36 was scored as 0-100, with a higher score indicating better quality of life. Approximately 26 (30%) of respondents achieved the body mass index (24 kg/m(2)) and more than 80% (n=77) achieved serum albumin level (>35.0 mg/dL) recommended for hemodialysis patients. The majority of respondents did not meet the energy (n=72, 80%) and protein (n=68,75%) recommendations. The total score of SF-36 was 54.1 +/- 19.2, while the score for the mental and physical components were 45.0 +/- 8.6 and 39.6 +/- 8.6, respectively. Factors associated with a higher MCS score were absence of diabetes mellitus (p=0.000) and lower serum calcium (p=0.004), while higher blood flow (p=0.000), higher serum creatinine (p=0.000) and lower protein intake (p= 0.006) were associated with a higher PCS score. To improve the overall quality of life of hemodialysis patients, a multidisciplinary intervention that includes medical, dietetic and psychosocial strategies that address factors associated with mental and physical quality of life are warranted to reduce further health complications and to improve quality of life.	[Yusop, Nor Baizura Md; Mun, Chan Yoke; Shariff, Zalilah Mohd] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Nutr & Dietet, Serdang 43400, Selangor, Malaysia; [Huat, Choo Beng] Manipal Med Collage, Dept Med, Melaka, Malaysia	Universiti Putra Malaysia	Shariff, ZM (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Nutr & Dietet, Serdang 43400, Selangor, Malaysia.	zalilahms@upm.edu.my						Abbas Tarek M, 2005, Hemodial Int, V9, P153, DOI 10.1111/j.1492-7535.2005.01126.x; Abu Bakar A, 2000, TOTAL QUAL MANAGE, V11, pS788; Agarwal SK, 2005, NEPHROL DIAL TRANSPL, V20, P1638, DOI 10.1093/ndt/gfh855; Allen KL, 2002, J RENAL NUTR, V12, P160, DOI 10.1053/jren.2002.33512; Anees M, 2011, IRAN J KIDNEY DIS, V5, P9; [Anonymous], 2006, DIAL REG PAK 2005 20; Borzou SR, 2009, SAUDI J KIDNEY DIS T, V20, P639; Bossola M, 2005, J RENAL NUTR, V15, P244, DOI 10.1053/j.jrn.2005.01.004; BROZEK J, 1951, BRIT J NUTR, V5, P194, DOI 10.1079/BJN19510025; Buckner S, 2003, J RENAL NUTR, V13, P295, DOI 10.1016/S1051-2276(03)00119-5; Chiang CK, 2004, BLOOD PURIFICAT, V22, P490, DOI 10.1159/000081730; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Durose CL, 2004, J AM DIET ASSOC, V104, P35, DOI 10.1016/j.jada.2003.10.016; Eknoyan G, 2004, KIDNEY INT, V66, P1310, DOI 10.1111/j.1523-1755.2004.00894.x; FAO/WHO/UNU, 2004, FOOD NUTR TECHN REP FOOD NUTR TECHN REP; Germin-Petrovic D, 2011, COLLEGIUM ANTROPOL, V35, P687; Gibson RS, 2005, PRINCIPLES NUTR ASSE, P290; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; HAYS RD, 1994, QUAL LIFE RES, V3, P329, DOI 10.1007/BF00451725; Hooi L S, 2006, Med J Malaysia, V61, P513; International Diabetes Federation, 2011, IDF DIABETES ATLAS; Ishimura E, 2001, J AM SOC NEPHROL, V12, P1921, DOI 10.1681/ASN.V1291921; Ismail A, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-39; Johansen KL, 2003, AM J CLIN NUTR, V77, P842, DOI 10.1093/ajcn/77.4.842; Jones CH, 2004, J RENAL NUTR, V14, P26, DOI 10.1053/j.jrn.2003.09.006; Kalantar-Zadeh K, 2001, J AM SOC NEPHROL, V12, P2797, DOI 10.1681/ASN.V12122797; Kalantar-Zadeh K, 2003, AM J KIDNEY DIS, V42, P864, DOI 10.1016/j.ajkd.2003.07.016; Kalantar-Zadeh K, 2006, AM J CLIN NUTR, V83, P202; Kloppenburg WD, 1999, KIDNEY INT, V55, P1961, DOI 10.1046/j.1523-1755.1999.00412.x; Kovesdy CP, 2010, CLIN J AM SOC NEPHRO, V5, P468, DOI 10.2215/CJN.06040809; Kugler C, 2005, J NURS SCHOLARSHIP, V37, P25, DOI 10.1111/j.1547-5069.2005.00009.x; Lim YN, 2005, 13 MAL DIAL TRANSP R; Lim YN, 2011, 18 MAL DIAL TRANSP; Lim YN, 2004, 11 MAL DIAL TRANSP; Liu W J, 2006, Med J Malaysia, V61, P540; Lou LM, 2007, NEFROLOGIA, V27, P38; Manns BJ, 2002, ASAIO J, V48, P565, DOI 10.1097/00002480-200209000-00021; Medical Nutrition Therapy Guidelines for Chronic, 2005, KIDN DIS; Mehrotra R, 2002, AM J KIDNEY DIS, V40, P133, DOI 10.1053/ajkd.2002.33922; Miller JE, 2010, AM J NEPHROL, V32, P403, DOI 10.1159/000319861; Morais Alvaro A. C., 2005, Clinics, V60, P185, DOI 10.1590/S1807-59322005000300002; Morsch CM, 2006, J CLIN NURS, V15, P498, DOI 10.1111/j.1365-2702.2006.01349.x; National Kidney Foundation, 2000, AM J KIDNEY DIS, V35; Neves KR, 2004, KIDNEY INT, V66, P2237, DOI 10.1111/j.1523-1755.2004.66013.x; Ohkawa S, 2005, NEPHROL DIAL TRANSPL, V20, P945, DOI 10.1093/ndt/gfh643; Ohri-Vachaspati P, 1999, J Ren Nutr, V9, P9; Piperi C, 2004, MOL CELL BIOCHEM, V265, P57, DOI 10.1023/B:MCBI.0000044315.74038.78; Pupim LB, 2002, AM J KIDNEY DIS, V40, P143, DOI 10.1053/ajkd.2002.33923; Pyram R, 2012, MATURITAS, V71, P94, DOI 10.1016/j.maturitas.2011.11.009; Rutledge C, 2000, NEPHROLOGY, V5, P27, DOI 10.1046/j.1440-1797.2000.00510.x; Sararaks S, 2001, Med J Malaysia, V56, P350; Slinin Y, 2005, J AM SOC NEPHROL, V16, P1788, DOI 10.1681/ASN.2004040275; Sorensen VR, 2007, DIABETOLOGIA, V50, P2254, DOI 10.1007/s00125-007-0810-1; Streja E, 2011, CLIN J AM SOC NEPHRO, V6, P1463, DOI 10.2215/CJN.09131010; Suzana S, 2002, ATLAS FOOD EXCHANGES; Tanaka M, 2007, NEPHROL DIAL TRANSPL, V22, P1658, DOI 10.1093/ndt/gfm008; Valderrabano F, 2001, AM J KIDNEY DIS, V38, P443, DOI 10.1053/ajkd.2001.26824; Wang VV, 2012, INT J ARTIF ORGANS, V35, P217, DOI 10.5301/ijao.5000014; Wee HL, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-93; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wong J S, 2005, Med J Malaysia, V60, P146; Wu AW, 2004, J AM SOC NEPHROL, V15, P743, DOI 10.1097/01.ASN.0000113315.81448.CA; Wu AYT, 2005, DIABETOLOGIA, V48, P17, DOI 10.1007/s00125-004-1599-9; Zyga S, 2005, J RENAL CARE, V31, P24, DOI 10.1111/j.1755-6686.2005.tb00385.x	65	32	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84152	10.1371/journal.pone.0084152	http://dx.doi.org/10.1371/journal.pone.0084152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GD	24358336	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000328735700153
J	Boch, S; Muller, J; Pratil, D; Blaserl, S; Fischer, M				Boch, Steffen; Mueller, Joerg; Pratil, Daniel; Blaserl, Stefan; Fischer, Markus			Up in the Tree - The Overlooked Richness of Bryophytes and Lichens in Tree Crowns	PLOS ONE			English	Article							EPIPHYTIC BRYOPHYTES; VERTICAL-DISTRIBUTION; STAND STRUCTURE; SPECIES COMPOSITION; BEECH FORESTS; DIVERSITY; BIODIVERSITY; ECOLOGY	Assessing diversity is among the major tasks in ecology and conservation science. In ecological and conservation studies, epiphytic cryptogams are usually sampled up to accessible heights in forests. Thus, their diversity, especially of canopy specialists, likely is underestimated. If the proportion of those species differs among forest types, plot-based diversity assessments are biased and may result in misleading conservation recommendations. We sampled bryophytes and lichens in 30 forest plots of 20 m x 20 m in three German regions, considering all substrates, and including epiphytic litter fall. First, the sampling of epiphytic species was restricted to the lower 2 m of trees and shrubs. Then, on one representative tree per plot, we additionally recorded epiphytic species in the crown, using tree climbing techniques. Per tree, on average 54% of lichen and 20% of bryophyte species were overlooked if the crown was not been included. After sampling all substrates per plot, including the bark of all shrubs and trees, still 38% of the lichen and 4% of the bryophyte species were overlooked if the tree crown of the sampled tree was not included. The number of overlooked lichen species varied strongly among regions. Furthermore, the number of overlooked bryophyte and lichen species per plot was higher in European beech than in coniferous stands and increased with increasing diameter at breast height of the sampled tree. Thus, our results indicate a bias of comparative studies which might have led to misleading conservation recommendations of plot-based diversity assessments.	[Boch, Steffen; Pratil, Daniel; Blaserl, Stefan; Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Boch, Steffen; Pratil, Daniel; Blaserl, Stefan; Fischer, Markus] Univ Bern, Bot Garden, Bern, Switzerland; [Mueller, Joerg] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany	University of Bern; University of Bern; University of Potsdam	Boch, S (corresponding author), Univ Bern, Inst Plant Sci, Bern, Switzerland.	steffen.boch@ips.unibe.ch	Boch, Steffen/L-5436-2016; Schulze, Ernst-Detlef/K-9627-2014; Fischer, Markus/C-6411-2008	Fischer, Markus/0000-0002-5589-5900	DFG (German Research Foundation); Biodiversity Exploratories SSP 1374 "Infrastructure-Biodiversity-Exploratories" [FI 1246/6-1, FI 1246/9-1]	DFG (German Research Foundation)(German Research Foundation (DFG)); Biodiversity Exploratories SSP 1374 "Infrastructure-Biodiversity-Exploratories"	The DFG (German Research Foundation; http://www.dfg.de/en/index.jsp) funded the study in the framework of the Biodiversity Exploratories SSP 1374 "Infrastructure-Biodiversity-Exploratories"(FI 1246/6-1, FI 1246/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aptroot A., 1997, V68, P203; Barkman J.J., 1958, BRYOLOGIST; Boch S, 2013, BASIC APPL ECOL, V14, P496, DOI 10.1016/j.baae.2013.06.001; Boch S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055461, 10.1371/journal.pone.0084913]; Bohn U., 2000, KARTE NATURLICHEN VE; CORNELISSEN JHC, 1989, J TROP ECOL, V5, P131, DOI 10.1017/S0266467400003400; Diaz IA, 2010, FOREST ECOL MANAG, V259, P1490, DOI 10.1016/j.foreco.2010.01.025; EVERSMAN S, 1987, BRYOLOGIST, V90, P212, DOI 10.2307/3242928; Fengel D., 1984, Wood: chemistry, ultrastructure, reactions.; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Friedel A., 2006, Feddes Repertorium, V117, P172, DOI 10.1002/fedr.200511084; Fritz O, 2008, BIOL CONSERV, V141, P655, DOI 10.1016/j.biocon.2007.12.006; Fritz O, 2009, BIODIVERS CONSERV, V18, P289, DOI 10.1007/s10531-008-9483-4; Fritz O, 2010, BIOL CONSERV, V143, P1008, DOI 10.1016/j.biocon.2010.01.016; Fritz O, 2009, APPL VEG SCI, V12, P93, DOI 10.1111/j.1654-109X.2009.01007.x; HARRIS GP, 1971, J ECOL, V59, P431, DOI 10.2307/2258323; Holz I, 2002, BRYOLOGIST, V105, P334, DOI 10.1639/0007-2745(2002)105[0334:BDMDAD]2.0.CO;2; Humphrey JW, 2002, BIOL CONSERV, V107, P165, DOI 10.1016/S0006-3207(02)00057-5; JARMAN SJ, 1995, NEW ZEAL J BOT, V33, P65, DOI 10.1080/0028825X.1995.10412944; Jonsson MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045701; Kiraly I, 2010, BIOL CONSERV, V143, P2063, DOI 10.1016/j.biocon.2010.05.014; Lutzoni F, 2009, CURR BIOL, V19, pR502, DOI 10.1016/j.cub.2009.04.034; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Marialigeti S, 2009, BIODIVERS CONSERV, V18, P2223, DOI 10.1007/s10531-009-9586-6; Marmor L, 2013, LICHENOLOGIST, V45, P51, DOI 10.1017/S0024282912000564; MAZIMPAKA V, 1995, NOVA HEDWIGIA, V61, P431; McCune B, 1997, NORTHWEST SCI, V71, P145; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Milne J, 1999, OERST HIKOBIA, V13, P23; Moning C, 2009, FOREST ECOL MANAG, V258, P745, DOI 10.1016/j.foreco.2009.05.015; Nascimbene J, 2013, FOREST ECOL MANAG, V298, P27, DOI 10.1016/j.foreco.2013.03.008; Nascimbene J, 2009, BIODIVERS CONSERV, V18, P1509, DOI 10.1007/s10531-008-9537-7; Nebel, 2000, MOOSE BADEN WURTTEMB; Nebel M, 2005, MOOSE BADEN WURTTEMB, V3; Nebel M, 2001, MOOSE BADEN WURTTEMB, V2; Nimis PL, 2002, EARTH ENV SCI, V7; Normann F, 2010, ECOL INDIC, V10, P1111, DOI 10.1016/j.ecolind.2010.03.008; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Porley R., 2005, MOSSES LIVERWORTS; R Core Team, 2016, R FDN STAT COMP; Ranius T, 2008, J VEG SCI, V19, P653, DOI 10.3170/2008-8-18433; Redei K, 2001, LESNICKY CASOPIS, V47, P135; Romanski J, 2011, BRYOLOGIST, V114, P720, DOI 10.1639/0007-2745-114.4.720; Sillett SC, 2000, NORTHWEST SCI, V74, P44; SILLETT SC, 1995, BRYOLOGIST, V98, P251, DOI 10.2307/3243312; Sillett SC, 2004, FOREST CANOPIES, P151, DOI [DOI 10.1016/B978-012457553-0/50013-7, 10.1016/B978-012457553-0/50013-7]; Sporn SG, 2010, BIODIVERS CONSERV, V19, P745, DOI 10.1007/s10531-009-9731-2; Svensson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062825; Tinya F, 2009, PLANT ECOL, V204, P69, DOI 10.1007/s11258-008-9566-z; Will-Wolf S, 2002, NATO SCI S SS IV EAR, V7, P203; WIRTH V., 2013, FLECHTEN DTSCH; WOLF JHD, 1993, ANN MO BOT GARD, V80, P928, DOI 10.2307/2399938; [No title captured]	53	62	69	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84913	10.1371/journal.pone.0084913	http://dx.doi.org/10.1371/journal.pone.0084913			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358373	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700107
J	Singh, NK; Kumar, KRR; Kumar, D; Shukla, P; Kirti, PB				Singh, Naveen Kumar; Kumar, Koppolu Raja Rajesh; Kumar, Dilip; Shukla, Pawan; Kirti, P. B.			Characterization of a Pathogen Induced Thaumatin-Like Protein Gene AdTLP from Arachis diogoi, a Wild Peanut	PLOS ONE			English	Article							OSMOTIN-LIKE PROTEIN; ANTIFREEZE PROTEINS; ANTIFUNGAL PROTEIN; ENHANCES RESISTANCE; BINDING PROTEINS; EXPRESSION; WHEAT; OVEREXPRESSION; INHIBITOR; TOLERANCE	Peanut (Arachis hypogaea L) is one of the widely cultivated and leading oilseed crops of the world and its yields are greatly affected by various biotic and abiotic stresses. Arachis diogoi, a wild relative of peanut, is an important source of genes for resistance against various stresses that affect peanut. In our previous study a thaumatin-like protein gene was found to be upregulated in a differential expression reverse transcription PCR (DDRT-PCR) study using the conidial spray of the late leaf spot pathogen, Phaeoisariopsis personata. In the present study, the corresponding full length cDNA was cloned using RACE-PCR and has been designated as AdTLP. It carried an open reading frame of 726 bp potentially capable of encoding a polypeptide of 241 amino acids with 16 conserved cysteine residues. The semi-quantitative RT-PCR analysis showed that the transcript level of AdTLP increased upon treatment with the late leaf spot pathogen of peanut, P. personata and various hormone treatments indicating its involvement in both, biotic and abiotic stresses. The antifungal activity of the purified recombinant protein was checked against different fungal pathogens, which showed enhanced anti-fungal activity compared to many other reported TLP proteins. The recombinant AdTLP-GFP fusion protein was found to be predominantly localized to extracellular spaces. Transgenic tobacco plants ectopically expressing AdTLP showed enhanced resistance to fungal pathogen, Rhizoctonia solani. The seedling assays showed enhanced tolerance of AdTLP transgenic plants against salt and oxidative stress. The transcript analysis of various defense related genes highlighted constitutively higher level expression of PR1a, PI-I and PI-II genes in transgenic plants. These results suggest that the AdTLP is a good candidate gene for enhancing stress resistance in crop plants.	[Singh, Naveen Kumar; Kumar, Koppolu Raja Rajesh; Kumar, Dilip; Shukla, Pawan; Kirti, P. B.] Univ Hyderabad, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Singh, NK (corresponding author), Univ Hyderabad, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India.	naveenks11@gmail.com	König, Simone/B-6504-2008; KUMAR, DINESH/GRJ-5448-2022; Kirti, P.B./R-1504-2019; Mani, Kannan/AFT-0678-2022; Kumar, Dilip/GQB-0364-2022; Krishnan, Muthukalingan/AAA-5953-2021	König, Simone/0000-0003-0672-7246; KUMAR, DINESH/0000-0002-9641-6662; Mani, Kannan/0000-0002-0897-8842; Kumar, Dilip/0000-0003-3721-4718; Kumar, Dilip/0000-0003-4566-1446; Singh, Naveen Kumar/0000-0001-7673-0198; PRASAD, TULIKA/0000-0003-1617-8375; Kumar, Koppolu Raja Rajesh/0000-0001-5153-6671	Council of Scientific and Industrial Research [38-1290/11/EMR-II]; Government of India; UGC	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Government of India; UGC(University Grants Commission, India)	This work was supported by a grant from the Council of Scientific and Industrial Research (grant no. 38-1290/11/EMR-II), Government of India. KRRK was supported by Dr. D. S. Kothari postdoctoral fellowship from UGC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya K, 2013, MOL BIOTECHNOL, V54, P609, DOI 10.1007/s12033-012-9603-y; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Chu KT, 2003, BIOCHEM BIOPH RES CO, V301, P364, DOI 10.1016/S0006-291X(02)02998-4; CORNELISSEN BJC, 1986, NATURE, V321, P531, DOI 10.1038/321531a0; Dafoe NJ, 2009, J PROTEOME RES, V8, P2341, DOI 10.1021/pr800968r; Das M, 2011, TRANSGENIC RES, V20, P231, DOI 10.1007/s11248-010-9405-6; Datta K, 1999, THEOR APPL GENET, V98, P1138, DOI 10.1007/s001220051178; Doxey AC, 2006, NAT BIOTECHNOL, V24, P852, DOI 10.1038/nbt1224; El-Kereamy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017973; Ferreira RB, 2007, MOL PLANT PATHOL, V8, P677, DOI 10.1111/J.1364-3703.2007.00419.X; Fierens E, 2007, BIOCHEM J, V403, P583, DOI 10.1042/BJ20061291; Fierens E, 2009, J ENZYM INHIB MED CH, V24, P646, DOI 10.1080/14756360802321831; Franco OL, 2002, EUR J BIOCHEM, V269, P397, DOI 10.1046/j.0014-2956.2001.02656.x; Fu DL, 2005, PLANT SCI, V168, P671, DOI 10.1016/j.plantsci.2004.09.032; Gao LL, 2007, MOL PLANT MICROBE IN, V20, P82, DOI 10.1094/MPMI-20-0082; Garcia-Casado C, 2000, PHYSIOL PLANTARUM, V110, P172; Goel D, 2010, PROTOPLASMA, V245, P133, DOI 10.1007/s00709-010-0158-0; Gomez-Leyva JF, 2001, J PLANT PHYSIOL, V158, P177, DOI 10.1078/0176-1617-00191; Grenier J, 2000, MYCOLOGIA, V92, P841, DOI 10.2307/3761579; Grenier J, 1999, PLANT J, V19, P473, DOI 10.1046/j.1365-313X.1999.00551.x; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Ho VSM, 2007, PEPTIDES, V28, P760, DOI 10.1016/j.peptides.2007.01.005; HON WC, 1995, PLANT PHYSIOL, V109, P879, DOI 10.1104/pp.109.3.879; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Jami SK, 2007, J PLANT PHYSIOL, V164, P238, DOI 10.1016/j.jplph.2006.01.006; Johnson ET, 2011, MOL GENET GENOMICS, V285, P517, DOI 10.1007/s00438-011-0626-z; Kempema LA, 2007, PLANT PHYSIOL, V143, P849, DOI 10.1104/pp.106.090662; Kim BG, 2009, PHYSIOL MOL PLANT P, V74, P3, DOI 10.1016/j.pmpp.2009.07.001; Kim MJ, 2005, PLANT MOL BIOL, V59, P981, DOI 10.1007/s11103-005-2619-y; Kobayashi K, 2000, PLANT CELL PHYSIOL, V41, P148, DOI 10.1093/pcp/41.2.148; Kombrink E., 1997, PLANT RELATIONSHIPS, DOI [10.1007/978-3-662-10370-8_7, DOI 10.1007/978-3-662-10370-8_7]; Kumar KRR, 2011, PLANT MOL BIOL, V75, P497, DOI 10.1007/s11103-011-9747-3; Kuwabara C, 2002, PHYSIOL PLANTARUM, V115, P101, DOI 10.1034/j.1399-3054.2002.1150112.x; Ladyzhenskaia E P, 2006, Prikl Biokhim Mikrobiol, V42, P462; Liu JJ, 2010, PLANT CELL REP, V29, P419, DOI 10.1007/s00299-010-0826-8; Looze Y, 2009, PHYTOCHEMISTRY, V70, P970, DOI 10.1016/j.phytochem.2009.05.005; Mackintosh CA, 2007, PLANT CELL REP, V26, P479, DOI 10.1007/s00299-006-0265-8; Munis MFH, 2010, BIOCHEM BIOPH RES CO, V393, P38, DOI 10.1016/j.bbrc.2010.01.069; Ogoshi A, 1996, RHIZOCTONIA SPECIES: TAXONOMY, MOLECULAR BIOLOGY, ECOLOGY, PATHOLOGY AND DISEASE CONTROL, P1; Pande S, 2001, PLANT DIS, V85, P851, DOI 10.1094/PDIS.2001.85.8.851; Pressey R, 1997, PHYTOCHEMISTRY, V44, P1241, DOI 10.1016/S0031-9422(96)00667-X; Rajam MV, 2007, BIOL PLANTARUM, V51, P135, DOI 10.1007/s10535-007-0026-8; Rao NK, 2003, GENET RESOUR CROP EV, V50, P707, DOI 10.1023/A:1025055018954; ROBERTS WK, 1990, J GEN MICROBIOL, V136, P1771, DOI 10.1099/00221287-136-9-1771; Sakamoto Y, 2006, PLANT PHYSIOL, V141, P793, DOI 10.1104/pp.106.076679; Seo PJ, 2008, PLANT CELL PHYSIOL, V49, P334, DOI 10.1093/pcp/pcn011; Song XM, 2005, PLANT MOL BIOL, V57, P13, DOI 10.1007/s11103-004-6637-y; Tachi H, 2009, PLANT PHYSIOL BIOCH, V47, P73, DOI 10.1016/j.plaphy.2008.09.012; Takemoto D, 1997, PLANT CELL PHYSIOL, V38, P441, DOI 10.1093/oxfordjournals.pcp.a029187; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Velazhahan R, 2003, BIOL PLANTARUM, V47, P347, DOI 10.1023/B:BIOP.0000023876.55053.5e; Velazhahan R, 1999, PATHOGENESIS-RELATED PROTEINS IN PLANTS, P107; Vijayan S, 2008, APPL MICROBIOL BIOT, V80, P1023, DOI 10.1007/s00253-008-1648-2; Vitali A, 2006, PLANT PHYSIOL BIOCH, V44, P604, DOI 10.1016/j.plaphy.2006.09.008; Wang QH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016930; Wang XJ, 2010, PHYSIOL PLANTARUM, V139, P27, DOI 10.1111/j.1399-3054.2009.01338.x; Ye XY, 1999, BIOCHEM BIOPH RES CO, V263, P130, DOI 10.1006/bbrc.1999.1166; Yeh S, 2000, PLANT PHYSIOL, V124, P1251, DOI 10.1104/pp.124.3.1251; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035	61	79	97	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e83963	10.1371/journal.pone.0083963	http://dx.doi.org/10.1371/journal.pone.0083963			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367621	gold, Green Published, Green Submitted			2022-12-27	WOS:000328741900026
J	Zhang, Q; Sun, J; Liu, SZ; Wei, QP				Zhang, Qiang; Sun, Jian; Liu, Songzhong; Wei, Qinping			Manure Refinement Affects Apple Rhizosphere Bacterial Community Structure: A Study in Sandy Soil	PLOS ONE			English	Article							MICROBIAL COMMUNITY; PYROSEQUENCING REVEALS; LOESS PLATEAU; LAND-USE; DIVERSITY; LANDSCAPE; ROOTS; CHINA; SCALE	We used DNA-based pyrosequencing to characterize the bacterial community structure of the sandy soil of an apple orchard with different manure ratios. Five manure percentages (5%, 10%, 15%, 20% and 25%) were examined. More than 10,000 valid reads were obtained for each replicate. The communities were composed of five dominant groups (Proteobacteria, Actinobacteria, Chloroflexi, Acidobacteria and Bacteroidetes), of which Proteobacteria content gradually decreased from 41.38% to 37.29% as manure ratio increased from 0% to 25%, respectively. Redundancy analysis showed that 37 classes were highly correlated with manure ratio, 18 of which were positively correlated. Clustering revealed that the rhizosphere samples were grouped into three components: low manure (control, 5%) treatment, medium manure (10%, 15%) treatment and high manure (20%, 25%) treatment. Venn analysis of species types of these three groups revealed that the bacteria community difference was primarily reflected by quantity ratio rather than species variety. Although greater manure content led to higher soil organic matter content, the medium manure improved soil showed the highest urease activity and saccharase activity, while 5% to 20% manure ratio improvement also resulted in higher bacteria diversity than control and 25% manure ratio treatment. Our experimental results suggest that the use of a proper manure ratio results in significantly higher soil enzyme activity and different bacteria community patterns, whereas the use of excessive manure amounts has negative effect on soil quality.	[Zhang, Qiang; Sun, Jian; Liu, Songzhong; Wei, Qinping] Beijing Acad Agr & Forestry Sci, Inst Forestry & Pomol, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry	Wei, QP (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Forestry & Pomol, Beijing, Peoples R China.	qinpingwei@gmail.com			China Agriculture Research System [CARS-28]	China Agriculture Research System	China Agriculture Research System, CARS-28, Minister of Agriculture (PRC), http://english.agri.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Alkorta Itziar, 2003, Rev Environ Health, V18, P65; Bell TH, 2011, APPL ENVIRON MICROB, V77, P4163, DOI 10.1128/AEM.00172-11; Bougnom B. P., 2012, Organic Agriculture, V2, P1, DOI 10.1007/s13165-012-0020-0; Bougnom B.P., 2009, BODENKULT, V60, P5; Chenu C, 2000, SOIL SCI SOC AM J, V64, P1479, DOI 10.2136/sssaj2000.6441479x; DeBruyn JM, 2009, ENVIRON SCI TECHNOL, V43, P3467, DOI 10.1021/es803348g; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Feris K, 2003, APPL ENVIRON MICROB, V69, P5563, DOI 10.1128/AEM.69.9.5563-5573.2003; Ge GF, 2010, PLANT SOIL, V326, P31, DOI 10.1007/s11104-009-0186-8; Guckland A, 2009, J PLANT NUTR SOIL SC, V172, P500, DOI 10.1002/jpln.200800072; Imfeld G, 2012, EUR J SOIL BIOL, V49, P22, DOI 10.1016/j.ejsobi.2011.11.010; Inceoglu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023321; Jackson SA, 2012, MICROB ECOL, V64, P105, DOI 10.1007/s00248-011-0002-x; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Kindler R, 2006, SOIL BIOL BIOCHEM, V38, P2860, DOI 10.1016/j.soilbio.2006.04.047; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kwon S, 2010, J MICROBIOL BIOTECHN, V20, P1717, DOI 10.4014/jmb.1007.07012; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lin XG, 2012, ENVIRON SCI TECHNOL, V46, P5764, DOI 10.1021/es3001695; Makhalanyane TP, 2012, ENV MICROBIOLOGY REP; Manter DK, 2010, MICROB ECOL, V60, P157, DOI 10.1007/s00248-010-9658-x; Marx MC, 2005, SOIL BIOL BIOCHEM, V37, P35, DOI 10.1016/j.soilbio.2004.05.024; Mazzola M, 1999, PHYTOPATHOLOGY, V89, P920, DOI 10.1094/PHYTO.1999.89.10.920; Militon C, 2010, FEMS MICROBIOL ECOL, V74, P669, DOI 10.1111/j.1574-6941.2010.00982.x; MILLER S.S., 2002, J TREE FRUIT PRODUCT, V31, P11, DOI DOI 10.1300/J072V03N01_; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Nocker A, 2010, INT MICROBIOL, V13, P59, DOI 10.2436/20.1501.01.111; Plassart P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044279; Qiu MH, 2012, BIOL FERT SOILS, V48, P807, DOI 10.1007/s00374-012-0675-4; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Francisco SS, 2011, J SCI FOOD AGR, V91, P1569, DOI 10.1002/jsfa.4349; Sherry A, 2013, INT BIODETER BIODEGR, V81, P105, DOI 10.1016/j.ibiod.2012.04.009; Sugiyama A, 2010, PLANT DIS, V94, P1329, DOI 10.1094/PDIS-02-10-0090; Tekere M, 2012, AFR J MICROBIOL RES, V6, P4993, DOI 10.5897/AJMR12.250; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; WAKABAYASHI H, 1986, INT J SYST BACTERIOL, V36, P396, DOI 10.1099/00207713-36-3-396; Wang B, 2011, ENVIRON EARTH SCI, V62, P915, DOI 10.1007/s12665-010-0577-4; Wang J, 2001, J ARID ENVIRON, V48, P537, DOI 10.1006/jare.2000.0763; WU QT, 1994, CAN J MICROBIOL, V40, P916, DOI 10.1139/m94-147	43	38	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76937	10.1371/journal.pone.0076937	http://dx.doi.org/10.1371/journal.pone.0076937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155909	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300043
J	Singh, NK; Pakkianathan, BC; Kumar, M; Prasad, T; Kannan, M; Konig, S; Krishnan, M				Singh, Nitin Kumar; Pakkianathan, Britto Cathrin; Kumar, Manish; Prasad, Tulika; Kannan, Mani; Koenig, Simone; Krishnan, Muthukalingan			Vitellogenin from the Silkworm, Bombyx mori: An Effective Anti-Bacterial Agent	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTOR; PURIFICATION; PROTEIN; HEMOLYMPH; BINDING; IDENTIFICATION; LIPOPROTEINS; LEPIDOPTERA; EXPRESSION; PHOSVITIN	Silkworm, Bombyx mori, vitellogenin (Vg) was isolated from perivisceral fat body of day 3 of pupa. Both Vg subunits were co-purified as verified by mass spectrometry and immunoblot. Purified Vg responded to specific tests for major posttranslational modifications on native gels indicating its nature as lipo-glyco-phosphoprotein. The Vg fraction had strong antibacterial activity against Gram negative bacterium Escherichia coli and Gram positive bacterium Bacillus subtilis. Microscopic images showed binding of Vg to bacterial cells and their destruction. When infected silkworm larvae were treated with purified Vg they survived the full life cycle in contrast to untreated animals. This result showed that Vg has the ability to inhibit the proliferation of bacteria in the silkworm fluid system without disturbing the regular metabolism of the host.	[Singh, Nitin Kumar; Pakkianathan, Britto Cathrin; Kannan, Mani; Krishnan, Muthukalingan] Bharathidasan Univ, Dept Environm Biotechnol, Tiruchirappalli, Tamil Nadu, India; [Kumar, Manish; Prasad, Tulika] Jawaharlal Nehru Univ, Adv Instrumentat Res Facil, New Delhi 110067, India; [Koenig, Simone] Univ Munster, Interdisciplinary Ctr Clin Res, D-48149 Munster, Germany	Bharathidasan University; Jawaharlal Nehru University, New Delhi; University of Munster	Krishnan, M (corresponding author), Bharathidasan Univ, Dept Environm Biotechnol, Tiruchirappalli, Tamil Nadu, India.	profmkrish@gmail.com	König, Simone/B-6504-2008; KUMAR, DINESH/GRJ-5448-2022; Kirti, P.B./R-1504-2019; Mani, Kannan/AFT-0678-2022; Kumar, Dilip/GQB-0364-2022; Krishnan, Muthukalingan/AAA-5953-2021	König, Simone/0000-0003-0672-7246; KUMAR, DINESH/0000-0002-9641-6662; Mani, Kannan/0000-0002-0897-8842; Kumar, Dilip/0000-0003-3721-4718; Kumar, Dilip/0000-0003-4566-1446; Singh, Naveen Kumar/0000-0001-7673-0198; PRASAD, TULIKA/0000-0003-1617-8375; Kumar, Koppolu Raja Rajesh/0000-0001-5153-6671	Indo-German Academic Exchange Service PPP program; Department of Biotechnology; Department of Science and Technology; University Grant Commission (UGC); DST-FIST, New Delhi, India; BRNS Mumbai	Indo-German Academic Exchange Service PPP program; Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); University Grant Commission (UGC)(University Grants Commission, India); DST-FIST, New Delhi, India(Department of Science & Technology (India)); BRNS Mumbai(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS))	This project was made possible by funding of the Indo-German Academic Exchange Service PPP program. The authors are highly thankful to Department of Biotechnology, Department of Science and Technology, University Grant Commission (UGC), DST-FIST, New Delhi, India, and BRNS Mumbai for providing the financial support to carry out this research work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiyodi KG, 2002, ENFIELD REPROD BIO A, P70; Almenara DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053460; Amdam GV, 2006, NATURE, V439, P76, DOI 10.1038/nature04340; Choi So Joung, 1997, Korean Journal of Entomology, V27, P53; CUTTING JA, 1973, ANAL BIOCHEM, V54, P386, DOI 10.1016/0003-2697(73)90367-9; Garcia J, 2010, FISH SHELLFISH IMMUN, V29, P293, DOI 10.1016/j.fsi.2010.04.010; HAGEDORN HH, 1979, ANNU REV ENTOMOL, V24, P475, DOI 10.1146/annurev.en.24.010179.002355; HARNISH DG, 1982, J EXP ZOOL, V220, P1, DOI 10.1002/jez.1402200102; HAUNERLAND NH, 1987, ANAL BIOCHEM, V161, P307, DOI 10.1016/0003-2697(87)90455-6; Havukainen H, 2011, J EXP BIOL, V214, P582, DOI 10.1242/jeb.048314; Hyrsl P, 2005, BIOLOGIA, V60, P207; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Khan MAS, 2000, J AGR FOOD CHEM, V48, P1503, DOI 10.1021/jf990700r; Krishnan M., 2010, MASS SPECTROM, V2, P179; Li AK, 2003, J BIOL CHEM, V278, P2799, DOI 10.1074/jbc.M205067200; Li ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001940; Liu Chao Liang, 2001, Journal of Insect Biotechnology and Sericology, V70, P95; Liu QH, 2009, IMMUNOBIOLOGY, V214, P257, DOI 10.1016/j.imbio.2008.10.003; Magalhaes I, 2004, J CHROMATOGR B, V799, P87, DOI 10.1016/j.jchromb.2003.10.026; Maltais D, 2009, FISH PHYSIOL BIOCHEM, V35, P241, DOI 10.1007/s10695-008-9205-6; Maruta K, 2002, ARCH INSECT BIOCHEM, V50, P97, DOI 10.1002/arch.10035; Meng Yan, 2008, Journal of Insect Biotechnology and Sericology, V77, P35; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; MUNDALL EC, 1979, COMP BIOCHEM PHYS B, V63, P459, DOI 10.1016/0305-0491(79)90047-6; Nakamura A, 1999, BIOCHEM BIOPH RES CO, V264, P580, DOI 10.1006/bbrc.1999.1549; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Pakkianathan BC, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-5; PAN ML, 1971, J INSECT PHYSIOL, V17, P677, DOI 10.1016/0022-1910(71)90116-8; PAN ML, 1969, SCIENCE, V165, P393, DOI 10.1126/science.165.3891.393; Rono MK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000434; Rosenberg IM, 1996, PROTEIN ANAL PURIFIC, P265; Sambook J, 1989, MOL CLONING LAB MANU; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Shi XD, 2006, FISH SHELLFISH IMMUN, V20, P769, DOI 10.1016/j.fsi.2005.09.005; Smolenaars MMW, 2007, J LIPID RES, V48, P489, DOI 10.1194/jlr.R600028-JLR200; STIFANI S, 1990, BIOCHIM BIOPHYS ACTA, V1045, P271, DOI 10.1016/0005-2760(90)90130-P; Tong Z, 2010, IMMUNOBIOLOGY, V215, P898, DOI 10.1016/j.imbio.2009.10.001; Tufail M, 2000, ARCH INSECT BIOCHEM, V45, P37, DOI 10.1002/1520-6327(200009)45:1&lt;37::AID-ARCH4&gt;3.0.CO;2-8; Vanishree V, 1998, THESIS BHARATHIDASAN; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang SH, 2011, J BIOL CHEM, V286, P22653, DOI 10.1074/jbc.M111.247635; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Warrier S, 2002, MOL REPROD DEV, V61, P536, DOI 10.1002/mrd.10106; WHEELER DE, 1990, ARCH INSECT BIOCHEM, V14, P253, DOI 10.1002/arch.940140405; YANO K, 1994, BBA-GENE STRUCT EXPR, V1218, P1, DOI 10.1016/0167-4781(94)90094-9; YANO K, 1994, FEBS LETT, V356, P207, DOI 10.1016/0014-5793(94)01265-2; ZACHARIUS RM, 1969, ANAL BIOCHEM, V30, P148, DOI 10.1016/0003-2697(69)90383-2; Zhang SC, 2005, FISH SHELLFISH IMMUN, V19, P93, DOI 10.1016/j.fsi.2004.10.008; Zhang SC, 2011, INT J BIOCHEM CELL B, V43, P303, DOI 10.1016/j.biocel.2010.11.003	50	79	97	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73005	10.1371/journal.pone.0073005	http://dx.doi.org/10.1371/journal.pone.0073005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24367621	Green Published, Green Submitted, gold			2022-12-27	WOS:000324408400013
J	Anderson, KE; Kielkowska, A; Durrant, TN; Juvin, V; Clark, J; Stephens, LR; Hawkins, PT				Anderson, Karen E.; Kielkowska, Anna; Durrant, Tom N.; Juvin, Veronique; Clark, Jonathan; Stephens, Len R.; Hawkins, Phillip T.			Lysophosphatidylinositol-Acyltransferase-1 (LPIAT1) Is Required to Maintain Physiological Levels of PtdIns and PtdInsP(2) in the Mouse	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; LYSOPHOSPHOLIPID ACYLTRANSFERASES; CAENORHABDITIS-ELEGANS; PHOSPHATIDYLINOSITOL; MEMBRANE; PHOSPHOINOSITIDES; TISSUES; MBOA-7; MICE	We disrupted the gene encoding lysophosphatidylinositol-acyltransferase-1 (LPIAT1) in the mouse with the aim of understanding its role in determining cellular phosphoinositide content. LPIAT1(-/-) mice were born at lower than Mendelian ratios and exhibited a severe developmental brain defect. We compared the phospholipid content of livers and brains from LPIAT1(-/-) and LPIAT1(+/+) littermates by LC-ESI/MS. In accord with previous studies, the most abundant molecular species of each phosphoinositide class (PtdIns, PtdInsP, PtdInsP(2) and PtdInsP(3)) possessed a C38:4 complement of fatty-acyl esters (C18:0 and C20:4 are usually assigned to the sn-1 and sn-2 positions, respectively). LPIAT1(-/-) liver and brain contained relatively less of the C38:4 species of PtdIns, PtdInsP and PtdInsP(2) (dropping from 95-97% to 75-85% of the total species measured for each lipid class) and relatively more of the less abundant species (PtdInsP(3) less abundant species were below our quantification levels). The increases in the less abundant PtdIns and PtdInsP(2) species did not compensate for the loss in C38:4 species, resulting in a 26-44% reduction in total PtdIns and PtdInsP(2) levels in both brain and liver. LPIAT1(-/-) brain and liver also contained increased levels of C18:0 lyso-PtdIns (300% and 525% respectively) indicating a defect in the reacylation of this molecule. LPIAT1(-/-) brain additionally contained significantly reduced C38:4 PC and PE levels (by 47% and 55% respectively), possibly contributing to the phenotype in this organ. The levels of all other molecular species of PC, PE, PS and PA measured in the brain and liver were very similar between LPIAT1(-/-) and LPIAT1(+/+) samples. These results suggest LPIAT1 activity plays a non-redundant role in maintaining physiological levels of PtdIns within an active deacylation/reacylation cycle in mouse tissues. They also suggest that this pathway must act in concert with other, as yet unidentified, mechanisms to achieve the enrichment observed in C38:4 molecular species of phosphoinositides.	[Anderson, Karen E.; Durrant, Tom N.; Juvin, Veronique; Stephens, Len R.; Hawkins, Phillip T.] Babraham Inst, Inositide Lab, Cambridge, England; [Kielkowska, Anna; Clark, Jonathan] Babraham Biosci Technol Ltd, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Stephens, LR (corresponding author), Babraham Inst, Inositide Lab, Babraham Res Campus, Cambridge, England.	len.stephens@babraham.ac.uk; phillip.hawkins@babraham.ac.uk	Jones, Beryl/N-5842-2019; Walton, Alexander/W-5786-2019	Jones, Beryl/0000-0003-2925-0807; Walton, Alexander/0000-0001-8635-873X; Anderson, Karen/0000-0002-7394-6660; Hawkins, Phillip/0000-0002-6979-0464; Corby-Harris, Vanessa/0000-0001-7680-0328; stephens, len/0000-0002-2771-3487; Durrant, Tom N/0000-0002-0503-9364	Biotechnology and Biological Sciences Research Council United Kingdom Signalling ISPG [BB/J004456/1]; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0413, BB/I003916/1, BBS/E/B/000C0415] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council United Kingdom Signalling ISPG(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is supported by the Biotechnology and Biological Sciences Research Council United Kingdom Signalling ISPG BB/J004456/1 (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER A, 1990, LIPIDS, V25, P473, DOI 10.1007/BF02538091; Clark J, 2011, NAT METHODS, V8, P267, DOI 10.1038/NMETH.1564; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Fan YY, 2012, J LIPID RES, V53, P1287, DOI 10.1194/jlr.M024216; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Kim YJ, 2011, DEV CELL, V21, P813, DOI 10.1016/j.devcel.2011.09.005; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Lee HC, 2012, MOL BIOL CELL, V23, P4689, DOI 10.1091/mbc.E12-09-0673; Lee HC, 2012, GENES CELLS, V17, P748, DOI 10.1111/j.1365-2443.2012.01624.x; Lung M, 2009, J BIOL CHEM, V284, P31062, DOI 10.1074/jbc.M109.050617; Milne SB, 2005, J LIPID RES, V46, P1796, DOI 10.1194/jlr.D500010-JLR200; PALMER FBS, 1986, BIOCHEM CELL BIOL, V64, P117, DOI 10.1139/o86-019; Pettitt TR, 2006, J LIPID RES, V47, P1588, DOI 10.1194/jlr.D600004-JLR200; Rouzer CA, 2007, BIOCHEMISTRY-US, V46, P6026, DOI 10.1021/bi0621617; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Shulga YV, 2010, BIOCHEMISTRY-US, V49, P312, DOI 10.1021/bi901551e; Steinhauer J, 2009, MOL BIOL CELL, V20, P5224, DOI 10.1091/mbc.E09-05-0382; Stoffel W, 2008, EMBO J, V27, P2281, DOI 10.1038/emboj.2008.156; Taguchi R, 2010, J CHROMATOGR A, V1217, P4229, DOI 10.1016/j.chroma.2010.04.034; VADNAL RE, 1989, BIOCHEM BIOPH RES CO, V163, P995, DOI 10.1016/0006-291X(89)92320-6; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vogel P, 2012, VET PATHOL, V49, P166, DOI 10.1177/0300985811415708	27	215	222	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58425	10.1371/journal.pone.0058425	http://dx.doi.org/10.1371/journal.pone.0058425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	24358254	gold, Green Published			2022-12-27	WOS:000315637900141
J	Hung, CJ; Wu, CC; Chen, WY; Chang, CY; Kuan, YH; Pan, HC; Liao, SL; Chen, CJ				Hung, Chih-Jen; Wu, Chih-Cheng; Chen, Wen-Ying; Chang, Cheng-Yi; Kuan, Yu-Hsiang; Pan, Hung-Chuan; Liao, Su-Lan; Chen, Chun-Jung			Depression-Like Effect of Prenatal Buprenorphine Exposure in Rats	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; OXIDATIVE STRESS; METHADONE TREATMENT; PREFRONTAL CORTEX; POSTMORTEM BRAIN; OPIOID RECEPTOR; GENE-EXPRESSION; SUICIDE VICTIMS; MECHANISMS; INCREASES	Studies indicate that perinatal opioid exposure produces a variety of short-and long-term neurobehavioral consequences. However, the precise modes of action are incompletely understood. Buprenorphine, a mixed agonist/antagonist at the opioid receptors, is currently being used in clinical trials for managing pregnant opioid addicts. This study provides evidence of depression-like consequence following prenatal exposure to supra-therapeutic dose of buprenorphine and sheds light on potential mechanisms of action in a rat model involving administration of intraperitoneal injection to pregnant Sprague-Dawley rats starting from gestation day 7 and lasting for 14 days. Results showed that pups at postnatal day 21 but not the dams had worse parameters of depression-like neurobehaviors using a forced swimming test and tail suspension test, independent of gender. Neurobehavioral changes were accompanied by elevation of oxidative stress, reduction of plasma levels of brain-derived neurotrophic factor (BDNF) and serotonin, and attenuation of tropomyosin-related kinase receptor type B (TrkB) phosphorylation, extracellular signal-regulated kinase (ERK) phosphorylation, protein kinase A activity, cAMP response element-binding protein (CREB) phosphorylation, and CREB DNA-binding activity. Since BDNF/serotonin and CREB signaling could orchestrate a positive feedback loop, our findings suggest that the induction of oxidative stress, reduction of BDNF and serotonin expression, and attenuation of CREB signaling induced by prenatal exposure to supra-therapeutic dose of buprenorphine provide evidence of potential mechanism for the development of depression-like neurobehavior.	[Hung, Chih-Jen; Wu, Chih-Cheng] Taichung Vet Gen Hosp, Dept Anesthesiol, Taichung, Taiwan; [Hung, Chih-Jen; Chen, Chun-Jung] HungKuang Univ, Grad Sch Nursing, Taichung, Taiwan; [Wu, Chih-Cheng] Providence Univ, Dept Financial & Computat Math, Taichung, Taiwan; [Chen, Wen-Ying] Natl Chung Hsing Univ, Dept Vet Med, Taichung 40227, Taiwan; [Chang, Cheng-Yi] Fong Yuan Hosp, Dept Surg, Taichung, Taiwan; [Kuan, Yu-Hsiang] Chung Shan Med Univ, Dept Pharmacol, Taichung, Taiwan; [Pan, Hung-Chuan] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan; [Pan, Hung-Chuan] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan; [Liao, Su-Lan; Chen, Chun-Jung] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Chen, Chun-Jung] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Chen, Chun-Jung] Tunghai Univ, Ctr Gen Educ, Taichung 40704, Taiwan	Taichung Veterans General Hospital; Hungkuang University; Providence University - Taiwan; National Chung Hsing University; Chung Shan Medical University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Chung Hsing University; Tunghai University	Chen, CJ (corresponding author), HungKuang Univ, Grad Sch Nursing, Taichung, Taiwan.	cjchen@vghtc.gov.tw	Kuan, Yu-Hsiang/R-1181-2019	Kuan, Yu-Hsiang/0000-0002-8991-6394	Taichung Veterans General Hospital [TCVGH-1007306C]; Yen Tjing Ling Medical Foundation, Taiwan, Republic of China [CI-98-10]	Taichung Veterans General Hospital; Yen Tjing Ling Medical Foundation, Taiwan, Republic of China	This study was supported by grants from Taichung Veterans General Hospital [TCVGH-1007306C] and the Yen Tjing Ling Medical Foundation [CI-98-10], Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto WA, 2011, AM J OBSTET GYNECOL, V205, P302, DOI 10.1016/j.ajog.2011.04.001; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Bhatia HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028451; Blandthorn J, 2011, WOMEN BIRTH, V24, P32, DOI 10.1016/j.wombi.2010.07.001; Chung CP, 2013, PSYCHIAT RES, V206, P213, DOI 10.1016/j.psychres.2012.10.018; Coyle MG, 2012, ADDICTION, V107, P63, DOI 10.1111/j.1360-0443.2012.04040.x; Dwivedi Y, 2002, AM J PSYCHIAT, V159, P66, DOI 10.1176/appi.ajp.159.1.66; Dwivedi Y, 2001, J NEUROCHEM, V77, P916, DOI 10.1046/j.1471-4159.2001.00300.x; Dwivedi Yogesh, 2008, Neuropsychiatr Dis Treat, V4, P161; Englberger W, 2006, EUR J PHARMACOL, V534, P95, DOI 10.1016/j.ejphar.2006.01.022; Farid WO, 2008, CURR NEUROPHARMACOL, V6, P125, DOI 10.2174/157015908784533842; Guzman DC, 2006, NEUROCHEM RES, V31, P549, DOI 10.1007/s11064-006-9053-7; Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011; Jansson LM, 2011, NEUROTOXICOL TERATOL, V33, P240, DOI 10.1016/j.ntt.2010.09.003; JARVIS MAE, 1994, J PSYCHOACTIVE DRUGS, V26, P155, DOI 10.1080/02791072.1994.10472263; Kakko J, 2008, DRUG ALCOHOL DEPEN, V96, P69, DOI 10.1016/j.drugalcdep.2008.01.025; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lesch KP, 2001, J AFFECT DISORDERS, V62, P57, DOI 10.1016/S0165-0327(00)00351-7; Li J, 2013, EUR J PHARMACOL, V707, P112, DOI 10.1016/j.ejphar.2013.03.010; Liebenberg N, 2011, NEUROSCI LETT, V498, P158, DOI 10.1016/j.neulet.2011.05.004; Lund IO, 2013, SUBST ABUS-RES TREAT, V7, P61, DOI 10.4137/SART.S10955; Malanga CJ, 1999, CLIN PERINATOL, V26, P17, DOI 10.1016/S0095-5108(18)30070-8; Marquez P, 2007, NEUROPHARMACOLOGY, V52, P1336, DOI 10.1016/j.neuropharm.2007.01.005; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; Ozcan ME, 2004, INT CLIN PSYCHOPHARM, V19, P89, DOI 10.1097/01.yic.0000110796.97676.89; Pandey GN, 2007, INT J NEUROPSYCHOPH, V10, P621, DOI 10.1017/S1461145706007231; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Pettit AS, 2012, NEUROSCIENCE, V200, P211, DOI 10.1016/j.neuroscience.2011.10.039; Qi XL, 2008, NEUROBIOL DIS, V31, P278, DOI 10.1016/j.nbd.2008.05.003; Reus GZ, 2011, BEHAV BRAIN RES, V221, P166, DOI 10.1016/j.bbr.2011.02.024; Robinson SE, 2002, NEUROTOXICOL TERATOL, V24, P137, DOI 10.1016/S0892-0362(01)00185-4; ROUNSAVILLE BJ, 1982, ARCH GEN PSYCHIAT, V39, P151; Sanchez ES, 2008, GLIA, V56, P1017, DOI 10.1002/glia.20675; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Tardito D, 2006, PHARMACOL REV, V58, P115, DOI 10.1124/pr.58.1.7; Velez ML, 2009, PEDIATR RES, V66, P704, DOI 10.1203/PDR.0b013e3181bc035d; Walsh SL, 2003, DRUG ALCOHOL DEPEN, V70, pS13, DOI 10.1016/S0376-8716(03)00056-5; Wu VW, 2001, EUR J PHARMACOL, V414, P211, DOI 10.1016/S0014-2999(01)00807-X; Xuan AG, 2012, LIFE SCI, V90, P463, DOI 10.1016/j.lfs.2012.01.001; Zhang LL, 2011, NEUROSCIENCE, V196, P203, DOI 10.1016/j.neuroscience.2011.08.069	41	55	55	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82262	10.1371/journal.pone.0082262	http://dx.doi.org/10.1371/journal.pone.0082262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	23437111	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300026
J	Yu, Y; Wang, R; Nan, YC; Zhang, LS; Zhang, YJ				Yu, Ying; Wang, Rong; Nan, Yuchen; Zhang, Linsheng; Zhang, Yanjin			Induction of STAT1 Phosphorylation at Serine 727 and Expression of Proinflammatory Cytokines by Porcine Reproductive and Respiratory Syndrome Virus	PLOS ONE			English	Article							MORPHOLINO OLIGOMERS; TARGETED DISRUPTION; SIGNALING PATHWAY; PRRS VIRUS; TRANSCRIPTION; PROTEIN; REPLICATION; INFECTION; INTERLEUKIN-8; MACROPHAGES	Porcine reproductive and respiratory syndrome virus (PRRSV) is a viral pathogen that causes acute respiratory illnesses in young pigs. Since 1987, PRRSV has contributed substantial economic losses to the swine industry. Elevation of proinflammatory cytokines in PRRSV-infected pigs is thought to contribute to PRRSV pathogenesis. In this study, PRRSV VR-2385, a Type 2 strain with moderate virulence, was found to induce phosphorylation of signal transducer and activator of transcription 1 (STAT1) at serine 727 (pSTAT1-S727) in MARC-145 cells. No phosphorylated STAT1 at tyrosine 701 was detected, which indicates that the pSTAT1-S727 elevation was interferon-independent. The PRRSV-induced pSTAT1-S727, however, was dose-dependent and its levels increased with infection time. IngelVac PRRS MLV strain had a minimal effect on pSTAT1-S727. Compared to MLV-infected cells, VR-2385 infection caused significantly higher level of expression of proinflammatory cytokines, including interleukin 1 beta (IL-1beta) and IL-8. The VR-2385-induced pSTAT1-S727 and cytokine expression were reduced after SB203580, an inhibitor of p38 mitogen-activated protein kinase (MAPK), or methylthioadenosine (MTA), a methyl transferase inhibitor, was added to the cells. The SB203580 and MTA-mediated inhibition suggested that the virus-induced pSTAT1-S727 was dependent on p38 MAPK pathway. In primary porcine alveolar macrophages (PAMs), VR-2385 also induced pSTAT1-S727 and expression of proinflammatory cytokines and chemokines, including IL-1beta, IL-8, chemokine ligand 2 (CCL2) and chemokine (C-X-C motif) ligand 10 (CXCL10). Similarly, SB203580 treatment of PAM cells blocked the elevation of pSTAT1-S727 and cytokine expression. Overexpression of individual viral proteins showed that non-structural protein 12 (nsp12) was able to induce elevation of pSTAT1-S727 and the expression of IL-1 beta and IL-8. These results indicated that PRRSV VR-2385 induces pSTAT1-S727 and the expression of proinflammatory cytokines, which contributes to the insight of PRRSV pathogenesis.	[Yu, Ying; Zhang, Linsheng] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Yu, Ying; Wang, Rong; Nan, Yuchen; Zhang, Yanjin] Univ Maryland, Mol Virol Lab, VA MD Reg Coll Vet Med, College Pk, MD 20742 USA; [Yu, Ying; Wang, Rong; Nan, Yuchen; Zhang, Yanjin] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA	Northwest A&F University - China; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Zhang, LS (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	linszhang@nwsuaf.edu.cn; zhangyj@umd.edu	Nan, Yuchen/ABF-3746-2021; Zhang, Yanjin/H-5035-2019; Nan, Yuchen/F-9917-2014; Schneider, Harald/B-6681-2008	Nan, Yuchen/0000-0002-4442-8004; Wang, Rong/0000-0002-9947-4307; Schneider, Harald/0000-0002-4548-7268; Zhang, Yanjin/0000-0002-5847-3260	China Scholarship Council; National Pork Board	China Scholarship Council(China Scholarship Council); National Pork Board	This study was partially supported by National Pork Board. Y. Yu, R. Wang, and Y. Nan were partially supported by China Scholarship Council. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An TQ, 2011, EMERG INFECT DIS, V17, P1782, DOI 10.3201/eid1709.110411; Bautista EM, 1996, ARCH VIROL, V141, P1357, DOI 10.1007/BF01718837; Conti P, 2003, IMMUNOL LETT, V86, P123, DOI 10.1016/S0165-2478(03)00002-6; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DENBOON JA, 1995, J VIROL, V69, P4500, DOI 10.1128/JVI.69.7.4500-4505.1995; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Faaberg K.S., 2011, VIRUS TAXONOMY; Firth AE, 2011, J GEN VIROL, V92, P1097, DOI 10.1099/vir.0.029264-0; Gomez-Laguna J, 2010, J COMP PATHOL, V142, P51, DOI 10.1016/j.jcpa.2009.07.004; Hevia H, 2004, HEPATOLOGY, V39, P1088, DOI 10.1002/hep.20154; Hou J, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-165; KIM HS, 1993, ARCH VIROL, V133, P477, DOI 10.1007/BF01313785; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; KUNKEL SL, 1991, EXP LUNG RES, V17, P17, DOI 10.3109/01902149109063278; Lunney JK, 2010, VIRAL IMMUNOL, V23, P127, DOI 10.1089/vim.2009.0087; Lusso P, 2000, VIROLOGY, V273, P228, DOI 10.1006/viro.2000.0443; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MEULENBERG JJM, 1995, VIROLOGY, V206, P155, DOI 10.1016/S0042-6822(95)80030-1; Miguel JC, 2010, VET IMMUNOL IMMUNOP, V135, P314, DOI 10.1016/j.vetimm.2010.01.002; Moreno B, 2010, MULT SCLER J, V16, P1102, DOI 10.1177/1352458510375968; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Nan YC, 2012, VIROLOGY, V432, P261, DOI 10.1016/j.virol.2012.05.015; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Opriessnig T, 2011, ANTIVIR RES, V91, P36, DOI 10.1016/j.antiviral.2011.04.012; Patel D, 2008, ANTIVIR RES, V77, P95, DOI 10.1016/j.antiviral.2007.09.002; Patel D, 2010, J VIROL, V84, P11045, DOI 10.1128/JVI.00655-10; Patel D, 2009, ANTIVIR THER, V14, P899, DOI 10.3851/IMP1409; Ramsauer K, 2002, P NATL ACAD SCI USA, V99, P12859, DOI 10.1073/pnas.192264999; ROSSOW KD, 1995, VET PATHOL, V32, P361, DOI 10.1177/030098589503200404; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Song S, 2013, DEV COMP IMMUNOL, V39, P265, DOI 10.1016/j.dci.2012.10.001; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Van Reeth K, 1999, RES VET SCI, V67, P47, DOI 10.1053/rvsc.1998.0277; van Reeth K, 2000, VET RES, V31, P187, DOI 10.1051/vetres:2000113; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wu WH, 2001, VIROLOGY, V287, P183, DOI 10.1006/viro.2001.1034; Zhang YJ, 2007, ANTIVIR RES, V73, P12, DOI 10.1016/j.antiviral.2006.05.017	39	36	43	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61967	10.1371/journal.pone.0061967	http://dx.doi.org/10.1371/journal.pone.0061967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	24367634	Green Published, gold, Green Submitted			2022-12-27	WOS:000318340400062
J	Ghosh, A; Sarkar, S; Mandal, AK; Das, N				Ghosh, Aparajita; Sarkar, Sibani; Mandal, Ardhendu K.; Das, Nirmalendu			Neuroprotective Role of Nanoencapsulated Quercetin in Combating Ischemia-Reperfusion Induced Neuronal Damage in Young and Aged Rats	PLOS ONE			English	Article							DRUG-DELIVERY; NITRIC-OXIDE; LIPID-PEROXIDATION; CEREBRAL-ISCHEMIA; BRAIN; DEATH; FLAVONOIDS; NANOPARTICLES; ANTIOXIDANTS; MEMBRANE	Cerebral stroke is the leading cause of death and permanent disability among elderly people. In both humans and animals, cerebral ischemia damages the nerve cells in vulnerable regions of the brain, viz., hippocampus, cerebral cortex, cerebellum, and hypothalamus. The present study was conducted to evaluate the therapeutic efficacy of nanoencapsulated quercetin (QC) in combating ischemia-reperfusion-induced neuronal damage in young and aged Swiss Albino rats. Cerebral ischemia was induced by occlusion of the common carotid arteries of both young and aged rats followed by reperfusion. Nanoencapsulated quercetin (2.7 mg/kg b wt) was administered to both groups of animals via oral gavage two hours prior to ischemic insults as well as post-operation till day 3. Cerebral ischemia and 30 min consecutive reperfusion caused a substantial increase in lipid peroxidation, decreased antioxidant enzyme activities and tissue osmolality in different brain regions of both groups of animals. It also decreased mitochondrial membrane microviscosity and increased reactive oxygen species (ROS) generation in different brain regions of young and aged rats. Among the brain regions studied, the hippocampus appeared to be the worst affected region showing increased upregulation of iNOS and caspase-3 activity with decreased neuronal count in the CA1 and CA3 subfields of both young and aged rats. Furthermore, three days of continuous reperfusion after ischemia caused massive damage to neuronal cells. However, it was observed that oral treatment of nanoencapsulated quercetin (2.7 mg/kg b wt) resulted in downregulation of iNOS and caspase-3 activities and improved neuronal count in the hippocampal subfields even 3 days after reperfusion. Moreover, the nanoformulation imparted a significant level of protection in the antioxidant status in different brain regions, thus contributing to a better understanding of the given pathophysiological processes causing ischemic neuronal damage.	[Ghosh, Aparajita; Sarkar, Sibani; Mandal, Ardhendu K.; Das, Nirmalendu] Indian Inst Chem Biol, Biomembrane Div, Kolkata, W Bengal, India; [Ghosh, Aparajita] Bose Inst, Div Mol Med, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Department of Science & Technology (India); Bose Institute	Das, N (corresponding author), Indian Inst Chem Biol, Biomembrane Div, Kolkata, W Bengal, India.	dasnirmalendu@hotmail.com	; Jabgunde, Amit/I-8155-2018; Ghosh, Sougata/GOH-0726-2022; Mandal, Ardhendu Kumar/R-3694-2018; Pardesi, Karishma/D-5827-2012; Ghosh, Sougata/C-6409-2018	Dhavale, Dilip/0000-0001-8221-6347; Jabgunde, Amit/0000-0002-9324-8552; Jagtap, Soham/0000-0002-8687-7326; Ghosh, Sougata/0000-0001-8631-0357; Mandal, Ardhendu Kumar/0000-0001-8336-1220; Shinde, Vaishali/0000-0001-8800-7247; Patil, Ajay B./0000-0003-0509-4926; Pardesi, Karishma/0000-0001-7535-6317; Ghosh, Sougata/0000-0003-0077-1318	Indian Council of Medical Research (ICMR), Government of India [58/17/2003-BMS]; Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi	Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Indian Council of Medical Research (ICMR), Adhoc Project number 58/17/2003-BMS, Government of India, and the Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1995, STROKE, V26, P1478, DOI 10.1161/01.STR.26.8.1478; Aebi H, 1984, Methods Enzymol, V105, P121; Almeida A, 1999, BRAIN RES, V816, P580, DOI 10.1016/S0006-8993(98)01240-2; Bala I, 2004, CRIT REV THER DRUG, V21, P387, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i5.20; Batandier C, 2002, J CELL MOL MED, V6, P175, DOI 10.1111/j.1582-4934.2002.tb00185.x; BORS W, 1990, METHOD ENZYMOL, V186, P343; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Chan PH, 1998, J NEUROSCI, V18, P8292, DOI 10.1523/jneurosci.18-20-08292.1998; Changtam C, 2010, EUR J MED CHEM, V45, P941, DOI 10.1016/j.ejmech.2009.11.035; Chen J, 1997, J NEUROCHEM, V69, P232; Chrissobolis S, 2008, TRENDS MOL MED, V14, P495, DOI 10.1016/j.molmed.2008.09.003; DAVIES DC, 1992, ACTA NEUROPATHOL, V83, P510, DOI 10.1007/BF00310028; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; DogruAbbasoglu S, 1997, MECH AGEING DEV, V98, P177, DOI 10.1016/S0047-6374(97)00082-1; EARNSHAW WC, 1995, CURR OPIN CELL BIOL, V7, P337, DOI 10.1016/0955-0674(95)80088-3; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; GINSBERG MD, 1994, ANN NEUROL, V36, P553, DOI 10.1002/ana.410360402; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; GROSS SS, 1995, ANNU REV PHYSIOL, V57, P737, DOI 10.1146/annurev.ph.57.030195.003513; Hariharan S, 2006, PHARM RES-DORDR, V23, P184, DOI 10.1007/s11095-005-8418-y; Harry GJ, 2003, NEUROTOXICOLOGY, V24, P343, DOI 10.1016/S0161-813X(03)00039-1; Hartmann A, 2000, P NATL ACAD SCI USA, V97, P2875, DOI 10.1073/pnas.040556597; HAVSTEEN B, 1983, BIOCHEM PHARMACOL, V32, P1141, DOI 10.1016/0006-2952(83)90262-9; HORN M, 1992, ACTA NEUROPATHOL, V85, P79, DOI 10.1007/BF00304636; ISSA AM, 1990, J NEUROSCI, V10, P3247; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kong LD, 2000, CELL MOL LIFE SCI, V57, P500, DOI 10.1007/PL00000710; KONTOS HA, 1985, CIRC RES, V57, P508, DOI 10.1161/01.RES.57.4.508; Lee H, 2004, J NEUROSCI RES, V77, P892, DOI 10.1002/jnr.20193; Lee JC, 2003, EXP CELL RES, V291, P386, DOI 10.1016/S0014-4827(03)00410-5; Lockman PR, 2002, DRUG DEV IND PHARM, V28, P1, DOI 10.1081/DDC-120001481; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; McCracken E, 2000, J CEREBR BLOOD F MET, V20, P1529, DOI 10.1097/00004647-200011000-00002; MEANEY MJ, 1988, SCIENCE, V239, P766, DOI 10.1126/science.3340858; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Olivier Jean-Christophe, 2005, NeuroRx, V2, P108, DOI 10.1007/BF03206647; Piantadosi CA, 1996, STROKE, V27, P327, DOI 10.1161/01.STR.27.2.327; RAPOPORT SI, 1978, J THEOR BIOL, V74, P439, DOI 10.1016/0022-5193(78)90224-2; RECKNAGEL RO, 1984, METHOD ENZYMOL, V105, P331; Rodriguez RJ, 2001, FOOD CHEM TOXICOL, V39, P437, DOI 10.1016/S0278-6915(00)00159-9; Ruozi B, 2007, TALANTA, V73, P12, DOI 10.1016/j.talanta.2007.03.031; Sarkar A, 1995, CANCER BIOCHEM BIOPH, V15, P111; Sarkar S, 2002, J DRUG TARGET, V10, P573, DOI 10.1080/106118021000072681; Silva GA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S4; Squire L.R., 2002, NEUROPSYCHOLOGY MEMO; Taylor CP, 1999, J NEUROSCI, V19, P619; Vergoni AV, 2009, NANOMED-NANOTECHNOL, V5, P369, DOI 10.1016/j.nano.2009.02.005; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Zhu DH, 2005, J CELL SCI, V118, P3695, DOI 10.1242/jcs.02507	52	114	119	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e57735	10.1371/journal.pone.0057735	http://dx.doi.org/10.1371/journal.pone.0057735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	24367520	gold, Green Published, Green Submitted			2022-12-27	WOS:000317909500001
J	Boch, S; Prati, D; Hessenmoller, D; Schulze, ED; Fischer, M				Boch, Steffen; Prati, Daniel; Hessenmoeller, Dominik; Schulze, Ernst-Detlef; Fischer, Markus			Richness of Lichen Species, Especially of Threatened Ones, Is Promoted by Management Methods Furthering Stand Continuity	PLOS ONE			English	Article							EPIPHYTIC LICHENS; OLD-GROWTH; BRYOPHYTE COMMUNITIES; BEECH FORESTS; DIVERSITY; CONSERVATION; BIODIVERSITY; DISPERSAL; INDICATOR; QUALITY	Lichens are a key component of forest biodiversity. However, a comprehensive study analyzing lichen species richness in relation to several management types, extending over different regions and forest stages and including information on site conditions is missing for temperate European forests. In three German regions (Schwabische Alb, Hainich-Dun, Schorfheide-Chorin), the so-called Biodiversity Exploratories, we studied lichen species richness in 631 forest plots of 400 m(2) comprising different management types (unmanaged, selection cutting, deciduous and coniferous age-class forests resulting from clear cutting or shelterwood logging), various stand ages, and site conditions, typical for large parts of temperate Europe. We analyzed how lichen species richness responds to management and habitat variables (standing biomass, cover of deadwood, cover of rocks). We found strong regional differences with highest lichen species richness in the Schwabische Alb, probably driven by regional differences in former air pollution, and in precipitation and habitat variables. Overall, unmanaged forests harbored 22% more threatened lichen species than managed age-class forests. In general, total, corticolous, and threatened lichen species richness did not differ among management types of deciduous forests. However, in the Schwabische-Alb region, deciduous forests had 61% more lichen species than coniferous forests and they had 279% more threatened and 76% more corticolous lichen species. Old deciduous age classes were richer in corticolous lichen species than young ones, while old coniferous age-classes were poorer than young ones. Overall, our findings highlight the importance of stand continuity for conservation. To increase total and threatened lichen species richness we suggest (1) conserving unmanaged forests, (2) promoting silvicultural methods assuring stand continuity, (3) conserving old trees in managed forests, (4) promoting stands of native deciduous tree species instead of coniferous plantations, and (5) increasing the amount of deadwood in forests.	[Boch, Steffen; Prati, Daniel; Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Boch, Steffen; Prati, Daniel; Fischer, Markus] Univ Bern, Bot Gardens, Bern, Switzerland; [Boch, Steffen; Prati, Daniel; Fischer, Markus] Univ Bern, Oeschger Ctr, Bern, Switzerland; [Hessenmoeller, Dominik; Schulze, Ernst-Detlef] Max Planck Inst Biogeochem, D-07745 Jena, Germany	University of Bern; University of Bern; University of Bern; Max Planck Society	Boch, S (corresponding author), Univ Bern, Inst Plant Sci, Bern, Switzerland.	steffen.boch@ips.unibe.ch	Boch, Steffen/L-5436-2016; Schulze, Ernst-Detlef/K-9627-2014; Fischer, Markus/C-6411-2008	Fischer, Markus/0000-0002-5589-5900	DFG (German Research Foundation) in the framework of the Biodiversity Exploratories "Infrastructure-Biodiversity-Exploratories" [SSP 1374, FI 1246/6-1, FI 1246/9-1]	DFG (German Research Foundation) in the framework of the Biodiversity Exploratories "Infrastructure-Biodiversity-Exploratories"(German Research Foundation (DFG))	The DFG (German Research Foundation; http://www.dfg.de/en/index.jsp) funded the study in the framework of the Biodiversity Exploratories SSP 1374 "Infrastructure-Biodiversity-Exploratories" (FI 1246/6-1, FI 1246/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamini A, 2005, CONSERV BIOL, V19, P1051, DOI 10.1111/j.1523-1739.2005.00086.x; Berge E, 1998, TELLUS B, V50, P205, DOI 10.1034/j.1600-0889.1998.t01-2-00001.x; Caruso A, 2008, BIOL CONSERV, V141, P47, DOI 10.1016/j.biocon.2007.08.021; Edman M, 2008, J APPL ECOL, V45, P26, DOI 10.1111/j.1365-2664.2007.01354.x; Ellenberg H., 2010, OKOLOGISCHER DYNAMIS; Fedrowitz K, 2012, J APPL ECOL, V49, P493, DOI 10.1111/j.1365-2664.2012.02113.x; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Friedel A., 2006, Feddes Repertorium, V117, P172, DOI 10.1002/fedr.200511084; Fritz O, 2008, BIOL CONSERV, V141, P655, DOI 10.1016/j.biocon.2007.12.006; Fritz O, 2010, BIOL CONSERV, V143, P1008, DOI 10.1016/j.biocon.2010.01.016; Fritz O, 2009, APPL VEG SCI, V12, P93, DOI 10.1111/j.1654-109X.2009.01007.x; Gilbert Oliver L., 1992, P159; Graae BJ, 1997, FOREST ECOL MANAG, V96, P111, DOI 10.1016/S0378-1127(97)00046-7; Gustafsson L, 2004, BASIC APPL ECOL, V5, P123, DOI 10.1078/1439-1791-00223; Hessenmoller D., 2011, Forstarchiv, V82, P171; Horstkotte T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028779; Humphrey JW, 2002, BIOL CONSERV, V107, P165, DOI 10.1016/S0006-3207(02)00057-5; Jairus K, 2009, J APPL ECOL, V46, P930, DOI 10.1111/j.1365-2664.2009.01672.x; Juriado I, 2009, BIODIVERS CONSERV, V18, P105, DOI 10.1007/s10531-008-9460-y; Kirschbaum U, 2006, GEFAHRST REINHALT L, V66, P272; LESICA P, 1991, CAN J BOT, V69, P1745, DOI 10.1139/b91-222; Lohmus A, 2007, BIOL CONSERV, V135, P405, DOI 10.1016/j.biocon.2006.10.015; Lohmus A, 2010, BIOL CONSERV, V143, P891, DOI 10.1016/j.biocon.2009.12.036; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Marmor L, 2011, ECOL INDIC, V11, P1270, DOI 10.1016/j.ecolind.2011.01.009; Moning C, 2009, ECOL INDIC, V9, P922, DOI 10.1016/j.ecolind.2008.11.002; Moning C, 2009, FOREST ECOL MANAG, V258, P745, DOI 10.1016/j.foreco.2009.05.015; Muir PS, 2006, ECOL APPL, V16, P1207, DOI 10.1890/1051-0761(2006)016[1207:IOOROG]2.0.CO;2; Nascimbene J, 2007, FOREST ECOL MANAG, V247, P43, DOI 10.1016/j.foreco.2007.04.011; Nascimbene J, 2010, FOREST ECOL MANAG, V260, P603, DOI 10.1016/j.foreco.2010.05.016; Neitlich PN, 1997, CONSERV BIOL, V11, P172, DOI 10.1046/j.1523-1739.1997.95492.x; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Parviainen J, 2003, J ENVIRON MANAGE, V67, P27, DOI 10.1016/S0301-4797(02)00185-8; Parviainen J, 2000, FORESTRY, V73, P107, DOI 10.1093/forestry/73.2.107; Perhans K, 2009, BIOL CONSERV, V142, P1125, DOI 10.1016/j.biocon.2008.12.033; Peterson EB, 2001, J VEG SCI, V12, P511, DOI 10.2307/3237003; Purvis OW, 2010, SYST BIODIVERS, V8, P193, DOI 10.1080/14772001003782088; PYKALA J, 2006, BASIC APPL ECOL, V223, P84, DOI DOI 10.1016/J.FORECO.2005.10.059; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ranius T, 2008, J VEG SCI, V19, P653, DOI 10.3170/2008-8-18433; Rolstad J, 2001, ECOL APPL, V11, P421, DOI 10.1890/1051-0761(2001)011[0421:ELINCS]2.0.CO;2; Rose Francis, 1992, P211; Rudolphi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018639; Scheidegger Christoph, 2009, Fungal Biology Reviews, V23, P55, DOI 10.1016/j.fbr.2009.10.003; Seaward MRD, 2008, LICHEN BIOLOGY, 2ND EDITION, P274, DOI 10.1017/CBO9780511790478.015; Sillett SC, 2000, ECOL APPL, V10, P789, DOI 10.1890/1051-0761(2000)010[0789:DLOELR]2.0.CO;2; Svoboda D, 2010, ENVIRON POLLUT, V158, P812, DOI 10.1016/j.envpol.2009.10.001; Thor Goran, 1995, Mitteilungen der Eidgenoessischen Forschungsanstalt fuer Wald Schnee und Landschaft, V70, P29; Uliczka H, 2000, BIOL CONSERV, V95, P343, DOI 10.1016/S0006-3207(00)00022-7; Umweltbundesamt, 2005, DAT UMW ZUST UMW DEU; Werth S, 2006, ECOLOGY, V87, P2037, DOI 10.1890/0012-9658(2006)87[2037:QDAELI]2.0.CO;2; Wirth V., 1996, SCHRIFTENREIHE VEGET, V28, P307; Wolseley PA, 2006, LICHENOLOGIST, V38, P307, DOI 10.1017/S0024282906006190	53	62	69	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55461	10.1371/journal.pone.0055461	http://dx.doi.org/10.1371/journal.pone.0055461			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	24358373	Green Published, gold, Green Submitted			2022-12-27	WOS:000315483200052
J	Tandon, M; Johnson, J; Li, ZH; Xu, SP; Wipf, P; Wang, QJ				Tandon, Manuj; Johnson, James; Li, Zhihong; Xu, Shuping; Wipf, Peter; Wang, Qiming Jane			New Pyrazolopyrimidine Inhibitors of Protein Kinase D as Potent Anticancer Agents for Prostate Cancer Cells	PLOS ONE			English	Article							IN-VIVO; C-MU; GROWTH; IDENTIFICATION; PROLIFERATION; ACTIVATION; EXPRESSION; SLINGSHOT; EPIDERMIS; INVASION	The emergence of protein kinase D (PKD) as a potential therapeutic target for several diseases including cancer has triggered the search for potent, selective, and cell-permeable small molecule inhibitors. In this study, we describe the identification, in vitro characterization, structure-activity analysis, and biological evaluation of a novel PKD inhibitory scaffold exemplified by 1-naphthyl PP1 (1-NA-PP1). 1-NA-PP1 and IKK-16 were identified as pan-PKD inhibitors in a small-scale targeted kinase inhibitor library assay. Both screening hits inhibited PKD isoforms at about 100 nM and were ATP-competitive inhibitors. Analysis of several related kinases indicated that 1-NA-PP1 was highly selective for PKD as compared to IKK-16. SAR analysis showed that 1-NA-PP1 was considerably more potent and showed distinct substituent effects at the pyrazolopyrimidine core. 1-NA-PP1 was cell-active, and potently blocked prostate cancer cell proliferation by inducing G2/M arrest. It also potently blocked the migration and invasion of prostate cancer cells, demonstrating promising anticancer activities on multiple fronts. Overexpression of PKD1 or PKD3 almost completely reversed the growth arrest and the inhibition of tumor cell invasion caused by 1-NA-PP1, indicating that its anti-proliferative and anti-invasive activities were mediated through the inhibition of PKD. Interestingly, a 12-fold increase in sensitivity to 1-NA-PP1 could be achieved by engineering a gatekeeper mutation in the active site of PKD1, suggesting that 1-NA-PP1 could be paired with the analog-sensitive PKD1(M659G) for dissecting PKD-specific functions and signaling pathways in various biological systems.	[Tandon, Manuj; Li, Zhihong; Xu, Shuping; Wang, Qiming Jane] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Johnson, James; Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Johnson, James; Wipf, Peter] Univ Pittsburgh, Ctr Chem Methodol & Lib Dev, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wipf, P (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.	pwipf@pitt.edu; qjw1@pitt.edu	Wang, Qiming Jane/B-6064-2012; Wipf, Peter/AAG-1771-2021; Johnson, Eric/C-5668-2012	Wang, Qiming Jane/0000-0002-9502-4851; Wipf, Peter/0000-0001-7693-5863; Johnson, Eric/0000-0001-7797-8347; Baker, Tom/0000-0002-0876-2312	National Institutes of Health [R01CA129127-01, R01CA142580-01, P50-GM067082]; NATIONAL CANCER INSTITUTE [R01CA142580, R01CA129127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM067082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (R01CA129127-01, R01CA142580-01, and P50-GM067082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Azoitei N, 2011, NEURO-ONCOLOGY, V13, P710, DOI 10.1093/neuonc/nor084; Barluenga J, 1999, PURE APPL CHEM, V71, P431, DOI 10.1351/pac199971030431; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Bishop AC, 1999, J AM CHEM SOC, V121, P627, DOI 10.1021/ja983267v; Biswas MHU, 2010, CANCER RES, V70, P2095, DOI 10.1158/0008-5472.CAN-09-4155; Bravo-Altamirano K, 2011, ACS MED CHEM LETT, V2, P154, DOI 10.1021/ml100230n; Chen J, 2008, CANCER RES, V68, P3844, DOI 10.1158/0008-5472.CAN-07-5156; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Endo S, 2006, BIOCHEM BIOPH RES CO, V341, P261, DOI 10.1016/j.bbrc.2005.12.179; Evans IM, 2010, BIOCHEM J, V429, P565, DOI 10.1042/BJ20100578; Gamber GG, 2011, BIOORG MED CHEM LETT, V21, P1447, DOI 10.1016/j.bmcl.2011.01.014; George Kara M, 2011, Pharmaceutics, V3, P186, DOI 10.3390/pharmaceutics3020186; Guo J, 2012, CANC CHEMOTHER PHARM; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Huynh QK, 2006, ARCH BIOCHEM BIOPHYS, V450, P141, DOI 10.1016/j.abb.2006.02.014; Kuan YH, 2006, BIOCHEM PHARMACOL, V71, P1735, DOI 10.1016/j.bcp.2006.03.012; LaValle CR, 2010, BBA-REV CANCER, V1806, P183, DOI 10.1016/j.bbcan.2010.05.003; LaValle Courtney R., 2010, BMC Chemical Biology, V10, P5, DOI 10.1186/1472-6769-10-5; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Meredith EL, 2010, J MED CHEM, V53, P5400, DOI 10.1021/jm100075z; Meredith EL, 2010, J MED CHEM, V53, P5422, DOI 10.1021/jm100076w; Monovich L, 2010, FEBS LETT, V584, P631, DOI 10.1016/j.febslet.2009.12.014; Murphy RC, 2010, ACS MED CHEM LETT, V1, P331, DOI 10.1021/ml100096t; Niswender CM, 2002, J BIOL CHEM, V277, P28916, DOI 10.1074/jbc.M203327200; O'Dwyer M E, 2000, Lancet Oncol, V1, P207, DOI 10.1016/S1470-2045(00)00149-2; Ochi N, 2011, J CELL PHYSIOL, V226, P1074, DOI 10.1002/jcp.22421; Oumata N, 2008, J MED CHEM, V51, P5229, DOI 10.1021/jm800109e; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Rennecke J, 1999, INT J CANCER, V80, P98, DOI 10.1002/(SICI)1097-0215(19990105)80:1<98::AID-IJC19>3.3.CO;2-4; Ristich VL, 2006, BRIT J DERMATOL, V154, P586, DOI 10.1111/j.1365-2133.2005.07073.x; Sharlow ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025134; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Sreenivasan A, 2003, MOL CELL BIOL, V23, P6327, DOI 10.1128/MCB.23.17.6327-6337.2003; Tandon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044653; Todorovic N, 2011, TETRAHEDRON LETT, V52, P5761, DOI 10.1016/j.tetlet.2011.08.103; Verheijen JC, 2009, J MED CHEM, V52, P8010, DOI 10.1021/jm9013828; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Weiss EL, 2000, NAT CELL BIOL, V2, P677, DOI 10.1038/35036300	44	36	42	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75601	10.1371/journal.pone.0075601	http://dx.doi.org/10.1371/journal.pone.0075601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24367484	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200115
J	Hung, CM; Lin, RC; Chu, JH; Yeh, CF; Yao, CJ; Li, SH				Hung, Chih-Ming; Lin, Rong-Chien; Chu, Jui-Hua; Yeh, Chia-Fen; Yao, Chiou-Ju; Li, Shou-Hsien			The De Novo Assembly of Mitochondrial Genomes of the Extinct Passenger Pigeon (Ectopistes migratorius) with Next Generation Sequencing	PLOS ONE			English	Article							ANCIENT DNA; NUCLEAR GENOME; AMPLIFICATION; MTDNA	The information from ancient DNA (aDNA) provides an unparalleled opportunity to infer phylogenetic relationships and population history of extinct species and to investigate genetic evolution directly. However, the degraded and fragmented nature of aDNA has posed technical challenges for studies based on conventional PCR amplification. In this study, we present an approach based on next generation sequencing to efficiently sequence the complete mitochondrial genome (mitogenome) of two extinct passenger pigeons (Ectopistes migratorius) using de novo assembly of massive short (90 bp), paired-end or single-end reads. Although varying levels of human contamination and low levels of postmortem nucleotide lesion were observed, they did not impact sequencing accuracy. Our results demonstrated that the de novo assembly of shotgun sequence reads could be a potent approach to sequence mitogenomes, and offered an efficient way to infer evolutionary history of extinct species.	[Hung, Chih-Ming] Univ Minnesota, Bell Museum, St Paul, MN 55108 USA; [Hung, Chih-Ming] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Hung, Chih-Ming; Lin, Rong-Chien; Chu, Jui-Hua; Yeh, Chia-Fen; Li, Shou-Hsien] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Yao, Chiou-Ju] Natl Museum Nat Sci, Dept Biol, Taichung, Taiwan	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Taiwan Normal University	Li, SH (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	t43028@ntnu.edu.tw	Kuan, Yu-Hsiang/R-1181-2019	Kuan, Yu-Hsiang/0000-0002-8991-6394	National Science Council of Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This project is funded by the National Science Council of Taiwan to SHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson E, 2008, MOL BIOL EVOL, V25, P2181, DOI 10.1093/molbev/msn163; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Cassista S, 2009, UNDERGRADUATE J ANTH, V1, P141; Catling Paul M., 2001, Biodiversity, V2, P2; COLLURA RV, 1995, NATURE, V378, P485, DOI 10.1038/378485a0; Dalen L, 2007, P NATL ACAD SCI USA, V104, P6726, DOI 10.1073/pnas.0701341104; de Moraes-Barros N, 2007, GENET MOL BIOL, V30, P1181, DOI 10.1590/S1415-47572007000600024; Edwards CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009255; Ermini L, 2008, CURR BIOL, V18, P1687, DOI 10.1016/j.cub.2008.09.028; Gilbert MTP, 2008, P NATL ACAD SCI USA, V105, P8327, DOI 10.1073/pnas.0802315105; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Gregory T.R., 2005, ANIMAL GENOME SIZE D; Ho SYW, 2010, MITOCHONDRION, V10, P1, DOI 10.1016/j.mito.2009.09.005; Kan XZ, 2010, GENET MOL RES, V9, P1234, DOI 10.4238/vol9-2gmr853; Knapp M, 2010, GENES-BASEL, V1, P227, DOI 10.3390/genes1020227; Krause J, 2006, NATURE, V439, P724, DOI 10.1038/nature04432; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Leonard JA, 2008, MOL ECOL, V17, P4186, DOI 10.1111/j.1365-294X.2008.03891.x; Lindqvist C, 2010, P NATL ACAD SCI USA, V107, P5053, DOI 10.1073/pnas.0914266107; LOPEZ JV, 1994, J MOL EVOL, V39, P174; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Millar CD, 2008, TRENDS ECOL EVOL, V23, P386, DOI 10.1016/j.tree.2008.04.002; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Miller W, 2009, GENOME RES, V19, P213, DOI 10.1101/gr.082628.108; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Oskam CL, 2010, P ROY SOC B-BIOL SCI, V277, P1991, DOI 10.1098/rspb.2009.2019; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Poulakakis N, 2008, P NATL ACAD SCI USA, V105, P15464, DOI 10.1073/pnas.0805340105; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rawlence NJ, 2009, P ROY SOC B-BIOL SCI, V276, P3395, DOI 10.1098/rspb.2009.0755; Rohland N, 2004, BIOTECHNIQUES, V36, P814, DOI 10.2144/04365ST05; Rowe KC, 2011, MOL ECOL RESOUR, V11, P1082, DOI 10.1111/j.1755-0998.2011.03052.x; Schorger A, 1955, PASSENGER PIGEON; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Shapiro B, 2002, SCIENCE, V295, P1683, DOI 10.1126/science.295.5560.1683; Stiller M, 2009, GENOME RES, V19, P1843, DOI 10.1101/gr.095760.109	42	55	55	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56301	10.1371/journal.pone.0056301	http://dx.doi.org/10.1371/journal.pone.0056301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437111	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200057
J	Anderson, KE; Sheehan, TH; Mott, BM; Maes, P; Snyder, L; Schwan, MR; Walton, A; Jones, BM; Corby-Harris, V				Anderson, Kirk E.; Sheehan, Timothy H.; Mott, Brendon M.; Maes, Patrick; Snyder, Lucy; Schwan, Melissa R.; Walton, Alexander; Jones, Beryl M.; Corby-Harris, Vanessa			Microbial Ecology of the Hive and Pollination Landscape: Bacterial Associates from Floral Nectar, the Alimentary Tract and Stored Food of Honey Bees (Apis mellifera)	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; GUT BACTERIA; SYMBIONTS; COMMUNITIES; EVOLUTION; MICROFLORA; DIVERSITY; POLLEN; ANTS; MICROORGANISMS	Nearly all eukaryotes are host to beneficial or benign bacteria in their gut lumen, either vertically inherited, or acquired from the environment. While bacteria core to the honey bee gut are becoming evident, the influence of the hive and pollination environment on honey bee microbial health is largely unexplored. Here we compare bacteria from floral nectar in the immediate pollination environment, different segments of the honey bee (Apis mellifera) alimentary tract, and food stored in the hive (honey and packed pollen or "beebread''). We used cultivation and sequencing to explore bacterial communities in all sample types, coupled with culture-independent analysis of beebread. We compare our results from the alimentary tract with both culture-dependent and culture-independent analyses from previous studies. Culturing the foregut (crop), midgut and hindgut with standard media produced many identical or highly similar 16S rDNA sequences found with 16S rDNA clone libraries and next generation sequencing of 16S rDNA amplicons. Despite extensive culturing with identical media, our results do not support the core crop bacterial community hypothesized by recent studies. We cultured a wide variety of bacterial strains from 6 of 7 phylogenetic groups considered core to the honey bee hindgut. Our results reveal that many bacteria prevalent in beebread and the crop are also found in floral nectar, suggesting frequent horizontal transmission. From beebread we uncovered a variety of bacterial phylotypes, including many possible pathogens and food spoilage organisms, and potentially beneficial bacteria including Lactobacillus kunkeei, Acetobacteraceae and many different groups of Actinobacteria. Contributions of these bacteria to colony health may include general hygiene, fungal and pathogen inhibition and beebread preservation. Our results are important for understanding the contribution to pollinator health of both environmentally vectored and core microbiota, and the identification of factors that may affect bacterial detection and transmission, colony food storage and disease susceptibility.	[Anderson, Kirk E.] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA; [Anderson, Kirk E.; Sheehan, Timothy H.; Mott, Brendon M.; Maes, Patrick; Snyder, Lucy; Schwan, Melissa R.; Walton, Alexander; Jones, Beryl M.; Corby-Harris, Vanessa] USDA ARS Carl Hayden Bee Res Ctr, Tucson, AZ USA; [Sheehan, Timothy H.; Maes, Patrick] Univ Arizona, Dept Microbiol, Tucson, AZ USA; [Mott, Brendon M.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Walton, Alexander] Iowa State Univ, Dept Ecol & Evolut, Ames, IA USA; [Jones, Beryl M.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA	University of Arizona; University of Arizona; Arizona State University; Arizona State University-Tempe; Iowa State University; University of Illinois System; University of Illinois Urbana-Champaign	Anderson, KE (corresponding author), Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA.	kirk.anderson@ars.usda.gov	Jones, Beryl/N-5842-2019; Walton, Alexander/W-5786-2019	Jones, Beryl/0000-0003-2925-0807; Walton, Alexander/0000-0001-8635-873X; Anderson, Karen/0000-0002-7394-6660; Hawkins, Phillip/0000-0002-6979-0464; Corby-Harris, Vanessa/0000-0001-7680-0328; stephens, len/0000-0002-2771-3487; Durrant, Tom N/0000-0002-0503-9364	Agricultural Research Service-U.S. Department of Agriculture Carl Hayden Bee Research Center, Tucson AZ; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0413, BB/I003916/1, BBS/E/B/000C0415] Funding Source: researchfish	Agricultural Research Service-U.S. Department of Agriculture Carl Hayden Bee Research Center, Tucson AZ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided entirely by the USA tax-payer supported operating budget of the Agricultural Research Service-U.S. Department of Agriculture Carl Hayden Bee Research Center, Tucson AZ. There were no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2012, J MICROBIOL, V50, P735, DOI 10.1007/s12275-012-2188-0; Alvarez-Perez S, 2012, FEMS MICROBIOL ECOL, V80, P591, DOI 10.1111/j.1574-6941.2012.01329.x; Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Anderson KE, 2012, MOL ECOL, V21, P2282, DOI 10.1111/j.1365-294X.2011.05464.x; Aween MM, 2012, J FOOD SCI, V77, pM364, DOI 10.1111/j.1750-3841.2012.02776.x; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Barke J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-109; Bottacini F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044229; Brucker RM, 2012, EVOLUTION, V66, P349, DOI 10.1111/j.1558-5646.2011.01454.x; Bution ML, 2008, MICRON, V39, P897, DOI 10.1016/j.micron.2007.11.008; Chen YP, 2010, APIDOLOGIE, V41, P364, DOI 10.1051/apido/2010021; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; CRAILSHEIM K, 1988, J INSECT PHYSIOL, V34, P85, DOI 10.1016/0022-1910(88)90158-8; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; DAESCHEL MA, 1987, FEMS MICROBIOL LETT, V46, P357, DOI 10.1111/j.1574-6968.1987.tb02472.x; Dawkins R, 2004, BIOL PHILOS, V19, P377, DOI 10.1023/B:BIPH.0000036180.14904.96; DeSantis TZ, 2006, APPL ENV MICROBIOL; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Disayathanoowat T, 2012, FEMS MICROBIOL ECOL, V79, P273, DOI 10.1111/j.1574-6941.2011.01216.x; Endo A, 2011, INT J SYST EVOL MICR; Endo A, 2009, SYST APPL MICROBIOL, V32, P593, DOI 10.1016/j.syapm.2009.08.002; Engel, 2013, INT J SYST EVOL MICR, DOI 10.109.; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Evans J, 2006, J MOL EVOL, V62, P785, DOI 10.1007/s00239-005-0176-2; Evans Jay D., 2006, BMC Ecology, V6, P4, DOI 10.1186/1472-6785-6-4; Feldhaar Heike, 2009, Journal of Biology (London), V8, P31, DOI 10.1186/jbiol129; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Fridman S, 2012, ENV MICROBIOL REP, V4, P97, DOI 10.1111/j.1758-2229.2011.00309.x; Gibson CM, 2010, ECOL LETT, V13, P223, DOI 10.1111/j.1461-0248.2009.01416.x; GILLIAM M, 1987, J INVERTEBR PATHOL, V49, P70, DOI 10.1016/0022-2011(87)90127-3; GILLIAM M, 1983, J INVERTEBR PATHOL, V42, P187, DOI 10.1016/0022-2011(83)90061-7; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Gordon DM, 2001, MICROBIOL-SGM, V147, P1079, DOI 10.1099/00221287-147-5-1079; GOTELLI NJ, 2002, ECOSIM NULL MODELS S; Gupta AK, 2012, FEMS MICROBIOL ECOL, V79, P581, DOI 10.1111/j.1574-6941.2011.01248.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hendriksma HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059589; Garcia AH, 2011, J BIOSCIENCES, V36, P939, DOI 10.1007/s12038-011-9107-0; Holldobler B., 2008, SUPERORGANISM BEAUTY; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hughes DP, 2008, TRENDS ECOL EVOL, V23, P672, DOI 10.1016/j.tree.2008.07.011; INGLIS GD, 1993, MICROBIAL ECOL, V26, P125, DOI 10.1007/BF00177048; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Jojima Y, 2004, INT J SYST EVOL MICR, V54, P2263, DOI 10.1099/ijs.0.02911-0; Judd T. M., 2011, SOCIAL INSECTS STRUC; Kacaniova M, 2004, FOLIA MICROBIOL, V49, P169, DOI 10.1007/BF02931394; Kaltenpoth M, 2009, TRENDS MICROBIOL, V17, P529, DOI 10.1016/j.tim.2009.09.006; Kautz S, 2013, APPL ENVIRON MICROB, V79, P525, DOI 10.1128/AEM.03107-12; Kikuchi Y, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-2; Koch H, 2013, MOL ECOL, V22, P2028, DOI 10.1111/mec.12209; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; Kwong WK, 2013, INT J SYST EVOL MICR, V63, P2008, DOI 10.1099/ijs.0.044875-0; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOPER GM, 1980, APIDOLOGIE, V11, P63, DOI 10.1051/apido:19800108; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Mattila HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032962; McFrederick QS, 2013, APPL ENVIRON MICROB, V79, P1803, DOI 10.1128/AEM.03681-12; McFrederick QS, 2012, MOL ECOL, V21, P1754, DOI 10.1111/j.1365-294X.2012.05496.x; Michener C.D., 1986, Contributions of the American Entomological Institute, V22, P1; Microbiome F, 2013, UNEXPECTED DIVERSITY, DOI [10.1128/mBio.00602-12, DOI 10.1128/MBI0.00602-12.EDIT0R]; Millet V, 2000, LETT APPL MICROBIOL, V30, P136, DOI 10.1046/j.1472-765X.2000.00684.x; Mohr KI, 2007, APPL MICROBIOL BIOT, V75, P573, DOI 10.1007/s00253-007-0846-7; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Neveling DP, 2012, CURR MICROBIOL; Newton ILG, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-221; Ohkuma M., 2001, RIKEN REV, V41, P69; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; Olofsson TC, 2009, J APICULT RES, V48, P233, DOI 10.3896/IBRA.1.48.4.02; PAIN JANINE, 1966, ANN ABEILLE [PARIS], V9, P209, DOI 10.1051/apido:19660302; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Promnuan Y, 2009, WORLD J MICROB BIOT, V25, P1685, DOI 10.1007/s11274-009-0051-1; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rada V, 1997, APIDOLOGIE, V28, P357, DOI 10.1051/apido:19970603; Rangberg A, 2012, INTEGR COMP BIOL, V52, P89, DOI 10.1093/icb/ics089; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rosengaus RB, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.31; RUIZARGU.T, 1973, J GEN MICROBIOL, V76, P211, DOI 10.1099/00221287-76-1-211; RUIZARGUESO T, 1975, APPL MICROBIOL, V30, P893, DOI 10.1128/AEM.30.6.893-896.1975; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Russell JA, 2009, P NATL ACAD SCI USA, V106, P21236, DOI 10.1073/pnas.0907926106; Sabree ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041250; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Seipke RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022028; Shamala TR, 2000, LETT APPL MICROBIOL, V30, P453, DOI 10.1046/j.1472-765X.2000.00746.x; SUZUKI I, 1991, MILCHWISSENSCHAFT, V46, P635; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TROYER K, 1984, BEHAV ECOL SOCIOBIOL, V14, P189, DOI 10.1007/BF00299618; Turner J. Scott, 2005, American Entomologist, V51, P36; Turner JS, 2004, BIOL PHILOS, V19, P327, DOI 10.1023/B:BIPH.0000036115.65522.a1; Vasquez A, 2011, MICROBIOLOGY TODAY, V38, P226; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Vasquez A, 2009, J APICULT RES, V48, P189, DOI 10.3896/IBRA.1.48.3.07; VIDAVER AK, 1982, ANNU REV MICROBIOL, V36, P495, DOI 10.1146/annurev.mi.36.100182.002431; Vojvodic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072106; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	106	215	222	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83125	10.1371/journal.pone.0083125	http://dx.doi.org/10.1371/journal.pone.0083125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358254	gold, Green Published, Green Submitted			2022-12-27	WOS:000328737700049
J	Welch, JR; Brondizio, ES; Hetrick, SS; Coimbra, CEA				Welch, James R.; Brondizio, Eduardo S.; Hetrick, Scott S.; Coimbra, Carlos E. A., Jr.			Indigenous Burning as Conservation Practice: Neotropical Savanna Recovery amid Agribusiness Deforestation in Central Brazil	PLOS ONE			English	Article							CERRADO VEGETATION; FIRE MANAGEMENT; CLIMATE-CHANGE; MATO-GROSSO; PEOPLES; ABUNDANCE; FORESTS	International efforts to address climate change by reducing tropical deforestation increasingly rely on indigenous reserves as conservation units and indigenous peoples as strategic partners. Considered win-win situations where global conservation measures also contribute to cultural preservation, such alliances also frame indigenous peoples in diverse ecological settings with the responsibility to offset global carbon budgets through fire suppression based on the presumed positive value of non-alteration of tropical landscapes. Anthropogenic fire associated with indigenous ceremonial and collective hunting practices in the Neotropical savannas (cerrado) of Central Brazil is routinely represented in public and scientific conservation discourse as a cause of deforestation and increased CO2 emissions despite a lack of supporting evidence. We evaluate this claim for the Xavante people of Pimentel Barbosa Indigenous Reserve, Brazil. Building upon 23 years of longitudinal interdisciplinary research in the area, we used multi-temporal spatial analyses to compare land cover change under indigenous and agribusiness management over the last four decades (1973-2010) and quantify the contemporary Xavante burning regime contributing to observed patterns based on a four year sample at the end of this sequence (2007-2010). The overall proportion of deforested land remained stable inside the reserve (0.6%) but increased sharply outside (1.5% to 26.0%). Vegetation recovery occurred where reserve boundary adjustments transferred lands previously deforested by agribusiness to indigenous management. Periodic traditional burning by the Xavante had a large spatial distribution but repeated burning in consecutive years was restricted. Our results suggest a need to reassess overreaching conservation narratives about the purported destructiveness of indigenous anthropogenic fire in the cerrado. The real challenge to conservation in the fire-adapted cerrado biome is the long-term sustainability of indigenous lands and other tropical conservation islands increasingly subsumed by agribusiness expansion rather than the localized subsistence practices of indigenous and other traditional peoples.	[Welch, James R.; Coimbra, Carlos E. A., Jr.] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil; [Brondizio, Eduardo S.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [Brondizio, Eduardo S.; Hetrick, Scott S.] Indiana Univ, Anthropol Ctr Training & Res Global Environm Chan, Bloomington, IN USA	Fundacao Oswaldo Cruz; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Welch, JR (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil.	welch@ensp.fiocruz.br	Brondizio, Eduardo/R-7643-2019; Welch, James R/B-5042-2013	Welch, James R/0000-0002-9094-5491; Chunco, Amanda/0000-0002-8265-327X; Coimbra Jr., Carlos E. A./0000-0003-4085-1080	Brazilian National School of Public Health (INOVA-ENSP program); Fulbright Commission (Fulbright-Hays DDRAF) [P022A040016]; Brazilian Research Council (CNPq) [475674/2008-1, 403569/2008-7, 500072/2010-8]	Brazilian National School of Public Health (INOVA-ENSP program); Fulbright Commission (Fulbright-Hays DDRAF); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financing was provided by the Brazilian National School of Public Health (INOVA-ENSP program), the Fulbright Commission (Fulbright-Hays DDRAF no. P022A040016), and the Brazilian Research Council (CNPq grants 475674/2008-1, 403569/2008-7, and 500072/2010-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSON PH, 1987, SCIENCE, V235, P1450, DOI 10.1126/science.235.4795.1450; Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; [Anonymous], BIODIVERS BRAS; [Anonymous], 2002, XAVANTE TRANSITION H; [Anonymous], 2011, BIODIVERS BRAS; [Anonymous], 2006, SAVANA DRY FORESTS L; [Anonymous], 2013, HUMAN ENV INTERACTIO; Aragao LEOC, 2010, SCIENCE, V328, P1275, DOI 10.1126/science.1186925; Birrell K, 2012, J HUM RIGHTS ENVIRON, V3, P196, DOI 10.4337/jhre.2012.03.02; Boer MM, 2009, FOREST ECOL MANAG, V259, P132, DOI 10.1016/j.foreco.2009.10.005; Briani DC, 2004, BIODIVERS CONSERV, V13, P1023, DOI 10.1023/B:BIOC.0000014467.27138.0b; Brondizio ES, 2009, ANNU REV ENV RESOUR, V34, P253, DOI 10.1146/annurev.environ.020708.100707; Cavalcanti Roberto B., 1997, Ornitologia Neotropical, V8, P85; COUTINHO LM, 1990, ECOL STU AN, V84, P82; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; De Castro EA, 1998, J TROP ECOL, V14, P263, DOI 10.1017/S0266467498000212; de Melo MM, 2013, SOC NATUR RESOUR, V26, P478, DOI 10.1080/08941920.2012.713087; Diaz M.d.C.V., 2002, PRECO OCULTO FOGO AM; EITEN G, 1972, BOT REV, V38, P201, DOI 10.1007/BF02859158; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Ferreira JuCnior L.G, 2011, REV BRASILEIRA CARTO, V63, P461; Flowers N. M., 1983, ADAPTIVE RESPONSES N, P357; FRIZZO, 2011, OECOLOGIA AUSTR RIO, V15, P365, DOI DOI 10.4257/0EC0.2011.1502.13; Garfield S, 2001, INDIGENOUS STRUGGLE; Georgescu M, 2013, GEOPHYS RES LETT, V40, P972, DOI 10.1002/grl.50206; GROSS DR, 1979, SCIENCE, V206, P1043, DOI 10.1126/science.206.4422.1043; Hecht S. B., 2009, P143, DOI 10.1007/978-1-4020-9031-8_7; Kassu Milanez F, 2010, AGUA BOA NEWS   1212; Klink C.A., 2002, CERRADOS BRAZIL ECOL, P69, DOI DOI 10.7312/0LIV12042; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Leach M, 2012, J PEASANT STUD, V39, P285, DOI 10.1080/03066150.2012.658042; Ledru Marie-Pierre., 2002, CERRADOS BRAZIL ECOL, P33; Leeuwenberg FJ, 2000, BIOL RESOURCE MANAGE, P375; Leite DLP, 2007, THESIS U BRASILIA BR; Leonel M., 2000, ESTUD AV-SAO PAULO, V14, P231, DOI [10.1590/S0103-40142000000300019, DOI 10.1590/S0103-40142000000300019]; McGregor S, 2010, HUM ECOL, V38, P721, DOI 10.1007/s10745-010-9362-y; Miranda H.S., 2002, CERRADOS BRAZIL ECOL, P51, DOI 10.7312/oliv12042-005; Mistry J, 1998, PROG PHYS GEOG, V22, P425, DOI 10.1177/030913339802200401; Mistry J, 2005, HUM ECOL, V33, P365, DOI 10.1007/s10745-005-4143-8; Mittermeier Russell A., 2004, P1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nascimento LJ, 2013, G1 MATO GROSSO  0820; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Oliveira M, 2001, DIARIO CUIABA   0814; Pereira C. A., 2004, Floresta, V34, P95; Phalan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051759; Pivello VR, 2011, FIRE ECOL, V7, P24, DOI 10.4996/fireecology.0701024; Prada M, 1995, BIOTROPICA, V27, P513, DOI 10.2307/2388965; Prada M, 2004, AUSTRAL ECOL, V29, P568, DOI 10.1111/j.1442-9993.2004.01391.x; Prada M, 2001, MAMMALIA, V65, P55, DOI 10.1515/mamm.2001.65.1.55; Ramos-Neto MB, 2000, ENVIRON MANAGE, V26, P675, DOI 10.1007/s002670010124; Ratter JA, 1997, ANN BOT-LONDON, V80, P223, DOI 10.1006/anbo.1997.0469; Ricketts TH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000331; Simon MF, 2009, P NATL ACAD SCI USA, V106, P20359, DOI 10.1073/pnas.0903410106; Soares R. V., 2002, Floresta, V32, P219; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Turnhout E, 2012, NATURE, V488, P454, DOI 10.1038/488454a; United Nations, 2012, 2 SESS PLEN M DET MO; van Dam C, 2011, FORESTS, V2, P394, DOI 10.3390/f2010394; van Wilgen BW, 2010, J APPL ECOL, V47, P631, DOI 10.1111/j.1365-2664.2010.01800.x; VanWey LK, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0168; Villalobos M. P., 2002, THESIS U BRASILIA BR; VITT LJ, 1993, J HERPETOL, V27, P46, DOI 10.2307/1564904; WARMING Eugenius, 1892, LAGOA SANTA BIDRAG B; WELCH J. R., 2013, PRIMEIRA MARGEM RIO; Welch JR, 2009, HUM ECOL, V37, P13, DOI 10.1007/s10745-009-9216-7; Whitehead PJ, 2003, INT J WILDLAND FIRE, V12, P415, DOI 10.1071/WF03027	67	82	98	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81226	10.1371/journal.pone.0081226	http://dx.doi.org/10.1371/journal.pone.0081226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EG	24349045	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300022
